Citrus Sinensis ID: 016481

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------39
Protein Sequence
MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKDSQCN
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccccccHHHHHHHHcccccccccccccccEEEEEEEcccccccccccEEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccEEccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHcccccccccEEEEEEccccccccccEEEEEEEEcccccccccHHHHHHHHHHHHHcccccEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEcccHccEEEcccccccHcHccccccccccccccEEEEEcccccHccHHHHHHccccHHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHHccHcccccHHHHHHHHHHHcccccccccccccccEcccccccccccccccccc
Coil and Loop (DISEMBL)
mgncwckwepsvyivssnpksespkdespsekakkeysklpsnpeevedlrrdsaanpliaftyDELRIITANfrqdrvlggggfgcvyKGFISedlreglqpvpvavkvhdgdnsyqgHREWLAEVIFLghlshpnlVKLIGYCCEDEHRVLIYEFMARgsvennlfskvllplpwsiRMKIAFGAAKGLAFLheaekpviyrdfktsnilldtdynaklsdfglakdgpegdkshvstrimgtygyaapeyimtghltprsdvysFGVVLLEILTGrksldksrparEQNLADWALPLLKEKKKLLNIidprlegdypvkgVHKAAMLAYHClnhnpkarplMRDIVdsleplqvlpdeaptpknfvtvvtpeepkaeiqtkdsqcn
Flexible Loop (DISEMBL)
mgncwckwepsvyivssnpksespkdespsekakkeysklpsnpeevedlrrdsAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDfglakdgpegdkshvstRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTgrksldksrpareqnladwalplLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLqvlpdeaptpknfVTVVTPeepkaeiqtkdsqcn
Low Complexity Region (SEG)
MGNCWCKWEPSVYIVssnpksespkdespsekakkeYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLggggfgCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAlpllkekkkllNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKDSQCN
Disordered region (IsUnstruct)
***CWCKWEPSVYIV*****************************************NPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA**********VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR************NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL*************************************
Disordered Region (DISOPRED)
MGNC*******************************************************IAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP***********************************
Disordered Region (DISEMBL)
MGNCWCKWEPSVYIVS*********************************LRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPE**************
Disordered Region (DISPRO)
********************************************************NPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL*******************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKDSQCN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	389	2.2.26 [Sep-21-2011]
Q9FM85	408	Probable receptor-like pr	yes	no	0.969	0.924	0.808	0.0
Q8GXZ3	410	Serine/threonine-protein	no	no	0.910	0.863	0.630	1e-128
Q9LFP7	493	Probable receptor-like pr	no	no	0.902	0.711	0.573	1e-112
Q9SRH7	490	Receptor-like serine/thre	no	no	0.940	0.746	0.528	1e-108
P46573	412	Protein kinase APK1B, chl	no	no	0.768	0.725	0.622	1e-106
Q06548	410	Protein kinase APK1A, chl	no	no	0.768	0.729	0.6	1e-103
Q9CAH1	450	Putative receptor-like pr	no	no	0.830	0.717	0.567	1e-103
P43293	389	Probable serine/threonine	no	no	0.956	0.956	0.488	1e-102
O49840	426	Protein kinase 2B, chloro	no	no	0.763	0.697	0.588	1e-101
O48814	395	Serine/threonine-protein	no	no	0.773	0.762	0.573	1e-100

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  636 bits (1640), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/386 (80%), Positives = 342/386 (88%), Gaps = 9/386 (2%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPS--EKAKKEYSKLPSNPEEVEDLRRDSAANP 58
           MGNCWC++EP  + VS+N KSESPK++SP+  +K  KE  KLPSNP+EVEDLRRDSAANP
Sbjct: 1   MGNCWCRFEPLNHRVSANAKSESPKEQSPTVEDKHIKEVQKLPSNPKEVEDLRRDSAANP 60

Query: 59  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDL--REGLQPVPVAVKVHDGDNS 116
           LIAFTY+EL+ IT+NFRQDRVLGGGGFG VYKGFI EDL  +E  +P+PVAVKVHDGDNS
Sbjct: 61  LIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNS 120

Query: 117 YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP 176
           +QGHREWLAEVIFLG LSHPNLVKLIGYCCED HRVLIYE+MARGSVENNLFS+VLLPL 
Sbjct: 121 FQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLS 180

Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
           W+IRMKIAFGAAKGLAFLHEA+KPVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDKS
Sbjct: 181 WAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKS 240

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
           HVSTRIMGTYGYAAPEYIMTGHLTP SDVYSFGVVLLE+LTGRKSLDKSRP REQNL DW
Sbjct: 241 HVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDW 300

Query: 297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
           ALPLLKEKKK+LNI+DP++  +YPVK V KAAMLAYHCLN NPKARPLMRDIVDSLEPLQ
Sbjct: 301 ALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQ 360

Query: 357 VLPDEA----PTPKNFVTVVTPEEPK 378
              +EA    P  K  +T++  E PK
Sbjct: 361 ATEEEALLVPPVQKAVITIID-EMPK 385

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  459 bits (1181), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 227/360 (63%), Positives = 276/360 (76%), Gaps = 6/360 (1%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLI 60
           MGNC  + E +V+     P++++ + +    ++  + S  PS P   +D R   +   +I
Sbjct: 1   MGNCGTRDEAAVF----TPQAQAQQLQKKHSRSVSDLSD-PSTPRFRDDSRTPISYAQVI 55

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
            FT  EL  IT +FR D +LG GGFG VYKG+I ++LR GL+ +PVAVKV + +   QGH
Sbjct: 56  PFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEG-LQGH 114

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           REWL EV FLG L HPNLVKLIGYCCED+HR+L+YEFM RGS+EN+LF K   PL WS R
Sbjct: 115 REWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRR 174

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M IA GAAKGLAFLH AE+PVIYRDFKTSNILLD+DY AKLSDFGLAK GP+GD++HVST
Sbjct: 175 MMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 234

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
           R+MGTYGYAAPEY+MTGHLT RSDVYSFGVVLLE+LTGRKS+DK+RP++EQNL DWA P 
Sbjct: 235 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPK 294

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD 360
           L +K+KLL IIDPRLE  Y V+   KA  LAY+CL+ NPKARPLM D+V++LEPLQ   D
Sbjct: 295 LNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGD 354

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  405 bits (1040), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 207/361 (57%), Positives = 264/361 (73%), Gaps = 10/361 (2%)

Query: 16  SSNPKS-ESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANF 74
           S+N KS + P  +  S           S P   E+L   + ++ L  FT+++L++ T NF
Sbjct: 86  SANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEEL---NISSHLRKFTFNDLKLSTRNF 142

Query: 75  RQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVHDGDNSYQGHREWLAEVIFLG 131
           R + +LG GGFGCV+KG+I E+    ++P   + VAVK  + D   QGH+EWLAE+ FLG
Sbjct: 143 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDG-LQGHKEWLAEINFLG 201

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
           +L HPNLVKL+GYC ED+ R+L+YEFM RGS+EN+LF + L PLPWSIRMKIA GAAKGL
Sbjct: 202 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGL 260

Query: 192 AFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           +FLHE A KPVIYRDFKTSNILLD DYNAKLSDFGLAKD P+  K+HVSTR+MGTYGYAA
Sbjct: 261 SFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAA 320

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 310
           PEY+MTGHLT +SDVYSFGVVLLE+LTGR+S+DK+RP  E NL +WA P L +K++   +
Sbjct: 321 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRL 380

Query: 311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVT 370
           +DPRLEG + +KG  K   LA  CL+ +PK RP M D+V++L+PL  L D A +   F T
Sbjct: 381 LDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQT 440

Query: 371 V 371
           +
Sbjct: 441 M 441

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  392 bits (1008), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 206/390 (52%), Positives = 266/390 (68%), Gaps = 24/390 (6%)

Query: 4   CWCKWEPSVYIVSSNPKSESPKDESPS----EKAKKEYSKLPSNPEEVEDLRRD---SAA 56
           CW K+   V   SS    E+    S S    + A  + +  P  P        +   S +
Sbjct: 48  CWVKFRYIVCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESSLS 107

Query: 57  NPLIA-----------FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP-- 103
            P+I+           F++ +L++ T NFR + +LG GGFGCV+KG++ E+    ++P  
Sbjct: 108 TPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 167

Query: 104 -VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGS 162
            + VAVK  + D   QGH+EWLAE+ +LG+L HPNLVKL+GYC ED+ R+L+YEFM RGS
Sbjct: 168 GLTVAVKTLNPDG-LQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 226

Query: 163 VENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKL 221
           +EN+LF + L PLPWSIRMKIA GAAKGL+FLHE A KPVIYRDFKTSNILLD +YNAKL
Sbjct: 227 LENHLFRRSL-PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKL 285

Query: 222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           SDFGLAKD P+  K+HVSTR+MGTYGYAAPEY+MTGHLT +SDVYSFGVVLLE+LTGR+S
Sbjct: 286 SDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 345

Query: 282 LDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
           +DK+RP  E NL +WA P L +K++   ++DPRLEG + VKG  K   LA  CL+ + K 
Sbjct: 346 MDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKI 405

Query: 342 RPLMRDIVDSLEPLQVLPDEAPTPKNFVTV 371
           RP M ++V+ L+PL  L D A     F T+
Sbjct: 406 RPKMSEVVEVLKPLPHLKDMASASYYFQTM 435

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  386 bits (992), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 190/305 (62%), Positives = 230/305 (75%), Gaps = 6/305 (1%)

Query: 59  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVHDGDN 115
           L +FT+ EL+  T NFR D VLG GGFG V+KG+I E      +P   V +AVK  + D 
Sbjct: 54  LKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQD- 112

Query: 116 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLL 173
            +QGH+EWLAEV +LG  SHPNLVKLIGYC EDEHR+L+YEFM RGS+EN+LF +     
Sbjct: 113 GWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQ 172

Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
           PL W++R+K+A GAAKGLAFLH AE  VIYRDFKTSNILLD++YNAKLSDFGLAKDGP G
Sbjct: 173 PLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTG 232

Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 293
           DKSHVSTRIMGTYGYAAPEY+ TGHLT +SDVYS+GVVLLE+L+GR+++DK+RP  EQ L
Sbjct: 233 DKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKL 292

Query: 294 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
            +WA PLL  K+KL  +ID RL+  Y ++   K A LA  CL    K RP M ++V  LE
Sbjct: 293 VEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLE 352

Query: 354 PLQVL 358
            +Q L
Sbjct: 353 HIQTL 357

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  374 bits (961), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 183/305 (60%), Positives = 231/305 (75%), Gaps = 6/305 (1%)

Query: 59  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVHDGDN 115
           L +F++ EL+  T NFR D VLG GGFGCV+KG+I E      +P   + +AVK  + D 
Sbjct: 53  LKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDG 112

Query: 116 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-- 173
            +QGH+EWLAEV +LG  SH +LVKLIGYC EDEHR+L+YEFM RGS+EN+LF + L   
Sbjct: 113 -WQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQ 171

Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
           PL W +R+K+A GAAKGLAFLH +E  VIYRDFKTSNILLD++YNAKLSDFGLAKDGP G
Sbjct: 172 PLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIG 231

Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 293
           DKSHVSTR+MGT+GYAAPEY+ TGHLT +SDVYSFGVVLLE+L+GR+++DK+RP+ E+NL
Sbjct: 232 DKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNL 291

Query: 294 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
            +WA P L  K+K+  +ID RL+  Y ++   K A L+  CL    K RP M ++V  LE
Sbjct: 292 VEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLE 351

Query: 354 PLQVL 358
            +Q L
Sbjct: 352 HIQSL 356

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAH1|Y1725_ARATH Putative receptor-like protein kinase At1g72540 OS=Arabidopsis thaliana GN=At1g72540 PE=2 SV=1

 Score =  374 bits (960), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 184/324 (56%), Positives = 232/324 (71%), Gaps = 1/324 (0%)

Query: 62  FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 121
           FTY+EL+ IT  F +   LG GGFG VYKGF+ + L+ GL+  PVAVK    +   QGHR
Sbjct: 72  FTYEELKTITQGFSKYNFLGEGGFGEVYKGFVDDSLKTGLKDQPVAVKALKREGG-QGHR 130

Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           EWLAEVI LG L HP+LV L+GYCCED+ R+L+YE+M RG++E++LF K    LPW  R+
Sbjct: 131 EWLAEVIILGQLKHPHLVNLVGYCCEDDERLLVYEYMERGNLEDHLFQKYGGALPWLTRV 190

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           KI  GAAKGL FLH+ EKPVIYRDFK SNILL +D+++KLSDFGLA DG E + S+ +  
Sbjct: 191 KILLGAAKGLEFLHKQEKPVIYRDFKPSNILLSSDFSSKLSDFGLATDGSEEEDSNFTKS 250

Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL 301
           +MGT GYAAPEYI  G+LT  SDV+SFGVVLLE+LT RK+++K R  R +NL +WA P+L
Sbjct: 251 VMGTEGYAAPEYISAGNLTTMSDVFSFGVVLLEMLTARKAVEKYRAQRGRNLVEWARPML 310

Query: 302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE 361
           K+  KL  IIDP LEG Y V+G+ KAA LAY CL+HNPK+RP M  +V +LEP+  L D 
Sbjct: 311 KDPNKLERIIDPSLEGKYSVEGIRKAAALAYQCLSHNPKSRPTMTTVVKTLEPILDLKDI 370

Query: 362 APTPKNFVTVVTPEEPKAEIQTKD 385
              P  ++  V       EI+ KD
Sbjct: 371 QNGPFVYIVPVAGVSEVHEIKCKD 394

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  372 bits (956), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 189/387 (48%), Positives = 260/387 (67%), Gaps = 15/387 (3%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLI 60
           MG C+     +    S+   S+    +     +   +S +P    E+  L+  +  N   
Sbjct: 1   MGGCFSNRIKTDIASSTWLSSKFLSRDGSKGSSTASFSYMPRTEGEI--LQNANLKN--- 55

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVHDGDNSY 117
            F+  EL+  T NFR D V+G GGFGCV+KG+I E      +P   + +AVK  + +  +
Sbjct: 56  -FSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQE-GF 113

Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--PL 175
           QGHREWLAE+ +LG L HPNLVKLIGYC E+EHR+L+YEFM RGS+EN+LF +     PL
Sbjct: 114 QGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPL 173

Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
            W+ R+++A GAA+GLAFLH A+  VIYRDFK SNILLD++YNAKLSDFGLA+DGP GD 
Sbjct: 174 SWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDN 233

Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 295
           SHVSTR+MGT GYAAPEY+ TGHL+ +SDVYSFGVVLLE+L+GR+++DK++P  E NL D
Sbjct: 234 SHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVD 293

Query: 296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
           WA P L  K++LL ++DPRL+G Y +    K A+LA  C++ + K+RP M +IV ++E L
Sbjct: 294 WARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEEL 353

Query: 356 QVLPD---EAPTPKNFVTVVTPEEPKA 379
            +  +   E   P+  +  +  + P+A
Sbjct: 354 HIQKEASKEQQNPQISIDNIINKSPQA 380

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  369 bits (947), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 177/301 (58%), Positives = 227/301 (75%), Gaps = 4/301 (1%)

Query: 59  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVHDGDN 115
           L AFT++EL+  T NFR D +LG GGFG V+KG+I        +P   + VAVK    + 
Sbjct: 68  LKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEG 127

Query: 116 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 175
            YQGH+EWL EV +LG LSHPNLVKL+GYC E E+R+L+YEFM +GS+EN+LF +   PL
Sbjct: 128 -YQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPL 186

Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
            W+IRMK+A GAAKGL FLH+A+  VIYRDFK +NILLD ++N+KLSDFGLAK GP GDK
Sbjct: 187 TWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDK 246

Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 295
           +HVST++MGT+GYAAPEY+ TG LT +SDVYSFGVVLLE+L+GR+++DKS+   EQ+L D
Sbjct: 247 THVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVD 306

Query: 296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
           WA P L +K+KL  I+D RL G YP KG + AA LA  CLN + K RP M +++  L+ L
Sbjct: 307 WATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQL 366

Query: 356 Q 356
           +
Sbjct: 367 E 367

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  367 bits (941), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 176/307 (57%), Positives = 230/307 (74%), Gaps = 6/307 (1%)

Query: 55  AANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQP---VPVAVKVH 111
           ++ P+ +FT++EL++ T NFR D V+G GGFGCV+KG++ E      +P   + +AVK  
Sbjct: 48  SSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKL 107

Query: 112 DGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK- 170
           + +  +QGHREWL E+ +LG LSHPNLVKLIGYC EDEHR+L+YEFM +GS+EN+LF + 
Sbjct: 108 NQEG-FQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRG 166

Query: 171 -VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 229
               PLPW +R+ +A  AAKGLAFLH     VIYRD K SNILLD DYNAKLSDFGLA+D
Sbjct: 167 AYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARD 226

Query: 230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
           GP GD S+VSTR+MGTYGYAAPEY+ +GHL  RSDVYSFGV+LLEIL+G+++LD +RPA+
Sbjct: 227 GPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAK 286

Query: 290 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
           E+NL DWA P L  K+K+L I+D RL+  Y  +   + A +A  CL+  PK+RP M  +V
Sbjct: 287 EENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVV 346

Query: 350 DSLEPLQ 356
            +L+ LQ
Sbjct: 347 RALQQLQ 353

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	389
255564816	385	Protein kinase APK1B, chloroplast precur	0.982	0.992	0.857	0.0
147783438	380	hypothetical protein VITISV_020249 [Viti	0.976	1.0	0.855	0.0
225435796	380	PREDICTED: probable receptor-like protei	0.976	1.0	0.855	0.0
358248287	381	probable receptor-like protein kinase At	0.971	0.992	0.825	0.0
255636669	381	unknown [Glycine max]	0.971	0.992	0.823	0.0
356512582	382	PREDICTED: probable receptor-like protei	0.971	0.989	0.808	0.0
297793143	419	hypothetical protein ARALYDRAFT_331952 [	0.971	0.902	0.810	1e-180
15241220	408	protein kinase family protein [Arabidops	0.969	0.924	0.808	1e-180
449452642	390	PREDICTED: probable receptor-like protei	0.938	0.935	0.857	1e-178
224052859	371	predicted protein [Populus trichocarpa]	0.904	0.948	0.827	1e-177

>gi|255564816|ref|XP_002523402.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223537352|gb|EEF38981.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  686 bits (1770), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/385 (85%), Positives = 357/385 (92%), Gaps = 3/385 (0%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLI 60
           MGNCWC+WEPS+Y VSSN KSESPK ESPS K + +  KLPSNPEEVEDLRRDSAANPL+
Sbjct: 1   MGNCWCRWEPSIYRVSSNAKSESPKCESPSGKPRNDDRKLPSNPEEVEDLRRDSAANPLV 60

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
           AFTYDEL+IIT NFRQDR+LGGGGFG VYKGFI+E+LREGL+P+PVAVKVHDGDNSYQGH
Sbjct: 61  AFTYDELKIITGNFRQDRLLGGGGFGSVYKGFITEELREGLEPLPVAVKVHDGDNSYQGH 120

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           REWLAEVIFLG LSHPNLVKLIGYCCEDEHRVLIYE+MARGSVENNLFS+VLLPLPW +R
Sbjct: 121 REWLAEVIFLGQLSHPNLVKLIGYCCEDEHRVLIYEYMARGSVENNLFSRVLLPLPWYVR 180

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD +YNAKLSDFGLAKDGP GDK+HVST
Sbjct: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDVEYNAKLSDFGLAKDGPMGDKTHVST 240

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
           RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE+LTGRKSLDKS PAREQNLADWALPL
Sbjct: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLELLTGRKSLDKSLPAREQNLADWALPL 300

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD 360
           LKEKKK+LNIIDPRLEGDYP+KGVHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQ+ P+
Sbjct: 301 LKEKKKILNIIDPRLEGDYPIKGVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQI-PE 359

Query: 361 EAPTPKNFVTVVTPEEPKAEIQTKD 385
           EA   K+  TV++  +   EI+ K+
Sbjct: 360 EASNGKSVFTVISVSD--GEIKRKE 382

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147783438|emb|CAN77488.1| hypothetical protein VITISV_020249 [Vitis vinifera]

 Score =  680 bits (1754), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/381 (85%), Positives = 349/381 (91%), Gaps = 1/381 (0%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLI 60
           MGNCWC+W+PS+Y VSSN KSESPKD+SPS K  K+  KLPSNPEEVEDLRRDSAANPLI
Sbjct: 1   MGNCWCRWKPSIYRVSSNAKSESPKDQSPSVKPMKDIRKLPSNPEEVEDLRRDSAANPLI 60

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
            FT++EL+ IT NFRQD VLGGGGFG VYKGF++EDL EG QP+PVAVKVHDGDNS+QGH
Sbjct: 61  VFTFNELKQITGNFRQDYVLGGGGFGSVYKGFVTEDLMEGHQPLPVAVKVHDGDNSFQGH 120

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           REWLAEVIFLG LSHPNLVKLIGYCCEDEHRVL+YE+MARGSVENNLFS+VLLPL W IR
Sbjct: 121 REWLAEVIFLGQLSHPNLVKLIGYCCEDEHRVLVYEYMARGSVENNLFSRVLLPLSWYIR 180

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           MKIAFGAAKGLAFLH+AEKPVIYRDFKTSNILLD DYN KLSDFGLAKDGPEGDKSHVST
Sbjct: 181 MKIAFGAAKGLAFLHDAEKPVIYRDFKTSNILLDLDYNPKLSDFGLAKDGPEGDKSHVST 240

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
           RIMGTYGYAAPEYIMTGHL+PRSDVYSFGVVLLE+LTGRKSLDKSRPAREQNL DWALPL
Sbjct: 241 RIMGTYGYAAPEYIMTGHLSPRSDVYSFGVVLLELLTGRKSLDKSRPAREQNLTDWALPL 300

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD 360
           L+EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQV  D
Sbjct: 301 LREKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQVATD 360

Query: 361 EAPTPKNFVTVVTPEEPKAEI 381
            +P  + F TV+T E P A +
Sbjct: 361 VSPDKQTF-TVITNEVPNAAV 380

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225435796|ref|XP_002285747.1| PREDICTED: probable receptor-like protein kinase At5g56460 [Vitis vinifera]

 Score =  680 bits (1754), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/381 (85%), Positives = 349/381 (91%), Gaps = 1/381 (0%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLI 60
           MGNCWC+W+PS+Y VSSN KSESPKD+SPS K  K+  KLPSNPEEVEDLRRDSAANPLI
Sbjct: 1   MGNCWCRWKPSIYRVSSNAKSESPKDQSPSVKPMKDIRKLPSNPEEVEDLRRDSAANPLI 60

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
            FT++EL+ IT NFRQD VLGGGGFG VYKGF++EDL EGLQP+PVAVKVHDGDNS+QGH
Sbjct: 61  VFTFNELKQITGNFRQDYVLGGGGFGSVYKGFVTEDLMEGLQPLPVAVKVHDGDNSFQGH 120

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           REWLAEVIFLG LSHPNLVKLIGY CEDEHRVL+YE+MARGSVENNLFS+VLLPL W IR
Sbjct: 121 REWLAEVIFLGQLSHPNLVKLIGYGCEDEHRVLVYEYMARGSVENNLFSRVLLPLSWYIR 180

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           MKIAFGAAKGLAFLH+AEKPVIYRDFKTSNILLD DYN KLSDFGLAKDGPEGDKSHVST
Sbjct: 181 MKIAFGAAKGLAFLHDAEKPVIYRDFKTSNILLDLDYNPKLSDFGLAKDGPEGDKSHVST 240

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
           RIMGTYGYAAPEYIMTGHL+PRSDVYSFGVVLLE+LTGRKSLDKSRPAREQNL DWALPL
Sbjct: 241 RIMGTYGYAAPEYIMTGHLSPRSDVYSFGVVLLELLTGRKSLDKSRPAREQNLTDWALPL 300

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD 360
           L+EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQV  D
Sbjct: 301 LREKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQVATD 360

Query: 361 EAPTPKNFVTVVTPEEPKAEI 381
            +P  + F TV+T E P A +
Sbjct: 361 VSPDKQTF-TVITNEVPNAAV 380

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358248287|ref|NP_001239855.1| probable receptor-like protein kinase At5g56460-like [Glycine max] gi|223452321|gb|ACM89488.1| protein kinase [Glycine max]

 Score =  651 bits (1680), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/385 (82%), Positives = 343/385 (89%), Gaps = 7/385 (1%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLI 60
           MGNCWC+WE S Y VSSN KSE    ++   K + + SKLPSNPEEVEDLRRDSAANPLI
Sbjct: 1   MGNCWCRWESSEYRVSSNVKSE----QNQGTKQRHDDSKLPSNPEEVEDLRRDSAANPLI 56

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
           AFTYDEL+IITANFRQDRVLGGGGFG VYKGFISE+LREGL  + VAVKVHDGDNS+QGH
Sbjct: 57  AFTYDELKIITANFRQDRVLGGGGFGRVYKGFISEELREGLPTLAVAVKVHDGDNSHQGH 116

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           REWLAEVIFLG LSHPNLVKLIGYCCEDEHRVLIYE+M+RGSVE+NLFSK+LLPLPWSIR
Sbjct: 117 REWLAEVIFLGQLSHPNLVKLIGYCCEDEHRVLIYEYMSRGSVEHNLFSKILLPLPWSIR 176

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD +YN+KLSDFGLAKDGP GDKSHVST
Sbjct: 177 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDQEYNSKLSDFGLAKDGPVGDKSHVST 236

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
           R+MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE+LTGRKSLDK RPAREQNLA+WALPL
Sbjct: 237 RVMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLELLTGRKSLDKLRPAREQNLAEWALPL 296

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD 360
           LKEKKK LNIIDPRL+GDYP+K VHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQ    
Sbjct: 297 LKEKKKFLNIIDPRLDGDYPIKAVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQA-HT 355

Query: 361 EAPTPKNFVTVVTPEEPKAEIQTKD 385
           E P  K     +  E P++ ++ KD
Sbjct: 356 EVPIGKTL--TIISEVPESGLKMKD 378

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255636669|gb|ACU18671.1| unknown [Glycine max]

 Score =  648 bits (1672), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 317/385 (82%), Positives = 342/385 (88%), Gaps = 7/385 (1%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLI 60
           MGNCWC+WE S Y VSSN KSE    ++   K + + SKLPSNPEEVEDLRRDSAANPLI
Sbjct: 1   MGNCWCRWESSEYRVSSNVKSE----QNQGTKQRHDDSKLPSNPEEVEDLRRDSAANPLI 56

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
           AFTY EL+IITANFRQDRVLGGGGFG VYKGFISE+LREGL  + VAVKVHDGDNS+QGH
Sbjct: 57  AFTYGELKIITANFRQDRVLGGGGFGRVYKGFISEELREGLPTLAVAVKVHDGDNSHQGH 116

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           REWLAEVIFLG LSHPNLVKLIGYCCEDEHRVLIYE+M+RGSVE+NLFSK+LLPLPWSIR
Sbjct: 117 REWLAEVIFLGQLSHPNLVKLIGYCCEDEHRVLIYEYMSRGSVEHNLFSKILLPLPWSIR 176

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD +YN+KLSDFGLAKDGP GDKSHVST
Sbjct: 177 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDQEYNSKLSDFGLAKDGPVGDKSHVST 236

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
           R+MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE+LTGRKSLDK RPAREQNLA+WALPL
Sbjct: 237 RVMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLELLTGRKSLDKLRPAREQNLAEWALPL 296

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD 360
           LKEKKK LNIIDPRL+GDYP+K VHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQ    
Sbjct: 297 LKEKKKFLNIIDPRLDGDYPIKAVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQA-HT 355

Query: 361 EAPTPKNFVTVVTPEEPKAEIQTKD 385
           E P  K     +  E P++ ++ KD
Sbjct: 356 EVPIGKTL--TIISEVPESGLKMKD 378

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356512582|ref|XP_003524997.1| PREDICTED: probable receptor-like protein kinase At5g56460-like [Glycine max]

 Score =  639 bits (1648), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/386 (80%), Positives = 341/386 (88%), Gaps = 8/386 (2%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLI 60
           MGNCWC+W+ S Y VSSN KSE    ++   K + + SKLPSNPEEVEDLRRD+AANPLI
Sbjct: 1   MGNCWCRWKSSEYRVSSNVKSE----QNQGTKQRHDDSKLPSNPEEVEDLRRDTAANPLI 56

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDL-REGLQPVPVAVKVHDGDNSYQG 119
           AFTYDEL+I+TANFR DRVLGGGGFG VYKGFISE+L R+GL  + VAVKVHDGDNS+QG
Sbjct: 57  AFTYDELKIVTANFRPDRVLGGGGFGSVYKGFISEELIRQGLPTLAVAVKVHDGDNSHQG 116

Query: 120 HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           HREWLAEVIFLG LSHPNLVKLIGYCCEDEHRVLIYE+M+RGSVE+NLFSK+LLP+PWS 
Sbjct: 117 HREWLAEVIFLGQLSHPNLVKLIGYCCEDEHRVLIYEYMSRGSVEHNLFSKILLPMPWST 176

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
           RMKIAFGAAKGLAFLHEA+KPVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDKSHVS
Sbjct: 177 RMKIAFGAAKGLAFLHEADKPVIYRDFKTSNILLDQDYNAKLSDFGLAKDGPVGDKSHVS 236

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP 299
           TR+MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE+LTGRKSLDK RPAREQNLA+WALP
Sbjct: 237 TRVMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLELLTGRKSLDKLRPAREQNLAEWALP 296

Query: 300 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP 359
           LLKEKKK LNIIDPRL+GDYP+K VHKAAMLAYHCLN NPKARPLMRDIVDSLEPLQ   
Sbjct: 297 LLKEKKKFLNIIDPRLDGDYPIKAVHKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQA-H 355

Query: 360 DEAPTPKNFVTVVTPEEPKAEIQTKD 385
            E P  K     +  E P++ ++ KD
Sbjct: 356 TEVPIGKTL--TIISEVPESGLKMKD 379

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297793143|ref|XP_002864456.1| hypothetical protein ARALYDRAFT_331952 [Arabidopsis lyrata subsp. lyrata] gi|297310291|gb|EFH40715.1| hypothetical protein ARALYDRAFT_331952 [Arabidopsis lyrata subsp. lyrata]

 Score =  638 bits (1645), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 312/385 (81%), Positives = 340/385 (88%), Gaps = 7/385 (1%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPS--EKAKKEYSKLPSNPEEVEDLRRDSAANP 58
           MGNCWC++EP  + VS+N KSESPK++SP+  +K  KE  KLPSNP+EVEDLRRDSAANP
Sbjct: 1   MGNCWCRFEPLNHRVSANAKSESPKEQSPTVEDKHIKEVQKLPSNPKEVEDLRRDSAANP 60

Query: 59  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDL--REGLQPVPVAVKVHDGDNS 116
           LIAFTY+EL+ IT NFRQDRVLGGGGFG VYKGFI EDL  ++  QP+PVAVKVHDGDNS
Sbjct: 61  LIAFTYEELKNITGNFRQDRVLGGGGFGSVYKGFIKEDLGDQDVPQPLPVAVKVHDGDNS 120

Query: 117 YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP 176
           +QGHREWLAEVIFLG LSHPNLVKLIGYCCED HRVLIYE+MARGSVENNLFS+VLLPL 
Sbjct: 121 FQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLS 180

Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
           W+IRMKIAFGAAKGLAFLHEA+KPVIYRDFKTSNILLD +YNAKLSDFGLAKDGP GDKS
Sbjct: 181 WAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMEYNAKLSDFGLAKDGPVGDKS 240

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
           HVSTRIMGTYGYAAPEYIMTGHLTP SDVYSFGVVLLE+LTGRKSLDKSRP REQNL DW
Sbjct: 241 HVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDW 300

Query: 297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
           ALPLLKEKKK+LNI+DPR+  +YPVK V KAAMLAYHCLN NPKARPLMRDIVDSLEPLQ
Sbjct: 301 ALPLLKEKKKVLNIVDPRMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQ 360

Query: 357 VLPDEA---PTPKNFVTVVTPEEPK 378
              +EA   PT +  V  +  E PK
Sbjct: 361 ATEEEALLVPTVQKAVVTIIDEMPK 385

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15241220|ref|NP_200457.1| protein kinase family protein [Arabidopsis thaliana] gi|75334057|sp|Q9FM85.1|Y5564_ARATH RecName: Full=Probable receptor-like protein kinase At5g56460 gi|10177845|dbj|BAB11274.1| protein kinase-like protein [Arabidopsis thaliana] gi|22135984|gb|AAM91574.1| protein kinase-like protein [Arabidopsis thaliana] gi|30725688|gb|AAP37866.1| At5g56460 [Arabidopsis thaliana] gi|332009386|gb|AED96769.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  636 bits (1640), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 312/386 (80%), Positives = 342/386 (88%), Gaps = 9/386 (2%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPS--EKAKKEYSKLPSNPEEVEDLRRDSAANP 58
           MGNCWC++EP  + VS+N KSESPK++SP+  +K  KE  KLPSNP+EVEDLRRDSAANP
Sbjct: 1   MGNCWCRFEPLNHRVSANAKSESPKEQSPTVEDKHIKEVQKLPSNPKEVEDLRRDSAANP 60

Query: 59  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDL--REGLQPVPVAVKVHDGDNS 116
           LIAFTY+EL+ IT+NFRQDRVLGGGGFG VYKGFI EDL  +E  +P+PVAVKVHDGDNS
Sbjct: 61  LIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNS 120

Query: 117 YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP 176
           +QGHREWLAEVIFLG LSHPNLVKLIGYCCED HRVLIYE+MARGSVENNLFS+VLLPL 
Sbjct: 121 FQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLS 180

Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
           W+IRMKIAFGAAKGLAFLHEA+KPVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDKS
Sbjct: 181 WAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKS 240

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
           HVSTRIMGTYGYAAPEYIMTGHLTP SDVYSFGVVLLE+LTGRKSLDKSRP REQNL DW
Sbjct: 241 HVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDW 300

Query: 297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
           ALPLLKEKKK+LNI+DP++  +YPVK V KAAMLAYHCLN NPKARPLMRDIVDSLEPLQ
Sbjct: 301 ALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQ 360

Query: 357 VLPDEA----PTPKNFVTVVTPEEPK 378
              +EA    P  K  +T++  E PK
Sbjct: 361 ATEEEALLVPPVQKAVITIID-EMPK 385

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452642|ref|XP_004144068.1| PREDICTED: probable receptor-like protein kinase At5g56460-like [Cucumis sativus] gi|449493564|ref|XP_004159351.1| PREDICTED: probable receptor-like protein kinase At5g56460-like [Cucumis sativus]

 Score =  629 bits (1622), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 313/365 (85%), Positives = 331/365 (90%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLI 60
           MGNCW +WEP+V  VSSN KSESPK ES S   +     LPSNP+EVEDLRRDSA NPLI
Sbjct: 1   MGNCWYRWEPTVNRVSSNAKSESPKVESTSPYTRNNEHNLPSNPKEVEDLRRDSATNPLI 60

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
           AFT+DEL++IT NFRQDRVLGGGGFG VYKGFI+EDLREG+ P+PVAVKVHDG NSYQGH
Sbjct: 61  AFTFDELKLITGNFRQDRVLGGGGFGSVYKGFITEDLREGIVPLPVAVKVHDGFNSYQGH 120

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           REWLAEVIFLG LSHPNLVKLIGYCCEDEHRVLIYE+M RGSVENNLFS+VLLPLPWSIR
Sbjct: 121 REWLAEVIFLGQLSHPNLVKLIGYCCEDEHRVLIYEYMPRGSVENNLFSRVLLPLPWSIR 180

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD+DYN KLSDFGLAKDGP GDKSHVST
Sbjct: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDSDYNPKLSDFGLAKDGPVGDKSHVST 240

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
           RIMGTYGYAAPEYI+TGHLTPRSDVYSFGVVLLE+LTGRKSLDK RPAREQNL DWALPL
Sbjct: 241 RIMGTYGYAAPEYILTGHLTPRSDVYSFGVVLLELLTGRKSLDKLRPAREQNLTDWALPL 300

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD 360
           LKEKKKL+ I+DPRL G+YPVKG HKAAMLAYHCLN NPKARPLMRDIVDSLEPLQ   D
Sbjct: 301 LKEKKKLMTIVDPRLGGEYPVKGFHKAAMLAYHCLNKNPKARPLMRDIVDSLEPLQETID 360

Query: 361 EAPTP 365
           EA  P
Sbjct: 361 EAVAP 365

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224052859|ref|XP_002297616.1| predicted protein [Populus trichocarpa] gi|222844874|gb|EEE82421.1| predicted protein [Populus trichocarpa]

 Score =  628 bits (1620), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 307/371 (82%), Positives = 328/371 (88%), Gaps = 19/371 (5%)

Query: 1   MGNCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLI 60
           MGNC C+WE SVY    N KS SPK++SPS +  ++  KLPSNPEEVEDLRRDSAANPLI
Sbjct: 1   MGNCCCRWELSVY----NAKSVSPKEQSPSGRPIQDDRKLPSNPEEVEDLRRDSAANPLI 56

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
           AFT+DEL++IT NFRQD +LGGGGFG VYKG I++D RE LQP+ VAVKVHDGDNSYQGH
Sbjct: 57  AFTFDELKLITENFRQDHLLGGGGFGSVYKGIIAKDSREELQPLQVAVKVHDGDNSYQGH 116

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           REWLAEVIFLG LSHPNLVKLIGYCC+DEHRVLIYE+MARGSVENNLFS+VLLPLPWSIR
Sbjct: 117 REWLAEVIFLGQLSHPNLVKLIGYCCQDEHRVLIYEYMARGSVENNLFSRVLLPLPWSIR 176

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDK+HVST
Sbjct: 177 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDQDYNAKLSDFGLAKDGPMGDKTHVST 236

Query: 241 RIMGTYGYAAPEYIMT---------------GHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
           RIMGTYGYAAPEYIMT               GHLTPRSDVYSFGVVLLE+LTGRKSLDKS
Sbjct: 237 RIMGTYGYAAPEYIMTGNKLGLIHCLSNFHSGHLTPRSDVYSFGVVLLELLTGRKSLDKS 296

Query: 286 RPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM 345
           RP REQNL DWALPLLKEK+KLLNI+DPRLEGDYP+KG  KAAMLAYHCLN NPKARPLM
Sbjct: 297 RPGREQNLTDWALPLLKEKRKLLNIVDPRLEGDYPIKGFQKAAMLAYHCLNRNPKARPLM 356

Query: 346 RDIVDSLEPLQ 356
           RDIVDSLEPLQ
Sbjct: 357 RDIVDSLEPLQ 367

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	389
TAIR|locus:2161093	408	AT5G56460 [Arabidopsis thalian	0.969	0.924	0.733	8.1e-147
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.820	0.778	0.65	7e-109
TAIR|locus:2064712	462	RIPK "RPM1-induced protein kin	0.856	0.720	0.605	2.3e-101
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.807	0.693	0.593	5.8e-98
TAIR|locus:2157101	494	AT5G35580 [Arabidopsis thalian	0.884	0.696	0.556	5.8e-98
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.835	0.659	0.577	3.2e-97
TAIR|locus:2057770	424	ARSK1 "root-specific kinase 1"	0.809	0.742	0.589	8.4e-97
TAIR|locus:2060167	442	AT2G07180 [Arabidopsis thalian	0.812	0.714	0.577	1.4e-96
TAIR|locus:2200863	424	AT1G61590 [Arabidopsis thalian	0.786	0.721	0.590	4.2e-95
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.791	0.628	0.582	1.3e-93

TAIR|locus:2161093 AT5G56460 [Arabidopsis thaliana (taxid:3702)]

 Score = 1434 (509.9 bits), Expect = 8.1e-147, P = 8.1e-147
 Identities = 283/386 (73%), Positives = 307/386 (79%)

Query:     1 MGNCWCKWEPSVYIVXXXXXXXX--XXXXXXXXXXXXXYSKLPSNPEEVEDLRRDSAANP 58
             MGNCWC++EP  + V                         KLPSNP+EVEDLRRDSAANP
Sbjct:     1 MGNCWCRFEPLNHRVSANAKSESPKEQSPTVEDKHIKEVQKLPSNPKEVEDLRRDSAANP 60

Query:    59 LIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDL--REGLQPVPVAVKVHDGDNS 116
             LIAFTY+EL+ IT+NFRQDRVL       VYKGFI EDL  +E  +P+PVAVKVHDGDNS
Sbjct:    61 LIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNS 120

Query:   117 YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP 176
             +QGHREWLAEVIFLG LSHPNLVKLIGYCCED HRVLIYE+MARGSVENNLFS+VLLPL 
Sbjct:   121 FQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLS 180

Query:   177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
             W+IRMKIAFGAAKGLAFLHEA+KPVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDKS
Sbjct:   181 WAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKS 240

Query:   237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
             HVSTRIMGTYGYAAPEYIMTGHLTP SDVYSFGVVLLE+LTGRKSLDKSRP REQNL DW
Sbjct:   241 HVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDW 300

Query:   297 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
             A           NI+DP++  +YPVK V KAAMLAYHCLN NPKARPLMRDIVDSLEPLQ
Sbjct:   301 ALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQ 360

Query:   357 VLPDEA----PTPKNFVTVVTPEEPK 378
                +EA    P  K  +T++  E PK
Sbjct:   361 ATEEEALLVPPVQKAVITIID-EMPK 385

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1076 (383.8 bits), Expect = 7.0e-109, P = 7.0e-109
 Identities = 208/320 (65%), Positives = 243/320 (75%)

Query:    41 PSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREG 100
             PS P   +D R   +   +I FT  EL  IT +FR D +L       VYKG+I ++LR G
Sbjct:    36 PSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVG 95

Query:   101 LQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMAR 160
             L+ +PVAVKV + +   QGHREWL EV FLG L HPNLVKLIGYCCED+HR+L+YEFM R
Sbjct:    96 LKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLR 154

Query:   161 GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK 220
             GS+EN+LF K   PL WS RM IA GAAKGLAFLH AE+PVIYRDFKTSNILLD+DY AK
Sbjct:   155 GSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 214

Query:   221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK 280
             LSDFGLAK GP+GD++HVSTR+MGTYGYAAPEY+MTGHLT RSDVYSFGVVLLE+LTGRK
Sbjct:   215 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRK 274

Query:   281 SLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPK 340
             S+DK+RP++EQNL DWA            IIDPRLE  Y V+   KA  LAY+CL+ NPK
Sbjct:   275 SVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPK 334

Query:   341 ARPLMRDIVDSLEPLQVLPD 360
             ARPLM D+V++LEPLQ   D
Sbjct:   335 ARPLMSDVVETLEPLQCTGD 354

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
 Identities = 204/337 (60%), Positives = 230/337 (68%)

Query:    41 PSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREG 100
             PS+    EDL    A + L  FT  EL++IT +F     L       V+KGFI + LR G
Sbjct:    54 PSSNTLSEDLSISLAGSDLHVFTLAELKVITQSFSSTNFLGEGGFGPVHKGFIDDKLRPG 113

Query:   101 LQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMAR 160
             L+  PVAVK+ D +   QGHREWL EV+FLG L H NLVKLIGYCCE+EHR L+YEFM R
Sbjct:   114 LKAQPVAVKLLDLEG-LQGHREWLTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPR 172

Query:   161 GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK 220
             GS+EN LF +    LPWS RMKIA GAA GL FLHEAE PVIYRDFK SNILLD+DY AK
Sbjct:   173 GSLENQLFRRYSASLPWSTRMKIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAK 232

Query:   221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK 280
             LSDFGLAKDGPEGD +HVSTR+MGT GYAAPEYIMTGHLT RSDVYSFGVVLLE+LTGR+
Sbjct:   233 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRR 292

Query:   281 SLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPK 340
             S+DK R +REQNL DWA            I+DPRLEG Y   G  KAA LAY CL+H PK
Sbjct:   293 SVDKKRSSREQNLVDWARPMLNDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPK 352

Query:   341 ARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEP 377
              RP M  +V  L  L+   D    P    T   P  P
Sbjct:   353 NRPCMSAVVSILNDLK---DYNDIPMGTFTYTVPNTP 386

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
 Identities = 190/320 (59%), Positives = 240/320 (75%)

Query:    56 ANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQP---VPVAVKVHD 112
             ++ L  F +++L++ T NFR + +L      CV+KG+I E+    ++P   + VAVK  +
Sbjct:    85 SSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 144

Query:   113 GDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL 172
              D   QGH+EWLAE+ FLG+L HP+LVKL+GYC E++ R+L+YEFM RGS+EN+LF + L
Sbjct:   145 PDG-LQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRRTL 203

Query:   173 LPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 231
              PLPWS+RMKIA GAAKGLAFLHE AEKPVIYRDFKTSNILLD +YNAKLSDFGLAKD P
Sbjct:   204 -PLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAP 262

Query:   232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 291
             +  KSHVSTR+MGTYGYAAPEY+MTGHLT +SDVYSFGVVLLEILTGR+S+DKSRP  EQ
Sbjct:   263 DEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQ 322

Query:   292 NLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS 351
             NL +W             ++DPRLEG Y +KG  KA  +A  CLN + KARP M ++V++
Sbjct:   323 NLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEA 382

Query:   352 LEPLQVLPDEAPTPKNFVTV 371
             L+PL  L D A +  +F T+
Sbjct:   383 LKPLPNLKDFASSSSSFQTM 402

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2157101 AT5G35580 [Arabidopsis thaliana (taxid:3702)]

 Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
 Identities = 193/347 (55%), Positives = 238/347 (68%)

Query:    41 PSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREG 100
             PS+    EDL    A + L  FT  ELR+IT +F     L       V+KGFI + LR G
Sbjct:    43 PSSTTLSEDLSISLAGSDLHVFTQAELRVITQSFSSSNFLGEGGFGPVHKGFIDDKLRPG 102

Query:   101 LQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMAR 160
             L+  PVAVK+ D D   QGHRE++ EV+ LG L HPNLVKLIGYCCE+ HR+L+YEFM R
Sbjct:   103 LKAQPVAVKLLDLDG-LQGHREFMTEVMCLGKLKHPNLVKLIGYCCEEAHRLLVYEFMPR 161

Query:   161 GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK 220
             GS+E+ LF +  LPLPW+ R+ IA+ AAKGL FLHEAEKP+IYRDFK SNILLD+DY AK
Sbjct:   162 GSLESQLFRRCSLPLPWTTRLNIAYEAAKGLQFLHEAEKPIIYRDFKASNILLDSDYTAK 221

Query:   221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK 280
             LSDFGLAKDGP+GD +HVSTR+MGT GYAAPEYIMTGHLT +SDVYSFGVVLLE+LTGRK
Sbjct:   222 LSDFGLAKDGPQGDDTHVSTRVMGTQGYAAPEYIMTGHLTAKSDVYSFGVVLLELLTGRK 281

Query:   281 SLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPK 340
             S+D +R +R++ L +WA            I+DPRLE  Y   G  KAA LAY CL + PK
Sbjct:   282 SVDIARSSRKETLVEWARPMLNDARKLGRIMDPRLEDQYSETGARKAATLAYQCLRYRPK 341

Query:   341 ARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKDSQ 387
              RP +  +V  L+ ++   D+ P      T   P +P+ E++    Q
Sbjct:   342 TRPDISTVVSVLQDIKDYKDDIPI--GIFTYTVPTKPRREVKETSLQ 386

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
 Identities = 193/334 (57%), Positives = 244/334 (73%)

Query:    42 SNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGL 101
             S P   E+L   + ++ L  FT+++L++ T NFR + +L      CV+KG+I E+    +
Sbjct:   113 STPVISEEL---NISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPV 169

Query:   102 QP---VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM 158
             +P   + VAVK  + D   QGH+EWLAE+ FLG+L HPNLVKL+GYC ED+ R+L+YEFM
Sbjct:   170 KPGTGLTVAVKTLNPDG-LQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFM 228

Query:   159 ARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDY 217
              RGS+EN+LF + L PLPWSIRMKIA GAAKGL+FLHE A KPVIYRDFKTSNILLD DY
Sbjct:   229 PRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADY 287

Query:   218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             NAKLSDFGLAKD P+  K+HVSTR+MGTYGYAAPEY+MTGHLT +SDVYSFGVVLLE+LT
Sbjct:   288 NAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 347

Query:   278 GRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNH 337
             GR+S+DK+RP  E NL +WA            ++DPRLEG + +KG  K   LA  CL+ 
Sbjct:   348 GRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSR 407

Query:   338 NPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTV 371
             +PK RP M D+V++L+PL  L D A +   F T+
Sbjct:   408 DPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTM 441

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 962 (343.7 bits), Expect = 8.4e-97, P = 8.4e-97
 Identities = 187/317 (58%), Positives = 232/317 (73%)

Query:    41 PSNPEEV-EDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLRE 99
             PS+P  V +DL     +  L  FT  ELR+IT NF +  +L       VYKGFI + ++ 
Sbjct:    54 PSSPMSVMDDLSHSFTSQKLRLFTLSELRVITHNFSRSNMLGEGGFGPVYKGFIDDKVKP 113

Query:   100 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
             G++  PVAVK  D  + +QGHREWLAE++FLG LS+ +LVKLIG+CCE+E RVL+YE+M 
Sbjct:   114 GIEAQPVAVKALDL-HGHQGHREWLAEILFLGQLSNKHLVKLIGFCCEEEQRVLVYEYMP 172

Query:   160 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
             RGS+EN LF +  L + W IRMKIA GAAKGLAFLHEAEKPVIYRDFKTSNILLD+DYNA
Sbjct:   173 RGSLENQLFRRNSLAMAWGIRMKIALGAAKGLAFLHEAEKPVIYRDFKTSNILLDSDYNA 232

Query:   220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             KLSDFGLAKDGPEG+ +HV+TR+MGT GYAAPEYIMTGHLT  +DVYSFGVVLLE++TG+
Sbjct:   233 KLSDFGLAKDGPEGEHTHVTTRVMGTQGYAAPEYIMTGHLTTMNDVYSFGVVLLELITGK 292

Query:   280 KSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP 339
             +S+D +R  REQ+L +WA            IIDPRL   +  +    AA LAY CL+ +P
Sbjct:   293 RSMDNTRTRREQSLVEWARPMLRDQRKLERIIDPRLANQHKTEAAQVAASLAYKCLSQHP 352

Query:   340 KARPLMRDIVDSLEPLQ 356
             K RP M ++V  LE +Q
Sbjct:   353 KYRPTMCEVVKVLESIQ 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2060167 AT2G07180 [Arabidopsis thaliana (taxid:3702)]

 Score = 960 (343.0 bits), Expect = 1.4e-96, P = 1.4e-96
 Identities = 183/317 (57%), Positives = 229/317 (72%)

Query:    40 LPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLRE 99
             LP  P+ ++DL+ +     +  FTY+E++I T  FR D +L       VYKG I E +R 
Sbjct:    56 LPLAPKNIKDLQSNPGYENVDIFTYEEMKIATKQFRPDYILGEGGFGVVYKGVIDESVRV 115

Query:   100 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
             G +   VA+K  + +  +QG REWLAEV +LG LSHPNLVKLIGYCCED+HR+L+YE+MA
Sbjct:   116 GFKSTKVAIKELNPEG-FQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMA 174

Query:   160 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
              GS+E +LF +V   L W+ RMKIA  AAKGLAFLH AE+ +IYRD KT+NILLD  YNA
Sbjct:   175 MGSLEKHLFRRVGCTLTWTKRMKIALDAAKGLAFLHGAERSIIYRDLKTANILLDEGYNA 234

Query:   220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             KLSDFGLAKDGP GD++HVSTR+MGTYGYAAPEY+MTGHLT RSDVY FGV+LLE+L G+
Sbjct:   235 KLSDFGLAKDGPRGDQTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGK 294

Query:   280 KSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP 339
             +++DKSR  RE NL +WA            IIDPR++G Y  K + K A LAY CL+ NP
Sbjct:   295 RAMDKSRACREHNLVEWARPLLNHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNP 354

Query:   340 KARPLMRDIVDSLEPLQ 356
             K RPLM  +V+ LE L+
Sbjct:   355 KGRPLMNHVVEVLETLK 371

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200863 AT1G61590 [Arabidopsis thaliana (taxid:3702)]

 Score = 946 (338.1 bits), Expect = 4.2e-95, P = 4.2e-95
 Identities = 182/308 (59%), Positives = 229/308 (74%)

Query:    48 EDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVA 107
             EDL +   A+ L+ F   EL++IT +F  + +L       VYKG++ + LR+ L+  PVA
Sbjct:    74 EDLAQTLGAD-LVDFQMCELKMITQSFSGNYLLGEGGFGKVYKGYVDDYLRQSLKAQPVA 132

Query:   108 VKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL 167
             VK+ D +   QGHREWL+EVIFLG L HPNLVKLIGYCCE+E RVLIYEFM RGS+EN+L
Sbjct:   133 VKLLDIEG-LQGHREWLSEVIFLGQLKHPNLVKLIGYCCEEEERVLIYEFMPRGSLENHL 191

Query:   168 FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 227
             F ++ L LPW+ R+KIA  AAKGLAFLH+ E P+IYRDFKTSNILLD+D+ AKLSDFGLA
Sbjct:   192 FRRISLSLPWATRLKIAVAAAKGLAFLHDLESPIIYRDFKTSNILLDSDFTAKLSDFGLA 251

Query:   228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
             K GPEG KSHV+TR+MGTYGYAAPEY+ TGHLT +SDVYS+GVVLLE+LTGR++ +KSRP
Sbjct:   252 KMGPEGSKSHVTTRVMGTYGYAAPEYVSTGHLTTKSDVYSYGVVLLELLTGRRATEKSRP 311

Query:   288 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 347
               +QN+ DW+            ++DPRL G Y VK     A+LA  C++ NPK RP M  
Sbjct:   312 KNQQNIIDWSKPYLTSSRRLRCVMDPRLAGQYSVKAAKDTALLALQCVSPNPKDRPKMLA 371

Query:   348 IVDSLEPL 355
             +V++LE L
Sbjct:   372 VVEALESL 379

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 932 (333.1 bits), Expect = 1.3e-93, P = 1.3e-93
 Identities = 183/314 (58%), Positives = 231/314 (73%)

Query:    62 FTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQP---VPVAVKVHDGDNSYQ 118
             F++ +L++ T NFR + +L      CV+KG++ E+    ++P   + VAVK  + D   Q
Sbjct:   124 FSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDG-LQ 182

Query:   119 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS 178
             GH+EWLAE+ +LG+L HPNLVKL+GYC ED+ R+L+YEFM RGS+EN+LF + L PLPWS
Sbjct:   183 GHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWS 241

Query:   179 IRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
             IRMKIA GAAKGL+FLHE A KPVIYRDFKTSNILLD +YNAKLSDFGLAKD P+  K+H
Sbjct:   242 IRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTH 301

Query:   238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 297
             VSTR+MGTYGYAAPEY+MTGHLT +SDVYSFGVVLLE+LTGR+S+DK+RP  E NL +WA
Sbjct:   302 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361

Query:   298 XXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV 357
                         ++DPRLEG + VKG  K   LA  CL+ + K RP M ++V+ L+PL  
Sbjct:   362 RPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPH 421

Query:   358 LPDEAPTPKNFVTV 371
             L D A     F T+
Sbjct:   422 LKDMASASYYFQTM 435

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FM85	Y5564_ARATH	2, ., 7, ., 1, 1, ., 1	0.8082	0.9691	0.9240	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	389
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-34
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-26
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-22
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-21
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-21
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-20
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-20
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-13
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	9e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.001
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  173 bits (441), Expect = 6e-52
 Identities = 86/277 (31%), Positives = 131/277 (47%), Gaps = 23/277 (8%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
            + LG G FG VYKG +    +   + V VAVK    D S Q   E+L E   +  L HP
Sbjct: 4   GKKLGEGAFGEVYKGTL--KGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 196
           N+VKL+G C E+E  +++ E+M  G + + L       L  S  +  A   A+G+ +L  
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE- 120

Query: 197 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIM 255
             K  I+RD    N L+  +   K+SDFGL++D  + D       ++     + APE + 
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLK 177

Query: 256 TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL 315
            G  T +SDV+SFGV+L EI T  +      P    + A+  L  LK+  +L     P+ 
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYLKKGYRL-----PK- 225

Query: 316 EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 352
               P     +   L   C   +P+ RP   ++V+ L
Sbjct: 226 ----PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  171 bits (437), Expect = 3e-51
 Identities = 87/277 (31%), Positives = 130/277 (46%), Gaps = 24/277 (8%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
            + LG G FG VYKG +    + G + V VAVK    D S Q   E+L E   +  L HP
Sbjct: 4   GKKLGEGAFGEVYKGKL--KGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 196
           N+VKL+G C E+E   ++ E+M  G + + L  K    L  S  +  A   A+G+ +L  
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE- 119

Query: 197 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIM 255
             K  I+RD    N L+  +   K+SDFGL++D  + D       ++     + APE + 
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLK 176

Query: 256 TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL 315
            G  T +SDV+SFGV+L EI T  +      P    +  +  L  LK   +L     P+ 
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYLKNGYRL-----PQ- 224

Query: 316 EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 352
               P     +   L   C   +P+ RP   ++V+ L
Sbjct: 225 ----PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  167 bits (425), Expect = 5e-50
 Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 62/275 (22%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG GGFG VY     +  ++      VA+K+   ++S     E L E+  L  L+HPN+V
Sbjct: 1   LGEGGFGTVYLARDKKTGKK------VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIV 54

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
           KL G   ++ H  L+ E+   GS++ +L  +    L     ++I     +GL +LH    
Sbjct: 55  KLYGVFEDENHLYLVMEYCEGGSLK-DLLKENEGKLSEDEILRILLQILEGLEYLH--SN 111

Query: 200 PVIYRDFKTSNILLD-TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TG 257
            +I+RD K  NILLD  +   KL+DFGL+K         +   I+GT  Y APE ++  G
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKG 169

Query: 258 HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG 317
           + + +SD++S GV+L E+                              +L ++I      
Sbjct: 170 YYSEKSDIWSLGVILYEL-----------------------------PELKDLIR----- 195

Query: 318 DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 352
                            L  +P+ RP  ++I++ L
Sbjct: 196 ---------------KMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  165 bits (419), Expect = 2e-48
 Identities = 85/289 (29%), Positives = 126/289 (43%), Gaps = 40/289 (13%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           + LG G FG VYKG +     +  +   VAVK    D S +  +++L E   +  L HPN
Sbjct: 1   KKLGEGAFGEVYKGKLK---GKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPN 57

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGS-------VENNLFSKVLLPLPWSIRMKIAFGAAKG 190
           +V+L+G C E+E   L+ E+M  G              S     L     +  A   AKG
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST------RIMG 244
           + +L    K  ++RD    N L+  D   K+SDFGL++D  + D     T      R M 
Sbjct: 118 MEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM- 174

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 304
                APE +  G  T +SDV+SFGV+L EI T   +     P    +  +  L  L++ 
Sbjct: 175 -----APESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPGLSNEE-VLEYLRKG 223

Query: 305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
            +L     P    D       +   L   C   +P+ RP   ++V+ LE
Sbjct: 224 YRLPK---PEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  159 bits (404), Expect = 2e-46
 Identities = 85/285 (29%), Positives = 129/285 (45%), Gaps = 33/285 (11%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
               + LG G FG VYKG +  D         VAVK      S +   E+L E   +  L
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGD--GEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL 58

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 193
           SHPN+V+L+G C + E   ++ E+M  G + + L  K    L     +++A   AKG+ +
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST------RIMGTYG 247
           L    K  ++RD    N L+  +   K+SDFGL++D  E D            + M    
Sbjct: 118 LE--SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM---- 171

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 307
             APE +  G  T +SDV+SFGV+L EI T  +      P    +  +  L LL++  +L
Sbjct: 172 --APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLEDGYRL 223

Query: 308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 352
                PR E         +   L   C  ++P+ RP   ++V+ L
Sbjct: 224 -----PRPENCPD-----ELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  157 bits (400), Expect = 8e-46
 Identities = 92/284 (32%), Positives = 131/284 (46%), Gaps = 33/284 (11%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG-DNSYQGHREWLAEVIFLGH 132
           +   R LG G FG VYK    +    G     VAVK+        +  +    E+  L  
Sbjct: 1   YELLRKLGSGSFGTVYKA---KHKGTGKI---VAVKILKKRSEKSKKDQTARREIRILRR 54

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFGAAKG 190
           LSHPN+V+LI    + +H  L+ E+   G     LF  +    PL      KIA    +G
Sbjct: 55  LSHPNIVRLIDAFEDKDHLYLVMEYCEGGD----LFDYLSRGGPLSEDEAKKIALQILRG 110

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L +LH     +I+RD K  NILLD +   K++DFGLAK       S ++T + GT  Y A
Sbjct: 111 LEYLHS--NGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMA 166

Query: 251 PEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 309
           PE ++ G    P+ DV+S GV+L E+LTG+       P   +N+ D       + + +  
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKP------PFSGENILD-------QLQLIRR 213

Query: 310 IIDPRLEGDYPVKGVHKAAM--LAYHCLNHNPKARPLMRDIVDS 351
           I+ P LE D P           L   CLN +P  RP   +I+  
Sbjct: 214 ILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQH 257

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  154 bits (393), Expect = 8e-45
 Identities = 74/272 (27%), Positives = 113/272 (41%), Gaps = 31/272 (11%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           +     LG G FG VY      D + G     VA+KV       +     L E+  L  L
Sbjct: 1   YEILEKLGEGSFGKVYLA---RDKKTGKL---VAIKVIKKKKIKKDRERILREIKILKKL 54

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 193
            HPN+V+L     +++   L+ E+   G + + L  +  L      R          L +
Sbjct: 55  KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSALEY 112

Query: 194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 253
           LH   K +++RD K  NILLD D + KL+DFGLA+         ++T + GT  Y APE 
Sbjct: 113 LHS--KGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEV 167

Query: 254 IMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII-D 312
           ++        D++S GV+L E+LTG+       P    +          +  +L   I  
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDD----------QLLELFKKIGK 211

Query: 313 PRLEGDYPVKGVHKAAM-LAYHCLNHNPKARP 343
           P+     P   +   A  L    L  +P+ R 
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (325), Expect = 8e-35
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 15/211 (7%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 131
            + +  +LG G FG VY      D   G     +AVK V    +S +       E+  L 
Sbjct: 1   EWTRGELLGRGSFGSVYLAL---DKDTGEL---MAVKSVELSGDSEEELEALEREIRILS 54

Query: 132 HLSHPNLVKLIGYCCEDEHRVL-IY-EFMARGSVENNLFSKVLLPLPWS-IRMKIAFGAA 188
            L HPN+V+  G   ++E   L I+ E+++ GS+ +    K    LP   IR K      
Sbjct: 55  SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS--LLKKFGKLPEPVIR-KYTRQIL 111

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           +GLA+LH     +++RD K +NIL+D+D   KL+DFG AK   + +    +  + GT  +
Sbjct: 112 EGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            APE I        +D++S G  ++E+ TG+
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  126 bits (319), Expect = 5e-34
 Identities = 76/278 (27%), Positives = 117/278 (42%), Gaps = 44/278 (15%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLG 131
           F     +G GGFG VYK       R G     VA+KV   +     +   + + E+  L 
Sbjct: 2   FEILEKIGKGGFGEVYKAR---HKRTG---KEVAIKVIKLESKEKKE---KIINEIQILK 52

Query: 132 HLSHPNLVKLIG-YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
              HPN+VK  G Y  +DE   ++ EF + GS+++ L       L  S    +     KG
Sbjct: 53  KCKHPNIVKYYGSYLKKDE-LWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKG 110

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L +LH     +I+RD K +NILL +D   KL DFGL+    +    +    ++GT  + A
Sbjct: 111 LEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMA 165

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE-----QNLADWALPLLKEKK 305
           PE I       ++D++S G+  +E+  G+    +  P +       N      P L+  +
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP----PGLRNPE 221

Query: 306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
           K  +                    L   CL  NP+ RP
Sbjct: 222 KWSDEF---------------KDFL-KKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 2e-30
 Identities = 82/287 (28%), Positives = 134/287 (46%), Gaps = 27/287 (9%)

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH 135
             R LG G FG VY+G +++ + +G     VA+K  + + S +   E+L E   +   + 
Sbjct: 10  LIRELGQGSFGMVYEG-LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC 68

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------VLLPLPWSIRMKIAFGA 187
            ++V+L+G     +  +++ E MA+G +++ L S+         L P      +++A   
Sbjct: 69  HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           A G+A+L  A K  ++RD    N ++  D   K+ DFG+ +D  E D      + +    
Sbjct: 129 ADGMAYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 307
           + APE +  G  T +SDV+SFGVVL E+ T               LA+     L  ++ L
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQPYQGLSNEEVL 231

Query: 308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 354
             +ID     D P     K   L   C  +NPK RP   +IV SL+ 
Sbjct: 232 KFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 1e-29
 Identities = 75/233 (32%), Positives = 125/233 (53%), Gaps = 23/233 (9%)

Query: 67  LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           LRI+      + +VLG G FG VYKG    +  E ++ +PVA+KV   + S + ++E L 
Sbjct: 1   LRILKETELEKIKVLGSGAFGTVYKGVWIPEG-EKVK-IPVAIKVLREETSPKANKEILD 58

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGS----VENN---LFSKVLLPLPWS 178
           E   +  + HP++V+L+G C   + + LI + M  G     V N+   + S+ L  L W 
Sbjct: 59  EAYVMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYL--LNWC 115

Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 238
           +++      AKG+++L   EK +++RD    N+L+ T  + K++DFGLAK     +K + 
Sbjct: 116 VQI------AKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH 167

Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
           +        + A E I+    T +SDV+S+GV + E++T G K  +   PA E
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  114 bits (288), Expect = 2e-29
 Identities = 85/298 (28%), Positives = 122/298 (40%), Gaps = 44/298 (14%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           + LG G FG V       D         VAVK  +     Q   ++  E+  L  L H N
Sbjct: 10  KQLGEGHFGKVELC--RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 138 LVKLIGYCCEDEHRV---LIYEFMARGSV-------ENNLFSKVLLPLPWSIRMKIAFGA 187
           +VK  G  CE        LI E++  GS+        + +  K LL          +   
Sbjct: 68  IVKYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL--------LFSSQI 118

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST--RIMGT 245
            KG+ +L    +  I+RD    NIL++++   K+SDFGLAK  PE    +          
Sbjct: 119 CKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKS-------LDKSRPAREQNLADWA 297
           + Y APE + T   +  SDV+SFGV L E+ T G  S       L     A+ Q +    
Sbjct: 177 FWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235

Query: 298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
           L LLKE ++L     PR     P     +   L   C    P+ RP   D++  ++ L
Sbjct: 236 LELLKEGERL-----PR-----PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (284), Expect = 3e-28
 Identities = 84/292 (28%), Positives = 127/292 (43%), Gaps = 30/292 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 130
           ++R  R LG G FG VY      D +       VA+KV     ++  +    +L E+  L
Sbjct: 1   SYRILRKLGEGSFGEVYLA---RDRK------LVALKVLAKKLESKSKEVERFLREIQIL 51

Query: 131 GHLSHP-NLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAA 188
             L+HP N+VKL  +  ++    L+ E++  GS+E+ L       PL  S  + I     
Sbjct: 52  ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQIL 111

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFGLAKDGPEGDKS----HVSTRIM 243
             L +LH   K +I+RD K  NILLD D    KL DFGLAK  P+   +     + +  +
Sbjct: 112 SALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 244 GTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
           GT GY APE ++     + +  SD++S G+ L E+LTG    +          +      
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE------KNSSATSQT 223

Query: 301 LKEKKKL-LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS 351
           LK   +L    +   L    P      A+ L    L  +PK R      +  
Sbjct: 224 LKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 6e-28
 Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 13/202 (6%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           ++G G FG VYKG    +L  G     VA+K +       +  +  + E+  L +L HPN
Sbjct: 7   LIGRGAFGVVYKGL---NLETGDF---VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 197
           +VK IG     +   +I E+   GS+   +  K   P P S+     +   +GLA+LHE 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHE- 117

Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG 257
            + VI+RD K +NIL   D   KL+DFG+A      D S     ++GT  + APE I   
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 258 HLTPRSDVYSFGVVLLEILTGR 279
             +  SD++S G  ++E+LTG 
Sbjct: 175 GASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 3e-27
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 26/205 (12%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           +G G FG V  G          +   VAVK + D   + Q    +LAE   +  L HPNL
Sbjct: 14  IGKGEFGDVMLGD--------YRGQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNL 62

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 198
           V+L+G   +     ++ E+MA+GS+ + L S+    +  + ++  A    +G+ +L   E
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--E 120

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD---GPEGDKSHVSTRIMGTYGYAAPEYIM 255
           K  ++RD    N+L+  D  AK+SDFGLAK+   G +  K  V         + APE + 
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALR 172

Query: 256 TGHLTPRSDVYSFGVVLLEILT-GR 279
               + +SDV+SFG++L EI + GR
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 5e-27
 Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 24/210 (11%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSH 135
           ++V+GGG FG V +G +    +   + + VA+K +  G +  Q   ++L E   +G   H
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGK---KEIDVAIKTLKAGSSDKQ-RLDFLTEASIMGQFDH 64

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAK 189
           PN+++L G   +    ++I E+M  GS++  L      F+   L       + +  G A 
Sbjct: 65  PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-------VGMLRGIAS 117

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSHVSTRIMGTYG 247
           G+ +L  +E   ++RD    NIL++++   K+SDFGL++  +  E   +    +I     
Sbjct: 118 GMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIR 173

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           + APE I     T  SDV+SFG+V+ E+++
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  106 bits (266), Expect = 2e-26
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 12/204 (5%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           F  +R LG G FG V++G            V VA+K+   D+  +  +++  EV  L  L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNR-------VRVAIKILKSDDLLK-QQDFQKEVQALKRL 59

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 193
            H +L+ L   C   E   +I E M +GS+   L S     LP +  + +A   A+G+A+
Sbjct: 60  RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119

Query: 194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 253
           L E  +  I+RD    NIL+  D   K++DFGLA+   E        +I   Y + APE 
Sbjct: 120 LEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEA 175

Query: 254 IMTGHLTPRSDVYSFGVVLLEILT 277
              G  + +SDV+SFG++L E+ T
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  105 bits (263), Expect = 5e-26
 Identities = 73/212 (34%), Positives = 106/212 (50%), Gaps = 16/212 (7%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
             LG G FG VY+G  ++ L  G  P+ VAVK      + Q  +E+L E   + + +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNL-------FSKVLLPLPWSIRMKIAFGAAKG 190
           +VKL+G C  +E + +I E M  G + + L       F   LL L     + I    AKG
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL--KELLDICLDVAKG 118

Query: 191 LAFLHEAEKPVIYRDFKTSNILL-----DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             +L +     I+RD    N L+     D D   K+ DFGLA+D  + D        +  
Sbjct: 119 CVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             + APE ++ G  T +SDV+SFGV++ EILT
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  105 bits (263), Expect = 6e-26
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 17/222 (7%)

Query: 68  RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEV 127
            I  +  R    LG G FG VYKG ++    E L    VA+K    +   +  +E+  E 
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTG-PNERLSATSVAIKTLKENAEPKVQQEFRQEA 59

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------------VLL 173
             +  L HPN+V L+G C +++   +++E++A G +   L                 V  
Sbjct: 60  ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119

Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
            L  S  + IA   A G+ +L  +    ++RD    N L+      K+SDFGL++D    
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177

Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           D   V ++ +    +  PE I+ G  T  SD++SFGVVL EI
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  104 bits (261), Expect = 1e-25
 Identities = 79/290 (27%), Positives = 120/290 (41%), Gaps = 27/290 (9%)

Query: 72  ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 131
            +    R LG G FG VY+G            + VAVK      S Q   ++L E + + 
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYR-GRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS 64

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMK----IAFG 186
             +H N+V+LIG   E   R ++ E MA G +++ L  ++     P S+ MK     A  
Sbjct: 65  KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
            AKG  +L   E   I+RD    N LL        AK++DFG+A+D           R M
Sbjct: 125 VAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 303
               +  PE  + G  T ++DV+SFGV+L EI +        R  +E       +  +  
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVTG 236

Query: 304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
             +L          D P         +   C  H P+ RP    I++ ++
Sbjct: 237 GGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  100 bits (252), Expect = 2e-24
 Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 15/212 (7%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           R LG G FG V+ G       E  + + VAVK      S    +++  E   L +  H N
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKEL-VAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK----VLL--------PLPWSIRMKIAF 185
           +VK  G C E +  ++++E+M  G +   L S       L         L  S  ++IA 
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A G+ +L  A +  ++RD  T N L+  D   K+ DFG+++D    D   V    M  
Sbjct: 130 QIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             +  PE IM    T  SDV+SFGVVL EI T
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.8 bits (242), Expect = 4e-23
 Identities = 55/161 (34%), Positives = 79/161 (49%), Gaps = 16/161 (9%)

Query: 124 LAEVIFLGHLSHPNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           L E   L  ++HP +VKL  +     +E   L+ E+   G + ++L  +           
Sbjct: 41  LTERNILSRINHPFIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER---- 94

Query: 182 KIAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 238
              F AA+    L +LH     +IYRD K  NILLD D + KL+DFGLAK+      S  
Sbjct: 95  -ARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRT 150

Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           +T   GT  Y APE ++        D +S GV+L E+LTG+
Sbjct: 151 NTFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 96.4 bits (240), Expect = 7e-23
 Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 19/208 (9%)

Query: 78  RVLGGGGFGCVYKG-FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
           RV+G G FGCVY G  I  D ++    +  AVK  +     +   ++L E I +   SHP
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQK----IHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHP 56

Query: 137 NLVKLIGYCCEDE---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGL 191
           N++ L+G C   E     VL Y  M  G + N + S+   P   +++  I FG   AKG+
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPY--MKHGDLRNFIRSETHNP---TVKDLIGFGLQVAKGM 111

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYA 249
            +L  A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 112 EYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILT 277
           A E + T   T +SDV+SFGV+L E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 96.6 bits (241), Expect = 9e-23
 Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 21/217 (9%)

Query: 80  LGGGGFGCVY-------KGFISEDLREG---LQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
           LG G FG V+       + F  +   E      PV VAVKV   D S     ++L EV  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV---------ENNLFSKVLLPLPWSIR 180
           L  LS PN+ +L+G C  D    +I E+M  G +         E +  +     L +S  
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           + +A   A G+ +L       ++RD  T N L+  +Y  K++DFG++++    D   V  
Sbjct: 133 LYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG 190

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           R      + A E ++ G  T +SDV++FGV L EILT
Sbjct: 191 RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 99.5 bits (248), Expect = 1e-22
 Identities = 91/290 (31%), Positives = 139/290 (47%), Gaps = 34/290 (11%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
           I ++ +++ V+  G  G  YKG   + ++ G+Q V   VK  +  NS        +E+  
Sbjct: 688 ILSSLKEENVISRGKKGASYKG---KSIKNGMQFV---VKEINDVNSIP-----SSEIAD 736

Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +G L HPN+VKLIG C  ++   LI+E+     +E    S+VL  L W  R KIA G AK
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEY-----IEGKNLSEVLRNLSWERRRKIAIGIAK 791

Query: 190 GLAFLHEAEKP-VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
            L FLH    P V+  +     I++D      L    L+  G         T+   +  Y
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGL----LCTDTKCFISSAY 844

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL 308
            APE   T  +T +SD+Y FG++L+E+LTG+   D        ++ +WA     +   L 
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSD-CHLD 902

Query: 309 NIIDPRLEGDYPVKGVHKAAM-----LAYHCLNHNPKARPLMRDIVDSLE 353
             IDP + GD     V++  +     LA HC   +P ARP   D++ +LE
Sbjct: 903 MWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 83/309 (26%), Positives = 126/309 (40%), Gaps = 45/309 (14%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISE-DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 131
           N    + LG G FG V K        R G     VAVK+   + S    R+ L+E   L 
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGY--TTVAVKMLKENASSSELRDLLSEFNLLK 58

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV----------------------ENNLFS 169
            ++HP+++KL G C +D   +LI E+   GS+                       + L +
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 170 KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 229
                L     +  A+  ++G+ +L  AE  +++RD    N+L+      K+SDFGL++D
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPA 288
             E D     ++      + A E +     T +SDV+SFGV+L EI+T G        P 
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236

Query: 289 REQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
           R  N       LLK   ++          + P     +   L   C    P  RP   DI
Sbjct: 237 RLFN-------LLKTGYRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Query: 349 VDSLEPLQV 357
              LE + V
Sbjct: 280 SKELEKMMV 288

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 40/220 (18%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVP----VAVKV--HDGDNSYQGHREWLAEV 127
                 LG G  G V K          +   P    +AVK    + + + Q  ++ L E+
Sbjct: 3   LEYLGELGAGNSGVVSK----------VLHRPTGKIMAVKTIRLEINEAIQ--KQILREL 50

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA 187
             L   + P +V   G    +    +  E+M  GS++  +  +V   +P  I  KIA   
Sbjct: 51  DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAV 109

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM---- 243
            KGL +LHE  K +I+RD K SNIL+++    KL DFG            VS +++    
Sbjct: 110 LKGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLA 156

Query: 244 ----GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
               GT  Y APE I     + +SD++S G+ L+E+ TGR
Sbjct: 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 94.9 bits (236), Expect = 4e-22
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 31/229 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQP----VPVAVKVHDGDNSYQGHREWLAEVI 128
           N    R +G G FG V++         GL P      VAVK+   + S     ++  E  
Sbjct: 6   NIEYVRDIGQGAFGRVFQA-----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--------------------F 168
            +    HPN+VKL+G C   +   L++E+MA G +   L                     
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 169 SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK 228
               LPL  + ++ IA   A G+A+L  +E+  ++RD  T N L+  +   K++DFGL++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Query: 229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           +    D    S        +  PE I     T  SDV+++GVVL EI +
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 94.7 bits (235), Expect = 4e-22
 Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 31/286 (10%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           R LG G FG VY+G  + D+ +G     VAVK  +   S +   E+L E   +   +  +
Sbjct: 12  RELGQGSFGMVYEG-NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP--------LPWSIRMKIAFGA-- 187
           +V+L+G   + +  +++ E MA G +++ L  + L P         P +++  I   A  
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ +D  E D      + +    
Sbjct: 129 ADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 307
           + APE +  G  T  SD++SFGVVL EI +               LA+     L  ++ L
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 231

Query: 308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
             ++D     D P     +   L   C   NPK RP   +IV+ L+
Sbjct: 232 KFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 94.5 bits (235), Expect = 4e-22
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 22/214 (10%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHP 136
           ++LG G FG V +G +S+D  +G   + VAVK    D  +Y    E+L+E   +    HP
Sbjct: 5   KILGEGEFGSVMEGQLSQD--DG-SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61

Query: 137 NLVKLIGYCCEDEHR------VLIYEFMARGSVENNLFSKVL--LP--LPWSIRMKIAFG 186
           N++KLIG C E          ++I  FM  G + + L    L  LP  LP    +K    
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRIM 243
            A G+ +L  + +  I+RD    N +L  D    ++DFGL+K    GD   +  ++   +
Sbjct: 122 IALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
               + A E +     T +SDV++FGV + EI T
Sbjct: 180 K---WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 94.3 bits (234), Expect = 5e-22
 Identities = 75/289 (25%), Positives = 135/289 (46%), Gaps = 39/289 (13%)

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH 135
           + +V+G G FG V++G +      G + V VA+K      + +  +++L+E   +G  SH
Sbjct: 9   KQKVIGAGEFGEVFRGILK---MPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAK 189
            N+++L G   + +  ++I E+M  G+++  L      FS   L       + +  G A 
Sbjct: 66  HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-------VGMLRGIAA 118

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTY 246
           G+ +L  ++   ++RD    NIL++++   K+SDFGL++   D PEG  +    +I    
Sbjct: 119 GMKYL--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PI 174

Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK 306
            + APE I     T  SDV+SFG+V+ E+++  +     RP        W +       +
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE-----RPY-------WDM----SNHE 218

Query: 307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
           ++  I+       P+        L   C   +   RP   DIV+ L+ L
Sbjct: 219 VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 93.7 bits (233), Expect = 6e-22
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 10/201 (4%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
             +G G FG VYKG     L+   +   VAVK           R++L E   L    HPN
Sbjct: 1   EKIGKGNFGDVYKGV----LKGNTE---VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPN 53

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 197
           +VKLIG C + +   ++ E +  GS+   L  K    L     ++++  AA G+ +L   
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLE-- 110

Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG 257
            K  I+RD    N L+  +   K+SDFG++++   G  +           + APE +  G
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 258 HLTPRSDVYSFGVVLLEILTG 278
             T  SDV+S+G++L E  + 
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 44/282 (15%)

Query: 72  ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 131
           ++  + +VLG G  G VYK         G      A+K    D   +  ++ L E+  L 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVR---HKPTGKI---YALKKIHVDGDEEFRKQLLRELKTLR 54

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
               P +VK  G   ++    ++ E+M  GS+ + L  K +  +P  +   IA    KGL
Sbjct: 55  SCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGL 112

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGY 248
            +LH  ++ +I+RD K SN+L+++    K++DFG++K   +  +   + V     GT  Y
Sbjct: 113 DYLH-TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTY 166

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL 308
            +PE I     +  +D++S G+ LLE   G+       P        +         +L+
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGK------FPFLPPGQPSFF--------ELM 212

Query: 309 NII----DPRLEGDYPVKGVHKAAMLAY---HCLNHNPKARP 343
             I     P L  +        +         CL  +PK RP
Sbjct: 213 QAICDGPPPSLPAE------EFSPEFRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 17/203 (8%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG G FG V KG     L +  + V VAVK    ++   G +E+L E   +  L HP +V
Sbjct: 3   LGHGNFGSVVKGVY---LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
           +LIG  C+ E  +L+ E    G +   L  +  +P+     +  A   A G+A+L    K
Sbjct: 60  RLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--AHQVAMGMAYLE--SK 114

Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG-----YAAPEYI 254
             ++RD    N+LL   + AK+SDFG+++    G   + +T    T G     + APE I
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPECI 170

Query: 255 MTGHLTPRSDVYSFGVVLLEILT 277
             G  + +SDV+S+GV L E  +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 92.0 bits (228), Expect = 4e-21
 Identities = 90/320 (28%), Positives = 149/320 (46%), Gaps = 57/320 (17%)

Query: 67  LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           +RI+     ++ +VLG G FG VYKG    D  E ++ +PVA+KV   + S + ++E L 
Sbjct: 1   MRILKETELKKVKVLGSGAFGTVYKGIWIPD-GENVK-IPVAIKVLRENTSPKANKEILD 58

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPWS 178
           E   +  +  P + +L+G C     + L+ + M  G +       ++ + S+ LL   W 
Sbjct: 59  EAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLN--WC 115

Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----DGPE-- 232
           +++      AKG+++L E    +++RD    N+L+ +  + K++DFGLA+    D  E  
Sbjct: 116 VQI------AKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167

Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQ 291
            D   V  + M      A E I+    T +SDV+S+GV + E++T G K  D   PARE 
Sbjct: 168 ADGGKVPIKWM------ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE- 219

Query: 292 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS 351
                 +P L EK + L           P        M+   C   + + RP  R++VD 
Sbjct: 220 ------IPDLLEKGERLP---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264

Query: 352 LEPLQVLPDEAPTPKNFVTV 371
              +      A  P  FV +
Sbjct: 265 FSRM------ARDPSRFVVI 278

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 91.4 bits (228), Expect = 4e-21
 Identities = 71/297 (23%), Positives = 115/297 (38%), Gaps = 60/297 (20%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW-LAEVIFLG 131
            +   + +G G FG VY         +G       +K  D  N  +  RE  L EV  L 
Sbjct: 1   KYEIIKQIGKGSFGKVYLV---RRKSDG---KLYVLKEIDLSNMSEKEREDALNEVKILK 54

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGS----VENNLFSKVLLP----LPWSIRMKI 183
            L+HPN++K      E     ++ E+   G     ++         P    L W +++  
Sbjct: 55  KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL-- 112

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
                  L +LH   + +++RD K  NI L ++   KL DFG++K           T + 
Sbjct: 113 ----CLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV- 164

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 303
           GT  Y +PE         +SD++S G VL E+ T +       P   +NL + AL +LK 
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK------HPFEGENLLELALKILKG 218

Query: 304 K---------KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS 351
           +          +L N++                       L  +P+ RP +  I+ S
Sbjct: 219 QYPPIPSQYSSELRNLVSS--------------------LLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 90.9 bits (226), Expect = 6e-21
 Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 11/201 (5%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG G FG V +G   E    G + +PVAVK    D       ++L E   +  L H NL+
Sbjct: 3   LGDGSFGVVRRG---EWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
           +L G        +++ E    GS+ + L    L     S     A   A G+ +L    K
Sbjct: 60  RLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES--K 116

Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST---RIMGTYGYAAPEYIMT 256
             I+RD    NILL +D   K+ DFGL +  P+ +  +V     ++   + + APE + T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRT 174

Query: 257 GHLTPRSDVYSFGVVLLEILT 277
              +  SDV+ FGV L E+ T
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 91.6 bits (227), Expect = 6e-21
 Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 22/217 (10%)

Query: 80  LGGGGFG----CVYKGFISEDLREGL-----QPVPVAVKVHDGDNSYQGHREWLAEVIFL 130
           LG G FG    C  +G ++E L EG      QPV VAVK+   D +     ++L E+  +
Sbjct: 13  LGEGQFGEVHLCEAEG-LAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL---------LP-LPWSIR 180
             L +PN+++L+G C  D+   +I E+M  G +   L  + +         +P +  +  
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           + +A   A G+ +L  A    ++RD  T N L+   Y  K++DFG++++   GD   +  
Sbjct: 132 LYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           R +    + A E I+ G  T  SDV++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 90.6 bits (225), Expect = 8e-21
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 28/215 (13%)

Query: 75  RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REWLAEVIFLGHL 133
           R+  +LG G FG VY+G   +D       V   V + D   + Q   ++   E+  L  L
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDD--GDFFAVKE-VSLADDGQTGQEAVKQLEQEIALLSKL 59

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM---KIAFGAAKG 190
            HPN+V+ +G   E+++  +  E +  GS+   L      P P  IR+   +I      G
Sbjct: 60  QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP-VIRLYTRQIL----LG 114

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-----GT 245
           L +LH+  +  ++RD K +NIL+DT+   KL+DFG+AK         V          G+
Sbjct: 115 LEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGS 164

Query: 246 YGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
             + APE I   G     +D++S G  +LE+ TG+
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 59/186 (31%), Positives = 80/186 (43%), Gaps = 28/186 (15%)

Query: 107 AVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY---EFMARGSV 163
           A+K    D +    ++ L E+        P +VK  G    DE    I    E+   GS+
Sbjct: 30  ALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG-AFLDESSSSIGIAMEYCEGGSL 88

Query: 164 E----------NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL 213
           +            +  KVL         KIA    KGL++LH   + +I+RD K SNILL
Sbjct: 89  DSIYKKVKKRGGRIGEKVLG--------KIAESVLKGLSYLHS--RKIIHRDIKPSNILL 138

Query: 214 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 273
                 KL DFG++    E   S   T   GT  Y APE I     +  SDV+S G+ LL
Sbjct: 139 TRKGQVKLCDFGVSG---ELVNSLAGT-FTGTSFYMAPERIQGKPYSITSDVWSLGLTLL 194

Query: 274 EILTGR 279
           E+   R
Sbjct: 195 EVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 27/284 (9%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           R LG G FG VY+G I++ + +      VA+K  +   S +   E+L E   +   +  +
Sbjct: 12  RELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLPWSIRMKIAFGAAK 189
           +V+L+G   + +  ++I E M RG +++ L S         V  P      +++A   A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           G+A+L+ A K  ++RD    N ++  D+  K+ DFG+ +D  E D      + +    + 
Sbjct: 131 GMAYLN-ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 309
           +PE +  G  T  SDV+SFGVVL EI T               LA+     +  ++ L  
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGMSNEQVLRF 233

Query: 310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
           +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 234 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 70/212 (33%), Positives = 106/212 (50%), Gaps = 23/212 (10%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGH 132
            + +R LG G FG V+ G  +           VAVK    G  S +    +L E   +  
Sbjct: 8   LKLERKLGAGQFGEVWMGTWNGT-------TKVAVKTLKPGTMSPE---AFLQEAQIMKK 57

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKG 190
           L H  LV+L   C E+E   ++ E+M++GS+ + L S     L LP  + M  A   A+G
Sbjct: 58  LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEG 115

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK--SHVSTRIMGTYGY 248
           +A+L    +  I+RD    NIL+  +   K++DFGLA+   E D+  +    +      +
Sbjct: 116 MAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKF--PIKW 170

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 279
            APE    G  T +SDV+SFG++L EI+T GR
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 72/233 (30%), Positives = 123/233 (52%), Gaps = 23/233 (9%)

Query: 67  LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           LRI+    F++ +VLG G FG VYKG    +  E ++ +PVA+K      S + ++E L 
Sbjct: 1   LRILKETEFKKIKVLGSGAFGTVYKGLWIPE-GEKVK-IPVAIKELREATSPKANKEILD 58

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPWS 178
           E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W 
Sbjct: 59  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--WC 115

Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 238
           +++      AKG+ +L E  + +++RD    N+L+ T  + K++DFGLAK     +K + 
Sbjct: 116 VQI------AKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
           +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 89.6 bits (222), Expect = 3e-20
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 20/198 (10%)

Query: 96  DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY 155
           ++R+G +P+ VAVK+   D +     ++L EV  L  L  PN+++L+G C +++   +I 
Sbjct: 40  NVRKG-RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMIT 98

Query: 156 EFMARGSVENNLFSKVLL--------------PLP---WSIRMKIAFGAAKGLAFLHEAE 198
           E+M  G +   L S  L                LP   +S  + +A   A G+ +L  + 
Sbjct: 99  EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SS 156

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH 258
              ++RD  T N L+  +   K++DFG++++   GD   +  R +    + A E I+ G 
Sbjct: 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216

Query: 259 LTPRSDVYSFGVVLLEIL 276
            T  SDV++FGV L EIL
Sbjct: 217 FTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 88.9 bits (220), Expect = 3e-20
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG G FGCV KG      ++    + VA+KV   +N      E + E   +  L +P +V
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ----IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
           ++IG  CE E  +L+ E MA G   N   S     +  S  +++    + G+ +L    K
Sbjct: 59  RMIG-VCEAEALMLVME-MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG--K 114

Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTG 257
             ++RD    N+LL   + AK+SDFGL+K     D S+   R  G +   + APE I   
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 258 HLTPRSDVYSFGVVLLEILT-GRKSLDK 284
             + RSDV+S+G+ + E  + G+K   K
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKK 201

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 89.2 bits (221), Expect = 3e-20
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 23/219 (10%)

Query: 68  RII-TANFRQDRVLGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           RI+     R+ ++LG G FG V+KG  I E   + ++ +PVA+K     +  Q  +E   
Sbjct: 2   RILKETELRKLKLLGSGVFGTVHKGIWIPEG--DSIK-IPVAIKTIQDRSGRQTFQEITD 58

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPWS 178
            ++ +G L H  +V+L+G C     + L+ +    GS+        ++L  + LL   W 
Sbjct: 59  HMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLN--WC 115

Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 238
           +++      AKG+ +L E    +++R+    NILL +D   +++DFG+A      DK + 
Sbjct: 116 VQI------AKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167

Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +       + A E I+ G  T +SDV+S+GV + E+++
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 88.8 bits (220), Expect = 4e-20
 Identities = 60/218 (27%), Positives = 112/218 (51%), Gaps = 23/218 (10%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 128
           I  +  + ++V+G G FG V  G +      G + +PVA+K      + +  R++L+E  
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLK---LPGKREIPVAIKTLKAGYTEKQRRDFLSEAS 57

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSIRMK 182
            +G   HPN++ L G   + +  +++ E+M  GS++  L      F+ + L       + 
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-------VG 110

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDKSHVS 239
           +  G A G+ +L  ++   ++RD    NIL++++   K+SDFGL++   D PE   +   
Sbjct: 111 MLRGIASGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +I     + APE I     T  SDV+S+G+V+ E+++
Sbjct: 169 GKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 88.8 bits (220), Expect = 5e-20
 Identities = 64/221 (28%), Positives = 115/221 (52%), Gaps = 30/221 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK--------VHDGDNSYQGHREWL 124
            + + + LG G F   Y+   + D++ G     +AVK          + +   +  R+  
Sbjct: 1   EWLKGQQLGTGAFSSCYQ---ARDVKTG---TLMAVKQVTYVRNTSSEQEEVVEALRK-- 52

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            E+  +  L+HP++++++G  CED H  L  E+MA GSV ++L SK       ++ +   
Sbjct: 53  -EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSK-YGAFKEAVIINYT 109

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFG----LAKDGPEGDKSHVS 239
               +GL++LHE +  +I+RD K +N+L+D T    +++DFG    LA  G    +    
Sbjct: 110 EQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQ 165

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            +++GT  + APE ++ G    RS DV+S G V++E+ T +
Sbjct: 166 GQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 88.3 bits (219), Expect = 5e-20
 Identities = 69/266 (25%), Positives = 108/266 (40%), Gaps = 30/266 (11%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           +G G FG V+K     D R     V    ++     + +   E + E   L  L    ++
Sbjct: 8   IGKGSFGVVFKVVRKADKR-----VYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
           +      +     ++ E+   G +   L  +   PLP     +       GLA LH   K
Sbjct: 63  RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS--K 120

Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
            +++RD K+ N+ LD   N K+ D G+AK     D ++ +  I+GT  Y +PE       
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDKPY 178

Query: 260 TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDY 319
             +SDV++ GVVL E  TG+   D    A  Q     AL        +L II        
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFD----ANNQG----AL--------ILKIIRGVFP--- 219

Query: 320 PVKGVHKAAM--LAYHCLNHNPKARP 343
           PV  ++   +  L   CL  + + RP
Sbjct: 220 PVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 88.4 bits (219), Expect = 5e-20
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 10/208 (4%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           VLG G +G VY G  ++   + +    V +   +   + + + +   EV  L  L H N+
Sbjct: 7   VLGKGAYGTVYCGLTNQG--QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 198
           V+ +G C +D    +  EF+  GS+ + L      PLP  +  K       G+A+LH   
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLH--N 120

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD----GPEGDKSHVSTRIMGTYGYAAPEYI 254
             V++RD K +N++L  +   KL DFG A+     G  G  S++   + GT  + APE I
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 255 MTGHLTPRSDVYSFGVVLLEILTGRKSL 282
                  +SD++S G  + E+ TG+  L
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.4 bits (219), Expect = 6e-20
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 21/210 (10%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
           + V+G G FG V +G +      G + + VA+K      + +  R++L+E   +G   HP
Sbjct: 9   EEVIGAGEFGEVCRGRLKL---PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAKG 190
           N++ L G   +    ++I EFM  G++++ L      F+ + L       + +  G A G
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-------VGMLRGIAAG 118

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG---TYG 247
           + +L  +E   ++RD    NIL++++   K+SDFGL++   +       T  +G      
Sbjct: 119 MKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           + APE I     T  SDV+S+G+V+ E+++
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 81/283 (28%), Positives = 116/283 (40%), Gaps = 55/283 (19%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           F     +G G FG VYK     D R       VA+KV D + +     +   E+ FL   
Sbjct: 3   FTLLECIGKGSFGEVYKAI---DKRTN---QVVAIKVIDLEEAEDEIEDIQQEIQFLSQC 56

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF---GAAKG 190
             P + K  G   +     +I E+   GS        +L P        IAF       G
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSC-----LDLLKPGKLD-ETYIAFILREVLLG 110

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYG 247
           L +LHE  K  I+RD K +NILL  + + KL+DFG++     G  +   ++    +GT  
Sbjct: 111 LEYLHEEGK--IHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPF 163

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 307
           + APE I       ++D++S G+  +E+  G           E  L+D     L   + L
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKG-----------EPPLSD-----LHPMRVL 207

Query: 308 LNIID---PRLEGDY---PVKG-VHKAAMLAYHCLNHNPKARP 343
             I     P LEG+    P K  V         CLN +PK RP
Sbjct: 208 FLIPKNNPPSLEGNKFSKPFKDFVSL-------CLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 81/290 (27%), Positives = 131/290 (45%), Gaps = 34/290 (11%)

Query: 80  LGGGGFG-CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPN 137
           LG G FG  V    I  D  +  +PV VAVK+   D + +   + ++E+  +  +  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNL-----------FSKVLLP---LPWSIRMKI 183
           ++ L+G C +D    ++ E+ ++G++   L           F    LP   L +   +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 140 AYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 303
               + APE +     T +SDV+SFGV+L EI T   S     P  E         LLKE
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------LFKLLKE 251

Query: 304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
             ++          D P    H+  M+   C +  P  RP  + +V+ L+
Sbjct: 252 GHRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 87.3 bits (216), Expect = 2e-19
 Identities = 79/289 (27%), Positives = 131/289 (45%), Gaps = 31/289 (10%)

Query: 80  LGGGGFG----CVYKG---FISEDLR---EGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
           LG G FG    C  +G   F+ +D      G QPV VAVK+   D +     ++L E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP----------WSI 179
           +  L  PN+++L+  C   +   +I E+M  G + N   S+                +S 
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTISYST 131

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
            + +A   A G+ +L       ++RD  T N L+  +Y  K++DFG++++   GD   + 
Sbjct: 132 LIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP 299
            R +    + + E I+ G  T  SDV++FGV L EILT  K    S+ + EQ + +    
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG-E 248

Query: 300 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
             +++ + + +  P L  D   K       L   C   N K RP  ++I
Sbjct: 249 FFRDQGRQVYLPKPALCPDSLYK-------LMLSCWRRNAKERPSFQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 75/252 (29%), Positives = 131/252 (51%), Gaps = 32/252 (12%)

Query: 67  LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREWL 124
           LRI+     ++ +VLG G FG VYKG     + EG    +PVA+K+ +     + + E++
Sbjct: 1   LRILKETELKRVKVLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEFM 57

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E + +  + HP+LV+L+G C     + L+ + M  G +       ++N+ S++L  L W
Sbjct: 58  DEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL--LNW 114

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L   E+ +++RD    N+L+ +  + K++DFGLA+     +K +
Sbjct: 115 CVQI------AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166

Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW 296
            +        + A E I     T +SDV+S+GV + E++T G K  D   P RE      
Sbjct: 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE------ 219

Query: 297 ALPLLKEKKKLL 308
            +P L EK + L
Sbjct: 220 -IPDLLEKGERL 230

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 86.8 bits (216), Expect = 2e-19
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 22/212 (10%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGH 132
           + +   LG G +G VYK     D + G     VA+K    DN  +G     L E+  L  
Sbjct: 1   YEKLEKLGEGTYGVVYKAR---DKKTG---EIVALKKIRLDNEEEGIPSTALREISLLKE 54

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS---KVLLPLPWSIRMKIAFGAAK 189
           L HPN+VKL+     +    L++E+      + +L     K   PL  ++   I +   +
Sbjct: 55  LKHPNIVKLLDVIHTERKLYLVFEYC-----DMDLKKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           GLA+ H     +++RD K  NIL++ D   KL+DFGLA+      +++ +  ++ T  Y 
Sbjct: 110 GLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYR 165

Query: 250 APEYIMTG--HLTPRSDVYSFGVVLLEILTGR 279
           APE I+ G  H +   D++S G +  E++TG+
Sbjct: 166 APE-ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 86.5 bits (214), Expect = 3e-19
 Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 30/292 (10%)

Query: 74  FRQDRVLGGGGFGCV--YKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 131
            ++ RVLG G FG V  Y    + D    +    VAVK    +   Q    W  E+  L 
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEM----VAVKTLKRECGQQNTSGWKKEINILK 61

Query: 132 HLSHPNLVKLIGYCCEDEHR---VLIYEFMARGSVENNL------FSKVLLPLPWSIRMK 182
            L H N+VK  G CC ++      LI E++  GS+ + L       +++LL         
Sbjct: 62  TLYHENIVKYKG-CCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--------- 111

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH-VSTR 241
            A    +G+A+LH   +  I+RD    N+LLD D   K+ DFGLAK  PEG + + V   
Sbjct: 112 FAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169

Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL 301
                 + A E +     +  SDV+SFGV L E+LT      +S P + + +       +
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQM 228

Query: 302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
               +L+ +++  +    P     +  +L  +C     K RP  R ++  L+
Sbjct: 229 TV-VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 85.8 bits (212), Expect = 4e-19
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 22/208 (10%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           ++G G FG V +G   E   +      VAVK    D + Q    +L E   +  L H NL
Sbjct: 13  IIGEGEFGAVLQG---EYTGQ-----KVAVKNIKCDVTAQA---FLEETAVMTKLHHKNL 61

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 198
           V+L+G    +   +++ E M++G++ N L ++    +     ++ +   A+G+ +L    
Sbjct: 62  VRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES-- 118

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG-DKSHVSTRIMGTYGYAAPEYIMTG 257
           K +++RD    NIL+  D  AK+SDFGLA+ G  G D S +  +      + APE +   
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHK 172

Query: 258 HLTPRSDVYSFGVVLLEILT-GRKSLDK 284
             + +SDV+S+GV+L E+ + GR    K
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPK 200

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 85.4 bits (211), Expect = 5e-19
 Identities = 77/283 (27%), Positives = 125/283 (44%), Gaps = 47/283 (16%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           + +G G FG V  G          +   VAVK    D + Q    +LAE   +  L H N
Sbjct: 12  QTIGKGEFGDVMLG--------DYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSN 60

Query: 138 LVKLIGYCCEDEHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 196
           LV+L+G   E++  + I  E+MA+GS+ + L S+    L     +K +    + + +L E
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-E 119

Query: 197 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTRIMGTYGYAAPEYIM 255
           A    ++RD    N+L+  D  AK+SDFGL K+     D   +  +      + APE + 
Sbjct: 120 ANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 172

Query: 256 TGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR 314
               + +SDV+SFG++L EI + GR    +             +P LK+       + PR
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPR-------------IP-LKD-------VVPR 211

Query: 315 LEGDYPVKGVHKAAMLAY----HCLNHNPKARPLMRDIVDSLE 353
           +E  Y +        + Y     C + +   RP    + + LE
Sbjct: 212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 5e-19
 Identities = 73/286 (25%), Positives = 118/286 (41%), Gaps = 55/286 (19%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           LG G FG V+ G       +    + VA+K + +G  S     +++ E   +  LSHPNL
Sbjct: 12  LGSGQFGVVHLG-------KWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNL 61

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLHEA 197
           V+L G C +     ++ E+MA G + N L   K  L   W + M       + + +L   
Sbjct: 62  VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVCEAMEYLESN 119

Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVSTRIMGTYGYAA 250
               I+RD    N L+  D   K+SDFGLA+          +G K  V         +A 
Sbjct: 120 G--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK--------WAP 169

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 310
           PE       + +SDV+SFGV++ E+ +  K                 +P   E+     +
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGK-----------------MPY--ERFSNSEV 210

Query: 311 IDPRLEGDYPVKGVHKAAM----LAYHCLNHNPKARPLMRDIVDSL 352
           ++    G Y +     A      + Y C +  P+ RP  + ++  L
Sbjct: 211 VESVSAG-YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 28/209 (13%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNL 138
           +G G +G VYK     D   G     VA+K        +G  +  L E+  L  L+HPN+
Sbjct: 7   IGEGTYGVVYKA---RDKLTG---EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL----LPLPWSIRMKIAFGAAKGLAFL 194
           +KL+          L++EFM     + +L+ K++      LP S+     +   +GLAF 
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM-----DTDLY-KLIKDRQRGLPESLIKSYLYQLLQGLAFC 114

Query: 195 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSH-VSTRIMGTYGYAAP 251
           H     +++RD K  N+L++T+   KL+DFGLA+    P    +H V TR      Y AP
Sbjct: 115 HSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAP 167

Query: 252 EYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
           E ++     +   D++S G +  E+L+ R
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 85.1 bits (211), Expect = 7e-19
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 58/288 (20%)

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV---HDGDNSYQGHREWLAEVIFLGH 132
           +   +GGG FG VY   ++ D  E +     AVK     D D      +E   E+  L  
Sbjct: 4   RGNKIGGGTFGKVYTA-VNLDTGELM-----AVKEIRIQDNDPK--TIKEIADEMKVLEL 55

Query: 133 LSHPNLVKLIGYCCEDEHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA--K 189
           L HPNLVK  G     E +V I+ E+ + G++E  L    +L       +   +     +
Sbjct: 56  LKHPNLVKYYGVEVHRE-KVYIFMEYCSGGTLEELLEHGRILDE----HVIRVYTLQLLE 110

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG-- 247
           GLA+LH     +++RD K +NI LD +   KL DFG A       K   +T  MG     
Sbjct: 111 GLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEEVQS 162

Query: 248 ------YAAPEYIMTGHLTPR---SDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 298
                 Y APE I  G        +D++S G V+LE+ TG+      RP  E +  ++ +
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK------RPWSELD-NEFQI 215

Query: 299 PL---LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
                   K  + + +    EG   +            CL  +PK RP
Sbjct: 216 MFHVGAGHKPPIPDSLQLSPEGKDFLD----------RCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 25/215 (11%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLA---EVI 128
           N+R+ ++LG G FG VY  +  +  RE      +AVK V    +S +  +E  A   E+ 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRE------LAVKQVPFDPDSPETKKEVNALECEIQ 56

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
            L +L H  +V+  G   +DE   +  E+M  GSV++ L  K    L  ++  K      
Sbjct: 57  LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL 114

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD------GPEGDKSHVSTRI 242
           +G+ +LH     +++RD K +NIL D+  N KL DFG +K          G KS     +
Sbjct: 115 EGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-----V 167

Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            GT  + +PE I       ++DV+S G  ++E+LT
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 84.2 bits (208), Expect = 1e-18
 Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 15/199 (7%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           +G G FG V+ G+  E  +       VA+K + +G  S +   +++ E   +  LSHP L
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-------VAIKTIREGAMSEE---DFIEEAQVMMKLSHPKL 61

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 198
           V+L G C E     L++EFM  G + + L ++          + +     +G+A+L  + 
Sbjct: 62  VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSN 120

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH 258
             VI+RD    N L+  +   K+SDFG+ +   + D+   ST       +++PE      
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSK 177

Query: 259 LTPRSDVYSFGVVLLEILT 277
            + +SDV+SFGV++ E+ +
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 21/220 (9%)

Query: 75  RQDRVL----GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 130
           R+D VL    G G FG V+       L E    + VAVK    + S    +++  E   L
Sbjct: 4   RRDIVLKWELGEGAFGKVFLAECHNLLPEQ-DKMLVAVKALK-EASESARQDFQREAELL 61

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-----KVLL--------PLPW 177
             L H ++V+  G C E    ++++E+M  G +   L S     K+L          L  
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
              + IA   A G+ +L  A    ++RD  T N L+      K+ DFG+++D    D   
Sbjct: 122 GQMLAIASQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179

Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           V  R M    +  PE I+    T  SD++SFGVVL EI T
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 40/214 (18%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 136
           + LG G FG V+ G+ +   +       VAVK +  G  S Q    +L E   +  L H 
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTK-------VAVKTLKPGTMSVQA---FLEEANLMKTLQHD 61

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS----KVLLPLPWSIRMKIAFGA--AKG 190
            LV+L     ++E   +I E+MA+GS+ + L S    KVLLP        I F A  A+G
Sbjct: 62  KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP------KLIDFSAQIAEG 115

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVSTRIM 243
           +A++    K  I+RD + +N+L+      K++DFGLA+          EG K  +     
Sbjct: 116 MAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK---- 169

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
               + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 170 ----WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 76/293 (25%), Positives = 127/293 (43%), Gaps = 36/293 (12%)

Query: 77  DRVLGGGGFGCVYKG-FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-S 134
            + LG G FG V K   +  D     +   VAVK+   D + +   + ++E+  +  +  
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPN--ETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVEN--------NLFSKVLLPLPWSIRMK---- 182
           H N++ L+G C ++    ++ E+ A G++ +          ++    P P    +     
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 183 --IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
              A+  A+G+ FL  A K  I+RD    N+L+  D+  K++DFGLA+D    D    +T
Sbjct: 135 VSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
                  + APE +     T +SDV+SFGV+L EI T   S     P  E         L
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------LFKL 246

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
           LKE  ++          + P     +   L   C +  P  RP  + +V+ L+
Sbjct: 247 LKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 61/241 (25%), Positives = 110/241 (45%), Gaps = 18/241 (7%)

Query: 112 DGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV 171
              +S +  ++ L E+  +     P +V   G    + +  +  EFM  GS++     K 
Sbjct: 41  GAKSSVR--KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR--IYKK 96

Query: 172 LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 231
             P+P  I  KIA    +GL +L+   + +++RD K SNIL+++    KL DFG++    
Sbjct: 97  GGPIPVEILGKIAVAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVS---- 151

Query: 232 EGDK-SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE 290
            G+  + ++   +GT  Y +PE I  G  T +SDV+S G+ ++E+  G+     S    +
Sbjct: 152 -GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210

Query: 291 QNLADWALPLLKEKKKLLNIIDPRL-EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
                  + +L   ++++    PRL   D+P             CL  +P  RP  + + 
Sbjct: 211 GQDD--PMGILDLLQQIVQEPPPRLPSSDFP----EDLRDFVDACLLKDPTERPTPQQLC 264

Query: 350 D 350
            
Sbjct: 265 A 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 83.4 bits (206), Expect = 3e-18
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 13/209 (6%)

Query: 72  ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 131
            + + +R+LG G FG + +G +        + +PVA+       S +  R +LAE + LG
Sbjct: 5   KSIKIERILGTGRFGELCRGCLK---LPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLG 61

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
              H N+V+L G        +++ E+M+ G++++ L  K    L     M +  G A G+
Sbjct: 62  QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGM 120

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG---Y 248
            +L  +E   +++      +L+++D   K+S F       E DKS      M       +
Sbjct: 121 KYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQE-DKSEAIYTTMSGKSPVLW 174

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           AAPE I   H +  SDV+SFG+V+ E+++
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           +LG G FG V+KG + +         PVAVK    D   +   ++L+E   L    HPN+
Sbjct: 2   LLGKGNFGEVFKGTLKDK-------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 198
           VKLIG C + +   ++ E +  G   + L  K    L     +K A  AA G+A+L    
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE--S 111

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH 258
           K  I+RD    N L+  +   K+SDFG+++   +G  S    + +    + APE +  G 
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGR 170

Query: 259 LTPRSDVYSFGVVLLEILT 277
            +  SDV+S+G++L E  +
Sbjct: 171 YSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 83.0 bits (205), Expect = 4e-18
 Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 30/209 (14%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           LG G FG V+ G+ +   +       VA+K +  G  S +    +LAE   +  L HP L
Sbjct: 14  LGAGQFGEVWMGYYNGHTK-------VAIKSLKQGSMSPEA---FLAEANLMKQLQHPRL 63

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 198
           V+L     + E   +I E+M  GS+ + L +   + L  +  + +A   A+G+AF+    
Sbjct: 64  VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER-- 120

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVSTRIMGTYGYAAP 251
           K  I+RD + +NIL+      K++DFGLA+          EG K  +         + AP
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK--------WTAP 172

Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILT-GR 279
           E I  G  T +SDV+SFG++L EI+T GR
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 76/290 (26%), Positives = 128/290 (44%), Gaps = 34/290 (11%)

Query: 80  LGGGGFG-CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPN 137
           LG G FG  V    I  D  +  +   VAVK+   D + +   + ++E+  +  +  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--------------MKI 183
           ++ L+G C +D    +I E+ ++G++   L ++    + +                 +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           A+  A+G+ +L  A K  I+RD    N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 146 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 303
               + APE +     T +SDV+SFGV+L EI T   S     P  E         LLKE
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKE 257

Query: 304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
             ++          D P    ++  M+   C +  P  RP  + +V+ L+
Sbjct: 258 GHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 19/206 (9%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           R LG G FG V++G  +          PVAVK           +++LAE   +  L HP 
Sbjct: 12  RKLGAGQFGEVWEGLWNNT-------TPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPK 62

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLH 195
           L++L   C  +E   ++ E M  GS+   L       L LP  I M  A   A G+A+L 
Sbjct: 63  LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYLE 120

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRIMGTYGYAAPEYI 254
              +  I+RD    N+L+  +   K++DFGLA+   E   ++    +      + APE  
Sbjct: 121 A--QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAA 176

Query: 255 MTGHLTPRSDVYSFGVVLLEILT-GR 279
           +    + +SDV+SFG++L EI+T GR
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 82.8 bits (204), Expect = 8e-18
 Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 19/218 (8%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISE--DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 130
           N    R LG G FG   K F++E  +L      + VAVK    D S    +++  E   L
Sbjct: 6   NIVLKRELGEGAFG---KVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELL 61

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK----VLLP-------LPWSI 179
            +L H ++VK  G C E +  ++++E+M  G +   L +     VL+        L  S 
Sbjct: 62  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
            + IA   A G+ +L  A +  ++RD  T N L+  +   K+ DFG+++D    D   V 
Sbjct: 122 MLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
              M    +  PE IM    T  SDV+S GVVL EI T
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 80  LGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSYQGH----REWLAEVIFLGHLS 134
           LG GGFG V      S++    L+ V    K H  +   Q H    +E L E       +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVK---KRHIVETGQQEHIFSEKEILEEC------N 51

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGS-----VENNLFSKVLLPLPWSIRMKIAFGAAK 189
           HP +VKL     + ++  ++ E+   G       +  LF +      ++ R  IA     
Sbjct: 52  HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE------YTARFYIAC-VVL 104

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
              +LH   + +IYRD K  N+LLD++   KL DFG AK    G K+       GT  Y 
Sbjct: 105 AFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYV 159

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE I+        D +S G++L E+LTGR
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 26/218 (11%)

Query: 78  RVLGGGGFGCVYKGFISE--DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH 135
           R LG G FG   K F++E  +L      + VAVK    D +    +++  E   L +L H
Sbjct: 11  RELGEGAFG---KVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQH 66

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP----------------LPWSI 179
            ++VK  G C + +  ++++E+M  G +  N F +   P                L  S 
Sbjct: 67  EHIVKFYGVCGDGDPLIMVFEYMKHGDL--NKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
            + IA   A G+ +L  A +  ++RD  T N L+  +   K+ DFG+++D    D   V 
Sbjct: 125 MLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
              M    +  PE IM    T  SDV+SFGV+L EI T
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 22/228 (9%)

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMK 182
           +E+  L  L H N+V+ +G+   +E+  +  E++  GS+ + L  + +    L      +
Sbjct: 57  SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ 116

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           +     +GLA+LH   K +++RD K  N+L+D D   K+SDFG++K   +   +  +  +
Sbjct: 117 VL----EGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 243 MGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
            G+  + APE I +     + + D++S G V+LE+  GR      RP  ++        L
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIAAMFKL 224

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
             ++        P +  D  +     A      C   NP  RP  R++
Sbjct: 225 GNKRSA------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 78  RVLGGGGFGCVYK----GFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL-AEVIFLGH 132
           + LG G FG V +    G    D       + VAVK+     ++   RE L +E+  + H
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSD-----AVMKVAVKMLK-PTAHSSEREALMSELKIMSH 94

Query: 133 L-SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
           L +H N+V L+G C      ++I E+   G + N L  K    L     +  ++  AKG+
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV---STRIMGTYGY 248
           AFL  A K  I+RD    N+LL      K+ DFGLA+D    D ++V   + R+     +
Sbjct: 155 AFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARL--PVKW 209

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            APE I     T  SDV+S+G++L EI +
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 41/218 (18%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK------VHDGDNSYQGHREWLAEVIFLG 131
             +G G  G V+K   ++D   G     VA+K      +  G        + L E+  L 
Sbjct: 6   GRIGEGAHGIVFK---AKDRETG---ETVALKKVALRRLEGG-----IPNQALREIKALQ 54

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL----PLPWSIRMKIAFGA 187
              HP +VKL+         VL+ E+M          S+VL     PLP +         
Sbjct: 55  ACQHPYVVKLLDVFPHGSGFVLVMEYMPSD------LSEVLRDEERPLPEAQVKSYMRML 108

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA---KDGPEGDKSH-VSTRIM 243
            KG+A++H     +++RD K +N+L+  D   K++DFGLA    +      SH V+TR  
Sbjct: 109 LKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-- 164

Query: 244 GTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGR 279
               Y APE ++ G     P  D+++ G +  E+L G 
Sbjct: 165 ---WYRAPE-LLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 80.3 bits (198), Expect = 4e-17
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LGGG +G VY+G      +  L    VAVK    D       E+L E   +  + HPNLV
Sbjct: 14  LGGGQYGEVYEGVWK---KYSLT---VAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLV 65

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
           +L+G C  +    +I EFM  G++ + L       +   + + +A   +  + +L   +K
Sbjct: 66  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KK 123

Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVSTRIMGTYGYAAPE 252
             I+RD    N L+  ++  K++DFGL++           G K  +         + APE
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------WTAPE 175

Query: 253 YIMTGHLTPRSDVYSFGVVLLEILT 277
            +     + +SDV++FGV+L EI T
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 79.7 bits (197), Expect = 5e-17
 Identities = 68/246 (27%), Positives = 104/246 (42%), Gaps = 26/246 (10%)

Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VA+K  D +       E   EV  +   +HPN+VK        +   L+  +++ GS+ +
Sbjct: 29  VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLD 88

Query: 166 NLFSKVLLP-LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
            + S      L  +I   +     KGL +LH   +  I+RD K  NILL  D + K++DF
Sbjct: 89  IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--IHRDIKAGNILLGEDGSVKIADF 146

Query: 225 G----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGR 279
           G    LA  G       V    +GT  + APE +   H    ++D++SFG+  +E+ TG 
Sbjct: 147 GVSASLADGG--DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204

Query: 280 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKA--AMLAYHCLNH 337
               K              P +K     L    P LE     K   K+   M++  CL  
Sbjct: 205 APYSK-------------YPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMIS-LCLQK 250

Query: 338 NPKARP 343
           +P  RP
Sbjct: 251 DPSKRP 256

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 21/227 (9%)

Query: 66  ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           EL +    F ++  LG   FG +YKG +     +  Q V  A+K     N+ Q   E+  
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLV--AIKTLKDINNPQQWGEFQQ 56

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------------- 170
           E   +  L HPN+V L+G   +++   +++E++ +G +   L  +               
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 171 VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG 230
           V   L     + IA   A G+ +L  +    +++D    NIL+    + K+SD GL+++ 
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREI 174

Query: 231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
              D   V  + +    +  PE IM G  +  SD++SFGVVL EI +
Sbjct: 175 YSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 79.9 bits (198), Expect = 7e-17
 Identities = 65/241 (26%), Positives = 101/241 (41%), Gaps = 36/241 (14%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
            +G G  G VYK       +E      VA+K        Q     + E++ +    HPN+
Sbjct: 26  KIGEGASGEVYKATDRATGKE------VAIKKMRLRK--QNKELIINEILIMKDCKHPNI 77

Query: 139 VKLIGYCCEDEHRVLIYEFMARGS----VENNLFSKVLLPLPWSIRMK---IAFGAA--- 188
           V         +   ++ E+M  GS    +  N            +RM    IA+      
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----------FVRMNEPQIAYVCREVL 126

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           +GL +LH   + VI+RD K+ NILL  D + KL+DFG A    +      S  ++GT  +
Sbjct: 127 QGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYW 182

Query: 249 AAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKK 306
            APE I       P+ D++S G++ +E+  G     +  P R   L     +P LK  +K
Sbjct: 183 MAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEK 241

Query: 307 L 307
            
Sbjct: 242 W 242

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.9 bits (195), Expect = 9e-17
 Identities = 51/182 (28%), Positives = 76/182 (41%), Gaps = 28/182 (15%)

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  L+HP LV L     ++E+  L+ + +  G             L + +  K+
Sbjct: 48  LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD------------LRYHLSQKV 95

Query: 184 AFGAAK----------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
            F   +           L +LH   K +I+RD K  NILLD   +  ++DF +A      
Sbjct: 96  KFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153

Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD-KSRPAREQN 292
                +T   GT GY APE +     +   D +S GV   E L G++     SR  R+Q 
Sbjct: 154 TL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210

Query: 293 LA 294
            A
Sbjct: 211 RA 212

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.4 bits (196), Expect = 9e-17
 Identities = 78/300 (26%), Positives = 123/300 (41%), Gaps = 33/300 (11%)

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
           AF    L+ IT        LG G FG V+         EG +   V VK           
Sbjct: 1   AFPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGE-TLVLVKALQKTKDENLQ 52

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF-----SKVLLPL 175
            E+  E+     LSH N+V+L+G C E E   +I E+   G ++  L       + L P 
Sbjct: 53  SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP 112

Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
           P S + K+A      L   H +    ++RD    N L+ +    K+S   L+KD    + 
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172

Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 295
             +   ++    + APE +     + +SDV+SFGV++ E+ T  + L     + E+ L  
Sbjct: 173 YKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE-LPFYGLSDEEVLNR 230

Query: 296 WALPLLKEKKKLLNIID--PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                L+  K  L + +  P          ++K   L   C   NPK RP   ++V +L 
Sbjct: 231 -----LQAGKLELPVPEGCP--------SRLYK---LMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 78/318 (24%), Positives = 140/318 (44%), Gaps = 41/318 (12%)

Query: 57  NPLIAFTYDELRIITANFRQDRVLGGGGFG-CVYKGFISEDLREGLQPVPVAVKVHDGDN 115
           +P   F+ D+L +        + LG G FG  V    +  D  +  + V VAVK+   D 
Sbjct: 7   DPRWEFSRDKLTL-------GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA 59

Query: 116 SYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP 174
           + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++   L ++    
Sbjct: 60  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119

Query: 175 LPWSIRM--------------KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK 220
           + +S  +                 +  A+G+ +L  A +  I+RD    N+L+  +   K
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMK 177

Query: 221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK 280
           ++DFGLA+D    D    +T       + APE +     T +SDV+SFGV++ EI T   
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237

Query: 281 SLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPK 340
           S     P  E         LLKE  ++          D P    ++  M+   C +  P 
Sbjct: 238 SPYPGIPVEE------LFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPS 281

Query: 341 ARPLMRDIVDSLEPLQVL 358
            RP  + +V+ L+ +  L
Sbjct: 282 HRPTFKQLVEDLDRILTL 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 24/221 (10%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           F     LG G +G VYK    E  +       VA+KV   +   Q   E + E+  L   
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQ------VVAIKVVPVEEDLQ---EIIKEISILKQC 55

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN--NLFSKVLLPLPWSIRMKIAF---GAA 188
             P +VK  G   ++    ++ E+   GSV +   + +K L         +IA       
Sbjct: 56  DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL------TEEEIAAILYQTL 109

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           KGL +LH  +K  I+RD K  NILL+ +  AKL+DFG++  G   D       ++GT  +
Sbjct: 110 KGLEYLHSNKK--IHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFW 165

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
            APE I       ++D++S G+  +E+  G+       P R
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 73/286 (25%), Positives = 133/286 (46%), Gaps = 44/286 (15%)

Query: 78  RVLGGGGFG--CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH 135
           RVLG G FG   +Y+   +ED       + V  +V+    S +  R+ L E++ L  L H
Sbjct: 6   RVLGKGAFGEATLYRR--TED-----DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL----LPLPWSIRMKIAFGAAKGL 191
           PN++    +   D++ +LI    A G     L+ K++          + +   F     +
Sbjct: 59  PNIIAYYNHF-MDDNTLLIEMEYANGG---TLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           +++H+A   +++RD KT NI L      KL DFG++K    G +  ++  ++GT  Y +P
Sbjct: 115 SYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSP 170

Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 311
           E         +SD+++ G VL E+LT +++ D + P                    LN++
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------------------LNLV 210

Query: 312 DPRLEGDY-PVKGVHKAAM--LAYHCLNHNPKARPLMRDIVDSLEP 354
              ++G+Y PV  V+ + +  L +  L  +P+ RP   +++D    
Sbjct: 211 VKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 18/151 (11%)

Query: 135 HPNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK--- 189
           HP L +L  + C    +    + E++  G +  ++        P +      F AA+   
Sbjct: 55  HPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRAR-----FYAAEIVL 107

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTYGY 248
           GL FLHE  + +IYRD K  N+LLD++ + K++DFG+ K+G  G    V+T    GT  Y
Sbjct: 108 GLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDY 162

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            APE +      P  D ++ GV+L E+L G+
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 33/273 (12%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           +++  ++G G +G VY+G      R       VA+K+ + D       +   EV  L  L
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGR------VVALKIINLDTPDDDVSDIQREVALLSQL 56

Query: 134 SH---PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
                PN+ K  G   +     +I E+   GSV   + +  +     S+ ++    A   
Sbjct: 57  RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA--- 113

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L ++H+    VI+RD K +NIL+    N KL DFG+A    +   S   +  +GT  + A
Sbjct: 114 LKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMA 169

Query: 251 PEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 309
           PE I  G     ++D++S G+ + E+ TG          R       A+ L+ + K    
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AMMLIPKSKP--- 219

Query: 310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR 342
              PRLE +   K + +   +A  CL+  PK R
Sbjct: 220 ---PRLEDNGYSKLLRE--FVAA-CLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 69/206 (33%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWL-AEVIFLGHLSHPN 137
           +G G  G VYK      +R       +AVK +    N  +  R  +  +V+   H   P 
Sbjct: 23  IGSGTCGQVYK------MRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDC-PY 75

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 197
           +VK  GY   D    +  E M+  +  + L  ++  P+P  I  K+     K L +L E 
Sbjct: 76  IVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE- 132

Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG 257
           +  VI+RD K SNILLD   N KL DFG++  G   D S   TR  G   Y APE I   
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYMAPERIDPP 189

Query: 258 HLTP----RSDVYSFGVVLLEILTGR 279
              P    R+DV+S G+ L+E+ TG+
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 77.6 bits (192), Expect = 4e-16
 Identities = 60/237 (25%), Positives = 95/237 (40%), Gaps = 49/237 (20%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG------DNSYQGHREWLAE 126
           +F+  +++G G F  V      E  +E       A+K+ D               E    
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKE------YAIKILDKRQLIKEKKVKYVKIEKEV- 54

Query: 127 VIFLGHLS-HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
              L  L+ HP ++KL  Y  +DE  +  + E+       N    + +     S+  K  
Sbjct: 55  ---LTRLNGHPGIIKLY-YTFQDEENLYFVLEY-----APNGELLQYIRKYG-SLDEKCT 104

Query: 185 -FGAA---KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS---- 236
            F AA     L +LH   K +I+RD K  NILLD D + K++DFG AK            
Sbjct: 105 RFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Query: 237 HVSTRIM--------------GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             +T I               GT  Y +PE +        SD+++ G ++ ++LTG+
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 77/290 (26%), Positives = 128/290 (44%), Gaps = 39/290 (13%)

Query: 78  RVLGGGGFGCVYKGFISED---LREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS 134
           + LG G FG V +G +++D   L+  ++ + +A+       +     ++L+E + +    
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI------CTRSEMEDFLSEAVCMKEFD 58

Query: 135 HPNLVKLIGYCCEDEHR------VLIYEFMARGSVENNLFSKVL----LPLPWSIRMKIA 184
           HPN+++LIG C +          V+I  FM  G + + L    L      LP  + +K  
Sbjct: 59  HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
              A G+ +L  + K  I+RD    N +L+ + N  ++DFGL+K    GD          
Sbjct: 119 TDIASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LADWALPLLKE 303
              + A E +     T +SDV+SFGV + EI T  ++     P  E + + D+    L++
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT---PYPGVENSEIYDY----LRQ 229

Query: 304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
             +L    D  L+G Y          L   C   NPK RP    +   LE
Sbjct: 230 GNRLKQPPDC-LDGLYS---------LMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.1 bits (190), Expect = 5e-16
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 12/202 (5%)

Query: 77  DRVLGGGGFGCVYKG-FIS-EDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS 134
            R +G G FG VY+G ++S E+ +     + VAVK      S     ++L E   +    
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEK-----IAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL 194
           HP++VKLIG    +    ++ E    G + + L       L  +  +  ++  +  LA+L
Sbjct: 66  HPHIVKLIG-VITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYL 123

Query: 195 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYI 254
               K  ++RD    N+L+ +    KL DFGL++   E +  + +++      + APE I
Sbjct: 124 E--SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESI 180

Query: 255 MTGHLTPRSDVYSFGVVLLEIL 276
                T  SDV+ FGV + EIL
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.1 bits (190), Expect = 5e-16
 Identities = 88/307 (28%), Positives = 132/307 (42%), Gaps = 64/307 (20%)

Query: 80  LGGGGFG----CVYKGFISEDLREGLQPVPVAVK--VHDGDNSYQGHREWLAEVIFLGHL 133
           LG G FG    C Y     + L++    V VAVK   H         R++  E+  L  L
Sbjct: 12  LGKGNFGSVELCRY-----DPLQDNTGEV-VAVKKLQHSTAEHL---RDFEREIEILKSL 62

Query: 134 SHPNLVKLIGYCCEDEHR--VLIYEFMARGSV----ENN---LFSKVLLPLPWSIRMKIA 184
            H N+VK  G C     R   L+ E++  GS+    + +   L  + LL     I     
Sbjct: 63  QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI----- 117

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
               KG+ +L    K  ++RD  T NIL++++   K+ DFGL K  P+ DK +   R  G
Sbjct: 118 ---CKGMEYL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPG 171

Query: 245 ---TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR-PARE---------- 290
               + Y APE +     +  SDV+SFGVVL E+ T     DKS  P  E          
Sbjct: 172 ESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFMRMMGNDKQ 227

Query: 291 -QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
            Q +    + LLK   +L     P   G  P + ++    +   C N++P  RP   ++ 
Sbjct: 228 GQMIVYHLIELLKNNGRL-----PAPPG-CPAE-IY---AIMKECWNNDPSQRPSFSELA 277

Query: 350 DSLEPLQ 356
             +E ++
Sbjct: 278 LQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 16/215 (7%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGH 132
           F   R+LG G FG V +  +  +         VAVK+   D  S     E+L E   +  
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSF---QKVAVKMLKADIFSSSDIEEFLREAACMKE 57

Query: 133 LSHPNLVKLIGYCCEDEHR------VLIYEFMARGSVENNLFSKVL----LPLPWSIRMK 182
             HPN++KLIG       +      ++I  FM  G +   L    +      LP    ++
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
                A G+ +L  + K  I+RD    N +L+ +    ++DFGL+K    GD        
Sbjct: 118 FMIDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                + A E +     T  SDV++FGV + EI+T
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.8 bits (189), Expect = 7e-16
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 18/211 (8%)

Query: 79  VLGGGGFGCVYKGF--ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLGHLSH 135
           ++G G FG VY G    S +L    Q    +V      +  +   + LA E+  L  L H
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSA-SSKDRKRSMLDALAREIALLKELQH 65

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAF 193
            N+V+ +G   + +H  +  E++  GSV    N +      L  +   +I     KGL +
Sbjct: 66  ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNY 121

Query: 194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-----IMGTYGY 248
           LH   + +I+RD K +NIL+D     K+SDFG++K   E +     T      + G+  +
Sbjct: 122 LHN--RGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPSLQGSVFW 178

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            APE +     T ++D++S G +++E+LTG+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 9e-16
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 33/213 (15%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNL 138
           +G G +G VYK     + + G     VA+K    +N  +G     + E+  L  L HPN+
Sbjct: 7   IGEGTYGQVYKA---RNKKTG---ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 139 VKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------- 189
           V+L             +++E+M     +++L + +L     S  +K      K       
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYM-----DHDL-TGLLD----SPEVKFTESQIKCYMKQLL 110

Query: 190 -GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
            GL +LH     +++RD K SNIL++ D   KL+DFGLA+       S   T  + T  Y
Sbjct: 111 EGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWY 167

Query: 249 AAPEYIMTG--HLTPRSDVYSFGVVLLEILTGR 279
             PE ++ G     P  D++S G +L E+  G+
Sbjct: 168 RPPE-LLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 74/222 (33%), Positives = 115/222 (51%), Gaps = 35/222 (15%)

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS- 134
           QD V+G G FG V K  I +D   GL+ +  A+K      S   HR++  E+  L  L  
Sbjct: 12  QD-VIGEGNFGQVLKARIKKD---GLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 135 HPNLVKLIGYCCEDEHRVLIY---EFMARGSVENNLF-SKVLLPLP-----------WSI 179
           HPN++ L+G C   EHR  +Y   E+   G++ + L  S+VL   P            S 
Sbjct: 67  HPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 180 RMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
           +  + F A  A+G+ +L  ++K  I+RD    NIL+  +Y AK++DFGL++    G + +
Sbjct: 124 QQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY 177

Query: 238 VSTRIMGTYG--YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           V  + MG     + A E +     T  SDV+S+GV+L EI++
Sbjct: 178 VK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 73/210 (34%), Positives = 108/210 (51%), Gaps = 26/210 (12%)

Query: 78  RVLGGGGFGCVY--KGFISEDLREGLQPVPV----AVKVHDGDNSYQGHREWLAEVIFLG 131
           +VLG G FG V+  +     D  + L  + V     +KV D   + +  R+ LAEV    
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQ-LYAMKVLKKATLKVRDRVRT-KMERDILAEV---- 55

Query: 132 HLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 189
             +HP +VKL  Y  + E ++ LI +F+  G +   L  +V+          + F  A+ 
Sbjct: 56  --NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-----TEEDVKFYLAEL 107

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            LA  H     +IYRD K  NILLD + + KL+DFGL+K+  + +K   S    GT  Y 
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165

Query: 250 APEYI-MTGHLTPRSDVYSFGVVLLEILTG 278
           APE +   GH T  +D +SFGV++ E+LTG
Sbjct: 166 APEVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 76/272 (27%), Positives = 115/272 (42%), Gaps = 34/272 (12%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           +G G FG VYKG I    +E      VA+K+ D + +     +   E+  L     P + 
Sbjct: 12  IGKGSFGEVYKG-IDNRTKE-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
           +  G   +     +I E++  GS  + L      PL  +    I     KGL +LH   K
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERK 122

Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
             I+RD K +N+LL    + KL+DFG+A  G   D        +GT  + APE I     
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 260 TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDY 319
             ++D++S G+  +E+  G        P R   L     P             P LEG Y
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQY 225

Query: 320 --PVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
             P K   +A      CLN +P+ RP  ++++
Sbjct: 226 SKPFKEFVEA------CLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 74/293 (25%), Positives = 132/293 (45%), Gaps = 36/293 (12%)

Query: 80  LGGGGFGCVYK--GFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HP 136
           LG G FG V +   +  +  R   Q V VAVK+   + + +   + ++E+  +  +  H 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPD-QTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNL-----------FSKVLLP---LPWSIRMK 182
           N++ L+G C ++    +I E+ A+G++   L           F    +P   L +   + 
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
            A+  A+G+ +L    +  I+RD    N+L+  D   K++DFGLA+   + D    ++  
Sbjct: 139 CAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK 302
                + APE +     T +SDV+SFG+++ EI T   S     P  E         LL+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE------LFKLLR 250

Query: 303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
           E  ++          D P    H+  ML   C +  P  RP  + +V++L+ +
Sbjct: 251 EGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 79/278 (28%), Positives = 122/278 (43%), Gaps = 34/278 (12%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           F +   +G G FG V+KG    D R   Q V VA+K+ D + +     +   E+  L   
Sbjct: 6   FTKLEKIGKGSFGEVFKGI---DNRT--QKV-VAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 193
             P + K  G   +D    +I E++  GS  + L      PL  +    I     KGL +
Sbjct: 60  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDY 116

Query: 194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 253
           LH  +K  I+RD K +N+LL      KL+DFG+A  G   D        +GT  + APE 
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 254 IMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP 313
           I       ++D++S G+  +E+  G     +  P +        L L+ +         P
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNNP------P 219

Query: 314 RLEGDY--PVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
            LEG+Y  P+K   +A      CLN  P  RP  ++++
Sbjct: 220 TLEGNYSKPLKEFVEA------CLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 25/204 (12%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR-EWLAEVIFLGHLSHPNL 138
           LG G FG V KG     +++  + V  AVK+   DN+    + E L E   +  L +P +
Sbjct: 3   LGSGNFGTVKKGMYK--MKKSEKTV--AVKILKNDNNDPALKDELLREANVMQQLDNPYI 58

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVEN------NLFSKVLLPLPWSIRMKIAFGAAKGLA 192
           V++IG  CE E  +L+ E    G +        ++  K +  L   + M        G+ 
Sbjct: 59  VRMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMK 109

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAA 250
           +L E     ++RD    N+LL T + AK+SDFGL+K     D+++   +  G +   + A
Sbjct: 110 YLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYA 166

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLE 274
           PE +     + +SDV+SFGV++ E
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 57/218 (26%), Positives = 85/218 (38%), Gaps = 34/218 (15%)

Query: 79  VLGGGGFGCVYK------GFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL-AEVIFLG 131
            +G G FG V K      G I            +  K  D  N  +  ++ L +EV  L 
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKI------------LVWKEIDYGNMTEKEKQQLVSEVNILR 54

Query: 132 HLSHPNLVKLIGYCC-EDEHRVLIY-EFMARGSVENNL--FSKVLLPLPWSIRMKIAFGA 187
            L HPN+V+            + I  E+   G +   +    K    +      +I    
Sbjct: 55  ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114

Query: 188 AKGLAFLHEAEKP---VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTR 241
              L   H    P   V++RD K +NI LD + N KL DFGLAK         K++V   
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV--- 171

Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             GT  Y +PE +       +SD++S G ++ E+    
Sbjct: 172 --GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG G FG VYK   ++    GL      +++   +       +++ E+  L    HPN+V
Sbjct: 13  LGDGAFGKVYK---AQHKETGLFAAAKIIQIESEEEL----EDFMVEIDILSECKHPNIV 65

Query: 140 KLI-GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 198
            L   Y  E++  +LI EF   G++++ +  ++   L       +     + L FLH   
Sbjct: 66  GLYEAYFYENKLWILI-EFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHS-- 121

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYAAPEYIM-- 255
             VI+RD K  NILL  D + KL+DFG+ AK+     K       +GT  + APE +   
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACE 178

Query: 256 TGHLTP---RSDVYSFGVVLLEILTGR 279
           T    P   ++D++S G+ L+E+    
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.5 bits (184), Expect = 7e-15
 Identities = 58/176 (32%), Positives = 86/176 (48%), Gaps = 43/176 (24%)

Query: 126 EVIFLGHLS-HPNLVKLIGYCCEDEHRV-------LIYEFMARGSVENNLFSKVLLPLPW 177
           E++FL  L  HPN+VKL+     +  +        L++E+M     E +L   V      
Sbjct: 56  EIMFLQELGDHPNIVKLL-----NVIKAENDKDIYLVFEYM-----ETDL-HAV------ 98

Query: 178 SIRMK---------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK 228
            IR           I +   K L ++H     VI+RD K SNILL++D   KL+DFGLA+
Sbjct: 99  -IRANILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR 155

Query: 229 ---DGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGR 279
              +  E  ++ V T  + T  Y APE I+ G    T   D++S G +L E+L G+
Sbjct: 156 SLSELEENPENPVLTDYVATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.4 bits (180), Expect = 9e-15
 Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 35/276 (12%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           +LG G  G VYK +     R       +AVKV   D + +  ++ ++E+  L     P +
Sbjct: 8   ILGHGNGGTVYKAYHLLTRR------ILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 198
           +   G    +    +  EFM  GS++      V   +P  +  +IA    KGL +L   +
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSLD------VYRKIPEHVLGRIAVAVVKGLTYLWSLK 115

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH 258
             +++RD K SN+L++T    KL DFG++        + ++   +GT  Y APE I    
Sbjct: 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ----LVNSIAKTYVGTNAYMAPERISGEQ 169

Query: 259 LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGD 318
               SDV+S G+  +E+  GR       P  ++N     +PL     +LL  I   ++ D
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPY----PQIQKNQGS-LMPL-----QLLQCI---VDED 216

Query: 319 YPVKGVHKAAMLAYH----CLNHNPKARPLMRDIVD 350
            PV  V + +    H    C+   PK RP   +++D
Sbjct: 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 73.0 bits (179), Expect = 9e-15
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 21/202 (10%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           LG G FG V  G       +      VA+K + +G  S     E++ E   +  LSH  L
Sbjct: 12  LGTGQFGVVKYG-------KWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKL 61

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE 198
           V+L G C +     ++ E+M+ G + N L        P  + +++     +G+A+L    
Sbjct: 62  VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLE--S 118

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIM 255
           K  I+RD    N L+D     K+SDFGL++     D  + S+  +G+     ++ PE ++
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPPEVLL 174

Query: 256 TGHLTPRSDVYSFGVVLLEILT 277
               + +SDV++FGV++ E+ +
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 39/254 (15%)

Query: 106 VAVKVHDGDNSYQGHR--EWLAEVIFLGHLSHPNLVKLIGY-CCEDEHRVLIYEFMARGS 162
           VA+K+   D   + H+   +  E      L HPN+V L+            ++E++   +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 163 VENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNA 219
           +   L +   LP   + R+ +       LA  H     +++RD K  NI++       +A
Sbjct: 66  LREVLAADGALPAGETGRLMLQ--VLDALACAHNQG--IVHRDLKPQNIMVSQTGVRPHA 121

Query: 220 KLSDFGLAKDGP---EGDKSHVS--TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 274
           K+ DFG+    P   + D + ++  T ++GT  Y APE +    +TP SD+Y++G++ LE
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181

Query: 275 ILTGRKSLDKSRPAR--EQNLA--DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAML 330
            LTG++ +  +  A    Q L+  D +LP             P + G       H    +
Sbjct: 182 CLTGQRVVQGASVAEILYQQLSPVDVSLP-------------PWIAG-------HPLGQV 221

Query: 331 AYHCLNHNPKARPL 344
               LN +P+ R  
Sbjct: 222 LRKALNKDPRQRAA 235

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 59/217 (27%), Positives = 88/217 (40%), Gaps = 43/217 (19%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-------------QGHREWLAE 126
           LG GGFG V                  A +V      Y             +G +  L E
Sbjct: 1   LGKGGFGEVC-----------------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNE 43

Query: 127 VIFLGHLSHPNLVKLIGYCCED-EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
              L  +S   +V L  Y  E  +   L+   M  G ++ ++++      P +   +  F
Sbjct: 44  KKILEKVSSRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA---RAIF 99

Query: 186 GAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
            AA+   GL  LH+  + ++YRD K  N+LLD   N ++SD GLA +   G K       
Sbjct: 100 YAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA-- 155

Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            GT GY APE +         D ++ G  L E++ GR
Sbjct: 156 -GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 67/219 (30%), Positives = 113/219 (51%), Gaps = 34/219 (15%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPN 137
           V+G G FG V +  I +D   GL+ +  A+K+     S   HR++  E+  L  L  HPN
Sbjct: 9   VIGEGNFGQVIRAMIKKD---GLK-MNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 138 LVKLIGYCCEDEHRVLIY---EFMARGSVENNLF-SKVLLPLPWSIR------------- 180
           ++ L+G C   E+R  +Y   E+   G++ + L  S+VL   P   +             
Sbjct: 65  IINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           ++ A   A G+ +L  +EK  I+RD    N+L+  +  +K++DFGL++    G++ +V  
Sbjct: 122 LQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK- 174

Query: 241 RIMGTYG--YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           + MG     + A E +     T +SDV+SFGV+L EI++
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 11/199 (5%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           +G G FG V+ G +  D        PVAVK            ++L E   L   SHPN+V
Sbjct: 3   IGRGNFGEVFSGRLRAD------NTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSK-VLLPLPWSIRMKIAFGAAKGLAFLHEAE 198
           +LIG C + +   ++ E +  G     L ++   L +   I+M     AA G+ +L    
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM--VENAAAGMEYLE--S 112

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH 258
           K  I+RD    N L+      K+SDFG++++  +G  +           + APE +  G 
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 259 LTPRSDVYSFGVVLLEILT 277
            +  SDV+SFG++L E  +
Sbjct: 173 YSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 54/150 (36%), Positives = 77/150 (51%), Gaps = 16/150 (10%)

Query: 135 HPNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK--- 189
           HP L  L  YC     E+   + E++  G +  ++ S     LP     +  F AA+   
Sbjct: 55  HPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP-----RATFYAAEIIC 107

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           GL FLH   K ++YRD K  NILLDTD + K++DFG+ K+   GD    +    GT  Y 
Sbjct: 108 GLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYI 163

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE ++        D +SFGV+L E+L G+
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 76/304 (25%), Positives = 104/304 (34%), Gaps = 73/304 (24%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVK----VHDGDNSYQGHREWLAEVIFLGHLS 134
           V+G G +G V K       R       VA+K      D ++     +  L EV  L  L 
Sbjct: 8   VVGEGAYGVVLK------CRNKATGEIVAIKKFKESEDDEDV---KKTALREVKVLRQLR 58

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP-----LPWSIRMKIAFGAAK 189
           H N+V L           L++E+     VE  L    LL      LP        +   +
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEY-----VERTLLE--LLEASPGGLPPDAVRSYIWQLLQ 111

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH----VSTRIMGT 245
            +A+ H     +I+RD K  NIL+      KL DFG A+       S     V+TR    
Sbjct: 112 AIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR---- 165

Query: 246 YGYAAPE----YIMTGHLTPRSDVYSFGVVLLEILTGR----------------KSLDKS 285
             Y APE        G      DV++ G ++ E+L G                 K L   
Sbjct: 166 -WYRAPELLVGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL 221

Query: 286 RPA------REQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP 339
            P+           A  A P   +        +  LE  YP K    A      CL  +P
Sbjct: 222 PPSHQELFSSNPRFAGVAFPEPSQ-------PES-LERRYPGKVSSPALDFLKACLRMDP 273

Query: 340 KARP 343
           K R 
Sbjct: 274 KERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 28/216 (12%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PN 137
           V+G G FG V K  I +D   GL+ +  A+K      S   HR++  E+  L  L H PN
Sbjct: 2   VIGEGNFGQVLKARIKKD---GLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLF-SKVLLPLPWSIR-------------MKI 183
           ++ L+G C    +  L  E+   G++ + L  S+VL   P                 +  
Sbjct: 58  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           A   A+G+ +L  ++K  I+RD    NIL+  +Y AK++DFGL++    G + +V  + M
Sbjct: 118 AADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTM 170

Query: 244 GTYG--YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           G     + A E +     T  SDV+S+GV+L EI++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 71.4 bits (175), Expect = 3e-14
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 13/213 (6%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 131
            + + RV+G G FG V+      D +   ++ +PV     D   + Q       E   L 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN------ECQVLK 54

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            LSHPN+++      ED+  +++ E+   G++   +  +    L     +   F     L
Sbjct: 55  LLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILH--FFVQILL 112

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           A  H   K +++RD KT NILLD      K+ DFG++K      KS   T ++GT  Y +
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYIS 169

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
           PE         +SD+++ G VL E+ + +++ +
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 29/212 (13%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           VLG G +G VY      DL   ++     +   D       H E    +    +L H N+
Sbjct: 15  VLGKGTYGIVYAA---RDLSTQVRIAIKEIPERDSRYVQPLHEE----IALHSYLKHRNI 67

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA--KGLAFLHE 196
           V+ +G   E+    +  E +  GS+   L SK   PL  + +  I +     +GL +LH+
Sbjct: 68  VQYLGSDSENGFFKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHD 126

Query: 197 AEKPVIYRDFKTSNILLDTDYNA--KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAA 250
            +  +++RD K  N+L++T Y+   K+SDFG    LA   P       +    GT  Y A
Sbjct: 127 NQ--IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMA 177

Query: 251 PEYI---MTGHLTPRSDVYSFGVVLLEILTGR 279
           PE I     G+  P +D++S G  ++E+ TG+
Sbjct: 178 PEVIDKGPRGYGAP-ADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 27/217 (12%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK---VHDGDNSYQG-HREWLAEVI 128
            + + + LG G +  VYK    E  R       VA+K   + +   +  G +   L E+ 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGR------IVAIKKIKLGERKEAKDGINFTALREIK 54

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKIAFG 186
            L  L HPN++ L+       +  L++EFM    +E  +  K ++  P  I+  M +   
Sbjct: 55  LLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL- 112

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGDK--SHVSTRIM 243
             +GL +LH     +++RD K +N+L+ +D   KL+DFGLA+  G    K    V TR  
Sbjct: 113 --RGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW- 167

Query: 244 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
               Y APE +    H     D++S G +  E+L   
Sbjct: 168 ----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 80/261 (30%), Positives = 116/261 (44%), Gaps = 44/261 (16%)

Query: 93  ISEDLREGLQPVPVAVKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLIG-YCCEDEH 150
           I+ D   G Q   VAVK  D     Q  RE L  EV+ +    HPN+V++   Y   DE 
Sbjct: 37  IATDKSTGRQ---VAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL 91

Query: 151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYR 204
            V++ EF+  G+         L  +    RM       +     K L+FLH   + VI+R
Sbjct: 92  WVVM-EFLEGGA---------LTDIVTHTRMNEEQIATVCLAVLKALSFLHA--QGVIHR 139

Query: 205 DFKTSNILLDTDYNAKLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
           D K+ +ILL +D   KLSDFG    ++K+ P   KS V     GT  + APE I      
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLV-----GTPYWMAPEVISRLPYG 193

Query: 261 PRSDVYSFGVVLLEILTGRKSLDKSRPARE-QNLADWALPLLKEKKKLLNIIDPRLEG-- 317
              D++S G++++E++ G        P +  + + D   P LK   K    + PRL    
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK----VSPRLRSFL 249

Query: 318 -DYPVKGVHKAAMLAYHCLNH 337
               V+   + A  A   LNH
Sbjct: 250 DRMLVRDPAQRAT-AAELLNH 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 71.8 bits (176), Expect = 6e-14
 Identities = 80/254 (31%), Positives = 119/254 (46%), Gaps = 47/254 (18%)

Query: 134 SHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK--- 189
           +HP LV L   C + E R+  + EF++ G +  ++  +  LP          F +A+   
Sbjct: 54  NHPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLP-----EEHARFYSAEISL 107

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIMGTYGY 248
            L FLHE  + +IYRD K  N+LLD + + KL+D+G+ K+G   GD    ++   GT  Y
Sbjct: 108 ALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNY 162

Query: 249 AAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWALPLLKEKK 305
            APE I+ G     S D ++ GV++ E++ GR   D        +QN  D+   ++ EK+
Sbjct: 163 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ 221

Query: 306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PLMRDI-V 349
               I  PR      V    KA+ +    LN +PK R               P  R+I  
Sbjct: 222 ----IRIPR---SLSV----KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270

Query: 350 DSLEPLQVLPDEAP 363
           D LE  QVLP   P
Sbjct: 271 DLLEQKQVLPPYKP 284

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 71.0 bits (175), Expect = 8e-14
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 46/220 (20%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA--EVIFLGHL-S 134
           + LG G FG VY     E          VA+K       +    E +   EV  L  L  
Sbjct: 5   KQLGDGTFGSVYLARNKETGEL------VAIKKMK--KKFYSWEECMNLREVKSLRKLNE 56

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF----SKVLLPLPWSIRMKIAFGAAKG 190
           HPN+VKL     E++    ++E+M     E NL+     +   P   S+   I +   +G
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD----GPEGDKSHVSTRIMGTY 246
           LA +H+      +RD K  N+L+      K++DFGLA++     P  D  +VSTR     
Sbjct: 112 LAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTR----- 162

Query: 247 GYAAPEYIMTGHLTPRS-------DVYSFGVVLLEILTGR 279
            Y APE ++      RS       D+++ G ++ E+ T R
Sbjct: 163 WYRAPEILL------RSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 17/214 (7%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA---EVIF 129
           N+R+ ++LG G FG VY  +  +  RE       A +V     S +  +E  A   E+  
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRE-----LAAKQVQFDPESPETSKEVSALECEIQL 57

Query: 130 LGHLSHPNLVKLIGYCCED--EHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           L +L H  +V+  G C  D  E  + I+ E+M  GSV++ L  K    L  S+  K    
Sbjct: 58  LKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQ 114

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-IMGT 245
             +G+++LH     +++RD K +NIL D+  N KL DFG +K       S    R + GT
Sbjct: 115 ILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             + +PE I       ++DV+S G  ++E+LT +
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 47/254 (18%)

Query: 134 SHPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFSKVLLPLP----WSIRMKIAFGAA 188
           +HP LV L   C + E R+  + E++  G +  ++  +  LP      +S  + +A    
Sbjct: 54  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA---- 108

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTRIMGTYG 247
             L +LHE  + +IYRD K  N+LLD++ + KL+D+G+ K+G   GD    ++   GT  
Sbjct: 109 --LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPN 161

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWALPLLKEKK 305
           Y APE +         D ++ GV++ E++ GR   D   S    +QN  D+   ++ EK+
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 221

Query: 306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PLMRDI-V 349
             +           P     KAA +    LN +PK R               P  R++  
Sbjct: 222 IRI-----------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270

Query: 350 DSLEPLQVLPDEAP 363
           D +E  QV+P   P
Sbjct: 271 DLMEQKQVVPPFKP 284

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 69/233 (29%), Positives = 95/233 (40%), Gaps = 42/233 (18%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPN 137
           V+G G +G VYK       + G     VA+K+ D     +   E   E   L   S HPN
Sbjct: 13  VIGEGTYGKVYKA---RHKKTGQL---VAIKIMDIIEDEE--EEIKEEYNILRKYSNHPN 64

Query: 138 LVKLIG-------YCCEDEHRVLIYEFMARGS----VENNLFSKVLLPLPWSIRMKIAF- 185
           +    G          +D+   L+ E    GS    V+        L   W     IA+ 
Sbjct: 65  IATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYI 118

Query: 186 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
                +GLA+LHE    VI+RD K  NILL  +   KL DFG++        S +  R  
Sbjct: 119 LRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DSTLGRRNT 172

Query: 242 IMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
            +GT  + APE I            RSDV+S G+  +E+  G+  L    P R
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 33/161 (20%)

Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFS---KV-LLPLPWSIRMKIA 184
           L  + HP LV L G   +D+  + L+ E++  G     LFS   K    P P +      
Sbjct: 55  LQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGG----ELFSHLRKSGRFPEPVA-----R 104

Query: 185 FGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           F AA+    L +LH  +  ++YRD K  N+LLD+D   K++DFG AK         V  R
Sbjct: 105 FYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGR 154

Query: 242 IM---GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 278
                GT  Y APE I+  G+     D ++ G+++ E+L G
Sbjct: 155 TYTLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG G FG VYK    E        V  A KV D   S +   +++ E+  L    HPN+V
Sbjct: 13  LGDGAFGKVYKAQNKE------TGVLAAAKVID-TKSEEELEDYMVEIDILASCDHPNIV 65

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
           KL+     + +  ++ EF A G+V+  +  ++  PL       +     + L +LHE + 
Sbjct: 66  KLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRVVCKQTLEALNYLHENK- 123

Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TG 257
            +I+RD K  NIL   D + KL+DFG++       +   S   +GT  + APE +M  T 
Sbjct: 124 -IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETS 180

Query: 258 HLTP---RSDVYSFGVVLLEI 275
              P   ++DV+S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 49/215 (22%)

Query: 80  LGGGGFGCVYKG--FISEDLREGLQPVPVAVKV---HDGDN--SYQGHREWLAEVIFLGH 132
           +G G +G VYK     + +L        VA+KV     GD+    Q       E+  L  
Sbjct: 11  IGSGTYGDVYKARDIATGEL--------VAIKVIKLEPGDDFEIIQQ------EISMLKE 56

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
             HPN+V   G     +   ++ E+   GS+++ ++     PL       +     KGLA
Sbjct: 57  CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLA 115

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI---------- 242
           +LHE  K  I+RD K +NILL  D + KL+DFG            VS ++          
Sbjct: 116 YLHETGK--IHRDIKGANILLTEDGDVKLADFG------------VSAQLTATIAKRKSF 161

Query: 243 MGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLLE 274
           +GT  + APE       G    + D+++ G+  +E
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 29/217 (13%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEV 127
           I   + + ++ LG G FG V+    ++  +       VAVK +  G  S +    +LAE 
Sbjct: 3   IPRESLKLEKKLGAGQFGEVWMATYNKHTK-------VAVKTMKPGSMSVEA---FLAEA 52

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA 187
             +  L H  LVKL     + E   +I EFMA+GS+ + L S      P    +  +   
Sbjct: 53  NVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 111

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVST 240
           A+G+AF+ +  +  I+RD + +NIL+      K++DFGLA+          EG K  +  
Sbjct: 112 AEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK- 168

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE I  G  T +SDV+SFG++L+EI+T
Sbjct: 169 -------WTAPEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 37/90 (41%), Positives = 53/90 (58%), Gaps = 4/90 (4%)

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           GL FLH+  K +IYRD K  N+LLD D + K++DFG+ K+   G+    ++   GT  Y 
Sbjct: 108 GLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYI 163

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +SFGV+L E+L G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 17/205 (8%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           F   R +G G FG VY    + D+R   + V +    + G  S +  ++ + EV FL  +
Sbjct: 27  FTDLREIGHGSFGAVY---FARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI 82

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 193
            HPN ++  G C   EH   +      GS  ++L      PL       I  GA +GLA+
Sbjct: 83  KHPNSIEYKG-CYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAY 140

Query: 194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 253
           LH     +I+RD K  NILL      KL+DFG A      +        +GT  + APE 
Sbjct: 141 LHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEV 192

Query: 254 IMT---GHLTPRSDVYSFGVVLLEI 275
           I+    G    + DV+S G+  +E+
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 49/120 (40%), Positives = 61/120 (50%), Gaps = 7/120 (5%)

Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 234
           +P  I  KIA    K L +L E  K +I+RD K SNILLD + N KL DFG++  G   D
Sbjct: 104 IPEEILGKIAVATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVD 160

Query: 235 KSHVSTRIMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGRKSLDKSRPAREQ 291
            S   TR  G   Y APE I          RSDV+S G+ L E+ TG+    K     +Q
Sbjct: 161 -SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ 219

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           F   R +G G FG VY    + D+R   + V +    + G  S +  ++ + EV FL  L
Sbjct: 17  FSDLREIGHGSFGAVY---FARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 193
            HPN ++  G C   EH   +      GS  ++L      PL       +  GA +GLA+
Sbjct: 73  RHPNTIQYRG-CYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 253
           LH     +I+RD K  NILL      KL DFG A      +        +GT  + APE 
Sbjct: 131 LHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEV 182

Query: 254 IMT---GHLTPRSDVYSFGVVLLEI 275
           I+    G    + DV+S G+  +E+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 45/132 (34%), Positives = 63/132 (47%), Gaps = 11/132 (8%)

Query: 167 LFSKVLLP---LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + KV      +P  I  KIA    K L +LH     VI+RD K SN+L++ +   KL D
Sbjct: 89  FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCD 147

Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYI----MTGHLTPRSDVYSFGVVLLEILTGR 279
           FG++  G   D S   T   G   Y APE I           +SDV+S G+ ++E+ TGR
Sbjct: 148 FGIS--GYLVD-SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Query: 280 KSLDKSRPAREQ 291
              D  +   +Q
Sbjct: 205 FPYDSWKTPFQQ 216

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 69/213 (32%), Positives = 99/213 (46%), Gaps = 33/213 (15%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH--REWLAE--VIFLGHL 133
           RVLG G FG V    + E  R        AVKV   D   Q       + E  ++ L   
Sbjct: 1   RVLGKGSFGKVMLARLKESGR------LYAVKVLKKDVILQDDDVECTMTEKRILSLAR- 53

Query: 134 SHPNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM---KIAFGAA 188
           +HP L +L  YCC    +    + EF+  G +        +  +  S R    +  F AA
Sbjct: 54  NHPFLTQL--YCCFQTPDRLFFVMEFVNGGDL--------MFHIQKSRRFDEARARFYAA 103

Query: 189 K---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
           +    L FLH+  K +IYRD K  N+LLD + + KL+DFG+ K+G    K+  ++   GT
Sbjct: 104 EITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGT 159

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             Y APE +      P  D ++ GV+L E+L G
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 51/154 (33%), Positives = 75/154 (48%), Gaps = 25/154 (16%)

Query: 134 SHPNLVKLIGYCC--EDEHRVLIYEFMARGS----VENNLFSKVLLPLPWSIRMKIAFGA 187
            HP LV L  + C   ++H   + E+ A G     +  ++FS+           +  F A
Sbjct: 60  RHPFLVNL--FACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP----------RAVFYA 107

Query: 188 AK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
           A    GL +LHE    ++YRD K  N+LLDT+   K++DFGL K+G  G     ST   G
Sbjct: 108 ACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-FCG 163

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + APE +     T   D +  GV++ E+L G
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 69.1 bits (170), Expect = 5e-13
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 67/234 (28%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK--------VHDGDNSYQGHREWLAEVIF 129
           + +G G +G V       D R G +   VA+K        + D        +  L E+  
Sbjct: 6   KPIGSGAYGVVCSAV---DKRTGRK---VAIKKISNVFDDLIDA-------KRILREIKL 52

Query: 130 LGHLSHPNLVKLI------GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           L HL H N++ L+          ED + V ++ E M     E +L  KV       I+  
Sbjct: 53  LRHLRHENIIGLLDILRPPSP--EDFNDVYIVTELM-----ETDL-HKV-------IKSP 97

Query: 183 ----------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-DGP 231
                       +   +GL +LH A   VI+RD K SNIL++++ + K+ DFGLA+   P
Sbjct: 98  QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155

Query: 232 EGDKS-----HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           + D+      +V TR      Y APE +++    T   D++S G +  E+LT +
Sbjct: 156 DEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.4 bits (167), Expect = 6e-13
 Identities = 51/148 (34%), Positives = 74/148 (50%), Gaps = 12/148 (8%)

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---GL 191
           +P L  L       EH   + EF+  G +  ++  K    L      +  F AA+   GL
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVCGL 109

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
            FLH   K +IYRD K  N++LD D + K++DFG+ K+   GD    ++   GT  Y AP
Sbjct: 110 QFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAP 165

Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           E +     T   D +SFGV+L E+L G+
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           +G G FG VY  F +       + V V    + G  + +  ++ + EV FL  L HPN +
Sbjct: 29  IGHGSFGAVY--FATNSHTN--EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
           +  G   ++    L+ E+   GS  ++L      PL       I  GA +GLA+LH    
Sbjct: 85  EYKGCYLKEHTAWLVMEY-CLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142

Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT--- 256
             I+RD K  NILL      KL+DFG A       KS  +   +GT  + APE I+    
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDE 194

Query: 257 GHLTPRSDVYSFGVVLLEI 275
           G    + DV+S G+  +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 42/104 (40%), Positives = 58/104 (55%), Gaps = 9/104 (8%)

Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+   GL FLH   K +IYRD K  N++LD + + K++DFG+ K+   G K   +T
Sbjct: 104 VFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TT 158

Query: 241 RIM-GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
           R   GT  Y APE I         D ++FGV+L E+L G+   D
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 67.9 bits (166), Expect = 8e-13
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 14/212 (6%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +G G +G VYK   + +   G     VA+K    D   +G     + E+  L 
Sbjct: 1   NFQKVEKIGEGTYGVVYK---ARNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLK 54

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 55  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 114 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 169

Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGRKSL 282
           E ++   + +   D++S G +  E++T R++L
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 73/210 (34%), Positives = 101/210 (48%), Gaps = 26/210 (12%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           R +G G FG VY    + D+R   + V +    + G  S +  ++ + EV FL  L HPN
Sbjct: 21  REIGHGSFGAVY---FARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 138 LVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLL-PLPWSIRMKIAFGAAKGLAFLH 195
            ++  G C   EH   L+ E+   GS  + L  +V   PL       I  GA +GLA+LH
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS--TRIMGTYGYAAPEY 253
             E+  I+RD K  NILL      KL+DFG A        S VS     +GT  + APE 
Sbjct: 133 SHER--IHRDIKAGNILLTEPGTVKLADFGSA--------SLVSPANSFVGTPYWMAPEV 182

Query: 254 IMT---GHLTPRSDVYSFGVVLLEILTGRK 280
           I+    G    + DV+S G+  +E L  RK
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIE-LAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 19/226 (8%)

Query: 66  ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           E+ + T  F ++  LG   FG VYKG +      G Q   VA+K            E+  
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLF-GTAPGEQTQAVAIKTLKDKAEGPLREEFKH 57

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------------V 171
           E +    L HPN+V L+G   +++   +I+ + +   +   L  +              V
Sbjct: 58  EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 172 LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 231
              L  +  + I    A G+ FL  +   V+++D  T N+L+    N K+SD GL ++  
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             D   +    +    + +PE IM G  +  SD++S+GVVL E+ +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.5 bits (165), Expect = 9e-13
 Identities = 75/290 (25%), Positives = 121/290 (41%), Gaps = 51/290 (17%)

Query: 80  LGGGGFGCVYKGFI----SEDLREGLQPVPVAVKVHDGDNSYQGHREWLA--EVI-FLGH 132
           LG G F  +YKG +      D+    Q V V +KV         HR+ LA  E    +  
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-----SDHRDSLAFFETASLMSQ 57

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGL 191
           LSH +LVKL G C  DE+ +++ E++  G ++  L   K  + L W  ++ +A   A  L
Sbjct: 58  LSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASAL 114

Query: 192 AFLHEAEKPVIYRDFKTSNILL-----DTDYN--AKLSDFGLAKDGPEGDKSHVSTRIMG 244
            +L   +K +++ +    NIL+     +  Y    KLSD G+        +     RI  
Sbjct: 115 HYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI-- 168

Query: 245 TYGYAAPEYIMTGHLTPRS--DVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK 302
              + APE I  G  +     D +SFG  LLEI +  +    +  + E+          +
Sbjct: 169 --PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK----------E 216

Query: 303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 352
              +  + +        P+    + A L   C  ++P  RP  R I+  L
Sbjct: 217 RFYQDQHRL--------PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 27/214 (12%)

Query: 134 SHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK--- 189
           S+P LV L   C +   R+ L+ E++  G +  ++  +  LP          F AA+   
Sbjct: 54  SNPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLP-----EEHARFYAAEICI 107

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIMGTYGY 248
            L FLHE  + +IYRD K  N+LLD D + KL+D+G+ K+G   GD    ++   GT  Y
Sbjct: 108 ALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNY 162

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL 308
            APE +         D ++ GV++ E++ GR   D      + N  D+   ++ EK    
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--- 219

Query: 309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR 342
            I  PR           KA+ +    LN +PK R
Sbjct: 220 -IRIPRFLS-------VKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 68/285 (23%), Positives = 121/285 (42%), Gaps = 49/285 (17%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 136
           + LG G FG V+ G       +    + VA+K +++G  S     +++ E   +  LSHP
Sbjct: 10  KELGSGQFGVVHLG-------KWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHP 59

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAKG 190
            LV+L G C + +   ++ EFM  G + N L       SK +L       + +     +G
Sbjct: 60  KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-------LSMCQDVCEG 112

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           + +L       I+RD    N L+ +    K+SDFG+ +   + D+   S+       ++ 
Sbjct: 113 MEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSP 169

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 310
           PE       + +SDV+SFGV++ E+ T  K                 +P   EKK    +
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGK-----------------MPF--EKKSNYEV 210

Query: 311 IDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 352
           ++    G     P         + Y C +  P+ RP   +++ ++
Sbjct: 211 VEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 23/226 (10%)

Query: 74  FRQDRVLGGGGFG--CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 131
           FRQ RVLG GGFG  C  +   +  +    +     +K   G++     ++ L +V    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV---- 57

Query: 132 HLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 189
              +   V  + Y  E +  + L+   M  G ++ ++++   +  P     +  F AA+ 
Sbjct: 58  ---NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN---MGNPGFEEERALFYAAEI 111

Query: 190 --GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
             GL  LH   +  +YRD K  NILLD   + ++SD GLA   PEG+   +  R+ GT G
Sbjct: 112 LCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVG 166

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL--DKSRPAREQ 291
           Y APE +     T   D +  G ++ E++ G+      K +  RE+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 81/294 (27%), Positives = 126/294 (42%), Gaps = 36/294 (12%)

Query: 78  RVLGGGGFG----CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           R LG G FG    C Y     E    G Q   VAVK    ++      +   E+  L +L
Sbjct: 10  RDLGEGHFGKVELCRYD---PEGDNTGEQ---VAVKSLKPESGGNHIADLKKEIEILRNL 63

Query: 134 SHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            H N+VK  G C ED      LI EF+  GS++  L  +    +    ++K A    KG+
Sbjct: 64  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGM 122

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR--IMGTYGYA 249
            +L    +  ++RD    N+L+++++  K+ DFGL K   E DK + + +  +     + 
Sbjct: 123 DYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWY 179

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKS--------LDKSRPAREQNLADWALPLL 301
           APE ++       SDV+SFGV L E+LT   S        L    P   Q      + +L
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239

Query: 302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
           +E K+L     PR     P     +   L   C    P  R   +++++  E +
Sbjct: 240 EEGKRL-----PR-----PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 44/124 (35%), Positives = 70/124 (56%), Gaps = 7/124 (5%)

Query: 156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           E M  GS++  L  K    +P +I  KI+    +GL +L E  K +++RD K SNIL+++
Sbjct: 79  EHMDGGSLDQVL--KKAGRIPENILGKISIAVLRGLTYLREKHK-IMHRDVKPSNILVNS 135

Query: 216 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
               KL DFG++  G   D   ++   +GT  Y +PE +   H T +SD++S G+ L+E+
Sbjct: 136 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191

Query: 276 LTGR 279
             GR
Sbjct: 192 AIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 56/185 (30%), Positives = 91/185 (49%), Gaps = 12/185 (6%)

Query: 126 EVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
           E++ +    HPN+V  L  Y   DE  V++ E++A GS+ + +    +          + 
Sbjct: 66  EILVMRENKHPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDE---GQIAAVC 121

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIM 243
               + L FLH  +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++
Sbjct: 122 RECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMV 176

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLK 302
           GT  + APE +      P+ D++S G++ +E++ G        P R   L A    P L+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ 236

Query: 303 EKKKL 307
             +KL
Sbjct: 237 NPEKL 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 30/270 (11%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           +G G FG V+KG    D R   Q V VA+K+ D + +     +   E+  L     P + 
Sbjct: 12  IGKGSFGEVFKGI---DNRT--QQV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
           K  G   +     +I E++  GS  + L +        +  +K      KGL +LH  +K
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK 122

Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
             I+RD K +N+LL    + KL+DFG+A  G   D        +GT  + APE I     
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178

Query: 260 TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDY 319
             ++D++S G+  +E+  G        P R        L L+ +         P L G++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMR-------VLFLIPKNNP------PTLTGEF 225

Query: 320 PVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
                         CLN +P  RP  ++++
Sbjct: 226 ----SKPFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 30/213 (14%)

Query: 80  LGGGGFGCVY--KGFISEDLREGLQPVPVAVKVHDGDNSYQGHR--EWLAEVIFLGHLSH 135
           +  G +G V+  K   + D+         A+KV    +  + ++  + L E   L     
Sbjct: 1   ISKGAYGRVFLAKKKSTGDI--------YAIKVIKKADMIRKNQVDQVLTERDILSQAQS 52

Query: 136 PNLVKLIGYCCEDEHRV-LIYEFMARG---SVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
           P +VKL  Y  + +  + L+ E++  G   S+  N+ S     L   +           L
Sbjct: 53  PYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGS-----LDEDVARIYIAEIVLAL 106

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS------TRIMGT 245
            +LH     +I+RD K  NIL+D++ + KL+DFGL+K G    + +++       RI+GT
Sbjct: 107 EYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             Y APE I+    +   D +S G +L E L G
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 18/209 (8%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           +G G FG V  G    +   G+    V VK      +      +L EV     L+HPN++
Sbjct: 3   IGNGWFGKVLLG----EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLH 195
           + +G C E    +L+ EF   G ++N L S       +     +  ++A   A GL +LH
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLLWLH 117

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY-- 253
           +A+   I+ D    N  L  D + K+ D+GLA +    D             + APE   
Sbjct: 118 QAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 254 -----IMTGHLTPRSDVYSFGVVLLEILT 277
                ++    T +S+++S GV + E+ T
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 15/210 (7%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-WLAEVIFLG 131
           +F+  + LG G +G VYK     D +        A+K  D  +  Q  RE  + E+  L 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQF------YALKEVDLGSMSQKEREDAVNEIRILA 54

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFGAAK 189
            ++HPN++       +     ++ E+   G +   +  +      +P     +I     +
Sbjct: 55  SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           GL  LHE +  +++RD K++NILL  +   K+ D G++K      K +++   +GT  Y 
Sbjct: 115 GLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYM 168

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE       + +SD++S G +L E+ T  
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 55/239 (23%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
             +G G  G VYK      +         A+KV  G++     R+   E+  L  ++HPN
Sbjct: 80  NRIGSGAGGTVYK------VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPN 133

Query: 138 LVKLIGYCCED------EHRVLIYEFMARGSVEN-NLFSKVLLPLPWSIRMKIAFGAAKG 190
           +VK     C D      E +VL+ EFM  GS+E  ++  +  L         +A     G
Sbjct: 134 VVK-----CHDMFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLA-------DVARQILSG 180

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM------- 243
           +A+LH   + +++RD K SN+L+++  N K++DFG+         S +  + M       
Sbjct: 181 IAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGV---------SRILAQTMDPCNSSV 229

Query: 244 GTYGYAAPEYIMTGHLTPR-----SDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 297
           GT  Y +PE I T            D++S GV +LE   GR      R        DWA
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ------GDWA 282

Length = 353

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 29/218 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLA---EVI 128
           N+R  ++LG G FG VY  + ++  RE  ++ VP      D D S +  +E  A   E+ 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPF-----DPD-SQETSKEVNALECEIQ 56

Query: 129 FLGHLSHPNLVKLIGYCCED--EHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
            L +L H  +V+  G C  D  E ++ I+ E+M  GS+++ L  K    L  ++  +   
Sbjct: 57  LLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTR 113

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD------GPEGDKSHVS 239
              +G+++LH     +++RD K +NIL D+  N KL DFG +K          G KS   
Sbjct: 114 QILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--- 168

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             + GT  + +PE I       ++DV+S    ++E+LT
Sbjct: 169 --VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 27/219 (12%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLA---EVI 128
           N+R  ++LG G FG VY  + ++  RE      +AVK V     S +  +E  A   E+ 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRE------LAVKQVQFDPESPETSKEVNALECEIQ 56

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
            L +L H  +V+  G   +   R L    E M  GS+++ L  K    L  ++  K    
Sbjct: 57  LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQ 114

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD------GPEGDKSHVST 240
             +G+++LH     +++RD K +NIL D+  N KL DFG +K          G KS    
Sbjct: 115 ILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS---- 168

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            + GT  + +PE I       ++D++S G  ++E+LT +
Sbjct: 169 -VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           NF+Q   LG G +  VYKG      R       VA+K    D         + E+  +  
Sbjct: 1   NFKQLEKLGEGTYATVYKG------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKE 54

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL-----FSKVLLPLPWSIRMKIAFGA 187
           L H N+V+L      +   +L++E+M     + +L        V   L  +      +  
Sbjct: 55  LKHENIVRLHDVIHTENKLMLVFEYM-----DKDLKKYMDTHGVRGALDPNTVKSFTYQL 109

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
            KG+AF HE    V++RD K  N+L++     KL+DFGLA+    G   +  +  + T  
Sbjct: 110 LKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLAR--AFGIPVNTFSNEVVTLW 165

Query: 248 YAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
           Y AP+ ++       S D++S G ++ E++TGR
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 7/99 (7%)

Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+    L FLH     VIYRD K  NILLD + + KL+DFG+ K+G        +T
Sbjct: 99  RFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT 154

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
              GT  Y APE +      P  D ++ GV++ E++ G+
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 29/259 (11%)

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  K++ 
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSI 110

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
              +GLA+L E  + +++RD K SNIL+++    KL DFG++  G   D   ++   +GT
Sbjct: 111 AVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 165

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 305
             Y +PE +   H + +SD++S G+ L+E+  GR  +    P  ++  A +  P++  ++
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIFGRPVVDGEE 223

Query: 306 KLLNIIDPRLE-GDYPVKGVHKAAMLAYHCLNHNPKARPLMR--DIVDSL--EPLQVLPD 360
              + I PR      PV G             H   +RP M   +++D +  EP   LP+
Sbjct: 224 GEPHSISPRPRPPGRPVSG-------------HGMDSRPAMAIFELLDYIVNEPPPKLPN 270

Query: 361 EAPTP--KNFVTVVTPEEP 377
              TP  + FV     + P
Sbjct: 271 GVFTPDFQEFVNKCLIKNP 289

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 17/159 (10%)

Query: 124 LAEVIFLGHLSHPNLVKLI-GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM 181
             E   L  LSHP +V ++  +  +DE+RV  + EF+  G +  +L      P       
Sbjct: 66  AQEKSILMELSHPFIVNMMCSF--QDENRVYFLLEFVVGGELFTHLRKAGRFP------N 117

Query: 182 KIA--FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
            +A  + A   LAF +   K +IYRD K  N+LLD   + K++DFG AK  P+      +
Sbjct: 118 DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----T 172

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             + GT  Y APE I +       D ++ GV+L E + G
Sbjct: 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH 195
           P + KL       ++  L+ E++  G   + +  K L  LP     +       G+  LH
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM 255
           +  + +I+RD K  N+L+D   + KL+DFGL+++G        + + +GT  Y APE I+
Sbjct: 115 Q--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETIL 166

Query: 256 TGHLTPRSDVYSFGVVLLEILTG 278
                  SD +S G V+ E L G
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 7/92 (7%)

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGY 248
           LA  H  +  +IYRD K  NILLD++ +  L+DFGL+K+    E ++++      GT  Y
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEY 172

Query: 249 AAPEYIMTGHLTPRS--DVYSFGVVLLEILTG 278
            APE I  G        D +S GV+  E+LTG
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           +L  G FG ++ G + ++     + V V   V D  +  Q     L E   L  LSH N+
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKT-VKDHASEIQVTL-LLQESCLLYGLSHQNI 70

Query: 139 VKLIGYCCED-EHRVLIYEFMARGSVENNLFSKVLLPL--PWSIRMK----IAFGAAKGL 191
           + ++  C ED E   ++Y +M  G+++  L    L     P ++  +    +A   A G+
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE-----GDKSHVSTRIMGT 245
           ++LH+    VI++D    N ++D +   K++D  L++D  P      GD  +   + M  
Sbjct: 131 SYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM-- 186

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
               A E ++    +  SDV+SFGV+L E++T
Sbjct: 187 ----ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 67/243 (27%), Positives = 114/243 (46%), Gaps = 23/243 (9%)

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E++ +  L +PN+V  +      +   ++ E++A GS+ + +    +     +    +  
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA---AVCR 122

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMG 244
              + L FLH  +  VI+RD K+ N+LL  D + KL+DFG  A+  PE  K    + ++G
Sbjct: 123 ECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVG 177

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKE 303
           T  + APE +      P+ D++S G++ +E++ G        P R   L A    P L+ 
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN 237

Query: 304 KKKLLNI----IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP 359
            +KL  I    ++  LE D   +G  K  +L +  L     A+PL      SL PL +  
Sbjct: 238 PEKLSPIFRDFLNRCLEMDVEKRGSAK-ELLQHPFLK---LAKPL-----SSLTPLILAA 288

Query: 360 DEA 362
            EA
Sbjct: 289 KEA 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 7/154 (4%)

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  K++ 
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSI 110

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
              KGL +L E  K +++RD K SNIL+++    KL DFG++  G   D   ++   +GT
Sbjct: 111 AVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 165

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 23/226 (10%)

Query: 74  FRQDRVLGGGGFG--CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 131
           FRQ RVLG GGFG  C  +   +  +    +     +K   G++     ++ L +V    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV---- 57

Query: 132 HLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 189
              +   V  + Y  E +  + L+   M  G ++ +++             +  F AA+ 
Sbjct: 58  ---NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVFYAAEI 111

Query: 190 --GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
             GL  LH+    ++YRD K  NILLD   + ++SD GLA   PEG    +  R+ GT G
Sbjct: 112 CCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVG 166

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQ 291
           Y APE +     T   D ++ G +L E++ G+      K +  RE+
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 45/220 (20%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK--------VHDGDNSYQGHREWLAEVIF 129
             +G G +G V   F ++  R+      VA+K              +Y+       E+  
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRK------VAIKKLSRPFQSAIHAKRTYR-------ELRL 67

Query: 130 LGHLSHPNLVKLIGYCCEDEHR------VLIYEFMARGSVENNLFSKVLLPLPWS---IR 180
           L H+ H N++ L+                L+   M    + N +  + L     S   I+
Sbjct: 68  LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKL-----SDDHIQ 121

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
             + +   +GL ++H A   +I+RD K SNI ++ D   K+ DFGLA+   +    +V+T
Sbjct: 122 F-LVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVAT 178

Query: 241 RIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
           R      Y APE ++   H     D++S G ++ E+LTG+
Sbjct: 179 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG G FG VYK    E           A KV +  +  +   +++ E+  L   +HP +V
Sbjct: 20  LGDGAFGKVYKAKNKE------TGALAAAKVIETKSEEE-LEDYMVEIEILATCNHPYIV 72

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR----MKIAFGAAKGLAFLH 195
           KL+G    D    ++ EF   G+V+      ++L L   +       I     + L +LH
Sbjct: 73  KLLGAFYWDGKLWIMIEFCPGGAVD-----AIMLELDRGLTEPQIQVICRQMLEALQYLH 127

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM 255
                +I+RD K  N+LL  D + KL+DFG++    +  +   S   +GT  + APE +M
Sbjct: 128 S--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVM 183

Query: 256 --TGHLTP---RSDVYSFGVVLLEI 275
             T   TP   ++D++S G+ L+E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 34/211 (16%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           LG G FG V+ G  + + +       VAVK +  G  S +    +L E   +  L H  L
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-------VAVKTLKPGTMSPES---FLEEAQIMKKLRHDKL 63

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLF--SKVLLPLPWSIRMKIAFGAAKGLAFLHE 196
           V+L     E E   ++ E+M++GS+ + L       L LP  + M  A   A G+A++  
Sbjct: 64  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYIER 120

Query: 197 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKSHVSTRIMGTYGYA 249
                I+RD +++NIL+      K++DFGLA+          +G K  +         + 
Sbjct: 121 MN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK--------WT 170

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILT-GR 279
           APE  + G  T +SDV+SFG++L E++T GR
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.6 bits (154), Expect = 3e-11
 Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 21/235 (8%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLGHLSHPNL 138
           +G G  G VY      D+  G +     V +   +   Q  +E +  E++ +    +PN+
Sbjct: 28  IGQGASGTVYTAM---DVATGQE-----VAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 139 VK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 197
           V  L  Y   DE  V++ E++A GS+ + +    +     +    +     + L FLH  
Sbjct: 80  VNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSN 135

Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT 256
           +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + APE +  
Sbjct: 136 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 190

Query: 257 GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKKLLNI 310
               P+ D++S G++ +E++ G        P R   L A    P L+  +KL  I
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 62/293 (21%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPV----AVKVH------DGDNSYQGHREWLAEVIF 129
           LG G FGCVYK      +R+      +     + VH      D     +   + ++EV  
Sbjct: 8   LGSGAFGCVYK------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 130 LG-HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------------KVLLPLP 176
           +   L HPN+V+      E+  R+ I   +  G+     F+            ++     
Sbjct: 62  IKEQLRHPNIVRYYKTFLEN-DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI----- 115

Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
           W+I +++       L +LH+ EK +++RD   +NI+L  D    ++DFGLAK      K 
Sbjct: 116 WNIFVQMVLA----LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK- 169

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
              T ++GT  Y+ PE +       ++DV++FG +L ++ T         P    N+   
Sbjct: 170 --LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSL 221

Query: 297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
           A  +++         +P  EG Y          +   CL  + +ARP   DI+
Sbjct: 222 ATKIVEAV------YEPLPEGMYS----EDVTDVITSCLTPDAEARP---DII 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 19/208 (9%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 131
           + R +  LG G FG V+ G  +   R       VA+K +  G  S +    +L E   + 
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTWNGTTR-------VAIKTLKPGTMSPEA---FLQEAQVMK 56

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAK 189
            L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + M  A   A 
Sbjct: 57  KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQIAS 113

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++            + 
Sbjct: 114 GMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWT 170

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILT 277
           APE  + G  T +SDV+SFG++L E+ T
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 38/281 (13%)

Query: 72  ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK---VHDGDNSYQGHREWLAEVI 128
           ANFR ++ +G G F  VY+          L  VPVA+K   + D  ++ +   + + E+ 
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCL------LDGVPVALKKVQIFDLMDA-KARADCIKEID 54

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKIAFG 186
            L  L+HPN++K      ED    ++ E    G +   +  F K    +P     K    
Sbjct: 55  LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L  +H   + V++RD K +N+ +      KL D GL +      K+  +  ++GT 
Sbjct: 115 LCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTP 170

Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK 306
            Y +PE I       +SD++S G +L E                  +A    P   +K  
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMN 212

Query: 307 LLNIIDPRLEGDY-PVKGVHKAA---MLAYHCLNHNPKARP 343
           L ++     + DY P+   H +     L   C+N +P+ RP
Sbjct: 213 LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 35/93 (37%), Positives = 57/93 (61%), Gaps = 4/93 (4%)

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-DGPEGDKSHVSTRIMGTYG 247
           +GL ++H A   V++RD K SN+LL+T+ + K+ DFGLA+   PE D +   T  + T  
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 248 YAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
           Y APE ++      ++ D++S G +L E+L+ R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 69/285 (24%), Positives = 117/285 (41%), Gaps = 44/285 (15%)

Query: 71  TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHRE-WLAEVI 128
             NF+ ++ +G G F  VYK      L +G     VA+K V   +      R+  L E+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKA---ICLLDGR---VVALKKVQIFEMMDAKARQDCLKEID 54

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLP----WSIRMK 182
            L  L HPN++K +    E+    ++ E    G +   +  F K    +P    W   ++
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           +       L  +H   K +++RD K +N+ +      KL D GL +      K+  +  +
Sbjct: 115 LC----SALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSL 166

Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK 302
           +GT  Y +PE I       +SD++S G +L E                  +A    P   
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYG 208

Query: 303 EKKKLLNIIDPRLEGDY-PVKGVHKAAML---AYHCLNHNPKARP 343
           +K  L ++     + DY P+   H +  L      C+N +P+ RP
Sbjct: 209 DKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 18/208 (8%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           +G G FG V  G    ++  G  P  V VK      S Q   ++L E      L H NL+
Sbjct: 3   IGNGWFGKVILG----EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFS----KVLLPLPWSIRMKIAFGAAKGLAFLH 195
           + +G C E    +L+ EF   G ++  L S    +++ P P +++ ++A   A GL  LH
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEIALGLLHLH 117

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM 255
           +     I+ D    N LL  D   K+ D+GL+ +  + D      ++     + APE + 
Sbjct: 118 KNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 256 TGH-------LTPRSDVYSFGVVLLEIL 276
             H        T  S+V+S GV + E+ 
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 7/162 (4%)

Query: 119 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-HRVLIYEFMARGSVENNLFSKVLLPLPW 177
           G +  L E   L  ++ P +V L  Y  E + H  L+   M  G ++ ++++     L  
Sbjct: 36  GEKMALLEKEILEKVNSPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-- 92

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +   I + A      LH     ++YRD K  N+LLD   N +LSD GLA +  +G    
Sbjct: 93  EMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-- 150

Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             T+  GT GY APE +     +   D ++ G  + E++ GR
Sbjct: 151 -ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.0 bits (150), Expect = 7e-11
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 19/208 (9%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 131
           + R D  LG G FG V+ G  +   +       VA+K +  G    +    +L E   + 
Sbjct: 7   SLRLDVKLGQGCFGEVWMGTWNGTTK-------VAIKTLKPGTMMPEA---FLQEAQIMK 56

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAK 189
            L H  LV L     E E   ++ EFM +GS+ + L       L LP  + M  A   A 
Sbjct: 57  KLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM--AAQIAD 113

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           G+A++       I+RD + +NIL+  +   K++DFGLA+   E ++            + 
Sbjct: 114 GMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWT 170

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILT 277
           APE  + G  T +SDV+SFG++L E++T
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 55/160 (34%), Positives = 78/160 (48%), Gaps = 15/160 (9%)

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E+  L  L HPNLV LI          L++E+    +V N L  K    +P  +  KI
Sbjct: 48  LREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNEL-EKNPRGVPEHLIKKI 105

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKS-HVST 240
            +   + + F H+     I+RD K  NIL+      KL DFG A+   GP  D + +V+T
Sbjct: 106 IWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT 163

Query: 241 RIMGTYGYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTG 278
           R      Y APE ++  T +  P  DV++ G V  E+LTG
Sbjct: 164 R-----WYRAPELLVGDTQYGPP-VDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 80/291 (27%), Positives = 133/291 (45%), Gaps = 34/291 (11%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLGHLSHPNL 138
           +G G  G VY      D+  G +     V +   +   Q  +E +  E++ +    +PN+
Sbjct: 27  IGQGASGTVYTAI---DIATGQE-----VAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 139 VK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 197
           V  L  Y   DE  V++ E++A GS+ + +    +     +    +     + L FLH  
Sbjct: 79  VNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALDFLHSN 134

Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT 256
           +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + APE +  
Sbjct: 135 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 189

Query: 257 GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKKL----LNII 311
               P+ D++S G++ +E++ G        P R   L A    P L+  ++L     + +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249

Query: 312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA 362
           +  LE D   +G  K  +L +  L     A+PL      SL PL +   EA
Sbjct: 250 NRCLEMDVDRRGSAK-ELLQHPFLK---LAKPL-----SSLTPLIIAAKEA 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 6/97 (6%)

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTY 246
           + GL FLH   + +IYRD K  N++LD++ + K++DFG+ K   E     V+TR   GT 
Sbjct: 111 SVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTP 165

Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
            Y APE I         D +++GV+L E+L G+   D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 17/153 (11%)

Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA-- 187
           L  +SHP +++L     +     ++ E++  G     LFS +     +S    + + +  
Sbjct: 55  LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGE----LFSYLRNSGRFSNSTGLFYASEI 110

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTY 246
              L +LH   K ++YRD K  NILLD + + KL+DFG AK      K    T  + GT 
Sbjct: 111 VCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTP 162

Query: 247 GYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 278
            Y APE I   GH     D ++ G+++ E+L G
Sbjct: 163 EYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)

Query: 106 VAVKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+ D     Q  RE L  EV+ +    H N+V++       E   ++ EF+  G++ 
Sbjct: 49  VAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL- 105

Query: 165 NNLFSKVLLPLPWSIRMKIAF---GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 221
            ++ S+  L        +IA       + L +LH   + VI+RD K+ +ILL  D   KL
Sbjct: 106 TDIVSQTRLN-----EEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKL 158

Query: 222 SDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           SDFG    ++KD P+         ++GT  + APE I         D++S G++++E++ 
Sbjct: 159 SDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD 212

Query: 278 GRKSLDKSRPARE-QNLADWALPLLKEKKKLLNIIDPRLE 316
           G        P +  + L D   P LK   K+  ++   LE
Sbjct: 213 GEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 36/91 (39%), Positives = 48/91 (52%), Gaps = 4/91 (4%)

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           A  L +LH     +IYRD K  NILLD+  +  L+DFGL K+G E  K+  ++   GT  
Sbjct: 106 ASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPE 161

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 41/105 (39%), Positives = 58/105 (55%), Gaps = 15/105 (14%)

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIMGTYGYA 249
           LA  H  ++ +IYRD K  NILLD   + KL+DFGL K+   EG  +H      GT  Y 
Sbjct: 111 LALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYM 167

Query: 250 APEYIM-TGHLTPRSDVYSFGVVLLEILTG---------RKSLDK 284
           APE +M +GH     D +S G ++ ++LTG         +K++DK
Sbjct: 168 APEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 36/93 (38%), Positives = 49/93 (52%), Gaps = 10/93 (10%)

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA---KDGPEGDKSHVSTRIMGTY 246
           GL  LH+  + +IYRD K  N+LLD D N ++SD GLA   KDG    K +      GT 
Sbjct: 109 GLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTP 161

Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           G+ APE +         D ++ GV L E++  R
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 48/228 (21%)

Query: 72  ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFL 130
             F +   +G G +G VY+     D   G     VA+K    DN   G     L E+  L
Sbjct: 7   TEFEKLNRIGEGTYGIVYRA---RDTTSGEI---VALKKVRMDNERDGIPISSLREITLL 60

Query: 131 GHLSHPNLVKL---------------IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 175
            +L HPN+V+L               + YC +D   +L          +N        P 
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL----------DNM-------PT 103

Query: 176 PWSI-RMK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
           P+S  ++K +     +GL +LHE    +I+RD K SN+LL      K++DFGLA+    G
Sbjct: 104 PFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYG 159

Query: 234 DKSHVSTRIMGTYGYAAPEYI--MTGHLTPRSDVYSFGVVLLEILTGR 279
             +   T  + T  Y APE +   T + T   D+++ G +L E+L  +
Sbjct: 160 LPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 67/284 (23%), Positives = 115/284 (40%), Gaps = 44/284 (15%)

Query: 72  ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK------VHDGDNSYQGHREWLA 125
           ANF+ ++ +G G F  VY+     D +      PVA+K      + D     +  ++ + 
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRK------PVALKKVQIFEMMDA----KARQDCVK 51

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKI 183
           E+  L  L+HPN++K +    ED    ++ E    G +   +  F K    +P     K 
Sbjct: 52  EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
                  +  +H   + V++RD K +N+ +      KL D GL +      K+  +  ++
Sbjct: 112 FVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 167

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 303
           GT  Y +PE I       +SD++S G +L E                  +A    P   +
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGD 209

Query: 304 KKKLLNIIDPRLEGDY-PVKGVH---KAAMLAYHCLNHNPKARP 343
           K  L ++     + DY P+   H   K   L   C+  +P  RP
Sbjct: 210 KMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--QGHREWLAEVIFLGHLSHPN 137
           +G G +G VYK   + D   G      +V+V   ++       RE +A +  L    HPN
Sbjct: 8   IGVGAYGTVYK---ARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPN 63

Query: 138 LVKLIGYCC----EDEHRV-LIYEFMARGSVENNL---FSKVLLP-LPWSIRMKIAFGAA 188
           +V+L+  C     + E +V L++E      V+ +L     KV  P LP      +     
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFE-----HVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS-TRIMGTYG 247
           +GL FLH     +++RD K  NIL+ +    KL+DFGLA+         ++ T ++ T  
Sbjct: 119 RGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLW 172

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 282
           Y APE ++        D++S G +  E+   RK L
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 3/90 (3%)

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            L +LH +EK V+YRD K  N++LD D + K++DFGL K+G + D + + T   GT  Y 
Sbjct: 107 ALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT-FCGTPEYL 163

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 37/90 (41%), Positives = 52/90 (57%), Gaps = 7/90 (7%)

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           GL  +H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +GT+GY 
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYM 162

Query: 250 APEYIMTGHLTPRS-DVYSFGVVLLEILTG 278
           APE +  G     S D +S G +L ++L G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 30/210 (14%)

Query: 78  RVLGGGGFG-CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
           RV+G G FG  +    ++ D +  ++ + +       ++S +       E + L  + HP
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK-------EAVLLAKMKHP 58

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPWSIRMKIAFGAAK 189
           N+V        D H  ++ E+   G +          LF +  + L W ++M        
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFVQM-------- 109

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSHVSTRIMGTYG 247
            L   H  EK V++RD K+ NI L  +   KL DFG A+    P    ++  T + GT  
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYV-GTPY 165

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           Y  PE         +SD++S G +L E+ T
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 21/219 (9%)

Query: 74  FRQDRVLGGGGFG--CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 131
           FR  RVLG GGFG  C  +   +  +    +     +K   G+      +  L +V    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV---- 57

Query: 132 HLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 189
              +   V  + Y  E +  + L+   M  G ++ ++++   +  P     +  F AA+ 
Sbjct: 58  ---NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN---MGNPGFDEQRAIFYAAEL 111

Query: 190 --GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
             GL  L      ++YRD K  NILLD   + ++SD GLA   PEG+   V  R+ GT G
Sbjct: 112 CCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVG 166

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR 286
           Y APE I     T   D +  G ++ E++ G+    K +
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 36/218 (16%)

Query: 81  GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQG-HREWLAEVIFLGHLSHPNL 138
           G G +G VYK       + G      A+K   GD   Y G  +    E+  L  L H N+
Sbjct: 9   GRGTYGRVYKA----KRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENV 64

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLF-------SKVLLPLPWSIRMKIAFGAAKGL 191
           V L+    E   + +   ++     E++L+           + +P S+   + +    G+
Sbjct: 65  VSLVEVFLEHADKSV---YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNA----KLSDFGLAK--DGP-----EGDKSHVST 240
            +LH     V++RD K +NIL+  +       K+ D GLA+  + P     + D   V  
Sbjct: 122 HYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV-- 177

Query: 241 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILT 277
               T  Y APE ++   H T   D+++ G +  E+LT
Sbjct: 178 ----TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 38/97 (39%), Positives = 55/97 (56%), Gaps = 6/97 (6%)

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTY 246
           A GL FLH   K +IYRD K  N++LD++ + K++DFG+ K   E     V+T+   GT 
Sbjct: 111 AIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTP 165

Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
            Y APE I         D ++FGV+L E+L G+   +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 59.5 bits (144), Expect = 4e-10
 Identities = 68/284 (23%), Positives = 117/284 (41%), Gaps = 52/284 (18%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           +G G FG   K  + +   +G Q V   + +       +   E   EV  L ++ HPN+V
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSP--KEREESRKEVAVLSNMKHPNIV 62

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSK------VLLP----LPWSIRMKIAFGAAK 189
           +      E+ +  ++ ++   G    +L+ K      VL P    L W +++        
Sbjct: 63  QYQESFEENGNLYIVMDYCEGG----DLYKKINAQRGVLFPEDQILDWFVQI-------- 110

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            LA  H  ++ +++RD K+ NI L  D   KL DFG+A+         ++   +GT  Y 
Sbjct: 111 CLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYL 168

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 309
           +PE         +SD+++ G VL E+ T + + +        N+          K  +L 
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG------NM----------KNLVLK 212

Query: 310 IIDPRLEGDYPVKGVHKAA---MLAYHCLNHNPKARPLMRDIVD 350
           II     G YP    H +     L       NP+ RP +  I++
Sbjct: 213 II----RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 69/269 (25%), Positives = 105/269 (39%), Gaps = 71/269 (26%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
            R  +VLG G FG V +      + +      VAVK+     +   H+  ++E+  L H+
Sbjct: 9   LRLGKVLGHGAFGKVVEASAF-GIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHI 67

Query: 134 -SHPNLVKLIGYCCEDEHRVL-IYEF---------------------------------- 157
            +H N+V L+G C +    ++ I EF                                  
Sbjct: 68  GNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAM 127

Query: 158 --------MARGSVENNLFSKVLL------------------PLPWSIRMKIAFGAAKGL 191
                          + LFS+                     PL     +  +F  A+G+
Sbjct: 128 VEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGM 187

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV---STRIMGTYGY 248
            FL  A +  I+RD    NILL  +   K+ DFGLA+D  + D  +V   S R+     +
Sbjct: 188 EFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGSARL--PLKW 242

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            APE I     T +SDV+SFGV+L EI +
Sbjct: 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 40/113 (35%), Positives = 60/113 (53%), Gaps = 8/113 (7%)

Query: 172 LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 231
             PL     ++ +   A+G+ FL  A K  I+RD    N+LL     AK+ DFGLA+D  
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD-I 262

Query: 232 EGDKSHV---STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
             D ++V   + R+     + APE I     T +SDV+S+G++L EI +  KS
Sbjct: 263 MNDSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 39/106 (36%), Positives = 54/106 (50%), Gaps = 11/106 (10%)

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L   H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +GT+GY A
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYMA 163

Query: 251 PEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 295
           PE +  G     S D +S G +L ++L G        P R+    D
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHS------PFRQHKTKD 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 22/211 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR--EWLAEVIFL 130
           +F   R LG G FG V    I    +    P PVA+K  +     +  +     +E   L
Sbjct: 31  DFNFIRTLGTGSFGRV----ILATYKNEDFP-PVAIKRFEKSKIIKQKQVDHVFSERKIL 85

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
            +++HP  V L G   ++ +  L+ EF+  G     L      P      +   + A   
Sbjct: 86  NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP----NDVGCFYAAQIV 141

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYG 247
           L F +     ++YRD K  N+LLD D   K++DFG AK         V TR   + GT  
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPE 193

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE ++       +D ++ G+ + EIL G
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           LA  H  +  ++YRD K  NILLD++ +  L+DFGL+K+    +K    +   GT  Y A
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMA 174

Query: 251 PEYI--MTGHLTPRSDVYSFGVVLLEILTG 278
           PE I    GH     D +S G+++ E+LTG
Sbjct: 175 PEIIRGKGGH-GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 33/222 (14%)

Query: 108 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 165
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G+   
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGA--- 103

Query: 166 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
                 L  +    RM       +     K L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 104 ------LTDIVTHTRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRV 155

Query: 220 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 156 KLSDFGFCAQVSKEVPR------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209

Query: 276 LTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG 317
           + G        P +   +    LP    K K L+ + P L+G
Sbjct: 210 VDGEPPYFNEPPLKAMKMIRDNLP---PKLKNLHKVSPSLKG 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 131 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 183

Query: 249 AAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 9/159 (5%)

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKI 183
           E+  L  +SH  ++ LI       +R      M     + +LF+ V    PLP    + I
Sbjct: 136 EIDILKTISHRAIINLI-----HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
                + LA+LH   + +I+RD KT NI LD   NA L DFG A        +       
Sbjct: 191 QRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 282
           GT    +PE +       ++D++S G+VL E+     +L
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 36/91 (39%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           LA  H  +  +IYRD K  NILLD++ +  L+DFGL+K+  E D+   +    GT  Y A
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMA 174

Query: 251 PEYIM---TGHLTPRSDVYSFGVVLLEILTG 278
           P+ +     GH     D +S GV++ E+LTG
Sbjct: 175 PDIVRGGDGGH-DKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 6/151 (3%)

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA 187
           + L ++ HP LV L       E    + +F+  G +  +L  +   P P + R   A   
Sbjct: 48  VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EI 105

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           A  L +LH     ++YRD K  NILLD+  +  L+DFGL K+G    +S  +T   GT  
Sbjct: 106 ASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPE 161

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE I         D +  G VL E+L G
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 64/235 (27%), Positives = 101/235 (42%), Gaps = 43/235 (18%)

Query: 71  TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK---VHDGDNSYQGHREWLAEV 127
             ++     LG G FG VYK      ++ G     VA+K   +H+  + +      L E+
Sbjct: 7   LRDYEILGKLGEGTFGEVYKA---RQIKTGRV---VALKKILMHNEKDGF--PITALREI 58

Query: 128 IFLGHLSHPNLVKLIGYCCE--DEHR------VLIYEFMAR---GSVENNLFSKVLLPLP 176
             L  L HPN+V LI    E  D+ +       ++  +M     G +EN     V L   
Sbjct: 59  KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTES 115

Query: 177 WSIR--MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK------ 228
             I+  M       +G+ +LHE    +++RD K +NIL+D     K++DFGLA+      
Sbjct: 116 -QIKCYMLQLL---EGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169

Query: 229 ---DGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
               G  G  +   T ++ T  Y  PE ++     T   D++  G V  E+ T R
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 34/93 (36%), Positives = 50/93 (53%)

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           LA  H   K +I+RD K++NILL ++   KL DFG +K         V     GT  Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
           PE       + ++D++S GV+L E+LT ++  D
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 38/97 (39%), Positives = 54/97 (55%), Gaps = 8/97 (8%)

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV---ST 240
           +F  A+G+ FL  A +  I+RD    NILL  +   K+ DFGLA+D  + D  +V     
Sbjct: 179 SFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDA 235

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           R+     + APE I     T +SDV+SFGV+L EI +
Sbjct: 236 RL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 26/209 (12%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLSHPNL 138
           +G G +G VYKG      R       VA+K    ++  +G     + E+  L  L HPN+
Sbjct: 8   IGEGTYGVVYKG------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 139 VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA------FGAAKGLA 192
           V L     ++    LI+EF++          K L  LP    M         +   +G+ 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMD------LKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
           F H   + V++RD K  N+L+D     KL+DFGLA+    G    V T  + T  Y APE
Sbjct: 116 FCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPE 171

Query: 253 YIM--TGHLTPRSDVYSFGVVLLEILTGR 279
            ++    + TP  D++S G +  E+ T +
Sbjct: 172 VLLGSPRYSTP-VDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 74  FRQDRVLGGGGFG--CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA--EVIF 129
           FR  RVLG GGFG  C  +   +  +         A K  +     +   E +A  E   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKM--------YACKKLEKKRIKKRKGEAMALNEKQI 53

Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
           L  ++   +V L  Y  E +  + L+   M  G ++ ++++   +  P     +  F AA
Sbjct: 54  LEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVFYAA 109

Query: 189 K---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
           +   GL  LH     ++YRD K  NILLD   + ++SD GLA + PEG+   +  R+ GT
Sbjct: 110 EITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GT 164

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            GY APE +     T   D +  G ++ E++ G+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 40/172 (23%)

Query: 124 LAEVIFLGHLS-HPNLVKLIGYCCEDEHRVL----------IYEFMARGSVENNLFSKVL 172
           L E+  L  LS HPN+++LI    + +   L          +YE + +G           
Sbjct: 45  LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELI-KGRKR-------- 95

Query: 173 LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE 232
            PLP        +   K L  +H     + +RD K  NIL+  D   KL+DFG  +    
Sbjct: 96  -PLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIK-DDILKLADFGSCR---- 147

Query: 233 GDKSH------VSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILT 277
           G  S       +STR      Y APE ++T G+  P+ D+++ G V  EIL+
Sbjct: 148 GIYSKPPYTEYISTR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 70/229 (30%), Positives = 100/229 (43%), Gaps = 37/229 (16%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNL 138
           +G G +G VYK     + ++G      AVK+ D  +      E  AE   L  L  HPN+
Sbjct: 30  IGKGTYGKVYK---VTNKKDGSL---AAVKILDPISDVDEEIE--AEYNILQSLPNHPNV 81

Query: 139 VKLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLL---PLPWSIRMKIAFGAAKG 190
           VK  G   + +  V     L+ E    GSV   L   +L+    L  ++   I +GA  G
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAMISYILYGALLG 140

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI-----MGT 245
           L  LH     +I+RD K +NILL T+   KL DFG++           STR+     +GT
Sbjct: 141 LQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVS-------AQLTSTRLRRNTSVGT 191

Query: 246 YGYAAPEYIMTGH-----LTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
             + APE I            R DV+S G+  +E+  G   L    P +
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 54/183 (29%), Positives = 73/183 (39%), Gaps = 35/183 (19%)

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           AE   L     P +VKL  Y  +DE  + L+ E+M  G + N L  K + P         
Sbjct: 50  AERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-----A 103

Query: 184 AFGAAKGLAFLHEAEK-PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS------ 236
            F  A+ +  L    K   I+RD K  NIL+D D + KL+DFGL K   +          
Sbjct: 104 RFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163

Query: 237 ----------HVSTR-----------IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
                      V  R            +GT  Y APE +         D +S GV+L E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223

Query: 276 LTG 278
           L G
Sbjct: 224 LYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 18/207 (8%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG G +G VYK             V +A+K    +       + + E+  L     P +V
Sbjct: 9   LGKGNYGSVYKVLHRP------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIV 62

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRMKIAFGAAKGLAFLHEAE 198
              G    +    +  E+M  GS++      V    +P  +  +I +   KGL FL E E
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-E 121

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH 258
             +I+RD K +N+L++ +   KL DFG++ +      S   T I G   Y APE I +G 
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN---LVASLAKTNI-GCQSYMAPERIKSGG 177

Query: 259 LTPR------SDVYSFGVVLLEILTGR 279
                     SDV+S G+ +LE+  GR
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 50/178 (28%), Positives = 72/178 (40%), Gaps = 22/178 (12%)

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           +   +  A+G+ FL  A K  ++RD    N+LL      K+ DFGLA+D    D ++VS 
Sbjct: 240 LSFTYQVARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH-DSNYVSK 296

Query: 241 -RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP 299
                   + APE I     T  SDV+S+G++L EI +               L     P
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS---------------LGGTPYP 341

Query: 300 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR---DIVDSLEP 354
            +       N I        P     +   +   C N  P+ RP      DIV+SL P
Sbjct: 342 GMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 51/157 (32%), Positives = 76/157 (48%), Gaps = 13/157 (8%)

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+  L  L H NLV LI      +   L++EF+   +V ++L  K    L  S   K  F
Sbjct: 50  EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDL-EKYPNGLDESRVRKYLF 107

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGP-EGDKSHVSTRI 242
              +G+ F H     +I+RD K  NIL+      KL DFG A+    P E    +V+TR 
Sbjct: 108 QILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR- 164

Query: 243 MGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTG 278
                Y APE ++      R+ D+++ G ++ E+LTG
Sbjct: 165 ----WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 28/217 (12%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-----VHDGDNSYQGHREWL 124
           IT  +   + +G G FG V         R+ L    VA+K           + + +RE  
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSA------RDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-- 59

Query: 125 AEVIFLGHLSHPNLVKLIG-YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
             +  L HL H N++ L   +    E    + E +    +   L S+   PL        
Sbjct: 60  --LKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSR---PLEKQFIQYF 113

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
            +   +GL ++H A   V++RD K SNIL++ + + K+ DFGLA+        +VSTR  
Sbjct: 114 LYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY- 170

Query: 244 GTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGR 279
               Y APE ++T        D++S G +  E+L G+
Sbjct: 171 ----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 6/90 (6%)

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIMGTYGYA 249
           L +LH  +  V+YRD K  N++LD D + K++DFGL K+G  +G          GT  Y 
Sbjct: 108 LGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYL 162

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 5/90 (5%)

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           LA  H  +  ++YRD K  NILLD   +  L DFGL+K       +  +    GT  Y A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLA 164

Query: 251 PEYIM--TGHLTPRSDVYSFGVVLLEILTG 278
           PE ++   G+ T   D +S GV++ E+  G
Sbjct: 165 PEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 4/89 (4%)

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L +LH   + V+YRD K  N++LD D + K++DFGL K+G   D + + T   GT  Y A
Sbjct: 108 LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT-FCGTPEYLA 163

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           PE +         D +  GVV+ E++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 19/160 (11%)

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF------MARGSVENN-LFSKVLLPLPWS 178
           EVI L  + HPN+V       E+    ++ E+      M R + +   LFS+  + L W 
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI-LSWF 107

Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDGPEGDKSH 237
           +++ +      GL  +H+  + +++RD K+ NI L  +   AKL DFG+A+     D   
Sbjct: 108 VQISL------GLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSME 157

Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           ++   +GT  Y +PE         ++D++S G VL E+ T
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 33/171 (19%)

Query: 124 LAEVIFLGHLSHPNLVKL----IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           L E+  L  L HPN+V +    +G    +  ++    +M    VE++L  K L+      
Sbjct: 52  LREINILLKLQHPNIVTVKEVVVG---SNLDKI----YMVMEYVEHDL--KSLME----- 97

Query: 180 RMKIAFGAAK----------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 229
            MK  F  ++          G+A LH+    +++RD KTSN+LL+     K+ DFGLA+ 
Sbjct: 98  TMKQPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAR- 154

Query: 230 GPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
              G      T+++ T  Y APE ++     +   D++S G +  E+LT +
Sbjct: 155 -EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 37/107 (34%), Positives = 60/107 (56%), Gaps = 6/107 (5%)

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           +GL +LH A   +++RD K  N+L++++   K+ DFGLA+   E D+S   T+ + T  Y
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYY 170

Query: 249 AAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 293
            APE I+ G  H T   D++S G +  E+L  R       P ++ +L
Sbjct: 171 RAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 8/97 (8%)

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV---ST 240
           +F  AKG+ FL  A +  I+RD    NILL  +   K+ DFGLA+D  + D  +V     
Sbjct: 185 SFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDA 241

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           R+     + APE I     T +SDV+SFGV+L EI +
Sbjct: 242 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 47/173 (27%), Positives = 69/173 (39%), Gaps = 17/173 (9%)

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           +  ++  AKG++FL  A K  I+RD    NILL      K+ DFGLA+D        V  
Sbjct: 217 LSFSYQVAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
                  + APE I     T  SDV+S+G++L EI +               L     P 
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPG 319

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
           +    K   +I        P     +   +   C + +P  RP  + IV  +E
Sbjct: 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           +GL ++H A   V++RD K SN+LL+ + + K+ DFGLA+     +K    T  + T  Y
Sbjct: 119 RGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWY 174

Query: 249 AAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSL 282
            APE ++     T   DV+S G +  E+L GRK L
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 8/156 (5%)

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+  L  L+HPN+V+L+     +    L++EF+    ++  + S  L  L   +     +
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
              +G+A+ H     V++RD K  N+L+D +   KL+DFGLA+    G      T  + T
Sbjct: 107 QLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVT 162

Query: 246 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGR 279
             Y APE ++      TP  D++S G +  E++  R
Sbjct: 163 LWYRAPEILLGSRQYSTP-VDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+        +V TR      Y
Sbjct: 129 KGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WY 181

Query: 249 AAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
            APE I+   H T   D++S G ++ E+LTG+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)

Query: 108 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 165
           V V   D   Q  RE L  EV+ +    H N+V +   Y   DE  V++ EF+  G+   
Sbjct: 50  VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM-EFLEGGA--- 105

Query: 166 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
                 L  +    RM       +     + L++LH   + VI+RD K+ +ILL +D   
Sbjct: 106 ------LTDIVTHTRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRI 157

Query: 220 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           KLSDFG    ++K+ P+         ++GT  + APE I         D++S G++++E+
Sbjct: 158 KLSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211

Query: 276 LTGRKSLDKSRPARE-QNLADWALPLLKEKKKLLNII 311
           + G        P +  + + D   P +K+  K+ +++
Sbjct: 212 IDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVL 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 23/221 (10%)

Query: 65  DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REW 123
           D    +   ++Q + +G G  G V   F      + +  + VAVK        Q H +  
Sbjct: 14  DSTFTVLKRYQQLKPIGSGAQGIVCAAF------DTVLGINVAVKKLSRPFQNQTHAKRA 67

Query: 124 LAEVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPW 177
             E++ L  ++H N++ L+          E +   L+ E M     + NL   + + L  
Sbjct: 68  YRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIHMELDH 122

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
                + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       + 
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNF 177

Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           + T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 4/91 (4%)

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           A  + +LH     +IYRD K  NILLD+  +  L+DFGL K+G E +++  ++   GT  
Sbjct: 106 ASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPE 161

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            L +LH  +  ++YRD K  N++LD D + K++DFGL K+G   D + + T   GT  Y 
Sbjct: 107 ALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKT-FCGTPEYL 162

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 99/409 (24%), Positives = 171/409 (41%), Gaps = 80/409 (19%)

Query: 27  ESPSEKAKKEYS-KLPSNPEEVEDLRRDSAANPLIAFTYDELRII--------TANFRQD 77
           E  + KA K  S K   N +++++  R    N       DE ++I          +++  
Sbjct: 14  EEKNHKANKGGSGKFEMNDKKLDEEERSHNNNA--GEDEDEEKMIDNDINRSPNKSYKLG 71

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
            ++G G FG VY+  I  D  E      VA+K    D  Y+       E++ + +L+H N
Sbjct: 72  NIIGNGSFGVVYEA-ICIDTSE-----KVAIKKVLQDPQYKNR-----ELLIMKNLNHIN 120

Query: 138 LVKLIGYCCEDEHRV--------LIYEFMARGSVENNL--FSKVLLPLPWSIRMKIAFGA 187
           ++ L  Y   +  +         ++ EF+ + +V   +  +++    LP  +    ++  
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL 179

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDGPEGDK--SHVSTRIMG 244
            + LA++H   K + +RD K  N+L+D + +  KL DFG AK+   G +  S++ +R   
Sbjct: 180 CRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-- 235

Query: 245 TYGYAAPEYIM-TGHLTPRSDVYSFGVVLLE------ILTGRKSLDK--------SRPAR 289
              Y APE ++   + T   D++S G ++ E      I +G+ S+D+          P  
Sbjct: 236 ---YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292

Query: 290 EQ------NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNH-NP--- 339
           +Q      N AD   P +K K   L  + P+   D  +  + +   L Y  L   NP   
Sbjct: 293 DQLKEMNPNYADIKFPDVKPKD--LKKVFPKGTPDDAINFISQ--FLKYEPLKRLNPIEA 348

Query: 340 KARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKDSQC 388
            A P   D+ D    L    D+ P   NF          AEI+     C
Sbjct: 349 LADPFFDDLRDPCIKLPKYIDKLPDLFNFC--------DAEIKEMSDAC 389

Length = 440

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 9/104 (8%)

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
            GL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+        +V TR      Y
Sbjct: 128 CGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WY 180

Query: 249 AAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 291
            APE I+   H     D++S G ++ E+LTG K+L K +   +Q
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQ 223

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 36/236 (15%)

Query: 70  ITANFRQ-DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW----- 123
           I+  + Q    LG G +G V K   + D   G       VK+ +  N     R+      
Sbjct: 6   ISERYIQKGAHLGEGTYGKVEK---AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 124 -----LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW- 177
                L E+  +  + H N++ L+    E +   L+ + MA   ++  +  K+ L     
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQV 121

Query: 178 -SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------- 228
             I ++I      GL  LH+     ++RD   +NI +++    K++DFGLA+        
Sbjct: 122 KCILLQIL----NGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175

Query: 229 DGPEGDKSHVSTRIMG----TYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
           D    D++      M     T  Y APE +M       + D++S G +  E+LTG+
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 37/89 (41%), Positives = 49/89 (55%), Gaps = 6/89 (6%)

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-DGPEGDKSHVSTRIMGTYGYA 249
           L  LH+    VIYRD K  NILLD   +  L DFGL K +  + DK++      GT  Y 
Sbjct: 106 LENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYL 160

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           APE ++    T   D ++ GV+L E+LTG
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 49/226 (21%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR-EWLAEVIFLGHLSHPN 137
            +G G +G VYK       R+      VA+K    DN  +G     + E+  L  L+H N
Sbjct: 14  QIGEGTYGQVYKA------RDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67

Query: 138 LVKLIGYCCEDEHRV----------LIYEFMAR---GSVENNL----------FSKVLLP 174
           +V L     + +  +          L++E+M     G +E+ L          F K LL 
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL- 126

Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 234
                         +GL + H+  K  ++RD K SNILL+     KL+DFGLA+     +
Sbjct: 127 --------------EGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 235 KSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
               + +++ T  Y  PE ++      P  DV+S G +L E+ T +
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 68/277 (24%), Positives = 115/277 (41%), Gaps = 35/277 (12%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           +F   + +G G +G VYK   + ++  G       +K+  G++     +E    +I +  
Sbjct: 10  DFELIQRIGSGTYGDVYK---ARNVNTGELAAIKVIKLEPGEDFAVVQQE----IIMMKD 62

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
             H N+V   G     +   +  EF   GS+++     V  PL  S    ++    +GL 
Sbjct: 63  CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD--IYHVTGPLSESQIAYVSRETLQGLY 120

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
           +LH   K  ++RD K +NILL  + + KL+DFG++           S   +GT  + APE
Sbjct: 121 YLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPE 176

Query: 253 YIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL---ADWALPLLKEKKK 306
                  G      D+++ G+  +E+   +  +    P R   L   +++  P LK+K K
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236

Query: 307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
             N               H    +A   L  NPK RP
Sbjct: 237 WSN-------------SFHHFVKMA---LTKNPKKRP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 73/293 (24%), Positives = 123/293 (41%), Gaps = 60/293 (20%)

Query: 80  LGGGGFGCVYKGFI------SEDLREGLQPVPVAVKVHDGDNSYQGHRE----WLAEVIF 129
           LG G    +Y G +       +D     + + V +KV D       HR+    +      
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLD-----PSHRDISLAFFETASM 57

Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAA 188
           +  +SH ++V L G C  D   +++ EF+  G ++  +  K  +L  PW  + K+A   A
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLA 115

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILL-----DTDYNA--KLSDFGLAKDGPEGDKSHVSTR 241
             L++L +  K +++ +  T NILL     D +     KLSD G+           V +R
Sbjct: 116 SALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPIT--------VLSR 165

Query: 242 --IMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEI-LTGRKSL-DKSRPAREQNLADW 296
              +    + APE +  + +L+  +D +SFG  L EI   G   L DK+   +E+     
Sbjct: 166 QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ 225

Query: 297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
            + +    K+L                    A L  HC+N++P  RP  R I+
Sbjct: 226 CMLVTPSCKEL--------------------ADLMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 18/208 (8%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVA-VKVHDGDNSYQGHREWLAEVIFLGHLS---H 135
           +G G +G V+K   + DL+ G + V +  V+V  G+         + EV  L HL    H
Sbjct: 9   IGEGAYGKVFK---ARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLETFEH 63

Query: 136 PNLVKLIGYCC---EDEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRMKIAFGAAKGL 191
           PN+V+L   C     D    L   F            KV  P +P      + F   +GL
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
            FLH     V++RD K  NIL+ +    KL+DFGLA+           T ++ T  Y AP
Sbjct: 124 DFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAP 178

Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           E ++        D++S G +  E+   +
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 52.9 bits (127), Expect = 5e-08
 Identities = 45/180 (25%), Positives = 76/180 (42%), Gaps = 22/180 (12%)

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP----WSIRMKIAFGAAKGL 191
           PN+V L  Y   ++   L+ +    G + +++   + +P      W+  M +A  A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGDKSHVSTRIMGTYGYAA 250
             LH   + ++ RD   +NILLD   + +L+ F    +     D   V         Y A
Sbjct: 101 --LHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--LLKEKKKLL 308
           PE       T   D +S G +L E+LTG K+L +  P+         +P  + +E + LL
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSEEARSLL 209

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 15/99 (15%)

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----DGPEGD--KSHVSTRI 242
           + L ++H A   V +RD K  NIL + D   K+ DFGLA+    D P       +V+TR 
Sbjct: 114 RALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR- 170

Query: 243 MGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE   +     TP  D++S G +  E+LTG+
Sbjct: 171 ----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 53.4 bits (129), Expect = 6e-08
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 37/213 (17%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHL---SH 135
           +G G +G VYK     DL  G     VA+K      S +G     L E+  L  L    H
Sbjct: 7   IGEGAYGTVYKA---RDLNTGRF---VALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 136 PNLVKLIGYC--CEDEHRV---LIYEFMARGSVENNL---FSKVL---LPLPWSIRMKIA 184
           PN+V+L+  C     +  +   L++E      V+ +L    SK     LP P +I+  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLP-PETIK-DLM 113

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS-TRIM 243
               +G+ FLH     +++RD K  NIL+ +D   K++DFGLA+         ++ T ++
Sbjct: 114 RQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVV 167

Query: 244 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEI 275
            T  Y APE ++ + + TP  D++S G +  E+
Sbjct: 168 VTLWYRAPEVLLQSSYATP-VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 74/281 (26%), Positives = 123/281 (43%), Gaps = 34/281 (12%)

Query: 80  LGGGGFGCVYKGFISEDLREG--LQPVPVAVKVHDGDNSYQGHREWLAEVI-FLGHLSHP 136
           LG G F  ++KG I  ++ +   L    V +KV D   S++ + E   E    +  LSH 
Sbjct: 3   LGQGTFTKIFKG-IRREVGDYGELHKTEVLLKVLD--KSHRNYSESFFEAASMMSQLSHK 59

Query: 137 NLVKLIGYC-CEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAAKGLAFL 194
           +LV   G C C DE  +++ E++  GS++  L  +K L+ + W  ++++A   A  L FL
Sbjct: 60  HLVLNYGVCVCGDES-IMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFL 116

Query: 195 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT--YGYAAPE 252
              +K + + +    N+LL  + + K  +    K    G    V  + +      +  PE
Sbjct: 117 E--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174

Query: 253 YIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 311
            I    +L+  +D +SFG  L EI +G                D  L  L  +KKL    
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG---------------GDKPLSALDSQKKLQ-FY 218

Query: 312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 352
           + R +   P     + A L   C+++ P  RP  R I+  L
Sbjct: 219 EDRHQ--LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 36/129 (27%), Positives = 73/129 (56%), Gaps = 9/129 (6%)

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAK--DGPEGDKSHVSTRIMGT 245
           +GL ++H A   V++RD K +N+ ++T D   K+ DFGLA+  D     K ++S  ++  
Sbjct: 125 RGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 246 YGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE- 303
           + Y +P  +++  + T   D+++ G +  E+LTG+     +    +  L   ++P+++E 
Sbjct: 183 W-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241

Query: 304 -KKKLLNII 311
            + +LLN+I
Sbjct: 242 DRNELLNVI 250

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 39/107 (36%), Positives = 58/107 (54%), Gaps = 10/107 (9%)

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTY 246
           GL ++H A   V++RD K  N+L++ D   K+ DFGLA+   + P  +   + T  + T 
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATR 173

Query: 247 GYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 291
            Y APE IM      T   DV+S G +L E+L GRK + K +   +Q
Sbjct: 174 WYRAPE-IMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQ 218

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 79/273 (28%), Positives = 111/273 (40%), Gaps = 34/273 (12%)

Query: 67  LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE 126
           LR     F    V+G G +G VYKG      R        A+KV D     +   E   E
Sbjct: 11  LRDPAGIFELVEVVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTEDEE--EEIKLE 62

Query: 127 VIFLGHLSH-PNLVKLIGYCCE------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           +  L   SH  N+    G   +      D+   L+ EF   GSV + + +     L    
Sbjct: 63  INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSH 237
              I     +GLA LH  +  VI+RD K  N+LL  +   KL DFG++   D   G ++ 
Sbjct: 123 IAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN- 179

Query: 238 VSTRIMGTYGYAAPEYIMTGHLTP------RSDVYSFGVVLLEILTGRKSLDKSRPAREQ 291
                +GT  + APE I      P      RSD++S G+  +E+  G   L    P R  
Sbjct: 180 ---TFIGTPYWMAPEVIACDE-NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235

Query: 292 NLADW-ALPLLKEK---KKLLNIIDPRLEGDYP 320
            L      P LK K   KK ++ I+  L  +Y 
Sbjct: 236 FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYL 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 18/151 (11%)

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAFGAAKGL 191
           P +V+L     +D++  ++ E+M  G + N L S   +P  W    +  + +A  A   +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
             +H        RD K  N+LLD   + KL+DFG      E       T + GT  Y +P
Sbjct: 162 GLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISP 212

Query: 252 EYIMT----GHLTPRSDVYSFGVVLLEILTG 278
           E + +    G+     D +S GV L E+L G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 69/228 (30%), Positives = 99/228 (43%), Gaps = 35/228 (15%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNL 138
           +G G +G V+K    ++  +    V +   +HD D   +      AE   L  LS HPN+
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKA--AVKILDPIHDIDEEIE------AEYNILKALSDHPNV 77

Query: 139 VKLIG-YCCED----EHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKIAFGAAKGL 191
           VK  G Y  +D    +   L+ E    GSV + +  F K    +   I   I   A  GL
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI-----MGTY 246
             LH  +   I+RD K +NILL T+   KL DFG++           STR+     +GT 
Sbjct: 138 QHLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGVS-------AQLTSTRLRRNTSVGTP 188

Query: 247 GYAAPEYI-----MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
            + APE I     +      R DV+S G+  +E+  G   L    P R
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           +GL ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   +    +V+TR      Y
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181

Query: 249 AAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
            APE ++   H     D++S G ++ E+L G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG G +  V+KG      R  L    VA+K    ++        + EV  L  L H N+V
Sbjct: 14  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 140 KLIGYCCEDEHRVLIYEFMAR---------GSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
            L      D+   L++E++ +         G++ +    K+ L           +   +G
Sbjct: 68  TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL-----------YQILRG 116

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           LA+ H   + V++RD K  N+L++     KL+DFGLA+      K++ +  +  T  Y  
Sbjct: 117 LAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRP 172

Query: 251 PEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           P+ ++ +   + + D++  G +  E+ +GR
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 4/95 (4%)

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST-RI 242
           ++  A G+ FL  A K  ++RD    N+L+      K+ DFGLA+D    D +++S    
Sbjct: 245 SYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYISKGST 301

Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                + APE I     T  SDV+SFG++L EI T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG G +  V+KG      R  L    VA+K    ++        + EV  L +L H N+V
Sbjct: 13  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 140 KLIGYCCEDEHRVLIYEFM---ARGSVEN--NLFS----KVLLPLPWSIRMKIAFGAAKG 190
            L      +    L++E++    +  ++N  NL S    K+ +           F   +G
Sbjct: 67  TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM-----------FQLLRG 115

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L++ H+  + +++RD K  N+L++     KL+DFGLA+      K++ +  +  T  Y  
Sbjct: 116 LSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRP 171

Query: 251 PEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 293
           P+ ++  T + TP  D++  G +L E+ TGR     S    E +L
Sbjct: 172 PDVLLGSTEYSTP-IDMWGVGCILYEMATGRPMFPGSTVKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 42/162 (25%), Positives = 66/162 (40%), Gaps = 11/162 (6%)

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            E+I    L HPN++  +     D    ++   MA GS E+ L +     LP      I 
Sbjct: 48  QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFIL 107

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF----GLAKDGPEGDKSHVST 240
                 L ++H   K  I+R  K S+ILL  D    LS       + K G      H   
Sbjct: 108 KDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165

Query: 241 R-IMGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTG 278
           +  +    + +PE +   + G+   +SD+YS G+   E+  G
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 18/186 (9%)

Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           V V++ D +N  + H + L   + L H   HPN++             +I  FMA GS  
Sbjct: 28  VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87

Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD- 223
           + L +     +  ++   I FGA +GL +LH+     I+R+ K S+IL+  D    LS  
Sbjct: 88  SLLKTYFPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGL 145

Query: 224 ---FGLAKDGPEG----DKSHVSTRIMGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLL 273
              + L ++G +     D    ST ++    + +PE +   + G+   +SD+YS G+   
Sbjct: 146 SHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKSDIYSVGITAC 201

Query: 274 EILTGR 279
           E+ TGR
Sbjct: 202 ELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 16/102 (15%)

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDK----SHVSTR 241
           +GL ++H A   VI+RD K SN+L++ D   ++ DFG+A+     P   K     +V+TR
Sbjct: 118 RGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 242 IMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSL 282
                 Y APE +++    T   D++S G +  E+L GR+ L
Sbjct: 176 -----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           A  L +LH     ++YRD K  NILLD+  +  L+DFGL K+  E + +  ++   GT  
Sbjct: 106 ASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPE 161

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 25/236 (10%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           +G G +G VYK   + +L  G       +K+  GD+     +E    +  +    H N+V
Sbjct: 17  VGSGTYGDVYK---ARNLHTGELAAVKIIKLEPGDDFSLIQQE----IFMVKECKHCNIV 69

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF---GAAKGLAFLHE 196
              G     E   +  E+   GS+++     V  PL     ++IA+      +GLA+LH 
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLS---ELQIAYVCRETLQGLAYLHS 124

Query: 197 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM- 255
             K  ++RD K +NILL  + + KL+DFG+A           S   +GT  + APE    
Sbjct: 125 KGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAV 180

Query: 256 --TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL---ADWALPLLKEKKK 306
              G      D+++ G+  +E+   +  +    P R   L   +++  P LK+K K
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 45/199 (22%), Positives = 86/199 (43%), Gaps = 31/199 (15%)

Query: 98  REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-------- 149
           + G QP PV +K+     +       L E + L +++HP+++++                
Sbjct: 87  KPG-QPDPVVLKIGQKGTT-------LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138

Query: 150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS 209
           +   +Y ++ + S           PLP    + I     +GL +LH     +I+RD KT 
Sbjct: 139 YSSDLYTYLTKRSR----------PLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTE 186

Query: 210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 269
           NI ++      + D G A+  P    + +   + GT    APE +       ++D++S G
Sbjct: 187 NIFINDVDQVCIGDLGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAG 243

Query: 270 VVLLEILTGRKSLDKSRPA 288
           +VL E+L    ++ +  P+
Sbjct: 244 IVLFEMLAYPSTIFEDPPS 262

Length = 357

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 34/215 (15%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLSHPNL 138
           +G G +G V+K   + +  E      VA+K    D+  +G     L E+  L  L H N+
Sbjct: 8   IGEGTYGTVFKA-KNRETHE-----IVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61

Query: 139 VKLIGYCCEDEHRVLIYEFM----------ARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
           V+L      D+   L++E+             G ++  +    +  L             
Sbjct: 62  VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------------L 109

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           KGLAF H     V++RD K  N+L++ +   KL+DFGLA+    G      +  + T  Y
Sbjct: 110 KGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWY 165

Query: 249 AAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSL 282
             P+ +    L   S D++S G +  E+    + L
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 36/228 (15%)

Query: 66  ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-------VHDGDNSYQ 118
           +LR+   +F   +V+G G FG V      + +R        A+K       +   D+++ 
Sbjct: 37  KLRMKAEDFDVIKVIGRGAFGEV------QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF- 89

Query: 119 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS 178
               +  E   + H +   +V+L     +D++  ++ E+M  G + N L S   +P  W+
Sbjct: 90  ----FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWA 144

Query: 179 I----RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 234
                 + +A  A   + F+H        RD K  N+LLD   + KL+DFG         
Sbjct: 145 RFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196

Query: 235 KSHVSTRIMGTYGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTG 278
                T + GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 5e-07
 Identities = 64/244 (26%), Positives = 94/244 (38%), Gaps = 55/244 (22%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD-----GDNSYQGHREWLAEVI 128
           F++ ++LG G  G V+   +      G      A+KV D       N  +       E+ 
Sbjct: 3   FKKIKLLGKGDVGRVF---LVRLKGTGK---LFALKVLDKKEMIKRNKVK-RVLTEQEI- 54

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS-IRMKIA-FG 186
            L  L HP L  L      + +  L+ ++   G     LF  +L   P   +  ++A F 
Sbjct: 55  -LATLDHPFLPTLYASFQTETYLCLVMDYCPGG----ELFR-LLQRQPGKCLSEEVARFY 108

Query: 187 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--------------D 229
           AA+    L +LH     ++YRD K  NILL    +  LSDF L+K               
Sbjct: 109 AAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166

Query: 230 GPEGDKSH----------VSTRIM---GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEI 275
           G      +           S R     GT  Y APE I   GH     D ++ G++L E+
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEM 225

Query: 276 LTGR 279
           L G 
Sbjct: 226 LYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 28/222 (12%)

Query: 137 NLVKLIGY---CCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
           N++K+ G+     +D  R+ LI E+  RG +   L  +    L +  ++ +A    KGL 
Sbjct: 79  NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLY 136

Query: 193 FLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
            L++   KP  Y++  + + L+  +Y  K+   GL K        +V+   M  + Y   
Sbjct: 137 NLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF--MVYFSYKML 192

Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 311
             I + + T + D+YS GVVL EI TG+   +        +L      ++ +   L    
Sbjct: 193 NDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL------IINKNNSL---- 241

Query: 312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
             +L  D P     +   +   C +H+   RP +++I+ +L 
Sbjct: 242 --KLPLDCP----LEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 21/168 (12%)

Query: 124 LAEVIFLGHLSHPNLVKLIGYC-----CEDEHR---VLIYEFMAR--GSVENNLFSKVLL 173
           L E+  L  L H N+V LI  C       + ++    L++EF       + +N   K  L
Sbjct: 59  LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL 118

Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGP 231
                + MK+      GL ++H  +  +++RD K +NIL+  D   KL+DFGLA+     
Sbjct: 119 SEIKKV-MKMLL---NGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLS 172

Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILT 277
           +  K +  T  + T  Y  PE ++ G     P  D++  G ++ E+ T
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPE-LLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 18/205 (8%)

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           V+G G +G V K       R       VA+K   D + + +     L E+  L  L   N
Sbjct: 8   VVGEGAYGVVLK------CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP---LPWSIRMKIAFGAAKGLAFL 194
           +V+L           L++E++ +  +E  L  +  +P    P  +R  I +   K + + 
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLE--LLEE--MPNGVPPEKVRSYI-YQLIKAIHWC 116

Query: 195 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYI 254
           H+ +  +++RD K  N+L+  +   KL DFG A++  EG  ++  T  + T  Y +PE +
Sbjct: 117 HKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELL 173

Query: 255 MTGHLTPRSDVYSFGVVLLEILTGR 279
           +        D++S G +L E+  G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 31/210 (14%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG G +  VYKG      R  L    VA+K    ++        + EV  L  L H N+V
Sbjct: 14  LGEGTYATVYKG------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 140 KLIGYCCEDEHRVLIYEFMAR---------GSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
            L      ++   L++E++ +         G+  N    K+ L           F   +G
Sbjct: 68  TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFL-----------FQLLRG 116

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L + H   + V++RD K  N+L++     KL+DFGLA+      K++ +  +  T  Y  
Sbjct: 117 LNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRP 172

Query: 251 PEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           P+ ++ +   + + D++  G +  E+ TGR
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 5/159 (3%)

Query: 126 EVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
           E   L  L HPN+V     +  ED    ++  F   G + + L  +    LP +  ++  
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
              A  L +LHE  K +++RD KT N+ L      K+ D G+A+     ++  +++ ++G
Sbjct: 109 VQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLIG 164

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
           T  Y +PE         +SDV++ G  + E+ T + + +
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 7/156 (4%)

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+  L  + H N+V+L      ++   L++E++     ++   S      P  I+  + +
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL-Y 109

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMG 244
              +G+A+ H     V++RD K  N+L+D   NA KL+DFGLA+    G      T  + 
Sbjct: 110 QILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVV 165

Query: 245 TYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           T  Y APE ++ + H +   D++S G +  E++  +
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 32/96 (33%), Positives = 44/96 (45%), Gaps = 6/96 (6%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           I+RD K  N L+D   + KL+DFGL+K       S     ++G+  Y APE +       
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRGKGYDF 177

Query: 262 RSDVYSFGVVLLEILTGRKSLDKSRPARE-QNLADW 296
             D +S G +L E L G      S P    +NL  W
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 74/257 (28%), Positives = 105/257 (40%), Gaps = 35/257 (13%)

Query: 67  LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD--GDNSYQGHREWL 124
           LR     F    ++G G +G VYKG      R        A+KV D  GD       E  
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTGDE----EEEIK 50

Query: 125 AEVIFLGHLSH-PNLVKLIGYCCE------DEHRVLIYEFMARGSVENNLFSKVLLPLPW 177
            E+  L   SH  N+    G   +      D+   L+ EF   GSV + + +     L  
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDK 235
                I     +GL+ LH+ +  VI+RD K  N+LL  +   KL DFG++   D   G +
Sbjct: 111 EWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 168

Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTP------RSDVYSFGVVLLEILTGRKSLDKSRPAR 289
           +      +GT  + APE I      P      +SD++S G+  +E+  G   L    P R
Sbjct: 169 N----TFIGTPYWMAPEVIACDE-NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223

Query: 290 EQNLADW-ALPLLKEKK 305
              L      P LK KK
Sbjct: 224 ALFLIPRNPAPRLKSKK 240

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 17/222 (7%)

Query: 80  LGGGGFGCVYKGF--ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           LG G +  VYKG   I+  L        VA+KV             + E   L  L H N
Sbjct: 13  LGEGSYATVYKGISRINGQL--------VALKVISMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 197
           +V L       E    ++E+M     +  +     L  P+++R+   F   +GLA++H  
Sbjct: 65  IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH-PYNVRL-FMFQLLRGLAYIHG- 121

Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-T 256
            + +++RD K  N+L+      KL+DFGLA+      +++ S  +  T  Y  P+ ++  
Sbjct: 122 -QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGA 178

Query: 257 GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 298
              +   D++  G + +E+L G+ +        EQ    W +
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 41/153 (26%), Positives = 70/153 (45%)

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
           +E+  L    H  +VK       D+  +LI E+ + G +   +  ++   LP+       
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
                 LA      + +++RD K++NI L      KL DFG +K   +     V++   G
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           T  Y APE       + ++D++S GV+L E+LT
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 23/152 (15%)

Query: 144 YCCED--EHRVLIYEFMARGSVENNLFSKVLLPLPWSI-RMKIAFGAAKGLAFLHEAEKP 200
           +C  +   H  ++ E++  G     L  K +  LP  + RM  A      L +LH     
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFA-ETVLALEYLHNYG-- 121

Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDG--------PEGD-----KSHVSTRIMGTYG 247
           +++RD K  N+L+ +  + KL+DFGL+K G         EG      +  +  ++ GT  
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 248 YAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 278
           Y APE I+  G+  P  D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKP-VDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.2 bits (114), Expect = 3e-06
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 22/178 (12%)

Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMELDHER 120

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 121 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE------ILTGRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E      +  GR  +D+     EQ
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 18/151 (11%)

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAFGAAKGL 191
           P +V+L     +D +  ++ E+M  G + N L S   +P  W    +  + +A  A   +
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
            F+H        RD K  N+LLD   + KL+DFG      +       T + GT  Y +P
Sbjct: 162 GFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 212

Query: 252 EYIMT----GHLTPRSDVYSFGVVLLEILTG 278
           E + +    G+     D +S GV L E+L G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+    G    ++  ++  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE I+        D++S G ++ E++ G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 9/92 (9%)

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRIMGTYG 247
           G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+          +V TR    Y 
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR----Y- 182

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           Y APE I+        D++S G ++ E++ G 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 6/157 (3%)

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E   L  ++HP++++L G    ++   LI   + R   +   +      +     + I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
              + + +LHE    +I+RD K  NI ++   +  L DFG A   P    ++      GT
Sbjct: 190 SVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGT 246

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 282
               APE +      P  D++S G+VL E+ T   SL
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 31/209 (14%)

Query: 80  LGGGGFGCVY-----KGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS 134
           LG G FG VY     K    E L+  L+ +PV      G+ +     +   E   L  L 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPV------GELNPNETVQANQEAQLLSKLD 60

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL----FSKVLLPLP----WSIRMKIAFG 186
           HP +VK      E +   +I E+     ++  L     +   L       W I++ +   
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL--- 117

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
              G+ ++H+  + +++RD K  NI L  +   K+ DFG+++         ++T   GT 
Sbjct: 118 ---GVHYMHQ--RRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLATTFTGTP 169

Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
            Y +PE +       +SD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 61/262 (23%), Positives = 95/262 (36%), Gaps = 78/262 (29%)

Query: 78  RVLGGGGFGCVYKGF------------ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           R++G GG G VY  +            I EDL                +N     + +L 
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDL---------------SENPLL-KKRFLR 51

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA----------------RGSVENNLFS 169
           E      L HP +V +   C + +    +Y  M                 + S+   L  
Sbjct: 52  EAKIAADLIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE 108

Query: 170 KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-- 227
           K  +    SI  KI       + ++H   K V++RD K  NILL       + D+G A  
Sbjct: 109 KTSVGAFLSIFHKIC----ATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162

Query: 228 KDGPEGDKSHVST--------------RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 273
           K   E D   +                +I+GT  Y APE ++    +  +D+Y+ GV+L 
Sbjct: 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILY 222

Query: 274 EILT---------GRKSLDKSR 286
           ++LT         GRK   +  
Sbjct: 223 QMLTLSFPYRRKKGRKISYRDV 244

Length = 932

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 9e-06
 Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 21/158 (13%)

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR-------MKIAF 185
           L HPN+++ +G C E    +L++E+   G +++ L  +      W  R        ++A 
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMAC 106

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A G+  +H+     ++ D    N  L +D   K+ D+G+     + D           
Sbjct: 107 EIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164

Query: 246 YGYAAPEYI-------MTGHLTPRSDVYSFGVVLLEIL 276
             + APE +       +T   T  S+V++ GV L E+ 
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 6/107 (5%)

Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPE 232
           PLP        +   KG+A  H+    V++RD K  N+L+D      K++D GL +    
Sbjct: 106 PLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163

Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 278
             KS+  T  + T  Y APE ++   H +   D++S G +  E+   
Sbjct: 164 PVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 39/227 (17%)

Query: 79  VLGGGGFGCVYKGF--ISEDLREGLQPVPVAVKV----HDGDNSYQGHREWLAEVIFLGH 132
            LG G +  VYKG   ++  L        VA+K     H+    +   RE       L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQL--------VALKEIRLEHEEGAPFTAIRE----ASLLKD 59

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK----IAFGAA 188
           L H N+V L       +   L++E++           + +      + M       F   
Sbjct: 60  LKHANIVTLHDIIHTKKTLTLVFEYLDTD------LKQYMDDCGGGLSMHNVRLFLFQLL 113

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL--AKDGPEGDKSHVSTRIMGTY 246
           +GLA+ H+  + V++RD K  N+L+      KL+DFGL  AK  P    S+       T 
Sbjct: 114 RGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----TL 167

Query: 247 GYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 291
            Y  P+ ++  T + T   D++  G +  E+ TGR     S    +Q
Sbjct: 168 WYRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 21/162 (12%)

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL--------LPLPW 177
           E++ LG L+H N++K+     E+  R     +M     + +L+S +          PL  
Sbjct: 213 EILALGRLNHENILKI-----EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267

Query: 178 SIR--MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
             R  MK    A   + ++H+  K +I+RD K  NI L+ D    L DFG A    E ++
Sbjct: 268 QTRAIMKQLLCA---VEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKER 321

Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  +GT    +PE +        +D++S G++LL++L+
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 33/117 (28%), Positives = 43/117 (36%), Gaps = 44/117 (37%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG-DKSHVST-------------------- 240
           I+RD K  N+LLD   + KLSDFGL      G  KSH +                     
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHRTEFYRILSHALPSNFLDFISKP 178

Query: 241 --------------RIM-----GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
                         R +     GT  Y APE  +        D +S GV++ E+L G
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 39/234 (16%)

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF-SKVLLPLPWSIRMKIAFGA 187
            +  +SH +L  + G C      +++ EF+  G ++  L   K  +P+ W  ++ +A   
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILL-------DTDYNAKLSDFGLAKDGPEGDKSHVST 240
           A  L++L +  K +++ +    NILL        T    KLSD G++       +     
Sbjct: 127 ASALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS--REERVE 182

Query: 241 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEI-LTGRKSLDKSRPAREQNLADWAL 298
           RI     + APE +  G  L+  +D +SFG  LLEI   G   L +  P+ ++       
Sbjct: 183 RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY---- 234

Query: 299 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 352
               EKK  L           P     + A L   CL + P  RP  R I+  L
Sbjct: 235 ----EKKHRL-----------PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 31/97 (31%), Positives = 44/97 (45%), Gaps = 6/97 (6%)

Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
           +I+RD KT N+L++   +  L DFG A        +     I GT    APE +     T
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340

Query: 261 PRSDVYSFGVVLLEILTGRKSL------DKSRPAREQ 291
           P  D++S G+V+ E      SL      D+ RP   Q
Sbjct: 341 PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ 377

Length = 461

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 39/132 (29%), Positives = 53/132 (40%), Gaps = 43/132 (32%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFGL---------AKDGPEGDKSHVS------------- 239
           I+RD K  NIL+D D + KL+DFGL         +K   +GD                  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 240 --------------TRIM-----GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
                          R +     GT  Y APE ++ TG+ T   D +S GV+L E+L G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQ 241

Query: 280 KSLDKSRPAREQ 291
                  PA  Q
Sbjct: 242 PPFLADTPAETQ 253

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 14/86 (16%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT- 256
           ++RD K  N+LLD + + +L+DFG    + +DG     +  S+  +GT  Y +PE +   
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPEILQAM 178

Query: 257 ----GHLTPRSDVYSFGVVLLEILTG 278
               G   P  D +S GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.4 bits (105), Expect = 6e-05
 Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 14/86 (16%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-- 255
           ++RD K  N+LLD + + +L+DFG    L  DG     +  S   +GT  Y +PE +   
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-----TVQSNVAVGTPDYISPEILQAM 178

Query: 256 ---TGHLTPRSDVYSFGVVLLEILTG 278
               G   P  D +S GV + E+L G
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 50/214 (23%), Positives = 97/214 (45%), Gaps = 15/214 (7%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV 139
           LG G +  VYKG      +  +    VA+KV             + E   L  L H N+V
Sbjct: 13  LGEGSYATVYKG------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-PWSIRMKIAFGAAKGLAFLHEAE 198
            L       E   L++E++     +     K    L P ++++ + F   +GL+++H+  
Sbjct: 67  LLHDIIHTKETLTLVFEYVHTDLCQ--YMDKHPGGLHPENVKLFL-FQLLRGLSYIHQ-- 121

Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TG 257
           + +++RD K  N+L+      KL+DFGLA+   +   SH  +  + T  Y  P+ ++ + 
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGST 179

Query: 258 HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 291
             +   D++  G + +E++ G  +    +  ++Q
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.9 bits (103), Expect = 8e-05
 Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 14/86 (16%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT- 256
           ++RD K  NIL+D + + +L+DFG    L +DG     +  S+  +GT  Y +PE +   
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPDYISPEILQAM 178

Query: 257 ----GHLTPRSDVYSFGVVLLEILTG 278
               G   P  D +S GV + E+L G
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 7/84 (8%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT----- 256
           ++RD K  N+L+D   + KL+DFG A      +K   S   +GT  Y APE + T     
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 257 -GHLTPRSDVYSFGVVLLEILTGR 279
            G      D +S GV+  E++ GR
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 38/135 (28%), Positives = 53/135 (39%), Gaps = 45/135 (33%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFGLA-------------------KDGPE---------- 232
           I+RD K  NIL+D D + KL+DFGL                    +D  E          
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 233 ---GD----------KSH---VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 276
              GD          K H   ++  ++GT  Y APE ++    T   D +S GV+L E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 277 TGRKSLDKSRPAREQ 291
            G+       P   Q
Sbjct: 243 VGQPPFLAPTPTETQ 257

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 65/262 (24%), Positives = 109/262 (41%), Gaps = 55/262 (20%)

Query: 116 SYQGHRE-----WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLF 168
           SY+G +E      + EV  +  L H N+V+ I       ++ L  + EF   G +  N+ 
Sbjct: 47  SYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ 106

Query: 169 S--KVLLPLPWSIRMKIAFGAAKGLAFLHEAE-----KPVIYRDFKTSNILLDTDYN--- 218
              K+   +     + I       LA+ H  +     + V++RD K  NI L T      
Sbjct: 107 KCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166

Query: 219 --------------AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPR 262
                         AK+ DFGL+K+      +H     +GT  Y +PE ++  T     +
Sbjct: 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDK 223

Query: 263 SDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVK 322
           SD+++ G ++ E+ +G+    K+      N +     L+ E K+      P    D P+K
Sbjct: 224 SDMWALGCIIYELCSGKTPFHKA-----NNFSQ----LISELKR-----GP----DLPIK 265

Query: 323 GVHKAA-MLAYHCLNHNPKARP 343
           G  K   +L  + LN + K RP
Sbjct: 266 GKSKELNILIKNLLNLSAKERP 287

Length = 1021

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 35/135 (25%), Positives = 48/135 (35%), Gaps = 45/135 (33%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFGL--------------AKDGPEGDKSHVSTR------ 241
           I+RD K  NIL+D D + KL+DFGL              + D    D    S        
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 242 -------------------------IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 276
                                    ++GT  Y APE ++    T   D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 277 TGRKSLDKSRPAREQ 291
            G+       P   Q
Sbjct: 243 VGQPPFLAQTPLETQ 257

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 35/218 (16%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNL 138
           +G G +G VYK       ++G      A+K  +G   S    RE    +  L  L HPN+
Sbjct: 9   VGRGTYGHVYKA----KRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNV 60

Query: 139 VKL--IGYCCEDEHRVLIYEF----------MARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           + L  +     D    L++++            R S  N    K  + LP S+   + + 
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPMQLPRSMVKSLLYQ 116

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAKLSDFGLAK--DGPEGDKSHVST 240
              G+ +LH     V++RD K +NIL+  +       K++D G A+  + P    + +  
Sbjct: 117 ILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 241 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILT 277
            ++ T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 175 VVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 53/233 (22%), Positives = 82/233 (35%), Gaps = 53/233 (22%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFGL------------------------------AKDGP 231
           I+RD K  N+LLD+  + KLSDFGL                              +K   
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 232 EG---DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA 288
           E    ++  ++   +GT  Y APE  M        D +S GV++ E+L G        P 
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 289 RE-QNLADWALPL-------LKEKKKLLNIIDPRLEGDYPV--KGVHKAAMLA------Y 332
              + + +W   L       + EK K L I+    E ++ +   GV +           +
Sbjct: 243 ETYKKVMNWKETLIFPPEVPISEKAKDL-ILRFCCEWEHRIGAPGVEEIKTNPFFEGVDW 301

Query: 333 HCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQTKD 385
             +   P A P+    +D        PD         T   PE    + + KD
Sbjct: 302 EHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPE---TDYKNKD 351

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 31/110 (28%), Positives = 42/110 (38%), Gaps = 33/110 (30%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFGLA---------------KDGPEGD------------ 234
           I+RD K  N+LLD   + KLSDFGL                   P  D            
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 235 ------KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
                 +  ++   +GT  Y APE  M        D +S GV++ E+L G
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 35/218 (16%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNL 138
           +G G +G VYK       ++G      A+K  +G   S    RE    +  L  L HPN+
Sbjct: 9   VGRGTYGHVYKA----KRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNV 60

Query: 139 VKL--IGYCCEDEHRVLIYEF----------MARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           + L  +     D    L++++            R S  N    K  + LP  +   + + 
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQ 116

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTD----YNAKLSDFGLAK--DGPEGDKSHVST 240
              G+ +LH     V++RD K +NIL+  +       K++D G A+  + P    + +  
Sbjct: 117 ILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 241 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILT 277
            ++ T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 175 VVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 32/123 (26%), Positives = 42/123 (34%), Gaps = 47/123 (38%)

Query: 202 IYRDFKTSNILLDTDYNAKLSDFGL---------------------AKDGPEGDKSHV-- 238
           I+RD K  NIL+D   + KLSDFGL                      K+  +   S    
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 239 -----------------STRIM-----GTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEI 275
                            + R+M     GT  Y APE I          D +S G ++ E 
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGAIMFEC 241

Query: 276 LTG 278
           L G
Sbjct: 242 LIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 38.7 bits (91), Expect = 0.003
 Identities = 34/103 (33%), Positives = 46/103 (44%), Gaps = 19/103 (18%)

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK-----LSDFGLAKDGPEGDKS 236
           KI     + L  LH+    +I+ D K  N+L    Y+       L D+GL K    G  S
Sbjct: 113 KIIRQLVEALNDLHKHN--IIHNDIKLENVL----YDRAKDRIYLCDYGLCK--IIGTPS 164

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTG 278
                  GT  Y +PE I  GH    S D ++ GV+  E+LTG
Sbjct: 165 CYD----GTLDYFSPEKI-KGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	389
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.83
smart00090	237	RIO RIO-like kinase.	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.42
KOG1243	690	consensus Protein kinase [General function predict	99.39
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.3
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.29
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
COG4248	637	Uncharacterized protein with protein kinase and he	99.21
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.13
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.07
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.94
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.92
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.91
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.8
PRK09902	216	hypothetical protein; Provisional	98.72
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.57
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.56
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.5
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.42
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.39
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.35
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.31
PF01636	239	APH: Phosphotransferase enzyme family This family	98.31
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.26
PLN02876	822	acyl-CoA dehydrogenase	98.24
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.16
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.06
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.03
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.88
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.81
PRK10593	297	hypothetical protein; Provisional	97.77
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.72
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.7
PRK05231	319	homoserine kinase; Provisional	97.65
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.64
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.63
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.59
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.4
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.17
KOG2270	520	consensus Serine/threonine protein kinase involved	97.04
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.03
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.01
PLN02236	344	choline kinase	96.92
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	96.7
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.66
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.64
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.63
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.6
PRK12396	409	5-methylribose kinase; Reviewed	96.46
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.36
PLN02756	418	S-methyl-5-thioribose kinase	96.34
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.24
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.2
PTZ00384	383	choline kinase; Provisional	96.16
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.1
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.87
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.86
PRK06148	1013	hypothetical protein; Provisional	95.51
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.49
PRK11768	325	serine/threonine protein kinase; Provisional	94.54

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-54  Score=384.81  Aligned_cols=256  Identities=26%  Similarity=0.375  Sum_probs=217.0

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++++..+.||+|..|+||+++++.+.+-      +|+|.+.........+++.+|+++++..+||+||++||.|...+
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i------~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKI------YALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeE------EEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            345677789999999999999988776554      99999977777788899999999999999999999999999999


Q ss_pred             -eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          150 -HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       150 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                       .++|+||||++|+|.+.+...  +++++.....++.++++||.|||. ++  ||||||||.|||++..|.|||||||.+
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEecccccc
Confidence             599999999999999988665  479999999999999999999996 55  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ..+...    ...+..||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+.....+.           -+
T Consensus       227 ~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~-----------Ll  291 (364)
T KOG0581|consen  227 GILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE-----------LL  291 (364)
T ss_pred             HHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH-----------HH
Confidence            876543    456689999999999999999999999999999999999999999875221111110           01


Q ss_pred             hhhcCCCCCCCCCh-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          308 LNIIDPRLEGDYPV-KGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       308 ~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..+++ ......|. .++.++++|+..||++||.+|||+.++++|
T Consensus       292 ~~Iv~-~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  292 CAIVD-EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             HHHhc-CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            11222 11223344 388999999999999999999999999988

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-52  Score=394.24  Aligned_cols=250  Identities=27%  Similarity=0.415  Sum_probs=213.6

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .+|..+++||+|+|+.||+++...+...      ||+|++.+..  .......+.+|+++.+.|+|||||+++++|.+.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~------~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEV------VAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcE------EEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence            4699999999999999999987555444      9999987643  3344567789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ++|||.|+|..|+|..++.++  ..+++.+++.++.||+.||.|||+++  |+|||||..|+|++++.+|||+|||+|..
T Consensus        92 nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeee
Confidence            999999999999999988744  48999999999999999999999988  99999999999999999999999999998


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      +.....  ...+.||||.|.|||++....++..+||||+||+||.||.|++||....-              .+....+.
T Consensus       168 le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------------kety~~Ik  231 (592)
T KOG0575|consen  168 LEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------------KETYNKIK  231 (592)
T ss_pred             ecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH--------------HHHHHHHH
Confidence            764322  35568999999999999999999999999999999999999999986421              11111111


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .-    .-.+|...+.++.+||.++|+.||.+|||+.+||.|
T Consensus       232 ~~----~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  232 LN----EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             hc----CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            11    123455678999999999999999999999999987

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-53  Score=381.35  Aligned_cols=257  Identities=25%  Similarity=0.360  Sum_probs=210.4

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh------hHHHHHHHHHHHhccCCCccceEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ------GHREWLAEVIFLGHLSHPNLVKLI  142 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~  142 (389)
                      .+.+.|.+.+.||+|+||.|-+|+.+.+.+.      ||||++.+.....      ......+|+++|++|+|||||+++
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~------vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~  242 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQ------VAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIK  242 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcE------EEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEe
Confidence            3566799999999999999999987666554      9999988764222      223456899999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC---CcE
Q 016481          143 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNA  219 (389)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~---~~v  219 (389)
                      ++|......|+||||++||+|.+.+..+.  .+.+..-..+++|++.|+.|||+.|  |+||||||+|||+..+   ..+
T Consensus       243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~ll  318 (475)
T KOG0615|consen  243 DFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLL  318 (475)
T ss_pred             eeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEE
Confidence            99999999999999999999999997765  5566677889999999999999988  9999999999999766   789


Q ss_pred             EEeccCCCcCCCCCCCccccccccccccccCccccccCCC---CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL---TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      ||+|||+|+....   .....+.||||.|.|||++.+.++   ..++|+|||||++|-+|+|.+||+.....+  .+   
T Consensus       319 KItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl---  390 (475)
T KOG0615|consen  319 KITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL---  390 (475)
T ss_pred             Eecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH---
Confidence            9999999998653   335677999999999999987654   347899999999999999999998654321  00   


Q ss_pred             HhHHHHhhhhhhhhcCCCC--CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          297 ALPLLKEKKKLLNIIDPRL--EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                                ..++...+.  ........+.++.+||.+||..||++|||+.++|+|=|
T Consensus       391 ----------~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW  439 (475)
T KOG0615|consen  391 ----------KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW  439 (475)
T ss_pred             ----------HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence                      011111111  12234577899999999999999999999999998743

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-51  Score=368.33  Aligned_cols=253  Identities=29%  Similarity=0.452  Sum_probs=210.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..+|...+.||.|+||+||+|+++.+...      ||||.+.... .....+.+..|+.+|+.++|||||++++++..++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~------VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTE------VAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCce------EEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            36899999999999999999988776544      9999988765 4555667789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC------CcEEEec
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD------YNAKLSD  223 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~------~~vkl~D  223 (389)
                      .+|+|||||+||+|.+++..+.  .+++..+..++.|++.||++||+++  ||||||||.|||++..      -.+||+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecc
Confidence            9999999999999999998876  7899999999999999999999977  9999999999999765      4689999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      ||+|+.+..+.   ...+.||++.|||||+++...|+.|+|+||+|+|+|+|++|++||......+....       +..
T Consensus       159 FGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~-------~~k  228 (429)
T KOG0595|consen  159 FGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY-------IKK  228 (429)
T ss_pred             cchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-------Hhc
Confidence            99999987543   45568999999999999999999999999999999999999999997655432211       111


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..        ......+...+..+.+++...|+.+|.+|.++.+...+
T Consensus       229 ~~--------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  229 GN--------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             cc--------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence            11        11222333445556678888888888888877776544

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-51  Score=381.74  Aligned_cols=290  Identities=57%  Similarity=0.959  Sum_probs=250.5

Q ss_pred             CCcccCHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc
Q 016481           58 PLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN  137 (389)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n  137 (389)
                      +...|++.++...+++|.....||+|+||.||+|...+.       ..||||.+....... ..+|.+|+.++.+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-------~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~N  132 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-------TVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPN  132 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-------CEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcC
Confidence            566789999999999999999999999999999987654       239999877654433 566999999999999999


Q ss_pred             cceEEeEEEeCC-eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceecCCCCCCeEEcC
Q 016481          138 LVKLIGYCCEDE-HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDT  215 (389)
Q Consensus       138 iv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~ivH~Dlkp~Nili~~  215 (389)
                      +|+++|||.+.+ +.+||+|||.+|+|.++++.....+++|..+++|+.++|.||+|||... ++|||||||+.|||+|+
T Consensus       133 lv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~  212 (361)
T KOG1187|consen  133 LVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE  212 (361)
T ss_pred             cccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence            999999999998 5999999999999999998765548899999999999999999999854 47999999999999999


Q ss_pred             CCcEEEeccCCCcCCCCCCCccccccc-cccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH
Q 016481          216 DYNAKLSDFGLAKDGPEGDKSHVSTRI-MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  294 (389)
Q Consensus       216 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  294 (389)
                      +++.||+|||+|+..+.. ... .... .||..|+|||.+..+..+.++|||||||+++||++|+.+.+...+.....+.
T Consensus       213 ~~~aKlsDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~  290 (361)
T KOG1187|consen  213 DFNAKLSDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV  290 (361)
T ss_pred             CCCEEccCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence            999999999999765541 111 1112 7999999999999999999999999999999999999999877666666789


Q ss_pred             HHHhHHHHhhhhhhhhcCCCCC-CCCCh-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          295 DWALPLLKEKKKLLNIIDPRLE-GDYPV-KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      +|..+.+.+. .+..++|+.+. ..++. .....+..+...|++.+|.+||++.++++.|+.+...
T Consensus       291 ~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  291 EWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            9987777665 88999999987 55554 5777899999999999999999999999999666554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3e-51  Score=381.49  Aligned_cols=261  Identities=32%  Similarity=0.538  Sum_probs=218.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++...+.||.|+||+||+|.|.....       ||+|++.... .......|.+|+.+|.+++|||||+++|++.+..
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~-------vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~  112 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWRGTDV-------VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP  112 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeCCcee-------EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            3445556679999999999998876543       8999988653 2233678999999999999999999999999887


Q ss_pred             -eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-cEEEeccCCC
Q 016481          150 -HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLA  227 (389)
Q Consensus       150 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-~vkl~Dfg~a  227 (389)
                       .+++|||||++|+|.++++......+++..+..++.+|+.||.|||+.++ ||||||||+|||++.++ ++||+|||++
T Consensus       113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccc
Confidence             79999999999999999988545589999999999999999999999665 99999999999999997 9999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccc--cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +......  ...+...||+.|||||++.  ...|+.++||||||+++|||+||+.||....+...               
T Consensus       192 r~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---------------  254 (362)
T KOG0192|consen  192 REKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---------------  254 (362)
T ss_pred             eeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---------------
Confidence            8754321  2233378999999999999  56999999999999999999999999998764211               


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                       .........+..++..++..+..++..||+.||++||++.+|+..|+.+..
T Consensus       255 -~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  255 -ASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             -HHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence             112222334455566688999999999999999999999999999988755

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-51  Score=384.06  Aligned_cols=265  Identities=29%  Similarity=0.433  Sum_probs=230.1

Q ss_pred             HHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEe
Q 016481           64 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG  143 (389)
Q Consensus        64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~  143 (389)
                      .+.+.+-...+++.+.||+|-||.||.|.|+...+       ||+|.+....  .....|.+|+.+|++|+|+|||++++
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~-------vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~g  268 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTK-------VAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYG  268 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCc-------ccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEE
Confidence            34455556667788999999999999999987654       9999988753  33467889999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          144 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       144 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      +|..++.+|||||||..|+|.+++.......+...+.+.++.|||+||+||++++  +|||||..+||||+++..+||+|
T Consensus       269 V~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsD  346 (468)
T KOG0197|consen  269 VCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISD  346 (468)
T ss_pred             EEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcc
Confidence            9999899999999999999999999877778999999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      ||+|+...+ +.........-+..|.|||.+....++.+||||||||+||||+| |+.||.+...               
T Consensus       347 FGLAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---------------  410 (468)
T KOG0197|consen  347 FGLARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---------------  410 (468)
T ss_pred             cccccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---------------
Confidence            999994433 33333444556889999999999999999999999999999999 9999988753               


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                        .++.+.++...+-+.|..|+.++.+++..||+.+|++||||..+...|+.+-.
T Consensus       411 --~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  411 --EEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             --HHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence              33556667777777888999999999999999999999999999998887644

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-51  Score=363.80  Aligned_cols=252  Identities=26%  Similarity=0.334  Sum_probs=209.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.++||+|+||+||.++.+++.      ..||.|++++...  .........|..+|..++||.||+++-.|++.
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~------kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~   97 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTG------KIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE   97 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccC------ceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence            468999999999999999999766444      4499999887642  23456778899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+|+|+||+.||.|..++.+..  .+++..+.-++..|+.||.|||+.+  ||||||||+|||+|.+|+++|+|||+++
T Consensus        98 ~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccch
Confidence            99999999999999999997765  7899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......  ....+.|||+.|||||++.+.+|+.++|+||||+++|+|++|.+||...+...      +...         
T Consensus       174 ~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~---------  236 (357)
T KOG0598|consen  174 EDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDK---------  236 (357)
T ss_pred             hcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHH---------
Confidence            643322  23455899999999999999999999999999999999999999998765321      1111         


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC----CHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP----LMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~~il~~  351 (389)
                       +...+ ....+.-.+.++++++.++|+.||++|.    ++.+|.+|
T Consensus       237 -I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  237 -ILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             -HhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence             11111 1222334678999999999999999996    56665544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-51  Score=349.61  Aligned_cols=254  Identities=24%  Similarity=0.312  Sum_probs=205.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEe-EEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIG-YCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~  148 (389)
                      ..+|++.++||+|.||+||++....+...      +|.|.+.-+. .....+....|+.+|++|+|||||++++ .+.++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l------~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~   91 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKL------VALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED   91 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcch------hhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence            35788999999999999999976655444      8998877543 3445567889999999999999999998 45444


Q ss_pred             Ce-EEEEEEecCCCChhhhhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CceecCCCCCCeEEcCCCcEEEec
Q 016481          149 EH-RVLIYEFMARGSVENNLF--SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK--PVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       149 ~~-~~lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      .. ++||||||.+|+|...+.  +...+.+++..+++++.|++.||+.+|+.-+  .|+||||||.||+++.+|.|||+|
T Consensus        92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence            44 899999999999999884  3455689999999999999999999998333  399999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      ||+++.+...  .....+.+|||.||+||++.+.+|+.++||||+||++|||+.-++||.+.+-      ..        
T Consensus       172 fGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~--------  235 (375)
T KOG0591|consen  172 FGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LS--------  235 (375)
T ss_pred             chhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HH--------
Confidence            9999987543  2345568999999999999999999999999999999999999999987521      11        


Q ss_pred             hhhhhhhcCCCCCCCCC-hHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 016481          304 KKKLLNIIDPRLEGDYP-VKGVHKAAMLAYHCLNHNPKARPLMRDIV  349 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~~il  349 (389)
                         +.+.+...--.+.| .-.+.+++.|+..|+..||+.||+.-.++
T Consensus       236 ---L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v  279 (375)
T KOG0591|consen  236 ---LCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYV  279 (375)
T ss_pred             ---HHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence               11111111122234 45689999999999999999999843333

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.8e-49  Score=343.34  Aligned_cols=266  Identities=24%  Similarity=0.303  Sum_probs=212.1

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh-hHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      +.|+...++|+|+||+||+|+++++++-      ||||++....... ..+-.++|+++|++++|+|+|.++++|.....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqI------VAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQI------VAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccE------EEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence            4688889999999999999987766554      9999987665434 34556899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++|+|||+. ++.+.+..... ..+...+..++.|++.|+.|+|+++  +|||||||+||||+.+|.+||||||+|+.+
T Consensus        76 lhLVFE~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   76 LHLVFEYCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             eEEEeeecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhh
Confidence            9999999987 55555655433 6788999999999999999999988  999999999999999999999999999988


Q ss_pred             CCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ....  ...+..+.|..|+|||++.| ..|...+||||+||++.||++|.+.|++..+.+........+..+-  +.-++
T Consensus       152 ~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~--prhq~  227 (396)
T KOG0593|consen  152 SAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI--PRHQS  227 (396)
T ss_pred             cCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC--HHHHH
Confidence            7422  23445678999999999998 6899999999999999999999999999887766544332221110  11111


Q ss_pred             hcC----------CCCCCC--C---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          310 IID----------PRLEGD--Y---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       310 ~~~----------~~~~~~--~---~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ++.          |.....  .   -...+..+.+|+++||+.||++|++-++++.|
T Consensus       228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            111          111111  1   11346688999999999999999999999876

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=365.97  Aligned_cols=254  Identities=25%  Similarity=0.333  Sum_probs=212.4

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  147 (389)
                      ..+|.+++.||+|+|++|++|+.+.+.+.      ||||++.+.-  ......-+..|-.+|.+| .||.|++++-.|.+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~ke------YAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD  145 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKE------YAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD  145 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCce------eeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence            46899999999999999999987776555      9999986542  111223345688899999 79999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      +..+|+|+||+++|+|.+++...+  .+++..+...+.+|+.||+|||++|  ||||||||+|||+|.+++++|+|||.|
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeecccc
Confidence            999999999999999999998775  7899999999999999999999988  999999999999999999999999999


Q ss_pred             cCCCCCCCc-----------cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          228 KDGPEGDKS-----------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       228 ~~~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      +.+......           ....+++||..|.+||+|.....++.+|||+||||+|+|+.|.+||...++..-      
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli------  295 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI------  295 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH------
Confidence            877542211           112458999999999999999999999999999999999999999998764311      


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                                +.+++.  +.-.++..++..+.+|+++.|..||.+|++.++|.+|.
T Consensus       296 ----------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 ----------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ----------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                      111111  12234556668999999999999999999999999883

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=353.66  Aligned_cols=264  Identities=29%  Similarity=0.403  Sum_probs=213.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  149 (389)
                      ..+|..++.||+|+||.||++..+.+...      .|||......... .+.+.+|+.+|++++|||||+++|...... 
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~------~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGEL------MAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcc------eeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            34678889999999999999987765333      9999987664333 667889999999999999999999754444 


Q ss_pred             -eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-CCcEEEeccCCC
Q 016481          150 -HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLA  227 (389)
Q Consensus       150 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-~~~vkl~Dfg~a  227 (389)
                       .+++.|||+.+|+|.+++..... .+++..+....+|+++||+|||+++  |||+||||+|||++. ++.+||+|||++
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a  165 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLA  165 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccc
Confidence             68999999999999999988776 7999999999999999999999977  999999999999999 799999999999


Q ss_pred             cCCCC-CCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          228 KDGPE-GDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       228 ~~~~~-~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      ..... ...........||+.|||||++..+ ...+++|||||||++.||+||++||....     ....+         
T Consensus       166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~---------  231 (313)
T KOG0198|consen  166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEA---------  231 (313)
T ss_pred             cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHH---------
Confidence            87653 1112223347899999999999853 33459999999999999999999998631     00111         


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                       +..+......+.+|...+.++.+|+.+||.+||+.|||+.++|+|....+..+
T Consensus       232 -~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  232 -LLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -HHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence             11111111223556678899999999999999999999999999976665554

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-48  Score=351.68  Aligned_cols=267  Identities=24%  Similarity=0.328  Sum_probs=219.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .-..+|++...||.|..++||+|+......      .||||++..+........+.+|+..|+.++||||+.++..|..+
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e------~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNE------VVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCC------EEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            345789999999999999999998765543      39999999887777788899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..+|+||.||.+|++.+.+...-...+.+..+..|+++++.||.|||.+|  .||||||+.||||+.+|.|||+|||.+.
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeee
Confidence            99999999999999999998887778999999999999999999999988  9999999999999999999999999876


Q ss_pred             CCCCCCCcc-c-cccccccccccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          229 DGPEGDKSH-V-STRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       229 ~~~~~~~~~-~-~~~~~gt~~y~aPE~l~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      .+....... . .....||++|||||+++.  .+|+.|+||||||+++.||.+|..||....+.....+.      +.  
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t------Lq--  246 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT------LQ--  246 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH------hc--
Confidence            554322111 1 145789999999999764  57999999999999999999999999988765321110      00  


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .......-..+..+....++..++.++..||++||++|||+.+++++
T Consensus       247 n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  247 NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            00000001122222334557789999999999999999999999977

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=366.52  Aligned_cols=270  Identities=26%  Similarity=0.392  Sum_probs=221.7

Q ss_pred             cCHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccce
Q 016481           62 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVK  140 (389)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  140 (389)
                      ...++|.+..+++.+...||+|.||+||+|+|.++         ||||++.-+. .....+.|..|+.++++-+|.||+-
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlL  452 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILL  452 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccccc---------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhee
Confidence            34477888889999999999999999999999987         9999988654 4456688999999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      +.|++..++. .||+.+|+|.+|+.+++... ..+.......|++|+++||.|||..+  |||||||..|||+.++++||
T Consensus       453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVk  528 (678)
T KOG0193|consen  453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVK  528 (678)
T ss_pred             eehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEE
Confidence            9999999888 99999999999999998765 36888889999999999999999966  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  297 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  297 (389)
                      |+|||++..-.............|...|||||+++.   .+|++.+||||||+++|||++|..||.......-....   
T Consensus       529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV---  605 (678)
T KOG0193|consen  529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV---  605 (678)
T ss_pred             EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe---
Confidence            999999875443333333445678999999999974   47899999999999999999999999944322111110   


Q ss_pred             hHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                          ..+.-..+      ......++++++.+|+..||.+++++||.|.+|+..|+.+..
T Consensus       606 ----GrG~l~pd------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  606 ----GRGYLMPD------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ----cccccCcc------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence                00000000      011233678899999999999999999999999998777655

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-49  Score=360.95  Aligned_cols=271  Identities=25%  Similarity=0.301  Sum_probs=219.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  147 (389)
                      ++.++|.+.++||.|+||.||+|+.+.+...      ||||.++......+.---++|+..|++|+ ||||+++++++.+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~------VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d   80 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGEL------VAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD   80 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCce------eeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence            4567899999999999999999987766554      99999987654444444568999999999 9999999999998


Q ss_pred             CC-eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          148 DE-HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       148 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      .. .+|+|||||+ .+|++.+..+ ...+++..+..|+.||++||+|+|.+|  +.|||+||+|||+..+..+||+|||+
T Consensus        81 ~~~~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGL  156 (538)
T KOG0661|consen   81 NDRILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGL  156 (538)
T ss_pred             cCceEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccc
Confidence            88 9999999996 5999998887 678999999999999999999999988  99999999999999888999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH---
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK---  302 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---  302 (389)
                      |+......   ..+..+.|..|+|||+|. ...|+.+.||||+|||++|+.+-++.|.+..+.++..-..-++....   
T Consensus       157 ARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~  233 (538)
T KOG0661|consen  157 AREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS  233 (538)
T ss_pred             ccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence            99876543   234467899999999986 45789999999999999999999999999988776544332221111   


Q ss_pred             --hhhhhhhhcCCCCCC-------CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          303 --EKKKLLNIIDPRLEG-------DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       303 --~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                        +...+...+.-.+..       ..-...+.++.+++.+||++||.+|||+.++|++-
T Consensus       234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence              111122222211111       11123688999999999999999999999999884

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-48  Score=334.89  Aligned_cols=238  Identities=26%  Similarity=0.355  Sum_probs=206.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .+|++.+.||.|+||+|.+++.+.+...      +|+|++....  ...+......|..+|+.+.||+++++++.+.+.+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~y------YAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~  117 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNY------YAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS  117 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCce------eehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence            5788899999999999999987766444      9999998764  2334456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+||||++||.|..++++..  ++++..+.-++.+|+.||+|||+.+  |++|||||+|||+|.+|.+||+|||+|+.
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEE
Confidence            9999999999999999997654  7899999999999999999999988  99999999999999999999999999998


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...     ...+.||||.|+|||++...+|..++|.|||||++|||+.|.+||....+.                ....+
T Consensus       194 v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------------~iY~K  252 (355)
T KOG0616|consen  194 VSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------------QIYEK  252 (355)
T ss_pred             ecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------HHHHH
Confidence            754     245689999999999999999999999999999999999999999876652                11222


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCC
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR  342 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  342 (389)
                      ++....  .+|.-++.++.+|+.+.|+.|-.+|
T Consensus       253 I~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 ILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            222222  3566678999999999999999999

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=361.82  Aligned_cols=251  Identities=24%  Similarity=0.387  Sum_probs=213.1

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ..|...++||+|+.|.||.|+...+...      ||||.+..... ....-+++|+.+|+..+|+|||.+++.|...+.+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~------VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQE------VAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCce------EEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence            4688889999999999999976655444      99999876532 2234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |+|||||+||+|.+.+...   .+++.++..|++.++.||+|||..+  |+|||||.+|||++.+|.+||+|||++..+.
T Consensus       346 WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            9999999999999887554   5889999999999999999999977  9999999999999999999999999998876


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  ...+.+|||.|||||++....|++++||||||++++||+.|++||-...+.....+             +.  .
T Consensus       421 ~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------------Ia--~  483 (550)
T KOG0578|consen  421 EEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------------IA--T  483 (550)
T ss_pred             cccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------------Hh--h
Confidence            5432  34558999999999999999999999999999999999999999987665433222             11  1


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ........+...+..+++|+.+||..|+++|+++.+||+|
T Consensus       484 ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  484 NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            1222334466788999999999999999999999999988

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-47  Score=354.35  Aligned_cols=257  Identities=26%  Similarity=0.338  Sum_probs=210.9

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh----hhHHHHHHHHHHHhccC-CCccceEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY----QGHREWLAEVIFLGHLS-HPNLVKLIG  143 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~  143 (389)
                      ...+.|.+++.||+|+||.|++|.+..+..      .||+|++......    .....+.+|+.+++.+. ||||+++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~------~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e   87 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGE------KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE   87 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCC------eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence            345789999999999999999998766553      3999987664211    22345568999999999 999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC-CcEEEe
Q 016481          144 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLS  222 (389)
Q Consensus       144 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~-~~vkl~  222 (389)
                      ++.....+|+||||+.||+|.+++...  .++.+..+..+++|++.|++|||+++  |+||||||+|||++.+ +++||+
T Consensus        88 v~~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   88 VFATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             EEecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEe
Confidence            999999999999999999999999883  37888999999999999999999977  9999999999999999 999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCC-CC-cccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-LT-PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |||++....  .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|..||........          
T Consensus       164 DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l----------  231 (370)
T KOG0583|consen  164 DFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL----------  231 (370)
T ss_pred             ccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH----------
Confidence            999999874  1122455689999999999999987 85 789999999999999999999997432110          


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHH-HHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKG-VHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                            ...+...  ...+|... +.++..|+.+||..||.+|+++.+|+.+=+-.
T Consensus       232 ------~~ki~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~  279 (370)
T KOG0583|consen  232 ------YRKIRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQ  279 (370)
T ss_pred             ------HHHHhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence                  0001111  11233344 78999999999999999999999999664333

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-49  Score=354.55  Aligned_cols=251  Identities=27%  Similarity=0.365  Sum_probs=216.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ..|+..+.||+|.||.||+|.+..+.+.      ||+|++..+.......++.+|+.++.+++++||.++|+.+..+..+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~------vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKV------VAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             cccccchhccccccceeeeeeeccccce------EEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            4577789999999999999987776655      9999999888778888889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      +++||||.||++.+.+....  .+.+.....++++++.||.|||.++  .+|||||+.|||+..+|.|||+|||.+....
T Consensus        87 wiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeee
Confidence            99999999999999887654  3477777889999999999999987  9999999999999999999999999988765


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  ...+++|||.|||||++.+..|+.++||||||++++||.+|.+|+....+...                 .-.+
T Consensus       163 ~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----------------lflI  223 (467)
T KOG0201|consen  163 NTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----------------LFLI  223 (467)
T ss_pred             chhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----------------EEec
Confidence            5432  23568999999999999999999999999999999999999999998776321                 1222


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .+..++.....++..+.+|+..||++||+.||++.++|+|
T Consensus       224 pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  224 PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            2222333344678889999999999999999999999976

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.8e-47  Score=324.30  Aligned_cols=268  Identities=25%  Similarity=0.326  Sum_probs=213.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhh-HHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .+|...++||+|.||.||+|++..+++.      ||||.++..+.... ....++|++.|+.++|+||+.++++|...+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~------VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKR------VAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcE------EEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            4688889999999999999987766554      99999887643333 3567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +.+|+|||+. +|...+.+.. ..+....+..++.+++.||+|||.+.  |+||||||+|+||+.+|.+||+|||+|+.+
T Consensus        76 l~lVfEfm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   76 LSLVFEFMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             eEEEEEeccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhcc
Confidence            9999999964 8888776654 47888899999999999999999988  999999999999999999999999999988


Q ss_pred             CCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh--HHHHhhh--
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--PLLKEKK--  305 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~--  305 (389)
                      ...+...  ...+.|..|+|||++.|. .|+..+||||.|||+.||+.|.+-|.+..+.++....-..+  +...+.+  
T Consensus       152 ~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  152 GSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             CCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence            6654332  223789999999999875 69999999999999999999999999887766543322111  1111111  


Q ss_pred             ----hhhhh--cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          306 ----KLLNI--IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       306 ----~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                          +..++  .........-...+.++.+|+.+||.+||.+|++++|++++
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                11111  11111111233456778999999999999999999999987

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.5e-47  Score=356.64  Aligned_cols=271  Identities=29%  Similarity=0.395  Sum_probs=210.9

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      .+..++|++.+.||+|+||.||+|.+.... .......||+|++...........+.+|+.+++.+ +||||+++++++.
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGID-KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccC-CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            344578999999999999999999753321 11233459999987655555566788999999999 8999999999887


Q ss_pred             eC-CeEEEEEEecCCCChhhhhhcCC------------------------------------------------------
Q 016481          147 ED-EHRVLIYEFMARGSVENNLFSKV------------------------------------------------------  171 (389)
Q Consensus       147 ~~-~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  171 (389)
                      .. +.+++||||+++|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            64 46899999999999998886431                                                      


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcccccccccc
Q 016481          172 ------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT  245 (389)
Q Consensus       172 ------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt  245 (389)
                            ..++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...............++
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                  124777888999999999999999977  999999999999999999999999999865432222222334567


Q ss_pred             ccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHH
Q 016481          246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGV  324 (389)
Q Consensus       246 ~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (389)
                      +.|+|||++.+..++.++|||||||++|||++ |..||........  +.    .....          ......+...+
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~----------~~~~~~~~~~~  303 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKD----------GTRMRAPENAT  303 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhc----------CCCCCCCCCCC
Confidence            88999999999999999999999999999997 9999986532211  00    00000          01111233456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          325 HKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       325 ~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      ..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-47  Score=361.82  Aligned_cols=252  Identities=26%  Similarity=0.376  Sum_probs=214.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +-|++++-||.|+-|.|.+|++..+++.      +|||++....  .......+.+|+.+|+.+.||||++++++|.+..
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGql------aaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~   85 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQL------AAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ   85 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccce------eEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence            4588899999999999999977666554      9999987652  2233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ++|+|.||++||.|.+++..++  ++++.++.+++.||+.|+.|+|..+  |+||||||+|+|+|..+++||+|||+|..
T Consensus        86 ~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsL  161 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASL  161 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeec
Confidence            9999999999999999998876  7899999999999999999999988  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      -..+.   ...+.||+|.|.|||+++|..| +.++||||+|||||.||+|+.||++.+      +.....++.       
T Consensus       162 e~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LLlKV~-------  225 (786)
T KOG0588|consen  162 EVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLLLKVQ-------  225 (786)
T ss_pred             ccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHHHHHH-------
Confidence            44332   4556799999999999999999 568999999999999999999999532      111111111       


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                           .-..++|..++.++++||.+||..||++|.|+++|++|-.-
T Consensus       226 -----~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l  266 (786)
T KOG0588|consen  226 -----RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL  266 (786)
T ss_pred             -----cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence                 11234577889999999999999999999999999999543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-47  Score=352.48  Aligned_cols=270  Identities=24%  Similarity=0.263  Sum_probs=211.4

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  148 (389)
                      .+.|+..++||+|+||.||+|+...+.+      .||+|.++.+.. .....-..+||.||++|+||||+++.+...+. 
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgk------ivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGK------IVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCc------EEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            3568889999999999999997665554      499999887653 33445567899999999999999999988876 


Q ss_pred             -CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          149 -EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       149 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                       +.+|+|+|||+. +|..++... ...|++.++..+++|++.||.|+|+.+  |+|||||..|||||.+|.+||+|||+|
T Consensus       190 ~~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  190 SGSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             CceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccce
Confidence             799999999986 788766543 447999999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH-HHhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL-LKEKK  305 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~  305 (389)
                      +.+...... ..+..+.|..|+|||+|.|. .|+.++|+||.||||.||+.|++.|.+..+..+....--.-.- ..+.+
T Consensus       266 r~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  266 RFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            977654332 25567889999999999976 7999999999999999999999999998776654332211000 00000


Q ss_pred             ---hhh--hhcCCCCC-----CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          306 ---KLL--NIIDPRLE-----GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       306 ---~~~--~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         .+.  ..+.+...     .+.-...+..+.+|+..+|..||.+|.|+.++|.+
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence               111  00000000     00012346788999999999999999999999976

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-47  Score=354.13  Aligned_cols=281  Identities=26%  Similarity=0.360  Sum_probs=225.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCC-CChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|.+.+.||+|+||+||+|+-+.+.+      .||+|.+.+. +...+...+.+|+++++.++||||+.++++|....+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~------~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQ------VVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccccee------EEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            478888999999999999997555544      4999998764 345566788899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++|+||+.| +|...+....  .+++..+..++.+++.||.|||+++  |+|||+||.|||++.+|.+|++|||+|+..
T Consensus        76 ~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhc
Confidence            9999999976 9999887665  7899999999999999999999987  999999999999999999999999999987


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ..+  ....++..|||.|||||++.+..|+..+|+||||||+|||++|++||-...      +...+..+.+        
T Consensus       151 ~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~--------  214 (808)
T KOG0597|consen  151 STN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILK--------  214 (808)
T ss_pred             ccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhc--------
Confidence            653  345667899999999999999999999999999999999999999997432      1111111111        


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH-hcccc-CCCCCCCCC--CCcccccCCCCCCccccc
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS-LEPLQ-VLPDEAPTP--KNFVTVVTPEEPKAEIQT  383 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~-L~~~~-~~~~~~~~p--~~~~~~~~~~~~~~~~~~  383 (389)
                       ++   ...|...+..+..|+...|.+||..|.+..+++.| +++-. .+...+..|  ..+.+..+|+..+...+.
T Consensus       215 -d~---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn~~Ppe~kek~~k  287 (808)
T KOG0597|consen  215 -DP---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTNNTPPEYKEKDRK  287 (808)
T ss_pred             -CC---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccccCCChHHHHhhhc
Confidence             11   11244678899999999999999999999999987 43322 222222222  344555556665555543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.3e-47  Score=349.46  Aligned_cols=257  Identities=24%  Similarity=0.301  Sum_probs=208.3

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      +-.++|.+++.||+|+||.||+|+-+.++.      .+|+|++++..  ...++..++.|..+|....+++||+++-.|+
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~------iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ  211 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGE------IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ  211 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCc------EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence            345689999999999999999997665544      49999998764  2334567788999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      +.+++||||||++||++..+|....  .+++..+...+.+++.|+..+|.+|  +|||||||+|+|||..|++||+|||+
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGL  287 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGL  287 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccc
Confidence            9999999999999999999997765  7888999999999999999999988  99999999999999999999999999


Q ss_pred             CcCCCC----------------------CCCc-----cc------------------cccccccccccCccccccCCCCc
Q 016481          227 AKDGPE----------------------GDKS-----HV------------------STRIMGTYGYAAPEYIMTGHLTP  261 (389)
Q Consensus       227 a~~~~~----------------------~~~~-----~~------------------~~~~~gt~~y~aPE~l~~~~~~~  261 (389)
                      +.-+..                      .+..     ..                  ..+.+|||.|+|||++.+.+|+.
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~  367 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK  367 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence            753211                      0000     00                  01256999999999999999999


Q ss_pred             ccchhHHHHHHHHHHhCCCCCCCCCchhh-hhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCC
Q 016481          262 RSDVYSFGVVLLEILTGRKSLDKSRPARE-QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPK  340 (389)
Q Consensus       262 ~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  340 (389)
                      .+|+||||||+||||.|.+||....+... ..+..|-               ..+..+-...++.++.+||.+||. ||+
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr---------------~~l~fP~~~~~s~eA~DLI~rll~-d~~  431 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR---------------ETLKFPEEVDLSDEAKDLITRLLC-DPE  431 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---------------hhccCCCcCcccHHHHHHHHHHhc-CHH
Confidence            99999999999999999999998765431 1111111               111222223456899999999999 999


Q ss_pred             CCCC---HHHHHHH
Q 016481          341 ARPL---MRDIVDS  351 (389)
Q Consensus       341 ~Rps---~~~il~~  351 (389)
                      +|..   +.||.+|
T Consensus       432 ~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  432 NRLGSKGAEEIKKH  445 (550)
T ss_pred             HhcCcccHHHHhcC
Confidence            9984   7888766

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2e-47  Score=372.01  Aligned_cols=271  Identities=29%  Similarity=0.440  Sum_probs=232.6

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+...+....+.||+|+||+||+|....-. -......||||.++.....+...+|.+|+.++..|+|||||+++|+|.+
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~-p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLL-PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCC-CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            344566777889999999999999654322 2344567999999999888889999999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCC--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKV--------LLP----LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT  215 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~--------~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~  215 (389)
                      ++.+++|+|||..|||.++|..+.        ..+    ++..+.+.|+.|||.||.||-++.  +|||||..+|+||.+
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGE  638 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceecc
Confidence            999999999999999999996532        223    788999999999999999999977  999999999999999


Q ss_pred             CCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhH
Q 016481          216 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLA  294 (389)
Q Consensus       216 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~  294 (389)
                      +..|||+|||+++.....+.......-.-..+|||||.++.+.|+.+||||||||+|||+++ |+.||.+....+     
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-----  713 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-----  713 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence            99999999999998877776666555667899999999999999999999999999999999 999998765432     


Q ss_pred             HHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                                  +++.+..+...+.|.+++.++.+|+..||+..|.+||+|++|-..|+.....
T Consensus       714 ------------VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  714 ------------VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ------------HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                        2223333333567889999999999999999999999999999999876544

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-46  Score=355.18  Aligned_cols=246  Identities=28%  Similarity=0.395  Sum_probs=207.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccC-CCccceEEeEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLS-HPNLVKLIGYC  145 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~  145 (389)
                      +-..+|++.++||+|.||+|+++..+.+.+.      +|||.++++.  ...++...+.|.+|+.... ||.++.++.+|
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~------yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f  438 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEY------YAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF  438 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcE------EEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc
Confidence            3456899999999999999999987776554      9999998875  3445677888999988775 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      +..+++|+||||+.||++..+.   ....+++..+.-++..++.||.|||.++  |||||||.+|||+|.+|++||+|||
T Consensus       439 QT~~~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  439 QTKEHLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             ccCCeEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccc
Confidence            9999999999999999944333   2347999999999999999999999988  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +++.....+  ...+++||||.|||||++.+..|+.++|+|||||+|||||.|..||.+.++.+..   +          
T Consensus       514 lcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F---d----------  578 (694)
T KOG0694|consen  514 LCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF---D----------  578 (694)
T ss_pred             cccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---H----------
Confidence            999865332  2567799999999999999999999999999999999999999999986643211   1          


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM  345 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  345 (389)
                         .++.  ....+|.-++.++..+++++|+++|++|...
T Consensus       579 ---sI~~--d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  579 ---SIVN--DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---HHhc--CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence               1111  1223566778999999999999999999955

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.1e-45  Score=337.70  Aligned_cols=272  Identities=26%  Similarity=0.410  Sum_probs=210.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccc----------cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccce
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLR----------EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK  140 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  140 (389)
                      .++|++.+.||+|+||.||+|.+.....          .......||+|.+...........+.+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4689999999999999999998654321          122344699999887655555677889999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChhhhhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 016481          141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKV-----------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIY  203 (389)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH  203 (389)
                      +++++.+.+..++||||+.+|+|.+++....                 ...+++..+..++.|++.||+|||+.+  |+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence            9999999999999999999999999885432                 124677888999999999999999977  999


Q ss_pred             cCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh--CCCC
Q 016481          204 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT--GRKS  281 (389)
Q Consensus       204 ~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt--g~~p  281 (389)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986644433223334556889999999998899999999999999999987  5667


Q ss_pred             CCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          282 LDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       282 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                      |.......   ...........       .........+..++..+.+|+.+||+.||++|||+.+|.+.|+.
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDEQ---VIENAGEFFRD-------QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHHH---HHHHHHHHhhh-------ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            76543221   11111111100       00001111233456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.5e-45  Score=350.18  Aligned_cols=269  Identities=26%  Similarity=0.356  Sum_probs=210.2

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      ....++|++.+.||+|+||.||+|.+.... .......||+|++...........+.+|+.+++.+ +||||+++++++.
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~-~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLF-KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccc-cCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            344568999999999999999999753221 12234459999987655445556788999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCC-------------------------------------------------------
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKV-------------------------------------------------------  171 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------  171 (389)
                      ..+..++||||+++|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999998885432                                                       


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCC
Q 016481          172 ------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  233 (389)
Q Consensus       172 ------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~  233 (389)
                                        ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                              124678888999999999999999977  999999999999999999999999999866443


Q ss_pred             CCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      ..........++..|+|||++.+..++.++|||||||++|+|++ |..||.......  ....+              +.
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~--------------~~  331 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM--------------IK  331 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH--------------HH
Confidence            22222223445678999999999999999999999999999998 888997643221  11111              11


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .......+...+.++.+|+.+||+.||++||++.+|++.|++.
T Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1111111223457899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-46  Score=337.52  Aligned_cols=272  Identities=25%  Similarity=0.283  Sum_probs=214.7

Q ss_pred             CHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-------------hhhHHHHHHHHHH
Q 016481           63 TYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-------------YQGHREWLAEVIF  129 (389)
Q Consensus        63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~  129 (389)
                      ...+-....+.|++.+.||+|.||.|-+|+...+.+.      ||||++.+...             ....+...+||.+
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l------~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIai  161 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKL------YAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAI  161 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeecCCCcE------EEEEeechhhhhhhcccccccccccCcHHHHHHHHHH
Confidence            3334445568899999999999999999987665554      99999865421             0112467789999


Q ss_pred             HhccCCCccceEEeEEEeC--CeEEEEEEecCCCChhhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceecCC
Q 016481          130 LGHLSHPNLVKLIGYCCED--EHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF  206 (389)
Q Consensus       130 l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dl  206 (389)
                      |++++|||||+++++..+.  +.+|||+|||..|.+..--   ...+ +.+.+++.++++++.||+|||.++  ||||||
T Consensus       162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDI  236 (576)
T KOG0585|consen  162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDI  236 (576)
T ss_pred             HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC--eecccc
Confidence            9999999999999998764  6899999999998765422   2223 889999999999999999999988  999999


Q ss_pred             CCCCeEEcCCCcEEEeccCCCcCCCCCC---CccccccccccccccCccccccCC---C-CcccchhHHHHHHHHHHhCC
Q 016481          207 KTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRIMGTYGYAAPEYIMTGH---L-TPRSDVYSFGVVLLEILTGR  279 (389)
Q Consensus       207 kp~Nili~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~---~-~~~~DiwslG~il~elltg~  279 (389)
                      ||.|+|++.+|+|||+|||.+.....+.   .........|||.|+|||...++.   + +.+.||||+||+||.|+.|+
T Consensus       237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~  316 (576)
T KOG0585|consen  237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ  316 (576)
T ss_pred             chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence            9999999999999999999988663321   112233478999999999988732   3 56889999999999999999


Q ss_pred             CCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          280 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       280 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                      .||.+....                .-..+++...+..+...++...+.+||+++|.+||+.|.++.+|..|.+--....
T Consensus       317 ~PF~~~~~~----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  317 LPFFDDFEL----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             CCcccchHH----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            999875322                1122334444443434467889999999999999999999999999998877764


Q ss_pred             CC
Q 016481          360 DE  361 (389)
Q Consensus       360 ~~  361 (389)
                      ..
T Consensus       381 ~~  382 (576)
T KOG0585|consen  381 SP  382 (576)
T ss_pred             CC
Confidence            44

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-45  Score=351.06  Aligned_cols=270  Identities=26%  Similarity=0.368  Sum_probs=212.3

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  145 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  145 (389)
                      |....++|.+.+.||+|+||.||+|++..... ......||+|.+...........+.+|+.+++.+ +|+||+++++++
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGK-EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCc-ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            33445689999999999999999998654332 2234459999998665555566788999999999 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCC------------------------------------------------------
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKV------------------------------------------------------  171 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  171 (389)
                      ......++||||+.+|+|.+++....                                                      
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            99999999999999999999875421                                                      


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          172 --------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       172 --------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                                    ..++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                          124678888999999999999999977  9999999999999999999999999987654332222


Q ss_pred             ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCC
Q 016481          238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  316 (389)
Q Consensus       238 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (389)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |+.||........  .              .........
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~--------------~~~~~~~~~  333 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F--------------YKMVKRGYQ  333 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H--------------HHHHHcccC
Confidence            2223345678999999998899999999999999999997 9999976432211  0              000111111


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          317 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ...+...+.++.+++.+||+.||++|||+.+|++.|+++
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            112223467899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-45  Score=322.51  Aligned_cols=268  Identities=21%  Similarity=0.257  Sum_probs=209.6

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhh-HHHHHHHHHHHhccCCCccceEEeEEEe--C
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLSHPNLVKLIGYCCE--D  148 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~--~  148 (389)
                      ++|+....|++|+||.||+|+++.+..-      ||+|.++.+..... -.-.++||.+|.+++|||||.+..+...  -
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eI------VALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEI------VALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCccee------EEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            4688899999999999999987666544      99999886653322 2345789999999999999999987653  4


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+|+|||||+. +|...+.... .++...++..+..|++.|++|||.+.  |+|||||++|+|++..|.+||+|||+|+
T Consensus       150 d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  150 DKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             ceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhh
Confidence            579999999986 8887776554 68999999999999999999999988  9999999999999999999999999999


Q ss_pred             CCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh--------H
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--------P  299 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~  299 (389)
                      .+...-  ...+..+.|..|+|||++.+. .|+.+.|+||+|||+.||+++++.|.+.....+.+..-..+        +
T Consensus       226 ~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  226 EYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             hhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence            876542  234557889999999999875 69999999999999999999999999887665433221110        0


Q ss_pred             HHHhhh-----hhhhhcCCCCCCCCChH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          300 LLKEKK-----KLLNIIDPRLEGDYPVK-GVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       300 ~~~~~~-----~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      -+....     .+.......++..++.. .+..-++|+..+|.+||.+|.|+.+.|+|
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            000000     00000001112222222 46788999999999999999999999988

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-44  Score=332.54  Aligned_cols=264  Identities=29%  Similarity=0.465  Sum_probs=215.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|++.+.||+|+||.||+|....... ......|++|.+...........+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE-RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC-CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            578899999999999999997655432 2334559999987665555566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVL--------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      +++|||+++|+|.+++.....              ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCCC
Confidence            999999999999998865421              35788889999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHH
Q 016481          218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       218 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  296 (389)
                      .++|+|||++......+.........+++.|+|||.+.+..++.++|||||||++|||++ |..||........      
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------  235 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------  235 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence            999999999886544333223334567889999999998899999999999999999998 9999986543211      


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                                 ...+........+..++.++.+|+.+||+.||.+||++++|+++|+++
T Consensus       236 -----------~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         236 -----------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             -----------HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                       111111112223456678999999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.2e-46  Score=343.85  Aligned_cols=253  Identities=26%  Similarity=0.350  Sum_probs=218.8

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|..++++|+|+||.+++++++.+.+.      |++|.+.... .....+....|..+++++.|||||.+.+.|..++.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~------~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKL------YVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCce------EEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence            5788999999999999999877766554      9999887654 33344567889999999999999999999998888


Q ss_pred             -EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          151 -RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       151 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                       ++|||+||+||++.+.+.......+++..+..++.|++.|+.|||++.  |+|||||+.|||++.++.|||+|||+|+.
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhh
Confidence             999999999999999998887778999999999999999999999866  99999999999999999999999999998


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ....+  ....+..||+.||+||++.+.+|..++|||||||++|||++-+++|...+-.                 .+..
T Consensus       156 l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----------------~Li~  216 (426)
T KOG0589|consen  156 LNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----------------ELIL  216 (426)
T ss_pred             cCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----------------HHHH
Confidence            76543  2345689999999999999999999999999999999999999999876422                 1222


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .+......+.+...+.+++.++..||+.+|..||++.++|.+
T Consensus       217 ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  217 KINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            222333455677788999999999999999999999999976

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.7e-46  Score=331.56  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=214.4

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .-+|++.+.||+|.||.|-+|+.+..++.      ||||.++++.  ..++...+.+|++||..|+||||+.++++|.+.
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~------VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk  125 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGRE------VAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK  125 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcE------eehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence            45799999999999999999976555444      9999988764  455667788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+.|||||..+|.|++++....  .+++.++..+++||..|+.|+|.++  ++|||||.+|||+|.++++||+|||++.
T Consensus       126 dKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSN  201 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhh
Confidence            99999999999999999997765  7899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      .+....   ...++||+|-|.+||+++|.+| .+.+|-|||||+||.|..|..||++.+-.                 .+
T Consensus       202 ly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----------------~l  261 (668)
T KOG0611|consen  202 LYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----------------RL  261 (668)
T ss_pred             hhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-----------------HH
Confidence            876543   4567999999999999999998 68999999999999999999999986422                 11


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      .+.+...--  .....+..+..||++||..+|++|.|+.+|..|-+
T Consensus       262 vrQIs~GaY--rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  262 VRQISRGAY--REPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             HHHhhcccc--cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            111111110  11233466788999999999999999999999864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=368.17  Aligned_cols=269  Identities=30%  Similarity=0.453  Sum_probs=227.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .....+.+.||+|+||.||.|...+..... ....||+|.+....+.+...+|++|..+|+.++|||||+++|++.+.+.
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~-~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSV-SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCc-cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            345677889999999999999876544332 2677999999998888999999999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          151 RVLIYEFMARGSVENNLFSKV-----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      .+|++|||+||+|..++.+..     ...++....+.++.+||.|+.||++.+  .|||||..+|+|++....|||+|||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999997651     346888999999999999999999966  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      +|+.....+.........-..+|||||.+....++.++|||||||++||++| |..||...+..+...            
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------------  915 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------------  915 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------------
Confidence            9997665554443333455689999999999999999999999999999999 999999776543221            


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                          ..+... +.+.|..|+..+.+++.+||+.+|++||+|..|++.+..+-...
T Consensus       916 ----~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  916 ----DVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ----HHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                111222 44557788999999999999999999999999999887774443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.4e-45  Score=333.81  Aligned_cols=253  Identities=26%  Similarity=0.336  Sum_probs=204.2

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      |+..+.||+|+||.||+|.+..+.+.      ||+|.+.....  ......+.+|+.+++.++|+||+++++++...+..
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~------~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~   75 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKM------YACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCce------EEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence            67789999999999999987655443      99998765421  22234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++|+|.+.+.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIP  153 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence            99999999999988876655456899999999999999999999977  9999999999999999999999999998654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............             ...+
T Consensus       154 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~-------------~~~~  217 (285)
T cd05631         154 EGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV-------------DRRV  217 (285)
T ss_pred             CCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH-------------HHHh
Confidence            322   123357899999999999999999999999999999999999999865432111000             0000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~  351 (389)
                       ......++...+.++.+|+.+||+.||++||+     +.++++|
T Consensus       218 -~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         218 -KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence             00111233455788999999999999999997     8898876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.1e-44  Score=337.30  Aligned_cols=268  Identities=24%  Similarity=0.313  Sum_probs=209.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+..+..      .||+|++...........+.+|+.+++.++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGL------IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCc------EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            4689999999999999999998765443      3999998766555556778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+ +|+|+||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            999999999999999886543  6889999999999999999999731 2999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh-------
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-------  303 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------  303 (389)
                      ....    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.............  ......       
T Consensus       155 ~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~  228 (331)
T cd06649         155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHS  228 (331)
T ss_pred             cccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccc
Confidence            3321    233578999999999999999999999999999999999999997654322110000  000000       


Q ss_pred             ------------------------hhhhhh-hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          304 ------------------------KKKLLN-IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       304 ------------------------~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                                              ...+.. +.............+.++.+|+.+||++||++|||+.+|++|..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~  303 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF  303 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence                                    000000 00000011111235678999999999999999999999999854

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5e-46  Score=345.28  Aligned_cols=246  Identities=29%  Similarity=0.463  Sum_probs=207.2

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      ....++-||.|+-|.||+|+.+...        ||||.++.-      +  ..+|+-|++|+|+||+.|.|+|.....+|
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl~net--------VAVKKV~el------k--ETdIKHLRkLkH~NII~FkGVCtqsPcyC  188 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRLHNET--------VAVKKVREL------K--ETDIKHLRKLKHPNIITFKGVCTQSPCYC  188 (904)
T ss_pred             HhhhhhhhccCcccceeeeeccCce--------ehhHHHhhh------h--hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence            3344577999999999999865432        999987532      1  15788899999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      ||||||..|.|...|....  .++......|..+|+.||.|||.+.  |||||||.-||||..+..|||+|||.++....
T Consensus       189 IiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             EeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            9999999999999997655  7888899999999999999999987  99999999999999999999999999887654


Q ss_pred             CCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      .   ...-.++||..|||||++...+.+.++|||||||+|||||||..||..-+...    .            +...-.
T Consensus       265 ~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I------------IwGVGs  325 (904)
T KOG4721|consen  265 K---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I------------IWGVGS  325 (904)
T ss_pred             h---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e------------EEeccC
Confidence            3   23345899999999999999999999999999999999999999998643211    1            111112


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      -.+....|..++..+.-|+++||+-.|..||+|++|+.||+-...
T Consensus       326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            234456678889999999999999999999999999999975543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=347.35  Aligned_cols=276  Identities=28%  Similarity=0.454  Sum_probs=226.1

Q ss_pred             cCHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecC--CCChhhHHHHHHHHHHHhccCCCccc
Q 016481           62 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG--DNSYQGHREWLAEVIFLGHLSHPNLV  139 (389)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv  139 (389)
                      +..+.|.+..++..+.++||+|+||.||+|.++.....  ....||+|....  ........+++.|.++|++++|||||
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~--~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV  224 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF--KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV  224 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecCCc--eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence            34455667777888889999999999999987654331  112289999885  34566678999999999999999999


Q ss_pred             eEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcE
Q 016481          140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA  219 (389)
Q Consensus       140 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~v  219 (389)
                      +++|++.....+++|||+|.||+|.++|..... .++..+...++.+.+.||+|||+.+  ++||||..+|+|++.++.+
T Consensus       225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeE
Confidence            999999999999999999999999999987654 6889999999999999999999977  9999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccc-cccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHH
Q 016481          220 KLSDFGLAKDGPEGDKSHVST-RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWA  297 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~  297 (389)
                      ||+|||+++.....   .... ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+....+.       
T Consensus       302 KISDFGLs~~~~~~---~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v-------  371 (474)
T KOG0194|consen  302 KISDFGLSRAGSQY---VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV-------  371 (474)
T ss_pred             EeCccccccCCcce---eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH-------
Confidence            99999998875411   1111 1235789999999999999999999999999999999 8889998754321       


Q ss_pred             hHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCC
Q 016481          298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE  361 (389)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~  361 (389)
                               ...+.....+...+...+.++..++.+||..||++||+|.++.+.|+.+......
T Consensus       372 ---------~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  372 ---------KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ---------HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                     1111122333444556688899999999999999999999999999888766543

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-45  Score=325.66  Aligned_cols=282  Identities=24%  Similarity=0.315  Sum_probs=217.9

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCC-CChhhHHHHHHHHHHHhccCCCccceEEeEEEe-
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-  147 (389)
                      +...|...+.||.|+||.|..|..+.+...      ||||.+... ......++..+|+++|+.++|+||+.+++++.- 
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~------VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEK------VAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP   93 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCE------eehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence            445677789999999999999987766544      999998743 244556788899999999999999999998864 


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          148 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       148 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                          -..+|+|+|+| +.+|...+....  .++...+..++.|++.||.|+|+.+  |+||||||.|+|++.+..+||+|
T Consensus        94 ~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             cccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEecc
Confidence                45789999999 458888776653  5888999999999999999999988  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH--
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL--  300 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--  300 (389)
                      ||+|+...........+..+.|..|.|||++. ...|+.+.||||+|||+.||++|++.|.+.+...+..+.....+.  
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            99999875432222345577899999999875 568999999999999999999999999988766654433222111  


Q ss_pred             ------HHhh--hhhhhhcCCCCCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccCCCCCC
Q 016481          301 ------LKEK--KKLLNIIDPRLEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVLPDEA  362 (389)
Q Consensus       301 ------~~~~--~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~~~~~~  362 (389)
                            +...  ......+......++   -......+.+|+.+||.+||.+|+|+.++|.|  |...-+..+.+
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence                  1100  001111111111111   11457889999999999999999999999988  66665554444

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-45  Score=309.59  Aligned_cols=253  Identities=27%  Similarity=0.372  Sum_probs=214.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|.+++.||+|.||.||.|+.+.+...      ||+|++.+..  ......++.+|+.|-..|+||||++++++|.+.
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~I------valKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFI------VALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcE------EEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            46899999999999999999987665443      9999987653  122335677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..+|+++||...|+++..+.......+++.....+..|++.||.|+|..+  |+||||||+|+|++..+.+|++|||.+.
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCcee
Confidence            99999999999999999999777778999999999999999999999966  9999999999999999999999999988


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ..+.    ....+.|||..|.+||...+..++..+|+|++|++.||++.|.+||......   ..           ...+
T Consensus       173 ~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---et-----------YkrI  234 (281)
T KOG0580|consen  173 HAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ET-----------YKRI  234 (281)
T ss_pred             ecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HH-----------HHHH
Confidence            7542    2345689999999999999999999999999999999999999999865411   11           1111


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ..+    ...+|...+..++++|.+||.++|.+|.+..++++|-+
T Consensus       235 ~k~----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  235 RKV----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             HHc----cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence            111    12234567789999999999999999999999998853

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-44  Score=324.79  Aligned_cols=261  Identities=27%  Similarity=0.296  Sum_probs=218.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .+.|++.+.||+|.-|+||+|....+..      .+|+|++.+...  .....+...|..||+.+.||.++.+|..|..+
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~------~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNC------LFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD  149 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCc------eEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence            4568888999999999999998776653      399999987642  23345667799999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...|+|||||+||+|....+++....+++..+.-++..++.||+|||..|  ||+|||||+||||.++|++-|+||.++.
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccc
Confidence            99999999999999999999999999999999999999999999999977  9999999999999999999999999864


Q ss_pred             CCCC---------------------------------CCCc---------------------cccccccccccccCcccc
Q 016481          229 DGPE---------------------------------GDKS---------------------HVSTRIMGTYGYAAPEYI  254 (389)
Q Consensus       229 ~~~~---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~l  254 (389)
                      ....                                 ....                     ....+++||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            3211                                 0000                     011236799999999999


Q ss_pred             ccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHh
Q 016481          255 MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHC  334 (389)
Q Consensus       255 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  334 (389)
                      .|.+.+.++|+|+|||.+||||.|..||.+.+..                ..+.+++...+..+.....+..+++||++.
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~L  371 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKL  371 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence            9999999999999999999999999999886532                334455554444444446789999999999


Q ss_pred             hccCCCCCCC----HHHHHHH--hccc
Q 016481          335 LNHNPKARPL----MRDIVDS--LEPL  355 (389)
Q Consensus       335 l~~dP~~Rps----~~~il~~--L~~~  355 (389)
                      |.+||++|..    +.||.+|  ++.+
T Consensus       372 LvKdP~kRlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  372 LVKDPSKRLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             hccChhhhhccccchHHhhcCccccCC
Confidence            9999999998    9999877  4444

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8e-45  Score=340.98  Aligned_cols=249  Identities=25%  Similarity=0.337  Sum_probs=205.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|.+.+.||+|+||.||+|+++.+.+      .||+|++....  .......+.+|+.+++.++||||+++++++..+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   90 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGE------YYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE   90 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence            3679999999999999999998765544      39999986432  123345678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..|+||||+.+|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCce
Confidence            99999999999999999887653  6788889999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .....     .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+....                .
T Consensus       167 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----------------~  225 (329)
T PTZ00263        167 KVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY----------------E  225 (329)
T ss_pred             EcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH----------------H
Confidence            65432     12357999999999999999999999999999999999999999765432110                0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~L  352 (389)
                      .+....  ..++...+..+.+|+.+||+.||.+||+     +.++++|-
T Consensus       226 ~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp  272 (329)
T PTZ00263        226 KILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP  272 (329)
T ss_pred             HHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence            111111  1223335678899999999999999996     79999873

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.4e-44  Score=325.98  Aligned_cols=261  Identities=23%  Similarity=0.377  Sum_probs=210.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||+|+||.||+|.++...   .....||+|.+...........+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~---~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPS---KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCC---CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            357899999999999999999765432   23455999998876555556678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++++|||.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            999999999999999886543 36889999999999999999999977  999999999999999999999999987654


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .... ........++..|+|||++.+..++.++|||||||++|++++ |..||........   .              .
T Consensus       158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~--------------~  219 (266)
T cd05064         158 KSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---I--------------K  219 (266)
T ss_pred             cccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---H--------------H
Confidence            2211 111112345678999999999999999999999999999875 9999976543211   0              0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .+........+..++..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         220 AVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            0111111223445678899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-45  Score=335.09  Aligned_cols=248  Identities=23%  Similarity=0.282  Sum_probs=204.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||.||+|....+.+      .||+|++....  .......+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEH------YYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCC------EEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence            378899999999999999998765443      39999986432  1233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++||||+.+|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            9999999999999999886653  6888999999999999999999977  99999999999999999999999999886


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.........      ...         
T Consensus       151 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~------~~i---------  210 (291)
T cd05612         151 LRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY------EKI---------  210 (291)
T ss_pred             ccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH---------
Confidence            5432     22357999999999999999999999999999999999999999865432110      000         


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHh
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDSL  352 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~L  352 (389)
                       ...  ...++...+..+.+|+.+||+.||.+||+     +.++++|-
T Consensus       211 -~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         211 -LAG--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             -HhC--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence             000  11223344678999999999999999995     99999884

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.2e-44  Score=339.01  Aligned_cols=244  Identities=25%  Similarity=0.330  Sum_probs=199.3

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (389)
                      +.||+|+||.||+|....+.+      .||+|++....  .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGK------YYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEE
Confidence            469999999999998665543      39999987532  2233456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCC
Q 016481          156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  235 (389)
Q Consensus       156 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~  235 (389)
                      ||+.+|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++...... 
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  149 (323)
T cd05571          75 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-
Confidence            9999999998886543  6889999999999999999999977  9999999999999999999999999987532211 


Q ss_pred             ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCC
Q 016481          236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  315 (389)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (389)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.........   ..             +...  
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~-------------~~~~--  210 (323)
T cd05571         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---EL-------------ILME--  210 (323)
T ss_pred             -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH---HH-------------HHcC--
Confidence             1223467999999999999999999999999999999999999999764322110   00             0000  


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          316 EGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      ...++...+.++.+|+.+||+.||++||     ++.++++|
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            1123345678899999999999999999     89999977

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.7e-44  Score=339.09  Aligned_cols=256  Identities=25%  Similarity=0.338  Sum_probs=200.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|...+.||+|+||.||+|++..+.+      .||+|++...........+.+|+.+++.++|+||+++++++...+.+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGR------LYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCC------EEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            467778999999999999998765443      39999987655555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++|+|.+..      ...+..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus       148 ~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        148 QVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             EEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            9999999999886532      3456777889999999999999977  9999999999999999999999999988654


Q ss_pred             CCCCccccccccccccccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ....  ......||..|+|||++..     ...+.++|||||||++|+|++|+.||.............   .       
T Consensus       220 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~-------  287 (353)
T PLN00034        220 QTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---A-------  287 (353)
T ss_pred             cccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---H-------
Confidence            3211  1233579999999998743     234568999999999999999999997432211110000   0       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                          .........+..++.++.+|+.+||+.||++||++.++++|-.-...
T Consensus       288 ----~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        288 ----ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             ----HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                00011122234567889999999999999999999999998544433

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4e-44  Score=329.82  Aligned_cols=269  Identities=22%  Similarity=0.280  Sum_probs=203.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||.||+|+++.+...      ||+|++..... ......+.+|+.+++.++|+||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~------~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEI------VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcE------EEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            4789999999999999999987655443      99998875432 2334567789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||++++.+......  ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999998766544322  236889999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh-HH-------HH
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL-PL-------LK  302 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~-------~~  302 (389)
                      ...... ......|++.|+|||++.+..++.++|||||||++|+|++|++||................ +.       ..
T Consensus       151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            432211 1223578999999999999899999999999999999999999998754432211111000 00       00


Q ss_pred             hhhhhhhhcCCCCC------CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          303 EKKKLLNIIDPRLE------GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       303 ~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..........+...      .......+..+.+|+.+||+.||++|||+.++++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000000      00112346789999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-44  Score=327.22  Aligned_cols=256  Identities=34%  Similarity=0.531  Sum_probs=204.1

Q ss_pred             ccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEE
Q 016481           76 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (389)
                      +.+.||.|.||.||+|.+..  ........|+||.+...........+.+|+..+++++||||++++|++...+..++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~--~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ--KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES--TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEc--ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccc
Confidence            46789999999999999874  2334456699999977656666788999999999999999999999999888899999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCC
Q 016481          156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  235 (389)
Q Consensus       156 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~  235 (389)
                      ||+++|+|.+++.......+++..+..++.|++.||+|||+.+  ++|+||+++||+++.++.+||+|||++........
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence            9999999999998886668999999999999999999999977  99999999999999999999999999987633333


Q ss_pred             ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                      ............|+|||.+.+..++.++||||||+++||+++ |+.||........      ...           +...
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~------~~~-----------~~~~  221 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI------IEK-----------LKQG  221 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH------HHH-----------HHTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccc-----------cccc
Confidence            333334567889999999999889999999999999999999 7889876533210      000           1111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .....+..++..+.+++.+||+.||++|||+.+|++.|
T Consensus       222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11223445678899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-43  Score=322.59  Aligned_cols=262  Identities=24%  Similarity=0.428  Sum_probs=212.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.++....   ....||+|.............+.+|+.+++.++|+||+++++++...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGK---KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCC---CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            4579999999999999999998765422   2344999998776555566778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|.+++..... .+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.++|+|||+++..
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999999998866433 6889999999999999999999977  999999999999999999999999999877


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....             
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~-------------  220 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKA-------------  220 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHH-------------
Confidence            53222222223445678999999998899999999999999999998 999997543221   1110             


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                       +......+.+...+..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus       221 -~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         221 -VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             011111122334567899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.4e-44  Score=329.87  Aligned_cols=268  Identities=21%  Similarity=0.274  Sum_probs=202.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||.|+||.||+|....+..      .||+|.+...........+.+|+.+++.++||||+++++++......
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTEN------LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCC------EEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            579999999999999999997655433      39999987554333445677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            999999975 8888876543 35788899999999999999999977  9999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH-----H---HH
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-----L---LK  302 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----~---~~  302 (389)
                      ....  ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.................     .   ..
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         155 VPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             CCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            3221  1233568999999999875 5689999999999999999999999987654332211100000     0   00


Q ss_pred             hhhhhhhhcCCCCCCC----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          303 EKKKLLNIIDPRLEGD----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..........+.....    .....+.++.+|+.+||+.||.+|||+.++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000111111111000    011345778999999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-44  Score=337.48  Aligned_cols=256  Identities=25%  Similarity=0.246  Sum_probs=206.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|.+.+.||+|+||.||+|++..+.+      .||+|++....  .......+..|+.++..++||||+++++++...+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGE------IVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            368999999999999999998765443      39999987542  1233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..|+||||++||+|.+++....  .+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            9999999999999999886543  6888999999999999999999977  99999999999999999999999999886


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........       +...   ..
T Consensus       151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-------i~~~---~~  215 (333)
T cd05600         151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN-------LKYW---KE  215 (333)
T ss_pred             ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH-------HHhc---cc
Confidence            543     22346799999999999999999999999999999999999999987543321110       0000   00


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .+............+.++.+|+.+||+.+|++||++.++++|-
T Consensus       216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~  258 (333)
T cd05600         216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP  258 (333)
T ss_pred             cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence            0110000001124568899999999999999999999999883

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.7e-44  Score=326.67  Aligned_cols=266  Identities=26%  Similarity=0.416  Sum_probs=209.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +..++|++.+.||+|+||.||+|.+..... ......||+|.+..........++.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCC-CCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            456789999999999999999998654322 1234559999986554444556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          149 EHRVLIYEFMARGSVENNLFSKV--------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      ...++||||+.+|+|.+++....        ...+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEE
Confidence            99999999999999999886432        124577888999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALP  299 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  299 (389)
                      |+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......   ....   
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~---  233 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRF---  233 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---
Confidence            999999876543322222222456788999999998899999999999999999999 788987653221   1110   


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          300 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                       .         ... .....+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus       234 -~---------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 -V---------MEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -H---------HcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence             0         000 0112233456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6e-44  Score=342.16  Aligned_cols=271  Identities=25%  Similarity=0.363  Sum_probs=213.0

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYC  145 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~  145 (389)
                      +....++|+++++||+|+||.||+|.+....+ ......||+|++...........+.+|+.+++.+. ||||+++++++
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSR-SQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCC-CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            34446789999999999999999997643221 22334599999976655555677889999999996 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCC------------------------------------------------------
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKV------------------------------------------------------  171 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  171 (389)
                      ...+.+|+||||+++|+|.+++....                                                      
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            99999999999999999998875421                                                      


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCe
Q 016481          172 ----------------------------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  211 (389)
Q Consensus       172 ----------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Ni  211 (389)
                                                              ...+++..+..++.|++.||+|||+.+  |+|+||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Ni  268 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhE
Confidence                                                    124677888899999999999999977  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhh
Q 016481          212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE  290 (389)
Q Consensus       212 li~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~  290 (389)
                      |++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            999999999999999886543322222233457788999999999999999999999999999997 9999976432110


Q ss_pred             hhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          291 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                        .    ...+          ........+...+..+.+++.+||+.||++||++.+|.+.|+.+.
T Consensus       349 --~----~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         349 --F----YNKI----------KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             --H----HHHH----------hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence              0    0000          011111223345688999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.3e-44  Score=336.27  Aligned_cols=269  Identities=27%  Similarity=0.384  Sum_probs=210.2

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  147 (389)
                      +..++|++.+.||+|+||.||+|...... .......||+|++...........+..|+.+++++ +|+||+++++++..
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIE-KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccc-cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            44568999999999999999999754322 12234569999987655455556778899999999 79999999998764


Q ss_pred             -CCeEEEEEEecCCCChhhhhhcCC-------------------------------------------------------
Q 016481          148 -DEHRVLIYEFMARGSVENNLFSKV-------------------------------------------------------  171 (389)
Q Consensus       148 -~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------  171 (389)
                       +..++++|||+++|+|.+++....                                                       
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             467889999999999998875422                                                       


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcccccccccccc
Q 016481          172 ----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG  247 (389)
Q Consensus       172 ----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~  247 (389)
                          ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++................++..
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                125788999999999999999999977  99999999999999999999999999987644332222333456778


Q ss_pred             ccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHH
Q 016481          248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHK  326 (389)
Q Consensus       248 y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (389)
                      |+|||++.+..++.++|||||||++|+|++ |..||......+.  +..              .+........+...+.+
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~  304 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR--------------RLKEGTRMRAPEYATPE  304 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH--------------HHhccCCCCCCccCCHH
Confidence            999999999999999999999999999998 9999976432211  000              00000111123345678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       327 l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      +.+++.+||+.+|++||++.+|+++|+.+-
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-46  Score=314.15  Aligned_cols=258  Identities=22%  Similarity=0.293  Sum_probs=208.8

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+.+.|.+.+.||+|.|+.||++.+..+++.      +|+|++.... .....+++.+|++|.+.|+||||+++.+.+..
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~------fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~   81 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLE------FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE   81 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHH------HHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc
Confidence            3456788899999999999999976655444      8888876432 33466778899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC---CCcEEEecc
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDF  224 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~---~~~vkl~Df  224 (389)
                      .+..|+|+|+|.|++|..-+..+  ..+++..+-..++||+++|.|+|.++  |||||+||+|+++..   ..-+||+||
T Consensus        82 ~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~F  157 (355)
T KOG0033|consen   82 ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADF  157 (355)
T ss_pred             cceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeeccc
Confidence            99999999999999998666544  25677778889999999999999987  999999999999943   446999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      |+|..+..+.   .-....|||.|||||++...+|+..+|||+.|||||-||.|.+||.+.+....      ...++...
T Consensus       158 GvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I~~g~  228 (355)
T KOG0033|consen  158 GLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQIKAGA  228 (355)
T ss_pred             ceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHHhccc
Confidence            9999877322   33457899999999999999999999999999999999999999987543211      01111111


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      .        ....+.....++++.+|+.+||..||.+|.|+.|.|+|-+
T Consensus       229 y--------d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  229 Y--------DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW  269 (355)
T ss_pred             c--------CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence            1        1123344567889999999999999999999999997743

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-43  Score=330.57  Aligned_cols=266  Identities=26%  Similarity=0.395  Sum_probs=212.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||+|+||.||+|.+..+..  .....||+|.+...........+..|+.+++.++||||+++++++... .
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGE--KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCC--ccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            3579999999999999999998754322  123458999987655555567788999999999999999999998764 5


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++|+||+.+|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccc
Confidence            689999999999999887653 35788889999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||........                 ..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-----------------~~  222 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----------------SS  222 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------HH
Confidence            54332222223345778999999999999999999999999999998 9999976532211                 01


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                      .+........+..++..+.+++.+||..||++||++.+++..|..+...+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         223 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            11111111223345678899999999999999999999999998776544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.8e-43  Score=328.19  Aligned_cols=268  Identities=22%  Similarity=0.303  Sum_probs=200.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|.+.+.||+|+||.||+|....+.+      .||+|++...........+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGK------LVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCC------EEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe
Confidence            3689999999999999999998655433      3999998765433334566789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+. ++|.+++.... ..++...+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          78 LTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             EEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            999999995 67887776543 36788899999999999999999977  999999999999999999999999998754


Q ss_pred             CCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh------
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE------  303 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------  303 (389)
                      ....  .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....+.... + .........      
T Consensus       154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~-~~~~~~~~~~~~~~~  229 (303)
T cd07869         154 SVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ-L-ERIFLVLGTPNEDTW  229 (303)
T ss_pred             cCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-H-HHHHHHhCCCChhhc
Confidence            3221  12233578999999999875 45889999999999999999999999865432211 1 000000000      


Q ss_pred             --hhhhhhhcCCCCCCCCC---------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          304 --KKKLLNIIDPRLEGDYP---------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       304 --~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                        ................+         ...+..+.+|+.+||+.||++|||+.++++|=
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~  289 (303)
T cd07869         230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE  289 (303)
T ss_pred             cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence              00000000000000000         01236788999999999999999999999873

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=352.85  Aligned_cols=269  Identities=24%  Similarity=0.413  Sum_probs=234.1

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ++-.+...+.++||.|.||.|++|+++...+.   ...||||.++..-......+|+.|..||.++.||||+++.|+...
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkr---e~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk  701 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKR---EITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK  701 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCc---ceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence            44456678889999999999999998876644   455999999988888888999999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ...+.||+|||++|+|+.+|..+.+ .+++-+...+++.|+.||.||-+++  +|||||..+|||+|.+..+|++|||++
T Consensus       702 s~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  702 SKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             CceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccce
Confidence            9999999999999999999988775 4888999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCC-CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          228 KDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       228 ~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +.+.+.. .......-....+|.|||.+....++.++||||+||+|||.++ |..||-.+..                 +
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----------------Q  841 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------------Q  841 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----------------H
Confidence            9775543 2222222345789999999999999999999999999999887 9999986643                 3


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                      ++++-++...+.+.|++|+..|..|+..||++|-.+||.|.+|+..|.++-.-|
T Consensus       842 dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  842 DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            345556666777889999999999999999999999999999999998875444

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-43  Score=325.05  Aligned_cols=247  Identities=21%  Similarity=0.309  Sum_probs=199.6

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEe----CCeE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE----DEHR  151 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  151 (389)
                      ..||+|++|.||+|.+..        ..||+|.+.....  ......+.+|+.++++++||||+++++++.+    ...+
T Consensus        26 ~~i~~g~~~~v~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         26 VLIKENDQNSIYKGIFNN--------KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             eEEeeCCceEEEEEEECC--------EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence            679999999999997632        3399999876432  2224667799999999999999999999876    3578


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      ++||||+++|+|.+++....  .+++.....++.+++.||.|||.. +  ++||||||+||+++.++.+||+|||+++..
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            99999999999999987643  678889999999999999999974 6  889999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ....     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||........   ..             
T Consensus       174 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~-------------  232 (283)
T PHA02988        174 SSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YD-------------  232 (283)
T ss_pred             cccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HH-------------
Confidence            3321     23468899999999976  6899999999999999999999999986543211   10             


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      ...........+..++..+.+|+.+||+.||++|||++++++.|+.++.
T Consensus       233 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            0111111222344567889999999999999999999999999987653

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.7e-43  Score=332.50  Aligned_cols=268  Identities=24%  Similarity=0.318  Sum_probs=206.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+..+..      .+|+|++...........+.+|+++++.++|+||+++++++...+.
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGL------IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCc------EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence            4789999999999999999997665443      3899988765555555678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      +++||||+.+|+|.+++....  .+++..+..++.+++.||.|||+. +  |+|+||||+|||++.++.+||+|||++..
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  153 (333)
T cd06650          78 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence            999999999999999886543  578899999999999999999973 5  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh-----------
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL-----------  298 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-----------  298 (389)
                      .....    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.............-..           
T Consensus       154 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (333)
T cd06650         154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP  229 (333)
T ss_pred             hhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence            53221    223578999999999999899999999999999999999999997543321110000000           


Q ss_pred             -------HHHH---------hhhhhhhhcCCCCCCCC-ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          299 -------PLLK---------EKKKLLNIIDPRLEGDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       299 -------~~~~---------~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                             ....         ....+...+........ ....+.++.+|+.+||++||++|||+.+++.|-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~  300 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA  300 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence                   0000         00000000000000011 112457799999999999999999999999873

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.5e-43  Score=323.19  Aligned_cols=263  Identities=28%  Similarity=0.400  Sum_probs=210.8

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|.+.+.||+|+||.||+|.+..... ......||+|.+...........+.+|+.+++.+.|+||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEP-ENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccC-cCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            468888999999999999997644311 1234559999988765554567888999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcE
Q 016481          152 VLIYEFMARGSVENNLFSKV------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA  219 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~v  219 (389)
                      ++||||+++|+|.+++....            ...+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCeE
Confidence            99999999999999986542            234788889999999999999999977  9999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHh
Q 016481          220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  298 (389)
                      +|+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||........   ...+ 
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~-  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECI-  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH-
Confidence            9999999876533222222233456788999999999999999999999999999998 9999976543211   1100 


Q ss_pred             HHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          299 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                                   ........+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus       238 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 -------------TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                         0111112233456889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=331.93  Aligned_cols=254  Identities=26%  Similarity=0.290  Sum_probs=216.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh--hhHHHHHHHHHHHhccC-CCccceEEeEEE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--QGHREWLAEVIFLGHLS-HPNLVKLIGYCC  146 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~  146 (389)
                      +...|.+.+.||+|.||.||+|+.+.+.+.      +|+|.+.+....  .....+.+|+.+|+++. |||||.++++|.
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~------~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e  106 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKE------VACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE  106 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCce------eEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            456799999999999999999987776444      999998776432  23467789999999998 999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC----CcEEEe
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD----YNAKLS  222 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~----~~vkl~  222 (389)
                      ....+++|||++.||.|.+.+...   .+++..+..++.|++.++.|||+.|  |+||||||+|+|+...    +.+|++
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEe
Confidence            999999999999999999999877   3899999999999999999999977  9999999999999533    579999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      |||++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||..........          
T Consensus       182 DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----------  248 (382)
T KOG0032|consen  182 DFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----------  248 (382)
T ss_pred             eCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----------
Confidence            9999998765   224556899999999999999999999999999999999999999998765432211          


Q ss_pred             hhhhhhhhcC--CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          303 EKKKLLNIID--PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       303 ~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                            .+..  .....+.....+..+.+++..||..||.+|+|+.++|+|-|
T Consensus       249 ------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  249 ------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             ------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence                  1111  12344455677899999999999999999999999999865

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.6e-43  Score=326.76  Aligned_cols=269  Identities=25%  Similarity=0.379  Sum_probs=214.9

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  145 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  145 (389)
                      +.+..++|++.+.||+|+||.||+|.+..... ......+|+|.............+.+|+.+++.+ +|+||+++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN-PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCC-CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            34455689999999999999999998754331 2233559999988665555566788999999999 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCe
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSK--------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  211 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Ni  211 (389)
                      ...+.++++|||+.+|+|..++...              ....+++..++.++.|++.||+|||+++  |+|+||||+||
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Ni  163 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNV  163 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeE
Confidence            9999999999999999999988542              2346889999999999999999999977  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhh
Q 016481          212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE  290 (389)
Q Consensus       212 li~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~  290 (389)
                      +++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            999999999999999987654332222222345678999999998999999999999999999998 9999976542211


Q ss_pred             hhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          291 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .                 ..+........+...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       244 ~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 F-----------------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             H-----------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            0                 11111111223345567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.3e-43  Score=320.70  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=209.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|.+.+.||+|+||.||+|.+......      |++|.....  ......+.+|+.+++.++|+||+++++++..+..
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~------~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLT------VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   76 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCce------EEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC
Confidence            45688899999999999999987654443      999998754  2334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~  154 (263)
T cd05052          77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM  154 (263)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccc
Confidence            999999999999999987665557899999999999999999999977  999999999999999999999999998876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........                 ..
T Consensus       155 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-----------------~~  216 (263)
T cd05052         155 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----------------YE  216 (263)
T ss_pred             ccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------HH
Confidence            432211 1112334678999999999999999999999999999998 9999976532211                 00


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .+........+...+.++.+++.+||+.||++||++.++++.|+.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         217 LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            1111122233445678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.5e-44  Score=336.38  Aligned_cols=249  Identities=24%  Similarity=0.321  Sum_probs=204.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|.+.+.||+|+||.||+|.+....     ...||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNED-----FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCC-----CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            457999999999999999999754432     1249999875432  223345677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+|+||||+.+|+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            99999999999999999887654  6889999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .....     .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+...   .             .
T Consensus       180 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~-------------~  238 (340)
T PTZ00426        180 VVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---Y-------------Q  238 (340)
T ss_pred             ecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---H-------------H
Confidence            65321     2245799999999999999999999999999999999999999986543211   0             0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      .+....  ..++...+..+.+++++||+.||++|+     +++++++|
T Consensus       239 ~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        239 KILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            001110  112334567889999999999999995     89999988

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.9e-43  Score=326.54  Aligned_cols=269  Identities=26%  Similarity=0.353  Sum_probs=213.6

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      ....++|.+.+.||+|+||.||+|.+.... .......||+|.+...........+.+|+.+++++ +|+||+++++++.
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLS-KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCC-CCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            344567999999999999999999754321 12234459999987654445556788999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      ..+..++||||+.+|+|.+++.......+++..+..++.+++.||+|||+.+  |+|+||||+||+++.++.++|+|||+
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCcc
Confidence            9999999999999999999987654445899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +................++..|+|||.+.+..++.++|||||||++|+|++ |..||.........              
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--------------  253 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--------------  253 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--------------
Confidence            886644322112223456788999999999999999999999999999998 99999765432110              


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                        ...+........+...+.++.+++.+||+.+|++||++.++++.|+++
T Consensus       254 --~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         254 --YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              001111111122233467899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-43  Score=346.41  Aligned_cols=254  Identities=20%  Similarity=0.258  Sum_probs=204.3

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      .|.+.+.||+|+||.||+|....+.     ...||+|...... ......+..|+.+++.++||||+++++++..++.+|
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~-----~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDP-----KEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCC-----CeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            4899999999999999999754431     2238888765442 333456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          153 LIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +||||++||+|.+++...  ...++++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            999999999999887542  2346888999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ............+||+.|+|||++.+..++.++|||||||++|+|++|+.||........      .          ...
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~------~----------~~~  283 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI------M----------QQV  283 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------H----------HHH
Confidence            543322234456799999999999999999999999999999999999999976532210      0          000


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ... .....+...+.++.+++.+||+.||++||++.+++.+
T Consensus       284 ~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        284 LYG-KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             HhC-CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            000 0112234456789999999999999999999999754

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-44  Score=349.00  Aligned_cols=261  Identities=23%  Similarity=0.276  Sum_probs=216.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeE-EEe-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGY-CCE-  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~-  147 (389)
                      .-++++.++|.+|||+.||+|......      ..||+|++-.. .....+...+|+.+|+.|. |+|||.+++. ... 
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~------~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGG------KKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCC------ceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            456888999999999999999866553      33999987766 5667788899999999997 9999999993 221 


Q ss_pred             -----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          148 -----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       148 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                           .-.++|.||||.||.|.+++..+....|++.++++|+.++++|+++||....+|||||||-+||||+.+|++|||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence                 135689999999999999998777777999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCcCCCCCCCcccc-------ccccccccccCcccc---ccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhh
Q 016481          223 DFGLAKDGPEGDKSHVS-------TRIMGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN  292 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~l---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  292 (389)
                      |||.|......-.....       -...-|+.|+|||++   .+..++.|+|||+|||+||-||....||+....     
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----  263 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----  263 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----
Confidence            99998754322111000       013469999999987   477899999999999999999999999987532     


Q ss_pred             hHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          293 LADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                                     ..++......+.....+..+.+||..||+.||++||++-+++..+-.+...
T Consensus       264 ---------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 ---------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ---------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                           344555555444567899999999999999999999999999998777554

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-43  Score=322.60  Aligned_cols=266  Identities=28%  Similarity=0.425  Sum_probs=213.2

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +..++|++.+.||+|+||.||+|.++.... ......||+|.............+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVK-GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCC-CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            345689999999999999999998764331 2234559999987665555566788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          149 EHRVLIYEFMARGSVENNLFSKV--------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      ...++||||+++|+|.+++....        ...+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.+|
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEE
Confidence            99999999999999999886532        224678889999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALP  299 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  299 (389)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||........   ..+   
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~---  233 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKF---  233 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHH---
Confidence            999999886544332222233457889999999988889999999999999999998 9999976543221   110   


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          300 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                                 +........+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       234 -----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         234 -----------VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -----------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                       01111112334457889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-43  Score=332.44  Aligned_cols=244  Identities=25%  Similarity=0.320  Sum_probs=198.3

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (389)
                      +.||+|+||.||+|....+..      .||+|++....  .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGR------YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEE
Confidence            469999999999997655443      39999987542  2233456678999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCC
Q 016481          156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  235 (389)
Q Consensus       156 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~  235 (389)
                      ||+++|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++....... 
T Consensus        75 E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-  149 (323)
T cd05595          75 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-
Confidence            9999999988876543  6889999999999999999999977  9999999999999999999999999987532211 


Q ss_pred             ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCC
Q 016481          236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  315 (389)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (389)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........                .+...  
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----------------~~~~~--  210 (323)
T cd05595         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----------------LILME--  210 (323)
T ss_pred             -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH----------------HHhcC--
Confidence             12234679999999999999999999999999999999999999997654321100                00000  


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          316 EGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      ...++...+.++.+|+.+||+.||++||     ++.++++|
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            1122345578899999999999999998     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=330.49  Aligned_cols=242  Identities=27%  Similarity=0.304  Sum_probs=197.0

Q ss_pred             ecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           80 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        80 lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      ||+|+||.||+|....+.+      .||+|++....  .......+..|+.+++.++||||+++++++...+..++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~------~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQR------IYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcC
Confidence            7999999999998665443      39999886432  233446677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                      +++|+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......  .
T Consensus        75 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  148 (312)
T cd05585          75 INGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--D  148 (312)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--C
Confidence            99999999887643  6889999999999999999999977  9999999999999999999999999987543221  1


Q ss_pred             ccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCC
Q 016481          238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  317 (389)
Q Consensus       238 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (389)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||........      ..          .++..  ..
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~----------~~~~~--~~  210 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YR----------KILQE--PL  210 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HH----------HHHcC--CC
Confidence            23346799999999999999999999999999999999999999986532210      00          11111  11


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 016481          318 DYPVKGVHKAAMLAYHCLNHNPKARPL---MRDIVDS  351 (389)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dP~~Rps---~~~il~~  351 (389)
                      .++...+.++.+|+.+||+.||++||+   +.++++|
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            234456688999999999999999975   6777776

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-43  Score=331.83  Aligned_cols=245  Identities=23%  Similarity=0.300  Sum_probs=199.3

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (389)
                      +.||+|+||.||+|....+.+      .||+|++....  .......+.+|+.+++.++||||+++++++...+.+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGK------YYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEE
Confidence            469999999999997655443      39999987542  2234456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCC
Q 016481          156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  235 (389)
Q Consensus       156 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~  235 (389)
                      ||+++|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++...... 
T Consensus        75 Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-  149 (328)
T cd05593          75 EYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-  149 (328)
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence            9999999988886543  6889999999999999999999977  9999999999999999999999999987543211 


Q ss_pred             ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCC
Q 016481          236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  315 (389)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (389)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.........      .          .+..  .
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~------~----------~~~~--~  210 (328)
T cd05593         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------E----------LILM--E  210 (328)
T ss_pred             -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH------H----------Hhcc--C
Confidence             1223467999999999999999999999999999999999999999764322110      0          0000  0


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 016481          316 EGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDSL  352 (389)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~L  352 (389)
                      ...++...+.++.+|+.+||+.||++|+     ++.++++|-
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  252 (328)
T cd05593         211 DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS  252 (328)
T ss_pred             CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence            1123345568899999999999999997     899999873

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.7e-43  Score=322.08  Aligned_cols=262  Identities=26%  Similarity=0.396  Sum_probs=209.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||+|+||.||+|.+....  ......|++|.+...........+.+|+.+++.++||||+++++++..+...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPG--MDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCC--CCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            56888999999999999999754322  1233459999987655555556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          152 VLIYEFMARGSVENNLFSKV---------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      ++||||+++|+|.+++....               ...+++..+..++.|++.||+|||+++  ++|+||||+||+++.+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~  160 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCC
Confidence            99999999999999885321               124778888999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHH
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~  295 (389)
                      +.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....+...     
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~-----  235 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV-----  235 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence            9999999999987544332222333456778999999988889999999999999999998 9999976532111     


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                                  ...+........+..++..+.+++.+||+.||++||++.+|+++|..
T Consensus       236 ------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 ------------IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                        01111111112334556889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.9e-43  Score=338.28  Aligned_cols=255  Identities=24%  Similarity=0.261  Sum_probs=200.0

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .|.+.+.||+|+||+||+|+...+.+      .||+|++....  .......+..|+.+++.++|+||+++++++.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~------~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHA------LYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            68889999999999999998665543      39999986532  22334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++||||++||+|.+++....  .+++..+..++.|++.||+|||..+  |+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            999999999999999887654  6888899999999999999999977  999999999999999999999999997643


Q ss_pred             CCCCC---------------------------------------------ccccccccccccccCccccccCCCCcccch
Q 016481          231 PEGDK---------------------------------------------SHVSTRIMGTYGYAAPEYIMTGHLTPRSDV  265 (389)
Q Consensus       231 ~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~Di  265 (389)
                      .....                                             .......+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            11000                                             000123579999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhh--ccCCCCCC
Q 016481          266 YSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCL--NHNPKARP  343 (389)
Q Consensus       266 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dP~~Rp  343 (389)
                      |||||++|||++|+.||....+.....      .       ... .......+.....+.++.+|+.+|+  ..+|..||
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~~------~-------i~~-~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQL------K-------VIN-WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHHH------H-------HHc-cccccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence            999999999999999998654322110      0       000 0001111112245688999999854  55566699


Q ss_pred             CHHHHHHH
Q 016481          344 LMRDIVDS  351 (389)
Q Consensus       344 s~~~il~~  351 (389)
                      ++.++++|
T Consensus       298 ~~~~~l~h  305 (381)
T cd05626         298 GADDIKAH  305 (381)
T ss_pred             CHHHHhcC
Confidence            99999988

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.9e-43  Score=315.38  Aligned_cols=250  Identities=25%  Similarity=0.395  Sum_probs=200.6

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      +.||+|+||.||+|.+..+.+.      ||+|.............+.+|+.+++.++|+||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~------~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTP------VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEecCCce------EEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence            4689999999999987655443      9999887655555567788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                      +.+++|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++..........
T Consensus        75 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  151 (252)
T cd05084          75 VQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS  151 (252)
T ss_pred             ccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence            99999999886543 35789999999999999999999977  9999999999999999999999999987654321111


Q ss_pred             ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCC
Q 016481          238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  316 (389)
Q Consensus       238 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (389)
                      .......+..|+|||.+.+..++.++||||||+++|+|++ |..||.........                 ..+.....
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-----------------~~~~~~~~  214 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-----------------EAIEQGVR  214 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-----------------HHHHcCCC
Confidence            1111223567999999998899999999999999999998 88888754322110                 01111112


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          317 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ...+...+..+.+|+.+||+.+|++|||+.++++.|+
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2334455678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.3e-43  Score=322.26  Aligned_cols=263  Identities=26%  Similarity=0.381  Sum_probs=209.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|++.+.||+|+||.||+|.+..+.. ......||+|.+...........+..|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAP-GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            457778999999999999997654321 2234569999998665544456788899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      ++++||+.+++|.+++....              ...+++..+..++.|++.||+|||+++  |+||||||+||+++.++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCCC
Confidence            99999999999998874321              134788888999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHH
Q 016481          218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       218 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  296 (389)
                      .+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......   ... 
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~-  237 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIE-  237 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH-
Confidence            999999999887644332222333456789999999988889999999999999999998 888887643221   110 


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                                   .+........+..++..+.+|+.+||+.+|++||++++|+..|+.
T Consensus       238 -------------~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 -------------MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -------------HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                         011111122344567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-44  Score=337.44  Aligned_cols=256  Identities=26%  Similarity=0.283  Sum_probs=206.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|.+.+.||+|+||.||+|....+.+      .||+|++....  .......+..|+.++..++|+||+++++++.+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQ------VYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCC------EEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            478999999999999999998765443      39999987532  1233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ++++||||+.+|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            999999999999999998766  37889999999999999999999977  99999999999999999999999999886


Q ss_pred             CCCCC---------------------------CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCC
Q 016481          230 GPEGD---------------------------KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL  282 (389)
Q Consensus       230 ~~~~~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf  282 (389)
                      .....                           .........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            54332                           001123357999999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHh
Q 016481          283 DKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-MRDIVDSL  352 (389)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~~il~~L  352 (389)
                      .........      ..       +... ...+..+.....+.++.+|+.+||. ||.+||+ +.++++|-
T Consensus       231 ~~~~~~~~~------~~-------i~~~-~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         231 YSDTLQETY------NK-------IINW-KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             CCCCHHHHH------HH-------Hhcc-CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            876532110      00       0000 0111111112257889999999998 9999999 99999884

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-43  Score=330.97  Aligned_cols=268  Identities=22%  Similarity=0.333  Sum_probs=199.1

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC---
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED---  148 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---  148 (389)
                      +|++.+.||+|+||.||+|+...+..      .||+|.+.... .......+.+|+.+++.++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGE------KVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCC------EEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            58889999999999999998665544      39999886432 223345678999999999999999999987543   


Q ss_pred             --CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          149 --EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       149 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                        ..+|+||||+. ++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          75 EFKDIYVVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCcc
Confidence              35899999995 68888876543  6889999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCc-cccccccccccccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH-------
Q 016481          227 AKDGPEGDKS-HVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW-------  296 (389)
Q Consensus       227 a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-------  296 (389)
                      ++........ .......||+.|+|||++.+  ..++.++|||||||++|+|++|++||..............       
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9865332211 11234579999999999876  6789999999999999999999999976543221111000       


Q ss_pred             --HhHHHHh-hhhhhhhcCCCCCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          297 --ALPLLKE-KKKLLNIIDPRLEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       297 --~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        ....... .......+........   ....+..+.+++.+||+.||++|||+.++++|
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence              0000000 0001111111111110   01235678999999999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.7e-43  Score=319.71  Aligned_cols=263  Identities=28%  Similarity=0.400  Sum_probs=207.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|.+.+.||+|+||.||+|.+..... ......|++|.............+..|+.+++.++|+||+++++++.+...
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDG-DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCC-CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3578999999999999999998765211 113445999988765555556678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC---cEEEe
Q 016481          151 RVLIYEFMARGSVENNLFSKVL-----LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---NAKLS  222 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~---~vkl~  222 (389)
                      .++||||++||+|.+++.....     ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++   .+||+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEec
Confidence            9999999999999998865432     35889999999999999999999977  99999999999998654   59999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      |||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||........   ..      
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~------  232 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME------  232 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH------
Confidence            9999987633221111222334568999999998899999999999999999997 9999986543211   10      


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                              .+........+..++..+.+++.+||+.+|++||++.+++++|+
T Consensus       233 --------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 --------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                    11111112234455678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.2e-44  Score=317.45  Aligned_cols=269  Identities=25%  Similarity=0.349  Sum_probs=203.8

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC---
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE---  149 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---  149 (389)
                      .|...+++|.|+||.||+|...++...      ||||..-.+.....     +|+.+|+.+.|||||++.-+|....   
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~------vAIKKv~~d~r~kn-----rEl~im~~l~HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEE------VAIKKVLQDKRYKN-----RELQIMRKLDHPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCce------eEEEEecCCCCcCc-----HHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence            577789999999999999988776443      99999876644332     6999999999999999998886432   


Q ss_pred             --eEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC-CcEEEecc
Q 016481          150 --HRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDF  224 (389)
Q Consensus       150 --~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~-~~vkl~Df  224 (389)
                        .+.+|||||+. +|.+.+..  .....++.-.+.-+..||++||+|||+++  |+||||||.|+|+|.+ |.+|||||
T Consensus        94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen   94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccC
Confidence              44689999974 89888764  23456777788889999999999999977  9999999999999976 99999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH---
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL---  300 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---  300 (389)
                      |.|+....+...   .+...|..|+|||++.|. .|+.+.||||.||++.||+.|++.|.+.+...+....--+...   
T Consensus       171 GSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~  247 (364)
T KOG0658|consen  171 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR  247 (364)
T ss_pred             CcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence            999988665533   345678899999999875 7999999999999999999999999986554432221111100   


Q ss_pred             --HHhhh------hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccCC
Q 016481          301 --LKEKK------KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  358 (389)
Q Consensus       301 --~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~~  358 (389)
                        +....      ...++....+..-+....+.++.+|+.++|+++|.+|.++.+++.|  +..+...
T Consensus       248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence              00000      0111111111111344568899999999999999999999999976  5555443

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.6e-43  Score=319.77  Aligned_cols=264  Identities=24%  Similarity=0.383  Sum_probs=207.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|++.+.||+|+||.||+|.+..+...  ....+++|............++..|+.+++.+.||||+++++++. ....
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDS--IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCc--eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            5788899999999999999987544321  123478888765444444567778888999999999999999875 4567


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++++||+.+|+|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            89999999999999987543 36889999999999999999999977  9999999999999999999999999998654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..||....+...   .+              .
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~--------------~  223 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---PD--------------L  223 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH--------------H
Confidence            4332222333567788999999998899999999999999999998 9999986543211   11              1


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      +........+..++..+..++.+||..||++|||+.++++.|..+..-
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         224 LEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             HHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            111111111223456788999999999999999999999999886643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.8e-43  Score=321.77  Aligned_cols=264  Identities=29%  Similarity=0.412  Sum_probs=210.3

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      +|++.+.||+|+||.||+|....... ......+++|.+...........+..|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKG-RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCC-CCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            47888999999999999997643221 12234588998876655555677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 016481          153 LIYEFMARGSVENNLFSKV----------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  210 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~N  210 (389)
                      +|+||+.+|+|.+++....                      ...+++..+..++.|++.||+|||+++  ++|+||||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n  157 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN  157 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence            9999999999998875321                      135788899999999999999999977  9999999999


Q ss_pred             eEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchh
Q 016481          211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAR  289 (389)
Q Consensus       211 ili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  289 (389)
                      |+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999886543322212223456778999999988889999999999999999998 999997654321


Q ss_pred             hhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          290 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      .   .              ..+........+...+..+.+++.+||+.+|++||++.++++.|+++-
T Consensus       238 ~---~--------------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 L---F--------------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             H---H--------------HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            1   1              111111122233445678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-44  Score=305.72  Aligned_cols=255  Identities=26%  Similarity=0.361  Sum_probs=211.5

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-------ChhhHHHHHHHHHHHhccC-CCccce
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-------SYQGHREWLAEVIFLGHLS-HPNLVK  140 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~-h~niv~  140 (389)
                      ..-+.|...+.||+|..++|.+|.++.+++.      +|+|++....       ...-...-.+|+.||+++. ||+|+.
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e------~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~   87 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKE------FAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID   87 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccc------eeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence            3445788888999999999999988777665      8888765321       1112234457999999985 999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      +.++|..+..+++|+|.|+.|.|.+++.+..  .++++....|++|+.+|++|||..+  ||||||||+|||++++.++|
T Consensus        88 l~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   88 LQDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             eeeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceE
Confidence            9999999999999999999999999997765  6889999999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCcccccc------CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  294 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  294 (389)
                      |+|||+|..+..+.   .....||||+|+|||.+..      .+|+..+|+|++|+|||.||.|.+||-.....      
T Consensus       164 isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm------  234 (411)
T KOG0599|consen  164 ISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM------  234 (411)
T ss_pred             EeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH------
Confidence            99999999987765   3456899999999999863      47899999999999999999999999754221      


Q ss_pred             HHHhHHHHhhhhhhhhcCCC--CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          295 DWALPLLKEKKKLLNIIDPR--LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                                -.+..++...  +..+...+.+..+.+||.+||+.||++|.|+.++|.|-
T Consensus       235 ----------lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  235 ----------LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             ----------HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence                      1122222222  23344567889999999999999999999999999884

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-43  Score=314.66  Aligned_cols=274  Identities=24%  Similarity=0.279  Sum_probs=208.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCc-cceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPN-LVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~  148 (389)
                      ...|...++||+|+||+||+|+.+.+++.      ||+|.++.+... ..-....+|+.+++.++|+| |+.+++++...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~------VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~   83 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKF------VALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTS   83 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCE------EEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence            34577778899999999999987766544      999998876542 22244578999999999999 99999999887


Q ss_pred             C------eEEEEEEecCCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          149 E------HRVLIYEFMARGSVENNLFSKVL--LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       149 ~------~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      +      .+++|+||++. +|..++.....  ..++...+..++.|++.||+|||+++  |+||||||.||||+.+|.+|
T Consensus        84 ~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lK  160 (323)
T KOG0594|consen   84 NNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLK  160 (323)
T ss_pred             ccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEe
Confidence            7      89999999964 89888866543  35777889999999999999999988  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh-
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL-  298 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-  298 (389)
                      |+|||+|+...-...  ..+...+|..|+|||++.+. .|+...||||+|||++||+++++.|.+..+.......-... 
T Consensus       161 laDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG  238 (323)
T KOG0594|consen  161 LADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG  238 (323)
T ss_pred             eeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC
Confidence            999999996543222  24456889999999999987 79999999999999999999999999877644321111110 


Q ss_pred             -HHHHhhhhhhhhcCC--CCCCCC-C-------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccc
Q 016481          299 -PLLKEKKKLLNIIDP--RLEGDY-P-------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPL  355 (389)
Q Consensus       299 -~~~~~~~~~~~~~~~--~~~~~~-~-------~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~  355 (389)
                       +.....+.+....+-  .+.... +       ........+++.+||+.+|.+|.|+..++.|  +..+
T Consensus       239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence             000000111100000  000000 1       1112578999999999999999999999988  5544

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-43  Score=336.32  Aligned_cols=255  Identities=23%  Similarity=0.262  Sum_probs=202.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||.||+|.+..+.+      .||+|++....  .......+.+|+.+++.++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGH------IYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            478999999999999999998765543      39999986432  1233455778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+||||+.+|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeeccccee
Confidence            9999999999999999887654  6899999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCcc------------------------------------ccccccccccccCccccccCCCCcccchhHHHHHHH
Q 016481          230 GPEGDKSH------------------------------------VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL  273 (389)
Q Consensus       230 ~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~  273 (389)
                      ........                                    .....+||+.|+|||++.+..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            43211000                                    011246999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 016481          274 EILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL---MRDIVD  350 (389)
Q Consensus       274 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~~il~  350 (389)
                      +|++|..||....+....   .   ...       .. ...+..+.....+.++.+|+.+||. +|.+|++   +.++++
T Consensus       231 el~~G~~Pf~~~~~~~~~---~---~i~-------~~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         231 EMLVGYPPFCSDNPQETY---R---KII-------NW-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCCCCCHHHHH---H---HHH-------cC-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999999999866432210   0   000       00 0011111112346788999999997 9999998   999988


Q ss_pred             H
Q 016481          351 S  351 (389)
Q Consensus       351 ~  351 (389)
                      |
T Consensus       296 h  296 (364)
T cd05599         296 H  296 (364)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-43  Score=333.85  Aligned_cols=263  Identities=20%  Similarity=0.244  Sum_probs=198.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|.+.+.||+|+||.||+|.+..+.+.      ||+|....       ..+.+|+.+++.++||||+++++++.....
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~------vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~  157 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEH------VVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKF  157 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCE------EEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence            35799999999999999999987655443      99997532       245689999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++|+|++. ++|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++...
T Consensus       158 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        158 TCLILPRYK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             eEEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            999999995 68888776543  6789999999999999999999977  999999999999999999999999998754


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhh-----hhhHHHHhHH-----
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE-----QNLADWALPL-----  300 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~~-----  300 (389)
                      .... ........||+.|+|||++.+..++.++|||||||++|+|++|..||........     ..+...+...     
T Consensus       233 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        233 VDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             cccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence            3221 1122346799999999999999999999999999999999999988754322110     0000000000     


Q ss_pred             ------HHhhhhhh-hhcC--CCCCCCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          301 ------LKEKKKLL-NIID--PRLEGDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       301 ------~~~~~~~~-~~~~--~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                            ........ ....  .......     ....+.++.+|+.+||+.||++|||+.++++|=
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp  377 (391)
T PHA03212        312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA  377 (391)
T ss_pred             hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence                  00000000 0000  0000000     113467899999999999999999999999874

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.7e-43  Score=344.80  Aligned_cols=259  Identities=24%  Similarity=0.276  Sum_probs=208.0

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      .....+|++.+.||+|+||+||+|....+.+      .||+|++.... .......+.+|+.++..++|+||+++++.+.
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~------~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGE------PFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCC------EEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            3445799999999999999999997655443      49999986543 3444566788999999999999999988765


Q ss_pred             eCC--------eEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          147 EDE--------HRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       147 ~~~--------~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      ...        .+++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.+  |+||||||+|||++.+
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN  179 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC
Confidence            432        368999999999999988653  2346889999999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      +.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~  253 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------V  253 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------H
Confidence            9999999999987654332333345689999999999999999999999999999999999999998653211      1


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ...          .+. ......+...+.++.+++.+||+.||++||++.+++++
T Consensus       254 ~~~----------~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        254 MHK----------TLA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHH----------Hhc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            000          010 11122344567889999999999999999999999876

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-42  Score=318.89  Aligned_cols=266  Identities=25%  Similarity=0.417  Sum_probs=211.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||+|+||+||+|.+..+...  ....||+|.............+.+|+.+++.+.|+||+++++++.. ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN--VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCc--cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence            45789999999999999999987654332  2345899998766555556778899999999999999999999875 45


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeec
Confidence            789999999999999886543 36899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......   ...              
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~--------------  222 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPD--------------  222 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH--------------
Confidence            43322211222345678999999999999999999999999999998 999997543211   111              


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                      .+........+..++..+.+++.+||+.||++||++.++++.|+.+...+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         223 LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            11111111223345678899999999999999999999999998876664

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.3e-43  Score=325.58  Aligned_cols=271  Identities=25%  Similarity=0.392  Sum_probs=213.0

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeecccccc-CcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  145 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  145 (389)
                      .+..++|.+.+.||+|+||.||+|.+....+. ......+|+|.+...........+..|+.+++.+ +|+||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34457899999999999999999976443221 1223459999988654455556788899999999 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCe
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVL--------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  211 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Ni  211 (389)
                      ...+..++||||+.+|+|.+++.....              ..+++..+..++.|++.||+|||+++  ++|+||||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Ni  171 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV  171 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHhe
Confidence            999999999999999999999865421              24788899999999999999999977  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhh
Q 016481          212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE  290 (389)
Q Consensus       212 li~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~  290 (389)
                      +++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||....... 
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-  250 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-  250 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-
Confidence            999999999999999876543221111222334578999999999899999999999999999998 888987543211 


Q ss_pred             hhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          291 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                        +.              ..+........+...+.++.+++.+||..+|++||++.++++.|+.+..
T Consensus       251 --~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         251 --LF--------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             --HH--------------HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence              10              0111111222344556889999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.2e-43  Score=325.90  Aligned_cols=244  Identities=27%  Similarity=0.356  Sum_probs=193.5

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhc-cCCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGH-LSHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|.+..+.+      .||+|.+....  .......+..|..++.. .+||||+++++++.....+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNE------FFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            469999999999998765443      39999987532  12233445566667664 4799999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||++||+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          75 MEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            99999999998886543  6889999999999999999999977  9999999999999999999999999987643322


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.........      ..          +..  
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~------~~----------i~~--  210 (316)
T cd05592         151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF------DS----------ILN--  210 (316)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH------HH----------HHc--
Confidence              1233467999999999999999999999999999999999999999865432110      00          000  


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR-DIVDS  351 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~il~~  351 (389)
                      ....++...+.++.+|+.+||+.||++||++. ++++|
T Consensus       211 ~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            01123344567889999999999999999875 66554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.9e-43  Score=337.19  Aligned_cols=254  Identities=23%  Similarity=0.256  Sum_probs=199.7

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      +|++.+.||+|+||.||+|+...+.+      .||+|++....  .......+.+|+.+++.++|+||+++++.+.+...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~------~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKA------LYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCC------EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            68899999999999999998665543      39999986532  12334567789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            999999999999999886653  6788899999999999999999977  999999999999999999999999997532


Q ss_pred             CCCCC---------------------------------------------ccccccccccccccCccccccCCCCcccch
Q 016481          231 PEGDK---------------------------------------------SHVSTRIMGTYGYAAPEYIMTGHLTPRSDV  265 (389)
Q Consensus       231 ~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~Di  265 (389)
                      .....                                             .......+||+.|+|||++.+..|+.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            11000                                             000123479999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-
Q 016481          266 YSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-  344 (389)
Q Consensus       266 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-  344 (389)
                      |||||++|||++|++||....+.....      .       ... .......+.....+.++.+++.+|+ .+|.+|++ 
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~------~-------i~~-~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  296 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQM------K-------VIN-WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK  296 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHHH------H-------HHc-cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence            999999999999999998654322110      0       000 0111111112345678889998876 49999997 


Q ss_pred             --HHHHHHH
Q 016481          345 --MRDIVDS  351 (389)
Q Consensus       345 --~~~il~~  351 (389)
                        +.++++|
T Consensus       297 ~~~~ei~~h  305 (382)
T cd05625         297 NGADEIKAH  305 (382)
T ss_pred             CCHHHHhcC
Confidence              9998877

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.7e-43  Score=334.69  Aligned_cols=268  Identities=24%  Similarity=0.298  Sum_probs=211.9

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-C-----CccceEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-H-----PNLVKLI  142 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~  142 (389)
                      .+..+|.+.+.||+|+||.|-+|.+..+...      ||||+++...  ....+...|+.+|..|+ |     -|+|+++
T Consensus       183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~------VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~  254 (586)
T KOG0667|consen  183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEI------VAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRML  254 (586)
T ss_pred             eeEEEEEEEEEecccccceeEEEEecCCCcE------EEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence            4455889999999999999999987776655      9999998753  44456678999999987 3     5799999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC--CcEE
Q 016481          143 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAK  220 (389)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~--~~vk  220 (389)
                      ++|...+|+|||+|++. -+|++++......+++...+..++.||+.||..||.++  |||+||||+|||+...  ..||
T Consensus       255 d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vK  331 (586)
T KOG0667|consen  255 DYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIK  331 (586)
T ss_pred             eccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCcee
Confidence            99999999999999995 59999999988889999999999999999999999988  9999999999999643  3799


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh--
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--  298 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--  298 (389)
                      |+|||.|......-     .....+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.++.+......-++  
T Consensus       332 VIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~  406 (586)
T KOG0667|consen  332 VIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL  406 (586)
T ss_pred             EEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence            99999998754432     24567888999999999999999999999999999999999999887766442221111  


Q ss_pred             ---HHHHhhhhhhhhcCC---------------------------------CCC-------CCCChHHHHHHHHHHHHhh
Q 016481          299 ---PLLKEKKKLLNIIDP---------------------------------RLE-------GDYPVKGVHKAAMLAYHCL  335 (389)
Q Consensus       299 ---~~~~~~~~~~~~~~~---------------------------------~~~-------~~~~~~~~~~l~~li~~cl  335 (389)
                         .++........+++.                                 +.+       ..........+.+|+++||
T Consensus       407 Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L  486 (586)
T KOG0667|consen  407 PPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL  486 (586)
T ss_pred             CCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence               000000001111111                                 000       0011133567899999999


Q ss_pred             ccCCCCCCCHHHHHHHh
Q 016481          336 NHNPKARPLMRDIVDSL  352 (389)
Q Consensus       336 ~~dP~~Rps~~~il~~L  352 (389)
                      .+||.+|+|..++++|-
T Consensus       487 ~~dP~~R~tp~qal~Hp  503 (586)
T KOG0667|consen  487 EWDPAERITPAQALNHP  503 (586)
T ss_pred             ccCchhcCCHHHHhcCc
Confidence            99999999999999983

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-43  Score=337.27  Aligned_cols=256  Identities=22%  Similarity=0.231  Sum_probs=199.5

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|.+.+.||+|+||.||+|..+.+.+      .||+|.+....  .......+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGK------IYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCC------EEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            378899999999999999997765544      39999876432  2233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..|+||||++||+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999999999886543  6888999999999999999999977  99999999999999999999999999864


Q ss_pred             CCCCCCc---------------------------------------------cccccccccccccCccccccCCCCcccc
Q 016481          230 GPEGDKS---------------------------------------------HVSTRIMGTYGYAAPEYIMTGHLTPRSD  264 (389)
Q Consensus       230 ~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~D  264 (389)
                      .......                                             ......+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            3211000                                             0001246999999999999999999999


Q ss_pred             hhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCC--
Q 016481          265 VYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR--  342 (389)
Q Consensus       265 iwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R--  342 (389)
                      ||||||++|||++|..||.........  .    . +      ... ...+..+.....+.++.+|+.+||. +|.+|  
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~--~----~-i------~~~-~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHETY--R----K-I------INW-RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHHHH--H----H-H------Hcc-CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            999999999999999999765432110  0    0 0      000 0001111112346789999999998 66665  


Q ss_pred             -CCHHHHHHHh
Q 016481          343 -PLMRDIVDSL  352 (389)
Q Consensus       343 -ps~~~il~~L  352 (389)
                       +++.+++.|-
T Consensus       296 r~~~~~~l~hp  306 (377)
T cd05629         296 RGGAHEIKSHP  306 (377)
T ss_pred             CCCHHHHhcCC
Confidence             5999999884

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.4e-43  Score=333.04  Aligned_cols=256  Identities=24%  Similarity=0.262  Sum_probs=198.6

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||+||+|..+.+.+      .||+|++....  .......+..|+.++..++|+||+++++.+.+..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGH------VYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCC------EEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            478999999999999999997665443      39999986532  1223356778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            9999999999999999987653  6899999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------------cccccccccccccCccccccCCCCcccchhHHHHHHHHHH
Q 016481          230 GPEGDKS---------------------------------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL  276 (389)
Q Consensus       230 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ell  276 (389)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            4321100                                 0012357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 016481          277 TGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLN--HNPKARPLMRDIVDS  351 (389)
Q Consensus       277 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rps~~~il~~  351 (389)
                      +|+.||....+....   .   .       +... ...+..+.....+.++.+++.+++.  .++..||++.+|++|
T Consensus       231 ~G~~Pf~~~~~~~~~---~---~-------i~~~-~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         231 IGYPPFCSETPQETY---K---K-------VMNW-KETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             hCCCCCCCCCHHHHH---H---H-------HHcC-cCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999999865432110   0   0       0000 0000001111345778888888664  233356899999988

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.5e-43  Score=334.87  Aligned_cols=270  Identities=24%  Similarity=0.365  Sum_probs=212.3

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYC  145 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~  145 (389)
                      +.+..++|.+.+.||+|+||.||+|++.... .......||+|++...........+..|+.++..+. ||||+++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLS-HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCC-CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            4455667889999999999999999876432 222345599999986654444567889999999997 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCC-----------------------------------------------------
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVL-----------------------------------------------------  172 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  172 (389)
                      ...+..++||||+.+|+|.+++.....                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            999999999999999999998864311                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCC
Q 016481          173 -------------------------------------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS  209 (389)
Q Consensus       173 -------------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~  209 (389)
                                                                 ..+++..+..++.|++.||+|||+.+  ++||||||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~  268 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAAR  268 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcc
Confidence                                                       13566778889999999999999966  999999999


Q ss_pred             CeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCch
Q 016481          210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPA  288 (389)
Q Consensus       210 Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~  288 (389)
                      |||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986533222112223457889999999998889999999999999999998 89998754321


Q ss_pred             hhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          289 REQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ..  .              ...+........+...+.++.+|+.+||..+|++||++++|++.|+.+
T Consensus       349 ~~--~--------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         349 EQ--F--------------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HH--H--------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11  0              011111111223444578899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.6e-43  Score=317.14  Aligned_cols=256  Identities=25%  Similarity=0.363  Sum_probs=207.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.++||+|+||.||+|.....       ..||+|.+....  .....+..|+.+++.++|+||+++++.+.....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~-------~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNS-------TKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP   75 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCC-------ceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46899999999999999999975432       238999876532  234678889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .+++|||+.+|+|.+++.......+++..+..++.+++.||+|||..+  ++|+||||+||+++.++.++|+|||++...
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceec
Confidence            999999999999999987665557888999999999999999999977  999999999999999999999999999875


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ...    +      ..
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~------~~  219 (261)
T cd05072         154 EDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSA----L------QR  219 (261)
T ss_pred             CCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHH----H------Hc
Confidence            432211 1222346778999999998889999999999999999998 9999976433211   100    0      00


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                          ....+.....+.++.+++.+||+.+|++||+++++++.|+.+
T Consensus       220 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         220 ----GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                011112224567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-44  Score=331.65  Aligned_cols=270  Identities=25%  Similarity=0.412  Sum_probs=229.9

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      +...+...+.++||+|-||.|.+|....       +..||+|+++.+......++|.+|+++|.+++||||+.++|+|..
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecC-------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            4556678899999999999999997554       344999999998877778999999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ++.+++|+|||+.|+|.+++..+............|+.||+.||+||.+.+  +|||||.++|+|++.++++||+|||++
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccc
Confidence            999999999999999999998875544455566789999999999999988  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT--GRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +.+..++........+-..+|||+|.+.-+.++.++|+|+||+++||+++  ...||+.....+          ++.+..
T Consensus       685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----------vven~~  754 (807)
T KOG1094|consen  685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----------VVENAG  754 (807)
T ss_pred             cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----------HHHhhh
Confidence            98888888888888888999999999999999999999999999999765  777888665432          122223


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      .+............|.-++..+.+++..||+.|-++||+|+++..+|....
T Consensus       755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            333222233334557788999999999999999999999999999987643

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5e-43  Score=328.21  Aligned_cols=248  Identities=26%  Similarity=0.372  Sum_probs=197.5

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHH---hccCCCccceEEeEEEeC
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFL---GHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~  148 (389)
                      |++.+.||+|+||.||+|.+..+.+.      ||+|++....  .......+..|++++   +.++||||+++++++...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGEL------YAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence            67789999999999999987655443      9999986432  122334555666554   566799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..|+||||+++|+|...+...   .+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++.
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            9999999999999998877543   6899999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......  ......+|++.|+|||++.+..++.++|||||||++|+|++|+.||.........      ..         
T Consensus       150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~---------  212 (324)
T cd05589         150 EGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DS---------  212 (324)
T ss_pred             cCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HH---------
Confidence            543221  1233467999999999999999999999999999999999999999865432110      00         


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~L  352 (389)
                       +...  ...++...+..+.+++.+||+.||.+||     ++.+++++-
T Consensus       213 -i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         213 -IVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             -HHhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence             0000  1112334567889999999999999999     688888763

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-43  Score=321.68  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=204.2

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .|++.+.||+|+||.||++.+..+.+      .||+|.+.....  ......+.+|+.+++.++|+||+++++.+..++.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGK------MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCc------eEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            47888999999999999997654433      499998865321  1223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++||||+.+|+|.+++.......+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            999999999999998887655557899999999999999999999977  999999999999999999999999998865


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      .....   .....|++.|+|||++.+..++.++||||||+++|+|++|+.||.........  ..           +...
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~--~~-----------~~~~  216 (285)
T cd05605         153 PEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR--EE-----------VERR  216 (285)
T ss_pred             CCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH--HH-----------HHHH
Confidence            43221   22357899999999999889999999999999999999999999864322110  00           0000


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      +. .....++...+..+.+|+.+||+.||++||     ++.++++|
T Consensus       217 ~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         217 VK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             hh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            10 011223344677899999999999999999     88899877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.4e-42  Score=319.29  Aligned_cols=272  Identities=28%  Similarity=0.386  Sum_probs=213.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccc----------cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccce
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLR----------EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK  140 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  140 (389)
                      ..+|++.+.||+|+||.||+|.+.....          .......||+|.+...........+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3579999999999999999997654332          112345689999887665566678889999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChhhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCe
Q 016481          141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKV---------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  211 (389)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Ni  211 (389)
                      +++++..++..++||||+.+++|.+++....         ...+++..+..++.|++.||+|||+++  |+|+||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhce
Confidence            9999999999999999999999999886543         125789999999999999999999977  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCCchh
Q 016481          212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT--GRKSLDKSRPAR  289 (389)
Q Consensus       212 li~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~  289 (389)
                      +++.++.++|+|||+++.....+.........+++.|+|||.+.+..++.++|||||||++|+|++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            999999999999999886544332223334567789999999988889999999999999999998  777886543221


Q ss_pred             hhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          290 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                         .......       .............+..++.++.+++.+||+.||++|||+.+|++.|+.
T Consensus       242 ---~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         242 ---VIENAGH-------FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ---HHHHHHh-------ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence               1111100       000001111112233456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.1e-43  Score=323.87  Aligned_cols=271  Identities=24%  Similarity=0.381  Sum_probs=214.4

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccc-cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLR-EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      +...+|.+.+.||+|+||.||+|.+..... .......||+|.............+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            445688999999999999999997533211 12233469999987655455567788999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeE
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  212 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nil  212 (389)
                      .....++||||+.+|+|.+++....              ...+++..+..++.|++.||+|||+++  |+|+||||+||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil  169 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVL  169 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEE
Confidence            9999999999999999999886532              134778889999999999999999977  999999999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhh
Q 016481          213 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQ  291 (389)
Q Consensus       213 i~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  291 (389)
                      ++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||........ 
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-  248 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-  248 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-
Confidence            99999999999999987644332222223456778999999998899999999999999999998 7888875432211 


Q ss_pred             hhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          292 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                        .   .           .+........+..++..+.+++.+||+.+|++||++.++++.|+++..+
T Consensus       249 --~---~-----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         249 --F---K-----------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             --H---H-----------HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence              0   0           0111111122345678899999999999999999999999999887665

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.3e-43  Score=321.89  Aligned_cols=268  Identities=23%  Similarity=0.302  Sum_probs=197.5

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhcc---CCCccceEEeEEE--
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHL---SHPNLVKLIGYCC--  146 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~--  146 (389)
                      +|++.+.||+|+||.||+|.+....     +..||+|.+..... ......+.+|+.+++.+   .||||+++++++.  
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~   76 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNG-----GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   76 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCC-----CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence            6899999999999999999764321     23489998765432 22233455677776665   6999999999885  


Q ss_pred             ---eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          147 ---EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       147 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                         ....+++||||+. ++|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEcc
Confidence               3457899999996 58988887665556899999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh-HHHHh-HHH
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWAL-PLL  301 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~-~~~  301 (389)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+......... .+... +..
T Consensus       154 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~  230 (290)
T cd07862         154 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  230 (290)
T ss_pred             ccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            99987654321   23345789999999999988999999999999999999999999987654321110 00000 000


Q ss_pred             Hhhhhhh----hhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          302 KEKKKLL----NIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       302 ~~~~~~~----~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .......    ..+......   ......+..+.+|+.+||+.||++|||+.++++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0000000    000000000   0112346778999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-44  Score=299.84  Aligned_cols=267  Identities=24%  Similarity=0.295  Sum_probs=211.4

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+-.++|++.+.||+|||+-||++....+.+.      ||+|++.... .++.+..++|++..++++|||++++++....
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~------YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~   89 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHL------YALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLR   89 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccc------hhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence            34467899999999999999999875444443      9999887664 5566788899999999999999999887644


Q ss_pred             C-----CeEEEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          148 D-----EHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       148 ~-----~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      +     ...|++++|+..|+|.+.+....  +..+++.+.+.|+.++++||.+||+...++.||||||.|||+...+.++
T Consensus        90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence            3     35899999999999999886543  3368999999999999999999999888899999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccc-------cccccccccccCccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCCchhh
Q 016481          221 LSDFGLAKDGPEGDKSHV-------STRIMGTYGYAAPEYIMTG---HLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE  290 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~l~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  290 (389)
                      |.|||.+...+-.-....       -.....|..|+|||++.-+   ..+.++|||||||++|+|+.|..||+..-.   
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---  246 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---  246 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---
Confidence            999999876543211111       1124578999999998744   467899999999999999999999984321   


Q ss_pred             hhhHHHHhHHHHhhhhh-hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          291 QNLADWALPLLKEKKKL-LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       291 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                                  .+..+ ..........+.....+..+..|+++||+.||.+||++.+++.+++.+.
T Consensus       247 ------------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 ------------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ------------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                        11121 1222222222333347899999999999999999999999999987653

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.4e-43  Score=329.76  Aligned_cols=258  Identities=25%  Similarity=0.292  Sum_probs=201.9

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC---ChhhHHHHHHHHHHHhccC-CCccceEEeEEEeC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED  148 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  148 (389)
                      +|++.+.||+|+||.||+|+....   ...+..||+|++....   .......+..|+.+++.++ |+||+.+++++...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTG---HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEccc---CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence            588899999999999999875432   1234559999986431   1223455678999999995 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+++||||+.+|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          78 AKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999999887654  6889999999999999999999977  9999999999999999999999999988


Q ss_pred             CCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..........   ....        
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~--------  221 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSR--------  221 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHH--------
Confidence            65332221 22346799999999999865 47899999999999999999999997543211110   0000        


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDSL  352 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~L  352 (389)
                       .+..  .....+...+..+.+++.+||+.||++||     +++++++|-
T Consensus       222 -~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  268 (332)
T cd05614         222 -RILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP  268 (332)
T ss_pred             -HHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence             0000  11123344567899999999999999999     788999873

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-42  Score=319.71  Aligned_cols=271  Identities=25%  Similarity=0.375  Sum_probs=207.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccc--------cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLR--------EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG  143 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~  143 (389)
                      ++|++.+.||+|+||.||+|.......        .......||+|.............+.+|+++++.++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            579999999999999999987643211        112234589999887655555667889999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE
Q 016481          144 YCCEDEHRVLIYEFMARGSVENNLFSKV----------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL  213 (389)
Q Consensus       144 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili  213 (389)
                      ++......++||||+.+++|.+++....          ...+++..++.++.|++.||+|||+++  ++|+||||+||++
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill  162 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV  162 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEE
Confidence            9999999999999999999999885432          124678889999999999999999977  9999999999999


Q ss_pred             cCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCCchhhh
Q 016481          214 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT--GRKSLDKSRPAREQ  291 (389)
Q Consensus       214 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~~~  291 (389)
                      +.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++  |..||........ 
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~-  241 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV-  241 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH-
Confidence            9999999999999876543332222233456778999999998899999999999999999998  6667765432211 


Q ss_pred             hhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          292 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                       . .....       .............+...+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       242 -~-~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         242 -I-ENTGE-------FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             -H-HHHHH-------hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence             1 00000       000000001111122356789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.1e-43  Score=328.18  Aligned_cols=249  Identities=27%  Similarity=0.346  Sum_probs=200.3

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCC-CccceEEeEEEeCC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCEDE  149 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~  149 (389)
                      +|++.+.||+|+||.||+|..+.+.+      .||+|++....  .......+..|..++..+.| ++|+.+++++...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDE------LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            58889999999999999998665443      39999987532  22344567789999998875 56888999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            9999999999999998886543  6788999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.........                ..
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~----------------~~  212 (324)
T cd05587         151 NIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----------------QS  212 (324)
T ss_pred             cCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH----------------HH
Confidence            322211  223467999999999999999999999999999999999999999865432110                00


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~il~~  351 (389)
                      +..  ....++...+.++.+++.+||+.||.+|++.     +++++|
T Consensus       213 i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         213 IME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            111  1112334456789999999999999999976     677766

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=314.80  Aligned_cols=257  Identities=27%  Similarity=0.405  Sum_probs=207.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||.||+|.+..+       ..||+|.+....  .....+.+|+.++++++|+||+++++++...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNT-------TPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE   74 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCC-------eEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence            346799999999999999999975432       239999987543  23456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          75 PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            9999999999999999987665557899999999999999999999977  99999999999999999999999999887


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ....... .......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.........                 
T Consensus       153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-----------------  214 (261)
T cd05068         153 IKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-----------------  214 (261)
T ss_pred             ccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-----------------
Confidence            6432111 1111223467999999999899999999999999999999 99999765422110                 


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ..+........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         215 QQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            00111111122344568899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=325.07  Aligned_cols=282  Identities=23%  Similarity=0.305  Sum_probs=228.9

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.+-|.+.+.||+|.|+.|-+|++.      .++..||||++.+.. .......+..|++.|+.++|||||++|++....
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHV------FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHV------FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ   89 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhh------cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence            3456888999999999999998644      444559999987654 333446778999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-CCcEEEeccCCC
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLA  227 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-~~~vkl~Dfg~a  227 (389)
                      ..+|+|+|+-++|+|++++..+.. .+.+..+.+++.||+.|+.|+|...  +|||||||+||.+.+ -|-|||+|||++
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFS  166 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeecccc
Confidence            999999999999999999988754 6899999999999999999999977  999999999998865 588999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCC-cccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT-PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ..+..+.   ...+.||++.|-|||++.|..|+ +++||||||||||.|.+|++||...++.+                .
T Consensus       167 Nkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------------T  227 (864)
T KOG4717|consen  167 NKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------------T  227 (864)
T ss_pred             ccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----------------h
Confidence            8876654   34568999999999999999995 68999999999999999999998765432                2


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc--cccCCCCCCCCCCCcccccCCCCCCcccc
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE--PLQVLPDEAPTPKNFVTVVTPEEPKAEIQ  382 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  382 (389)
                      +..++|-+.  ..|.-.+.++++||..||..||++|.+..+|..+-|  ..-..+ -+.+|.-...+...+.-++++|
T Consensus       228 LTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~-sT~iPLvsr~~L~ee~Ha~IIq  302 (864)
T KOG4717|consen  228 LTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL-STAIPLVSRHHLPEEAHATIIQ  302 (864)
T ss_pred             hhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc-cccCceeehhhCChHHHHHHHH
Confidence            233333222  346677899999999999999999999999998744  333222 2346665555555555455554

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.9e-43  Score=327.49  Aligned_cols=251  Identities=27%  Similarity=0.378  Sum_probs=198.3

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|.+..+.+.      ||+|++....  .......+..|..++..+ +||||+++++++.....+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~------~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRI------YAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence            4699999999999987655443      9999987542  223345677899999888 699999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+++|+|..++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          75 IEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence            99999999998876543  6899999999999999999999977  9999999999999999999999999987532211


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchh--hhhhHHHHhHHHHhhhhhhhhcC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR--EQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  .....++....+.         .
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~  219 (329)
T cd05588         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL---------E  219 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH---------c
Confidence              12334679999999999999999999999999999999999999997432111  1111122111111         1


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL------MRDIVDS  351 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~~il~~  351 (389)
                      ..  ...+...+.++.+++.+||+.||.+|++      +.++++|
T Consensus       220 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         220 KQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            11  1223345678999999999999999997      6888877

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-42  Score=319.97  Aligned_cols=267  Identities=27%  Similarity=0.419  Sum_probs=210.1

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +..++|++.+.||+|+||.||+|..+.... ......||+|.+...........+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCC-CCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            456789999999999999999997654221 2234569999987655445556678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          149 EHRVLIYEFMARGSVENNLFSKV--------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      ...++||||+.+|+|.+++....        ........+..++.|++.||.|||+++  |+||||||+||+++.++.++
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999986432        123567788899999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALP  299 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  299 (389)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....   
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~---  233 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKF---  233 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---
Confidence            999999886543332222222345778999999998899999999999999999998 788987643321   1110   


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          300 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                       +         ... .....+..++..+.+++.+||+.||++|||+.++++.|.+.
T Consensus       234 -~---------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 -V---------MDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             -H---------HcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence             0         000 01112234467899999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8e-43  Score=326.65  Aligned_cols=248  Identities=26%  Similarity=0.326  Sum_probs=198.4

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC---ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|+.....   ..+..||+|++....   .......+..|+.+++.++||||+++++++..++..|+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGA---DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEcccC---CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            67999999999999754321   234559999986432   122334567899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+.+|+|.+++....  .+.+..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          79 LEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             EeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999999999886654  5788888899999999999999977  9999999999999999999999999987543222


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........      .          ..+... 
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~----------~~~~~~-  215 (323)
T cd05584         155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------I----------DKILKG-  215 (323)
T ss_pred             C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------H----------HHHHcC-
Confidence            1  22335799999999999998999999999999999999999999986543210      0          011111 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDSL  352 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~L  352 (389)
                       ....+...+..+.+|+.+||+.||++||     ++.++++|-
T Consensus       216 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~  257 (323)
T cd05584         216 -KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP  257 (323)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence             1122344567899999999999999999     899998863

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-42  Score=325.80  Aligned_cols=275  Identities=25%  Similarity=0.403  Sum_probs=216.6

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccC-cCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGY  144 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~  144 (389)
                      +.+...+|++.+.||+|+||.||+|.+....+.. .....||+|.............+.+|+.+++++ +|+||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            4455568999999999999999999765432221 223458999887665555667888999999999 79999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  210 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~N  210 (389)
                      +...+..++++||+.+|+|.+++....              ...+++..+..++.|++.||+|||+++  ++||||||+|
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~N  164 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARN  164 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccce
Confidence            999999999999999999999886532              234778888999999999999999977  9999999999


Q ss_pred             eEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchh
Q 016481          211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAR  289 (389)
Q Consensus       211 ili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  289 (389)
                      |+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999886543322111222344578999999999999999999999999999998 888987653221


Q ss_pred             hhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCC
Q 016481          290 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  360 (389)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~  360 (389)
                      ..                 ..+........+...+.++.+++.+||+.+|++||++.++++.|+.+.....
T Consensus       245 ~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         245 LF-----------------KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             HH-----------------HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence            10                 0011111122234556789999999999999999999999999998875543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-43  Score=328.44  Aligned_cols=254  Identities=23%  Similarity=0.338  Sum_probs=207.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEE-EecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK-~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  148 (389)
                      ...|++.++||+||.+.||++..-+..      . ||+| +.......+....|..|+..|.+|+ |.+||+++++-..+
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~------i-yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQ------I-YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCc------c-hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            446899999999999999998643322      1 5555 4445567778889999999999996 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+|+||||-+ .+|..+|.........| .++.++.|++.++.++|.+|  |||.||||.|+|+ -.|.+||+|||+|.
T Consensus       433 ~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLl-VkG~LKLIDFGIA~  507 (677)
T KOG0596|consen  433 GYLYMVMECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLL-VKGRLKLIDFGIAN  507 (677)
T ss_pred             ceEEEEeeccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEE-EeeeEEeeeechhc
Confidence            99999999964 58888887766544444 67889999999999999988  9999999999999 56799999999999


Q ss_pred             CCCCCCCccccccccccccccCccccccCC-----------CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-----------LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  297 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----------~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  297 (389)
                      ..............+||+.||+||.+....           .+.++||||||||||+|+.|+.||....           
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----------  576 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----------  576 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----------
Confidence            888776666677799999999999986433           4568999999999999999999998532           


Q ss_pred             hHHHHhhhhhhhhcCCCCCCCCChHH-HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          298 LPLLKEKKKLLNIIDPRLEGDYPVKG-VHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                          -....+..+.++...-+++.-- ..++.++++.||..||++||++.++|+|
T Consensus       577 ----n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  577 ----NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ----HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                1234566777776555554322 2339999999999999999999999988

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.2e-43  Score=333.60  Aligned_cols=255  Identities=22%  Similarity=0.229  Sum_probs=203.0

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ..++|++.+.||+|+||.||+|....+...      ||+|++....  .......+..|+.+++.++||||+++++++.+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~  114 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQV------YAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD  114 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCE------EEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            346899999999999999999987655443      9999986421  12233456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      +..+|+||||++||+|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         115 DKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccce
Confidence            99999999999999999988653   5788888999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccccccccCccccccC----CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTG----HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      ........ ......+||+.|+|||++.+.    .++.++|||||||++|+|++|+.||........             
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------------  255 (370)
T cd05596         190 MKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------------  255 (370)
T ss_pred             eeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-------------
Confidence            76543221 122346799999999998753    378999999999999999999999986543210             


Q ss_pred             hhhhhhhcCCC--CCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHh
Q 016481          304 KKKLLNIIDPR--LEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDSL  352 (389)
Q Consensus       304 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~il~~L  352 (389)
                         ...+....  +..+.....+.++.+|+.+||+.+|++  |+++.++++|-
T Consensus       256 ---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         256 ---YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             ---HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence               01111111  111112245788999999999999998  99999999884

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.6e-42  Score=323.43  Aligned_cols=271  Identities=24%  Similarity=0.378  Sum_probs=212.9

Q ss_pred             HHhcCCcccceecCCCceEEEEeeecccccc-CcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      ...++|.+.+.||+|+||.||+|......+. ......+|+|.+...........+..|+.+++.+ .||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            3456889999999999999999975432211 1234458999987655555566788999999999 5999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeE
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  212 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nil  212 (389)
                      ..+..++||||+.+|+|.+++....              ...+++..+..++.|++.||.|||+++  ++|+||||+||+
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil  166 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVL  166 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEE
Confidence            9999999999999999999986532              235788899999999999999999977  999999999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhh
Q 016481          213 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQ  291 (389)
Q Consensus       213 i~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  291 (389)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||........ 
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-  245 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-  245 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            99999999999999987643322111222334568999999998899999999999999999999 8999976532211 


Q ss_pred             hhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          292 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                        ...              +........+..++.++.+++.+||+.||++||++.++++.|+.+...
T Consensus       246 --~~~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         246 --FKL--------------LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             --HHH--------------HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence              100              001111122345567889999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.5e-43  Score=330.34  Aligned_cols=245  Identities=25%  Similarity=0.325  Sum_probs=197.6

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (389)
                      +.||+|+||.||+|....+.+      .||+|++....  .......+..|+.+++.++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGR------YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEE
Confidence            469999999999997654433      49999987532  2233456678999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       156 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      ||+++|+|..++....  .+++..+..++.|++.||+|||+ .+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          75 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  150 (325)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence            9999999998876543  68899999999999999999997 56  9999999999999999999999999987543221


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........                +... 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~----------------i~~~-  211 (325)
T cd05594         151 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----------------ILME-  211 (325)
T ss_pred             c--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH----------------HhcC-
Confidence            1  22345799999999999999999999999999999999999999976542211000                0000 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDSL  352 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~L  352 (389)
                       ...++...+.++.+|+.+||+.||++|+     ++.++++|-
T Consensus       212 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  253 (325)
T cd05594         212 -EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK  253 (325)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence             1122334567899999999999999997     899999873

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.6e-43  Score=336.91  Aligned_cols=255  Identities=22%  Similarity=0.235  Sum_probs=200.5

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||.||+|....+.+      .||+|++....  .......+.+|+.+++.++|+||+++++.+.+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNA------LYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD   74 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCC------EEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            479999999999999999998665433      49999986432  1123455778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            9999999999999999986653  6788888999999999999999977  99999999999999999999999999753


Q ss_pred             CCCCC-----------------------------------------CccccccccccccccCccccccCCCCcccchhHH
Q 016481          230 GPEGD-----------------------------------------KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSF  268 (389)
Q Consensus       230 ~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Diwsl  268 (389)
                      +....                                         ........+||+.|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            21000                                         0000113579999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC---CH
Q 016481          269 GVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP---LM  345 (389)
Q Consensus       269 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~  345 (389)
                      ||++|+|++|+.||....+......      .. .       .............+.++.+++.+|+ .+|.+|+   ++
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~~~------i~-~-------~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQLK------VI-N-------WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHHHH------Hh-c-------cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence            9999999999999987654321100      00 0       0001111112245678889999877 4999999   99


Q ss_pred             HHHHHH
Q 016481          346 RDIVDS  351 (389)
Q Consensus       346 ~~il~~  351 (389)
                      .++++|
T Consensus       296 ~ell~h  301 (376)
T cd05598         296 DEIKAH  301 (376)
T ss_pred             HHHhCC
Confidence            999988

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.9e-43  Score=316.21  Aligned_cols=256  Identities=30%  Similarity=0.462  Sum_probs=210.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||.|+||.||+|.+.. ..      .+++|.+.... ......+..|+.+++.++|+||+++++++.....
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~------~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   76 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RV------RVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP   76 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CC------cEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence            3578899999999999999998765 22      39999987553 3334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.+||+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhc
Confidence            999999999999999998766667899999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .....  ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ....             
T Consensus       155 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~-------------  216 (261)
T cd05148         155 KEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQ-------------  216 (261)
T ss_pred             CCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH-------------
Confidence            43221  1223456778999999988899999999999999999998 899997654211   1110             


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                       +........+..++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         217 -ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence             111112233445678899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.4e-43  Score=326.83  Aligned_cols=244  Identities=28%  Similarity=0.378  Sum_probs=196.1

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|..+.+.+      .||+|++....  .......+..|..++..+ +||||+++++++...+.+|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGR------LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCC------EEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEE
Confidence            469999999999998765543      39999986532  223345667788888776 699999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          75 MEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             EcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            99999999998886553  6889999999999999999999977  9999999999999999999999999987543221


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ..             .+... 
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~-------------~i~~~-  211 (320)
T cd05590         151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FE-------------AILND-  211 (320)
T ss_pred             --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HH-------------HHhcC-
Confidence              123346799999999999999999999999999999999999999986543211   00             00110 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLM------RDIVDS  351 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~~il~~  351 (389)
                       ....+...+.++.+|+.+||+.||++||++      .++++|
T Consensus       212 -~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         212 -EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence             011233456789999999999999999998      777776

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-42  Score=325.77  Aligned_cols=251  Identities=26%  Similarity=0.375  Sum_probs=197.0

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|....+.+      .||+|++....  .......+..|+.++.++ +||||+++++++...+.+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTER------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCC------EEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence            469999999999998765544      39999987542  223345567888888776 799999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+++......
T Consensus        75 ~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          75 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            99999999988876543  6899999999999999999999977  9999999999999999999999999987532211


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchh--hhhhHHHHhHHHHhhhhhhhhcC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR--EQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......+....+.         .
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~---------~  219 (329)
T cd05618         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL---------E  219 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh---------c
Confidence              12234679999999999999999999999999999999999999996422111  1111111111111         1


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL------MRDIVDS  351 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~~il~~  351 (389)
                      .  ...++...+..+.+|+.+||+.||++||+      +.++++|
T Consensus       220 ~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            1  11234455678899999999999999998      4788777

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-42  Score=326.02  Aligned_cols=249  Identities=25%  Similarity=0.326  Sum_probs=199.6

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDE  149 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  149 (389)
                      +|.+.+.||+|+||.||+|....+..      .||+|++....  .......+..|..++..+ .|++|+.+++++...+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDE------LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            58889999999999999998765443      39999987542  122334566788888777 4899999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++||||+++|+|.+.+....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            9999999999999998886553  6888999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........   .             ..
T Consensus       151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~-------------~~  212 (323)
T cd05616         151 NMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F-------------QS  212 (323)
T ss_pred             cCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---H-------------HH
Confidence            43211  122346799999999999999999999999999999999999999986543211   0             00


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~il~~  351 (389)
                      +...  ...++...+.++.+++.+||+.||++|++.     .++++|
T Consensus       213 i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         213 IMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHhC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            1111  112344567889999999999999999985     677655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.9e-43  Score=332.50  Aligned_cols=256  Identities=22%  Similarity=0.251  Sum_probs=202.4

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      ...++|++.+.||+|+||.||+|.+..+.+.      ||+|++....  .......+.+|+.+++.++||||+++++++.
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKV------YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ  113 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3456899999999999999999987655443      9999986421  2223345678999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      .+..+|+||||+++|+|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         114 DDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999999988543   5788899999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCC----CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH----LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      +........ ......+||+.|+|||++.+..    ++.++|||||||++|+|++|+.||........            
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------------  255 (370)
T cd05621         189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------------  255 (370)
T ss_pred             ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------------
Confidence            986543221 1223467999999999997643    78899999999999999999999986542211            


Q ss_pred             hhhhhhhhcCCC--CCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHh
Q 016481          303 EKKKLLNIIDPR--LEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDSL  352 (389)
Q Consensus       303 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~il~~L  352 (389)
                          ...++...  +..+.....+..+.+++.+||+.++.+  |+++.++++|-
T Consensus       256 ----~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp  305 (370)
T cd05621         256 ----YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP  305 (370)
T ss_pred             ----HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence                11111111  111112245778899999999866554  89999999983

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3e-42  Score=311.74  Aligned_cols=252  Identities=22%  Similarity=0.284  Sum_probs=206.4

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      +|++.+.||.|+||.||++.+..+..      .+|+|.+...........+..|+.+++.++|+||+++++.+.....++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQ------KYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCc------eEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence            57889999999999999997665443      399998865544455667788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      +||||+++|+|.+++.......++...+..++.|++.||.|||+++  |+|+||||+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            9999999999999887655556889999999999999999999977  99999999999999999999999999876543


Q ss_pred             CCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      ...  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||........      ...       ..    
T Consensus       153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~-------~~----  213 (255)
T cd08219         153 PGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILK-------VC----  213 (255)
T ss_pred             ccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHH-------Hh----
Confidence            221  22335689999999999988899999999999999999999999986432211      000       00    


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .......+...+..+.+|+.+||+.||++||++.+++..
T Consensus       214 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         214 QGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            011112233456789999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.7e-42  Score=316.98  Aligned_cols=272  Identities=25%  Similarity=0.386  Sum_probs=208.3

Q ss_pred             hcCCcccceecCCCceEEEEeeecccc----------ccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccce
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDL----------REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK  140 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  140 (389)
                      .++|++.+.||+|+||.||+|.+....          ........||+|.............+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357999999999999999998654321          1112234589999886655555678889999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChhhhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCe
Q 016481          141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVL---------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  211 (389)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Ni  211 (389)
                      +++++...+..++||||+.+|+|.+++.....         ..+++..+..++.|++.||+|||+.+  ++|+||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheE
Confidence            99999999999999999999999998865421         23667889999999999999999977  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCCchh
Q 016481          212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT--GRKSLDKSRPAR  289 (389)
Q Consensus       212 li~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~  289 (389)
                      +++.++.++|+|||++................+++.|++||...+..++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999886543322222223445678999999888889999999999999999998  778887543321


Q ss_pred             hhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          290 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                      .  .. ......       ...........+..++..+.+|+.+||+.||++||++.+|++.|+.
T Consensus       242 ~--~~-~~~~~~-------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 V--IE-NTGEFF-------RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H--HH-HHHHHH-------hhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1  10 000000       0000001111223456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.1e-42  Score=317.99  Aligned_cols=266  Identities=26%  Similarity=0.377  Sum_probs=210.8

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|.+.+.||+|+||.||+|.+.... .......+++|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLS-PTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccC-CCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            46888899999999999999754321 12234458888876543 33345688899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      ++||||+++++|.+++....              ...+++..+..++.|++.||+|||+++  |+|+||||+||+++.++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence            99999999999999986532              134788999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHH
Q 016481          218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       218 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  296 (389)
                      .++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |+.||.........   ..
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~  237 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---EC  237 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH
Confidence            999999999976544332222233456889999999999999999999999999999999 99999765432210   00


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                                    +........+..++..+.+++.+||+.||++||++.++++.|+.+...
T Consensus       238 --------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         238 --------------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             --------------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                          011111112234567899999999999999999999999999988553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.9e-42  Score=312.39  Aligned_cols=261  Identities=21%  Similarity=0.281  Sum_probs=208.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||.||+|++..+...      ||+|.+....  .......+..|+.+++.++||||+++++++...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~------~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKP------VALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCE------EEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            5799999999999999999987655443      9999875422  2334456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          150 HRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ..++|+||+++|+|.+++...  ....++...+..++.|++.||+|||+++  ++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccc
Confidence            999999999999999877532  2345788899999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ........  ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||........    .+...       +
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~----~~~~~-------~  220 (267)
T cd08228         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF----SLCQK-------I  220 (267)
T ss_pred             eeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH----HHHHH-------H
Confidence            86543221  12235688999999999988899999999999999999999999965432111    11100       0


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      .   ............+..+.+++.+||+.+|++||++.++++.|+.++
T Consensus       221 ~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         221 E---QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             h---cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            0   001111122345678999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-42  Score=313.74  Aligned_cols=260  Identities=29%  Similarity=0.461  Sum_probs=205.1

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe--
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH--  150 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--  150 (389)
                      |.+.+.||+|+||.||+|....+..   ....||+|.+.... .......+.+|+.+++.++|+||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDG---SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCC---CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            5678999999999999997654321   23449999987643 33445678899999999999999999998866554  


Q ss_pred             ----EEEEEEecCCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          151 ----RVLIYEFMARGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       151 ----~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                          .++++||+++|+|..++...    ....+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEEC
Confidence                79999999999999887543    2236889999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ..++.    
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----  228 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----  228 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----
Confidence            9999886644332222222345778999999988899999999999999999999 889987643221   11110    


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                                ........+..++.++.+++.+||+.||++||++.+++++|+.+
T Consensus       229 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 ----------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----------HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                      01111223445678899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.3e-42  Score=317.31  Aligned_cols=266  Identities=26%  Similarity=0.383  Sum_probs=209.5

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|.+.+.||+|+||.||++...... .......+|+|.+.... ......+.+|+.+++.++|+||+++++++...+.+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~-~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCC-CCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            47889999999999999999753321 12233458899886542 34456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          152 VLIYEFMARGSVENNLFSKV-----------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      ++||||+++++|.+++....           ...+++..+..++.|++.||+|||+++  ++||||||+||+++.++.++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEE
Confidence            99999999999999886432           234899999999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALP  299 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  299 (389)
                      |+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........   ..    
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~----  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE----  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----
Confidence            999999886543322222223446788999999999999999999999999999998 9999976543211   00    


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          300 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      .+..          ......+...+.++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       234 ~i~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         234 CITQ----------GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHc----------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            0000          000111223457899999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.7e-42  Score=311.43  Aligned_cols=251  Identities=24%  Similarity=0.426  Sum_probs=200.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||+|+||.||+|.++...       .+|+|.+....  .....+..|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~-------~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQI-------KVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL   74 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCc-------eEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence            56888999999999999999765432       38999876442  2235678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||+++...
T Consensus        75 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            99999999999999886543 25889999999999999999999977  9999999999999999999999999987653


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ..... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||........   ...    +..       
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~----i~~-------  216 (256)
T cd05114         152 DDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEM----ISR-------  216 (256)
T ss_pred             CCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HHC-------
Confidence            32211 1122345678999999998899999999999999999999 9999976543211   000    000       


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                         ......+...+..+.+++.+||+.+|++||++.++++.|
T Consensus       217 ---~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         217 ---GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               001111223456789999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.5e-42  Score=322.25  Aligned_cols=244  Identities=27%  Similarity=0.347  Sum_probs=193.5

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|.++.+..      .||+|.+.....  ......+..|..++... +||||+++++++...+++|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGE------YFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence            469999999999998765543      399999875321  22334556677777654 899999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+.+|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          75 MEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             ECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            99999999998886643  6788999999999999999999977  9999999999999999999999999987532221


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ..    .+       ...   
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~~----~~-------~~~---  211 (316)
T cd05620         151 N--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---FE----SI-------RVD---  211 (316)
T ss_pred             C--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH----HH-------HhC---
Confidence            1  23346799999999999999999999999999999999999999976543211   00    00       000   


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR-DIVDS  351 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~il~~  351 (389)
                       ...++...+.++.+++.+||+.||++||++. ++++|
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         212 -TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence             1122334567899999999999999999984 67654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.4e-42  Score=313.55  Aligned_cols=259  Identities=28%  Similarity=0.422  Sum_probs=201.3

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC----
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED----  148 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----  148 (389)
                      |.+++.||+|+||.||+|.+.....    ...+|+|.+.... .......+..|+.+++.++|+||+++++++...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~----~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDS----ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCC----eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            4567899999999999998654432    2348999876543 334456788899999999999999999987432    


Q ss_pred             --CeEEEEEEecCCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          149 --EHRVLIYEFMARGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       149 --~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                        ...+++|||+.+|+|.+++...    ....+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEEC
Confidence              2568999999999999877432    2235789999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      |||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ....    +
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----~  227 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDY----L  227 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----H
Confidence            9999987654332222223456778999999999999999999999999999999 899997643321   1110    1


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ..          ......+..++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       228 ~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 RQ----------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             Hc----------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11          001112334567799999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2e-42  Score=326.59  Aligned_cols=268  Identities=29%  Similarity=0.373  Sum_probs=206.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  148 (389)
                      ..++|++.+.||+|+||.||+|.+.... .......||+|++...........+.+|+.++..+ +|+||+++++++...
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGID-KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCC-ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            3568999999999999999999754321 22334569999997655455566788999999999 689999999987654


Q ss_pred             -CeEEEEEEecCCCChhhhhhcCC--------------------------------------------------------
Q 016481          149 -EHRVLIYEFMARGSVENNLFSKV--------------------------------------------------------  171 (389)
Q Consensus       149 -~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  171 (389)
                       ...++||||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             56789999999999998885431                                                        


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccc
Q 016481          172 ---------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI  242 (389)
Q Consensus       172 ---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~  242 (389)
                               ...+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++...............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                     123577788899999999999999977  999999999999999999999999998865332221122234


Q ss_pred             cccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCCh
Q 016481          243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPV  321 (389)
Q Consensus       243 ~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (389)
                      .++..|+|||.+.+..++.++||||||+++|+|++ |..||........  ..    .....          ......+.
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~----------~~~~~~~~  305 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKE----------GTRMRAPD  305 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhc----------cCCCCCCC
Confidence            45678999999999999999999999999999997 9999975432111  00    00000          01111122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          322 KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       322 ~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ..+.++.+++.+||+.||++|||+.+|+++|+.+.
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            34567899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.1e-42  Score=318.96  Aligned_cols=264  Identities=25%  Similarity=0.343  Sum_probs=208.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||.||+|....+..    ...+++|.+...........+..|+.+++++ +||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGL----KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCC----cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            578999999999999999997655432    1237888877544444556788999999999 69999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      +++|+||+++|+|.+++....              ...+++..+..++.|++.||+|||+++  |+|+||||+|||++.+
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~  155 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGEN  155 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCC
Confidence            999999999999999986532              124788899999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHH
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~  295 (389)
                      +.+||+|||++.......   .......+..|+|||++.+..++.++|||||||++|+|++ |..||........   . 
T Consensus       156 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~-  228 (297)
T cd05089         156 LASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---Y-  228 (297)
T ss_pred             CeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H-
Confidence            999999999986432111   1111233567999999998899999999999999999997 9999976543211   0 


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCC
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE  361 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~  361 (389)
                                   ..+........+..++..+.+|+.+||+.+|.+||++.++++.|+.+......
T Consensus       229 -------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         229 -------------EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             -------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                         00111111222344567899999999999999999999999999877655433

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-42  Score=325.65  Aligned_cols=244  Identities=26%  Similarity=0.349  Sum_probs=196.5

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|....+..      .||+|++....  .......+..|..++..+ +||||+++++++...+.+|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDE------VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEECCCCC------EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEE
Confidence            469999999999998765443      39999987542  223345566788888866 799999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+++|+|...+....  .+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          75 MEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            99999999998886543  6888999999999999999999977  9999999999999999999999999987543222


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........   .             .+....
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---~-------------~i~~~~  212 (321)
T cd05591         151 V--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF---E-------------SILHDD  212 (321)
T ss_pred             c--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH---H-------------HHHcCC
Confidence            1  233467999999999999999999999999999999999999999865432110   0             011100


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARP-------LMRDIVDS  351 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-------s~~~il~~  351 (389)
                        ...+...+.++.+++.+||+.||++||       ++.++++|
T Consensus       213 --~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 --VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence              112233567899999999999999999       88999877

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.5e-43  Score=330.14  Aligned_cols=255  Identities=21%  Similarity=0.187  Sum_probs=202.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|.+.+.||+|+||.||+|....+.+      .||+|++.....  ......+..|+.+++.++|+||+++++++.+..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGD------IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            368899999999999999997665443      399999875421  233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeE
Confidence            9999999999999999887652 36899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccccccccCccccc------cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIM------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      ....... ......||+.|+|||++.      +..++.++|||||||++|+|++|+.||........  +    ..    
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~----~~----  220 (330)
T cd05601         152 LTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--Y----NN----  220 (330)
T ss_pred             CCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH--H----HH----
Confidence            5433221 223357999999999987      45678999999999999999999999976543211  0    00    


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         +... ......+.....+..+.+|+.+||+ +|.+||++.++++|
T Consensus       221 ---i~~~-~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         221 ---IMNF-QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ---HHcC-CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence               0000 0001111122356789999999998 99999999999987

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-42  Score=330.83  Aligned_cols=269  Identities=23%  Similarity=0.238  Sum_probs=203.4

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+...+|.+.+.||+|+||.||+|.....    .....|++|.+....      ...+|+.+++.++||||+++++++..
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~----~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~  157 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGD----EQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRW  157 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCC----ccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEee
Confidence            34456899999999999999999865432    233458999876532      23479999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ....++|||++. ++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++
T Consensus       158 ~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a  232 (392)
T PHA03207        158 KSTVCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAA  232 (392)
T ss_pred             CCEEEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccc
Confidence            999999999995 6888888433  47899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh-h--
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-K--  304 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~--  304 (389)
                      ................||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+............+...+.. .  
T Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~  312 (392)
T PHA03207        233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE  312 (392)
T ss_pred             cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence            8665443333334567999999999999999999999999999999999999999765432111111000000000 0  


Q ss_pred             ----------hhhhhhcCCCCCCCC--C-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          305 ----------KKLLNIIDPRLEGDY--P-----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       305 ----------~~~~~~~~~~~~~~~--~-----~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                                ..+.. ........+  +     ...+.++.+++.+||+.||++|||+.+++.+=
T Consensus       313 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        313 FPQNGSTNLCKHFKQ-YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             cCCccchhHHHHHHh-hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                      00000 000001100  0     12356788999999999999999999999883

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-42  Score=310.80  Aligned_cols=255  Identities=26%  Similarity=0.371  Sum_probs=205.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC----hhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS----YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      +.|.+.+.||+|++|.||+|....+.+      .|++|.+.....    ......+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~------~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGR------ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCc------EEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence            468899999999999999997654433      399998764321    1233567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ...+++|+||+++++|.+.+....  .++...+..++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccc
Confidence            999999999999999999886543  5788889999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccc-cccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          228 KDGPEGDKSHV-STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       228 ~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ........... .....++..|+|||++.+..++.++||||||+++|+|++|+.||........                
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----------------  215 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA----------------  215 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH----------------
Confidence            76543221111 1235678899999999998999999999999999999999999975432211                


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .............+...+..+.+++.+||+.+|++||++.+++++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         216 IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence            0111111112233445678899999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3e-42  Score=320.81  Aligned_cols=269  Identities=21%  Similarity=0.295  Sum_probs=202.6

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|.+.+.||+|+||.||+|+...+..      .||+|.+...........+.+|+.+++.++|+||+++++++..++..
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTEN------LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCC------eEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            579999999999999999997655433      39999887554433445677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++....
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 TLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             EEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecC
Confidence            999999975 7887775543 35788899999999999999999977  9999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh--------HHHH
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--------PLLK  302 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~  302 (389)
                      ....  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||................        +.+.
T Consensus       156 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         156 VPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             CCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            3221  1223567999999998865 468999999999999999999999998765433221111100        0000


Q ss_pred             hhhhhhhhcCCCCCC----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          303 EKKKLLNIIDPRLEG----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ........-.+....    ......+.++.+|+.+||+.||.+|||+.++++|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  287 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA  287 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence            000000000000000    01123467889999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.5e-42  Score=311.57  Aligned_cols=256  Identities=26%  Similarity=0.392  Sum_probs=204.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +..++|++.+.||+|+||.||+|.+....       .+|+|.+.....  ....+.+|+.++++++|+|++++++++. .
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-------~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWNGNT-------KVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-E   72 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEecCCc-------eeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence            34568999999999999999999754322       289998876433  2346789999999999999999999875 5


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...+++|||+.+++|.+++.......+++..+..++.+++.||+|||+++  ++|+||||+||+++.++.++|+|||++.
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeee
Confidence            66899999999999999987655556899999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...            
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~------------  214 (260)
T cd05070         151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLE------------  214 (260)
T ss_pred             eccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHH------------
Confidence            65432211 1122345678999999988889999999999999999999 899997643211   111            


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                        .+......+.+...+..+.+|+.+||..+|++|||+.++++.|+.
T Consensus       215 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         215 --QVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --HHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              011111222344556789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.1e-42  Score=316.28  Aligned_cols=248  Identities=24%  Similarity=0.325  Sum_probs=197.0

Q ss_pred             ecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           80 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        80 lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      ||+|+||+||+|.+..+.+      .||+|.+.....  ......+..|+.+++.++|+||+++.+++.....+++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQMRATGK------LYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEEccCCc------EEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence            6999999999997665543      399999865422  22335667899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCC
Q 016481          158 MARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  235 (389)
Q Consensus       158 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~  235 (389)
                      +++|+|...+...  ....+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            9999998877442  2346899999999999999999999977  99999999999999999999999999876543322


Q ss_pred             ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCC
Q 016481          236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  315 (389)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (389)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........            .........  
T Consensus       153 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~------------~~~~~~~~~--  216 (280)
T cd05608         153 --KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK------------ELKQRILND--  216 (280)
T ss_pred             --cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH------------HHHHhhccc--
Confidence              1233578999999999999999999999999999999999999997643221100            000011111  


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          316 EGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      ....+...+..+.+++.+||+.||++||     ++.++++|
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         217 SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            1123345678899999999999999999     77888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.4e-42  Score=323.97  Aligned_cols=251  Identities=27%  Similarity=0.352  Sum_probs=198.6

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|....+.+.      ||+|++....  .......+..|+.++.++ +|+||+.+++++.....+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQI------YAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence            4699999999999987655443      9999987543  223345677899998888 599999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          75 IEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            99999999998876543  6899999999999999999999977  9999999999999999999999999987532211


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.............+....+..         . 
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~-  218 (327)
T cd05617         151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------K-  218 (327)
T ss_pred             --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------C-
Confidence              1233467999999999999999999999999999999999999999754332222222222211111         1 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPL------MRDIVDS  351 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~~il~~  351 (389)
                       ....+...+..+.+++.+||+.||++|++      +.++++|
T Consensus       219 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         219 -PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence             11233445678899999999999999998      4688776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.1e-42  Score=319.82  Aligned_cols=259  Identities=27%  Similarity=0.364  Sum_probs=204.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  149 (389)
                      .++|.+.+.||+|+||.||+|.+..+..    ...+++|.............+.+|+.++.++ +|+||+++++++...+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCc----eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            3578899999999999999998654322    1236788776544445556788899999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT  215 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~  215 (389)
                      .+++||||+++|+|.+++....              ...+++..+..++.|++.||+|||+++  ++||||||+|||++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~  159 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE  159 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecC
Confidence            9999999999999999886542              235788999999999999999999977  999999999999999


Q ss_pred             CCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhH
Q 016481          216 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLA  294 (389)
Q Consensus       216 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~  294 (389)
                      ++.+||+|||++.......   ......++..|+|||++.+..++.++|||||||++|+|++ |..||........   .
T Consensus       160 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~  233 (303)
T cd05088         160 NYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y  233 (303)
T ss_pred             CCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---H
Confidence            9999999999986432111   1111234678999999988889999999999999999998 9999975432210   0


Q ss_pred             HHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                                    ..+........+...+..+.+|+.+||+.+|++||++.+++..|+.+
T Consensus       234 --------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         234 --------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             --------------HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                          00111111122334567889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.4e-42  Score=311.90  Aligned_cols=262  Identities=25%  Similarity=0.436  Sum_probs=209.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|+..+.||+|+||.||+|....+..   ....+++|.............+..|+.+++.++|+||+++.+++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGR---KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            4578889999999999999998754322   2335999998765445556778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceec
Confidence            999999999999999886543 46889999999999999999999977  999999999999999999999999998766


Q ss_pred             CCCCCccc-cccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          231 PEGDKSHV-STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       231 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ........ ......+..|+|||++.+..++.++|||||||++|+|++ |+.||.......   ...             
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~-------------  221 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMK-------------  221 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHH-------------
Confidence            43322111 111234567999999998889999999999999999997 999997543211   100             


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                       .+......+.+...+.++.+++.+||+.+|++||++.++++.|+++
T Consensus       222 -~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         222 -AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -HHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             0011112222334567899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.7e-42  Score=323.78  Aligned_cols=244  Identities=28%  Similarity=0.386  Sum_probs=196.9

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|.+..+..      .||+|++....  .......+..|..+++.+ +||||+++++++...+.+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDE------LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            469999999999998765443      39999987532  223345567788888877 699999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+++|+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          75 MEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            99999999998886553  6899999999999999999999977  9999999999999999999999999987532221


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ..             .+... 
T Consensus       151 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~-------------~i~~~-  211 (318)
T cd05570         151 V--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQ-------------SILED-  211 (318)
T ss_pred             C--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HH-------------HHHcC-
Confidence            1  12335799999999999999999999999999999999999999976542211   00             00010 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  351 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~il~~  351 (389)
                       ...++...+..+.+|+.+||+.||++||++     .+++++
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         212 -EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence             111233456789999999999999999999     999876

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.4e-42  Score=314.53  Aligned_cols=276  Identities=28%  Similarity=0.386  Sum_probs=209.1

Q ss_pred             cCC-cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC--
Q 016481           72 ANF-RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  148 (389)
Q Consensus        72 ~~~-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  148 (389)
                      ++| .+.+.||+|+||+||++.....  ....+..||+|.+...........+.+|+.+++.++||||+++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPA--NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccc--cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            344 8889999999999998764321  12234459999987665444556788999999999999999999987653  


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..+++||||+.+|+|.+++...   .+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++.
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeeccccc
Confidence            4689999999999999988654   5899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccc-cccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHV-STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      .......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ......... ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~  233 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVRL  233 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhhh
Confidence            7654322111 1223456779999999888899999999999999999999999865432211 111100000 000111


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ...++.......+...+.++.+++.+||+.||++|||++++++.|+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2222222222334456789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.5e-42  Score=311.57  Aligned_cols=257  Identities=27%  Similarity=0.408  Sum_probs=206.4

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ++..++|++.++||+|+||.||+|..+..       ..||+|.+.....  ....+.+|+.+++.++|+||+++++++. 
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~-------~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   71 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGH-------TKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-   71 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCC-------ceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence            34567899999999999999999975432       2399998875432  3356788999999999999999999874 


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+..+++|||+.+++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcce
Confidence            567899999999999999887666567899999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ........ .......++..|+|||++.+..++.++||||||+++|+|++ |+.||........   .            
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~------------  213 (260)
T cd05067         150 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---I------------  213 (260)
T ss_pred             eecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---H------------
Confidence            76543221 11223456778999999998899999999999999999999 9999976542211   0            


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                        ..+........+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus       214 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         214 --QNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence              0011111112233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.7e-42  Score=321.96  Aligned_cols=244  Identities=27%  Similarity=0.380  Sum_probs=193.5

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhc-cCCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGH-LSHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|.+..+.+.      ||+|++....  .......+..|..++.. ++||||+++++++...+.+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQF------FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCE------EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEE
Confidence            4699999999999987655433      9999987542  12233455667777775 4899999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+++|+|..++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          75 MEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            99999999999886543  6788999999999999999999977  9999999999999999999999999987543222


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ...    +       ....+ 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~----i-------~~~~~-  213 (316)
T cd05619         151 A--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---FQS----I-------RMDNP-  213 (316)
T ss_pred             C--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---HHH----H-------HhCCC-
Confidence            1  22345799999999999999999999999999999999999999986543211   000    0       00011 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR-DIVDS  351 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~il~~  351 (389)
                         .++...+.++.+++.+||+.||++||++. ++++|
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         214 ---CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             ---CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence               12233567889999999999999999997 66654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-41  Score=323.24  Aligned_cols=269  Identities=21%  Similarity=0.285  Sum_probs=199.4

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+..+|++.+.||+|+||.||+|....+..      .||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   91 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGI------NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP   91 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCc------eeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            345789999999999999999997655433      39999986543 23344667789999999999999999998864


Q ss_pred             CC------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          148 DE------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       148 ~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                      ..      .+|+||||+++ +|...+..    .++...+..++.|++.||.|||+++  |+||||||+|||++.++.+||
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl  164 (359)
T cd07876          92 QKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI  164 (359)
T ss_pred             CCCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEE
Confidence            43      57999999975 56655532    4788888999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhh---------
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN---------  292 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---------  292 (389)
                      +|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......         
T Consensus       165 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  241 (359)
T cd07876         165 LDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP  241 (359)
T ss_pred             ecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999987643221   2233578999999999999999999999999999999999999998664322100         


Q ss_pred             ---hHHHHhHHHHh----hhhhh-----hhcCCCC---CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          293 ---LADWALPLLKE----KKKLL-----NIIDPRL---EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       293 ---~~~~~~~~~~~----~~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                         +..........    .....     .......   ........+..+.+|+.+||+.||++|||+.++++|-+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence               00000000000    00000     0000000   00011123567899999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=308.36  Aligned_cols=254  Identities=31%  Similarity=0.470  Sum_probs=208.0

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      +.||+|+||.||+|.+....   .....|++|.+...........+.+|+.+++.++|+||+++++++......++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD---GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCC---CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            46999999999999876531   123449999988765554567888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          158 MARGSVENNLFSKV-------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       158 ~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++++|.+++....       ...+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||.+...
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999987652       347899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...              
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~--------------  218 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLE--------------  218 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--------------
Confidence            55432222334567889999999988899999999999999999999 699998763221   110              


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      .+........+...+.++.+++.+||+.+|++|||+.+++++|+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         219 YLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            01111122334455788999999999999999999999999885

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5e-42  Score=314.37  Aligned_cols=248  Identities=24%  Similarity=0.340  Sum_probs=194.6

Q ss_pred             ecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           80 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        80 lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      ||+|+||.||++..+.+.+      .||+|.+.....  ......+..|+.+++.++||||+++++++..+.++++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGK------MYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEccCCc------EEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEec
Confidence            7999999999998765544      399998864321  11233455699999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                      ++||+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||++.......   
T Consensus        75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---  149 (277)
T cd05607          75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---  149 (277)
T ss_pred             CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence            99999998887666557889999999999999999999977  9999999999999999999999999987654322   


Q ss_pred             ccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCC
Q 016481          238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  317 (389)
Q Consensus       238 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (389)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.........  ...          ...........
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~----------~~~~~~~~~~~  217 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EEL----------KRRTLEDEVKF  217 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHH----------HHHhhcccccc
Confidence            123357899999999999888999999999999999999999999754321110  000          00111111110


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          318 DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       .....+.++.+|+.+||+.||++||+++++++.
T Consensus       218 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         218 -EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             -ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence             112356789999999999999999999665543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=334.11  Aligned_cols=283  Identities=21%  Similarity=0.298  Sum_probs=201.9

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC------CCccceE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS------HPNLVKL  141 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~  141 (389)
                      ....++|++.+.||+|+||+||+|.+....+      .||||++....  .....+..|+.+++.+.      |.+++.+
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~------~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i  196 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKE------YCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKI  196 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCe------EEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence            3445789999999999999999997655433      39999986432  22234455777766664      4558888


Q ss_pred             EeEEEeC-CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCC--
Q 016481          142 IGYCCED-EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDY--  217 (389)
Q Consensus       142 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~--  217 (389)
                      ++++... .++++|||++ |++|.+++....  .+++..+..++.|++.||.|||. .+  ||||||||+|||++.++  
T Consensus       197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTV  271 (467)
T ss_pred             EEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcc
Confidence            8888764 5789999998 678988886653  68899999999999999999997 46  99999999999998765  


Q ss_pred             --------------cEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCC
Q 016481          218 --------------NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD  283 (389)
Q Consensus       218 --------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~  283 (389)
                                    .+||+|||.+.....     .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                          499999998764322     1234689999999999999999999999999999999999999998


Q ss_pred             CCCchhhhhhHHHHhH-----HH-----Hhhhhhhhh---cCCCCC---------CC-C-ChHHHHHHHHHHHHhhccCC
Q 016481          284 KSRPAREQNLADWALP-----LL-----KEKKKLLNI---IDPRLE---------GD-Y-PVKGVHKAAMLAYHCLNHNP  339 (389)
Q Consensus       284 ~~~~~~~~~~~~~~~~-----~~-----~~~~~~~~~---~~~~~~---------~~-~-~~~~~~~l~~li~~cl~~dP  339 (389)
                      ................     +.     .+...+...   +.+...         .. . .......+.+||.+||++||
T Consensus       347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  426 (467)
T PTZ00284        347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR  426 (467)
T ss_pred             CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence            7654332221111000     00     000000000   000000         00 0 00124567899999999999


Q ss_pred             CCCCCHHHHHHHhccccCCCCCCCCCCCc
Q 016481          340 KARPLMRDIVDSLEPLQVLPDEAPTPKNF  368 (389)
Q Consensus       340 ~~Rps~~~il~~L~~~~~~~~~~~~p~~~  368 (389)
                      ++|||+.++|+|=.-.+..+.-...|-++
T Consensus       427 ~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~  455 (467)
T PTZ00284        427 QKRLNARQMTTHPYVLKYYPECRQHPNYP  455 (467)
T ss_pred             hhCCCHHHHhcCccccccCCccccCCCCC
Confidence            99999999999855545444444555554

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.7e-42  Score=328.70  Aligned_cols=259  Identities=22%  Similarity=0.233  Sum_probs=203.2

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      .....++|++.+.||+|+||.||+|.++.+.+.      ||+|++....  .......+.+|+.+++.++||||+++++.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~------~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV------YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA  111 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcE------EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            344557899999999999999999987665443      9999986421  12233456789999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      +..+..+++||||++||+|.+++...   .++...+..++.|++.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         112 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999999988653   5788888999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCC----CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH----LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |++........ ......+||+.|+|||++.+..    ++.++|||||||++|+|++|..||........          
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----------  255 (371)
T cd05622         187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----------  255 (371)
T ss_pred             CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH----------
Confidence            99986543221 1223467999999999987543    78999999999999999999999986543211          


Q ss_pred             HHhhhhhhhhcCC--CCCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHhc
Q 016481          301 LKEKKKLLNIIDP--RLEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDSLE  353 (389)
Q Consensus       301 ~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~il~~L~  353 (389)
                            ...++..  .+..+.....+..+.+++.+||+.++.+  |+++.++++|..
T Consensus       256 ------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~  306 (371)
T cd05622         256 ------YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  306 (371)
T ss_pred             ------HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence                  0011110  1111112346788999999999844443  789999999853

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.5e-42  Score=311.68  Aligned_cols=261  Identities=25%  Similarity=0.411  Sum_probs=208.6

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||+|+||.||+|.++.+.+.   ...||+|.............+..|+.+++.++||||+++++++..+...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKR---EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCC---ceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            4688899999999999999987654332   3459999987655555567889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccc
Confidence            99999999999998886543 36889999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccc---cccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          232 EGDKSHVSTRI---MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       232 ~~~~~~~~~~~---~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ...........   ..+..|+|||.+.+..++.++||||||+++|||++ |..||.......   ...++          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i----------  224 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI----------  224 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH----------
Confidence            32221111111   12457999999999999999999999999999886 999997654321   11111          


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                          ......+.+..++..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus       225 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         225 ----EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                01111122334567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.2e-42  Score=316.16  Aligned_cols=255  Identities=27%  Similarity=0.382  Sum_probs=203.5

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .|+..+.||+|+||.||+|.+..+.+.      ||+|.+.....  ......+..|+.+++.++|+||+.+++.+...+.
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~------~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKM------YACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCce------EEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence            367789999999999999987665443      99998765322  2223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++||||+.+|+|.+++.......+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            999999999999999886655557899999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      .....   .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.............   .....       
T Consensus       153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~-------  219 (285)
T cd05630         153 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE-------  219 (285)
T ss_pred             CCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhh-------
Confidence            43221   123478999999999999999999999999999999999999998643211100000   00000       


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHh
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDSL  352 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~L  352 (389)
                          .....+...+.++.+|+.+||+.||++|||     +.++++|-
T Consensus       220 ----~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~  262 (285)
T cd05630         220 ----VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP  262 (285)
T ss_pred             ----hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence                011123345678899999999999999999     88999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.7e-42  Score=311.38  Aligned_cols=254  Identities=26%  Similarity=0.381  Sum_probs=203.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.++||+|+||.||+|.+..+.       .||+|.+.....  ....+.+|+.+++.++|+||+++++++. ...
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~   74 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEP   74 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc-------eEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCC
Confidence            467999999999999999999765432       299999875432  2356788999999999999999999874 456


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+.+|+|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||.++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeec
Confidence            899999999999999997654456789999999999999999999977  999999999999999999999999999765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.........   .              
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~---~--------------  214 (262)
T cd05071         153 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---D--------------  214 (262)
T ss_pred             cccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH---H--------------
Confidence            433221 1122446778999999988899999999999999999999 88898765322110   0              


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                      .+........+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus       215 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         215 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            000011112234556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-42  Score=309.07  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=201.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|++.+.||+|+||.||+|.++..       ..+|+|++.....  ....+.+|+.+++.++|+||+++++++...+..
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~-------~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGK-------IDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI   74 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCC-------ccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence            4688899999999999999976432       2289998765322  234677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++++|.+++..... .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||+++...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          75 FIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             EEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecc
Confidence            999999999999998875443 6889999999999999999999977  9999999999999999999999999987653


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      .... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....+....   .          .+   
T Consensus       152 ~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~----------~~---  214 (256)
T cd05059         152 DDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---E----------SV---  214 (256)
T ss_pred             cccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---H----------HH---
Confidence            2211 11112234567999999999999999999999999999999 89999765432110   0          00   


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                       ........+...+.++.+++.+||+.+|++|||+.++++.|.
T Consensus       215 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         215 -SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             -HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence             111111223345788999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.8e-42  Score=309.45  Aligned_cols=252  Identities=24%  Similarity=0.407  Sum_probs=201.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|++.+.||+|+||.||+|.+...       ..+|+|.+....  .....+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~-------~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI   74 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCC-------CcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence            4688899999999999999976432       129999877543  2335688999999999999999999999998999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+.+|+|.+++..... .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||.++...
T Consensus        75 ~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          75 YIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecC
Confidence            999999999999998865433 6899999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      .... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ...          ..+ 
T Consensus       152 ~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~----------~~~-  216 (256)
T cd05113         152 DDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEK----------VSQ-  216 (256)
T ss_pred             CCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH----------Hhc-
Confidence            3221 11112345678999999998889999999999999999998 9999976543211   000          000 


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                         ......+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus       217 ---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         217 ---GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               0011112234678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.4e-41  Score=307.91  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=199.8

Q ss_pred             eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEec
Q 016481           79 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM  158 (389)
Q Consensus        79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (389)
                      .||+|+||.||+|.+....    ....||+|+............+.+|+.++++++|+||+++++++. ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~----~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRK----KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCC----CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            3899999999999764322    123499999876655555567889999999999999999999875 45789999999


Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccc
Q 016481          159 ARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV  238 (389)
Q Consensus       159 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~  238 (389)
                      ++|+|.+++.... ..+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.+||+|||++...........
T Consensus        77 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          77 SGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            9999999886432 36899999999999999999999977  99999999999999999999999999886543322111


Q ss_pred             -cccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCC
Q 016481          239 -STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  316 (389)
Q Consensus       239 -~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (389)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |..||........                 ...+.....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----------------~~~~~~~~~  216 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-----------------MSFIEQGKR  216 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-----------------HHHHHCCCC
Confidence             111234678999999988889999999999999999996 9999986543211                 111111112


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          317 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ...+..++.++.+++.+||..||++||++.+|.+.|+.+
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            233445678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-41  Score=307.67  Aligned_cols=252  Identities=25%  Similarity=0.349  Sum_probs=207.0

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|.+.+.||+|+||.||+|.+..+...      |++|.+.... .......+..|+.+++.++||||+++++++...+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~------~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRV------YAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcE------EEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            477889999999999999987655443      9999876432 344556788899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++++|.+++.......+++..+..++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            99999999999999987765567899999999999999999999977  9999999999999999999999999988654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||........   ..             ...
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~-------------~~~  214 (256)
T cd08529         153 DNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---IL-------------KII  214 (256)
T ss_pred             Cccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HH-------------HHH
Confidence            3321  22335788999999999998999999999999999999999999986542210   00             000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       .......+...+..+.+++.+||+.+|++||++.+++.+
T Consensus       215 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         215 -RGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -cCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             011112233556889999999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-41  Score=312.37  Aligned_cols=263  Identities=26%  Similarity=0.386  Sum_probs=206.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|...+.||+|+||.||+|..... ........+++|..... .......+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecC-CCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            35688899999999999999864321 11223445888987654 34445678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVL-------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      .+++|||+.+|+|.+++.....             ..+++..+..++.|++.||+|||+.+  ++|+||||+|||++.++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~~  159 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCCC
Confidence            9999999999999998865421             24788999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHH
Q 016481          218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       218 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  296 (389)
                      .+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||..........    
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----  235 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE----  235 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH----
Confidence            999999999876543322122223345788999999999999999999999999999998 999997543321110    


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                                   ..........+..++..+.+|+.+||+.||++||++.+|++.|+.
T Consensus       236 -------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 -------------CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -------------HHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                         000111112233456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.2e-42  Score=314.08  Aligned_cols=265  Identities=23%  Similarity=0.352  Sum_probs=211.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe-CC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-DE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~  149 (389)
                      .++|.+.+.||+|+||.||+|.+..+.  ......|++|.+...........+.+|+.+++.++|+||+++++++.. ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~--~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEK--PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCC--CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            568999999999999999999876522  112344899988766556666778899999999999999999998766 56


Q ss_pred             eEEEEEEecCCCChhhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          150 HRVLIYEFMARGSVENNLFSKVL------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      ..+++++|+.+|+|.+++.....      ..+++..+..++.+++.||+|||+++  ++|+||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECC
Confidence            78999999999999998865422      45889999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      ||+++.+.............++..|+|||++.+..++.++||||||+++|++++ |+.||....+..   +..+.     
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~-----  232 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL-----  232 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH-----
Confidence            999986644332222223456778999999998899999999999999999999 999998654321   11110     


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                               ........+..++.++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       233 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         233 ---------KDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             ---------HcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                     001111122345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=307.65  Aligned_cols=254  Identities=28%  Similarity=0.433  Sum_probs=202.2

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      ++||+|+||.||+|++.....   ....+|+|.............+..|+.+++.+.|+||+++++++. ....++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSG---KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCC---CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            469999999999997654431   223499999887655445567889999999999999999999875 5568999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                      +++|+|.+++....  .+++..+..++.|++.||+|||..+  ++|+||||+||+++.++.+||+|||+++.........
T Consensus        77 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          77 APLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999999987654  6889999999999999999999977  9999999999999999999999999988664433211


Q ss_pred             c-cccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCC
Q 016481          238 V-STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  315 (389)
Q Consensus       238 ~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (389)
                      . .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...+.              ....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~--------------~~~~  215 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAML--------------ESGE  215 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH--------------HcCC
Confidence            1 111234567999999998899999999999999999998 999997654321   11111              1111


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          316 EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ....+..++..+.+++.+||..+|++||++.++++.|+.+.
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            11233445678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.2e-42  Score=314.29  Aligned_cols=264  Identities=27%  Similarity=0.381  Sum_probs=208.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+.... .......||+|.+...........+.+|+.+++.++||||+++++++..+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccC-CCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            467999999999999999999764311 1123345999998766555556778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 016481          151 RVLIYEFMARGSVENNLFSKV--------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  210 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~N  210 (389)
                      .++||||+++|+|.+++....                    ...+++..++.++.|++.||+|||..+  ++|+||||+|
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~n  160 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRN  160 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhh
Confidence            999999999999999886432                    124678888999999999999999977  9999999999


Q ss_pred             eEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchh
Q 016481          211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAR  289 (389)
Q Consensus       211 ili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  289 (389)
                      |+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876543322212222345677999999998899999999999999999998 888886543321


Q ss_pred             hhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          290 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                      .   ..              .+........+...+.++.+|+.+||+.||++|||+.++++.|++
T Consensus       241 ~---~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 V---IY--------------YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H---HH--------------HHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1   00              000011111233456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=325.17  Aligned_cols=263  Identities=26%  Similarity=0.405  Sum_probs=226.1

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.....++.+.||.|-||.||+|......  ......||||..+.+......+.|+.|..+|+.++||||++++|+|.+ 
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~--kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-  462 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPE--KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-  462 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccc--cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence            33445566789999999999999876542  334566999999998888888999999999999999999999999975 


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...+||||+++.|.|..++..... .++......++.||+.+|+|||+..  .|||||..+|||+.....|||+|||+++
T Consensus       463 ~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  463 QPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             cceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhh
Confidence            567999999999999999977654 6888999999999999999999966  9999999999999999999999999999


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      .+.+...... +...-...|||||.++...++.++|||-|||++||++. |..||.+-..                 .++
T Consensus       540 ~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------sDV  601 (974)
T KOG4257|consen  540 YLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------SDV  601 (974)
T ss_pred             hccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------cce
Confidence            9877654433 34456778999999999999999999999999999876 9999986532                 345


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      +..++..-+.+.|..|++.+..|+.+||.+||.+||.|.+|...|..+
T Consensus       602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            556667777888999999999999999999999999999998777443

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=311.39  Aligned_cols=265  Identities=25%  Similarity=0.417  Sum_probs=212.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||+|+||.||+|.++.+..  .....+|+|.............+.+|+.+++.++|+||+++++++.. ..
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~--~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGE--KVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCC--CcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            3578899999999999999998765432  12345899988766555556778899999999999999999999877 78


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+.+|+|.+++..... .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||+++..
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            8999999999999998876533 5899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .............++..|+|||.+....++.++||||||+++|++++ |+.||.......   +..              
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~--------------  222 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPD--------------  222 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH--------------
Confidence            54332222222334678999999988889999999999999999998 999998654321   110              


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      .+........+..++..+.+++.+||..||++||++.++++.|..+...
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         223 LLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            1111111222334557789999999999999999999999999887554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-42  Score=329.85  Aligned_cols=255  Identities=24%  Similarity=0.273  Sum_probs=200.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||.||+|..+.+.+      .||+|++....  .......+..|+.++..++|+||+++++.+.+.+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGH------IYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCC------EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            368899999999999999998765544      39999986432  2233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            9999999999999999887653  6889999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------------cccccccccccccCccccccCCCCcccchhHHHHHHHHHH
Q 016481          230 GPEGDKS---------------------------------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL  276 (389)
Q Consensus       230 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ell  276 (389)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            4321100                                 0012357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 016481          277 TGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL---MRDIVDS  351 (389)
Q Consensus       277 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~~il~~  351 (389)
                      +|+.||....+.....      .       +... ......+.....+.++.+++.+|+. ||.+|++   +.++++|
T Consensus       231 tG~~Pf~~~~~~~~~~------~-------i~~~-~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         231 IGYPPFCSETPQETYR------K-------VMNW-KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             cCCCCCCCCCHHHHHH------H-------HHcC-CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            9999998655432110      0       0000 0001101111246788999998775 9999984   7888887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.1e-41  Score=310.23  Aligned_cols=262  Identities=24%  Similarity=0.411  Sum_probs=208.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||+|+||.||+|.++....   ....+|+|.+...........+..|+.+++.++||||+++++++..++.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGK---REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCC---CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            3578899999999999999997653322   2234899998765545556778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            999999999999999886553 36788999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCcc-ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          231 PEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ....... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||.......   .....          .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----------~  223 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----------E  223 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----------h
Confidence            4432111 1112234568999999998899999999999999999887 999997654321   11110          0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .    ....+.+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       224 ~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         224 E----GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C----CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0    111122334567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.1e-42  Score=336.13  Aligned_cols=262  Identities=22%  Similarity=0.352  Sum_probs=193.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  148 (389)
                      ..+|++.+.||+|+||.||+|....+.+      .||+|.+.....     ...+|+.+++.++|+||+++++++...  
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~------~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~~~  133 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSE------KVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTECF  133 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCC------EEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence            4579999999999999999998765443      399998764321     223699999999999999999876432  


Q ss_pred             ------CeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-cE
Q 016481          149 ------EHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NA  219 (389)
Q Consensus       149 ------~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-~v  219 (389)
                            ..+++||||+++ +|.+++..  .....+++..+..++.|++.||+|||+.+  |+||||||+|||++.++ .+
T Consensus       134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~v  210 (440)
T PTZ00036        134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTL  210 (440)
T ss_pred             ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCce
Confidence                  256799999975 67666643  23447899999999999999999999977  99999999999998664 79


Q ss_pred             EEeccCCCcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh
Q 016481          220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  298 (389)
                      ||+|||+++.......   .....||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+......  +.....
T Consensus       211 kL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~  285 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQ  285 (440)
T ss_pred             eeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH
Confidence            9999999987643321   2235789999999998764 689999999999999999999999987543321  111110


Q ss_pred             HH----HHhh----hhhhh-----hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          299 PL----LKEK----KKLLN-----IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       299 ~~----~~~~----~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..    ....    .....     .....+...++...+.++.+|+.+||++||.+|||+.++++|
T Consensus       286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            00    0000    00000     000001111233346789999999999999999999999987

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.4e-41  Score=316.11  Aligned_cols=269  Identities=24%  Similarity=0.314  Sum_probs=206.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||+|+||.||+|.+..+..      .+|+|.............+.+|+.++++++||||+++++++..++.+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGL------IMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI   74 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCe------EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence            368999999999999999997665443      38999887654445556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+ ++  ++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            9999999999999998665  368899999999999999999997 46  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh-------
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-------  303 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------  303 (389)
                      ....    .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....................       
T Consensus       151 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         151 IDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             cccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence            3321    23357899999999998888999999999999999999999999754322111111000000000       


Q ss_pred             ------------hhhhhhhcCCCCCCCCC-hHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          304 ------------KKKLLNIIDPRLEGDYP-VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       304 ------------~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                                  ................+ ...+.++.+|+.+||+.||++||++.+++++..-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  290 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI  290 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence                        00000000000001111 1256779999999999999999999999988543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.8e-42  Score=311.42  Aligned_cols=257  Identities=30%  Similarity=0.473  Sum_probs=203.7

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      +.||+|+||.||+|.+............+++|.+...........+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999876543223334558999876654444566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-----cEEEeccCCC
Q 016481          158 MARGSVENNLFSKV-----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-----NAKLSDFGLA  227 (389)
Q Consensus       158 ~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-----~vkl~Dfg~a  227 (389)
                      +++|+|.+++....     ...+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++     .++|+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999986532     234788899999999999999999976  99999999999999877     8999999998


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ................++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ....          
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~----------  225 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQH----------  225 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHH----------
Confidence            76544332222223456788999999999999999999999999999998 999997543221   1110          


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                          +........+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       226 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         226 ----VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ----HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                0111111223445688999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5e-42  Score=321.32  Aligned_cols=244  Identities=27%  Similarity=0.330  Sum_probs=192.7

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHH-HHhccCCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVI-FLGHLSHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||+||+|.+..+.+      .||+|++....  .......+..|.. +++.++||||+++++.+...+..++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGK------FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEE
Confidence            469999999999998765544      39999986532  1222334455554 46788999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+.+|+|..++....  .+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          75 LDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             EcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            99999999998886543  6888999999999999999999977  9999999999999999999999999987543221


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........      ..          .++...
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~----------~i~~~~  212 (323)
T cd05575         151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YD----------NILNKP  212 (323)
T ss_pred             --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HH----------HHHcCC
Confidence              123346799999999999999999999999999999999999999986542210      00          011111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLM----RDIVDS  351 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~~il~~  351 (389)
                        ...+...+..+.+++.+||+.||.+||++    .+++++
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         213 --LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence              11223346789999999999999999987    477765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=309.17  Aligned_cols=257  Identities=28%  Similarity=0.413  Sum_probs=207.7

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +..++|++.+.||.|+||.||+|.+.+.       ..|++|.+.....  ....+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~-------~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGT-------TKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE   73 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCC-------ceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence            4457899999999999999999975432       2289998875432  345688899999999999999999999988


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...++||||+++++|.+++.......+++..+..++.+++.||+|||+++  ++|+||||+||+++.++.++|+|||++.
T Consensus        74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~  151 (261)
T cd05034          74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLAR  151 (261)
T ss_pred             CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccce
Confidence            99999999999999999997765557899999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ....... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ....           
T Consensus       152 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~-----------  216 (261)
T cd05034         152 LIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQ-----------  216 (261)
T ss_pred             eccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----------
Confidence            6543211 11112335678999999998899999999999999999998 999997653221   1000           


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                         +........+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       217 ---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         217 ---VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               01111112233346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2e-41  Score=306.91  Aligned_cols=251  Identities=26%  Similarity=0.367  Sum_probs=198.5

Q ss_pred             eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           79 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      .||+|+||.||+|.+....    ....+|+|++..... ......+..|+.+++.+.|+||+++++++. ....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKK----SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecCC----CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            5899999999999754221    233499999875432 334567889999999999999999999875 4577999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                      +++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+|+||||.||+++.++.+||+|||++..........
T Consensus        77 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          77 AELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            99999999886543  6889999999999999999999977  9999999999999999999999999998754332211


Q ss_pred             -ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCC
Q 016481          238 -VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  315 (389)
Q Consensus       238 -~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (389)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |..||........                 ...+....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-----------------~~~i~~~~  215 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-----------------TQMIESGE  215 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHCCC
Confidence             1112344678999999988889999999999999999998 9999986543211                 11111112


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          316 EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ....+..++.++.+++.+||+.||++||++++|.+.|+..
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            2233445678899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-41  Score=311.05  Aligned_cols=254  Identities=26%  Similarity=0.359  Sum_probs=200.8

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      +|++.+.||+|+||.||+|.+..+..      .||+|.............+..|+.++++++||||+++++.+......+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   75 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRR------ILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRIS   75 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCc------EEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEE
Confidence            67888999999999999997655433      399999876544445567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      +||||+++++|..+      ..+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++.....
T Consensus        76 lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          76 ICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            99999999988653      24678888999999999999999977  99999999999999999999999999876543


Q ss_pred             CCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      ..    .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.............-.         ......
T Consensus       148 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---------~~~~~~  214 (279)
T cd06619         148 SI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL---------LQCIVD  214 (279)
T ss_pred             cc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH---------HHHHhc
Confidence            21    23357899999999999999999999999999999999999999754322111000000         000000


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ...........+.++.+++.+||+.||++||++.+++++-.
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~  255 (279)
T cd06619         215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF  255 (279)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence            00000111234567899999999999999999999998843

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-41  Score=309.57  Aligned_cols=256  Identities=24%  Similarity=0.311  Sum_probs=201.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||+|+||.||+|+...+..      .||+|+...... .....+.+|+.+++.++||||+++++++...+.
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~------~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~   80 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGE------LAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK   80 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCe------EEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Confidence            3579999999999999999998655443      399998865432 233457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          81 LWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceee
Confidence            999999999999999886543  6789999999999999999999977  999999999999999999999999998865


Q ss_pred             CCCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      .....  ......|+..|+|||.+.   ...++.++|||||||++|+|++|+.||....+......  +         ..
T Consensus       157 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--~---------~~  223 (267)
T cd06646         157 TATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--M---------SK  223 (267)
T ss_pred             ccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--e---------ec
Confidence            33211  122356889999999884   34578899999999999999999999965432211000  0         00


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .....+..  ......+..+.+|+.+||+.||++||++.+++++|
T Consensus       224 ~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         224 SNFQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00000101  11123467899999999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.7e-41  Score=312.10  Aligned_cols=253  Identities=26%  Similarity=0.355  Sum_probs=202.4

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      |+..+.||+|+||+||+|.+..+.+      .||+|.+.....  ......+.+|+.+++.++|+||+.+++.+..++..
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGK------MYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL   75 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCc------EEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence            6778899999999999998765544      399998865421  12234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999999999998887655557999999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ...   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.............            ....
T Consensus       154 ~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~------------~~~~  218 (285)
T cd05632         154 EGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD------------RRVL  218 (285)
T ss_pred             CCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------Hhhh
Confidence            322   1223578999999999999999999999999999999999999998654321110100            0000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~  351 (389)
                      ..  ...++...+..+.+|+..||+.||++||+     +.+++++
T Consensus       219 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         219 ET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             cc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            00  11123345677899999999999999999     7788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3e-41  Score=307.74  Aligned_cols=257  Identities=25%  Similarity=0.359  Sum_probs=195.3

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      +.||+|+||.||+|.+...    .....+++|.+...........+.+|+.+++.++||||+++++++.+....++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSG----YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCC----CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            4689999999999976432    223448999887665555556788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          158 MARGSVENNLFSKV---LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       158 ~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      +++|+|.+++....   ....++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            99999999886532   224567778889999999999999977  9999999999999999999999999987543332


Q ss_pred             CccccccccccccccCccccccC-------CCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTG-------HLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      .........++..|+|||++.+.       .++.++||||||+++|+|++ |+.||...........   .   ..  ..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~---~---~~--~~  226 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY---T---VR--EQ  226 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH---H---hh--cc
Confidence            22222335678889999998642       35789999999999999996 9999976543321110   0   00  00


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ......+    ......+..+.+++..|+ .+|++|||+.+|+..|+
T Consensus       227 ~~~~~~~----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLKLPKP----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCCC----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0111111    112234567888999999 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-43  Score=326.98  Aligned_cols=265  Identities=26%  Similarity=0.410  Sum_probs=228.6

Q ss_pred             CHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEE
Q 016481           63 TYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLI  142 (389)
Q Consensus        63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~  142 (389)
                      ..+.|+.-..+.+...+||.|.||.||.|+|+...-.      ||||.++.+.  ....+|+.|..+|+.++|||+|+++
T Consensus       258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslT------vAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLL  329 (1157)
T KOG4278|consen  258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT------VAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLL  329 (1157)
T ss_pred             CcchhhccchheeeeeccCCCcccceeeeeeecccee------eehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHh
Confidence            3467888788888899999999999999999876655      9999998764  4567899999999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          143 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                      |+|..+...|||+|||..|+|.+++...+...++.-..+.++.||..||+||...+  +|||||..+|+|+.++..||++
T Consensus       330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvA  407 (1157)
T KOG4278|consen  330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVA  407 (1157)
T ss_pred             hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEee
Confidence            99999999999999999999999999988888888889999999999999999966  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      |||+++.+.. +.............|.|||.+....++.++|||+|||+|||+.| |-.||.+.+...            
T Consensus       408 DFGLsRlMtg-DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq------------  474 (1157)
T KOG4278|consen  408 DFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------  474 (1157)
T ss_pred             ccchhhhhcC-CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH------------
Confidence            9999998754 33333334556788999999999999999999999999999998 888998764322            


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                           +-.+++...+-+.|..|+..+..|+..||++.|.+||+|.++.+.||.+
T Consensus       475 -----VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  475 -----VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             -----HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence                 2223344444455778899999999999999999999999999888765

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.8e-41  Score=307.74  Aligned_cols=254  Identities=27%  Similarity=0.372  Sum_probs=203.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+....       .+|+|.......  ....+.+|+.+++.++|+|++++++++. ...
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-------~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   74 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTT-------KVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEP   74 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCc-------eEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCC
Confidence            467899999999999999999765432       289998765432  2356778999999999999999998875 456


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+.+|+|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEc
Confidence            899999999999999997665556889999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....+...   ...             
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~-------------  215 (260)
T cd05069         153 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ-------------  215 (260)
T ss_pred             cCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-------------
Confidence            432211 1122346778999999988889999999999999999999 9999976543211   000             


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                       +........+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus       216 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         216 -VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -HHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             00011112233456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.4e-42  Score=321.96  Aligned_cols=239  Identities=25%  Similarity=0.311  Sum_probs=188.8

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHH-HHhccCCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVI-FLGHLSHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|++..+.+      .||+|++.....  ......+..|.. +++.++|+||+++++++...+.+|+|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEK------FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEE
Confidence            469999999999998765543      399999865321  122234444444 46788999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+.+|+|.+++....  .+.+..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~  150 (325)
T cd05602          75 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  150 (325)
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence            99999999999886543  5778888899999999999999977  9999999999999999999999999987543221


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ...             +... 
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~-------------i~~~-  211 (325)
T cd05602         151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDN-------------ILNK-  211 (325)
T ss_pred             --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHH-------------HHhC-
Confidence              123346799999999999999999999999999999999999999986543211   000             0000 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR  346 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  346 (389)
                       ....+...+..+.+++.+||+.||.+||++.
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (325)
T cd05602         212 -PLQLKPNITNSARHLLEGLLQKDRTKRLGAK  242 (325)
T ss_pred             -CcCCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence             1112234567899999999999999999876

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.4e-42  Score=320.05  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=198.4

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDE  149 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  149 (389)
                      +|...+.||+|+||.||+|....+.+.      ||+|++....  .......+..|..+++.+. |++|+.+++++...+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDEL------YAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            477789999999999999987655443      9999987532  1233455677888888876 578888999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccc
Confidence            9999999999999999886543  6889999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........   .             ..
T Consensus       151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~-------------~~  212 (323)
T cd05615         151 HMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---F-------------QS  212 (323)
T ss_pred             cCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---H-------------HH
Confidence            43221  122345799999999999999999999999999999999999999986543211   0             00


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~il~~  351 (389)
                      +...  ....+...+.++.+++.+||+.||.+|++.     .++++|
T Consensus       213 i~~~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         213 IMEH--NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             HHhC--CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence            1111  112234456788999999999999999974     566655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-42  Score=323.82  Aligned_cols=247  Identities=28%  Similarity=0.319  Sum_probs=197.1

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  156 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (389)
                      +.||+|+||.||++.....   ...+..||+|++..... ......+..|+.++++++||||+++++++...+.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITG---PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEecc---CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            6799999999999865322   12345599999875321 2233456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCc
Q 016481          157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  236 (389)
Q Consensus       157 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~  236 (389)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++.......  
T Consensus        79 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          79 FLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            999999999886543  6899999999999999999999977  9999999999999999999999999987653321  


Q ss_pred             cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCC
Q 016481          237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  316 (389)
Q Consensus       237 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (389)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........                ..+...  .
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~----------------~~i~~~--~  214 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM----------------TMILKA--K  214 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH----------------HHHHcC--C
Confidence            1223467999999999999989999999999999999999999999865432110                000111  1


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 016481          317 GDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  351 (389)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~  351 (389)
                      ..++...+..+.+|+.+||+.||++||+     +.+++++
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence            1233445678999999999999999999     5556655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=306.21  Aligned_cols=251  Identities=27%  Similarity=0.458  Sum_probs=207.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|.+.+.||.|+||.||+|....        ..||+|.......  ....+.+|+.+++.++|+||+++++++.....
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~--------~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRG--------QKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP   74 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecC--------cEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence            4578899999999999999997542        3399999876543  45678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|.+++.......+++..+..++.|++.||.|||+++  ++|+||||+||+++.++.++|+|||+++..
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccc
Confidence            999999999999999987766557899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .....     ...++..|+|||.+.+..++.++||||||+++|+|++ |..||........   .              .
T Consensus       153 ~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~--------------~  210 (256)
T cd05039         153 SQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V--------------P  210 (256)
T ss_pred             ccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---H--------------H
Confidence            33211     2345677999999988889999999999999999997 9999976532211   0              0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .+........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         211 HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            0011111122334568899999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-41  Score=317.90  Aligned_cols=261  Identities=20%  Similarity=0.316  Sum_probs=193.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||+|+||.||+|.......      .||+|+.....       ...|+.+++.++|+||+++++++.....
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~  131 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPD------PVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAI  131 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCc------eEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence            4579999999999999999998665433      38999854332       2358999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++|||++. ++|.+++.... ..+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus       132 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        132 TCMVLPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             eEEEEEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            999999995 58888876543 36899999999999999999999977  999999999999999999999999998753


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCC-CCCCchhhhhhH---HHHhHHHHhh--
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL-DKSRPAREQNLA---DWALPLLKEK--  304 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf-~~~~~~~~~~~~---~~~~~~~~~~--  304 (389)
                      ....   ......||+.|+|||++.+..++.++|||||||++|||+++..++ ............   ......+...  
T Consensus       208 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~  284 (357)
T PHA03209        208 VVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV  284 (357)
T ss_pred             ccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence            2211   123357999999999999999999999999999999999865554 332211111110   0001100000  


Q ss_pred             --hhh---------hhhcCC--CCCCC-------CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 --KKL---------LNIIDP--RLEGD-------YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 --~~~---------~~~~~~--~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        ..+         ..+++.  .....       .....+.++.+||.+||+.||.+|||+.++++|
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        285 HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             ChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence              000         000000  00000       011234567789999999999999999999987

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.7e-41  Score=305.73  Aligned_cols=260  Identities=22%  Similarity=0.333  Sum_probs=208.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||.||+|....+.+      .||+|.+....  .......+.+|+.++++++|+||+++++++...+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGR------VVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCC------EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            579999999999999999998764433      39999876422  2333567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          150 HRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ..++||||+++|+|.+++...  ....+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEecccee
Confidence            999999999999999887542  2345789999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ........  ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......    ..+.           
T Consensus       154 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-----------  216 (267)
T cd08224         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-----------  216 (267)
T ss_pred             eeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHH-----------
Confidence            76543221  122356889999999999889999999999999999999999999654311    1110           


Q ss_pred             hhhcCCCCCCCCCh-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          308 LNIIDPRLEGDYPV-KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       308 ~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ...+........+. ..+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         217 CKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            00011111112222 55678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-41  Score=312.98  Aligned_cols=267  Identities=24%  Similarity=0.301  Sum_probs=195.9

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh-hHHHHHHHHHHHhcc---CCCccceEEeEEEe-
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-GHREWLAEVIFLGHL---SHPNLVKLIGYCCE-  147 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-  147 (389)
                      +|++.+.||+|+||.||+|.+..+.+      .||+|.+....... ....+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGH------FVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCc------EEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            58889999999999999998765544      39999887543221 123344566666655   69999999998764 


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          148 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       148 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                          ...+++||||+. ++|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|
T Consensus        75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECc
Confidence                346899999997 48888887655556899999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhh-hHHHHh-HHH
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LADWAL-PLL  301 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~-~~~  301 (389)
                      ||++.......   ......||..|+|||++.+..++.++|||||||++|+|++|++||.......... ...... ...
T Consensus       152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07863         152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  228 (288)
T ss_pred             cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence            99988654322   1223568999999999999999999999999999999999999997654332110 000000 000


Q ss_pred             Hhhhhhhh----hcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          302 KEKKKLLN----IIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       302 ~~~~~~~~----~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ........    ...+...   .......+..+.+++.+||+.||++|||+.+++.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000000    0000000   01112346778999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-41  Score=323.60  Aligned_cols=267  Identities=23%  Similarity=0.326  Sum_probs=200.4

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC--
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE--  149 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--  149 (389)
                      +|.+.+.||+|+||.||+|....+.+      .||+|.+.... .......+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGK------RVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCC------EEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            47889999999999999997654433      39999886532 2334567889999999999999999999998776  


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          150 ---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       150 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                         .+|+||||+. ++|.+.+...  ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccc
Confidence               8899999996 5788777544  36899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH------
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP------  299 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------  299 (389)
                      ++....... .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....+............      
T Consensus       150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            886543221 122334688999999998874 579999999999999999999999987654432211110000      


Q ss_pred             HHHhhhhhhhhc-CCCCC-C------CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          300 LLKEKKKLLNII-DPRLE-G------DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       300 ~~~~~~~~~~~~-~~~~~-~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +..........+ ..... .      ......+.++.+|+.+||+.||++|||+.++++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            000000000000 00000 0      1112336788999999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-41  Score=322.48  Aligned_cols=268  Identities=20%  Similarity=0.273  Sum_probs=199.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+.++|++.+.||+|+||.||+|......+      .||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   87 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDR------NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCc------eEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence            356799999999999999999997654433      39999887543 23344667789999999999999999998864


Q ss_pred             C------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          148 D------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       148 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                      .      ...++||||+++ +|.+.+..    .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          88 QKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             cccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEE
Confidence            3      357999999975 66665532    4788888999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH------
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD------  295 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~------  295 (389)
                      +|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..........-      
T Consensus       161 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             eeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999998653321   2233578999999999999999999999999999999999999998754322110000      


Q ss_pred             ---H-------HhHHHHhhhhhhhhcCCCC--------CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          296 ---W-------ALPLLKEKKKLLNIIDPRL--------EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       296 ---~-------~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                         +       ................+..        ........+.++.+|+.+||+.||++|||+.++++|-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp  312 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP  312 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence               0       0000000000000000000        0011122356789999999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.1e-41  Score=306.51  Aligned_cols=250  Identities=26%  Similarity=0.396  Sum_probs=202.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEE-eCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC-EDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~  149 (389)
                      ..+|.+.+.||+|+||.||+|...        +..|++|......   ....+..|+.+++.++|+|++++++++. ..+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--------~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   73 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--------CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence            357899999999999999998643        2338999886542   2456788999999999999999999764 456


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.+||+|||++..
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~  151 (256)
T cd05082          74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE  151 (256)
T ss_pred             ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCcccee
Confidence            7899999999999999987766556889999999999999999999977  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .....     ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......   ..              
T Consensus       152 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~--------------  209 (256)
T cd05082         152 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV--------------  209 (256)
T ss_pred             ccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HH--------------
Confidence            43321     22345678999999998899999999999999999997 999997543211   10              


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ..+........+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         210 PRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            00111111222334568899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.4e-42  Score=320.82  Aligned_cols=244  Identities=27%  Similarity=0.335  Sum_probs=191.4

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHH-HHhccCCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVI-FLGHLSHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|++..+..      .||+|++....  .......+..|.. +++.++||||+++++++...+..|+|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGS------FYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCC------EEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEE
Confidence            469999999999998765544      39999986532  1222334555554 57889999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+++|+|...+....  .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (321)
T cd05603          75 LDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE  150 (321)
T ss_pred             EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence            99999999988876543  6788888999999999999999977  9999999999999999999999999987532221


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+....   .             ..+... 
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~-------------~~i~~~-  211 (321)
T cd05603         151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---Y-------------DNILHK-  211 (321)
T ss_pred             --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---H-------------HHHhcC-
Confidence              123346799999999999999999999999999999999999999986542110   0             001111 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH----HHHHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR----DIVDS  351 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~----~il~~  351 (389)
                       ....+...+..+.+++.+||+.||.+||++.    +++++
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         212 -PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence             1122334567889999999999999999753    66554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.8e-41  Score=304.84  Aligned_cols=254  Identities=27%  Similarity=0.403  Sum_probs=204.1

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      +.||+|++|.||+|.+....   .....||+|.+...........+..|+.++++++|+||+++++.+.. ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSG---GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCC---CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            46899999999999875531   22234899998876554556788899999999999999999999988 899999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                      +++|+|.+++.......+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.+||+|||++..........
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            99999999987654356899999999999999999999977  9999999999999999999999999998765432211


Q ss_pred             -ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCC
Q 016481          238 -VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL  315 (389)
Q Consensus       238 -~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (389)
                       ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........   .   ...       .   ...
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~---~~~-------~---~~~  218 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL---K---KID-------K---EGE  218 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---HHH-------h---cCC
Confidence             1123457788999999999899999999999999999999 99999755432110   0   000       0   011


Q ss_pred             CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          316 EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11123345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.9e-41  Score=307.27  Aligned_cols=260  Identities=23%  Similarity=0.304  Sum_probs=207.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|.+.+.||+|+||.||+|....+...      +++|.+....  .......+.+|+.+++.++|+||+++++++..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~------~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVP------VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCce------EEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence            4688889999999999999986655433      9999775432  2234467888999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          150 HRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ..+++|||+++++|.+++..  .....+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhh
Confidence            99999999999999988753  22346889999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ........  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........    ....       ..
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~-------~~  220 (267)
T cd08229         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCK-------KI  220 (267)
T ss_pred             hccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HHhh-------hh
Confidence            76543221  12235689999999999988999999999999999999999999975432110    0000       00


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .   ........+...+..+.+++.+||+.||++|||+.+|++.++++
T Consensus       221 ~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         221 E---QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             h---cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            0   11111111234677899999999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-41  Score=308.08  Aligned_cols=255  Identities=29%  Similarity=0.475  Sum_probs=202.7

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhH-HHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      |++.+.||+|+||+||+|....+...      ||+|++......... .....|+.+++.++|+||+++++++......+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~------~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQK------VAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEE------EEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeE------EEEEEeccccccccccchhhhhhhcccccccccccccccccccccccc
Confidence            67889999999999999987766544      999999876543333 23456999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      +||||+++++|.+++...  ..++...+..++.|++.||++||+.+  |+|+||||+||+++.++.++|+|||.+.....
T Consensus        75 ~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~  150 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSE  150 (260)
T ss_dssp             EEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred             cccccccccccccccccc--cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccc
Confidence            999999999999998733  36799999999999999999999977  99999999999999999999999999875411


Q ss_pred             CCCccccccccccccccCccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                        .........++..|+|||++. +..++.++||||||+++|+|++|..||.................   .  ......
T Consensus       151 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~--~~~~~~  223 (260)
T PF00069_consen  151 --NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---R--PLPSSS  223 (260)
T ss_dssp             --TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---T--HHHHHT
T ss_pred             --cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---c--cccccc
Confidence              122334467899999999998 88899999999999999999999999987622222211111100   0  000000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .      ........+.+++.+||+.||++||++.+++++
T Consensus       224 ~------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 Q------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             T------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             c------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0      000113789999999999999999999999976

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-41  Score=328.42  Aligned_cols=264  Identities=21%  Similarity=0.234  Sum_probs=197.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ...|.+.+.||+|+||.||+|.+....+      .||+|....       ..+.+|+.++++++|+||+++++++...+.
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~------~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~  234 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQ------RVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGL  234 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCC------EEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            4479999999999999999998765443      399996432       234579999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++|||++. ++|..++.... ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       235 ~~lv~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~  310 (461)
T PHA03211        235 TCLVLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFA  310 (461)
T ss_pred             EEEEEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence            999999995 68888876543 36899999999999999999999977  999999999999999999999999999865


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchh-h----hhhHHHHhHHHHhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR-E----QNLADWALPLLKEKK  305 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~----~~~~~~~~~~~~~~~  305 (389)
                      .............||+.|+|||++.+..++.++|||||||++|||++|..|+....... .    ..+...+........
T Consensus       311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~  390 (461)
T PHA03211        311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD  390 (461)
T ss_pred             ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence            44322222334679999999999999999999999999999999999887653322111 0    111111110000000


Q ss_pred             hh------------hh----hcCCCCCCCCC---hHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          306 KL------------LN----IIDPRLEGDYP---VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       306 ~~------------~~----~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..            ..    ...+.......   ...+..+.+|+.+||+.||.+|||+.|+|+|
T Consensus       391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00            00    00000000000   1234578999999999999999999999987

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-41  Score=307.44  Aligned_cols=252  Identities=28%  Similarity=0.384  Sum_probs=198.5

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCeEEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYE  156 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  156 (389)
                      +.||+|+||.||+|.+..+...    ..+++|.............+..|+.++.++ +||||+++++++...+.+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLR----MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCe----eEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3689999999999987654321    237888887554445556788999999999 79999999999999999999999


Q ss_pred             ecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          157 FMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       157 ~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                      |+++|+|.+++....              ...+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEEC
Confidence            999999999886532              124788899999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      |||++.......   .......+..|+|||++.+..++.++||||||+++|+|++ |..||.......   ..       
T Consensus       155 dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~-------  221 (270)
T cd05047         155 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY-------  221 (270)
T ss_pred             CCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HH-------
Confidence            999986432111   1111234667999999988899999999999999999997 999997543211   00       


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                             ..+........+...+.++.+++.+||+.||.+|||+.+++..|+.+
T Consensus       222 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         222 -------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             -------HHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                   00111111122334567889999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=328.22  Aligned_cols=258  Identities=26%  Similarity=0.393  Sum_probs=222.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++.++.++||+|.||.|++|.|+....+.   ..||||+++.+.......+|++|+.+|-+|+|+|++++||+..+ ..
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~---V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKH---VNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcE---EeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence            345677899999999999999998754443   45999999988766678899999999999999999999999987 77


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +.+|||+++.|+|++.|.......+.......++.||+.||+||.+.+  +|||||..+|+|+.....|||+|||+.+.+
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceecc
Confidence            889999999999999998866667889999999999999999999966  999999999999999999999999999988


Q ss_pred             CCCCCccccc-cccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          231 PEGDKSHVST-RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       231 ~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ..++..+... .......|+|||.++...++.++|||+|||++|||++ |+.||.+-...                 .+.
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----------------qIL  325 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----------------QIL  325 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----------------HHH
Confidence            7766555433 2456778999999999999999999999999999999 88899876533                 334


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +.+|.+-+..-+..|+.++.++++.||..+|.+||+|..|.+.
T Consensus       326 ~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  326 KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            4455555556688899999999999999999999999999744

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.5e-41  Score=305.08  Aligned_cols=256  Identities=29%  Similarity=0.405  Sum_probs=205.1

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +...+|++.+.||+|+||.||+|.+....       .+++|......  .....+.+|+.+++.++|+||+++++++.. 
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~-------~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   72 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHT-------KVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-   72 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCc-------cEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence            45678999999999999999999754322       28999876542  234567889999999999999999999877 


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...+++|||+++|+|.+++.......+++..+..++.+++.||.|||+.+  ++|+||||+||+++.++.+||+|||++.
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~  150 (260)
T cd05073          73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLAR  150 (260)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCccee
Confidence            78899999999999999997765556888899999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ........ ......++..|+|||++.+..++.++|+||||+++|++++ |+.||.........   .+    +      
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~----~------  216 (260)
T cd05073         151 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RA----L------  216 (260)
T ss_pred             eccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HH----H------
Confidence            65432211 1222345678999999998889999999999999999999 99999765332111   00    0      


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                          ........+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       217 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         217 ----ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                0111111223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-41  Score=317.76  Aligned_cols=244  Identities=28%  Similarity=0.336  Sum_probs=191.5

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHH-HHhccCCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVI-FLGHLSHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||+|+||.||+|....+..      .||+|++....  .......+..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGK------CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence            469999999999998655443      49999986532  1223344555554 46778999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+.+|+|..++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          75 LDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            99999999988876543  6889999999999999999999977  9999999999999999999999999987542221


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........   .   .          ......
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~---~----------~~~~~~  212 (325)
T cd05604         151 D--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM---Y---D----------NILHKP  212 (325)
T ss_pred             C--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH---H---H----------HHHcCC
Confidence            1  22346799999999999999999999999999999999999999986542211   0   0          001111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHH----HHHHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR----DIVDS  351 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~----~il~~  351 (389)
                      .  ..+...+..+.+++.+||+.||.+||+++    ++++|
T Consensus       213 ~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         213 L--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             c--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence            0  11223457788999999999999999875    56554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.8e-41  Score=308.23  Aligned_cols=254  Identities=26%  Similarity=0.326  Sum_probs=200.5

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  148 (389)
                      ..+.|++.+.||+|+||.||+|.+..+.+      .||+|......  .....+..|+.+++.+ +|+||+++++++...
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~------~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQ------LAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCc------EEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            34678889999999999999998765543      39999986543  2335677899999988 699999999998753


Q ss_pred             ------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          149 ------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       149 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                            ...++||||+.+|+|.+++.......+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.++|+
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEc
Confidence                  46899999999999999887655557889999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  297 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  297 (389)
                      |||++........  ......|++.|+|||++.     +..++.++|||||||++|+|++|+.||....+......    
T Consensus       154 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----  227 (272)
T cd06637         154 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----  227 (272)
T ss_pred             cCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----
Confidence            9999876533211  223467899999999986     34688899999999999999999999975443211100    


Q ss_pred             hHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                               ......   ........+.++.+|+.+||..||.+|||+.++++|
T Consensus       228 ---------~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         228 ---------IPRNPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ---------HhcCCC---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                     000000   111122345789999999999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-44  Score=308.05  Aligned_cols=250  Identities=25%  Similarity=0.351  Sum_probs=210.8

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      -|.+.++||+|+||.||+|.+++.+..      +|||.+.-+   .+.+++..|+.++++...|++|++||.+.....++
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v------~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW  104 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHV------LAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW  104 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcE------EEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence            466778999999999999988776654      999998755   45567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      ||||||..|++.+.+..+. .++.+.++..+++..+.||+|||...  =+|||||..|||++.+|..||+|||.|..+.+
T Consensus       105 IVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             eehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            9999999999999886654 48999999999999999999999966  89999999999999999999999999876543


Q ss_pred             CCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      .-  ....+..|||.|||||++..-+|+.++||||||++..||..|++||..-.+.....+             +.  ..
T Consensus       182 TM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------------IP--T~  244 (502)
T KOG0574|consen  182 TM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------------IP--TK  244 (502)
T ss_pred             hH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------------cc--CC
Confidence            21  223457899999999999999999999999999999999999999997665432111             00  01


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +......|...+.++.+|+++||-+.|++|-|+.++++|
T Consensus       245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            111112356778999999999999999999999999987

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=308.14  Aligned_cols=250  Identities=26%  Similarity=0.361  Sum_probs=205.8

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|.+.+.||.|+||.||+|.+..+..      .|++|.+...........+.+|+.+++.++|+||+++++++..+..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQ------VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL   74 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCe------EEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence            368888999999999999998765443      39999987665445556788899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++|+||+.+++|.+++...   ++++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999999988654   7899999999999999999999977  9999999999999999999999999988765


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ...  .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+....      .       ....  
T Consensus       150 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------~-------~~~~--  212 (274)
T cd06609         150 STM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------F-------LIPK--  212 (274)
T ss_pred             ccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------H-------Hhhh--
Confidence            432  1223356888999999999888999999999999999999999999765422110      0       0001  


Q ss_pred             CCCCCCCCChH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVK-GVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        ......+.. ++..+.+++.+||..||++||++++++++
T Consensus       213 --~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         213 --NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             --cCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              111111112 56789999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-41  Score=301.78  Aligned_cols=250  Identities=28%  Similarity=0.433  Sum_probs=200.9

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      ++||.|+||.||+|.+.. .+.      |++|.............+..|+.+++++.|+||+++++++......++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~------v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTE------VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCc------EEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence            469999999999997654 333      9999987665444556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                      +.+++|.+++.... ..+++..+..++.+++.+|+|||+++  ++|+||+|+||+++.++.++|+|||++..........
T Consensus        74 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          74 VPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            99999999886543 26788899999999999999999977  9999999999999999999999999987654222111


Q ss_pred             ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCC
Q 016481          238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  316 (389)
Q Consensus       238 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (389)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........                 .+.....
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~-----------------~~~~~~~  213 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-----------------RIESGYR  213 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH-----------------HHhcCCC
Confidence            1112334667999999998899999999999999999999 888887654321110                 0111111


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          317 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                      ...+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            12234556789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7e-41  Score=302.90  Aligned_cols=253  Identities=24%  Similarity=0.347  Sum_probs=206.7

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|+..+.||.|+||.||.+....+..      .+++|.+.... .......+.+|+.++++++|+||+++++++.+.+.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDS------LVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCc------EEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            58889999999999999987655433      38999876543 344556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      +++|||+++|+|.+++.......+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            99999999999999987764557899999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  ......+++.|+|||.+.+..++.++||||||+++|+|++|..||........      ..          .+.
T Consensus       153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~----------~~~  214 (256)
T cd08221         153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VV----------KIV  214 (256)
T ss_pred             cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HH----------HHH
Confidence            4321  22345789999999999888899999999999999999999999976432210      00          000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .... ...+...+.++.+++.+||+.+|++||++.++++++
T Consensus       215 ~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         215 QGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            1111 112234567899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.9e-41  Score=305.35  Aligned_cols=257  Identities=24%  Similarity=0.353  Sum_probs=193.2

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      +.||+|+||.||+|.....    .....+++|.+...........+.+|+.+++.++|+||+++++.+......++||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG----MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecC----CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence            3589999999999965432    223448899876554455556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          158 MARGSVENNLFSKVL---LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      +++|+|.+++.....   ...++.....++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccch
Confidence            999999999866432   23467778899999999999999977  9999999999999999999999999987543322


Q ss_pred             CccccccccccccccCcccccc-------CCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMT-------GHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      .........++..|+|||++..       ..++.++|||||||++|+|++ |..||....+...  +.    .....  .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~----~~~~~--~  226 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LK----QVVRE--Q  226 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HH----HHhhc--c
Confidence            1111223456778999998743       356889999999999999999 7888876532210  00    00000  0


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      .....    ....+...+..+..++..|| .||++|||+.+|++.|.
T Consensus       227 ~~~~~----~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 DIKLP----KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CccCC----CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            00111    11223345677788999998 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.1e-41  Score=306.17  Aligned_cols=263  Identities=25%  Similarity=0.356  Sum_probs=208.6

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|.+.+.||.|+||.||+|+.+.... ......|++|.............+.+|+.++++++|+||+++++++.+....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEE-EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCc-CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            578899999999999999998765432 2334559999887654443456788999999999999999999999998999


Q ss_pred             EEEEEecCCCChhhhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          152 VLIYEFMARGSVENNLFSKVL-------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      ++||||+++|+|.+++.....       ..+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.++++||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999865542       25889999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      |++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...        
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~--------  229 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN--------  229 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH--------
Confidence            99875432211 11223456778999999988889999999999999999999 888986543211   100        


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                           ...........+..++..+.+++.+||+.+|++||++.++++.|.+
T Consensus       230 -----~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         230 -----RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -----HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                 0001111112233456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-40  Score=300.55  Aligned_cols=248  Identities=28%  Similarity=0.450  Sum_probs=198.8

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      +.||+|+||.||+|.... .      ..+|+|.............+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~~-~------~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKD-K------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEecC-C------cEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEEC
Confidence            468999999999997432 2      239999987665555556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                      +++++|.+++.... ..+++..+..++.+++.+|.|||+++  ++|+||||+||+++.++.+||+|||++......... 
T Consensus        74 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-  149 (250)
T cd05085          74 VPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-  149 (250)
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccc-
Confidence            99999999886543 35789999999999999999999977  999999999999999999999999998754332111 


Q ss_pred             ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCC
Q 016481          238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  316 (389)
Q Consensus       238 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (389)
                      ......++..|+|||++.+..++.++||||||+++|++++ |..||.........   .              .+.....
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~--------------~~~~~~~  212 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---E--------------QVEKGYR  212 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---H--------------HHHcCCC
Confidence            1112344677999999998899999999999999999998 99999765332110   0              0011111


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          317 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ...+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2223445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.1e-41  Score=321.19  Aligned_cols=267  Identities=19%  Similarity=0.271  Sum_probs=199.2

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|.+.+.||+|+||.||+|......+.      ||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcE------EEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            457899999999999999999976554433      9999987543 233345677899999999999999999987543


Q ss_pred             ------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          149 ------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       149 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                            ..+|+||||+++ +|.+.+..    .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus        96 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875          96 KSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             ccccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEE
Confidence                  357999999965 67766632    4778888999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH-------
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD-------  295 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~-------  295 (389)
                      |||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.........       
T Consensus       169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (364)
T cd07875         169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC  245 (364)
T ss_pred             eCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998653321   2234578999999999999999999999999999999999999998765432111000       


Q ss_pred             --H---HhHH----HHhhhhhh-----hhcCCC---CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          296 --W---ALPL----LKEKKKLL-----NIIDPR---LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       296 --~---~~~~----~~~~~~~~-----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                        +   ....    ........     ......   ...........++++|+.+||+.||++|||+.++++|-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp  319 (364)
T cd07875         246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  319 (364)
T ss_pred             HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence              0   0000    00000000     000000   00011112346789999999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-41  Score=316.85  Aligned_cols=258  Identities=19%  Similarity=0.210  Sum_probs=198.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||.||+|+...+.+      .||+|++....  .......+.+|+.++..++|+||+.+++++..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQ------VYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            478999999999999999998765544      39999986421  2223455778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ++|+||||+.||+|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceee
Confidence            999999999999999988653 236889999999999999999999977  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      ...... .......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||........      ..... ..
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~-~~  223 (331)
T cd05597         152 LLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIM-NH  223 (331)
T ss_pred             cCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHH-cC
Confidence            543221 11223469999999999863     4578899999999999999999999976532211      00000 00


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHh
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDSL  352 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~il~~L  352 (389)
                      ....     .+ .......+..+.+++.+||..++++  |+++.++++|-
T Consensus       224 ~~~~-----~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp  267 (331)
T cd05597         224 KEHF-----QF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP  267 (331)
T ss_pred             CCcc-----cC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence            0000     00 1111235678899999988665444  88999999983

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.1e-41  Score=302.92  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=203.8

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe-CCe
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-DEH  150 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~  150 (389)
                      +|++.+.||.|++|.||++....+.+      .||+|.+.... .......+..|+.+++.++|+|++++++.+.. ...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGK------QYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCc------EEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            48889999999999999998665443      39999886543 23345567889999999999999999998764 456


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++||||+++++|.+++.......+++..+..++.+++.||++||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEe
Confidence            899999999999999987755557899999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ....  .......+++.|+|||++.+..++.++||||||+++|+|++|+.||........      .....         
T Consensus       153 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~---------  215 (257)
T cd08223         153 ENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRII---------  215 (257)
T ss_pred             cccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH---------
Confidence            3322  122345789999999999999999999999999999999999999975432110      00000         


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       . ......+...+.++.+++.+||+.||++||++.+++++
T Consensus       216 -~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         216 -E-GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -h-cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             0 01112234567889999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.7e-41  Score=309.45  Aligned_cols=252  Identities=21%  Similarity=0.336  Sum_probs=204.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||+|+||.||+|+...+..      .|++|.+...... ....+.+|+.+++.++|+||+++++.+....+
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~------~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~   91 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCc------EEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence            3589999999999999999998655443      3999988765332 34567789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|.+++...   .+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.++|+|||++...
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             EEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            99999999999999988543   5788899999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      .....  ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+....  ..    ..         
T Consensus       167 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~----~~---------  229 (296)
T cd06654         167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YL----IA---------  229 (296)
T ss_pred             ccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HH----Hh---------
Confidence            43221  122357899999999999888999999999999999999999999765432110  00    00         


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .........+...+..+.+++.+||..||++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            00111111233456788999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-40  Score=305.31  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=208.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ..|+..+.||.|+||.||+|.+..+..      .||+|.+...........+.+|+.+++.+.|+||+++++++.++...
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQ------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCE------EEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            457788899999999999998665443      39999987655455567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++|+|.+++...   ++++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          78 WIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            9999999999999988643   6788889999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  ......++..|+|||++.+..++.++|+||||+++|+|++|..||....+....                 ...
T Consensus       153 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------~~~  213 (277)
T cd06640         153 DTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----------------FLI  213 (277)
T ss_pred             CCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----------------hhh
Confidence            3221  122346888999999999888999999999999999999999999865432111                 011


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ........+...+..+.+++.+||+.+|++||++.+++.+-.
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06640         214 PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF  255 (277)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence            111123344567788999999999999999999999998843

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.2e-41  Score=312.23  Aligned_cols=265  Identities=24%  Similarity=0.424  Sum_probs=208.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|+..+.||+|+||.||+|.+..+...  ....||+|.+...........+.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGET--VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCc--ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            35788899999999999999987654332  12348999887665545555788999999999999999999988654 5


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||+++..
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccc
Confidence            678999999999999886543 35788999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....   ..++    .        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~----~--------  224 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDL----L--------  224 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----H--------
Confidence            54332222223456778999999999999999999999999999997 999997653221   1111    1        


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                        ........+..++..+.+++.+||..+|++||++.++++.|..+...
T Consensus       225 --~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         225 --EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             --HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              11111112233457789999999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-41  Score=344.10  Aligned_cols=258  Identities=22%  Similarity=0.310  Sum_probs=200.9

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      ....++|++.+.||.|+||+||+|.+.....      .||+|.+.... .......+..|+.+++.++|||||+++++|.
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~------~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~   82 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQE------FFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL   82 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCe------EEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            4456799999999999999999998765433      38999876543 3344567889999999999999999999886


Q ss_pred             e--CCeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceecCCCCCCeEEcC--
Q 016481          147 E--DEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAE-----KPVIYRDFKTSNILLDT--  215 (389)
Q Consensus       147 ~--~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~ivH~Dlkp~Nili~~--  215 (389)
                      .  ...+||||||+++|+|.+++...  ....+++..++.|+.||+.||+|||..+     .+|||+||||+||||+.  
T Consensus        83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            5  45789999999999999988653  2246899999999999999999999854     45999999999999954  


Q ss_pred             ---------------CCcEEEeccCCCcCCCCCCCccccccccccccccCcccccc--CCCCcccchhHHHHHHHHHHhC
Q 016481          216 ---------------DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTG  278 (389)
Q Consensus       216 ---------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwslG~il~elltg  278 (389)
                                     .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||+|+|++|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                           2458999999998654322   1234579999999999864  4588999999999999999999


Q ss_pred             CCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          279 RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       279 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..||........     ... .+...        +.+.   ....+.++.+||..||+.+|.+||++.++|.+
T Consensus       240 k~PF~~~~~~~q-----li~-~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        240 KTPFHKANNFSQ-----LIS-ELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCCCCcCCcHHH-----HHH-HHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            999975432211     100 00000        0010   11245789999999999999999999999965

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.6e-41  Score=311.08  Aligned_cols=271  Identities=21%  Similarity=0.272  Sum_probs=202.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|.+.+.||.|+||.||+|....+..      .||+|.+...........+.+|+.+++.++|+||+++++++..+...
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDN------LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCc------EEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            579999999999999999997654433      49999987554444445667899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+. ++|..++.... ..+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.++|+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            99999997 58888776543 36788999999999999999999977  9999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh--------HHHH
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--------PLLK  302 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~  302 (389)
                      ....  ......+++.|+|||++.+. .++.++||||||+++|+|++|++||................        +...
T Consensus       156 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         156 IPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            3221  12234678999999998754 57889999999999999999999998664332111100000        0000


Q ss_pred             hhhhhhhhcCCCCCC----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          303 EKKKLLNIIDPRLEG----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                      ..........+....    ......+..+.+|+.+||+.||.+|||+.++++|-+-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f  289 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF  289 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            000000000000000    0112346788999999999999999999999987443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-41  Score=308.42  Aligned_cols=276  Identities=24%  Similarity=0.344  Sum_probs=206.5

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC--Ce
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--EH  150 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~  150 (389)
                      -|++.+.||+|+||.||+|.....  ....+..||+|.+...........+.+|+.+++.+.|+||+++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPE--GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccC--CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            368889999999999999975421  12234559999987665555566788999999999999999999998775  57


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||++|++|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||+++..
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCcccccc
Confidence            899999999999999886543 25789999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...... .......++..|+|||++.+..++.++||||||+++|+|+++..|+..................  .......
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  237 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM--TVTRLVR  237 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc--cHHHHHH
Confidence            443221 1122356778899999998888999999999999999999987765332110000000000000  0000000


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .+........+..++..+.+|+.+||+.||++||++.++++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111111222345678899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8e-41  Score=307.44  Aligned_cols=263  Identities=25%  Similarity=0.321  Sum_probs=208.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||+|+||+||+|.+..+..      .||+|+............+.+|+.+++.++||||+++++++.....+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGT------VMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI   78 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCc------EEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence            578888999999999999998665443      38999877654445567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      ++||||+++++|.+++...  ..+++..+..++.+++.||.|||+ ++  ++|+||+|+||+++.++.++|+|||++...
T Consensus        79 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            9999999999999887654  368999999999999999999996 46  999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhh-----hhhHHHHhHHHHhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE-----QNLADWALPLLKEKK  305 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~  305 (389)
                      ....    .....|+..|+|||++.+..++.++|||||||++|+|++|..||........     .....+...      
T Consensus       155 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------  224 (284)
T cd06620         155 INSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ------  224 (284)
T ss_pred             hhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH------
Confidence            3221    1235789999999999888999999999999999999999999986543211     111111111      


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                          +............++..+.+|+.+||+.||++||++.+++++..-++..
T Consensus       225 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         225 ----IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             ----HhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                1110001111123567899999999999999999999999986555543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.9e-41  Score=303.26  Aligned_cols=255  Identities=26%  Similarity=0.436  Sum_probs=195.7

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEE-eCCeEEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC-EDEHRVLIYE  156 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e  156 (389)
                      +.||+|+||.||+|.+....   .....||+|.+...........+..|+.+++.++||||+++++++. .+...++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD---GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCC---CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            46899999999999865322   2234599998865444455677888999999999999999999775 4556899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCc
Q 016481          157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  236 (389)
Q Consensus       157 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~  236 (389)
                      |+.+|+|.+++..... ...+..+..++.|++.||+|||+.+  ++|+||||+|||++.++.+||+|||+++........
T Consensus        78 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999999998865432 4567778889999999999999977  999999999999999999999999998765332111


Q ss_pred             --cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhC-CCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCC
Q 016481          237 --HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG-RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  313 (389)
Q Consensus       237 --~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (389)
                        .......++..|+|||.+.+..++.++||||||+++|+|++| .+||.......   ....              +..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~--------------~~~  217 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY--------------LLQ  217 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH--------------Hhc
Confidence              111234567789999999888999999999999999999995 56666443211   1110              000


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          314 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ......+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       218 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         218 GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111111223457889999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.9e-41  Score=308.08  Aligned_cols=256  Identities=26%  Similarity=0.367  Sum_probs=204.1

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||+|+||.||+|.+.....      .||+|.+...........+.+|+.++++++|+||+++++.+...+.+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGV------TMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAV   74 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCc------EEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeE
Confidence            368889999999999999998765443      39999887654445557788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          152 VLIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ++||||+++++|..++.... ...+++..+..++.+++.||.|||. .+  |+|+||||+||+++.++.++|+|||++..
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~  152 (286)
T cd06622          75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGN  152 (286)
T ss_pred             EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence            99999999999988776532 2368999999999999999999996 36  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccCccccccC------CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTG------HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      .....    .....+++.|+|||.+.+.      .++.++|||||||++|+|++|+.||.........   .        
T Consensus       153 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~--------  217 (286)
T cd06622         153 LVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---A--------  217 (286)
T ss_pred             ccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---H--------
Confidence            53221    2234688899999998654      3588999999999999999999999754321110   0        


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                        .+..+.. ......+..++.++.+|+.+||+.+|++||++.+++++-+
T Consensus       218 --~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         218 --QLSAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             --HHHHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence              0011111 1112234457788999999999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-41  Score=318.10  Aligned_cols=265  Identities=20%  Similarity=0.298  Sum_probs=197.1

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+.++|.+.+.||.|+||.||+|....+.+      .||+|.+..... ......+.+|+.+++.++|+||+++++++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQ------KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCC------EEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence            456789999999999999999997655433      399999875432 2334567789999999999999999998753


Q ss_pred             C------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          148 D------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       148 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                      .      ...|++++++ +++|.+.+..   ..+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||
T Consensus        86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl  159 (343)
T cd07878          86 ATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRI  159 (343)
T ss_pred             cccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEE
Confidence            3      4578999998 6788876643   26899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH-HH---
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DW---  296 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~~---  296 (389)
                      +|||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ..   
T Consensus       160 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07878         160 LDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT  234 (343)
T ss_pred             cCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999999865432     223578999999999876 56899999999999999999999999865432211000 00   


Q ss_pred             -----HhHHHHh-hhhhhhhcCCCCCCC----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          297 -----ALPLLKE-KKKLLNIIDPRLEGD----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       297 -----~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                           ....... .......+. .....    .....+..+.+|+.+||+.||++|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         235 PSPEVLKKISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCHHHHHhcchhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 0000000 000000000 00000    001124567899999999999999999999988

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.3e-41  Score=307.24  Aligned_cols=278  Identities=23%  Similarity=0.298  Sum_probs=204.8

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe--CC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~  149 (389)
                      .+|++.+.||+|+||.||+|.....  ....+..||+|.+.... ......+.+|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPL--QDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCC--cCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            4688899999999999999875321  12233459999986543 3445678899999999999999999998754  34


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++..
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            6899999999999999886543 35889999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccc-cccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHV-STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......... .....++..|+|||++.+..++.++||||||+++|||++|..++................ .......+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  236 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ-GQMIVYHLI  236 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccc-cccchHHHH
Confidence            654322111 111234556999999998899999999999999999999887764332111000000000 000000011


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ..+........+..++.++.+|+.+||+.+|++|||+.+|++.|+.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            111212222233456678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.7e-41  Score=317.39  Aligned_cols=255  Identities=19%  Similarity=0.210  Sum_probs=199.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|.+.+.||+|+||.||+|+...+.+      .||+|++....  .......+..|+.++..++|+||+.+++++...+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTER------IYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            478999999999999999997665443      39999986421  1223345678899999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..|+||||+.||+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceee
Confidence            9999999999999999987632 36888999999999999999999977  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      ...... .......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||........  +           
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~-----------  217 (331)
T cd05624         152 MNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--Y-----------  217 (331)
T ss_pred             ccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH--H-----------
Confidence            543221 11223579999999999875     4678899999999999999999999976543211  0           


Q ss_pred             hhhhhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHh
Q 016481          305 KKLLNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDSL  352 (389)
Q Consensus       305 ~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~il~~L  352 (389)
                         ..+......   .......+.++.+++.+||..++++  |+++.++++|-
T Consensus       218 ---~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~  267 (331)
T cd05624         218 ---GKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA  267 (331)
T ss_pred             ---HHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence               001110000   1111234678999999999876654  56899998873

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-40  Score=302.62  Aligned_cols=259  Identities=26%  Similarity=0.351  Sum_probs=208.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||.|+||+||+|....+..      .+++|.+...........+.+|+.+++.++|+||+++++.+..+...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNE------KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCc------EEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE
Confidence            478999999999999999997654433      39999987655444667888999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          152 VLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      ++|||++++++|.+++..... ..+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            999999999999999876433 46899999999999999999999977  999999999999999999999999998766


Q ss_pred             CCCCCcc--ccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          231 PEGDKSH--VSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       231 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      .......  ......|+..|+|||++... .++.++|+||||+++|+|++|+.||....+..  .+....          
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~----------  220 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTL----------  220 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHh----------
Confidence            5432221  22335689999999998876 78999999999999999999999997654321  111100          


Q ss_pred             hhhcCCCCCCCC-ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          308 LNIIDPRLEGDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       308 ~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       ....+.+.... ....+..+.+++.+||..||++||++.+|++|
T Consensus       221 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         221 -QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             -cCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             00011111111 12456889999999999999999999999976

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-40  Score=304.05  Aligned_cols=262  Identities=24%  Similarity=0.353  Sum_probs=207.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|.+.+.||+|+||.||+|.+....   .....|++|.............+.+|+.+++.++|+||+++++++.+ ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPE---NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCC---CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            356888999999999999999765431   12334899988766545556678899999999999999999998865 56


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++|+|.+++.... ..+++..+..++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||+++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeec
Confidence            789999999999999986543 35899999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........   ..    +.       
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~----~~-------  222 (270)
T cd05056         158 EDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GR----IE-------  222 (270)
T ss_pred             ccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH----HH-------
Confidence            44321 11122334568999999988889999999999999999986 99999765432111   00    00       


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                         .......+..++..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus       223 ---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         223 ---NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ---cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence               001112234556789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.5e-41  Score=316.77  Aligned_cols=254  Identities=19%  Similarity=0.208  Sum_probs=198.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|.+.+.||+|+||.||++.++...+      .||+|++....  .......+..|+.++..++|+||+++++++.+..
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADK------VFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCC------EEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            378999999999999999998765543      39999986421  1222345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchhee
Confidence            9999999999999999987532 36889999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      ...... ......+||+.|+|||++.     ...++.++|||||||++|+|++|+.||........      .       
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~-------  217 (332)
T cd05623         152 LMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------Y-------  217 (332)
T ss_pred             cccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------H-------
Confidence            433221 1223357999999999986     34688999999999999999999999986532211      0       


Q ss_pred             hhhhhhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 016481          305 KKLLNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~il~~  351 (389)
                         ..+.......   .....++.++.+|+.+||..++++  |+++.++++|
T Consensus       218 ---~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         218 ---GKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ---HHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence               0111111011   112245788999999999765555  7899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.7e-41  Score=307.79  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=204.1

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +.|...+.||+|+||.||+|.+..+..      .||+|.............+.+|+.+++.++|+||+++++++......
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKE------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL   77 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCe------EEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence            346677889999999999997655433      39999987654445556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++++|.+++..   ..+++..+..++.|++.||.|||..+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEcccccccccc
Confidence            999999999999988754   26788999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+....                 ..+
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------~~~  213 (277)
T cd06642         153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-----------------FLI  213 (277)
T ss_pred             Ccch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-----------------hhh
Confidence            3221  122356888999999999989999999999999999999999999754322110                 001


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ............+..+.+++.+||+.+|++||++.+++++-
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         214 PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            11111222334567899999999999999999999999873

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=321.47  Aligned_cols=247  Identities=29%  Similarity=0.396  Sum_probs=204.2

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCC--CChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      |.-.+.||.|+||.||-|++..+...      ||||.+.-.  .+.....+++.|+++|+++.|||++.+.|+|..+...
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~ev------VAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta  101 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA  101 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccce------eeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence            55577899999999999987665444      999997643  3455668899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |+|||||- |+-.+.+.-+. .++-+.++..|+.+.+.||+|||+++  .||||||..|||+++.|.|||+|||.|....
T Consensus       102 WLVMEYCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  102 WLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHHHHHHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcC
Confidence            99999995 57777665443 37888889999999999999999988  9999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      +      ..+++|||.|||||++.   .+.|+-++|||||||+..||...++|+..++...   .          -..+.
T Consensus       178 P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS---A----------LYHIA  238 (948)
T KOG0577|consen  178 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---A----------LYHIA  238 (948)
T ss_pred             c------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---H----------HHHHH
Confidence            3      34578999999999986   4579999999999999999999999987664321   1          11222


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      +.-.|.+.   ....+..++.|+..||++-|.+|||..+++.|-
T Consensus       239 QNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  239 QNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             hcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence            22222232   346788999999999999999999999998764

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=311.19  Aligned_cols=256  Identities=25%  Similarity=0.288  Sum_probs=206.1

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh--hhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .+|.+.+.||+|+||.||+|....+.+      .||+|.+......  .....+..|+.+++.++|+||+++++.+....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGK------LFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCc------EEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence            368889999999999999997665433      3999998765433  24566788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            9999999999999999887655567899999999999999999999977  99999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCC
Q 016481          230 GPEGDKS---------------------------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL  282 (389)
Q Consensus       230 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf  282 (389)
                      .......                           .......||..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4322110                           0111246889999999999988999999999999999999999999


Q ss_pred             CCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC----HHHHHHH
Q 016481          283 DKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL----MRDIVDS  351 (389)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~il~~  351 (389)
                      ........                .................+..+.+++.+||..||++||+    +.+++++
T Consensus       233 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         233 KGSNRDET----------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCCchHHH----------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            86543211                11111111111112225788999999999999999999    8888886

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.3e-41  Score=306.90  Aligned_cols=268  Identities=22%  Similarity=0.251  Sum_probs=199.3

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|++.+.||+|++|.||+|+...+..      .||+|.+..... ......+.+|+.+++.++||||+++++++..+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQ------IVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCc------EEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            57888999999999999998655433      399998765432 22335677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          152 VLIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      ++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            99999997 58888775433 246889999999999999999999977  999999999999999999999999998754


Q ss_pred             CCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH--HHHh------HHH
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA--DWAL------PLL  301 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~------~~~  301 (389)
                      ....  .......+++.|+|||++.+. .++.++||||||+++|+|++|++||............  .+..      +..
T Consensus       152 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         152 GIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             CCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence            3221  122234678999999988654 5789999999999999999999999865432211000  0000      000


Q ss_pred             HhhhhhhhhcCC---CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          302 KEKKKLLNIIDP---RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       302 ~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ............   ..........+.++.+++.+||+.||++|||+.+|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000000000000   00001112356788999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-40  Score=302.18  Aligned_cols=252  Identities=24%  Similarity=0.388  Sum_probs=201.9

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh--------hhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--------QGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      +|.+.+.||.|+||.||+|....+..      .||+|.+......        .....+.+|+.+++.++||||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGE------LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS   74 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCc------EEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            47888999999999999997654433      3999987654221        122457789999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      +......++||||+++++|.+++....  .+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          75 SLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEeccc
Confidence            999999999999999999999886543  6788889999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCc----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          225 GLAKDGPEGDKS----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       225 g~a~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |+++........    .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........          
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----------  220 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA----------  220 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH----------
Confidence            998876422111    111234688999999999988899999999999999999999999986432110          


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                            ...... ......+...+..+.+++.+||+.||++||++.+++++
T Consensus       221 ------~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         221 ------IFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ------HHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                  000000 11222344567889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=300.21  Aligned_cols=255  Identities=24%  Similarity=0.315  Sum_probs=205.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|.+.+.||.|+||.||+|....+..      .+++|.+...... ....+..|+.+++.++||||+++++++.....+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   75 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGE------LVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL   75 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCC------EEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEE
Confidence            578999999999999999998655433      3999998765333 456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      +++|||+.+++|.+++.... ..++...+..++.|++.||+|||+++  |+|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          76 WIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             EEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhh
Confidence            99999999999998876542 36889999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTG---HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ....  ......++..|+|||.+.+.   .++.++||||||+++|+|++|+.||....+.......      .      .
T Consensus       153 ~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~------~------~  218 (262)
T cd06613         153 ATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI------S------K  218 (262)
T ss_pred             hhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H------h
Confidence            3211  12235688899999999876   8899999999999999999999999875533211100      0      0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..+.+ .........+.++.+++.+||..+|.+|||+.+|+.+
T Consensus       219 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         219 SNFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ccCCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000 0111233456789999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-40  Score=299.84  Aligned_cols=257  Identities=30%  Similarity=0.467  Sum_probs=206.0

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (389)
                      +++.+.||.|+||.||+|.+.....  .....||+|.............+..|+.+++.++|+||+++++++...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG--EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC--CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            4567899999999999998765431  22355999999766554456788899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  233 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~  233 (389)
                      +|||+++++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999987654333899999999999999999999977  999999999999999999999999998876543


Q ss_pred             CCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      .... .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||........   ..              .+.
T Consensus       157 ~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~--------------~~~  218 (258)
T smart00219      157 DYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LE--------------YLK  218 (258)
T ss_pred             cccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH--------------HHh
Confidence            2211 112347789999999988889999999999999999998 8888876432111   00              001


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .......+...+.++.+++.+||+.||++|||+.++++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      219 KGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1111122333678899999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-42  Score=296.01  Aligned_cols=258  Identities=21%  Similarity=0.221  Sum_probs=205.9

Q ss_pred             HHhcCCccc-ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           69 IITANFRQD-RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        69 ~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      .++++|.+. ++||-|-.|.|-.|..+.++.+      +|+|++...      ....+|+++.-.. .|||||.++++|.
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ek------fALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVye  125 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEK------FALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYE  125 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhh------hHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhh
Confidence            356778775 6899999999999988777665      999998653      2344677776555 4999999999875


Q ss_pred             e----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC---CCcE
Q 016481          147 E----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNA  219 (389)
Q Consensus       147 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~---~~~v  219 (389)
                      +    ...+.+|||.|+||.|...+.++....+++.++..|++||+.|+.|||+.+  |.||||||+|+|...   +..+
T Consensus       126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~l  203 (400)
T KOG0604|consen  126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPL  203 (400)
T ss_pred             hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcce
Confidence            3    457789999999999999999999889999999999999999999999988  999999999999964   4579


Q ss_pred             EEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH
Q 016481          220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP  299 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  299 (389)
                      ||+|||+|+.-..   .....+.|.||.|.|||++....|+...|+||+||++|-||+|.+||-.+.....         
T Consensus       204 KLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---------  271 (400)
T KOG0604|consen  204 KLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------  271 (400)
T ss_pred             EecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---------
Confidence            9999999987543   2234568999999999999999999999999999999999999999965533210         


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          300 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                       .......+..-.-.++.+.....+..+.++|+.+|+.+|.+|.|+.++++|=+
T Consensus       272 -spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw  324 (400)
T KOG0604|consen  272 -SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW  324 (400)
T ss_pred             -ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence             00111111111111223334466889999999999999999999999998844

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.9e-41  Score=304.53  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=200.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|.+.+.||+|+||.||+|....+.+      .||+|.+..... .....+.+|+.+++.++||||+++++.+...+..
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~   81 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGE------LAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL   81 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCc------EEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence            478888999999999999997665443      399999875532 3345577899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++++|.+++....  .+++..+..++.|++.||.|||+++  ++|+||||+||+++.++.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             EEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            99999999999999886543  6889999999999999999999977  9999999999999999999999999987653


Q ss_pred             CCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ...  .......|+..|+|||++.   ...++.++|||||||++|+|++|..||....+.......       .    ..
T Consensus       158 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-------~----~~  224 (267)
T cd06645         158 ATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------T----KS  224 (267)
T ss_pred             Ccc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-------h----cc
Confidence            221  1123357899999999874   456889999999999999999999998754432111000       0    00


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ....+...  .....+..+.+++.+||+.+|++||++.+|++|
T Consensus       225 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         225 NFQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00011110  011245678999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8e-41  Score=338.93  Aligned_cols=261  Identities=22%  Similarity=0.296  Sum_probs=202.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.++||+|+||.||+|++..+.+      .||+|++....  ......++.+|+.+++.++||||+++++++.+.+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~------~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSR------RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCc------EEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            579999999999999999998665444      39999987543  2334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          150 HRVLIYEFMARGSVENNLFSKV---------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      ..++||||++||+|.+++....         ....++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEE
Confidence            9999999999999998875421         123556778899999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCC----------------ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCC
Q 016481          221 LSDFGLAKDGPEGDK----------------SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK  284 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~  284 (389)
                      |+|||+++.......                ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999986521110                0011225799999999999999999999999999999999999999976


Q ss_pred             CCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhccc
Q 016481          285 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-LMRDIVDSLEPL  355 (389)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~~il~~L~~~  355 (389)
                      ....... ..          .   ....+... ......+..+.+++.+||+.||++|| +++++++.|+..
T Consensus       234 ~~~~ki~-~~----------~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        234 KKGRKIS-YR----------D---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             cchhhhh-hh----------h---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            3321100 00          0   00000000 00123457789999999999999997 667777767654

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-40  Score=311.94  Aligned_cols=266  Identities=18%  Similarity=0.214  Sum_probs=196.9

Q ss_pred             ccceecCC--CceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           76 QDRVLGGG--GFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        76 ~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      +.++||+|  +|++||++....+...      ||+|.+..... ......+.+|+.+++.++||||+++++++..++..+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEY------VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcE------EEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            45789999  7899999977655444      99999876543 333455667999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      +||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.++++||+.+.....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999999999999987654456899999999999999999999977  99999999999999999999999986543321


Q ss_pred             CCCc-----cccccccccccccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH---
Q 016481          233 GDKS-----HVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK---  302 (389)
Q Consensus       233 ~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---  302 (389)
                      ....     .......++..|+|||++.+  ..++.++|||||||++|+|++|+.||........  ..........   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  231 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLL  231 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccc
Confidence            1110     01122356788999999976  4689999999999999999999999975432211  0000000000   


Q ss_pred             h-----hhhhh-----hhcC-----------------CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          303 E-----KKKLL-----NIID-----------------PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       303 ~-----~~~~~-----~~~~-----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +     .....     ...+                 ...........+..+.+|+.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0     00000     0000                 000011122346789999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-40  Score=300.20  Aligned_cols=251  Identities=27%  Similarity=0.396  Sum_probs=205.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||.|+||.||+|.+..+..      .+++|.+.....   ...+.+|+.+++.++|+||+++++.+......
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   73 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQ------VVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDL   73 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCc------EEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE
Confidence            579999999999999999998765433      399999865422   56788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |+++||+.+++|.+++.... ..+++..+..++.|++.||.|||..+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        74 ~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          74 WIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             EEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            99999999999999886533 46899999999999999999999977  9999999999999999999999999988764


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  ......++..|+|||++.+..++.++||||||+++|+|++|+.||....+......             .... 
T Consensus       151 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~-  214 (256)
T cd06612         151 DTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------------IPNK-  214 (256)
T ss_pred             cCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------------hccC-
Confidence            4321  12234588899999999999999999999999999999999999986543221100             0000 


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       .......+...+..+.+++.+||+.||++|||+.+++++
T Consensus       215 -~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         215 -PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             -CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence             000111233456789999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.5e-40  Score=303.79  Aligned_cols=253  Identities=27%  Similarity=0.370  Sum_probs=200.6

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (389)
                      |++.+.||.|+||.||+|.+..+..      .+++|.+... .......+..|+.+++.++|+||+++++++..+...++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~------~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~   79 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGV------LAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   79 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCe------EEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence            5778899999999999997665443      3888887654 33455678889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  233 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~  233 (389)
                      |+||+++++|...+... ..++++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          80 LIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            99999999998877543 236899999999999999999999977  999999999999999999999999998764322


Q ss_pred             CCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          234 DKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .  .......+++.|+|||++.     +..++.++|||||||++|+|++|++||....+...  ...           ..
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~-----------~~  221 (282)
T cd06643         157 I--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLK-----------IA  221 (282)
T ss_pred             c--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHH-----------Hh
Confidence            1  1223356899999999984     44578899999999999999999999976542211  000           00


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ....+  ....+...+.++.+|+.+||+.||++||++.+++++-.
T Consensus       222 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         222 KSEPP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             hcCCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence            00000  11123345678999999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-40  Score=305.84  Aligned_cols=256  Identities=28%  Similarity=0.329  Sum_probs=201.1

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      ....+.|++.+.||.|+||.||+|.+.....      .+|+|+.....  .....+..|+.+++++ +|+||+++++++.
T Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~------~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636          12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQ------LAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             cChhhhhhhheeeccCCCeEEEEEEEcCCCc------EEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            3445789999999999999999998765443      39999876542  3345677899999988 6999999999885


Q ss_pred             e------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          147 E------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       147 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      .      ....+++|||+.+|+|.+++.......+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.++
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEE
Confidence            3      467899999999999999887655556888889999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  295 (389)
                      |+|||++........  ......|++.|+|||.+.     ...++.++|||||||++|+|++|..||....+......  
T Consensus       162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--  237 (282)
T cd06636         162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--  237 (282)
T ss_pred             EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence            999999876532211  123356899999999886     34678899999999999999999999975443211100  


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                                    ..............+.++.+|+.+||+.||.+||++.+|+++
T Consensus       238 --------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         238 --------------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             --------------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                          000111111122456789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.2e-40  Score=304.62  Aligned_cols=254  Identities=26%  Similarity=0.361  Sum_probs=201.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .+.|++.+.||.|+||.||+|.+..+...      |++|..... .......+..|+.+++.++|+||+++++.+..++.
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~------~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGAL------AAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK   83 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCce------EEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe
Confidence            35699999999999999999977654443      999998754 34445678889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|...+.... ..+++..+..++.|++.+|+|||+++  ++|+||||+||+++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          84 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             EEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999987765443 36889999999999999999999977  999999999999999999999999988754


Q ss_pred             CCCCCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      ....  .......+++.|+|||++.     ...++.++|||||||++|+|++|..||....+...  ..    .      
T Consensus       161 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~------  226 (292)
T cd06644         161 VKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL----K------  226 (292)
T ss_pred             cccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HH----H------
Confidence            2211  1123356889999999985     34568899999999999999999999976543210  00    0      


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       ......+  ....+...+.++.+++.+||+.||++||++.+++++
T Consensus       227 -~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         227 -IAKSEPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -HhcCCCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             0000000  111233456788999999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=318.67  Aligned_cols=243  Identities=24%  Similarity=0.291  Sum_probs=188.4

Q ss_pred             ecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc---CCCccceEEeEEEeCCeEEEE
Q 016481           80 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL---SHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        80 lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv  154 (389)
                      ||+|+||+||+|+...+..      .||+|++....  .......+..|..++..+   .||||+++++.+.....+|+|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRR------IYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEECCCCC------EEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence            7999999999997665443      39999986432  112233445566666655   699999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      |||+.+|+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          75 TDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             EcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            99999999998886543  6889999999999999999999977  9999999999999999999999999987543222


Q ss_pred             CccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  313 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (389)
                      .  .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.........      .. +..       -..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~------~~-i~~-------~~~  214 (330)
T cd05586         151 K--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY------RN-IAF-------GKV  214 (330)
T ss_pred             C--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH------HH-HHc-------CCC
Confidence            1  22346799999999998764 5899999999999999999999999765322110      00 000       000


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCC----CHHHHHHH
Q 016481          314 RLEGDYPVKGVHKAAMLAYHCLNHNPKARP----LMRDIVDS  351 (389)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~~il~~  351 (389)
                      .+.   ....+.++.+|+.+||+.||++||    ++.++++|
T Consensus       215 ~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         215 RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            111   112467889999999999999998    67888776

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.3e-40  Score=299.47  Aligned_cols=257  Identities=21%  Similarity=0.326  Sum_probs=192.4

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      +.||+|+||.||+|......    ....+++|.............+.+|+.+++.++||||+++++.+......++||||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDT----GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY   76 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCC----CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence            35899999999998654322    22347788776655455567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCC
Q 016481          158 MARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  235 (389)
Q Consensus       158 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~  235 (389)
                      +++|+|.+++....  ....+...+..++.|++.||+|||+.+  ++|+||||+|||++.++.++|+|||++........
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            99999999886542  234667778899999999999999977  99999999999999999999999999764322211


Q ss_pred             ccccccccccccccCcccccc-------CCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          236 SHVSTRIMGTYGYAAPEYIMT-------GHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ........++..|+|||++..       ..++.++||||||+++|+|++ |..||....+...  +    ......  ..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~----~~~~~~--~~  226 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV--L----NHVIKD--QQ  226 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHhh--cc
Confidence            112234568899999998753       245789999999999999997 5678865433211  0    000111  11


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ....++    ..+...+..+.+++..|| .+|++||++.+|++.|.
T Consensus       227 ~~~~~~----~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         227 VKLFKP----QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cccCCC----ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111122    222235677888999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.2e-40  Score=306.36  Aligned_cols=251  Identities=22%  Similarity=0.368  Sum_probs=204.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|++.+.||.|+||.||+|....+.+.      |++|.+..... .....+.+|+.+++.++|+||+++++++.....+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~------v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQE------VAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcE------EEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            4699999999999999999976554433      99998865432 3345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++|+||+.+++|..++...   .+++..+..++.+++.||+|||+++  ++|+||||+||+++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             EEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            9999999999999887543   5789999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....+......       +      ..  
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-------~------~~--  229 (296)
T cd06655         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------I------AT--  229 (296)
T ss_pred             cccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------H------Hh--
Confidence            3321  12235688999999999988899999999999999999999999987654321110       0      00  


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ........+...+..+.+++.+||..||++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            0000111233456789999999999999999999999977

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.7e-40  Score=300.09  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=198.5

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+|...+.||+|+||.||+|....+..      .|++|.+....    .......+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGR------ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD   75 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCc------EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence            478999999999999999997655443      39999876432    12334567789999999999999999998875


Q ss_pred             --CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          148 --DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       148 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                        ...+++++||+++++|.+++....  .+++.....++.|++.||+|||+.+  |+|+||+|+||+++.++.++|+|||
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCC
Confidence              367889999999999999886543  5788888999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCC-ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          226 LAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       226 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      ++........ ........++..|+|||.+.+..++.++|||||||++|+|++|+.||........              
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--------------  217 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--------------  217 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--------------
Confidence            9876532111 1112235688999999999998899999999999999999999999975432110              


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        .............+...+..+.+++ +||..+|++||++.+|++|
T Consensus       218 --~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         218 --IFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             --HHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence              0111111112233445567778888 6888899999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-40  Score=311.14  Aligned_cols=265  Identities=22%  Similarity=0.303  Sum_probs=188.0

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe--CCeEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DEHRVLI  154 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  154 (389)
                      +++||+|+||.||+|+.+..    .....||+|.+.....   ...+.+|+.+++.++||||+++++++..  +...++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~----~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG----KDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccC----CCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            46899999999999975432    2234599998865432   2345689999999999999999998854  4578999


Q ss_pred             EEecCCCChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE----cCCCcEEEec
Q 016481          155 YEFMARGSVENNLFSK-------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSD  223 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili----~~~~~vkl~D  223 (389)
                      |||+. ++|.+++...       ....+++..+..++.|++.||+|||+.+  |+||||||+|||+    +.++.+||+|
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            99995 5787766432       1235888999999999999999999977  9999999999999    4567899999


Q ss_pred             cCCCcCCCCCCCc-cccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhh------hhHH
Q 016481          224 FGLAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ------NLAD  295 (389)
Q Consensus       224 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~~~  295 (389)
                      ||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.........      ....
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~  235 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  235 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence            9999875432211 11234678999999999877 45899999999999999999999999754322110      0000


Q ss_pred             HHhHHH-----Hhhhhh---------hhhcCCCCC---------CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          296 WALPLL-----KEKKKL---------LNIIDPRLE---------GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       296 ~~~~~~-----~~~~~~---------~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .+....     ......         .........         .......+..+.+|+.+||+.||++|||+.++++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000000     000000         000000000         00001123568899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.8e-40  Score=307.12  Aligned_cols=252  Identities=21%  Similarity=0.338  Sum_probs=203.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||+|+||.||+|....+..      .||+|.+..... .....+..|+.+++.++|+||+++++++..+..
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQ------EVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCC------EEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            3689999999999999999997655444      399998865432 234567789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             EEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            99999999999999988543   5788899999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      .....  ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+......               ..
T Consensus       166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---------------~~  228 (297)
T cd06656         166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---------------IA  228 (297)
T ss_pred             cCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---------------ec
Confidence            43221  12235688999999999998899999999999999999999999976543211000               00


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .........+...+..+.+++.+||+.||++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         229 TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00001111233456778999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.2e-40  Score=299.59  Aligned_cols=252  Identities=22%  Similarity=0.313  Sum_probs=205.3

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|++.+.||+|+||.||++....+.+      .|++|.+.... .......+.+|+.+++.++|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGK------QYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCC------EEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            58889999999999999997655443      39999876432 334456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++|+||+.+++|.+.+.......+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            99999999999999887655556889999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.......      ....          .+
T Consensus       153 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~----------~~  214 (256)
T cd08218         153 STVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLK----------II  214 (256)
T ss_pred             cchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHH----------Hh
Confidence            3221  1223468889999999998889999999999999999999999997543211      0000          00


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      . ......+...+.++.+++.+||+.+|++||++.+++++
T Consensus       215 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         215 R-GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             c-CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            0 01112234557889999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.4e-40  Score=301.01  Aligned_cols=253  Identities=28%  Similarity=0.385  Sum_probs=200.7

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-----hhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-----YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      +|++.+.||.|+||.||+|....       +..+|+|.+.....     ......+.+|+.+++.++|+||+++++++.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~-------~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQ-------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcC-------CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec
Confidence            57889999999999999996422       23399998764321     2233567789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ....++|+||+++++|.+++.+..  .+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhh
Confidence            999999999999999999986643  6788999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCC----CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          228 KDGPEGD----KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       228 ~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      .......    .........|+..|+|||.+.+..++.++||||||+++|+|++|..||..........      . ...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~-~~~  222 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF------Y-IGA  222 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH------H-hhh
Confidence            7643211    1111223568999999999999899999999999999999999999997643221100      0 000


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                              ........+...+.++.+++.+||+.+|++||++.+++++
T Consensus       223 --------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         223 --------HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             --------ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                    0001112233456889999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-40  Score=304.24  Aligned_cols=277  Identities=25%  Similarity=0.298  Sum_probs=209.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe--CC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~  149 (389)
                      .+|.+.+.||+|+||.||+|.+....  ...+..||+|.+...........+..|+.+++.+.|+||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLG--DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCC--CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            46778899999999999999865331  123445999998766443345678899999999999999999999877  56


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++++|.+++..... .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            88999999999999998866532 5889999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCcc-ccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ........ ......++..|+|||.+.+..++.++||||||+++|+|++|..|+................  ......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~  236 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG--QMIVTRLL  236 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc--cccHHHHH
Confidence            65322211 1112345667999999988899999999999999999999999986542221100000000  00000111


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ..+........+..++.++.+|+.+||+.+|++||++.+|++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111122222344567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.9e-40  Score=299.03  Aligned_cols=253  Identities=25%  Similarity=0.330  Sum_probs=200.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+|++.+.||+|+||.||+|....+.+      .|++|.+....    .......+.+|+.+++.+.|+||+++++++.+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~------~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   75 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGR------ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD   75 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCc------EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence            578999999999999999998765544      39999875432    12334577889999999999999999998876


Q ss_pred             C--CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          148 D--EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       148 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      .  ..+++||||+++++|.+++....  .+++.....++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCc
Confidence            3  56889999999999999886553  5788888999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          226 LAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       226 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      ++......... .......++..|+|||++.+..++.++||||||+++|+|++|+.||........              
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--------------  217 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--------------  217 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--------------
Confidence            98765332111 112235688999999999888899999999999999999999999975422211              


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        .............+...+..+.+++.+||. +|++||++.+++++
T Consensus       218 --~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         218 --IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             --HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence              011111111223345667888999999995 99999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.1e-40  Score=298.44  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=204.0

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|+..+.||+|+||.||+|....+..      .+|+|.+.... .......+..|+.+++.++|+||+++++.+......
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQK------LVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCc------EEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            58889999999999999998665433      39999876542 334456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC-CcEEEeccCCCcCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDG  230 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~-~~vkl~Dfg~a~~~  230 (389)
                      ++||||+++++|.+++.......+++..+..++.+++.+|+|||+++  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999999999999997765556899999999999999999999977  9999999999999855 46899999998876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ....   ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........   .   ..          .
T Consensus       153 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~---~~----------~  213 (256)
T cd08220         153 SSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---V---LK----------I  213 (256)
T ss_pred             CCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---H---HH----------H
Confidence            4332   12235688999999999988899999999999999999999999976532211   0   00          0


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .. ......+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       214 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         214 MS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             Hh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            00 11112233456789999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.4e-40  Score=301.16  Aligned_cols=257  Identities=24%  Similarity=0.370  Sum_probs=200.7

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC---------hhhHHHHHHHHHHHhccCCCccceEEe
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS---------YQGHREWLAEVIFLGHLSHPNLVKLIG  143 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~~~~  143 (389)
                      +|.+.+.||.|+||.||+|....+.+      .||+|.+.....         ......+..|+.+++.++|+||+++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   75 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGE------MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG   75 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCc------eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            57888999999999999997654433      399998753211         111245678999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          144 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       144 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      ++......++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+++  ++|+||+|+||+++.++.++|+|
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          76 FETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             EeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEee
Confidence            999999999999999999999988665  36888999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHH
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      ||++................|+..|+|||.+....  ++.++|+||||+++|+|++|..||.........  ..    . 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~----~-  224 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--FK----L-  224 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--HH----h-
Confidence            99987654322222223356889999999987654  889999999999999999999999754322110  00    0 


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                           ................++..+.+++.+||+.||++||++.+++.|
T Consensus       225 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         225 -----GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             -----hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                 000011111112223456889999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-40  Score=299.19  Aligned_cols=247  Identities=24%  Similarity=0.373  Sum_probs=190.7

Q ss_pred             ceecCCCceEEEEeeeccccc------cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           78 RVLGGGGFGCVYKGFISEDLR------EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +.||+|+||.||+|++.....      .......|++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            468999999999998643221      11234458889876543 23345677889999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc-------EEEecc
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-------AKLSDF  224 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~-------vkl~Df  224 (389)
                      ++||||+++|+|..++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.       ++++||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            99999999999988775443 36889999999999999999999977  999999999999987654       899999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccc-cCCCCcccchhHHHHHHHHHH-hCCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEIL-TGRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      |++......      ....++..|+|||.+. +..++.++|||||||++|+|+ .|..||..........          
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----------  220 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----------  220 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH----------
Confidence            998754321      2245788899999887 567899999999999999998 5888887543211100          


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                          .   ......  .......++.+|+.+||+.||++||++.+|+.+|+
T Consensus       221 ----~---~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         221 ----F---YEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ----H---HhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                0   000000  11123467899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-40  Score=302.63  Aligned_cols=255  Identities=26%  Similarity=0.369  Sum_probs=205.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|+..+.||.|+||.||+|.++.+.+.      +++|.+...........+.+|+.+++.+.||||+++++.+......
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~------~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKI------MAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI   74 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcE------EEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE
Confidence            3677889999999999999987654443      9999887765555667788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      ++++||+.+++|.+++.... ..++...+..++.|++.||+|||+ .+  ++|+||||+||+++.++.++|+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          75 SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            99999999999999886653 478899999999999999999998 77  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ....    .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ......          ..
T Consensus       152 ~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~----------~~  216 (265)
T cd06605         152 VNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQ----------YI  216 (265)
T ss_pred             HHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHH----------HH
Confidence            3221    11267889999999999999999999999999999999999999765321111 111111          11


Q ss_pred             cCCCCCCCCChH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          311 IDPRLEGDYPVK-GVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .... ....+.. .+.++.+++.+||..||++|||+.+++.+
T Consensus       217 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         217 VNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             hcCC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            1111 1111222 67789999999999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=303.56  Aligned_cols=254  Identities=26%  Similarity=0.368  Sum_probs=202.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||.|+||.||+|.+..+.      ..+|+|..... .......+..|+.+++.++|+||+++++.+..+..
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETG------LFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENK   76 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCC------cEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe
Confidence            356889999999999999999765433      34999998654 33445678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhh
Confidence            999999999999998876543 36899999999999999999999977  999999999999999999999999988764


Q ss_pred             CCCCCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      .....  ......+++.|+|||++.     +..++.++||||||+++|+|++|+.||........  ..    .      
T Consensus       154 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~----~------  219 (280)
T cd06611         154 KSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL----K------  219 (280)
T ss_pred             ccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH----H------
Confidence            33221  122356899999999975     34567899999999999999999999986543211  00    0      


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       ......+.  ...+...+.++.+++.+||+.+|++||++.+++++
T Consensus       220 -~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         220 -ILKSEPPT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -HhcCCCCC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             00000011  11133456789999999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=290.78  Aligned_cols=287  Identities=26%  Similarity=0.349  Sum_probs=222.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  149 (389)
                      .++......||.|+.|.||+++...+..-      .|||.+.........++++..+.++..-+ +|.||+.+|+|..+.
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~i------iAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~  164 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHI------IAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT  164 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceE------EEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence            34566678899999999999987765544      99999988777777888889998887665 899999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++.||.|.  .-.+.+..+...++++..+-++...++.||.||... ++|+|||+||+|||+|+.|++||||||++-.
T Consensus       165 dV~IcMelMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  165 DVFICMELMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             hHHHHHHHHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeecccccce
Confidence            9999999983  444455555566899999999999999999999863 3499999999999999999999999999877


Q ss_pred             CCCCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      +-+..   ..+...|-+.|||||.+.   ...|+.++||||||+.++||.||+.||.+....-+  ..          ..
T Consensus       242 lvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~l----------tk  306 (391)
T KOG0983|consen  242 LVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VL----------TK  306 (391)
T ss_pred             eeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HH----------HH
Confidence            65432   334467999999999986   34689999999999999999999999987543211  10          11


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCCCCCCcccccCCCCCCccccc
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVTVVTPEEPKAEIQT  383 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  383 (389)
                      +.+...+.++..  ..++..+.+|+..||++|+.+||...++++|=--....+..--++.-+..|+..+++..++..
T Consensus       307 vln~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~~~~~~~~~~~~  381 (391)
T KOG0983|consen  307 VLNEEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDVMAKTESPRTSGV  381 (391)
T ss_pred             HHhcCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHHHhcccccccCCc
Confidence            112122333322  237899999999999999999999999998843333333345556666666666655555443

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.4e-40  Score=297.69  Aligned_cols=253  Identities=25%  Similarity=0.444  Sum_probs=200.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||+|+||.||+|.+...       ..+|+|.+.....  ....+..|+.++++++||||+++++++.....
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~-------~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEK-------RKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP   73 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCC-------CeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCc
Confidence            35788899999999999999976532       2289998765432  23467889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+.+++|.+++.... ..+++..+..++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  150 (256)
T cd05112          74 ICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFV  150 (256)
T ss_pred             eEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeec
Confidence            999999999999998886543 35788999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........   .       ..      
T Consensus       151 ~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~-------~~------  213 (256)
T cd05112         151 LDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---V-------ET------  213 (256)
T ss_pred             ccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---H-------HH------
Confidence            33211 11122345678999999998899999999999999999998 9999976432210   0       00      


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                       +........+...+..+.+|+.+||+.+|++||++.++++.|.
T Consensus       214 -~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         214 -INAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -HhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence             0000111112234578999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-40  Score=301.75  Aligned_cols=247  Identities=25%  Similarity=0.378  Sum_probs=192.9

Q ss_pred             ceecCCCceEEEEeeecccccc-CcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  156 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (389)
                      +.||.|+||.||+|........ ......|++|...... ......+..|+.+++.+.||||+++++++..+...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            4689999999999987544322 2334558888875432 2334567789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc--------EEEeccCCCc
Q 016481          157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN--------AKLSDFGLAK  228 (389)
Q Consensus       157 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~--------vkl~Dfg~a~  228 (389)
                      |+++|+|..++..... .+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.        ++++|||++.
T Consensus        80 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          80 YVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             cCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            9999999998876543 6788999999999999999999977  999999999999987765        6999999886


Q ss_pred             CCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCC-CCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR-KSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      .....      ....++..|+|||++.+ ..++.++||||||+++|+|++|. .||....+......       .     
T Consensus       157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~-----  218 (258)
T cd05078         157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------Y-----  218 (258)
T ss_pred             ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------H-----
Confidence            54321      22467889999999986 45799999999999999999985 56654332211100       0     


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                           ..  ....+.....++.+++.+||+.||++|||+++|++.|+
T Consensus       219 -----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         219 -----ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -----Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 00  11123334467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=321.11  Aligned_cols=252  Identities=26%  Similarity=0.405  Sum_probs=203.4

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (389)
                      |.++..||.|+||.||+|..+++.-      ..|.|++... +.....+|+-||.||..+.||+||++++.|..++.++|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~------lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKL------LAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchh------hhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            5556779999999999997664432      2566766544 45667889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  233 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~  233 (389)
                      +.|||.||.....+.... ..+++.++..+++|++.||.|||+.+  |||||||..|||++.+|.++|+|||.+..... 
T Consensus       107 liEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-  182 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-  182 (1187)
T ss_pred             EEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchh-
Confidence            999999999888776553 47999999999999999999999977  99999999999999999999999998754321 


Q ss_pred             CCccccccccccccccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          234 DKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                       ......++.|||+|||||+.++     .+|+.++||||||++|.||..+.+|-...++...      ++++.+..    
T Consensus       183 -t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV------llKiaKSe----  251 (1187)
T KOG0579|consen  183 -TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE----  251 (1187)
T ss_pred             -HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH------HHHHhhcC----
Confidence             1223345899999999999864     5799999999999999999999999876554321      11111110    


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                         .|.+  -.|...+..+.+|+.+||.+||..||++.++++|-
T Consensus       252 ---PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  252 ---PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             ---CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence               0111  12445678899999999999999999999999873

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.6e-40  Score=302.33  Aligned_cols=268  Identities=24%  Similarity=0.311  Sum_probs=201.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||.||+|.+..+.+      .||+|.+..... ......+.+|+.+++.++|+||+++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQ------IVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCc------EEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            468899999999999999998765443      399998764432 2233456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|...+...  ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceec
Confidence            99999999988777765443  26899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH-HHHhHHHHhhhhh-
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWALPLLKEKKKL-  307 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~-  307 (389)
                      .....  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.......... ............. 
T Consensus       151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         151 TGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            44321  1223467889999999876 55789999999999999999999999876543322111 0000000000000 


Q ss_pred             ------hhhcCCCCCCCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          308 ------LNIIDPRLEGDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       308 ------~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                            .....+......     ....+..+.+|+.+||+.||++||++.+++.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                  000000000000     01236778999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.6e-40  Score=298.03  Aligned_cols=247  Identities=27%  Similarity=0.442  Sum_probs=199.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|++.+.||+|+||.||+|...        +..||+|......   ....+.+|+.+++.++||||+++++++... ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~--------~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   73 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYT--------GQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GL   73 (254)
T ss_pred             HHceeeeeeccCCCCceEecccC--------CCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-Cc
Confidence            57899999999999999998532        2339999986542   235677899999999999999999998654 57


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+.+|+|.+++.......+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||++....
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            99999999999999987765556889999999999999999999977  9999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ...     .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.........                 ..
T Consensus       152 ~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~  209 (254)
T cd05083         152 MGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-----------------EC  209 (254)
T ss_pred             ccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-----------------HH
Confidence            221     12234567999999998899999999999999999998 99999765432110                 00


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                      +........+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         210 VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            11111112233456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.8e-40  Score=300.75  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=189.9

Q ss_pred             eecCCCceEEEEeeeccccc------------------cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccce
Q 016481           79 VLGGGGFGCVYKGFISEDLR------------------EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK  140 (389)
Q Consensus        79 ~lg~G~~g~Vy~~~~~~~~~------------------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  140 (389)
                      .||+|+||.||+|.+..+..                  .......|++|++.... ......+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            58999999999997543211                  12234568899886543 233456778999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC---
Q 016481          141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---  217 (389)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~---  217 (389)
                      +++++......++||||+++|+|..++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++..+   
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence            999999999999999999999998887653 336889999999999999999999976  99999999999997643   


Q ss_pred             ----cEEEeccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHH-hCCCCCCCCCchhhh
Q 016481          218 ----NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEIL-TGRKSLDKSRPAREQ  291 (389)
Q Consensus       218 ----~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~  291 (389)
                          .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|+|+ +|+.||....+....
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                3899999987643221      12357788999998875 56899999999999999985 699999765432211


Q ss_pred             hhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          292 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ..       ...          .  ...+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus       232 ~~-------~~~----------~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 RF-------YEK----------K--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH-------HHh----------c--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11       000          0  0111122357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.4e-40  Score=302.11  Aligned_cols=254  Identities=26%  Similarity=0.324  Sum_probs=195.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHH-HhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF-LGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||.||+|.++.+.+.      ||+|.+...........+..|+.+ ++.++||||+++++++..++.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTI------MAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcE------EEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence            4788999999999999999987655443      999998765443344555566665 566789999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          151 RVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+++|||++ |+|.+++...  ....+++..+..++.|++.||+|||++ +  ++|+||||+||+++.++.+||+|||++
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~  151 (283)
T cd06617          75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS  151 (283)
T ss_pred             EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999996 5787766442  234689999999999999999999985 6  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccccccccCcccccc----CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      .......   ......++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||........ .+.    .    
T Consensus       152 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~----~----  219 (283)
T cd06617         152 GYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLK----Q----  219 (283)
T ss_pred             ccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHH----H----
Confidence            8653321   1222468889999998865    4568899999999999999999999975322110 000    0    


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                         ......+..   .....+.++.+++.+||..+|++||++.+++++-
T Consensus       220 ---~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  262 (283)
T cd06617         220 ---VVEEPSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP  262 (283)
T ss_pred             ---HHhcCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence               000001111   1123467899999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.3e-40  Score=299.49  Aligned_cols=260  Identities=27%  Similarity=0.419  Sum_probs=200.6

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC---
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE---  149 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---  149 (389)
                      |.+.+.||+|+||.||+|.+....   ..+..||+|.+.... .......+.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSED---GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccC---CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            567889999999999999765432   223459999887543 3344567889999999999999999999886532   


Q ss_pred             ---eEEEEEEecCCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          150 ---HRVLIYEFMARGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       150 ---~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                         ..+++++|+.+|+|.+++...    ....++...+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEEC
Confidence               347889999999998876432    1235788899999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      |||+++...............+++.|++||.+.+..++.++||||||+++|+|++ |++||.......   ...+..   
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---  229 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---  229 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---
Confidence            9999886543222112222345678999999998889999999999999999999 889987654321   111110   


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                       ..          .....+...+..+.+++.+||+.+|++|||+.+++..|+.+
T Consensus       230 -~~----------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 -KG----------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -cC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             00          00111234557899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-41  Score=318.59  Aligned_cols=246  Identities=26%  Similarity=0.392  Sum_probs=202.7

Q ss_pred             eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEec
Q 016481           79 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM  158 (389)
Q Consensus        79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (389)
                      +||+|.||+||-|++..+...      +|||-+.... .+..+-+..||.+.++|+|.|||+++|.+.+++++-|.||-+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvr------IaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqV  654 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVR------IAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQV  654 (1226)
T ss_pred             EeecCceeEEEeeccccceeE------EEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence            699999999999987665544      9999887553 344566788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-CCcEEEeccCCCcCCCCCCC
Q 016481          159 ARGSVENNLFSKVLLPL--PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKDGPEGDK  235 (389)
Q Consensus       159 ~~gsL~~~l~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-~~~vkl~Dfg~a~~~~~~~~  235 (389)
                      +||+|.+.+...=+ ++  .+.......+||++||.|||.+.  |||||||-+||||+. .|.+||+|||.++.+..-  
T Consensus       655 PGGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--  729 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--  729 (1226)
T ss_pred             CCCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccC--
Confidence            99999998866432 44  67788889999999999999977  999999999999974 689999999999876542  


Q ss_pred             ccccccccccccccCccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCC
Q 016481          236 SHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  313 (389)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (389)
                      .....++.||..|||||++-.+  +|+.++|||||||++.||.||++||-........               +.+.---
T Consensus       730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---------------MFkVGmy  794 (1226)
T KOG4279|consen  730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---------------MFKVGMY  794 (1226)
T ss_pred             CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---------------hhhhcce
Confidence            2345568899999999999754  6899999999999999999999999754322111               1111111


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          314 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +..+++|...+.+++.||.+|+..||.+||+++++|.-
T Consensus       795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            22456788999999999999999999999999999864

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.9e-40  Score=303.15  Aligned_cols=247  Identities=26%  Similarity=0.361  Sum_probs=203.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||.||+|.+..+.+      .||+|.+....  .......+.+|+.+++++.||||+++++++..+.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGK------YYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            468899999999999999998765433      39999886432  2233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++||||+++++|.+++....  .++...+..++.|++.||.|||+.+  ++|+||+|+||+++.++.+||+|||++..
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            9999999999999999886653  6889999999999999999999977  99999999999999999999999999887


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ....     .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........   .             ..
T Consensus       151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-------------~~  209 (290)
T cd05580         151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---Y-------------EK  209 (290)
T ss_pred             cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---H-------------HH
Confidence            5433     2235789999999999888889999999999999999999999976542110   0             00


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      ....  ....+...+..+.+++.+||..||.+|+     ++.++++|
T Consensus       210 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         210 ILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            0000  1122334468899999999999999999     88888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-40  Score=303.31  Aligned_cols=269  Identities=25%  Similarity=0.321  Sum_probs=202.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||.||+|.+..+..      .|++|.+.... .......+.+|+.+++.++|+||+++++++..++.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~------~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGE------IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCc------EEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence            368899999999999999998765543      39999876543 23334677899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||++++.+.......  ..++...+..++.+++.||+|||..+  ++|+||+|+||+++.++.+||+|||++...
T Consensus        75 ~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          75 LYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             EEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            99999999886665544332  35889999999999999999999977  999999999999999999999999998876


Q ss_pred             CCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH-HHHh-----
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-LLKE-----  303 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~-----  303 (389)
                      ..... .......++..|+|||++.+. .++.++||||||+++|+|++|++||................. ....     
T Consensus       151 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         151 RARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             CCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence            54332 122335688899999999888 889999999999999999999999986543321111100000 0000     


Q ss_pred             --hhhhh--hhcCCC----CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 --KKKLL--NIIDPR----LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 --~~~~~--~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        .....  ......    ....++..++.++.+|+.+||..+|++||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence              00000  000000    0001222347889999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.9e-40  Score=299.09  Aligned_cols=250  Identities=25%  Similarity=0.390  Sum_probs=203.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +-|...+.||.|+||.||+|.+..+..      .||+|.............+.+|+.+++.++|+||+++++++..+...
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   77 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQK------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   77 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCc------EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence            347788999999999999997655433      39999887554445556788899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++++|..++...   .+++..+..++.+++.++.|||..+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          78 WIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            9999999999999887543   5789999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.........      .           .+
T Consensus       153 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~-----------~~  213 (277)
T cd06641         153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL------F-----------LI  213 (277)
T ss_pred             cchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH------H-----------HH
Confidence            3221  122356888999999998888899999999999999999999999754322100      0           00


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ........+...+.++.+++.+||+.+|++||++.+++.+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         214 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0111112233456789999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-41  Score=319.83  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=199.5

Q ss_pred             cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe--EE
Q 016481           75 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH--RV  152 (389)
Q Consensus        75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~  152 (389)
                      +....||+|+|-+||+|.+..++.   ......+|+-..........+|..|+.+|+.|+|+||++++++|.+...  +.
T Consensus        43 k~~evLGrGafKtVYka~De~~gi---EVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGI---EVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccch---hhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence            445789999999999998644432   2223345555545566677889999999999999999999999987665  88


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC-CcEEEeccCCCcCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDGP  231 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~-~~vkl~Dfg~a~~~~  231 (389)
                      +|+|+|..|+|..+..+..  .+....+..|++||+.||.|||++.++|+|||||.+||||+.+ |.|||+|+|+|....
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            9999999999999997765  6788899999999999999999999999999999999999754 899999999998765


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ...    .....|||.|||||+.. ..|+..+||||||++++||.|+..||..=... .+.+    .++          +
T Consensus       198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-AQIY----KKV----------~  257 (632)
T KOG0584|consen  198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-AQIY----KKV----------T  257 (632)
T ss_pred             ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-HHHH----HHH----------H
Confidence            422    33378999999999776 89999999999999999999999999742211 1111    111          1


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ....+..+..-..+++++||.+||.. .++|||+.++|++
T Consensus       258 SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  258 SGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             cCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            11111111222357899999999999 9999999999976

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.2e-40  Score=306.72  Aligned_cols=265  Identities=22%  Similarity=0.301  Sum_probs=187.7

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe--CCeEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DEHRVLI  154 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  154 (389)
                      +.+||+|+||.||+|..+..    .....||+|.+.....   ...+.+|+.+++.++||||+++++++..  +...++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~----~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDG----KDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCC----CccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            36799999999999975432    2234599998865432   2356689999999999999999998854  5678999


Q ss_pred             EEecCCCChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE----cCCCcEEEec
Q 016481          155 YEFMARGSVENNLFSK-------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSD  223 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili----~~~~~vkl~D  223 (389)
                      |||+.+ +|.+.+...       ....+++..+..++.|++.||.|||+.+  |+||||||+|||+    +.++.+||+|
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            999964 777666321       1235788899999999999999999977  9999999999999    5667899999


Q ss_pred             cCCCcCCCCCCCc-cccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhh-------hhH
Q 016481          224 FGLAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ-------NLA  294 (389)
Q Consensus       224 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~~  294 (389)
                      ||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.........       .+.
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~  235 (317)
T cd07867         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD  235 (317)
T ss_pred             ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence            9999876433211 11233578999999999876 45799999999999999999999999754322110       000


Q ss_pred             HHHh----------HHHHhhh---hhhhhcCCC------C---CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          295 DWAL----------PLLKEKK---KLLNIIDPR------L---EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       295 ~~~~----------~~~~~~~---~~~~~~~~~------~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ....          .......   .........      +   ...........+.+|+.+||+.||.+|||+.++++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            0000          0000000   000000000      0   000011224568899999999999999999999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.9e-40  Score=297.95  Aligned_cols=256  Identities=24%  Similarity=0.414  Sum_probs=203.4

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-----hhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-----YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      +|+..+.||+|+||.||+|....+..      .||+|.+.....     ......+..|+.+++.++|+||+++++++.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~------~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGT------LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCc------EEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            47888999999999999997655443      399998864321     1234678889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-cEEEeccCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGL  226 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-~vkl~Dfg~  226 (389)
                      .+..++|+||+.+++|.+++....  ++++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccc
Confidence            999999999999999999886543  6888999999999999999999977  99999999999998775 599999999


Q ss_pred             CcCCCCCCC--ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          227 AKDGPEGDK--SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       227 a~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      +........  ........++..|+|||.+.+..++.++||||||+++|+|++|..||...........           
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----------  219 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-----------  219 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-----------
Confidence            876643211  1112235688999999999988999999999999999999999999975432111100           


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        .............+...+.++.+++.+||+.+|++||++.+++++
T Consensus       220 --~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         220 --IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             --HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence              001111112233455667889999999999999999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9e-40  Score=295.67  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=201.7

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +|+..+.||+|+||.||+|....+..      .|++|.+....    .......+..|+.+++.++|+||+++++++..+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGD------FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE   74 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCc------EEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence            47788999999999999998764433      39999875432    123456788899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..+++|+||+++++|.+++....  .+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.+||+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccce
Confidence            99999999999999999886543  5788999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ......   ......++..|++||.+.... ++.++|+||||+++|+|++|+.||.........      ...       
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~-------  214 (258)
T cd06632         151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKI-------  214 (258)
T ss_pred             eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHH-------
Confidence            654322   223456899999999987766 899999999999999999999999765421110      000       


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         .........+...+..+.+++.+||+.+|++||++.+++.+
T Consensus       215 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         215 ---GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ---HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence               00000112233456888999999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.1e-40  Score=304.03  Aligned_cols=256  Identities=27%  Similarity=0.348  Sum_probs=198.5

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  150 (389)
                      ++|...+.||+|+||.||++.+..+..      .||+|.+...........+..|+.++.++. |+||+++++++..+..
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~   77 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGT------IMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD   77 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCC------EEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence            356667889999999999997665443      399999876544455667888999999996 9999999999999999


Q ss_pred             EEEEEEecCCCChhhh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          151 RVLIYEFMARGSVENN---LFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      .+++|||+.+ ++.++   +.......+++..+..++.+++.||+|||+. +  ++||||||+||+++.++.++|+|||+
T Consensus        78 ~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~  154 (288)
T cd06616          78 CWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI  154 (288)
T ss_pred             EEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecch
Confidence            9999999864 55443   3333345789999999999999999999974 6  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG---HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      +.......   ......|+..|+|||++.+.   .++.++||||||+++|+|++|+.||.......     .       .
T Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~-------~  219 (288)
T cd06616         155 SGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-----D-------Q  219 (288)
T ss_pred             hHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-----H-------H
Confidence            87654322   11234688999999998766   68999999999999999999999997543110     0       0


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .........+.+....+...+.++.+|+.+||+.||++|||+.+|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         220 LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             HhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000111111222222334467889999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=307.38  Aligned_cols=255  Identities=26%  Similarity=0.353  Sum_probs=210.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +.|+..++||+|+||.||-|....+++      .||.|.+.+.+-  .....-.+.|..+|..++.+.||.+--.|...+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGK------MYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGK------MYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD  258 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchh------hHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence            458889999999999999987655544      488887765431  223345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++|+..|+||+|.-++.+.+...+++..+.-.+.+|+.||++||..+  ||+|||||+|||+|+.|+++|+|+|+|..
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEe
Confidence            9999999999999999998888888999999999999999999999977  99999999999999999999999999999


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      +..+..   ....+||.+|||||++.+..|+...|+|||||++|||+.|+.||.........             .++.+
T Consensus       337 i~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------eEvdr  400 (591)
T KOG0986|consen  337 IPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------EEVDR  400 (591)
T ss_pred             cCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------HHHHH
Confidence            877553   33358999999999999999999999999999999999999999865432211             00000


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~il~~  351 (389)
                      .+ ......++..+++++.++....|++||++|...     +++.+|
T Consensus       401 r~-~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  401 RT-LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             HH-hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence            00 011234567788999999999999999999754     466554

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.8e-40  Score=300.36  Aligned_cols=261  Identities=27%  Similarity=0.333  Sum_probs=200.8

Q ss_pred             HHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEe
Q 016481           65 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIG  143 (389)
Q Consensus        65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~  143 (389)
                      +.+....++|++.+.||+|+||.||+|....+.+      .+|+|+......  ....+..|+.+++.+ +|+||+++++
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~------~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGS------KAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCc------eeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            3334456789999999999999999998655433      399998764322  234567899999999 6999999999


Q ss_pred             EEE-----eCCeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          144 YCC-----EDEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       144 ~~~-----~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      ++.     .+..+++||||+++++|.+.+...  ....+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~  160 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE  160 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCC
Confidence            874     345789999999999999877532  2346788889999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhh
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ  291 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  291 (389)
                      +.++|+|||++........  ......|++.|+|||++..     ..++.++|||||||++|+|++|+.||....+....
T Consensus       161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~  238 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL  238 (286)
T ss_pred             CCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH
Confidence            9999999999876543221  1223568999999998853     45788999999999999999999999765432110


Q ss_pred             hhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          292 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                        .           .......+  ....+...+..+.+|+.+||+.||++|||+.++++++
T Consensus       239 --~-----------~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         239 --F-----------KIPRNPPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             --h-----------hccccCCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence              0           00000000  1111223456799999999999999999999999885

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.2e-39  Score=298.91  Aligned_cols=269  Identities=23%  Similarity=0.287  Sum_probs=199.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|....+...      |++|.+...........+.+|+.+++.++|+||+++++++..+..
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~------~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQL------VALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcE------EEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence            36799999999999999999987655443      999998765433333456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+. ++|.+.+.... ..+++..+..++.|++.||.|||..+  |+|+||||+||+++.++.++|+|||+++..
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEecccccccc
Confidence            999999995 67777765443 35778888899999999999999977  999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh---HHHH---h
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL---PLLK---E  303 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~~~---~  303 (389)
                      .....  ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.............|..   +.-.   .
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         154 SIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             CCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence            33221  12234578999999998764 57889999999999999999999998654432211111100   0000   0


Q ss_pred             hhhhhhhcCCCCCCCC---------ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 KKKLLNIIDPRLEGDY---------PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ...+............         ....+..+.+++.+||..||.+|||+.+++.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0000000000000000         01125678899999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.4e-40  Score=301.39  Aligned_cols=266  Identities=23%  Similarity=0.277  Sum_probs=203.0

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|.+.+.||.|+||.||+|.+..+..      .|++|.+..... ......+.+|+.+++.++|+||+++++++..+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGE------TVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCc------eEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            58889999999999999998765433      399998876542 33346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++|+||+ +++|.+++.... ..+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            9999999 999999886544 46899999999999999999999977  9999999999999999999999999988764


Q ss_pred             CCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH-----hhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK-----EKK  305 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----~~~  305 (389)
                      .... .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||.........   ........     ...
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  226 (286)
T cd07832         151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWP  226 (286)
T ss_pred             CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHh
Confidence            4321 112235689999999998754 4689999999999999999998888765432211   11110000     000


Q ss_pred             ---hhh---hhcCCCCC----CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          306 ---KLL---NIIDPRLE----GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       306 ---~~~---~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                         .+.   ....+...    .....+.+..+.+++.+||+.||++||++.+++.|-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence               000   00000000    001123458899999999999999999999999873

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-40  Score=301.93  Aligned_cols=268  Identities=21%  Similarity=0.277  Sum_probs=197.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||+|++|.||+|....+.      ..||+|.+...........+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTG------QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTL   78 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCC------cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence            67999999999999999999765443      349999987554333334566899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccC
Confidence            999999974 89888765443 6889999999999999999999977  9999999999999999999999999987543


Q ss_pred             CCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH-Hh-----HHHHhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW-AL-----PLLKEK  304 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~-----~~~~~~  304 (389)
                      ....  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.............+ ..     ......
T Consensus       155 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         155 VPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             CCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence            2111  1122356889999999875 4588999999999999999999999976542211100000 00     000000


Q ss_pred             hhhhhhcCCCCC--------CCC-ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNIIDPRLE--------GDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~--------~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ............        ... .......+.+++.+||+.+|++|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            000000000000        000 01112678899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-39  Score=295.24  Aligned_cols=245  Identities=27%  Similarity=0.421  Sum_probs=192.3

Q ss_pred             ceecCCCceEEEEeeecccccc----CcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLRE----GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (389)
                      +.||+|+||.||+|.+......    ......+++|........  ...+.+|+.+++.++|+||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            4689999999999987654421    223345788876654322  5677889999999999999999999888 77899


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-------cEEEeccCC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-------NAKLSDFGL  226 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-------~vkl~Dfg~  226 (389)
                      ||||+.+|+|.+++..... .+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++       .+||+|||+
T Consensus        78 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            9999999999998876543 6888999999999999999999977  99999999999999887       799999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccC--CCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      +.....      .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||...........  +       
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~--~-------  219 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF--Y-------  219 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH--H-------
Confidence            886533      1123567789999999876  78999999999999999999 5777766532211100  0       


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                           .  ..   ...+......+.+++.+||..+|++||++.++++.|+
T Consensus       220 -----~--~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 -----Q--DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -----h--cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 0  00   0011111278899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=298.00  Aligned_cols=254  Identities=29%  Similarity=0.378  Sum_probs=199.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  149 (389)
                      .++|++.+.||+|+||.||+|..+.+..      .+++|++.....  ....+.+|+.+++++ .|+||+++++++....
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQ------LVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCc------EEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            4789999999999999999998654433      399998875532  345678899999998 6999999999997644


Q ss_pred             ------eEEEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          150 ------HRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       150 ------~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                            .+++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEE
Confidence                  5899999999999998876533  457899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      +|||++.......  .......|+..|+|||++..     ..++.++||||||+++|+|++|+.||........  ..  
T Consensus       155 ~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~--  228 (275)
T cd06608         155 VDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF--  228 (275)
T ss_pred             CCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH--
Confidence            9999987653321  12233568999999998754     3467899999999999999999999975432211  00  


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        .       ......+  ....+...+..+.+|+.+||..||++|||+.+++++
T Consensus       229 --~-------~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         229 --K-------IPRNPPP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             --H-------hhccCCC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence              0       0000001  111123356789999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-40  Score=324.83  Aligned_cols=278  Identities=19%  Similarity=0.216  Sum_probs=193.2

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCc-------------CcccEEEEEecCCCChhhHHHHHHHHHHHhccC
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGL-------------QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS  134 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~-------------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~  134 (389)
                      ..+.++|++.+.||+|+||+||+|.++.......             ....++.|....  .......+.+|+.+++.++
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~Ei~il~~l~  221 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA--GSRAAIQLENEILALGRLN  221 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc--chHHHHHHHHHHHHHHhCC
Confidence            3456789999999999999999986543221100             000011122111  1233456778999999999


Q ss_pred             CCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCe
Q 016481          135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL---LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  211 (389)
Q Consensus       135 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Ni  211 (389)
                      |+||+++++++...+..|+|++++. ++|..++.....   .......+..++.|++.||+|||+++  |+||||||+||
T Consensus       222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NI  298 (501)
T PHA03210        222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENI  298 (501)
T ss_pred             CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence            9999999999999999999999995 577777654321   12345667789999999999999977  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCC-CCCCCCchhh
Q 016481          212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK-SLDKSRPARE  290 (389)
Q Consensus       212 li~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~-pf~~~~~~~~  290 (389)
                      |++.++.+||+|||+++....... .......||+.|+|||++.+..|+.++|||||||++|||++|.. ||........
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            999999999999999987643321 12234679999999999999999999999999999999999886 4443332222


Q ss_pred             hhhHHHHhHHH---Hh----hhhhhhhcCCCC----CCCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          291 QNLADWALPLL---KE----KKKLLNIIDPRL----EGDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       291 ~~~~~~~~~~~---~~----~~~~~~~~~~~~----~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..+...+..+.   .+    ...+...+....    ....     ....+.++.+++.+||++||++|||+.++++|
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            22222111000   00    000111111000    0000     01134567888999999999999999999987

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-39  Score=296.63  Aligned_cols=253  Identities=24%  Similarity=0.339  Sum_probs=197.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +.+.....||+|+||.||+|.+..+..      .|++|...... ......+.+|+.+++.++|+||+++++++..++..
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQV------RIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCc------EEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence            344455689999999999997655433      39999876543 34456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-CCcEEEeccCCCc
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPL--PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAK  228 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-~~~vkl~Dfg~a~  228 (389)
                      ++|+||+++++|.+++..... .+  +...+..++.|++.||+|||+.+  |+|+||||+||+++. ++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            999999999999998875422 34  77888899999999999999977  999999999999976 6799999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      .......  ......+++.|+|||++.+.  .++.++||||||+++|+|++|+.||..........   +.         
T Consensus       158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~---------  223 (268)
T cd06624         158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FK---------  223 (268)
T ss_pred             ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hh---------
Confidence            6543221  12234688999999998654  37889999999999999999999997543211110   00         


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         ..........+...+.++.+++.+||+.+|++|||+.+++.+
T Consensus       224 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         224 ---VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ---hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence               000011122344566889999999999999999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=294.36  Aligned_cols=252  Identities=24%  Similarity=0.313  Sum_probs=206.7

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      -.++|...++||+|.||.|.+|+.+.+.+      .||+|+++++.  .......-+.|-++|+..+||.+..+.-.|+.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k------~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt  239 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGK------LYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT  239 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCc------eeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence            35688999999999999999997665544      49999998764  23344556789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+++|+||||..||.|.-++.+..  .+++....-.-..|+.||.|||+.+  ||+||||.+|+|+|.+|++||+|||++
T Consensus       240 ~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLC  315 (516)
T KOG0690|consen  240 QDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLC  315 (516)
T ss_pred             CceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccc
Confidence            999999999999999988776543  6788888888899999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      +..-.  ......++||||.|+|||++....|..++|+|.+||++|||++|+.||...+......+              
T Consensus       316 KE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL--------------  379 (516)
T KOG0690|consen  316 KEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL--------------  379 (516)
T ss_pred             hhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH--------------
Confidence            86432  22345679999999999999999999999999999999999999999976543211111              


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      +-.    ....+|...++++..|+...|.+||.+|.     .+.+|..|
T Consensus       380 Il~----ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  380 ILM----EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             HHh----hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            000    01234667789999999999999999996     35555443

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.2e-40  Score=303.28  Aligned_cols=266  Identities=23%  Similarity=0.279  Sum_probs=197.6

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|++.+.||+|+||.||+|++..+..      .||+|.+...... .....+.+|+.+++.++|+||+++++++.+....
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~------~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHE------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCc------EEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            58888999999999999998765543      3999988654322 2234566899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||+++...
T Consensus        75 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          75 TLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             EEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            99999997 57887775533 36899999999999999999999977  9999999999999999999999999988654


Q ss_pred             CCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH-----hhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK-----EKK  305 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----~~~  305 (389)
                      ....  ......+++.|+|||++.+. .++.++|||||||++|+|++|..||........ .+ ..+.....     ...
T Consensus       151 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~  226 (284)
T cd07839         151 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWP  226 (284)
T ss_pred             CCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhH
Confidence            3221  12234678999999998764 478999999999999999999998654332211 11 00000000     000


Q ss_pred             hhhhhcCCC----CC-----CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          306 KLLNIIDPR----LE-----GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       306 ~~~~~~~~~----~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ......+..    ..     .......+.++.+++.+||+.||.+|||+.++++|-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            000000000    00     011123467889999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=297.70  Aligned_cols=249  Identities=25%  Similarity=0.354  Sum_probs=201.2

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC---CCccceEEeEEEeCC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYCCEDE  149 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~  149 (389)
                      .|...+.||.|+||.||+|.+..+..      .|++|.+...........+.+|+.+++.+.   |||++++++++....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGR------VVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCc------EEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence            47778899999999999998755443      399999876544555567788999999986   999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++++|.+++...   .+++..+..++.|++.||.|||..+  |+|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            999999999999999887543   6889999999999999999999977  99999999999999999999999999887


Q ss_pred             CCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......  ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||..........             ...
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------------~~~  215 (277)
T cd06917         151 LNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------------LIP  215 (277)
T ss_pred             cCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------------ccc
Confidence            654332  1233568999999998865 457899999999999999999999997653221100             000


Q ss_pred             hhcCCCCCCCCCh-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          309 NIIDPRLEGDYPV-KGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..    .....+. ..+.++.+++.+||+.||++||++.+++.+
T Consensus       216 ~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         216 KS----KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             cC----CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            00    0111111 256789999999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-39  Score=294.82  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=203.1

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe--CC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DE  149 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~  149 (389)
                      +|.+.+.||.|+||.||+|.+..+..      .||+|.+.... .......+..|+.+++.++|+||+++++++..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGK------ILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCC------EEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            57888999999999999997665443      39999876543 34445678889999999999999999998764  45


Q ss_pred             eEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          150 HRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLH-----EAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                      ..+++|||+++++|.+++...  ....+++..+..++.+++.||.|||     +.+  ++|+||+|+||+++.++.+||+
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEe
Confidence            789999999999999988653  2346889999999999999999999     655  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      |||++........  ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.......   +..       
T Consensus       153 d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~-------  220 (265)
T cd08217         153 DFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LAS-------  220 (265)
T ss_pred             cccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHH-------
Confidence            9999887654321  1233568999999999998889999999999999999999999998654211   111       


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                             .+........+...+..+.+++.+||+.+|++||++.+|+++
T Consensus       221 -------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         221 -------KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -------HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                   011111123344567889999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-39  Score=294.72  Aligned_cols=254  Identities=26%  Similarity=0.348  Sum_probs=208.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|.+.+.||.|++|.||+|....+.+      .|++|.+...........+..|+..+..++|+||+++++++.....+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~------~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGK------IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI   74 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCc------EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence            368889999999999999998765443      39999987765444567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      ++||||+++++|.+++...  ..++...+..++.|++.||+|||+ .+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceec
Confidence            9999999999999998765  478999999999999999999999 88  999999999999999999999999998866


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ......  .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..............             +
T Consensus       151 ~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-------------~  215 (264)
T cd06623         151 ENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-------------I  215 (264)
T ss_pred             ccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-------------H
Confidence            433221  1235688999999999988999999999999999999999999976643111111110             0


Q ss_pred             cCCCCCCCCChH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          311 IDPRLEGDYPVK-GVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      . .......+.. .+..+.+++.+||..+|++||++.+++++
T Consensus       216 ~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         216 C-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             h-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0 1111122233 56889999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.7e-39  Score=293.69  Aligned_cols=255  Identities=27%  Similarity=0.382  Sum_probs=202.6

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|.+.+.||+|+||.||+|....+.+      .|++|.+...... .....+..|+.+++.++|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGE------LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCc------EEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            58889999999999999997655433      3999998765432 3567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++|+||+++++|.+++....  .+++..+..++.+++.||+|||+.+  |+|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             EEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            99999999999999887643  5788889999999999999999977  9999999999999999999999999988765


Q ss_pred             CCCCccc--cccccccccccCccccccCC---CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          232 EGDKSHV--STRIMGTYGYAAPEYIMTGH---LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       232 ~~~~~~~--~~~~~gt~~y~aPE~l~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      .......  .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||...........     .       
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~-----~-------  218 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-----H-------  218 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH-----H-------
Confidence            4322111  12356889999999998766   88999999999999999999999975432111000     0       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ......+.+  +.....+..+.+++.+||+.+|++||++.+++.+
T Consensus       219 ~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         219 VGAGHKPPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             HhcCCCCCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000011  1112336788999999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-40  Score=308.07  Aligned_cols=275  Identities=22%  Similarity=0.290  Sum_probs=200.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  148 (389)
                      .++|.+.+.||+|+||.||+|.+..+..      .||+|.+...........+..|+.+++.++|+||+++++++...  
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGV------KVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF   77 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCC------eEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence            5789999999999999999998765443      39999986543344456678899999999999999999987543  


Q ss_pred             ---CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          149 ---EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       149 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                         ...++|+||+. ++|...+...   .+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          78 ESFNDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             cccceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECccc
Confidence               35899999996 4777766433   6899999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCc-cccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh--HHH
Q 016481          226 LAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--PLL  301 (389)
Q Consensus       226 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~  301 (389)
                      ++......... .......|++.|+|||++.+ ..++.++|||||||++|+|++|++||................  +..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~  231 (336)
T cd07849         152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ  231 (336)
T ss_pred             ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            98765432211 11223578999999998754 568999999999999999999999997654322110000000  000


Q ss_pred             Hhh--------hhhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccC
Q 016481          302 KEK--------KKLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQV  357 (389)
Q Consensus       302 ~~~--------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~  357 (389)
                      ...        ..............   .....+.++.+++.+||+.||++|||+.+++++  |+...+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            000        00000000000000   011235778999999999999999999999998  555543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.2e-39  Score=301.04  Aligned_cols=255  Identities=22%  Similarity=0.295  Sum_probs=198.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|.+.+.||+|+||.||+|.+....+.      |++|.+.....  ......+..|+.+++.++||||+++++.+..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~------v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQR------FAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcE------EEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence            3688899999999999999987655443      99998765432  233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++||||++|++|.+++....  .+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.++|+|||+++.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            9999999999999999986543  6889999999999999999999977  99999999999999999999999999864


Q ss_pred             CCCCCC-------------ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          230 GPEGDK-------------SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       230 ~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      ......             ........++..|+|||.+.+..++.++||||||+++|+|++|..||.+......  .   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~--~---  225 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--F---  225 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H---
Confidence            211100             0011124578899999999888899999999999999999999999975432210  0   


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH---HHHHHH
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM---RDIVDS  351 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~~il~~  351 (389)
                       .....     .....+    ......+.++.+++.+||+.||++||++   .+++++
T Consensus       226 -~~~~~-----~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 -GQVIS-----DDIEWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -HHHHh-----cccCCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence             00000     000000    0111356788999999999999999985   555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.4e-40  Score=302.60  Aligned_cols=268  Identities=24%  Similarity=0.301  Sum_probs=200.1

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||.||+|.+..+.+      .||+|.+...... .....+.+|+.+++.++||||+++++++..+..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQ------IVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCC------EEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            368889999999999999998765433      3999987654322 234567789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++|+||+++++|..+....  ..+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             EEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            99999999998887765443  25889999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh-HHHHhH-------HH
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALP-------LL  301 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~-------~~  301 (389)
                      .....  ......++..|+|||++.+ ..++.++||||||+++|+|++|++||..........- ..+...       ..
T Consensus       151 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         151 AAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             cCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence            43321  2233567899999999875 4578899999999999999999999976543221100 000000       00


Q ss_pred             HhhhhhhhhcCCCCCC-----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          302 KEKKKLLNIIDPRLEG-----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ...........+....     ......+..+.+|+.+||+.+|++||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0000000000000000     0012346789999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-39  Score=296.05  Aligned_cols=260  Identities=26%  Similarity=0.313  Sum_probs=203.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe--CC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~  149 (389)
                      ++|...+.||.|++|.||+|....+.      ..+|+|.+...........+.+|+.+++.++||||+++++++..  ..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   74 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTG------MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS   74 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCC------eEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence            36788899999999999999876543      33999998765444556778899999999999999999998865  34


Q ss_pred             eEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          150 HRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+++||||+++++|.+++..  .....++...+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccc
Confidence            78999999999999887643  22346788999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCch--hhhhhHHHHhHHHHhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA--REQNLADWALPLLKEKK  305 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~  305 (389)
                      .......    .....++..|+|||.+.+..++.++||||||+++|+|++|..||......  .......+...      
T Consensus       153 ~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------  222 (287)
T cd06621         153 GELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN------  222 (287)
T ss_pred             ccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc------
Confidence            7643322    12346788999999999999999999999999999999999999865321  11111111100      


Q ss_pred             hhhhhcCCCCCCCC--ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          306 KLLNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       306 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                          ...+.+....  ....+..+.+|+.+||+.+|++|||+.+++.+-.
T Consensus       223 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~  268 (287)
T cd06621         223 ----MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW  268 (287)
T ss_pred             ----CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence                0001111111  1234678999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.8e-40  Score=297.32  Aligned_cols=251  Identities=25%  Similarity=0.325  Sum_probs=204.6

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      +|.+.+.||.|+||.||+|.+..+..      .||+|.+....  .......+.+|+.++++++||||+++++++..+..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKK------MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCc------EEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            47889999999999999997654433      39999887543  22345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++|+||+.|++|.+++...  ..++...+..++.|+++||.|||.++  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            99999999999999988665  37889999999999999999999977  999999999999999999999999998875


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ....   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........+.              ..
T Consensus       151 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------------~~  213 (258)
T cd05578         151 TPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR--------------AK  213 (258)
T ss_pred             CCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH--------------HH
Confidence            4432   123356888999999999888999999999999999999999999866532111110              00


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH--HHHHHH
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM--RDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~~il~~  351 (389)
                      ... .....+...+..+.+++.+||+.||.+||++  ++++++
T Consensus       214 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         214 QET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             hcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence            110 1122344456889999999999999999999  777653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.9e-39  Score=298.45  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=202.5

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|.+.+.||+|+||.||+|....+..      .|++|.+..... .....+..|+.+++.++||||+++++++...+..
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQ------EVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCC------EEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            589999999999999999997554433      399998764422 2345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++|+||+++++|.+++...   .+++..+..++.|++.||.|||+++  ++|+||+|+||+++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            9999999999999988654   5788899999999999999999977  9999999999999999999999999887654


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  ......+++.|+|||.+.+..++.++|+||||+++|++++|+.||....+......             .  ..
T Consensus       167 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-------------~--~~  229 (293)
T cd06647         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------------I--AT  229 (293)
T ss_pred             cccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-------------h--hc
Confidence            3321  12235688999999999888899999999999999999999999986543211100             0  00


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ........+...+..+.+++.+||+.+|++||++.+++.|
T Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0011111233456789999999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-39  Score=298.47  Aligned_cols=266  Identities=24%  Similarity=0.314  Sum_probs=199.9

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|+..+.||.|+||.||+|+...+..      .||+|.+..... ......+..|+.++++++||||+++++++.+....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGE------VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCC------EEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            47888999999999999998665443      399998865432 22335677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+. ++|..++.......+++..+..++.|++.||+|||..+  ++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999996 58888887655567899999999999999999999977  9999999999999999999999999987653


Q ss_pred             CCCCccccccccccccccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh----------HH
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL----------PL  300 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----------~~  300 (389)
                      ....  ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||........  ......          +.
T Consensus       152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  227 (284)
T cd07860         152 VPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPG  227 (284)
T ss_pred             cCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhh
Confidence            3221  122345788999999887654 58899999999999999999999976543221  111000          00


Q ss_pred             HHhhhhhhhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKEKKKLLNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..........+.....   .......+.++.+++.+||+.||++||++.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0000000000000000   00111245678899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-39  Score=292.16  Aligned_cols=254  Identities=23%  Similarity=0.316  Sum_probs=202.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCC----CChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD----NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+|++.+.||+|+||.||+|.+..+..      .|++|.+...    ........+.+|+.+++.++|+||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   75 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGR------ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD   75 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCC------EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence            578999999999999999997654433      4999987532    123345678889999999999999999999876


Q ss_pred             C--CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          148 D--EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       148 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      .  ..+++++||+++++|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccc
Confidence            4  46889999999999999886543  5788889999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCC-ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          226 LAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       226 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      +++....... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||.......               
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------  216 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---------------  216 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---------------
Confidence            9886532111 111223568999999999998889999999999999999999999997543211               


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                       ...+..........+...+..+.+++.+||+ +|.+||++.+++.|.
T Consensus       217 -~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         217 -AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             -HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence             1111111122233455677889999999999 579999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.7e-39  Score=293.83  Aligned_cols=255  Identities=22%  Similarity=0.341  Sum_probs=200.3

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC---------ChhhHHHHHHHHHHHhc-cCCCccceEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---------SYQGHREWLAEVIFLGH-LSHPNLVKLI  142 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~niv~~~  142 (389)
                      .|++.+.||+|+||.||+|.+..+.     ...+|+|.+....         ......++..|+.++.. ++|+||++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~-----~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~   75 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNG-----QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY   75 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCC-----CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEE
Confidence            4788899999999999999876521     2348999765321         22334556778888864 7899999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCCcE
Q 016481          143 GYCCEDEHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNA  219 (389)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~~v  219 (389)
                      +++..++..++||||+++++|.+.+..  .....+++..++.++.|++.||.|||. .+  ++|+||+|+||+++.++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcE
Confidence            999999999999999999999987743  223468899999999999999999995 45  9999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH
Q 016481          220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP  299 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  299 (389)
                      +|+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.........        
T Consensus       154 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~--------  222 (269)
T cd08528         154 TITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA--------  222 (269)
T ss_pred             EEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH--------
Confidence            999999988754432   233457899999999999888999999999999999999999999754322110        


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          300 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                              ................+..+.+++.+||+.||++||++.++..+|.
T Consensus       223 --------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         223 --------TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --------HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                    0000111111111234578999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-39  Score=301.17  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=199.0

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      .|.....||+|+||.||++....+..      .||+|.+.... ......+.+|+.+++.++|+||+++++.+...+..+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~------~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGK------QVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCC------EEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence            34445679999999999997654433      39999876542 334456788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      +||||+++++|.+++...   .+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.++|+|||++.....
T Consensus        96 lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658          96 VVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             EEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            999999999999877443   5788999999999999999999977  99999999999999999999999999875433


Q ss_pred             CCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....+.....             .....+.
T Consensus       171 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------------~~~~~~~  235 (292)
T cd06658         171 EVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-------------RIRDNLP  235 (292)
T ss_pred             ccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHhcCC
Confidence            221  1233568999999999998899999999999999999999999997654322110             0111111


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ....  .....+..+.+++.+||..||++|||+.+++++
T Consensus       236 ~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         236 PRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             Cccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1111  112345678999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.6e-39  Score=296.26  Aligned_cols=247  Identities=26%  Similarity=0.353  Sum_probs=196.6

Q ss_pred             ecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           80 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        80 lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      ||+|+||+||+|....+.+.      ||+|.+....  .......+..|+.+++.++||||+++++.+...+..|+||||
T Consensus         1 lg~g~~g~vy~~~~~~~~~~------~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKM------YACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcE------EEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEec
Confidence            68999999999976654433      9999876432  122344567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                      +++++|.+++.......+++..+..++.|++.||.|||..+  ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---  149 (277)
T cd05577          75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---  149 (277)
T ss_pred             CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---
Confidence            99999999987765557899999999999999999999977  9999999999999999999999999987654311   


Q ss_pred             ccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCC
Q 016481          238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  317 (389)
Q Consensus       238 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (389)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..........             .+..... ....
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~-~~~~  215 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-------------ELKRRTL-EMAV  215 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-------------HHHhccc-cccc
Confidence            1223467889999999988889999999999999999999999997654311100             0000000 0112


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          318 DYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      ..+...+..+.+++.+||+.||++||     ++.+++.|
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            23344578899999999999999999     77778765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2e-39  Score=293.33  Aligned_cols=252  Identities=21%  Similarity=0.336  Sum_probs=203.0

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|.+.+.||.|+||.||+|..+.+...      +|+|.+.... .......+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~------~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEH------CVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCce------EEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            578889999999999999987665544      8999876532 123345677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-cEEEeccCCCcCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLAKDG  230 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-~vkl~Dfg~a~~~  230 (389)
                      ++|+||+.+++|.+++.......+++..+..++.+++.||+|||+.+  ++|+||||+||+++.++ .++|+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999999999999887665556899999999999999999999977  99999999999998875 4699999998765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ....  .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......      ....          .
T Consensus       153 ~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~----------~  214 (257)
T cd08225         153 NDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLK----------I  214 (257)
T ss_pred             cCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHH----------H
Confidence            4322  12223468999999999988889999999999999999999999997543221      1111          0


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .... ........+.++.+++.+||..+|++|||+.+++++
T Consensus       215 ~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         215 CQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             hccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1111 111223445789999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.9e-39  Score=292.57  Aligned_cols=245  Identities=26%  Similarity=0.326  Sum_probs=199.0

Q ss_pred             ecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           80 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        80 lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      ||.|+||.||+|+...+.      ..|++|.+.....  ......+..|+.+++.++|+||+++++.+.++...++|+||
T Consensus         1 lg~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVKSKN------RTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEECCCC------cEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEec
Confidence            699999999999876533      3499999875432  23446788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                      +++++|.+++....  .++...+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---  147 (262)
T cd05572          75 CLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---  147 (262)
T ss_pred             CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence            99999999886653  5788999999999999999999977  9999999999999999999999999988765432   


Q ss_pred             ccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCC
Q 016481          238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  317 (389)
Q Consensus       238 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (389)
                      ......++..|++||.+.+..++.++|+||||+++|+|++|..||..........              ...........
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------------~~~~~~~~~~~  213 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI--------------YNDILKGNGKL  213 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH--------------HHHHhccCCCC
Confidence            1223568899999999988889999999999999999999999998654211110              11111111122


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 016481          318 DYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  351 (389)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~  351 (389)
                      .++...+.++.+++.+||+.+|++||+     +.+++++
T Consensus       214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            334444788999999999999999999     8898875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.8e-39  Score=294.44  Aligned_cols=261  Identities=22%  Similarity=0.286  Sum_probs=195.4

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeC--Ce
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED--EH  150 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~  150 (389)
                      |++.+.||+|+||.||+|....+..      .||+|.+..............|+.+++++. |+||+++++++.+.  +.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~------~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGK------YYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCc------EEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence            6778899999999999997665443      399998876533333334557888898885 99999999999887  89


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++||||++ |+|.+.+.... ..+++..+..++.|++.||+|||+.+  ++|+||+|+||+++. +.+||+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          75 LALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             EEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            999999997 58888776543 36899999999999999999999977  999999999999999 99999999999865


Q ss_pred             CCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh-hhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-KKKLL  308 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  308 (389)
                      .....   .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+.....   .+....... .....
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~  223 (282)
T cd07831         150 YSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI---AKIHDVLGTPDAEVL  223 (282)
T ss_pred             ccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH---HHHHHHcCCCCHHHH
Confidence            43221   123457899999997654 55788999999999999999999999876543211   111110000 00000


Q ss_pred             hhcCC------CCCC-------CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          309 NIIDP------RLEG-------DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       309 ~~~~~------~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..+..      ....       ......+..+.+++.+||+.+|++||++.+++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00000      0000       0012346889999999999999999999999976

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.9e-39  Score=297.19  Aligned_cols=253  Identities=28%  Similarity=0.354  Sum_probs=199.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      ...|...+.||+|+||.||+|....+..      .||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~   87 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE   87 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCc------EEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence            3568889999999999999998665433      39999876432  233445788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...++||||+. |++.+.+.... ..+++..+..++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++.
T Consensus        88 ~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          88 HTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             CeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcce
Confidence            99999999997 57776664432 36899999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      .....      ....+++.|+|||++.   ...++.++||||||+++|+|++|+.||...........            
T Consensus       164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~------------  225 (307)
T cd06607         164 LVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------------  225 (307)
T ss_pred             ecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH------------
Confidence            64322      2346788999999884   35688999999999999999999999976543211000            


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                       ..   ........+...+..+.+++.+||+.||++||++.+|+.+..-.
T Consensus       226 -~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  271 (307)
T cd06607         226 -IA---QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL  271 (307)
T ss_pred             -Hh---cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence             00   00001111234567899999999999999999999999875433

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-40  Score=309.43  Aligned_cols=258  Identities=23%  Similarity=0.291  Sum_probs=215.4

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ...|.+.+.||+|.|+.|.+|++..+..+      ||||++.+.. .......+.+|+++|..++|||||+++.+.....
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~------VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTE------VAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCce------EEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            45799999999999999999987766554      9999988764 3334456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+||||+.+|.+.+++..+.  +..+..+..++.|+.++++|||+.+  |||||||++|||++.+.++||+|||++..
T Consensus       129 ~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeecccccee
Confidence            9999999999999999998776  4555888899999999999999977  99999999999999999999999999998


Q ss_pred             CCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      +..+   ....+.||++.|.|||++.+..| .+.+|+||+|+++|.|+.|..||++..-...                ..
T Consensus       205 ~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L----------------r~  265 (596)
T KOG0586|consen  205 FDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL----------------RP  265 (596)
T ss_pred             eccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc----------------cc
Confidence            7643   34567899999999999999888 6799999999999999999999997542110                01


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                      +.+..++  ..+.-.+.++.++|+++|-.+|.+|++.+++.++-+......
T Consensus       266 rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  266 RVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             hheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence            1111111  123345678899999999999999999999998876554443

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.9e-39  Score=305.47  Aligned_cols=267  Identities=20%  Similarity=0.285  Sum_probs=199.7

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+..+|+..+.||+|+||.||+|....+.+.      ||+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQN------VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP   86 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCE------EEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence            4568899999999999999999986655443      9999986432 23334567789999999999999999998864


Q ss_pred             C------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          148 D------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       148 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                      .      ...|+||||+. ++|.+.+...    ++...+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL  159 (353)
T cd07850          87 QKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI  159 (353)
T ss_pred             CCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEE
Confidence            3      35799999996 5788776432    788888999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhh-hH------
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LA------  294 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-~~------  294 (389)
                      +|||+++......   ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... ..      
T Consensus       160 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  236 (353)
T cd07850         160 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP  236 (353)
T ss_pred             ccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999998654322   1223468899999999999999999999999999999999999997654321100 00      


Q ss_pred             --HHHh-------HHHHhhhh-----hhhhcCCC----CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          295 --DWAL-------PLLKEKKK-----LLNIIDPR----LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       295 --~~~~-------~~~~~~~~-----~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        .+..       ........     ........    .....+...+..+.+++.+||+.||++|||+.++|.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000       00000000     00000000    0000122346778999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.8e-39  Score=297.59  Aligned_cols=267  Identities=24%  Similarity=0.301  Sum_probs=200.3

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh----hhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY----QGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +|.+.+.||+|+||.||+|.+..+..      .|++|.+......    .....+..|+.+++.++|+||+++++++...
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGR------IVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCc------EEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence            47788999999999999998665433      3999998755322    2234566799999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..++||||+ +|+|.+++.... ..+++..+..++.|++.||+|||+++  |+|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeee
Confidence            9999999999 889999886543 36899999999999999999999977  9999999999999999999999999988


Q ss_pred             CCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH-HHH-hHHHHh--
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWA-LPLLKE--  303 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~~~-~~~~~~--  303 (389)
                      .......  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||....+....... ... .+....  
T Consensus       151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         151 SFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             eccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence            6544321  1222456888999998865 46789999999999999999998888765443211000 000 000000  


Q ss_pred             -hhhhhhhcCCCCCCC-----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 -KKKLLNIIDPRLEGD-----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 -~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       ...+...........     .....+..+.+++.+||+.||++|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             000000000000001     112346789999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.5e-39  Score=295.10  Aligned_cols=244  Identities=24%  Similarity=0.325  Sum_probs=189.1

Q ss_pred             eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh--hhHHHHHHHHHHHh---ccCCCccceEEeEEEeCCeEEE
Q 016481           79 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--QGHREWLAEVIFLG---HLSHPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~l  153 (389)
                      .||+|+||.||+|....+..      .+|+|.+......  .....+..|..+++   ...|+||+.+++.+..++..++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGK------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEECCCCc------EEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence            48999999999997654433      4999988654321  11223344444433   3469999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  233 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~  233 (389)
                      ||||+.+|+|.+++....  .+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          75 ILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            999999999998886543  6899999999999999999999977  999999999999999999999999998754332


Q ss_pred             CCccccccccccccccCccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          234 DKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      .    .....|+..|+|||.+. +..++.++|||||||++|+|++|..||..............               .
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---------------~  211 (279)
T cd05633         151 K----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---------------T  211 (279)
T ss_pred             C----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---------------h
Confidence            1    12346899999999886 45689999999999999999999999976533211111000               0


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      .......+...+.++.+++.+||+.||++||     +++++++|
T Consensus       212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         212 LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            0112223445678899999999999999999     69999988

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.4e-39  Score=299.56  Aligned_cols=250  Identities=23%  Similarity=0.318  Sum_probs=198.6

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (389)
                      |.....||+|+||.||+|....+..      .||+|.+..... .....+.+|+.+++.++||||+++++++..++..++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~------~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i   95 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGR------QVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV   95 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCC------EEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence            4445679999999999997654433      399999865432 334567789999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  233 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~  233 (389)
                      |+||+++++|...+...   .+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.++|+|||++......
T Consensus        96 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          96 LMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             EEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            99999999998876442   5789999999999999999999977  999999999999999999999999998754332


Q ss_pred             CCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCC
Q 016481          234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  313 (389)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (389)
                      ..  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+......       +..      ....
T Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-------~~~------~~~~  235 (297)
T cd06659         171 VP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-------LRD------SPPP  235 (297)
T ss_pred             cc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------Hhc------cCCC
Confidence            21  12335789999999999988999999999999999999999999976543221100       000      0000


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          314 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                        ........+..+.+++.+||+.+|++||++.+++++-
T Consensus       236 --~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~  272 (297)
T cd06659         236 --KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHP  272 (297)
T ss_pred             --CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence              0111223457789999999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.8e-39  Score=296.09  Aligned_cols=255  Identities=29%  Similarity=0.363  Sum_probs=197.8

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  148 (389)
                      ..++|.+.+.||+|+||.||+|....+.+      .+|+|.......  ....+..|+.+++.+ +|||++++++++...
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~------~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGS------LAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCC------EEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            46789999999999999999997665443      399998865322  234566789999988 799999999998653


Q ss_pred             -----CeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          149 -----EHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       149 -----~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                           ...++||||+++|+|.+++...  ....+++..+..++.|++.||.|||..+  ++|+||||+||+++.++.+||
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEE
Confidence                 3689999999999999887532  2346889999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccC-----CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-----HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      +|||++........  ......|+..|+|||++...     .++.++|||||||++|+|++|+.||....+...  +.. 
T Consensus       170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~-  244 (291)
T cd06639         170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFK-  244 (291)
T ss_pred             eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHH-
Confidence            99999876543221  12234688999999998643     368899999999999999999999986543211  100 


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                                ......+..  ..+......+.+|+.+||+.+|++||++.++++|
T Consensus       245 ----------~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         245 ----------IPRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ----------HhcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                      000000011  1122345679999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=331.16  Aligned_cols=260  Identities=23%  Similarity=0.248  Sum_probs=214.3

Q ss_pred             HHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEE
Q 016481           65 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLI  142 (389)
Q Consensus        65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~  142 (389)
                      ..++.-.++|.+.++||+|+||.|.+++.+.+.+.      ||.|++.+-.  .......|..|..+|..-+.+-|+.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~V------YAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKV------YAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccc------hhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            34566678999999999999999999987766554      9999987622  122345688899999988899999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          143 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                      -.|.++.++|+|||||+||+|...+....  ++++..+.-++..|+.||.-||+.|  +|||||||+|||+|..|++||+
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLA  217 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLA  217 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeec
Confidence            99999999999999999999999887765  7999999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccc----c-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM----T-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  297 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  297 (389)
                      |||.+-.+... ........+|||.|.+||++.    + +.|+..+|+||+||++|||+.|..||-...      +.   
T Consensus       218 DFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lv---  287 (1317)
T KOG0612|consen  218 DFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LV---  287 (1317)
T ss_pred             cchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HH---
Confidence            99998776543 333456689999999999996    3 568999999999999999999999996421      11   


Q ss_pred             hHHHHhhhhhhhhcCCCCCCCCC--hHHHHHHHHHHHHhhccCCCCCCC---HHHHHHHh
Q 016481          298 LPLLKEKKKLLNIIDPRLEGDYP--VKGVHKAAMLAYHCLNHNPKARPL---MRDIVDSL  352 (389)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps---~~~il~~L  352 (389)
                             ....++++..-...+|  .+.+.++.+||.+.+. +|+.|..   +.++..|-
T Consensus       288 -------eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  288 -------ETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             -------HHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence                   1223334433333444  5678999999998887 8888888   99999884

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.7e-39  Score=289.12  Aligned_cols=252  Identities=25%  Similarity=0.335  Sum_probs=206.5

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|.+.+.||.|+||.||+|.+..+.      ..|++|.+..... ......+..|+++++.++|+|++++.+.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDG------KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCC------cEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            5788899999999999999875433      3499999876532 24456778899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          152 VLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ++|+||+++++|.+.+....  ...+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceee
Confidence            99999999999999887643  357899999999999999999999977  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .....  .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||........      ..           
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~-----------  213 (258)
T cd08215         153 LSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL------AL-----------  213 (258)
T ss_pred             cccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH------HH-----------
Confidence            54432  123345789999999999988899999999999999999999999976542110      00           


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..........+...+..+.+++.+||..+|++||++.+++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         214 KILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            001111222333566889999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.3e-39  Score=294.15  Aligned_cols=268  Identities=23%  Similarity=0.284  Sum_probs=200.2

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      +|++.+.||.|++|.||+|++..+..      .||+|.+...........+..|+.+++.++|+||+++++++...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGE------IVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCe------EEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEE
Confidence            58889999999999999998765443      399999876544444456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          153 LIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      +||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            99999975 8888775543 246899999999999999999999977  9999999999999999999999999987543


Q ss_pred             CCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh-HHHH-hH------HHH
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWA-LP------LLK  302 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~-~~------~~~  302 (389)
                      ....  ......++..|++||++.+. .++.++||||||+++|+|++|+.||........... .... .+      .+.
T Consensus       152 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         152 IPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             CCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            3211  12234578899999988664 578899999999999999999999986543221110 0000 00      000


Q ss_pred             hhhhhhhhcCCCC---CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          303 EKKKLLNIIDPRL---EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       303 ~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .............   ........+..+.+++.+||+.||.+||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000000000000   000112346778999999999999999999999865

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.8e-38  Score=296.42  Aligned_cols=257  Identities=27%  Similarity=0.380  Sum_probs=202.5

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .|...+.||+|+||.||+|.+..+..      .||+|.+....  .......+..|+.+++.++|+|++++++++..+..
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~------~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNE------VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT   99 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCc------EEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence            37778899999999999998655433      39999876432  22334578889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+. |+|.+.+... ..++++..+..++.+++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++...
T Consensus       100 ~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         100 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             EEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            999999997 4777766543 336889999999999999999999977  999999999999999999999999998754


Q ss_pred             CCCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ...      ....|++.|+|||.+.   ...++.++|||||||++|+|++|+.||.........                
T Consensus       176 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~----------------  233 (317)
T cd06635         176 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------------  233 (317)
T ss_pred             CCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH----------------
Confidence            321      2346888999999974   456889999999999999999999998764322110                


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE  361 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~  361 (389)
                      ..+.............+..+.+++.+||+.+|.+||++.++++++..+...+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         234 YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             HHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence            000011111111234567899999999999999999999999998776665444

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1e-38  Score=293.77  Aligned_cols=254  Identities=24%  Similarity=0.382  Sum_probs=204.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .+.|...+.||+|+||.||+|.+..+..      .|++|.+.....  ....+..|+.+++.++|+||+++++.+.....
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGK------EVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCc------EEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            4568888999999999999998764433      399999876533  45667889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++|+||+++++|.+++.... ..+++..+..++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            999999999999999987654 46899999999999999999999977  999999999999999999999999987755


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      .....  ......++..|++||++.+..++.++|+||||+++|+|++|+.||....+......       ..     ...
T Consensus       167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~-------~~-----~~~  232 (286)
T cd06614         167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL-------IT-----TKG  232 (286)
T ss_pred             ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HH-----hcC
Confidence            43221  12234578899999999888899999999999999999999999986543211100       00     000


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      . +  ....+..++..+.+++.+||+.+|.+||++.+++.+-
T Consensus       233 ~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         233 I-P--PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             C-C--CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence            0 0  0111223567899999999999999999999999763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-38  Score=293.58  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=199.6

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      +|...+.||+|++|.||+|....+..      .+++|.+.... ......+.+|+.+++.++|+||+++++++...+..+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~   92 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGR------QVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELW   92 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCC------EEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEE
Confidence            45556899999999999997654433      39999876432 233456788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      +|+||+.+++|.+++..   ..+++..+..++.|++.||+|||+++  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        93 ~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          93 VVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             EEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            99999999999998866   26888999999999999999999977  99999999999999999999999998775433


Q ss_pred             CCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      ...  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....+.....      .       ......
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~------~-------~~~~~~  232 (285)
T cd06648         168 EVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK------R-------IRDNLP  232 (285)
T ss_pred             CCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH------H-------HHhcCC
Confidence            211  1223568999999999998889999999999999999999999997654321110      0       000000


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +...  .+...+..+.+++.+||+.+|++||++.+++++
T Consensus       233 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         233 PKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            1111  122355789999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.2e-39  Score=297.27  Aligned_cols=268  Identities=22%  Similarity=0.268  Sum_probs=199.6

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCccceEEeEEEeC--
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  148 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  148 (389)
                      ++|++.+.||.|+||.||+|.+..+.+      .+++|.+...... .....+.+|+.++++++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGE------IVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCc------EEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            478889999999999999998765433      3899988654322 2233566899999999999999999998877  


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...|+||||+. ++|.+.+..... .+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++.
T Consensus        79 ~~~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          79 DKIYMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             CcEEEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCcee
Confidence            89999999997 488887765432 6899999999999999999999977  9999999999999999999999999988


Q ss_pred             CCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH-HHHh-HHHHhh-
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWAL-PLLKEK-  304 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~-~~~~~~-  304 (389)
                      .......  ......+++.|+|||.+.+. .++.++||||||+++|+|++|.+||............ .... +..... 
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         155 EYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             eccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            6644321  12234678899999998754 4689999999999999999999999865433211100 0000 000000 


Q ss_pred             --hhhh--------hhcCCCCCCCCChH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 --KKLL--------NIIDPRLEGDYPVK-GVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 --~~~~--------~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        ..+.        ......+...++.. .+..+.+++.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence              0000        00001111122222 46778999999999999999999999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.5e-38  Score=287.31  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=208.0

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeC--C
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--E  149 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~  149 (389)
                      +|...+.||+|++|.||+|....+..      .|++|....... ......+.+|+.++++++|+||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGE------LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCc------EEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            47788999999999999998765433      399998865532 24456788999999999999999999999988  8


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++|+||+++++|.+++....  .+++..+..++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            9999999999999999887654  7899999999999999999999977  99999999999999999999999999887


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ..............++..|+|||.+.+..++.++||||||+++|+|++|..||........               ....
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~  215 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---------------ALYK  215 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---------------HHHh
Confidence            6554321112345789999999999888899999999999999999999999987651110               0011


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..........+...+..+.+++.+||+.||++||++.+++.+
T Consensus       216 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            111122233444557899999999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-38  Score=286.55  Aligned_cols=251  Identities=28%  Similarity=0.419  Sum_probs=204.4

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      +|...+.||+|++|.||+|.+..+..      .+++|....... .....+.+|+.+++.++|+||+++++++......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   73 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGK------EVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELW   73 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCc------EEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            47888999999999999998765433      399999876543 34567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      +++||+++++|.+++.... ..+++..+..++.+++.+|.+||..+  ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        74 l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          74 IVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             EEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            9999999999999886653 47899999999999999999999977  99999999999999999999999999887654


Q ss_pred             CCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      ...   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........             ......
T Consensus       151 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~  214 (253)
T cd05122         151 TKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-------------IATNGP  214 (253)
T ss_pred             ccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-------------HHhcCC
Confidence            332   2345788999999999888899999999999999999999999986543211110             000000


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +..  ......+..+.+++.+||+.||++|||+.+++++
T Consensus       215 ~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         215 PGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            001  1111236789999999999999999999999976

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-38  Score=300.34  Aligned_cols=276  Identities=26%  Similarity=0.360  Sum_probs=201.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  147 (389)
                      +.++|++.+.||+|+||.||+|.+..+..      .+|+|.+.... .......+.+|+.+++++ +|+||+++++++..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~   78 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKE------VVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA   78 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCe------EEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence            45789999999999999999998654433      38999875432 223345567899999999 99999999998865


Q ss_pred             C--CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          148 D--EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       148 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      .  ..+++||||+. ++|..++...   .+.+..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          79 ENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             CCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeecc
Confidence            3  46899999997 5888877554   6788888899999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCc---cccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh---
Q 016481          226 LAKDGPEGDKS---HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL---  298 (389)
Q Consensus       226 ~a~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---  298 (389)
                      ++.........   .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||................   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            98866443221   12233568999999998765 467899999999999999999999997654432211100000   


Q ss_pred             ------HHH-HhhhhhhhhcCCCC---CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccC
Q 016481          299 ------PLL-KEKKKLLNIIDPRL---EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQV  357 (389)
Q Consensus       299 ------~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~  357 (389)
                            .+. .....+...+....   ........+.++.+++.+||+.||++|||+.+++++  +..+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                  000 00000000000000   000111246789999999999999999999999987  555433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.5e-38  Score=293.78  Aligned_cols=266  Identities=17%  Similarity=0.186  Sum_probs=187.8

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhH----------HHHHHHHHHHhccCCCcc
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH----------REWLAEVIFLGHLSHPNL  138 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~ni  138 (389)
                      +...+|.+.+.||+|+||.||+|.+..+..   ....+++|+..........          .....+...+..+.|+||
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~---~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHC---INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcc---cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            345789999999999999999998765421   1223677764433211110          112234445667789999


Q ss_pred             ceEEeEEEeCC----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc
Q 016481          139 VKLIGYCCEDE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  214 (389)
Q Consensus       139 v~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~  214 (389)
                      +.+++++....    ..+++++++. .++.+.+...  ...++..+..++.|++.||+|||+.+  |+||||||+|||++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~  160 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD  160 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc
Confidence            99999766543    3467788764 3565554332  24577888999999999999999977  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCc-----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchh
Q 016481          215 TDYNAKLSDFGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR  289 (389)
Q Consensus       215 ~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  289 (389)
                      .++.++|+|||+|+........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999999865432111     11123569999999999999999999999999999999999999998653221


Q ss_pred             hh-hhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          290 EQ-NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       290 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      .. ....  ....      .++......   ....+..+.+++..|++.+|++||++++|++.|+
T Consensus       241 ~~~~~~~--~~~~------~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        241 NLIHAAK--CDFI------KRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHhH--HHHH------HHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11 0000  0000      011111110   1123578999999999999999999999998763

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-39  Score=293.95  Aligned_cols=267  Identities=21%  Similarity=0.272  Sum_probs=199.6

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh-hHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      |++.+.||.|++|.||+|.+..+..      .||+|.+....... ....+..|+.+++.++|+|++++++++..+...+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGE------IVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCC------EEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            6678899999999999998765443      39999887543222 2346778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      ++|||++ ++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            9999995 68998886655456899999999999999999999977  99999999999999999999999999876533


Q ss_pred             CCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhh-hhHHHHh-------HHHHh
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ-NLADWAL-------PLLKE  303 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~-------~~~~~  303 (389)
                      ...  ......+++.|+|||++.+. .++.++||||||+++|+|++|++||......... ...+...       .....
T Consensus       152 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         152 PVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             Ccc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence            211  12224568899999988764 5789999999999999999999999865443211 0000000       00000


Q ss_pred             hhhhhhhcCC---CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 KKKLLNIIDP---RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 ~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .......+..   ..........+..+.+++.+||+.||++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000000   00011122345788999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-39  Score=302.70  Aligned_cols=276  Identities=22%  Similarity=0.317  Sum_probs=203.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  148 (389)
                      ..+|.+.+.||+|+||.||+|....+..      .||+|.+.... .......+..|+.+++.++|+||+++++++... 
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   77 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNE------KVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH   77 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCC------eEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence            4689999999999999999997655433      39999876532 222345667899999999999999999987643 


Q ss_pred             ----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          149 ----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       149 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                          ...|+|+||+. ++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          78 REAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             ccccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcC
Confidence                35899999995 6888877654  36899999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh-----
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL-----  298 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-----  298 (389)
                      |++.......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||................     
T Consensus       153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  230 (337)
T cd07858         153 GLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE  230 (337)
T ss_pred             ccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9998654322  12233567889999998865 468999999999999999999999997654322111100000     


Q ss_pred             ---HHHHh--hhhhhhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccCCC
Q 016481          299 ---PLLKE--KKKLLNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVLP  359 (389)
Q Consensus       299 ---~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~~~  359 (389)
                         ..+..  .......+.....   .......+.++.+++.+||+.||++|||+.++++|  |..+....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~  301 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS  301 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence               00000  0000000000000   01112456788999999999999999999999998  66554443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.6e-39  Score=289.25  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=204.7

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|++.+.||+|+||.||++..+.+..      .+++|.+.... .......+..|+.+++.++|+||+++++++......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQ------FYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCC------EEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            57888999999999999997665443      39999886543 233456677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          152 VLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ++|+||+++++|..++...  ....+++..+..++.+++.||+|||+.+  ++|+||+|+||+++.++.+||+|||++..
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhh
Confidence            9999999999999988652  2246788999999999999999999977  99999999999999999999999999887


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ....    ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||.........                 .
T Consensus       153 ~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-----------------~  211 (256)
T cd08530         153 LKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-----------------Y  211 (256)
T ss_pred             hccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------------H
Confidence            6543    122356889999999999999999999999999999999999999865432110                 0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..........+...+.++.+++.+||+.+|++||++.+++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         212 KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            011111122334567889999999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-38  Score=298.95  Aligned_cols=265  Identities=22%  Similarity=0.268  Sum_probs=195.4

Q ss_pred             ceecCC--CceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGG--GFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (389)
                      ..||+|  +||+||+|.+..+.+.      ||+|+..... .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTL------VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcE------EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence            356666  9999999976554443      9999987543 333446778899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      +||+.+|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++++||+.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            99999999999887765556899999999999999999999977  9999999999999999999999998654322111


Q ss_pred             C-ccc----cccccccccccCccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH--------
Q 016481          235 K-SHV----STRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--------  299 (389)
Q Consensus       235 ~-~~~----~~~~~gt~~y~aPE~l~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------  299 (389)
                      . ...    .....++..|+|||++.+.  .++.++|||||||++|+|++|..||.........  ......        
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~  233 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDI  233 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccc
Confidence            0 000    1112356679999999764  4789999999999999999999999865432211  000000        


Q ss_pred             -HHHhhhh----------------------hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          300 -LLKEKKK----------------------LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       300 -~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                       .......                      ........+.......++..+.+|+.+||+.||++|||+.+++++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence             0000000                      0000011112222345678899999999999999999999999774

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-41  Score=336.22  Aligned_cols=255  Identities=27%  Similarity=0.352  Sum_probs=205.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .-+|..+.+||.|.||.||.|...+++.-      .|+|-+..... ......+.+|..++..++|||+|+++|+-.+.+
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGel------lAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGEL------LAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccch------hhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH
Confidence            34677788999999999999987665543      67776554322 333455678999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..+|.||||++|+|.+.+....  -.++.....+..|++.|++|||++|  ||||||||+||+++.+|.+|++|||.|..
T Consensus      1308 kv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeE
Confidence            9999999999999999886543  3555666678889999999999988  99999999999999999999999999988


Q ss_pred             CCCCCC--ccccccccccccccCccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          230 GPEGDK--SHVSTRIMGTYGYAAPEYIMTG---HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       230 ~~~~~~--~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      ......  ........||+.|||||++.+.   +...++|||||||++.||+||+.||...+.....             
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI------------- 1450 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI------------- 1450 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH-------------
Confidence            755321  1123357899999999999754   4567899999999999999999999876543221             


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         ..-+...-.+++|...+.+-++|+.+||..||++|.++.||+++
T Consensus      1451 ---My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1451 ---MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ---HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence               11122233445677789999999999999999999999999987

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=296.54  Aligned_cols=272  Identities=22%  Similarity=0.290  Sum_probs=197.4

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC--
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  148 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  148 (389)
                      +|.+.+.||+|+||.||+|.....    ..+..||+|.+....  .......+.+|+.+++.++||||+++++++...  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~----~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG----KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD   76 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC----CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC
Confidence            478889999999999999987552    123449999987632  112234567899999999999999999999988  


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC----CCcEEE
Q 016481          149 EHRVLIYEFMARGSVENNLFSKV---LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT----DYNAKL  221 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~----~~~vkl  221 (389)
                      ..+++||||+++ +|.+.+....   ...++...+..++.|++.||+|||+.+  |+|+||||+||+++.    ++.+||
T Consensus        77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          77 KSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             ceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEE
Confidence            889999999975 6766654322   236889999999999999999999977  999999999999999    899999


Q ss_pred             eccCCCcCCCCCCC-ccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhh-------hh
Q 016481          222 SDFGLAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE-------QN  292 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~  292 (389)
                      +|||++........ ........+++.|+|||++.+. .++.++||||||+++|+|++|++||........       ..
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            99999886543322 1112235678999999988764 578999999999999999999999986544320       01


Q ss_pred             hHHHHhHH----------HHhhhhhhhhcCCCCCCCCC-----------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          293 LADWALPL----------LKEKKKLLNIIDPRLEGDYP-----------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       293 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +......+          ...........+......++           ...+.++.+++.+||+.||++|||+.++++|
T Consensus       234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            11000000          00000000000000001111           0345678999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.8e-40  Score=287.19  Aligned_cols=276  Identities=22%  Similarity=0.299  Sum_probs=202.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhH-HHHHHHHHHHhccCCCccceEEeEEEe-CC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCE-DE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~-~~  149 (389)
                      ..|+..+.||+|+||.||+|.-+.+...  ....+|||.+..+...... ...-+|+.+++.++|||++.+..++.. +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~k--r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDK--RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcc--cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            5799999999999999999964433221  1345999998876433222 345689999999999999999998877 88


Q ss_pred             eEEEEEEecCCCChhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC----CcEEEe
Q 016481          150 HRVLIYEFMARGSVENNLFSK---VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD----YNAKLS  222 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~----~~vkl~  222 (389)
                      .+++++||.+. +|...+.-+   ....++...+..|+.||+.|+.|||++-  |+||||||.|||+..+    |.|||+
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEee
Confidence            99999999986 888777433   2346889999999999999999999988  9999999999999877    999999


Q ss_pred             ccCCCcCCCCCCCcc-ccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhh-------hhh
Q 016481          223 DFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE-------QNL  293 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~  293 (389)
                      |||+++.+...-... .....+.|..|+|||++.|. .|+++.||||.|||+.||++-++.|.+....-.       ..+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999876543322 23346789999999999875 689999999999999999999998875432211       111


Q ss_pred             HHH----------HhHHHHhhhhhhhhcCC---CCCCCC--------ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          294 ADW----------ALPLLKEKKKLLNIIDP---RLEGDY--------PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       294 ~~~----------~~~~~~~~~~~~~~~~~---~~~~~~--------~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ...          .++-+++.++....+..   ......        ....++...+|+.++|++||-+|.|+.+.+++.
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            000          01111111111111110   000000        001234488999999999999999999999885

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-38  Score=293.98  Aligned_cols=269  Identities=20%  Similarity=0.263  Sum_probs=197.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|++|.||+|.+..+.+      .||+|.+..... ......+.+|+.+++.++|+||+++++++.....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNE------TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCc------EEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            478999999999999999998655433      399998765432 2233567789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-CCcEEEeccCCCcC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKD  229 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-~~~vkl~Dfg~a~~  229 (389)
                      .++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||+|+||+++. ++.+||+|||++..
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            999999996 58888776655445688888899999999999999977  999999999999985 56799999999876


Q ss_pred             CCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH-HHH-hH---HHHh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWA-LP---LLKE  303 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~~~-~~---~~~~  303 (389)
                      .....  .......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||....+....... ... .+   ....
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        153 FGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             cCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            43221  11223467889999998876 45789999999999999999999999865432211100 000 00   0000


Q ss_pred             hhhhhhhc--CCCCCC----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 KKKLLNII--DPRLEG----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 ~~~~~~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ...+....  .+....    ......+.++.+++.+||+.+|++||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000000  000000    0112345778999999999999999999999976

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-38  Score=294.86  Aligned_cols=271  Identities=24%  Similarity=0.267  Sum_probs=196.4

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .++|.+.+.||+|+||.||+|....+..      .||+|.+...... .....+.+|+.+++.++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQ------IVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCc------EEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            4579999999999999999998665443      4999987654322 22344567999999999999999999886644


Q ss_pred             --------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          150 --------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       150 --------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                              ..++||||+. ++|.+.+.... ..+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             ccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEE
Confidence                    4599999996 47877765443 36899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCc--cccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh
Q 016481          222 SDFGLAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  298 (389)
                      +|||++.........  .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||....+...........
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999998765432211  112234678899999988764 47889999999999999999999998765433222111110


Q ss_pred             HH-----HHhhhhhhhhcCCCCCCCC---------ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          299 PL-----LKEKKKLLNIIDPRLEGDY---------PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       299 ~~-----~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..     ..........-........         +...+..+.+|+.+||+.||++|||+.++++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            00     0000000000000000000         01124567899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=313.96  Aligned_cols=266  Identities=26%  Similarity=0.417  Sum_probs=230.0

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      ..+..++||+|+||+||+|.|....  ..-+.+||||++......+.-.+++.|..+|..++|||++++++++.... +.
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Peg--e~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEG--ENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCC--ceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            4566789999999999999998762  33467899999988877777889999999999999999999999998765 88


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      ||++||++|.|.++++.+. ..+-.+..+.|..||++||.|||.+.  +|||||..+|||+..-..+|+.|||+++....
T Consensus       774 lvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            9999999999999997754 36888889999999999999999876  99999999999999999999999999998877


Q ss_pred             CCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ...........-.+.|||-|.+....|+.++|||||||++||++| |..||.+...                 .++..++
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dll  913 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDLL  913 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHHH
Confidence            665555555566788999999999999999999999999999999 9999987642                 2344455


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCC
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE  361 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~  361 (389)
                      +...+...|..++.++.-++.+||..|+..||+|+++...+.++...|..
T Consensus       914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr  963 (1177)
T KOG1025|consen  914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR  963 (1177)
T ss_pred             hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence            55555667888999999999999999999999999999999877666544

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.3e-38  Score=294.65  Aligned_cols=270  Identities=25%  Similarity=0.276  Sum_probs=197.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh-hHHHHHHHHHHHhccCCCccceEEeEEEeC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-GHREWLAEVIFLGHLSHPNLVKLIGYCCED-  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  148 (389)
                      .++|.+.+.||+|+||.||+|.+..+..      .||+|.+....... ....+.+|+.++++++|+||+++++++... 
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGE------IVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH   79 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCc------EEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence            3579999999999999999998765443      39999886543222 223456799999999999999999998754 


Q ss_pred             -CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          149 -EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       149 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                       +..++||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++
T Consensus        80 ~~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          80 LDSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             CCeEEEEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcccee
Confidence             568999999964 7887775532 46899999999999999999999977  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH-------
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-------  299 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------  299 (389)
                      ........  ......+++.|+|||++.+ ..++.++||||||+++|+|++|++||....+............       
T Consensus       156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         156 RTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW  233 (309)
T ss_pred             eecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            87643321  1122345788999999875 5679999999999999999999999986654332111100000       


Q ss_pred             -HHHhhhhhhhhcCCCCCCC----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          300 -LLKEKKKLLNIIDPRLEGD----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       300 -~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                       .............+.....    .....+..+.+++.+||+.||++|||+.+++.|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence             0000000000000000000    0011367788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.4e-38  Score=294.03  Aligned_cols=267  Identities=22%  Similarity=0.248  Sum_probs=196.1

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccC-CCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||.||+|.+..+.+      .||+|........ .....+.+|+.+++.+. |+||+++++++....
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~------~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCc------EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            368899999999999999998765544      3999987654322 22356778999999995 699999999988766


Q ss_pred             e-----EEEEEEecCCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-CCcEE
Q 016481          150 H-----RVLIYEFMARGSVENNLFSKV---LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAK  220 (389)
Q Consensus       150 ~-----~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-~~~vk  220 (389)
                      .     .|+||||+++ +|.+++....   ...+++..+..++.|++.||.|||+.+  |+|+||+|+||+++. ++.+|
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEE
Confidence            5     8999999985 7888775432   236799999999999999999999977  999999999999998 88999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP  299 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  299 (389)
                      |+|||+++.......  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+....  ......
T Consensus       152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~  227 (295)
T cd07837         152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFKL  227 (295)
T ss_pred             EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHH
Confidence            999999876533211  1122356888999998865 45789999999999999999999999865433211  100000


Q ss_pred             HHHhhh-------hhhhhcC-CCCC----CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          300 LLKEKK-------KLLNIID-PRLE----GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       300 ~~~~~~-------~~~~~~~-~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ......       ....... +...    .......+.++.+|+.+||+.||.+||++.+++.|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000       0000000 0000    00112356789999999999999999999999876

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.4e-39  Score=300.55  Aligned_cols=271  Identities=21%  Similarity=0.308  Sum_probs=201.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEE---
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCC---  146 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~---  146 (389)
                      .++|.+.+.||.|+||.||+|..+.+..      .||+|.+..... ......+.+|+.+++.++||||+++++++.   
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~------~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   77 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGK------KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG   77 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCC------EEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence            4689999999999999999998665544      399998875432 233456778999999999999999999875   


Q ss_pred             -eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          147 -EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       147 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                       ....+++||||+. |+|.+++....  .+++..+..++.|++.||+|||.++  |+|+||||+||+++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          78 ADFKDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             CCCceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccc
Confidence             3457899999995 68888775443  5899999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCc--cccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH---
Q 016481          226 LAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP---  299 (389)
Q Consensus       226 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---  299 (389)
                      ++.........  .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~  232 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS  232 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence            98765332211  11223578999999999865 4689999999999999999999999976554322111110000   


Q ss_pred             --HHH--hhhhhh---hhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          300 --LLK--EKKKLL---NIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       300 --~~~--~~~~~~---~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                        ...  ......   +........   ......+.++.+++.+||+.||++||++.+++.+-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence              000  000000   000000000   01123468899999999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.3e-38  Score=288.45  Aligned_cols=244  Identities=24%  Similarity=0.331  Sum_probs=188.9

Q ss_pred             eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh--hhHHHHHHHH---HHHhccCCCccceEEeEEEeCCeEEE
Q 016481           79 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--QGHREWLAEV---IFLGHLSHPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~l  153 (389)
                      .||+|+||.||+|....+.+      .||+|.+......  .....+..|.   ..++...||||+.+++++...+..++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGK------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEecCCC------EEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence            48999999999997655433      3999988654321  1112233343   34445579999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  233 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~  233 (389)
                      ||||+.||+|..++...  ..+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++......
T Consensus        75 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          75 ILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            99999999999888654  36899999999999999999999977  999999999999999999999999998765332


Q ss_pred             CCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          234 DKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      .    .....|+..|+|||++.+. .++.++||||||+++|+|++|+.||............           ...    
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-----------~~~----  211 (278)
T cd05606         151 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------RMT----  211 (278)
T ss_pred             C----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-----------HHh----
Confidence            1    2235789999999998754 6899999999999999999999999865322111100           000    


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      .......+...+.++.+++.+||..+|.+||     ++.+++++
T Consensus       212 ~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         212 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            0111223334578899999999999999999     99999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-38  Score=285.31  Aligned_cols=244  Identities=24%  Similarity=0.290  Sum_probs=188.3

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHH-hccCCCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFL-GHLSHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.||.|+||.||+|....+.+      .||+|.+.....  ......+..|..++ ....|+||+++++++...+.+|+|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGD------YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCC------eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence            568999999999997655433      399999865421  12223334454443 455899999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      +||+++++|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.....  
T Consensus        76 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--  149 (260)
T cd05611          76 MEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--  149 (260)
T ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc--
Confidence            99999999999886543  6888999999999999999999977  99999999999999999999999999875432  


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                          .....++..|+|||.+.+..++.++||||||+++|+|++|..||........  ..    ... .       ....
T Consensus       150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~-~-------~~~~  211 (260)
T cd05611         150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--FD----NIL-S-------RRIN  211 (260)
T ss_pred             ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--HH----HHH-h-------cccC
Confidence                2234688899999999888899999999999999999999999976543211  00    000 0       0011


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCH---HHHHHH
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLM---RDIVDS  351 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~~il~~  351 (389)
                      ........++..+.+++.+||+.||++||++   .++++|
T Consensus       212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            1111222456889999999999999999966   566554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-38  Score=282.40  Aligned_cols=250  Identities=29%  Similarity=0.461  Sum_probs=204.8

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|.+.+.||+|++|.||+|......+      .|++|....... ......+.+|+.++++++|+|++++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGD------FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCc------EEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            57888999999999999997655443      399999876532 23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            9999999999999988665  37899999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      .....  .....++..|+|||.+.+..++.++||||||+++|+|++|..||........  ..           ...   
T Consensus       151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~-----------~~~---  212 (254)
T cd06627         151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LF-----------RIV---  212 (254)
T ss_pred             CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HH-----------HHh---
Confidence            43321  2335688999999999888889999999999999999999999976542111  00           000   


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       .......+...+..+.+++.+||+.+|++||++.+++.+
T Consensus       213 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         213 -QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             -ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence             011122334456889999999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=280.05  Aligned_cols=280  Identities=21%  Similarity=0.253  Sum_probs=210.3

Q ss_pred             CCCCcccCHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-
Q 016481           56 ANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-  134 (389)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-  134 (389)
                      ++.....++.++..+++     +.||+|+++.|--|+...+..+      ||||++.+. ......++.+|+.++.+.+ 
T Consensus        67 ~~ss~~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~E------YAVKiidKq-~gHsR~RvfREVe~f~~Cqg  134 (463)
T KOG0607|consen   67 ATSSLSGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKE------YAVKIIDKQ-PGHSRSRVFREVETFYQCQG  134 (463)
T ss_pred             ccccccchHHHHHHhHH-----HHhcCccceeeeeeeeeccchh------hhhhhhhcC-CchHHHHHHHHHHHHHHhcC
Confidence            33344445555544443     6799999999999876665554      999999877 4445667889999998885 


Q ss_pred             CCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc
Q 016481          135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  214 (389)
Q Consensus       135 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~  214 (389)
                      |+||+.++++|.++...|+|||-|.||+|..++..+.  .+++.++.++.++|+.||.+||..|  |.||||||+|||..
T Consensus       135 h~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~  210 (463)
T KOG0607|consen  135 HKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCE  210 (463)
T ss_pred             CccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeec
Confidence            9999999999999999999999999999999998775  7899999999999999999999966  99999999999996


Q ss_pred             CCC---cEEEeccCCCcCCCCC-----CCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCC
Q 016481          215 TDY---NAKLSDFGLAKDGPEG-----DKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKS  281 (389)
Q Consensus       215 ~~~---~vkl~Dfg~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~p  281 (389)
                      ...   -|||+||.+..-....     .......+.+|+..|||||++.     ...|+.+.|.||||||+|-||+|.+|
T Consensus       211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP  290 (463)
T KOG0607|consen  211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP  290 (463)
T ss_pred             CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence            554   3799999876433221     1222234578999999999863     34689999999999999999999999


Q ss_pred             CCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCC--CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          282 LDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE--GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       282 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      |.+....+--+-.--.= ...+..-+..+.+....  ..-...++.++.+++...|..|+.+|.++.++++|-
T Consensus       291 FvG~Cg~dCGWdrGe~C-r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP  362 (463)
T KOG0607|consen  291 FVGHCGADCGWDRGEVC-RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP  362 (463)
T ss_pred             ccCccCCcCCccCCCcc-HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence            99876533111000000 00001111222222221  111335689999999999999999999999999863

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.2e-38  Score=285.27  Aligned_cols=247  Identities=22%  Similarity=0.216  Sum_probs=191.8

Q ss_pred             HHhcCCccccee--cCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEE
Q 016481           69 IITANFRQDRVL--GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  145 (389)
Q Consensus        69 ~~~~~~~~~~~l--g~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  145 (389)
                      ...++|.+.+.+  |.|+||.||++..+.+..      .+|+|.........      .|+.....+ +|+||+++++.+
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQK------LFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCCCc------EEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEE
Confidence            344677777776  999999999997655443      38999876532111      122222222 699999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-cEEEecc
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDF  224 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-~vkl~Df  224 (389)
                      ...+..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++ .++|+||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecC
Confidence            99999999999999999999886654  7899999999999999999999977  99999999999999988 9999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      |++......      ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... .....+..      
T Consensus       155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~------  221 (267)
T PHA03390        155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLK------  221 (267)
T ss_pred             ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHH------
Confidence            998765321      12468899999999999899999999999999999999999998543221 11111110      


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-MRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~~il~~  351 (389)
                           ....  ....+...+..+.+++.+||+.||.+||+ ++++++|
T Consensus       222 -----~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        222 -----RQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -----hhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                 0110  11122356788999999999999999995 6999876

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.7e-38  Score=291.91  Aligned_cols=254  Identities=27%  Similarity=0.351  Sum_probs=199.5

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCC--CChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..|...+.||+|+||.||+|+...+..      .+++|.+...  ........+.+|+.+++.++|+|++++++++....
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   88 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCc------EEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence            346677889999999999998765433      3999987643  23334467788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+. |++.+.+.... ..+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        89 ~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          89 TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             eeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCccccee
Confidence            9999999996 57777665433 36788999999999999999999977  99999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ....      ....+++.|+|||.+.   ...++.++|||||||++|+|++|..||..........              
T Consensus       165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--------------  224 (308)
T cd06634         165 MAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------------  224 (308)
T ss_pred             ecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--------------
Confidence            4321      2346888999999975   3467889999999999999999999987543221100              


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                        ...............+..+.+|+.+||+.+|++||++.+++++..-...
T Consensus       225 --~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         225 --HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             --HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence              0000011111123456789999999999999999999999999766554

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.9e-38  Score=293.47  Aligned_cols=256  Identities=27%  Similarity=0.342  Sum_probs=196.3

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  148 (389)
                      ..++|++.+.||+|+||.||+|.++.+..      .||+|.+...........+..|+.++.... |+||+++++++...
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGH------VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCe------EEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            34678999999999999999998765433      399999876544444456667777666664 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ...++||||+. +++.+.+.... ..+++..+..++.|++.||+|||+ .+  |+|+||+|+||+++.++.+||+|||++
T Consensus        87 ~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          87 SDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             CeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccc
Confidence            99999999985 46666654432 378999999999999999999997 46  999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccccccccCccccccCC----CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH----LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      ........   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||....... ..+.         
T Consensus       163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~---------  229 (296)
T cd06618         163 GRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLT---------  229 (296)
T ss_pred             hhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHH---------
Confidence            76543221   12245788999999987654    7889999999999999999999997532211 0000         


Q ss_pred             hhhhhhhcCCCC-CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          304 KKKLLNIIDPRL-EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       304 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                           ..+.... .......++.++.+|+.+||+.||++||++.+++.+-.
T Consensus       230 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         230 -----KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             -----HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence                 0011000 00111134678999999999999999999999998854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=290.89  Aligned_cols=272  Identities=23%  Similarity=0.313  Sum_probs=210.0

Q ss_pred             HHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC--CC----c
Q 016481           64 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS--HP----N  137 (389)
Q Consensus        64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~----n  137 (389)
                      +.....+..+|.+...+|+|.||.|-.+.+...      ...||+|+++.-.  ......+-|+.+++++.  .|    -
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~------~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~r  152 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRET------KEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFR  152 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCC------CceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceE
Confidence            344456688999999999999999999976655      3349999987542  22344567999999994  22    2


Q ss_pred             cceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC--
Q 016481          138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT--  215 (389)
Q Consensus       138 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~--  215 (389)
                      +|.+.++|...++.|||+|.+ |-|+.+++...+-.+++...+..++.|+++++++||+.+  ++|.||||+|||+-.  
T Consensus       153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSE  229 (415)
T ss_pred             EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccc
Confidence            788888999999999999999 569999999988889999999999999999999999977  999999999999822  


Q ss_pred             ------------------CCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh
Q 016481          216 ------------------DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT  277 (389)
Q Consensus       216 ------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt  277 (389)
                                        +..|+|+|||.|+......     ...+.|..|.|||++++-+++..+||||+||||+||.+
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence                              2358999999998754322     34678999999999999999999999999999999999


Q ss_pred             CCCCCCCCCchhhhhhHHHHhHHHHh----hhhhhh--------------------hcCCCCCC----CCChHHHHHHHH
Q 016481          278 GRKSLDKSRPAREQNLADWALPLLKE----KKKLLN--------------------IIDPRLEG----DYPVKGVHKAAM  329 (389)
Q Consensus       278 g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~--------------------~~~~~~~~----~~~~~~~~~l~~  329 (389)
                      |...|...+..+...+...++..+..    .....+                    ..++..+.    ........++.+
T Consensus       305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD  384 (415)
T KOG0671|consen  305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD  384 (415)
T ss_pred             cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence            99999988765544343333211100    000000                    00000000    012245678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 016481          330 LAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       330 li~~cl~~dP~~Rps~~~il~~  351 (389)
                      |+++||.+||.+|+|+.|+|.|
T Consensus       385 Ll~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  385 LLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHHHccCccccccHHHHhcC
Confidence            9999999999999999999987

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.9e-38  Score=290.50  Aligned_cols=252  Identities=24%  Similarity=0.336  Sum_probs=204.5

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccC-CCccceEEeEEEeC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED  148 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  148 (389)
                      ++|.+.+.||+|+||.||+|....+..      .|++|+.....  .......+..|+.+++++. |+||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNK------EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCC------EEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            478899999999999999998765433      39999886532  2233456778999999998 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+++  ++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCcccc
Confidence            99999999999999999887654  6899999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCc------------------cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhh
Q 016481          229 DGPEGDKS------------------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE  290 (389)
Q Consensus       229 ~~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  290 (389)
                      ........                  .......++..|+|||++.+..++.++||||||++++++++|+.||........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            65432211                  112235678999999999888899999999999999999999999986642111


Q ss_pred             hhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 016481          291 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM----RDIVDS  351 (389)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~~il~~  351 (389)
                        +              .....  .....+...+..+.+|+.+||+.||++||++    .++++|
T Consensus       231 --~--------------~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         231 --F--------------QKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             --H--------------HHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence              0              00000  1112333446789999999999999999999    888876

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-38  Score=287.26  Aligned_cols=266  Identities=25%  Similarity=0.318  Sum_probs=198.8

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCCeEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  152 (389)
                      |.+.+.||+|+||.||+|......+      .|++|.+.............+|+..++.+. |+||+++++++..++..+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGE------LVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCc------EEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEE
Confidence            6678899999999999998765433      399998765533333334457899999999 999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      +||||+ +|+|.+.+.......+++..+..++.|++.+|.|||+++  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            999999 789998887665557899999999999999999999977  99999999999999999999999999876543


Q ss_pred             CCCccccccccccccccCccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh-HHHHhH----HHHhhhh
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALP----LLKEKKK  306 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~----~~~~~~~  306 (389)
                      ...   .....++..|+|||++. +..++.++|+||||+++|+|++|++||........... ..+...    ...+...
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         152 RPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            221   22346788999999875 44578999999999999999999999976644322110 000000    0000000


Q ss_pred             hhhhcCCCCC-------CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          307 LLNIIDPRLE-------GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       307 ~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +.........       .......+..+.+++.+||+.||++||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000       00011125779999999999999999999999876

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.2e-38  Score=286.35  Aligned_cols=246  Identities=26%  Similarity=0.328  Sum_probs=194.2

Q ss_pred             ecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           80 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        80 lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      ||.|+||.||+|.+..+.+      .+++|.+.....  ......+..|+.+++.++|+||+++++.+......|+|+||
T Consensus         1 lg~g~~~~vy~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGD------IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEECCCCC------EEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEec
Confidence            6899999999998665433      499999865432  23446678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCC--
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK--  235 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~--  235 (389)
                      +.+++|.+++....  .+++..+..++.|++.||+|||..+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          75 LPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            99999999887654  6899999999999999999999977  99999999999999999999999999876543211  


Q ss_pred             ----ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          236 ----SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       236 ----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                          ........++..|+|||.+.+..++.++||||||+++|+|++|..||....+....      .          ...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~----------~~~  214 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------Q----------NIL  214 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------H----------HHh
Confidence                11223356888999999998888999999999999999999999999765432110      0          000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH---HHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM---RDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~~il~~  351 (389)
                      ............+..+.+++.+||+.+|++|||+   .+++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         215 NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             cCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            0001111111136889999999999999999999   555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.1e-38  Score=289.01  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=196.9

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  156 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (389)
                      ...||+|+||.||+|....+..      .||+|.+... .......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~------~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGK------LVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCe------EEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence            4679999999999998765444      3999987543 23345668889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCc
Q 016481          157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  236 (389)
Q Consensus       157 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~  236 (389)
                      |+++++|.+++...   .+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        98 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--  170 (292)
T cd06657          98 FLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  170 (292)
T ss_pred             cCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccc--
Confidence            99999999876443   5788999999999999999999977  9999999999999999999999999987654322  


Q ss_pred             cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCC
Q 016481          237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  316 (389)
Q Consensus       237 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (389)
                      .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........             ........+.
T Consensus       171 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-------------~~~~~~~~~~  237 (292)
T cd06657         171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-------------IRDNLPPKLK  237 (292)
T ss_pred             ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhhCCcccC
Confidence            112335688999999999888899999999999999999999999986543211110             0001111111


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          317 GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        .....+..+.+++.+||+.||.+||++.+++.+
T Consensus       238 --~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         238 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             --CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence              112345678999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.9e-38  Score=293.06  Aligned_cols=267  Identities=20%  Similarity=0.224  Sum_probs=196.8

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCC-CChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      +.+++.+|.|+++.||++.  .      .+..||+|.+... ........+..|+.+++.++|+||+++++++...+..+
T Consensus         4 ~~i~~~~~~~~~v~~~~~~--~------~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   75 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHK--P------TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELY   75 (314)
T ss_pred             hhhhHhhcCCceEEEEEec--C------CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEE
Confidence            3445556666666666543  2      2334999998765 34455677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      ++|||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||.+.....
T Consensus        76 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~  153 (314)
T cd08216          76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIK  153 (314)
T ss_pred             EEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecc
Confidence            9999999999999987665556889999999999999999999977  99999999999999999999999998875532


Q ss_pred             CCCc-----cccccccccccccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH----H
Q 016481          233 GDKS-----HVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL----L  301 (389)
Q Consensus       233 ~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----~  301 (389)
                      ....     .......++..|+|||++.+  ..++.++|||||||++|+|++|+.||........  ........    +
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  231 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLL  231 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCcccc
Confidence            2111     11123457888999999876  4588999999999999999999999986543221  10000000    0


Q ss_pred             H------hhhhhhh----hcCC----CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          302 K------EKKKLLN----IIDP----RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       302 ~------~~~~~~~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .      .......    ...+    ..........+.++.+|+.+||+.||++|||+.+++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            0      0000000    0000    011112334567899999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.7e-38  Score=295.91  Aligned_cols=281  Identities=23%  Similarity=0.253  Sum_probs=202.4

Q ss_pred             hcCCcc-cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh-------------hHHHHHHHHHHHhccCCC
Q 016481           71 TANFRQ-DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-------------GHREWLAEVIFLGHLSHP  136 (389)
Q Consensus        71 ~~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~  136 (389)
                      .++|.. .+.||.|+||.||+|.+.....      .||+|.+.......             ....+.+|+.+++.++|+
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   80 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGK------IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHE   80 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCC------eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCc
Confidence            456754 5779999999999998654433      39999876542211             012467899999999999


Q ss_pred             ccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       137 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      ||+++++++......++||||+. |+|.+++....  .+++.....++.|++.||+|||+.+  ++|+||+|+||+++.+
T Consensus        81 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~  155 (335)
T PTZ00024         81 NIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK  155 (335)
T ss_pred             ceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCC
Confidence            99999999999999999999996 58888886543  6888999999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCC------------CccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCC
Q 016481          217 YNAKLSDFGLAKDGPEGD------------KSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLD  283 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~  283 (389)
                      +.++|+|||++.......            .........+++.|+|||.+.+. .++.++|||||||++|+|++|.+||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999999987654110            00111224568889999998764 46899999999999999999999998


Q ss_pred             CCCchhhhhhHHHHhHHHHhh-----h---hhhhh--cCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016481          284 KSRPAREQNLADWALPLLKEK-----K---KLLNI--IDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD  350 (389)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~-----~---~~~~~--~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~  350 (389)
                      ...+.....   .+.......     .   .....  ......   .......+.++.+++.+||+.||++||++.+++.
T Consensus       236 ~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        236 GENEIDQLG---RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCHHHHHH---HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            765432111   000000000     0   00000  000000   0011233677899999999999999999999998


Q ss_pred             HhccccCCCCCCCCC
Q 016481          351 SLEPLQVLPDEAPTP  365 (389)
Q Consensus       351 ~L~~~~~~~~~~~~p  365 (389)
                      +-+--.......+.|
T Consensus       313 ~~~~~~~~~~~~~~~  327 (335)
T PTZ00024        313 HEYFKSDPLPCDPSQ  327 (335)
T ss_pred             CcccCCCCCCCCccc
Confidence            855444433333333

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-38  Score=289.28  Aligned_cols=266  Identities=23%  Similarity=0.274  Sum_probs=201.0

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      |.+.+.||.|++|.||+|....+..      .+++|.+...... .....+..|+.+++.++|+||+++++++..+...+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGE------IVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCc------EEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            5677899999999999998654433      3999987755322 33456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      +|+||+.+ +|.+.+.... ..+++..+..++.|++.||.|||.++  |+|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            99999975 8888776643 47899999999999999999999977  99999999999999999999999999877654


Q ss_pred             CCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH--hHHHHhhhhhhh
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA--LPLLKEKKKLLN  309 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~  309 (389)
                      ..  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...............  .+..........
T Consensus       151 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         151 PV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             Cc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence            32  112234678899999998876 7899999999999999999999999876543221111000  000000000000


Q ss_pred             --------hcCCC--CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          310 --------IIDPR--LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       310 --------~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                              .....  .........+.++.+++.+||+.||.+||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                    00000  0001123457889999999999999999999999976

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=290.93  Aligned_cols=247  Identities=26%  Similarity=0.339  Sum_probs=203.1

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccC-CCccceEEeE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLS-HPNLVKLIGY  144 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~  144 (389)
                      .+-..+|....+||+|+||.|.+|.-+.+..      .+|||+++++..  ..+...-+.|-++|.... -|.+++++.+
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdE------LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDE------LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcch------hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence            4456789999999999999999986444433      399999887642  222334456777877664 7889999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      |+.-+.+|+||||+.||+|..++..-.  .+.+..+.-.+..|+-||-+||+.|  |++||||.+|||++.+|++||+||
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DF  494 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADF  494 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeec
Confidence            999999999999999999999887665  5677778889999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      |+++.--..+  ....+.||||.|+|||++...+|+.++|+||+||+|||||.|++||++.++.+.              
T Consensus       495 GmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el--------------  558 (683)
T KOG0696|consen  495 GMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--------------  558 (683)
T ss_pred             ccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH--------------
Confidence            9998644333  235568999999999999999999999999999999999999999998764421              


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL  344 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps  344 (389)
                        ...+.+..  -.+|...+.++.++++..|.+.|.+|..
T Consensus       559 --F~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  559 --FQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --HHHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence              22222222  2457778899999999999999999964

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-38  Score=297.01  Aligned_cols=278  Identities=25%  Similarity=0.332  Sum_probs=207.4

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCC--
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE--  149 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--  149 (389)
                      +|++.+.||.|+||.||+|.......      .|++|.+..... ......+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGR------KVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCc------EEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            58889999999999999998654433      399998875432 334467888999999999999999999988765  


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          150 ---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       150 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                         .+|+||||+. ++|.+.+....  .+++..+..++.+++.||+|||+++  |+|+||||.||+++.++.++|+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          75 DFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             cccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCc
Confidence               8899999997 57888776543  7899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCc-cccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH----
Q 016481          227 AKDGPEGDKS-HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL----  300 (389)
Q Consensus       227 a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----  300 (389)
                      +......... .......++..|+|||++.+. .++.++||||||+++|+|++|.+||..................    
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            8876543210 112335678899999999887 8899999999999999999999999876543211110000000    


Q ss_pred             -H--HhhhhhhhhcC---CCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccCCCCC
Q 016481          301 -L--KEKKKLLNIID---PRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVLPDE  361 (389)
Q Consensus       301 -~--~~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~~~~~  361 (389)
                       .  .........+.   ....   .......+..+.+++.+||+.||++||++.+++.+  |+.++..+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence             0  00000000000   0000   00112246788999999999999999999999987  6666665433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=289.53  Aligned_cols=284  Identities=27%  Similarity=0.424  Sum_probs=213.8

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhc--cCCCccceEEeEEEeCC-
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH--LSHPNLVKLIGYCCEDE-  149 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~-  149 (389)
                      ...+.+.||+|+||.||+|.+..        ..||||++..    +....|..|.+|++.  ++|+||++++++-.... 
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~--------~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDN--------RLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             chhhHHHhhcCccceeehhhccC--------ceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            45567889999999999997654        3399999864    456677788888775  47999999999876554 


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceecCCCCCCeEEcCCCcE
Q 016481          150 ---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-------EKPVIYRDFKTSNILLDTDYNA  219 (389)
Q Consensus       150 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------~~~ivH~Dlkp~Nili~~~~~v  219 (389)
                         .++||++|.+.|+|.+++..+   .++|....+++..+++||+|||..       .++|+|||||..|||+..+++.
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence               889999999999999999877   689999999999999999999983       3579999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccccccccCccccccCC-CC-----cccchhHHHHHHHHHHhCCCCCC-CCCchhhhh
Q 016481          220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-LT-----PRSDVYSFGVVLLEILTGRKSLD-KSRPAREQN  292 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-----~~~DiwslG~il~elltg~~pf~-~~~~~~~~~  292 (389)
                      .|+|||+|..+..+.........+||.+|||||+|.+.- +.     .+.||||+|.++|||++.-.-+. +..+.....
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp  435 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP  435 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence            999999999887665544455589999999999997642 22     36899999999999998443332 211111111


Q ss_pred             hH---------HHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCC
Q 016481          293 LA---------DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAP  363 (389)
Q Consensus       293 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~  363 (389)
                      +.         +-.+.++........+ ...+...   .....+.+.+..||..||+-|.|+.-+-+++..+..+... +
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~-p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~-~  510 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKI-PDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED-S  510 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCC-hhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc-c
Confidence            11         1111111111111111 1111111   3357788999999999999999999999999998888666 6


Q ss_pred             CCCCcccccCCCC
Q 016481          364 TPKNFVTVVTPEE  376 (389)
Q Consensus       364 ~p~~~~~~~~~~~  376 (389)
                      .++.....+|+..
T Consensus       511 ~~~s~~~~~~~~~  523 (534)
T KOG3653|consen  511 SGESSSSLVTPVD  523 (534)
T ss_pred             CCccccccCCCCc
Confidence            6777766666665

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-38  Score=288.00  Aligned_cols=267  Identities=24%  Similarity=0.287  Sum_probs=198.4

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC--Ce
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--EH  150 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~  150 (389)
                      |.+.+.||.|+||.||+|.+..+..      .+|+|.+.... .......+.+|+.+++.++|+|++++++++...  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~------~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGE------LVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCe------EEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            6678899999999999998765433      39999987653 223345677899999999999999999999888  89


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++|+||+++ +|..++.... ..+++..+..++.|++.||+|||..+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          75 IYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             EEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            9999999974 8888776543 36899999999999999999999977  999999999999999999999999998876


Q ss_pred             CCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH-HHHhHH-HHhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWALPL-LKEKKKL  307 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~-~~~~~~~  307 (389)
                      ...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ ...... .......
T Consensus       151 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         151 TKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             cCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence            543211 1223457888999998765 45789999999999999999999999865532211110 000000 0000000


Q ss_pred             hh-----hcCC------CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          308 LN-----IIDP------RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       308 ~~-----~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..     ....      .+...+...++..+.+++.+||+.+|++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00     0000      00000111136788999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2e-37  Score=288.83  Aligned_cols=246  Identities=28%  Similarity=0.383  Sum_probs=194.2

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      |...+.||+|+||.||+|+...+..      .|++|.+....  .......+..|+.+++.++|+|++++++++.+....
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~------~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNE------VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCc------EEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            6667889999999999997654433      49999876432  223345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |+||||+. |++.+.+.... .++++..+..++.|++.+|.|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        97 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             EEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            99999996 57777665433 36889999999999999999999977  9999999999999999999999999986432


Q ss_pred             CCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .      .....|+..|+|||++.   ...++.++||||||+++|+|++|..||..........      .       ..
T Consensus       173 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~-------~~  233 (313)
T cd06633         173 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------H-------IA  233 (313)
T ss_pred             C------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------H-------HH
Confidence            2      22356889999999984   4568889999999999999999999997654321110      0       00


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..   ..........+..+.+|+.+||+.+|++||++.+++.+
T Consensus       234 ~~---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         234 QN---DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             hc---CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   00111122345678999999999999999999999977

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=316.43  Aligned_cols=272  Identities=28%  Similarity=0.421  Sum_probs=223.1

Q ss_pred             HHHHHhcCCcccceecCCCceEEEEeeecccccc-CcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEe
Q 016481           66 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIG  143 (389)
Q Consensus        66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~  143 (389)
                      .|++..++..+.+.||+|+||.|++|..+.-... ......||||.........+...+..|+.+|+.+. |+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            4566666777888999999999999976544332 12356799999998777777889999999999995 999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCC
Q 016481          144 YCCEDEHRVLIYEFMARGSVENNLFSKV------------L--LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS  209 (389)
Q Consensus       144 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~  209 (389)
                      ++...+.+++|+||+..|+|.+++....            .  ..++......++.||+.||+||++..  +|||||..+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaR  447 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAAR  447 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhh
Confidence            9999999999999999999999997654            0  13788899999999999999999965  999999999


Q ss_pred             CeEEcCCCcEEEeccCCCcCCCCCCCccccccc-cccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCc
Q 016481          210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI-MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRP  287 (389)
Q Consensus       210 Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  287 (389)
                      |||+..+..+||+|||+|+.....+........ .-...|||||.+....|+.++|||||||++||+++ |..||.+...
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999999999999999999976554433322111 13556999999999999999999999999999999 8899987332


Q ss_pred             hhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          288 AREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ..                ++.+.+....+...|..++.++.++++.||+.+|++||+|.++.+.|+.+
T Consensus       528 ~~----------------~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 TE----------------ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            21                11223334444455777889999999999999999999999999999884

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-38  Score=295.39  Aligned_cols=274  Identities=22%  Similarity=0.285  Sum_probs=201.3

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      ..+.++|.+.+.||+|+||.||+|....+..      .||+|...... .......+..|+.+++.++|+||+++++++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGA------KVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT   84 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCc------EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence            3457789999999999999999997655443      39999886432 2233456778999999999999999999887


Q ss_pred             eCC------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          147 EDE------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       147 ~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      .+.      ..++||||+ +++|..++..   ..+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          85 PDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             CCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEE
Confidence            543      458999999 6788877754   26889999999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhh-hhHH---
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ-NLAD---  295 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~---  295 (389)
                      |+|||++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... ....   
T Consensus       159 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~  233 (343)
T cd07880         159 ILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG  233 (343)
T ss_pred             EeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999998865332     123467889999999876 45889999999999999999999999865432110 0000   


Q ss_pred             -----HHhHHHHh-hhhhhhhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccCC
Q 016481          296 -----WALPLLKE-KKKLLNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  358 (389)
Q Consensus       296 -----~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~~  358 (389)
                           +....... .......+......   ......+..+.+++.+||+.||++|||+.+++.+  ++.....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence                 00000000 00000000000000   0112345678999999999999999999999966  5555444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-39  Score=306.11  Aligned_cols=202  Identities=34%  Similarity=0.473  Sum_probs=174.1

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC-----
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-----  148 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  148 (389)
                      |...+.||+|+||.||+|+++.+++.      ||||.++............+|+.+|++++|+|||+++++-...     
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~------vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRL------VAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccc------hhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            45567899999999999987776655      9999998866666667788999999999999999999875443     


Q ss_pred             -CeEEEEEEecCCCChhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC--CC--cEEEe
Q 016481          149 -EHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT--DY--NAKLS  222 (389)
Q Consensus       149 -~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~--~~--~vkl~  222 (389)
                       ....+|||||.||||+..+.+ .+...+++.+.+.++.+++.||.|||.++  ||||||||.||++-.  +|  ..||+
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeee
Confidence             366899999999999999865 34467999999999999999999999988  999999999999832  23  57999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCC
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSR  286 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~  286 (389)
                      |||.|+..+++.   ...+..||..|++||+... ..|+..+|.|||||++|++.||..||....
T Consensus       167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            999999887654   5677899999999999984 889999999999999999999999996543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.2e-38  Score=318.76  Aligned_cols=256  Identities=29%  Similarity=0.391  Sum_probs=193.2

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      ...++|+..+.||+||||.||+++.+-+++.      ||||.+...........+.+|+..+.+|+|||||+++..|.+.
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~------YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs  549 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGRE------YAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVES  549 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchh------hhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence            4567899999999999999999988777665      9999998776666678889999999999999999997533100


Q ss_pred             --------------------------------------------------------------------------------
Q 016481          149 --------------------------------------------------------------------------------  148 (389)
Q Consensus       149 --------------------------------------------------------------------------------  148 (389)
                                                                                                      
T Consensus       550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~  629 (1351)
T KOG1035|consen  550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN  629 (1351)
T ss_pred             CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHH
Q 016481          149 ---------------------------------------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK  189 (389)
Q Consensus       149 ---------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~  189 (389)
                                                             ..+||-||||+..++.+.+.+.... -....+++++++|++
T Consensus       630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILE  708 (1351)
T ss_pred             cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHH
Confidence                                                   1247788888876666655444321 145677899999999


Q ss_pred             HHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC------C----------CCCccccccccccccccCccc
Q 016481          190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP------E----------GDKSHVSTRIMGTYGYAAPEY  253 (389)
Q Consensus       190 ~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~------~----------~~~~~~~~~~~gt~~y~aPE~  253 (389)
                      ||+|+|+.|  ||||||||.||+++.++.|||+|||+|....      .          +......+..+||.-|+|||+
T Consensus       709 GLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  709 GLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            999999977  9999999999999999999999999998721      0          111113345789999999999


Q ss_pred             cccCC---CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCC--CCCChHHHHHHH
Q 016481          254 IMTGH---LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE--GDYPVKGVHKAA  328 (389)
Q Consensus       254 l~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~  328 (389)
                      +.+..   |+.|+|+||||||++||+.   ||+..-  +..             ..+.++-+..++  ..+..+....-+
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa-------------~iL~~LR~g~iP~~~~f~~~~~~~e~  848 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERA-------------SILTNLRKGSIPEPADFFDPEHPEEA  848 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHH-------------HHHHhcccCCCCCCcccccccchHHH
Confidence            97654   9999999999999999997   465321  000             111111122222  222334455668


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 016481          329 MLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       329 ~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .+|.+||+.||.+|||+.++|+.
T Consensus       849 slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  849 SLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHHHhcCCCccCCCHHHHhhc
Confidence            89999999999999999999965

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.7e-38  Score=290.43  Aligned_cols=271  Identities=25%  Similarity=0.285  Sum_probs=198.7

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ...++|.+.+.||+|+||.||+|.++.+..      .||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~   77 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGE------LVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTD   77 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCc------EEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence            345789999999999999999998765443      399998865432 2233456689999999999999999998876


Q ss_pred             CC----------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          148 DE----------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       148 ~~----------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      ..          .+++|+||+++ ++...+... ...+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~  153 (302)
T cd07864          78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKG  153 (302)
T ss_pred             cchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCC
Confidence            54          88999999976 677666544 346899999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       218 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      .+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||..............
T Consensus       154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~  232 (302)
T cd07864         154 QIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR  232 (302)
T ss_pred             cEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            999999999886644321 11122356788999998865 4578999999999999999999999986543221111100


Q ss_pred             Hh--HHHHhhhhhhhh-----cC------CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          297 AL--PLLKEKKKLLNI-----ID------PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       297 ~~--~~~~~~~~~~~~-----~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..  +.......+...     .+      .... ......+..+.+++.+||+.||++||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00  000000000000     00      0000 0011246789999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.2e-38  Score=283.91  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=195.7

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecC----CCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG----DNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +|.+.+.||+|+||.||++.+......      +++|+...    .........+..|+.+++.++||||+++++++.+.
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAE------ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCc------ceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence            588899999999999999976544222      44444432    11222334566789999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          149 EHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      ...++|+||+++++|.+.+..  .....+++..+..++.|++.||.|||+.+  ++|+||+|+||+++. +.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCc
Confidence            999999999999999988754  23346899999999999999999999977  999999999999975 5699999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      +........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......      ...        
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~--------  215 (260)
T cd08222         152 SRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVL--------  215 (260)
T ss_pred             eeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHH--------
Confidence            876543221  2233568889999999988889999999999999999999999997543211      000        


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        .... ......+...+.++.+++.+||+.||++||++.+++++
T Consensus       216 --~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         216 --RIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             --HHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence              0001 11112344567889999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=285.63  Aligned_cols=264  Identities=23%  Similarity=0.290  Sum_probs=195.8

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh-hHHHHHHHHHHHhcc---CCCccceEEeEEEeCC
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-GHREWLAEVIFLGHL---SHPNLVKLIGYCCEDE  149 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~  149 (389)
                      |++.+.||+|+||.||+|.++.+..      .||+|.+....... ....+..|+.+++++   .|+||+++++++....
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGR------FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCC------EEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            6678899999999999998765333      39999987543222 223455677776655   5999999999998877


Q ss_pred             e-----EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          150 H-----RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       150 ~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      .     ++++|||+.+ +|.+++.......+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             CCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEecc
Confidence            6     9999999974 7888876654446899999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      |++........   .....++..|+|||++.+..++.++|||||||++|+|++|.+||........  +...........
T Consensus       152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~  226 (287)
T cd07838         152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPS  226 (287)
T ss_pred             CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCC
Confidence            99877643321   1224578899999999998999999999999999999999999986543221  111110000000


Q ss_pred             -hh---h----hhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 -KK---L----LNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 -~~---~----~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       ..   .    .........   .......+..+.+++.+||+.||++||++.+++.|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence             00   0    000000000   11112346778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.4e-38  Score=296.32  Aligned_cols=268  Identities=23%  Similarity=0.311  Sum_probs=194.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  148 (389)
                      ..+|.+.+.||.|+||.||+|....+..      .||+|.+..... .....+.+|+.+++.++||||+++++++...  
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~------~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDK------RVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCc------EEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            4689999999999999999997665443      399998765533 3446677899999999999999999876543  


Q ss_pred             ------------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc-C
Q 016481          149 ------------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-T  215 (389)
Q Consensus       149 ------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~-~  215 (389)
                                  ...++||||++ ++|.+++...   .+++..+..++.|++.||.|||+.+  |+||||||+||+++ .
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~  150 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTE  150 (342)
T ss_pred             ccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCC
Confidence                        35799999997 5888777532   5889999999999999999999977  99999999999997 4


Q ss_pred             CCcEEEeccCCCcCCCCCCCc-cccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 016481          216 DYNAKLSDFGLAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL  293 (389)
Q Consensus       216 ~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  293 (389)
                      ++.++|+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+......
T Consensus       151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~  230 (342)
T cd07854         151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL  230 (342)
T ss_pred             CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            567899999998765322111 11122457889999998754 5678899999999999999999999987654332111


Q ss_pred             HHHHhHH--HHhhhhhhhh----cC-CCCCCC-----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          294 ADWALPL--LKEKKKLLNI----ID-PRLEGD-----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       294 ~~~~~~~--~~~~~~~~~~----~~-~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .....+.  ..........    .. ......     .....+.++.+|+.+||+.||++|||+.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            1000000  0000000000    00 000000     011345788999999999999999999999977

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.5e-37  Score=291.54  Aligned_cols=271  Identities=24%  Similarity=0.307  Sum_probs=201.2

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+.++|++.+.||.|+||.||+|....+.+.      ||+|.+.... .......+..|+.+++.++||||+++.+++..
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   80 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQN------VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS   80 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCE------EEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence            3567899999999999999999976655443      9999876432 22334567789999999999999999998865


Q ss_pred             -CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          148 -DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       148 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                       ....++|+||+ +++|...+...   +++...+..++.|++.||+|||+.+  |+|+||+|.||+++.++.++|+|||+
T Consensus        81 ~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          81 PLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             CCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCcccc
Confidence             56789999999 56888776533   5778888899999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH-H--------H
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-D--------W  296 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~--------~  296 (389)
                      +......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ +        +
T Consensus       155 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  229 (328)
T cd07856         155 ARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV  229 (328)
T ss_pred             ccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            8754321     123467889999998766 57899999999999999999999999866542211110 0        0


Q ss_pred             HhHHHHh-hhhhhhhcCCCCCCCCC-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccCC
Q 016481          297 ALPLLKE-KKKLLNIIDPRLEGDYP-----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  358 (389)
Q Consensus       297 ~~~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~~  358 (389)
                      ....... ...+...+.  .....+     ...+..+.+++.+||+.+|++||++.+++.+  ++..+..
T Consensus       230 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         230 INTICSENTLRFVQSLP--KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HHhccchhhHHHHhhcc--ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence            0000000 000000000  011111     1245789999999999999999999999988  4444433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-37  Score=293.27  Aligned_cols=271  Identities=21%  Similarity=0.314  Sum_probs=199.1

Q ss_pred             HHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEe
Q 016481           65 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIG  143 (389)
Q Consensus        65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~  143 (389)
                      ..+..+.++|.+.+.||+|+||.||+|....+.      ..||+|.+.... .......+.+|+.+++.++|+||+++++
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~   83 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTG------LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD   83 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCC------eEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence            344566789999999999999999999765443      349999887542 2223456778999999999999999999


Q ss_pred             EEEeC------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          144 YCCED------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       144 ~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      ++...      ...+++++++ +++|.+.+...   .+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~  157 (345)
T cd07877          84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             eeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCC
Confidence            87643      3468888887 77888776543   5889999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh-HH
Q 016481          218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-AD  295 (389)
Q Consensus       218 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~  295 (389)
                      .+||+|||++......     .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||........... ..
T Consensus       158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999998764321     223467889999998866 5688999999999999999999999976543221110 00


Q ss_pred             H-------HhHHHHh--hhhhhhhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          296 W-------ALPLLKE--KKKLLNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       296 ~-------~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .       ....+..  .......+......   ......+.++.+|+.+||+.||++||++.+++.+=
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence            0       0000000  00000001100000   00112356789999999999999999999999884

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=279.46  Aligned_cols=254  Identities=25%  Similarity=0.347  Sum_probs=205.7

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEe
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIG  143 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~  143 (389)
                      +.+-..+|.+.++||+|+|+.|.+++++.+.+.      ||+|+++++.  ......=...|-.+..+- +||.+|.++.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qi------yamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs  318 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQI------YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS  318 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehccccee------eehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence            445567899999999999999999987766554      9999877653  222222334566666555 6999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          144 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       144 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      +|..+..+++|.||++||+|.-++.+..  .++++.+.-....|+.||.|||+.|  |++||||.+|+|+|..|++||+|
T Consensus       319 cfqtesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  319 CFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             hhcccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecc
Confidence            9999999999999999999987776554  6889998899999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCC-CchhhhhhHHHHhHHHH
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS-RPAREQNLADWALPLLK  302 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~~~~~~~~~~  302 (389)
                      +|+++..-.  ......++||||.|.|||++.+..|...+|+|+||++++||+.|+.||+.- ....+.+..++..+++.
T Consensus       395 ygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil  472 (593)
T KOG0695|consen  395 YGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL  472 (593)
T ss_pred             cchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh
Confidence            999986432  223466799999999999999999999999999999999999999999743 23334555666655554


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP  343 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  343 (389)
                      +...           ..|...+..+..+++..|++||.+|.
T Consensus       473 ekqi-----------riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  473 EKQI-----------RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hhcc-----------cccceeehhhHHHHHHhhcCCcHHhc
Confidence            4322           23445567788999999999999995

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.9e-37  Score=291.40  Aligned_cols=270  Identities=23%  Similarity=0.267  Sum_probs=194.2

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhcc-CCCccceEEeEEEe---
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE---  147 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---  147 (389)
                      +|.+.+.||+|+||.||+|......    .+..||+|.+..... ......+.+|+.+++++ +|+||+++++.+..   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS----EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC----cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            4788899999999999999865441    123499998765322 22345677899999999 59999999987543   


Q ss_pred             -CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          148 -DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       148 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                       ....+++++|+. ++|.+.+...  ..+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.+||+|||+
T Consensus        77 ~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          77 NFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence             246788999985 6888887544  36889999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCc--cccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH---------
Q 016481          227 AKDGPEGDKS--HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA---------  294 (389)
Q Consensus       227 a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---------  294 (389)
                      +.........  .......|++.|+|||++.+ ..++.++||||||+++|+|++|++||............         
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9865432211  11223578999999998765 56899999999999999999999999865432111000         


Q ss_pred             HHHhHHHHhh-hhhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          295 DWALPLLKEK-KKLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       295 ~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .+........ ..............   .....+..+.+|+.+||+.||++|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000000 00000000000000   111235789999999999999999999999977

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-37  Score=287.08  Aligned_cols=260  Identities=25%  Similarity=0.294  Sum_probs=199.1

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC---hhhHHHHHHHHHHHhcc-CCCccceEEeEEEeC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS---YQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  148 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  148 (389)
                      +|.+.+.||+|+||.||+|.......   .+..||+|.+.....   ......+..|+.++.++ +|+||+++++.+..+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHD---AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecccc---CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence            47888999999999999987543221   234599998864321   22335677899999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...++||||+.+|+|.+++....  .+++..+..++.|++.+|.|||+.+  ++|+||+|.||+++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999999999886543  6888999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ....... .......|+..|+|||.+.+..  ++.++||||||+++|+|++|..||........  .......       
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~-------  223 (288)
T cd05583         154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRR-------  223 (288)
T ss_pred             ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHH-------
Confidence            6543321 1122356899999999987655  78899999999999999999999964322110  0011000       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                      .   ..  .....+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       224 ~---~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         224 I---LK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             H---Hc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0   00  0112233456788999999999999999998777655543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.9e-37  Score=285.75  Aligned_cols=257  Identities=26%  Similarity=0.318  Sum_probs=198.2

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC---ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  148 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  148 (389)
                      +|++.+.||.|+||.||+|.......   .+..||+|++....   .......+..|+.+++.+ +|+||+.+++++..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~---~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHD---SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCC---CCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence            47888999999999999997543211   23459999986532   122335567899999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||+|+|||++.++.+||+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999999887653  6788999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ....... .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.......  ........       
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~-------  223 (290)
T cd05613         154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRR-------  223 (290)
T ss_pred             ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHH-------
Confidence            6543221 112235689999999998753  46789999999999999999999997432211  01111000       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                         ...  .....+...+..+.+++.+||+.||++||     ++.+++++
T Consensus       224 ---~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         224 ---ILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ---hhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence               000  01123344567889999999999999997     78888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=301.44  Aligned_cols=244  Identities=25%  Similarity=0.250  Sum_probs=200.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  149 (389)
                      ...|.+...+|.|+|+.|-.+.+..+...      .++|++......     ..+|+.++... .|+||+++++.+.++.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~------~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQE------PAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccc------hhheeccccccc-----cccccchhhhhcCCCcceeecceecCCc
Confidence            45788888899999999999977665554      899998766211     12466555544 6999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE-cCCCcEEEeccCCCc
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-DTDYNAKLSDFGLAK  228 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili-~~~~~vkl~Dfg~a~  228 (389)
                      +.|+|||++.|+-+.+.+....   .....+..|+.+|+.++.|||++|  +|||||||+|||+ +..++++|+|||.+.
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhh
Confidence            9999999999999998887654   223777889999999999999977  9999999999999 689999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .....     ..+.+-|..|.|||++...+|++++||||||++||+||+|+.||......                   .
T Consensus       465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~  520 (612)
T KOG0603|consen  465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------I  520 (612)
T ss_pred             hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------------H
Confidence            76543     33467899999999999999999999999999999999999999865432                   1


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                      ++......+.+....+..+++|+.+||+.||.+||++.+++.|=+.
T Consensus       521 ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  521 EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            1111112333346678999999999999999999999999988665

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-37  Score=293.84  Aligned_cols=272  Identities=21%  Similarity=0.305  Sum_probs=198.5

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+..+|.+.+.||+|+||.||+|++..+..      .||+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~   85 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGE------KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTS   85 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCc------EEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecc
Confidence            345789999999999999999998654433      39999876532 22233567789999999999999999998865


Q ss_pred             C------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          148 D------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       148 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                      .      ...++|+||+.. +|....    ...+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||
T Consensus        86 ~~~~~~~~~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL  158 (342)
T cd07879          86 AVSGDEFQDFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKI  158 (342)
T ss_pred             cccCCCCceEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEE
Confidence            4      356999999964 666543    225788999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH-
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-  299 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-  299 (389)
                      +|||+++.....     .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||................+ 
T Consensus       159 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  233 (342)
T cd07879         159 LDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  233 (342)
T ss_pred             eeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999998764322     123467889999999876 4688999999999999999999999986543221111000000 


Q ss_pred             ---HHHh---hhhhhhhcC--CC-CCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccCC
Q 016481          300 ---LLKE---KKKLLNIID--PR-LEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  358 (389)
Q Consensus       300 ---~~~~---~~~~~~~~~--~~-~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~~  358 (389)
                         ...+   .........  +. .....   ....+..+.+|+.+||+.||++||++.+++.|  ++..+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence               0000   000000000  00 00000   01245678999999999999999999999977  7776654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-39  Score=295.06  Aligned_cols=246  Identities=26%  Similarity=0.326  Sum_probs=206.9

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (389)
                      .+.||.|.||+||-|++..++++      ||||++.+.+ .......+..|+.||+.+.||.||.+.-.|...+.++.||
T Consensus       569 devLGSGQFG~VYgg~hRktGrd------VAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRD------VAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HhhccCCcceeeecceecccCce------eeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            48899999999999988777766      9999987654 3334466778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC---CcEEEeccCCCcCCCC
Q 016481          156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAKLSDFGLAKDGPE  232 (389)
Q Consensus       156 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~---~~vkl~Dfg~a~~~~~  232 (389)
                      |-+ .|+..+++......++++....-++.||+.||.|||-.+  |+|+||||+|||+...   .++||||||+|+....
T Consensus       643 EKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  643 EKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            999 468888887777779999999999999999999999977  9999999999999654   4799999999998765


Q ss_pred             CCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      ..   ...+.+|||.|+|||++..++|...-|+||.|||+|--|+|.-||+...+..+                  ++.+
T Consensus       720 ks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd------------------QIQN  778 (888)
T KOG4236|consen  720 KS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND------------------QIQN  778 (888)
T ss_pred             hh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH------------------Hhhc
Confidence            32   34568999999999999999999999999999999999999999986432211                  1111


Q ss_pred             CC--CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          313 PR--LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       313 ~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ..  .+.....+++..+.+||...|+..-.+|-|+...+.|-
T Consensus       779 AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  779 AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence            11  12233456788999999999999999999999988774

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.6e-37  Score=328.99  Aligned_cols=263  Identities=31%  Similarity=0.500  Sum_probs=203.2

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +...|...+.||+|+||.||+|.+..+..      .||+|.+.......     ..|+.++++++|||||++++++.+..
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~-----~~~~~~l~~l~HpnIv~~~~~~~~~~  756 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIKNGM------QFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEK  756 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECCCCc------EEEEEEccCCcccc-----HHHHHHHhhCCCCCcceEEEEEEcCC
Confidence            34567888899999999999998654443      39999886542211     24688899999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..++||||+++|+|.+++.     .+++..+..++.|++.||+|||.. .++|+||||||+||+++.++..++. ||...
T Consensus       757 ~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        757 GAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             CCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            9999999999999999884     378899999999999999999944 2459999999999999998888775 66544


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ....      .....+|+.|+|||++.+..|+.++|||||||++|||++|+.||+..... ......|...... .....
T Consensus       831 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~  902 (968)
T PLN00113        831 LLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYS-DCHLD  902 (968)
T ss_pred             cccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcC-ccchh
Confidence            3221      11236789999999999999999999999999999999999999643221 2233444332211 12233


Q ss_pred             hhcCCCCCCC--CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          309 NIIDPRLEGD--YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       309 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      ..+++.+...  .+.....++.+++.+||+.||++||++.++++.|+.+..
T Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            3444444322  334556778899999999999999999999999987744

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-38  Score=295.41  Aligned_cols=265  Identities=23%  Similarity=0.328  Sum_probs=198.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|.+.+.||+|+||.||+|++..+...      ||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRK------VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA   86 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcE------EEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence            467899999999999999999987654433      9999876542 223345677899999999999999999887665


Q ss_pred             Ce------EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          149 EH------RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       149 ~~------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                      +.      .++|+||+ +++|.+++..   ..+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          87 SSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             ccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEc
Confidence            54      89999999 6689887764   36899999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh-HH-----
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-AD-----  295 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~-----  295 (389)
                      |||++......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... ..     
T Consensus       161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~  235 (343)
T cd07851         161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP  235 (343)
T ss_pred             ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence            99998865432     223467889999999865 3678999999999999999999999976543321110 00     


Q ss_pred             ---HHhHHHHh-hhhhhhhcCCCCCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          296 ---WALPLLKE-KKKLLNIIDPRLEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       296 ---~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         +....... .......+.......+   ....+.++.+++.+||+.||++|||+.+|+.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence               00000000 0000000000000010   11236789999999999999999999999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-37  Score=289.37  Aligned_cols=271  Identities=25%  Similarity=0.267  Sum_probs=195.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  148 (389)
                      .++|.+.+.||.|+||.||+|.++.+...      +|+|.+..... ......+.+|+.+++.++|+||+++++++... 
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~------~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRV------VALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcE------EEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            46899999999999999999987655443      89998764432 22234556899999999999999999987543 


Q ss_pred             -------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          149 -------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       149 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                             ..+++|+||+.+ +|...+... ...+++..+..++.|+++||+|||+.+  |+|+||||+||+++.++.++|
T Consensus        81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             ccccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEE
Confidence                   346999999964 677666543 336899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCcc---------ccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhh
Q 016481          222 SDFGLAKDGPEGDKSH---------VSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ  291 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  291 (389)
                      +|||++..........         ......+++.|+|||.+.+. .++.++||||||+++|+|++|++||.........
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999987654322111         11224578889999987654 5789999999999999999999999865543221


Q ss_pred             hhHHHHhH-----HHHhhhhhhhhcCCCCCCCCC-------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          292 NLADWALP-----LLKEKKKLLNIIDPRLEGDYP-------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       292 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ........     .......+............+       ......+.+++.+||+.||++|||+.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            11100000     000000000000000000000       1223678899999999999999999999876

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-37  Score=283.48  Aligned_cols=266  Identities=25%  Similarity=0.312  Sum_probs=199.3

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      |+..+.||+|+||.||+|....+..      .|++|.+.... .......+..|+.+++.++|+||+++++++......+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGE------IVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCc------EEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            5667889999999999998765443      39999987653 2233456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      +|+||++ ++|.+++.... ..+++..+..++.+++.||+|||.++  |+|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            9999997 58999887653 36899999999999999999999977  99999999999999999999999999876543


Q ss_pred             CCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh-HHHHh----HHHHhhhh
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWAL----PLLKEKKK  306 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~----~~~~~~~~  306 (389)
                      ...  ......++..|+|||.+.+. .++.++||||||+++|+|++|.+||........... .....    ........
T Consensus       151 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         151 PLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             Ccc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            221  12234567889999998776 789999999999999999999999976543221100 00000    00000000


Q ss_pred             hh--hhcCCCCCC----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          307 LL--NIIDPRLEG----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       307 ~~--~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +.  ...-+....    ......+..+.+++.+||+.||++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            00  000000000    0011236789999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=297.06  Aligned_cols=254  Identities=24%  Similarity=0.317  Sum_probs=211.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      ..++.+...||-|+||.|-++..+....      .+|+|++++..  .......+..|..+|...+.|.||++|-.|.+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~------~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~  492 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKA------TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS  492 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccch------HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence            3456667789999999999987655433      37888776543  344456678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      .++|++||-|-||.|...+.++.  .++.....-++..+++|++|||+++  ||+|||||+|++++.+|-+||.|||+|+
T Consensus       493 kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHH
Confidence            99999999999999999887765  6788888888999999999999977  9999999999999999999999999999


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ....+...   -++||||.|.|||++...+.+.++|.||||+++||||+|.+||++.++..--++   +          .
T Consensus       569 ki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~---I----------L  632 (732)
T KOG0614|consen  569 KIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL---I----------L  632 (732)
T ss_pred             HhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH---H----------H
Confidence            88765543   358999999999999999999999999999999999999999999876532211   1          1


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHhc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDSLE  353 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~L~  353 (389)
                      ..++   .-.+|..++..+.+|+++..+.+|.+|..     +.+|.+|-+
T Consensus       633 kGid---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  633 KGID---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             hhhh---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence            1111   22345667788999999999999999986     788888853

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=275.20  Aligned_cols=257  Identities=28%  Similarity=0.317  Sum_probs=199.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhc-cCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH-LSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~  150 (389)
                      ++.+-...||.|+||+|++-.++...+.      .|||.++......+.++++.|.....+ -++||||+++|....++.
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~------mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd  137 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKL------MAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD  137 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcE------EEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence            3455567899999999999766655444      999999988777777888888887554 469999999999999999


Q ss_pred             EEEEEEecCCCChhhh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          151 RVLIYEFMARGSVENN---LFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .||-||+|+- ||..+   +..-....+++..+..|....+.||.||... ..|||||+||+|||++..|.+||||||++
T Consensus       138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIc  215 (361)
T KOG1006|consen  138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGIC  215 (361)
T ss_pred             eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccch
Confidence            9999999963 55433   3344455799999999999999999999864 33999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccccccccCccccc--cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      -.+.+   +...+...|-..|||||.+.  +.+|+.++||||||++|||+.||+.||.+.+...+            +-.
T Consensus       216 GqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe------------ql~  280 (361)
T KOG1006|consen  216 GQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE------------QLC  280 (361)
T ss_pred             HhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH------------HHH
Confidence            76543   22344467888999999986  44699999999999999999999999987643211            111


Q ss_pred             hhhhhcCCCCCCCCC-hHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          306 KLLNIIDPRLEGDYP-VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .+...-.+.+..+.. ...+..+..++..||.+|..+||.+.+++++
T Consensus       281 ~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  281 QVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            111111122222221 3467889999999999999999999999865

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-37  Score=275.02  Aligned_cols=242  Identities=28%  Similarity=0.325  Sum_probs=195.9

Q ss_pred             ecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEe
Q 016481           80 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF  157 (389)
Q Consensus        80 lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (389)
                      ||+|+||.||+|....+.      ..+++|.+.....  ......+..|+.+++.++|+||+++++.+..+...++||||
T Consensus         1 lg~G~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTG------KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECCCC------cEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEec
Confidence            699999999999765433      3499998765432  22445778899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc
Q 016481          158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH  237 (389)
Q Consensus       158 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~  237 (389)
                      +.+++|.+++....  .+++..+..++.|++.||.|||..+  ++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        75 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~  148 (250)
T cd05123          75 APGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--S  148 (250)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCC--C
Confidence            99999999886654  6889999999999999999999977  9999999999999999999999999987654322  1


Q ss_pred             ccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCC
Q 016481          238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  317 (389)
Q Consensus       238 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (389)
                      ......++..|++||.+.+..++.++|+||||+++|+|++|..||.......   ..             .....  ...
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~-------------~~~~~--~~~  210 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IY-------------EKILK--DPL  210 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH-------------HHHhc--CCC
Confidence            2334568889999999988888999999999999999999999997654311   00             00011  111


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCCCH---HHHHHH
Q 016481          318 DYPVKGVHKAAMLAYHCLNHNPKARPLM---RDIVDS  351 (389)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dP~~Rps~---~~il~~  351 (389)
                      ..+...+..+.+++.+||..||++||++   .+++++
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            2333446888999999999999999999   677655

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-37  Score=278.45  Aligned_cols=279  Identities=26%  Similarity=0.380  Sum_probs=208.5

Q ss_pred             CCCCcccCHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHh--cc
Q 016481           56 ANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG--HL  133 (389)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~--~l  133 (389)
                      +++......-..+.+..+.++.+.||+|.||.||+|.|.+..        ||||++...    +...+.+|.+|++  .|
T Consensus       195 SGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~--------VAVKiF~sr----dE~SWfrEtEIYqTvmL  262 (513)
T KOG2052|consen  195 SGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGED--------VAVKIFSSR----DERSWFRETEIYQTVML  262 (513)
T ss_pred             CCCCCCchhHhHHhhhheeEEEEEecCccccceeeccccCCc--------eEEEEeccc----chhhhhhHHHHHHHHHh
Confidence            333344455566788889999999999999999999987653        999999754    3345566777776  46


Q ss_pred             CCCccceEEeEEEeC----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----C-CCcee
Q 016481          134 SHPNLVKLIGYCCED----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-----E-KPVIY  203 (389)
Q Consensus       134 ~h~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~-~~ivH  203 (389)
                      +|+||+.+++.-..+    ..++||++|.+.|||+|+|.+.   .++.....+++..++.||++||..     | +.|.|
T Consensus       263 RHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH  339 (513)
T KOG2052|consen  263 RHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH  339 (513)
T ss_pred             ccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence            999999999876543    3789999999999999999874   788899999999999999999974     2 56999


Q ss_pred             cCCCCCCeEEcCCCcEEEeccCCCcCCCCC-CCccc-cccccccccccCccccccC----CC-C-cccchhHHHHHHHHH
Q 016481          204 RDFKTSNILLDTDYNAKLSDFGLAKDGPEG-DKSHV-STRIMGTYGYAAPEYIMTG----HL-T-PRSDVYSFGVVLLEI  275 (389)
Q Consensus       204 ~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~-~~~~~-~~~~~gt~~y~aPE~l~~~----~~-~-~~~DiwslG~il~el  275 (389)
                      ||||..|||+..++...|+|+|+|...... +.... ....+||.+|||||+|...    .+ + ..+||||||+++||+
T Consensus       340 RDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi  419 (513)
T KOG2052|consen  340 RDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI  419 (513)
T ss_pred             cccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence            999999999999999999999999876543 22222 2347899999999998642    12 2 368999999999998


Q ss_pred             Hh----------CCCCCCCCCchhhhhhHHHHhHHHHhhhh--hhhhcCCCCC-CCCChHHHHHHHHHHHHhhccCCCCC
Q 016481          276 LT----------GRKSLDKSRPAREQNLADWALPLLKEKKK--LLNIIDPRLE-GDYPVKGVHKAAMLAYHCLNHNPKAR  342 (389)
Q Consensus       276 lt----------g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~R  342 (389)
                      ..          =++||-..-+.+..         +.+..+  ..+.+.|..+ ..........+..+++.||..+|.-|
T Consensus       420 arRc~~ggi~eey~~Pyyd~Vp~DPs---------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aR  490 (513)
T KOG2052|consen  420 ARRCESGGIVEEYQLPYYDVVPSDPS---------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAAR  490 (513)
T ss_pred             HHHhhcCCEehhhcCCcccCCCCCCC---------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhh
Confidence            76          13455443332211         111111  1111112221 11234667888999999999999999


Q ss_pred             CCHHHHHHHhccccCC
Q 016481          343 PLMRDIVDSLEPLQVL  358 (389)
Q Consensus       343 ps~~~il~~L~~~~~~  358 (389)
                      .|+--|.+.|.++...
T Consensus       491 ltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  491 LTALRIKKTLAKLSNS  506 (513)
T ss_pred             hHHHHHHHHHHHHhcC
Confidence            9999999999888653

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.2e-36  Score=309.09  Aligned_cols=147  Identities=27%  Similarity=0.329  Sum_probs=129.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|.+.+.||+|+||.||+|.+..+.+      .||+|++....  .......+..|+.+++.++|+||+++++++....
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~------~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSK------LYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCc------EEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            579999999999999999998765443      39999987532  2233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ++|+||||+.|++|.+++....  .+++..+..++.||+.||.|||..+  |+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999999886543  5788889999999999999999977  9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=283.13  Aligned_cols=265  Identities=24%  Similarity=0.378  Sum_probs=206.7

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhh------HHHHHHHHHHHhccCCCccce
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG------HREWLAEVIFLGHLSHPNLVK  140 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~  140 (389)
                      -..+..+|.++.+||+|+|+.||+|.+....+      .||+|+........+      .+...+|.+|.+.|.||.||+
T Consensus       458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqR------YvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK  531 (775)
T KOG1151|consen  458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQR------YVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK  531 (775)
T ss_pred             CcchHHHHHHHHHhccccHHHHHHhcccchhh------eeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence            34566789999999999999999997655444      499999765543332      344568999999999999999


Q ss_pred             EEeEEEe-CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc---CC
Q 016481          141 LIGYCCE-DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD---TD  216 (389)
Q Consensus       141 ~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~---~~  216 (389)
                      +|++|.- .+..|-|+|||+|.+|.-++..+.  .+++.++..|+.||+.||.||.....+|||-||||.|||+-   ..
T Consensus       532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gtac  609 (775)
T KOG1151|consen  532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTAC  609 (775)
T ss_pred             eeeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccc
Confidence            9999975 457788999999999988886654  68899999999999999999999999999999999999994   34


Q ss_pred             CcEEEeccCCCcCCCCCCCc-----cccccccccccccCcccccc----CCCCcccchhHHHHHHHHHHhCCCCCCCCCc
Q 016481          217 YNAKLSDFGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRP  287 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~  287 (389)
                      |.+||+|||+++.+.+....     .......||..|++||.+.-    ...+.++||||+|||+|..+.|+.||..+..
T Consensus       610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            78999999999987654322     22344789999999998753    2467899999999999999999999986532


Q ss_pred             hhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          288 AREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .. .         +.+...+.+-.+  ...+.....+.++.+||++||++.-++|.++.++..+
T Consensus       690 QQ-d---------ILqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  690 QQ-D---------ILQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             HH-H---------HHhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            21 1         111111211111  1112223567889999999999999999999988754

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=250.05  Aligned_cols=267  Identities=23%  Similarity=0.287  Sum_probs=202.7

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhh-HHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +|...++||+|.||+||+|+..++...      ||+|.++.+..... -...++|+-+++.++|.|||+++++...+..+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~ei------valkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEI------VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccce------EEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            466678999999999999976665444      99999886654333 36678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      -+|+|||.. +|..+..+. ...++...+..++.|++.||.++|+++  +.||||||.|.||+.+|.+|++|||+++.+.
T Consensus        77 tlvfe~cdq-dlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   77 TLVFEFCDQ-DLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             EEeHHHhhH-HHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            999999964 677665444 457899999999999999999999988  9999999999999999999999999998754


Q ss_pred             CCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHH--hhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLK--EKKKL  307 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~  307 (389)
                      -.  .........|..|.+|.++.|. -|+...|+||.|||+.|+.. |++.|.+.+-.++....-|.+....  ..+.+
T Consensus       153 ip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  153 IP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             Cc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence            32  2223345789999999999876 58999999999999999987 7777887764443322222221111  11112


Q ss_pred             hhhcCCCCCCCCC---------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          308 LNIIDPRLEGDYP---------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       308 ~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .+.-+-....-++         ......=++++.+.|.-+|..|.++...+++
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1111111111111         1223445789999999999999999999876

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.4e-36  Score=271.96  Aligned_cols=226  Identities=22%  Similarity=0.240  Sum_probs=179.8

Q ss_pred             CCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEecCCCC
Q 016481           83 GGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGS  162 (389)
Q Consensus        83 G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  162 (389)
                      |.||.||++++..+.+.      ||+|.+....      .+..|...+....||||+++++++......++||||++||+
T Consensus         4 g~~~~v~~~~~~~~~~~------~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVMDTRTQQT------FILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEEEccCCcE------EEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCC
Confidence            89999999987665544      9999987542      12234444555679999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccc
Q 016481          163 VENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI  242 (389)
Q Consensus       163 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~  242 (389)
                      |.+++....  .+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++++|||.+......     ....
T Consensus        72 L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~  142 (237)
T cd05576          72 LWSHISKFL--NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGE  142 (237)
T ss_pred             HHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccC
Confidence            999886653  5889999999999999999999977  999999999999999999999999987654332     1224


Q ss_pred             cccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChH
Q 016481          243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVK  322 (389)
Q Consensus       243 ~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (389)
                      .++..|+|||.+.+..++.++||||+|+++|+|++|..|+......                      .........+..
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------------------~~~~~~~~~~~~  200 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------------------INTHTTLNIPEW  200 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------------------cccccccCCccc
Confidence            5677899999998888999999999999999999999887542110                      000001122334


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 016481          323 GVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  351 (389)
Q Consensus       323 ~~~~l~~li~~cl~~dP~~Rps~-----~~il~~  351 (389)
                      .+..+.+++.+||+.||++||++     .++++|
T Consensus       201 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         201 VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             CCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence            56789999999999999999986     666654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-39  Score=270.37  Aligned_cols=274  Identities=23%  Similarity=0.303  Sum_probs=203.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEe--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  147 (389)
                      .+.|....+||+|.||.||+|+.+.+.+.      ||+|+..-++. ...-...++|+++|..++|+|++.+++.|..  
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kk------valkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~   89 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKK------VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccch------hHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence            45677788999999999999976655444      88776543322 2222456789999999999999999887642  


Q ss_pred             ------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          148 ------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       148 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                            ...+|+||.+|+. +|...+... ...++..++.+++.++..||.|+|.+.  |+|||+|++|+||+.+|.+||
T Consensus        90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilkl  165 (376)
T KOG0669|consen   90 TPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKL  165 (376)
T ss_pred             CCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEe
Confidence                  3458999999975 777766544 347899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCc--cccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH-
Q 016481          222 SDFGLAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA-  297 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-  297 (389)
                      +|||+++.+...+..  ...+..+.|..|++||.+.|. .|++..|||..|||+.||+++.+.+.++.......+..-. 
T Consensus       166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc  245 (376)
T KOG0669|consen  166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC  245 (376)
T ss_pred             eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence            999999876543322  223446779999999999875 6899999999999999999999999988766554443211 


Q ss_pred             -------hHHHHhhhhhhhhc-CCCCCCC--------CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          298 -------LPLLKEKKKLLNII-DPRLEGD--------YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       298 -------~~~~~~~~~~~~~~-~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                             ++...+.+-...+- +|-..+.        -+...++++.+|+.++|..||.+|++++++++|-.-
T Consensus       246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F  318 (376)
T KOG0669|consen  246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF  318 (376)
T ss_pred             ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence                   11111111011110 0000000        022235688999999999999999999999988543

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=295.41  Aligned_cols=258  Identities=28%  Similarity=0.347  Sum_probs=209.5

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYC  145 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~  145 (389)
                      +...++-|++.+.||.|.+|.||+++...+...      .|+|+.......+  .++..|..+++.+. |||++.++++|
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~------aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQL------AAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCce------eeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEE
Confidence            334456799999999999999999976655443      8888887654333  34557888998875 99999999988


Q ss_pred             Ee-----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          146 CE-----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       146 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      ..     ++.+|||||||.|||..+++..-.+..+.|..+..|++.++.||.+||.+.  ++|||||-.|||++.++.||
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEE
Confidence            63     679999999999999999998777778999999999999999999999976  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccC-----CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-----HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  295 (389)
                      |+|||.+..+...-  ....+..|||.|||||++...     .|+.++|+||||++..||--|.+|+-.+.+....    
T Consensus       164 LvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL----  237 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL----  237 (953)
T ss_pred             Eeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh----
Confidence            99999987654321  223447899999999999753     4778999999999999999999999877654221    


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                                 +...-+|.....-+...+.++.+||..||.+|-++||+..++|+|
T Consensus       238 -----------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  238 -----------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             -----------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                       111111222222356789999999999999999999999999876

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=271.35  Aligned_cols=272  Identities=24%  Similarity=0.312  Sum_probs=228.6

Q ss_pred             HHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEe
Q 016481           64 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG  143 (389)
Q Consensus        64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~  143 (389)
                      ..++.+-..+++..-.+-+|.||.||+|.|.+.. .......|.+|.++...+..+...++.|.-.+..+.|||+..+.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEd-t~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREED-TYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccC-CcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            3445566677888889999999999999887543 333445688899888888888889999999999999999999999


Q ss_pred             EEEe-CCeEEEEEEecCCCChhhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          144 YCCE-DEHRVLIYEFMARGSVENNLFS------KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       144 ~~~~-~~~~~lv~e~~~~gsL~~~l~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      ++.+ ....+.++.++.-|+|..++..      ...+.++..+...++.|++.|++|||.++  |||.||..+|++|++.
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhh
Confidence            8765 4577888999999999999862      23345677788899999999999999988  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHH
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~  295 (389)
                      .+|||+|=.+++.+-.++......+...+..||+||.+....|+.++|+||||+++|||+| |+.||-.-+|.+...+  
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y--  510 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY--  510 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH--
Confidence            9999999999998887777666666778899999999999999999999999999999999 9999987776543222  


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                                     +....+...|.+|++++..++..||..+|++||+++++..-|..+
T Consensus       511 ---------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  511 ---------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ---------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                           223333445778999999999999999999999999999877544

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-36  Score=282.38  Aligned_cols=252  Identities=23%  Similarity=0.270  Sum_probs=191.7

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      |..++.||-|+||.|-+++-.++      ...||.|.+++...  .........|..||..-..+-||++|-.|.+.+.+
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT------~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDT------RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             eEEEeeecccccceeEEEeecch------hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            55567899999999999865544      23489998876531  22334566799999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |+||+|++||++..+|.+..  -|++..+...+..+..|+++.|..|  .|||||||+|||||.+|++||+|||++.-+.
T Consensus       705 YFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccce
Confidence            99999999999999887765  6788888888899999999999977  9999999999999999999999999976332


Q ss_pred             ---------CCCCcc-------------------------------ccccccccccccCccccccCCCCcccchhHHHHH
Q 016481          232 ---------EGDKSH-------------------------------VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVV  271 (389)
Q Consensus       232 ---------~~~~~~-------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~i  271 (389)
                               .++...                               .....+||+.|+|||++...+|+..+|+||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence                     111000                               0012569999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCchhhhhh-HHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC---CHHH
Q 016481          272 LLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP---LMRD  347 (389)
Q Consensus       272 l~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~~  347 (389)
                      ||||+.|++||-...+...+.. ..|               ...+...+..+.+.++.++|.++.. ++++|.   .+.+
T Consensus       861 l~em~~g~~pf~~~tp~~tq~kv~nw---------------~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~  924 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQYKVINW---------------RNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQ  924 (1034)
T ss_pred             HHHHhhCCCCccCCCCCcceeeeeeh---------------hhccccccccccCHHHHHHHHHHhc-Chhhhhcccchhh
Confidence            9999999999987665432211 111               1112222334556777777765443 566666   3444


Q ss_pred             HHHH
Q 016481          348 IVDS  351 (389)
Q Consensus       348 il~~  351 (389)
                      |..|
T Consensus       925 vKaH  928 (1034)
T KOG0608|consen  925 VKAH  928 (1034)
T ss_pred             hhcC
Confidence            6554

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.7e-35  Score=290.81  Aligned_cols=268  Identities=19%  Similarity=0.223  Sum_probs=170.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeE-----
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGY-----  144 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-----  144 (389)
                      ..++|.+.+.||+|+||.||+|++..+..  ..+..||+|.+......   .....+  .++...+.++..+...     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~--~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS--KKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc--ccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            34689999999999999999998766511  22344999987643211   111111  1122222222222221     


Q ss_pred             -EEeCCeEEEEEEecCCCChhhhhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecC
Q 016481          145 -CCEDEHRVLIYEFMARGSVENNLFSKVLL------------------PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD  205 (389)
Q Consensus       145 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~D  205 (389)
                       ...+...++|+||+.+++|.+++......                  ......+..++.|++.||+|||+++  |+|||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRD  280 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRD  280 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCc
Confidence             24566889999999999999888654210                  0112345678999999999999977  99999


Q ss_pred             CCCCCeEEcC-CCcEEEeccCCCcCCCCCCCccccccccccccccCccccccC----------------------CCCcc
Q 016481          206 FKTSNILLDT-DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG----------------------HLTPR  262 (389)
Q Consensus       206 lkp~Nili~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~~~  262 (389)
                      |||+|||++. ++.+||+|||+|+....... .......+++.|+|||.+...                      .++.+
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            9999999985 57999999999986543321 223446789999999976432                      23456


Q ss_pred             cchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCC------CChHHHHHHHHHHHHhhc
Q 016481          263 SDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGD------YPVKGVHKAAMLAYHCLN  336 (389)
Q Consensus       263 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~  336 (389)
                      +|||||||++|||+++..+++.........+.....    ........+.+.....      ..........+|+.+||+
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDY----DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCC----cHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            799999999999999776654321110000000000    0000111111111000      001113345689999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 016481          337 HNPKARPLMRDIVDS  351 (389)
Q Consensus       337 ~dP~~Rps~~~il~~  351 (389)
                      +||++|||+.++++|
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.8e-34  Score=256.47  Aligned_cols=240  Identities=30%  Similarity=0.381  Sum_probs=192.7

Q ss_pred             CceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEecCCCCh
Q 016481           84 GFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV  163 (389)
Q Consensus        84 ~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  163 (389)
                      +||.||+|.+..+..      .+++|+............+.+|+..++.++|+||+++++++......++++||+.+++|
T Consensus         1 ~~g~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKKTGK------LVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECCCCc------EEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence            589999998765433      39999987664433257888999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcccccccc
Q 016481          164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM  243 (389)
Q Consensus       164 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~  243 (389)
                      ..++....  .++...+..++.+++.++.+||..+  ++|+||+|.||+++.++.++|+|||.+.......   ......
T Consensus        75 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~  147 (244)
T smart00220       75 FDLLKKRG--RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFV  147 (244)
T ss_pred             HHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc---cccccc
Confidence            99886654  3788999999999999999999977  9999999999999999999999999988765432   233456


Q ss_pred             ccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCCh-H
Q 016481          244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPV-K  322 (389)
Q Consensus       244 gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  322 (389)
                      ++..|++||.+.+..++.++||||||+++|+|++|..||.......  ...+.             ............ .
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~-------------~~~~~~~~~~~~~~  212 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKK-------------IGKPKPPFPPPEWK  212 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHH-------------HhccCCCCcccccc
Confidence            8889999999998889999999999999999999999997632111  00000             000001100011 1


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          323 GVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       323 ~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .+.++.+++.+||..+|++||++.+++++
T Consensus       213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      213 ISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             CCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence            56789999999999999999999999974

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-34  Score=260.24  Aligned_cols=132  Identities=24%  Similarity=0.355  Sum_probs=113.1

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-----C---CccceEEe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-----H---PNLVKLIG  143 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~  143 (389)
                      ++|.+.++||.|.|++||+|.+....+.      ||+|+.+...  ...+..+.||++|++++     |   .+||++++
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~------VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRY------VALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeE------EEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            7899999999999999999986655444      9999998653  23345678999999884     2   46999999


Q ss_pred             EEEe----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE
Q 016481          144 YCCE----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL  213 (389)
Q Consensus       144 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili  213 (389)
                      .|..    +.|+|+|+|++ |.+|+.++....-+.++...+..|++|++.||.|||.. -+|||.||||+|||+
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLL  221 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeee
Confidence            8864    67999999999 67899999888888999999999999999999999975 249999999999997

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.1e-33  Score=271.47  Aligned_cols=274  Identities=18%  Similarity=0.231  Sum_probs=183.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccc----------cCcCcccEEEEEecCCCChhhHHH--------------HHHH
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLR----------EGLQPVPVAVKVHDGDNSYQGHRE--------------WLAE  126 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----------~~~~~~~vaiK~~~~~~~~~~~~~--------------~~~E  126 (389)
                      .++|.+.++||+|+||.||+|.......          .......||||.+..... ....+              ...|
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHHH
Confidence            5689999999999999999997532211          112335699999865422 11122              2346


Q ss_pred             HHHHhccCCCcc-----ceEEeEEEe--------CCeEEEEEEecCCCChhhhhhcCCC---------------------
Q 016481          127 VIFLGHLSHPNL-----VKLIGYCCE--------DEHRVLIYEFMARGSVENNLFSKVL---------------------  172 (389)
Q Consensus       127 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------  172 (389)
                      +.++.+++|.++     +.++++|..        .+..++||||+.+|+|.+++.....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666777765544     566676642        3568999999999999998864211                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCc
Q 016481          173 -LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP  251 (389)
Q Consensus       173 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  251 (389)
                       ..+++..+..++.|++.+|.|||..+  |+||||||+|||++.++.+||+|||++......... ......+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence             12456778899999999999999977  999999999999999999999999999765432211 11123458899999


Q ss_pred             cccccCC--------------------C--CcccchhHHHHHHHHHHhCCC-CCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          252 EYIMTGH--------------------L--TPRSDVYSFGVVLLEILTGRK-SLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       252 E~l~~~~--------------------~--~~~~DiwslG~il~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      |++....                    |  ....||||+||++|+|++|.. ||........ .+..+...    .....
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~~~~~----~~~~r  454 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQYDND----LNRWR  454 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhhccch----HHHHH
Confidence            9886432                    1  124799999999999999986 6653211110 01000000    00000


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCC---CCCCCHHHHHHHhc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP---KARPLMRDIVDSLE  353 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~~il~~L~  353 (389)
                      ...............+....+|+.+||..+|   .+|+|+.++|+|-.
T Consensus       455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~  502 (507)
T PLN03224        455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF  502 (507)
T ss_pred             hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence            0011111111223457889999999999876   68999999999843

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=252.98  Aligned_cols=268  Identities=23%  Similarity=0.326  Sum_probs=201.6

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC---
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED---  148 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---  148 (389)
                      +.+..+.||-|+||.||.+++..+.+.      |+.|.+..-. .....+.+.+|+++|..++|.|++..++...-.   
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrr------valkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKR------VALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccc------hhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            556678999999999999877666555      9988876432 334456788999999999999999988876432   


Q ss_pred             --CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          149 --EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       149 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                        +.+|.++|+|. .+|...+.+-  +.++...+.-++.||++||.|||+.+  |+||||||.|+|++.+..+||||||+
T Consensus       128 fFqEiYV~TELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  128 FFQELYVLTELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHHHHHHHHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEeccccc
Confidence              35678899985 4777766543  36777778889999999999999988  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH------
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP------  299 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------  299 (389)
                      ++.-...+ ....+..+.|..|+|||+++|. .|+.+.||||.|||+.||+..+..|..-.+.+...+..-.+.      
T Consensus       203 ARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea  281 (449)
T KOG0664|consen  203 ARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA  281 (449)
T ss_pred             ccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence            99754433 2334456789999999999976 689999999999999999999999988777766554332211      


Q ss_pred             --HHHhhhhhhhhcCCCCC-CCC--------ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          300 --LLKEKKKLLNIIDPRLE-GDY--------PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       300 --~~~~~~~~~~~~~~~~~-~~~--------~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                        ...++.... ++..... ..+        +.....+...++..+|.+||++|.+..+.+.++-
T Consensus       282 Mr~ACEGAk~H-~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  282 MKYACEGAKNH-VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHHhhhhHHH-hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence              111111111 1111111 111        2233466788899999999999999999998863

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=238.72  Aligned_cols=209  Identities=26%  Similarity=0.292  Sum_probs=171.1

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  145 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  145 (389)
                      +.+..++...+..||+|++|.|-+-++.      ..+...|+|.+......+...+.++|+.+..+. .+|.+|.++|..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~------~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~  114 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHI------QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL  114 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeec------cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence            4455566667788999999998765443      344559999998877778888888999987655 699999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      .....++|.||.|+ .||..+...  ..+..+++...-+|+..++.||.|||+. ..++|||+||.|||||.+|+||+||
T Consensus       115 ~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCD  192 (282)
T KOG0984|consen  115 FREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICD  192 (282)
T ss_pred             hccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcc
Confidence            99999999999996 366655432  2345789999999999999999999985 3499999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCcccccc----CCCCcccchhHHHHHHHHHHhCCCCCCCCC
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTGRKSLDKSR  286 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~DiwslG~il~elltg~~pf~~~~  286 (389)
                      ||++-.+.+.-   ..+...|-..|||||.+..    ..|+.++||||||+++.||.+++.||+...
T Consensus       193 FGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  193 FGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             cccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            99987764321   2233568888999998853    479999999999999999999999998654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=277.41  Aligned_cols=246  Identities=28%  Similarity=0.365  Sum_probs=185.2

Q ss_pred             CcccceecCCCceE-EEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCCeE
Q 016481           74 FRQDRVLGGGGFGC-VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        74 ~~~~~~lg~G~~g~-Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  151 (389)
                      |.-.+.+|.|+-|+ ||+|...+        +.||||.+..+    ......+|+..|+.-+ |||||++++.-.+.+.+
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~--------R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~  578 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEG--------REVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL  578 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCC--------ceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence            33446789998875 89986543        34999988644    2334558999998874 99999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC---C--CcEEEecc
Q 016481          152 VLIYEFMARGSVENNLFSKVL--LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---D--YNAKLSDF  224 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~---~--~~vkl~Df  224 (389)
                      ||..|+|. .+|.+++.....  .....-....++.|++.||++||+.+  ||||||||.||||+.   +  ..++|+||
T Consensus       579 YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  579 YIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             EEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccc
Confidence            99999995 699999876411  11111234678889999999999987  999999999999965   3  46899999


Q ss_pred             CCCcCCCCCCCccc-cccccccccccCccccccCCCCcccchhHHHHHHHHHHhC-CCCCCCCCchhhhhhHHHHhHHHH
Q 016481          225 GLAKDGPEGDKSHV-STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG-RKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       225 g~a~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      |+++....+..... .....||-+|+|||++....-+.++|||||||++|+.++| .+||...-..+..        ++.
T Consensus       656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------Il~  727 (903)
T KOG1027|consen  656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------ILT  727 (903)
T ss_pred             ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--------hhc
Confidence            99999876544322 3457899999999999998888899999999999999996 8899864221110        000


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ....+..         .......++.+||.+|++.||..||++.+||.|
T Consensus       728 ~~~~L~~---------L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  728 GNYTLVH---------LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             Cccceee---------eccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            1111100         011111288999999999999999999999976

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=4.4e-34  Score=263.50  Aligned_cols=270  Identities=21%  Similarity=0.196  Sum_probs=204.2

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC------CCccce
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS------HPNLVK  140 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~  140 (389)
                      .+++.++|.+....|+|-|++|-+|.+.....      .||||++....  .-++.=+.|+.+|++|+      --|+++
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~------~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQ------EVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCC------eeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            45677889999999999999999997544333      49999998653  33345568999999995      247899


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC-Cc
Q 016481          141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YN  218 (389)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~-~~  218 (389)
                      ++-.|...+|+|||+|-+. .+|.+.+...+ ...+....+..++.|+..||..|...+  |+|.||||+|||+++. ..
T Consensus       499 l~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcce
Confidence            9999999999999999884 58888886543 346788899999999999999999988  9999999999999876 46


Q ss_pred             EEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH-
Q 016481          219 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA-  297 (389)
Q Consensus       219 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-  297 (389)
                      +||||||.|.......-    +....+-.|.|||++.|..|+...|+||.||+||||.||+..|++.......-+.--+ 
T Consensus       576 LKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             eeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            89999999987655432    1234456799999999999999999999999999999999999987765543221100 


Q ss_pred             ----hHHHHhh------------------------------------hhhhhhcCCCC-CCCCChHHHHHHHHHHHHhhc
Q 016481          298 ----LPLLKEK------------------------------------KKLLNIIDPRL-EGDYPVKGVHKAAMLAYHCLN  336 (389)
Q Consensus       298 ----~~~~~~~------------------------------------~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~  336 (389)
                          ..++...                                    .++...+-... ...-.......+.+|+.+||.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence                0111110                                    00000000000 001122456788999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 016481          337 HNPKARPLMRDIVDS  351 (389)
Q Consensus       337 ~dP~~Rps~~~il~~  351 (389)
                      .||++|.|..++|+|
T Consensus       732 LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  732 LDPEKRITVNQALKH  746 (752)
T ss_pred             cChhhcCCHHHHhcC
Confidence            999999999999987

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.1e-33  Score=233.75  Aligned_cols=261  Identities=17%  Similarity=0.262  Sum_probs=194.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED-  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~-  148 (389)
                      .++|++.+++|+|.++.||.|....+...      ++||+++.    ...+.+.+|+.+|+.|. ||||++++++..++ 
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK------~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~  106 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEK------CVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE  106 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCce------EEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence            46799999999999999999976554443      99999864    34567789999999997 99999999998765 


Q ss_pred             -CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC-CcEEEeccCC
Q 016481          149 -EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGL  226 (389)
Q Consensus       149 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~-~~vkl~Dfg~  226 (389)
                       ....+|+||+++.+......     .++...+...+.+++.||.|+|+.|  |+|||+||.|++||.. ..++|+|+|+
T Consensus       107 SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGL  179 (338)
T KOG0668|consen  107 SKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGL  179 (338)
T ss_pred             ccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecch
Confidence             46789999998876554332     4556677888999999999999977  9999999999999865 5699999999


Q ss_pred             CcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhh-----------hH
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-----------LA  294 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-----------~~  294 (389)
                      |..+..+....   ..+.+..|--||++.. ..|+.+-|+|||||++..|+..+.||........+-           +.
T Consensus       180 AEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~  256 (338)
T KOG0668|consen  180 AEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY  256 (338)
T ss_pred             HhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence            99887654322   2456677889998875 468999999999999999999999997665443321           11


Q ss_pred             HHHhHH-HHhhhhhhhhcCCCC--------CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          295 DWALPL-LKEKKKLLNIIDPRL--------EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       295 ~~~~~~-~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .++.+. +........++....        ..+.....++++.+|+.+.|..|-++|+|++|...|
T Consensus       257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            111110 000111111111111        111112336889999999999999999999999876

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=238.46  Aligned_cols=275  Identities=20%  Similarity=0.300  Sum_probs=202.0

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeE-EEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGY-CCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~  147 (389)
                      +.+.|.+.+.||+|.||.+-+|.++.....      +++|.+...  .....+|.+|...--.|. |.||+.-|++ |..
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~------ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTR------IVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceE------EEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            457899999999999999999977665444      999998765  344578889988766675 8999998875 566


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC--CCcEEEeccC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT--DYNAKLSDFG  225 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~--~~~vkl~Dfg  225 (389)
                      .+.+++++||++.|+|...+...   .+.+.....++.|+++|+.|+|+.+  +||||||.+||||..  .-+|||||||
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             CceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecc
Confidence            77888999999999999877654   5667778899999999999999977  999999999999942  3479999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccC---C--CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG---H--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      .++....     .......+..|.+||+....   .  ..+.+|||.||+++|.+|||..||.. .......+..|.+-.
T Consensus       169 ~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~  242 (378)
T KOG1345|consen  169 LTRKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWL  242 (378)
T ss_pred             cccccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHh
Confidence            9876432     22234567789999976532   2  36789999999999999999999983 344455555554433


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCC---CCHHHHHHHhccccCCCCCCCCCCCccccc
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---PLMRDIVDSLEPLQVLPDEAPTPKNFVTVV  372 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~~il~~L~~~~~~~~~~~~p~~~~~~~  372 (389)
                      ......+.+.+         ..++..+..+.++-|..+|++|   .++..-...++....+-....+-+...+.+
T Consensus       243 ~rk~~~~P~~F---------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~~~tn~  308 (378)
T KOG1345|consen  243 KRKNPALPKKF---------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEEDYYTNI  308 (378)
T ss_pred             cccCccCchhh---------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhhcccccc
Confidence            22222222211         1346778889999999999999   444444445555555544444444444443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=261.73  Aligned_cols=198  Identities=24%  Similarity=0.315  Sum_probs=168.5

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhh-------HHHHHHHHHHHhccC---CCccceE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-------HREWLAEVIFLGHLS---HPNLVKL  141 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~---h~niv~~  141 (389)
                      .+|...+.+|.|+||.|++|.+++....      |+||.+.+++-..+       .-.+-.||.||..++   |+||+++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~e------VViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYE------VVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceE------EEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            4699999999999999999998877554      99999887642111       011225999999997   9999999


Q ss_pred             EeEEEeCCeEEEEEEecC-CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          142 IGYCCEDEHRVLIYEFMA-RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       142 ~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      +++|.+++++||+||... |-+|.+++..+.  .+++.++..|++|++.|+++||+.+  |||||||-+|+.++.+|-+|
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEE
Confidence            999999999999999864 346778776654  7899999999999999999999988  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCC
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLD  283 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~  283 (389)
                      |+|||.|.....+    ....+.||..|.|||++.|..| ...-|||+||+++|.++....||-
T Consensus       711 lidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  711 LIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999998765432    3456889999999999999988 567899999999999999888874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-33  Score=242.31  Aligned_cols=265  Identities=20%  Similarity=0.273  Sum_probs=194.9

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe-
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-  147 (389)
                      ...+|.-.+.+|.|.- .|-.|.+      ......||+|...... .....++..+|..++..++|+||++++.+|.- 
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D------~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFD------QVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecch------hhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            3467888888999987 4544432      3334558998866543 23344667789999999999999999999853 


Q ss_pred             -----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          148 -----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       148 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                           ....|+|||+|. ++|.+.+.    ..++......++.|++.|++|||+.+  |+||||||+||+++.++.+||.
T Consensus        88 ~~l~~~~e~y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             ccHHHHHhHHHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeec
Confidence                 346699999996 58888776    25677888999999999999999988  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhh-----------
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ-----------  291 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----------  291 (389)
                      |||+|+.....   ...+....|..|.|||++.+..|...+||||+||++.||++|...|.+.+..+.-           
T Consensus       161 dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd  237 (369)
T KOG0665|consen  161 DFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD  237 (369)
T ss_pred             cchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence            99999864332   3445578899999999999999999999999999999999999999865432210           


Q ss_pred             -hhHH----HHhHHHHhhhhhhh------hcCCCCCC--CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          292 -NLAD----WALPLLKEKKKLLN------IIDPRLEG--DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       292 -~~~~----~~~~~~~~~~~~~~------~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       ++.+    .+.-.....++...      +-|.-+..  ..+......+++++.+||..||++|.|++++|.|
T Consensus       238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence             0000    00000000000000      00011111  1122335678999999999999999999999998

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=1.3e-30  Score=227.11  Aligned_cols=213  Identities=34%  Similarity=0.533  Sum_probs=181.8

Q ss_pred             ecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEecC
Q 016481           80 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA  159 (389)
Q Consensus        80 lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (389)
                      ||+|.+|.||++....+.      ..+++|+............+.+|+..++.+.|++|+++++++......++++|++.
T Consensus         1 l~~g~~~~v~~~~~~~~~------~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKKTG------KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecCCC------cEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence            689999999999765433      33999998876443244678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-CCcEEEeccCCCcCCCCCCCccc
Q 016481          160 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKDGPEGDKSHV  238 (389)
Q Consensus       160 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-~~~vkl~Dfg~a~~~~~~~~~~~  238 (389)
                      +++|.+++.... ..++...+..++.+++.++++||..+  ++|+||+|.||+++. ++.++|+|||.+........  .
T Consensus        75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (215)
T cd00180          75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--L  149 (215)
T ss_pred             CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--h
Confidence            999999886543 36788999999999999999999977  999999999999999 89999999999886544321  1


Q ss_pred             cccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCC
Q 016481          239 STRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEG  317 (389)
Q Consensus       239 ~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (389)
                      .....+...|++||.+... .++.++|+|+||+++++|                                          
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            2335678889999999877 888999999999999999                                          


Q ss_pred             CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          318 DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                             ..+.+++.+|++.||++||++.+++++|
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                   3467899999999999999999999764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=260.43  Aligned_cols=255  Identities=24%  Similarity=0.309  Sum_probs=201.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|.+...+|.|++|.||+|+++...+      ..|+|+++.+.. ....-...|+-+++..+||||+.+++.+.....
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~e------laavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGE------LAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCc------hhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            4689999999999999999997665443      378888776532 233445579999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++.||||.||+|.+..+-.  .++.+-+...+++..+.||+|||+.+  =+|||||-.||++++.|.+|+.|||.+..+
T Consensus        87 lwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             cEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhh
Confidence            99999999999999876543  48888899999999999999999977  799999999999999999999999987655


Q ss_pred             CCCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ...  .....++.||+.|||||+..   ...|...+|||++|+...|+-.-++|.....+.....+..         .  
T Consensus       163 tat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT---------k--  229 (829)
T KOG0576|consen  163 TAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT---------K--  229 (829)
T ss_pred             hhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh---------c--
Confidence            321  12234588999999999863   5679999999999999999998888876655443222211         0  


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       ...++.-. .-+......+.+|++.||.++|++||++..+|.|
T Consensus       230 -S~~qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  230 -SGFQPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             -cCCCCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence             01111111 1133557889999999999999999999877653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.1e-29  Score=222.71  Aligned_cols=201  Identities=31%  Similarity=0.392  Sum_probs=171.1

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (389)
                      |.+.+.||.|++|.||+|....+..      .+++|.............+.+|+..++.++|+|++++++++......++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGE------LVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCc------EEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEE
Confidence            5677899999999999998765333      3999998865433345678889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  233 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~  233 (389)
                      ++|++++++|.+++..... .+++..+..++.+++.++.+||..+  ++|+||+|.||+++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             EEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999999999998876542 1788999999999999999999976  999999999999999999999999998876543


Q ss_pred             CCccccccccccccccCcccc-ccCCCCcccchhHHHHHHHHHHhCCCCCCC
Q 016481          234 DKSHVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEILTGRKSLDK  284 (389)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwslG~il~elltg~~pf~~  284 (389)
                      .. .......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       152 ~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      152 LA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            21 122335688899999998 667788899999999999999999999975

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=1.7e-30  Score=235.23  Aligned_cols=272  Identities=23%  Similarity=0.278  Sum_probs=197.4

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYC  145 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~  145 (389)
                      ...+...|...++||+|.|++||+|++...   ......||+|.+......   ..+..|+.+|..+. +.||+++.+++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~---~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~  104 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ---DTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCF  104 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh---ccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhh
Confidence            445677899999999999999999976652   234556999998765433   35668999999985 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-CCcEEEecc
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDF  224 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-~~~vkl~Df  224 (389)
                      ...+...+|+||++...-.+++..     ++...+...+..++.||+++|..|  ||||||||.|+|++. .+.-.|.||
T Consensus       105 rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  105 RNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             ccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEec
Confidence            999999999999999887776643     457788899999999999999977  999999999999975 467899999


Q ss_pred             CCCcCCCCCC--------------C------------------c----------cccccccccccccCcccccc-CCCCc
Q 016481          225 GLAKDGPEGD--------------K------------------S----------HVSTRIMGTYGYAAPEYIMT-GHLTP  261 (389)
Q Consensus       225 g~a~~~~~~~--------------~------------------~----------~~~~~~~gt~~y~aPE~l~~-~~~~~  261 (389)
                      |+|.......              .                  .          .......||++|.|||++.. ..-+.
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9987211000              0                  0          00012469999999999875 45688


Q ss_pred             ccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH--H-HHhHHHHh------------------hhhhhhhc-----CCCC
Q 016481          262 RSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA--D-WALPLLKE------------------KKKLLNII-----DPRL  315 (389)
Q Consensus       262 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~-~~~~~~~~------------------~~~~~~~~-----~~~~  315 (389)
                      ++||||.|+|++.+++++.||.........-..  . +...-+.+                  ..+...-+     ....
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            999999999999999999999765433221100  0 00000000                  00000000     0000


Q ss_pred             C--------CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          316 E--------GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       316 ~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .        .....-.+..+.+|+.+||..||.+|.|+.+.|+|
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0        00111235588999999999999999999999987

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.4e-29  Score=263.41  Aligned_cols=197  Identities=18%  Similarity=0.200  Sum_probs=139.0

Q ss_pred             cCC-CccceEEeEE-------EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 016481          133 LSH-PNLVKLIGYC-------CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYR  204 (389)
Q Consensus       133 l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~  204 (389)
                      ++| .||+.++++|       .....+++++|++ +++|.+++... ...+++..++.++.||+.||.|||+++  |+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG--IVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence            344 5777777766       2334677788988 56999998653 346899999999999999999999977  9999


Q ss_pred             CCCCCCeEEcCCC-------------------cEEEeccCCCcCCCCCCC--------------ccccccccccccccCc
Q 016481          205 DFKTSNILLDTDY-------------------NAKLSDFGLAKDGPEGDK--------------SHVSTRIMGTYGYAAP  251 (389)
Q Consensus       205 Dlkp~Nili~~~~-------------------~vkl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~aP  251 (389)
                      ||||+|||++..+                   .+|++|||+++.......              ........||+.|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            9999999996544                   455666666543211000              0001124688999999


Q ss_pred             cccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHH
Q 016481          252 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLA  331 (389)
Q Consensus       252 E~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  331 (389)
                      |++.+..|+.++|||||||++|||++|.+|+......    +...    .      ...+.+.     .......+..++
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~----~------~~~~~~~-----~~~~~~~~~~~~  245 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSL----R------HRVLPPQ-----ILLNWPKEASFC  245 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHH----H------HhhcChh-----hhhcCHHHHHHH
Confidence            9999999999999999999999999998886532110    0000    0      0001110     011124456888


Q ss_pred             HHhhccCCCCCCCHHHHHHHh
Q 016481          332 YHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       332 ~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .+||+.||.+||++.++++|-
T Consensus       246 ~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             HHhCCCChhhCcChHHHhhch
Confidence            999999999999999999874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=7e-28  Score=205.38  Aligned_cols=167  Identities=23%  Similarity=0.204  Sum_probs=126.2

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccc
Q 016481          161 GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST  240 (389)
Q Consensus       161 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~  240 (389)
                      |+|.+++.... ..+++..+..++.|++.||+|||+.+        ||+|||++.++.+|+  ||++.......      
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc------
Confidence            68888887543 36999999999999999999999855        999999999999999  99987653321      


Q ss_pred             cccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCC
Q 016481          241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP  320 (389)
Q Consensus       241 ~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (389)
                       ..||+.|+|||++.+..|+.++|||||||++|||++|+.||........ .+..+    .....   . ..+. ....+
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~----~~~~~---~-~~~~-~~~~~  132 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEIL----LNGMP---A-DDPR-DRSNL  132 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHH----HHHhc---c-CCcc-ccccH
Confidence             2689999999999999999999999999999999999999975432111 11111    10000   0 0000 00112


Q ss_pred             hHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          321 VKGVH--KAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       321 ~~~~~--~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .....  .+.+++.+||+.||++||++.++++++..+
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            23333  699999999999999999999999998654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1e-28  Score=211.68  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=198.2

Q ss_pred             ccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEE
Q 016481           76 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.-+|.+...|..|+|+|.+..        ++.|++.-.. ....-++|..|.-.|+.+.||||+.+++.|....++.++
T Consensus       194 l~tkl~e~hsgelwrgrwqgnd--------ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQGND--------IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             hhhhhccCCCcccccccccCcc--------hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            3456889999999999886543        7777765432 333346788899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe--ccCCCcCCCC
Q 016481          155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS--DFGLAKDGPE  232 (389)
Q Consensus       155 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~--Dfg~a~~~~~  232 (389)
                      ..||+.|+|+..++.......+..++.+++.+++.|++|||+..+-|-.--|....++||++.+.+|.  |--++     
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs-----  340 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS-----  340 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee-----
Confidence            99999999999999887777888999999999999999999987655566899999999999877664  32211     


Q ss_pred             CCCccccccccccccccCccccccCCCC---cccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTGHLT---PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                          .........|.||+||.+...+-+   .++|+|||++++|||.|...||....+.+-            ..    +
T Consensus       341 ----fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------------gm----k  400 (448)
T KOG0195|consen  341 ----FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------------GM----K  400 (448)
T ss_pred             ----eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------------hh----h
Confidence                112224567899999999876543   579999999999999999999987765431            11    1


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      +-...++...|...+..+..|+.-|++.||.+||.|..|+-.||++.
T Consensus       401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            12223445566777888999999999999999999999999998875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=4.1e-27  Score=207.10  Aligned_cols=275  Identities=17%  Similarity=0.209  Sum_probs=209.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  148 (389)
                      +.-.|+++++||+|.||..+.|..      -..+..||||.......   ..++..|.+.++.|. .++|...+-+...+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~N------l~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG   96 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKN------LYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEG   96 (449)
T ss_pred             ecccceeccccccCcceeeecccc------cccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence            345799999999999999999854      33456699999765432   234557888888885 79999999888888


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-----cEEEec
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-----NAKLSD  223 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-----~vkl~D  223 (389)
                      -+-.+|+|++ |.+|.| |++...+.|+.++++.++.|++.-++|+|+++  +|.|||||+|+||...+     .+.++|
T Consensus        97 ~~NiLVidLL-GPSLED-LFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiD  172 (449)
T KOG1165|consen   97 KYNILVIDLL-GPSLED-LFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIID  172 (449)
T ss_pred             chhhhhhhhh-CcCHHH-HHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEe
Confidence            8889999999 667776 55666778999999999999999999999977  99999999999996543     489999


Q ss_pred             cCCCcCCCCCCCc-----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh
Q 016481          224 FGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       224 fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  298 (389)
                      ||+|+.+.+....     ....+..||.+||+-....|.+-+.+.|+-|||-+++++|-|..||.+......+       
T Consensus       173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-------  245 (449)
T KOG1165|consen  173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-------  245 (449)
T ss_pred             ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-------
Confidence            9999988765432     2234578999999999999999999999999999999999999999876433221       


Q ss_pred             HHHHhhhhhhhhcCCCCCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCCCCCCccc
Q 016481          299 PLLKEKKKLLNIIDPRLEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVT  370 (389)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~~p~~~~~  370 (389)
                            ....++-+.+...+.   -..++.++..-+.-.=+.+-.+-|+..-+...+..+-+..+.+--.++.|.
T Consensus       246 ------~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~  314 (449)
T KOG1165|consen  246 ------EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWM  314 (449)
T ss_pred             ------HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence                  111222222211111   113466777777777777888889988888777766655555555555544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1e-25  Score=210.38  Aligned_cols=264  Identities=18%  Similarity=0.193  Sum_probs=197.3

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC----CCccceEEeEE-Ee
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS----HPNLVKLIGYC-CE  147 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~~~~~~-~~  147 (389)
                      +|.+.+.||+|+||.||.|......     ...+|+|........... .+..|..++..+.    .+++..+++.+ ..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~-----~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~   92 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK-----NKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRST   92 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC-----CeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence            8999999999999999999765543     234899987654322221 4556888888876    26899999999 47


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC-----CcEEEe
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-----YNAKLS  222 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~-----~~vkl~  222 (389)
                      +..-|+||+.+ |.+|.+.........++..++..++.|++.+|.++|+.|  ++||||||.|+++...     ..+.|.
T Consensus        93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEE
Confidence            78889999998 779998776555678999999999999999999999977  9999999999999765     469999


Q ss_pred             ccCCCc--CCCCCCCc----cc--cccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH
Q 016481          223 DFGLAK--DGPEGDKS----HV--STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  294 (389)
Q Consensus       223 Dfg~a~--~~~~~~~~----~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  294 (389)
                      |||+++  .+......    ..  .....||.+|.++.+..+...+.+.|+||++.++.+|+.|..||............
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~  249 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF  249 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence            999998  43222211    11  12355999999999999999999999999999999999999999765433221000


Q ss_pred             HHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                            ...   ......    .......+.++..+...+-..+...+|....+...|......
T Consensus       250 ------~~~---~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  250 ------EKD---PRKLLT----DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             ------HHH---hhhhcc----ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence                  000   000000    001223346677777777779999999999999887665444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-26  Score=193.87  Aligned_cols=258  Identities=21%  Similarity=0.254  Sum_probs=195.1

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  147 (389)
                      +..+.|++.++||+|+||.+|.|.......+      ||||+.......   ..+..|.++++.|+ ...|..+..++.+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~------VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e   82 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEE------VAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTE   82 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCce------EEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccc
Confidence            4567899999999999999999987766655      999998765433   34557889999997 4678888888999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC---CcEEEecc
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAKLSDF  224 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~---~~vkl~Df  224 (389)
                      ..+-.+||+++ |.+|.+.+ .-....++..+++.++-|++.-++|+|.++  .|||||||+|+|..-+   ..+.++||
T Consensus        83 ~~ynvlVMdLL-GPsLEdLf-nfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDF  158 (341)
T KOG1163|consen   83 KDYNVLVMDLL-GPSLEDLF-NFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDF  158 (341)
T ss_pred             cccceeeeecc-CccHHHHH-HHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEec
Confidence            99999999999 66777654 344457899999999999999999999977  9999999999999543   46899999


Q ss_pred             CCCcCCCCCCCc-----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH
Q 016481          225 GLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP  299 (389)
Q Consensus       225 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  299 (389)
                      |+|+.+.+....     .......||.+|.+-..+.+...+.+.|+-|+|.++.++.-|..||.+........-..    
T Consensus       159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE----  234 (341)
T KOG1163|consen  159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE----  234 (341)
T ss_pred             cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH----
Confidence            999987653322     12334789999999988888888999999999999999999999999876544322211    


Q ss_pred             HHHhhhhhhhhcCCCCCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          300 LLKEKKKLLNIIDPRLEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                               .+.+.+..-..   -...+.++...+.-|=..--++-|+...+-+.+
T Consensus       235 ---------kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  235 ---------KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             ---------HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence                     11111111111   112345666667777776777777765554443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=7.6e-26  Score=211.15  Aligned_cols=180  Identities=18%  Similarity=0.153  Sum_probs=133.9

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCccce-E
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVK-L  141 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~-~  141 (389)
                      ...+.++|.+.+.||+|+||+||+|+++...     +..||||......    .......+.+|+.+++.++|+|++. +
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l   87 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDP-----GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL   87 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCC-----CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence            3556789999999999999999999865422     1227999865331    2233456889999999999999985 4


Q ss_pred             EeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCC-CCCCeEEcCCCcEE
Q 016481          142 IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF-KTSNILLDTDYNAK  220 (389)
Q Consensus       142 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dl-kp~Nili~~~~~vk  220 (389)
                      ++    .+..|+||||++|++|.. +..     ..   ...++.+++.+|+|||+++  |+|||| ||+|||++.++.+|
T Consensus        88 ~~----~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         88 LA----TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             EE----cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEE
Confidence            43    246799999999998863 211     11   1457889999999999977  999999 99999999999999


Q ss_pred             EeccCCCcCCCCCCCccc------cccccccccccCccccccCC------CCcccchh
Q 016481          221 LSDFGLAKDGPEGDKSHV------STRIMGTYGYAAPEYIMTGH------LTPRSDVY  266 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~~------~~~~~Diw  266 (389)
                      |+|||+|+..........      .....+++.|+|||.+....      .+..+|-|
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999999987654332111      12467888999999886432      23446666

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=3.8e-24  Score=198.99  Aligned_cols=261  Identities=31%  Similarity=0.401  Sum_probs=197.4

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh--hHHHHHHHHHHHhccCCC-ccceEEeEEEeCCe
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ--GHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEH  150 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~  150 (389)
                      |.+.+.||.|+||.||++...         ..+++|.+.......  ....+.+|+.+++.+.|+ +|+++.+.+.....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence            677889999999999999765         238999887765443  367788999999999988 79999999987778


Q ss_pred             EEEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-cEEEeccCCCc
Q 016481          151 RVLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLAK  228 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-~vkl~Dfg~a~  228 (389)
                      .+++++++.++++.+.+..... ..+.......++.|++.++.|+|..+  ++|||+||+||+++..+ .++++|||++.
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            8999999999999965544322 26788899999999999999999977  99999999999999988 79999999998


Q ss_pred             CCCCCCCcc----ccccccccccccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCch-hhhhhHHHHhHH
Q 016481          229 DGPEGDKSH----VSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA-REQNLADWALPL  300 (389)
Q Consensus       229 ~~~~~~~~~----~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~  300 (389)
                      .........    ......|+..|++||.+.+   ..++...|+||+|++++++++|..||...... ........    
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~----  226 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI----  226 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH----
Confidence            654433221    2355789999999999987   57889999999999999999999997765431 00000000    


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +....  ...................+.+++..++..+|..|.+..+....
T Consensus       227 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         227 ILELP--TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHhcC--CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000  00000000000012224678899999999999999999887765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.2e-26  Score=230.12  Aligned_cols=261  Identities=21%  Similarity=0.248  Sum_probs=188.1

Q ss_pred             cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhh-HHHHHHHHHHHhccCCCccceEEeEEEeCCeEEE
Q 016481           75 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (389)
                      ...+++|.|++|.|+.+........ .....+.++ ......... ...+..|+-+-..+.|+|++.....+.+....+-
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~-~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~  398 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKS-FPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ  398 (601)
T ss_pred             CccceeeecccCceEEEEecCCCcc-chhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence            4567899999997776543322221 111112222 112212222 2225668878888999999888777666655556


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  233 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~  233 (389)
                      +||||++ +|...+....  .+....+..+++|++.|+.|+|+.|  |.|||+|++|+++..+|.+||+|||.+......
T Consensus       399 ~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            6999998 9999887652  5777888999999999999999988  999999999999999999999999998876554


Q ss_pred             CCc--cccccccccccccCccccccCCCCc-ccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          234 DKS--HVSTRIMGTYGYAAPEYIMTGHLTP-RSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       234 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ...  ......+|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||......+.....        .... ...
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--------~~~~-~~~  544 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--------NNYS-DQR  544 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--------hccc-ccc
Confidence            433  4566689999999999999999976 489999999999999999999866544332100        0000 000


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      -...-........+...+.++.+||+.||.+|.|+.+|++.
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            00000111223456788999999999999999999999864

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=3e-23  Score=180.60  Aligned_cols=175  Identities=10%  Similarity=0.097  Sum_probs=132.5

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh--hHHH------HHHHHHHHhccCCCccc
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ--GHRE------WLAEVIFLGHLSHPNLV  139 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~------~~~E~~~l~~l~h~niv  139 (389)
                      ..+.++|+..+.||.|+||.||++..  +.      ..+|+|++.......  ....      +.+|+..+.++.|++|.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~------~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~   98 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DY------GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA   98 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CC------CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence            45678999999999999999998632  12      239999987654222  1122      56899999999999999


Q ss_pred             eEEeEEEeC--------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCe
Q 016481          140 KLIGYCCED--------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  211 (389)
Q Consensus       140 ~~~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Ni  211 (389)
                      .+.+++...        +..++||||++|.+|.+..      .++.    ....+++.+|..+|.+|  ++|+|++|.||
T Consensus        99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Ni  166 (232)
T PRK10359         99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHG--MVSGDPHKGNF  166 (232)
T ss_pred             cceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcC--CccCCCChHHE
Confidence            999886543        3579999999999997763      1222    24558999999999987  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh
Q 016481          212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT  277 (389)
Q Consensus       212 li~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt  277 (389)
                      +++.+| ++|+|||...........              ..+++...|..++|+||||+++..+..
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999988 999999987654321110              013445567789999999999876544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-23  Score=199.57  Aligned_cols=230  Identities=29%  Similarity=0.335  Sum_probs=179.9

Q ss_pred             eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhh-HHHHHHHHHHHhccC-CCccceEEeEEEeCCeEEEEEE
Q 016481           79 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYE  156 (389)
Q Consensus        79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  156 (389)
                      .+|+|+||.|++++-..   ....+..+|.|...+...... ......|..++...+ ||.+|.++..+..+..++++++
T Consensus         1 vlg~g~~gkvfLvrk~~---g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAG---GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhc---cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            37999999999864221   122344477776655432111 113445778888887 9999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCc
Q 016481          157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  236 (389)
Q Consensus       157 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~  236 (389)
                      +..||+|...+....  .+.+.........++.++.++|..+  |+|||+|++||+++.+|++++.|||+++..-...  
T Consensus        78 ~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--  151 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--  151 (612)
T ss_pred             hcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhh--
Confidence            999999887775543  5667777778888999999999988  9999999999999999999999999988654322  


Q ss_pred             cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCC
Q 016481          237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE  316 (389)
Q Consensus       237 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (389)
                          ..|||..|||||++.  .+..++|.||||+++++|++|..||..       +.             +..++  +..
T Consensus       152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~-------------~~~Il--~~~  203 (612)
T KOG0603|consen  152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DT-------------MKRIL--KAE  203 (612)
T ss_pred             ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HH-------------HHHHh--hhc
Confidence                129999999999998  678899999999999999999999986       00             11111  123


Q ss_pred             CCCChHHHHHHHHHHHHhhccCCCCCCCH
Q 016481          317 GDYPVKGVHKAAMLAYHCLNHNPKARPLM  345 (389)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~  345 (389)
                      ..+|......+++++..++..+|..|...
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            35677888999999999999999999855

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=3e-22  Score=172.11  Aligned_cols=140  Identities=15%  Similarity=0.132  Sum_probs=104.7

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh-h------------------------HHHHHHHHHHHh
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-G------------------------HREWLAEVIFLG  131 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~------------------------~~~~~~E~~~l~  131 (389)
                      .+.||+|+||.||+|... +      +..||+|+++...... .                        ......|+..+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~------g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05147           2 NGCISTGKEANVYHATTA-N------GEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK   74 (190)
T ss_pred             CCccccccceEEEEEECC-C------CCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence            468999999999999754 2      3349999987542110 0                        011234899999


Q ss_pred             ccCCCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceecCCCCCC
Q 016481          132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL-HEAEKPVIYRDFKTSN  210 (389)
Q Consensus       132 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~ivH~Dlkp~N  210 (389)
                      .+.++++.....+... . .+|||||++|+++.......  ..++...+..++.|++.+|.++ |+.+  |+||||||+|
T Consensus        75 ~l~~~~v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~N  148 (190)
T cd05147          75 RLVTAGIPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYN  148 (190)
T ss_pred             HHHHCCCCCCcEEEec-C-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHH
Confidence            9987776443333222 2 38999999987766543322  3688899999999999999999 6877  9999999999


Q ss_pred             eEEcCCCcEEEeccCCCcCC
Q 016481          211 ILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       211 ili~~~~~vkl~Dfg~a~~~  230 (389)
                      ||++ ++.++|+|||+|...
T Consensus       149 Ili~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEEE-CCcEEEEEccccccC
Confidence            9998 478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=2.4e-22  Score=180.13  Aligned_cols=234  Identities=21%  Similarity=0.265  Sum_probs=146.6

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCC--CChhhHHHHHHHHHHHhccCC----------Cccce
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSH----------PNLVK  140 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h----------~niv~  140 (389)
                      .+..++.||.|+|+.||.+++.++...      +|+|+....  ......+++.+|......+.+          -.++-
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~------~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~   86 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEE------FAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV   86 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEE------EEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred             EEEEccccccCCceEEEEEEEccCCce------EEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence            356678999999999999987665554      999986533  233345666666655444322          12222


Q ss_pred             EEeEE---------EeCC--------eEEEEEEecCCCChhhhhh---cCCCC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 016481          141 LIGYC---------CEDE--------HRVLIYEFMARGSVENNLF---SKVLL--PLPWSIRMKIAFGAAKGLAFLHEAE  198 (389)
Q Consensus       141 ~~~~~---------~~~~--------~~~lv~e~~~~gsL~~~l~---~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~  198 (389)
                      .++..         ....        ..+++|+-+ .++|.+.+.   .....  .+.....+.+..|++..+++||..|
T Consensus        87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G  165 (288)
T PF14531_consen   87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG  165 (288)
T ss_dssp             -SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence            22222         1111        236678877 468877642   22221  2334455667789999999999988


Q ss_pred             CCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccC--------CCCcccchhHHHH
Q 016481          199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--------HLTPRSDVYSFGV  270 (389)
Q Consensus       199 ~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--------~~~~~~DiwslG~  270 (389)
                        +||+||+|+|++++.+|.++|+||+........     ......+..|.+||.....        .++.+.|.|+||+
T Consensus       166 --lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  166 --LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             --EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred             --eEecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence              999999999999999999999999876653221     1113456779999976432        4788999999999


Q ss_pred             HHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCC
Q 016481          271 VLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR  342 (389)
Q Consensus       271 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  342 (389)
                      ++|.|.+|..||+...+......                .+     .... +.+..++.||..+|+.+|.+|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~~----------------~f-----~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPEW----------------DF-----SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSGG----------------GG-----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCccccccc----------------cc-----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999999987643321110                01     1223 567889999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.5e-22  Score=180.05  Aligned_cols=197  Identities=19%  Similarity=0.241  Sum_probs=139.1

Q ss_pred             CCCccceEEeEEEe---------------------------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHH
Q 016481          134 SHPNLVKLIGYCCE---------------------------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG  186 (389)
Q Consensus       134 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~  186 (389)
                      +|||||++.++|.+                           ...+|+||..++. +|..++..+   ..+......++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence            49999999887632                           3356899988864 899888765   3455566778889


Q ss_pred             HHHHHHHHHhCCCCceecCCCCCCeEE--cCC--CcEEEeccCCCcCCCCC--C--CccccccccccccccCccccccCC
Q 016481          187 AAKGLAFLHEAEKPVIYRDFKTSNILL--DTD--YNAKLSDFGLAKDGPEG--D--KSHVSTRIMGTYGYAAPEYIMTGH  258 (389)
Q Consensus       187 i~~~l~~LH~~~~~ivH~Dlkp~Nili--~~~--~~vkl~Dfg~a~~~~~~--~--~~~~~~~~~gt~~y~aPE~l~~~~  258 (389)
                      +++|+.|||.++  |.|||+|.+|||+  +++  -.++|+|||.+-....-  .  .....-...|...-||||+....+
T Consensus       350 lLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  350 LLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999988  9999999999999  333  35799999976432110  0  000111245778899999986432


Q ss_pred             C------CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHH
Q 016481          259 L------TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAY  332 (389)
Q Consensus       259 ~------~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  332 (389)
                      -      -.++|.|+.|.+.||++....||-+..... .+...           .++-    ....++..++..+++++.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~-----------Yqe~----qLPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT-----------YQES----QLPALPSRVPPVARQLVF  491 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh-----------hhhh----hCCCCcccCChHHHHHHH
Confidence            1      247999999999999999999997633211 01110           1111    122345667788999999


Q ss_pred             HhhccCCCCCCCHHHHHHHh
Q 016481          333 HCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       333 ~cl~~dP~~Rps~~~il~~L  352 (389)
                      ..|+.||++|++.+-..+.|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999986655444

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=3e-23  Score=206.99  Aligned_cols=251  Identities=24%  Similarity=0.271  Sum_probs=178.3

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHH---HHHHHHHhccCCCccceEEeEEEeCC
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW---LAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +|...+.||.+.|=+|.+|++.+..        |+||++-+.......+.|   +.|++ ...+++||.+.+.-+-..+.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~--------vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL--------VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce--------EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH
Confidence            5677889999999999998754432        899987765533333333   44555 45568999999988877777


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..|+|-+|... +|+|.+..+.  -+...+.+.|+.|++.||.-+|..|  |+|+|||.+||||+.-.=+.|+||..-+.
T Consensus        95 AAylvRqyvkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   95 AAYLVRQYVKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHHhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCC
Confidence            78888899865 8888886553  2456677889999999999999977  99999999999998877789999976543


Q ss_pred             C--CCC---CCccccccccccccccCccccccCC-----------CCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 016481          230 G--PEG---DKSHVSTRIMGTYGYAAPEYIMTGH-----------LTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQN  292 (389)
Q Consensus       230 ~--~~~---~~~~~~~~~~gt~~y~aPE~l~~~~-----------~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  292 (389)
                      .  +..   +......+...-.+|+|||.+....           .+++.||||+||+++||++ |++||.-..-     
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-----  244 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-----  244 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-----
Confidence            2  222   2223333444566899999875421           4678999999999999988 7888873211     


Q ss_pred             hHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          293 LADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                       ..|-...........+.+           .+..++.++..|++.||++|.++.+.|+...+
T Consensus       245 -~aYr~~~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  245 -LAYRSGNADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             -HhHhccCccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence             111000000001111111           12467899999999999999999999987443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=4.2e-21  Score=165.49  Aligned_cols=142  Identities=18%  Similarity=0.118  Sum_probs=108.2

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh-----------------------h--HHHHHHHHHHHh
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-----------------------G--HREWLAEVIFLG  131 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------------------~--~~~~~~E~~~l~  131 (389)
                      .+.||+|+||.||+|... +      +..||+|+++......                       .  ...+..|...+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~------g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05145           2 NGCISTGKEANVYHARTG-D------GEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK   74 (190)
T ss_pred             CceeecCCCcEEEEEEcC-C------CCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence            578999999999999754 2      3449999987652110                       0  112346889999


Q ss_pred             ccCCCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCC
Q 016481          132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSN  210 (389)
Q Consensus       132 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~N  210 (389)
                      ++.|+++.....+...  ..++||||++|+++.......  ..++......++.+++.++.++|. .|  |+||||||+|
T Consensus        75 ~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~N  148 (190)
T cd05145          75 RLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYN  148 (190)
T ss_pred             HHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhh
Confidence            9999887555444433  248999999988654433222  256778889999999999999999 88  9999999999


Q ss_pred             eEEcCCCcEEEeccCCCcCCCC
Q 016481          211 ILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       211 ili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      |+++ ++.++|+|||++.....
T Consensus       149 Ill~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         149 ILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEEE-CCCEEEEEcccceecCC
Confidence            9998 78999999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.3e-20  Score=160.77  Aligned_cols=187  Identities=17%  Similarity=0.106  Sum_probs=134.5

Q ss_pred             cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh---hHHHHHHHHHHHhccC-CCccceEEeEEEeCCe
Q 016481           75 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ---GHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEH  150 (389)
Q Consensus        75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  150 (389)
                      .+...|++|+||+||.+..        ....++.+.+....-..   ....+.+|+++|++|. |++|+.++++    +.
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~   72 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG   72 (218)
T ss_pred             ccceeecCCCcceEEEeec--------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC
Confidence            3467899999999997632        12226666555432211   1224678999999995 5889999886    35


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCC-CCCCeEEcCCCcEEEeccCCCcC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF-KTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dl-kp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++|||+.|.+|......        . ...++.|++.+|.++|.+|  |+|||| ||+|||++.++.++|+|||+|..
T Consensus        73 ~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             EEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            6999999999888653311        1 1346778999999999988  999999 79999999999999999999986


Q ss_pred             CCCCCCc--c-c--------cccccccccccCccccccC-CCC-cccchhHHHHHHHHHHhCCCCCCC
Q 016481          230 GPEGDKS--H-V--------STRIMGTYGYAAPEYIMTG-HLT-PRSDVYSFGVVLLEILTGRKSLDK  284 (389)
Q Consensus       230 ~~~~~~~--~-~--------~~~~~gt~~y~aPE~l~~~-~~~-~~~DiwslG~il~elltg~~pf~~  284 (389)
                      .......  . .        ......++.|++|+..... ..+ .+.+.++.|.-+|.++|+..++-.
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            5432210  0 0        0113367788888764432 233 578999999999999999987643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1e-20  Score=191.99  Aligned_cols=196  Identities=19%  Similarity=0.191  Sum_probs=158.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC---CCccceEEeEEE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYCC  146 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~  146 (389)
                      -...|.+.+.||+|+||.||+|....       +..||+|+-+.......+..    .+++.+|+   -+.|+.+..++.
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-------~~~~alK~e~P~~~WEfYI~----~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-------GKLVALKVEKPPNPWEFYIC----LQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-------CcEEEEEeecCCCceeeeeh----HHHHHhhchhhhcchHHHHHHHc
Confidence            34567888899999999999997544       33499999888765543321    22333443   345666777777


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-------CCcE
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------DYNA  219 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-------~~~v  219 (389)
                      ..+.-++|+||.+.|+|.+++.  ....+++..++.+..|++..+..||..+  |||+||||+|+|+..       ...+
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             cCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccce
Confidence            7778899999999999999997  4457899999999999999999999988  999999999999943       3458


Q ss_pred             EEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCC
Q 016481          220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK  280 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~  280 (389)
                      +|+|||.+..+..-.........++|-.+-.+|++.|..+++.+|.|.|+.+++.||.|+.
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9999999987654433445566789999999999999999999999999999999999975

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=2.1e-20  Score=177.98  Aligned_cols=217  Identities=26%  Similarity=0.396  Sum_probs=162.6

Q ss_pred             HhccCCCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc-eecCCCC
Q 016481          130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPV-IYRDFKT  208 (389)
Q Consensus       130 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~i-vH~Dlkp  208 (389)
                      |+.+.|.|+.+++|.+.++...++|.+||.-|+|.+.+... ...+++.-...+.++++.||+|||...  | .|+.++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence            46788999999999999999999999999999999998774 346888888999999999999999854  5 8999999


Q ss_pred             CCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCC-------CCcccchhHHHHHHHHHHhCCCC
Q 016481          209 SNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-------LTPRSDVYSFGVVLLEILTGRKS  281 (389)
Q Consensus       209 ~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~~DiwslG~il~elltg~~p  281 (389)
                      .|++++....+||+|||+.................-..-|.|||++.+..       .+.+.||||||++++|+++-+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999987654211111111123455699999987642       36679999999999999999999


Q ss_pred             CCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCC-h-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          282 LDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP-V-KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       282 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      |.........  ...+..+. .      .-.+.+++... . ....++..++.+||..+|.+||++.++-..++.+...
T Consensus       158 ~~~~~~~~~~--~eii~~~~-~------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  158 FDLRNLVEDP--DEIILRVK-K------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccccCCh--HHHHHHHH-h------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9864333221  11111111 1      01111111111 1 3345789999999999999999999999888776554

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=8.1e-20  Score=158.54  Aligned_cols=136  Identities=18%  Similarity=0.180  Sum_probs=102.5

Q ss_pred             cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-----CCCccceEEeEEEeCC
Q 016481           75 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-----SHPNLVKLIGYCCEDE  149 (389)
Q Consensus        75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~  149 (389)
                      .-.+.||+|+||.||.  +..+..       .+||+...... .....+.+|+.+++.+     .||||+++++++.++.
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~-------k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~   74 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQ-------RCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC   74 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcC-------eEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC
Confidence            3457899999999995  332211       56888765422 2345688999999999     5799999999998763


Q ss_pred             ---eEE-EEEEe--cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceecCCCCCCeEEcC----CCc
Q 016481          150 ---HRV-LIYEF--MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL-AFLHEAEKPVIYRDFKTSNILLDT----DYN  218 (389)
Q Consensus       150 ---~~~-lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~ivH~Dlkp~Nili~~----~~~  218 (389)
                         .++ +|+||  +.+|+|.+++.+.   .+++.  ..++.+++.++ +|||+++  |+||||||+|||++.    ++.
T Consensus        75 g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         75 GTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             CCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCc
Confidence               434 78999  5579999999653   35544  35567777777 9999988  999999999999974    347


Q ss_pred             EEEeccCCC
Q 016481          219 AKLSDFGLA  227 (389)
Q Consensus       219 vkl~Dfg~a  227 (389)
                      ++|+||+.+
T Consensus       148 ~~LiDg~G~  156 (210)
T PRK10345        148 PVVCDNIGE  156 (210)
T ss_pred             EEEEECCCC
Confidence            999995433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.83  E-value=9.2e-21  Score=189.18  Aligned_cols=211  Identities=25%  Similarity=0.367  Sum_probs=144.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|..++.|..|++|.||..+++.+.      ..+|.|+-+...       +++.  ++.....|.+|          
T Consensus        81 ~e~df~~IklisngAygavylvrh~~tr------qrfa~kiNkq~l-------ilRn--ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETR------QRFAMKINKQNL-------ILRN--ILTFAGNPFVV----------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccc------cchhhcccccch-------hhhc--cccccCCccee----------
Confidence            3568999999999999999998765443      338875532210       1111  22223334333          


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                                 |+-...+....  +++...        +.+++|||+.+  |+|||+||+|.+|..-|++|++|||+++.
T Consensus       136 -----------gDc~tllk~~g--~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 -----------GDCATLLKNIG--PLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             -----------chhhhhcccCC--CCcchh--------hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhh
Confidence                       33333332222  333332        67899999966  99999999999999999999999998764


Q ss_pred             CCCCCCc-------------cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          230 GPEGDKS-------------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       230 ~~~~~~~-------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      .......             ......+||+.|.|||++...+|...+|+|++|+|+|+++.|..||.+..+.+..     
T Consensus       193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf-----  267 (1205)
T KOG0606|consen  193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-----  267 (1205)
T ss_pred             hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH-----
Confidence            3211100             0112369999999999999999999999999999999999999999987554321     


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP  343 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  343 (389)
                       ..++.+....   .+     . ......++++++.++|+.+|..|.
T Consensus       268 -g~visd~i~w---pE-----~-dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  268 -GQVISDDIEW---PE-----E-DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             -hhhhhhhccc---cc-----c-CcCCCHHHHHHHHHHHHhChHhhc
Confidence             1111111111   11     1 223457899999999999999997

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=1.1e-18  Score=155.05  Aligned_cols=143  Identities=15%  Similarity=0.107  Sum_probs=106.4

Q ss_pred             CCcccceecCCCceEEEEee-eccccccCcCcccEEEEEecCCCCh---------------------h--hHHHHHHHHH
Q 016481           73 NFRQDRVLGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSY---------------------Q--GHREWLAEVI  128 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~~~~~~~~vaiK~~~~~~~~---------------------~--~~~~~~~E~~  128 (389)
                      -|.+.+.||+|+||.||+|. ...+      +..||+|++......                     .  ....+..|+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~------g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGS------GKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCC------CcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            48899999999999999997 3322      334999998754210                     0  1123457999


Q ss_pred             HHhccCCC--ccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-ceecC
Q 016481          129 FLGHLSHP--NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP-VIYRD  205 (389)
Q Consensus       129 ~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-ivH~D  205 (389)
                      .+.++.+.  .+..+++.    ...++||||++|++|.......  .......+..++.|++.+|++||.  .+ |+|+|
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~D  174 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK--EGELVHGD  174 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCC
Confidence            99999753  23444432    2348999999998877654332  245566678899999999999998  45 99999


Q ss_pred             CCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          206 FKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       206 lkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      |||+||+++ ++.++|+|||.+...
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999 889999999988753

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=5.3e-20  Score=172.19  Aligned_cols=174  Identities=22%  Similarity=0.343  Sum_probs=128.0

Q ss_pred             CeEEEEEEecCCCChhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          149 EHRVLIYEFMARGSVENNLFSK-VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .++||.|++|..++|.+|+..+ .....++...+.++.|++.|+.|   .+  .+|+|+||.||++..+..+||+|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence            4689999999999999999643 34456788889999999999999   45  999999999999999999999999998


Q ss_pred             cCCCCCC----CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          228 KDGPEGD----KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       228 ~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      .......    .....+...||..||+||.+.+..|+.++||||||+||+||+.   +|......            .  
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er------------~--  466 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFER------------I--  466 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHH------------H--
Confidence            7654433    1222344789999999999999999999999999999999998   22211000            0  


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHH
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR  346 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  346 (389)
                       ..+..+-+..++..+. ...++-..|+.+++...|.+||++-
T Consensus       467 -~t~~d~r~g~ip~~~~-~d~p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  467 -ATLTDIRDGIIPPEFL-QDYPEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             -HhhhhhhcCCCChHHh-hcCcHHHHHHHHhcCCCcccCchHH
Confidence             0011111111110111 1123346899999999999999443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.8e-18  Score=150.57  Aligned_cols=135  Identities=18%  Similarity=0.221  Sum_probs=109.5

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--h-----hhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--Y-----QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      +.||+|++|.||+|.+.+        ..+++|.......  .     .....+.+|+.++..+.|++|.....++.....
T Consensus         2 ~~l~~G~~~~vy~~~~~~--------~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   73 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLG--------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN   73 (211)
T ss_pred             cccccCceEEEEEEeeCC--------CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC
Confidence            579999999999997522        2288887654321  1     112356789999999999998887777777788


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .++||||++|++|.+.+....     . ....++.+++.+|.++|..+  ++|+|++|.|||++ ++.++|+|||.+..
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            899999999999998875432     1 67889999999999999977  99999999999999 78999999998765

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=4.6e-18  Score=147.79  Aligned_cols=131  Identities=18%  Similarity=0.243  Sum_probs=103.3

Q ss_pred             eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--h-----hhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           79 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--Y-----QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .||+|+||.||+|.+..        ..+++|.......  .     ....++.+|+.+++.+.|+++.....++......
T Consensus         1 ~ig~G~~~~vy~~~~~~--------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLG--------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK   72 (199)
T ss_pred             CCCCCceEEEEEeecCC--------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC
Confidence            48999999999997432        2388888553321  1     1124566899999999988766555556667778


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ++||||++|++|.+.+.....         .++.+++.+|.+||+.+  ++|+|++|.||+++ ++.++++|||++..
T Consensus        73 ~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999999887644311         78889999999999977  99999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=8.1e-18  Score=167.61  Aligned_cols=138  Identities=20%  Similarity=0.225  Sum_probs=109.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCC--C-----ChhhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--N-----SYQGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~--~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      ..|...+.||+|+||.||+|.+....        +++|.....  .     .......+.+|+.+++.++|++++....+
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~  404 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD--------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY  404 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc--------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence            34567899999999999998764332        333332111  1     11223567789999999999999988888


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      +......++||||++|++|.+++.          ....++.+++.+|.+||+.+  ++||||||+|||+ .++.++|+||
T Consensus       405 ~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDF  471 (535)
T PRK09605        405 DVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDF  471 (535)
T ss_pred             EEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeC
Confidence            777778899999999999998774          34678899999999999977  9999999999999 6779999999


Q ss_pred             CCCcCC
Q 016481          225 GLAKDG  230 (389)
Q Consensus       225 g~a~~~  230 (389)
                      |+++..
T Consensus       472 Gla~~~  477 (535)
T PRK09605        472 GLGKYS  477 (535)
T ss_pred             cccccC
Confidence            998763

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.9e-17  Score=143.76  Aligned_cols=138  Identities=17%  Similarity=0.110  Sum_probs=103.9

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh---------------------hhHHHHHHHHHHHhc
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY---------------------QGHREWLAEVIFLGH  132 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------------------~~~~~~~~E~~~l~~  132 (389)
                      |.+.+.||+|+||.||+|... +      +..||+|++......                     .....+..|+.++..
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-D------GNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-C------CCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            888899999999999999753 2      233999986643210                     011124568888888


Q ss_pred             cCCCc--cceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 016481          133 LSHPN--LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  210 (389)
Q Consensus       133 l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~N  210 (389)
                      +.|++  ++..++    ....++||||++|++|......        .....++.+++.++.++|..+  ++|+||||+|
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~N  155 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFN  155 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCccc
Confidence            87764  444443    2455899999999988764321        234578889999999999977  9999999999


Q ss_pred             eEEcCCCcEEEeccCCCcCCCC
Q 016481          211 ILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       211 ili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      |+++.++.++|+|||++.....
T Consensus       156 ill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=1.4e-19  Score=179.97  Aligned_cols=258  Identities=24%  Similarity=0.257  Sum_probs=193.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  149 (389)
                      ..|.+.+.||+|+|+.|-.+....+.     ...+|.|.+.... ..........|..+-..+. |+|++++++...+.+
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~-----~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDP-----ESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCC-----cceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc
Confidence            35667777999999999876433222     2336666555432 2222333445777777776 999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceecCCCCCCeEEcCCC-cEEEeccCCC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH-EAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLA  227 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~ivH~Dlkp~Nili~~~~-~vkl~Dfg~a  227 (389)
                      ..+++++|..||++...+........+...+...+.|+..++.|+| ..+  +.|+||||+|.+++..+ .+++.|||+|
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhh
Confidence            9999999999999998884322224455566788899999999999 766  99999999999999999 9999999999


Q ss_pred             cCCCC-CCCccccccccc-cccccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          228 KDGPE-GDKSHVSTRIMG-TYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       228 ~~~~~-~~~~~~~~~~~g-t~~y~aPE~l~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      ..+.. ..........+| ++.|+|||...+.. ..+..|+||+|+++..+++|..|+........ .+..|        
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~--------  243 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSW--------  243 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceee--------
Confidence            98876 454455556788 99999999998854 47789999999999999999999986654321 11111        


Q ss_pred             hhhhhhcCCC--CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNIIDPR--LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                            ....  ..............+++.+++..+|..|.+.+++...
T Consensus       244 ------~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  244 ------KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             ------cccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                  1111  1112233456777889999999999999999988654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=2.4e-16  Score=135.48  Aligned_cols=139  Identities=22%  Similarity=0.189  Sum_probs=95.1

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh-hHHH----------------------HHHHHHHHhcc
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-GHRE----------------------WLAEVIFLGHL  133 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~----------------------~~~E~~~l~~l  133 (389)
                      .+.||+|+||.||+|... +      +..||+|++....... ....                      ...|...+..+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~------~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   74 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-D------GEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL   74 (187)
T ss_pred             CcccccccceeEEEEECC-C------CCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH
Confidence            568999999999999754 2      2349999877542111 1111                      12455555555


Q ss_pred             CCC--ccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCC
Q 016481          134 SHP--NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSN  210 (389)
Q Consensus       134 ~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~N  210 (389)
                      .+.  .+.+.+++    ...++||||++++.+.........  .. .....++.+++.++.++|. .+  |+|+||||+|
T Consensus        75 ~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~N  145 (187)
T cd05119          75 YEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYN  145 (187)
T ss_pred             HHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhh
Confidence            433  24444443    245899999998654322111111  11 5567889999999999998 77  9999999999


Q ss_pred             eEEcCCCcEEEeccCCCcCCCC
Q 016481          211 ILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       211 ili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      |+++ ++.++|+|||.+.....
T Consensus       146 ili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         146 ILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEE-CCcEEEEECcccccccC
Confidence            9999 88999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=6.9e-16  Score=127.33  Aligned_cols=135  Identities=21%  Similarity=0.197  Sum_probs=110.2

Q ss_pred             ccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCC--CccceEEeEEEeCCeEEE
Q 016481           76 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH--PNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~l  153 (389)
                      +.+.||.|.++.||++....        ..+++|.......   ...+..|+.+++.+.|  .++++++++....+..++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--------~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~   70 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--------EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYL   70 (155)
T ss_pred             cceecccccccceEEEEecC--------CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEE
Confidence            35779999999999997543        2399999866533   3567789999999976  589999988888788999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +|||+.|+.+...         +......++.+++.+|+++|... .+++|+|++|+||+++..+.++++|||.+...
T Consensus        71 v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          71 LMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            9999998776543         44556778889999999999852 34999999999999999899999999988753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=2.8e-15  Score=133.52  Aligned_cols=136  Identities=22%  Similarity=0.183  Sum_probs=98.4

Q ss_pred             ceec-CCCceEEEEeeeccccccCcCcccEEEEEecCCC------------ChhhHHHHHHHHHHHhccCCCcc--ceEE
Q 016481           78 RVLG-GGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN------------SYQGHREWLAEVIFLGHLSHPNL--VKLI  142 (389)
Q Consensus        78 ~~lg-~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~~~  142 (389)
                      ..|| .|+.|+||.+....        ..+++|.+....            .......+.+|+.++..+.|++|  +..+
T Consensus        37 ~~lg~~~g~gtv~~v~~~~--------~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl  108 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPG--------VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPI  108 (239)
T ss_pred             ceeecCCCCccEEEEEeCC--------ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeE
Confidence            4566 67778888765431        228888764321            01223457789999999998775  6667


Q ss_pred             eEEEeCC----eEEEEEEecCC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          143 GYCCEDE----HRVLIYEFMAR-GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       143 ~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      ++.....    ..++|||+++| .+|.+++...   .++..    .+.+++.+|.+||..|  |+|+||||.|||++.++
T Consensus       109 ~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~  179 (239)
T PRK01723        109 AARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDG  179 (239)
T ss_pred             eeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCC
Confidence            6644322    23599999997 5888776542   34443    3568899999999977  99999999999999989


Q ss_pred             cEEEeccCCCcCC
Q 016481          218 NAKLSDFGLAKDG  230 (389)
Q Consensus       218 ~vkl~Dfg~a~~~  230 (389)
                      .++|+|||.+...
T Consensus       180 ~v~LIDfg~~~~~  192 (239)
T PRK01723        180 KFWLIDFDRGELR  192 (239)
T ss_pred             CEEEEECCCcccC
Confidence            9999999988753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=4.5e-15  Score=141.81  Aligned_cols=256  Identities=23%  Similarity=0.280  Sum_probs=183.7

Q ss_pred             HhcCCcccceecC--CCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccC-CCccceEEeEE
Q 016481           70 ITANFRQDRVLGG--GGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLS-HPNLVKLIGYC  145 (389)
Q Consensus        70 ~~~~~~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~  145 (389)
                      ....|-+.+.+|.  |.+|.||.+....    ......+|+|.-+.... ......-++|+.....++ |+|.++.+..+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~----~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTN----SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCc----ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            3446777888999  9999999976411    22334488887443322 122223345776667775 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceecCCCCCCeEEcCC-CcEE
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK----GLAFLHEAEKPVIYRDFKTSNILLDTD-YNAK  220 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~ivH~Dlkp~Nili~~~-~~vk  220 (389)
                      ...+.+|+-+|++. .+|..+...... -++...+...+.+...    ||.++|+.+  ++|.|+||.||+...+ ...+
T Consensus       188 e~~~~lfiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  188 EGSGILFIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             ccCCcceeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceee
Confidence            99999999999995 688877765543 3667777788888888    999999977  9999999999999998 8899


Q ss_pred             EeccCCCcCCCCCCCc---cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH
Q 016481          221 LSDFGLAKDGPEGDKS---HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  297 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  297 (389)
                      ++|||+...+..+.-.   .......|...|++||++. .-++...||++||.++.+..+|..++...-..      .| 
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W-  335 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW-  335 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc-
Confidence            9999998877655422   1223347888999999764 56789999999999999999988766433100      00 


Q ss_pred             hHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                             ..+.+..   +..++-...+.++...+..|++.+|-.|++++.+.++
T Consensus       336 -------~~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  336 -------SQLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             -------ccccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                   0111111   1112222234566679999999999999999988755

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.55  E-value=7.3e-15  Score=130.15  Aligned_cols=203  Identities=22%  Similarity=0.275  Sum_probs=141.9

Q ss_pred             HhccCCCccceEEeEEEeC-----CeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 016481          130 LGHLSHPNLVKLIGYCCED-----EHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVI  202 (389)
Q Consensus       130 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~iv  202 (389)
                      +-++.|.|||+++.+|.+.     ....+++|||..|++..+|.+.  ....+....-.+|+-||..||.|||+..++|+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            4455699999999998653     3578999999999999998653  34456777778999999999999999999999


Q ss_pred             ecCCCCCCeEEcCCCcEEEeccCC--CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCC
Q 016481          203 YRDFKTSNILLDTDYNAKLSDFGL--AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK  280 (389)
Q Consensus       203 H~Dlkp~Nili~~~~~vkl~Dfg~--a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~  280 (389)
                      |+++..+.|++..+|-+|++----  ....-............+-++|.+||.-....-+.++|||+||+...+|..|..
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence            999999999999999888763211  000000000011222457788999998776777889999999999999999876


Q ss_pred             CCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          281 SLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       281 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .-.........  .       .........+...           .-++++.+|++-.|..||++++++-|.
T Consensus       281 q~tnseS~~~~--e-------e~ia~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  281 QSTNSESKVEV--E-------ENIANVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             ccCCCcceeeh--h-------hhhhhheeeccCc-----------cccCcCcccccCCCCCCcchhhhhcCc
Confidence            53322111000  0       0000111111111           124577899999999999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=1.9e-13  Score=132.22  Aligned_cols=143  Identities=19%  Similarity=0.115  Sum_probs=94.3

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhH------------------------------------
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH------------------------------------  120 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------------------  120 (389)
                      .+.||.|++|.||+|+.++.       ..||||+.+........                                    
T Consensus       122 ~~plasaSigQVh~A~l~~G-------~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l  194 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDG-------KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL  194 (437)
T ss_pred             CcceeeeehhheEEEEecCC-------CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence            36799999999999987542       33999998765311110                                    


Q ss_pred             ---HHHHHHHHHHhcc----CCCccceEEeEE-EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHH-HH
Q 016481          121 ---REWLAEVIFLGHL----SHPNLVKLIGYC-CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK-GL  191 (389)
Q Consensus       121 ---~~~~~E~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~-~l  191 (389)
                         -++..|...+.++    ++.+-+.+-.++ ......++||||++|++|.+....... ...   ...++..++. .+
T Consensus       195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHH
Confidence               0123344444443    222223322222 223456899999999999886543211 122   2345555555 46


Q ss_pred             HHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       192 ~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      ..+|..|  ++|+|++|.||+++.++.++++|||++.....
T Consensus       271 ~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       271 NQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            7889877  99999999999999999999999999877643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=2.1e-13  Score=133.50  Aligned_cols=146  Identities=16%  Similarity=0.082  Sum_probs=90.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh--------------------------------
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ--------------------------------  118 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------------------------------  118 (389)
                      -..|.. +.||+|++|.||+|+.+++++.      ||||+.+......                                
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~------VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~  191 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGRE------VVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA  191 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCE------EEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence            345666 7899999999999988764443      9999998652111                                


Q ss_pred             -hHHH------HHHHHHHHhccC----CCccceEEeEEEe-CCeEEEEEEecCCCChhhhh--hcCCCC--CCCHHHHHH
Q 016481          119 -GHRE------WLAEVIFLGHLS----HPNLVKLIGYCCE-DEHRVLIYEFMARGSVENNL--FSKVLL--PLPWSIRMK  182 (389)
Q Consensus       119 -~~~~------~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~--~~~~~~~~~  182 (389)
                       ....      +.+|..-+.++.    +.+.+.+-.++.+ ....++||||++|+.+.+..  ......  .+....+..
T Consensus       192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~  271 (537)
T PRK04750        192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV  271 (537)
T ss_pred             HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence             0111      223333333331    3333333333322 34567999999999997642  221110  122222233


Q ss_pred             HHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC----cEEEeccCCCcCCCC
Q 016481          183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAKLSDFGLAKDGPE  232 (389)
Q Consensus       183 i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~----~vkl~Dfg~a~~~~~  232 (389)
                      ++.|       +...|  ++|+|+||.||+++.++    .++++|||++.....
T Consensus       272 ~~~Q-------if~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQ-------VFRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------HHhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3333       33456  99999999999999888    999999999887654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.43  E-value=3.4e-12  Score=109.01  Aligned_cols=146  Identities=14%  Similarity=0.134  Sum_probs=97.9

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-----------h----------hhHHHH----HHHHHHHh
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-----------Y----------QGHREW----LAEVIFLG  131 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-----------~----------~~~~~~----~~E~~~l~  131 (389)
                      ...||.|.-+.||.|...+..........+|+|+.+....           .          .....+    .+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999996432110111234599998664320           0          001112    26888888


Q ss_pred             ccCC--CccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceecCCCC
Q 016481          132 HLSH--PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL-HEAEKPVIYRDFKT  208 (389)
Q Consensus       132 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~ivH~Dlkp  208 (389)
                      ++..  -++...+++    ..-+|||||+.++.+.......  ..++......+..+++.+|..| |..+  |||+||++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            8853  456666654    3558899999765443221111  1344455667788999999988 8877  99999999


Q ss_pred             CCeEEcCCCcEEEeccCCCcCCC
Q 016481          209 SNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       209 ~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      .||+++ ++.+.|+|||.+....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4689999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.42  E-value=1.1e-12  Score=110.75  Aligned_cols=130  Identities=22%  Similarity=0.099  Sum_probs=92.4

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCcc-ceEEeEEEeCCeEEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  155 (389)
                      .+.|+.|.++.||++...        +..|++|+......  ....+..|+.+++.+.+.++ .+++.+.  ....++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--------~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--------NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEEC--------CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEE
Confidence            356889999999998643        12399999765432  12234578888888865444 3455443  33458999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK---PVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       156 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~---~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ||++|.++...   .   .    ....++.+++.+|+.||..+.   .++|+|++|.||+++ ++.++++|||.+..
T Consensus        71 e~i~G~~l~~~---~---~----~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          71 EFIEGSELLTE---D---F----SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EecCCCccccc---c---c----cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99999877643   0   0    113456789999999998651   249999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=1.3e-11  Score=119.67  Aligned_cols=162  Identities=19%  Similarity=0.190  Sum_probs=117.2

Q ss_pred             ccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHH
Q 016481          104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI  183 (389)
Q Consensus       104 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i  183 (389)
                      .+|.|........ .......+-++.|+.++||||+++++.+..++++|+|+|-+.  .|..++....     ...+..-
T Consensus        38 ~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v~~G  109 (690)
T KOG1243|consen   38 GPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEVCLG  109 (690)
T ss_pred             CceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHHHHH
Confidence            3466666655544 223345567788999999999999999999999999999984  5665554432     4566777


Q ss_pred             HHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCccc
Q 016481          184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS  263 (389)
Q Consensus       184 ~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~  263 (389)
                      +.||+.||.+||..+ +++|++|.-..|+++..|..||++|.++........  ......--..|..|+.+....  -..
T Consensus       110 l~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~  184 (690)
T KOG1243|consen  110 LFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSI  184 (690)
T ss_pred             HHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cch
Confidence            889999999998543 399999999999999999999999988765433221  011111122345555442222  346


Q ss_pred             chhHHHHHHHHHHhC
Q 016481          264 DVYSFGVVLLEILTG  278 (389)
Q Consensus       264 DiwslG~il~elltg  278 (389)
                      |.|-|||++++++.|
T Consensus       185 D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  185 DSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhHHHHHHHHhCc
Confidence            999999999999999

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.36  E-value=2.1e-13  Score=137.24  Aligned_cols=250  Identities=20%  Similarity=0.220  Sum_probs=168.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .+.+.+.+-+-+|+++.++.+.-......      .++|+.....  .....+....+-.++-...+|-++...-.+.-.
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~------~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHT------RPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccc------cchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCC
Confidence            45677777888999999987643333211      3333332211  011111222222222223345556555555567


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..++++++|..+++|...++...  +............+..+++|||...  +.|+|++|.|+++..++..++.|||...
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccc
Confidence            78899999999999998886654  3444444555567778999999865  8999999999999999999999998432


Q ss_pred             CCCCC-----------------------------CCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCC
Q 016481          229 DGPEG-----------------------------DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR  279 (389)
Q Consensus       229 ~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~  279 (389)
                      .....                             +.........||+.|.+||.+.+......+|+|++|+++++.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            11100                             0001122357999999999999999999999999999999999999


Q ss_pred             CCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCC-CCCCChHHHHHHHHHHHHhhccCCCCCCCHH
Q 016481          280 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL-EGDYPVKGVHKAAMLAYHCLNHNPKARPLMR  346 (389)
Q Consensus       280 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  346 (389)
                      +||+...+...                +..+..... ...-+...+..+++++...+..+|.+|..+.
T Consensus      1033 pp~na~tpq~~----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQI----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhhh----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99997654321                111222111 1223456678899999999999999998876

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=2e-12  Score=123.89  Aligned_cols=252  Identities=20%  Similarity=0.148  Sum_probs=174.3

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccC-CCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLS-HPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  147 (389)
                      ...+|-.+..||.|.|+.|+.+. +.    ......|++|........ .....-+.|+.+...+. |.++++.+..|..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~-~r----~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVS-KR----PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeee-ec----CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence            34567888899999999999864 22    122333788876544321 22222345666666664 8999999999988


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC-CcEEEeccCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGL  226 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~-~~vkl~Dfg~  226 (389)
                      ..+.|+--|||+++++....  .....+.....+.+..|++.++.++|+..  ++|+|+||.||++..+ +..+++|||.
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             cccccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccc
Confidence            88889999999999887655  22234666777889999999999999966  9999999999999876 7789999998


Q ss_pred             CcCCCCCCCcccccccccccccc--CccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYA--APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      ...+...     .....+.-+++  ++.......+-.++|++|||..+.+.++|...-.....                 
T Consensus       414 ~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----------------  471 (524)
T KOG0601|consen  414 WTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----------------  471 (524)
T ss_pred             cccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----------------
Confidence            7643211     11123344444  44444566778899999999999999998764332211                 


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                        ...+..... ...+.. ..++..+.+.+...|+..||.+.++..+.+...
T Consensus       472 --~~~i~~~~~-p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  472 --SLTIRSGDT-PNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             --ceeeecccc-cCCCch-HHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence              011111101 111222 277788999999999999999999877665544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=6.1e-11  Score=98.07  Aligned_cols=132  Identities=19%  Similarity=0.231  Sum_probs=96.7

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--Chh-----hHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQ-----GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+++|+-+.+|.+.+.+.        .+++|......  .+.     ...+-.+|.+++..+.--.|....=+..+...
T Consensus         2 ~~i~~GAEa~i~~~~~~g~--------~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGL--------PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN   73 (204)
T ss_pred             chhhCCcceeEEeeeccCc--------ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC
Confidence            4578999999999855321        26677543321  111     11334569999988865555555556667778


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..|+|||++|..|.+.+...         ...++..+-..+.-||.+|  |||+||.++||++..++ +.++|||++..
T Consensus        74 ~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            88999999998888887655         1456667778888999988  99999999999997664 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=7.2e-11  Score=97.19  Aligned_cols=144  Identities=20%  Similarity=0.164  Sum_probs=103.5

Q ss_pred             ccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-----Chh--hHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           76 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-----SYQ--GHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      ....|-+|+-+.|+++.+....        .+||......     -.+  ...+..+|++++.++.--.|.-..=++.+.
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~--------~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEA--------AIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT   82 (229)
T ss_pred             cceeeeccceeeEeeeccCCce--------eEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec
Confidence            4678899999999999765432        5666533221     111  124456799999888655555555566666


Q ss_pred             CeEEEEEEecCC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC---cEEEecc
Q 016481          149 EHRVLIYEFMAR-GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---NAKLSDF  224 (389)
Q Consensus       149 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~---~vkl~Df  224 (389)
                      ..-.|+|||++| .++.+++...............++..+-+.+.-||.++  |+|+||..+||++..++   .+.++||
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEee
Confidence            777899999987 36777776655444333444788889999999999988  99999999999996554   3589999


Q ss_pred             CCCcC
Q 016481          225 GLAKD  229 (389)
Q Consensus       225 g~a~~  229 (389)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=1.7e-10  Score=101.73  Aligned_cols=142  Identities=18%  Similarity=0.196  Sum_probs=102.4

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCC--CccceEEeEEEeC---CeEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH--PNLVKLIGYCCED---EHRV  152 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~  152 (389)
                      +.|+.|.++.||++...+       +..+++|+............+..|..+++.+.+  .++.+++.+....   +..+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEecC-------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            568999999999986532       233999997654332234466789999999875  3456677766553   3668


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-----------------------------------  197 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----------------------------------  197 (389)
                      +||||++|+++...+..   ..++......++.+++.+|..||+.                                   
T Consensus        77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999999887765431   2455566666777777777777742                                   


Q ss_pred             -------------------CCCceecCCCCCCeEEcC--CCcEEEeccCCCcC
Q 016481          198 -------------------EKPVIYRDFKTSNILLDT--DYNAKLSDFGLAKD  229 (389)
Q Consensus       198 -------------------~~~ivH~Dlkp~Nili~~--~~~vkl~Dfg~a~~  229 (389)
                                         ...++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               134799999999999988  66789999998765

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.21  E-value=8.8e-10  Score=101.60  Aligned_cols=262  Identities=17%  Similarity=0.185  Sum_probs=157.8

Q ss_pred             cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeE------EEe
Q 016481           75 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGY------CCE  147 (389)
Q Consensus        75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~------~~~  147 (389)
                      ..++.||+|+-+.+|-.-.   ..+      .+.|+.......... +   .+..|... .||-+-.=+.+      .-+
T Consensus        14 ~~gr~LgqGgea~ly~l~e---~~d------~VAKIYh~Pppa~~a-q---k~a~la~~p~~p~~~~rvaWPqa~L~G~~   80 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---VRD------QVAKIYHAPPPAAQA-Q---KVAELAATPDAPLLNYRVAWPQATLHGGR   80 (637)
T ss_pred             CCCccccCCccceeeecch---hhc------hhheeecCCCchHHH-H---HHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence            3467899999999996321   111      456776654322221 1   22233333 35533221111      112


Q ss_pred             C-CeEEEEEEecCCCC-hhhhhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          148 D-EHRVLIYEFMARGS-VENNLF----SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       148 ~-~~~~lv~e~~~~gs-L~~~l~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                      . ..+-++|..+.|.. +.+++.    ++......|...++.++.++.+.+-||.+|  .+-+|+.++|+|+.+++.|.|
T Consensus        81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~L  158 (637)
T COG4248          81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVL  158 (637)
T ss_pred             ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEE
Confidence            2 23667888877642 222221    122234678999999999999999999988  888999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhC-CCCCCCCCchh--hhhh
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTG-RKSLDKSRPAR--EQNL  293 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~--~~~~  293 (389)
                      .|=..-...   .........+|...|.+||...     +..-+...|.|.||++++++|.| ++||.+-...-  ...+
T Consensus       159 VdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~  235 (637)
T COG4248         159 VDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL  235 (637)
T ss_pred             Ecccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence            985432222   1222333467999999999765     34457789999999999999886 99998542110  0001


Q ss_pred             H-HHHhHHHHhhhhhhhhcCCCCCCCCC-hHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHhccc
Q 016481          294 A-DWALPLLKEKKKLLNIIDPRLEGDYP-VKGVHKAAMLAYHCLNHN--PKARPLMRDIVDSLEPL  355 (389)
Q Consensus       294 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~d--P~~Rps~~~il~~L~~~  355 (389)
                      . +..........+-..-..+ -....| .-.+..+..++.+|+...  +.-|||++.++..|..+
T Consensus       236 E~~Ia~g~f~ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         236 ETDIAHGRFAYASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hhhhhcceeeechhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            0 0000000000000000000 011112 234678889999999754  67899999998877555

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.13  E-value=3.3e-09  Score=100.22  Aligned_cols=216  Identities=16%  Similarity=0.178  Sum_probs=147.7

Q ss_pred             CceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEE----eCCeEEEEEEecC
Q 016481           84 GFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC----EDEHRVLIYEFMA  159 (389)
Q Consensus        84 ~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~  159 (389)
                      ...+.|+|+.+.++..      |++|.++..+. +.......-+++++++.|.|+|++.++|.    .+..+++|++|++
T Consensus       288 ~~~Ttyk~~s~~DG~~------YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP  360 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNA------YVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP  360 (655)
T ss_pred             ccceeEeeeeccCCce------eeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence            4467899987666554      89998854432 22222234567899999999999999876    4568899999998


Q ss_pred             C-CChhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          160 R-GSVENNLFSKV-------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       160 ~-gsL~~~l~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      + ++|++..+...             ....++...+.++.|+..||.++|+.|  +.-+-|.+.+|+++.+.+++|...|
T Consensus       361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~  438 (655)
T KOG3741|consen  361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCG  438 (655)
T ss_pred             CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEeccc
Confidence            6 46777665421             234677889999999999999999988  8889999999999999999999998


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +.........                +-+.+   -.+-|.=.||.+++.|.||...-...+-.. ....+.         
T Consensus       439 i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~-~s~~~~---------  489 (655)
T KOG3741|consen  439 IMDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQ-SSHLTR---------  489 (655)
T ss_pred             ceeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchH-HHHHHH---------
Confidence            8765433220                11111   235688899999999999965322211110 000000         


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                                   .....+.++++++.-.....+++ -++.+++.+
T Consensus       490 -------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  490 -------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             -------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                         11234566777777777777766 566666654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.07  E-value=4.4e-09  Score=94.90  Aligned_cols=106  Identities=17%  Similarity=0.076  Sum_probs=79.0

Q ss_pred             HHHHHHHHHhccCCCc--cceEEeEEEe-----CCeEEEEEEecCCC-ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 016481          122 EWLAEVIFLGHLSHPN--LVKLIGYCCE-----DEHRVLIYEFMARG-SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF  193 (389)
Q Consensus       122 ~~~~E~~~l~~l~h~n--iv~~~~~~~~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~  193 (389)
                      .+.+|...+..+..-+  ++..++++..     ...-++|||++++. +|.+++......+.+......++.+++..+.-
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            3667888887774333  2334444432     23568999999876 68887754323355667778899999999999


Q ss_pred             HHhCCCCceecCCCCCCeEEcC-------CCcEEEeccCCCcC
Q 016481          194 LHEAEKPVIYRDFKTSNILLDT-------DYNAKLSDFGLAKD  229 (389)
Q Consensus       194 LH~~~~~ivH~Dlkp~Nili~~-------~~~vkl~Dfg~a~~  229 (389)
                      ||.+|  |+|+|+++.|||++.       ++.+.|+||+.+..
T Consensus       154 LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99988  999999999999975       46899999998753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.94  E-value=3.6e-10  Score=110.13  Aligned_cols=149  Identities=21%  Similarity=0.307  Sum_probs=105.5

Q ss_pred             HHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcc-------ccccccccccccCccccccCC
Q 016481          186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH-------VSTRIMGTYGYAAPEYIMTGH  258 (389)
Q Consensus       186 ~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~  258 (389)
                      +++.||.|+|.+ .++||++|.|++|.++.++..||+.|+++..........       ...-..-...|.|||++.+..
T Consensus       107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            344899999975 349999999999999999999999999877654321110       001123467899999999988


Q ss_pred             CCcccchhHHHHHHHHHH-hCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhcc
Q 016481          259 LTPRSDVYSFGVVLLEIL-TGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNH  337 (389)
Q Consensus       259 ~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  337 (389)
                      .+.++|+||||+++|.+. .|+..+........              .......+..-...+....+.++++=+.+++..
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--------------YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcch--------------hhhhhcccccccccccccCcHHHHHHHHHHhcC
Confidence            899999999999999999 45554543322111              111111111112233456788999999999999


Q ss_pred             CCCCCCCHHHHH
Q 016481          338 NPKARPLMRDIV  349 (389)
Q Consensus       338 dP~~Rps~~~il  349 (389)
                      ++..||++..++
T Consensus       252 ~~~~rp~~~~l~  263 (700)
T KOG2137|consen  252 DSAVRPTLDLLL  263 (700)
T ss_pred             CcccCcchhhhh
Confidence            999999777665

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.92  E-value=1.3e-08  Score=86.64  Aligned_cols=98  Identities=22%  Similarity=0.244  Sum_probs=62.0

Q ss_pred             HHHHHHHHhccCCC--ccceEEeEEEeCCeEEEEEEecC--CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhC
Q 016481          123 WLAEVIFLGHLSHP--NLVKLIGYCCEDEHRVLIYEFMA--RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF-LHEA  197 (389)
Q Consensus       123 ~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~  197 (389)
                      ..+|.+.|.++..-  ++.+++++.    .-+|||||++  |..+.. +....   +.......++.+++..+.. +|..
T Consensus        55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~-l~~~~---~~~~~~~~~~~~il~~~~~~~~~~  126 (188)
T PF01163_consen   55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPR-LKDVD---LSPEEPKELLEEILEEIIKMLHKA  126 (188)
T ss_dssp             HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGC-HHHCG---GGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred             HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhh-HHhcc---ccchhHHHHHHHHHHHHHHHHHhc
Confidence            45699999999754  466666543    3379999998  544443 33221   1122335566677774544 5787


Q ss_pred             CCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       198 ~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |  |+|+||.+.||+++.+ .+.++|||.+....
T Consensus       127 g--ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  127 G--IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             T--EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             C--ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            7  9999999999999887 99999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.91  E-value=1.4e-08  Score=89.24  Aligned_cols=137  Identities=18%  Similarity=0.094  Sum_probs=93.3

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC---------------------hhhHHHHHHHHHHHhc
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS---------------------YQGHREWLAEVIFLGH  132 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~E~~~l~~  132 (389)
                      ..++..||-|.-+.||.|....       +.++|+|..+....                     ........+|..+|.+
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~-------g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~  165 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPK-------GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQR  165 (304)
T ss_pred             HhhccccccCccceEEEEECCC-------CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHH
Confidence            5677899999999999997543       23499998765421                     0111234568888988


Q ss_pred             cCCC--ccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 016481          133 LSHP--NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  210 (389)
Q Consensus       133 l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~N  210 (389)
                      |...  .+.+.+++-    .=.+|||+++|-.|...-.       .......++..|+.-+.-+-..|  |||+|+++-|
T Consensus       166 L~~~G~~VP~P~~~n----RHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefN  232 (304)
T COG0478         166 LYPEGVKVPKPIAWN----RHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFN  232 (304)
T ss_pred             hhhcCCCCCCccccc----cceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchhe
Confidence            8643  566666543    4478999999866554221       12223334444555444444556  9999999999


Q ss_pred             eEEcCCCcEEEeccCCCcCC
Q 016481          211 ILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       211 ili~~~~~vkl~Dfg~a~~~  230 (389)
                      |+++++|.++++||-.+...
T Consensus       233 IlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EEEecCCCEEEEeCcccccC
Confidence            99999999999999876654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.80  E-value=1.1e-07  Score=82.92  Aligned_cols=105  Identities=24%  Similarity=0.148  Sum_probs=79.6

Q ss_pred             HHHHHHHHHHhccCC--CccceEEeEEEeC----CeEEEEEEecCCC-ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 016481          121 REWLAEVIFLGHLSH--PNLVKLIGYCCED----EHRVLIYEFMARG-SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF  193 (389)
Q Consensus       121 ~~~~~E~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~  193 (389)
                      ....+|...+..+..  =.++..+++....    ...++|+|++++. +|.+++.....  .+......++.+++..++-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            456678777776642  2244555555442    2458999999874 68887765332  5556678899999999999


Q ss_pred             HHhCCCCceecCCCCCCeEEcCCC---cEEEeccCCCcC
Q 016481          194 LHEAEKPVIYRDFKTSNILLDTDY---NAKLSDFGLAKD  229 (389)
Q Consensus       194 LH~~~~~ivH~Dlkp~Nili~~~~---~vkl~Dfg~a~~  229 (389)
                      ||.+|  |+|+|+++.|||++.++   .+.++||+-++.
T Consensus       134 lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99988  99999999999999887   899999997765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.72  E-value=3.2e-07  Score=78.78  Aligned_cols=140  Identities=16%  Similarity=0.107  Sum_probs=99.2

Q ss_pred             eecCCCceEEEEeeeccccccCcCcccEEEEEecCC--CC---hhhHHHHHHHHHHHhccCCC--ccceEEeEEE---eC
Q 016481           79 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NS---YQGHREWLAEVIFLGHLSHP--NLVKLIGYCC---ED  148 (389)
Q Consensus        79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~--~~---~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~---~~  148 (389)
                      --|+||.+.|++....+.        .+-+|.....  .+   +-....|.+|+..+.++..-  .+.... ++.   .+
T Consensus        25 N~~rgG~SgV~r~~~~g~--------~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~   95 (216)
T PRK09902         25 NYRRNGMSGVQCVERNGK--------KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIE   95 (216)
T ss_pred             CcCCCCcceEEEEEeCCc--------EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccC
Confidence            346789998998543222        2667764311  11   23456788999999888532  244444 222   11


Q ss_pred             --CeEEEEEEecCC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc--EEEec
Q 016481          149 --EHRVLIYEFMAR-GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN--AKLSD  223 (389)
Q Consensus       149 --~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~--vkl~D  223 (389)
                        -.-+||+|-++| -+|.+++......+.+......++.+++..++-||..|  +.|+|+.+.||+++.++.  ++++|
T Consensus        96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lID  173 (216)
T PRK09902         96 GEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLD  173 (216)
T ss_pred             CceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEE
Confidence              245899997754 46777776665556778888899999999999999988  999999999999986677  99999


Q ss_pred             cCCCcC
Q 016481          224 FGLAKD  229 (389)
Q Consensus       224 fg~a~~  229 (389)
                      |.-++.
T Consensus       174 lEk~r~  179 (216)
T PRK09902        174 LEKSRR  179 (216)
T ss_pred             hhccch
Confidence            986654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.57  E-value=1e-06  Score=76.79  Aligned_cols=154  Identities=19%  Similarity=0.117  Sum_probs=94.8

Q ss_pred             cCHHHHHHHhcCCcccc---eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhH--------HH--------
Q 016481           62 FTYDELRIITANFRQDR---VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH--------RE--------  122 (389)
Q Consensus        62 ~~~~~~~~~~~~~~~~~---~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~--------~~--------  122 (389)
                      .+...+..+.++..+..   .|+.|.-+.||+|...       ....+|+|+.......-..        ..        
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~r  107 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNR  107 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCH
Confidence            34455555556655544   4566778899998532       2334999998755311100        00        


Q ss_pred             -------HHHHHHHHhccC--CCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 016481          123 -------WLAEVIFLGHLS--HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF  193 (389)
Q Consensus       123 -------~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~  193 (389)
                             ..+|+.-|+++.  +-.+.+.+++.    .-.+||||+.....-.-..  ...++...+...+..++++.+.-
T Consensus       108 r~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~  181 (268)
T COG1718         108 RKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRR  181 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHH
Confidence                   123666666553  33344445444    3478999995431111111  11123333566777788888877


Q ss_pred             HHh-CCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          194 LHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       194 LH~-~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |-. .+  +||+||+.-|||+. ++.+.++|||.|....
T Consensus       182 l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         182 LYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHhcC--cccccchhhheEEE-CCeEEEEECccccccC
Confidence            766 66  99999999999999 8899999999987654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.56  E-value=2.1e-06  Score=75.83  Aligned_cols=138  Identities=16%  Similarity=0.093  Sum_probs=83.5

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc--cceEEeEEEeCCeEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN--LVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~  155 (389)
                      ..||+|..+.||+..    ..      .+++|+......   .....+|.++++.+..-.  +.+.+++....+...+||
T Consensus         7 ~~i~~G~t~~~y~~~----~~------~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~   73 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TG------KWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIY   73 (226)
T ss_pred             eeecCCCCcceeEec----CC------CEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeee
Confidence            568999999999831    11      278888765432   234567999998886332  467788877777888999


Q ss_pred             EecCCCC-hhhh---------------------hhcCCCCCCCHHHHH-HHHH----------HHHH-HHHHHH--hCCC
Q 016481          156 EFMARGS-VENN---------------------LFSKVLLPLPWSIRM-KIAF----------GAAK-GLAFLH--EAEK  199 (389)
Q Consensus       156 e~~~~gs-L~~~---------------------l~~~~~~~~~~~~~~-~i~~----------~i~~-~l~~LH--~~~~  199 (389)
                      |+++|.+ +...                     ++.-........... .+..          .+.. ...+|.  ....
T Consensus        74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            9999864 1111                     111100011111100 0000          0011 122222  2234


Q ss_pred             CceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       200 ~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .++|+|+.|.||+++.++ +.|+||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            578999999999999888 99999997754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.50  E-value=7.5e-07  Score=87.17  Aligned_cols=143  Identities=18%  Similarity=0.146  Sum_probs=88.9

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHH------------------------------------
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR------------------------------------  121 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~------------------------------------  121 (389)
                      ..|+.++-|.||+|++++.       ..||||+.+.........                                    
T Consensus       131 ~PiAsASIaQVH~A~L~sG-------~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         131 EPIASASIAQVHRAVLKSG-------EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             CchhhhhHhhheeEEecCC-------CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            6789999999999998762       339999988764221111                                    


Q ss_pred             ---HHHHHHHHHhccC-----CCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 016481          122 ---EWLAEVIFLGHLS-----HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF  193 (389)
Q Consensus       122 ---~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~  193 (389)
                         ++.+|..-+.+++     .+++.-..=++.-.+.-.++|||++|-.+.+...-.. ...+.+.+.....++.  +..
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q  280 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQ  280 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHH
Confidence               1112333333332     2222111122233456689999999988887643222 2444333333222222  222


Q ss_pred             HHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       194 LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      +-..|  ++|.|..|.||+++.+|++.+.|||+......
T Consensus       281 ~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            22246  99999999999999999999999999877654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.44  E-value=7.4e-06  Score=70.72  Aligned_cols=138  Identities=14%  Similarity=0.086  Sum_probs=86.1

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHH---------HHHHHHHhcc---CCC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW---------LAEVIFLGHL---SHP  136 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~---------~~E~~~l~~l---~h~  136 (389)
                      ++..+|...+.+-......|.+-..  +.+      .+++|..+..... ..+.|         .+++..+..+   ..-
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei--~~~------kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~   98 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI--DGK------KYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFT   98 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE--CCc------EEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence            5567888888888877776766422  222      2899987765322 11222         1233333333   222


Q ss_pred             ccceEEeEEE-----eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCe
Q 016481          137 NLVKLIGYCC-----EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  211 (389)
Q Consensus       137 niv~~~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Ni  211 (389)
                      .+..++-+..     .....+++|||++|..|.+...      ++.    .++..+.+++.-+|.+|  ++|+|+.|.|+
T Consensus        99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNF  166 (229)
T PF06176_consen   99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNF  166 (229)
T ss_pred             ccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcE
Confidence            3333332222     2234568999999987765431      222    24456777899999988  99999999999


Q ss_pred             EEcCCCcEEEeccCCCc
Q 016481          212 LLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       212 li~~~~~vkl~Dfg~a~  228 (389)
                      +++.+ .++++||+..+
T Consensus       167 lv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  167 LVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             EEECC-cEEEEECcccc
Confidence            99865 49999997644

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.42  E-value=1.9e-06  Score=89.14  Aligned_cols=196  Identities=20%  Similarity=0.233  Sum_probs=136.9

Q ss_pred             HHHHHHHHhccCCCccceEEeEEEeCCeEE----EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 016481          123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE  198 (389)
Q Consensus       123 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~  198 (389)
                      ...|+..+..+.|+|++.++.+........    +..+++..-++...+....  ..+....+.+..++.+||+|+|++.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            345777788889999999999876544333    3457787777777775554  6788888899999999999999975


Q ss_pred             CCceecCCCCC---CeEEcCCCcEEEe--ccCCCcCCCCCCCccccccccccccccCccccccCCCCcc--cchhHHHHH
Q 016481          199 KPVIYRDFKTS---NILLDTDYNAKLS--DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPR--SDVYSFGVV  271 (389)
Q Consensus       199 ~~ivH~Dlkp~---Nili~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~--~DiwslG~i  271 (389)
                        ..|.-+...   +.-.+..+.+.++  ||+..+.+.......   ...-+..|.++|......+..+  .|+|.+|..
T Consensus       307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             --cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHH
Confidence              555555444   4445566677777  998887765543222   2334556778888776666554  699999999


Q ss_pred             HHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          272 LLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       272 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +..+..|..+-.....                   ...+++        ........+...+|+..++++|+++.+++.+
T Consensus       382 ~~~~~~~~~i~~~~~~-------------------~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAV-------------------PVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HhhhhhcCcccccccc-------------------hhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            9999998765432210                   000110        0111256778899999999999999999987


Q ss_pred             h
Q 016481          352 L  352 (389)
Q Consensus       352 L  352 (389)
                      .
T Consensus       435 ~  435 (1351)
T KOG1035|consen  435 P  435 (1351)
T ss_pred             h
Confidence            4

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.39  E-value=5.9e-08  Score=94.08  Aligned_cols=184  Identities=17%  Similarity=0.107  Sum_probs=129.1

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc-cceEEeEEEeCCeEEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN-LVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  155 (389)
                      .+-+++|+++.+++.+...+.       ....+.+...      ....-++++|.+++||| .+..++-+..+...++++
T Consensus       247 fh~fvK~altknpKkRptaek-------lL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEK-------LLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhh-------heeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            345788999999986532211       1224444322      22335788999999999 777777777788999999


Q ss_pred             EecCCC-ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCC
Q 016481          156 EFMARG-SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD  234 (389)
Q Consensus       156 e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~  234 (389)
                      +++.++ +...... .....+..-+...+.+.-..+++++|+..  =+|+|    ||+..+ +..+.+||+....+....
T Consensus       314 ~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  314 RICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hhhcCCccccccCC-hhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc
Confidence            999877 2221111 11112333344556666778999999853  48888    777655 678999999887765543


Q ss_pred             CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCC
Q 016481          235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK  284 (389)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~  284 (389)
                         ......+|+.|+|||+.....+....|+|++|.-..+|--|.+|-..
T Consensus       386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence               34457899999999999999999999999999987788887776543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.35  E-value=9.2e-06  Score=72.77  Aligned_cols=139  Identities=18%  Similarity=0.091  Sum_probs=81.9

Q ss_pred             eecCCCc-eEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCCeEEEEEE
Q 016481           79 VLGGGGF-GCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYE  156 (389)
Q Consensus        79 ~lg~G~~-g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  156 (389)
                      .|..|.. +.||+.....  .      .+++|+.....    ...+.+|+.+++.+. +--+.+++++....+..++|||
T Consensus         5 ~~~~g~~~~~v~~~~~~~--~------~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   72 (244)
T cd05150           5 RVTEGQSGATVYRLDGKN--P------GLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTS   72 (244)
T ss_pred             ecCCCCCcCeEEEEcCCC--C------cEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEE
Confidence            3555655 7899874321  1      28888876542    234557888888774 4446677777776677899999


Q ss_pred             ecCCCChhhhh-------------------hcCC--CCCCCHH--HHHHHHH--------------------HHHHHHHH
Q 016481          157 FMARGSVENNL-------------------FSKV--LLPLPWS--IRMKIAF--------------------GAAKGLAF  193 (389)
Q Consensus       157 ~~~~gsL~~~l-------------------~~~~--~~~~~~~--~~~~i~~--------------------~i~~~l~~  193 (389)
                      +++|.++....                   +...  ..++...  .......                    .+...+..
T Consensus        73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T cd05150          73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE  152 (244)
T ss_pred             eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence            99987765431                   1100  0011100  0000000                    01111222


Q ss_pred             HHh-----CCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          194 LHE-----AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       194 LH~-----~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      |-.     ....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            211     123489999999999999987788999987654

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.31  E-value=2.6e-05  Score=67.07  Aligned_cols=132  Identities=19%  Similarity=0.265  Sum_probs=89.1

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC---------------ChhhHHHHHHHHHHHhccC------C
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---------------SYQGHREWLAEVIFLGHLS------H  135 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~E~~~l~~l~------h  135 (389)
                      ...||+|+.-.||.-  ..+..       .+||+.....               ......+..+|+..+..+.      +
T Consensus         6 ~~~i~~G~~R~cy~H--P~dp~-------~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~   76 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDDPN-------LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW   76 (199)
T ss_pred             CcccccCCCceEEEC--CCCCC-------eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence            457999999999973  22222       7899887665               1122345556666666555      8


Q ss_pred             CccceEEeEEEeCCeEEEEEEecCC------CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCC
Q 016481          136 PNLVKLIGYCCEDEHRVLIYEFMAR------GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS  209 (389)
Q Consensus       136 ~niv~~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~  209 (389)
                      .+|.+++|+......+-+|+|.+..      -+|.+++...   .++. ....   .+-+-..||-.++  |+.+|++|.
T Consensus        77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~---~L~~f~~~l~~~~--Iv~~dl~~~  147 (199)
T PF10707_consen   77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQ---ALDEFKRYLLDHH--IVIRDLNPH  147 (199)
T ss_pred             cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHH---HHHHHHHHHHHcC--CeecCCCcc
Confidence            8999999999999999999998653      2466666443   3443 3333   3334456777766  999999999


Q ss_pred             CeEEcCC---C-cEEEec-cCC
Q 016481          210 NILLDTD---Y-NAKLSD-FGL  226 (389)
Q Consensus       210 Nili~~~---~-~vkl~D-fg~  226 (389)
                      ||++...   . .++|+| ||.
T Consensus       148 NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             cEEEEecCCCceEEEEEeCCCC
Confidence            9999533   2 466666 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.31  E-value=6.9e-06  Score=72.71  Aligned_cols=141  Identities=18%  Similarity=0.167  Sum_probs=80.0

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCC--ccceEEeEEE---eCCeE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP--NLVKLIGYCC---EDEHR  151 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~---~~~~~  151 (389)
                      .+.|+.|..+.||+..... .       .+++|.....   .....+..|..+++.+...  .+..++....   .....
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~-------~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~   70 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-G-------RYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFP   70 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-S-------EEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEE
T ss_pred             CccCCCCCeeeEEEEEECC-c-------EEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccc
Confidence            3578999999999986443 1       2999997654   3445666888888887522  3556666443   23457


Q ss_pred             EEEEEecCCCChhh----------------hh---hcC--CCCCCCHHH---------HHHH------------HHHHHH
Q 016481          152 VLIYEFMARGSVEN----------------NL---FSK--VLLPLPWSI---------RMKI------------AFGAAK  189 (389)
Q Consensus       152 ~lv~e~~~~gsL~~----------------~l---~~~--~~~~~~~~~---------~~~i------------~~~i~~  189 (389)
                      +++|++++|..+..                .+   +..  ...+.....         ....            ...+..
T Consensus        71 ~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (239)
T PF01636_consen   71 YLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEE  150 (239)
T ss_dssp             EEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             eEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHH
Confidence            89999999887766                11   111  111111100         0000            111122


Q ss_pred             -HHHHHHh-----CCCCceecCCCCCCeEEc-CCCcEEEeccCCCc
Q 016481          190 -GLAFLHE-----AEKPVIYRDFKTSNILLD-TDYNAKLSDFGLAK  228 (389)
Q Consensus       190 -~l~~LH~-----~~~~ivH~Dlkp~Nili~-~~~~vkl~Dfg~a~  228 (389)
                       .+..++.     ....++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  151 RLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence             2333332     234599999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.26  E-value=8.5e-06  Score=67.37  Aligned_cols=128  Identities=20%  Similarity=0.212  Sum_probs=85.5

Q ss_pred             cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccc-eEEeEEEeCCeEEE
Q 016481           75 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLV-KLIGYCCEDEHRVL  153 (389)
Q Consensus        75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~l  153 (389)
                      +..+.|++|.+|.||+|.|...        .+|+|+.+.+.   ....+..|.++|..+.-.++- +++.+.    ..++
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~--------~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i   89 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGG--------EVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFI   89 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCc--------eEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEec----hhhh
Confidence            4457899999999999977643        39999987664   334666899999888755443 344433    3355


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCC-C-CCeEEcCCCcEEEeccCCCcC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFK-T-SNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlk-p-~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .|||++|..|.......     +    .+....+++.-.-|-..|  |-|..|. | .||++ .++.+.|+||..|..
T Consensus        90 ~me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv-~~~~~~iIDFd~At~  155 (201)
T COG2112          90 RMEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLG--IEHGELSRPWKNVLV-NDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhc--cchhhhcCCceeEEe-cCCcEEEEEccchhh
Confidence            69999998877654321     1    122334455544455545  8898887 4 45555 445899999988763

>PLN02876 acyl-CoA dehydrogenase

Probab=98.24  E-value=2.4e-05  Score=82.28  Aligned_cols=83  Identities=13%  Similarity=0.124  Sum_probs=55.9

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCcc--ceEEeEEEeC---Ce
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNL--VKLIGYCCED---EH  150 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~  150 (389)
                      .+.|+.|.+..+|+.......    ....+++|+............+.+|+++++.+. |.++  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~----~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG----SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC----cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            567899999999987543221    112377777654332223345778999999985 6654  7777777654   46


Q ss_pred             EEEEEEecCCCCh
Q 016481          151 RVLIYEFMARGSV  163 (389)
Q Consensus       151 ~~lv~e~~~~gsL  163 (389)
                      .|+||||++|..+
T Consensus       119 ~flVME~v~G~~~  131 (822)
T PLN02876        119 AFYIMEYLEGRIF  131 (822)
T ss_pred             ceEEEEecCCccc
Confidence            7999999988643

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.16  E-value=1.8e-05  Score=77.46  Aligned_cols=139  Identities=16%  Similarity=0.077  Sum_probs=84.0

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHH------------------------------------
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR------------------------------------  121 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~------------------------------------  121 (389)
                      +.||..+.|.||+|+.+.       +..||||+.+..-......                                    
T Consensus       167 ~piaaASlaQVhrA~L~~-------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL  239 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL  239 (538)
T ss_pred             chhhhcchhheEEEEecC-------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence            679999999999998776       2339999987763222111                                    


Q ss_pred             HHHHHHHH----HhccCCCc------cceEEeEEEeCCeEEEEEEecCCCChhhh--hhcCCCCCCCHHHHHHHHHHHHH
Q 016481          122 EWLAEVIF----LGHLSHPN------LVKLIGYCCEDEHRVLIYEFMARGSVENN--LFSKVLLPLPWSIRMKIAFGAAK  189 (389)
Q Consensus       122 ~~~~E~~~----l~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~~~~~~i~~~i~~  189 (389)
                      +|..|.+-    .+.+.|-+      |.+++-  .-.....++||||+|..+.+.  +.+.   .++...+..-+.+...
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~  314 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYL  314 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHH
Confidence            11122221    22233444      222222  223466899999999988764  3333   3333333332222211


Q ss_pred             HHHHHHhCCCCceecCCCCCCeEEc----CCCcEEEeccCCCcCCCC
Q 016481          190 GLAFLHEAEKPVIYRDFKTSNILLD----TDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       190 ~l~~LH~~~~~ivH~Dlkp~Nili~----~~~~vkl~Dfg~a~~~~~  232 (389)
                       -..++ .|  .+|+|-.|.||+++    .++.+.+.|||+......
T Consensus       315 -~qIf~-~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  315 -EQIFK-TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             -HHHHh-cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence             11222 35  99999999999998    367899999999876543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.06  E-value=2.2e-05  Score=67.18  Aligned_cols=101  Identities=26%  Similarity=0.308  Sum_probs=78.3

Q ss_pred             HHHHHHhccCC-CccceEEeEEEeCCeEEEEEEecCCCChhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-Cc
Q 016481          125 AEVIFLGHLSH-PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLHEAEK-PV  201 (389)
Q Consensus       125 ~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~i  201 (389)
                      .|..+++.+.+ +++++++|+|    .-++|.||...+++...... ......+|..+.+|+.++++.+.+++.... .+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47778888875 6999999999    33779999987766532100 111256899999999999999999987321 27


Q ss_pred             eecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          202 IYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       202 vH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .-.|++++|+-++.+|++|++|...+..
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcch
Confidence            7789999999999999999999986554

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.03  E-value=6.8e-05  Score=66.77  Aligned_cols=73  Identities=11%  Similarity=0.157  Sum_probs=44.5

Q ss_pred             ceecCCCce-EEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCC---ccceEEeEEEeC---Ce
Q 016481           78 RVLGGGGFG-CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP---NLVKLIGYCCED---EH  150 (389)
Q Consensus        78 ~~lg~G~~g-~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~  150 (389)
                      +.|+.|+.. .||+..     ..      +++|+.....   ....+.+|..+++.+...   .+..+++.....   ..
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~------~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~   68 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DD------MSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPW   68 (235)
T ss_pred             eeccCCCcccceEEcC-----Cc------eEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCc
Confidence            457777766 588741     11      7788755432   233567899998877531   344444443322   23


Q ss_pred             EEEEEEecCCCChh
Q 016481          151 RVLIYEFMARGSVE  164 (389)
Q Consensus       151 ~~lv~e~~~~gsL~  164 (389)
                      .+++|++++|.++.
T Consensus        69 ~~~l~~~i~G~~l~   82 (235)
T cd05155          69 PWSVYRWLEGETAT   82 (235)
T ss_pred             ceEEEEeecCCCCC
Confidence            48899999987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.88  E-value=0.00031  Score=62.40  Aligned_cols=76  Identities=24%  Similarity=0.173  Sum_probs=45.2

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc-cceEEeEEEeCCeEEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN-LVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  155 (389)
                      .+.|..|-...+|+......     ....|++|+.......  .....+|..+++.+...+ .++++..+.  +  .+||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~-----~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~   71 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKED-----NQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIY   71 (235)
T ss_pred             EEEcCCcccceEEEEEcCCC-----CCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEE
Confidence            35677888889998753320     0122888877643221  122336888888885333 344444332  2  3799


Q ss_pred             EecCCCCh
Q 016481          156 EFMARGSV  163 (389)
Q Consensus       156 e~~~~gsL  163 (389)
                      ||++|.++
T Consensus        72 e~i~G~~l   79 (235)
T cd05157          72 EFIPGRTL   79 (235)
T ss_pred             EeeCCCcC
Confidence            99998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.81  E-value=0.00032  Score=60.02  Aligned_cols=126  Identities=25%  Similarity=0.334  Sum_probs=86.1

Q ss_pred             cCCcccceecCCCc-eEEEEeeeccccccCcCcccEEEEEecC---CCC-----------h------hhHHHHHHHHHHH
Q 016481           72 ANFRQDRVLGGGGF-GCVYKGFISEDLREGLQPVPVAVKVHDG---DNS-----------Y------QGHREWLAEVIFL  130 (389)
Q Consensus        72 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~~~~~~~~vaiK~~~~---~~~-----------~------~~~~~~~~E~~~l  130 (389)
                      .+++..+.||.|.- |.||++...+.        .||+|+...   ...           .      ....-|..|.+..
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~--------~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAf  108 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGR--------IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAF  108 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCe--------EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhh
Confidence            67888999999999 99999865432        399999221   110           0      1123466788887


Q ss_pred             hccC---CCcc--ceEEeEEEeC------------------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHH
Q 016481          131 GHLS---HPNL--VKLIGYCCED------------------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA  187 (389)
Q Consensus       131 ~~l~---h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i  187 (389)
                      .+|+   +.++  |+++|+..-.                  ....||.||+....           .+.    ..-+.++
T Consensus       109 gRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~  173 (207)
T PF13095_consen  109 GRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQM  173 (207)
T ss_pred             HHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHH
Confidence            7774   5566  8999987322                  12357778775542           112    2344567


Q ss_pred             HHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       188 ~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+-|..+|..+  |+-+|+++.|..   +  -||+|||.+
T Consensus       174 ~~dl~~~~k~g--I~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  174 LRDLKILHKLG--IVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHCC--eeeccCcccccc---C--CEEEecccC
Confidence            77788899988  999999999986   2  388999864

>PRK10593 hypothetical protein; Provisional

Probab=97.77  E-value=0.0011  Score=61.14  Aligned_cols=78  Identities=13%  Similarity=0.064  Sum_probs=53.4

Q ss_pred             cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCC---CccceEEeEEEe---C
Q 016481           75 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH---PNLVKLIGYCCE---D  148 (389)
Q Consensus        75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~---~  148 (389)
                      .-.+.||.|..+.||+....+.        .+++|..+...   ....+..|...++.+.-   -.+.++++++..   .
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~--------~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~   85 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG--------NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP   85 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC--------CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence            3356799999999998632211        17778854311   12356678888888852   357788877754   3


Q ss_pred             CeEEEEEEecCCCCh
Q 016481          149 EHRVLIYEFMARGSV  163 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL  163 (389)
                      +..++|||+++|+++
T Consensus        86 g~~~LVmE~i~G~~~  100 (297)
T PRK10593         86 GPDVLLLERLRGVSV  100 (297)
T ss_pred             CCeEEEEeccCCEec
Confidence            668999999998765

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.72  E-value=0.0012  Score=63.01  Aligned_cols=78  Identities=21%  Similarity=0.131  Sum_probs=50.9

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCC-----CC-hhhHHHHHHHHHHHhccC---CCccceEEeEEEe
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-----NS-YQGHREWLAEVIFLGHLS---HPNLVKLIGYCCE  147 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~-----~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  147 (389)
                      .+.||.|.+..||++...+..+      .++||.-...     .. .....+...|...|+.+.   ..++++++.+  +
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~------svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D  102 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGK------SVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D  102 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCe------EEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C
Confidence            3578999999999987543211      2899984321     11 123445667888887763   2456777766  4


Q ss_pred             CCeEEEEEEecCCCC
Q 016481          148 DEHRVLIYEFMARGS  162 (389)
Q Consensus       148 ~~~~~lv~e~~~~gs  162 (389)
                      .+..++|||++++..
T Consensus       103 ~~~~~lVME~L~~~~  117 (401)
T PRK09550        103 EELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCCEEEEecCCCcc
Confidence            456789999998644

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.70  E-value=0.0007  Score=62.45  Aligned_cols=141  Identities=18%  Similarity=0.121  Sum_probs=80.0

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc--cceEEe------EEEeC
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN--LVKLIG------YCCED  148 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~------~~~~~  148 (389)
                      .+.|..|....+|+.....  .      .+++|+....    .......|+.++..+.+.+  +.+++.      +....
T Consensus        19 i~~i~~G~~n~~y~v~~~~--~------~~vLr~~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~   86 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS--G------RYVLTLFEKV----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA   86 (296)
T ss_pred             eecccCccccceEEEEeCC--C------cEEEEEcCCC----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence            4567778878999864321  1      2888987642    1234456777777774322  344433      22335


Q ss_pred             CeEEEEEEecCCCChhh----hh----------hcC--C-C------CCCCHHHHH----------HHHHHHHHHHHHHH
Q 016481          149 EHRVLIYEFMARGSVEN----NL----------FSK--V-L------LPLPWSIRM----------KIAFGAAKGLAFLH  195 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~----~l----------~~~--~-~------~~~~~~~~~----------~i~~~i~~~l~~LH  195 (389)
                      +..++|+++++|..+..    .+          +..  . .      ....+....          .....+..++.++.
T Consensus        87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  166 (296)
T cd05153          87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD  166 (296)
T ss_pred             CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence            56789999999876532    00          100  0 0      001111100          01111223344444


Q ss_pred             h-----CCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          196 E-----AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       196 ~-----~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .     ...+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            2     123599999999999999887778999987764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.65  E-value=0.0028  Score=59.10  Aligned_cols=31  Identities=29%  Similarity=0.383  Sum_probs=26.3

Q ss_pred             CCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       199 ~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .++||+|+.|.||+++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4599999999999998665568999998764

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.64  E-value=0.00057  Score=61.66  Aligned_cols=136  Identities=18%  Similarity=0.125  Sum_probs=73.9

Q ss_pred             ecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCcc-ceEEeEEEeCCeEEEEEEec
Q 016481           80 LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIYEFM  158 (389)
Q Consensus        80 lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~  158 (389)
                      +..|-.+.+|+....  .      ..+++|........-. ....+|..+++.+....+ .+++...  .  -++||||+
T Consensus         4 ~~~G~tn~~y~~~~~--~------~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i   70 (256)
T TIGR02721         4 LSGGLTNRSWRIEHP--G------ISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWL   70 (256)
T ss_pred             CCCcCcCCeEEEEeC--C------ccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEec
Confidence            556788889987421  1      2388887654322111 123568888888863323 3344332  2  36899999


Q ss_pred             CCCChhhh-----------------hhcCC--CCCCCHHH-HHHHHHHH---------HHHHHHHHhC------CCCcee
Q 016481          159 ARGSVENN-----------------LFSKV--LLPLPWSI-RMKIAFGA---------AKGLAFLHEA------EKPVIY  203 (389)
Q Consensus       159 ~~gsL~~~-----------------l~~~~--~~~~~~~~-~~~i~~~i---------~~~l~~LH~~------~~~ivH  203 (389)
                      +|..+...                 ++...  ..++.... ......++         ...+..+-..      ...++|
T Consensus        71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H  150 (256)
T TIGR02721        71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH  150 (256)
T ss_pred             cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence            98765421                 11111  11122111 11111111         1112222111      134899


Q ss_pred             cCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          204 RDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       204 ~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      +|+.|.||+++.++ +.|+||..+..
T Consensus       151 ~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       151 MDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCCcCcEEEeCCC-CEEEeccccCc
Confidence            99999999999877 78999998765

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.63  E-value=0.0021  Score=59.62  Aligned_cols=142  Identities=18%  Similarity=0.119  Sum_probs=77.8

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCC--ccceEEeE------EEeC
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP--NLVKLIGY------CCED  148 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~------~~~~  148 (389)
                      .+.++.|....+|+.... + .      .+++|+.......   .....|..++..|...  .+.+++..      ....
T Consensus        27 i~~~~~G~~n~~y~v~t~-~-~------~~vLK~~~~~~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-V-G------RYILTLYEKRVKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             ccccCCccccceEEEEeC-C-C------cEEEEEecCCCCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            356777777889986421 1 1      2888887553222   2333566666666321  13343331      1234


Q ss_pred             CeEEEEEEecCCCChhh--------------hhhcCCC---C------C-CCHHHHH------------HHHHHHHHHHH
Q 016481          149 EHRVLIYEFMARGSVEN--------------NLFSKVL---L------P-LPWSIRM------------KIAFGAAKGLA  192 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~--------------~l~~~~~---~------~-~~~~~~~------------~i~~~i~~~l~  192 (389)
                      +..+++++|++|..+..              .++....   .      . ..|....            .....+...++
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            66789999999865421              0111000   0      0 0111100            01112233444


Q ss_pred             HHHh-----CCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          193 FLHE-----AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       193 ~LH~-----~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ++..     ...+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            4432     235599999999999999887778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.59  E-value=0.00094  Score=61.79  Aligned_cols=81  Identities=22%  Similarity=0.214  Sum_probs=46.8

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc-cceEEeEEEeCCeEEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN-LVKLIGYCCEDEHRVLIYE  156 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  156 (389)
                      +.|..|-...||+............+..+++|+......  .......|..++..+...+ ..++++++.  +  .+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~--~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP--N--GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC--C--Cchhh
Confidence            456667777899875433211112234488999765432  2223456888888775322 334555443  2  35899


Q ss_pred             ecCCCChh
Q 016481          157 FMARGSVE  164 (389)
Q Consensus       157 ~~~~gsL~  164 (389)
                      |++|..+.
T Consensus        78 ~i~G~~l~   85 (302)
T cd05156          78 FIPSRTLT   85 (302)
T ss_pred             eeCCCcCC
Confidence            99887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.40  E-value=0.00032  Score=63.78  Aligned_cols=148  Identities=17%  Similarity=0.144  Sum_probs=94.2

Q ss_pred             cCHHHHHHHhcC---CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-------------------Chh-
Q 016481           62 FTYDELRIITAN---FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-------------------SYQ-  118 (389)
Q Consensus        62 ~~~~~~~~~~~~---~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-------------------~~~-  118 (389)
                      +.+-.+..+.++   +.+++.||-|.-+.||.+-...       +.+.++|+.+..+                   ++. 
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWly  151 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLY  151 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCC-------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhh
Confidence            444455555443   6778999999999999985432       2337777654332                   010 


Q ss_pred             -hHHHHHHHHHHHhccC-C-CccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 016481          119 -GHREWLAEVIFLGHLS-H-PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH  195 (389)
Q Consensus       119 -~~~~~~~E~~~l~~l~-h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH  195 (389)
                       ..-...+|...|+.|. | --+.+.+++.    .-++|||++.|-.|...-.-.     ..   ..+...+..-+--|.
T Consensus       152 LSRlaa~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~-----d~---~~ly~~lm~~Iv~la  219 (465)
T KOG2268|consen  152 LSRLAATKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRHVE-----DP---PTLYDDLMGLIVRLA  219 (465)
T ss_pred             hHHHHHHHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeeecC-----Ch---HHHHHHHHHHHHHHH
Confidence             1112346888888774 2 2344445443    447899999887766432211     11   223334444455666


Q ss_pred             hCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       196 ~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .+|  +||+|..-=||++.+++.++++||-.....
T Consensus       220 ~~G--lIHgDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  220 NHG--LIHGDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             HcC--ceecccchheeEEecCCCEEEeechHhhcc
Confidence            767  999999999999999999999999765543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.17  E-value=0.0072  Score=55.76  Aligned_cols=33  Identities=21%  Similarity=0.424  Sum_probs=29.2

Q ss_pred             CceecCCCCCCeEEcCCCcEEEeccCCCcCCCC
Q 016481          200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE  232 (389)
Q Consensus       200 ~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~  232 (389)
                      .++|+|+.+.|++++.++-+=|.||+++.....
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            489999999999999988899999999886543

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.04  E-value=0.011  Score=55.11  Aligned_cols=144  Identities=15%  Similarity=0.079  Sum_probs=85.1

Q ss_pred             cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-----------------------ChhhHHHH--HHHHHH
Q 016481           75 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-----------------------SYQGHREW--LAEVIF  129 (389)
Q Consensus        75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~--~~E~~~  129 (389)
                      .+...|..|.-+.||.|.....       ..+|||+.+...                       .+......  ..|++-
T Consensus       147 ~inGCiSTGKEANVYHat~~dG-------~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RN  219 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDG-------SEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRN  219 (520)
T ss_pred             ecccccccCccceeEeeecCCC-------ceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHH
Confidence            3456788899999999864332       228999865431                       01111111  236666


Q ss_pred             HhccCCCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCC
Q 016481          130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS  209 (389)
Q Consensus       130 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~  209 (389)
                      |.+++...|.-.--... .++ .|||+|+.. +-...-. .....++...+..+-.+++.-|.-|.... ++||.||+--
T Consensus       220 LkRl~~aGIP~PePIlL-k~h-VLVM~FlGr-dgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c-~LVHADLSEf  294 (520)
T KOG2270|consen  220 LKRLNNAGIPCPEPILL-KNH-VLVMEFLGR-DGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKC-RLVHADLSEF  294 (520)
T ss_pred             HHHHHhcCCCCCCceee-ecc-eEeeeeccC-CCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHh-ceeccchhhh
Confidence            66665444322111111 122 689999953 2111100 11124556666677777777776665432 2999999999


Q ss_pred             CeEEcCCCcEEEeccCCCcCCC
Q 016481          210 NILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       210 Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |+|+. +|.+.++|.+.+....
T Consensus       295 N~Lyh-dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  295 NLLYH-DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             hheEE-CCEEEEEEccccccCC
Confidence            99995 5689999999877643

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.03  E-value=0.0015  Score=62.89  Aligned_cols=165  Identities=22%  Similarity=0.306  Sum_probs=92.8

Q ss_pred             HHHHHHHHHHhccCCCccceEEeEEEe-CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 016481          121 REWLAEVIFLGHLSHPNLVKLIGYCCE-DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK  199 (389)
Q Consensus       121 ~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~  199 (389)
                      .+++....+++.+.|+|...++++... .....+|+|++ +.+|.+.+..+....             .+++    .++ 
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~-------------~s~~----~~~-   87 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKD-------------ESLL----AHG-   87 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccch-------------hhhc----ccc-
Confidence            345567778899999999999987754 34678899999 568888876654211             1111    122 


Q ss_pred             CceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCC
Q 016481          200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR  279 (389)
Q Consensus       200 ~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~  279 (389)
                       +.|..+            ++.+| -++...         ....|                +++||||+|.++.++..|.
T Consensus        88 -~~~~~~------------~~~td-~~~t~~---------~~~~~----------------pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   88 -VLHLNI------------IYITD-HFLTKY---------PSPIG----------------PKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             -cceehh------------hhccc-cccccC---------CCCCC----------------cchhhhhHHHHHHHHHHhh
Confidence             433322            23333 111100         00111                4999999999999999998


Q ss_pred             CCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 016481          280 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV  349 (389)
Q Consensus       280 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il  349 (389)
                      ..+......+   ....++..............   ...+...++.....+..+|+...|..||...++.
T Consensus       129 ~l~~~~~~s~---~l~~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  129 SLEAELTESE---YLEILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHHHHH---HHHHHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            7665332221   11111211111111110000   0012234567778899999999999998665544

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.01  E-value=9.6e-05  Score=78.92  Aligned_cols=157  Identities=15%  Similarity=-0.029  Sum_probs=110.9

Q ss_pred             HHHHHHhccCCCccceEEeEEE--eCCeEEEEEEecCCCChhhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhC---
Q 016481          125 AEVIFLGHLSHPNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFGAAKGLAFLHEA---  197 (389)
Q Consensus       125 ~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~---  197 (389)
                      .|..-++...|+++.....-..  .....+.+++|+.+|.+.+.+.+....  +....-+.....+...+..-.|+.   
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            3444455567888776655432  234558899999999999888665332  233333333333334555554442   


Q ss_pred             CCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh
Q 016481          198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT  277 (389)
Q Consensus       198 ~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt  277 (389)
                      +..-+|++||+-|.+|..+-.+|++++|+.+....  .....+...+++.|++|++...-.++.++|+|..|+.+|.+.-
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            34578999999999999999999999999883221  1123344678889999999888899999999999999999999


Q ss_pred             CCCCCC
Q 016481          278 GRKSLD  283 (389)
Q Consensus       278 g~~pf~  283 (389)
                      |..+|-
T Consensus      1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred             ccHHHH
Confidence            887664

>PLN02236 choline kinase

Probab=96.92  E-value=0.014  Score=55.00  Aligned_cols=145  Identities=16%  Similarity=0.094  Sum_probs=79.6

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCcc-ceEEeEEEeCCeEEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  155 (389)
                      ...|..|-.-.+|++.+.....  .....|++|+...... . ......|..+++.+..-++ .++++.+.. +   .|.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~--~~~~~~v~Ri~g~~t~-~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEG--NLGRKVLVRIYGEGVE-L-FFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCC--CCCCeEEEEEccCCCC-e-eechHHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence            3456568888999976432211  1224488998766432 2 2223568888888753333 345555532 2   589


Q ss_pred             EecCCCChhhh-----------------hhcCC--C-C-CCCHHHHHHHHHHH-----------------HHHHHHH---
Q 016481          156 EFMARGSVENN-----------------LFSKV--L-L-PLPWSIRMKIAFGA-----------------AKGLAFL---  194 (389)
Q Consensus       156 e~~~~gsL~~~-----------------l~~~~--~-~-~~~~~~~~~i~~~i-----------------~~~l~~L---  194 (389)
                      +|+++.++...                 ++...  . . ...+.....+..++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99987666421                 01111  0 0 11122222222111                 1111112   


Q ss_pred             -Hh--CCCCceecCCCCCCeEEcC-CCcEEEeccCCCcC
Q 016481          195 -HE--AEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKD  229 (389)
Q Consensus       195 -H~--~~~~ivH~Dlkp~Nili~~-~~~vkl~Dfg~a~~  229 (389)
                       ..  ....++|+|+++.||++++ ++.+.++||..+..
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             11  1234899999999999986 46899999988764

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=96.70  E-value=0.02  Score=52.67  Aligned_cols=79  Identities=16%  Similarity=0.145  Sum_probs=48.2

Q ss_pred             cCCCceEEEEeeecc--ccccCcCcccEEEEEecCCCCh----hhHHHHHHHHHHHhccC---------C----CccceE
Q 016481           81 GGGGFGCVYKGFISE--DLREGLQPVPVAVKVHDGDNSY----QGHREWLAEVIFLGHLS---------H----PNLVKL  141 (389)
Q Consensus        81 g~G~~g~Vy~~~~~~--~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~---------h----~niv~~  141 (389)
                      |.|-.|.+|++....  ..........++||........    .....|.+|+.+++.+-         +    ..+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            678889999987655  2233445567899997632211    12245667887776551         1    234555


Q ss_pred             EeEEEeCCeEEEEEEecC
Q 016481          142 IGYCCEDEHRVLIYEFMA  159 (389)
Q Consensus       142 ~~~~~~~~~~~lv~e~~~  159 (389)
                      +....+....+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            655555556789998653

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.66  E-value=0.034  Score=52.18  Aligned_cols=75  Identities=16%  Similarity=0.090  Sum_probs=44.2

Q ss_pred             eecCCCceEEEEeeeccccccCcCcccEEEEEecC------CCChhhHHHHHHHHHHHhccC--CC-ccceEEeEEEeCC
Q 016481           79 VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG------DNSYQGHREWLAEVIFLGHLS--HP-NLVKLIGYCCEDE  149 (389)
Q Consensus        79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~  149 (389)
                      .||.|....||++......      ..|+||.-..      +.-+-...+..-|...|+...  .| .+++++.  .++.
T Consensus         2 EigdGnlN~VfrV~~~~g~------~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGD------RAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE   73 (370)
T ss_pred             cCCCCceEEEEEEEcCCCC------eeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc
Confidence            4799999999998743211      2388886321      111222334446777776653  34 3444443  3455


Q ss_pred             eEEEEEEecCCC
Q 016481          150 HRVLIYEFMARG  161 (389)
Q Consensus       150 ~~~lv~e~~~~g  161 (389)
                      ...+|||+++..
T Consensus        74 ~~~~vMEdL~~~   85 (370)
T TIGR01767        74 MAVTVMEDLSHH   85 (370)
T ss_pred             cceehHhhCccc
Confidence            667899998553

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.64  E-value=0.027  Score=52.81  Aligned_cols=143  Identities=17%  Similarity=0.217  Sum_probs=77.1

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCcc-ceEEeEEEeCCeEEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIYE  156 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e  156 (389)
                      +.|..|-...+|+....+...   ....|++++......  ......+|..+++.+..-++ .++++++.  +.  +|.+
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~---~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~   90 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENG---NEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQS   90 (330)
T ss_pred             EEeCCcccceEEEEEecCCCC---CCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeC--Cc--Eeeh
Confidence            455557777899875432211   122488998765432  12233468888888864443 35555552  22  4899


Q ss_pred             ecCCCChhhh----------h-------hcCCC---C-CCCHHHHHHHHHHH----------------------HHHHH-
Q 016481          157 FMARGSVENN----------L-------FSKVL---L-PLPWSIRMKIAFGA----------------------AKGLA-  192 (389)
Q Consensus       157 ~~~~gsL~~~----------l-------~~~~~---~-~~~~~~~~~i~~~i----------------------~~~l~-  192 (389)
                      |++|.++...          +       +....   . ...+.....+..++                      ..-+. 
T Consensus        91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  170 (330)
T PLN02421         91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE  170 (330)
T ss_pred             hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence            9987655221          1       11110   0 11122222222111                      11111 


Q ss_pred             ---HHHhCC--CCceecCCCCCCeEEcC-CCcEEEeccCCCcC
Q 016481          193 ---FLHEAE--KPVIYRDFKTSNILLDT-DYNAKLSDFGLAKD  229 (389)
Q Consensus       193 ---~LH~~~--~~ivH~Dlkp~Nili~~-~~~vkl~Dfg~a~~  229 (389)
                         ++...+  ..++|.|+.+.||+++. ++.++++||..|..
T Consensus       171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence               111111  23789999999999975 57899999998764

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.63  E-value=0.041  Score=51.11  Aligned_cols=31  Identities=16%  Similarity=0.172  Sum_probs=27.8

Q ss_pred             CCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       199 ~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++|+|+.++|++++.++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            3599999999999999999999999988765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.60  E-value=0.03  Score=51.08  Aligned_cols=31  Identities=32%  Similarity=0.458  Sum_probs=25.8

Q ss_pred             CceecCCCCCCeEEcCCCc-EEEeccCCCcCC
Q 016481          200 PVIYRDFKTSNILLDTDYN-AKLSDFGLAKDG  230 (389)
Q Consensus       200 ~ivH~Dlkp~Nili~~~~~-vkl~Dfg~a~~~  230 (389)
                      .++|+|+.+.||+++.++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999987555 469999987653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.46  E-value=0.083  Score=50.29  Aligned_cols=76  Identities=14%  Similarity=0.125  Sum_probs=46.1

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecC----CCC-hhhHHHHHHHHHHHhccC--CC-ccceEEeEEEeC
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG----DNS-YQGHREWLAEVIFLGHLS--HP-NLVKLIGYCCED  148 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~----~~~-~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~  148 (389)
                      .+.||.|.-..||++.+....+      .|+||.-..    ..+ +-...+..-|..+|+...  .| ++++++.  .++
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~------svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNI------SVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDS  105 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCc------eEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECc
Confidence            4678999999999997532112      288886321    111 223445556777887664  34 4555554  345


Q ss_pred             CeEEEEEEecCC
Q 016481          149 EHRVLIYEFMAR  160 (389)
Q Consensus       149 ~~~~lv~e~~~~  160 (389)
                      ....+|||+++.
T Consensus       106 e~~~~vMEdL~~  117 (409)
T PRK12396        106 VMNCCVMEDLSD  117 (409)
T ss_pred             HHhhHHHHhCcc
Confidence            556789998854

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.36  E-value=0.017  Score=50.31  Aligned_cols=30  Identities=33%  Similarity=0.409  Sum_probs=21.0

Q ss_pred             CceecCCCCCCeEE-cCCCcEEEeccCCCcC
Q 016481          200 PVIYRDFKTSNILL-DTDYNAKLSDFGLAKD  229 (389)
Q Consensus       200 ~ivH~Dlkp~Nili-~~~~~vkl~Dfg~a~~  229 (389)
                      .++|.|+.+.||++ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            47899999999999 8889999999987653

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.34  E-value=0.12  Score=49.37  Aligned_cols=74  Identities=11%  Similarity=0.044  Sum_probs=46.4

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC---h---hhHHHHHHHHHHHhccC---CCccceEEeEEEe
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS---Y---QGHREWLAEVIFLGHLS---HPNLVKLIGYCCE  147 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~---~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  147 (389)
                      .+.||.|....||+....  .+      .++||.-.....   .   ....+...|...|+.+.   ..++.+++.++. 
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~------svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SG------SFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--Cc------cEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            567899999999997532  11      288887542111   0   12233334566666553   247778888776 


Q ss_pred             CCeEEEEEEecCC
Q 016481          148 DEHRVLIYEFMAR  160 (389)
Q Consensus       148 ~~~~~lv~e~~~~  160 (389)
                       +.-+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             445788999976

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.24  E-value=0.2  Score=46.43  Aligned_cols=30  Identities=23%  Similarity=0.325  Sum_probs=25.8

Q ss_pred             CCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       199 ~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            45899999999999987 6789999997654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.20  E-value=0.027  Score=48.81  Aligned_cols=87  Identities=15%  Similarity=0.080  Sum_probs=58.5

Q ss_pred             HHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 016481          121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP  200 (389)
Q Consensus       121 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~  200 (389)
                      .-|..+.+++.++.  .|+++..-  +...+-++.|+|..-.           -.+    ..++..=+.+|.-.|+.+.+
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i~~----~N~i~agi~~L~~fH~~~~~  163 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------INF----SNFITAGIKDLMDFHSENQH  163 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------cch----hHHHHHhHHHHHHhhccCCC
Confidence            34566778877764  46666532  3345568899884321           011    11111224677888977677


Q ss_pred             ceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          201 VIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       201 ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      .+|+|..|+||+-|..|.+||.|-+.
T Consensus       164 ~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  164 CLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             eecCCCChhheeecCCCCEEecChhh
Confidence            99999999999999999999999764

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=96.16  E-value=0.095  Score=50.08  Aligned_cols=82  Identities=16%  Similarity=0.112  Sum_probs=46.1

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc-cceEEeEEEeCCeEEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN-LVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  155 (389)
                      .+.|..|-...+|++..............|++.......  .....-.+|+.+++.+...+ -.++++.+..    ++|.
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~--~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~  128 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN--SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ  128 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC--ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence            455656888899998654322111111224444432221  11122346888988886444 3455665532    5899


Q ss_pred             EecCCCChh
Q 016481          156 EFMARGSVE  164 (389)
Q Consensus       156 e~~~~gsL~  164 (389)
                      ||++|.+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999987664

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.10  E-value=0.024  Score=51.88  Aligned_cols=73  Identities=25%  Similarity=0.275  Sum_probs=43.6

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC---CCccceEEeEEEeCCeEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l  153 (389)
                      .+.++.|....+|+..  .+.      ..+.+|+-...    ....|..|..-|+.|.   .-.+.+.+++....+.-++
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~------~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fL   89 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDG------GSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFL   89 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-------EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEE
T ss_pred             eEecCCCChhheEEEE--CCC------ccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceE
Confidence            4678889999999864  222      23899987622    2234556777777773   4567788888887777899


Q ss_pred             EEEecCCC
Q 016481          154 IYEFMARG  161 (389)
Q Consensus       154 v~e~~~~g  161 (389)
                      ||||++.+
T Consensus        90 lle~l~~~   97 (288)
T PF03881_consen   90 LLEFLEMG   97 (288)
T ss_dssp             EEE-----
T ss_pred             EEEeecCC
Confidence            99999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.87  E-value=0.036  Score=51.58  Aligned_cols=73  Identities=19%  Similarity=0.189  Sum_probs=54.0

Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      .+.|++|++. |+++.. +     .-..+.++..++.+.+..++-+... .+.-|||+...||||+ +|+|.|+||-+++
T Consensus       299 ~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             eEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEeeeee
Confidence            4567778775 444432 1     1235677788888887777776653 4588999999999999 9999999999998


Q ss_pred             CC
Q 016481          229 DG  230 (389)
Q Consensus       229 ~~  230 (389)
                      .-
T Consensus       370 l~  371 (488)
T COG5072         370 LS  371 (488)
T ss_pred             cc
Confidence            53

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.86  E-value=0.025  Score=53.36  Aligned_cols=58  Identities=22%  Similarity=0.204  Sum_probs=38.8

Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceecCCCCCCeEEc
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA-FLHEAEKPVIYRDFKTSNILLD  214 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~ivH~Dlkp~Nili~  214 (389)
                      .++-+|+.|-++..++...   ..++....+++.-.+.|+- .+--.+  .+|.|+.|.||++.
T Consensus       321 vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlir  379 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIR  379 (565)
T ss_pred             eeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEE
Confidence            5666788887777777554   3344555666665555553 233335  99999999999994

>PRK06148 hypothetical protein; Provisional

Probab=95.51  E-value=0.24  Score=53.65  Aligned_cols=32  Identities=41%  Similarity=0.456  Sum_probs=26.6

Q ss_pred             CCCceecCCCCCCeEEcCCC--cEE-EeccCCCcC
Q 016481          198 EKPVIYRDFKTSNILLDTDY--NAK-LSDFGLAKD  229 (389)
Q Consensus       198 ~~~ivH~Dlkp~Nili~~~~--~vk-l~Dfg~a~~  229 (389)
                      -.++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            35599999999999998775  555 999998765

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.49  E-value=0.088  Score=45.96  Aligned_cols=75  Identities=20%  Similarity=0.259  Sum_probs=49.6

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC---CCccceEEeEEEeCCeEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv  154 (389)
                      +.+..|.--..|...+   ..     ..+-+|+-..    .....|..|+.-|+.|.   .-.+.+++.+.....+.|+|
T Consensus        22 ~~v~gG~inea~~v~d---g~-----~~~FvK~n~~----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylV   89 (286)
T COG3001          22 EEVSGGDINEAWRLRD---GT-----DPFFVKCNQR----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLV   89 (286)
T ss_pred             cccCCccccceeEeec---CC-----cceEEEecch----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEE
Confidence            4455555555555321   11     2278887543    23456667877777664   35677888888899999999


Q ss_pred             EEecCCCChh
Q 016481          155 YEFMARGSVE  164 (389)
Q Consensus       155 ~e~~~~gsL~  164 (389)
                      |||++-|.+.
T Consensus        90 le~L~~~~~d   99 (286)
T COG3001          90 LEYLPTGPLD   99 (286)
T ss_pred             EeeccCCCCC
Confidence            9999987664

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.54  E-value=1.4  Score=41.24  Aligned_cols=29  Identities=24%  Similarity=0.242  Sum_probs=24.3

Q ss_pred             CCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       199 ~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .++||+|+.+.|||++ + .+.|+||+-+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            4589999999999995 4 578999998764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	389
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-43
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-42
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-42
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-41
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-31
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
3soa_A	444	Full-Length Human Camkii Length = 444		1e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 107/285 (37%), Positives = 160/285 (56%), Gaps = 13/285 (4%)
Query: 71  TANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 130
           T NF    ++       VYKG     LR+G +   VA+K    ++S QG  E+  E+  L
Sbjct: 38  TNNFDHKFLIGHGVFGKVYKGV----LRDGAK---VALKRRTPESS-QGIEEFETEIETL 89
Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL--LPLPWSIRMKIAFGAA 188
               HP+LV LIG+C E    +LIY++M  G+++ +L+   L  + + W  R++I  GAA
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           +GL +LH   + +I+RD K+ NILLD ++  K++DFG++K G E D++H+   + GT GY
Sbjct: 150 RGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXX 308
             PEY + G LT +SDVYSFGVVL E+L  R ++ +S P    NLA+WA           
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-VESHNNGQLE 266
Query: 309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
            I+DP L      + + K    A  CL  + + RP M D++  LE
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 106/285 (37%), Positives = 159/285 (55%), Gaps = 13/285 (4%)
Query: 71  TANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 130
           T NF    ++       VYKG     LR+G +   VA+K    ++S QG  E+  E+  L
Sbjct: 38  TNNFDHKFLIGHGVFGKVYKGV----LRDGAK---VALKRRTPESS-QGIEEFETEIETL 89
Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL--LPLPWSIRMKIAFGAA 188
               HP+LV LIG+C E    +LIY++M  G+++ +L+   L  + + W  R++I  GAA
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           +GL +LH   + +I+RD K+ NILLD ++  K++DFG++K G E  ++H+   + GT GY
Sbjct: 150 RGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXX 308
             PEY + G LT +SDVYSFGVVL E+L  R ++ +S P    NLA+WA           
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-VESHNNGQLE 266
Query: 309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
            I+DP L      + + K    A  CL  + + RP M D++  LE
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 162/300 (54%), Gaps = 14/300 (4%)
Query: 59  LIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ 118
           L  F+  EL++ + NF    +L       VYKG +++          VAVK    +    
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-------TLVAVKRLKEERXQG 77
Query: 119 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLLPLP 176
           G  ++  EV  +    H NL++L G+C     R+L+Y +MA GSV + L  +     PL 
Sbjct: 78  GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 137
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKP-VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
           W  R +IA G+A+GLA+LH+   P +I+RD K +NILLD ++ A + DFGLAK     D 
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD- 196
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN--L 293
            HV   + GT G+ APEY+ TG  + ++DV+ +GV+LLE++TG+++ D +R A + +  L
Sbjct: 197 XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 294 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
            DW             ++D  L+G+Y  + V +   +A  C   +P  RP M ++V  LE
Sbjct: 257 LDWVKGLLKEKKLEA-LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 14/300 (4%)
Query: 59  LIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ 118
           L  F+  EL++ + NF    +L       VYKG +++          VAVK    + +  
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADG-------XLVAVKRLKEERTQG 69
Query: 119 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLLPLP 176
           G  ++  EV  +    H NL++L G+C     R+L+Y +MA GSV + L  +     PL 
Sbjct: 70  GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKP-VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
           W  R +IA G+A+GLA+LH+   P +I+RD K +NILLD ++ A + DFGLAK     D 
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD- 188
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN--L 293
            HV   + G  G+ APEY+ TG  + ++DV+ +GV+LLE++TG+++ D +R A + +  L
Sbjct: 189 XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 294 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
            DW             ++D  L+G+Y  + V +   +A  C   +P  RP M ++V  LE
Sbjct: 249 LDWVKGLLKEKKLEA-LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 96/302 (31%), Positives = 160/302 (52%), Gaps = 18/302 (5%)
Query: 61  AFTYDELRIITANFRQDRV------LXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGD 114
           +F++ EL+ +T NF +  +      +       VYKG+++ +    ++ +   V +    
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDI---- 68
Query: 115 NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLL 173
            + +  +++  E+  +    H NLV+L+G+  + +   L+Y +M  GS+ + L       
Sbjct: 69  TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
           PL W +R KIA GAA G+ FLHE     I+RD K++NILLD  + AK+SDFGLA+   + 
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 293
            ++ + +RI+GT  Y APE  + G +TP+SD+YSFGVVLLEI+TG  ++D+ R    Q L
Sbjct: 187 AQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLL 243
Query: 294 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
            D             + ID ++  D     V     +A  CL+     RP ++ +   L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 354 PL 355
            +
Sbjct: 303 EM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/302 (31%), Positives = 159/302 (52%), Gaps = 18/302 (5%)
Query: 61  AFTYDELRIITANFRQDRV------LXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGD 114
           +F++ EL+ +T NF +  +      +       VYKG+++ +    ++ +   V +    
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDI---- 68
Query: 115 NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLL 173
            + +  +++  E+  +    H NLV+L+G+  + +   L+Y +M  GS+ + L       
Sbjct: 69  TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
           PL W +R KIA GAA G+ FLHE     I+RD K++NILLD  + AK+SDFGLA+   + 
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 293
            ++ +  RI+GT  Y APE  + G +TP+SD+YSFGVVLLEI+TG  ++D+ R    Q L
Sbjct: 187 AQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLL 243
Query: 294 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
            D             + ID ++  D     V     +A  CL+     RP ++ +   L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 354 PL 355
            +
Sbjct: 303 EM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 96/302 (31%), Positives = 158/302 (52%), Gaps = 18/302 (5%)
Query: 61  AFTYDELRIITANFRQDRV------LXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGD 114
           +F++ EL+ +T NF +  +      +       VYKG+++ +    ++ +   V +    
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDI---- 62
Query: 115 NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLL 173
            + +  +++  E+  +    H NLV+L+G+  + +   L+Y +M  GS+ + L       
Sbjct: 63  TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 122
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
           PL W +R KIA GAA G+ FLHE     I+RD K++NILLD  + AK+SDFGLA+   + 
Sbjct: 123 PLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 293
            +  +  RI+GT  Y APE  + G +TP+SD+YSFGVVLLEI+TG  ++D+ R    Q L
Sbjct: 181 AQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLL 237
Query: 294 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
            D             + ID ++  D     V     +A  CL+     RP ++ +   L+
Sbjct: 238 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296
Query: 354 PL 355
            +
Sbjct: 297 EM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 153/300 (51%), Gaps = 18/300 (6%)
Query: 61  AFTYDELRIITANFRQDRVLXXXXXX------CVYKGFISEDLREGLQPVPVAVKVHDGD 114
           +F++ EL+ +T NF +  +              VYKG+++ +    ++ +   V +    
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN-NTTVAVKKLAAMVDI---- 59
Query: 115 NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLL 173
            + +  +++  E+       H NLV+L+G+  + +   L+Y +   GS+ + L       
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP 119
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
           PL W  R KIA GAA G+ FLHE     I+RD K++NILLD  + AK+SDFGLA+   + 
Sbjct: 120 PLSWHXRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL 293
            +    +RI+GT  Y APE  + G +TP+SD+YSFGVVLLEI+TG  ++D+ R    Q L
Sbjct: 178 AQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLL 234
Query: 294 ADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
            D             + ID +   D     V     +A  CL+     RP ++ +   L+
Sbjct: 235 LDIKEEIEDEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 117/252 (46%), Gaps = 20/252 (7%)
Query: 106 VAVKV-HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+  + D   +   E+L EV  +  L HPN+V  +G   +  +  ++ E+++RGS+ 
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 165 NNLF-SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
             L  S     L    R+ +A+  AKG+ +LH    P+++RD K+ N+L+D  Y  K+ D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCD 182
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
           FGL++   +      S    GT  + APE +       +SDVYSFGV+L E+ T ++   
Sbjct: 183 FGLSR--LKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
              PA+                        RLE   P     + A +   C  + P  RP
Sbjct: 241 NLNPAQ--------------VVAAVGFKCKRLE--IPRNLNPQVAAIIEGCWTNEPWKRP 284
Query: 344 LMRDIVDSLEPL 355
               I+D L PL
Sbjct: 285 SFATIMDLLRPL 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 117/252 (46%), Gaps = 20/252 (7%)
Query: 106 VAVKV-HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+  + D   +   E+L EV  +  L HPN+V  +G   +  +  ++ E+++RGS+ 
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 165 NNLF-SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
             L  S     L    R+ +A+  AKG+ +LH    P+++R+ K+ N+L+D  Y  K+ D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
           FGL++   +      S    GT  + APE +       +SDVYSFGV+L E+ T ++   
Sbjct: 183 FGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
              PA+                        RLE   P     + A +   C  + P  RP
Sbjct: 241 NLNPAQ--------------VVAAVGFKCKRLE--IPRNLNPQVAAIIEGCWTNEPWKRP 284
Query: 344 LMRDIVDSLEPL 355
               I+D L PL
Sbjct: 285 SFATIMDLLRPL 296

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 127/296 (42%), Gaps = 39/296 (13%)
Query: 67  LRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL-A 125
           L I  A    + ++       VY+ F   D       V V    HD D       E +  
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGD------EVAVKAARHDPDEDISQTIENVRQ 55
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E      L HPN++ L G C ++ +  L+ EF ARG   N + S   +P    I +  A 
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF-ARGGPLNRVLSGKRIPP--DILVNWAV 112
Query: 186 GAAKGLAFLH-EAEKPVIYRDFKTSNILL-----DTDYN---AKLSDFGLAKDGPEGDKS 236
             A+G+ +LH EA  P+I+RD K+SNIL+     + D +    K++DFGLA++     K 
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
             +    G Y + APE I     +  SDV+S+GV+L E+LTG        P R  +    
Sbjct: 173 SAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV------PFRGID---- 218
Query: 297 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL 352
                        +   +L    P       A L   C N +P +RP   +I+D L
Sbjct: 219 ------GLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 43  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 99
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 100 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 154
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 214
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 215 KSDVWSFGVLLWELMT 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 45  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 101
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 102 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 156
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 217 KSDVWSFGVLLWELMT 232

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 46  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 102
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 103 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 157
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 158 RDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 217
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 218 KSDVWSFGVLLWELMT 233

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 45  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 101
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 102 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 156
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 217 KSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 46  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 102
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 103 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 157
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 158 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 217
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 218 KSDVWSFGVLLWELMT 233

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 34/288 (11%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VYKG +      G + VPVA+K      + +   ++L E   +G  SH N+++L G   +
Sbjct: 60  VYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117
Query: 148 DEHRVLIYEFMARGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIY 203
            +  ++I E+M  G+++  L  K     +L L   +R     G A G+ +L  A    ++
Sbjct: 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR-----GIAAGMKYL--ANMNYVH 170
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
           RD    NIL++++   K+SDFGL++   D PE   +    +I     + APE I     T
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTAPEAISYRKFT 228
Query: 261 PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYP 320
             SDV+SFG+V+ E++T        RP  E +                  I+       P
Sbjct: 229 SASDVWSFGIVMWEVMT-----YGERPYWELS-----------NHEVMKAINDGFRLPTP 272
Query: 321 VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNF 368
           +        L   C       RP   DIV  L+ L   PD   T  +F
Sbjct: 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 104 CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 160
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 161 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 215
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 276 KSDVWSFGVLLWELMT 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 50  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 106
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ FL  A K  ++
Sbjct: 107 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVH 161
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E D  H  T       + A E + T   T 
Sbjct: 162 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 221
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 222 KSDVWSFGVLLWELMT 237

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 92/171 (53%), Gaps = 15/171 (8%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           +E+  EV  + +L+HPN+VKL G        V+  EF+  G + + L  K   P+ WS++
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVK 124
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYN----AKLSDFGLAKDGPEGDK 235
           +++    A G+ ++     P+++RD ++ NI L + D N    AK++DFGL++       
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QS 179
Query: 236 SHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDK 284
            H  + ++G + + APE I       T ++D YSF ++L  ILTG    D+
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 91/171 (53%), Gaps = 15/171 (8%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           +E+  EV  + +L+HPN+VKL G        V+  EF+  G + + L  K   P+ WS++
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVK 124
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYN----AKLSDFGLAKDGPEGDK 235
           +++    A G+ ++     P+++RD ++ NI L + D N    AK++DFG ++       
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QS 179
Query: 236 SHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDK 284
            H  + ++G + + APE I       T ++D YSF ++L  ILTG    D+
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 44  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 100
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 101 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 155
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 156 RDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTT 215
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 216 KSDVWSFGVLLWELMT 231

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 91/171 (53%), Gaps = 15/171 (8%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           +E+  EV  + +L+HPN+VKL G        V+  EF+  G + + L  K   P+ WS++
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVK 124
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYN----AKLSDFGLAKDGPEGDK 235
           +++    A G+ ++     P+++RD ++ NI L + D N    AK++DF L++       
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QS 179
Query: 236 SHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDK 284
            H  + ++G + + APE I       T ++D YSF ++L  ILTG    D+
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 95/184 (51%), Gaps = 16/184 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           G + VPVA+K      + +  R++L+E   +G   HPN+++L G        +++ E+M 
Sbjct: 74  GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133
Query: 160 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
            GS++  L +      ++ L   +R     G   G+ +L  ++   ++RD    N+L+D+
Sbjct: 134 NGSLDTFLRTHDGQFTIMQLVGMLR-----GVGAGMRYL--SDLGYVHRDLAARNVLVDS 186
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D P+   +    +I     + APE I     +  SDV+SFGVV+
Sbjct: 187 NLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTAPEAIAFRTFSSASDVWSFGVVM 244
Query: 273 LEIL 276
            E+L
Sbjct: 245 WEVL 248

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 96/184 (52%), Gaps = 16/184 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           G + VPVA+K      + +  R++L+E   +G   HPN+++L G        +++ E+M 
Sbjct: 74  GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133
Query: 160 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
            GS++  L +      ++ L   +R     G   G+ +L  ++   ++RD    N+L+D+
Sbjct: 134 NGSLDTFLRTHDGQFTIMQLVGMLR-----GVGAGMRYL--SDLGYVHRDLAARNVLVDS 186
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D P  D ++ +T       + APE I     +  SDV+SFGVV+
Sbjct: 187 NLVCKVSDFGLSRVLEDDP--DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244
Query: 273 LEIL 276
            E+L
Sbjct: 245 WEVL 248

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 129/304 (42%), Gaps = 41/304 (13%)
Query: 65  DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 61
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+  +   ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 122 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-------GRKSLDKSRPAR 289
               + +    + +PE +  G  T  SDV+SFGVVL EI T       G  +    R   
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 239
Query: 290 EQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
           E  L D             N  D  LE             L   C  +NPK RP   +I+
Sbjct: 240 EGGLLD----------KPDNCPDMLLE-------------LMRMCWQYNPKMRPSFLEII 276
Query: 350 DSLE 353
            S++
Sbjct: 277 SSIK 280

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 64  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 120
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 121 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 175
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 176 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 235
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 236 KSDVWSFGVLLWELMT 251

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 90/178 (50%), Gaps = 16/178 (8%)
Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW 177
           +  R +L EV  +  L HPN++K IG   +D+    I E++  G++   +   +    PW
Sbjct: 49  ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLR-GIIKSMDSQYPW 107
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA------KDGP 231
           S R+  A   A G+A+LH     +I+RD  + N L+  + N  ++DFGLA      K  P
Sbjct: 108 SQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 232 EGDKS------HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
           EG +S           ++G   + APE I       + DV+SFG+VL EI+ GR + D
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 45  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 101
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 102 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 156
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 217 KSDVWSFGVLLWELMT 232

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 63  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 119
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 120 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 174
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 175 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 234
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 235 KSDVWSFGVLLWELMT 250

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 92/181 (50%), Gaps = 18/181 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VA+K   G  + +  RE+L+E   +G   HPN+++L G        +++ EFM  G++++
Sbjct: 47  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 106
Query: 166 NL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
            L      F+ + L       + +  G A G+ +L  AE   ++RD    NIL++++   
Sbjct: 107 FLRLNDGQFTVIQL-------VGMLRGIASGMRYL--AEMSYVHRDLAARNILVNSNLVC 157
Query: 220 KLSDFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 276
           K+SDFGL++   E       T  +G      + APE I     T  SD +S+G+V+ E++
Sbjct: 158 KVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 217
Query: 277 T 277
           +
Sbjct: 218 S 218

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 42  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 98
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 99  RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 153
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 213
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 214 KSDVWSFGVLLWELMT 229

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 37  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 93
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 94  RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 148
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 149 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 208
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 209 KSDVWSFGVLLWELMT 224

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 40  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 97  RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 151
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 212 KSDVWSFGVLLWELMT 227

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 45  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 101
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 102 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 156
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 157 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 217 KSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 44  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 100
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 101 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 155
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 156 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 215
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 216 KSDVWSFGVLLWELMT 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CVY G + ++  +G + +  AVK  +         ++L E I +   SHPN++ L+G C 
Sbjct: 43  CVYHGTLLDN--DG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 99
Query: 147 EDEHR-VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--AAKGLAFLHEAEKPVIY 203
             E   +++  +M  G + N + ++   P   +++  I FG   AKG+ +L  A K  ++
Sbjct: 100 RSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVH 154
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           RD    N +LD  +  K++DFGLA+D    E    H  T       + A E + T   T 
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 214
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+SFGV+L E++T
Sbjct: 215 KSDVWSFGVLLWELMT 230

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 27/297 (9%)
Query: 65  DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 70
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 131 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
               + +    + +PE +  G  T  SDV+SFGVVL EI T               LA+ 
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQ 233
Query: 297 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                        +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 234 PYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 92/181 (50%), Gaps = 18/181 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VA+K   G  + +  RE+L+E   +G   HPN+++L G        +++ EFM  G++++
Sbjct: 45  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 104
Query: 166 NL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
            L      F+ + L       + +  G A G+ +L  AE   ++RD    NIL++++   
Sbjct: 105 FLRLNDGQFTVIQL-------VGMLRGIASGMRYL--AEMSYVHRDLAARNILVNSNLVC 155
Query: 220 KLSDFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 276
           K+SDFGL++   E       T  +G      + APE I     T  SD +S+G+V+ E++
Sbjct: 156 KVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 215
Query: 277 T 277
           +
Sbjct: 216 S 216

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 133/304 (43%), Gaps = 33/304 (10%)
Query: 61  AFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
            F  DE  +        R L       VY+G +++ + +      VA+K  +   S +  
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 63
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVL 172
            E+L E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL
Sbjct: 64  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 173 LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE 232
            P   S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN 292
            D      + +    + +PE +  G  T  SDV+SFGVVL EI T  +     +P   Q 
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPY--QG 234
Query: 293 LADWAXXXXXXXXXXXNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
           L++              ++   +EG   D P         L   C  +NPK RP   +I+
Sbjct: 235 LSN------------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 282
Query: 350 DSLE 353
            S++
Sbjct: 283 SSIK 286

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 133/300 (44%), Gaps = 33/300 (11%)
Query: 65  DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 76
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+  +   ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 137 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
               + +    + +PE +  G  T  SDV+SFGVVL EI T  +     +P   Q L++ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPY--QGLSN- 246
Query: 297 AXXXXXXXXXXXNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                        ++   +EG   D P         L   C  +NPK RP   +I+ S++
Sbjct: 247 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 133/300 (44%), Gaps = 33/300 (11%)
Query: 65  DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 76
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+  +   ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 137 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
               + +    + +PE +  G  T  SDV+SFGVVL EI T  +     +P   Q L++ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPY--QGLSN- 246
Query: 297 AXXXXXXXXXXXNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                        ++   +EG   D P         L   C  +NPK RP   +I+ S++
Sbjct: 247 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 132/300 (44%), Gaps = 33/300 (11%)
Query: 65  DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 69
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 130 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
               + +    + +PE +  G  T  SDV+SFGVVL EI T  +     +P   Q L++ 
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPY--QGLSN- 239
Query: 297 AXXXXXXXXXXXNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                        ++   +EG   D P         L   C  +NPK RP   +I+ S++
Sbjct: 240 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 27/297 (9%)
Query: 65  DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 63
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+  +   ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 124 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
               + +    + +PE +  G  T  SDV+SFGVVL EI T               LA+ 
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQ 226
Query: 297 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                        +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 227 PYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 132/300 (44%), Gaps = 33/300 (11%)
Query: 65  DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 69
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 130 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
               + +    + +PE +  G  T  SDV+SFGVVL EI T  +     +P   Q L++ 
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPY--QGLSN- 239
Query: 297 AXXXXXXXXXXXNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                        ++   +EG   D P         L   C  +NPK RP   +I+ S++
Sbjct: 240 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 31/306 (10%)
Query: 58  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 117
           P   F  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEG-NARDIIKGEAETRVAVKTVNESASL 61
Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 175
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 119
Query: 176 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 227
                 P +++  I   A  A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           +D  E D      + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 178 RDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 227
Query: 288 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 347
                LA+              ++D     D P     +   L   C   NPK RP   +
Sbjct: 228 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 348 IVDSLE 353
           IV+ L+
Sbjct: 282 IVNLLK 287

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 132/300 (44%), Gaps = 33/300 (11%)
Query: 65  DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 66
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 127 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
               + +    + +PE +  G  T  SDV+SFGVVL EI T  +     +P   Q L++ 
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPY--QGLSN- 236
Query: 297 AXXXXXXXXXXXNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                        ++   +EG   D P         L   C  +NPK RP   +I+ S++
Sbjct: 237 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 132/300 (44%), Gaps = 33/300 (11%)
Query: 65  DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 70
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 131 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
               + +    + +PE +  G  T  SDV+SFGVVL EI T  +     +P   Q L++ 
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPY--QGLSN- 240
Query: 297 AXXXXXXXXXXXNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                        ++   +EG   D P         L   C  +NPK RP   +I+ S++
Sbjct: 241 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 128/304 (42%), Gaps = 41/304 (13%)
Query: 65  DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 63
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+  +   ++RD    N  +  D+  K+ DFG+ +D  E D  
Sbjct: 124 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-------GRKSLDKSRPAR 289
               + +    + +PE +  G  T  SDV+SFGVVL EI T       G  +    R   
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 241
Query: 290 EQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
           E  L D             N  D  LE             L   C  +NPK RP   +I+
Sbjct: 242 EGGLLD----------KPDNCPDMLLE-------------LMRMCWQYNPKMRPSFLEII 278
Query: 350 DSLE 353
            S++
Sbjct: 279 SSIK 282

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 27/297 (9%)
Query: 65  DELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R L       VY+G +++ + +      VA+K  +   S +   E+L
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFL 98
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS--------KVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L S         VL P  
Sbjct: 99  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+  +   ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 159 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
               + +    + +PE +  G  T  SDV+SFGVVL EI T               LA+ 
Sbjct: 217 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQ 261
Query: 297 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                        +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 262 PYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 317

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 121/235 (51%), Gaps = 25/235 (10%)
Query: 66  ELRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREW 123
           +LRI+     ++ +VL       VYKG     + EG    +PVA+K+ +     + + E+
Sbjct: 31  QLRILKETELKRVKVLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEF 87
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLP 176
           + E + +  + HP+LV+L+G C     + L+ + M  G +       ++N+ S++L  L 
Sbjct: 88  MDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLL--LN 144
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
           W +++      AKG+ +L   E+ +++RD    N+L+ +  + K++DFGLA+     +K 
Sbjct: 145 WCVQI------AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 196
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
           + +        + A E I     T +SDV+S+GV + E++T G K  D   P RE
Sbjct: 197 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE 250

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 121/235 (51%), Gaps = 25/235 (10%)
Query: 66  ELRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREW 123
           +LRI+     ++ +VL       VYKG     + EG    +PVA+K+ +     + + E+
Sbjct: 8   QLRILKETELKRVKVLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEF 64
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLP 176
           + E + +  + HP+LV+L+G C     + L+ + M  G +       ++N+ S++L  L 
Sbjct: 65  MDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLL--LN 121
Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
           W +++      AKG+ +L   E+ +++RD    N+L+ +  + K++DFGLA+     +K 
Sbjct: 122 WCVQI------AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 173
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
           + +        + A E I     T +SDV+S+GV + E++T G K  D   P RE
Sbjct: 174 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 128/302 (42%), Gaps = 31/302 (10%)
Query: 62  FTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 121
           F  DE  +        R L       VY+G  + D+ +G     VAVK  +   S +   
Sbjct: 4   FVPDEWEVSREKITLLRELGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL------ 175
           E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P       
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAENNPG 120
Query: 176 --PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 231
             P +++  I   A  A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ +D  
Sbjct: 121 RPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 178
Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 291
           E D      + +    + APE +  G  T  SD++SFGVVL EI +              
Sbjct: 179 ETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------------- 224
Query: 292 NLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS 351
            LA+              ++D     D P     +   L   C   NPK RP   +IV+ 
Sbjct: 225 -LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNL 282
Query: 352 LE 353
           L+
Sbjct: 283 LK 284

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 165 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 210
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 123 EYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 180
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 271 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 330
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 241 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 284
Query: 331 AYHCLNHNPKARPLMRDIVDSLEPLQVL 358
              C +  P  RP  + +V+ L+ +  L
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 88/185 (47%), Gaps = 14/185 (7%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D S    +++  E   L +L H ++VK  G C E +  ++++E+M  G +
Sbjct: 44  ILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL 102
Query: 164 ENNLFSK----VLLP-------LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 212
              L +     VL+        L  S  + IA   A G+ +L  A +  ++RD  T N L
Sbjct: 103 NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCL 160
Query: 213 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +  +   K+ DFG+++D    D   V    M    +  PE IM    T  SDV+S GVVL
Sbjct: 161 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 220
Query: 273 LEILT 277
            EI T
Sbjct: 221 WEIFT 225

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGLA+   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLARVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 273 LEILT 277
            E+++
Sbjct: 241 WEVMS 245

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 94/185 (50%), Gaps = 14/185 (7%)
Query: 100 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           G + + VA+K      + +  R++L+E   +G   HPN++ L G   +    ++I EFM 
Sbjct: 58  GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 117
Query: 160 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
            GS+++ L        ++ L   +R     G A G+ +L  A+   ++RD    NIL+++
Sbjct: 118 NGSLDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYL--ADMNYVHRDLAARNILVNS 170
Query: 216 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   +       T  +G      + APE I     T  SDV+S+G+V+
Sbjct: 171 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 230
Query: 273 LEILT 277
            E+++
Sbjct: 231 WEVMS 235

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 96/185 (51%), Gaps = 16/185 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           G + +PVA+K      + +  R++L E   +G   HPN++ L G   + +  +++ E+M 
Sbjct: 47  GKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 106
Query: 160 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
            GS++  L        ++ L   +R     G + G+ +L  ++   ++RD    NIL+++
Sbjct: 107 NGSLDTFLKKNDGQFTVIQLVGMLR-----GISAGMKYL--SDMGYVHRDLAARNILINS 159
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + APE I     T  SDV+S+G+V+
Sbjct: 160 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAFRKFTSASDVWSYGIVM 217
Query: 273 LEILT 277
            E+++
Sbjct: 218 WEVVS 222

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 31/306 (10%)
Query: 58  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 117
           P   F  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEG-NARDIIKGEAETRVAVKTVNESASL 61
Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 175
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 119
Query: 176 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 227
                 P +++  I   A  A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           +D  E D      + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 178 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 227
Query: 288 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 347
                LA+              ++D     D P     +   L   C   NPK RP   +
Sbjct: 228 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 348 IVDSLE 353
           IV+ L+
Sbjct: 282 IVNLLK 287

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 43  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 102
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 103 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 153
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 154 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 211
Query: 273 LEILT 277
            E+++
Sbjct: 212 WEVMS 216

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           G + V VA+K      + +  R++L E   +G   HPN+V L G     +  +++ EFM 
Sbjct: 68  GKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFME 127
Query: 160 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
            G+++  L        ++ L   +R     G A G+ +L  A+   ++RD    NIL+++
Sbjct: 128 NGALDAFLRKHDGQFTVIQLVGMLR-----GIAAGMRYL--ADMGYVHRDLAARNILVNS 180
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + APE I     T  SDV+S+G+V+
Sbjct: 181 NLVCKVSDFGLSRVIEDDPEAVYTTTGGKI--PVRWTAPEAIQYRKFTSASDVWSYGIVM 238
Query: 273 LEILT 277
            E+++
Sbjct: 239 WEVMS 243

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGFVHRDLAARNILINS 182
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 273 LEILT 277
            E+++
Sbjct: 241 WEVMS 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 60  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 119
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 120 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 170
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 171 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 228
Query: 273 LEILT 277
            E+++
Sbjct: 229 WEVMS 233

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 110/241 (45%), Gaps = 31/241 (12%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW--- 177
           + ++ E+  L  ++HPN+VKL G C       L+ E+   GS+ N L      PLP+   
Sbjct: 47  KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAE--PLPYYTA 102
Query: 178 SIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK 235
           +  M      ++G+A+LH  + K +I+RD K  N+LL       K+ DFG A D     +
Sbjct: 103 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQ 158
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK-SRPAREQNLA 294
           +H+ T   G+  + APE     + + + DV+S+G++L E++T RK  D+   PA      
Sbjct: 159 THM-TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---I 214
Query: 295 DWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 354
            WA           N+  P                L   C + +P  RP M +IV  +  
Sbjct: 215 MWAVHNGTRPPLIKNLPKP-------------IESLMTRCWSKDPSQRPSMEEIVKIMTH 261
Query: 355 L 355
           L
Sbjct: 262 L 262

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 70  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 129
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 130 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 180
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 181 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 238
Query: 273 LEILT 277
            E+++
Sbjct: 239 WEVMS 243

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 111
Query: 165 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 210
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 169
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 170 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 229
Query: 271 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 330
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 230 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 273
Query: 331 AYHCLNHNPKARPLMRDIVDSLEPLQVL 358
              C +  P  RP  + +V+ L+ +  L
Sbjct: 274 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 301

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 115
Query: 165 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 210
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 116 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 173
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 174 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 233
Query: 271 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 330
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 234 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 277
Query: 331 AYHCLNHNPKARPLMRDIVDSLEPLQVL 358
              C +  P  RP  + +V+ L+ +  L
Sbjct: 278 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 305

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 273 LEILT 277
            E+++
Sbjct: 241 WEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 273 LEILT 277
            E+++
Sbjct: 241 WEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 273 LEILT 277
            E+++
Sbjct: 241 WEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 273 LEILT 277
            E+++
Sbjct: 241 WEVMS 245

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 165 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 210
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 180
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 271 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 330
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 241 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 284
Query: 331 AYHCLNHNPKARPLMRDIVDSLEPLQVL 358
              C +  P  RP  + +V+ L+ +  L
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 110/241 (45%), Gaps = 31/241 (12%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW--- 177
           + ++ E+  L  ++HPN+VKL G C       L+ E+   GS+ N L      PLP+   
Sbjct: 46  KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAE--PLPYYTA 101
Query: 178 SIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK 235
           +  M      ++G+A+LH  + K +I+RD K  N+LL       K+ DFG A D     +
Sbjct: 102 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQ 157
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK-SRPAREQNLA 294
           +H+ T   G+  + APE     + + + DV+S+G++L E++T RK  D+   PA      
Sbjct: 158 THM-TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---I 213
Query: 295 DWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 354
            WA           N+  P                L   C + +P  RP M +IV  +  
Sbjct: 214 MWAVHNGTRPPLIKNLPKP-------------IESLMTRCWSKDPSQRPSMEEIVKIMTH 260
Query: 355 L 355
           L
Sbjct: 261 L 261

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 114
Query: 165 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 210
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 115 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 172
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 173 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 232
Query: 271 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 330
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 233 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 276
Query: 331 AYHCLNHNPKARPLMRDIVDSLEPLQVL 358
              C +  P  RP  + +V+ L+ +  L
Sbjct: 277 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 304

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 165 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 210
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 180
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 271 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 330
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 241 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 284
Query: 331 AYHCLNHNPKARPLMRDIVDSLEPLQVL 358
              C +  P  RP  + +V+ L+ +  L
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 128/306 (41%), Gaps = 31/306 (10%)
Query: 58  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 117
           P   +  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 3   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVNESASL 61
Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 175
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 119
Query: 176 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 227
                 P +++  I   A  A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           +D  E D      + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 178 RDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 227
Query: 288 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 347
                LA+              ++D     D P     +   L   C   NP  RP   +
Sbjct: 228 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPNMRPTFLE 281
Query: 348 IVDSLE 353
           IV+ L+
Sbjct: 282 IVNLLK 287

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 33/268 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 165 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 210
             L ++    L +S                +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 221
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 281
Query: 271 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 330
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 282 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 325
Query: 331 AYHCLNHNPKARPLMRDIVDSLEPLQVL 358
              C +  P  RP  + +V+ L+ +  L
Sbjct: 326 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 353

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 96/185 (51%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E+M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL +   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 273 LEILT 277
            E+++
Sbjct: 241 WEVMS 245

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 90/175 (51%), Gaps = 15/175 (8%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVE 164
           VAVK    D + Q    +LAE   +  L H NLV+L+G   E++  + ++ E+MA+GS+ 
Sbjct: 38  VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 94
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           + L S+    L     +K +    + + +L       ++RD    N+L+  D  AK+SDF
Sbjct: 95  DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDF 152
Query: 225 GLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           GL K+         ST+  G     + APE +     + +SDV+SFG++L EI +
Sbjct: 153 GLTKEAS-------STQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 90/175 (51%), Gaps = 15/175 (8%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVE 164
           VAVK    D + Q    +LAE   +  L H NLV+L+G   E++  + ++ E+MA+GS+ 
Sbjct: 32  VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           + L S+    L     +K +    + + +L       ++RD    N+L+  D  AK+SDF
Sbjct: 89  DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDF 146
Query: 225 GLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           GL K+         ST+  G     + APE +     + +SDV+SFG++L EI +
Sbjct: 147 GLTKEAS-------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 90/175 (51%), Gaps = 15/175 (8%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVE 164
           VAVK    D + Q    +LAE   +  L H NLV+L+G   E++  + ++ E+MA+GS+ 
Sbjct: 219 VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           + L S+    L     +K +    + + +L       ++RD    N+L+  D  AK+SDF
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDF 333
Query: 225 GLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           GL K+         ST+  G     + APE +     + +SDV+SFG++L EI +
Sbjct: 334 GLTKEAS-------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 96/185 (51%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENG 131
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGAVHRDLAARNILINS 182
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 273 LEILT 277
            E+++
Sbjct: 241 WEVMS 245

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           G + + VA+K      + +  R++L+E   +G   HPN++ L G   + +  ++I E+M 
Sbjct: 54  GKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYME 113
Query: 160 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
            GS++  L        ++ L   +R     G   G+ +L  ++   ++RD    NIL+++
Sbjct: 114 NGSLDAFLRKNDGRFTVIQLVGMLR-----GIGSGMKYL--SDMSAVHRDLAARNILVNS 166
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFG+++   D PE   +    +I     + APE I     T  SDV+S+G+V+
Sbjct: 167 NLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVM 224
Query: 273 LEILT 277
            E+++
Sbjct: 225 WEVMS 229

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 90/175 (51%), Gaps = 15/175 (8%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVE 164
           VAVK    D + Q    +LAE   +  L H NLV+L+G   E++  + ++ E+MA+GS+ 
Sbjct: 47  VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           + L S+    L     +K +    + + +L       ++RD    N+L+  D  AK+SDF
Sbjct: 104 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDF 161
Query: 225 GLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           GL K+         ST+  G     + APE +     + +SDV+SFG++L EI +
Sbjct: 162 GLTKEAS-------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 113/251 (45%), Gaps = 24/251 (9%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     +++ E   +  LSHP LV+L G C E     L++EFM  G + 
Sbjct: 34  VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           + L ++  L    ++ + +     +G+A+L EA   VI+RD    N L+  +   K+SDF
Sbjct: 91  DYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA--SVIHRDLAARNCLVGENQVIKVSDF 147
Query: 225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK 284
           G+ +   + D+   ST       +A+PE       + +SDV+SFGV++ E+ +  K   +
Sbjct: 148 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 206
Query: 285 SRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL 344
           +R   E                   +  PRL   +  +       +  HC    P+ RP 
Sbjct: 207 NRSNSE---------VVEDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPEDRPA 250
Query: 345 MRDIVDSLEPL 355
              ++  L  +
Sbjct: 251 FSRLLRQLAAI 261

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 96/185 (51%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E M  G
Sbjct: 43  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENG 102
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 103 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 153
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 154 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 211
Query: 273 LEILT 277
            E+++
Sbjct: 212 WEVMS 216

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 24/248 (9%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     +++ E   +  LSHP LV+L G C E     L++EFM  G + 
Sbjct: 32  VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           + L ++  L    ++ + +     +G+A+L EA   VI+RD    N L+  +   K+SDF
Sbjct: 89  DYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDF 145
Query: 225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK 284
           G+ +   + D+   ST       +A+PE       + +SDV+SFGV++ E+ +  K   +
Sbjct: 146 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204
Query: 285 SRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL 344
           +R   E                   +  PRL   +  +       +  HC    P+ RP 
Sbjct: 205 NRSNSE---------VVEDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPEDRPA 248
Query: 345 MRDIVDSL 352
              ++  L
Sbjct: 249 FSRLLRQL 256

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 33/268 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 165 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 210
             L ++    L +                 +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 108 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 165
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 271 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 330
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 226 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 269
Query: 331 AYHCLNHNPKARPLMRDIVDSLEPLQVL 358
              C +  P  RP  + +V+ L+ +  L
Sbjct: 270 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK    + S    +++  E   L  L H ++V+  G C E    ++++E+M  G +  
Sbjct: 51  VAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 109
Query: 166 NLFS-----KVLL--------PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 212
            L S     K+L         PL     + +A   A G+ +L  A    ++RD  T N L
Sbjct: 110 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCL 167
Query: 213 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +      K+ DFG+++D    D   V  R M    +  PE I+    T  SDV+SFGVVL
Sbjct: 168 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 227
Query: 273 LEILT 277
            EI T
Sbjct: 228 WEIFT 232

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 24/219 (10%)
Query: 68  RIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEV 127
           R++T +   DRV+       VY G   E + +    +  A+K        Q    +L E 
Sbjct: 20  RVVTHS---DRVIGKGHFGVVYHG---EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREG 73
Query: 128 IFLGHLSHPNLVKLIGYCCEDE---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
           + +  L+HPN++ LIG     E   H +L Y  M  G +   + S    P   +++  I+
Sbjct: 74  LLMRGLNHPNVLALIGIMLPPEGLPHVLLPY--MCHGDLLQFIRSPQRNP---TVKDLIS 128
Query: 185 FG--AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD----KSHV 238
           FG   A+G+ +L  AE+  ++RD    N +LD  +  K++DFGLA+D  + +    + H 
Sbjct: 129 FGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             R+     + A E + T   T +SDV+SFGV+L E+LT
Sbjct: 187 HARL--PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 124/286 (43%), Gaps = 31/286 (10%)
Query: 78  RVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           R L       VY+G  + D+ +G     VAVK  +   S +   E+L E   +   +  +
Sbjct: 22  RELGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 80
Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL--------PWSIRMKIAFGA-- 187
           +V+L+G   + +  +++ E MA G +++ L S  L P         P +++  I   A  
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ +D  E D      + +    
Sbjct: 139 ADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXX 307
           + APE +  G  T  SD++SFGVVL EI +               LA+            
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 241
Query: 308 XNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
             ++D     D P     +   L   C   NPK RP   +IV+ L+
Sbjct: 242 KFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK    + S    +++  E   L  L H ++V+  G C E    ++++E+M  G +  
Sbjct: 45  VAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 103
Query: 166 NLFS-----KVLL--------PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 212
            L S     K+L         PL     + +A   A G+ +L  A    ++RD  T N L
Sbjct: 104 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCL 161
Query: 213 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +      K+ DFG+++D    D   V  R M    +  PE I+    T  SDV+SFGVVL
Sbjct: 162 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 221
Query: 273 LEILT 277
            EI T
Sbjct: 222 WEIFT 226

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 96/185 (51%), Gaps = 20/185 (10%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+K      + +  R++L E   +G   HPN+++L G   + +  +++ E M  G
Sbjct: 72  KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENG 131
Query: 162 SVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           S+++ L      F+ + L       + +  G A G+ +L  ++   ++RD    NIL+++
Sbjct: 132 SLDSFLRKHDAQFTVIQL-------VGMLRGIASGMKYL--SDMGYVHRDLAARNILINS 182
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   D PE   +    +I     + +PE I     T  SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 273 LEILT 277
            E+++
Sbjct: 241 WEVMS 245

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           G + + VA+K      + +  R++L+E   +G   HPN++ L G   + +  ++I E+M 
Sbjct: 39  GKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYME 98
Query: 160 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
            GS++  L        ++ L   +R     G   G+ +L  ++   ++RD    NIL+++
Sbjct: 99  NGSLDAFLRKNDGRFTVIQLVGMLR-----GIGSGMKYL--SDMSYVHRDLAARNILVNS 151
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFG+++   D PE   +    +I     + APE I     T  SDV+S+G+V+
Sbjct: 152 NLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVM 209
Query: 273 LEILT 277
            E+++
Sbjct: 210 WEVMS 214

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 24/248 (9%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     +++ E   +  LSHP LV+L G C E     L++EFM  G + 
Sbjct: 34  VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 90
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           + L ++  L    ++ + +     +G+A+L EA   VI+RD    N L+  +   K+SDF
Sbjct: 91  DYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDF 147
Query: 225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK 284
           G+ +   + D+   ST       +A+PE       + +SDV+SFGV++ E+ +  K   +
Sbjct: 148 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 206
Query: 285 SRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL 344
           +R   E                   +  PRL   +  +       +  HC    P+ RP 
Sbjct: 207 NRSNSE---------VVEDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPEDRPA 250
Query: 345 MRDIVDSL 352
              ++  L
Sbjct: 251 FSRLLRQL 258

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           G + + VA+K      + +  R++L+E   +G   HPN++ L G   + +  ++I E+M 
Sbjct: 33  GKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYME 92
Query: 160 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
            GS++  L        ++ L   +R     G   G+ +L  ++   ++RD    NIL+++
Sbjct: 93  NGSLDAFLRKNDGRFTVIQLVGMLR-----GIGSGMKYL--SDMSYVHRDLAARNILVNS 145
Query: 216 DYNAKLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFG+++   D PE   +    +I     + APE I     T  SDV+S+G+V+
Sbjct: 146 NLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVM 203
Query: 273 LEILT 277
            E+++
Sbjct: 204 WEVMS 208

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 87/188 (46%), Gaps = 21/188 (11%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK    D +    +++  E   L +L H ++VK  G C + +  ++++E+M  G +  
Sbjct: 48  VAVKALK-DPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-- 104
Query: 166 NLFSKVLLP----------------LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS 209
           N F +   P                L  S  + IA   A G+ +L  A +  ++RD  T 
Sbjct: 105 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATR 162
Query: 210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 269
           N L+  +   K+ DFG+++D    D   V    M    +  PE IM    T  SDV+SFG
Sbjct: 163 NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 222
Query: 270 VVLLEILT 277
           V+L EI T
Sbjct: 223 VILWEIFT 230

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 24/248 (9%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     +++ E   +  LSHP LV+L G C E     L++EFM  G + 
Sbjct: 37  VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           + L ++  L    ++ + +     +G+A+L EA   VI+RD    N L+  +   K+SDF
Sbjct: 94  DYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDF 150
Query: 225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK 284
           G+ +   + D+   ST       +A+PE       + +SDV+SFGV++ E+ +  K   +
Sbjct: 151 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 209
Query: 285 SRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL 344
           +R   E                   +  PRL   +  +       +  HC    P+ RP 
Sbjct: 210 NRSNSE---------VVEDISTGFRLYKPRLASTHVYQ-------IMNHCWRERPEDRPA 253
Query: 345 MRDIVDSL 352
              ++  L
Sbjct: 254 FSRLLRQL 261

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 33/268 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++G++ 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 165 NNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 210
             L ++    L +                 +  A+  A+G+ +L  A K  I+RD    N
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARN 180
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           +L+  D   K++DFGLA+D    D    +T       + APE +     T +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 271 VLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAML 330
           +L EI T   S     P  E                   ++      D P    ++  M+
Sbjct: 241 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMM 284
Query: 331 AYHCLNHNPKARPLMRDIVDSLEPLQVL 358
              C +  P  RP  + +V+ L+ +  L
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+  RG V   L  + L             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYIT 120
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 224
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 225 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 93/185 (50%), Gaps = 14/185 (7%)
Query: 100 GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           G + + VA+K      + +  R++L+E   +G   HPN++ L G   +    ++I EFM 
Sbjct: 32  GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 91
Query: 160 RGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
            GS+++ L        ++ L   +R     G A G+ +L  A+   ++R     NIL+++
Sbjct: 92  NGSLDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYL--ADMNYVHRALAARNILVNS 144
Query: 216 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +   K+SDFGL++   +       T  +G      + APE I     T  SDV+S+G+V+
Sbjct: 145 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 204
Query: 273 LEILT 277
            E+++
Sbjct: 205 WEVMS 209

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 128/306 (41%), Gaps = 31/306 (10%)
Query: 58  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 117
           P   F  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEG-NARDIIKGEAETRVAVKTVNESASL 61
Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 175
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 119
Query: 176 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 227
                 P +++  I   A  A G+A+L+   K  ++RD    N ++  D+  K+ DFG+ 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           +D  E        + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 178 RDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 227
Query: 288 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 347
                LA+              ++D     D P     +   L   C   NPK RP   +
Sbjct: 228 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 348 IVDSLE 353
           IV+ L+
Sbjct: 282 IVNLLK 287

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 119/258 (46%), Gaps = 36/258 (13%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK + +G  S     E+  E   +  LSHP LVK  G C ++    ++ E+++ G + 
Sbjct: 35  VAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91
Query: 165 NNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS 222
           N L S  K L P   S  +++ +   +G+AFL   +   I+RD    N L+D D   K+S
Sbjct: 92  NYLRSHGKGLEP---SQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVS 146
Query: 223 DFGLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-G 278
           DFG+ +     D  +VS+  +GT     ++APE       + +SDV++FG+++ E+ + G
Sbjct: 147 DFGMTRYVL--DDQYVSS--VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202
Query: 279 RKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHN 338
           +   D    +                     +  P L  D           + Y C +  
Sbjct: 203 KMPYDLYTNSE----------VVLKVSQGHRLYRPHLASD-------TIYQIMYSCWHEL 245
Query: 339 PKARPLMRDIVDSLEPLQ 356
           P+ RP  + ++ S+EPL+
Sbjct: 246 PEKRPTFQQLLSSIEPLR 263

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 94/184 (51%), Gaps = 29/184 (15%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK +  G  S Q    +L E   +  L H  LV+L     ++E   +I EFMA+GS+ 
Sbjct: 39  VAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLL 95
Query: 165 NNLFS----KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK 220
           + L S    KVLLP       +IA    +G+A++    K  I+RD + +N+L+      K
Sbjct: 96  DFLKSDEGGKVLLPKLIDFSAQIA----EGMAYIER--KNYIHRDLRAANVLVSESLMCK 149
Query: 221 LSDFGLAK-------DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 273
           ++DFGLA+          EG K  +         + APE I  G  T +S+V+SFG++L 
Sbjct: 150 IADFGLARVIEDNEYTAREGAKFPIK--------WTAPEAINFGCFTIKSNVWSFGILLY 201
Query: 274 EILT 277
           EI+T
Sbjct: 202 EIVT 205

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 93/184 (50%), Gaps = 29/184 (15%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK +  G  S Q    +L E   +  L H  LV+L      +E   +I E+MA+GS+ 
Sbjct: 40  VAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLL 96
Query: 165 NNLFS----KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK 220
           + L S    KVLLP       +IA    +G+A++    K  I+RD + +N+L+      K
Sbjct: 97  DFLKSDEGGKVLLPKLIDFSAQIA----EGMAYIER--KNYIHRDLRAANVLVSESLMCK 150
Query: 221 LSDFGLAK-------DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 273
           ++DFGLA+          EG K  +         + APE I  G  T +SDV+SFG++L 
Sbjct: 151 IADFGLARVIEDNEYTAREGAKFPIK--------WTAPEAINFGCFTIKSDVWSFGILLY 202
Query: 274 EILT 277
           EI+T
Sbjct: 203 EIVT 206

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 19/156 (12%)
Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           ++F+G+ + P L  +  +C   E   L +   A    E     K L+         IA  
Sbjct: 83  LLFMGYSTKPQLAIVTQWC---EGSSLYHHLHAS---ETKFEMKKLI--------DIARQ 128
Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
            A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH   ++ G+ 
Sbjct: 129 TARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 247 GYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
            + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK    + S    +++  E   L  L H ++V+  G C E    ++++E+M  G +  
Sbjct: 74  VAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 132
Query: 166 NLFS-----KVLL--------PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 212
            L S     K+L         PL     + +A   A G+ +L  A    ++RD  T N L
Sbjct: 133 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCL 190
Query: 213 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           +      K+ DFG+++D    D   V  R M    +  PE I+    T  SDV+SFGVVL
Sbjct: 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250
Query: 273 LEILT 277
            EI T
Sbjct: 251 WEIFT 255

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/182 (34%), Positives = 87/182 (47%), Gaps = 22/182 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV---LIYEFMARGS 162
           VAVK    D   Q    W  E+  L  L H +++K  G CCED       L+ E++  GS
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKG-CCEDAGAASLQLVMEYVPLGS 121
Query: 163 VENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD 216
           + + L       +++LL          A    +G+A+LH   +  I+RD    N+LLD D
Sbjct: 122 LRDYLPRHSIGLAQLLL---------FAQQICEGMAYLHA--QHYIHRDLAARNVLLDND 170
Query: 217 YNAKLSDFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
              K+ DFGLAK  PEG + + V         + APE +        SDV+SFGV L E+
Sbjct: 171 RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230
Query: 276 LT 277
           LT
Sbjct: 231 LT 232

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 24/248 (9%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     +++ E   +  LSHP LV+L G C E     L++EFM  G + 
Sbjct: 54  VAIKTIKEGSMS---EDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 110
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           + L ++  L    ++ + +     +G+A+L EA   VI+RD    N L+  +   K+SDF
Sbjct: 111 DYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDF 167
Query: 225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK 284
           G+ +   + D+   ST       +A+PE       + +SDV+SFGV++ E+ +  K   +
Sbjct: 168 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 226
Query: 285 SRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL 344
           +R   E                   +  PRL   +  +       +  HC    P+ RP 
Sbjct: 227 NRSNSE---------VVEDISTGFRLYKPRLASTHVYQ-------IMNHCWKERPEDRPA 270
Query: 345 MRDIVDSL 352
              ++  L
Sbjct: 271 FSRLLRQL 278

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 119/239 (49%), Gaps = 23/239 (9%)
Query: 45  EEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKG-FISEDLREGLQP 103
           E +E L     AN ++A  + E        R+ +VL       V+KG +I E   E ++ 
Sbjct: 9   ESIEPLDPSEKANKVLARIFKE-----TELRKLKVLGSGVFGTVHKGVWIPEG--ESIK- 60
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           +PV +KV +  +  Q  +     ++ +G L H ++V+L+G C     + L+ +++  GS+
Sbjct: 61  IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSL 119
Query: 164 ENNL--FSKVLLP---LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN 218
            +++      L P   L W +++      AKG+ +L E    +++R+    N+LL +   
Sbjct: 120 LDHVRQHRGALGPQLLLNWGVQI------AKGMYYLEE--HGMVHRNLAARNVLLKSPSQ 171
Query: 219 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +++DFG+A   P  DK  + +       + A E I  G  T +SDV+S+GV + E++T
Sbjct: 172 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 85/162 (52%), Gaps = 18/162 (11%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + 
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 235
           +A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K
Sbjct: 120 MAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 177
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 178 FPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 84/158 (53%), Gaps = 15/158 (9%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +LAE   +  L H  LVKL     + E   +I EFMA+GS+ + L S      P    + 
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 282
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
            +   A+G+AF+ +  +  I+RD + +NIL+      K++DFGLA+ G +          
Sbjct: 283 FSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVGAKF--------- 331
Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 279
                + APE I  G  T +SDV+SFG++L+EI+T GR
Sbjct: 332 --PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 19/156 (12%)
Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           ++F+G+ + P L  +  +C   E   L +   A    E     K L+         IA  
Sbjct: 83  LLFMGYSTAPQLAIVTQWC---EGSSLYHHLHAS---ETKFEMKKLI--------DIARQ 128
Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
            A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH   ++ G+ 
Sbjct: 129 TARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 247 GYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
            + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 85/162 (52%), Gaps = 18/162 (11%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + 
Sbjct: 63  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 121
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 235
           +A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K
Sbjct: 122 MAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 179
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 180 FPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 8/188 (4%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARG 161
           + + VA+KV           E + E   +  L +P +V+LIG  C+ E  +L+ E    G
Sbjct: 36  KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGG 94
Query: 162 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 221
            +   L  K    +P S   ++    + G+ +L E  K  ++RD    N+LL   + AK+
Sbjct: 95  PLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKI 151
Query: 222 SDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-G 278
           SDFGL+K     D S+ + R  G +   + APE I     + RSDV+S+GV + E L+ G
Sbjct: 152 SDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 210
Query: 279 RKSLDKSR 286
           +K   K +
Sbjct: 211 QKPYKKMK 218

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 236
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 115 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKF 172
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 173 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 62  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 120
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 236
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 121 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 178
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 179 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 85/162 (52%), Gaps = 18/162 (11%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + 
Sbjct: 64  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 122
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 235
           +A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K
Sbjct: 123 MAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 180
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 181 FPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 85/162 (52%), Gaps = 18/162 (11%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + 
Sbjct: 60  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 118
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 235
           +A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K
Sbjct: 119 MAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 176
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 177 FPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 85/162 (52%), Gaps = 18/162 (11%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + 
Sbjct: 65  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 123
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 235
           +A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K
Sbjct: 124 MAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 181
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 182 FPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 116/275 (42%), Gaps = 42/275 (15%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+   + S    R+ L+E   L  ++HP+++KL G C +D   +LI E+   GS+  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 166 NLF-SKVLLP---------------------LPWSIRMKIAFGAAKGLAFLHEAEKPVIY 203
            L  S+ + P                     L     +  A+  ++G+ +L  AE  +++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMSLVH 173
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS 263
           RD    NIL+      K+SDFGL++D  E D     ++      + A E +     T +S
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 264 DVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVK 322
           DV+SFGV+L EI+T G        P R  NL                    R+E   P  
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH---------------RME--RPDN 276
Query: 323 GVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV 357
              +   L   C    P  RP+  DI   LE + V
Sbjct: 277 CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 85/162 (52%), Gaps = 18/162 (11%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + 
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 235
           +A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K
Sbjct: 114 MAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 172 FPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 57  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 115
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 236
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 116 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 173
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 174 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 58  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 116
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 236
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 117 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 174
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 175 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 86/165 (52%), Gaps = 19/165 (11%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +LAE   +  L H  LVKL     + E   +I EFMA+GS+ + L S      P    + 
Sbjct: 57  FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 115
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 235
            +   A+G+AF+ +  +  I+RD + +NIL+      K++DFGLA+          EG K
Sbjct: 116 FSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 173
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GR 279
             +         + APE I  G  T +SDV+SFG++L+EI+T GR
Sbjct: 174 FPIK--------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 116/275 (42%), Gaps = 42/275 (15%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+   + S    R+ L+E   L  ++HP+++KL G C +D   +LI E+   GS+  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 166 NLF-SKVLLP---------------------LPWSIRMKIAFGAAKGLAFLHEAEKPVIY 203
            L  S+ + P                     L     +  A+  ++G+ +L  AE  +++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVH 173
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS 263
           RD    NIL+      K+SDFGL++D  E D     ++      + A E +     T +S
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 264 DVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVK 322
           DV+SFGV+L EI+T G        P R  NL                    R+E   P  
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH---------------RME--RPDN 276
Query: 323 GVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV 357
              +   L   C    P  RP+  DI   LE + V
Sbjct: 277 CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 85/162 (52%), Gaps = 18/162 (11%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + 
Sbjct: 50  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 108
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 235
           +A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K
Sbjct: 109 MAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 167 FPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 236
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 115 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 173 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDKS 236
           A   A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+          EG K 
Sbjct: 115 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 172
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 173 PIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 87/182 (47%), Gaps = 22/182 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR---VLIYEFMARGS 162
           VAVK    D   Q    W  E+  L  L H +++K  G CCED+      L+ E++  GS
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKG-CCEDQGEKSLQLVMEYVPLGS 104
Query: 163 VENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD 216
           + + L       +++LL          A    +G+A+LH      I+R+    N+LLD D
Sbjct: 105 LRDYLPRHSIGLAQLLL---------FAQQICEGMAYLHSQH--YIHRNLAARNVLLDND 153
Query: 217 YNAKLSDFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
              K+ DFGLAK  PEG + + V         + APE +        SDV+SFGV L E+
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213
Query: 276 LT 277
           LT
Sbjct: 214 LT 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 84/162 (51%), Gaps = 18/162 (11%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +LAE   +  L H  LVKL     + E   +I EFMA+GS+ + L S      P    + 
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 235
            +   A+G+AF+ +  +  I+RD + +NIL+      K++DFGLA+          EG K
Sbjct: 289 FSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 346
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             +         + APE I  G  T +SDV+SFG++L+EI+T
Sbjct: 347 FPIK--------WTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 121/252 (48%), Gaps = 34/252 (13%)
Query: 42  SNPEEVED----LRRDSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDL 97
           S+PEE++D    L+RD   N LIA    ++ +   NF   R         VY+      +
Sbjct: 320 SDPEELKDKKLFLKRD---NLLIA----DIELGCGNFGSVR-------QGVYR------M 359
Query: 98  REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           R+  + + VA+KV           E + E   +  L +P +V+LIG  C+ E  +L+ E 
Sbjct: 360 RK--KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEM 416
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
              G +   L  K    +P S   ++    + G+ +L E  K  ++R+    N+LL   +
Sbjct: 417 AGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRH 473
Query: 218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
            AK+SDFGL+K     D S+ + R  G +   + APE I     + RSDV+S+GV + E 
Sbjct: 474 YAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 532
Query: 276 LT-GRKSLDKSR 286
           L+ G+K   K +
Sbjct: 533 LSYGQKPYKKMK 544

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 87/183 (47%), Gaps = 11/183 (6%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS 162
           + VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G 
Sbjct: 69  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 128
Query: 163 VENNLFSKVLLPL------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLD 214
           + N L  K    L      P  +R  + F +  A+G+AFL  A K  I+RD    N+LL 
Sbjct: 129 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLT 186
Query: 215 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 274
             + AK+ DFGLA+D        V         + APE I     T +SDV+S+G++L E
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 246
Query: 275 ILT 277
           I +
Sbjct: 247 IFS 249

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 116/275 (42%), Gaps = 42/275 (15%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+   + S    R+ L+E   L  ++HP+++KL G C +D   +LI E+   GS+  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 166 NLF-SKVLLP---------------------LPWSIRMKIAFGAAKGLAFLHEAEKPVIY 203
            L  S+ + P                     L     +  A+  ++G+ +L  AE  +++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVH 173
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS 263
           RD    NIL+      K+SDFGL++D  E D     ++      + A E +     T +S
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 264 DVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVK 322
           DV+SFGV+L EI+T G        P R  NL                    R+E   P  
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH---------------RME--RPDN 276
Query: 323 GVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV 357
              +   L   C    P  RP+  DI   LE + V
Sbjct: 277 CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 111/248 (44%), Gaps = 24/248 (9%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     +++ E   +  LSHP LV+L G C E     L+ EFM  G + 
Sbjct: 35  VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           + L ++  L    ++ + +     +G+A+L EA   VI+RD    N L+  +   K+SDF
Sbjct: 92  DYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDF 148
Query: 225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK 284
           G+ +   + D+   ST       +A+PE       + +SDV+SFGV++ E+ +  K   +
Sbjct: 149 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 207
Query: 285 SRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL 344
           +R   E                   +  PRL   +  +       +  HC    P+ RP 
Sbjct: 208 NRSNSE---------VVEDISTGFRLYKPRLASTHVYQ-------IMNHCWRERPEDRPA 251
Query: 345 MRDIVDSL 352
              ++  L
Sbjct: 252 FSRLLRQL 259

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 87/182 (47%), Gaps = 22/182 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR---VLIYEFMARGS 162
           VAVK    D   Q    W  E+  L  L H +++K  G CCED+      L+ E++  GS
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKG-CCEDQGEKSLQLVMEYVPLGS 104
Query: 163 VENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD 216
           + + L       +++LL          A    +G+A+LH      I+R+    N+LLD D
Sbjct: 105 LRDYLPRHSIGLAQLLL---------FAQQICEGMAYLHAQH--YIHRNLAARNVLLDND 153
Query: 217 YNAKLSDFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
              K+ DFGLAK  PEG + + V         + APE +        SDV+SFGV L E+
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213
Query: 276 LT 277
           LT
Sbjct: 214 LT 215

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 141
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 142 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 195
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 245
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 246 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+  RG V   L  + L             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYIT 120
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGT 174
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 224
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 225 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 87/183 (47%), Gaps = 11/183 (6%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS 162
           + VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 163 VENNLFSKVLLPL------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLD 214
           + N L  K    L      P  +R  + F +  A+G+AFL  A K  I+RD    N+LL 
Sbjct: 137 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLT 194
Query: 215 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 274
             + AK+ DFGLA+D        V         + APE I     T +SDV+S+G++L E
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 254
Query: 275 ILT 277
           I +
Sbjct: 255 IFS 257

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 132
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 133 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 186
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 236
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 237 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 273

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 74  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 131
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH   ++ G+
Sbjct: 132 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 246 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 139
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH   ++ G+
Sbjct: 140 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 246 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           ++F+G+ + P L  +  +C   E   L +   A    E     K L+         IA  
Sbjct: 71  LLFMGYSTKPQLAIVTQWC---EGSSLYHHLHAS---ETKFEMKKLI--------DIARQ 116
Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
            A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ G+ 
Sbjct: 117 TARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 247 GYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
            + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGT 169
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 111
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH   ++ G+
Sbjct: 112 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 169
Query: 246 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-- 163
           VAVK+   + S     ++  E   +    +PN+VKL+G C   +   L++E+MA G +  
Sbjct: 80  VAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139
Query: 164 --------------ENNLFSKVLL------PLPWSIRMKIAFGAAKGLAFLHEAEKPVIY 203
                          ++L ++  +      PL  + ++ IA   A G+A+L  +E+  ++
Sbjct: 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVH 197
Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS 263
           RD  T N L+  +   K++DFGL+++    D             +  PE I     T  S
Sbjct: 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES 257
Query: 264 DVYSFGVVLLEILT 277
           DV+++GVVL EI +
Sbjct: 258 DVWAYGVVLWEIFS 271

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 172
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 31/306 (10%)
Query: 58  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 117
           P   +  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 3   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEG-NARDIIKGEAETRVAVKTVNESASL 61
Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 175
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 119
Query: 176 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 227
                 P +++  I   A  A G+A+L+   K  ++R+    N ++  D+  K+ DFG+ 
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMT 177
Query: 228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           +D  E D      + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 178 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 227
Query: 288 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 347
                LA+              ++D     D P     +   L   C   NP  RP   +
Sbjct: 228 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPNMRPTFLE 281
Query: 348 IVDSLE 353
           IV+ L+
Sbjct: 282 IVNLLK 287

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 31/306 (10%)
Query: 58  PLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 117
           P   +  DE  +        R L       VY+G  + D+ +G     VAVK  +   S 
Sbjct: 4   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEG-NARDIIKGEAETRVAVKTVNESASL 62
Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL-- 175
           +   E+L E   +   +  ++V+L+G   + +  +++ E MA G +++ L S  L P   
Sbjct: 63  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS--LRPEAE 120
Query: 176 ------PWSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 227
                 P +++  I   A  A G+A+L+   K  ++R+    N ++  D+  K+ DFG+ 
Sbjct: 121 NNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMT 178
Query: 228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           +D  E D      + +    + APE +  G  T  SD++SFGVVL EI +          
Sbjct: 179 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------- 228
Query: 288 AREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD 347
                LA+              ++D     D P     +   L   C   NP  RP   +
Sbjct: 229 -----LAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPNMRPTFLE 282
Query: 348 IVDSLE 353
           IV+ L+
Sbjct: 283 IVNLLK 288

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 120
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 224
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 225 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 53  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 112
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 113 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 170
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 171 TARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 230
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 231 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 274
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 275 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 306

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 16  LRILKETEFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 72
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 129
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 130 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 181
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 234

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 169
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 116
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   ++ +S    GT
Sbjct: 117 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GT 170
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 220
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 221 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 13  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 69
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 126
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 127 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 178
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 179 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 231

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGT 169
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 116
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 117 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGT 170
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 220
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 221 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +  L+H N+V+ IG   +
Sbjct: 47  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQ 105
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 106 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 163
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 164 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 223
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 224 TSKTDTWSFGVLLWEIFS 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 55  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 114
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 115 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 172
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 173 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 232
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 233 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 276
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 277 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 308

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 16  LRILKETEFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 72
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 129
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 130 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 181
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 234

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 114
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 115 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 168
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 218
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 219 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 255

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 58  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 117
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 118 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 175
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 176 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 235
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 236 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 279
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 280 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 311

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 85/162 (52%), Gaps = 18/162 (11%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +LAE   +  L H  LV+L     + E   +I E+M  GS+ + L +   + L  +  + 
Sbjct: 51  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 109
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEGDK 235
           +A   A+G+AF+ E  +  I+R+ + +NIL+    + K++DFGLA+          EG K
Sbjct: 110 MAAQIAEGMAFIEE--RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             +         + APE I  G  T +SDV+SFG++L EI+T
Sbjct: 168 FPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 112 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 171
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 172 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 229
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 289
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 290 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 333
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 334 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 122
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 10  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 66
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 123
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 124 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 175
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 176 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 228

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 68
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 125
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 126 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 230

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGT 169
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 122
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 19  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 75
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 76  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 132
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 133 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 184
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 185 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 237

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 124
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 125 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 176
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 229

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGT 169
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +  L+H N+V+ IG   +
Sbjct: 61  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQ 119
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 120 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 177
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 178 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 237
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 238 TSKTDTWSFGVLLWEIFS 255

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 172
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 10  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 66
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLN--W 123
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 124 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 175
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 176 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 228

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 120
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGT 174
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 224
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 225 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 68
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 125
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 126 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 230

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 122
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 119
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 120 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 173
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 223
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 224 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 260

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 68
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 125
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 126 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 230

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDS-XQEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 122
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 124
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 125 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 176
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 229

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 16  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 72
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 129
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 130 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 181
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 234

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 161 GSVENNLFSKV-----------LLP---LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++             +P   + +   +   +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLN--W 122
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 15  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 71
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 72  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 128
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 129 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 180
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 181 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 233

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 68
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 125
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 126 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 230

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 112
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 113 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 166
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 167 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 216
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 217 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 253

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 120
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +    T + GT
Sbjct: 121 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 224
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP +R++++
Sbjct: 225 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLE 261

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASK 125
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 34  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 90
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 91  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 147
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 148 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 199
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 200 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASK 125
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 3   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 59
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 116
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 117 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 221

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 150
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 343 PLMRDI 348
             + DI
Sbjct: 254 ITIPDI 259

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 46  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 162
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 163 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 222
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 223 TSKTDTWSFGVLLWEIFS 240

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 164 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 209
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 177
Query: 210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 269
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 270 VVLLEILT 277
           V+L EI +
Sbjct: 238 VLLWEIFS 245

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 7/157 (4%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 139
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ G+
Sbjct: 140 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 246 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 10/151 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
           L  ++HP +VKL  Y  + E ++ LI +F+  G +   L  +V+          + F  A
Sbjct: 80  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-----TEEDVKFYLA 133
Query: 189 K-GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           +  LA  H     +IYRD K  NILLD + + KL+DFGL+K+  + +K   S    GT  
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191
Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE +     T  +D +SFGV++ E+LTG
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 7/157 (4%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 81  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 138
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ G+
Sbjct: 139 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 246 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 117
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K+++FG +   P   +    T + GT
Sbjct: 118 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGT 171
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 221
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 222 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 46  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 105 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 162
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 163 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 222
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 223 TSKTDTWSFGVLLWEIFS 240

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 7/157 (4%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 59  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 116
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ G+
Sbjct: 117 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 246 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 23/158 (14%)
Query: 127 VIFLGHLSHPNLVKLIGYCCEDE--HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
           ++F+G+ + P L  +  +C      H + I E           F  + L       + IA
Sbjct: 72  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE---------TKFEMIKL-------IDIA 115
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
              A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ G
Sbjct: 116 RQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 245 TYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
           +  + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 33  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 92
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 93  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 148
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 207
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 208 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 251
Query: 343 PLMRDI 348
             + DI
Sbjct: 252 ITIPDI 257

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I E+ ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   +++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 7/157 (4%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 111
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ G+
Sbjct: 112 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 246 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 150
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 343 PLMRDI 348
             + DI
Sbjct: 254 ITIPDI 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 141
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 142 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----LCGT 195
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 245
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 246 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 63  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 121
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 122 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 179
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 180 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 239
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 240 TSKTDTWSFGVLLWEIFS 257

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 47  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 105
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 106 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 163
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 164 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 223
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 224 TSKTDTWSFGVLLWEIFS 241

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 7/157 (4%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L    H N++  +GY  + +  + I      GS   +    +         + IA 
Sbjct: 56  EVGVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 113
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ G+
Sbjct: 114 QTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 171
Query: 246 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
             + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 150
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 343 PLMRDI 348
             + DI
Sbjct: 254 ITIPDI 259

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   ++     + GT
Sbjct: 116 ELANALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA----ALCGT 169
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G+       P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK-------PPFEANTYQDTYKRIS--- 219
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 164 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 209
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 168
Query: 210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 269
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 169 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 270 VVLLEILT 277
           V+L EI +
Sbjct: 229 VLLWEIFS 236

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 150
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 343 PLMRDI 348
             + DI
Sbjct: 254 ITIPDI 259

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 117
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 118 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 171
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 221
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 222 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 164 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 209
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 168
Query: 210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 269
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 169 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 270 VVLLEILT 277
           V+L EI +
Sbjct: 229 VLLWEIFS 236

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 150
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 343 PLMRDI 348
             + DI
Sbjct: 254 ITIPDI 259

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 150
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 343 PLMRDI 348
             + DI
Sbjct: 254 ITIPDI 259

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 53  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 111
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 112 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 169
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 170 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 229
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 230 TSKTDTWSFGVLLWEIFS 247

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 150
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 343 PLMRDI 348
             + DI
Sbjct: 254 ITIPDI 259

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 38  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 96
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 97  SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 154
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 155 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 214
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 215 TSKTDTWSFGVLLWEIFS 232

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 73  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 131
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 132 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 189
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 190 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 249
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 250 TSKTDTWSFGVLLWEIFS 267

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 83/150 (55%), Gaps = 8/150 (5%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
           L  ++HP +VKL  Y  + E ++ LI +F+  G    +LF+++   + ++      + A 
Sbjct: 80  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGG----DLFTRLSKEVMFTEEDVKFYLAE 134
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
             LA  H     +IYRD K  NILLD + + KL+DFGL+K+  + +K   S    GT  Y
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            APE +     T  +D +SFGV++ E+LTG
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 83/150 (55%), Gaps = 8/150 (5%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
           L  ++HP +VKL  Y  + E ++ LI +F+  G    +LF+++   + ++      + A 
Sbjct: 81  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGG----DLFTRLSKEVMFTEEDVKFYLAE 135
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
             LA  H     +IYRD K  NILLD + + KL+DFGL+K+  + +K   S    GT  Y
Sbjct: 136 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 193
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            APE +     T  +D +SFGV++ E+LTG
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/100 (40%), Positives = 58/100 (58%), Gaps = 5/100 (5%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           IA   A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++
Sbjct: 109 IARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 243 MGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGR 279
            G+  + APE I      P   +SDVY+FG+VL E++TG+
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 61  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 119
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 120 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 177
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 178 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 237
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 238 TSKTDTWSFGVLLWEIFS 255

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   ++     + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA----ALCGT 172
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 164 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 209
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 177
Query: 210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 269
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 270 VVLLEILT 277
           V+L EI +
Sbjct: 238 VLLWEIFS 245

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 116
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 117 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----TLCGT 170
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 220
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 221 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 64  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 122
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 123 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 180
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 181 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF 240
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 241 TSKTDTWSFGVLLWEIFS 258

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFG 150
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 209
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 210 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 253
Query: 343 PLMRDI 348
             + DI
Sbjct: 254 ITIPDI 259

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 61  VYEGQVS-GMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 119
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 120 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 177
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 178 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 237
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 238 TSKTDTWSFGVLLWEIFS 255

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K+++FG +   P   +    T + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGT 172
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 47  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 105
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 106 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 163
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 164 HRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 223
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 224 TSKTDTWSFGVLLWEIFS 241

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   ++     + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA----ALCGT 169
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 24/246 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VAVK+ D   +         E+     L+H N+VK  G+  E   + L  E+ + G + +
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            +   + +P P + R      A  G+ +LH     + +RD K  N+LLD   N K+SDFG
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLD 283
           LA      ++  +  ++ GT  Y APE +     H  P  DV+S G+VL  +L G    D
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWD 208
Query: 284 KSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYH-CLNHNPKAR 342
           +   +  Q  +DW                       P K +  A +   H  L  NP AR
Sbjct: 209 QPSDSC-QEYSDWKEKKTYLN---------------PWKKIDSAPLALLHKILVENPSAR 252
Query: 343 PLMRDI 348
             + DI
Sbjct: 253 ITIPDI 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N+V+ IG   +
Sbjct: 87  VYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRM----KIAFGAAKGLAFLHEAEKPVI 202
              R ++ E MA G +++ L      P  P S+ M     +A   A G  +L E     I
Sbjct: 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FI 203
Query: 203 YRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
           +RD    N LL        AK+ DFG+A+D             M    +  PE  M G  
Sbjct: 204 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF 263
Query: 260 TPRSDVYSFGVVLLEILT 277
           T ++D +SFGV+L EI +
Sbjct: 264 TSKTDTWSFGVLLWEIFS 281

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 88/187 (47%), Gaps = 17/187 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 120
Query: 164 ENNLFSKVLLPLPWSIRMKI-------------AFGAAKGLAFLHEAEKPVIYRDFKTSN 210
              L SK    +P+     +             +F  AKG+ FL  A +  I+RD    N
Sbjct: 121 STYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARN 178
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           ILL      K+ DFGLA+D  +               + APE I     T +SDV+SFGV
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 271 VLLEILT 277
           +L EI +
Sbjct: 239 LLWEIFS 245

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 89/187 (47%), Gaps = 15/187 (8%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS 162
           + VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 163 VENNLF--SKVLLPLP--------WSIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSN 210
           + N L   S+VL   P         S R  + F +  A+G+AFL  A K  I+RD    N
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARN 194
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           +LL   + AK+ DFGLA+D        V         + APE I     T +SDV+S+G+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 271 VLLEILT 277
           +L EI +
Sbjct: 255 LLWEIFS 261

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 88/186 (47%), Gaps = 16/186 (8%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 164 ENNLFSKVLLPLPWSIR------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 211
              L SK    +P+               +  +F  AKG+ FL  A +  I+RD    NI
Sbjct: 122 STYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNI 179
Query: 212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVV 271
           LL      K+ DFGLA+D  +               + APE I     T +SDV+SFGV+
Sbjct: 180 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 272 LLEILT 277
           L EI +
Sbjct: 240 LWEIFS 245

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 6   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 62
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 63  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 119
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      A+G+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 120 CVQI------AEGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 171
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 172 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 224

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 88/184 (47%), Gaps = 14/184 (7%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 164 ENNLFSKVLLPLPWSIRMK----------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILL 213
              L SK    +P+    K           +F  AKG+ FL  A +  I+RD    NILL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKXIHRDLAARNILL 177
Query: 214 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 273
                 K+ DFGLA+D  +               + APE I     T +SDV+SFGV+L 
Sbjct: 178 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 274 EILT 277
           EI +
Sbjct: 238 EIFS 241

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 172
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 164 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 209
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 177
Query: 210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 269
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 270 VVLLEILT 277
           V+L EI +
Sbjct: 238 VLLWEIFS 245

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 80/157 (50%), Gaps = 10/157 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           E+  L +L H N+VK  G C ED      LI EF+  GS++  L  K    +    ++K 
Sbjct: 61  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKY 119
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST--- 240
           A    KG+ +L    +  ++RD    N+L+++++  K+ DFGL K   E DK   +    
Sbjct: 120 AVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDD 176
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           R    + Y APE +M       SDV+SFGV L E+LT
Sbjct: 177 RDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 80/157 (50%), Gaps = 10/157 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           E+  L +L H N+VK  G C ED      LI EF+  GS++  L  K    +    ++K 
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKY 131
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST--- 240
           A    KG+ +L    +  ++RD    N+L+++++  K+ DFGL K   E DK   +    
Sbjct: 132 AVQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDD 188
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           R    + Y APE +M       SDV+SFGV L E+LT
Sbjct: 189 RDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 89/187 (47%), Gaps = 15/187 (8%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS 162
           + VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 163 VENNLF--SKVLLPLPW--------SIRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSN 210
           + N L   S+VL   P         S R  + F +  A+G+AFL  A K  I+RD    N
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARN 194
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGV 270
           +LL   + AK+ DFGLA+D        V         + APE I     T +SDV+S+G+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 271 VLLEILT 277
           +L EI +
Sbjct: 255 LLWEIFS 261

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 13  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 69
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 126
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 127 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 178
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 179 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 231

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----LCGT 172
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 222
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 223 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 88/184 (47%), Gaps = 14/184 (7%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 164 ENNLFSKVLLPLPWSIRMK----------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILL 213
              L SK    +P+    K           +F  AKG+ FL  A +  I+RD    NILL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNILL 177
Query: 214 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 273
                 K+ DFGLA+D  +               + APE I     T +SDV+SFGV+L 
Sbjct: 178 SEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 274 EILT 277
           EI +
Sbjct: 238 EIFS 241

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL +    K++DFG +   P   +      + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 169
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXX 305
             Y  PE I       + D++S GV+  E L G       +P  E N             
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRIS--- 219
Query: 306 XXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
                   R+E  +P      A  L    L HNP  RP++R++++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 12/184 (6%)
Query: 104 VPVAVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR-----VLIYEF 157
           + VAVK    DNS Q    E+L+E   +   SHPN+++L+G C E   +     ++I  F
Sbjct: 63  LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPF 122
Query: 158 MARGSVENNLFSKVLLP----LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL 213
           M  G +   L    L      +P    +K     A G+ +L  + +  ++RD    N +L
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCML 180
Query: 214 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 273
             D    ++DFGL+K    GD             + A E +     T +SDV++FGV + 
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240
Query: 274 EILT 277
           EI T
Sbjct: 241 EIAT 244

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 117/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I  + ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASK 125
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 15/156 (9%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E + L  ++HP ++++ G   + +   +I +++  G + + L      P P +      F
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-----KF 110
Query: 186 GAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
            AA+    L +LH   K +IYRD K  NILLD + + K++DFG AK  P+     V+  +
Sbjct: 111 YAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXL 163
Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            GT  Y APE + T       D +SFG+++ E+L G
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 8   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 121 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 176
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 84/150 (56%), Gaps = 8/150 (5%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
           L  ++HP +VKL  Y  + E ++ LI +F+  G +   L SK ++     ++  +A   A
Sbjct: 84  LADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELA 140
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
            GL  LH     +IYRD K  NILLD + + KL+DFGL+K+  + +K   S    GT  Y
Sbjct: 141 LGLDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEY 196
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            APE +     +  +D +S+GV++ E+LTG
Sbjct: 197 MAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 164 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 209
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 168
Query: 210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 269
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 169 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 270 VVLLEILT 277
           V+L EI +
Sbjct: 229 VLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 164 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 209
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 214
Query: 210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 269
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 274
Query: 270 VVLLEILT 277
           V+L EI +
Sbjct: 275 VLLWEIFS 282

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 115/227 (50%), Gaps = 24/227 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+       S + ++E L
Sbjct: 43  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIMELREATSPKANKEIL 99
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 100 DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 156
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K +
Sbjct: 157 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 208
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLD 283
            +        + A E I+    T +SDV+S+GV + E++T G K  D
Sbjct: 209 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 164 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 209
              L SK    +P+ +               +  +F  AKG+ FL  A +  I+RD    
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 168
Query: 210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 269
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 169 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 228
Query: 270 VVLLEILT 277
           V+L EI +
Sbjct: 229 VLLWEIFS 236

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 124
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 125 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 176
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 229

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN--W 124
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 125 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 176
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 229

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 11  NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 124 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 179
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 122
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 123 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 174
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 227

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 86/182 (47%), Gaps = 22/182 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR---VLIYEFMARGS 162
           VAVK        Q    W  E+  L  L H ++VK  G CCED+      L+ E++  GS
Sbjct: 40  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKG-CCEDQGEKSVQLVMEYVPLGS 98
Query: 163 VENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD 216
           + + L       +++LL          A    +G+A+LH   +  I+R     N+LLD D
Sbjct: 99  LRDYLPRHCVGLAQLLL---------FAQQICEGMAYLHA--QHYIHRALAARNVLLDND 147
Query: 217 YNAKLSDFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
              K+ DFGLAK  PEG + + V         + APE +        SDV+SFGV L E+
Sbjct: 148 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 207
Query: 276 LT 277
           LT
Sbjct: 208 LT 209

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 11  NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 124 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 179
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 117/239 (48%), Gaps = 35/239 (14%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           LRI+     R+ +VL       VYKG    D  E ++ +PVA+KV   + S + ++E L 
Sbjct: 11  LRILKETELRKVKVLGSGAFGTVYKGIWIPD-GENVK-IPVAIKVLRENTSPKANKEILD 68
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPWS 178
           E   +  +  P + +L+G C     + L+ + M  G +          L S+ LL   W 
Sbjct: 69  EAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLN--WC 125
Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----DGPE-- 232
           +++      AKG+++L +    +++RD    N+L+ +  + K++DFGLA+    D  E  
Sbjct: 126 MQI------AKGMSYLEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 177
Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            D   V  + M      A E I+    T +SDV+S+GV + E++T G K  D   PARE
Sbjct: 178 ADGGKVPIKWM------ALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE 229

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 118 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 173
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 124
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 125 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 176
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 229

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 86/182 (47%), Gaps = 22/182 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR---VLIYEFMARGS 162
           VAVK        Q    W  E+  L  L H ++VK  G CCED+      L+ E++  GS
Sbjct: 41  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKG-CCEDQGEKSVQLVMEYVPLGS 99
Query: 163 VENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD 216
           + + L       +++LL          A    +G+A+LH   +  I+R     N+LLD D
Sbjct: 100 LRDYLPRHCVGLAQLLL---------FAQQICEGMAYLHA--QHYIHRALAARNVLLDND 148
Query: 217 YNAKLSDFGLAKDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
              K+ DFGLAK  PEG + + V         + APE +        SDV+SFGV L E+
Sbjct: 149 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 208
Query: 276 LT 277
           LT
Sbjct: 209 LT 210

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 172
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 108
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  +
Sbjct: 109 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEV 164
Query: 244 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           + E+  L  L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +    
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 107
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
            F   +GLAF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  +
Sbjct: 108 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEV 163
Query: 244 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
            T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 7/158 (4%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 60  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILG 117
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           K++    +GLA+L E  + +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 118 KVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 172
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            +GT  Y APE +   H + +SD++S G+ L+E+  GR
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 117/272 (43%), Gaps = 33/272 (12%)
Query: 102 QPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMAR 160
           + V VAVK+   D + +   + ++E+  +  +  H N++ L+G C +D    +I  + ++
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASK 125
Query: 161 GSVENNLFSKVLLPLPWSIRMK--------------IAFGAAKGLAFLHEAEKPVIYRDF 206
           G++   L ++    + +S  +                 +  A+G+ +L  A +  I+RD 
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDL 183
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              N+L+  +   K++DFGLA+D    D    +T       + APE +     T +SDV+
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 267 SFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHK 326
           SFGV++ EI T   S     P  E                   ++      D P    ++
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 287
Query: 327 AAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL 358
             M+   C +  P  RP  + +V+ L+ +  L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 118/234 (50%), Gaps = 25/234 (10%)
Query: 67  LRIIT-ANFRQDRVLXXXXXXCVYKGFISEDLREGLQ-PVPVAVKVHDGDNSYQGHREWL 124
           LRI+    F++ +VL       VYKG     + EG +  +PVA+K      S + ++E L
Sbjct: 16  LRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEIL 72
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV-------ENNLFSKVLLPLPW 177
            E   +  + +P++ +L+G C     + LI + M  G +       ++N+ S+ LL   W
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN--W 129
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +++      AKG+ +L +  + +++RD    N+L+ T  + K++DFG AK     +K +
Sbjct: 130 CVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 181
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE 290
            +        + A E I+    T +SDV+S+GV + E++T G K  D   PA E
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 234

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---G 190
            HP L  +       E+   + E++  G +  ++ S     L      +  F AA+   G
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILG 131
Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L FLH   K ++YRD K  NILLD D + K++DFG+ K+   GD    +    GT  Y A
Sbjct: 132 LQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDYIA 187
Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           PE ++        D +SFGV+L E+L G+
Sbjct: 188 PEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 18/212 (8%)
Query: 72  ANFRQDRVLXXXXXXCVYKG-FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 130
              R+ +VL       V+KG +I E   E ++ +PV +KV +  +  Q  +     ++ +
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEG--ESIK-IPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLP---LPWSIRMKIAF 185
           G L H ++V+L+G C     + L+ +++  GS+ +++      L P   L W +++    
Sbjct: 70  GSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI---- 124
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             AKG+ +L E    +++R+    N+LL +    +++DFG+A   P  DK  + +     
Sbjct: 125 --AKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             + A E I  G  T +SDV+S+GV + E++T
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 112 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 169
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 170 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 224
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 106/257 (41%), Gaps = 31/257 (12%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 37  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 94
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 95  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 152
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSL 282
           FGL++    GD             + APE +     + +SDV++FGV+L EI T G    
Sbjct: 153 FGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211
Query: 283 DKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY----PVKGVHKAAMLAYHCLNHN 338
               P++   L                     LE DY    P     K   L   C   N
Sbjct: 212 PGIDPSQVYEL---------------------LEKDYRMERPEGCPEKVYELMRACWQWN 250
Query: 339 PKARPLMRDIVDSLEPL 355
           P  RP   +I  + E +
Sbjct: 251 PSDRPSFAEIHQAFETM 267

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF++   +++ + +  L  +P  +     F   +GL
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 104/247 (42%), Gaps = 10/247 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI EF+  GS+
Sbjct: 44  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSL 103
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
              L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 104 REYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 160
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 161 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 219
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 220 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 278
Query: 342 RPLMRDI 348
           RP  RD+
Sbjct: 279 RPSFRDL 285

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---G 190
            HP L  +       E+   + E++  G +  ++ S     L      +  F AA+   G
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILG 130
Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L FLH   K ++YRD K  NILLD D + K++DFG+ K+   GD    +    GT  Y A
Sbjct: 131 LQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIA 186
Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           PE ++        D +SFGV+L E+L G+
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF++   +++ + +  L  +P  +     F   +GL
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 119 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 134
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 135 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 189
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 17/189 (8%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS 162
           + VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 163 VENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKT 208
           + N L  K    L +S                +  +   A+G+AFL  A K  I+RD   
Sbjct: 137 LLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL--ASKNCIHRDVAA 194
Query: 209 SNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSF 268
            N+LL   + AK+ DFGLA+D        V         + APE I     T +SDV+S+
Sbjct: 195 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 254
Query: 269 GVVLLEILT 277
           G++L EI +
Sbjct: 255 GILLWEIFS 263

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 7/158 (4%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 53  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 110
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++  G   D+  ++  
Sbjct: 111 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANE 165
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 166 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           +F H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 117 SFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 106/257 (41%), Gaps = 31/257 (12%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 37  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 94
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 95  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 152
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSL 282
           FGL++    GD             + APE +     + +SDV++FGV+L EI T G    
Sbjct: 153 FGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211
Query: 283 DKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY----PVKGVHKAAMLAYHCLNHN 338
               P++   L                     LE DY    P     K   L   C   N
Sbjct: 212 PGIDPSQVYEL---------------------LEKDYRMERPEGCPEKVYELMRACWQWN 250
Query: 339 PKARPLMRDIVDSLEPL 355
           P  RP   +I  + E +
Sbjct: 251 PSDRPSFAEIHQAFETM 267

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 24/196 (12%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS 162
           + VAVK+             ++E+  + HL  H N+V L+G C      ++I E+   G 
Sbjct: 62  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 121
Query: 163 VENNLFSKVLLPL-------------------PWSIRMKIAFGA--AKGLAFLHEAEKPV 201
           + N L  K    L                   P  +R  + F +  A+G+AFL  A K  
Sbjct: 122 LLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNC 179
Query: 202 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           I+RD    N+LL   + AK+ DFGLA+D        V         + APE I     T 
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 239
Query: 262 RSDVYSFGVVLLEILT 277
           +SDV+S+G++L EI +
Sbjct: 240 QSDVWSYGILLWEIFS 255

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  +++ + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 40  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 97
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 98  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 155
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 156 FGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 45  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 104
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 105 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 161
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 162 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 220
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 221 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 279
Query: 342 RPLMRDI 348
           RP  RD+
Sbjct: 280 RPSFRDL 286

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 39/219 (17%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVH--DGDNSYQGHREWLAEVIFLGHLSHPNLVKLI-- 142
           CV+K  +  D         VAVK+       S+Q  RE    +     + H NL++ I  
Sbjct: 30  CVWKAQLMNDF--------VAVKIFPLQDKQSWQSERE----IFSTPGMKHENLLQFIAA 77
Query: 143 ---GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE--- 196
              G   E E   LI  F  +GS+ + L   ++    W+    +A   ++GL++LHE   
Sbjct: 78  EKRGSNLEVE-LWLITAFHDKGSLTDYLKGNII---TWNELCHVAETMSRGLSYLHEDVP 133
Query: 197 -----AEKPVI-YRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
                  KP I +RDFK+ N+LL +D  A L+DFGLA     G     +   +GT  Y A
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMA 193
Query: 251 PEYIMTGHLT------PRSDVYSFGVVLLEILTGRKSLD 283
           PE ++ G +        R D+Y+ G+VL E+++  K+ D
Sbjct: 194 PE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 39  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 98
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 99  RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 155
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 156 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 214
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 215 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 273
Query: 342 RPLMRDI 348
           RP  RD+
Sbjct: 274 RPSFRDL 280

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 171
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 41  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 101 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 157
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 158 FGLTKVLPQ-DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 217 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 275
Query: 342 RPLMRDI 348
           RP  RD+
Sbjct: 276 RPSFRDL 282

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 44  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 102 LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 160 FGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF++   ++  + +  L  +P  +     F   +GL
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 118 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF++   ++  + +  L  +P  +     F   +GL
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 41  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 101 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 157
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 158 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 217 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 275
Query: 342 RPLMRDI 348
           RP  RD+
Sbjct: 276 RPSFRDL 282

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 40  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 99
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 100 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 156
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 157 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 215
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 216 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 274
Query: 342 RPLMRDI 348
           RP  RD+
Sbjct: 275 RPSFRDL 281

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 119 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 105/248 (42%), Gaps = 10/248 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 72  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 132 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 188
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 189 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 248 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 306
Query: 342 RPLMRDIV 349
           RP  RD+ 
Sbjct: 307 RPSFRDLA 314

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 9/233 (3%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 178
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 117
Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 238
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 118 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 174
Query: 239 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 233
Query: 297 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
                        ++        P     +  M+   C N+N   RP  RD+ 
Sbjct: 234 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 41  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 101 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 157
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 158 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 217 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 275
Query: 342 RPLMRDI 348
           RP  RD+
Sbjct: 276 RPSFRDL 282

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 44  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 102 LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 160 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 119 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 171
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 96
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 96
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 47  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 106
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 107 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 163
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 164 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 222
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 223 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 281
Query: 342 RPLMRDI 348
           RP  RD+
Sbjct: 282 RPSFRDL 288

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 105/248 (42%), Gaps = 10/248 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 46  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 105
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 106 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 162
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 163 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 221
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 222 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 280
Query: 342 RPLMRDIV 349
           RP  RD+ 
Sbjct: 281 RPSFRDLA 288

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 106/257 (41%), Gaps = 31/257 (12%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 37  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 94
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 95  LDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 152
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSL 282
           FGL++    GD             + APE +     + +SDV++FGV+L EI T G    
Sbjct: 153 FGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211
Query: 283 DKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY----PVKGVHKAAMLAYHCLNHN 338
               P++   L                     LE DY    P     K   L   C   N
Sbjct: 212 PGIDPSQVYEL---------------------LEKDYRMERPEGCPEKVYELMRACWQWN 250
Query: 339 PKARPLMRDIVDSLEPL 355
           P  RP   +I  + E +
Sbjct: 251 PSDRPSFAEIHQAFETM 267

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHP-NLVKLIGYCCEDEHRVL-IYEFMARGSV 163
           VAVK+     ++  HR  ++E+  L H+ H  N+V L+G C +    ++ I EF   G++
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 164 ENNLFSKVLLPLPWSIR--------------MKIAFGAAKGLAFLHEAEKPVIYRDFKTS 209
              L SK    +P+                 +  +F  AKG+ FL  A +  I+RD    
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAAR 179
Query: 210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFG 269
           NILL      K+ DFGLA+D  +               + APE I     T +SDV+SFG
Sbjct: 180 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 239
Query: 270 VVLLEILT 277
           V+L EI +
Sbjct: 240 VLLWEIFS 247

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 9/233 (3%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 178
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 63  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 121
Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 238
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 122 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 178
Query: 239 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 179 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 237
Query: 297 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
                        ++        P     +  M+   C N+N   RP  RD+ 
Sbjct: 238 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 118 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 118 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 119 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + + E+  L   + P +V   G    D    +  E M  GS++  L  K    +P  I  
Sbjct: 69  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 126
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           K++    KGL +L E  K +++RD K SNIL+++    KL DFG++    +     ++  
Sbjct: 127 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 181
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            +GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 44  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 102 LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 160 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 8   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 121 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 176
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 44  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 101
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 102 LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 160 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +  ++  + +  L  +P  +     F   +GL
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 118 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 40  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 97
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 98  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 155
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 156 FGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 41  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 98
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 99  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 156
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 157 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 52  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 109
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 110 LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 167
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 168 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 44  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 102 LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 160 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 59  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 118
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L  K    +     ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 119 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 175
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 176 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 234
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 235 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 293
Query: 342 RPLMRDI 348
           RP  RD+
Sbjct: 294 RPSFRDL 300

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 43  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 101 LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 158
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 159 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 3/156 (1%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           ++L E   L   SHPN+V+LIG C + +   ++ E +  G     L ++    L     +
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLL 216
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           ++   AA G+ +L    K  I+RD    N L+      K+SDFG++++  +G  +     
Sbjct: 217 QMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGL 274
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                 + APE +  G  +  SDV+SFG++L E  +
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 39  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 97  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 9/232 (3%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPWS 178
           R++  E+  L  L H N+VK  G C     R   LI E++  GS+ + L  K    +   
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHI 132
Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 238
             ++      KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+ DK   
Sbjct: 133 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXX 189
Query: 239 STRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
             +  G     + APE +     +  SDV+SFGVVL E+ T  +   KS PA    +   
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEFMRMIGN 248
Query: 297 AXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
                        ++        P     +  M+   C N+N   RP  RD+
Sbjct: 249 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 41  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 98
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 99  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 156
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 157 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 5/174 (2%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           + VAVK    D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++
Sbjct: 41  LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 98
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L       +   + + +A   +  + +L   +K  I+RD    N L+  ++  K++D
Sbjct: 99  LDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD 156
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           FGL++    GD             + APE +     + +SDV++FGV+L EI T
Sbjct: 157 FGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 105/247 (42%), Gaps = 10/247 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 44  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 103
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L +         + ++      KG+ +L    K  I+RD  T NIL++ +   K+ D
Sbjct: 104 RDYLQAHAERIDHIKL-LQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGD 160
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK     +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 161 FGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 219
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 220 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 278
Query: 342 RPLMRDI 348
           RP  RD+
Sbjct: 279 RPSFRDL 285

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 106/247 (42%), Gaps = 10/247 (4%)
Query: 107 AVKVHDGDNSYQGH-REWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--VLIYEFMARGSV 163
            V V    +S + H R++  E+  L  L H N+VK  G C     R   LI E++  GS+
Sbjct: 42  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 101
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
            + L  K    +     ++      KG+ +L    K  I+R+  T NIL++ +   K+ D
Sbjct: 102 RDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRNLATRNILVENENRVKIGD 158
Query: 224 FGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           FGL K  P+ DK +   +  G     + APE +     +  SDV+SFGVVL E+ T  + 
Sbjct: 159 FGLTKVLPQ-DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 217
Query: 282 LDKSRPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
             KS PA    +                ++        P     +  M+   C N+N   
Sbjct: 218 -SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 276
Query: 342 RPLMRDI 348
           RP  RD+
Sbjct: 277 RPSFRDL 283

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VA+K+ D + +     +   E+  L     P + K  G   +D    +I E++  GS  +
Sbjct: 50  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 109
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            L      PL  +    I     KGL +LH  +K  I+RD K +N+LL      KL+DFG
Sbjct: 110 LLEPG---PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFG 164
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G     + 
Sbjct: 165 VA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
Query: 286 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARP 343
            P +   L                   P LEG+Y  P+K   +A      CLN  P  RP
Sbjct: 223 HPMKVLFLIPKNNP-------------PTLEGNYSKPLKEFVEA------CLNKEPSFRP 263
Query: 344 LMRDIV 349
             ++++
Sbjct: 264 TAKELL 269

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VA+K+ D + +     +   E+  L     P + K  G   +D    +I E++  GS  +
Sbjct: 55  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 114
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            L      PL  +    I     KGL +LH  +K  I+RD K +N+LL      KL+DFG
Sbjct: 115 LLEPG---PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFG 169
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G     + 
Sbjct: 170 VA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227
Query: 286 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARP 343
            P +   L                   P LEG+Y  P+K   +A      CLN  P  RP
Sbjct: 228 HPMKVLFLIPKNNP-------------PTLEGNYSKPLKEFVEA------CLNKEPSFRP 268
Query: 344 LMRDIV 349
             ++++
Sbjct: 269 TAKELL 274

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 3/156 (1%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           ++L E   L   SHPN+V+LIG C + +   ++ E +  G     L ++    L     +
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLL 216
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           ++   AA G+ +L    K  I+RD    N L+      K+SDFG++++  +G  +     
Sbjct: 217 QMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                 + APE +  G  +  SDV+SFG++L E  +
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VA+K+ D + +     +   E+  L     P + K  G   +D    +I E++  GS  +
Sbjct: 35  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 94
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            L      PL  +    I     KGL +LH  +K  I+RD K +N+LL      KL+DFG
Sbjct: 95  LLEPG---PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G     + 
Sbjct: 150 VA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207
Query: 286 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARP 343
            P +   L                   P LEG+Y  P+K   +A      CLN  P  RP
Sbjct: 208 HPMKVLFLIPKNNP-------------PTLEGNYSKPLKEFVEA------CLNKEPSFRP 248
Query: 344 LMRDIV 349
             ++++
Sbjct: 249 TAKELL 254

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VA+K+ D + +     +   E+  L     P + K  G   +D    +I E++  GS  +
Sbjct: 35  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 94
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            L      PL  +    I     KGL +LH  +K  I+RD K +N+LL      KL+DFG
Sbjct: 95  LLEPG---PLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFG 149
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G     + 
Sbjct: 150 VA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207
Query: 286 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARP 343
            P +   L                   P LEG+Y  P+K   +A      CLN  P  RP
Sbjct: 208 HPMKVLFLIPKNNP-------------PTLEGNYSKPLKEFVEA------CLNKEPSFRP 248
Query: 344 LMRDIV 349
             ++++
Sbjct: 249 TAKELL 254

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 92/190 (48%), Gaps = 24/190 (12%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGY----CCEDEHRVLIYEFMARG 161
           VAVK+    +      E+  EV  L  + H N+++ IG        D    LI  F  +G
Sbjct: 50  VAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107
Query: 162 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-------AEKPVI-YRDFKTSNILL 213
           S+ + L + V+    W+    IA   A+GLA+LHE         KP I +RD K+ N+LL
Sbjct: 108 SLSDFLKANVV---SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164
Query: 214 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT------PRSDVYS 267
             +  A ++DFGLA     G  +  +   +GT  Y APE ++ G +        R D+Y+
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYA 223
Query: 268 FGVVLLEILT 277
            G+VL E+ +
Sbjct: 224 MGLVLWELAS 233

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 98  REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 156
           R  L    VAVK+ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 210
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 269
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 270 VVLLEILTGRKSLDKSRPAREQNLAD 295
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 98  REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 156
           R  L    VAVK+ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 210
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 269
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 270 VVLLEILTGRKSLDKSRPAREQNLAD 295
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 7/156 (4%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L    H N++  +GY  +D +  ++ ++    S+  +L  +      + + + IA 
Sbjct: 82  EVAVLRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQL-IDIAR 139
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A+G+ +LH   K +I+RD K++NI L      K+ DFGLA        S    +  G+
Sbjct: 140 QTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGS 197
Query: 246 YGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTG 278
             + APE I      P   +SDVYS+G+VL E++TG
Sbjct: 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 5/158 (3%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           + +  EV     LSH N+V +I    ED+   L+ E++   ++   + S      P S+ 
Sbjct: 56  KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVD 111
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
             I F         H  +  +++RD K  NIL+D++   K+ DFG+AK   E   +  + 
Sbjct: 112 TAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TN 170
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            ++GT  Y +PE          +D+YS G+VL E+L G
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN--NLFSKVLLPLPWS 178
           +E + E+  +     P++VK  G   ++    ++ E+   GSV +   L +K L     +
Sbjct: 69  QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA 128
Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 238
             ++      KGL +LH   K  I+RD K  NILL+T+ +AKL+DFG+A  G   D    
Sbjct: 129 TILQ---STLKGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAK 181
Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
              ++GT  + APE I        +D++S G+  +E+  G+       P R
Sbjct: 182 RNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 85/168 (50%), Gaps = 21/168 (12%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 175
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 132
Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 133 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 181
Query: 236 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
           ++   +  G +   + APE I     + +SDV+SFGV++ E  + G+K
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 85/168 (50%), Gaps = 21/168 (12%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 175
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 132
Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 133 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 181
Query: 236 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
           ++   +  G +   + APE I     + +SDV+SFGV++ E  + G+K
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           V  A KV D   S +   +++ E+  L    HPN+VKL+     + +  ++ EF A G+V
Sbjct: 63  VLAAAKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 121
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
           +  +  ++  PL  S    +       L +LH+    +I+RD K  NIL   D + KL+D
Sbjct: 122 DAVML-ELERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLAD 178
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTP---RSDVYSFGVVLLEI 275
           FG++       +   S   +GT  + APE +M  T    P   ++DV+S G+ L+E+
Sbjct: 179 FGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++E + +  ++  + +  L  +P  +     F   +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 98  REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 156
           R  L    VAVK+ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 210
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 269
           +LLD D N K++DFG + +   G+K        G   YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 270 VVLLEILTGRKSLDKSRPAREQNLAD 295
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 85/168 (50%), Gaps = 21/168 (12%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 175
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 130
Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 131 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 179
Query: 236 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
           ++   +  G +   + APE I     + +SDV+SFGV++ E  + G+K
Sbjct: 180 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           V  A KV D   S +   +++ E+  L    HPN+VKL+     + +  ++ EF A G+V
Sbjct: 63  VLAAAKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 121
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
           +  +  ++  PL  S    +       L +LH+    +I+RD K  NIL   D + KL+D
Sbjct: 122 DAVML-ELERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLAD 178
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTP---RSDVYSFGVVLLEI 275
           FG++       +   S   +GT  + APE +M  T    P   ++DV+S G+ L+E+
Sbjct: 179 FGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 98  REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 156
           R  L    VAVK+ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 35  RHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVME 94
Query: 157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 210
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 95  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KYIVHRDLKAEN 144
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 269
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 145 LLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 270 VVLLEILTGRKSLDKSRPAREQNLAD 295
           V+L  +++G      S P   QNL +
Sbjct: 202 VILYTLVSG------SLPFDGQNLKE 221

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 3/156 (1%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           E+L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L       +   + +
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 321
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
            +A   +  + +L   +K  I+R+    N L+  ++  K++DFGL++    GD       
Sbjct: 322 YMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAG 378
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                 + APE +     + +SDV++FGV+L EI T
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 175
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 110
Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 111 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 159
Query: 236 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 160 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 175
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 122
Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 123 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 171
Query: 236 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 114/257 (44%), Gaps = 39/257 (15%)
Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           +F    +HP LV L   C + E R+  + E++  G +  ++  +  LP   +      + 
Sbjct: 73  VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR----FYS 127
Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTRIMGT 245
           A   LA  +  E+ +IYRD K  N+LLD++ + KL+D+G+ K+G   GD    ++   GT
Sbjct: 128 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSXFCGT 184
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWAXXXXXX 303
             Y APE +         D ++ GV++ E++ GR   D   S    +QN  D+       
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--- 241
Query: 304 XXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PLMRDI 348
                 I++ ++    P     KAA +    LN +PK R               P  R++
Sbjct: 242 ------ILEKQIR--IPRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNV 293
Query: 349 -VDSLEPLQVLPDEAPT 364
             D +E  QV+P   P 
Sbjct: 294 DWDMMEQKQVVPPFKPN 310

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 175
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 116
Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 117 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 165
Query: 236 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 166 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 85/168 (50%), Gaps = 21/168 (12%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 175
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 112
Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 113 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 161
Query: 236 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
           ++   +  G +   + APE I     + +SDV+SFGV++ E  + G+K
Sbjct: 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 98  REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 156
           R  L    VAV++ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 210
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 269
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 270 VVLLEILTGRKSLDKSRPAREQNLAD 295
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 98  REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 156
           R  L    VAV++ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 210
           + + G V + L +          RMK     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 269
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 270 VVLLEILTGRKSLDKSRPAREQNLAD 295
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 3/156 (1%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           E+L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L       +   + +
Sbjct: 301 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 360
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
            +A   +  + +L   +K  I+R+    N L+  ++  K++DFGL++    GD       
Sbjct: 361 YMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAG 417
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                 + APE +     + +SDV++FGV+L EI T
Sbjct: 418 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 175
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 475
Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 476 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 524
Query: 236 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 525 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 98  REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 156
           R  L    VAVK+ D    +    ++   EV  +  L+HPN+VKL      ++   L+ E
Sbjct: 27  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 86
Query: 157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 210
           + + G V + L +       W   MK     AK       + + H+  K +++RD K  N
Sbjct: 87  YASGGEVFDYLVAH-----GW---MKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 136
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 269
           +LLD D N K++DFG + +   G+K        G+  YAAPE      +  P  DV+S G
Sbjct: 137 LLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLG 193
Query: 270 VVLLEILTGRKSLDKSRPAREQNLAD 295
           V+L  +++G      S P   QNL +
Sbjct: 194 VILYTLVSG------SLPFDGQNLKE 213

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 175
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 474
Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 475 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 523
Query: 236 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           ++   +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 77  DRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
           +R+L       VY+G  +    E +    VAVK    D +     ++++E + + +L HP
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 69
Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGS----VENNLFS-KVLLPLPWSIRMKIAFGAAKGL 191
           ++VKLIG   E+E   +I E    G     +E N  S KVL  + +S+++       K +
Sbjct: 70  HIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI------CKAM 122
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS-TRIMGTYGYAA 250
           A+L       ++RD    NIL+ +    KL DFGL++   + D    S TR+     + +
Sbjct: 123 AYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMS 178
Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           PE I     T  SDV+ F V + EIL+  K 
Sbjct: 179 PESINFRRFTTASDVWMFAVCMWEILSFGKQ 209

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 117/261 (44%), Gaps = 47/261 (18%)
Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFSKVLLPLP----WSIRMK 182
           +F    +HP LV L   C + E R+  + E++  G +  ++  +  LP      +S  + 
Sbjct: 105 VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTR 241
           +A      L +LHE  + +IYRD K  N+LLD++ + KL+D+G+ K+G   GD    ++ 
Sbjct: 164 LA------LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTST 212
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWAXX 299
             GT  Y APE +         D ++ GV++ E++ GR   D   S    +QN  D+   
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272
Query: 300 XXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PL 344
                     I++ ++    P     KAA +    LN +PK R               P 
Sbjct: 273 V---------ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321
Query: 345 MRDI-VDSLEPLQVLPDEAPT 364
            R++  D +E  QV+P   P 
Sbjct: 322 FRNVDWDMMEQKQVVPPFKPN 342

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 114/257 (44%), Gaps = 39/257 (15%)
Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           +F    +HP LV L   C + E R+  + E++  G +  ++  +  LP   +      + 
Sbjct: 62  VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR----FYS 116
Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTRIMGT 245
           A   LA  +  E+ +IYRD K  N+LLD++ + KL+D+G+ K+G   GD    ++   GT
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSXFCGT 173
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWAXXXXXX 303
             Y APE +         D ++ GV++ E++ GR   D   S    +QN  D+       
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--- 230
Query: 304 XXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PLMRDI 348
                 I++ ++    P     KAA +    LN +PK R               P  R++
Sbjct: 231 ------ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282
Query: 349 -VDSLEPLQVLPDEAPT 364
             D +E  QV+P   P 
Sbjct: 283 DWDMMEQKQVVPPFKPN 299

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 77  DRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
           +R+L       VY+G  +    E +    VAVK    D +     ++++E + + +L HP
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGS----VENNLFS-KVLLPLPWSIRMKIAFGAAKGL 191
           ++VKLIG   E+E   +I E    G     +E N  S KVL  + +S+++       K +
Sbjct: 74  HIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI------CKAM 126
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS-TRIMGTYGYAA 250
           A+L       ++RD    NIL+ +    KL DFGL++   + D    S TR+     + +
Sbjct: 127 AYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMS 182
Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           PE I     T  SDV+ F V + EIL+  K 
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 77  DRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
           +R+L       VY+G  +    E +    VAVK    D +     ++++E + + +L HP
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 85
Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGS----VENNLFS-KVLLPLPWSIRMKIAFGAAKGL 191
           ++VKLIG   E+E   +I E    G     +E N  S KVL  + +S+++       K +
Sbjct: 86  HIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI------CKAM 138
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS-TRIMGTYGYAA 250
           A+L       ++RD    NIL+ +    KL DFGL++   + D    S TR+     + +
Sbjct: 139 AYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMS 194
Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           PE I     T  SDV+ F V + EIL+  K 
Sbjct: 195 PESINFRRFTTASDVWMFAVCMWEILSFGKQ 225

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 114/257 (44%), Gaps = 39/257 (15%)
Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           +F    +HP LV L   C + E R+  + E++  G +  ++  +  LP   +      + 
Sbjct: 58  VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR----FYS 112
Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-GDKSHVSTRIMGT 245
           A   LA  +  E+ +IYRD K  N+LLD++ + KL+D+G+ K+G   GD    ++   GT
Sbjct: 113 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSXFCGT 169
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD--KSRPAREQNLADWAXXXXXX 303
             Y APE +         D ++ GV++ E++ GR   D   S    +QN  D+       
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--- 226
Query: 304 XXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---------------PLMRDI 348
                 I++ ++    P     KAA +    LN +PK R               P  R++
Sbjct: 227 ------ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 278
Query: 349 -VDSLEPLQVLPDEAPT 364
             D +E  QV+P   P 
Sbjct: 279 DWDMMEQKQVVPPFKPN 295

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 11/177 (6%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSV 163
           V  A KV D   S +   +++ E+  L    HPN+VKL+     + +  ++ EF A G+V
Sbjct: 63  VLAAAKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 121
Query: 164 ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
           +  +  ++  PL  S    +       L +LH+    +I+RD K  NIL   D + KL+D
Sbjct: 122 DAVML-ELERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLAD 178
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTP---RSDVYSFGVVLLEI 275
           FG++       +       +GT  + APE +M  T    P   ++DV+S G+ L+E+
Sbjct: 179 FGVSAKNTRXIQRR--DXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS------KVLLPL 175
           E LAE   +  L +P +V++IG  CE E  +L+ E    G +   L        K ++ L
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 116
Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
              + M        G+ +L E+    ++RD    N+LL T + AK+SDFGL+K     D+
Sbjct: 117 VHQVSM--------GMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADE 165
Query: 236 SHVSTRIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           +    +  G +   + APE I     + +SDV+SFGV++ E  +
Sbjct: 166 NXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VYKG +      G Q   VA+K            E+  E +    L HPN+V L+G   +
Sbjct: 42  VYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100
Query: 148 DEHRVLIYEFMARG----------------SVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
           D+   +I+ + + G                S +++   K  L  P  + +     A  G+
Sbjct: 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA--GM 158
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
            +L  +   V+++D  T N+L+    N K+SD GL ++    D   +    +    + AP
Sbjct: 159 EYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216
Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILT 277
           E IM G  +  SD++S+GVVL E+ +
Sbjct: 217 EAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 24/197 (12%)
Query: 103 PVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARG 161
            + VAVK+             ++E+  +  L SH N+V L+G C       LI+E+   G
Sbjct: 75  SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 134
Query: 162 SVENNLFSKV---------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
            + N L SK                      L  L +   +  A+  AKG+ FL    K 
Sbjct: 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KS 192
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+      K+ DFGLA+D        V         + APE +  G  T
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 252
Query: 261 PRSDVYSFGVVLLEILT 277
            +SDV+S+G++L EI +
Sbjct: 253 IKSDVWSYGILLWEIFS 269

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E+   ++I E+M++GS+ + L  ++   L LP  + 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 119 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQ 173
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +       VYK       R  L    VA+K    D   +G     + E+  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++E + +  ++  + +  L  +P  +     F   +GL
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +++    +  T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++   + +   D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           VYKG +      G Q   VA+K            E+  E +    L HPN+V L+G   +
Sbjct: 25  VYKGHLFGPA-PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 83
Query: 148 DEHRVLIYEFMARG----------------SVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
           D+   +I+ + + G                S +++   K  L  P  + +     A  G+
Sbjct: 84  DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA--GM 141
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
            +L  +   V+++D  T N+L+    N K+SD GL ++    D   +    +    + AP
Sbjct: 142 EYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 199
Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILT 277
           E IM G  +  SD++S+GVVL E+ +
Sbjct: 200 EAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 27/198 (13%)
Query: 106 VAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K+ D    +    ++   EV  +  L+HPN+VKL      ++   LI E+ + G V 
Sbjct: 40  VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVF 99
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSNILLDTDYN 218
           + L +          RMK     +K       + + H+  K +++RD K  N+LLD D N
Sbjct: 100 DYLVAHG--------RMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMN 149
Query: 219 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILT 277
            K++DFG + +   G K        G+  YAAPE      +  P  DV+S GV+L  +++
Sbjct: 150 IKIADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 206
Query: 278 GRKSLDKSRPAREQNLAD 295
           G      S P   QNL +
Sbjct: 207 G------SLPFDGQNLKE 218

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 31/200 (15%)
Query: 98  REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCEDEHRVLIY- 155
           ++GL+ +  A+K      S   HR++  E+  L  L H PN++ L+G C   EHR  +Y 
Sbjct: 38  KDGLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYL 93
Query: 156 --EFMARGSVENNLF-SKVLLPLP-----------WSIRMKIAFGA--AKGLAFLHEAEK 199
             E+   G++ + L  S+VL   P            S +  + F A  A+G+ +L  ++K
Sbjct: 94  AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQK 151
Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTG 257
             I+RD    NIL+  +Y AK++DFGL++    G + +V  + MG     + A E +   
Sbjct: 152 QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYS 206
Query: 258 HLTPRSDVYSFGVVLLEILT 277
             T  SDV+S+GV+L EI++
Sbjct: 207 VYTTNSDVWSYGVLLWEIVS 226

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 71  TANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 130
           ++ F+Q   L       VYKG            V VA+K    D+        + E+  +
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGL------NKTTGVYVALKEVKLDSEEGTPSTAIREISLM 57
Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA----FG 186
             L H N+V+L      +    L++EFM    ++  + S+ +   P  + + +     + 
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
             +GLAF HE +  +++RD K  N+L++     KL DFGLA+    G   +  +  + T 
Sbjct: 117 LLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLAR--AFGIPVNTFSSEVVTL 172
Query: 247 GYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            Y AP+ +M       S D++S G +L E++TG+
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 31/200 (15%)
Query: 98  REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCEDEHRVLIY- 155
           ++GL+ +  A+K      S   HR++  E+  L  L H PN++ L+G C   EHR  +Y 
Sbjct: 48  KDGLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYL 103
Query: 156 --EFMARGSVENNLF-SKVLLPLP-----------WSIRMKIAFGA--AKGLAFLHEAEK 199
             E+   G++ + L  S+VL   P            S +  + F A  A+G+ +L  ++K
Sbjct: 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQK 161
Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTG 257
             I+RD    NIL+  +Y AK++DFGL++    G + +V  + MG     + A E +   
Sbjct: 162 QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYS 216
Query: 258 HLTPRSDVYSFGVVLLEILT 277
             T  SDV+S+GV+L EI++
Sbjct: 217 VYTTNSDVWSYGVLLWEIVS 236

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 102/246 (41%), Gaps = 28/246 (11%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VA+K+ D + +     +   E+  L     P + +  G   +     +I E++  GS  +
Sbjct: 47  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD 106
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            L      PL  +    I     KGL +LH   K  I+RD K +N+LL    + KL+DFG
Sbjct: 107 LLKPG---PLEETYIATILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFG 161
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G       
Sbjct: 162 VA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219
Query: 286 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARP 343
            P R   L                   P LEG +  P K   +A      CLN +P+ RP
Sbjct: 220 HPMRVLFLIPKNSP-------------PTLEGQHSKPFKEFVEA------CLNKDPRFRP 260
Query: 344 LMRDIV 349
             ++++
Sbjct: 261 TAKELL 266

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E+   ++I E+M++GS+ + L  ++   L LP  + 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 119 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 173
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 27/198 (13%)
Query: 106 VAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K+ D    +    ++   EV  +  L+HPN+VKL      ++   LI E+ + G V 
Sbjct: 43  VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVF 102
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSNILLDTDYN 218
           + L +          RMK     +K       + + H+  K +++RD K  N+LLD D N
Sbjct: 103 DYLVAHG--------RMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMN 152
Query: 219 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILT 277
            K++DFG + +   G K        G   YAAPE      +  P  DV+S GV+L  +++
Sbjct: 153 IKIADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 278 GRKSLDKSRPAREQNLAD 295
           G      S P   QNL +
Sbjct: 210 G------SLPFDGQNLKE 221

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYIT 119
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL ++   K++DFG +   P   +    T + GT
Sbjct: 120 ELANALSYCH--SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGT 173
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             Y  PE I       + D++S GV+  E L G
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 124 LAEVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           + E++ +    +PN+V  L  Y   DE  V + E++A GS+ + +    +     +    
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIA---A 120
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTR 241
           +     + L FLH  +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + 
Sbjct: 121 VCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSE 175
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
           ++GT  + APE +      P+ D++S G++ +E++ G        P R
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + 
Sbjct: 50  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 108
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 109 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQ 163
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 164 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 200

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 124 LAEVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           + E++ +    +PN+V  L  Y   DE  V + E++A GS+ + +    +     +    
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIA---A 120
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTR 241
           +     + L FLH  +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + 
Sbjct: 121 VCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RST 175
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
           ++GT  + APE +      P+ D++S G++ +E++ G        P R
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 124 LAEVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           + E++ +    +PN+V  L  Y   DE  V + E++A GS+ + +    +     +    
Sbjct: 66  INEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIA---A 121
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTR 241
           +     + L FLH  +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + 
Sbjct: 122 VCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSX 176
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
           ++GT  + APE +      P+ D++S G++ +E++ G        P R
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 224

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 124 LAEVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           + E++ +    +PN+V  L  Y   DE  V + E++A GS+ + +    +     +    
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIA---A 120
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTR 241
           +     + L FLH  +  VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + 
Sbjct: 121 VCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSX 175
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
           ++GT  + APE +      P+ D++S G++ +E++ G        P R
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + 
Sbjct: 51  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 109
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 110 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 164
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 165 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 16/229 (6%)
Query: 73  NFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH--REWLAEVIFL 130
           +F+   +L       VY+   +E +  GL+   VA+K+ D    Y+    +    EV   
Sbjct: 12  DFKVGNLLGKGSFAGVYR---AESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
             L HP++++L  Y  +  +  L+ E    G +   L ++V  P   +           G
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITG 124
Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           + +LH     +++RD   SN+LL  + N K++DFGLA       + H +  + GT  Y +
Sbjct: 125 MLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYIS 180
Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN---LADW 296
           PE          SDV+S G +   +L GR   D        N   LAD+
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 119 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 173
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + 
Sbjct: 49  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 107
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 108 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 162
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 163 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 119 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 173
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 4/155 (2%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +L E   +  L H  LV+L     E E   ++ E+M +GS+ + L       L     + 
Sbjct: 51  FLEEAQIMKKLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVD 109
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           +A   A G+A++       I+RD +++NIL+      K++DFGLA+   E ++       
Sbjct: 110 MAAQVAAGMAYIERMN--YIHRDLRSANILVGNGLICKIADFGLARL-IEDNEXTARQGA 166
Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                + APE  + G  T +SDV+SFG++L E++T
Sbjct: 167 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 201

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 3/157 (1%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
            E+L E   +  + HPNLV+L+G C  +    ++ E+M  G++ + L       +   + 
Sbjct: 73  EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVL 132
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           + +A   +  + +L   +K  I+RD    N L+  ++  K++DFGL++    GD      
Sbjct: 133 LYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHVVKVADFGLSRL-MTGDTYTAHA 189
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE +     + +SDV++FGV+L EI T
Sbjct: 190 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + 
Sbjct: 53  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 111
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 112 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 166
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 167 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 285 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 339
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 31/200 (15%)
Query: 98  REGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCEDEHRVLIY- 155
           ++GL+ +  A+K      S   HR++  E+  L  L H PN++ L+G C   EHR  +Y 
Sbjct: 45  KDGLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYL 100
Query: 156 --EFMARGSVENNLF-SKVLLPLP-----------WSIRMKIAFGA--AKGLAFLHEAEK 199
             E+   G++ + L  S+VL   P            S +  + F A  A+G+ +L  ++K
Sbjct: 101 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQK 158
Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY--GYAAPEYIMTG 257
             I+R+    NIL+  +Y AK++DFGL++    G + +V  + MG     + A E +   
Sbjct: 159 QFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYS 213
Query: 258 HLTPRSDVYSFGVVLLEILT 277
             T  SDV+S+GV+L EI++
Sbjct: 214 VYTTNSDVWSYGVLLWEIVS 233

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEG 233
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+          +G
Sbjct: 285 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            K  +         + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 341 AKFPIK--------WTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + 
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 368 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 422
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 98  REGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 156
           R  L    VAVK+ D    +    ++   EV     L+HPN+VKL      ++   L+ E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXE 93
Query: 157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSN 210
           + + G V + L +          R K     AK       + + H+  K +++RD K  N
Sbjct: 94  YASGGEVFDYLVAHG--------RXKEKEARAKFRQIVSAVQYCHQ--KFIVHRDLKAEN 143
Query: 211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 269
           +LLD D N K++DFG + +   G+K        G   YAAPE      +  P  DV+S G
Sbjct: 144 LLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 270 VVLLEILTGRKSLDKSRPAREQNLAD 295
           V+L  +++G      S P   QNL +
Sbjct: 201 VILYTLVSG------SLPFDGQNLKE 220

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 92  FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR 151
           + + D+R   + V +    + G  S +  ++ + EV FL  L HPN ++  G C   EH 
Sbjct: 32  YFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHT 89
Query: 152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 211
             +      GS  ++L      PL       +  GA +GLA+LH     +I+RD K  NI
Sbjct: 90  AWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNI 146
Query: 212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSF 268
           LL      KL DFG A      +        +GT  + APE I+    G    + DV+S 
Sbjct: 147 LLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 269 GVVLLEI 275
           G+  +E+
Sbjct: 201 GITCIEL 207

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 92  FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR 151
           + + D+R   + V +    + G  S +  ++ + EV FL  L HPN ++  G C   EH 
Sbjct: 71  YFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHT 128
Query: 152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 211
             +      GS  ++L      PL       +  GA +GLA+LH     +I+RD K  NI
Sbjct: 129 AWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNI 185
Query: 212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSF 268
           LL      KL DFG A      +        +GT  + APE I+    G    + DV+S 
Sbjct: 186 LLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEGQYDGKVDVWSL 239
Query: 269 GVVLLEI 275
           G+  +E+
Sbjct: 240 GITCIEL 246

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  +    L LP  + 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 285 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 339
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  + H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + 
Sbjct: 60  FLQEAQVMKKIRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 119 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 173
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD   +NIL+  +   K++DFGLA+   E ++     
Sbjct: 119 M--AAQIASGMAYVERMN--YVHRDLAAANILVGENLVCKVADFGLARL-IEDNEYTARQ 173
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 17  CIGEGQFG-DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 76  LIGVITENPVWI-IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE--SKR 131
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+ ++   KL DFGL++   +      S   +    + APE I     T
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL-PIKWMAPESINFRRFT 190
Query: 261 PRSDVYSFGVVLLEIL 276
             SDV+ FGV + EIL
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV    HL HPN+++L GY  +     LI E+   G+V   L  + L             
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYIT 119
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L++ H   K VI+RD K  N+LL ++   K++DFG +   P   +      + GT
Sbjct: 120 ELANALSYCH--SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD----TLCGT 173
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             Y  PE I       + D++S GV+  E L G
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/110 (43%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 234
           +P  I  KI     K L  L E  K +I+RD K SNILLD   N KL DFG++  G   D
Sbjct: 122 IPEEILGKITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVD 178
Query: 235 KSHVSTRIMGTYGYAAPEYI-----MTGHLTPRSDVYSFGVVLLEILTGR 279
            S   TR  G   Y APE I       G+   RSDV+S G+ L E+ TGR
Sbjct: 179 -SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGR 226

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 57/115 (49%), Gaps = 3/115 (2%)
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 232
           P+     +++   A + L F H+    +I+RD K +NIL+      K+ DFG+A+     
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANILISATNAVKVVDFGIARAIADS 169
Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG        P
Sbjct: 170 GNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++GS+ + L  ++   L LP  + 
Sbjct: 227 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 285
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGL   G   + +  + 
Sbjct: 286 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL---GRLIEDNEYTA 338
Query: 241 RIMGTY--GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           R    +   + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 339 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++G + + L  ++   L LP  + 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVD 118
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 119 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 173
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 124 LAEVIFLGHLSHPNLVK-LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           + E++ +    +PN+V  L  Y   DE  V + E++A GS+ + +    +     +    
Sbjct: 66  INEILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIA---A 121
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTR 241
           +     + L FLH  +  VI+R+ K+ NILL  D + KL+DFG  A+  PE  K    + 
Sbjct: 122 VCRECLQALEFLHSNQ--VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RST 176
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
           ++GT  + APE +      P+ D++S G++ +E++ G        P R
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 224

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M +GS+ + L  +    L LP  + 
Sbjct: 57  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD 115
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M      A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 116 MSAQI--ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 170
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 171 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 8/157 (5%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M++G + + L  ++   L LP  + 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVD 118
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M  A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++     
Sbjct: 119 M--AAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 173
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 18/178 (10%)
Query: 106 VAVKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VAVK+ D     Q  RE L  EV+ +    H N+V++       E   ++ EF+  G++ 
Sbjct: 73  VAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL- 129
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
            ++ S+V L         +     + LA+LH   + VI+RD K+ +ILL  D   KLSDF
Sbjct: 130 TDIVSQVRLNEEQI--ATVCEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDF 185
Query: 225 G----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           G    ++KD P+         ++GT  + APE I         D++S G++++E++ G
Sbjct: 186 GFCAQISKDVPK------RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 22/164 (13%)
Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIR 180
           +L E   +  L H  LV+L     E E   ++ E+M +GS+ + L  +    L LP  + 
Sbjct: 57  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD 115
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-------DGPEG 233
           M      A G+A++       ++RD + +NIL+  +   K++DFGLA+          +G
Sbjct: 116 MSAQI--ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQG 171
Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            K  +         + APE  + G  T +SDV+SFG++L E+ T
Sbjct: 172 AKFPIK--------WTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 19/191 (9%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS 162
           + VAVK+             ++E+  L +L +H N+V L+G C      ++I E+   G 
Sbjct: 70  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 129
Query: 163 VENNLFSK----------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 206
           + N L  K                  L L     +  ++  AKG+AFL  A K  I+RD 
Sbjct: 130 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDL 187
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              NILL      K+ DFGLA+D        V         + APE I     T  SDV+
Sbjct: 188 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 247
Query: 267 SFGVVLLEILT 277
           S+G+ L E+ +
Sbjct: 248 SYGIFLWELFS 258

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 7/158 (4%)
Query: 120 HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           +R  L E+  L  LSHPN++ L+       +  L+++FM    +E  +    L+  P  I
Sbjct: 56  NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHI 114
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
           +  +     +GL +LH+    +++RD K +N+LLD +   KL+DFGLAK     ++++  
Sbjct: 115 KAYMLM-TLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXH 171
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEIL 276
             +  T  Y APE +    +     D+++ G +L E+L
Sbjct: 172 QVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--- 180
           + E+  L  L HPN+V LI     +    L++EFM +         KVL      ++   
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD------LKKVLDENKTGLQDSQ 120
Query: 181 MKI-AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
           +KI  +   +G+A  H+    +++RD K  N+L+++D   KL+DFGLA+    G      
Sbjct: 121 IKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSY 176
Query: 240 TRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           T  + T  Y AP+ +M +   +   D++S G +  E++TG+
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 131 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 397 CIGEGQFG-DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 456 LIGVITENPVWI-IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE--SKR 511
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 261 PRSDVYSFGVVLLEIL 276
             SDV+ FGV + EIL
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 19/191 (9%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS 162
           + VAVK+             ++E+  L +L +H N+V L+G C      ++I E+   G 
Sbjct: 72  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 131
Query: 163 VENNLFSK----------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 206
           + N L  K                  L L     +  ++  AKG+AFL  A K  I+RD 
Sbjct: 132 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDL 189
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              NILL      K+ DFGLA+D        V         + APE I     T  SDV+
Sbjct: 190 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 249
Query: 267 SFGVVLLEILT 277
           S+G+ L E+ +
Sbjct: 250 SYGIFLWELFS 260

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF-MARGSVENNLFSKVLLPLPWSIRMKIA 184
           E++ L H+ H N++ L+            Y+F +    ++ +L   + L         + 
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV 132
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
           +   KGL ++H A   V++RD K  N+ ++ D   K+ DFGLA+        +V TR   
Sbjct: 133 YQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 187
Query: 245 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 291
              Y APE I++  H     D++S G ++ E+LTG K+L K +   +Q
Sbjct: 188 --WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQ 232

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--- 180
           + E+  L  L HPN+V LI     +    L++EFM +         KVL      ++   
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD------LKKVLDENKTGLQDSQ 120
Query: 181 MKI-AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
           +KI  +   +G+A  H+    +++RD K  N+L+++D   KL+DFGLA+      +S+  
Sbjct: 121 IKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-- 176
Query: 240 TRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           T  + T  Y AP+ +M +   +   D++S G +  E++TG+
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 24/154 (15%)
Query: 134 SHPNLVKLIGYCCED--EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA---FGAA 188
           +HP L +L  +CC    +    + EF+  G +        +  +  S R   A   F AA
Sbjct: 82  NHPFLTQL--FCCFQTPDRLFFVMEFVNGGDL--------MFHIQKSRRFDEARARFYAA 131
Query: 189 K---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-G 244
           +    L FLH+  K +IYRD K  N+LLD + + KL+DFG+ K   EG  + V+T    G
Sbjct: 132 EIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCG 186
Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  Y APE +      P  D ++ GV+L E+L G
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 131 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 131 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 56/93 (60%), Gaps = 4/93 (4%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIMGTYG 247
           +GL ++H A   V++RD K SN+L++T  + K+ DFGLA+   PE D +   T  + T  
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 248 YAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
           Y APE ++      +S D++S G +L E+L+ R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 11/160 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+ +L  L HP+++KL          V++ E+ A G + + +  K  +      R     
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A      H+    +++RD K  N+LLD + N K++DFGL+    +G+    S    G+
Sbjct: 118 ICAIEYCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GS 170
Query: 246 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSLD 283
             YAAPE ++ G L   P  DV+S G+VL  +L GR   D
Sbjct: 171 PNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 19/191 (9%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS 162
           + VAVK+             ++E+  L +L +H N+V L+G C      ++I E+   G 
Sbjct: 77  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 136
Query: 163 VENNLFSK----------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 206
           + N L  K                  L L     +  ++  AKG+AFL  A K  I+RD 
Sbjct: 137 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDL 194
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              NILL      K+ DFGLA+D        V         + APE I     T  SDV+
Sbjct: 195 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 267 SFGVVLLEILT 277
           S+G+ L E+ +
Sbjct: 255 SYGIFLWELFS 265

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 3/115 (2%)
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 232
           P+     +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+     
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG        P
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 131 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 3/115 (2%)
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 232
           P+     +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+     
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG        P
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 3/115 (2%)
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 232
           P+     +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+     
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG        P
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 151 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 3/115 (2%)
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 232
           P+     +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+     
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG        P
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 133 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 133 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 136 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 129 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 137 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 128 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 19/191 (9%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS 162
           + VAVK+             ++E+  L +L +H N+V L+G C      ++I E+   G 
Sbjct: 54  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 163 VENNLFSK----------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 206
           + N L  K                  L L     +  ++  AKG+AFL  A K  I+RD 
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDL 171
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              NILL      K+ DFGLA+D        V         + APE I     T  SDV+
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 267 SFGVVLLEILT 277
           S+G+ L E+ +
Sbjct: 232 SYGIFLWELFS 242

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 17  CIGEGQFG-DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 76  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 131
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 261 PRSDVYSFGVVLLEIL 276
             SDV+ FGV + EIL
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 17  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 76  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 131
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 261 PRSDVYSFGVVLLEIL 276
             SDV+ FGV + EIL
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 129 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 19  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 78  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 133
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 261 PRSDVYSFGVVLLEIL 276
             SDV+ FGV + EIL
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 16/160 (10%)
Query: 126 EVIFLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           E+  L HL H N++ L+         ED   V +   +    + N + S+ L        
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF- 135
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
             + +   +GL ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V+T
Sbjct: 136 --LVYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVAT 191
Query: 241 RIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
           R      Y APE ++   H     D++S G ++ E+L G+
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 3/115 (2%)
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPE 232
           P+     +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+     
Sbjct: 129 PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 186
Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
           G+    +  ++GT  Y +PE      +  RSDVYS G VL E+LTG        P
Sbjct: 187 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 139 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 196
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 131 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 14  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 73  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 128
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 261 PRSDVYSFGVVLLEIL 276
             SDV+ FGV + EIL
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 133 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  +
Sbjct: 151 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 20  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 79  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 134
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 261 PRSDVYSFGVVLLEIL 276
             SDV+ FGV + EIL
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 22  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 81  LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 136
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 261 PRSDVYSFGVVLLEIL 276
             SDV+ FGV + EIL
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 12/173 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+ +L  L HP+++KL       +  +++ E+       N LF  ++     S +    F
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEARRF 108
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
                 A  +     +++RD K  N+LLD   N K++DFGL+    +G+    S    G+
Sbjct: 109 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 165
Query: 246 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSL-DKSRPAREQNLAD 295
             YAAPE +++G L   P  DV+S GV+L  +L  R    D+S P   +N+++
Sbjct: 166 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 217

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 45  CIGEGQFG-DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 104 LIGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKR 159
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+ ++   KL DFGL++   E    + +++      + APE I     T
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 261 PRSDVYSFGVVLLEIL 276
             SDV+ FGV + EIL
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF-MARGSVENNLFSKVLLPLPWSIRMKIA 184
           E++ L H+ H N++ L+            Y+F +    ++ +L   + +         + 
Sbjct: 91  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLV 150
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
           +   KGL ++H A   V++RD K  N+ ++ D   K+ DFGLA+        +V TR   
Sbjct: 151 YQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 205
Query: 245 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 291
              Y APE I++  H     D++S G ++ E+LTG K+L K +   +Q
Sbjct: 206 --WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQ 250

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 17/170 (10%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
           AE   L  + HP +V LI          LI E+++ G     LF ++     +       
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE----LFMQLEREGIFMEDTACF 125
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           + A   +A  H  +K +IYRD K  NI+L+   + KL+DFGL K+   +G  +H      
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---FC 182
Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG---------RKSLDK 284
           GT  Y APE +M        D +S G ++ ++LTG         +K++DK
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 12/173 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+ +L  L HP+++KL       +  +++ E+       N LF  ++     S +    F
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEARRF 112
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
                 A  +     +++RD K  N+LLD   N K++DFGL+    +G+    S    G+
Sbjct: 113 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 169
Query: 246 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSL-DKSRPAREQNLAD 295
             YAAPE +++G L   P  DV+S GV+L  +L  R    D+S P   +N+++
Sbjct: 170 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 221

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 12/173 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+ +L  L HP+++KL       +  +++ E+       N LF  ++     S +    F
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEARRF 118
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
                 A  +     +++RD K  N+LLD   N K++DFGL+    +G+    S    G+
Sbjct: 119 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 175
Query: 246 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSL-DKSRPAREQNLAD 295
             YAAPE +++G L   P  DV+S GV+L  +L  R    D+S P   +N+++
Sbjct: 176 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 227

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            L +LH +EK V+YRD K  N++LD D + K++DFGL K+G + D + + T   GT  Y 
Sbjct: 263 ALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT-FCGTPEYL 319
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            L +LH +EK V+YRD K  N++LD D + K++DFGL K+G + D + + T   GT  Y 
Sbjct: 260 ALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT-FCGTPEYL 316
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 12/173 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+ +L  L HP+++KL       +  +++ E+       N LF  ++     S +    F
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEARRF 117
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
                 A  +     +++RD K  N+LLD   N K++DFGL+    +G+    S    G+
Sbjct: 118 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 174
Query: 246 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSL-DKSRPAREQNLAD 295
             YAAPE +++G L   P  DV+S GV+L  +L  R    D+S P   +N+++
Sbjct: 175 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 226

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 5/135 (3%)
Query: 152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 211
            L+   M  G ++ +++       P +  +  A     GL  LH     ++YRD K  NI
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENI 317
Query: 212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVV 271
           LLD   + ++SD GLA   PEG    +  R+ GT GY APE +     T   D ++ G +
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCL 374
Query: 272 LLEILTGRKSLDKSR 286
           L E++ G+    + +
Sbjct: 375 LYEMIAGQSPFQQRK 389

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 17  CIGEGQFG-DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 76  LIGVITENPVWI-IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE--SKR 131
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+      KL DFGL++   E    + +++      + APE I     T
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 261 PRSDVYSFGVVLLEIL 276
             SDV+ FGV + EIL
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 124 LAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           L EV  L  +S HPN+++L      +    L+++ M +G + + L  KV L    +   K
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--RK 115
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           I     + +  LH+    +++RD K  NILLD D N KL+DFG +     G+K      +
Sbjct: 116 IMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EV 170
Query: 243 MGTYGYAAPEYIMTGH------LTPRSDVYSFGVVLLEILTG 278
            GT  Y APE I               D++S GV++  +L G
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-IMGTYGY 248
           GL FLH+  + +IYRD K  N++LD++ + K++DFG+ K   E     V+TR   GT  Y
Sbjct: 132 GLFFLHK--RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCGTPDY 186
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
            APE I         D +++GV+L E+L G+   D
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH 195
           P +V+  G    +    +  E M  G+    L  ++  P+P  I  K+     K L +L 
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM 255
           E +  VI+RD K SNILLD     KL DFG++    + DK+    R  G   Y APE I 
Sbjct: 142 E-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-DKA--KDRSAGCAAYMAPERID 197
Query: 256 TGHLTP-----RSDVYSFGVVLLEILTGR 279
               T      R+DV+S G+ L+E+ TG+
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
           AE   L  + HP +V LI          LI E+++ G     LF ++     +       
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE----LFMQLEREGIFMEDTACF 125
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
           + A   +A  H  +K +IYRD K  NI+L+   + KL+DFGL K+        V+    G
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHXFCG 183
Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG---------RKSLDK 284
           T  Y APE +M        D +S G ++ ++LTG         +K++DK
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 87  CVYKGFISEDLREGLQPVP------VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           C+ +G    D+ +G+   P      VA+K      S     ++L E + +    HP++VK
Sbjct: 397 CIGEGQFG-DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
           LIG   E+   + I E    G + + L  +    L  +  +  A+  +  LA+L    K 
Sbjct: 456 LIGVITENPVWI-IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE--SKR 511
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT 260
            ++RD    N+L+      KL DFGL++   E    + +++      + APE I     T
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 261 PRSDVYSFGVVLLEIL 276
             SDV+ FGV + EIL
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 5/135 (3%)
Query: 152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 211
            L+   M  G ++ +++       P +  +  A     GL  LH     ++YRD K  NI
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENI 317
Query: 212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVV 271
           LLD   + ++SD GLA   PEG    +  R+ GT GY APE +     T   D ++ G +
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCL 374
Query: 272 LLEILTGRKSLDKSR 286
           L E++ G+    + +
Sbjct: 375 LYEMIAGQSPFQQRK 389

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 124 LAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           L EV  L  +S HPN+++L      +    L+++ M +G + + L  KV L    +   K
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--RK 128
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           I     + +  LH+    +++RD K  NILLD D N KL+DFG +     G+K      +
Sbjct: 129 IMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EV 183
Query: 243 MGTYGYAAPEYIMTGH------LTPRSDVYSFGVVLLEILTG 278
            GT  Y APE I               D++S GV++  +L G
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+  L    HP+++KL           ++ E+++ G + + +     L    S R+    
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
               G+ + H     V++RD K  N+LLD   NAK++DFGL+    +G+    S    G+
Sbjct: 126 --LSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GS 178
Query: 246 YGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSLD 283
             YAAPE +++G L   P  D++S GV+L  +L G    D
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 104/253 (41%), Gaps = 38/253 (15%)
Query: 114 DNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--DEHRVLIYEFMARGSVENNLFSKV 171
           D S +  R++  E   L   SHPN++ ++G C      H  LI  +M  GS+ N L    
Sbjct: 45  DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT 104
Query: 172 LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS--DFGLAKD 229
              +  S  +K A   A+G+AFLH  E  +      + ++++D D  A++S  D   +  
Sbjct: 105 NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164
Query: 230 GPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPR--SDVYSFGVVLLEILTGRKSLDKSR 286
            P           M    + APE +      T R  +D++SF V+L E++T         
Sbjct: 165 SPGR---------MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT--------- 206
Query: 287 PAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPV--KGVH-KAAMLAYHCLNHNPKARP 343
             RE   AD +                 LEG  P    G+    + L   C+N +P  RP
Sbjct: 207 --REVPFADLSNMEIGMKVA--------LEGLRPTIPPGISPHVSKLMKICMNEDPAKRP 256
Query: 344 LMRDIVDSLEPLQ 356
               IV  LE +Q
Sbjct: 257 KFDMIVPILEKMQ 269

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 97/244 (39%), Gaps = 24/244 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VA+K+ D + +     +   E+  L       + K  G   +     +I E++  GS  +
Sbjct: 51  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALD 110
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
            L +        +  +K      KGL +LH  +K  I+RD K +N+LL    + KL+DFG
Sbjct: 111 LLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFG 165
Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
           +A  G   D        +GT  + APE I       ++D++S G+  +E+  G       
Sbjct: 166 VA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223
Query: 286 RPAREQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM 345
            P R   L                   P L GD+              CLN +P  RP  
Sbjct: 224 HPMRVLFLIPKNNP-------------PTLVGDF----TKSFKEFIDACLNKDPSFRPTA 266
Query: 346 RDIV 349
           ++++
Sbjct: 267 KELL 270

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 124 LAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           L EV  L  +S HPN+++L      +    L+++ M +G + + L  KV L    +   K
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--RK 128
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           I     + +  LH+    +++RD K  NILLD D N KL+DFG +     G+K      +
Sbjct: 129 IMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SV 183
Query: 243 MGTYGYAAPEYIMTGH------LTPRSDVYSFGVVLLEILTG 278
            GT  Y APE I               D++S GV++  +L G
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 11/158 (6%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L EV  L  L HPN++KL  +  +  +  L+ E    G + + + S+       + R  I
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--I 131
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 240
                 G+ ++H  +  +++RD K  N+LL++   D N ++ DFGL+      + S    
Sbjct: 132 IRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMK 186
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L EV  L  L HPN++KL  +  +  +  L+ E    G + + + S+       + R  I
Sbjct: 80  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--I 137
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 240
                 G+ ++H+ +  +++RD K  N+LL++   D N ++ DFGL+      + S    
Sbjct: 138 IRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMK 192
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 193 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 83/195 (42%), Gaps = 15/195 (7%)
Query: 90  KGFISEDLREGLQPVPVA-VKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYC 145
           K F + DL+ G + V +  V+V  G+         + EV  L HL    HPN+V+L   C
Sbjct: 26  KVFKARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLETFEHPNVVRLFDVC 83
Query: 146 C---EDEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRMKIAFGAAKGLAFLHEAEKPV 201
                D    L   F            KV  P +P      + F   +GL FLH     V
Sbjct: 84  TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--V 141
Query: 202 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           ++RD K  NIL+ +    KL+DFGLA+           T ++ T  Y APE ++      
Sbjct: 142 VHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 262 RSDVYSFGVVLLEIL 276
             D++S G +  E+ 
Sbjct: 199 PVDLWSVGCIFAEMF 213

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 72  ANFRQDRVLXXXXXXCVYKGFISEDLREG--LQPVPVAVK---VHDGDNSYQGHREWLAE 126
           ANFR ++ +         +G  SE  R    L  VPVA+K   + D  ++ +   + + E
Sbjct: 32  ANFRIEKKIG--------RGQFSEVYRAACLLDGVPVALKKVQIFDLMDA-KARADCIKE 82
Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKIA 184
           +  L  L+HPN++K      ED    ++ E    G +   +  F K    +P     K  
Sbjct: 83  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
                 L  +H   + V++RD K +N+ +      KL D GL +      K+  +  ++G
Sbjct: 143 VQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 198
Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           T  Y +PE I       +SD++S G +L E+
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 11/158 (6%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L EV  L  L HPN++KL  +  +  +  L+ E    G + + + S+       + R  I
Sbjct: 97  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--I 154
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 240
                 G+ ++H  +  +++RD K  N+LL++   D N ++ DFGL+      + S    
Sbjct: 155 IRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMK 209
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 210 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 135 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR- 191
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 137 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR- 193
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +      +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 89/176 (50%), Gaps = 14/176 (7%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 36  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 92
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 93  NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 149
Query: 225 GLAKDGPEGDKSHVSTRIMGT---YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           GL++     D  + S+R  G+     ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 150 GLSRYVL--DDEYTSSR--GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG-PEGDKSHVSTRIM 243
           +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ D +      +
Sbjct: 136 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            T  Y APE ++      +S D++S G +L E+L+ R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 11/158 (6%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L EV  L  L HPN++KL  +  +  +  L+ E    G + + + S+       + R  I
Sbjct: 98  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--I 155
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 240
                 G+ ++H  +  +++RD K  N+LL++   D N ++ DFGL+      + S    
Sbjct: 156 IRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMK 210
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 211 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 126 EVIFLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           E+  L HL H N++ L+         ED   V +   +    + N +  + L        
Sbjct: 69  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF- 127
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
             + +   +GL ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V+T
Sbjct: 128 --LVYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVAT 183
Query: 241 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           R      Y APE ++   H     D++S G ++ E+L G+
Sbjct: 184 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 137 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR- 193
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 135 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR- 191
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL 194
           HP+++ LI          L+++ M +G + + L  KV L    +    I     + ++FL
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET--RSIMRSLLEAVSFL 216
Query: 195 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYI 254
           H     +++RD K  NILLD +   +LSDFG +     G+K      + GT GY APE +
Sbjct: 217 HANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEIL 271
Query: 255 MTGH------LTPRSDVYSFGVVLLEILTG 278
                          D+++ GV+L  +L G
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 51  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 108 NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 164
Query: 225 GLAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           GL++   + ++ S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 165 GLSRYVLDDEETSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 137 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR- 193
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 83/195 (42%), Gaps = 15/195 (7%)
Query: 90  KGFISEDLREGLQPVPVA-VKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYC 145
           K F + DL+ G + V +  V+V  G+         + EV  L HL    HPN+V+L   C
Sbjct: 26  KVFKARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLETFEHPNVVRLFDVC 83
Query: 146 C---EDEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRMKIAFGAAKGLAFLHEAEKPV 201
                D    L   F            KV  P +P      + F   +GL FLH     V
Sbjct: 84  TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--V 141
Query: 202 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           ++RD K  NIL+ +    KL+DFGLA+           T ++ T  Y APE ++      
Sbjct: 142 VHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 262 RSDVYSFGVVLLEIL 276
             D++S G +  E+ 
Sbjct: 199 PVDLWSVGCIFAEMF 213

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 126 EVIFLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           E+  L HL H N++ L+         ED   V +   +    + N +  + L        
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF- 135
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
             + +   +GL ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V+T
Sbjct: 136 --LVYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVAT 191
Query: 241 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           R      Y APE ++   H     D++S G ++ E+L G+
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 141 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR- 197
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 16/160 (10%)
Query: 126 EVIFLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           E+  L H+ H N++ L+         E+ + V +   +    + N + S+ L        
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF- 129
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
             + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGL +   +    +V+T
Sbjct: 130 --LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVAT 185
Query: 241 RIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 132 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR- 188
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 136 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR- 192
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 83/195 (42%), Gaps = 15/195 (7%)
Query: 90  KGFISEDLREGLQPVPVA-VKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYC 145
           K F + DL+ G + V +  V+V  G+         + EV  L HL    HPN+V+L   C
Sbjct: 26  KVFKARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLETFEHPNVVRLFDVC 83
Query: 146 C---EDEHRVLIYEFMARGSVENNLFSKVLLP-LPWSIRMKIAFGAAKGLAFLHEAEKPV 201
                D    L   F            KV  P +P      + F   +GL FLH     V
Sbjct: 84  TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--V 141
Query: 202 IYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP 261
           ++RD K  NIL+ +    KL+DFGLA+           T ++ T  Y APE ++      
Sbjct: 142 VHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 262 RSDVYSFGVVLLEIL 276
             D++S G +  E+ 
Sbjct: 199 PVDLWSVGCIFAEMF 213

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 136 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 192
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 31  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 88  NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 144
Query: 225 GLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           GL++   + +  S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 145 GLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 136 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 192
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 140 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 196
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 197 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 137 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 193
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 127 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 183
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 184 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 135 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 191
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 135 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 191
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 129 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 185
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 132 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 188
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 136 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 192
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 35  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 91
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 92  NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 148
Query: 225 GLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           GL++   + +  S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 149 GLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 132 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 188
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 142 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 198
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 199 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 126 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 182
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 126 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 182
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 132 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 188
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 142 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 198
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 199 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 142 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 198
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 199 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 127 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 183
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 184 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 7/179 (3%)
Query: 102 QPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           + V VAVK    D  +  +   +++ EV  +  L H NL++L G       + ++ E   
Sbjct: 39  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAP 97
Query: 160 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
            GS+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    
Sbjct: 98  LGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLV 154
Query: 220 KLSDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           K+ DFGL +  P+ D  +V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 155 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 141 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 197
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR- 180
           +++ E+  L    HP +VKL+G    D    ++ EF   G+V+      ++L L   +  
Sbjct: 54  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD-----AIMLELDRGLTE 108
Query: 181 ---MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
                +     + L FLH   K +I+RD K  N+L+  + + +L+DFG++    +  +  
Sbjct: 109 PQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 166
Query: 238 VSTRIMGTYGYAAPEYIM--TGHLTP---RSDVYSFGVVLLEI 275
            S   +GT  + APE +M  T   TP   ++D++S G+ L+E+
Sbjct: 167 DS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 150 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 206
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 207 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 150 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 206
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 207 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 36  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 92
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 93  NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 149
Query: 225 GLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           GL++   + +  S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 150 GLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 128 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 184
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 149 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 205
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 206 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CV KG   E  R       VAVK+    +     RE   E+     L H N++  I    
Sbjct: 15  CVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIASDM 72
Query: 147 EDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------E 196
              +      LI  +   GS+ + L  + L P    + +++A  AA GLA LH      +
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 197 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG-DKSHVSTR-IMGTYGYAAPEYI 254
            +  + +RDFK+ N+L+ ++    ++D GLA    +G D   +     +GT  Y APE +
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 255 MTGHLT------PRSDVYSFGVVLLEI 275
                T        +D+++FG+VL EI
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 81/191 (42%), Gaps = 19/191 (9%)
Query: 104 VPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS 162
           + VAVK+             ++E+  L +L +H N+V L+G C      ++I E+   G 
Sbjct: 77  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 136
Query: 163 VENNLFSK----------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 206
           + N L  K                  L L     +  ++  AKG+AFL  A K  I+RD 
Sbjct: 137 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDL 194
Query: 207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVY 266
              NILL      K+ DFGLA+         V         + APE I     T  SDV+
Sbjct: 195 AARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 267 SFGVVLLEILT 277
           S+G+ L E+ +
Sbjct: 255 SYGIFLWELFS 265

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 153 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 209
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 210 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR- 180
           +++ E+  L    HP +VKL+G    D    ++ EF   G+V+      ++L L   +  
Sbjct: 62  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD-----AIMLELDRGLTE 116
Query: 181 ---MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
                +     + L FLH   K +I+RD K  N+L+  + + +L+DFG++    +  +  
Sbjct: 117 PQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174
Query: 238 VSTRIMGTYGYAAPEYIM--TGHLTP---RSDVYSFGVVLLEI 275
            S   +GT  + APE +M  T   TP   ++D++S G+ L+E+
Sbjct: 175 DS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 51  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 108 NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 164
Query: 225 GLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           GL++   + +  S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 165 GLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 153 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR- 209
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 210 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 149 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 205
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 206 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 126 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 182
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 7/179 (3%)
Query: 102 QPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           + V VAVK    D  +  +   +++ EV  +  L H NL++L G       + ++ E   
Sbjct: 35  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAP 93
Query: 160 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
            GS+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    
Sbjct: 94  LGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLV 150
Query: 220 KLSDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           K+ DFGL +  P+ D  +V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 7/179 (3%)
Query: 102 QPVPVAVKVHDGDNSYQ--GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           + V VAVK    D   Q     +++ EV  +  L H NL++L G       + ++ E   
Sbjct: 35  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAP 93
Query: 160 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
            GS+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    
Sbjct: 94  LGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLV 150
Query: 220 KLSDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           K+ DFGL +  P+ D  +V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L EV  L  L HPN+ KL  +  +  +  L+ E    G + + + S+       + R  I
Sbjct: 74  LREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--I 131
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 240
                 G+ + H  +  +++RD K  N+LL++   D N ++ DFGL+      + S    
Sbjct: 132 IRQVLSGITYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKXK 186
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 106 VAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVE 164
           VA+K + +G  S     E++ E   + +LSH  LV+L G C +     +I E+MA G + 
Sbjct: 42  VAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 98
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           N L  ++         +++     + + +L    K  ++RD    N L++     K+SDF
Sbjct: 99  NYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF 155
Query: 225 GLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           GL++   + +  S V ++      ++ PE +M    + +SD+++FGV++ EI +
Sbjct: 156 GLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 7/179 (3%)
Query: 102 QPVPVAVKVHDGDNSYQ--GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           + V VAVK    D   Q     +++ EV  +  L H NL++L G       + ++ E   
Sbjct: 39  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAP 97
Query: 160 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
            GS+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    
Sbjct: 98  LGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLV 154
Query: 220 KLSDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           K+ DFGL +  P+ D  +V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 155 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR 
Sbjct: 159 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 215
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 216 ----WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 7/179 (3%)
Query: 102 QPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           + V VAVK    D  +  +   +++ EV  +  L H NL++L G       + ++ E   
Sbjct: 45  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAP 103
Query: 160 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
            GS+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    
Sbjct: 104 LGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLV 160
Query: 220 KLSDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           K+ DFGL +  P+ D  +V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            L +LH +EK V+YRD K  N++LD D + K++DFGL K+G +   +       GT  Y 
Sbjct: 122 ALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYL 178
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            L +LH +EK V+YRD K  N++LD D + K++DFGL K+G +   +       GT  Y 
Sbjct: 121 ALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYL 177
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            L +LH +EK V+YRD K  N++LD D + K++DFGL K+G +   +       GT  Y 
Sbjct: 120 ALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYL 176
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 13/185 (7%)
Query: 104 VPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR------VLIYE 156
           V VAVK+   D  +     E+L E   +    HP++ KL+G       +      ++I  
Sbjct: 52  VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILP 111
Query: 157 FMARGSVENNLFSKVL----LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 212
           FM  G +   L +  +      LP    ++     A G+ +L  + +  I+RD    N +
Sbjct: 112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCM 169
Query: 213 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           L  D    ++DFGL++    GD             + A E +     T  SDV++FGV +
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229
Query: 273 LEILT 277
            EI+T
Sbjct: 230 WEIMT 234

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKI 183
           E+  L  + HPN+V L        H  LI + ++ G     LF +++    ++ R   ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG----ELFDRIVEKGFYTERDASRL 121
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNIL---LDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F     + +LH+    +++RD K  N+L   LD D    +SDFGL+K     D   V +
Sbjct: 122 IFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              GT GY APE +     +   D +S GV+   +L G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKI 183
           E+  L  + HPN+V L        H  LI + ++ G     LF +++    ++ R   ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG----ELFDRIVEKGFYTERDASRL 121
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNIL---LDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F     + +LH+    +++RD K  N+L   LD D    +SDFGL+K     D   V +
Sbjct: 122 IFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              GT GY APE +     +   D +S GV+   +L G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR- 186
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKI 183
           E+  L  + HPN+V L        H  LI + ++ G     LF +++    ++ R   ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG----ELFDRIVEKGFYTERDASRL 121
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNIL---LDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F     + +LH+    +++RD K  N+L   LD D    +SDFGL+K     D   V +
Sbjct: 122 IFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              GT GY APE +     +   D +S GV+   +L G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKI 183
           E+  L  + HPN+V L        H  LI + ++ G     LF +++    ++ R   ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG----ELFDRIVEKGFYTERDASRL 121
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNIL---LDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F     + +LH+    +++RD K  N+L   LD D    +SDFGL+K     D   V +
Sbjct: 122 IFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              GT GY APE +     +   D +S GV+   +L G
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR- 186
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR- 186
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR 
Sbjct: 126 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR- 182
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-IMGTY 246
           A GL FL    K +IYRD K  N++LD++ + K++DFG+ K   E     V+T+   GT 
Sbjct: 452 AIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTP 506
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            Y APE I         D ++FGV+L E+L G+
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 108 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 165
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 57  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 115
Query: 166 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 116 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 164
Query: 220 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 165 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 218
Query: 276 LTG 278
           + G
Sbjct: 219 VDG 221

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 7/179 (3%)
Query: 102 QPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           + V VAVK    D  +  +   +++ EV  +  L H NL++L G       + ++ E   
Sbjct: 35  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAP 93
Query: 160 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
            GS+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    
Sbjct: 94  LGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLV 150
Query: 220 KLSDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           K+ DFGL +  P+ D   V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 151 KIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
           + A   L   H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +G
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VG 352
Query: 245 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 278
           T+GY APE +  G      +D +S G +L ++L G
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
           + A   L   H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +G
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VG 352
Query: 245 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 278
           T+GY APE +  G      +D +S G +L ++L G
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ D+GLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKL------IGYCCEDEHRVLIYEFMA 159
           VA+K    + S +    W  E+  +  L+HPN+V        +     ++  +L  E+  
Sbjct: 43  VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCE 102
Query: 160 RGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
            G +    N F          IR  ++   +  L +LHE    +I+RD K  NI+L    
Sbjct: 103 GGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHENR--IIHRDLKPENIVLQPGP 159
Query: 218 NA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 274
                K+ D G AK   E D+  + T  +GT  Y APE +     T   D +SFG +  E
Sbjct: 160 QRLIHKIIDLGYAK---ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFE 216
Query: 275 ILTG 278
            +TG
Sbjct: 217 CITG 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTY 246
           A GL FL    K +IYRD K  N++LD++ + K++DFG+ K   E     V+T+   GT 
Sbjct: 131 AIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTP 185
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            Y APE I         D ++FGV+L E+L G+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR 
Sbjct: 150 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR- 206
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 207 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 108 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 165
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 179 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 237
Query: 166 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 238 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 286
Query: 220 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 287 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 340
Query: 276 LTG 278
           + G
Sbjct: 341 VDG 343

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKL------IGYCCEDEHRVLIYEFMA 159
           VA+K    + S +    W  E+  +  L+HPN+V        +     ++  +L  E+  
Sbjct: 42  VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCE 101
Query: 160 RGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
            G +    N F          IR  ++   +  L +LHE    +I+RD K  NI+L    
Sbjct: 102 GGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHENR--IIHRDLKPENIVLQPGP 158
Query: 218 NA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 274
                K+ D G AK   E D+  + T  +GT  Y APE +     T   D +SFG +  E
Sbjct: 159 QRLIHKIIDLGYAK---ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFE 215
Query: 275 ILTG 278
            +TG
Sbjct: 216 CITG 219

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 108 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 165
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 59  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 117
Query: 166 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 118 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 166
Query: 220 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 167 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 220
Query: 276 LTG 278
           + G
Sbjct: 221 VDG 223

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
           + A   L   H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +G
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VG 352
Query: 245 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 278
           T+GY APE +  G      +D +S G +L ++L G
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
           + A   L   H   + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +G
Sbjct: 296 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VG 351
Query: 245 TYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 278
           T+GY APE +  G      +D +S G +L ++L G
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           GL  LH+  + +IYRD K  N+LLD D N ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE ++        D ++ GV L E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           GL  LH+  + +IYRD K  N+LLD D N ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE ++        D ++ GV L E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           GL  LH+  + +IYRD K  N+LLD D N ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE ++        D ++ GV L E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +C +D+ ++    +      +N    K +  +         F  A+
Sbjct: 91  MSRLDHPFFVKLY-FCFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 145
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 146 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           GL  LH+  + +IYRD K  N+LLD D N ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE ++        D ++ GV L E++  R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 108 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 165
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 106
Query: 166 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 107 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 155
Query: 220 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 156 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 276 LTG 278
           + G
Sbjct: 210 VDG 212

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 7/179 (3%)
Query: 102 QPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
           + V VAVK    D  +  +   +++ EV  +  L H NL++L G       + ++ E   
Sbjct: 45  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAP 103
Query: 160 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
            GS+ + L       L  ++  + A   A+G+ +L    K  I+RD    N+LL T    
Sbjct: 104 LGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLV 160
Query: 220 KLSDFGLAKDGPEGDKSHVSTRIMGT-YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           K+ DFGL +  P+ D   V        + + APE + T   +  SD + FGV L E+ T
Sbjct: 161 KIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 23/176 (13%)
Query: 112 DGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV 171
           D  N  + H E   E+  L  L HPN++KL     + ++  L+ EF   G     LF ++
Sbjct: 82  DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQI 137
Query: 172 LLPLPWS--IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAKLSDFGL 226
           +    +       I      G+ +LH+    +++RD K  NILL+      N K+ DFGL
Sbjct: 138 INRHKFDECDAANIMKQILSGICYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGL 195
Query: 227 ----AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
               +KD    D+       +GT  Y APE ++      + DV+S GV++  +L G
Sbjct: 196 SSFFSKDYKLRDR-------LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 108 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 165
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 52  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 110
Query: 166 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 111 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 159
Query: 220 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 160 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 213
Query: 276 LTG 278
           + G
Sbjct: 214 VDG 216

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 108 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLI-GYCCEDEHRVLIYEFMARGSVEN 165
           V V   D   Q  RE L  EV+ +    H N+V++   Y   DE  V + EF+  G++ +
Sbjct: 102 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV-VMEFLEGGALTD 160
Query: 166 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
                    +    RM       +     + L+ LH   + VI+RD K+ +ILL  D   
Sbjct: 161 ---------IVTHTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRV 209
Query: 220 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           KLSDFG    ++K+ P          ++GT  + APE I      P  D++S G++++E+
Sbjct: 210 KLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 263
Query: 276 LTG 278
           + G
Sbjct: 264 VDG 266

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 15/160 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--M 181
           L EV  L  L HPN++KL     +     ++ E    G     LF +++    +S     
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAA 124
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHV 238
           +I      G+ ++H+    +++RD K  NILL++   D + K+ DFGL+    +  K  +
Sbjct: 125 RIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--M 180
Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             RI GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 15/160 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--M 181
           L EV  L  L HPN++KL     +     ++ E    G     LF +++    +S     
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAA 124
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHV 238
           +I      G+ ++H+    +++RD K  NILL++   D + K+ DFGL+    +  K  +
Sbjct: 125 RIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--M 180
Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             RI GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 15/160 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--M 181
           L EV  L  L HPN++KL     +     ++ E    G     LF +++    +S     
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAA 124
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHV 238
           +I      G+ ++H  +  +++RD K  NILL++   D + K+ DFGL+    +  K  +
Sbjct: 125 RIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--M 180
Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             RI GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 50/85 (58%), Gaps = 6/85 (7%)
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL- 259
           V++RD K  N+LLD   NAK++DFGL+    +G+    S    G+  YAAPE +++G L 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLY 187
Query: 260 -TPRSDVYSFGVVLLEILTGRKSLD 283
             P  D++S GV+L  +L G    D
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+  FGLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 14/195 (7%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VA+K  + +       E L E+  +    HPN+V         +   L+ + ++ GSV +
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 166 NLFSKVLLP------LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
            +   V         L  S    I     +GL +LH+  +  I+RD K  NILL  D + 
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSV 155
Query: 220 KLSDFGLA---KDGPEGDKSHVSTRIMGTYGYAAPEYI--MTGHLTPRSDVYSFGVVLLE 274
           +++DFG++     G +  ++ V    +GT  + APE +  + G+   ++D++SFG+  +E
Sbjct: 156 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIE 214
Query: 275 ILTGRKSLDKSRPAR 289
           + TG     K  P +
Sbjct: 215 LATGAAPYHKYPPMK 229

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+    HL H N+V+ +G   E+    +  E +  GS+   L SK   PL  +    I F
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDN-EQTIGF 126
Query: 186 GAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVST 240
              +   GL +LH+ +  +++RD K  N+L++T Y+   K+SDFG +K       +  + 
Sbjct: 127 YTKQILEGLKYLHDNQ--IVHRDIKGDNVLINT-YSGVLKISDFGTSKR--LAGINPCTE 181
Query: 241 RIMGTYGYAAPEYIMTGHLTPR-----SDVYSFGVVLLEILTGR 279
              GT  Y APE I  G   PR     +D++S G  ++E+ TG+
Sbjct: 182 TFTGTLQYMAPEIIDKG---PRGYGKAADIWSLGCTIIEMATGK 222

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/244 (21%), Positives = 100/244 (40%), Gaps = 39/244 (15%)
Query: 116 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--VLL 173
           S +   E   EV  L ++ HPN+V+      E+    ++ ++   G +   + ++  VL 
Sbjct: 63  SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122
Query: 174 P----LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 229
                L W +++         LA  H  ++ +++RD K+ NI L  D   +L DFG+A+ 
Sbjct: 123 QEDQILDWFVQI--------CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR- 173
Query: 230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
                   ++   +GT  Y +PE         +SD+++ G VL E+ T + + +      
Sbjct: 174 -VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---- 228
Query: 290 EQNLADWAXXXXXXXXXXXNIIDPRLEGDYPVKGVHKA---AMLAYHCLNHNPKARPLMR 346
                              N++   + G +P   +H +     L       NP+ RP + 
Sbjct: 229 ----------------SMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVN 272
Query: 347 DIVD 350
            I++
Sbjct: 273 SILE 276

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 14/195 (7%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN 165
           VA+K  + +       E L E+  +    HPN+V         +   L+ + ++ GSV +
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 166 NLFSKVLLP------LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
            +   V         L  S    I     +GL +LH+  +  I+RD K  NILL  D + 
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSV 160
Query: 220 KLSDFGLA---KDGPEGDKSHVSTRIMGTYGYAAPEYI--MTGHLTPRSDVYSFGVVLLE 274
           +++DFG++     G +  ++ V    +GT  + APE +  + G+   ++D++SFG+  +E
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIE 219
Query: 275 ILTGRKSLDKSRPAR 289
           + TG     K  P +
Sbjct: 220 LATGAAPYHKYPPMK 234

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 21/163 (12%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS----- 178
           L EV  L  L HPN++KL  +  +  +  L+ E    G     LF +++L   +S     
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGG----ELFDEIILRQKFSEVDAA 107
Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 235
           + MK       G  +LH  +  +++RD K  N+LL++   D   K+ DFGL+     G K
Sbjct: 108 VIMKQVLS---GTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK 162
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             +  R +GT  Y APE ++      + DV+S GV+L  +L G
Sbjct: 163 --MKER-LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 9/157 (5%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVEN-NLFSKVLLPLPWSIRMK 182
           + E+  L  L H NLV L+  C + +   L++EF+    +++  LF      L + +  K
Sbjct: 72  MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQK 128
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
             F    G+ F H     +I+RD K  NIL+      KL DFG A+         V    
Sbjct: 129 YLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDE 184
Query: 243 MGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTG 278
           + T  Y APE ++      ++ DV++ G ++ E+  G
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS----- 178
           L EV  L  L HPN++KL  +  +  +  L+ E    G     LF +++L   +S     
Sbjct: 69  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGG----ELFDEIILRQKFSEVDAA 124
Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 235
           + MK       G  +LH+    +++RD K  N+LL++   D   K+ DFGL+     G K
Sbjct: 125 VIMKQVLS---GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK 179
Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
                  +GT  Y APE ++      + DV+S GV+L  +L G
Sbjct: 180 ---MKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+    HL HPN++++  Y  + +   L+ EF  RG +   L          S       
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 124
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-G 244
             A  L + H  E+ VI+RD K  N+L+      K++DFG +   P      +  R M G
Sbjct: 125 --ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRXMCG 175
Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
           T  Y  PE I       + D++  GV+  E L G    D
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            L +LH   + V+YRD K  N++LD D + K++DFGL K+G   D + + T   GT  Y 
Sbjct: 120 ALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-FCGTPEYL 175
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            L +LH   + V+YRD K  N++LD D + K++DFGL K+G   D + + T   GT  Y 
Sbjct: 117 ALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-FCGTPEYL 172
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 59/121 (48%), Gaps = 5/121 (4%)
Query: 156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           EF  +G++E  +  +    L   + +++     KG+ ++H   K +I+RD K SNI L  
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFLVD 171
Query: 216 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
               K+ DFGL        K    TR  GT  Y +PE I +       D+Y+ G++L E+
Sbjct: 172 TKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 276 L 276
           L
Sbjct: 229 L 229

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DF LA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+    HL HPN++++  Y  + +   L+ EF  RG +   L          S       
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 123
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-G 244
             A  L + H  E+ VI+RD K  N+L+      K++DFG +   P      +  R M G
Sbjct: 124 --ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRXMCG 174
Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD 283
           T  Y  PE I       + D++  GV+  E L G    D
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            L +LH   + V+YRD K  N++LD D + K++DFGL K+G   D + + T   GT  Y 
Sbjct: 117 ALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-FCGTPEYL 172
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 13/178 (7%)
Query: 106 VAVKV--HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG--YCCEDEHRVLIYEFMARG 161
           VAVK   H G +     R++  E+  L  L    +VK  G  Y    +   L+ E++  G
Sbjct: 43  VAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 99
Query: 162 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 221
            + + L  +    L  S  +  +    KG+ +L    +  ++RD    NIL++++ + K+
Sbjct: 100 CLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKI 156
Query: 222 SDFGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           +DFGLAK  P  DK +   R  G     + APE +     + +SDV+SFGVVL E+ T
Sbjct: 157 ADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 13/178 (7%)
Query: 106 VAVKV--HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG--YCCEDEHRVLIYEFMARG 161
           VAVK   H G +     R++  E+  L  L    +VK  G  Y    +   L+ E++  G
Sbjct: 42  VAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 98
Query: 162 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 221
            + + L  +    L  S  +  +    KG+ +L    +  ++RD    NIL++++ + K+
Sbjct: 99  CLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKI 155
Query: 222 SDFGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           +DFGLAK  P  DK +   R  G     + APE +     + +SDV+SFGVVL E+ T
Sbjct: 156 ADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCE--DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           E+  L  L HPN+VKL+    +  ++H  +++E + +G V   +    L PL        
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQARFY 142
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
                KG+ +LH  +  +I+RD K SN+L+  D + K++DFG++ +    D   + +  +
Sbjct: 143 FQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTV 198
Query: 244 GTYGYAAPEY------IMTGHLTPRSDVYSFGVVLLEILTGR 279
           GT  + APE       I +G      DV++ GV L   + G+
Sbjct: 199 GTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQ 237

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/85 (40%), Positives = 50/85 (58%), Gaps = 6/85 (7%)
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL- 259
           V++RD K  N+LLD   NAK++DFGL+    +G+    S    G+  YAAPE +++G L 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPE-VISGRLY 187
Query: 260 -TPRSDVYSFGVVLLEILTGRKSLD 283
             P  D++S GV+L  +L G    D
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+    HL H N+V+ +G   E+    +  E +  GS+   L SK   PL  +    I F
Sbjct: 55  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDN-EQTIGF 112
Query: 186 GAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVST 240
              +   GL +LH+ +  +++RD K  N+L++T Y+   K+SDFG +K       +  + 
Sbjct: 113 YTKQILEGLKYLHDNQ--IVHRDIKGDNVLINT-YSGVLKISDFGTSKR--LAGINPCTE 167
Query: 241 RIMGTYGYAAPEYIMTGHLTPR-----SDVYSFGVVLLEILTGR 279
              GT  Y APE I  G   PR     +D++S G  ++E+ TG+
Sbjct: 168 TFTGTLQYMAPEIIDKG---PRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 13/178 (7%)
Query: 106 VAVKV--HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG--YCCEDEHRVLIYEFMARG 161
           VAVK   H G +     R++  E+  L  L    +VK  G  Y    +   L+ E++  G
Sbjct: 55  VAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 162 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 221
            + + L  +    L  S  +  +    KG+ +L    +  ++RD    NIL++++ + K+
Sbjct: 112 CLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKI 168
Query: 222 SDFGLAKDGPEGDKSHVSTRIMGT--YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           +DFGLAK  P  DK +   R  G     + APE +     + +SDV+SFGVVL E+ T
Sbjct: 169 ADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V+TR 
Sbjct: 130 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR- 186
Query: 243 MGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           +F  AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  +           
Sbjct: 204 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 261
Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
               + APE I     T +SDV+SFGV+L EI +
Sbjct: 262 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 94  SEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHR- 151
           S D R G   V    K+ D   +    +    E++ L  LS H N+V L+     D  R 
Sbjct: 28  SIDRRTG--EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85
Query: 152 -VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN 210
             L++++M    +   + + +L P+    +  + +   K + +LH     +++RD K SN
Sbjct: 86  VYLVFDYM-ETDLHAVIRANILEPVH---KQYVVYQLIKVIKYLHSG--GLLHRDMKPSN 139
Query: 211 ILLDTDYNAKLSDFGLAK-----------------DGPEG--DKSHVSTRIMGTYGYAAP 251
           ILL+ + + K++DFGL++                 +  E   D   + T  + T  Y AP
Sbjct: 140 ILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP 199
Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E ++ +   T   D++S G +L EIL G+
Sbjct: 200 EILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           +F  AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  +           
Sbjct: 199 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
               + APE I     T +SDV+SFGV+L EI +
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 12/164 (7%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP---WSIRM 181
            E+     L +P++V   G+  +D+   ++ E   R S+      +  +  P   + +R 
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
            I     +G+ +LH     VI+RD K  N+ L+ D + K+ DFGLA    E D     T 
Sbjct: 151 TI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATK-IEFDGERKKT- 201
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
           + GT  Y APE +     +   D++S G +L  +L G+   + S
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 30/183 (16%)
Query: 108 VKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLVKLIG-YCCEDEHRVLIYEFMARGSVEN 165
           V V   D   Q  RE L  EV+ +    H N+V +   Y   DE  V++ EF+  G++ +
Sbjct: 73  VAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVM-EFLEGGALTD 131
Query: 166 NLFSKVLLPLPWSIRMK------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
                    +    RM       +     + L++LH   + VI+RD K+ +ILL +D   
Sbjct: 132 ---------IVTHTRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRI 180
Query: 220 KLSDFG----LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           KLSDFG    ++K+ P+         ++GT  + APE I         D++S G++++E+
Sbjct: 181 KLSDFGFCAQVSKEVPK------RKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 234
Query: 276 LTG 278
           + G
Sbjct: 235 IDG 237

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE 140
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +     +  SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           +F  AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  +           
Sbjct: 197 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 254
Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
               + APE I     T +SDV+SFGV+L EI +
Sbjct: 255 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 107/247 (43%), Gaps = 37/247 (14%)
Query: 53  DSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVK--- 109
           ++A   LIA    EL  + + +   R +       V  G  SE        +PVA+K   
Sbjct: 7   EAAMRDLIA----ELHAMQSPYTVQRFISSGSYGAVCAGVDSEG-------IPVAIKRVF 55
Query: 110 --VHDG------DNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE----HRVLIYEF 157
             V DG       +S+   R  L E+  L H  HPN++ L       E    H++ +   
Sbjct: 56  NTVSDGRTVNILSDSFLCKR-VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE 114
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           + R  +   +  + ++  P  I+    +    GL  LHEA   V++RD    NILL  + 
Sbjct: 115 LMRTDLAQVIHDQRIVISPQHIQY-FMYHILLGLHVLHEA--GVVHRDLHPGNILLADNN 171
Query: 218 NAKLSDFGLAK-DGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEI 275
           +  + DF LA+ D  + +K+H  T       Y APE +M     T   D++S G V+ E+
Sbjct: 172 DITICDFNLAREDTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 276 LTGRKSL 282
              RK+L
Sbjct: 228 F-NRKAL 233

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           +F  AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  +           
Sbjct: 206 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 263
Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
               + APE I     T +SDV+SFGV+L EI +
Sbjct: 264 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 7/160 (4%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E+  L  L H N+V+L      D+   L++EF  +       F      L   I    
Sbjct: 49  LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEIVKSF 106
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
            F   KGL F H   + V++RD K  N+L++ +   KL+DFGLA+    G      +  +
Sbjct: 107 LFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLADFGLAR--AFGIPVRCYSAEV 162
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSL 282
            T  Y  P+ +    L   S D++S G +  E+    + L
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 107/247 (43%), Gaps = 37/247 (14%)
Query: 53  DSAANPLIAFTYDELRIITANFRQDRVLXXXXXXCVYKGFISEDLREGLQPVPVAVK--- 109
           ++A   LIA    EL  + + +   R +       V  G  SE        +PVA+K   
Sbjct: 7   EAAMRDLIA----ELHAMQSPYTVQRFISSGSYGAVCAGVDSEG-------IPVAIKRVF 55
Query: 110 --VHDG------DNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE----HRVLIYEF 157
             V DG       +S+   R  L E+  L H  HPN++ L       E    H++ +   
Sbjct: 56  NTVSDGRTVNILSDSFLCKR-VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE 114
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           + R  +   +  + ++  P  I+    +    GL  LHEA   V++RD    NILL  + 
Sbjct: 115 LMRTDLAQVIHDQRIVISPQHIQY-FMYHILLGLHVLHEA--GVVHRDLHPGNILLADNN 171
Query: 218 NAKLSDFGLAK-DGPEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEI 275
           +  + DF LA+ D  + +K+H  T       Y APE +M     T   D++S G V+ E+
Sbjct: 172 DITICDFNLAREDTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 276 LTGRKSL 282
              RK+L
Sbjct: 228 F-NRKAL 233

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLXGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP---WSIRM 181
            E+     L +P++V   G+  +D+   ++ E   R S+      +  +  P   + +R 
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVST 240
            I     +G+ +LH     VI+RD K  N+ L+ D + K+ DFGLA K   +G++     
Sbjct: 151 TI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX-- 201
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
            + GT  Y APE +     +   D++S G +L  +L G+   + S
Sbjct: 202 -LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 185 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           +GA     L +LH   + V+YRD K  N++LD D + K++DFGL K+G     +      
Sbjct: 110 YGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAF 185
           +   + P +V+L     +D++  ++ E+M  G + N L S   +P  W    +  + +A 
Sbjct: 129 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLAL 187
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
            A   +  +H        RD K  N+LLD   + KL+DFG      E    H  T + GT
Sbjct: 188 DAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GT 238
Query: 246 YGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTG 278
             Y +PE + +    G+     D +S GV L E+L G
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTY 246
           +GL ++H A+  VI+RD K SN+L++ +   K+ DFG+A+       +  +  T  + T 
Sbjct: 170 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 247 GYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRK 280
            Y APE +++ H  T   D++S G +  E+L  R+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            L +LH   + V+YRD K  N++LD D + K++DFGL K+G     +       GT  Y 
Sbjct: 122 ALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 177
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE +         D +  GVV+ E++ GR
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLVGIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + T  Y APE I+        D++S GV++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLVGIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + T  Y APE I+        D++S GV++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           LA  H  +  +IYRD K  NILLD++ +  L+DFGL+K+    D++  +    GT  Y A
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMA 228
Query: 251 PEYIM---TGHLTPRSDVYSFGVVLLEILTG 278
           P+ +    +GH     D +S GV++ E+LTG
Sbjct: 229 PDIVRGGDSGH-DKAVDWWSLGVLMYELLTG 258

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 185 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           +GA     L +LH   + V+YRD K  N++LD D + K++DFGL K+G     +      
Sbjct: 110 YGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP---WSIRM 181
            E+     L +P++V   G+  +D+   ++ E   R S+      +  +  P   + +R 
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVST 240
            I     +G+ +LH     VI+RD K  N+ L+ D + K+ DFGLA K   +G++     
Sbjct: 151 TI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KK 200
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
            + GT  Y APE +     +   D++S G +L  +L G+   + S
Sbjct: 201 DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 185 FGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           +GA     L +LH   + V+YRD K  N++LD D + K++DFGL K+G     +      
Sbjct: 110 YGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSHVSTRIMGTY 246
           +GL ++H A+  VI+RD K SN+L++ +   K+ DFG+A+       +  +  T  + T 
Sbjct: 169 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 247 GYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRK 280
            Y APE +++ H  T   D++S G +  E+L  R+
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP---WSIRM 181
            E+     L +P++V   G+  +D+   ++ E   R S+      +  +  P   + +R 
Sbjct: 75  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 134
Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVST 240
            I     +G+ +LH     VI+RD K  N+ L+ D + K+ DFGLA K   +G++     
Sbjct: 135 TI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KK 184
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
            + GT  Y APE +     +   D++S G +L  +L G+   + S
Sbjct: 185 DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 120
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 121 MSYLLYQMLXGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 175
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 63  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 117
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 118 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 62  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 116
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 117 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLXGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 64  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 118
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 119 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP-EGDKSHVSTRIMGTY 246
            KG+ +L    +  ++RD    NIL++++ + K++DFGLAK  P + D   V        
Sbjct: 121 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            + APE +     + +SDV+SFGVVL E+ T
Sbjct: 179 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 20/162 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHR------VLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E+  L H+ H N++ L+     DE         L+  FM  G+    L     L      
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLG---ED 128
Query: 180 RMK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 238
           R++ + +   KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+         V
Sbjct: 129 RIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXV 186
Query: 239 STRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
            TR      Y APE I+     T   D++S G ++ E++TG+
Sbjct: 187 VTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 61  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 115
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 116 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 15/181 (8%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK- 182
           L E+  L H  H N++ +      D        ++ +  ++ +L   +   +     ++ 
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---------DGPEG 233
             +   + +  LH +   VI+RD K SN+L++++ + K+ DFGLA+           P G
Sbjct: 117 FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLDKSRPAREQN 292
            +S + T  + T  Y APE ++T     R+ DV+S G +L E+   R+ +   R  R Q 
Sbjct: 175 QQSGM-TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQL 232
Query: 293 L 293
           L
Sbjct: 233 L 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 68  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 122
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 123 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 98  REGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 156
           R+ +  V  A+K+      S   + + L EV  L  L HPN++KL  +  +  +  L+ E
Sbjct: 57  RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116
Query: 157 FMARGSVENNLFSKVLL-PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
               G + + +  ++    +  ++ +K       G+ +LH  +  +++RD K  N+LL++
Sbjct: 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLS---GVTYLH--KHNIVHRDLKPENLLLES 171
Query: 216 ---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
              D   K+ DFGL+      ++  +  R +GT  Y APE ++      + DV+S GV+L
Sbjct: 172 KEKDALIKIVDFGLS--AVFENQKKMKER-LGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
Query: 273 LEILTG 278
             +L G
Sbjct: 228 FILLAG 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 139 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 87  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 141
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 142 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 12/109 (11%)
Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL--AKDGPEGDK 235
           S+ + I    A+ + FLH   K +++RD K SNI    D   K+ DFGL  A D  E ++
Sbjct: 118 SVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 236 SHVS--------TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 276
           + ++        T  +GT  Y +PE I     + + D++S G++L E+L
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 139 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 15/181 (8%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK- 182
           L E+  L H  H N++ +      D        ++ +  ++ +L   +   +     ++ 
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---------DGPEG 233
             +   + +  LH +   VI+RD K SN+L++++ + K+ DFGLA+           P G
Sbjct: 117 FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLDKSRPAREQN 292
            +S + T  + T  Y APE ++T     R+ DV+S G +L E+   R+ +   R  R Q 
Sbjct: 175 QQSGM-TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQL 232
Query: 293 L 293
           L
Sbjct: 233 L 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 139 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 87  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 141
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 142 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 83  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 137
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 138 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 18/161 (11%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            E+  L  LSHPN++KL           L+ E +  G     LF +++    +S R   A
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERD--A 150
Query: 185 FGAAK----GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSH 237
             A K     +A+LHE    +++RD K  N+L  T   D   K++DFGL+K     +   
Sbjct: 151 ADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQV 205
Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           +   + GT GY APE +      P  D++S G++   +L G
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           A  L +LH     ++YRD K  NILLD+  +  L+DFGL K+  E + +  ++   GT  
Sbjct: 149 ASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPE 204
Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE +         D +  G VL E+L G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 83  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 137
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 138 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 139 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 141 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP  VKL  +  +D+ ++    +      +N    K +  +         F  A+
Sbjct: 89  MSRLDHPFFVKLY-FTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 143
Query: 190 ---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
               L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT 
Sbjct: 144 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 8/107 (7%)
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD---G 230
           P+     +  +F  A+G+ FL  + +  I+RD    NILL  +   K+ DFGLA+D    
Sbjct: 195 PITMEDLISYSFQVARGMEFL--SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           P+  +    TR+     + APE I     + +SDV+S+GV+L EI +
Sbjct: 253 PDYVRKG-DTRL--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ L  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIHMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       + + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGY 248
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++  V   + GT  Y
Sbjct: 153 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 207
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
            APE +     +   DV+S G ++  +L G+   + S
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 121
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 122 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 176
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGY 248
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++  V   + GT  Y
Sbjct: 151 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 205
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
            APE +     +   DV+S G ++  +L G+   + S
Sbjct: 206 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 128
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 129 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 183
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ L  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 71  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIHMELDHER 125
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       + + 
Sbjct: 126 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---ASTNFMM 180
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 181 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 121
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 122 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 176
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 120
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 121 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 165
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 166 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 220
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGY 248
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++  V   + GT  Y
Sbjct: 127 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 181
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
            APE +     +   DV+S G ++  +L G+   + S
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 128
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 129 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 183
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 17/102 (16%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-------------GDK 235
           + L+++H   + +I+RD K  NI +D   N K+ DFGLAK+                G  
Sbjct: 127 EALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 236 SHVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEIL 276
            ++++ I GT  Y A E +  TGH   + D+YS G++  E++
Sbjct: 185 DNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 35/204 (17%)
Query: 88  VYKGFISEDLREGLQPVPVA-VKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLI---- 142
           VYKG  +E        V VA  ++ D   +    + +  E   L  L HPN+V+      
Sbjct: 42  VYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWE 95
Query: 143 ----GYCCEDEHRVLIYEFMARGSVENNL----FSKVLLPLPWSIRMKIAFGAAKGLAFL 194
               G  C     VL+ E    G+++  L      K+ +   W  ++       KGL FL
Sbjct: 96  STVKGKKC----IVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQFL 145
Query: 195 HEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 253
           H    P+I+RD K  NI +     + K+ D GLA       ++  +  ++GT  + APE 
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFXAPEX 201
Query: 254 IMTGHLTPRSDVYSFGVVLLEILT 277
               +     DVY+FG   LE  T
Sbjct: 202 YEEKY-DESVDVYAFGXCXLEXAT 224

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 17/102 (16%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE-------------GDK 235
           + L+++H   + +I+RD K  NI +D   N K+ DFGLAK+                G  
Sbjct: 127 EALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 236 SHVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEIL 276
            ++++ I GT  Y A E +  TGH   + D+YS G++  E++
Sbjct: 185 DNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 7/160 (4%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E+  L  L H N+V+L      D+   L++EF  +       F      L   I    
Sbjct: 49  LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEIVKSF 106
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
            F   KGL F H   + V++RD K  N+L++ +   KL++FGLA+    G      +  +
Sbjct: 107 LFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLAR--AFGIPVRCYSAEV 162
Query: 244 GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSL 282
            T  Y  P+ +    L   S D++S G +  E+    + L
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 72  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 126
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 127 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 181
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 182 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 239

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   L+ E M     + NL   + + L    
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 165
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 166 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 220
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 23/207 (11%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CV KG   E  R   Q   VAVK+    +     RE   E+     L H N++  I    
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 147 EDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------E 196
              H      LI  +   GS+ + L    L  L     ++I    A GLA LH      +
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 197 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTR-IMGTYGYAAPEYI 254
            +  + +RD K+ NIL+  +    ++D GLA       ++  V     +GT  Y APE +
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 255 MTGHLT------PRSDVYSFGVVLLEI 275
                        R D+++FG+VL E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL- 191
           L HPN+V+L     E+ H  LI++ +  G +  ++ ++      +      +    + L 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILE 132
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           A LH  +  V++RD K  N+LL +       KL+DFGLA +  EG++        GT GY
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQ-QAWFGFAGTPGY 190
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            +PE +         D+++ GV+L  +L G
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 128
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 129 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 183
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 23/207 (11%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CV KG   E  R   Q   VAVK+    +     RE   E+     L H N++  I    
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 147 EDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------E 196
              H      LI  +   GS+ + L    L  L     ++I    A GLA LH      +
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 197 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTR-IMGTYGYAAPEYI 254
            +  + +RD K+ NIL+  +    ++D GLA       ++  V     +GT  Y APE +
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 255 MTGHLT------PRSDVYSFGVVLLEI 275
                        R D+++FG+VL E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLVGIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL---LPLPWSIRMK 182
           E+  +  L HP LV L     +D   V+IYEFM+ G     LF KV      +     ++
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVE 153
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVST 240
                 KGL  +HE     ++ D K  NI+  T  +   KL DFGL           V+T
Sbjct: 154 YMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 211
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              GT  +AAPE      +   +D++S GV+   +L+G
Sbjct: 212 ---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+    G    ++
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMT 183
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             ++  Y Y APE I+        D++S G ++ E++ G
Sbjct: 184 PEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL---LPLPWSIRMK 182
           E+  +  L HP LV L     +D   V+IYEFM+ G     LF KV      +     ++
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVE 259
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVST 240
                 KGL  +HE     ++ D K  NI+  T  +   KL DFGL           V+T
Sbjct: 260 YMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 317
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              GT  +AAPE      +   +D++S GV+   +L+G
Sbjct: 318 ---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK- 182
           L E+  L H  H N++ +      D        ++ +  ++ +L   +   +     ++ 
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK---------DGPEG 233
             +   + +  LH +   VI+RD K SN+L++++ + K+ DFGLA+           P G
Sbjct: 117 FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLDKSRPAREQN 292
            +S +    + T  Y APE ++T     R+ DV+S G +L E+   R+ +   R  R Q 
Sbjct: 175 QQSGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQL 232
Query: 293 L 293
           L
Sbjct: 233 L 233

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 23/207 (11%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           CV KG   E  R   Q   VAVK+    +     RE   E+     L H N++  I    
Sbjct: 44  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 101
Query: 147 EDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------E 196
              H      LI  +   GS+ + L    L  L     ++I    A GLA LH      +
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 197 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTR-IMGTYGYAAPEYI 254
            +  + +RD K+ NIL+  +    ++D GLA       ++  V     +GT  Y APE +
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 255 MTGHLT------PRSDVYSFGVVLLEI 275
                        R D+++FG+VL E+
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 89/195 (45%), Gaps = 22/195 (11%)
Query: 93  ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV 152
           + E+   GL+ V   +K  + D S     +  AE+  L  L HPN++K+     ED H +
Sbjct: 40  LVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE-VFEDYHNM 95
Query: 153 LIYEFMARGS------VENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF 206
            I      G       V      K L     +  MK    A   LA+ H   + V+++D 
Sbjct: 96  YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFH--SQHVVHKDL 150
Query: 207 KTSNILL-DTDYNA--KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS 263
           K  NIL  DT  ++  K+ DFGLA+     +    ST   GT  Y APE +    +T + 
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPE-VFKRDVTFKC 206
Query: 264 DVYSFGVVLLEILTG 278
           D++S GVV+  +LTG
Sbjct: 207 DIWSAGVVMYFLLTG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLSQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           T  + T  Y APE I+        D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 11/158 (6%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E+  L  L HPNLV L+          L++E+     +      +    +P  +   I
Sbjct: 50  LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHE--LDRYQRGVPEHLVKSI 107
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSHVSTR 241
            +   + + F H+     I+RD K  NIL+      KL DFG A+   GP    S     
Sbjct: 108 TWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGP----SDYYDD 161
Query: 242 IMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 278
            + T  Y +PE ++      P  DV++ G V  E+L+G
Sbjct: 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 65/153 (42%), Gaps = 8/153 (5%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+    HL HPN+++L  Y  +     LI E+  RG +   L          +    I  
Sbjct: 73  EIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRT--ATIME 130
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A  L + H   K VI+RD K  N+LL      K++DFG +   P    S     + GT
Sbjct: 131 ELADALMYCH--GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAP----SLRRKTMCGT 184
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             Y  PE I       + D++  GV+  E+L G
Sbjct: 185 LDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 50/221 (22%)
Query: 87  CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE--VIFLGHLSHPNLVKLIGY 144
            VYKG + E         PVAVKV     S+   + ++ E  +  +  + H N+ + I  
Sbjct: 28  AVYKGSLDER--------PVAVKVF----SFANRQNFINEKNIYRVPLMEHDNIARFI-- 73
Query: 145 CCEDEH--------RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH- 195
              DE          +L+ E+   GS+   L    L    W    ++A    +GLA+LH 
Sbjct: 74  -VGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 196 -----EAEKPVI-YRDFKTSNILLDTDYNAKLSDFGLA------KDGPEGDKSHVSTRIM 243
                +  KP I +RD  + N+L+  D    +SDFGL+      +    G++ + +   +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 244 GTYGYAAPEYIMTGHLTPRS--------DVYSFGVVLLEIL 276
           GT  Y APE ++ G +  R         D+Y+ G++  EI 
Sbjct: 190 GTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 57/121 (47%), Gaps = 5/121 (4%)
Query: 156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           EF  +G++E  +  +    L   + +++     KG+ ++H   K +I RD K SNI L  
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVD 157
Query: 216 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
               K+ DFGL        K     R  GT  Y +PE I +       D+Y+ G++L E+
Sbjct: 158 TKQVKIGDFGLVTSLKNDGK---RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214
Query: 276 L 276
           L
Sbjct: 215 L 215

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 75  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 129
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 130 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 184
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              + T  Y APE I+        D++S G ++ E++ G
Sbjct: 185 VPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGY 248
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++      + GT  Y
Sbjct: 129 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNY 183
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
            APE +     +   DV+S G ++  +L G+   + S
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGY 248
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++      + GT  Y
Sbjct: 129 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNY 183
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
            APE +     +   DV+S G ++  +L G+   + S
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGY 248
           G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++      + GT  Y
Sbjct: 133 GCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNY 187
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
            APE +     +   DV+S G ++  +L G+   + S
Sbjct: 188 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 9/159 (5%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLF--SKVLLPLPWSI 179
           ++EV  L  L HPN+V+      +  +  L  + E+   G + + +   +K    L    
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 180 RMKIAFGAAKGLAFLH---EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            +++       L   H   +    V++RD K +N+ LD   N KL DFGLA+     D S
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTS 171
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
              T  +GT  Y +PE +       +SD++S G +L E+
Sbjct: 172 FAKT-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 99/251 (39%), Gaps = 34/251 (13%)
Query: 114 DNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE--HRVLIYEFMARGSVENNLFSKV 171
           D S +  R++  E   L   SHPN++ ++G C      H  LI  +   GS+ N L    
Sbjct: 45  DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGT 104
Query: 172 LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 231
              +  S  +K A   A+G AFLH  E  +      + ++ +D D  A++S   +     
Sbjct: 105 NFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQ 164
Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPR--SDVYSFGVVLLEILTGRKSLDKSRPA 288
              + +          + APE +      T R  +D +SF V+L E++T           
Sbjct: 165 SPGRXYAP-------AWVAPEALQKKPEDTNRRSADXWSFAVLLWELVT----------- 206
Query: 289 REQNLADWAXXXXXXXXXXXNIIDPRLEGDYPV--KGVH-KAAMLAYHCLNHNPKARPLM 345
           RE   AD +                 LEG  P    G+    + L   C N +P  RP  
Sbjct: 207 REVPFADLSNXEIGXKVA--------LEGLRPTIPPGISPHVSKLXKICXNEDPAKRPKF 258
Query: 346 RDIVDSLEPLQ 356
             IV  LE  Q
Sbjct: 259 DXIVPILEKXQ 269

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 69
Query: 148 DE----HRVLIYEFMARGSVEN--NLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------ 195
           D        L+ ++   GS+ +  N ++  +  +     +K+A   A GLA LH      
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 124
Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY 253
           + +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE 
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 254 ----IMTGHLTP--RSDVYSFGVVLLEI 275
               I   H     R+D+Y+ G+V  EI
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+    G    + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMME 183
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
             ++  Y Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 184 PEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 67  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 121
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 122 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 176
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 234

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 203 YRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPR 262
           +RD K  NIL+  D  A L DFG+A    +   + +   + GT  Y APE     H T R
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 263 SDVYSFGVVLLEILTG 278
           +D+Y+   VL E LTG
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 12/106 (11%)
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL--AKDGPEGDKSHV 238
           + I    A+ + FLH   K +++RD K SNI    D   K+ DFGL  A D  E +++ +
Sbjct: 167 LHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 239 S--------TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 276
           +           +GT  Y +PE I   + + + D++S G++L E+L
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 68
Query: 148 DE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------EA 197
           D        L+ ++   GS+ + L ++  + +   I  K+A   A GLA LH      + 
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQG 125
Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY-- 253
           +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE   
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 254 --IMTGHLTP--RSDVYSFGVVLLEI 275
             I   H     R+D+Y+ G+V  EI
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM----------ARGSVENNLFSKVLL 173
           + E+  L  L H N+VKL       +  VL++E +            G +E+      LL
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
            L              G+A+ H+  + V++RD K  N+L++ +   K++DFGLA+    G
Sbjct: 108 QL------------LNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLAR--AFG 151
Query: 234 DKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 278
                 T  + T  Y AP+ +M +   +   D++S G +  E++ G
Sbjct: 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAF 185
           +   + P +V+L     +D +  ++ E+M  G + N L S   +P  W    +  + +A 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLAL 181
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
            A   + F+H        RD K  N+LLD   + KL+DFG      +       T + GT
Sbjct: 182 DAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 232
Query: 246 YGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTG 278
             Y +PE + +    G+     D +S GV L E+L G
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM----------ARGSVENNLFSKVLL 173
           + E+  L  L H N+VKL       +  VL++E +            G +E+      LL
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
            L              G+A+ H+  + V++RD K  N+L++ +   K++DFGLA+    G
Sbjct: 108 QL------------LNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLAR--AFG 151
Query: 234 DKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 278
                 T  + T  Y AP+ +M +   +   D++S G +  E++ G
Sbjct: 152 IPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 78  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 132
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+       S + 
Sbjct: 133 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 187
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
           T  + T  Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 188 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 245

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM----------ARGSVENNLFSKVLL 173
           + E+  L  L H N+VKL       +  VL++E +            G +E+      LL
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
            L              G+A+ H+  + V++RD K  N+L++ +   K++DFGLA+    G
Sbjct: 108 QL------------LNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLAR--AFG 151
Query: 234 DKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 278
                 T  + T  Y AP+ +M +   +   D++S G +  E++ G
Sbjct: 152 IPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 71
Query: 148 DE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------EA 197
           D        L+ ++   GS+ + L ++  + +   I  K+A   A GLA LH      + 
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQG 128
Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY-- 253
           +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE   
Sbjct: 129 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 188
Query: 254 --IMTGHLTP--RSDVYSFGVVLLEI 275
             I   H     R+D+Y+ G+V  EI
Sbjct: 189 DSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 74
Query: 148 DE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------EA 197
           D        L+ ++   GS+ + L ++  + +   I  K+A   A GLA LH      + 
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQG 131
Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY-- 253
           +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE   
Sbjct: 132 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 191
Query: 254 --IMTGHLTP--RSDVYSFGVVLLEI 275
             I   H     R+D+Y+ G+V  EI
Sbjct: 192 DSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 91  GFISEDLREGLQP----VPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC 146
           GF   DL EGL          +  H+  +  +  RE     +F    +HPN+++L+ YC 
Sbjct: 41  GFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF----NHPNILRLVAYCL 96
Query: 147 ED---EHRV-LIYEFMARGSVENNL--FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
            +   +H   L+  F  RG++ N +         L     + +  G  +GL  +H   K 
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKG 154
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDG---PEGDKSHVSTRIMG----TYGYAAPE- 252
             +RD K +NILL  +    L D G         EG +  ++ +       T  Y APE 
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 253 YIMTGH--LTPRSDVYSFGVVLLEILTGRKSLD 283
           + +  H  +  R+DV+S G VL  ++ G    D
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 107
Query: 148 DE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------EA 197
           D        L+ ++   GS+ + L ++  + +   I  K+A   A GLA LH      + 
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQG 164
Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY-- 253
           +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE   
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224
Query: 254 --IMTGHLTP--RSDVYSFGVVLLEI 275
             I   H     R+D+Y+ G+V  EI
Sbjct: 225 DSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL- 191
           L HPN+V+L     E+ H  LI++ +  G +  ++ ++      +      +    + L 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILE 121
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           A LH  +  V++R+ K  N+LL +       KL+DFGLA +  EG++        GT GY
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQ-AWFGFAGTPGY 179
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            +PE +         D+++ GV+L  +L G
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 88  VYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE 147
           + KG   E  R   +   VAVK+          RE  AE+     L H N++  I    +
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 94
Query: 148 DE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------EA 197
           D        L+ ++   GS+ + L ++  + +   I  K+A   A GLA LH      + 
Sbjct: 95  DNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQG 151
Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY-- 253
           +  + +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE   
Sbjct: 152 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 211
Query: 254 --IMTGHLTP--RSDVYSFGVVLLEI 275
             I   H     R+D+Y+ G+V  EI
Sbjct: 212 DSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAF 185
           +   + P +V+L     +D +  ++ E+M  G + N L S   +P  W    +  + +A 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLAL 186
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
            A   + F+H        RD K  N+LLD   + KL+DFG      +       T + GT
Sbjct: 187 DAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 237
Query: 246 YGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTG 278
             Y +PE + +    G+     D +S GV L E+L G
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW----SIRMKIAF 185
           +   + P +V+L     +D +  ++ E+M  G + N L S   +P  W    +  + +A 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLAL 186
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
            A   + F+H        RD K  N+LLD   + KL+DFG      +       T + GT
Sbjct: 187 DAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 237
Query: 246 YGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTG 278
             Y +PE + +    G+     D +S GV L E+L G
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 68/157 (43%), Gaps = 10/157 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL---FSKVLLP-LPWSIRMKIAF 185
           L    HPN+V+L+  C        I   +    V+ +L     K   P LP      +  
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
              +GL FLH     +++RD K  NIL+ +    KL+DFGLA+           T ++ T
Sbjct: 128 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVVVT 182
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 282
             Y APE ++        D++S G +  E+   RK L
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 9/159 (5%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLF--SKVLLPLPWSI 179
           ++EV  L  L HPN+V+      +  +  L  + E+   G + + +   +K    L    
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 180 RMKIAFGAAKGLAFLH---EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            +++       L   H   +    V++RD K +N+ LD   N KL DFGLA+        
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDE 170
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
             +   +GT  Y +PE +       +SD++S G +L E+
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 9/159 (5%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLF--SKVLLPLPWSI 179
           ++EV  L  L HPN+V+      +  +  L  + E+   G + + +   +K    L    
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 180 RMKIAFGAAKGLAFLH---EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            +++       L   H   +    V++RD K +N+ LD   N KL DFGLA+       +
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDT 170
Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
             +   +GT  Y +PE +       +SD++S G +L E+
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK-VLLPLPWSIRMKIA 184
           E+  L  + H N+V L        H  L+ + ++ G + + +  + V      S+ ++  
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV 115
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYNAKL--SDFGLAKDGPEGDKSHVSTR 241
             A K   +LHE    +++RD K  N+L L  + N+K+  +DFGL+K    G    + + 
Sbjct: 116 LSAVK---YLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMST 166
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             GT GY APE +     +   D +S GV+   +L G
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 126 EVIFLGHLSHPNLVKLIGYCC------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSI 179
           E++ +  ++H N++ L+          E +   ++ E M     + NL   + + L    
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 127
Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
              + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+    G    + 
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMME 183
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT------GRKSLDKSRPAREQ 291
             ++  Y Y APE I+        D++S G ++ E++       GR  +D+     EQ
Sbjct: 184 PEVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 25/166 (15%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMAR---------GSVENNLFSKVLLP 174
           + EV  L  L H N+V L      ++   L++E++ +         G++ N    K+ L 
Sbjct: 48  IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL- 106
Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 234
                     F   +GLA+ H   + V++RD K  N+L++     KL+DFGLA+      
Sbjct: 107 ----------FQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154
Query: 235 KSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           K++ +  +  T  Y  P+ ++ +   + + D++  G +  E+ TGR
Sbjct: 155 KTYDNEVV--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 15/101 (14%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG------------DKS 236
           + L+++H   + +I+R+ K  NI +D   N K+ DFGLAK+                  S
Sbjct: 127 EALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 237 HVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEIL 276
              T  +GT  Y A E +  TGH   + D YS G++  E +
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 130 LGHLSHPNLVKLIGY--CCEDEHRVLIYEFMARGSVEN-------NLFSKVLLPLPWSIR 180
           L  L HPN+V+L  Y     +  R  IY  +    V +       N + + + P P  I+
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-DTDYNAKLSDFGLAK--DGPEGDKSH 237
           +   F   + +  LH     V +RD K  N+L+ + D   KL DFG AK     E + ++
Sbjct: 133 V-FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 238 VSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTG 278
           + +R      Y APE I    H T   D++S G +  E++ G
Sbjct: 192 ICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E+M  G    ++FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG----DMFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     K++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E+M  G    ++FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG----DMFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     K++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 10/158 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E++    LS P +V L G   E     +  E +  GS+   +  K +  LP    +    
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLG 157
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFG----LAKDGPEGDKSHVST 240
            A +GL +LH   + +++ D K  N+LL +D + A L DFG    L  DG  G       
Sbjct: 158 QALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL-GKSLLTGD 214
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            I GT  + APE +M      + D++S   ++L +L G
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E++    LS P +V L G   E     +  E +  GS+      K +  LP    +    
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ--LIKQMGCLPEDRALYYLG 173
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFG----LAKDGPEGDKSHVST 240
            A +GL +LH   + +++ D K  N+LL +D + A L DFG    L  DG  G       
Sbjct: 174 QALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL-GKSLLTGD 230
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            I GT  + APE +M      + D++S   ++L +L G
Sbjct: 231 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            E+  L  L+HP ++K+  +  + E   ++ E M  G     LF KV+     + R+K A
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVV----GNKRLKEA 114
Query: 185 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 235
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 115 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 170
Query: 236 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 278
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 171 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            E+  L  L+HP ++K+  +  + E   ++ E M  G     LF KV+     + R+K A
Sbjct: 63  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVV----GNKRLKEA 113
Query: 185 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 235
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 114 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 169
Query: 236 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 278
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 170 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 9/123 (7%)
Query: 114 DNSYQGHREWLAEVIFLGHLS-HPNLVKL-----IGYCCEDEHR---VLIYEFMARGSVE 164
            N  + +R  + EV F+  LS HPN+V+      IG    D  +   +L+ E      VE
Sbjct: 63  SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE 122
Query: 165 NNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
                +   PL     +KI +   + +  +H  + P+I+RD K  N+LL      KL DF
Sbjct: 123 FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 225 GLA 227
           G A
Sbjct: 183 GSA 185

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP------LPWSIRMKIAFG 186
           L HPN+V+L     E+    L+++ +  G +  ++ ++              I   IA+ 
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIM 243
            + G          +++R+ K  N+LL +       KL+DFGLA +  + +  H      
Sbjct: 121 HSNG----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 167
Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 168 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            E+  L  L+HP ++K+  +  + E   ++ E M  G     LF KV+     + R+K A
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVV----GNKRLKEA 114
Query: 185 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 235
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 115 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 170
Query: 236 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 278
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 171 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            E+  L  L+HP ++K+  +  + E   ++ E M  G     LF KV+     + R+K A
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVV----GNKRLKEA 114
Query: 185 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 235
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 115 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 170
Query: 236 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 278
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 171 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 10/158 (6%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E++    LS P +V L G   E     +  E +  GS+   +  K +  LP    +    
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLG 171
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFG----LAKDGPEGDKSHVST 240
            A +GL +LH   + +++ D K  N+LL +D + A L DFG    L  DG  G       
Sbjct: 172 QALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL-GKSLLTGD 228
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            I GT  + APE +M      + D++S   ++L +L G
Sbjct: 229 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP------LPWSIRMKIAFG 186
           L HPN+V+L     E+    L+++ +  G +  ++ ++              I   IA+ 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIM 243
            + G          +++R+ K  N+LL +       KL+DFGLA +  + +  H      
Sbjct: 122 HSNG----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 168
Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL---FSKVLLP-LPWSIRMKIAF 185
           L    HPN+V+L+  C        I   +    V+ +L     K   P LP      +  
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
              +GL FLH     +++RD K  NIL+ +    KL+DFGLA+             ++ T
Sbjct: 120 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVVT 174
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 282
             Y APE ++        D++S G +  E+   RK L
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLP------LPWSIRMKIAFG 186
           L HPN+V+L     E+    L+++ +  G +  ++ ++              I   IA+ 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIM 243
            + G          +++R+ K  N+LL +       KL+DFGLA +  + +  H      
Sbjct: 122 HSNG----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 168
Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 14/157 (8%)
Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKIAF 185
           I L +  HPN++ L     + ++  ++ E M  G     L  K+L    +S R    + F
Sbjct: 68  ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLF 123
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYN---AKLSDFGLAKDGPEGDKSHVSTR 241
              K + +LH   + V++RD K SNIL +D   N    ++ DFG AK     +   + T 
Sbjct: 124 TITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAENGLLMTP 180
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              T  + APE +         D++S GV+L  +LTG
Sbjct: 181 CY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 10/163 (6%)
Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           R    E+  +  L HP LV L     ++E   ++ + +  G +  +L   V      +++
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETVK 118
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           +   F     +A  +   + +I+RD K  NILLD   +  ++DF +A   P   ++ ++T
Sbjct: 119 L---FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT 173
Query: 241 RIMGTYGYAAPEYIMTGHLTPRS---DVYSFGVVLLEILTGRK 280
            + GT  Y APE   +      S   D +S GV   E+L GR+
Sbjct: 174 -MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            E+  L  L+HP ++K+  +  + E   ++ E M  G     LF KV+     + R+K A
Sbjct: 70  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVV----GNKRLKEA 120
Query: 185 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 235
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 121 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 176
Query: 236 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 278
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 177 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E++    L+ P +V L G   E     +  E +  GS+   +  +  LP     R     
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRALYYL 191
Query: 186 GAA-KGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFG----LAKDGPEGDKSHVS 239
           G A +GL +LH   + +++ D K  N+LL +D  +A L DFG    L  DG  G      
Sbjct: 192 GQALEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG-LGKSLLTG 248
Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             I GT  + APE ++      + DV+S   ++L +L G
Sbjct: 249 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            E+  L  L+HP ++K+  +  + E   ++ E M  G     LF KV+     + R+K A
Sbjct: 189 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGE----LFDKVV----GNKRLKEA 239
Query: 185 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 235
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 240 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 295
Query: 236 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 278
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 296 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            E+  L  L+HP ++K+  +   +++ +++ E M  G     LF KV+     + R+K A
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGE----LFDKVV----GNKRLKEA 253
Query: 185 ------FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 235
                 +     + +LHE    +I+RD K  N+LL +   D   K++DFG +K    G+ 
Sbjct: 254 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGET 309
Query: 236 SHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTG 278
           S + T + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 310 SLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 11/149 (7%)
Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL 194
           HPN+VKL     +  H  L+ E +  G     LF ++     +S             A  
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGE----LFERIKKKKHFSETEASYIMRKLVSAVS 120
Query: 195 HEAEKPVIYRDFKTSNILLDTDYN----AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           H  +  V++RD K  N+L  TD N     K+ DFG A+  P  D   + T    T  YAA
Sbjct: 121 HMHDVGVVHRDLKPENLLF-TDENDNLEIKIIDFGFARLKPP-DNQPLKTPCF-TLHYAA 177
Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           PE +         D++S GV+L  +L+G+
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 22/164 (13%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E++    L+ P +V L G   E     +  E +  GS+   +  +  LP     R     
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRALYYL 172
Query: 186 GAA-KGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFG---------LAKDGPEGD 234
           G A +GL +LH   + +++ D K  N+LL +D  +A L DFG         L KD   GD
Sbjct: 173 GQALEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD 230
Query: 235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
                  I GT  + APE ++      + DV+S   ++L +L G
Sbjct: 231 Y------IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 5/149 (3%)
Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
           L HP++V+L+     D    +++EFM    +   +  +      +S  +   +      A
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
             +  +  +I+RD K  N+LL +  N+   KL DFG+A     G+   V+   +GT  + 
Sbjct: 143 LRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGGRVGTPHFM 200
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           APE +         DV+  GV+L  +L+G
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL---FSKVLLP-LPWSIRMKIAF 185
           L    HPN+V+L+  C        I   +    V+ +L     K   P LP      +  
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
              +GL FLH     +++RD K  NIL+ +    KL+DFGLA+             ++ T
Sbjct: 120 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVVT 174
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 282
             Y APE ++        D++S G +  E+   RK L
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYC---------CEDEHRVLIYEFMARGSVENNLFSKVLLP 174
           L E+  L  L H N+V LI  C         C+     L+++F         L S VL+ 
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLA--GLLSNVLVK 121
Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 234
              S   ++      GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+      
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 235 KSH---VSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILT 277
            S       R++ T  Y  PE ++      P  D++  G ++ E+ T
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLP------WSIRMKIAFG 186
           L HPN+V+L     E+    L+++ +  G +  ++ ++              I   IA+ 
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIM 243
            + G          +++R+ K  N+LL +       KL+DFGLA +  + +  H      
Sbjct: 145 HSNG----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 191
Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYC---------CEDEHRVLIYEFMARGSVENNLFSKVLLP 174
           L E+  L  L H N+V LI  C         C+     L+++F         L S VL+ 
Sbjct: 64  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLA--GLLSNVLVK 120
Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 234
              S   ++      GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+      
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 235 KSH---VSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILT 277
            S       R++ T  Y  PE ++      P  D++  G ++ E+ T
Sbjct: 179 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYC---------CEDEHRVLIYEFMARGSVENNLFSKVLLP 174
           L E+  L  L H N+V LI  C         C+     L+++F         L S VL+ 
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLA--GLLSNVLVK 121
Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 234
              S   ++      GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+      
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 235 KSH---VSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILT 277
            S       R++ T  Y  PE ++      P  D++  G ++ E+ T
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL---FSKVLLP-LPWSIRMKIAF 185
           L    HPN+V+L+  C        I   +    V+ +L     K   P LP      +  
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
              +GL FLH     +++RD K  NIL+ +    KL+DFGLA+             ++ T
Sbjct: 120 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVT 174
Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSL 282
             Y APE ++        D++S G +  E+   RK L
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 145
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 165
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
            + A   L F +     +IYRD K  N+L+D     +++DFG AK          +  + 
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLC 220
Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 221 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYC---------CEDEHRVLIYEFMARGSVENNLFSKVLLP 174
           L E+  L  L H N+V LI  C         C+     L+++F         L S VL+ 
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCK-ASIYLVFDFCEHDLA--GLLSNVLVK 121
Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 234
              S   ++      GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+      
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 235 KSH---VSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILT 277
            S       R++ T  Y  PE ++      P  D++  G ++ E+ T
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 12/157 (7%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK-VLLPLPWSIRMKIA 184
           E+  L  + H N+V L        H  L+ + ++ G + + +  K        S  ++  
Sbjct: 70  EIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQV 129
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
             A   + +LH     +++RD K  N+L    D +    +SDFGL+K   +GD   V + 
Sbjct: 130 LDA---VYYLHRM--GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMST 181
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             GT GY APE +     +   D +S GV+   +L G
Sbjct: 182 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 234
           +P  I  KIA    K L  LH ++  VI+RD K SN+L++     K+ DFG++  G   D
Sbjct: 150 IPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVD 206
Query: 235 KSHVSTRIMGTYGYAAPEYI-----MTGHLTPRSDVYSFGVVLLEILTGR 279
            S   T   G   Y APE I       G+ + +SD++S G+ ++E+   R
Sbjct: 207 -SVAKTIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILR 254

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 76  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 131
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 132 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK--------RVKGRTW 183
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 184 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL- 191
           L H N+V+L     E+    L+++ +  G +  ++ ++      +      +    + L 
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILE 114
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           A LH  +  V++RD K  N+LL +       KL+DFGLA +  +GD+        GT GY
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE-VQGDQQ-AWFGFAGTPGY 172
Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            +PE +         D+++ GV+L  +L G
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 13/149 (8%)
Query: 148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFK 207
           D+   L+ EF   GSV + + +     L       I     +GL+ LH+ +  VI+RD K
Sbjct: 99  DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIK 156
Query: 208 TSNILLDTDYNAKLSDFGLAK--DGPEGDKSHVSTRIMGTYGYAAPEYIMT-----GHLT 260
             N+LL  +   KL DFG++   D   G ++      +GT  + APE I           
Sbjct: 157 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRN----TFIGTPYWMAPEVIACDENPDATYD 212
Query: 261 PRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
            +SD++S G+  +E+  G   L    P R
Sbjct: 213 FKSDLWSLGITAIEMAEGAPPLCDMHPMR 241

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHA----- 143
Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 241 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 89/234 (38%), Gaps = 43/234 (18%)
Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 193
            HP +++L+ +    E  +L+ E   R     +LF  +    P        F      A 
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLE---RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 194 LHEAEKPVIYRDFKTSNILLDTDYN-AKLSDFG---LAKDGPEGDKSHVSTRIMGTYGYA 249
            H   + V++RD K  NIL+D     AKL DFG   L  D P  D         GT  Y+
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-------FDGTRVYS 205
Query: 250 APEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAXXXXXXXXXX 307
            PE+I     H  P + V+S G++L +++ G    ++ +   E  L              
Sbjct: 206 PPEWISRHQYHALP-ATVWSLGILLYDMVCGDIPFERDQEILEAEL-------------- 250
Query: 308 XNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE 361
                      +P         L   CL   P +RP + +I+  L+P    P E
Sbjct: 251 ----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL--LDPWMQTPAE 292

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 84  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA----- 138
Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 139 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 188
Query: 241 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 189 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA----- 143
Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 241 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA----- 143
Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 241 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA----- 143
Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 241 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     K++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ ++  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 80/191 (41%), Gaps = 40/191 (20%)
Query: 135 HPNLVKLIGYCCEDEHRVL-----IYEFMARGSVENNLFSKVLLPL-----PWSIRMKIA 184
           HPN+++   YC E   R L     +     +  VE+   S   L L     P S+  +IA
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------------DYNAKLSDFGLAKDGP 231
                G+A LH  +  +I+RD K  NIL+ T             +    +SDFGL K   
Sbjct: 126 ----SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 232 EGDKSHVST--RIMGTYGYAAPEYIMTGH-------LTPRSDVYSFGVVLLEILTGRKSL 282
            G  S  +      GT G+ APE +   +       LT   D++S G V   IL+  K  
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 283 DKSRPAREQNL 293
              + +RE N+
Sbjct: 240 FGDKYSRESNI 250

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E+   G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+++D     K++DFGLAK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+++D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G + ++L        P +     
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA----- 164
Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 165 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 214
Query: 241 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 215 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 83/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +   +       G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEA--TEFLKQILNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPAFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK--IAF 185
           I L +  HPN++ L     + +H  L+ E M  G     L  K+L    +S R    +  
Sbjct: 73  ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGG----ELLDKILRQKFFSEREASFVLH 128
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYN---AKLSDFGLAKDGPEGDKSHVSTR 241
              K + +LH   + V++RD K SNIL +D   N    ++ DFG AK     +   + T 
Sbjct: 129 TIGKTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTP 185
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              T  + APE +         D++S G++L  +L G
Sbjct: 186 CY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL---LPLPWSIRMK 182
           E+  +  L HP L+ L     +    VLI EF++ G     LF ++      +  +  + 
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYKMSEAEVIN 153
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAKDGPEGDKSHVST 240
               A +GL  +H  E  +++ D K  NI+ +T    + K+ DFGLA      +   V+T
Sbjct: 154 YMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
               T  +AAPE +    +   +D+++ GV+   +L+G
Sbjct: 212 ---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK--IAF 185
           I L +  HPN++ L     + +H  L+ E M  G     L  K+L    +S R    +  
Sbjct: 73  ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGG----ELLDKILRQKFFSEREASFVLH 128
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYN---AKLSDFGLAKDGPEGDKSHVSTR 241
              K + +LH   + V++RD K SNIL +D   N    ++ DFG AK     +   + T 
Sbjct: 129 TIGKTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTP 185
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              T  + APE +         D++S G++L  +L G
Sbjct: 186 CY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 57/113 (50%), Gaps = 16/113 (14%)
Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-------- 226
           +P  I  KIA    K L  LH ++  VI+RD K SN+L++     K+ DFG+        
Sbjct: 106 IPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164
Query: 227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           AKD   G K +++   +       PE    G+ + +SD++S G+ ++E+   R
Sbjct: 165 AKDIDAGCKPYMAPERIN------PELNQKGY-SVKSDIWSLGITMIELAILR 210

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 31/193 (16%)
Query: 91  GFISEDLREGLQPVPVAVK--VHDGDNSYQGH----REWLAEVIFLGHLSHPNLVKLIGY 144
           G+I   L   +   PV +K  VH GD   Q      R++LAEV+      HP++V++  +
Sbjct: 94  GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV------HPSIVQIFNF 147
Query: 145 C-CEDEH----RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
               D H      ++ E++   S++ +   K  LP+  +I   +    A  L++LH    
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPA--LSYLHSIG- 202
Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL 259
            ++Y D K  NI+L T+   KL D G         + +    + GT G+ APE + TG  
Sbjct: 203 -LVYNDLKPENIML-TEEQLKLIDLGAVS------RINSFGYLYGTPGFQAPEIVRTGP- 253
Query: 260 TPRSDVYSFGVVL 272
           T  +D+Y+ G  L
Sbjct: 254 TVATDIYTVGRTL 266

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 126 EVIFLGHLSHPNLVKL-IGYCCEDEHRVLIYEFMARGSVENNLF------SKVLLPLPWS 178
           E+  +  L H N+V+L   +    E + ++Y  +    V   ++      S+    LP  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSH 237
                 +   + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ + 
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN- 179
Query: 238 VSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
             + I   Y Y APE I      T   DV+S G VL E+L G+
Sbjct: 180 -VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 55/128 (42%), Gaps = 36/128 (28%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD------------- 229
           I +    G  F+HE+   +I+RD K +N LL+ D + K+ DFGLA+              
Sbjct: 136 ILYNLLLGEKFIHES--GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193
Query: 230 ---------GPEGDK------SHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLL 273
                    GP          SHV TR      Y APE I+   + T   D++S G +  
Sbjct: 194 EEKEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTNSIDIWSTGCIFA 248
Query: 274 EILTGRKS 281
           E+L   KS
Sbjct: 249 ELLNMMKS 256

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 245
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 187
Query: 246 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 245
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 187
Query: 246 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 17/130 (13%)
Query: 153 LIYEFMARGSVENNLFSKVLLPL--------PWSIRMKIAFGAAKGLAFLHEAEKPVIYR 204
           +IYE+M   S+    F +    L        P  +   I        +++H  EK + +R
Sbjct: 120 IIYEYMENDSILK--FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHR 176
Query: 205 DFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPR 262
           D K SNIL+D +   KLSDFG ++     DK    +R  GTY +  PE+    + +   +
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESE--YMVDKKIKGSR--GTYEFMPPEFFSNESSYNGAK 232
Query: 263 SDVYSFGVVL 272
            D++S G+ L
Sbjct: 233 VDIWSLGICL 242

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 245
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 146 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 200
Query: 246 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 201 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 245
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 187
Query: 246 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 245
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 169 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 223
Query: 246 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 224 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 245
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 167 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 221
Query: 246 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 222 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 13/185 (7%)
Query: 100 GLQPVPVAVKVHDGDNSYQG--HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GL+     +K      S +G    E   EV  L  + HPN++ L          VLI E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI-LLDTD 216
           ++ G + + L  K  L    +           G+ +LH   K + + D K  NI LLD +
Sbjct: 97  VSGGELFDFLAQKESLSEEEA--TSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKN 152
Query: 217 Y---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 273
               + KL DFGLA +  +G +      I GT  + APE +    L   +D++S GV+  
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 274 EILTG 278
            +L+G
Sbjct: 210 ILLSG 214

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 245
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 138 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 192
Query: 246 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 193 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 245
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 161 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 215
Query: 246 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 216 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 245
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 171 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 225
Query: 246 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 226 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR--MKIAF 185
           I L +  HPN++ L     + ++  ++ E    G     L  K+L    +S R    + F
Sbjct: 68  ILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGG----ELLDKILRQKFFSEREASAVLF 123
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYN---AKLSDFGLAKDGPEGDKSHVSTR 241
              K + +LH   + V++RD K SNIL +D   N    ++ DFG AK     +   + T 
Sbjct: 124 TITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAENGLLXTP 180
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              T  + APE +         D++S GV+L   LTG
Sbjct: 181 CY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGT 245
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++ +R    
Sbjct: 212 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 266
Query: 246 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
             Y APE I      T   DV+S G VL E+L G+
Sbjct: 267 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 137
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 138 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 189
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 83/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +   +       G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEA--TEFLKQILNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E+   G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+++D     K++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 145
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 145
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y AP  I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 145
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 75  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 130
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
            + A   L F +     +IYRD K  N+L+D     +++DFG AK      K    T + 
Sbjct: 131 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWT-LC 185
Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 186 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 47/290 (16%)
Query: 88  VYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREWLAEVIF-----LGHLSHPNLVKL 141
           ++KG   E    G L    V +KV D     + HR + +E  F     +  LSH +LV  
Sbjct: 24  IFKGVRREVGDYGQLHETEVLLKVLD-----KAHRNY-SESFFEAASMMSKLSHKHLVLN 77
Query: 142 IGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKP 200
            G C   +  +L+ EF+  GS++  L  +K  + + W  ++++A   A  + FL   E  
Sbjct: 78  YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE--ENT 133
Query: 201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR--IMGTYGYAAPEYIMT-G 257
           +I+ +    NILL  + + K  +    K    G    V  +  +     +  PE I    
Sbjct: 134 LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPK 193
Query: 258 HLTPRSDVYSFGVVLLEILTG----RKSLDKSRPAREQNLADWAXXXXXXXXXXXNIIDP 313
           +L   +D +SFG  L EI +G      +LD  R  + Q   D                  
Sbjct: 194 NLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQFYED------------------ 233
Query: 314 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAP 363
                 P     + A L  +C+++ P  RP  R I+  L  L   PD  P
Sbjct: 234 --RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL-FTPDLVP 280

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 145
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E+   G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+++D     +++DFGLAK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 145
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 187
Query: 248 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E+   G     +FS +     +S     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHAR 145
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+++D     K++DFG AK         V  R  
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 197
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 152 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 206
Query: 248 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 55/125 (44%), Gaps = 33/125 (26%)
Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD------------- 229
           I +    G  F+HE+   +I+RD K +N LL+ D + K+ DFGLA+              
Sbjct: 134 ILYNLLLGENFIHES--GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 230 ------GPEGDK------SHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEIL 276
                 GP          SHV TR      Y APE I+   + T   D++S G +  E+L
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 277 TGRKS 281
              +S
Sbjct: 247 NMLQS 251

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G     +FS +     +S     
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHAR 165
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 217
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 35  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 95  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 149
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 150 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206
Query: 273 LEILTG 278
             +L+G
Sbjct: 207 YILLSG 212

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 13/91 (14%)
Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYG 247
             +LH  +  +IYRD K  N+L+D     K++DFG AK         V  R   + GT  
Sbjct: 155 FEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPE 204
Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE I++       D ++ GV++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 141 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 195
Query: 248 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 134 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 188
Query: 248 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 187
Query: 248 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 35  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 95  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 149
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 150 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206
Query: 273 LEILTG 278
             +L+G
Sbjct: 207 YILLSG 212

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 187
Query: 248 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 145 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 199
Query: 248 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 137 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 191
Query: 248 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 145 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 199
Query: 248 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   + I   Y 
Sbjct: 167 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY- 221
Query: 248 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
           Y APE I      T   DV+S G VL E+L G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 77/187 (41%), Gaps = 36/187 (19%)
Query: 135 HPNLVKLIGYCCEDEHRVL-----IYEFMARGSVENNLFSKVLLPL-----PWSIRMKIA 184
           HPN+++   YC E   R L     +     +  VE+   S   L L     P S+  +IA
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------------DYNAKLSDFGLAKDGP 231
                G+A LH  +  +I+RD K  NIL+ T             +    +SDFGL K   
Sbjct: 144 ----SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 232 EGDKSHVST--RIMGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR 286
            G            GT G+ APE +       LT   D++S G V   IL+  K     +
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 257
Query: 287 PAREQNL 293
            +RE N+
Sbjct: 258 YSRESNI 264

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 77/187 (41%), Gaps = 36/187 (19%)
Query: 135 HPNLVKLIGYCCEDEHRVL-----IYEFMARGSVENNLFSKVLLPL-----PWSIRMKIA 184
           HPN+++   YC E   R L     +     +  VE+   S   L L     P S+  +IA
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------------DYNAKLSDFGLAKDGP 231
                G+A LH  +  +I+RD K  NIL+ T             +    +SDFGL K   
Sbjct: 144 ----SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 232 EGDKSHVST--RIMGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR 286
            G            GT G+ APE +       LT   D++S G V   IL+  K     +
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 257
Query: 287 PAREQNL 293
            +RE N+
Sbjct: 258 YSRESNI 264

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 119/291 (40%), Gaps = 49/291 (16%)
Query: 88  VYKGFISEDLREG-LQPVPVAVKVHDGDNSYQGHREWLAEVIF-----LGHLSHPNLVKL 141
           ++KG   E    G L    V +KV D     + HR + +E  F     +  LSH +LV  
Sbjct: 24  IFKGVRREVGDYGQLHETEVLLKVLD-----KAHRNY-SESFFEAASMMSKLSHKHLVLN 77
Query: 142 IGYC-CEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
            G C C DE+ +L+ EF+  GS++  L  +K  + + W  ++++A   A  + FL   E 
Sbjct: 78  YGVCFCGDEN-ILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLE--EN 132
Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR--IMGTYGYAAPEYIMT- 256
            +I+ +    NILL  + + K  +    K    G    V  +  +     +  PE I   
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENP 192
Query: 257 GHLTPRSDVYSFGVVLLEILTG----RKSLDKSRPAREQNLADWAXXXXXXXXXXXNIID 312
            +L   +D +SFG  L EI +G      +LD  R  + Q   D                 
Sbjct: 193 KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQFYED----------------- 233
Query: 313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAP 363
                  P     + A L  +C+++ P  RP  R I+  L  L   PD  P
Sbjct: 234 ---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL-FTPDLVP 280

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 13/91 (14%)
Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYG 247
             +LH  +  +IYRD K  N+++D     K++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE I++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+I    L HPN+V+         H  ++ E+ + G     LF ++     +S      F
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFF 120
Query: 186 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAKDGPEGDKSHVSTR 241
                 G+++ H  +  V +RD K  N LLD       K+ DFG +K      +   +  
Sbjct: 121 FQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 176
Query: 242 IMGTYGYAAPEYIMTGHLTPR-SDVYSFGVVLLEILTG 278
            +GT  Y APE ++      + +DV+S GV L  +L G
Sbjct: 177 -VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++A G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT    APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 14/103 (13%)
Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           M IA  +   L ++H        RD K  NIL+D + + +L+DFG      E D +  S+
Sbjct: 184 MVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSS 234
Query: 241 RIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTG 278
             +GT  Y +PE +       G   P  D +S GV + E+L G
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 13/91 (14%)
Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYG 247
             +LH  +  +IYRD K  N+++D     K++DFG AK         V  R   + GT  
Sbjct: 155 FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPE 204
Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE I++       D ++ GV++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 13/91 (14%)
Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYG 247
             +LH  +  +IYRD K  N+++D     K++DFG AK         V  R   + GT  
Sbjct: 155 FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPE 204
Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE I++       D ++ GV++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 13/91 (14%)
Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR---IMGTYG 247
             +LH  +  +IYRD K  N+++D     K++DFG AK         V  R   + GT  
Sbjct: 155 FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPE 204
Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           Y APE I++       D ++ GV++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA----- 143
Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 241 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR-MKIA 184
           E+  +  L HPN+++L     ++    L+ E    G +   +  K +     + R MK  
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTR 241
             A   +A+ H+    V +RD K  N L  T   D   KL DFGLA     G    + T+
Sbjct: 116 LSA---VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTK 168
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           + GT  Y +P+ ++ G   P  D +S GV++  +L G
Sbjct: 169 V-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G + ++L        P +     
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA----- 144
Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 145 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 194
Query: 241 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G + ++L        P +     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA----- 143
Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 144 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 241 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+I    L HPN+V+         H  ++ E+ + G     LF ++     +S      F
Sbjct: 64  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFF 119
Query: 186 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAKDGPEGDKSHVSTR 241
                 G+++ H  +  V +RD K  N LLD       K+ DFG +K      +   +  
Sbjct: 120 FQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 175
Query: 242 IMGTYGYAAPEYIMTGHLTPR-SDVYSFGVVLLEILTG 278
            +GT  Y APE ++      + +DV+S GV L  +L G
Sbjct: 176 -VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E++  G + ++L        P +     
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA----- 136
Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F AA+      +LH  +  +IYRD K  N+L+D     +++DFG AK         V  
Sbjct: 137 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 186
Query: 241 R---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           R   + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 187 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 13/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L  + HPN++ L          VLI E ++ G + + L  K  L    + +     
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 124
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-----KLSDFGLAKDGPEGDKSHVST 240
               G+ +LH   K + + D K  NI+L  D N      KL DFG+A     G++     
Sbjct: 125 --LDGVHYLHS--KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKIEAGNEF---K 176
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+I    L HPN+V+         H  ++ E+ + G     LF ++     +S      F
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFF 120
Query: 186 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAKDGPEGDKSHVSTR 241
                 G+++ H  +  V +RD K  N LLD       K++DFG +K      +   +  
Sbjct: 121 FQQLISGVSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA-- 176
Query: 242 IMGTYGYAAPEYIMTGHLTPR-SDVYSFGVVLLEILTG 278
            +GT  Y APE ++      + +DV+S GV L  +L G
Sbjct: 177 -VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 13/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L  + HPN++ L          VLI E ++ G + + L  K  L    + +     
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-----KLSDFGLAKDGPEGDKSHVST 240
               G+ +LH   K + + D K  NI+L  D N      KL DFG+A     G++     
Sbjct: 118 --LDGVHYLHS--KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKIEAGNEF---K 169
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 66/133 (49%), Gaps = 16/133 (12%)
Query: 152 VLIYEFMARGSVENNLFSKVLLPLPWSIR----MKIAFGAAKGLAFLHEAEKPVIYRDFK 207
           +LI E+ A G +    FS  L  L   +     +++     +G+ +LH+    +++ D K
Sbjct: 105 ILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLK 158
Query: 208 TSNILLDTDY---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSD 264
             NILL + Y   + K+ DFG+++      +      IMGT  Y APE +    +T  +D
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EIMGTPEYLAPEILNYDPITTATD 215
Query: 265 VYSFGVVLLEILT 277
           +++ G++   +LT
Sbjct: 216 MWNIGIIAYMLLT 228

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 100 GLQPVPVAVKVHDGDNSYQG-HREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GLQ     +K     +S +G  RE +  EV  L  + HPN++ L          +LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGEL 95
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
           +A G + + L  K  L    +           G+ +LH  +  + + D K  NI+L  D 
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIML-LDR 150
Query: 218 NA-----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
           N      K+ DFGLA     G++      I GT  + APE +    L   +D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
Query: 273 LEILTG 278
             +L+G
Sbjct: 208 YILLSG 213

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 22/152 (14%)
Query: 139 VKLIGYCCEDE-HRVLIYEFMARGSVENNLFSKVLLPLPWSI------RMKIAFGAAKGL 191
           +  + Y  +DE H  L+ ++   G +   L SK    LP  +       M +A  +   L
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 194
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
            ++H        RD K  N+LLD + + +L+DFG      + D +  S+  +GT  Y +P
Sbjct: 195 HYVH--------RDIKPDNVLLDVNGHIRLADFGSCLKMND-DGTVQSSVAVGTPDYISP 245
Query: 252 EYIMT-----GHLTPRSDVYSFGVVLLEILTG 278
           E +       G   P  D +S GV + E+L G
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR-MKIA 184
           E+  +  L HPN+++L     ++    L+ E    G +   +  K +     + R MK  
Sbjct: 73  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 132
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTR 241
             A   +A+ H+    V +RD K  N L  T   D   KL DFGLA     G    + T+
Sbjct: 133 LSA---VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTK 185
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           + GT  Y +P+ ++ G   P  D +S GV++  +L G
Sbjct: 186 V-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   L  ++ P LVKL     ++ +  ++ E+   G     +FS +     +S     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHAR 144
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
            + A   L F +     +IYRD K  N+++D     +++DFG AK         V  R  
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 242 -IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            + GT  Y APE I++       D ++ GV++ E+  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 13/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV  L  + HPN++ L          VLI E ++ G + + L  K  L    + +     
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-----KLSDFGLAKDGPEGDKSHVST 240
               G+ +LH   K + + D K  NI+L  D N      KL DFG+A     G++     
Sbjct: 139 --LDGVHYLHS--KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKIEAGNEF---K 190
Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 191 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 22/152 (14%)
Query: 139 VKLIGYCCEDE-HRVLIYEFMARGSVENNLFSKVLLPLPWSI------RMKIAFGAAKGL 191
           +  + Y  +DE H  L+ ++   G +   L SK    LP  +       M +A  +   L
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 210
Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
            ++H        RD K  N+LLD + + +L+DFG      + D +  S+  +GT  Y +P
Sbjct: 211 HYVH--------RDIKPDNVLLDVNGHIRLADFGSCLKMND-DGTVQSSVAVGTPDYISP 261
Query: 252 EYIMT-----GHLTPRSDVYSFGVVLLEILTG 278
           E +       G   P  D +S GV + E+L G
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 38/75 (50%), Gaps = 4/75 (5%)
Query: 199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG- 257
           K +I+RD K  NI++  D+  KL DFG A     G   +      GT  Y APE +M   
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAPEVLMGNP 205
Query: 258 HLTPRSDVYSFGVVL 272
           +  P  +++S GV L
Sbjct: 206 YRGPELEMWSLGVTL 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/174 (22%), Positives = 74/174 (42%), Gaps = 25/174 (14%)
Query: 116 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 175
           S + H++   E      L HPN+V+L     E+    L+++ +  G +  ++ ++     
Sbjct: 70  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY--- 126
Query: 176 PWSIRMKIAFGAAKGLAFLHEA--------EKPVIYRDFKTSNILLDTDYNA---KLSDF 224
                    +  A     +H+         +  +++RD K  N+LL +       KL+DF
Sbjct: 127 ---------YSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADF 177
Query: 225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           GLA +     ++       GT GY +PE +         D+++ GV+L  +L G
Sbjct: 178 GLAIEVQGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 27/180 (15%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           EV+      H N+V  +G C    H  +I   + +G    ++     + L  +   +IA 
Sbjct: 79  EVMAYRQTRHENVVLFMGACMSPPHLAIITS-LCKGRTLYSVVRDAKIVLDVNKTRQIAQ 137
Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL------AKDGPEGDKSHVS 239
              KG+ +LH   K ++++D K+ N+  D      ++DFGL       + G   DK  + 
Sbjct: 138 EIVKGMGYLH--AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 240 TRIMGTYGYAAPEYIMTGHLTP-----------RSDVYSFGVVLLEILTGRKSLDKSRPA 288
               G   + APE I    L+P            SDV++ G +  E L  R+   K++PA
Sbjct: 195 N---GWLCHLAPEIIR--QLSPDTEEDKLPFSKHSDVFALGTIWYE-LHAREWPFKTQPA 248

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 40/191 (20%)
Query: 135 HPNLVKLIGYCCEDEHRVL-----IYEFMARGSVENNLFSKVLLPL-----PWSIRMKIA 184
           HPN+++   YC E   R L     +     +  VE+   S   L L     P S+  +IA
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------------DYNAKLSDFGLAKDGP 231
                G+A LH  +  +I+RD K  NIL+ T             +    +SDFGL K   
Sbjct: 126 ----SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 232 EGDKSHVST--RIMGTYGYAAPEYIMTGH-------LTPRSDVYSFGVVLLEILTGRKSL 282
            G            GT G+ APE +   +       LT   D++S G V   IL+  K  
Sbjct: 180 SGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 283 DKSRPAREQNL 293
              + +RE N+
Sbjct: 240 FGDKYSRESNI 250

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+I    L HPN+V+         H  +I E+ + G     L+ ++     +S      F
Sbjct: 66  EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG----ELYERICNAGRFSEDEARFF 121
Query: 186 GAA--KGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAKDGPEGDKSHVSTR 241
                 G+++ H  +  + +RD K  N LLD       K+ DFG +K      +   +  
Sbjct: 122 FQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 177
Query: 242 IMGTYGYAAPEYIMTGHLTPR-SDVYSFGVVLLEILTG 278
            +GT  Y APE ++      + +DV+S GV L  +L G
Sbjct: 178 -VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 115 NSYQGHREWLAEVIFLGHLSHP------NLVKLIGYCCEDEHRVLIYEFMARGSVE---N 165
           N  + HR+   E+  L HL         N++ ++       H  + +E ++    E    
Sbjct: 132 NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK 191
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSD 223
           N F    LPL   +R K A    + L  LH+    +I+ D K  NILL     +  K+ D
Sbjct: 192 NKFQGFSLPL---VR-KFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVID 245
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           FG +      +   V T I   + Y APE I+        D++S G +L E+LTG
Sbjct: 246 FGSSCY----EHQRVYTXIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 116 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 175
           S + H++   E      L HPN+V+L     E+    L+++ +  G +  ++ ++     
Sbjct: 43  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR----- 97
Query: 176 PWSIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGP 231
            +      +    + L  ++      +++RD K  N+LL +       KL+DFGLA +  
Sbjct: 98  EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-V 156
Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           +GD+        GT GY +PE +         D+++ GV+L  +L G
Sbjct: 157 QGDQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 116 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 175
           S + H++   E      L HPN+V+L     E+    L+++ +  G +  ++ ++     
Sbjct: 43  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR----- 97
Query: 176 PWSIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGP 231
            +      +    + L  ++      +++RD K  N+LL +       KL+DFGLA +  
Sbjct: 98  EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-V 156
Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           +GD+        GT GY +PE +         D+++ GV+L  +L G
Sbjct: 157 QGDQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 41/197 (20%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE----HRVLIYEFMARG 161
           VAVKV          RE   E+     + H N++  I    +         LI ++   G
Sbjct: 63  VAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120
Query: 162 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH------EAEKPVIYRDFKTSNILLDT 215
           S+ + L S  L        +K+A+ +  GL  LH      + +  + +RD K+ NIL+  
Sbjct: 121 SLYDYLKSTTLDA---KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177
Query: 216 DYNAKLSDFGLA----KDGPEGDKSHVSTRIMGTYGYAAPE-------------YIMTGH 258
           +    ++D GLA     D  E D    +TR+ GT  Y  PE             YIM   
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPP-NTRV-GTKRYMPPEVLDESLNRNHFQSYIM--- 232
Query: 259 LTPRSDVYSFGVVLLEI 275
               +D+YSFG++L E+
Sbjct: 233 ----ADMYSFGLILWEV 245

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 115 NSYQGHREWLAEVIFLGHLSHP------NLVKLIGYCCEDEHRVLIYEFMARGSVE---N 165
           N  + HR+   E+  L HL         N++ ++       H  + +E ++    E    
Sbjct: 132 NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK 191
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSD 223
           N F    LPL   +R K A    + L  LH+    +I+ D K  NILL     +  K+ D
Sbjct: 192 NKFQGFSLPL---VR-KFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVID 245
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           FG +      +   V T I   + Y APE I+        D++S G +L E+LTG
Sbjct: 246 FGSSCY----EHQRVYTXIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 16/113 (14%)
Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-------- 226
           +P  I  KIA    K L  LH ++  VI+RD K SN+L++     K  DFG+        
Sbjct: 133 IPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDV 191
Query: 227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           AKD   G K + +   +       PE    G+ + +SD++S G+  +E+   R
Sbjct: 192 AKDIDAGCKPYXAPERIN------PELNQKGY-SVKSDIWSLGITXIELAILR 237

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 32/183 (17%)
Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E+  L  L+H ++VK++      +      E      + ++ F K+     +   + I
Sbjct: 100 LREIAILNRLNHDHVVKVLDIVIPKDVEKF-DELYVVLEIADSDFKKLFRTPVYLTELHI 158
Query: 184 A---FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKS-- 236
               +    G+ ++H A   +++RD K +N L++ D + K+ DFGLA+  D PE   S  
Sbjct: 159 KTLLYNLLVGVKYVHSA--GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 237 ------------------HVSTRIMG---TYGYAAPEYI-MTGHLTPRSDVYSFGVVLLE 274
                             ++  ++ G   T  Y APE I +  + T   DV+S G +  E
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 275 ILT 277
           +L 
Sbjct: 277 LLN 279

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 115 NSYQGHREWLAEVIFLGHLSHP------NLVKLIGYCCEDEHRVLIYEFMARGS---VEN 165
           N  + HR+   E+  L HL         N++ ++       H  + +E ++      ++ 
Sbjct: 132 NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK 191
Query: 166 NLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSD 223
           N F    LPL   +R K A    + L  LH+    +I+ D K  NILL     +  K+ D
Sbjct: 192 NKFQGFSLPL---VR-KFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVID 245
Query: 224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           FG +    +     + +R      Y APE I+        D++S G +L E+LTG
Sbjct: 246 FGSSCYEHQRVYXXIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 67/149 (44%), Gaps = 5/149 (3%)
Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
           L HP++V+L+     D    +++EFM    +   +  +      +S  +   +      A
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
             +  +  +I+RD K   +LL +  N+   KL  FG+A     G+   V+   +GT  + 
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFM 200
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           APE +         DV+  GV+L  +L+G
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 39/182 (21%)
Query: 125 AEVIFLGHL--SHPN----LVKLIGYCCEDEHRVLIYEFMARGS---VENNLFSKVLLPL 175
           +E+  L HL  + PN     V+++ +     H  +++E +   +   ++ N F    LP 
Sbjct: 60  SEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF----LPF 115
Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDY----------------- 217
                 K+A+   K + FLH  +  + + D K  NIL + +DY                 
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 218 -NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEIL 276
            + K+ DFG A    E   + VSTR      Y APE I+    +   DV+S G +L+E  
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTR-----HYRAPEVILALGWSQPCDVWSIGCILIEYY 228
Query: 277 TG 278
            G
Sbjct: 229 LG 230

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 67/149 (44%), Gaps = 5/149 (3%)
Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
           L HP++V+L+     D    +++EFM    +   +  +      +S  +   +      A
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
             +  +  +I+RD K   +LL +  N+   KL  FG+A     G+   V+   +GT  + 
Sbjct: 145 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFM 202
Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           APE +         DV+  GV+L  +L+G
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF--SKVLLPLPWSIRMKI 183
           E+  +  L H NL++L          VL+ E++  G + + +   S  L  L   + MK 
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK- 194
Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNIL-LDTDYNA-KLSDFGLAKDGPEGDKSHVSTR 241
                +G+  +H+    +++ D K  NIL ++ D    K+ DFGLA+     +K  V+  
Sbjct: 195 --QICEGIRHMHQM--YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN-- 248
Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             GT  + APE +    ++  +D++S GV+   +L+G
Sbjct: 249 -FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 22/94 (23%)
Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL--------AKDGPEGDKSHVSTRI 242
           LA  H   + +++ D K +NI L      KL DFGL        A +  EGD  +++  +
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 243 M-GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           + G+YG AA             DV+S G+ +LE+
Sbjct: 228 LQGSYGTAA-------------DVFSLGLTILEV 248

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 153 LIYEFMARGSVENNLFSKVLL-PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 211
           L++E M  GS+ +++  +     L  S+ ++     A  L FLH   K + +RD K  NI
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDFLH--NKGIAHRDLKPENI 142
Query: 212 LLDTDYN---AKLSDFGLAKD-GPEGDKSHVSTRIM----GTYGYAAPEYI-----MTGH 258
           L +        K+ DFGL       GD S +ST  +    G+  Y APE +         
Sbjct: 143 LCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 259 LTPRSDVYSFGVVLLEILTG 278
              R D++S GV+L  +L+G
Sbjct: 203 YDKRCDLWSLGVILYILLSG 222

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 14/158 (8%)
Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E+I    L HPN+V+         H  ++ E+ + G     LF ++     +S      F
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFF 120
Query: 186 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAKDGPEGDKSHVSTR 241
                 G+++ H  +  V +RD K  N LLD       K+  FG +K      +   +  
Sbjct: 121 FQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST-- 176
Query: 242 IMGTYGYAAPEYIMTGHLTPR-SDVYSFGVVLLEILTG 278
            +GT  Y APE ++      + +DV+S GV L  +L G
Sbjct: 177 -VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 25/186 (13%)
Query: 106 VAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR--------VLIY-- 155
           VA+K    D  ++     +  ++      HPN+V L  +   +  +        VL Y  
Sbjct: 67  VAIKKVLQDKRFKNRELQIMRIV-----KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
Query: 156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT 215
           E + R S     ++K+   +P  +     +   + LA++H     + +RD K  N+LLD 
Sbjct: 122 ETVYRASRH---YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDP 176
Query: 216 DYNA-KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLL 273
                KL DFG AK    G+ +   + I   Y Y APE I    + T   D++S G V+ 
Sbjct: 177 PSGVLKLIDFGSAKILIAGEPN--VSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMA 233
Query: 274 EILTGR 279
           E++ G+
Sbjct: 234 ELMQGQ 239

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 13/185 (7%)
Query: 100 GLQPVPVAVKVHDGDNSYQG--HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GL+     +K      S +G    E   EV  L  + H N++ L          VLI E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI-LLDTD 216
           ++ G + + L  K  L    +           G+ +LH   K + + D K  NI LLD +
Sbjct: 97  VSGGELFDFLAQKESLSEEEA--TSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKN 152
Query: 217 Y---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 273
               + KL DFGLA +  +G +      I GT  + APE +    L   +D++S GV+  
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 274 EILTG 278
            +L+G
Sbjct: 210 ILLSG 214

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 26/172 (15%)
Query: 126 EVIFLGHLSHPNLVKL--IGYCCEDEHRVLIYEF----------MARGSVENNLFSKVLL 173
           E+  L  L HPN++ L  +     D    L++++            R S  N    K  +
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPV 123
Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAKLSDFGLAK- 228
            LP  +   + +    G+ +LH     V++RD K +NIL+  +       K++D G A+ 
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 229 -DGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTG 278
            + P    + +   ++ T+ Y APE ++   H T   D+++ G +  E+LT 
Sbjct: 182 FNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 13/185 (7%)
Query: 100 GLQPVPVAVKVHDGDNSYQG--HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GL+     +K      S +G    E   EV  L  + H N++ L          VLI E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI-LLDTD 216
           ++ G + + L  K  L    +           G+ +LH   K + + D K  NI LLD +
Sbjct: 97  VSGGELFDFLAQKESLSEEEA--TSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKN 152
Query: 217 Y---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 273
               + KL DFGLA +  +G +      I GT  + APE +    L   +D++S GV+  
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 274 EILTG 278
            +L+G
Sbjct: 210 ILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 13/185 (7%)
Query: 100 GLQPVPVAVKVHDGDNSYQG--HREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEF 157
           GL+     +K      S +G    E   EV  L  + H N++ L          VLI E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96
Query: 158 MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI-LLDTD 216
           ++ G + + L  K  L    +           G+ +LH   K + + D K  NI LLD +
Sbjct: 97  VSGGELFDFLAQKESLSEEEA--TSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKN 152
Query: 217 Y---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLL 273
               + KL DFGLA +  +G +      I GT  + APE +    L   +D++S GV+  
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 274 EILTG 278
            +L+G
Sbjct: 210 ILLSG 214

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	389
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-171
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-145
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-82
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-65
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-59
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-54
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-50
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-34
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-33
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-33
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-33
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-28
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-27
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-27
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-24
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-24
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-24
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-20
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-18
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-18
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-09
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-15
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-13
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-11
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  510 bits (1317), Expect = 0.0
 Identities = 107/320 (33%), Positives = 172/320 (53%), Gaps = 24/320 (7%)

Query: 48  EDLRRDSAANPLIAFTYDELRIITANFRQDR------VLGGGGFGCVYKGFISEDLREGL 101
           E+   + +     +F++ EL+ +T NF +         +G GGFG VYKG+++       
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT----- 55

Query: 102 QPVPVAVK---VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFM 158
               VAVK         + +  +++  E+  +    H NLV+L+G+  + +   L+Y +M
Sbjct: 56  ---TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112

Query: 159 ARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY 217
             GS+ + L       PL W +R KIA GAA G+ FLHE     I+RD K++NILLD  +
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAF 170

Query: 218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            AK+SDFGLA+   +  ++ +++RI+GT  Y APE  + G +TP+SD+YSFGVVLLEI+T
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIIT 229

Query: 278 GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNH 337
           G  ++D+ R    Q L D    +  E+K + + ID ++  D     V     +A  CL+ 
Sbjct: 230 GLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHE 286

Query: 338 NPKARPLMRDIVDSLEPLQV 357
               RP ++ +   L+ +  
Sbjct: 287 KKNKRPDIKKVQQLLQEMTA 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  478 bits (1233), Expect = e-171
 Identities = 115/303 (37%), Positives = 169/303 (55%), Gaps = 13/303 (4%)

Query: 62  FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 121
               +L   T NF    ++G G FG VYKG     LR+G     VA+K      S QG  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGV----LRDG---AKVALKRRT-PESSQGIE 80

Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF--SKVLLPLPWSI 179
           E+  E+  L    HP+LV LIG+C E    +LIY++M  G+++ +L+      + + W  
Sbjct: 81  EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
           R++I  GAA+GL +LH   + +I+RD K+ NILLD ++  K++DFG++K G E D++H+S
Sbjct: 141 RLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP 299
           T + GT GY  PEY + G LT +SDVYSFGVVL E+L  R ++ +S P    NLA+WA+ 
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258

Query: 300 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP 359
                 +L  I+DP L      + + K    A  CL  + + RP M D++  LE    L 
Sbjct: 259 SH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

Query: 360 DEA 362
           +  
Sbjct: 318 ESV 320

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  413 bits (1063), Expect = e-145
 Identities = 118/297 (39%), Positives = 176/297 (59%), Gaps = 14/297 (4%)

Query: 62  FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 121
           F+  EL++ + NF    +LG GGFG VYKG     L +G     VAVK    + +  G  
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGR----LADGTL---VAVKRLKEERTQGGEL 72

Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKV--LLPLPWSI 179
           ++  EV  +    H NL++L G+C     R+L+Y +MA GSV + L  +     PL W  
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132

Query: 180 RMKIAFGAAKGLAFLHEAEKP-VIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV 238
           R +IA G+A+GLA+LH+   P +I+RD K +NILLD ++ A + DFGLAK     D +HV
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THV 191

Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ--NLADW 296
           +T + GT G+ APEY+ TG  + ++DV+ +GV+LLE++TG+++ D +R A +    L DW
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
              LLKE KKL  ++D  L+G+Y  + V +   +A  C   +P  RP M ++V  LE
Sbjct: 252 VKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  253 bits (648), Expect = 3e-82
 Identities = 77/323 (23%), Positives = 130/323 (40%), Gaps = 39/323 (12%)

Query: 62  FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 121
              + L   +   +   V   G FGCV+K  +  +         VAVK+       Q  +
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE--------YVAVKIF----PIQDKQ 61

Query: 122 EWLAE--VIFLGHLSHPNLVKLIGYCCEDEHRV----LIYEFMARGSVENNLFSKVLLPL 175
            W  E  V  L  + H N+++ IG             LI  F  +GS+ + L +     +
Sbjct: 62  SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VV 118

Query: 176 PWSIRMKIAFGAAKGLAFLHE-------AEKP-VIYRDFKTSNILLDTDYNAKLSDFGLA 227
            W+    IA   A+GLA+LHE         KP + +RD K+ N+LL  +  A ++DFGLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

Query: 228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-----TPRSDVYSFGVVLLEILTGRKSL 282
                G  +  +   +GT  Y APE +            R D+Y+ G+VL E+ +   + 
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

Query: 283 DKSRPAREQNLAD--WALPLLKEKKKL--LNIIDPRLEGDY-PVKGVHKAAMLAYHCLNH 337
           D           +     P L++ +++       P L   +    G+         C +H
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298

Query: 338 NPKARPLMRDIVDSLEPLQVLPD 360
           + +AR     + + +  +Q L +
Sbjct: 299 DAEARLSAGCVGERITQMQRLTN 321

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  209 bits (534), Expect = 4e-65
 Identities = 66/341 (19%), Positives = 127/341 (37%), Gaps = 50/341 (14%)

Query: 60  IAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG 119
           +     E  +   N +   ++G G +G VYKG     L E     PVAVKV     S+  
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKG----SLDER----PVAVKV----FSFAN 48

Query: 120 HREWLAE--VIFLGHLSHPNLVKLIGYCCEDE-----HRVLIYEFMARGSVENNLFSKVL 172
            + ++ E  +  +  + H N+ + I              +L+ E+   GS+   L     
Sbjct: 49  RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-- 106

Query: 173 LPLPWSIRMKIAFGAAKGLAFLHE-------AEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
               W    ++A    +GLA+LH         +  + +RD  + N+L+  D    +SDFG
Sbjct: 107 -TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165

Query: 226 LAK------DGPEGDKSHVSTRIMGTYGYAAPEYIM-------TGHLTPRSDVYSFGVVL 272
           L+           G++ + +   +GT  Y APE +              + D+Y+ G++ 
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 273 LEILTGRKSLDKSRPAREQNLA----DWALPLLKEKKKL--LNIIDPRLEGDYPVKGVHK 326
            EI      L       E  +A        P  ++ + L       P+    +    +  
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285

Query: 327 AAM--LAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTP 365
            ++      C + + +AR   +   + +  L ++ +   + 
Sbjct: 286 RSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  197 bits (503), Expect = 9e-61
 Identities = 84/333 (25%), Positives = 143/333 (42%), Gaps = 35/333 (10%)

Query: 34  KKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFI 93
           K  +   P +  ++           +     D++ I   +      +G G FG V++   
Sbjct: 2   KHHHHHHPMSDYDIPTTENLYFQGAM---DGDDMDIPWCDLNIKEKIGAGSFGTVHRAE- 57

Query: 94  SEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV 152
                       VAVK+  + D   +   E+L EV  +  L HPN+V  +G   +  +  
Sbjct: 58  -------WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110

Query: 153 LIYEFMARGSVENNLFSK-VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI 211
           ++ E+++RGS+   L        L    R+ +A+  AKG+ +LH    P+++R+ K+ N+
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170

Query: 212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVV 271
           L+D  Y  K+ DFGL++       S  S    GT  + APE +       +SDVYSFGV+
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228

Query: 272 LLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKA-AML 330
           L E+ T ++      P    N A     +  + K+L          + P + ++   A +
Sbjct: 229 LWELATLQQ------PWGNLNPAQVVAAVGFKCKRL----------EIP-RNLNPQVAAI 271

Query: 331 AYHCLNHNPKARPLMRDIVDSLEPLQ--VLPDE 361
              C  + P  RP    I+D L PL    +P  
Sbjct: 272 IEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (491), Expect = 7e-59
 Identities = 80/332 (24%), Positives = 134/332 (40%), Gaps = 48/332 (14%)

Query: 64  YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW 123
           Y E+ +       + V+G G FG V K           +   VA+K  + ++     + +
Sbjct: 7   YKEIEV-------EEVVGRGAFGVVCKAK--------WRAKDVAIKQIESESE---RKAF 48

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMK 182
           + E+  L  ++HPN+VKL G C       L+ E+   GS+ N L   + L     +  M 
Sbjct: 49  IVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106

Query: 183 IAFGAAKGLAFLH-EAEKPVIYRDFKTSNILLDTDYN-AKLSDFGLAKDGPEGDKSHVST 240
                ++G+A+LH    K +I+RD K  N+LL       K+ DFG A D          T
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMT 161

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
              G+  + APE     + + + DV+S+G++L E++T RK      P  E     + +  
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK------PFDEIGGPAFRIMW 215

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKA-AMLAYHCLNHNPKARPLMRDIVDSLEPLQVL- 358
                    +I          K + K    L   C + +P  RP M +IV  +  L    
Sbjct: 216 AVHNGTRPPLI----------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

Query: 359 --PDEAPTPKNFVTVVTPEEPKAEIQTKDSQC 388
              DE        ++   E+ + E     ++ 
Sbjct: 266 PGADEPLQYPCQHSLPPGEDGRVEPYVDFAEF 297

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  189 bits (482), Expect = 5e-58
 Identities = 71/302 (23%), Positives = 117/302 (38%), Gaps = 50/302 (16%)

Query: 64  YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHRE 122
           + +L            L     G ++KG          Q   + VKV    D S +  R+
Sbjct: 9   FKQLNF-------LTKLNENHSGELWKGR--------WQGNDIVVKVLKVRDWSTRKSRD 53

Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCE--DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
           +  E   L   SHPN++ ++G C      H  LI  +M  GS+ N L       +  S  
Sbjct: 54  FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA 113

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           +K A   A+G+AFLH  E  +      + ++++D D  A++S   +         S  S 
Sbjct: 114 VKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSP 166

Query: 241 RIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 297
             M    + APE +           +D++SF V+L E++T         P  + +  +  
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV------PFADLSNMEIG 220

Query: 298 LPLLKEKKKLLNI---IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 354
           + +  E  +   I   I P +            + L   C+N +P  RP    IV  LE 
Sbjct: 221 MKVALEGLR-PTIPPGISPHV------------SKLMKICMNEDPAKRPKFDMIVPILEK 267

Query: 355 LQ 356
           +Q
Sbjct: 268 MQ 269

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  184 bits (469), Expect = 5e-56
 Identities = 77/309 (24%), Positives = 133/309 (43%), Gaps = 56/309 (18%)

Query: 64  YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSY 117
            +E+         ++ +G GGFG V+KG + +          VA+K              
Sbjct: 18  DNEIEY-------EKQIGKGGFGLVHKGRLVK------DKSVVAIKSLILGDSEGETEMI 64

Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW 177
           +  +E+  EV  + +L+HPN+VKL G         ++ EF+  G + + L  K   P+ W
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-PIKW 121

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-----DYNAKLSDFGLAKDGPE 232
           S+++++    A G+ ++     P+++RD ++ NI L +        AK++DFGL++    
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177

Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSLDKSRPARE 290
               H  + ++G + + APE I       T ++D YSF ++L  ILTG        P  E
Sbjct: 178 -QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDE 230

Query: 291 QNLADWALPLLKEKKKL-LNI---IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR 346
            +        +  ++ L   I     PRL              +   C + +PK RP   
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFS 278

Query: 347 DIVDSLEPL 355
            IV  L  L
Sbjct: 279 YIVKELSEL 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  182 bits (464), Expect = 7e-55
 Identities = 75/304 (24%), Positives = 119/304 (39%), Gaps = 40/304 (13%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
            VLG G FG   K       RE      + +K     +     R +L EV  +  L HPN
Sbjct: 16  EVLGKGCFGQAIKV----THRE--TGEVMVMKELIRFDEET-QRTFLKEVKVMRCLEHPN 68

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA 197
           ++K IG   +D+    I E++  G++   + S      PWS R+  A   A G+A+LH  
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHS- 126

Query: 198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAK------------DGPEGDKSHVSTRIMGT 245
              +I+RD  + N L+  + N  ++DFGLA+               +         ++G 
Sbjct: 127 -MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 305
             + APE I       + DV+SFG+VL EI+  R + D     R  +        L  + 
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDYLPRTMDFG------LNVRG 238

Query: 306 KLLNIIDPRLEGDYPVKGVHKA-AMLAYHCLNHNPKARPLMRDIVDSLEPLQV-LPDEAP 363
            L                   +   +   C + +P+ RP    +   LE L++ L    P
Sbjct: 239 FL------DRY---CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289

Query: 364 TPKN 367
               
Sbjct: 290 LGPQ 293

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (463), Expect = 1e-54
 Identities = 62/341 (18%), Positives = 114/341 (33%), Gaps = 42/341 (12%)

Query: 41  PSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREG 100
           P     +   R         +    E  I         ++G G FG VY G    +    
Sbjct: 2   PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---- 57

Query: 101 LQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA 159
                VA+++     ++    + +  EV+      H N+V  +G C    H  +I     
Sbjct: 58  -----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112

Query: 160 RGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA 219
             ++ + +     + L  +   +IA    KG+ +LH   K ++++D K+ N+  D +   
Sbjct: 113 GRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKV 168

Query: 220 KLSDFGLAK---DGPEGDKSHVSTRIMGTYGYAAPEYIMTG---------HLTPRSDVYS 267
            ++DFGL         G +        G   + APE I              +  SDV++
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228

Query: 268 FGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKA 327
            G +  E+           P + Q     A+          N+    +  +         
Sbjct: 229 LGTIWYELHAREW------PFKTQPAE--AIIWQMGTGMKPNLSQIGMGKEI-------- 272

Query: 328 AMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNF 368
           + +   C     + RP    ++D LE L         P +F
Sbjct: 273 SDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHF 313

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  177 bits (452), Expect = 1e-53
 Identities = 87/305 (28%), Positives = 133/305 (43%), Gaps = 52/305 (17%)

Query: 64  YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV---HDGDNSYQGH 120
           + EL +       + ++G GGFG VY+ F             VAVK       ++  Q  
Sbjct: 6   FAELTL-------EEIIGIGGFGKVYRAF--------WIGDEVAVKAARHDPDEDISQTI 50

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR 180
                E      L HPN++ L G C ++ +  L+ EF   G +   L  K    +P  I 
Sbjct: 51  ENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDIL 107

Query: 181 MKIAFGAAKGLAFLH-EAEKPVIYRDFKTSNILLD--------TDYNAKLSDFGLAKDGP 231
           +  A   A+G+ +LH EA  P+I+RD K+SNIL+         ++   K++DFGLA+   
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--- 164

Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ 291
           E  ++   +   G Y + APE I     +  SDV+S+GV+L E+LTG        P R  
Sbjct: 165 EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV------PFRGI 217

Query: 292 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKA-AMLAYHCLNHNPKARPLMRDIVD 350
           +    A  +   K          L    P     +  A L   C N +P +RP   +I+D
Sbjct: 218 DGLAVAYGVAMNKL--------ALP--IP-STCPEPFAKLMEDCWNPDPHSRPSFTNILD 266

Query: 351 SLEPL 355
            L  +
Sbjct: 267 QLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  178 bits (453), Expect = 2e-53
 Identities = 77/298 (25%), Positives = 125/298 (41%), Gaps = 29/298 (9%)

Query: 63  TYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHR 121
             D+  I        + +G G FG VYKG    D         VAVK+ +    + Q  +
Sbjct: 15  AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQ 65

Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM 181
            +  EV  L    H N++  +G         ++ ++    S+ ++L +           +
Sbjct: 66  AFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLI 123

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
            IA   A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA +      SH   +
Sbjct: 124 DIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181

Query: 242 IMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 298
           + G+  + APE I      P   +SDVY+FG+VL E++TG+       P    N  D  +
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQII 235

Query: 299 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
            ++       ++   R      +K +    M    CL      RP    I+  +E L 
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRL----MAE--CLKKKRDERPSFPRILAEIEELA 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  171 bits (436), Expect = 6e-51
 Identities = 69/314 (21%), Positives = 113/314 (35%), Gaps = 43/314 (13%)

Query: 68  RIITANFRQDRVLGGGGFGCVYKG-FISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE 126
           R +  +      +G G +G V++G +  E+         VAVK+    +     RE   E
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQGEN---------VAVKIFSSRDEKSWFRE--TE 52

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +     L H N++  I       H      LI  +   GS+ + L       L     ++
Sbjct: 53  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLR 109

Query: 183 IAFGAAKGLAFLHEAEK------PVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGD 234
           I    A GLA LH           + +RD K+ NIL+  +    ++D GLA         
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169

Query: 235 KSHVSTRIMGTYGYAAPE------YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA 288
               +   +GT  Y APE       +       R D+++FG+VL E+     S       
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229

Query: 289 R----EQNLADWALPLLKE---KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
           +    +    D +   +++     +    I  R   D  +  + K   L   C   NP A
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK---LMKECWYQNPSA 286

Query: 342 RPLMRDIVDSLEPL 355
           R     I  +L  +
Sbjct: 287 RLTALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  172 bits (437), Expect = 1e-50
 Identities = 67/320 (20%), Positives = 112/320 (35%), Gaps = 53/320 (16%)

Query: 68  RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEV 127
           R I    +  + +G G +G V+ G      R       VAVKV          RE   E+
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMG----KWRG----EKVAVKVFFTTEEASWFRE--TEI 82

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
                + H N++  I    +         LI ++   GS+ + L S     L     +K+
Sbjct: 83  YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKL 139

Query: 184 AFGAAKGLAFLHE------AEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDK 235
           A+ +  GL  LH        +  + +RD K+ NIL+  +    ++D GLA        + 
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTP-------RSDVYSFGVVLLEILTGRKSLDKSRPA 288
                  +GT  Y  PE ++   L          +D+YSFG++L E+          R  
Sbjct: 200 DIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR--------RCV 250

Query: 289 REQNLADWALPLLKEKKKLLNIID-----------PRLEGDYPVKGVHKA-AMLAYHCLN 336
               + ++ LP         +  D           P     +      +    L   C  
Sbjct: 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310

Query: 337 HNPKARPLMRDIVDSLEPLQ 356
           HNP +R     +  +L  + 
Sbjct: 311 HNPASRLTALRVKKTLAKMS 330

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  170 bits (432), Expect = 7e-50
 Identities = 81/357 (22%), Positives = 129/357 (36%), Gaps = 49/357 (13%)

Query: 26  DESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGF 85
           D S       E + L     ++      S    L        R I         +G G F
Sbjct: 2   DPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLL------VQRTIARTIVLQESIGKGRF 55

Query: 86  GCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC 145
           G V++G      R       VAVK+          RE  AE+     L H N++  I   
Sbjct: 56  GEVWRG----KWRG----EEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 105

Query: 146 CEDEHRV----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE----- 196
            +D        L+ ++   GS+ + L       +     +K+A   A GLA LH      
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 197 AEKPVI-YRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSHVSTRIMGTYGYAAPEY 253
             KP I +RD K+ NIL+  +    ++D GLA   D             +GT  Y APE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE- 221

Query: 254 IMTGHLTP-------RSDVYSFGVVLLEILTGRKSLDKSR----PAREQNLADWALPLLK 302
           ++   +         R+D+Y+ G+V  EI               P  +   +D ++  ++
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281

Query: 303 E---KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
           +   ++KL   I  R +    ++ + K   +   C   N  AR     I  +L  L 
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAK---IMRECWYANGAARLTALRIKKTLSQLS 335

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (376), Expect = 2e-41
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 11/218 (5%)

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
           A   D+  +   +      +G G FG V+ G +            VAVK           
Sbjct: 103 AVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR------ADNTLVAVKSCRETLPPDLK 156

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSI 179
            ++L E   L   SHPN+V+LIG C + +   ++ E +  G     L +    L +   +
Sbjct: 157 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLL 216

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
           +M     AA G+ +L    K  I+RD    N L+      K+SDFG++++  +G  +   
Sbjct: 217 QM--VGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                   + APE +  G  +  SDV+SFG++L E  +
Sbjct: 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  138 bits (350), Expect = 4e-38
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 23/214 (10%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           R LG G FG VY+G +++ + +      VA+K  +   S +   E+L E   +   +  +
Sbjct: 31  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNL--------FSKVLLPLPWSIRMKIAFGAAK 189
           +V+L+G   + +  ++I E M RG +++ L         + VL P   S  +++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRI----M 243
           G+A+L       ++RD    N ++  D+  K+ DFG+ +D  E D  +      +    M
Sbjct: 150 GMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                 +PE +  G  T  SDV+SFGVVL EI T
Sbjct: 208 ------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  135 bits (343), Expect = 5e-37
 Identities = 78/348 (22%), Positives = 134/348 (38%), Gaps = 55/348 (15%)

Query: 38  SKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDL 97
           S L     +   L+     NP          I   +      LG G FG V+      +L
Sbjct: 7   SSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLA-ECHNL 65

Query: 98  REGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 156
                 + VAVK + +   S    +++  E   L  L H ++V+  G C E    ++++E
Sbjct: 66  LPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123

Query: 157 FMARGS-----------VENNLFSKVLLPLPWSIR--MKIAFGAAKGLAFLHEAEKPVIY 203
           +M  G             +     + + P P  +   + +A   A G+ +L  A    ++
Sbjct: 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVH 181

Query: 204 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRI----MGTYGYAAPEYIMTG 257
           RD  T N L+      K+ DFG+++D    D  +    T +    M       PE I+  
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM------PPESILYR 235

Query: 258 HLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE 316
             T  SDV+SFGVVL EI T G+      +P  + +  + A+  + + ++L         
Sbjct: 236 KFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTE-AIDCITQGREL--------- 279

Query: 317 GDYPV---KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDE 361
            + P      V+    +   C    P+ R  ++D+   L+ L   P  
Sbjct: 280 -ERPRACPPEVYA---IMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  135 bits (342), Expect = 7e-37
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 10/217 (4%)

Query: 67  LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           LRI+    F++ +VLG G FG VYKG    +  +    +PVA+K      S + ++E L 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILD 66

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIA 184
           E   +  + +P++ +L+G  C      LI + M  G + + +   K  +   + +     
Sbjct: 67  EAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--C 123

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
              AKG+ +L   ++ +++RD    N+L+ T  + K++DFGLAK     +K + +     
Sbjct: 124 VQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
              + A E I+    T +SDV+S+GV + E++T G K
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  135 bits (341), Expect = 7e-37
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 27/216 (12%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 136
           ++LG G FG V +G + +   E    + VAVK +   ++S +   E+L+E   +   SHP
Sbjct: 40  KILGEGEFGSVMEGNLKQ---EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 137 NLVKLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLLPLPWSIRMK----IAFGA 187
           N+++L+G C E   +      +I  FM  G +   L    L   P  I ++         
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRI--- 242
           A G+ +L  + +  ++RD    N +L  D    ++DFGL+K    GD  +     ++   
Sbjct: 157 ALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 243 -MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +      A E +     T +SDV++FGV + EI T
Sbjct: 215 WI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  134 bits (339), Expect = 8e-37
 Identities = 67/290 (23%), Positives = 108/290 (37%), Gaps = 62/290 (21%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGH 132
            + D  +G G F  VYKG    D       V VA   + D   +    + +  E   L  
Sbjct: 28  LKFDIEIGRGSFKTVYKGL---DTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKG 81

Query: 133 LSHPNLVKLIGYC---CEDEHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
           L HPN+V+         + +  +++  E M  G+++   + K    +   +         
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT--YLKRFKVMKIKVLRSWCRQIL 139

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           KGL FLH    P+I+RD K  NI +     + K+ D GLA       ++  +  ++GT  
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPE 195

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTG--------------RKSLDKSRPAREQNL 293
           + APE     +     DVY+FG+ +LE+ T               R+     +PA    +
Sbjct: 196 FMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254

Query: 294 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
           A    P +KE      II+                     C+  N   R 
Sbjct: 255 AI---PEVKE------IIE--------------------GCIRQNKDERY 275

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  134 bits (340), Expect = 1e-36
 Identities = 82/327 (25%), Positives = 123/327 (37%), Gaps = 35/327 (10%)

Query: 53  DSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD 112
             A   L     D         ++ R LG G FG V       D         VAVK   
Sbjct: 12  HGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCY--DPTNDGTGEMVAVKALK 69

Query: 113 GDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV--LIYEFMARGSVENNLFSK 170
            D   Q    W  E+  L  L H +++K  G C +       L+ E++  GS+ + L  +
Sbjct: 70  ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PR 128

Query: 171 VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG 230
             + L   +    A    +G+A+LH   +  I+RD    N+LLD D   K+ DFGLAK  
Sbjct: 129 HSIGLAQLLLF--AQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184

Query: 231 PEGD---KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSL 282
           PEG    +                  APE +        SDV+SFGV L E+LT    S 
Sbjct: 185 PEGHEYYRVREDGDSPVFWY------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238

Query: 283 DKSRPAREQNLADWALPLLKEKKKLLNIIDP--RLE--GDYPVKGVHKAAMLAYHCLNHN 338
                  E          +     L  +++   RL      P + V+    L  +C    
Sbjct: 239 SPPTKFLELIGIAQGQMTVLR---LTELLERGERLPRPDKCPAE-VY---HLMKNCWETE 291

Query: 339 PKARPLMRDIVDSLEPL-QVLPDEAPT 364
              RP   +++  L+ + +    +AP+
Sbjct: 292 ASFRPTFENLIPILKTVHEKYQGQAPS 318

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  133 bits (338), Expect = 2e-36
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 28/217 (12%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 136
           R+LG G FG V +  + +   E    V VAVK +     +     E+L E   +    HP
Sbjct: 29  RMLGKGEFGSVREAQLKQ---EDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 137 NLVKLIGYCCEDEHRV------LIYEFMARGSVENNLFSKVLLPLPWSIRMK----IAFG 186
           ++ KL+G       +       +I  FM  G +   L +  +   P+++ ++        
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRI-- 242
            A G+ +L  + +  I+RD    N +L  D    ++DFGL++    GD  +   ++++  
Sbjct: 146 IACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 243 --MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             +      A E +     T  SDV++FGV + EI+T
Sbjct: 204 KWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  132 bits (335), Expect = 4e-36
 Identities = 73/294 (24%), Positives = 110/294 (37%), Gaps = 36/294 (12%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           R LG G FG V       D         VAVK    ++      +   E+  L +L H N
Sbjct: 27  RDLGEGHFGKVELCRY--DPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 138 LVKLIGYCCEDEHRV--LIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFL 194
           +VK  G C ED      LI EF+  GS++  L   K  + L   ++   A    KG+ +L
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY--AVQICKGMDYL 142

Query: 195 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI----MGTYG 247
               +  ++RD    N+L+++++  K+ DFGL K                          
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY---- 196

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK 306
             APE +M       SDV+SFGV L E+LT             +          +     
Sbjct: 197 --APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR--- 251

Query: 307 LLNIIDP--RLEGDYPV---KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
           L+N +    RL    P      V+    L   C    P  R   +++++  E L
Sbjct: 252 LVNTLKEGKRLPC--PPNCPDEVY---QLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  132 bits (334), Expect = 5e-36
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 24/214 (11%)

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLS 134
           +D+ LG G FG V KG+     +       VAVK+  +  N      E LAE   +  L 
Sbjct: 21  EDKELGSGNFGTVKKGY----YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 76

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL 194
           +P +V++IG  CE E  +L+ E    G +   L     +     I +      + G+ +L
Sbjct: 77  NPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL--VHQVSMGMKYL 133

Query: 195 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI----MGTYG 247
              E   ++RD    N+LL T + AK+SDFGL+K     +   K+    +          
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---- 187

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
             APE I     + +SDV+SFGV++ E  + G+K
Sbjct: 188 --APECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (340), Expect = 1e-35
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 19/227 (8%)

Query: 52  RDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVH 111
            +        F      +     +  + +G G FG V  G          +   VAVK  
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD--------YRGNKVAVKCI 224

Query: 112 DGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSK 170
             D +    + +LAE   +  L H NLV+L+G   E++  + ++ E+MA+GS+ + L S+
Sbjct: 225 KNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 281

Query: 171 VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG 230
               L     +K +    + + +L       ++RD    N+L+  D  AK+SDFGL K+ 
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339

Query: 231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                +  + ++     + APE +     + +SDV+SFG++L EI +
Sbjct: 340 ---SSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  131 bits (332), Expect = 2e-35
 Identities = 80/316 (25%), Positives = 123/316 (38%), Gaps = 41/316 (12%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           R LG G FG VY+G +S  +     P+ VAVK      S Q   ++L E + +   +H N
Sbjct: 36  RGLGHGAFGEVYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNL-----FSKVLLPLPWSIRMKIAFGAAKGLA 192
           +V+ IG   +   R ++ E MA G +++ L            L     + +A   A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 193 FLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGD--KSHVSTRI----M 243
           +L   E   I+RD    N LL        AK+ DFG+A+D       +      +    M
Sbjct: 155 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLK 302
                  PE  M G  T ++D +SFGV+L EI + G        P   ++  +  L  + 
Sbjct: 213 ------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQE-VLEFVT 259

Query: 303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA 362
              ++          D P         +   C  H P+ RP    I++ +E     PD  
Sbjct: 260 SGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309

Query: 363 PTPKNFVTVVTPEEPK 378
            T          EE +
Sbjct: 310 NTALPIEYGPLVEEEE 325

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  131 bits (332), Expect = 3e-35
 Identities = 79/314 (25%), Positives = 123/314 (39%), Gaps = 41/314 (13%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
           R LG G FG VY+G     +     P+ VAVK      S Q   ++L E + +   +H N
Sbjct: 77  RGLGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFS---KVLLPLPWSIR--MKIAFGAAKGLA 192
           +V+ IG   +   R ++ E MA G +++ L     +   P   ++   + +A   A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 193 FLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGD--KSHVSTRI----M 243
           +L   E   I+RD    N LL        AK+ DFG+A+D       +      +    M
Sbjct: 196 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLK 302
                  PE  M G  T ++D +SFGV+L EI + G        P   ++  +  L  + 
Sbjct: 254 ------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQE-VLEFVT 300

Query: 303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA 362
              ++          D P         +   C  H P+ RP    I++ +E     PD  
Sbjct: 301 SGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350

Query: 363 PTPKNFVTVVTPEE 376
            T          EE
Sbjct: 351 NTALPIEYGPLVEE 364

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (328), Expect = 3e-35
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 35/217 (16%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
           + V+G G FGCVY G +   L    + +  AVK  +         ++L E I +   SHP
Sbjct: 30  NEVIGRGHFGCVYHGTL---LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86

Query: 137 NLVKLIGYCCEDEHRVL-IYEFMARGSV-------ENNLFSKVLLPLPWSIRMKIAFGAA 188
           N++ L+G C   E   L +  +M  G +        +N   K L+              A
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--------GFGLQVA 138

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD----KSHVSTRI-- 242
           KG+ +L  A K  ++RD    N +LD  +  K++DFGLA+D  + +     +    ++  
Sbjct: 139 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196

Query: 243 --MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             M      A E + T   T +SDV+SFGV+L E++T
Sbjct: 197 KWM------ALESLQTQKFTTKSDVWSFGVLLWELMT 227

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  129 bits (327), Expect = 4e-35
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 28/225 (12%)

Query: 62  FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR 121
           F      +     +  + +G G FG V  G          +   VAVK    D +    +
Sbjct: 11  FYRSGWALNMKELKLLQTIGKGEFGDVMLGD--------YRGNKVAVKCIKNDAT---AQ 59

Query: 122 EWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI-YEFMARGSVENNLFSKVLLPLPWSIR 180
            +LAE   +  L H NLV+L+G   E++  + I  E+MA+GS+ + L S+    L     
Sbjct: 60  AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 119

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           +K +    + + +L       ++RD    N+L+  D  AK+SDFGL K+      +  + 
Sbjct: 120 LKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTG 174

Query: 241 RI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
           ++           APE +     + +SDV+SFG++L EI + GR 
Sbjct: 175 KLPVKWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  130 bits (329), Expect = 5e-35
 Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 21/233 (9%)

Query: 57  NPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS 116
           +P  A       I  +   + +V+G G FG VYKG +      G + VPVA+K      +
Sbjct: 29  DPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYT 86

Query: 117 YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPL 175
            +   ++L E   +G  SH N+++L G   + +  ++I E+M  G+++  L        +
Sbjct: 87  EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV 146

Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA---KDGPE 232
              + M    G A G+ +L  A    ++RD    NIL++++   K+SDFGL+   +D PE
Sbjct: 147 LQLVGM--LRGIAAGMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202

Query: 233 GDKSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
              +    +I           APE I     T  SDV+SFG+V+ E++T G +
Sbjct: 203 ATYTTSGGKIPIRWT------APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (328), Expect = 7e-35
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 10/217 (4%)

Query: 67  LRIIT-ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           LRI+    F++ +VLG G FG VYKG    +  +    +PVA+K      S + ++E L 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILD 66

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIA 184
           E   +  + +P++ +L+G  C      LI + M  G + + +   K  +   + +     
Sbjct: 67  EAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--C 123

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
              AKG+ +L   ++ +++RD    N+L+ T  + K++DFGLAK     +K + +     
Sbjct: 124 VQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
              + A E I+    T +SDV+S+GV + E++T G K
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  133 bits (336), Expect = 7e-35
 Identities = 75/305 (24%), Positives = 129/305 (42%), Gaps = 27/305 (8%)

Query: 51  RRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV 110
           +R+      ++  YD+  +   +      LGGG +G VY+G   +        + VAVK 
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKT 252

Query: 111 HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK 170
              D       E+L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L   
Sbjct: 253 LKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310

Query: 171 VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG 230
               +   + + +A   +  + +L   +K  I+R+    N L+  ++  K++DFGL++  
Sbjct: 311 NRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL- 367

Query: 231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE 290
             GD             + APE +     + +SDV++FGV+L EI T         P   
Sbjct: 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM-----SPYPG 422

Query: 291 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
            +L+     LL++  ++      R     P     K   L   C   NP  RP   +I  
Sbjct: 423 IDLSQ-VYELLEKDYRM-----ER-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471

Query: 351 SLEPL 355
           + E +
Sbjct: 472 AFETM 476

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  129 bits (327), Expect = 8e-35
 Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 9/206 (4%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
            +VLG G FG V+KG    +       +PV +KV +  +  Q  +     ++ +G L H 
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESI--KIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAAKGLAFLH 195
           ++V+L+G  C      L+ +++  GS+ +++   +  L     +        AKG+ +L 
Sbjct: 76  HIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW--GVQIAKGMYYL- 131

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM 255
             E  +++R+    N+LL +    +++DFG+A   P  DK  + +       + A E I 
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 256 TGHLTPRSDVYSFGVVLLEILT-GRK 280
            G  T +SDV+S+GV + E++T G +
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAE 216

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (325), Expect = 8e-35
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 29/220 (13%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
             LG   FG VYKG        G Q   VA+K            E+  E +    L HPN
Sbjct: 15  EELGEDRFGKVYKG-HLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGS----------VENNLFSKVLLPLPWSIRMK----I 183
           +V L+G   +D+   +I+ + + G             +   +     +  ++       +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTR 241
               A G+ +L  +   V+++D  T N+L+    N K+SD GL ++    D  K   ++ 
Sbjct: 134 VAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 242 I----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           +    M      APE IM G  +  SD++S+GVVL E+ +
Sbjct: 192 LPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (325), Expect = 1e-34
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)

Query: 75  RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS 134
             DRV+G G FG VY G   +   +    +  A+K        Q    +L E + +  L+
Sbjct: 24  HSDRVIGKGHFGVVYHGEYID---QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 135 HPNLVKLIGYCCEDEHRVL-IYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLA 192
           HPN++ LIG     E     +  +M  G +   + S +    +   I        A+G+ 
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGME 138

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD----KSHVSTRI----MG 244
           +L  AE+  ++RD    N +LD  +  K++DFGLA+D  + +    + H   R+      
Sbjct: 139 YL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT- 195

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                A E + T   T +SDV+SFGV+L E+LT
Sbjct: 196 -----ALESLQTYRFTTKSDVWSFGVLLWELLT 223

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  131 bits (331), Expect = 2e-34
 Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 29/305 (9%)

Query: 56  ANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN 115
                    D   I   + R +  LG G FG V+ G  +           VA+K      
Sbjct: 168 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGT 220

Query: 116 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 175
                  +L E   +  L H  LV+L      +E   ++ E+M++GS+ + L  +    L
Sbjct: 221 M--SPEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYL 277

Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
                + +A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   E ++
Sbjct: 278 RLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNE 334

Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 295
                       + APE  + G  T +SDV+SFG++L E+ T  +      P       +
Sbjct: 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-----VPYPGMVNRE 389

Query: 296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
             L  ++   ++     P      P + +H    L   C    P+ RP    +   LE  
Sbjct: 390 -VLDQVERGYRM-----PCPPE-CP-ESLHD---LMCQCWRKEPEERPTFEYLQAFLEDY 438

Query: 356 QVLPD 360
               +
Sbjct: 439 FTSTE 443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  128 bits (325), Expect = 2e-34
 Identities = 60/227 (26%), Positives = 109/227 (48%), Gaps = 10/227 (4%)

Query: 57  NPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS 116
            P  A       I  +    ++++G G  G V  G +      G + VPVA+K      +
Sbjct: 34  EPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRL---RVPGQRDVPVAIKALKAGYT 90

Query: 117 YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPL 175
            +  R++L+E   +G   HPN+++L G        +++ E+M  GS++  L +      +
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150

Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGD 234
              + M    G   G+ +L  ++   ++RD    N+L+D++   K+SDFGL++    + D
Sbjct: 151 MQLVGM--LRGVGAGMRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206

Query: 235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
            ++ +T       + APE I     +  SDV+SFGVV+ E+L  G +
Sbjct: 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  128 bits (324), Expect = 2e-34
 Identities = 76/311 (24%), Positives = 116/311 (37%), Gaps = 51/311 (16%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLGHLSH 135
             LG G FG V       D         VAVK   H G +     R++  E+  L  L  
Sbjct: 29  SQLGKGNFGSVELCRY--DPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQILKALHS 83

Query: 136 PNLVKLIGYCCEDEHRV--LIYEFMARGSV-------ENNLFSKVLLPLPWSIRMKIAFG 186
             +VK  G       +   L+ E++  G +          L +  LL          +  
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL--------LYSSQ 135

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI- 242
             KG+ +L    +  ++RD    NIL++++ + K++DFGLAK  P            +  
Sbjct: 136 ICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 243 ---MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAL 298
                     APE +     + +SDV+SFGVVL E+ T   KS   S         +  +
Sbjct: 194 IFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247

Query: 299 PLLKEKKKLLNIIDP--RLE--GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 354
           P L     LL +++   RL      P + VH    L   C   +P+ RP    +   L+ 
Sbjct: 248 PALSR---LLELLEEGQRLPAPPACPAE-VH---ELMKLCWAPSPQDRPSFSALGPQLDM 300

Query: 355 LQVLPDEAPTP 365
           L        T 
Sbjct: 301 LWSGSRGCETH 311

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  128 bits (325), Expect = 2e-34
 Identities = 65/269 (24%), Positives = 112/269 (41%), Gaps = 44/269 (16%)

Query: 37  YSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISED 96
             +L  NP         +     + +  + +  +       R +G G FG V++   +  
Sbjct: 19  LDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYV-------RDIGEGAFGRVFQA-RAPG 70

Query: 97  LREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE 156
           L        VAVK+   + S     ++  E   +    +PN+VKL+G C   +   L++E
Sbjct: 71  LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130

Query: 157 FMARGS------------------VENNLFSKVLLPLPWSIRMK----IAFGAAKGLAFL 194
           +MA G                    + +  ++V  P P  +       IA   A G+A+L
Sbjct: 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190

Query: 195 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVSTRI----MGTYGY 248
             +E+  ++RD  T N L+  +   K++DFGL+++    D  K+  +  I    M     
Sbjct: 191 --SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM----- 243

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
             PE I     T  SDV+++GVVL EI +
Sbjct: 244 -PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  130 bits (330), Expect = 3e-34
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 15/221 (6%)

Query: 58  PLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 117
           P   +  D   I   + + ++ LG G FG V+            +   VAVK     +  
Sbjct: 174 PQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMA-------TYNKHTKVAVKTMKPGSMS 226

Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW 177
                +LAE   +  L H  LVKL       E   +I EFMA+GS+ + L S      P 
Sbjct: 227 V--EAFLAEANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 283

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KS 236
              +  +   A+G+AF+   ++  I+RD + +NIL+      K++DFGLA+   + +  +
Sbjct: 284 PKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
               +      + APE I  G  T +SDV+SFG++L+EI+T
Sbjct: 342 REGAKFP--IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  129 bits (326), Expect = 3e-34
 Identities = 74/282 (26%), Positives = 116/282 (41%), Gaps = 33/282 (11%)

Query: 12  VYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRII- 70
           V   S         +E  +   KK  S+              SA NP +      + I  
Sbjct: 27  VPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGP 86

Query: 71  -TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
            +     + V+G G FGCVY G + ++  +    +  AVK  +         ++L E I 
Sbjct: 87  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGK---KIHCAVKSLNRITDIGEVSQFLTEGII 143

Query: 130 LGHLSHPNLVKLIGYCCEDEHRVL-IYEFMARGSV-------ENNLFSKVLLPLPWSIRM 181
           +   SHPN++ L+G C   E   L +  +M  G +        +N   K L+        
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-------- 195

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
                 AKG+ FL  A K  ++RD    N +LD  +  K++DFGLA+D  + +   V  +
Sbjct: 196 GFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253

Query: 242 IMG------TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                         A E + T   T +SDV+SFGV+L E++T
Sbjct: 254 TGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  127 bits (321), Expect = 3e-34
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 25/223 (11%)

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
              Y    I   +    + LG G FG V  G              VA+K+    +  +  
Sbjct: 13  GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGSMSE-- 63

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSI 179
            E++ E   + +LSH  LV+L G C +     +I E+MA G + N L   +        +
Sbjct: 64  DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 123

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHV 238
            M       + + +L    K  ++RD    N L++     K+SDFGL++   + +  S V
Sbjct: 124 EM--CKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179

Query: 239 STRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            ++             PE +M    + +SD+++FGV++ EI +
Sbjct: 180 GSKFPVRWS------PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  126 bits (319), Expect = 4e-34
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLSHP 136
           + +G G FG V+ G+        L    VA+K   +G  S +   +++ E   +  LSHP
Sbjct: 14  QEIGSGQFGLVHLGYW-------LNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHP 63

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLH 195
            LV+L G C E     L+ EFM  G + + L + + L      + M       +G+A+L 
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYL- 120

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRI----MGTYGYAA 250
             E  VI+RD    N L+  +   K+SDFG+ +   +    S   T+            +
Sbjct: 121 -EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------S 173

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
           PE       + +SDV+SFGV++ E+ + G+ 
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (320), Expect = 4e-34
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 24/213 (11%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
           D  LG G FG V +G      R   + + VA+KV           E + E   +  L +P
Sbjct: 15  DIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIRMKIAFGAAKGLAFLH 195
            +V+LIG  C+ E  +L+ E    G +   L   +  +P+     +      + G+ +L 
Sbjct: 71  YIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL--LHQVSMGMKYL- 126

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI----MGTYGY 248
             EK  ++RD    N+LL   + AK+SDFGL+K     D    +  + +           
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----- 180

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
            APE I     + RSDV+S+GV + E L+ G+K
Sbjct: 181 -APECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  126 bits (320), Expect = 9e-34
 Identities = 69/233 (29%), Positives = 104/233 (44%), Gaps = 37/233 (15%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           N    + LG G FG V K      L+       VAVK+   + S    R+ L+E   L  
Sbjct: 24  NLVLGKTLGEGEFGKVVKATA-FHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGS------------------VENNLFSKVLLP 174
           ++HP+++KL G C +D   +LI E+   GS                    +   S +  P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 175 LPWSIRMK----IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG 230
              ++ M      A+  ++G+ +L  AE  +++RD    NIL+      K+SDFGL++D 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200

Query: 231 PEGD--KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            E D        RI    M      A E +     T +SDV+SFGV+L EI+T
Sbjct: 201 YEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  131 bits (331), Expect = 9e-34
 Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 32/287 (11%)

Query: 3   NCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAF 62
           +     +  +  ++S+  +  P   +  +K       +P +    E    D         
Sbjct: 275 STLTHPQRRIDTLNSDGYTPEPARITSPDK----PRPMPMDTSVFESPFSDPEELKDKKL 330

Query: 63  TYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE 122
                 ++ A    D  LG G FG V +G      R   + + VA+KV           E
Sbjct: 331 FLKRDNLLIA----DIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEE 382

Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRM 181
            + E   +  L +P +V+LIG  C+ E  +L+ E    G +   L   +  +P+     +
Sbjct: 383 MMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 441

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHV 238
                 + G+ +L   EK  ++R+    N+LL   + AK+SDFGL+K     D    +  
Sbjct: 442 --LHQVSMGMKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497

Query: 239 STRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
           + +            APE I     + RSDV+S+GV + E L+ G+K
Sbjct: 498 AGKWPLKWY------APECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  125 bits (317), Expect = 1e-33
 Identities = 75/308 (24%), Positives = 116/308 (37%), Gaps = 53/308 (17%)

Query: 73  NFRQDRVLGGGGFGCVYKG-FISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFL 130
           +   +  LG G F  ++KG          L    V +KV      +Y     +      +
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMM 66

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAK 189
             LSH +LV   G C   +  +L+ EF+  GS++  L   K  + + W + +  A   A 
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAA 124

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYN--------AKLSDFGLAKDGPEGDKSHVSTR 241
            + FL   E  +I+ +    NILL  + +         KLSD G++      D       
Sbjct: 125 AMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182

Query: 242 IMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALP 299
            +       PE I    +L   +D +SFG  L EI + G K      P          L 
Sbjct: 183 WV------PPECIENPKNLNLATDKWSFGTTLWEICSGGDK------P----------LS 220

Query: 300 LLKEKKKLLNIID----PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
            L  ++KL    D    P  +    +      A L  +C+++ P  RP  R I+  L  L
Sbjct: 221 ALDSQRKLQFYEDRHQLPAPKAA-EL------ANLINNCMDYEPDHRPSFRAIIRDLNSL 273

Query: 356 QVLPDEAP 363
              PD  P
Sbjct: 274 FT-PDLVP 280

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  127 bits (322), Expect = 1e-33
 Identities = 83/361 (22%), Positives = 145/361 (40%), Gaps = 53/361 (14%)

Query: 17  SNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQ 76
           S   S S    +P  +     S     P        +   +P   F  D+L +       
Sbjct: 33  SAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLG------ 86

Query: 77  DRVLGGGGFGCVYKGFISE-DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-S 134
            + LG G FG V        D  +  + V VAVK+   D + +   + ++E+  +  +  
Sbjct: 87  -KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGS--------------VENNLFSKVLLPLPWSIR 180
           H N++ L+G C +D    +I E+ ++G+                 ++       + +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHV 238
           +   +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D  K   
Sbjct: 206 VSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263

Query: 239 STRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA 294
           + R+    M      APE +     T +SDV+SFGV++ EI T   S     P  E    
Sbjct: 264 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 313

Query: 295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 354
                LLKE  ++          D P    ++  M+   C +  P  RP  + +V+ L+ 
Sbjct: 314 --LFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361

Query: 355 L 355
           +
Sbjct: 362 I 362

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  125 bits (317), Expect = 1e-33
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 32/221 (14%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 136
           R LG G FG V+      +L      + VAVK + D   +    +++  E   L +L H 
Sbjct: 21  RELGEGAFGKVFLA-ECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHE 77

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGS----------VENNLFSKVLLPLPWSIRMK---- 182
           ++VK  G C + +  ++++E+M  G               L           + +     
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHVST 240
           IA   A G+ +L  A +  ++RD  T N L+  +   K+ DFG+++D    D  +    T
Sbjct: 138 IASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 241 RI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +    M       PE IM    T  SDV+SFGV+L EI T
Sbjct: 196 MLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  127 bits (320), Expect = 2e-33
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 22/213 (10%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
           D+V+G G FG V  G +        + + VA+K      + +  R++L E   +G   HP
Sbjct: 50  DKVVGAGEFGEVCSGRLKLP---SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLH 195
           N+++L G   + +  +++ E+M  GS+++ L        +   + M    G A G+ +L 
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--LRGIASGMKYL- 163

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA---KDGPEGDKSHVSTRI----MGTYGY 248
            ++   ++RD    NIL++++   K+SDFGL    +D PE   +    +I          
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----- 217

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
            +PE I     T  SDV+S+G+VL E+++ G +
Sbjct: 218 -SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  125 bits (315), Expect = 2e-33
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 21/227 (9%)

Query: 61  AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
           +    +  I   +   +R+LG G FG VY+G          + + VAVK    D +    
Sbjct: 1   SMGGPQYGIAREDVVLNRILGEGFFGEVYEGVY---TNHKGEKINVAVKTCKKDCTLDNK 57

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSI 179
            ++++E + + +L HP++VKLIG   E+E   +I E    G + + L   K  L +   +
Sbjct: 58  EKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLV 116

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHV 238
               +    K +A+L       ++RD    NIL+ +    KL DFGL++   + D     
Sbjct: 117 LY--SLQICKAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 172

Query: 239 STRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
            TR+    M      +PE I     T  SDV+ F V + EIL+ G++
Sbjct: 173 VTRLPIKWM------SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  125 bits (317), Expect = 2e-33
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISE-DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 131
                + LG G FG V        D  +  + V VAVK+   D + +   + ++E+  + 
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95

Query: 132 HL-SHPNLVKLIGYCCEDEHRVLIYEFMARGS--------------VENNLFSKVLLPLP 176
            +  H N++ L+G C +D    +I E+ ++G+                 ++       + 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-- 234
           +   +   +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+D    D  
Sbjct: 156 FKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213

Query: 235 KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           K   + R+    M      APE +     T +SDV+SFGV++ EI T
Sbjct: 214 KKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  125 bits (315), Expect = 3e-33
 Identities = 75/296 (25%), Positives = 118/296 (39%), Gaps = 38/296 (12%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLGHLSH 135
           + LG G FG V       D  +      VAVK   H  +      R++  E+  L  L H
Sbjct: 16  QQLGKGNFGSVEMCRY--DPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQH 70

Query: 136 PNLVKLIGYCCEDEHRV--LIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLA 192
            N+VK  G C     R   LI E++  GS+ + L   K  +     ++        KG+ 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY--TSQICKGME 128

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI----MGT 245
           +L    K  I+RD  T NIL++ +   K+ DFGL K  P+     K              
Sbjct: 129 YLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-- 184

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 305
               APE +     +  SDV+SFGVVL E+ T  +          + + +     +    
Sbjct: 185 ----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-VF 239

Query: 306 KLLNIIDP--RLEGDYPV---KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
            L+ ++    RL    P      ++   M+   C N+N   RP  RD+   ++ ++
Sbjct: 240 HLIELLKNNGRLPR--PDGCPDEIY---MIMTECWNNNVNQRPSFRDLALRVDQIR 290

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  124 bits (314), Expect = 3e-33
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 21/229 (9%)

Query: 59  LIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ 118
            +  +  +  I        R +G G FG V++G     +      + VA+K      S  
Sbjct: 2   AMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDS 58

Query: 119 GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPW 177
              ++L E + +    HP++VKLIG    +    +I E    G + + L   K  L L  
Sbjct: 59  VREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLAS 117

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KS 236
            I    A+  +  LA+L    K  ++RD    N+L+ ++   KL DFGL++   +     
Sbjct: 118 LILY--AYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173

Query: 237 HVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
               ++    M      APE I     T  SDV+ FGV + EIL  G K
Sbjct: 174 ASKGKLPIKWM------APESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  125 bits (316), Expect = 3e-33
 Identities = 82/361 (22%), Positives = 135/361 (37%), Gaps = 58/361 (16%)

Query: 11  SVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRII 70
           S Y    +   + P  E+   +     +    +P + E+                 L+ +
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEE---------------RHLKFL 46

Query: 71  TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVI 128
                  + LG G FG V       D  +      VAVK   H  +      R++  E+ 
Sbjct: 47  -------QQLGKGNFGSVEMCRY--DPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIE 94

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRV--LIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAF 185
            L  L H N+VK  G C     R   LI E++  GS+ + L   K  +     ++     
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY--TS 152

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD---KSHVSTRI 242
              KG+ +L    K  I+RD  T NIL++ +   K+ DFGL K  P+     K       
Sbjct: 153 QICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210

Query: 243 ----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 298
                      APE +     +  SDV+SFGVVL E+ T  +          + + +   
Sbjct: 211 PIFWY------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264

Query: 299 PLLKEKKKLLNIIDP--RLE--GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 354
             +     L+ ++    RL      P + ++   M+   C N+N   RP  RD+   ++ 
Sbjct: 265 GQMI-VFHLIELLKNNGRLPRPDGCPDE-IY---MIMTECWNNNVNQRPSFRDLALRVDQ 319

Query: 355 L 355
           +
Sbjct: 320 I 320

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  129 bits (327), Expect = 3e-33
 Identities = 67/281 (23%), Positives = 107/281 (38%), Gaps = 29/281 (10%)

Query: 4   CWCKWEPSVYIVSSNPKS-ESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAF 62
                +     + S PK   + K    S       +   +   + ED     +       
Sbjct: 329 IIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPST------ 382

Query: 63  TYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE 122
              +  I        R +G G FG V++G     +      + VA+K      S     +
Sbjct: 383 --RDYEIQRERIELGRCIGEGQFGDVHQG---IYMSPENPAMAVAIKTCKNCTSDSVREK 437

Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRM 181
           +L E + +    HP++VKLIG    +    +I E    G + + L   K  L L   I  
Sbjct: 438 FLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILY 496

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-----KS 236
             A+  +  LA+L    K  ++RD    N+L+ ++   KL DFGL++   +       K 
Sbjct: 497 --AYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            +  + M      APE I     T  SDV+ FGV + EIL 
Sbjct: 553 KLPIKWM------APESINFRRFTSASDVWMFGVCMWEILM 587

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  124 bits (313), Expect = 3e-33
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 17/202 (8%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 136
             LG G FG V+ G+ +           VAVK +  G  S      +LAE   +  L H 
Sbjct: 19  ERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQ 68

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE 196
            LV+L       E   +I E+M  GS+ + L +   + L  +  + +A   A+G+AF+  
Sbjct: 69  RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125

Query: 197 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIM 255
            E+  I+RD + +NIL+    + K++DFGLA+   + +  +    +      + APE I 
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAIN 183

Query: 256 TGHLTPRSDVYSFGVVLLEILT 277
            G  T +SDV+SFG++L EI+T
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  124 bits (314), Expect = 3e-33
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 23/220 (10%)

Query: 64  YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHRE 122
           YD+  +   +      LGGG +G VY+G   +        + VAVK + +     +   E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE---E 55

Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
           +L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L       +   + + 
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTR 241
           +A   +  + +L   +K  I+RD    N L+  ++  K++DFGL++        +H   +
Sbjct: 116 MATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173

Query: 242 I----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                       APE +     + +SDV++FGV+L EI T
Sbjct: 174 FPIKWT------APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  125 bits (316), Expect = 4e-33
 Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 28/224 (12%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           N +  + LG G FG V +   +  L +    + VAVK+             ++E+  + H
Sbjct: 47  NLQFGKTLGAGAFGKVVEA-TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 133 L-SHPNLVKLIGYCCEDEHRVLIYEFMARGS------------VENNLFSKVLLPLPWSI 179
           L  H N+V L+G C      ++I E+   G               +  F+          
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSH 237
            +  +   A+G+AFL  A K  I+RD    N+LL   + AK+ DFGLA+D          
Sbjct: 166 LLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223

Query: 238 VSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
            + R+    M      APE I     T +SDV+S+G++L EI +
Sbjct: 224 GNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  124 bits (313), Expect = 5e-33
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 17/215 (7%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 130
           + R    LG G FG V +G          + V VAVK    D  +  +   +++ EV  +
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAK 189
             L H NL++L G         ++ E    GS+ + L   +    L    R   A   A+
Sbjct: 76  HSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAE 132

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT---Y 246
           G+ +L    K  I+RD    N+LL T    K+ DFGL +  P+ D  +V          +
Sbjct: 133 GMGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPF 188

Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
            + APE + T   +  SD + FGV L E+ T G++
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  124 bits (314), Expect = 6e-33
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 32/228 (14%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
                + LG G FG V +      L +    + VAVK+             ++E+  L +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATA-YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 133 L-SHPNLVKLIGYCCEDEHRVLIYEFMARGS------------VENNLFSKVLLPLPWSI 179
           L +H N+V L+G C      ++I E+   G             + +     ++     ++
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 180 RMK----IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD- 234
            ++     ++  AKG+AFL  A K  I+RD    NILL      K+ DFGLA+D      
Sbjct: 143 DLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 235 -KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                + R+    M      APE I     T  SDV+S+G+ L E+ +
Sbjct: 201 YVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  123 bits (311), Expect = 6e-33
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 28/211 (13%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHP 136
           + LG G FG V  G              VAVK + +G  S     E+  E   +  LSHP
Sbjct: 14  KELGSGQFGVVKLGKWKG-------QYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHP 63

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLH 195
            LVK  G C ++    ++ E+++ G + N L S    L     + M   +   +G+AFL 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFL- 120

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-KSHVSTRI----MGTYGYAA 250
                 I+RD    N L+D D   K+SDFG+ +   +    S V T+            A
Sbjct: 121 -ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS------A 173

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILT-GRK 280
           PE       + +SDV++FG+++ E+ + G+ 
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  128 bits (322), Expect = 9e-33
 Identities = 68/306 (22%), Positives = 121/306 (39%), Gaps = 31/306 (10%)

Query: 56  ANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN 115
                    D   I   + R +  LG G FG V+ G  +           VA+K      
Sbjct: 251 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-------GTTRVAIKTLKPGT 303

Query: 116 SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPL 175
                  +L E   +  L H  LV+L      +E   ++ E+M++GS+ + L  +    L
Sbjct: 304 MS--PEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYL 360

Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD- 234
                + +A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   + + 
Sbjct: 361 RLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418

Query: 235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA 294
            +    +      + APE  + G  T +SDV+SFG++L E+ T  +      P       
Sbjct: 419 TARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-----VPYPGMVNR 471

Query: 295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 354
           +  L  ++   ++     P      P + +H    L   C    P+ RP    +   LE 
Sbjct: 472 E-VLDQVERGYRM-----PCPPE-CP-ESLHD---LMCQCWRKEPEERPTFEYLQAFLED 520

Query: 355 LQVLPD 360
                +
Sbjct: 521 YFTSTE 526

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  124 bits (313), Expect = 1e-32
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 32/220 (14%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SH 135
             V+G G FG V K  I +D       +  A+K      S   HR++  E+  L  L  H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLR----MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGS----------VENNLFSKVLLPLPWSIRMK--- 182
           PN++ L+G C    +  L  E+   G+          +E +    +      ++  +   
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 183 -IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
             A   A+G+ +L  ++K  I+RD    NIL+  +Y AK++DFGL++      K     R
Sbjct: 146 HFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-MGR 202

Query: 242 I----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           +    M      A E +     T  SDV+S+GV+L EI++
Sbjct: 203 LPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  125 bits (315), Expect = 1e-32
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)

Query: 77  DRVLGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-S 134
            + LG G FG V     I  D  +  +   VAVK+   D + +   + ++E+  +  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGS----------VENNLFSKVLLPLPWSIRMK-- 182
           H N++ L+G C +D    +I E+ ++G+                          +  K  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 183 --IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD--KSHV 238
              A+  A+G+ +L  A K  I+RD    N+L+  D   K++DFGLA+D    D  K   
Sbjct: 194 VSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 239 STRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
           + R+    M      APE +     T +SDV+SFGV+L EI T
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  121 bits (306), Expect = 6e-32
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 31/227 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
             +  + LG G FG V +   +  + +      VAVK+     ++  HR  ++E+  L H
Sbjct: 28  RLKLGKPLGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 133 L-SHPNLVKLIGYCC-EDEHRVLIYEFMARGS------------VENNLFSKVLLPLPWS 178
           +  H N+V L+G C       ++I EF   G+            V   +  + L     +
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 179 IRMKIAFGA--AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD-- 234
           +   I +    AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  +    
Sbjct: 147 LEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204

Query: 235 KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                 R+    M      APE I     T +SDV+SFGV+L EI +
Sbjct: 205 VRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  119 bits (299), Expect = 9e-31
 Identities = 61/269 (22%), Positives = 98/269 (36%), Gaps = 22/269 (8%)

Query: 16  SSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFR 75
           S +  S      +   K     S          +          +     E R       
Sbjct: 2   SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH 135
               +G G FG V++     D + G Q    AVK    +           E++    LS 
Sbjct: 62  HQPRVGRGSFGEVHRMK---DKQTGFQ---CAVKKVRLEVFRV------EELVACAGLSS 109

Query: 136 PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH 195
           P +V L G   E     +  E +  GS+   +  K +  LP    +     A +GL +LH
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLH 167

Query: 196 EAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAK--DGPEGDKSHVSTRIM-GTYGYAAP 251
              + +++ D K  N+LL +D   A L DFG A         KS ++   + GT  + AP
Sbjct: 168 --TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

Query: 252 EYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           E +M       + D++S   ++L +L G 
Sbjct: 226 EVVMGKPC-DAKVDIWSSCCMMLHMLNGC 253

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  119 bits (300), Expect = 1e-30
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 39/230 (16%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHL-S 134
            +VLG G FG V        + +    + VAVK + +  +S +     ++E+  +  L S
Sbjct: 50  GKVLGSGAFGKVMNATA-YGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMTQLGS 107

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGS---------------------VENNLFSKVLL 173
           H N+V L+G C       LI+E+   G                       +     + L 
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
            L +   +  A+  AKG+ FL    K  ++RD    N+L+      K+ DFGLA+D    
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 234 D--KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                  + R+    M      APE +  G  T +SDV+S+G++L EI +
Sbjct: 226 SNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (297), Expect = 1e-30
 Identities = 59/217 (27%), Positives = 87/217 (40%), Gaps = 27/217 (12%)

Query: 72  ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV----HDGDNSYQG--HREWLA 125
             +R  R++G GG G VY+    ED     +   VA+K+       D  ++    RE  A
Sbjct: 34  GPYRLRRLVGRGGMGDVYEA---EDTV---RERIVALKLMSETLSSDPVFRTRMQRE--A 85

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL---PLPWSIRMK 182
                G L  P++V +  +   D    +         +     + +L    PL     + 
Sbjct: 86  RTA--GRLQEPHVVPIHDFGEIDGQLYVDMRL-----INGVDLAAMLRRQGPLAPPRAVA 138

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           I       L   H A     +RD K  NIL+  D  A L DFG+A    +   + +    
Sbjct: 139 IVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-T 195

Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           +GT  Y APE     H T R+D+Y+   VL E LTG 
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  117 bits (295), Expect = 2e-30
 Identities = 70/336 (20%), Positives = 108/336 (32%), Gaps = 40/336 (11%)

Query: 18  NPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITA---NF 74
           +             +     S     P  V    R  A+  L +  YD  R  +    +F
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMHQLQPRRVS--FRGEASETLQSPGYDPSRPESFFQQSF 59

Query: 75  RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHL 133
           ++   LG G +G V+K    ED R        AVK         +     LAEV     +
Sbjct: 60  QRLSRLGHGSYGEVFKVRSKEDGRL------YAVKRSMSPFRGPKDRARKLAEVGSHEKV 113

Query: 134 -SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
             HP  V+L     E     L  E     S++ +        LP +            LA
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC-EAWGASLPEAQVWGYLRDTLLALA 171

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
            LH   + +++ D K +NI L      KL DFGL  +        V     G   Y APE
Sbjct: 172 HLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPE 226

Query: 253 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID 312
            +   +    +DV+S G+ +LE+    +               W    L++       + 
Sbjct: 227 LLQGSY-GTAADVFSLGLTILEVACNMELPH--------GGEGW--QQLRQG-----YLP 270

Query: 313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
           P            +   +    L  +PK R     +
Sbjct: 271 PEFTAGLS----SELRSVLVMMLEPDPKLRATAEAL 302

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  117 bits (294), Expect = 2e-30
 Identities = 64/305 (20%), Positives = 115/305 (37%), Gaps = 56/305 (18%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           +F   + LG GGFG V++    ++  +       A+K     N      + + EV  L  
Sbjct: 6   DFEPIQCLGRGGFGVVFEA---KNKVDDCN---YAIKRIRLPNRELAREKVMREVKALAK 59

Query: 133 LSHPNLVKLIGYCCEDE---------HRVLIY---EFMARGSVENNLFS-KVLLPLPWSI 179
           L HP +V+      E            +V +Y   +   + ++++ +     +     S+
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----------D 229
            + I    A+ + FLH   K +++RD K SNI    D   K+ DFGL             
Sbjct: 120 CLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

Query: 230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
                     T  +GT  Y +PE I     + + D++S G++L E+L          P  
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------PFS 228

Query: 290 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHK---AAMLAYHCLNHNPKARPLMR 346
            Q           E+ + L  +       +P     K     ++    L+ +P  RP   
Sbjct: 229 TQM----------ERVRTLTDV---RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI 275

Query: 347 DIVDS 351
           +I+++
Sbjct: 276 NIIEN 280

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  115 bits (289), Expect = 1e-29
 Identities = 65/294 (22%), Positives = 112/294 (38%), Gaps = 58/294 (19%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 130
           +F++  ++G GGFG V+K    +   +G       +K   ++ + + +       EV  L
Sbjct: 12  DFKEIELIGSGGFGQVFKA---KHRIDGKT---YVIKRVKYNNEKAER-------EVKAL 58

Query: 131 GHLSHPNLVKLIGYCCEDEHRV----------------LIYEFMARGSVENNLFSKVLLP 174
             L H N+V   G     ++                  +  EF  +G++E  +  +    
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGD 234
           L   + +++     KG+ ++H   K +I RD K SNI L      K+ DFGL        
Sbjct: 119 LDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLK 173

Query: 235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA 294
                TR  GT  Y +PE I +       D+Y+ G++L E+L           A E +  
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD------TAFETS-- 225

Query: 295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
                     K   ++ D  +   +      K   L    L+  P+ RP   +I
Sbjct: 226 ----------KFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  115 bits (290), Expect = 1e-29
 Identities = 58/300 (19%), Positives = 112/300 (37%), Gaps = 50/300 (16%)

Query: 67  LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA- 125
           + +    +   + +G GG   V++   +E  +        A+K  + + +     +    
Sbjct: 23  MSVKGRIYSILKQIGSGGSSKVFQVL-NEKKQI------YAIKYVNLEEADNQTLDSYRN 75

Query: 126 EVIFLGHLSHPNL--VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           E+ +L  L   +   ++L  Y   D++  ++ E      + + L  K  +          
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWER--KSY 132

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
                + +  +H+    +++ D K +N L+      KL DFG+A        S V    +
Sbjct: 133 WKNMLEAVHTIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189

Query: 244 GTYGYAAPEYIM-----------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN 292
           GT  Y  PE I               ++P+SDV+S G +L  +  G+             
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------- 236

Query: 293 LADWALP---LLKEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMRDI 348
                 P   ++ +  KL  IIDP  E ++P     K    +   CL  +PK R  + ++
Sbjct: 237 -----TPFQQIINQISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  119 bits (300), Expect = 1e-29
 Identities = 49/216 (22%), Positives = 80/216 (37%), Gaps = 34/216 (15%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLG 131
           +     +  GG G +Y      D    +   PV +K   H GD   Q     +AE  FL 
Sbjct: 82  YEVKGCIAHGGLGWIYLA---LDRN--VNGRPVVLKGLVHSGDAEAQ--AMAMAERQFLA 134

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMA----RGSVENNLFSKVLLPLPWSIRMKIAFGA 187
            + HP++V++  +    +       ++      G    +L       LP +  +      
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ---SLKRSKGQKLPVAEAIAYLLEI 191

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----DGPEGDKSHVSTRIM 243
              L++LH     ++Y D K  NI+L  +   KL D G        G           + 
Sbjct: 192 LPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----------LY 238

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           GT G+ APE I+    T  +D+Y+ G  L  +    
Sbjct: 239 GTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDL 273

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  114 bits (288), Expect = 2e-29
 Identities = 65/306 (21%), Positives = 121/306 (39%), Gaps = 55/306 (17%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           +F +  VLG G FG V K     +  +       A+K              L+EV+ L  
Sbjct: 7   DFEEIAVLGQGAFGQVVKA---RNALDSRY---YAIKKIRHTEEKL--STILSEVMLLAS 58

Query: 133 LSHPNLVKLIGYCCEDEHRVL----------IY---EFMARGSVENNLFSKVLLPLPWSI 179
           L+H  +V+      E  + V           ++   E+   G++ + + S+ L       
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK----------- 228
             ++     + L+++H   + +I+RD K  NI +D   N K+ DFGLAK           
Sbjct: 119 W-RLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 229 --DGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKS 285
                 G   ++++ I GT  Y A E +  TGH   + D+YS G++  E++         
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------- 227

Query: 286 RPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM 345
             +      +    +LK+ + +     P  + +           +    ++H+P  RP  
Sbjct: 228 -FSTGMERVN----ILKKLRSVSIEFPPDFDDNKM----KVEKKIIRLLIDHDPNKRPGA 278

Query: 346 RDIVDS 351
           R +++S
Sbjct: 279 RTLLNS 284

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  114 bits (287), Expect = 2e-29
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 23/219 (10%)

Query: 68  RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-- 125
           +II   ++    LGGGG   VY     ED    +    VA+K        +   E L   
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLA---EDTILNI---KVAIKAIFIP--PREKEETLKRF 58

Query: 126 --EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL---PLPWSIR 180
             EV     LSH N+V +I    ED+   L+ E+     +E    S+ +    PL     
Sbjct: 59  EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY-----IEGPTLSEYIESHGPLSVDTA 113

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           +        G+   H+    +++RD K  NIL+D++   K+ DFG+AK   E   +  + 
Sbjct: 114 INFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH 171

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            ++GT  Y +PE          +D+YS G+VL E+L G 
Sbjct: 172 -VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  116 bits (292), Expect = 2e-29
 Identities = 68/351 (19%), Positives = 129/351 (36%), Gaps = 58/351 (16%)

Query: 16  SSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFR 75
           S      S   E+ + K ++++   P    + +D    SA   +         +    + 
Sbjct: 8   SGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECI--------SVKGRIYS 59

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD-GDNSYQGHREWLAEVIFLGHLS 134
             + +G GG   V++   +E  +        A+K  +  +   Q    +  E+ +L  L 
Sbjct: 60  ILKQIGSGGSSKVFQVL-NEKKQI------YAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112

Query: 135 HPNL--VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
             +   ++L  Y   D++  ++ E      + + L  K    +    R        + + 
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVH 169

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
            +H+    +++ D K +N L+  D   KL DFG+A        S V    +G   Y  PE
Sbjct: 170 TIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 253 YIM-----------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-- 299
            I               ++P+SDV+S G +L  +  G+                   P  
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------------TPFQ 268

Query: 300 -LLKEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMRDI 348
            ++ +  KL  IIDP  E ++P     K    +   CL  +PK R  + ++
Sbjct: 269 QIINQISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPEL 318

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  113 bits (286), Expect = 5e-29
 Identities = 66/310 (21%), Positives = 107/310 (34%), Gaps = 41/310 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           ++   + LG GGF  V      E L +G      A+K     +  Q   E   E      
Sbjct: 30  HYLFIQKLGEGGFSYVDLV---EGLHDGHF---YALKRILC-HEQQDREEAQREADMHRL 82

Query: 133 LSHPNLVKLIGYCCEDE---HRVLIY-EFMARGSVENNL--FSKVLLPLPWSIRMKIAFG 186
            +HPN+++L+ YC  +    H   +   F  RG++ N +         L     + +  G
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM--- 243
             +GL  +H   K   +RD K +NILL  +    L D G         +       +   
Sbjct: 143 ICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 244 ----GTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
                T  Y APE         +  R+DV+S G VL  ++ G        P         
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE------GPYDMVFQKGD 254

Query: 297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
           ++        + N +       +          L    +  +P  RP +  ++  LE LQ
Sbjct: 255 SV-----ALAVQNQLSIPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

Query: 357 -VLPDEAPTP 365
              P +  T 
Sbjct: 306 PPAPGQHTTQ 315

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  113 bits (285), Expect = 1e-28
 Identities = 68/308 (22%), Positives = 122/308 (39%), Gaps = 31/308 (10%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           F +   LG G  G V+K         G   + +A K+   +       + + E+  L   
Sbjct: 35  FEKISELGAGNGGVVFKVS---HKPSG---LVMARKLIHLEIKPAIRNQIIRELQVLHEC 88

Query: 134 SHPNLVKLIGYCCEDEHRVLIY-EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
           + P +V   G     +  + I  E M  GS++     K    +P  I  K++    KGL 
Sbjct: 89  NSPYIVGFYG-AFYSDGEISICMEHMDGGSLDQ--VLKKAGRIPEQILGKVSIAVIKGLT 145

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
           +L E  K +++RD K SNIL+++    KL DFG++    +   S  ++ + GT  Y +PE
Sbjct: 146 YLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPE 200

Query: 253 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID 312
            +   H + +SD++S G+ L+E+  GR  +        + +    +     +        
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260

Query: 313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTP--KNFVT 370
            R    + +      A+              L+  IV+   P   LP    +   ++FV 
Sbjct: 261 GRPLNKFGMDSRPPMAIF------------ELLDYIVNEPPPK--LPSGVFSLEFQDFVN 306

Query: 371 VVTPEEPK 378
               + P 
Sbjct: 307 KCLIKNPA 314

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  111 bits (281), Expect = 2e-28
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 31/220 (14%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV----HDGDNSYQG--HREWLAEV 127
           +    +LG GG   V+      DLR+      VAVKV       D S+     RE     
Sbjct: 14  YELGEILGFGGMSEVHLA---RDLRDHR---DVAVKVLRADLARDPSFYLRFRREAQN-- 65

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIY----EFMARGSVENNLFSKVLL---PLPWSIR 180
                L+HP +V +      +     +     E+     V+      ++    P+     
Sbjct: 66  --AAALNHPAIVAVYDTGEAETPAGPLPYIVMEY-----VDGVTLRDIVHTEGPMTPKRA 118

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
           +++   A + L F H+    +I+RD K +NI++      K+ DFG+A+   +   S   T
Sbjct: 119 IEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176

Query: 241 -RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             ++GT  Y +PE      +  RSDVYS G VL E+LTG 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  112 bits (282), Expect = 2e-28
 Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 50/294 (17%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLG 131
            +   + +G GG   V++   +E  +        A+K  + + +     +    E+ +L 
Sbjct: 10  IYSILKQIGSGGSSKVFQVL-NEKKQI------YAIKYVNLEEADNQTLDSYRNEIAYLN 62

Query: 132 HLSHPNL--VKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
            L   +   ++L  Y   D++  ++ E      + + L  K  +      R        +
Sbjct: 63  KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLE 119

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
            +  +H+    +++ D K +N L+      KL DFG+A        S V    +GT  Y 
Sbjct: 120 AVHTIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 250 APEYIM-----------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 298
            PE I               ++P+SDV+S G +L  +  G+                   
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------------T 218

Query: 299 P---LLKEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMRDI 348
           P   ++ +  KL  IIDP  E ++P     K    +   CL  +PK R  + ++
Sbjct: 219 PFQQIINQISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (282), Expect = 3e-28
 Identities = 39/357 (10%), Positives = 78/357 (21%), Gaps = 58/357 (16%)

Query: 29  PSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCV 88
                      L      VE +                L       +    L  G    V
Sbjct: 19  EELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVV 78

Query: 89  YKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC- 145
           +      D+         A+KV     +NS                L   +  +      
Sbjct: 79  FLV---RDVERL---EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132

Query: 146 -------------------------CEDEHRVLIYEFMARGSVEN-NLFSKVLL---PLP 176
                                        + +L+    +       +    V +      
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192

Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
                 +     +  A L    K +++  F   N+ +  D    L D         G + 
Sbjct: 193 ILALHILTAQLIRLAANLQS--KGLVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRG 248

Query: 237 HVSTRIMGTYGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA 294
             S+       YA  E++       T   + +  G+ +  +           P  +    
Sbjct: 249 PASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG--- 302

Query: 295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMRDIVD 350
                    K+  L +             +      L    LN + + R L  + ++
Sbjct: 303 -------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (282), Expect = 5e-28
 Identities = 56/391 (14%), Positives = 109/391 (27%), Gaps = 84/391 (21%)

Query: 30  SEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDEL---RIITANFRQDRVLGGGGFG 86
                   +         + L   S  N    F  +     R  T    +  VLG     
Sbjct: 35  RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRT--LVRGTVLGQEDPY 92

Query: 87  CVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAEVIFLGH-------- 132
              +     D   G       V V         +   Q   E L   +  G         
Sbjct: 93  AYLEA---TDQETG---ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146

Query: 133 ----------LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--------- 173
                     +  P   K+I    ++    ++  F     +++NL +   +         
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206

Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
            L    R+++     + LA LH     +++   +  +I+LD      L+ F       +G
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDG 262

Query: 234 DKSHVSTRIMGTYGYAAPEYIM----------TGHLTPRSDVYSFGVVLLEILTGRKSLD 283
             +          G+A PE                +T   D ++ G+ +  I        
Sbjct: 263 ASAVSPI----GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD---- 314

Query: 284 KSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
              P  +      +  + +  K +     P+     PV+       L    L +  + R 
Sbjct: 315 --LPNTDDAALGGSEWIFRSCKNI-----PQ-----PVRA------LLEGFLRYPKEDRL 356

Query: 344 LMRDIVDSLEPLQVLPDEAPTPKNFVTVVTP 374
           L    +++ E  Q+  + +     + T   P
Sbjct: 357 LPLQAMETPEYEQLRTELSAALPLYQTDGEP 387

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  110 bits (276), Expect = 1e-27
 Identities = 64/285 (22%), Positives = 114/285 (40%), Gaps = 38/285 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 130
           NFR ++ +G G F  VY+      L +G+    VA+K          +   + + E+  L
Sbjct: 33  NFRIEKKIGRGQFSEVYRAA---CLLDGVP---VALKKVQIFDLMDAKARADCIKEIDLL 86

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIY-EFMARGSVENNL--FSKVLLPLPWSIRMKIAFGA 187
             L+HPN++K       +++ + I  E    G +   +  F K    +P     K     
Sbjct: 87  KQLNHPNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
              L  +H   + V++RD K +N+ +      KL D GL +       +   + + GT  
Sbjct: 146 CSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPY 201

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 307
           Y +PE I       +SD++S G +L E+   +                   P   +K  L
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQS------------------PFYGDKMNL 243

Query: 308 LNIIDPRLEGDY-PVKGVH---KAAMLAYHCLNHNPKARPLMRDI 348
            ++     + DY P+   H   +   L   C+N +P+ RP +  +
Sbjct: 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (278), Expect = 1e-27
 Identities = 48/267 (17%), Positives = 85/267 (31%), Gaps = 23/267 (8%)

Query: 66  ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           E ++ +       +LG G F  VY+     DL +        +KV    N ++ +     
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEA-TQGDLNDAKNKQKFVLKVQKPANPWEFYIG-TQ 116

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL---PLPWSIRMK 182
            +  L        +K           VL+ E  + G++ N +          +P  + + 
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-----------DTDYNAKLSDFGLAKDGP 231
            A      +  +H+ E  +I+ D K  N +L           D      L D G + D  
Sbjct: 177 FAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR---KSLDKSRPA 288
              K  + T    T G+   E +       + D +     +  +L G       +     
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294

Query: 289 REQNLAD-WALPLLKE-KKKLLNIIDP 313
            E        L +  E    +LNI D 
Sbjct: 295 PEGLFRRLPHLDMWNEFFHVMLNIPDC 321

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  110 bits (278), Expect = 1e-27
 Identities = 43/228 (18%), Positives = 81/228 (35%), Gaps = 31/228 (13%)

Query: 73  NFRQDRVLGGGGFGCVY----KGFI--------SEDLREGLQPVPVAVKVHDGDNSYQGH 120
           ++R  R L  G F  +                 S   ++         K+          
Sbjct: 32  DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91

Query: 121 REWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSI 179
            E    +  +  + +   +   G    +   V +IYE+M   S+        +L   ++ 
Sbjct: 92  NE----LQIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146

Query: 180 RM------KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
            +       I        +++H  EK + +RD K SNIL+D +   KLSDFG ++   + 
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

Query: 234 DKSHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGR 279
               +     GTY +  PE+      +   + D++S G+ L  +    
Sbjct: 206 ---KIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  109 bits (274), Expect = 2e-27
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 25/216 (11%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK---VHDGDNSYQGHREWLAEVIF 129
                 VLG G +G VY G    DL      V +A+K     D   S   H E    +  
Sbjct: 23  ENGDRVVLGKGTYGIVYAGR---DLSNQ---VRIAIKEIPERDSRYSQPLHEE----IAL 72

Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIY-EFMARGSVENNLFSKV-LLPLPWSIRMKIAFGA 187
             HL H N+V+ +G    +   + I+ E +  GS+   L SK   L              
Sbjct: 73  HKHLKHKNIVQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
            +GL +LH  +  +++RD K  N+L++T     K+SDFG +K     +    +    GT 
Sbjct: 132 LEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTL 187

Query: 247 GYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTGR 279
            Y APE I     G+    +D++S G  ++E+ TG+
Sbjct: 188 QYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGK 222

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  109 bits (274), Expect = 4e-27
 Identities = 59/323 (18%), Positives = 114/323 (35%), Gaps = 33/323 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 131
            + + + +G G FG        +   +G Q     +K ++    S +   E   EV  L 
Sbjct: 25  KYVRLQKIGEGSFGKAILV---KSTEDGRQ---YVIKEINISRMSSKEREESRREVAVLA 78

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
           ++ HPN+V+      E+    ++ ++   G +   + ++  +       +         L
Sbjct: 79  NMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
             +H+  + +++RD K+ NI L  D   +L DFG+A+             I GT  Y +P
Sbjct: 139 KHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLSP 194

Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 311
           E         +SD+++ G VL E+ T +            ++      L+    K+++  
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLK------HAFEAGSM----KNLV---LKIISGS 241

Query: 312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDSLEPLQVLPDEAPTPK 366
            P +   Y     +    L       NP+ RP     L +  +       + P       
Sbjct: 242 FPPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEF 297

Query: 367 NFVTVVTPEEPKAEIQTKDSQCN 389
              T           +   S  N
Sbjct: 298 CLKTFSKFGSQPIPAKRPASGQN 320

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (274), Expect = 4e-27
 Identities = 48/371 (12%), Positives = 100/371 (26%), Gaps = 90/371 (24%)

Query: 35  KEYSKLPSNPEEVEDLRRDSAANPLI---------AFTYD-ELRIITANFRQDRVLGGGG 84
           + ++++P            SAA+ L+          F  + EL        +  VLG   
Sbjct: 26  ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 85

Query: 85  FGCVYKGFISEDLREGLQPVPVAVKV---------------------------HDGDNSY 117
                +    E            V V                                  
Sbjct: 86  PYAYLEATDQETGE------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE--HRVLIYEFMA--RGSVENNLFSKVLL 173
           + H  ++     +       ++++     +     R  +Y  M     +    L S    
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 174 --PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP 231
              L    R+++     + LA LH     +++   +  +I+LD      L+ F       
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254

Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMT-----------GHLTPRSDVYSFGVVLLEILTGRK 280
              +         + G+  PE                 +T   D ++ G+V+  I     
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD- 310

Query: 281 SLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPK 340
                 P  +      +  + +  K +     P+     PV+       L    L +  +
Sbjct: 311 -----LPITKDAALGGSEWIFRSCKNI-----PQ-----PVR------ALLEGFLRYPKE 349

Query: 341 ARPLMRDIVDS 351
            R L    +++
Sbjct: 350 DRLLPLQAMET 360

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  105 bits (265), Expect = 2e-26
 Identities = 61/284 (21%), Positives = 104/284 (36%), Gaps = 33/284 (11%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 131
           ++     +G G +G   K        +G     +  K +  G  +    +  ++EV  L 
Sbjct: 7   DYEVLYTIGTGSYGRCQKI---RRKSDGKI---LVWKELDYGSMTEAEKQMLVSEVNLLR 60

Query: 132 HLSHPNLVKLIG-YCCEDEHRVLIY-EFMARGSVENNL--FSKVLLPLPWSIRMKIAFGA 187
            L HPN+V+            + I  E+   G + + +   +K    L     +++    
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 188 AKGLAFLHE---AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
              L   H        V++RD K +N+ LD   N KL DFGLA+     D S   T + G
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-G 178

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 304
           T  Y +PE +       +SD++S G +L E+           P    +  + A       
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELA------- 225

Query: 305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
            K+      R+   Y      +   +    LN     RP + +I
Sbjct: 226 GKIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEI 265

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  104 bits (263), Expect = 5e-26
 Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE--WLAEVIFL 130
           +F   R LG G FG VY   ++ + +       +A+KV       +   E     EV   
Sbjct: 10  DFEIGRPLGKGKFGNVY---LAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQ 63

Query: 131 GHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFGA 187
            HL HPN+++L GY   D  RV LI E+   G+    ++ ++                  
Sbjct: 64  SHLRHPNILRLYGYF-HDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITEL 118

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           A  L++ H   K VI+RD K  N+LL +    K++DFG +   P    S   T + GT  
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLD 172

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           Y  PE I       + D++S GV+  E L G+
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  104 bits (262), Expect = 1e-25
 Identities = 71/289 (24%), Positives = 106/289 (36%), Gaps = 35/289 (12%)

Query: 65  DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
                   + +    +G G +G V K         G     +AVK        +  ++ L
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMV---HKPSG---QIMAVKRIRSTVDEKEQKQLL 68

Query: 125 AEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVE--NNLFSKVLLPLPWSIRM 181
            ++  +   S  P +V+  G    +    +  E M+    +    ++S +   +P  I  
Sbjct: 69  MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           KI     K L  L E  K +I+RD K SNILLD   N KL DFG++    +   S   TR
Sbjct: 129 KITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTR 184

Query: 242 IMGTYGYAAPEYIMTGHLTP----RSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 297
             G   Y APE I           RSDV+S G+ L E+ TGR    K     +Q      
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------ 238

Query: 298 LPLLKEKKKLLNIID---PRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
                    L  ++    P+L      +           CL  +   RP
Sbjct: 239 ---------LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  104 bits (261), Expect = 2e-25
 Identities = 66/314 (21%), Positives = 118/314 (37%), Gaps = 51/314 (16%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
             R  RVL  GGF  VY+    +D+  G +    A+K    +   + +R  + EV F+  
Sbjct: 29  RLRVRRVLAEGGFAFVYEA---QDVGSGRE---YALKRLLSNEE-EKNRAIIQEVCFMKK 81

Query: 133 LS-HPNLVKLIGYCCEDEHR-------VLIYEFMARGSVENNLFSKVLL-PLPWSIRMKI 183
           LS HPN+V+        +          L+   + +G +   L       PL     +KI
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA---KDGPEGDKSHVST 240
            +   + +  +H  + P+I+RD K  N+LL      KL DFG A      P+   S    
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201

Query: 241 RIM-------GTYGYAAPEYI-MTGHL--TPRSDVYSFGVVLLEILTGRKSLDKSRPARE 290
            ++        T  Y  PE I +  +     + D+++ G +L  +   +   +     R 
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261

Query: 291 QNLADWALP-LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
            N   +++P    +     ++I                       L  NP+ R  + ++V
Sbjct: 262 VN-GKYSIPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVV 300

Query: 350 DSLEPLQVLPDEAP 363
             L+ +    +  P
Sbjct: 301 HQLQEIAAARNVNP 314

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  101 bits (254), Expect = 1e-24
 Identities = 75/270 (27%), Positives = 115/270 (42%), Gaps = 30/270 (11%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           F +   +G G FG V+KG    D R       VA+K+ D + +     +   E+  L   
Sbjct: 24  FTKLEKIGKGSFGEVFKGI---DNRTQ---KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 193
             P + K  G   +D    +I E++  GS  + L      PL  +    I     KGL +
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDY 134

Query: 194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 253
           LH  +K  I+RD K +N+LL      KL+DFG+A  G   D        +GT  + APE 
Sbjct: 135 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 190

Query: 254 IMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP 313
           I       ++D++S G+  +E+  G     +  P +        L L+ +         P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNP------P 237

Query: 314 RLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
            LEG+Y  K + +   +   CLN  P  RP
Sbjct: 238 TLEGNYS-KPLKE--FVEA-CLNKEPSFRP 263

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  101 bits (253), Expect = 1e-24
 Identities = 52/220 (23%), Positives = 83/220 (37%), Gaps = 18/220 (8%)

Query: 67  LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE 126
           + +   +      LG G +G V K      +  G     +AVK      + Q  +  L +
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMR---HVPSG---QIMAVKRIRATVNSQEQKRLLMD 55

Query: 127 V-IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKI 183
           + I +  +  P  V   G    +    +  E M   S++            +P  I  KI
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKI 114

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           A    K L  LH     VI+RD K SN+L++     K+ DFG++                
Sbjct: 115 AVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDA 170

Query: 244 GTYGYAAPEYIMTGHLTP----RSDVYSFGVVLLEILTGR 279
           G   Y APE I           +SD++S G+ ++E+   R
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  101 bits (254), Expect = 1e-24
 Identities = 66/279 (23%), Positives = 105/279 (37%), Gaps = 38/279 (13%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
                 +G G  G V+K       + G     +AVK      + + ++  L ++  +   
Sbjct: 27  LENLGEMGSGTCGQVWKMR---FRKTG---HVIAVKQMRRSGNKEENKRILMDLDVVLKS 80

Query: 134 S-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
              P +V+  G    +    +  E M   + +  L  ++  P+P  I  K+     K L 
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALY 138

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
           +L E    VI+RD K SNILLD     KL DFG++             R  G   Y APE
Sbjct: 139 YLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPE 194

Query: 253 YIMTGHL-----TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 307
            I            R+DV+S G+ L+E+ TG+      +   E                L
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV---------------L 239

Query: 308 LNIID---PRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
             ++    P L G     G  + + +   CL  + + RP
Sbjct: 240 TKVLQEEPPLLPGHMGFSGDFQ-SFVKD-CLTKDHRKRP 276

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  101 bits (254), Expect = 1e-24
 Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 34/230 (14%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 128
                +    +LG G    V++G      R        A+KV +  +  +     + E  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRG------RHKKTGDLFAIKVFNNISFLRPVDVQMREFE 59

Query: 129 FLGHLSHPNLVKLIGY--CCEDEHRVLIYEFMARGSVENNLFSKV-----LLPLPWSIRM 181
            L  L+H N+VKL          H+VLI EF   GS    L++ +        LP S  +
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS----LYTVLEEPSNAYGLPESEFL 115

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSDFGLAKDGPEGDKSH 237
            +      G+  L   E  +++R+ K  NI+     D     KL+DFG A++  + ++  
Sbjct: 116 IVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

Query: 238 VSTRIMGTYGYAAPEYIMTGHL--------TPRSDVYSFGVVLLEILTGR 279
             +   GT  Y  P+      L            D++S GV      TG 
Sbjct: 174 --SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  103 bits (258), Expect = 1e-24
 Identities = 67/309 (21%), Positives = 110/309 (35%), Gaps = 54/309 (17%)

Query: 68  RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEV 127
           + +      +++LG G  G V      +   +G    PVAVK    D       E    +
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVF----QGSFQG---RPVAVKRMLIDFCDIALME----I 59

Query: 128 IFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGS-----VENNLFSKVLLPLPWSIRM 181
             L     HPN+++       D    +  E     +        N+  + L        +
Sbjct: 60  KLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPI 118

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------------DYNAKLSDFGLAK 228
            +    A G+A LH     +I+RD K  NIL+ T             +    +SDFGL K
Sbjct: 119 SLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176

Query: 229 DGPEGDKSHVSTR--IMGTYGYAAPEYIM-------TGHLTPRSDVYSFGVVLLEILTGR 279
               G  S  +      GT G+ APE +           LT   D++S G V   IL+  
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236

Query: 280 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP 339
           K     + +RE N       +++    L       ++  +    + +A  L    ++H+P
Sbjct: 237 KHPFGDKYSRESN-------IIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDP 284

Query: 340 KARPLMRDI 348
             RP    +
Sbjct: 285 LKRPTAMKV 293

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  100 bits (252), Expect = 1e-24
 Identities = 58/212 (27%), Positives = 85/212 (40%), Gaps = 22/212 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE--WLAEVIFL 130
           +F   R LG G FG VY        RE      +A+KV       +   E     E+   
Sbjct: 15  DFDIGRPLGKGKFGNVYLA------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ 68

Query: 131 GHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFGA 187
            HL HPN++++  Y   D  R+ L+ EF  RG     L+ ++                  
Sbjct: 69  SHLRHPNILRMYNYF-HDRKRIYLMLEFAPRGE----LYKELQKHGRFDEQRSATFMEEL 123

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           A  L + HE  + VI+RD K  N+L+      K++DFG +   P   +        GT  
Sbjct: 124 ADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLD 177

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           Y  PE I       + D++  GV+  E L G 
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  101 bits (255), Expect = 2e-24
 Identities = 76/343 (22%), Positives = 122/343 (35%), Gaps = 64/343 (18%)

Query: 19  PKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDR 78
           P    P        A           +E+ ++  D  +                 + + R
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR--------------RRYVRGR 47

Query: 79  VLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAEVIFLGH 132
            LG GGF   ++     D          A K+             +   E    +     
Sbjct: 48  FLGKGGFAKCFEI---SDADTKEV---FAGKIVPKSLLLKPHQREKMSME----ISIHRS 97

Query: 133 LSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
           L+H ++V   G+  ED   V ++ E   R S+      +  L  P + R         G 
Sbjct: 98  LAHQHVVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-R-YYLRQIVLGC 154

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTRIMGTYGYAA 250
            +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +G++  V   + GT  Y A
Sbjct: 155 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIA 209

Query: 251 PEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 309
           PE +   GH +   DV+S G ++  +L G+       P     L           K+   
Sbjct: 210 PEVLSKKGH-SFEVDVWSIGCIMYTLLVGKP------PFETSCL-----------KETYL 251

Query: 310 IIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
            I    + +Y  P      AA L    L  +P ARP + ++++
Sbjct: 252 RI---KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  101 bits (253), Expect = 2e-24
 Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 40/288 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           ++    V+G G    V   +      +      VA+K  + +       E L E+  +  
Sbjct: 16  DYELQEVIGSGATAVVQAAY---CAPKK---EKVAIKRINLEKCQTSMDELLKEIQAMSQ 69

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK---IAF---G 186
             HPN+V         +   L+ + ++ GSV + +   V      S  +    IA     
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG----LAKDGPEGDKSHVSTRI 242
             +GL +LH+  +  I+RD K  NILL  D + +++DFG    LA  G         T +
Sbjct: 130 VLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 243 MGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL 301
            GT  + APE +        ++D++SFG+  +E+ TG     K  P +        L L 
Sbjct: 188 -GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLT 239

Query: 302 KEKKKLLNIIDPRLEGDYPVKGVHKA------AMLAYHCLNHNPKARP 343
            +         P LE     K + K        M++  CL  +P+ RP
Sbjct: 240 LQNDP------PSLETGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRP 280

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  100 bits (251), Expect = 2e-24
 Identities = 69/288 (23%), Positives = 107/288 (37%), Gaps = 48/288 (16%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 126
            + + R LG GGF   ++     D          A K+             +   E    
Sbjct: 16  RYVRGRFLGKGGFAKCFEI---SDADTKEV---FAGKIVPKSLLLKPHQREKMSME---- 65

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           +     L+H ++V   G+  ED   V ++ E   R S+      +  L  P +       
Sbjct: 66  ISIHRSLAHQHVVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY--YLR 122

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
               G  +LH     VI+RD K  N+ L+ D   K+ DFGLA    E D       + GT
Sbjct: 123 QIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKV-LCGT 178

Query: 246 YGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 304
             Y APE +   GH +   DV+S G ++  +L G+       P     L           
Sbjct: 179 PNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKP------PFETSCL----------- 220

Query: 305 KKLLNIIDPRLEGDY--PVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
           K+    I    + +Y  P      AA L    L  +P ARP + ++++
Sbjct: 221 KETYLRI---KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =   99 bits (250), Expect = 3e-24
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 33/219 (15%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 126
           +F+   +LG G F  VY+    E +  GL+   VA+K+      +      +   E    
Sbjct: 12  DFKVGNLLGKGSFAGVYRA---ESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNE---- 61

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLL---PLPWSIRMK 182
           V     L HP++++L  Y  ED + V L+ E    G     +   +     P   +    
Sbjct: 62  VKIHCQLKHPSILELYNYF-EDSNYVYLVLEMCHNGE----MNRYLKNRVKPFSENEARH 116

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-KDGPEGDKSHVSTR 241
                  G+ +LH     +++RD   SN+LL  + N K++DFGLA +     +K +  T 
Sbjct: 117 FMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--T- 171

Query: 242 IMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           + GT  Y +PE    + H    SDV+S G +   +L GR
Sbjct: 172 LCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  102 bits (255), Expect = 4e-24
 Identities = 64/284 (22%), Positives = 104/284 (36%), Gaps = 45/284 (15%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           +F    VLG G  G +        + +      VAVK    +      RE    V  L  
Sbjct: 25  SFCPKDVLGHGAEGTIVY----RGMFDNR---DVAVKRILPECFSFADRE----VQLLRE 73

Query: 133 LS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
              HPN+++      + + + +  E  A  +++  +  K    L       +      GL
Sbjct: 74  SDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGL 131

Query: 192 AFLHEAEKPVIYRDFKTSNILL-----DTDYNAKLSDFGLAKDGPEGDKS-HVSTRIMGT 245
           A LH     +++RD K  NIL+          A +SDFGL K    G  S    + + GT
Sbjct: 132 AHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

Query: 246 YGYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK 302
            G+ APE +      + T   D++S G V   +++                     P  K
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----------------HPFGK 232

Query: 303 EKKKLLNII--DPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARP 343
             ++  NI+     L+  +P K     A  L    +  +P+ RP
Sbjct: 233 SLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP 276

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 99.7 bits (249), Expect = 5e-24
 Identities = 50/299 (16%), Positives = 98/299 (32%), Gaps = 66/299 (22%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-WLAEVIFLG 131
            F +   +G G FG V+K        +G      A+K      +     +  L EV    
Sbjct: 12  EFHELEKIGSGEFGSVFKCV---KRLDGCI---YAIKRSKKPLAGSVDEQNALREVYAHA 65

Query: 132 HLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNL--FSKVLLPLPWSIRMKIAFGAA 188
            L  H ++V+      ED+H ++  E+   GS+ + +    +++     +    +     
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTD-------------------YNAKLSDFGLAKD 229
           +GL ++H     +++ D K SNI +                         K+ D G    
Sbjct: 126 RGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182

Query: 230 GPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP 287
                 S       G   + A E +     HL P++D+++  + ++              
Sbjct: 183 ----RISSPQVEE-GDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAE-------- 228

Query: 288 AREQNLADWALPLLKEKKKLLNIID---PRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
                      PL +   +   I     PR+      +       L    ++ +P+ RP
Sbjct: 229 -----------PLPRNGDQWHEIRQGRLPRIPQVLSQEFTE----LLKVMIHPDPERRP 272

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  101 bits (252), Expect = 6e-24
 Identities = 55/230 (23%), Positives = 86/230 (37%), Gaps = 34/230 (14%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 128
                +    +LG G    V++G      + G      A+KV +  +  +     + E  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRG---RHKKTGDL---FAIKVFNNISFLRPVDVQMREFE 59

Query: 129 FLGHLSHPNLVKLIGY--CCEDEHRVLIYEFMARGSVENNLFSKV-----LLPLPWSIRM 181
            L  L+H N+VKL          H+VLI EF   GS    L++ +        LP S  +
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS----LYTVLEEPSNAYGLPESEFL 115

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSDFGLAKDGPEGDKSH 237
            +      G+  L   E  +++R+ K  NI+     D     KL+DFG A++    D   
Sbjct: 116 IVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQ 171

Query: 238 VSTRIMGTYGYAAPEYIMTGHL--------TPRSDVYSFGVVLLEILTGR 279
             +   GT  Y  P+      L            D++S GV      TG 
Sbjct: 172 FVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  102 bits (256), Expect = 6e-24
 Identities = 54/221 (24%), Positives = 83/221 (37%), Gaps = 29/221 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
            +     LG GGFG V +               VA+K    + S +    W  E+  +  
Sbjct: 15  PWEMKERLGTGGFGYVLRW------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK 68

Query: 133 LSHPNLVKLI------GYCCEDEHRVLIYEFMARGSVENNLFSKVLLP-----LPWSIRM 181
           L+HPN+V              ++  +L  E+   G     L   +        L      
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGD----LRKYLNQFENCCGLKEGPIR 124

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA---KLSDFGLAKDGPEGDKSHV 238
            +    +  L +LHE    +I+RD K  NI+L         K+ D G AK+  +G+    
Sbjct: 125 TLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT- 181

Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
              + GT  Y APE +     T   D +SFG +  E +TG 
Sbjct: 182 -EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  101 bits (253), Expect = 1e-23
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 35/228 (15%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----------HDGDNSYQ 118
           I  ++ + R LG G +G V      ++     +    A+KV            D + + +
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLC---KEKNGHSE---KAIKVIKKSQFDKGRYSDDNKNIE 87

Query: 119 GHREWLA-EVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLP 176
              E +  E+  L  L HPN++KL     ED+    L+ EF   G     LF +++    
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDV-FEDKKYFYLVTEFYEGG----ELFEQIINRHK 142

Query: 177 WSIRM--KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGP 231
           +       I      G+ +LH  +  +++RD K  NILL+      N K+ DFGL+    
Sbjct: 143 FDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200

Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           +  K       +GT  Y APE ++      + DV+S GV++  +L G 
Sbjct: 201 KDYKLR---DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (252), Expect = 1e-23
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 24/217 (11%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVI 128
           ++  +++ + LG G +G V       D    ++    A+K+    +        L  EV 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLC---RDKVTHVE---RAIKIIRKTSVSTSSNSKLLEEVA 88

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM--KIAF 185
            L  L HPN++KL  +  ED+    L+ E    G     LF +++  + ++      I  
Sbjct: 89  VLKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIK 143

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRI 242
               G+ +LH  +  +++RD K  N+LL++   D   K+ DFGL+       K       
Sbjct: 144 QVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ER 198

Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           +GT  Y APE ++      + DV+S GV+L  +L G 
Sbjct: 199 LGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 25/218 (11%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEV 127
            +  ++  RVLG G FG V      +D   G +    AVKV               L EV
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILC---KDKITGQE---CAVKVISKRQVKQKTDKESLLREV 77

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM--KIA 184
             L  L HPN++KL  +  ED+    L+ E    G     LF +++    +S     +I 
Sbjct: 78  QLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARII 132

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTR 241
                G+ ++H  +  +++RD K  N+LL++   D N ++ DFGL+       K      
Sbjct: 133 RQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---D 187

Query: 242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            +GT  Y APE ++ G    + DV+S GV+L  +L+G 
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 96.5 bits (240), Expect = 1e-22
 Identities = 46/259 (17%), Positives = 95/259 (36%), Gaps = 46/259 (17%)

Query: 111 HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK 170
               +S         ++  +   S  N V  +       +  +  +   + ++++ +  +
Sbjct: 96  DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155

Query: 171 VLLPLP-----WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG 225
             L          I ++IA    + + FLH   K +++RD K SNI    D   K+ DFG
Sbjct: 156 CSLEDREHGVCLHIFIQIA----EAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFG 209

Query: 226 LAKD----------GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEI 275
           L                       T  +GT  Y +PE I   + + + D++S G++L E+
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

Query: 276 LTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP---VKGVHKAAMLAY 332
           L                   ++     E+ +++  +       +P    +   +  M+  
Sbjct: 270 L-------------------YSFSTQMERVRIITDVR---NLKFPLLFTQKYPQEHMMVQ 307

Query: 333 HCLNHNPKARPLMRDIVDS 351
             L+ +P  RP   DI+++
Sbjct: 308 DMLSPSPTERPEATDIIEN 326

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 73/287 (25%), Positives = 112/287 (39%), Gaps = 59/287 (20%)

Query: 20  KSESPKDESPSEKAKKEYSKLPS---NPEEVEDLRRDSAANPLIAFTYDELRIITAN-FR 75
                 ++ P +   +E ++L     +     D       N  + + + E + +T N FR
Sbjct: 128 NCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFR 187

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY------------QGHREW 123
           Q RVLG GGFG V                  A +V      Y            +     
Sbjct: 188 QYRVLGKGGFGEVC-----------------ACQVRATGKMYACKKLEKKRIKKRKGEAM 230

Query: 124 -LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLF------SKVLLPL 175
            L E   L  ++   +V L  Y  E +  + L+   M  G    +L        +   P 
Sbjct: 231 ALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGG----DLKFHIYHMGQAGFPE 285

Query: 176 PWSIRMKIAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE 232
             ++     F AA+   GL  LH   + ++YRD K  NILLD   + ++SD GLA   PE
Sbjct: 286 ARAV-----FYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338

Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           G       R+ GT GY APE +     T   D ++ G +L E++ G+
Sbjct: 339 GQTIK--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 30/220 (13%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVI 128
               +    +LG G FG V K    +D     +    AVKV +  ++       +  EV 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKC---KDRITQQE---YAVKVINKASAKNKDTSTILREVE 73

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR-----MK 182
            L  L HPN++KL     ED     ++ E    G     LF +++    +S       +K
Sbjct: 74  LLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVS 239
             F     + ++H  +  +++RD K  NILL++   D + K+ DFGL+    +  K    
Sbjct: 129 QVFSG---ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-- 181

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
              +GT  Y APE ++ G    + DV+S GV+L  +L+G 
Sbjct: 182 -DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 95.0 bits (236), Expect = 7e-22
 Identities = 41/207 (19%), Positives = 70/207 (33%), Gaps = 16/207 (7%)

Query: 81  GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL-AEVIFLGHLSHPNLV 139
           G      V           G     V V+  + +        +L  E+      +HPN+V
Sbjct: 36  GFEDLMTVNLAR---YKPTGEY---VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK 199
                   D    ++  FMA GS ++ + +  +  +       I  G  K L ++H    
Sbjct: 90  PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH--M 147

Query: 200 PVIYRDFKTSNILLDTDYNAKLSDFG-LAKDGPEGDKSHVSTRIM----GTYGYAAPEYI 254
             ++R  K S+IL+  D    LS           G +  V             + +PE +
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207

Query: 255 MTGHL--TPRSDVYSFGVVLLEILTGR 279
                    +SD+YS G+   E+  G 
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGH 234

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 66/282 (23%), Positives = 111/282 (39%), Gaps = 45/282 (15%)

Query: 15  VSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANF 74
           +S  P++ S  +     +    +  +  + ++         A P         R    ++
Sbjct: 1   MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATP----GQGPDRPQEVSY 56

Query: 75  RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHL 133
              +V+G G FG VY+  + +          VA+K V       Q  R    E+  +  L
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKVL------QDKRFKNRELQIMRKL 104

Query: 134 SHPNLVKLIGYCCEDEHRV------LIYEFMARGSVENNL------FSKVLLPLPWSIRM 181
            H N+V+L  +      +       L+ +++        +      +S+    LP     
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVK 159

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHV 238
              +   + LA++H     + +RD K  N+LLD D    KL DFG AK    G+   S++
Sbjct: 160 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217

Query: 239 STRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR 279
            +R    Y Y APE I      T   DV+S G VL E+L G+
Sbjct: 218 CSR----Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 57/301 (18%), Positives = 108/301 (35%), Gaps = 50/301 (16%)

Query: 3   NCWCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSN---PEEVEDLRRDSAANPL 59
             + + +  ++    + ++ +       +   +   +           ++          
Sbjct: 112 AAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRF 171

Query: 60  IAFTYDELRIITAN-FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY- 117
           + + + E + +  + F   RVLG GGFG V+                 A ++      Y 
Sbjct: 172 LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF-----------------ACQMKATGKLYA 214

Query: 118 -----------QGHREW-LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVE 164
                      +   +  + E   L  +    +V L  Y  E +  + L+   M  G   
Sbjct: 215 CKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGG--- 270

Query: 165 NNLFSKVLLPLPWSIRMKIA---FGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYN 218
            ++   +      +   +     F  A+   GL  LH+  + +IYRD K  N+LLD D N
Sbjct: 271 -DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGN 327

Query: 219 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            ++SD GLA +   G          GT G+ APE ++        D ++ GV L E++  
Sbjct: 328 VRISDLGLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385

Query: 279 R 279
           R
Sbjct: 386 R 386

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 74/332 (22%), Positives = 124/332 (37%), Gaps = 53/332 (15%)

Query: 18  NPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRD-SAANPLIAFTYDELRIITANFRQ 76
           +    S   +  +E    +   + ++ +    LR      +P                  
Sbjct: 3   HHHHHSSGVDLGTENLYFQSGVV-THEQFKAALRMVVDQGDP------------RLLLDS 49

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
              +G G  G V       +   G Q   VAVK+ D     Q       EV+ +    H 
Sbjct: 50  YVKIGEGSTGIVCLAR---EKHSGRQ---VAVKMMDLRKQ-QRRELLFNEVVIMRDYQHF 102

Query: 137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF---GAAKGLAF 193
           N+V++       E   ++ EF+  G++  ++ S+V L         IA       + LA+
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQ-----IATVCEAVLQALAY 156

Query: 194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYAAPE 252
           LH   + VI+RD K+ +ILL  D   KLSDFG  A+   +  K    + + GT  + APE
Sbjct: 157 LHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPE 211

Query: 253 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKKLLNII 311
            I         D++S G++++E++ G        P +      D   P LK   K+  ++
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVL 271

Query: 312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
              LE                  L  +P+ R 
Sbjct: 272 RDFLE----------------RMLVRDPQERA 287

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 91.2 bits (227), Expect = 6e-21
 Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 39/275 (14%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           + +   +G G  G VY      D+  G +   VA++  +           + E++ +   
Sbjct: 22  YTRFEKIGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQ-PKKELIINEILVMREN 74

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF---GAAKG 190
            +PN+V  +      +   ++ E++A GS+  ++ ++  +         IA       + 
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQ-----IAAVCRECLQA 128

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYA 249
           L FLH     VI+RD K+ NILL  D + KL+DFG  A+  PE  K    T + GT  + 
Sbjct: 129 LEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPYWM 183

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL-ADWALPLLKEKKKLL 308
           APE +      P+ D++S G++ +E++ G        P R   L A    P L+  +KL 
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243

Query: 309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
            I    L                  CL  + + R 
Sbjct: 244 AIFRDFLN----------------RCLEMDVEKRG 262

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 16/209 (7%)

Query: 71  TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL 130
              F     LG G +G VYK         G     VA+K    ++  Q   E + E+  +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAI---HKETGQI---VAIKQVPVESDLQ---EIIKEISIM 78

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
                P++VK  G   ++    ++ E+   GSV +++       L       I     KG
Sbjct: 79  QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV-SDIIRLRNKTLTEDEIATILQSTLKG 137

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYA 249
           L +LH      I+RD K  NILL+T+ +AKL+DFG+  +      K +  T I GT  + 
Sbjct: 138 LEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN--TVI-GTPFWM 192

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           APE I        +D++S G+  +E+  G
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEG 221

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.5 bits (227), Expect = 3e-20
 Identities = 63/228 (27%), Positives = 93/228 (40%), Gaps = 50/228 (21%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-------------QG 119
           +F   R++G GGFG VY                   +  D    Y             QG
Sbjct: 190 DFSVHRIIGRGGFGEVY-----------------GCRKADTGKMYAMKCLDKKRIKMKQG 232

Query: 120 HREWLAEVIFLGHLS---HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPL 175
               L E I L  +S    P +V +  Y      ++  I + M  G +  +L    +   
Sbjct: 233 ETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE 291

Query: 176 PWSIRMKIAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE 232
                M+  F AA+   GL  +H   + V+YRD K +NILLD   + ++SD GLA D  +
Sbjct: 292 A---DMR--FYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
                    + GT+GY APE +  G     S D +S G +L ++L G 
Sbjct: 345 KK---PHASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 54/270 (20%), Positives = 96/270 (35%), Gaps = 39/270 (14%)

Query: 21  SESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVL 80
           S          + K +  K+    +  ED+ +     P+          +   +     L
Sbjct: 4   SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGS----VYDYYDILEEL 59

Query: 81  GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK 140
           G G FG V++     +   G        K  +             E+  +  L HP L+ 
Sbjct: 60  GSGAFGVVHRC---VEKATGRV---FVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLIN 112

Query: 141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG---AAK-------G 190
           L     +    VLI EF++ G  E  LF ++                            G
Sbjct: 113 LHDAFEDKYEMVLILEFLSGG--E--LFDRI-------AAEDYKMSEAEVINYMRQACEG 161

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVSTRIMGTYGY 248
           L  +HE    +++ D K  NI+ +T   +  K+ DFGLA    + +   +      T  +
Sbjct: 162 LKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEF 216

Query: 249 AAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           AAPE +    +   +D+++ GV+   +L+G
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 87.7 bits (218), Expect = 7e-20
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 33/222 (14%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
           I   F   R LG G FG V+     E+   GL+     +K  + D S     +  AE+  
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLV---EERSSGLE---RVIKTINKDRSQVPMEQIEAEIEV 73

Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR-------- 180
           L  L HPN++K+     ED H + ++ E    G  E  L  +++                
Sbjct: 74  LKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGYVAE 128

Query: 181 -MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKS 236
            MK    A   LA+ H   + V+++D K  NIL          K+ DFGLA+     +  
Sbjct: 129 LMKQMMNA---LAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH- 182

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             ST   GT  Y APE +    +T + D++S GVV+  +LTG
Sbjct: 183 --STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 87.8 bits (218), Expect = 8e-20
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 23/213 (10%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD--GDNSYQGHREWLAEVIFLG 131
           +     LG G FG VYK     +   G      A KV +   +   +   +++ E+  L 
Sbjct: 21  WEIVGELGDGAFGKVYKAK---NKETGAL---AAAKVIETKSEEELE---DYIVEIEILA 71

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
              HP +VKL+G    D    ++ EF   G+V + +  ++   L       +     + L
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEAL 130

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL-AKDGPEGDKSHVSTRIMGTYGYAA 250
            FLH   K +I+RD K  N+L+  + + +L+DFG+ AK+     K    + I GT  + A
Sbjct: 131 NFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD--SFI-GTPYWMA 185

Query: 251 PEYIMTGHLT-----PRSDVYSFGVVLLEILTG 278
           PE +M   +       ++D++S G+ L+E+   
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 89.9 bits (223), Expect = 9e-20
 Identities = 63/282 (22%), Positives = 99/282 (35%), Gaps = 36/282 (12%)

Query: 9   EPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELR 68
           EP+  ++    + +  +     E+ K    K  +     ++   D            +  
Sbjct: 95  EPTAPVLIPGDERKRRRGYDVDEQGKIVRGK-GTVSSNYDNYVFDIWKQYYPQPVEIKHD 153

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 128
            +  ++     LG G FG V++     +   G      A K     +          E+ 
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRV---TERATGNN---FAAKFVMTPHE-SDKETVRKEIQ 206

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG-- 186
            +  L HP LV L     +D   V+IYEFM+ G     LF KV                 
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG----ELFEKV-------ADEHNKMSED 255

Query: 187 -AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT--DYNAKLSDFGLAKDGPEGDKS 236
            A +       GL  +H  E   ++ D K  NI+  T      KL DFGL          
Sbjct: 256 EAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            V     GT  +AAPE      +   +D++S GV+   +L+G
Sbjct: 314 KV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 60/281 (21%), Positives = 105/281 (37%), Gaps = 41/281 (14%)

Query: 16  SSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFR 75
           S +  S S  +E+    +  + ++      +           P   F +  +        
Sbjct: 27  SGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVN 86

Query: 76  QD------RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
                    +LGGG FG V+K    E+   GL+   +A K+       +   E   E+  
Sbjct: 87  SFYTVSKTEILGGGRFGQVHKC---EETATGLK---LAAKIIKTRGM-KDKEEVKNEISV 139

Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--- 186
           +  L H NL++L          VL+ E++  G  E  LF ++       I          
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGG--E--LFDRI-------IDESYNLTELD 188

Query: 187 AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT--DYNAKLSDFGLAKDGPEGDKSH 237
                     G+  +H  +  +++ D K  NIL         K+ DFGLA+     +K  
Sbjct: 189 TILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246

Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           V     GT  + APE +    ++  +D++S GV+   +L+G
Sbjct: 247 V---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 58/281 (20%), Positives = 98/281 (34%), Gaps = 49/281 (17%)

Query: 17  SNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQ 76
           +  +S        +    +      + P+  E+L   S         +   +     +  
Sbjct: 39  AFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDP 98

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLA-EVIF 129
             V+G G    V +         G +    AVK+             +  RE    E   
Sbjct: 99  KDVIGRGVSSVVRRC---VHRATGHE---FAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 130 LGHLS-HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG- 186
           L  ++ HP+++ LI    E    + L+++ M +G  E  LF          +  K+A   
Sbjct: 153 LRQVAGHPHIITLIDS-YESSSFMFLVFDLMRKG--E--LFDY--------LTEKVALSE 199

Query: 187 --AAK-------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
                        ++FLH     +++RD K  NILLD +   +LSDFG +     G    
Sbjct: 200 KETRSIMRSLLEAVSFLH--ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---E 254

Query: 238 VSTRIMGTYGYAAPE------YIMTGHLTPRSDVYSFGVVL 272
               + GT GY APE                 D+++ GV+L
Sbjct: 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 39/229 (17%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVI 128
               F+ +R+ G G FG V  G              VA+K V   D  ++ +RE L  + 
Sbjct: 21  EMDRFQVERMAGQGTFGTVQLGKEKSTGM------SVAIKKVIQ-DPRFR-NRE-LQIMQ 71

Query: 129 FLGHLSHPNLVKLIGY-------CCEDEHRVLIYEFMARGSVENNL------FSKVLLPL 175
            L  L HPN+V+L  Y          D +  ++ E++      + L      + +  +  
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAP 126

Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFGLAKDGPEGD 234
           P  +     F   + +  LH     V +RD K  N+L++  D   KL DFG AK     +
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

Query: 235 K--SHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGR 279
              +++ +R    Y Y APE ++ G  H T   D++S G +  E++ G 
Sbjct: 187 PNVAYICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 30/219 (13%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL-AEVI 128
               +    +LG G FG V K    +D     +    AVKV +  ++       +  EV 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKC---KDRITQQE---YAVKVINKASAKNKDTSTILREVE 73

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR-----MK 182
            L  L HPN++KL     ED     ++ E    G  E  LF +++    +S       +K
Sbjct: 74  LLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGG--E--LFDEIIKRKRFSEHDAARIIK 128

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVS 239
             F     + ++H  +  +++RD K  NILL++   D + K+ DFGL+    +       
Sbjct: 129 QVFSG---ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KM 180

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
              +GT  Y APE ++ G    + DV+S GV+L  +L+G
Sbjct: 181 KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 54/278 (19%), Positives = 90/278 (32%), Gaps = 58/278 (20%)

Query: 51  RRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV 110
              S+    + F    L  +   +     +G G +G V       + +        A+K+
Sbjct: 5   HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVA---IENQTRAI---RAIKI 58

Query: 111 HD----GDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGS--- 162
            +       + +       EV  +  L HPN+ +L     EDE  + L+ E    G    
Sbjct: 59  MNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLD 117

Query: 163 --VENNLFSKVLLPLPWSIRMKIAFG--------------------------AAK----- 189
                   S     +                                      +      
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177

Query: 190 --GLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAK--DGPEGDKSHVSTRIM 243
              L +LH   + + +RD K  N L  T+ +   KL DFGL+K        + +  T   
Sbjct: 178 FSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235

Query: 244 GTYGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGR 279
           GT  + APE + T +    P+ D +S GV+L  +L G 
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 49/224 (21%), Positives = 82/224 (36%), Gaps = 36/224 (16%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-------HDGDNSYQGHREWLA 125
            +    +LG G +G V +   SE L         AVK+          +      +E   
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCR------RAVKILKKKKLRRIPNGEANVKKE--- 56

Query: 126 EVIFLGHLSHPNLVKL--IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
            +  L  L H N+++L  + Y  E +   ++ E+   G  E  +   V        R  +
Sbjct: 57  -IQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP-----EKRFPV 108

Query: 184 AFGAAK------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
                       GL +LH   + ++++D K  N+LL T    K+S  G+A+         
Sbjct: 109 CQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166

Query: 238 VSTRIMGTYGYAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGR 279
                 G+  +  PE           + D++S GV L  I TG 
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 61/259 (23%), Positives = 107/259 (41%), Gaps = 42/259 (16%)

Query: 38  SKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDL 97
           S  P N  ++  L   +    ++A            +   +V+G G FG V++  + E  
Sbjct: 6   SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD 65

Query: 98  REGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV---- 152
                   VA+K V       Q  R    E+  +  + HPN+V L  +   +  +     
Sbjct: 66  E-------VAIKKVL------QDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112

Query: 153 --LIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYR 204
             L+ E++        +      ++K+   +P  +     +   + LA++H     + +R
Sbjct: 113 LNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHR 165

Query: 205 DFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK--SHVSTRIMGTYGYAAPEYIMTG-HLT 260
           D K  N+LLD      KL DFG AK    G+   S++ +R    Y Y APE I    + T
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELIFGATNYT 220

Query: 261 PRSDVYSFGVVLLEILTGR 279
              D++S G V+ E++ G+
Sbjct: 221 TNIDIWSTGCVMAELMQGQ 239

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 85.5 bits (212), Expect = 9e-19
 Identities = 71/270 (26%), Positives = 108/270 (40%), Gaps = 41/270 (15%)

Query: 28  SPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQD--------RV 79
           S           +P+          D       A +  +  +    F+ D        R 
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE 61

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD--GDNSYQGHREWLAEVIFLGHLSHPN 137
           +G G FG VY      D+R       VA+K     G  S +  ++ + EV FL  L HPN
Sbjct: 62  IGHGSFGAVYFAR---DVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIR-MKIAF---GAAKGLAF 193
            ++  G    +    L+ E+   GS      S +L      ++ ++IA    GA +GLA+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSA-----SDLLEVHKKPLQEVEIAAVTHGALQGLAY 169

Query: 194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR--IMGTYGYAAP 251
           LH     +I+RD K  NILL      KL DFG A        S ++     +GT  + AP
Sbjct: 170 LHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAP 219

Query: 252 EYIMT---GHLTPRSDVYSFGVVLLEILTG 278
           E I+    G    + DV+S G+  +E+   
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAER 249

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 58/228 (25%), Positives = 86/228 (37%), Gaps = 42/228 (18%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD-----GDNSYQGHREWL 124
           +   +     LG G F  V K     +   GL+    A K                 E  
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKC---REKSTGLE---YAAKFIKKRQSRASRRGVCREEIE 63

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            EV  L  + HPN++ L          VLI E ++ G  E  LF          +  K +
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGG--E--LFDF--------LAQKES 111

Query: 185 F---GAAK-------GLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSDFGLAKDG 230
                A         G+ +LH   K + + D K  NI+L        + KL DFGLA + 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

Query: 231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            +G +      I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 170 EDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 27/216 (12%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD----GDNSYQGHREWLA 125
               +    V+G G F  V +     +   G Q    AVK+ D      +      +   
Sbjct: 22  FEDVYELCEVIGKGPFSVVRRC---INRETGQQ---FAVKIVDVAKFTSSPGLSTEDLKR 75

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR---- 180
           E      L HP++V+L+      +  + +++EFM    +   +  +      +S      
Sbjct: 76  EASICHMLKHPHIVELLET-YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134

Query: 181 -MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKS 236
            M+    A   L + H  +  +I+RD K   +LL +       KL  FG+A    E    
Sbjct: 135 YMRQILEA---LRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL- 188

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
            V+   +GT  + APE +         DV+  GV+L
Sbjct: 189 -VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 83.2 bits (206), Expect = 5e-18
 Identities = 74/288 (25%), Positives = 108/288 (37%), Gaps = 52/288 (18%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           F    ++G G +G VYKG     ++ G      A+KV D         E   E+  L   
Sbjct: 26  FELVELVGNGTYGQVYKGR---HVKTG---QLAAIKVMDVTG--DEEEEIKQEINMLKKY 77

Query: 134 S-HPNLVKLIG------YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF- 185
           S H N+    G          D+   L+ EF   GSV + + +     L       IA+ 
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYI 134

Query: 186 --GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR-- 241
                +GL+ LH+ +   I+RD K  N+LL  +   KL DFG++             R  
Sbjct: 135 CREILRGLSHLHQHKV--IHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRN 187

Query: 242 -IMGTYGYAAPEYIMTGHLT-----PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 295
             +GT  + APE I            +SD++S G+  +E+  G   L    P R      
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ 241

Query: 296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
            AL L+           PRL+     K       +   CL  N   RP
Sbjct: 242 -ALFLIPRNPA------PRLKSKKWSKKFQS--FIES-CLVKNHSQRP 279

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 82.7 bits (205), Expect = 5e-18
 Identities = 56/229 (24%), Positives = 83/229 (36%), Gaps = 50/229 (21%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-------HDGDNSYQGHRE 122
              N+    +LG G    V +           +    AVK+              Q  RE
Sbjct: 15  FYENYEPKEILGRGVSSVVRRC---IHKPTCKE---YAVKIIDVTGGGSFSAEEVQELRE 68

Query: 123 WLA-EVIFLGHLS-HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSI 179
               EV  L  +S HPN+++L     E      L+++ M +G  E  LF          +
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKG--E--LFDY--------L 115

Query: 180 RMKIAFG---AAK-------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 229
             K+        K        +  LH  +  +++RD K  NILLD D N KL+DFG +  
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 230 GPEGDKSHVSTRIMGTYGYAAPE------YIMTGHLTPRSDVYSFGVVL 272
              G        + GT  Y APE                 D++S GV++
Sbjct: 174 LDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 28/213 (13%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVI 128
            T  ++    LG G F  V +      +  G +    A  + +         + L  E  
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRC---VKVLAGQE---YAAMIINTKKLSARDHQKLEREAR 62

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR-----MK 182
               L HPN+V+L      +E    LI++ +  G  E  LF  ++    +S       ++
Sbjct: 63  ICRLLKHPNIVRLHDS-ISEEGHHYLIFDLVTGG--E--LFEDIVAREYYSEADASHCIQ 117

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVS 239
               A   +   H  +  V++R+ K  N+LL +       KL+DFGLA +     +    
Sbjct: 118 QILEA---VLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AW 170

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
               GT GY +PE +         D+++ GV+L
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 55/244 (22%), Positives = 92/244 (37%), Gaps = 51/244 (20%)

Query: 62  FTYDELRIITANFRQD----RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------- 110
            T D+  +     R +    + LG G  G V   F   + +   +   VA+++       
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF---ERKTCKK---VAIRIISKRKFA 174

Query: 111 HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK 170
                          E+  L  L+HP ++K+  +  + E   ++ E M  G  E  LF K
Sbjct: 175 IGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK 229

Query: 171 VLLPLPWSIRMKIAFG---AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DY 217
                   +                     + +LH  E  +I+RD K  N+LL +   D 
Sbjct: 230 --------VVGNKRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDC 279

Query: 218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL---TPRSDVYSFGVVLLE 274
             K++DFG +K   E     +   + GT  Y APE +++          D +S GV+L  
Sbjct: 280 LIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 336

Query: 275 ILTG 278
            L+G
Sbjct: 337 CLSG 340

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 65/270 (24%), Positives = 113/270 (41%), Gaps = 35/270 (12%)

Query: 23  SPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGG 82
            P+    +E+ ++++ +            + +          +  R+   +F    VLG 
Sbjct: 292 PPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGK 351

Query: 83  GGFGCV----YKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR-EW-LAE-VIFLGHLSH 135
           G FG V     KG  +++L         AVK+   D   Q    E  + E  +       
Sbjct: 352 GSFGKVMLSERKG--TDEL--------YAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401

Query: 136 PNLVKLIGYCC--EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---G 190
           P L +L  + C    +    + E++  G +  ++        P ++     F AA+   G
Sbjct: 402 PFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV-----FYAAEIAIG 454

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTYGYA 249
           L FL    K +IYRD K  N++LD++ + K++DFG+ K+         +T+   GT  Y 
Sbjct: 455 LFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYI 509

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           APE I         D ++FGV+L E+L G+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 30/218 (13%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
           I   +  +  +G G +G V            ++    A K        +    +  E+  
Sbjct: 7   INQYYTLENTIGRGSWGEVKIA---VQKGTRIR---RAAKKIPKYFV-EDVDRFKQEIEI 59

Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR-----MKI 183
           +  L HPN+++L     ED   + L+ E    G  E  LF +V+    +        MK 
Sbjct: 60  MKSLDHPNIIRLYET-FEDNTDIYLVMELCTGG--E--LFERVVHKRVFRESDAARIMKD 114

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 240
              A   +A+ H  +  V +RD K  N L  T   D   KL DFGLA     G    +  
Sbjct: 115 VLSA---VAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMR 166

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
             +GT  Y +P+ ++ G   P  D +S GV++  +L G
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 55/231 (23%), Positives = 83/231 (35%), Gaps = 48/231 (20%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWL 124
           +  ++     LG G F  V K         G +    A K                 E  
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKC---RQKGTGKE---YAAKFIKKRRLSSSRRGVSREEIE 56

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            EV  L  + HPN++ L          VLI E ++ G  E  LF  +             
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGG--E--LFDFL-----------AE 101

Query: 185 FG------AAK-------GLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSDFGLA 227
                   A +       G+ +LH   K + + D K  NI+L      +   KL DFG+A
Sbjct: 102 KESLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

Query: 228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
                G++      I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 160 HKIEAGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 57/228 (25%), Positives = 85/228 (37%), Gaps = 42/228 (18%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWL 124
           +   +     LG G F  V K     +   GL+    A K                 E  
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKC---REKSTGLE---YAAKFIKKRQSRASRRGVSREEIE 63

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            EV  L  + H N++ L          VLI E ++ G  E  LF          +  K +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG--E--LFDF--------LAQKES 111

Query: 185 F---GAAK-------GLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSDFGLAKDG 230
                A         G+ +LH   K + + D K  NI+L        + KL DFGLA + 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

Query: 231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            +G +      I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 170 EDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 33/219 (15%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD----GDNSYQGHREWLAEVI 128
           ++   + LG G +G V       +         VAVK+ D     D      +E    + 
Sbjct: 8   DWDLVQTLGEGAYGEVQLA---VNRVTEEA---VAVKIVDMKRAVDCPENIKKE----IC 57

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
               L+H N+VK  G+  E   + L  E+ + G  E  LF ++       I M     A 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGG--E--LFDRIEP----DIGMPEP-DAQ 108

Query: 189 K-------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
           +       G+ +LH     + +RD K  N+LLD   N K+SDFGLA      ++  +  +
Sbjct: 109 RFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 242 IMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           + GT  Y APE +          DV+S G+VL  +L G 
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 29/220 (13%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 127
           +   ++  + +G G  G V     + D         VA+K +     N     R    E+
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCA---AYDAVLDRN---VAIKKLSRPFQNQTHAKRA-YREL 112

Query: 128 IFLGHLSHPNLVKLI-----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + +  ++H N++ L+         E+   V L+ E M     + NL   + + L      
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMS 167

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS--HVS 239
            + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+          +V 
Sbjct: 168 YLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           TR      Y APE I+        D++S G ++ E++  +
Sbjct: 226 TRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 41/221 (18%), Positives = 77/221 (34%), Gaps = 36/221 (16%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
           +   +     LG G FG V++     +            K                E+  
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRC---VETSSKKT---YMAKFVKV--KGTDQVLVKKEISI 54

Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--- 186
           L    H N++ L       E  V+I+EF++    +  +F ++                  
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGL--D--IFERI-------NTSAFELNERE 103

Query: 187 AAK-------GLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSH 237
                      L FLH     + + D +  NI+  T  ++  K+ +FG A+    GD   
Sbjct: 104 IVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161

Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           +   +     Y APE      ++  +D++S G ++  +L+G
Sbjct: 162 L---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 51/217 (23%), Positives = 82/217 (37%), Gaps = 40/217 (18%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
           I   F    VLG G F  V+     +    G      A+K     +          E+  
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFLV---KQRLTGKL---FALKCIK-KSPAFRDSSLENEIAV 59

Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF--- 185
           L  + H N+V L     E      L+ + ++ G  E  LF +        I  +  +   
Sbjct: 60  LKKIKHENIVTLEDIY-ESTTHYYLVMQLVSGG--E--LFDR--------ILERGVYTEK 106

Query: 186 GAAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDK 235
            A+         + +LHE    +++RD K  N+L  T   +    ++DFGL+K    G  
Sbjct: 107 DASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162

Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
             + +   GT GY APE +     +   D +S GV+ 
Sbjct: 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 31/221 (14%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 127
           +   ++  + +G G  G V   +   D         VA+K +     N     R    E+
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAY---DAILERN---VAIKKLSRPFQNQTHAKRA-YREL 75

Query: 128 IFLGHLSHPNLVKLI-----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + +  ++H N++ L+         E+   V ++ E M     + NL   + + L    RM
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMEL-DHERM 129

Query: 182 K-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS--HV 238
             + +    G+  LH A   +I+RD K SNI++ +D   K+ DFGLA+          +V
Sbjct: 130 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187

Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            TR      Y APE I+        D++S G ++ E++ G 
Sbjct: 188 VTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 79.9 bits (198), Expect = 4e-17
 Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 39/218 (17%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVI 128
            + N+     LG G F  V +         GL+    A K+ +         + L  E  
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRC---VHKTTGLE---FAAKIINTKKLSARDFQKLEREAR 57

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG- 186
               L HPN+V+L     ++E    L+++ +  G  E  LF          I  +  +  
Sbjct: 58  ICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGG--E--LFED--------IVAREFYSE 104

Query: 187 --AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGD 234
             A+         +A+ H     +++R+ K  N+LL +       KL+DFGLA +  +  
Sbjct: 105 ADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161

Query: 235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
                    GT GY +PE +     +   D+++ GV+L
Sbjct: 162 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 39/218 (17%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVI 128
            + N+     LG G F  V +         GL+    A K+ +    S +  ++   E  
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRC---VHKTTGLE---FAAKIINTKKLSARDFQKLEREAR 80

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG- 186
               L HPN+V+L     ++E    L+++ +  G  E  LF          I  +  +  
Sbjct: 81  ICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGG--E--LFED--------IVAREFYSE 127

Query: 187 --AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGD 234
             A+         +A+ H     +++R+ K  N+LL +       KL+DFGLA +  +  
Sbjct: 128 ADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184

Query: 235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
                    GT GY +PE +     +   D+++ GV+L
Sbjct: 185 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 57/232 (24%), Positives = 85/232 (36%), Gaps = 50/232 (21%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWL 124
           +   +     LG G F  V K     +   GLQ    A K                 +  
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKC---REKSTGLQ---YAAKFIKKRRTKSSRRGVSREDIE 62

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
            EV  L  + HPN++ L     E++  V LI E +A G  E  LF  +            
Sbjct: 63  REVSILKEIQHPNVITLHEVY-ENKTDVILILELVAGG--E--LFDFL-----------A 106

Query: 184 AFG------AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT----DYNAKLSDFGL 226
                    A +       G+ +LH     + + D K  NI+L          K+ DFGL
Sbjct: 107 EKESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

Query: 227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
           A     G++      I GT  + APE +    L   +D++S GV+   +L+G
Sbjct: 165 AHKIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 53/244 (21%), Positives = 85/244 (34%), Gaps = 33/244 (13%)

Query: 50  LRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK 109
           L     A  L      E       +     LG G FG V+         +  +   V VK
Sbjct: 3   LEEPPKAVELEGLAACEGEYS-QKYSTMSPLGSGAFGFVWTA------VDKEKNKEVVVK 55

Query: 110 V-------HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGS 162
                    D         +   E+  L  + H N++K++          L+ E    G 
Sbjct: 56  FIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGL 115

Query: 163 VENNLFSKVLLPLPWSIRMKIAFGAAK------GLAFLHEAEKPVIYRDFKTSNILLDTD 216
              +LF+ +        R+     +         + +L    K +I+RD K  NI++  D
Sbjct: 116 ---DLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAED 166

Query: 217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEI 275
           +  KL DFG A     G   +      GT  Y APE +M   +  P  +++S GV L  +
Sbjct: 167 FTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223

Query: 276 LTGR 279
           +   
Sbjct: 224 VFEE 227

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 79.6 bits (197), Expect = 7e-17
 Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 24/212 (11%)

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLGHLS 134
             + LG G F  V +         G +    A K        Q  R  +  E+  L    
Sbjct: 33  TSKELGRGKFAVVRQC---ISKSTGQE---YAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 135 H-PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---- 189
             P ++ L          +LI E+ A G  E  +FS  L  L   +         K    
Sbjct: 87  SCPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
           G+ +LH+    +++ D K  NILL +     + K+ DFG+++      +      IMGT 
Sbjct: 143 GVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTP 197

Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            Y APE +    +T  +D+++ G++   +LT 
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 41/223 (18%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD----GDNSYQGHREWLAEVI 128
           ++   + LG G +G V       +         VAVK+ D     D      +E    + 
Sbjct: 8   DWDLVQTLGEGAYGEVQLA---VNRVTEEA---VAVKIVDMKRAVDCPENIKKE----IC 57

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK------ 182
               L+H N+VK  G+  E   + L  E+ + G  E  LF ++       I M       
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGG--E--LFDRIEP----DIGMPEPDAQR 109

Query: 183 -----IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
                +A     G+ +LH     + +RD K  N+LLD   N K+SDFGLA      ++  
Sbjct: 110 FFHQLMA-----GVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 238 VSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           +  ++ GT  Y APE +          DV+S G+VL  +L G 
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 79.2 bits (196), Expect = 9e-17
 Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 28/168 (16%)

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
             E   +  L HP  VKL  +  +D+ ++     +   G     L           IR  
Sbjct: 78  TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGE----LL--------KYIRKI 124

Query: 183 IAF--GAAK--------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE 232
            +F     +         L +LH   K +I+RD K  NILL+ D + +++DFG AK    
Sbjct: 125 GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 182

Query: 233 GDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
             K   +   +GT  Y +PE +         SD+++ G ++ +++ G 
Sbjct: 183 ESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGL 229

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 77/286 (26%), Positives = 117/286 (40%), Gaps = 49/286 (17%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-EVIFLG 131
           N+R  + +G G F  V         R  L    VA+K+ D         + L  EV  + 
Sbjct: 16  NYRLLKTIGKGNFAKVKLA------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 69

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK-- 189
            L+HPN+VKL      ++   LI E+ + G     +F  ++       RMK     +K  
Sbjct: 70  ILNHPNIVKLFEVIETEKTLYLIMEYASGG----EVFDYLVA----HGRMKEKEARSKFR 121

Query: 190 ----GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
                + + H+  K +++RD K  N+LLD D N K++DFG + +   G K        G 
Sbjct: 122 QIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GA 176

Query: 246 YGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 304
             YAAPE      +  P  DV+S GV+L  +++G        P   QN     L  L+E+
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS------LPFDGQN-----LKELRER 225

Query: 305 KKLLNIIDPRLEGDYPV-KGVHK-AAMLAYHCLNHNPKARPLMRDI 348
                +    L G Y +   +      L    L  NP  R  +  I
Sbjct: 226 -----V----LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 60/272 (22%), Positives = 94/272 (34%), Gaps = 66/272 (24%)

Query: 16  SSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFR 75
             +  S +      +     +Y    SN + + D                        F 
Sbjct: 20  FQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDF-----------------------FE 56

Query: 76  QDRVLGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS 134
            +  LG G    VY+           L+ +   V                 E+  L  LS
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT----------EIGVLLRLS 106

Query: 135 HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG---AAK- 189
           HPN++KL     E    + L+ E +  G     LF +        I  K  +    AA  
Sbjct: 107 HPNIIKLKEI-FETPTEISLVLELVTGGE----LFDR--------IVEKGYYSERDAADA 153

Query: 190 ------GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKDGPEGDKSHVST 240
                  +A+LH  E  +++RD K  N+L  T   D   K++DFGL+K         +  
Sbjct: 154 VKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMK 208

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
            + GT GY APE +      P  D++S G++ 
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 18/156 (11%)

Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
           L +  HP L  L  Y  +   R+  + E+   G +  +L  + +       R +  F  A
Sbjct: 59  LQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RAR--FYGA 112

Query: 189 K---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-G 244
           +    L +LH   + V+YRD K  N++LD D + K++DFGL K+G        + +   G
Sbjct: 113 EIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCG 167

Query: 245 TYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           T  Y APE +    +     D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 22/214 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ-GHREWLAEVIFLG 131
            F   +VLG G FG V   F+ + +         A+KV                E   L 
Sbjct: 25  QFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81

Query: 132 HLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 189
            ++HP +VKL  Y  + E ++ LI +F+  G +   L  +V+            F  A+ 
Sbjct: 82  EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-----KFYLAEL 135

Query: 190 --GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-GTY 246
              L  LH     +IYRD K  NILLD + + KL+DFGL+K+  + +K         GT 
Sbjct: 136 ALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTV 190

Query: 247 GYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
            Y APE +   GH T  +D +SFGV++ E+LTG 
Sbjct: 191 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 47/232 (20%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-------HDGDNSYQGHRE 122
           +   +   + LG G  G V   F   + +   +   VA+K+                   
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAF---ERKTCKK---VAIKIISKRKFAIGSAREADPALN 61

Query: 123 WLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
              E+  L  L+HP ++K+  +  + E   ++ E M  G  E  LF K        +   
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG--E--LFDK--------VVGN 108

Query: 183 IAFG---AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKD 229
                             + +LHE    +I+RD K  N+LL +   D   K++DFG +K 
Sbjct: 109 KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166

Query: 230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHL---TPRSDVYSFGVVLLEILTG 278
             E     + T   GT  Y APE +++          D +S GV+L   L+G
Sbjct: 167 LGETSL--MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 20/164 (12%)

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
             E+  +  L HP LV L  Y  +DE  + ++ + +  G +  +L   V         +K
Sbjct: 63  FKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVK 118

Query: 183 IAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
                 +    L +L    + +I+RD K  NILLD   +  ++DF +A   P   +    
Sbjct: 119 --LFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---I 171

Query: 240 TRIMGTYGYAAPEYIM----TGHLTPRSDVYSFGVVLLEILTGR 279
           T + GT  Y APE        G+ +   D +S GV   E+L GR
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGR 214

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 24/216 (11%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW---LAEVIF 129
            F   RVLG GG+G V   F    +         A+KV       +  ++     AE   
Sbjct: 18  CFELLRVLGKGGYGKV---FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74

Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
           L  + HP +V LI Y  +   ++ LI E+++ G +   L  + +     +      F  A
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-----CFYLA 128

Query: 189 K---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM-G 244
           +    L  LH+  K +IYRD K  NI+L+   + KL+DFGL K+          T    G
Sbjct: 129 EISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---VTHTFCG 183

Query: 245 TYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           T  Y APE +M +GH     D +S G ++ ++LTG 
Sbjct: 184 TIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 59/233 (25%), Positives = 85/233 (36%), Gaps = 52/233 (22%)

Query: 70  ITANFRQD-----RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
            +  F         VLG G    V       +L    +    AVK+ +            
Sbjct: 6   FSGRFEDVYQLQEDVLGEGAHARVQTC---INLITSQE---YAVKIIE-KQPGHIRSRVF 58

Query: 125 AEVIFLGHLS-HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
            EV  L     H N+++LI +  E+E R  L++E M  GS    + S         I  +
Sbjct: 59  REVEMLYQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGS----ILSH--------IHKR 105

Query: 183 IAFG---AAK-------GLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGLAKD 229
             F    A+         L FLH   K + +RD K  NIL +        K+ DF L   
Sbjct: 106 RHFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163

Query: 230 -GPEGDKSHVSTRIM----GTYGYAAPEYIMTGHLTPRS-----DVYSFGVVL 272
               GD S +ST  +    G+  Y APE +              D++S GV+L
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 66/283 (23%), Positives = 108/283 (38%), Gaps = 24/283 (8%)

Query: 5   WCKWEPSVYIVSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTY 64
           W       + V +  + E       +     +                +S A  +     
Sbjct: 80  WTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLA 139

Query: 65  DELRIITAN-FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR-E 122
                +T N F   ++LG G FG V         +E       A+K+   +         
Sbjct: 140 KPKHRVTMNEFEYLKLLGKGTFGKVILV------KEKATGRYYAMKILKKEVIVAKDEVA 193

Query: 123 W-LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIR 180
             L E   L +  HP L  L  Y  +   R+  + E+   G +  +L  + +       R
Sbjct: 194 HTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---R 249

Query: 181 MKIAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
            +  F  A+    L +LH +EK V+YRD K  N++LD D + K++DFGL K+G +     
Sbjct: 250 AR--FYGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 304

Query: 238 VSTRIM-GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            + +   GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 305 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 44/239 (18%)

Query: 64  YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHR- 121
             EL  + + +   R +  G +G V  G  SE +        VA+K V +  +  +    
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIP-------VAIKRVFNTVSDGRTVNI 66

Query: 122 ---EWLA-----EVIFLGHLSHPNLVKL----IGYCCEDEHRV-LIYEFMARGSVENNLF 168
               +L      E+  L H  HPN++ L    + +     H++ L+ E M       +L 
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDL- 120

Query: 169 SKVL----LPLPWSIRMK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD 223
           ++V+    + +     ++   +    GL  LHEA   V++RD    NILL  + +  + D
Sbjct: 121 AQVIHDQRIVIS-PQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICD 177

Query: 224 FGLAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
           F LA++         +V+ R      Y APE +M     T   D++S G V+ E+   +
Sbjct: 178 FNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 28/219 (12%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 127
           +   +     +G G +G V       D R G +   VA+K +     +     R    E+
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAI---DKRSGEK---VAIKKLSRPFQSEIFAKRA-YREL 74

Query: 128 IFLGHLSHPNLVKLI-----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRM 181
           + L H+ H N++ L+          + +   L+  FM     + +L   + L        
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQ 129

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
            + +   KGL ++H A   V++RD K  N+ ++ D   K+ DFGLA+        +V TR
Sbjct: 130 YLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 187

Query: 242 IMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                 Y APE I++  H     D++S G ++ E+LTG+
Sbjct: 188 W-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 63/278 (22%), Positives = 104/278 (37%), Gaps = 32/278 (11%)

Query: 15  VSSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANF 74
           ++ +      +  S    A           + +        AN     T    ++   NF
Sbjct: 1   MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANL----TGHAEKVGIENF 56

Query: 75  RQDRVLGGGGFGCVY--KGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREW-LAE-VI 128
              +VLG G +G V+  +     D  +       A+KV             E    E  +
Sbjct: 57  ELLKVLGTGAYGKVFLVRKISGHDTGK-----LYAMKVLKKATIVQKAKTTEHTRTERQV 111

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA 187
                  P LV L  Y  + E ++ LI +++  G +  +L  +                 
Sbjct: 112 LEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-----QIYV 165

Query: 188 AK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
            +    L  LH+    +IYRD K  NILLD++ +  L+DFGL+K+    +         G
Sbjct: 166 GEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCG 222

Query: 245 TYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGR 279
           T  Y AP+ +    +GH     D +S GV++ E+LTG 
Sbjct: 223 TIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGA 259

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 16/157 (10%)

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           +      HP L  +     + +  +  + E++  G +  ++ S     L  +      F 
Sbjct: 70  VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-----TFY 123

Query: 187 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           AA+   GL FLH   K ++YRD K  NILLD D + K++DFG+ K+   GD     T   
Sbjct: 124 AAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTF 178

Query: 244 -GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
            GT  Y APE ++        D +SFGV+L E+L G+
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 75.7 bits (187), Expect = 9e-16
 Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 36/220 (16%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 126
           ++     LG G FG V  G   E    G +   VAVK+         D   +  RE    
Sbjct: 12  HYVLGDTLGVGTFGKVKIG---EHQLTGHK---VAVKILNRQKIRSLDVVGKIKRE---- 61

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           +  L    HP+++KL           ++ E+++ G     LF  +        R++    
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE----LFDYICK----HGRVEEMEA 113

Query: 187 AAK------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
                     + + H     V++RD K  N+LLD   NAK++DFGL+    +G+    S 
Sbjct: 114 RRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 171

Query: 241 RIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
              G+  YAAPE I    +  P  D++S GV+L  +L G 
Sbjct: 172 ---GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 18/158 (11%)

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           + L ++ HP LV L  +  +   ++  + +++  G +  +L  +     P +      F 
Sbjct: 91  VLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-----RFY 144

Query: 187 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           AA+    L +LH     ++YRD K  NILLD+  +  L+DFGL K+  E +    +T   
Sbjct: 145 AAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTF 199

Query: 244 -GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
            GT  Y APE +    +     D +  G VL E+L G 
Sbjct: 200 CGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 42/307 (13%), Positives = 84/307 (27%), Gaps = 62/307 (20%)

Query: 68  RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLA 125
           RI    +R     GG      ++     D         VA+      G       +E L+
Sbjct: 27  RIANGRYRLLIFHGGVPPLQFWQA---LDTALD---RQVALTFVDPQGVLPDDVLQETLS 80

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
             + L  +  P + +++         +++ E++  GS++  +      P+     ++   
Sbjct: 81  RTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQE-VADTSPSPVG---AIRAMQ 136

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             A      H A   V       S + +  D +  L+                       
Sbjct: 137 SLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA-------------------- 174

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 305
                          P+ D+   G  L  +L  R       P  E  +     P  ++  
Sbjct: 175 --TMPDA-------NPQDDIRGIGASLYALLVNR------WPLPEAGVRSGLAPAERDTA 219

Query: 306 KLLNIIDPRLEGDYPVKGVHKA-AMLAYHCLNHNPKARP------LMRDIVDSLEPLQVL 358
                I+P          +    + +A   +  +   R       LM+      +  +VL
Sbjct: 220 G--QPIEPADIDR----DIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVL 273

Query: 359 PDEAPTP 365
                 P
Sbjct: 274 GPIDEAP 280

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 39/110 (35%), Positives = 52/110 (47%), Gaps = 14/110 (12%)

Query: 174 PLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG 233
            L     +  +F  AKG+ FL  A +  I+RD    NILL      K+ DFGLA+D  + 
Sbjct: 189 FLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246

Query: 234 D--KSHVSTRI----MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT 277
                    R+    M      APE I     T +SDV+SFGV+L EI +
Sbjct: 247 PDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 3/100 (3%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
             +  + LG G FG V +      + +      VAVK+     ++  HR  ++E+  L H
Sbjct: 23  RLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 133 L-SHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSK 170
           +  H N+V L+G C +    + +I EF   G++   L SK
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 63/300 (21%), Positives = 106/300 (35%), Gaps = 74/300 (24%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL-- 130
            +R   +LG GGFG V+ G     L + L    VA+KV   +          +    L  
Sbjct: 32  EYRLGPLLGKGGFGTVFAG---HRLTDRL---QVAIKVIPRNRVLGWSPLSDSVTCPLEV 85

Query: 131 -------GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
                      HP +++L+ +    E  +L+ E         +LF  +        +  +
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITE------KGPL 136

Query: 184 AFGAAK--------GLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLA---KDGP 231
             G ++         +   H   + V++RD K  NIL+D      KL DFG      D P
Sbjct: 137 GEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP 194

Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLT-PRSDVYSFGVVLLEILTGRKSLDKSRPARE 290
                       GT  Y+ PE+I         + V+S G++L +++ G            
Sbjct: 195 ----YTDFD---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD----------- 236

Query: 291 QNLADWALPLLKEKKKLLNIIDPRLEGDYPV-KGVHKAAM-LAYHCLNHNPKARPLMRDI 348
                  +P  ++++         LE +      V      L   CL   P +RP + +I
Sbjct: 237 -------IPFERDQEI--------LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 50/221 (22%), Positives = 80/221 (36%), Gaps = 46/221 (20%)

Query: 71  TANFRQD----RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE 126
           +  F         +G G +    +          ++    AVK+ D  +      E    
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRC---IHKATNME---FAVKIID-KSKRDPTEE---I 66

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
            I L +  HPN++ L     +D   V ++ E M  G     L  K        I  +  F
Sbjct: 67  EILLRYGQHPNIITLKDV-YDDGKYVYVVTELMKGGE----LLDK--------ILRQKFF 113

Query: 186 G---AAK-------GLAFLHEAEKPVIYRDFKTSNILL-DTDYNA---KLSDFGLAKDGP 231
               A+         + +LH   + V++RD K SNIL  D   N    ++ DFG AK   
Sbjct: 114 SEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171

Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
             +   +      T  + APE +         D++S GV+L
Sbjct: 172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 62/274 (22%), Positives = 98/274 (35%), Gaps = 45/274 (16%)

Query: 21  SESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVL 80
           S        S    +     P N      L       PL +            ++   +L
Sbjct: 3   SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES-----------QYQVGPLL 51

Query: 81  GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA-----EVIFLGHLSH 135
           G GGFG VY G     + + L   PVA+K  + D                EV+ L  +S 
Sbjct: 52  GSGGFGSVYSG---IRVSDNL---PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 136 --PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFGAAKGL 191
               +++L+ +    +  VLI E       +  LF  +     L   +     +   + +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAV 162

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLA---KDGPEGDKSHVSTRIMGTYG 247
              H     V++RD K  NIL+D +    KL DFG     KD              GT  
Sbjct: 163 RHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFD---GTRV 213

Query: 248 YAAPEYIMTGHL--TPRSDVYSFGVVLLEILTGR 279
           Y+ PE+I   H      + V+S G++L +++ G 
Sbjct: 214 YSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 18/158 (11%)

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           +F    +HP LV L   C + E R+  + E++  G +  ++  +  LP   +      F 
Sbjct: 62  VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-----RFY 115

Query: 187 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           +A+    L +LHE  + +IYRD K  N+LLD++ + KL+D+G+ K+G        +T   
Sbjct: 116 SAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 170

Query: 244 -GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            GT  Y APE I+ G     S D ++ GV++ E++ GR
Sbjct: 171 CGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 207

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 18/162 (11%)

Query: 126 EVIFLGHLSHPNLVKLIGYC-CEDEHRVLIY---EFMARGSVENNLFSKVLL-PLPWSIR 180
           E+  L  L HPN+VKL      +D +   +Y   E + +G     +     L PL     
Sbjct: 86  EIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGP----VMEVPTLKPLSEDQA 139

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
                   KG+ +LH   + +I+RD K SN+L+  D + K++DFG++ +  +G  + +S 
Sbjct: 140 RFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSDALLSN 196

Query: 241 RIMGTYGYAAPEYIMTGHLT---PRSDVYSFGVVLLEILTGR 279
            + GT  + APE +            DV++ GV L   + G+
Sbjct: 197 TV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 18/158 (11%)

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           I     +HP L +L   C +   R+  + EF+  G +  ++          +      F 
Sbjct: 76  ILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-----RFY 129

Query: 187 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           AA+    L FLH+  K +IYRD K  N+LLD + + KL+DFG+ K+G        +T   
Sbjct: 130 AAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATF 184

Query: 244 -GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
            GT  Y APE +    +  P  D ++ GV+L E+L G 
Sbjct: 185 CGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG--DNSYQGHREWLAEV 127
           +   ++    +G G +G V   F ++          VAVK       +     R    E+
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLR------VAVKKLSRPFQSIIHAKRT-YREL 79

Query: 128 IFLGHLSHPNLVKLI-----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWS-IR 180
             L H+ H N++ L+         E+ + V L+   M       +L + ++     +   
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADL-NNIVKCQKLTDDH 133

Query: 181 MK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
           ++ + +   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+
Sbjct: 134 VQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA 191

Query: 240 TRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
           TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 TRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 18/158 (11%)

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           +       P L +L   C +   R+  + E++  G +  ++        P +      F 
Sbjct: 73  VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-----VFY 126

Query: 187 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           AA+   GL FL    K +IYRD K  N++LD++ + K++DFG+ K+         +T+  
Sbjct: 127 AAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTF 181

Query: 244 -GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
            GT  Y APE I    +     D ++FGV+L E+L G+
Sbjct: 182 CGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 127
           + A +R  + +G G +G V       D R G +   VA+K ++    +     R    E+
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAV---DGRTGAK---VAIKKLYRPFQSELFAKRA-YREL 75

Query: 128 IFLGHLSHPNLVKLI-----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWS-IR 180
             L H+ H N++ L+         +D     L+  FM       +L  K++        R
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDL-GKLMKHEKLGEDR 129

Query: 181 MK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS 239
           ++ + +   KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+        +V 
Sbjct: 130 IQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187

Query: 240 TRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
           TR      Y APE I+     T   D++S G ++ E++TG+
Sbjct: 188 TRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 74.5 bits (184), Expect = 4e-15
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREW-----LAE 126
            + +   +G G +G V+K     +   G     VA+K   + ++             L E
Sbjct: 4   KYEKIGKIGEGSYGVVFKC---RNRDTG---QIVAIKKFLESED-----DPVIKKIALRE 52

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRM 181
           +  L  L HPNLV L+          L++E+      ++ +     L      +P  +  
Sbjct: 53  IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC-----DHTV--LHELDRYQRGVPEHLVK 105

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSH-V 238
            I +   + + F H+     I+RD K  NIL+      KL DFG A+   GP       V
Sbjct: 106 SITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163

Query: 239 STRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           +TR      Y +PE ++      P  DV++ G V  E+L+G 
Sbjct: 164 ATR-----WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 42/218 (19%)

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS- 134
           +D+ LG G F    K       +        AVK+          +E    +  L     
Sbjct: 15  KDKPLGEGSFSICRKC---VHKKSNQA---FAVKIISKRMEANTQKE----ITALKLCEG 64

Query: 135 HPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG---AAK- 189
           HPN+VKL      D+    L+ E +  G     LF +        I+ K  F    A+  
Sbjct: 65  HPNIVKLHEV-FHDQLHTFLVMELLNGGE----LFER--------IKKKKHFSETEASYI 111

Query: 190 ------GLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFGLAKDGPEGDKSHVST 240
                  ++ +H  +  V++RD K  N+L    + +   K+ DFG A+  P  ++  + T
Sbjct: 112 MRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKT 168

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
               T  YAAPE +         D++S GV+L  +L+G
Sbjct: 169 PC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 18/158 (11%)

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           +F    +HP LV L   C + E R+  + E++  G +  ++  +  LP   +      F 
Sbjct: 105 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-----RFY 158

Query: 187 AAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           +A+    L +LHE  + +IYRD K  N+LLD++ + KL+D+G+ K+G        +T   
Sbjct: 159 SAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 213

Query: 244 -GTYGYAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGR 279
            GT  Y APE I+ G     S D ++ GV++ E++ GR
Sbjct: 214 CGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 59/252 (23%), Positives = 102/252 (40%), Gaps = 32/252 (12%)

Query: 38  SKLPSNPEEVEDLRRDSAANPLIAFTYDELRIIT-ANFRQDRVLGGGGFGCVYKGFISED 96
           +K  S  E V++    +  + L  +            F + + LG G FG V        
Sbjct: 6   AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML------ 59

Query: 97  LREGLQPVPVAVKV----HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV 152
           ++        A+K+             H   L E   L  ++ P LVKL  +  +D   +
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHT--LNEKRILQAVNFPFLVKLE-FSFKDNSNL 116

Query: 153 -LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK---GLAFLHEAEKPVIYRDFKT 208
            ++ E++A G + ++L        P +      F AA+      +LH     +IYRD K 
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLTFEYLHS--LDLIYRDLKP 169

Query: 209 SNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYS 267
            N+L+D     +++DFG AK       +     + GT    APE I++ G+     D ++
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY-NKAVDWWA 223

Query: 268 FGVVLLEILTGR 279
            GV++ E+  G 
Sbjct: 224 LGVLIYEMAAGY 235

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 59/277 (21%), Positives = 103/277 (37%), Gaps = 50/277 (18%)

Query: 16  SSNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFR 75
             +P    P    P +         P+ P      ++    +        +  II     
Sbjct: 7   GQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPP-QQFPQFHVKSGLQIKKNAIIDDYKV 65

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLS 134
             +VLG G  G V + F   + R   +    A+K+  D   + +       EV      S
Sbjct: 66  TSQVLGLGINGKVLQIF---NKRTQEK---FALKMLQDCPKARR-------EVELHWRAS 112

Query: 135 -HPNLVKLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG-- 186
             P++V+++    E+ +       ++ E +  G     LFS++        R   AF   
Sbjct: 113 QCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGE----LFSRIQD------RGDQAFTER 161

Query: 187 -AA-------KGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA--KLSDFGLAKDGPEGDK 235
            A+       + + +LH     + +RD K  N+L      NA  KL+DFG AK+    + 
Sbjct: 162 EASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219

Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVL 272
             ++T    T  Y APE +         D++S GV++
Sbjct: 220 --LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 53/227 (23%), Positives = 99/227 (43%), Gaps = 39/227 (17%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVI 128
           +   +     +G G +G V   +   D    ++   VA+K +   ++     R  L E+ 
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAY---DNLNKVR---VAIKKISPFEHQTYCQRT-LREIK 77

Query: 129 FLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK- 182
            L    H N++ +          + +   ++ + M     E +L  K+       ++ + 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDL-YKL-------LKTQH 124

Query: 183 --------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK-DGPEG 233
                     +   +GL ++H A   V++RD K SN+LL+T  + K+ DFGLA+   P+ 
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

Query: 234 DKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
           D +   T  + T  Y APE ++     T   D++S G +L E+L+ R
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 40/222 (18%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREW-----LAE 126
            +    ++G G +G V K     +   G     VA+K   + D+      +      + E
Sbjct: 26  KYENLGLVGEGSYGMVMKC---RNKDTG---RIVAIKKFLESDD-----DKMVKKIAMRE 74

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRM 181
           +  L  L H NLV L+  C + +   L++EF+     ++ +     L      L + +  
Sbjct: 75  IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-----DHTI--LDDLELFPNGLDYQVVQ 127

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSH-V 238
           K  F    G+ F H     +I+RD K  NIL+      KL DFG A+    P       V
Sbjct: 128 KYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV 185

Query: 239 STRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           +TR      Y APE ++         DV++ G ++ E+  G 
Sbjct: 186 ATR-----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 36/220 (16%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 126
           ++     LG G FG V  G   +    G +   VAVK+         D   +  RE    
Sbjct: 17  HYILGDTLGVGTFGKVKVG---KHELTGHK---VAVKILNRQKIRSLDVVGKIRRE---- 66

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           +  L    HP+++KL           ++ E+++ G  E  LF  +      + R+     
Sbjct: 67  IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG--E--LFDYICK----NGRLDEKES 118

Query: 187 AAK------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
                    G+ + H     V++RD K  N+LLD   NAK++DFGL+    +G+    S 
Sbjct: 119 RRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 176

Query: 241 RIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
              G+  YAAPE I    +  P  D++S GV+L  +L G 
Sbjct: 177 ---GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 37/220 (16%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 126
            +     LG G FG V         +   +   VA+K          D   +  RE    
Sbjct: 10  PYIIRETLGEGSFGKVKLA---THYKTQQK---VALKFISRQLLKKSDMHMRVERE---- 59

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           + +L  L HP+++KL          V++ E+         LF  ++       RM    G
Sbjct: 60  ISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-----AGGELFDYIV----EKKRMTEDEG 110

Query: 187 AAK------GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
                     + + H     +++RD K  N+LLD + N K++DFGL+    +G+    S 
Sbjct: 111 RRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168

Query: 241 RIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
              G+  YAAPE I    +  P  DV+S G+VL  +L GR
Sbjct: 169 ---GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 54/258 (20%), Positives = 95/258 (36%), Gaps = 71/258 (27%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
            +  +   + LG G FG V + F  E  +        A+K    D  Y+       E+  
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGK------RFALKKVLQDPRYK-----NRELDI 53

Query: 130 LGHLSHPNLVKL--IGYCCEDEHRV----------------------------------- 152
           +  L H N++KL    Y   DE                                      
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 153 -LIYEFMARGSVENNL------FSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD 205
            +I E++      + L      F +    +P ++     +   + + F+H     + +RD
Sbjct: 114 NVIMEYV-----PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRD 166

Query: 206 FKTSNILLD-TDYNAKLSDFGLAKDGPEGDK--SHVSTRIMGTYGYAAPEYIMTG-HLTP 261
            K  N+L++  D   KL DFG AK     +   +++ +R    + Y APE ++     TP
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTP 221

Query: 262 RSDVYSFGVVLLEILTGR 279
             D++S G V  E++ G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 64/321 (19%), Positives = 116/321 (36%), Gaps = 79/321 (24%)

Query: 17  SNPKSESPKDESPSEKAKKEYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQ 76
           S+ ++ + +  +   +     S+      +     + +A+ P     +     I   +  
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQ----IPDRYEI 57

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEVIFLGHLS 134
             ++G G +G V + +   D  E      VA+K +    ++     R  L E+  L  L+
Sbjct: 58  RHLIGTGSYGHVCEAY---DKLEKRV---VAIKKILRVFEDLIDCKRI-LREIAILNRLN 110

Query: 135 HPNLVKL----IGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA- 188
           H ++VK+    I    E    + ++ E       +++   K+        R  +      
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDF-KKL-------FRTPVYLTELH 157

Query: 189 ---------KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKS- 236
                     G+ ++H A   +++RD K +N L++ D + K+ DFGLA+  D PE   S 
Sbjct: 158 IKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 237 ---------------------------HVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSF 268
                                      HV TR      Y APE I+     T   DV+S 
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW-----YRAPELILLQENYTEAIDVWSI 270

Query: 269 GVVLLEILTGRKSLDKSRPAR 289
           G +  E+L   K        R
Sbjct: 271 GCIFAELLNMIKENVAYHADR 291

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 60/291 (20%), Positives = 102/291 (35%), Gaps = 54/291 (18%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH--REWLAEVIFL 130
            +   + +G G FG         D         VAVK  +   +   +  RE    +I  
Sbjct: 21  RYDFVKDIGSGNFGVARLM---RDKLTKEL---VAVKYIERGAAIDENVQRE----IINH 70

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK- 189
             L HPN+V+         H  +I E+ + G     L+ ++      + R          
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGG----ELYERICN----AGRFSEDEARFFF 122

Query: 190 -----GLAFLHEAEKPVIYRDFKTSNILLDTDY--NAKLSDFGLAKDGPEGDKSHVSTRI 242
                G+++ H     + +RD K  N LLD       K+ DFG +K      +   +   
Sbjct: 123 QQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-- 178

Query: 243 MGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL 301
            GT  Y APE ++   +    +DV+S GV L  +L G        P  +           
Sbjct: 179 -GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAY------PFEDPEEP------- 224

Query: 302 KEKKKLLNIIDPRLEGDYPV-KGVH---KAAMLAYHCLNHNPKARPLMRDI 348
           ++ +K +  I   L   Y +   +    +   L       +P  R  + +I
Sbjct: 225 RDYRKTIQRI---LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 32/227 (14%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDG-DNSYQGHREWLAEVI 128
           I+++F+   +LG G +G V           G     VA+K  +  D      R  L E+ 
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSAT---HKPTGEI---VAIKKIEPFDKPLFALRT-LREIK 61

Query: 129 FLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWS-IRMK 182
            L H  H N++ +                +I E M     + +L  +V+     S   ++
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDL-HRVISTQMLSDDHIQ 115

Query: 183 -IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA----KDGPEGDKSH 237
              +   + +  LH +   VI+RD K SN+L++++ + K+ DFGLA    +   +  +  
Sbjct: 116 YFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 238 VSTRIMGTY----GYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGR 279
                M  +     Y APE ++T    +   DV+S G +L E+   R
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 34/229 (14%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
           + + +   + LG GG G V+      D     +   VA+K     +        L E+  
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAV---DNDCDKR---VAIKKIVLTDPQSVKHA-LREIKI 61

Query: 130 LGHLSHPNLVKLI-------------GYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPL 175
           +  L H N+VK+                   + + V ++ E+M     E +L + VL   
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDL-ANVLEQG 115

Query: 176 PWS-IRMK-IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAK-DGP 231
           P      +   +   +GL ++H A   V++RD K +N+ ++T D   K+ DFGLA+   P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

Query: 232 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
                   +  + T  Y +P  +++  + T   D+++ G +  E+LTG+
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 70.6 bits (174), Expect = 6e-14
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 30/220 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
            + +   +G G +G V+K    ++         VA+K    D+  +G     L E+  L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKA---KNRETH---EIVALKRVRLDDDDEGVPSSALREICLLK 56

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRMKIAFG 186
            L H N+V+L      D+   L++EF      + +L  K         L   I     F 
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFC-----DQDL--KKYFDSCNGDLDPEIVKSFLFQ 109

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSH-VSTRIM 243
             KGL F H   + V++RD K  N+L++ +   KL++FGLA+    P    S  V T   
Sbjct: 110 LLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL-- 165

Query: 244 GTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSL 282
               Y  P+ +      +   D++S G +  E+    + L
Sbjct: 166 ---WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 71.1 bits (175), Expect = 6e-14
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 30/219 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWLAEV 127
            F+Q   LG G +  VYKG            V VA+K       +G  S       + E+
Sbjct: 6   QFKQLEKLGNGTYATVYKG------LNKTTGVYVALKEVKLDSEEGTPSTA-----IREI 54

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMA---RGSVENNLFSKVLLPLPWSIRMKIA 184
             +  L H N+V+L      +    L++EFM    +  +++         L  ++     
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSH-VSTR 241
           +   +GLAF HE    +++RD K  N+L++     KL DFGLA     P    S  V T 
Sbjct: 115 WQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172

Query: 242 IMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
                 Y AP+ +M +   +   D++S G +L E++TG+
Sbjct: 173 -----WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 71.0 bits (175), Expect = 6e-14
 Identities = 51/165 (30%), Positives = 82/165 (49%), Gaps = 27/165 (16%)

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFS----KVLLPLPWS 178
             E + L  ++HP ++++     +D  ++ +I +++  G     LFS        P P  
Sbjct: 54  NDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGE----LFSLLRKSQRFPNP-- 106

Query: 179 IRMKIAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
              K  F AA+    L +LH   K +IYRD K  NILLD + + K++DFG AK  P+   
Sbjct: 107 -VAK--FYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161

Query: 236 SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGR 279
           +     + GT  Y APE + T  +     D +SFG+++ E+L G 
Sbjct: 162 T-----LCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGY 200

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 24/167 (14%)

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFS---KVLLPLPWSI 179
             E   +   + P +V+L  Y  +D+  + ++ E+M  G    +L +      +P  W+ 
Sbjct: 117 WEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGG----DLVNLMSNYDVPEKWA- 170

Query: 180 RMKIAFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
                F  A+    L  +H      I+RD K  N+LLD   + KL+DFG      +    
Sbjct: 171 ----RFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224

Query: 237 HVSTRIMGTYGYAAPEYIMT----GHLTPRSDVYSFGVVLLEILTGR 279
              T + GT  Y +PE + +    G+     D +S GV L E+L G 
Sbjct: 225 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 27/216 (12%)

Query: 80  LGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLGHLSHPNL 138
           +G G +G VYK    +D ++       A+K +     S    RE    +  L  L HPN+
Sbjct: 29  VGRGTYGHVYKA-KRKDGKDD---KDYALKQIEGTGISMSACRE----IALLRELKHPNV 80

Query: 139 VKLIGYCCEDEHR--VLIYEFMAR------GSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
           + L         R   L++++              +  +K  + LP  +   + +    G
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNA----KLSDFGLAK--DGPEGDKSHVSTRIMG 244
           + +LH     V++RD K +NIL+  +       K++D G A+  + P    + +   ++ 
Sbjct: 141 IHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197

Query: 245 TYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           T+ Y APE ++   H T   D+++ G +  E+LT  
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 38/165 (23%), Positives = 69/165 (41%), Gaps = 29/165 (17%)

Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFS-----KVLLPLPWSIRMKI 183
           L +     +  L  Y  +D++ + L+ ++   G    +L +     +  LP   +     
Sbjct: 128 LVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGG----DLLTLLSKFEDRLPEEMA----- 177

Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F  A+    +  +H+     ++RD K  NIL+D + + +L+DFG      E      S 
Sbjct: 178 RFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235

Query: 241 RIMGTYGYAAPEYIMT------GHLTPRSDVYSFGVVLLEILTGR 279
             +GT  Y +PE +         +  P  D +S GV + E+L G 
Sbjct: 236 -AVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGE 278

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 61/233 (26%), Positives = 93/233 (39%), Gaps = 55/233 (23%)

Query: 71  TANFRQD-----RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWL 124
                 D     +VLG G  G V + F     R G +    A+K+ +D   + Q      
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECF---HRRTGQK---CALKLLYDSPKARQ------ 70

Query: 125 AEVIFLGHLS-HPNLVKLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLLPLPWS 178
            EV      S  P++V ++    E+ H       +I E M  G     LFS++       
Sbjct: 71  -EVDHHWQASGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGE----LFSRIQE----- 119

Query: 179 IRMKIAFG---AAK-------GLAFLHEAEKPVIYRDFKTSNILL-DTDYNA--KLSDFG 225
            R   AF    AA+        + FLH     + +RD K  N+L    + +A  KL+DFG
Sbjct: 120 -RGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176

Query: 226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            AK+  +     + T    T  Y APE +         D++S GV++  +L G
Sbjct: 177 FAKETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 35/166 (21%), Positives = 63/166 (37%), Gaps = 29/166 (17%)

Query: 130 LGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFS-----KVLLPLPWSIRMKI 183
           L +     + +L  +  +DE+ + L+ E+   G    +L +        +P   +     
Sbjct: 115 LVNGDRRWITQLH-FAFQDENYLYLVMEYYVGG----DLLTLLSKFGERIPAEMA----- 164

Query: 184 AFGAAK---GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F  A+    +  +H      ++RD K  NILLD   + +L+DFG               
Sbjct: 165 RFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVY-------SFGVVLLEILTGR 279
            + GT  Y +PE +      P +  Y       + GV   E+  G+
Sbjct: 223 AV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 39/221 (17%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWLAEV 127
            + +   LG G +  VYKG      +  L    VA+K       +G          + EV
Sbjct: 3   TYIKLDKLGEGTYATVYKG------KSKLTDNLVALKEIRLEHEEGAPCTA-----IREV 51

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRMK 182
             L  L H N+V L      ++   L++E++     + +L  K  L      +       
Sbjct: 52  SLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-----DKDL--KQYLDDCGNIINMHNVKL 104

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA--KDGPEGDKSH-VS 239
             F   +GLA+ H   + V++RD K  N+L++     KL+DFGLA  K  P     + V 
Sbjct: 105 FLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV 162

Query: 240 TRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           T       Y  P+ ++ +   + + D++  G +  E+ TGR
Sbjct: 163 TL-----WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 69.1 bits (170), Expect = 3e-13
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 43/225 (19%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVA---VKVHDGDNSYQG-HREWLAEVI 128
            + +   LG G F  VYK     D         VA   +K+     +  G +R  L E+ 
Sbjct: 11  RYEKLDFLGEGQFATVYKA---RDKNTN---QIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
            L  LSHPN++ L+       +  L+++FM     E +L  +V++         +    +
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFM-----ETDL--EVIIK-----DNSLVLTPS 112

Query: 189 ----------KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKS 236
                     +GL +LH+    +++RD K +N+LLD +   KL+DFGLAK    P    +
Sbjct: 113 HIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170

Query: 237 H-VSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           H V TR      Y APE +          D+++ G +L E+L   
Sbjct: 171 HQVVTR-----WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 53/259 (20%), Positives = 97/259 (37%), Gaps = 60/259 (23%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 127
           +  N+    ++G G +G VY  +   D         VA+K V+   ++     R  L E+
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAY---DKNTEKN---VAIKKVNRMFEDLIDCKRI-LREI 76

Query: 128 IFLGHLSHPNLVKLI-----GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK 182
             L  L    +++L          + +   ++ E       +++L  K+        +  
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDL-KKL-------FKTP 123

Query: 183 IAFGAA----------KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA----- 227
           I                G  F+HE+   +I+RD K +N LL+ D + K+ DFGLA     
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181

Query: 228 -----------KDGPEGDKSHVSTRIMGTY----GYAAPEYIMTGHL-TPRSDVYSFGVV 271
                      ++   G  +    + + ++     Y APE I+     T   D++S G +
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241

Query: 272 LLEILTGRKSLDKSRPARE 290
             E+L   +S       R 
Sbjct: 242 FAELLNMLQSHINDPTNRF 260

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 45/230 (19%), Positives = 93/230 (40%), Gaps = 34/230 (14%)

Query: 64  YDELRI---ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
           Y+   +      +++  R LG G +  V++     +  +      V VK+          
Sbjct: 25  YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK------VVVKILKPVK----K 74

Query: 121 REWLAEVIFLGHLS-HPNLVKLIGYCCEDEHR--VLIYEFMARGSVENNLFSKVLLPLPW 177
           ++   E+  L +L   PN++ L     +   R   L++E      V N  F ++   L  
Sbjct: 75  KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTLTD 129

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-KLSDFGLAKDGPEGDK- 235
                  +   K L + H     +++RD K  N+++D ++   +L D+GLA+    G + 
Sbjct: 130 YDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187

Query: 236 -SHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSL 282
              V++R    Y +  PE ++          D++S G +L  ++  ++  
Sbjct: 188 NVRVASR----Y-FKGPE-LLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 35/219 (15%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 126
            +++   +G G +G VYK    +D +  +    VA+K        +G  S    RE    
Sbjct: 22  KYQKLEKVGEGTYGVVYKA---KDSQGRI----VALKRIRLDAEDEGIPS-TAIRE---- 69

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRM 181
           +  L  L HPN+V LI     +    L++EFM     E +L  K +L      L  S   
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-----EKDL--KKVLDENKTGLQDSQIK 122

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTR 241
              +   +G+A  H+    +++RD K  N+L+++D   KL+DFGLA+    G      T 
Sbjct: 123 IYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTH 178

Query: 242 IMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
            + T  Y AP+ +M +   +   D++S G +  E++TG+
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 68.0 bits (167), Expect = 8e-13
 Identities = 42/175 (24%), Positives = 73/175 (41%), Gaps = 35/175 (20%)

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRV--------LIYEFMARGSVENNLFSKVLLPLPW 177
           E+  L  L H N+V LI  C               L+++F      E++L    LL    
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDL--AGLLS--- 115

Query: 178 SIRMKIAFGAA----------KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA 227
              + + F  +           GL ++H     +++RD K +N+L+  D   KL+DFGLA
Sbjct: 116 --NVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLA 171

Query: 228 K--DGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
           +     +  + +  T  + T  Y  PE ++      P  D++  G ++ E+ T  
Sbjct: 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 41/222 (18%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 126
            +     +G G +G VYK       +        A+K        +G  S       + E
Sbjct: 3   KYHGLEKIGEGTYGVVYKA------QNNYGET-FALKKIRLEKEDEGIPSTT-----IRE 50

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-----PLPWSIRM 181
           +  L  L H N+VKL       +  VL++E +     + +L  K LL      L      
Sbjct: 51  ISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-----DQDL--KKLLDVCEGGLESVTAK 103

Query: 182 KIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD--GPEGDKSH-V 238
                   G+A+ H+  + V++RD K  N+L++ +   K++DFGLA+    P    +H +
Sbjct: 104 SFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161

Query: 239 STRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
            T       Y AP+ +M +   +   D++S G +  E++ G 
Sbjct: 162 VTL-----WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 38/223 (17%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV------HDGDNSYQGHREWLAE 126
            +R+   LG G +G VYK     D         VA+K        +G          + E
Sbjct: 35  RYRRITKLGEGTYGEVYKA---IDTVTNET---VAIKRIRLEHEEEGVPGTA-----IRE 83

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL----PLPWSIRMK 182
           V  L  L H N+++L      +    LI+E+      EN+L  K  +     +   +   
Sbjct: 84  VSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDL--KKYMDKNPDVSMRVIKS 136

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA-----KLSDFGLAKDGPEGDKSH 237
             +    G+ F H   +  ++RD K  N+LL     +     K+ DFGLA+    G    
Sbjct: 137 FLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--AFGIPIR 192

Query: 238 VSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGR 279
             T  + T  Y  PE ++ + H +   D++S   +  E+L   
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 64.3 bits (157), Expect = 9e-12
 Identities = 51/231 (22%), Positives = 93/231 (40%), Gaps = 40/231 (17%)

Query: 68  RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAE 126
            ++  +++  R +G G FG +++G    +L    Q   VA+K      ++ Q   E+   
Sbjct: 6   NVVGVHYKVGRRIGEGSFGVIFEG---TNLLNNQQ---VAIKFEPRRSDAPQLRDEYRTY 59

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM--KIA 184
            +  G      +  +  +  E  H VL+ + +   S+E +L         +S++     A
Sbjct: 60  KLLAG---CTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDL--CGRKFSVKTVAMAA 112

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK-----LSDFGLAK---DGPEGDKS 236
                 +  +H  EK ++YRD K  N L+    +       + DFG+ K   D     K 
Sbjct: 113 KQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQ 168

Query: 237 HVSTR----IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 279
           H+  R    + GT  Y +    +  HL    + R D+ + G V +  L G 
Sbjct: 169 HIPYREKKNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 52/230 (22%), Positives = 92/230 (40%), Gaps = 40/230 (17%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEV 127
           ++  NFR  + +G G FG +  G   ++L        VA+K+      + Q H E+    
Sbjct: 6   MVGPNFRVGKKIGCGNFGELRLG---KNLYTNEY---VAIKLEPMKSRAPQLHLEYRFYK 59

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM--KIAF 185
                     + ++  +    ++  ++ E +   S+E +LF        +S++    IA 
Sbjct: 60  QLGS---GDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDL--CDRTFSLKTVLMIAI 112

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK-----LSDFGLAK---DGPEGDKSH 237
                + ++H   K +IYRD K  N L+    N       + DF LAK   D     K H
Sbjct: 113 QLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKH 168

Query: 238 VSTR----IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 279
           +  R    + GT  Y +    +  HL    + R D+ + G + +  L G 
Sbjct: 169 IPYREHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 32/225 (14%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEV 127
            +   FR  R +G G FG +Y G    +++   +   VA+K+ +    + Q   E     
Sbjct: 4   RVGNKFRLGRKIGSGSFGEIYLG---TNIQTNEE---VAIKLENVKTKHPQLLYES---- 53

Query: 128 IFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
                L     +  +  +  E ++ VL+ + +   S+E +LF+     L     + +A  
Sbjct: 54  KIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQ 111

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK---LSDFGLAKD-GPEGDKSHVSTR- 241
               + F+H   K  ++RD K  N L+     A    + DFGLAK         H+  R 
Sbjct: 112 MINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169

Query: 242 ---IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 279
              + GT  YA+    +  HL    + R D+ S G VL+  L G 
Sbjct: 170 NKNLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 45/226 (19%), Positives = 91/226 (40%), Gaps = 42/226 (18%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS--- 134
           R LG G F  V+    ++D+        VA+K+  GD  Y        E+  L  ++   
Sbjct: 25  RKLGWGHFSTVWL---AKDMVNN---THVAMKIVRGDKVY--TEAAEDEIKLLQRVNDAD 76

Query: 135 --------HPNLVKLIGY----CCEDEHRVLIYEFMA---RGSVENNLFSKVLLPLPWSI 179
                     +++KL+ +         H V+++E +       ++      + L     +
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY---V 133

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD------TDYNAKLSDFGLAKDGPEG 233
           + +I+     GL ++H     +I+ D K  N+L++           K++D G A    E 
Sbjct: 134 K-QISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191

Query: 234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             + + TR      Y +PE ++       +D++S   ++ E++TG 
Sbjct: 192 YTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 64/244 (26%), Positives = 100/244 (40%), Gaps = 56/244 (22%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDG-DNSYQGHREWLAEV 127
           +   +   + LG G +G V+K     D R G     VAVK + D   NS    R    E+
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSI---DRRTGEV---VAVKKIFDAFQNSTDAQRT-FREI 59

Query: 128 IFLGHLS-HPNLVKL--IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMK-- 182
           + L  LS H N+V L  +     D    L++++M     E +L   V       IR    
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDL-HAV-------IRANIL 106

Query: 183 -------IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA-------- 227
                  + +   K + +LH     +++RD K SNILL+ + + K++DFGL+        
Sbjct: 107 EPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164

Query: 228 -------KDGPEGDKSHVSTRIMGTY----GYAAPEYIMTGHL-TPRSDVYSFGVVLLEI 275
                        +       I+  Y     Y APE ++     T   D++S G +L EI
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

Query: 276 LTGR 279
           L G+
Sbjct: 225 LCGK 228

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 36/228 (15%)

Query: 68  RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAE 126
             +   +R  R +G G FG +Y G       E      VA+K+      +   H E    
Sbjct: 5   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEE------VAIKLECVKTKHPQLHIES--- 55

Query: 127 VIFLGHLSH-PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRM--KI 183
                 +     +  +     E ++ V++ E +   S+E +LF+       +S++    +
Sbjct: 56  -KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNF--CSRKFSLKTVLLL 110

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK---LSDFGLAKD-GPEGDKSHVS 239
           A      + ++H   K  I+RD K  N L+          + DFGLAK         H+ 
Sbjct: 111 ADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 168

Query: 240 TR----IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 279
            R    + GT  YA+    +  HL    + R D+ S G VL+    G 
Sbjct: 169 YRENKNLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 42/227 (18%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH-----RE--WLA 125
            +     +G G +G V+K     DL+ G + V  A+K        +G      RE   L 
Sbjct: 12  QYECVAEIGEGAYGKVFKA---RDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 126 EVIFLGHLSHPNLVKLI----GYCCEDEHRV-LIYEFMARGSVENNLFSKVLL------P 174
               L    HPN+V+L         + E ++ L++E +     + +L     L       
Sbjct: 67  H---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----DQDL--TTYLDKVPEPG 116

Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEG 233
           +P      + F   +GL FLH     V++RD K  NIL+ +    KL+DFGLA+    + 
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174

Query: 234 DKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             +  V T       Y APE ++        D++S G +  E+   +
Sbjct: 175 ALTSVVVTL-----WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 34/225 (15%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 128
                +  D ++G G FG V K +   D  E      VA+K+     ++    +   EV 
Sbjct: 51  KWMDRYEIDSLIGKGSFGQVVKAY---DRVEQ---EWVAIKIIKNKKAF--LNQAQIEVR 102

Query: 129 FLGHLSHP------NLVKLIGYCCEDEHRVLIYEFMARGSVENNLF------SKVLLPLP 176
            L  ++         +V L  +     H  L++E +       NL+      +   + L 
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-----SYNLYDLLRNTNFRGVSLN 157

Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGD 234
              R K A      L FL   E  +I+ D K  NILL     +  K+ DFG +    +  
Sbjct: 158 -LTR-KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215

Query: 235 KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             ++ +R      Y +PE ++        D++S G +L+E+ TG 
Sbjct: 216 YQYIQSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 62.2 bits (152), Expect = 5e-11
 Identities = 57/227 (25%), Positives = 89/227 (39%), Gaps = 40/227 (17%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW----LAEVI 128
            +     +G G +G VYK     D   G     VA+K     N   G        + EV 
Sbjct: 10  RYEPVAEIGVGAYGTVYKA---RDPHSGHF---VALKSVRVPNGGGGGGGLPISTVREVA 63

Query: 129 FLGHLS---HPNLVKLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLL------P 174
            L  L    HPN+V+L+  C            L++E +     + +L  +  L       
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDL--RTYLDKAPPPG 116

Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEG 233
           LP      +     +GL FLH     +++RD K  NIL+ +    KL+DFGLA+    + 
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174

Query: 234 DKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
             +  V T       Y APE ++        D++S G +  E+   +
Sbjct: 175 ALTPVVVTL-----WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 56/305 (18%), Positives = 95/305 (31%), Gaps = 79/305 (25%)

Query: 36  EYSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISE 95
           E   L S+ +E ED          +    D   +    +   R LG G F  V+    S 
Sbjct: 4   EEEILGSDDDEQEDPNDYCKGGYHLVKIGD---LFNGRYHVIRKLGWGHFSTVWL---SW 57

Query: 96  DLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-----SHPN---LVKLIGY--- 144
           D++       VA+KV      Y        E+  L  +     + PN   +V+L+     
Sbjct: 58  DIQGKKF---VAMKVVKSAEHYTETALD--EIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112

Query: 145 -CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIY 203
                 H  +++E +    +   +       LP     KI     +GL +LH  +  +I+
Sbjct: 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH-TKCRIIH 170

Query: 204 RDFKTSNILLDTD----------------------------------------------- 216
            D K  NILL  +                                               
Sbjct: 171 TDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNA 230

Query: 217 --YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 274
                K++D G A    +     + TR      Y + E ++       +D++S   +  E
Sbjct: 231 EKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFE 285

Query: 275 ILTGR 279
           + TG 
Sbjct: 286 LATGD 290

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 50/238 (21%), Positives = 89/238 (37%), Gaps = 38/238 (15%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFI--SEDLREGLQPVPVAVKVHDGDNS--------YQ 118
           +  A ++    +G GGFGC+Y   +  SE +          VKV   DN         YQ
Sbjct: 32  MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAP---CVVKVEPSDNGPLFTELKFYQ 88

Query: 119 --GHREWLAEVIFLGHLSHPNLVKLIGY----CCEDEHRVLIYEFMARGSVENNLFSKVL 172
                E + + I    L +  + K  G          +R +I +      ++  ++    
Sbjct: 89  RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ-KIYEANA 146

Query: 173 LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK--LSDFGLAKD- 229
                   ++++      L ++H  E   ++ D K SN+LL+     +  L D+GLA   
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

Query: 230 GPEGDKSHVSTR----IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 279
            PEG     +        GT  + +    +  H     + R D+   G  +++ LTG 
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 42/236 (17%), Positives = 86/236 (36%), Gaps = 42/236 (17%)

Query: 73  NFRQDRVLGGGGFGCVYKGF--ISEDLREGLQPVPVAVKV-------HDGDNSYQ--GHR 121
            ++          G +Y+     +     G Q    ++K+        +  N +Q     
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102

Query: 122 EWLAEVIFLGHLSHPNLVKLIGY-CCEDEHRVLIYEFMARGSVEN--NLFSKVLLPLPWS 178
             + +   L       +   +G+   +D++R L+   + R S+++  ++  K +L    S
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSER-S 160

Query: 179 IRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK--LSDFGLAK---DGPEG 233
           +   +A      L FLH  E   ++ +    NI +D +  ++  L+ +G A         
Sbjct: 161 VLQ-VACRLLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP---- 213

Query: 234 DKSHVSTR------IMGTYGYAAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 279
              HV+          G   + +    M  H     + RSD+ S G  +L+ L G 
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 40/227 (17%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 128
            +   +   +V+G G FG V K +   D +       VA+K+   +  +  HR+   E+ 
Sbjct: 94  HVAYRYEVLKVIGKGSFGQVVKAY---DHKVH---QHVALKMVRNEKRF--HRQAAEEIR 145

Query: 129 FLGHLSH------PNLVKLIGYCCEDEHRVLI--------YEFMARGSVENNLFSKVLLP 174
            L HL         N++ ++       H  +         YE +     + N F    LP
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELI-----KKNKFQGFSLP 200

Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA-KLSDFGLAKDGPE 232
           L   +R K A    + L  LH+    +I+ D K  NILL     +  K+ DFG +    +
Sbjct: 201 L---VR-KFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254

Query: 233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
              +++ +R      Y APE I+        D++S G +L E+LTG 
Sbjct: 255 RVYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 49/275 (17%), Positives = 93/275 (33%), Gaps = 52/275 (18%)

Query: 37  YSKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISED 96
           +    S+  ++        + P       +  +    +   + +G GGFG +Y       
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMPFPEGKVLDD-MEGNQWVLGKKIGSGGFGLIYLA---FP 58

Query: 97  LREGLQPVPVAVKVHDGDNS--------YQ--GHREWLAEVIFLGHLSHPNLVKLIGY-- 144
             +  +     VKV   +N         YQ    ++ + + I    L +  +    G   
Sbjct: 59  TNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118

Query: 145 --CCEDEHRVLIYEFMARGSVE-----NNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLH 195
                  +R ++ E +    ++     N  F K  VL          +       L ++H
Sbjct: 119 TEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQ---------LGIRMLDVLEYIH 168

Query: 196 EAEKPVIYRDFKTSNILLDTDYNAK--LSDFGLAKD-GPEGDKSHVSTR----IMGTYGY 248
             E   ++ D K +N+LL      +  L+D+GL+    P G+             GT  +
Sbjct: 169 --ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEF 226

Query: 249 AAPEYIMTGHL----TPRSDVYSFGVVLLEILTGR 279
            +    +  H     + RSDV   G  +L  L G+
Sbjct: 227 TS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 46/172 (26%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLS- 134
            +VLG G  G V +     + R   +    A+K+  D   + +       EV      S 
Sbjct: 23  SQVLGLGINGKVLQI---FNKRTQEK---FALKMLQDCPKARR-------EVELHWRASQ 69

Query: 135 HPNLVKLIGYCCEDEHRV-----LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG--- 186
            P++V+++    E+ +       ++ E +  G  E  LFS++        R   AF    
Sbjct: 70  CPHIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSRIQD------RGDQAFTERE 118

Query: 187 AA-------KGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA--KLSDFGLAK 228
           A+       + + +LH     + +RD K  N+L      NA  KL+DFG AK
Sbjct: 119 ASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 3e-06
 Identities = 31/221 (14%), Positives = 60/221 (27%), Gaps = 78/221 (35%)

Query: 43  NPEEVEDLRRDSAANPLIAFTYDELRIITANFRQD-----RVLGGGGFGCVY-------- 89
            P E   +             +D L +    F         +L       +         
Sbjct: 367 EPAEYRKM-------------FDRLSV----FPPSAHIPTILL------SLIWFDVIKSD 403

Query: 90  -KGFISEDLREGL---QPVPVAVKVHD--------GDNSYQGHREWLAEVIFLGHLSHPN 137
               +++  +  L   QP    + +           +N Y  HR  +            +
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDD 463

Query: 138 LVKLI--GYCCEDEHRVLIYEFMAR--GSVEN----NLFSKVLLPLPWSIRMKI-----A 184
           L+      Y          Y  +     ++E+     LF  V L   + +  KI     A
Sbjct: 464 LIPPYLDQY---------FYSHIGHHLKNIEHPERMTLFRMVFLDFRF-LEQKIRHDSTA 513

Query: 185 FGAAKG-LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF 224
           + A+   L  L + +    Y+ +   N   D  Y   ++  
Sbjct: 514 WNASGSILNTLQQLKF---YKPYICDN---DPKYERLVNAI 548

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.2 bits (106), Expect = 3e-05
 Identities = 69/440 (15%), Positives = 132/440 (30%), Gaps = 140/440 (31%)

Query: 25  KDESPSEKA---KKEYSKLPSNPEEVEDLRR------DSAANPLIAFTYDELRI------ 69
           KD     K+   K+E   +  + + V    R            +  F  + LRI      
Sbjct: 36  KDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLM 95

Query: 70  --ITANFRQ------------DRVLGGGGFGCVYKGFIS-----EDLREGL---QPVPVA 107
             I    RQ            DR+          K  +S       LR+ L   +P    
Sbjct: 96  SPIKTEQRQPSMMTRMYIEQRDRLYNDNQV--FAKYNVSRLQPYLKLRQALLELRPAK-N 152

Query: 108 VKVHDGDNSYQGHREWLA-EVIFLGHLSHPNLVKL--------IGYCCEDEHRVLIYEFM 158
           V +  G     G + W+A +V     LS+    K+        +  C   E    + E +
Sbjct: 153 VLID-GVLGS-G-KTWVALDVC----LSYKVQCKMDFKIFWLNLKNCNSPE---TVLEML 202

Query: 159 ARGSVENNLFSKVLLPL------PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL 212
                   L  ++            +I+++I    A+    L         + ++   ++
Sbjct: 203 ------QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS-------KPYENCLLV 249

Query: 213 LDTDYNAK-LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVV 271
           L    NAK  + F L        K  ++TR             +T  L+  +  +     
Sbjct: 250 LLNVQNAKAWNAFNL------SCKILLTTRFKQ----------VTDFLSAATTTHISLDH 293

Query: 272 LLEILTGRKSLDKSRPAREQNLADWA------LPLLKEKKKLLNIIDPRLEGDYPVKGVH 325
               LT  +            L  +       LP  +E        +PR      +  + 
Sbjct: 294 HSMTLTPDEVKSL--------LLKYLDCRPQDLP--REVLT----TNPRR-----LSII- 333

Query: 326 KAAMLA--------YHCLNHNPKARPLMRDIVDSLEP---------LQVLPDEAPTPKNF 368
            A  +         +  +N +     ++   ++ LEP         L V P  A  P   
Sbjct: 334 -AESIRDGLATWDNWKHVNCDKLTT-IIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL 391

Query: 369 VTVVTPEEPKAEIQTKDSQC 388
           ++++  +  K+++    ++ 
Sbjct: 392 LSLIWFDVIKSDVMVVVNKL 411

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 47.2 bits (111), Expect = 4e-06
 Identities = 42/256 (16%), Positives = 72/256 (28%), Gaps = 70/256 (27%)

Query: 71  TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGH-----REW 123
           T   ++   +G G FG V++              PVA+K+   +G +   G       E 
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIADHT--------PVAIKIIAIEGPDLVNGSHQKTFEEI 70

Query: 124 LAEVIFLGHL---------SHPNLVKLIGYCC---------------------------- 146
           L E+I    L              + L    C                            
Sbjct: 71  LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130

Query: 147 --EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYR 204
             +D+   ++ EF   G     + +K+      +    I       LA    + +   +R
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLS---SLATAKSILHQLTASLAVAEASLR-FEHR 186

Query: 205 DFKTSNILLDTDYNAKLSDFGLAKD------GPEGDKSHVSTRIMGTYG------YAAPE 252
           D    N+LL      KL      K       G +      +   +   G       +  E
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDE 246

Query: 253 YIMTGHLTPRSDVYSF 268
            + TG    + D+Y  
Sbjct: 247 DLFTGDGDYQFDIYRL 262

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 62/244 (25%), Positives = 95/244 (38%), Gaps = 58/244 (23%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 128
           +++A +     LG G FG V +     D + G +   VAVK+    + Y       +E+ 
Sbjct: 11  VLSARYEIVDTLGEGAFGKVVECI---DHKAGGR--HVAVKIVKNVDRY--CEAARSEIQ 63

Query: 129 FLGHLSHP------NLVKLIGYCCEDEHRVL--------IYEFMARGSVENNLFSKVLLP 174
            L HL+          V+++ +     H  +         Y+F+     + N F     P
Sbjct: 64  VLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFI-----KENGFL----P 114

Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA-------------- 219
                  K+A+   K + FLH  +  + + D K  NIL   +DY                
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172

Query: 220 ----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLE 274
               K+ DFG A    E   + VSTR      Y APE I+  G   P  DV+S G +L+E
Sbjct: 173 NPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQP-CDVWSIGCILIE 226

Query: 275 ILTG 278
              G
Sbjct: 227 YYLG 230

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 52/244 (21%), Positives = 83/244 (34%), Gaps = 58/244 (23%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 128
            +   +     LG G FG V +       +       VA+K+      Y        E+ 
Sbjct: 16  WLQERYEIVGNLGEGTFGKVVECLDHARGKS-----QVALKIIRNVGKY--REAARLEIN 68

Query: 129 FLGHLSHP------NLVKLIGYCCEDEHRVL--------IYEFMARGSVENNLFSKVLLP 174
            L  +           V +  +     H  +         +EF+     + N F     P
Sbjct: 69  VLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL-----KENNFQ----P 119

Query: 175 LPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA-------------- 219
            P      +A+     L FLHE +  + + D K  NIL  ++++                
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177

Query: 220 ----KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLE 274
               +++DFG A    E   + V+TR      Y  PE I+  G   P  DV+S G +L E
Sbjct: 178 NTSIRVADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQP-CDVWSIGCILFE 231

Query: 275 ILTG 278
              G
Sbjct: 232 YYRG 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 59/249 (23%), Positives = 83/249 (33%), Gaps = 64/249 (25%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 128
           ++   F   R +G G FG V        +         AVKV      Y   R    E  
Sbjct: 32  LLNNAFLVIRKMGDGTFGRVLLCQ---HIDNKKY---YAVKVVRNIKKY--TRSAKIEAD 83

Query: 129 FLGHLSH-----PNLVKLIGYCCEDEHRVL--------IYEFMARGSVENNLFSKVLLPL 175
            L  + +      N+VK  G     +H  L        +YE +       N ++      
Sbjct: 84  ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEII-----TRNNYN----GF 134

Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL-DTDYNA--------------- 219
                        K L +L +    + + D K  NILL D  +                 
Sbjct: 135 HIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192

Query: 220 ---------KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFG 269
                    KL DFG A    +   S ++TR      Y APE I+  G     SD++SFG
Sbjct: 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGWDVS-SDMWSFG 246

Query: 270 VVLLEILTG 278
            VL E+ TG
Sbjct: 247 CVLAELYTG 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	389
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.05
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.76
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.61
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.54
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.44
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.36
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.27
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.24
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.13
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.85
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.6
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.58
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.51
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.4
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.37
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.36
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.32
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.25
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.15
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.98
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.92
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.77
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.64
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.38
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.69
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.14
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.71
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.01

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-60  Score=440.17  Aligned_cols=266  Identities=26%  Similarity=0.372  Sum_probs=219.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +++++.+.||+|+||+||+|.+.... .......||||.+.........++|.+|+.++++++|||||+++|++.+++.+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~-~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPA-PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC--------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCc-cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            46778899999999999999875421 22344569999998766556667899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      +||||||++|+|.+++....              ...+++..+..++.|++.||+|||+++  ||||||||+|||++.++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCCC
Confidence            99999999999999996532              235899999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHH
Q 016481          218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       218 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  296 (389)
                      .+||+|||+|+.....+........+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+......   .  
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~---~--  257 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---V--  257 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH---H--
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH---H--
Confidence            999999999987654443334455789999999999999999999999999999999998 8999987653211   1  


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                                  ..+......+.|..++.++.+|+.+||+.||++||||.+|+++|+....
T Consensus       258 ------------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          258 ------------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             ------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             ------------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence                        1111122234466778899999999999999999999999999987654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-60  Score=435.48  Aligned_cols=266  Identities=26%  Similarity=0.397  Sum_probs=210.8

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCC-CChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD-NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      ++..+++.+.+.||+|+||+||+|+++.+         ||||+++.. ......+.|.+|+.++++++|||||++++++.
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~~---------vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~  102 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWHGD---------VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT  102 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESSSE---------EEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEECCc---------EEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            34457889999999999999999976542         999998754 34455678999999999999999999999875


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      + +.++||||||+||+|.+++.... ..+++..+..++.|++.||+|||+++  ||||||||+|||++.++.+||+|||+
T Consensus       103 ~-~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          103 K-DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             S-SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             C-CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccC
Confidence            4 67899999999999999997653 36999999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      |+..............+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.........      ...+..
T Consensus       179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~  252 (307)
T 3omv_A          179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGR  252 (307)
T ss_dssp             CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHT
T ss_pred             ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhc
Confidence            987655443334456789999999999974   35899999999999999999999999865432211      000111


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                           ....+ .....+..++.++.+|+.+||+.||++|||+.+|+++|+.++..
T Consensus       253 -----~~~~p-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          253 -----GYASP-DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             -----TCCCC-CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             -----CCCCC-CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence                 01111 11233456778999999999999999999999999999888653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.7e-60  Score=442.44  Aligned_cols=253  Identities=21%  Similarity=0.304  Sum_probs=208.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||+||+|+++.+.+.      ||||++.... .......+.+|+.+++.++|||||++++++.+++.
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~------vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQ------YVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCE------EEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCE------EEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            5899999999999999999987665444      9999987653 34456778999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +|||||||+||+|.+++.......+++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|||+|+..
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceee
Confidence            999999999999999998776667899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ...  .......+||+.|||||++.+..|+.++|||||||++|||++|++||........      ...          +
T Consensus       176 ~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~----------i  237 (350)
T 4b9d_A          176 NST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------VLK----------I  237 (350)
T ss_dssp             CHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHH----------H
T ss_pred             cCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHH----------H
Confidence            431  1123457899999999999999999999999999999999999999987643211      111          1


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +... ....+..++.++.+||.+||+.||++|||+.++++|
T Consensus       238 ~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          238 ISGS-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HcCC-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111 112344567889999999999999999999999976

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.4e-60  Score=438.23  Aligned_cols=267  Identities=27%  Similarity=0.399  Sum_probs=212.4

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|.+.++||+|+||+||+|+++... ....+..||||++... .....++|.+|+.+|++++|||||++++++.+.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLL-PEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSC-C---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcc-cCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            357888999999999999999875421 1223456999999764 45566789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          151 RVLIYEFMARGSVENNLFSKV-------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      +|||||||++|+|.+++....             ..++++..+..++.|++.||+|||+.+  ||||||||+|||++.++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCC
Confidence            999999999999999986542             246899999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHH
Q 016481          218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       218 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  296 (389)
                      .+||+|||+|+.....+........+||+.|||||++.+..|+.++|||||||++|||+| |+.||........   ...
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~  272 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDC  272 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence            999999999987655444444455789999999999999999999999999999999999 9999987653321   110


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                          +..          ......|..++.++.+|+.+||+.||++|||+.+|+++|+.+...
T Consensus       273 ----i~~----------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          273 ----ITQ----------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ----HHH----------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----HHc----------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                111          112234556778999999999999999999999999999988654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.4e-60  Score=436.39  Aligned_cols=266  Identities=27%  Similarity=0.384  Sum_probs=217.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|.+.+.||+|+||+||+|.+.... ....+..||||++... .....++|.+|+.+|++++|||||++++++.+++.
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC-----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcc-cCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            467899999999999999999875421 1223556999999764 44556789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcE
Q 016481          151 RVLIYEFMARGSVENNLFSKV-----------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA  219 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~v  219 (389)
                      +|||||||++|+|.+++....           ...+++..+..++.|++.||+|||+++  ||||||||+|||++.++.+
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCcE
Confidence            999999999999999997542           346899999999999999999999977  9999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHh
Q 016481          220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  298 (389)
                      ||+|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||........   ...  
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~--  242 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IEC--  242 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHH--
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH--
Confidence            9999999986554433333344679999999999999999999999999999999999 9999987653221   110  


Q ss_pred             HHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          299 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                        +.          .......|..++.++.+|+.+||+.||++|||+++|++.|+.+..
T Consensus       243 --i~----------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          243 --IT----------QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             --HH----------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HH----------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence              11          111223455677899999999999999999999999999987643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.5e-60  Score=432.93  Aligned_cols=250  Identities=23%  Similarity=0.294  Sum_probs=211.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||+||+|+++.+.+.      ||+|++....  .......+.+|+.+|+.++|||||++++++.+++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~------~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSRE------YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCE------EEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            5799999999999999999987665544      9999986432  1233467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|||||||+||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+.
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            9999999999999999997654  7899999999999999999999977  99999999999999999999999999998


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...........+.+||+.|||||++.+..|+.++|||||||++|+|++|++||...+....   .   ..          
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~---~~----------  245 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI---F---AK----------  245 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HH----------
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HH----------
Confidence            7654444445568999999999999999999999999999999999999999987543211   1   01          


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV  349 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il  349 (389)
                      ++..  ...++...+.++.+|+.+||++||++|||+.|++
T Consensus       246 i~~~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          246 IIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHT--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHcC--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            1111  1123445678899999999999999999999853

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.1e-59  Score=439.40  Aligned_cols=275  Identities=27%  Similarity=0.353  Sum_probs=228.6

Q ss_pred             cCHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCC-Cccce
Q 016481           62 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVK  140 (389)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~  140 (389)
                      +....|++..++|++.+.||+|+||+||+|.+.... .......||||.+.........+.+.+|+.+|+++.| ||||+
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~-~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID-KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSS-STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCC-cccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            556778888899999999999999999999876543 2334456999999887766777889999999999975 89999


Q ss_pred             EEeEEEeC-CeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecC
Q 016481          141 LIGYCCED-EHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD  205 (389)
Q Consensus       141 ~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~D  205 (389)
                      ++++|.+. +.++||||||++|+|.+++....              ...+++..+..++.|++.||+|||+++  |||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRD  210 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD  210 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCc
Confidence            99999764 57899999999999999996532              235889999999999999999999977  99999


Q ss_pred             CCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCC
Q 016481          206 FKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDK  284 (389)
Q Consensus       206 lkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~  284 (389)
                      |||+|||++.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999997765444444455789999999999999999999999999999999998 9999987


Q ss_pred             CCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          285 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ......  +              ...+........|..++.++.+|+.+||+.||++|||+.+|+++|+.+
T Consensus       291 ~~~~~~--~--------------~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          291 VKIDEE--F--------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             CCCSHH--H--------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHH--H--------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            543211  1              111111122334556678999999999999999999999999999876

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-58  Score=430.60  Aligned_cols=252  Identities=21%  Similarity=0.306  Sum_probs=210.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ..|++.+.||+|+||+||+|+++.+.+.      ||||++..... .....+.+|+.+|+.++|||||+++++|.+++.+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~------vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  146 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL  146 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCE------EEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            5699999999999999999987765544      99999865422 2234577899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |||||||+||+|.+++...   .+++..+..++.|++.||+|||+++  ||||||||+|||++.+|.+||+|||+|+...
T Consensus       147 ~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          147 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             EEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecC
Confidence            9999999999999988753   6899999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ...  ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.......   .    .      +....
T Consensus       222 ~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~----~------i~~~~  286 (346)
T 4fih_A          222 KEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---K----M------IRDNL  286 (346)
T ss_dssp             SSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H----H------HHHSS
T ss_pred             CCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---H----H------HHcCC
Confidence            432  1244579999999999999999999999999999999999999999875433211   0    0      11111


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .+  ....+..++.++.+|+.+||+.||++|||+.|+++|=
T Consensus       287 ~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp  325 (346)
T 4fih_A          287 PP--RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  325 (346)
T ss_dssp             CC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             CC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence            11  1122345678999999999999999999999999883

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-58  Score=421.04  Aligned_cols=251  Identities=25%  Similarity=0.391  Sum_probs=203.0

Q ss_pred             CC-cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe---
Q 016481           73 NF-RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE---  147 (389)
Q Consensus        73 ~~-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---  147 (389)
                      +| ++.+.||+|+||+||+|.+..+...      ||+|.+.... .......+.+|+.+++.++|||||+++++|..   
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~------vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   99 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVE------VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeE------EEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence            44 6778899999999999987665443      9999986543 34455778999999999999999999999865   


Q ss_pred             -CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-CCcEEEeccC
Q 016481          148 -DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFG  225 (389)
Q Consensus       148 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-~~~vkl~Dfg  225 (389)
                       +..+|||||||+||+|.+++....  .+++..+..++.|++.||+|||+++.+||||||||+|||++. +|.+||+|||
T Consensus       100 ~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A          100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             TEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             CCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence             356899999999999999997654  789999999999999999999997767999999999999974 7999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +|+.....    .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||........  +..          
T Consensus       178 la~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~----------  240 (290)
T 3fpq_A          178 LATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR----------  240 (290)
T ss_dssp             GGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH----------
T ss_pred             CCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHH----------
Confidence            99864322    2345789999999998865 699999999999999999999999976543211  000          


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         .+.........+...++++.+|+.+||+.||++|||+.++++|
T Consensus       241 ---~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          241 ---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ---HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---HHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               0111111111223345789999999999999999999999987

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7e-59  Score=431.04  Aligned_cols=263  Identities=22%  Similarity=0.203  Sum_probs=211.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +.|++.++||+|+||.||+|+++.+.+.      ||||+++.+...      .+|+.+++.++|||||++++++.+++.+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~------vAiK~i~~~~~~------~~E~~il~~l~HpnIV~l~~~~~~~~~~  125 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQ------CAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWV  125 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEETTTCC------THHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCE------EEEEEECHHHhH------HHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4688889999999999999987665444      999999765322      3699999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-cEEEeccCCCcCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLAKDG  230 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-~vkl~Dfg~a~~~  230 (389)
                      |||||||+||+|.+++....  .+++..+..++.|++.||+|||+++  ||||||||+|||++.+| .+||+|||+|+..
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            99999999999999997654  7899999999999999999999977  99999999999999887 6999999999876


Q ss_pred             CCCCCc---cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          231 PEGDKS---HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       231 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ......   ......+||+.|||||++.+..|+.++|||||||++|||++|++||.........   .   ........ 
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~---~i~~~~~~-  274 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---L---KIASEPPP-  274 (336)
T ss_dssp             ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---H---HHHHSCCG-
T ss_pred             cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---H---HHHcCCCC-
Confidence            543211   1223468999999999999999999999999999999999999999865433211   0   11111000 


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCCCC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTP  365 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~~p  365 (389)
                              ....+..++.++.+|+.+||++||++|||+.|++++|............|
T Consensus       275 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP  324 (336)
T 4g3f_A          275 --------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP  324 (336)
T ss_dssp             --------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred             --------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence                    11234456789999999999999999999999999987664443333333

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.6e-58  Score=413.20  Aligned_cols=249  Identities=24%  Similarity=0.339  Sum_probs=194.8

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||+||+|++..+.+      .||+|++....  .......+.+|+.+++.++|||||++++++.+++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQ------KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCC------EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCC------EEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            689999999999999999998665544      49999987543  2233467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+||||+ +|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCee
Confidence            999999999 689999987654  7999999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .....   .....+||+.|||||++.+..| +.++|||||||++|+|++|+.||.......   +.   .. +..     
T Consensus       162 ~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~---~~-i~~-----  226 (275)
T 3hyh_A          162 MTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LF---KN-ISN-----  226 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HH-HHH-----
T ss_pred             cCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HH---HH-HHc-----
Confidence            54332   2345789999999999998886 579999999999999999999998654221   10   00 100     


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                          .  ...++...+.++.+|+.+||+.||++|||+.++++|=
T Consensus       227 ----~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  264 (275)
T 3hyh_A          227 ----G--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD  264 (275)
T ss_dssp             ----T--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred             ----C--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence                0  1123445678899999999999999999999999873

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-57  Score=433.20  Aligned_cols=252  Identities=22%  Similarity=0.313  Sum_probs=211.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ..|++.+.||+|+||.||+|+++.+.+.      ||||++..... .....+.+|+.+|+.++|||||+++++|.+++.+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~------vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  223 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL  223 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCE------EEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence            4699999999999999999987765544      99999875532 2334577999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |||||||+||+|.+++...   .+++..+..++.|++.||+|||+++  ||||||||+|||++.+|.+||+|||+|+...
T Consensus       224 ~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          224 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            9999999999999988654   6899999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+........       .      +....
T Consensus       299 ~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-------~------i~~~~  363 (423)
T 4fie_A          299 KEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------M------IRDNL  363 (423)
T ss_dssp             SSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------H------HHHSC
T ss_pred             CCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-------H------HHcCC
Confidence            4322  2445789999999999999999999999999999999999999998754332110       0      11111


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .+.  ...+..++.++.+||.+||+.||++|||+.|+|+|=
T Consensus       364 ~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp  402 (423)
T 4fie_A          364 PPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  402 (423)
T ss_dssp             CCC--CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             CCC--CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence            111  122335678999999999999999999999999873

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.5e-58  Score=420.01  Aligned_cols=253  Identities=28%  Similarity=0.322  Sum_probs=202.6

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||+||+|+...+   ...+..||+|++.... .......+.+|+.+++.++|||||++++++.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISG---SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSS---TTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccC---CCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            5799999999999999999975432   2234559999987543 12223457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +|+|||||+||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||+|+..
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999999997654  7899999999999999999999977  999999999999999999999999999865


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      .....  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.....   .             .+
T Consensus       177 ~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~-------------~i  238 (304)
T 3ubd_A          177 IDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM---T-------------MI  238 (304)
T ss_dssp             ----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H-------------HH
T ss_pred             cCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH---H-------------HH
Confidence            43221  234578999999999999999999999999999999999999999876433211   0             01


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  351 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~  351 (389)
                      ...  ...+|..++.++.+|+.+||+.||++|||     ++++++|
T Consensus       239 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          239 LKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             HcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            111  11234556789999999999999999998     4788876

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.4e-56  Score=406.76  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=192.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC--
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE--  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--  149 (389)
                      ++|++.+.||+|+||+||+|+++.+.+.      ||+|++...........+.+|+.+|+.++|||||+++++|.+.+  
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~------vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCN------YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCE------EEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCE------EEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            5699999999999999999987665444      99999876655666678899999999999999999999987544  


Q ss_pred             ----------eEEEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc
Q 016481          150 ----------HRVLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN  218 (389)
Q Consensus       150 ----------~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~  218 (389)
                                ++|+|||||+||+|.+++..... ...++..+..++.|++.||+|||+++  ||||||||+|||++.++.
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~  156 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDV  156 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCc
Confidence                      47999999999999999976543 23566778899999999999999977  999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCcc----------ccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCch
Q 016481          219 AKLSDFGLAKDGPEGDKSH----------VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA  288 (389)
Q Consensus       219 vkl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  288 (389)
                      +||+|||+|+.........          .....+||+.|||||++.+..|+.++|||||||++|||++   ||..... 
T Consensus       157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-  232 (299)
T 4g31_A          157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-  232 (299)
T ss_dssp             EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred             EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-
Confidence            9999999998765432111          1234689999999999999999999999999999999997   7753211 


Q ss_pred             hhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          289 REQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       ....             +........ .+.....++.+.+|+.+||+.||++|||+.++++|
T Consensus       233 -~~~~-------------~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          233 -RVRT-------------LTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             -HHHH-------------HHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHH-------------HHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             0000             000111111 01112344567889999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-55  Score=407.69  Aligned_cols=273  Identities=23%  Similarity=0.289  Sum_probs=200.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  149 (389)
                      ..+|.+.+.||+|+||+||+|++.+        ..||||++....  .....+..|+..+..++|||||++++++.+++ 
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~g--------~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~   71 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWRG--------EEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT--------EEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEECC--------EEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence            4578889999999999999998642        339999986532  11222335666677889999999999998654 


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceecCCCCCCeEEcCCCcEE
Q 016481          150 ---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA------EKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       150 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                         .+|||||||++|+|.+++...   ++++..+..++.|++.||+|||++      .++||||||||+|||++.++.+|
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence               689999999999999999765   689999999999999999999986      23599999999999999999999


Q ss_pred             EeccCCCcCCCCCCCcc--ccccccccccccCccccccC------CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhh
Q 016481          221 LSDFGLAKDGPEGDKSH--VSTRIMGTYGYAAPEYIMTG------HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN  292 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  292 (389)
                      |+|||+|+.........  .....+||+.|||||++.+.      .|+.++|||||||++|||+||.+||......... 
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-  227 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-  227 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-
Confidence            99999998754432211  22346899999999999764      3678999999999999999999887643321110 


Q ss_pred             hHHHHhHHHHhhhhhhhhcCCCCCCCCC-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          293 LADWALPLLKEKKKLLNIIDPRLEGDYP-----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      +..+..................++...+     ...+..+.+|+.+||+.||++||||.+|++.|+.+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0000000000000001112222222222     3466789999999999999999999999999988754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-54  Score=411.17  Aligned_cols=270  Identities=21%  Similarity=0.290  Sum_probs=206.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  147 (389)
                      .++|++.+.||+|+||+||+|+++.+.+.      ||||++.... .......+.+|+.+|+.++|||||++++++..  
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~------vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQ------VAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCE------EEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            46899999999999999999987665444      9999997654 33445678899999999999999999998754  


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          148 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       148 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                          .+.+|||||||+ |+|.+++....  .+++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEee
Confidence                368999999996 67999886643  7999999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCC--CccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          224 FGLAKDGPEGD--KSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       224 fg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      ||+|+.+....  ........+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+..............
T Consensus       202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~  281 (398)
T 4b99_A          202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT  281 (398)
T ss_dssp             CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998764322  12234457999999999998875 5699999999999999999999999876544322111000000


Q ss_pred             --------HH--hhhhhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 --------LK--EKKKLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 --------~~--~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                              ..  ........+.+.....   .....+.++.+||.+||++||++|||+.++|+|
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                    00  0000000011110000   011246789999999999999999999999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.4e-52  Score=395.41  Aligned_cols=268  Identities=22%  Similarity=0.248  Sum_probs=201.7

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  147 (389)
                      .+.++|++.+.||+|+||+||+|+.+.+   ...+..||+|.+.....   ..++.+|+.+|+.+ +||||+++++++.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~---~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQ---VGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBT---TSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEccc---CCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            3567899999999999999999976432   12334599999876532   34567899999988 69999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC-CcEEEeccCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGL  226 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~-~~vkl~Dfg~  226 (389)
                      .+++|+|||||+||+|.+.+.     .+++..+..++.|++.||+|||+++  |+||||||+|||++.+ +.+||+|||+
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            999999999999999999883     5889999999999999999999987  9999999999999876 7999999999


Q ss_pred             CcCCCCCCCc--------------------------cccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCC
Q 016481          227 AKDGPEGDKS--------------------------HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGR  279 (389)
Q Consensus       227 a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~  279 (389)
                      |+........                          ......+||+.|+|||++.+. .|+.++||||+||++|+|++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            9765432110                          112335899999999999875 5899999999999999999999


Q ss_pred             CCCCCCCchhhhhhHHHHhHHHHh---------------------------hhhhhhhcC---CC---------CCCCCC
Q 016481          280 KSLDKSRPAREQNLADWALPLLKE---------------------------KKKLLNIID---PR---------LEGDYP  320 (389)
Q Consensus       280 ~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~---~~---------~~~~~~  320 (389)
                      .||......... +. .+......                           ........+   +.         ......
T Consensus       245 ~Pf~~~~~~~~~-l~-~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  322 (361)
T 4f9c_A          245 YPFYKASDDLTA-LA-QIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW  322 (361)
T ss_dssp             SSSSCCSSHHHH-HH-HHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred             CCCCCCCCHHHH-HH-HHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence            999655432211 00 00000000                           000000000   00         000112


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          321 VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       321 ~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ...+.++.+|+.+||++||++|||+.|+|+|
T Consensus       323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          323 NEVPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            2456789999999999999999999999987

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.1e-52  Score=414.72  Aligned_cols=254  Identities=22%  Similarity=0.268  Sum_probs=212.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|+++.+.+.      ||+|++.... ......+.+|+.+|+.++|||||+++++|.+...
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~------~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNN------FAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCE------EEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            46899999999999999999987665544      9999987653 3445678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC--CcEEEeccCCCc
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAK  228 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~--~~vkl~Dfg~a~  228 (389)
                      +|||||||+||+|.+++.... ..+++..+..++.||+.||.|||+++  |+||||||+|||++.+  +.+||+|||+|+
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~  305 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA  305 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred             EEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeecccee
Confidence            999999999999999886543 36899999999999999999999977  9999999999999854  899999999999


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......   .....+||+.|||||++.+..|+.++|||||||++|+|++|++||.+........   .    +.      
T Consensus       306 ~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~---~----i~------  369 (573)
T 3uto_A          306 HLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR---N----VK------  369 (573)
T ss_dssp             ECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---H----HH------
T ss_pred             EccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---H----HH------
Confidence            875433   2345689999999999999999999999999999999999999998765432110   0    00      


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       ..+..+.......++.++.+||.+||+.||.+|||+.++|+|
T Consensus       370 -~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          370 -SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -TTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             001111112223457889999999999999999999999997

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.2e-52  Score=414.13  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=203.6

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-----ChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-----SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      ++|++.+.||+|+||.||+|+.+.+.+.      ||+|++....     ..........++.+++.++|||||+++++|.
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~------~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKM------YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCE------EEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            5799999999999999999987665444      9999986431     1111222234466777889999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      +.+.+|||||||+||+|..++....  .+++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|||+
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccce
Confidence            9999999999999999999997654  7899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      |+......    ..+.+||+.|||||++. +..|+.++|||||||++|||++|++||.+........+..          
T Consensus       339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~----------  404 (689)
T 3v5w_A          339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----------  404 (689)
T ss_dssp             CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH----------
T ss_pred             eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----------
Confidence            98765432    34579999999999996 4689999999999999999999999997543221111110          


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~  351 (389)
                         .+...  ...++..++.++.+||.+||+.||.+|++     +.+|++|
T Consensus       405 ---~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          405 ---MTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             ---HHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             ---hhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence               00111  12334556789999999999999999998     7899877

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.2e-50  Score=379.10  Aligned_cols=269  Identities=24%  Similarity=0.387  Sum_probs=222.2

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccc-cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLR-EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  147 (389)
                      ..++|++.+.||+|+||.||+|.+....+ ....+..||+|++...........+.+|+.+++.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            35789999999999999999998653222 22345669999998776666677899999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL  213 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili  213 (389)
                      .+.+|+||||+++|+|.+++....              ...+++..+..++.|++.||+|||+++  |+||||||+|||+
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll  236 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV  236 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEE
Confidence            999999999999999999987653              135789999999999999999999977  9999999999999


Q ss_pred             cCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 016481          214 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQN  292 (389)
Q Consensus       214 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  292 (389)
                      +.++.+||+|||+++...............+|+.|+|||++.+..|+.++|||||||++|||++ |..||........  
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~--  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence            9999999999999987654433333344567899999999999999999999999999999999 9999987543211  


Q ss_pred             hHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          293 LADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                                     ...+........+..++.++.+|+.+||+.||++||++.+++++|+.+..
T Consensus       315 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          315 ---------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             ---------------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                           11111112223445667889999999999999999999999999987753

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.6e-49  Score=367.21  Aligned_cols=278  Identities=40%  Similarity=0.703  Sum_probs=231.8

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||.||+|.+..       +..||+|...... ......+.+|+.+++.++||||+++++++...+
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRD-------GAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTT-------CCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             HHhccCccceeecCCCeeEEEEEECC-------CCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            45789999999999999999997542       2349999887653 344567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVL--LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ..++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccc
Confidence            99999999999999998865432  35899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ................||+.|+|||++.+..++.++||||||+++|+|++|+.||....+........|..... ....+
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  265 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQL  265 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TTTCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-ccccH
Confidence            86544333333344678999999999999999999999999999999999999998776655544544443321 22334


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      ...+++......+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            455566666667788899999999999999999999999999999877544

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.7e-49  Score=366.74  Aligned_cols=290  Identities=39%  Similarity=0.682  Sum_probs=233.6

Q ss_pred             CCcccCHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc
Q 016481           58 PLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN  137 (389)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n  137 (389)
                      ....++..++....++|.+.+.||+|+||.||+|.+..       +..||+|++...........+.+|+.+++.++|||
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~   88 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-------GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN   88 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS-------SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTT
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC-------CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCC
Confidence            34557788899999999999999999999999996432       23499999887654444446789999999999999


Q ss_pred             cceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceecCCCCCCeE
Q 016481          138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL--LPLPWSIRMKIAFGAAKGLAFLHEA---EKPVIYRDFKTSNIL  212 (389)
Q Consensus       138 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~---~~~ivH~Dlkp~Nil  212 (389)
                      |+++++++......++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||++   +  |+||||||+|||
T Consensus        89 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil  166 (326)
T 3uim_A           89 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANIL  166 (326)
T ss_dssp             BCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEE
T ss_pred             ccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEE
Confidence            99999999999999999999999999999876542  3589999999999999999999997   6  999999999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCc--hhh
Q 016481          213 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRP--ARE  290 (389)
Q Consensus       213 i~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~  290 (389)
                      ++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....  ...
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  245 (326)
T 3uim_A          167 LDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD  245 (326)
T ss_dssp             ECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred             ECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence            99999999999999987644322 223446699999999999999999999999999999999999999963211  111


Q ss_pred             hhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          291 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      ....+|...... ........+.......+...+..+.+++.+||+.||++|||+.+|+++|+.....
T Consensus       246 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  312 (326)
T 3uim_A          246 VMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA  312 (326)
T ss_dssp             SBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred             hhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence            222333322221 2234445555566677788899999999999999999999999999999875444

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.7e-49  Score=366.45  Aligned_cols=262  Identities=25%  Similarity=0.330  Sum_probs=210.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++...........+.+|+.+++.++||||+++++++.+.+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEE------AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCc------EEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            4689999999999999999998765444      3999998765544444667889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeecccee
Confidence            999999999999999886543  6899999999999999999999977  999999999999999999999999999866


Q ss_pred             CCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+             
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~-------------  221 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-------------  221 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH-------------
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH-------------
Confidence            44333333445789999999999988776 7789999999999999999999986543211 11111             


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                       .............+..+.+|+.+||+.||++|||+.+++++-+-.+.
T Consensus       222 -~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          222 -KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             -HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             -hcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence             11111111223456888999999999999999999999998654433

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.6e-49  Score=365.32  Aligned_cols=268  Identities=28%  Similarity=0.419  Sum_probs=209.4

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYC  145 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  145 (389)
                      +.+..++|++.+.||+|+||.||+|.+..        ..||+|++.... .......+.+|+.++++++||||+++++++
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHG--------SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEETT--------EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEECC--------CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34456789999999999999999997532        239999987654 344456788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      ......++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+.+|+||||||+|||++.++.+||+||
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence            999999999999999999999876532 2388999999999999999999996655999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      |+++......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........           
T Consensus       184 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~-----------  250 (309)
T 3p86_A          184 GLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA-----------  250 (309)
T ss_dssp             C-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-----------
T ss_pred             CCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------
Confidence            9997543321  123346799999999999999999999999999999999999999987653321100           


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCC
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  360 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~  360 (389)
                           ..........+..++.++.+|+.+||+.||++|||+.++++.|+.+.....
T Consensus       251 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          251 -----VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             -----HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             -----HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence                 000111223445567889999999999999999999999999998876543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.5e-49  Score=365.76  Aligned_cols=268  Identities=24%  Similarity=0.412  Sum_probs=219.5

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||.||+|.+..+..   ....||+|++...........+.+|+.+++.++||||+++++++.+.+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQ---RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTS---CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCC---CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            35689999999999999999998764432   344599999987766667788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            9999999999999999986543 36899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          230 GPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       230 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........                 
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-----------------  263 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----------------  263 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-----------------
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-----------------
Confidence            6543221 12223456889999999999999999999999999999999 9999976543211                 


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  360 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~  360 (389)
                      ...+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+...+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            11111112233445667889999999999999999999999999998865543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3e-48  Score=357.81  Aligned_cols=253  Identities=21%  Similarity=0.343  Sum_probs=209.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|++.+.||+|+||.||+|.+..+.+      .||+|.+..... .....+.+|+.+++.++||||+++++++...+.
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   91 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCC------EEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCc------EEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence            4689999999999999999997655443      499999865432 234567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++|+|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++...
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            99999999999999998765   5889999999999999999999977  999999999999999999999999998876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.......             .. 
T Consensus       167 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------------~~-  230 (297)
T 3fxz_A          167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------AT-  230 (297)
T ss_dssp             CSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HH-
T ss_pred             CCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------Hh-
Confidence            54322  233468999999999999999999999999999999999999999876543211100             00 


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                       ........+...+..+.+|+.+||+.||++|||+.++++|-
T Consensus       231 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  271 (297)
T 3fxz_A          231 -NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ  271 (297)
T ss_dssp             -HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             -CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence             00111223445678899999999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-48  Score=370.92  Aligned_cols=277  Identities=25%  Similarity=0.377  Sum_probs=227.9

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccc-cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLR-EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  145 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  145 (389)
                      .+..++|.+.+.||+|+||.||+|.+....+ .......||+|++...........+.+|+.+++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            4456789999999999999999998654332 22334569999998876667778889999999999 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCe
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  211 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Ni  211 (389)
                      ...+..++||||+++|+|.+++....              ...+++..+..++.|++.||+|||+.+  |+||||||+||
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI  222 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV  222 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceE
Confidence            99999999999999999999997654              235899999999999999999999977  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhh
Q 016481          212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE  290 (389)
Q Consensus       212 li~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~  290 (389)
                      |++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999987655433333444678899999999999999999999999999999999 9999986543211


Q ss_pred             hhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCC
Q 016481          291 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAP  363 (389)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~  363 (389)
                                       ...+........+..++.++.+|+.+||+.||++|||+.+|+++|+.+........
T Consensus       303 -----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          303 -----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             -----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             -----------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence                             11111112223344567889999999999999999999999999999876544333

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.1e-49  Score=372.38  Aligned_cols=276  Identities=27%  Similarity=0.347  Sum_probs=223.7

Q ss_pred             cCHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccce
Q 016481           62 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVK  140 (389)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  140 (389)
                      +....+.+..++|++.+.||+|+||.||+|.+... .....+..||+|++...........+.+|+.+++.+ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccc-cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            45566777788999999999999999999986432 123345669999998776666677899999999999 7999999


Q ss_pred             EEeEEEeCC-eEEEEEEecCCCChhhhhhcCCC-----------------------------------------------
Q 016481          141 LIGYCCEDE-HRVLIYEFMARGSVENNLFSKVL-----------------------------------------------  172 (389)
Q Consensus       141 ~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------  172 (389)
                      +++++...+ .+++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998755 48999999999999999876532                                               


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCC
Q 016481          173 -----------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  235 (389)
Q Consensus       173 -----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~  235 (389)
                                       ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             12889999999999999999999977  99999999999999999999999999987654443


Q ss_pred             ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                      ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.........                ...+...
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----------------~~~~~~~  312 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----------------CRRLKEG  312 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH----------------HHHHHHT
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH----------------HHHHHcC
Confidence            334445678999999999999999999999999999999998 99999865432210                0001111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      .....+...+.++.+++.+||+.||++|||+.+++++|+.+.
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            122234455688999999999999999999999999998763

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.2e-48  Score=361.57  Aligned_cols=252  Identities=25%  Similarity=0.348  Sum_probs=210.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .++|++.+.||+|+||.||+|.+..+.+.      ||+|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGRE------VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCE------EEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            46899999999999999999987655443      9999986543 3445667889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++..
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            9999999999999999987654  6899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccccccccCccccccCCCC-cccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT-PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .....   .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.........      ...        
T Consensus       164 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i--------  226 (328)
T 3fe3_A          164 FTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR------ERV--------  226 (328)
T ss_dssp             GSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH--------
T ss_pred             cCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH------HHH--------
Confidence            54432   23457899999999999988875 7999999999999999999999876432211      000        


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                        ...  ....+...+.++.+|+.+||+.||.+|||+.++++|-+
T Consensus       227 --~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          227 --LRG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             --HHC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             --HhC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence              001  11223445688999999999999999999999998843

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7e-48  Score=364.40  Aligned_cols=256  Identities=22%  Similarity=0.263  Sum_probs=208.9

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-----hhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      +.++|.+.+.||+|+||.||+|..+.+..      .||+|++......     .....+.+|+.+++.++||||++++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~------~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   83 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGL------EYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV   83 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCC------EEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence            45789999999999999999998765544      3999998765322     134678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC----cEE
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAK  220 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~----~vk  220 (389)
                      +.+...+++||||++||+|.+++....  .+++..+..++.|++.||.|||+++  |+||||||+|||++.++    .+|
T Consensus        84 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           84 YENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEE
Confidence            999999999999999999999986543  7899999999999999999999977  99999999999998776    799


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |+|||++.......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.......   .   ..
T Consensus       160 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~---~---~i  230 (361)
T 2yab_A          160 LIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---A---NI  230 (361)
T ss_dssp             ECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H---HH
T ss_pred             EEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---HH
Confidence            99999998765432   233468999999999999999999999999999999999999999875432110   0   00


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ...        ............+..+.+|+.+||..||++|||+.++++|-
T Consensus       231 ~~~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  274 (361)
T 2yab_A          231 TAV--------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (361)
T ss_dssp             HTT--------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             Hhc--------CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            000        00000011123467899999999999999999999999873

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.3e-49  Score=374.93  Aligned_cols=265  Identities=24%  Similarity=0.368  Sum_probs=216.9

Q ss_pred             HHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEE
Q 016481           66 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC  145 (389)
Q Consensus        66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  145 (389)
                      .+.+..++|++.+.||+|+||.||+|.+..+..      .||+|.+...........+.+|+.+++.++||||+++++++
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNT------LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCC------EEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCe------EEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344456789999999999999999998765433      39999988665555556788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      ...+.+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus       182 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGG
T ss_pred             ecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCC
Confidence            99999999999999999999987543 35889999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      +++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.........             
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------------  325 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------------  325 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------------
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------------
Confidence            9986543221111122346788999999999999999999999999999998 99999876432211             


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                          ..+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       326 ----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          326 ----EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             ----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                111111222334556788999999999999999999999999998775

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.4e-48  Score=358.77  Aligned_cols=263  Identities=27%  Similarity=0.385  Sum_probs=213.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|.+... .......+.+|+.+++.++||||+++++++.+++.
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~------~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   81 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGE------VMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR   81 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCC------EEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCc------EEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence            4689999999999999999998765544      3999988654 45566788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             eEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            999999999999999987643 36899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCcc------------ccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh
Q 016481          231 PEGDKSH------------VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       231 ~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  298 (389)
                      .......            ......||+.|+|||++.+..++.++||||||+++|+|++|..||....+........   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~---  235 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN---  235 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC---
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh---
Confidence            4332111            1114679999999999999999999999999999999999999997654322111100   


Q ss_pred             HHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          299 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                              .......    ..+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       236 --------~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          236 --------VRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             --------HHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------hhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                    0000000    11233456789999999999999999999999999888543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.4e-48  Score=358.43  Aligned_cols=269  Identities=29%  Similarity=0.400  Sum_probs=221.5

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+...+|.+.+.||+|+||.||+|.+.... ....+..||+|++...........+.+|+.+++.++||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLK-GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGG-GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccC-cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            344678999999999999999999764322 1233456999999877666677888999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVL----------------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD  205 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~D  205 (389)
                      .+..++||||+++|+|.+++.....                      ..+++..+..++.|++.||+|||+++  |+|+|
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~d  175 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRD  175 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccc
Confidence            9999999999999999999876532                      24789999999999999999999977  99999


Q ss_pred             CCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCC
Q 016481          206 FKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDK  284 (389)
Q Consensus       206 lkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~  284 (389)
                      |||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987654433323334567889999999999999999999999999999999 9999987


Q ss_pred             CCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          285 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      .......                 ..+........+..++..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       256 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          256 IPPERLF-----------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             CCGGGHH-----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHHH-----------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            6532211                 111111122334456788999999999999999999999999998764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.2e-48  Score=362.83  Aligned_cols=271  Identities=25%  Similarity=0.323  Sum_probs=208.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  149 (389)
                      .++|++.+.||+|+||.||+|.+..        ..||+|++...  .........|+.+++.++||||+++++++.... 
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLLN--------EYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS   92 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEETT--------EEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhheecccCceEEEEEEECC--------CEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence            5689999999999999999997642        34999998654  233345566899999999999999999998744 


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceecCCCCCCeEEcCC
Q 016481          150 ---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA----------EKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       150 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------~~~ivH~Dlkp~Nili~~~  216 (389)
                         .+++||||+++|+|.+++...   .+++..+..++.|++.||+|||+.          +  |+||||||+|||++.+
T Consensus        93 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           93 VDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT
T ss_pred             CCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC
Confidence               479999999999999999764   589999999999999999999987          6  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccC-----CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhh
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-----HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ  291 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  291 (389)
                      +.+||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|+|++|+.||.........
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            99999999999776544333333446899999999999863     4567889999999999999999999865443222


Q ss_pred             hhHHHHhHHHHhhhhhh-hhcCCCCCCCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          292 NLADWALPLLKEKKKLL-NIIDPRLEGDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       292 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      .+......... ...+. ...........     ....+.++.+|+.+||+.||++|||+.++++.|+.++.
T Consensus       248 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          248 PFEEEIGQHPS-LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             TTHHHHCSSCC-HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhhhccCCc-hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            22111000000 00000 11111111111     22456779999999999999999999999999988754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-49  Score=373.49  Aligned_cols=271  Identities=28%  Similarity=0.379  Sum_probs=218.2

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||.||+|.+.... ....+..||+|++...........+.+|+.+++.++||||+++++++....
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMP-NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCC-CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            3568999999999999999999865421 223455699999987666677778899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC---cEEE
Q 016481          150 HRVLIYEFMARGSVENNLFSKV-----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---NAKL  221 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~---~vkl  221 (389)
                      ..++||||+++|+|.+++....     ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++   .+||
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEE
Confidence            9999999999999999986543     235899999999999999999999977  99999999999998555   5999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      +|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||........          
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~----------  295 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----------  295 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----------
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------
Confidence            99999875422222222334568999999999999999999999999999999998 9999987643211          


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCC
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  360 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~  360 (389)
                             ...+........+..++..+.+|+.+||+.||++|||+.+|+++|+.+...+.
T Consensus       296 -------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          296 -------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             -------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             -------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence                   11111111222344566889999999999999999999999999988866543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-47  Score=359.95  Aligned_cols=251  Identities=24%  Similarity=0.316  Sum_probs=208.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|+.+.+.+      .||+|++....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~   77 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGR------YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH   77 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence            3689999999999999999998765443      49999986432  122345678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+|+||||++||+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||+++
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~  153 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchh
Confidence            99999999999999999887643  6899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........   ..   ..        
T Consensus       154 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~---~i--------  217 (337)
T 1o6l_A          154 EGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FE---LI--------  217 (337)
T ss_dssp             CSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HH--------
T ss_pred             hcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH---HH---HH--------
Confidence            643222  123457899999999999999999999999999999999999999986543211   00   00        


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                        ...  ...++...+.++.+|+.+||+.||++||     ++.++++|
T Consensus       218 --~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          218 --LME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --HcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence              000  1123445678899999999999999999     89999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.1e-48  Score=361.80  Aligned_cols=265  Identities=25%  Similarity=0.389  Sum_probs=209.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|++..+...  ....||+|.+...........+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCce--EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            46799999999999999999987654332  234479998876655566678899999999999999999999998754 


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++|+||+.+|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            789999999999999987754 36899999999999999999999977  999999999999999999999999999866


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .............+|+.|+|||++.+..++.++|||||||++|+|++ |+.||........                 ..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----------------~~  230 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----------------SS  230 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----------------HH
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-----------------HH
Confidence            54433333334567889999999999999999999999999999999 9999987643321                 11


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      .+........+..++..+.+++.+||+.||++||++.+++++|+.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            1111222233455678899999999999999999999999999887543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=368.26  Aligned_cols=258  Identities=21%  Similarity=0.254  Sum_probs=209.9

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+.++|++.+.||+|+||.||+|.+..+.+.      ||+|++..... ......+.+|+.+++.++||||+++++++.+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~------~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   81 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQE------YAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE   81 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEE------EEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcE------EEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE
Confidence            3567899999999999999999986655443      99999876543 3345678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc---CCCcEEEecc
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD---TDYNAKLSDF  224 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~---~~~~vkl~Df  224 (389)
                      .+..|+||||+.||+|.+.+....  .+++..+..++.|++.||.|||+++  |+||||||+|||++   .++.+||+||
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DF  157 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADF  157 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred             CCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccC
Confidence            999999999999999999987764  6899999999999999999999977  99999999999998   5678999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      |++........  ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||.........      ...... 
T Consensus       158 G~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~-  228 (444)
T 3soa_A          158 GLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY------QQIKAG-  228 (444)
T ss_dssp             SSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHT-
T ss_pred             ceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH------HHHHhC-
Confidence            99987654322  233468999999999999999999999999999999999999999865432111      000000 


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                             ............+.++.+|+.+||+.||++|||+.++++|-
T Consensus       229 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          229 -------AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP  269 (444)
T ss_dssp             -------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred             -------CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence                   00111112234578899999999999999999999999984

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.6e-48  Score=362.80  Aligned_cols=265  Identities=24%  Similarity=0.394  Sum_probs=211.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+..+..  .....||+|.+...........+.+|+.+++.++||||+++++++. ++.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGE--SIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTC--SCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCc--eEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            3589999999999999999998765432  2234588888765544444455668999999999999999999886 567


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+.+|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             cEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccccc
Confidence            899999999999999887642 36888899999999999999999977  999999999999999999999999999887


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .............||+.|+|||++.+..++.++||||||+++|+|++ |+.||..........                 
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----------------  228 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-----------------  228 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-----------------
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-----------------
Confidence            65444434445678889999999999999999999999999999999 999998754332111                 


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      .+........+..++.++.+++.+||+.||++|||+.+++++|+.+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          229 LLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             HHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             HHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1111112222334556788999999999999999999999999887543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-48  Score=361.59  Aligned_cols=271  Identities=26%  Similarity=0.343  Sum_probs=219.3

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ....++|++.+.||+|+||.||+|.+.... ....+..||+|++...........+.+|+.+++.++||||+++++++..
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSS-TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcC-CCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            345678999999999999999999875321 1123355999999877666667788999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKV----------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD  205 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~D  205 (389)
                      .+..++||||+++|+|.+++....                      ...+++..+..++.|++.||.|||+++  |+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~D  199 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRD  199 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCC
Confidence            999999999999999999987642                      146899999999999999999999977  99999


Q ss_pred             CCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCC
Q 016481          206 FKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDK  284 (389)
Q Consensus       206 lkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~  284 (389)
                      |||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999876543222222334678999999999999999999999999999999999 9999986


Q ss_pred             CCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          285 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      .......   .    .+         .. ......+..++..+.+|+.+||+.||++|||+.+++++|+.+...
T Consensus       280 ~~~~~~~---~----~~---------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          280 MAHEEVI---Y----YV---------RD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             SCHHHHH---H----HH---------HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CChHHHH---H----HH---------hC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            5432110   0    00         00 111123445668899999999999999999999999999988654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-47  Score=364.32  Aligned_cols=265  Identities=24%  Similarity=0.404  Sum_probs=205.4

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ..+|.+.+.||+|+||.||+|++....   ..+..||+|.+...........+.+|+.++++++||||+++++++.....
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPS---KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTT---SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCC---CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            468999999999999999999765322   22345999999876666667789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999999987543 36899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          231 PEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       231 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ...... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||........                 .
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~-----------------~  260 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-----------------I  260 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH-----------------H
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------H
Confidence            543211 11222346788999999999999999999999999999998 9999976543211                 1


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      ..+........+..++..+.+|+.+||+.||++||++.+|++.|+.+...
T Consensus       261 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            11111112223445678899999999999999999999999999887543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7e-48  Score=357.52  Aligned_cols=270  Identities=26%  Similarity=0.354  Sum_probs=220.7

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      .+..++|++.+.||+|+||.||+|.+... .....+..||+|++...........+.+|+.+++++ +||||+++++++.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGL-IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeec-cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            44567899999999999999999975432 122334569999998776666667889999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVL----------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSN  210 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~N  210 (389)
                      ..+..++||||+++|+|.+++.....                ..+++..+..++.|++.||+|||+++  |+|+||||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~N  175 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARN  175 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccce
Confidence            99999999999999999999876542                24899999999999999999999977  9999999999


Q ss_pred             eEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchh
Q 016481          211 ILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAR  289 (389)
Q Consensus       211 ili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  289 (389)
                      |+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            9999999999999999987655443333344567889999999999999999999999999999999 999998654321


Q ss_pred             hhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          290 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      .  ..    ...          ........+...+..+.+++.+||+.||.+|||+.+++++|+++.
T Consensus       256 ~--~~----~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          256 K--FY----KMI----------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             H--HH----HHH----------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H--HH----HHh----------ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            1  00    001          111112223445688999999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.1e-47  Score=350.55  Aligned_cols=265  Identities=23%  Similarity=0.323  Sum_probs=209.9

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      +.++|++.+.||+|+||.||+|.+..+..      .||+|.+....  .......+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNI------KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCS------EEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCC------eEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            45789999999999999999997655443      39999875432  34445778899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+..++||||++||+|.+++....  ++++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            999999999999999999987654  6899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........      ....      
T Consensus       159 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~------  225 (294)
T 4eqm_A          159 KALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHI------  225 (294)
T ss_dssp             TTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHH------
T ss_pred             cccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHh------
Confidence            87643321 1233467999999999999999999999999999999999999999876432210      0000      


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhccccCC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-LMRDIVDSLEPLQVL  358 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~~il~~L~~~~~~  358 (389)
                      .. ..+......+...+..+.+++.+||+.||++|| +++++++.|+.+...
T Consensus       226 ~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          226 QD-SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             SS-CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             hc-cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            00 000011112234568899999999999999999 999999999877554

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-48  Score=361.67  Aligned_cols=273  Identities=25%  Similarity=0.368  Sum_probs=216.5

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      .+..++|.+.+.||+|+||.||+|.+.... ....+..||+|++...........+.+|+.+++.+ +||||+++++++.
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGIS-KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCS-SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccc-cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            345678999999999999999999864321 12234569999998655445557788999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVL---------------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD  205 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~D  205 (389)
                      ..+..++||||+++|+|.+++.....                     ..+++..+..++.|++.||+|||+++  |+|||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~D  197 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRD  197 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCC
Confidence            99999999999999999999876532                     24789999999999999999999977  99999


Q ss_pred             CCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCC
Q 016481          206 FKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDK  284 (389)
Q Consensus       206 lkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~  284 (389)
                      |||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999986644333333444667889999999999999999999999999999998 9999987


Q ss_pred             CCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          285 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                      ......  +              ...+........+...+.++.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus       278 ~~~~~~--~--------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          278 IPVDAN--F--------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCCSHH--H--------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCcHHH--H--------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            543211  0              1111111222334456788999999999999999999999999998876543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.8e-47  Score=359.29  Aligned_cols=256  Identities=21%  Similarity=0.283  Sum_probs=209.4

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+.++|++.+.||+|+||.||+|.+..+..      .||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   99 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGL------EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE   99 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCC------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            345789999999999999999998765544      39999987653 34455678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC---CcEEEecc
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAKLSDF  224 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~---~~vkl~Df  224 (389)
                      .+..|+||||+.||+|.+.+....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.+   +.+||+||
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Df  175 (362)
T 2bdw_A          100 ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADF  175 (362)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeec
Confidence            999999999999999999886553  6899999999999999999999977  9999999999999765   45999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      |++.......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||........   ..   ..... 
T Consensus       176 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~---~i~~~-  245 (362)
T 2bdw_A          176 GLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YA---QIKAG-  245 (362)
T ss_dssp             TTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHT-
T ss_pred             CcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHhC-
Confidence            9998765432   22346899999999999999999999999999999999999999986543211   00   00000 


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                             ............+.++.+|+.+||+.||++||++.++++|
T Consensus       246 -------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          246 -------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -------CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -------CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   0001111123457889999999999999999999999987

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=355.48  Aligned_cols=256  Identities=23%  Similarity=0.283  Sum_probs=208.2

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-----hhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      +.++|.+.+.||+|+||.||+|....+..      .||+|++......     .....+.+|+.+++.++||||++++++
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   82 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGL------QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   82 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCC------EEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCc------EEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            34679999999999999999998765444      3999988654322     235678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC----cEE
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAK  220 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~----~vk  220 (389)
                      +......++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+++  |+||||||+|||++.++    .+|
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           83 YENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEE
Confidence            99999999999999999999998654  36899999999999999999999977  99999999999998887    899


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........      .
T Consensus       159 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------~  229 (326)
T 2y0a_A          159 IIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN------V  229 (326)
T ss_dssp             ECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH------H
T ss_pred             EEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH------H
Confidence            99999998764332   22346799999999999999999999999999999999999999986543211100      0


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ..        .............+..+.+|+.+||+.||++|||+.++++|-
T Consensus       230 ~~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          230 SA--------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             HH--------TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             Hh--------cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence            00        000011011123467889999999999999999999999974

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-47  Score=355.93  Aligned_cols=255  Identities=18%  Similarity=0.209  Sum_probs=208.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|.+....  .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~------~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   75 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKK------TYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCc------EEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence            4789999999999999999998765544      39999987542  344567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC--CCcEEEeccCCCc
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT--DYNAKLSDFGLAK  228 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~--~~~vkl~Dfg~a~  228 (389)
                      +++||||++||+|.+++.... ..+++..+..++.|++.||.|||+++  |+||||||+|||++.  ++.+||+|||++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            999999999999999886543 36899999999999999999999977  999999999999987  7899999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........      ........   
T Consensus       153 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~~~~---  220 (321)
T 1tki_A          153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII------ENIMNAEY---  220 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTCC---
T ss_pred             ECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHHHcCCC---
Confidence            765433   233467999999999999988999999999999999999999999875432111      00000000   


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                           ..........+.++.+|+.+||+.||++|||+.++++|-+
T Consensus       221 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          221 -----TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             -----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             -----CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence                 0000001134678999999999999999999999999843

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.7e-46  Score=345.18  Aligned_cols=284  Identities=37%  Similarity=0.631  Sum_probs=225.2

Q ss_pred             CcccCHHHHHHHhcCCccc------ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC---ChhhHHHHHHHHHH
Q 016481           59 LIAFTYDELRIITANFRQD------RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIF  129 (389)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~  129 (389)
                      ...+++.++..++++|...      +.||+|+||.||+|.+.        +..||+|++....   .......+.+|+.+
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~   83 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--------NTTVAVKKLAAMVDITTEELKQQFDQEIKV   83 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--------SCEEEEEEECCCTTSCTTTHHHHHHHHHHH
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--------CceEEEEEEecccCcchHHHHHHHHHHHHH
Confidence            3456677777777776655      89999999999999752        2339999986542   23345678899999


Q ss_pred             HhccCCCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCC
Q 016481          130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK-VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKT  208 (389)
Q Consensus       130 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp  208 (389)
                      ++.++||||+++++++...+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+++  |+|+||||
T Consensus        84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp  161 (307)
T 2nru_A           84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKS  161 (307)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred             HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCH
Confidence            99999999999999999999999999999999999988643 2346899999999999999999999977  99999999


Q ss_pred             CCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCch
Q 016481          209 SNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA  288 (389)
Q Consensus       209 ~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  288 (389)
                      +||+++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus       162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  240 (307)
T 2nru_A          162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP  240 (307)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred             HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence            999999999999999999987654333333344679999999998865 5889999999999999999999999865432


Q ss_pred             hhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          289 REQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ..  ...+..........+...+++.+ ...+...+..+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus       241 ~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          241 QL--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             SB--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HH--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            21  11111111112222333344333 3446678889999999999999999999999999998875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=357.52  Aligned_cols=266  Identities=25%  Similarity=0.397  Sum_probs=211.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+..+...  ....|++|.+...........+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCS--CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCce--EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            46899999999999999999987654332  234478888876655666778899999999999999999999998654 


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++|++|+.+|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            789999999999999987654 36899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .............+|+.|+|||++.+..++.++|||||||++|+|++ |..||........                 ..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-----------------~~  230 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----------------SS  230 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----------------HH
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-----------------HH
Confidence            54433333334567889999999999999999999999999999999 9999987643321                 11


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                      .+........+..++.++.+|+.+||+.||++|||+.++++.|+.+...+
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            11112222334456788999999999999999999999999998886543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4e-47  Score=362.73  Aligned_cols=258  Identities=25%  Similarity=0.366  Sum_probs=205.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  147 (389)
                      .++|++.+.||+|+||.||+|+++.+.+      .||+|++....  .......+..|..++.++ +||||+++++++.+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~------~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~  124 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDR------IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT  124 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence            4689999999999999999998765544      39999987542  122234567899999877 79999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+.+|+||||++||+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla  200 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMC  200 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeeccee
Confidence            999999999999999999887653  6899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhh--hhhHHHHhHHHHhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE--QNLADWALPLLKEKK  305 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~  305 (389)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........  ..........+    
T Consensus       201 ~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i----  274 (396)
T 4dc2_A          201 KEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI----  274 (396)
T ss_dssp             BCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH----
T ss_pred             eecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH----
Confidence            8633221  234457899999999999999999999999999999999999999975432211  11111111111    


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM------RDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~~il~~  351 (389)
                           ...  ...++...+.++.+|+.+||+.||++||++      .+|++|
T Consensus       275 -----~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          275 -----LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             -----HHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             -----hcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                 111  112344567889999999999999999985      788877

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=361.29  Aligned_cols=253  Identities=27%  Similarity=0.349  Sum_probs=203.5

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  145 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  145 (389)
                      +..++|++.+.||+|+||.||+|+++.+.+      .||+|++....  .......+..|..+++.+ +||||+++++++
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~------~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~   93 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGD------LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF   93 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCC------EEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence            335789999999999999999998765544      39999986532  122345677899999988 699999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      .+.+.+|+||||++||+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A           94 QTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEcccc
Confidence            99999999999999999999887653  6899999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +++......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........   .           
T Consensus       170 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~-----------  233 (353)
T 3txo_A          170 MCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL---F-----------  233 (353)
T ss_dssp             TCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-----------
T ss_pred             ceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH---H-----------
Confidence            998643322  223457899999999999999999999999999999999999999987643211   0           


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM------RDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~~il~~  351 (389)
                        ..+...  ...++...+..+.+|+.+||+.||++||++      .++++|
T Consensus       234 --~~i~~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          234 --EAILND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             --HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             --HHHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence              011111  112334456889999999999999999998      888876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.1e-47  Score=348.11  Aligned_cols=263  Identities=24%  Similarity=0.356  Sum_probs=204.2

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +..++|++.+.||+|+||.||+|.+..+..   ....||+|.............+.+|+.+++.++||||+++++++ .+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~   87 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-cc
Confidence            345789999999999999999998654322   23459999988766666677889999999999999999999998 45


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             CccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccccc
Confidence            67899999999999999987653 36899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........   .            
T Consensus       165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~------------  228 (281)
T 1mp8_A          165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G------------  228 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H------------
T ss_pred             ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---H------------
Confidence            7644321 12233467889999999999999999999999999999997 99999865433211   0            


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                        .+........+..++..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       229 --~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          229 --RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             --HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              00111112234456788999999999999999999999999998763

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.1e-47  Score=356.02  Aligned_cols=271  Identities=25%  Similarity=0.394  Sum_probs=220.0

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccc-cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLR-EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      +..++|++.+.||+|+||.||+|.+....+ ....+..||+|++...........+.+|+.+++.+ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            345789999999999999999998754322 22345569999998776666677889999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeE
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVL--------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  212 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nil  212 (389)
                      ..+.+++||||+++|+|.+++.....              ..+++..+..++.|++.||+|||+.+  |+|+||||+||+
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl  189 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL  189 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEE
Confidence            99999999999999999999876532              24889999999999999999999977  999999999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhh
Q 016481          213 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQ  291 (389)
Q Consensus       213 i~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  291 (389)
                      ++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            99999999999999987654433223334567889999999999899999999999999999999 99999865432110


Q ss_pred             hhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          292 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                         .    .+.          .......+..++.++.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       270 ---~----~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          270 ---K----LLK----------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             ---H----HHH----------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---H----HHh----------cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence               0    010          0111223445668899999999999999999999999999888543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=349.93  Aligned_cols=275  Identities=21%  Similarity=0.234  Sum_probs=214.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  149 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++...........+.+|+.+++.++||||+++++++.... 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGD------LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCc------EEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence            4689999999999999999998765443      499999876544455667789999999999999999999998765 


Q ss_pred             -eEEEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE----cCCCcEEEec
Q 016481          150 -HRVLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSD  223 (389)
Q Consensus       150 -~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili----~~~~~vkl~D  223 (389)
                       ..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+  |+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEcc
Confidence             88999999999999999876432 34899999999999999999999977  9999999999999    7788899999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccc--------cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  295 (389)
                      ||+++......   ......||+.|+|||++.        +..++.++|||||||++|+|++|+.||.........  ..
T Consensus       160 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~  234 (319)
T 4euu_A          160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KE  234 (319)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HH
T ss_pred             CCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HH
Confidence            99998765432   223467999999999986        578899999999999999999999999754332211  11


Q ss_pred             HHhHHHHhhhh-hhhhc------------CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          296 WALPLLKEKKK-LLNII------------DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       296 ~~~~~~~~~~~-~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      ........... ....+            ........+...+..+.+|+.+||+.||++|||+.+++++.......
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            11111111100 00000            00112234567889999999999999999999999999998765443

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.8e-47  Score=356.65  Aligned_cols=278  Identities=26%  Similarity=0.368  Sum_probs=199.5

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      +..++|++.+.||+|+||.||+|.+..+..   ....||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDG---SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCC---cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            345689999999999999999998665432   12349999987653 33446778899999999999999999999987


Q ss_pred             CCeE------EEEEEecCCCChhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          148 DEHR------VLIYEFMARGSVENNLFSKV----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       148 ~~~~------~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      ....      ++||||+.+|+|.+++....    ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTS
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCC
Confidence            7655      99999999999999885432    225899999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHH
Q 016481          218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       218 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  296 (389)
                      .+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||.........     
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-----  249 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-----  249 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-----
Confidence            999999999987654433333334567889999999999999999999999999999999 99999876533211     


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCCCCCCc
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNF  368 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~~p~~~  368 (389)
                                  ..+........+...+.++.+|+.+||+.||++|||+.++++.|+.+..-+...+....+
T Consensus       250 ------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p  309 (323)
T 3qup_A          250 ------------NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP  309 (323)
T ss_dssp             ------------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred             ------------HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence                        001111112234456688999999999999999999999999999887666555544443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=360.77  Aligned_cols=253  Identities=23%  Similarity=0.313  Sum_probs=207.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~------~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKK------MYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4689999999999999999998765544      39999986432  122346778999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+|+||||+.||+|..++....  .+++..+..++.|++.||.|||+++  |+||||||+|||++.+|.+||+|||++.
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceee
Confidence            99999999999999999887643  6899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      ......   .....+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||................       
T Consensus       164 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-------  233 (384)
T 4fr4_A          164 MLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-------  233 (384)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-------
T ss_pred             eccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-------
Confidence            764432   2345789999999999974   468999999999999999999999997654332221111100       


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-MRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~~il~~  351 (389)
                            .  ....++...+..+.+|+.+||+.||++||+ +.++++|
T Consensus       234 ------~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          234 ------T--TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             ------H--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             ------h--cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                  0  012234456788999999999999999998 8888764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.7e-47  Score=355.36  Aligned_cols=276  Identities=28%  Similarity=0.363  Sum_probs=222.2

Q ss_pred             cCHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccce
Q 016481           62 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVK  140 (389)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  140 (389)
                      +....+.+..++|++.+.||+|+||.||+|.+... .....+..||+|++...........+.+|+.+++.+ +||||++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecC-CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            34555666678999999999999999999976432 122345569999998776666677889999999999 6999999


Q ss_pred             EEeEEEeCC-eEEEEEEecCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecC
Q 016481          141 LIGYCCEDE-HRVLIYEFMARGSVENNLFSKVL--------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRD  205 (389)
Q Consensus       141 ~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~D  205 (389)
                      +++++...+ .+++||||+++|+|.+++.....              ..+++..+..++.|++.||.|||+++  |+|+|
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~d  173 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD  173 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--ccccc
Confidence            999987754 58999999999999999876542              12789999999999999999999977  99999


Q ss_pred             CCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCC
Q 016481          206 FKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDK  284 (389)
Q Consensus       206 lkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~  284 (389)
                      |||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987654433333444678899999999999999999999999999999998 9999976


Q ss_pred             CCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          285 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ......  +.    ..+..          ......+...+..+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus       254 ~~~~~~--~~----~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          254 VKIDEE--FC----RRLKE----------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCCSHH--HH----HHHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhHH--HH----HHhcc----------CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            543211  00    00000          1111223345678999999999999999999999999998764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-47  Score=354.58  Aligned_cols=269  Identities=27%  Similarity=0.428  Sum_probs=211.8

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ...+|++.+.||+|+||.||+|.+..+.  ......||+|++...........+.+|+.+++.++||||+++++++...+
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSS--GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCC--CCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            3467889999999999999999875432  12345599999987666666678899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++..
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchh
Confidence            9999999999999999987643 36899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          230 GPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       230 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........   .             
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~-------------  260 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---M-------------  260 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-------------
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---H-------------
Confidence            6443211 11223456889999999999999999999999999999999 9999976543211   0             


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  360 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~  360 (389)
                       ..+........+..++..+.+++.+||+.||++||++.+++++|+.+...+.
T Consensus       261 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          261 -KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             -HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             -HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence             0111111222344567889999999999999999999999999988755433

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.7e-47  Score=348.82  Aligned_cols=252  Identities=24%  Similarity=0.323  Sum_probs=198.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-------------------------hhHHHHHH
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-------------------------QGHREWLA  125 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~  125 (389)
                      .++|++.+.||+|+||.||+|++..+.+      .||+|++......                         .....+.+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNT------YYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ   85 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTE------EEEEEEEECC-------------------------------CHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCc------EEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence            4689999999999999999998665444      3999998654311                         11345788


Q ss_pred             HHHHHhccCCCccceEEeEEEe--CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 016481          126 EVIFLGHLSHPNLVKLIGYCCE--DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIY  203 (389)
Q Consensus       126 E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH  203 (389)
                      |+.+++.++||||+++++++.+  ...+++||||+++|+|.+++..   ..+++..+..++.|++.||+|||+++  |+|
T Consensus        86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH  160 (298)
T 2zv2_A           86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK--IIH  160 (298)
T ss_dssp             HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred             HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence            9999999999999999999986  5789999999999999876532   37899999999999999999999977  999


Q ss_pred             cCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCC---CCcccchhHHHHHHHHHHhCCC
Q 016481          204 RDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH---LTPRSDVYSFGVVLLEILTGRK  280 (389)
Q Consensus       204 ~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwslG~il~elltg~~  280 (389)
                      |||||+|||++.++.+||+|||++........  ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.
T Consensus       161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            99999999999999999999999987654321  233467999999999998765   3788999999999999999999


Q ss_pred             CCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          281 SLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       281 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ||........      ... +         .......+.....+.++.+|+.+||+.||++|||+.++++|
T Consensus       239 pf~~~~~~~~------~~~-~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          239 PFMDERIMCL------HSK-I---------KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSCCSSHHHH------HHH-H---------HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCCccHHHH------HHH-H---------hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            9986542211      000 0         00111111123456789999999999999999999999876

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.5e-47  Score=344.78  Aligned_cols=258  Identities=25%  Similarity=0.405  Sum_probs=211.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||.||+|.+...       ..||+|++.....  ....+.+|+.++++++||||+++++++.+.+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT-------EEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ChhhceeeheecCCCccEEEEEEecCC-------CeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            356899999999999999999986532       2399999886543  2356889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  155 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRF  155 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             ceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccc
Confidence            9999999999999999886543 36899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ..... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.........                 
T Consensus       156 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~-----------------  217 (269)
T 4hcu_A          156 VLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-----------------  217 (269)
T ss_dssp             BCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-----------------
T ss_pred             ccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH-----------------
Confidence            54321 111223567888999999999999999999999999999999 99999875432110                 


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      ..+........+...+..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          218 EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            0011111222334456889999999999999999999999999987753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.8e-47  Score=356.37  Aligned_cols=273  Identities=27%  Similarity=0.403  Sum_probs=220.7

Q ss_pred             HHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           65 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      +++.+..++|++.+.||+|+||.||+|.+.... ....+..||+|.+...........+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVV-KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEE-TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCcc-CCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            345566789999999999999999999865321 1123345999999877666666788899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKV--------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      +.+.+..++||||+++|+|.+++....        ...+++..+..++.|++.||+|||+++  |+||||||+||+++.+
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED  174 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence            999999999999999999999886421        246789999999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHH
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~  295 (389)
                      +.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........   .
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~  251 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---R  251 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---H
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH---H
Confidence            9999999999986543322222334567899999999999999999999999999999999 89999865432111   0


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                                   .... ......+..++..+.+|+.+||+.||++|||+.+++++|+.+..
T Consensus       252 -------------~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 -------------FVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -------------HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -------------HHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                         0000 11112234566889999999999999999999999999988744

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-47  Score=352.68  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=207.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|+.+.+.+      .||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~   78 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGR------YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA   78 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC
Confidence            3689999999999999999998765443      49999986432  112345677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||+++
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             CEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcce
Confidence            99999999999999999997654  6899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ....     .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.........                .
T Consensus       155 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------------~  213 (318)
T 1fot_A          155 YVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY----------------E  213 (318)
T ss_dssp             ECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------H
T ss_pred             ecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH----------------H
Confidence            6543     123468999999999999999999999999999999999999999865432110                0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      .++...  ..++...+.++.+|+.+||+.||++||     ++.++++|
T Consensus       214 ~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          214 KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            111111  123345568899999999999999999     89999977

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.9e-46  Score=350.96  Aligned_cols=263  Identities=17%  Similarity=0.184  Sum_probs=208.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||.||+|....+.+      .||+|++......   ..+..|+.+++.+ +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   77 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNE------YVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCG   77 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTE------EEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCc------EEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence            35789999999999999999998655443      4999998755332   2466899999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc-----EEEec
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-----AKLSD  223 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~-----vkl~D  223 (389)
                      ...++||||+ +++|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.     +||+|
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~D  153 (330)
T 2izr_A           78 KYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIID  153 (330)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred             CccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEE
Confidence            9999999999 89999988765 347999999999999999999999977  999999999999998887     99999


Q ss_pred             cCCCcCCCCCCCcc-----ccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh
Q 016481          224 FGLAKDGPEGDKSH-----VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       224 fg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  298 (389)
                      ||+++.........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+.
T Consensus       154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~  233 (330)
T 2izr_A          154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG  233 (330)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred             cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence            99998754432211     1235689999999999999999999999999999999999999998764333222211111


Q ss_pred             HHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          299 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      .....  .....+        ....+ ++.+++..||+.||.+||++.+|++.|+.+.
T Consensus       234 ~~~~~--~~~~~~--------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          234 DTKRA--TPIEVL--------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHHHH--SCHHHH--------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hhhcc--CCHHHH--------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            10000  000000        01123 8999999999999999999999999987663

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.2e-47  Score=343.15  Aligned_cols=259  Identities=26%  Similarity=0.399  Sum_probs=212.2

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||.||+|.+...       ..||+|++.....  ....+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQ-------YDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY   76 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             chhheeeeeeeccCCCceEEEEEecCc-------eeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            356899999999999999999976542       2399999876532  3356889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||++..
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           77 PIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             SEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             ceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCcccee
Confidence            9999999999999999886643 35899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........               
T Consensus       154 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---------------  217 (268)
T 3sxs_A          154 VLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK---------------  217 (268)
T ss_dssp             CCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---------------
T ss_pred             cchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH---------------
Confidence            644322 12233557788999999999899999999999999999999 9999986543321100               


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                        +........+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus       218 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          218 --VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             --HHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             --HHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence              001111122334567899999999999999999999999999998654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.1e-46  Score=343.48  Aligned_cols=257  Identities=29%  Similarity=0.522  Sum_probs=207.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhH------HHHHHHHHHHhccCCCccceEEeE
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH------REWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      .++|++.+.||+|+||.||+|.+..+.+.      ||+|++.........      ..+.+|+.+++.++||||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSV------VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCE------EEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hccceehhccccCCceeEEEEEEcCCceE------EEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            46899999999999999999987655443      999998654332211      567899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc-----E
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-----A  219 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~-----v  219 (389)
                      +.+..  ++||||+++|+|.+.+.... ..+++..+..++.|++.||+|||+++.+|+|+||||+||+++.++.     +
T Consensus        92 ~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           92 MHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             ETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             ecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence            86555  79999999999998886653 3789999999999999999999996655999999999999988776     9


Q ss_pred             EEeccCCCcCCCCCCCccccccccccccccCccccc--cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH
Q 016481          220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM--TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  297 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  297 (389)
                      ||+|||+++....     ......||+.|+|||++.  ...++.++||||||+++|+|++|+.||...........    
T Consensus       169 kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----  239 (287)
T 4f0f_A          169 KVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI----  239 (287)
T ss_dssp             EECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH----
T ss_pred             EeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH----
Confidence            9999999975432     233467999999999984  45678999999999999999999999986543321111    


Q ss_pred             hHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                                ............+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       240 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 ----------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ----------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ----------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                      011112223334556678999999999999999999999999999764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.7e-47  Score=373.70  Aligned_cols=264  Identities=25%  Similarity=0.385  Sum_probs=220.3

Q ss_pred             HHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEE
Q 016481           66 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC  145 (389)
Q Consensus        66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  145 (389)
                      .+.+...+|++.+.||+|+||.||+|.++....      .||+|.+.....  ....+.+|+.++++++||||+++++++
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~  285 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL------TVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVC  285 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTE------EEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCe------EEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            344556789999999999999999998775443      399999876532  356788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      .....+++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus       286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG  363 (495)
T 1opk_A          286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFG  363 (495)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTT
T ss_pred             ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecc
Confidence            99999999999999999999998766667899999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      +++...... ........+++.|+|||++.+..++.++|||||||++|||++ |..||........              
T Consensus       364 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--------------  428 (495)
T 1opk_A          364 LSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------  428 (495)
T ss_dssp             CEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--------------
T ss_pred             cceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--------------
Confidence            998764322 112233456789999999999999999999999999999999 9999987653211              


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                         ...+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       429 ---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          429 ---YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ---HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence               11112222333455667899999999999999999999999999988753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.7e-47  Score=356.88  Aligned_cols=254  Identities=24%  Similarity=0.309  Sum_probs=207.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++.....  ......+.+|+.+++.++||||+++++++...
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   81 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQ------KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP   81 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            3689999999999999999998765544      399999864311  11234677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...++||||+ +|+|.+++....  .+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           82 TDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             SEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             CEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccce
Confidence            9999999999 789998886654  6899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......                 +
T Consensus       157 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------------~  216 (336)
T 3h4j_B          157 IMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------------L  216 (336)
T ss_dssp             TTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------------C
T ss_pred             eccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------------H
Confidence            764432   2344689999999999998876 789999999999999999999997643211                 1


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ...+.. .....+...+..+.+|+.+||+.||.+|||+.++++|-+--.
T Consensus       217 ~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          217 FKKVNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             BCCCCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             HHHHHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            111111 112234456788999999999999999999999998854333

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-46  Score=357.40  Aligned_cols=255  Identities=21%  Similarity=0.270  Sum_probs=209.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|....+.+      .||+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~------~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGR------VFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCC------EEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            4689999999999999999998765543      39999987653 3344578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC--CCcEEEeccCCCc
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT--DYNAKLSDFGLAK  228 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~--~~~vkl~Dfg~a~  228 (389)
                      +++||||+.||+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.  ++.+||+|||++.
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccce
Confidence            999999999999999886543 36899999999999999999999977  999999999999974  5789999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........      .... .     
T Consensus       200 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~------~~i~-~-----  264 (387)
T 1kob_A          200 KLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------QNVK-R-----  264 (387)
T ss_dssp             ECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHH-H-----
T ss_pred             ecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH------HHHH-h-----
Confidence            765432   223457999999999999999999999999999999999999999875432111      0000 0     


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                        .............+.++.+|+.+||+.||++|||+.++++|-
T Consensus       265 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          265 --CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             --CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             --CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence              011111222334578899999999999999999999999984

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-47  Score=357.71  Aligned_cols=270  Identities=25%  Similarity=0.332  Sum_probs=219.0

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      .+..++|.+.+.||+|+||.||+|.+..... ......||+|.+...........+.+|+.+++.+ +||||+++++++.
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSS-SCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCc-ccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3446789999999999999999998765432 2234569999998776666677889999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKV------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  214 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~  214 (389)
                      ..+..++||||+++|+|.+++....            ...+++..+..++.|++.||+|||+++  |+|+||||+|||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEEC
Confidence            9999999999999999999886431            346789999999999999999999977  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 016481          215 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNL  293 (389)
Q Consensus       215 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  293 (389)
                      .++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........  
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--  276 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--  276 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--
Confidence            999999999999986544333223344567889999999999999999999999999999999 99999865432110  


Q ss_pred             HHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          294 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      .    ...          ........+...+..+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus       277 ~----~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          277 Y----KLV----------KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             H----HHH----------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----HHH----------hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            0    001          111111223344678999999999999999999999999997653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-46  Score=352.50  Aligned_cols=258  Identities=26%  Similarity=0.366  Sum_probs=207.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  147 (389)
                      .++|++.+.||+|+||.||+|+++.+.+      .||+|++....  .......+.+|+.+++.+ +||||+++++++..
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~   81 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDR------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT   81 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCC------EEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe
Confidence            3579999999999999999998765544      39999987542  334456678899999887 79999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ...+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a  157 (345)
T 3a8x_A           82 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMC  157 (345)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEecccc
Confidence            999999999999999999887643  6899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhh--hhhHHHHhHHHHhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE--QNLADWALPLLKEKK  305 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~  305 (389)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........  ..........+    
T Consensus       158 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i----  231 (345)
T 3a8x_A          158 KEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI----  231 (345)
T ss_dssp             BCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH----
T ss_pred             ccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH----
Confidence            8643221  123457899999999999999999999999999999999999999975322111  01111111111    


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM------RDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~~il~~  351 (389)
                           ...  ...++...+.++.+|+.+||+.||++||++      .++++|
T Consensus       232 -----~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          232 -----LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -----HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -----HcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                 111  112344567889999999999999999995      788877

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-46  Score=342.25  Aligned_cols=259  Identities=25%  Similarity=0.345  Sum_probs=210.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|++...........+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEE------AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCc------EEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence            35689999999999999999998765443      399999875544455577889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            999999999999999988654  36899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ..............||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ .+..+.           
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-----------  222 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK-----------  222 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH-----------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh-----------
Confidence            543332223345679999999999987775 7789999999999999999999986543211 111110           


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                         ............+..+.+|+.+||+.||++|||+.+++++-.
T Consensus       223 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (276)
T 2yex_A          223 ---EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (276)
T ss_dssp             ---TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             ---hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence               000111112345678999999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.3e-47  Score=342.47  Aligned_cols=256  Identities=25%  Similarity=0.317  Sum_probs=211.4

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  148 (389)
                      .++|++.+.||+|+||.||+|.+..        ..||+|++.... .......+.+|+.+++.++||||+++++++... 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQG--------NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEETT--------EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             HHHhHHHHHhcCCCcceEEEEEECC--------eeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            4689999999999999999998642        239999987654 344556788999999999999999999999877 


Q ss_pred             -CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          149 -EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       149 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                       ...++||||+++|+|.+++.......+++..+..++.|++.||+|||+++..|+|+||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence             7889999999999999999877666799999999999999999999986666999999999999999999999998886


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCc---ccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTP---RSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      .....       ....||+.|+|||++.+..++.   ++||||||+++|+|++|+.||.........             
T Consensus       161 ~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------------  220 (271)
T 3kmu_A          161 FSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-------------  220 (271)
T ss_dssp             CTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-------------
T ss_pred             eeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-------------
Confidence            54322       2346899999999998765544   799999999999999999999865432210             


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                         ............+...+.++.+++.+||+.||++|||+.++++.|+.+..
T Consensus       221 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          221 ---MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---HHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence               11111122233445567889999999999999999999999999988753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.5e-47  Score=349.74  Aligned_cols=262  Identities=25%  Similarity=0.397  Sum_probs=219.3

Q ss_pred             HHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEE
Q 016481           66 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC  145 (389)
Q Consensus        66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  145 (389)
                      .+.+..++|++.+.||+|+||.||+|.+..+..      .||+|.+....  .....+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~   78 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL------TVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVC   78 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTE------EEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCE------EEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            344566789999999999999999998765544      39999987653  3456788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      .+....++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             ccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCc
Confidence            99999999999999999999998877677999999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      ++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||........              
T Consensus       157 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--------------  221 (288)
T 3kfa_A          157 LSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------  221 (288)
T ss_dssp             GGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--------------
T ss_pred             cceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------
Confidence            998765432 222333567889999999999999999999999999999999 9999987643321              


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                         ...+........+..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       222 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          222 ---YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             ---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence               111111222233445678899999999999999999999999998765

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.5e-47  Score=351.17  Aligned_cols=281  Identities=24%  Similarity=0.307  Sum_probs=212.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe--
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  147 (389)
                      ...+|++.+.||+|+||.||+|++...  ....+..||+|++... .......+.+|+.+++.++||||+++++++..  
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPL--QDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTT--CSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecc--cCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            357899999999999999999975321  1223456999998765 34455678899999999999999999999865  


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ...+++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccc
Confidence            3568999999999999999876532 5899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          228 KDGPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       228 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ......... .......++..|+|||++.+..++.++||||||+++|+|++|..||................. ......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~  240 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFH  240 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCT-HHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcccc-chhHHH
Confidence            876543221 122335678889999999999999999999999999999999999875322111000000000 000011


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      ....+........+..++.++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            122222223334455677899999999999999999999999999988754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.7e-46  Score=344.71  Aligned_cols=264  Identities=27%  Similarity=0.437  Sum_probs=200.1

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      ++..++|++.+.||+|+||.||+|.+..+         ||+|++.... .......+.+|+.+++.++||||++++++. 
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~~---------vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-   89 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-   89 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESSSE---------EEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEcCc---------eEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence            34567899999999999999999975432         9999987554 344557788999999999999999999965 


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      .....++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           90 TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEcccee
Confidence            5667899999999999999886543 46899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      +................||+.|+|||++.   +..++.++||||||+++|+|++|+.||........  ..    .....
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~  240 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--II----EMVGR  240 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HH----HHHHH
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HH----HHhcc
Confidence            98655433333334467999999999987   66788999999999999999999999986543321  10    00100


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                           ....+ ........++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       241 -----~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          241 -----GSLSP-DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             -----TSCCC-CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -----cccCc-chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                 00111 111223355688999999999999999999999999998775

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-46  Score=352.14  Aligned_cols=255  Identities=22%  Similarity=0.330  Sum_probs=200.8

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +.++|++.+.||+|+||.||+|++..+.+      .||+|++...........+.+|+.+++.++||||+++++++.+..
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   77 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDC------NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETP   77 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCC------EEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCc------EEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence            34689999999999999999998765544      399999986655556678899999999999999999999986543


Q ss_pred             ---------------------------------------------------------eEEEEEEecCCCChhhhhhcCCC
Q 016481          150 ---------------------------------------------------------HRVLIYEFMARGSVENNLFSKVL  172 (389)
Q Consensus       150 ---------------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~  172 (389)
                                                                               .+++||||+++|+|.+++.....
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  157 (332)
T 3qd2_B           78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS  157 (332)
T ss_dssp             SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred             cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence                                                                     38999999999999999876543


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCc----------ccccc
Q 016481          173 -LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS----------HVSTR  241 (389)
Q Consensus       173 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~~  241 (389)
                       ...++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++........          .....
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence             23566678999999999999999977  999999999999999999999999999876543211          11233


Q ss_pred             ccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCCh
Q 016481          242 IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPV  321 (389)
Q Consensus       242 ~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (389)
                      ..||+.|+|||++.+..++.++||||||+++|+|++|..|+...     ...       .      ...... .......
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~-------~------~~~~~~-~~~~~~~  296 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRI-------I------TDVRNL-KFPLLFT  296 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHH-------H------HHHHTT-CCCHHHH
T ss_pred             cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHH-------H------HHhhcc-CCCcccc
Confidence            57999999999999999999999999999999999987654311     000       0      000000 0011122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          322 KGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       322 ~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..+.++.+|+.+||+.||++|||+.++++|
T Consensus       297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          297 QKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             cCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            445778999999999999999999999987

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.4e-47  Score=356.16  Aligned_cols=249  Identities=23%  Similarity=0.279  Sum_probs=208.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|+++.+.+      .||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  113 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGN------HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN  113 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCC------EEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            4689999999999999999998765544      39999986432  122345678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccce
Confidence            99999999999999999987653  6899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .....     ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.........      .          
T Consensus       190 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~----------  248 (350)
T 1rdq_E          190 RVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY------E----------  248 (350)
T ss_dssp             ECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------H----------
T ss_pred             eccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH------H----------
Confidence            75432     23468999999999999999999999999999999999999999865432110      0          


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~L  352 (389)
                      .+...  ...++...+.++.+|+.+||+.||++||+     +.+|++|-
T Consensus       249 ~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          249 KIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             HHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence            01111  11234456788999999999999999998     99999873

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-46  Score=366.47  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=210.7

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +..++|++.+.||+|+||.||+|.+..        ..||||++....   ....+.+|+.++++++||||+++++++...
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~~--------~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT--------EEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEecC--------CeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            345678999999999999999997652        239999998653   345788999999999999999999998776


Q ss_pred             C-eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          149 E-HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       149 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      . .+++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus       259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            5 7999999999999999998765556799999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      +.....     .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.........               
T Consensus       337 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---------------  396 (450)
T 1k9a_A          337 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---------------  396 (450)
T ss_dssp             EECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---------------
T ss_pred             cccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---------------
Confidence            854321     122367889999999999999999999999999999998 99999865432111               


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                        ..+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       397 --~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          397 --PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             --HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence              1111122233455677899999999999999999999999999987753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-46  Score=354.85  Aligned_cols=257  Identities=22%  Similarity=0.291  Sum_probs=204.8

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCccceEEeEE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVKLIGYC  145 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  145 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|++....    .......+.+|+.+++.++||||+++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQ------QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCC------EEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45689999999999999999998765544      39999975321    112356788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc---EE
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN---AK  220 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~---vk  220 (389)
                      ...+.+|+||||++||+|.+.+...  ....+++..+..++.|++.||+|||+++  |+||||||+|||++.++.   +|
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEE
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEE
Confidence            9999999999999999998877543  2335899999999999999999999977  999999999999976654   99


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |+|||++.......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......    ...   ..
T Consensus       174 l~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~---~i  244 (351)
T 3c0i_A          174 LGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFE---GI  244 (351)
T ss_dssp             ECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHH---HH
T ss_pred             EecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHH---HH
Confidence            99999998765432  1233468999999999999999999999999999999999999999864211    100   00


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ......        .........+.++.+|+.+||+.||++|||+.++++|
T Consensus       245 ~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          245 IKGKYK--------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HHTCCC--------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HcCCCC--------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000000        0000011346789999999999999999999999976

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1e-46  Score=355.30  Aligned_cols=253  Identities=25%  Similarity=0.312  Sum_probs=207.5

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  145 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  145 (389)
                      ...++|++.+.||+|+||.||+|..+.+.+.      ||+|++....  .......+..|..++..+ +||||+++++++
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~------~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDEL------YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEE------EEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCE------EEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            3457899999999999999999987665443      9999986532  112345677899999988 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      ...+.+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||
T Consensus        91 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           91 QTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCC
Confidence            99999999999999999999987643  6899999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +++......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........   .   .       
T Consensus       167 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~---~-------  231 (353)
T 2i0e_A          167 MCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F---Q-------  231 (353)
T ss_dssp             TCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---H-------
T ss_pred             cccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---H---H-------
Confidence            998643222  123457899999999999999999999999999999999999999986543211   0   0       


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~  351 (389)
                         .++..  ...++...+.++.+|+.+||+.||++||+     +.+|++|
T Consensus       232 ---~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          232 ---SIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ---HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ---HHHhC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               11111  11234456788999999999999999995     6888877

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.5e-47  Score=357.43  Aligned_cols=253  Identities=26%  Similarity=0.365  Sum_probs=206.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  145 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  145 (389)
                      ...++|.+.+.||+|+||.||+|+++.+.+      .||+|++....  .......+..|..++..+ +||||+++++++
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~   87 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQ------FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   87 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTE------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence            445789999999999999999998765544      39999986532  112345567889998876 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      .+.+.+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||
T Consensus        88 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           88 QTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeECh
Confidence            99999999999999999999987643  6899999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +++.......  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........   ..   . +..  
T Consensus       164 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~---~-i~~--  232 (345)
T 1xjd_A          164 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FH---S-IRM--  232 (345)
T ss_dssp             TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---H-HHH--
T ss_pred             hhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH---HH---H-HHh--
Confidence            9986433221  23457899999999999999999999999999999999999999986543211   00   0 000  


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR-DIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~il~~  351 (389)
                           .    ...++...+.++.+|+.+||+.||++||++. +|++|
T Consensus       233 -----~----~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          233 -----D----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             -----C----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -----C----CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                 0    1123344568899999999999999999998 88765

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-46  Score=350.22  Aligned_cols=268  Identities=23%  Similarity=0.340  Sum_probs=193.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+..+.      ..||+|.+...........+.+|+.+++.++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTG------VYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK   77 (317)
T ss_dssp             ---------------CEEEEEECSSSC------CEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCC------cEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe
Confidence            468999999999999999999765543      34999998765444444677889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          151 RVLIYEFMARGSVENNLFSKV----LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      +++||||++ |+|.+++....    ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCcc
Confidence            999999998 58988875432    235889999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh-h
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-K  304 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~  304 (389)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........   +...... .
T Consensus       155 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~  229 (317)
T 2pmi_A          155 ARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL---IFDIMGTPN  229 (317)
T ss_dssp             CEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCC
T ss_pred             ceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCC
Confidence            987543221  2234578999999999976 4689999999999999999999999987654332111   1000000 0


Q ss_pred             h----hhhh--hcCCCCC------------CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          305 K----KLLN--IIDPRLE------------GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       305 ~----~~~~--~~~~~~~------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .    ....  ...+...            .......+.++.+|+.+||+.||++|||+.++++|-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp  295 (317)
T 2pmi_A          230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP  295 (317)
T ss_dssp             TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence            0    0000  0000000            001123457899999999999999999999999873

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-47  Score=372.67  Aligned_cols=265  Identities=28%  Similarity=0.394  Sum_probs=216.1

Q ss_pred             HHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEe
Q 016481           64 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIG  143 (389)
Q Consensus        64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~  143 (389)
                      .+.+.+..++|.+.+.||+|+||.||+|.++..       ..||||++....  .....+.+|+.+++.++||||+++++
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~-------~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~  250 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH-------TKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHA  250 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTT-------EEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCc-------cEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEE
Confidence            344556678899999999999999999987532       239999997653  34568889999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          144 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       144 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      ++. .+.+++||||+.+|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus       251 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             EEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECS
T ss_pred             EEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEee
Confidence            986 677899999999999999997654446888999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      ||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.........   .       
T Consensus       328 FG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~-------  396 (454)
T 1qcf_A          328 FGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R-------  396 (454)
T ss_dssp             TTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H-------
T ss_pred             CCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---H-------
Confidence            99998754321 111223456789999999999999999999999999999999 99999875432211   0       


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                             .+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       397 -------~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          397 -------ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -------HHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                   0111112233455678899999999999999999999999999987543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-46  Score=359.20  Aligned_cols=278  Identities=18%  Similarity=0.228  Sum_probs=209.9

Q ss_pred             hcCCcccceecCC--CceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           71 TANFRQDRVLGGG--GFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .++|++.+.||+|  +||.||+|+++.+.+      .||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGE------YVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCC------EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCC------EEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            4689999999999  999999998765444      39999987543 33445677889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+.+++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||.+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccc
Confidence            999999999999999999998776667999999999999999999999977  999999999999999999999999987


Q ss_pred             cCCCCCCC-----ccccccccccccccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH-HHHhH
Q 016481          228 KDGPEGDK-----SHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA-DWALP  299 (389)
Q Consensus       228 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~  299 (389)
                      ........     ........||+.|+|||++.+  ..|+.++|||||||++|+|++|+.||............ .....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  255 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  255 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            65422111     111223578999999999987  67999999999999999999999999865443221000 00000


Q ss_pred             HHHhh-----hh-------------hhhhc---------CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH-
Q 016481          300 LLKEK-----KK-------------LLNII---------DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS-  351 (389)
Q Consensus       300 ~~~~~-----~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~-  351 (389)
                      .....     ..             ....+         ........+...+.++.+|+.+||+.||++|||+.++++| 
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp  335 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  335 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence            00000     00             00000         0000111233457889999999999999999999999988 


Q ss_pred             -hcccc
Q 016481          352 -LEPLQ  356 (389)
Q Consensus       352 -L~~~~  356 (389)
                       |..+.
T Consensus       336 ~f~~~~  341 (389)
T 3gni_B          336 FFKQIK  341 (389)
T ss_dssp             GGGGC-
T ss_pred             HHHHHh
Confidence             55443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.1e-46  Score=345.00  Aligned_cols=253  Identities=24%  Similarity=0.318  Sum_probs=207.3

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEE
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (389)
                      |...+.||+|+||.||+|+...+.+      .||||++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~------~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  119 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGR------QVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV  119 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCc------EEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence            6777899999999999998765443      39999987553 2345667899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCC
Q 016481          154 IYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG  233 (389)
Q Consensus       154 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~  233 (389)
                      ||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++......
T Consensus       120 v~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  194 (321)
T 2c30_A          120 LMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  194 (321)
T ss_dssp             EECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence            99999999999987543   6899999999999999999999977  999999999999999999999999998876442


Q ss_pred             CCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCC
Q 016481          234 DKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  313 (389)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (389)
                      ..  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........   .          .+.....+
T Consensus       195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~---~----------~~~~~~~~  259 (321)
T 2c30_A          195 VP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---K----------RLRDSPPP  259 (321)
T ss_dssp             SC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H----------HHHHSSCC
T ss_pred             cc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----------HHhcCCCC
Confidence            21  233468999999999999999999999999999999999999999865432211   0          01111111


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          314 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .+  ......+..+.+|+.+||+.||++|||+.+++++-.-.
T Consensus       260 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  299 (321)
T 2c30_A          260 KL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL  299 (321)
T ss_dssp             CC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred             Cc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            11  12234567899999999999999999999999985443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.7e-46  Score=342.90  Aligned_cols=267  Identities=23%  Similarity=0.281  Sum_probs=203.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||+||+|.+..+.+      .||+|++..... ......+.+|+.+++.++||||+++++++.+++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHE------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCc------eEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            579999999999999999998765544      399999875543 3344677899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++ ++.+.+.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           76 LTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999975 6666665433 36899999999999999999999977  999999999999999999999999999875


Q ss_pred             CCCCCccccccccccccccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh-----h
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-----K  304 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----~  304 (389)
                      ....  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... + ..+......     .
T Consensus       152 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~-~~i~~~~~~~~~~~~  227 (292)
T 3o0g_A          152 GIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-L-KRIFRLLGTPTEEQW  227 (292)
T ss_dssp             CSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-H-HHHHHHHCCCCTTTC
T ss_pred             CCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-H-HHHHHHhCCCChhhh
Confidence            4322  1233467899999999998765 899999999999999999988886543322211 1 100000000     0


Q ss_pred             hhhhhhcC---------CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          305 KKLLNIID---------PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       305 ~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .......+         ...........+..+.+|+.+||+.||++|||+.++++|=
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  284 (292)
T 3o0g_A          228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence            00000000         0001112234578899999999999999999999999873

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-46  Score=355.61  Aligned_cols=259  Identities=21%  Similarity=0.273  Sum_probs=197.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|+...+.+      .||+|++......  ...+.+|+.+++.++||||+++++++.....
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   90 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKE------LVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTH   90 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCC------EEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCc------EEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE
Confidence            4689999999999999999998765544      3999998764322  2457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc--EEEeccCCCc
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN--AKLSDFGLAK  228 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~--vkl~Dfg~a~  228 (389)
                      +++||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.  +||+|||+++
T Consensus        91 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           91 LAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             EEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            999999999999999886644  6899999999999999999999977  999999999999987765  9999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcc-cchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPR-SDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ......   ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........  .....          
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~----------  231 (361)
T 3uc3_A          167 SSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTI----------  231 (361)
T ss_dssp             -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHH----------
T ss_pred             cccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHH----------
Confidence            533221   2234679999999999998888665 8999999999999999999986543211  11111          


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ..+.......+.....+.++.+|+.+||+.||++|||+.++++|-+-.+
T Consensus       232 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          232 QRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             HHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             HHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            1111111111122235688999999999999999999999999854333

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.9e-46  Score=348.12  Aligned_cols=269  Identities=24%  Similarity=0.291  Sum_probs=202.3

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||+||+|.+..       +..||+|++...... .....+.+|+.+++.++||||+++++++.+.
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-------GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT-------SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC-------CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            45789999999999999999997633       234999998755332 2346678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..+++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           92 RCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             SCEEEEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCce
Confidence            999999999974 7887776543 36899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH--H---HH
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--L---LK  302 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~---~~  302 (389)
                      .......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................  .   ..
T Consensus       168 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          168 AFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             ETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             ecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            7543221  2334578999999999876 5689999999999999999999999987654332111100000  0   00


Q ss_pred             hhhhhhhhcCCC---CCC----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          303 EKKKLLNIIDPR---LEG----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       303 ~~~~~~~~~~~~---~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ....+.......   ...    ......+.++.+|+.+||+.||++|||+.++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            000000000000   000    0112345788999999999999999999999987

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.9e-46  Score=340.63  Aligned_cols=277  Identities=16%  Similarity=0.152  Sum_probs=216.0

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|++......   ..+.+|+.+++.+ +|+|++.+++++...
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   78 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQ------QVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEG   78 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTE------EEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCc------EEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence            45789999999999999999998654433      4999998754332   2456799999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc-----EEEec
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN-----AKLSD  223 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~-----vkl~D  223 (389)
                      ...++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.     +||+|
T Consensus        79 ~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~D  154 (298)
T 1csn_A           79 LHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVD  154 (298)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             ceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence            9999999999 999999987653 36899999999999999999999977  999999999999987766     99999


Q ss_pred             cCCCcCCCCCCCc-----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh
Q 016481          224 FGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       224 fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  298 (389)
                      ||++.........     .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..............+.
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            9999876543221     12334679999999999999999999999999999999999999998754432222211111


Q ss_pred             HHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCCCCCCcc
Q 016481          299 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFV  369 (389)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~~p~~~~  369 (389)
                      ..... ..... +        ...++.++.+++.+||+.||++||++.+|++.|+.+.............|
T Consensus       235 ~~~~~-~~~~~-~--------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  295 (298)
T 1csn_A          235 EKKQS-TPLRE-L--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  295 (298)
T ss_dssp             HHHHH-SCHHH-H--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             hhccC-ccHHH-H--------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence            10000 00000 0        11345789999999999999999999999999988865544433333434

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.7e-46  Score=339.82  Aligned_cols=254  Identities=31%  Similarity=0.505  Sum_probs=197.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC---hhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS---YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .++|++.+.||+|+||.||+|.+..        ..||+|++.....   ......+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIG--------DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK   77 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETT--------EEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcC--------CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            4689999999999999999997642        2399999865432   2334678889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceecCCCCCCeEEcC--------CCc
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEK-PVIYRDFKTSNILLDT--------DYN  218 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~ivH~Dlkp~Nili~~--------~~~  218 (389)
                      .+..++||||+++++|.+++...   .+++..+..++.|++.||+|||+.+. +|+|+||||+||+++.        ++.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             CCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence            99999999999999999888533   78999999999999999999999662 2889999999999986        678


Q ss_pred             EEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh
Q 016481          219 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       219 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  298 (389)
                      +||+|||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........       
T Consensus       155 ~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------  223 (271)
T 3dtc_A          155 LKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-------  223 (271)
T ss_dssp             EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-------
T ss_pred             eEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------
Confidence            9999999998654322    22357999999999999999999999999999999999999999875432111       


Q ss_pred             HHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          299 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                               ............+..++..+.+++.+||+.||++|||+.+++++|+.+
T Consensus       224 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          224 ---------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---------HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                     111112222334456678899999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.8e-47  Score=346.51  Aligned_cols=259  Identities=23%  Similarity=0.374  Sum_probs=208.7

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      .+..++|++.+.||+|+||.||+|.+...       ..||+|++.....  ....+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   90 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTK   90 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTT-------EEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCC-------CeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence            34467899999999999999999976532       2399999986543  23568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccc
Confidence            999999999999999999886532 36899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..........              
T Consensus       168 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~--------------  232 (283)
T 3gen_A          168 RYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE--------------  232 (283)
T ss_dssp             GGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--------------
T ss_pred             ccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH--------------
Confidence            8654321 111223457888999999999999999999999999999998 999998754321110              


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                         .+........+...+..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       233 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          233 ---HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             ---HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence               01111122223445678999999999999999999999999998764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.7e-46  Score=356.73  Aligned_cols=277  Identities=23%  Similarity=0.311  Sum_probs=199.0

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccC-CCccceEEeEEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLS-HPNLVKLIGYCC  146 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~  146 (389)
                      .+.++|++.+.||+|+||.||+|.+..+.+.      ||+|++.... .......+.+|+.+++.+. ||||+++++++.
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~   79 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEV------VAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR   79 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCE------EEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCE------EEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence            4568999999999999999999987655443      9999886542 3455567889999999997 999999999997


Q ss_pred             eCC--eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          147 EDE--HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       147 ~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      ..+  .+|+|||||+ |+|...+...   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DF  153 (388)
T 3oz6_A           80 ADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADF  153 (388)
T ss_dssp             CTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCC
T ss_pred             cCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCC
Confidence            544  7899999997 5898888664   6889999999999999999999987  999999999999999999999999


Q ss_pred             CCCcCCCCCC-------------------CccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCC
Q 016481          225 GLAKDGPEGD-------------------KSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDK  284 (389)
Q Consensus       225 g~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~  284 (389)
                      |+++......                   ........+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            9997653211                   1112334689999999999986 6789999999999999999999999987


Q ss_pred             CCchhhhhhHHHHh-----------------HHHHhhhhhhhhcCCCCCCC------------CChHHHHHHHHHHHHhh
Q 016481          285 SRPAREQNLADWAL-----------------PLLKEKKKLLNIIDPRLEGD------------YPVKGVHKAAMLAYHCL  335 (389)
Q Consensus       285 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~cl  335 (389)
                      ..............                 ....................            .+...+.++.+|+.+||
T Consensus       234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L  313 (388)
T 3oz6_A          234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL  313 (388)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence            65433221110000                 00000000000000000000            01134578999999999


Q ss_pred             ccCCCCCCCHHHHHHH--hccccC
Q 016481          336 NHNPKARPLMRDIVDS--LEPLQV  357 (389)
Q Consensus       336 ~~dP~~Rps~~~il~~--L~~~~~  357 (389)
                      +.||++|||+.++++|  |..+..
T Consensus       314 ~~dP~~R~t~~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          314 QFNPNKRISANDALKHPFVSIFHN  337 (388)
T ss_dssp             CSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred             ccCcccCCCHHHHhCCHHHHHhcC
Confidence            9999999999999998  544443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=350.81  Aligned_cols=254  Identities=23%  Similarity=0.331  Sum_probs=201.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCC--CccceEEeEEEe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSH--PNLVKLIGYCCE  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~  147 (389)
                      ..+|++.+.||+|+||.||+|....       +..||+|++.... .......+.+|+.+++.+.|  +||+++++++..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTT-------SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCC-------CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            4679999999999999999997532       2349999987543 34455778899999999986  999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+.+++|||+ .+|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++ ++.+||+|||++
T Consensus        81 ~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           81 DQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             SSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             CCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccc
Confidence            9999999995 5789999997754  6899999999999999999999977  99999999999997 578999999999


Q ss_pred             cCCCCCCCccccccccccccccCcccccc-----------CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMT-----------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      +...............||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.......       
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------  227 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------  227 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-------
Confidence            87655433333445689999999999865           678999999999999999999999997643211       


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                              ..+...+++.....++...+.++.+|+.+||+.||++|||+.++++|.
T Consensus       228 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          228 --------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             --------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                    112223333334444555567899999999999999999999999884

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.1e-46  Score=347.68  Aligned_cols=278  Identities=27%  Similarity=0.351  Sum_probs=218.7

Q ss_pred             hcCC-cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe--
Q 016481           71 TANF-RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  147 (389)
Q Consensus        71 ~~~~-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  147 (389)
                      ..+| ++.+.||+|+||.||+|.+...  ....+..||+|++...........+.+|+.+++.++||||+++++++.+  
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPT--NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSC--C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccC--CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            3455 9999999999999999865422  2234566999999877666667788999999999999999999999987  


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ...+++||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||++
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccc
Confidence            46889999999999999998765   4899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          228 KDGPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       228 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ......... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||........ ....+... ......
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~  259 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQG-QMTVLR  259 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCH-HHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhccccc-chhHHH
Confidence            876544322 123345688899999999999999999999999999999999999975322110 00000000 001112


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      +...+........+..++.++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            223333333444556677899999999999999999999999999987754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-47  Score=366.50  Aligned_cols=260  Identities=22%  Similarity=0.236  Sum_probs=207.3

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      +....++|++.+.||+|+||.||+|+++.+.+      .||+|++.....  ......+.+|+.+++.++||||++++++
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~------~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~  137 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK------VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA  137 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCc------EEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            33445789999999999999999998765544      399999864210  1112346689999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      +.+...+|+||||++||+|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+||
T Consensus       138 ~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          138 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999999988654   5899999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCC----CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH----LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |+++...... .......+||+.|+|||++.+..    |+.++|||||||++|+|++|+.||.........      ...
T Consensus       213 G~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i  285 (410)
T 3v8s_A          213 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKI  285 (410)
T ss_dssp             TTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHH
T ss_pred             ceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH------HHH
Confidence            9998764432 11234578999999999998765    889999999999999999999999865432111      010


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHh
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDSL  352 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~il~~L  352 (389)
                      ......        +..+.....+.++.+|+.+||+.+|.+  ||++.+|++|-
T Consensus       286 ~~~~~~--------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          286 MNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             HTHHHH--------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             Hhcccc--------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence            100000        011111245688999999999999998  99999999883

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.3e-46  Score=352.57  Aligned_cols=274  Identities=23%  Similarity=0.267  Sum_probs=211.4

Q ss_pred             cCHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-----CC
Q 016481           62 FTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-----HP  136 (389)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~  136 (389)
                      +++.....+.++|++.+.||+|+||.||+|.+..+.+      .||+|++...  ......+..|+.+++.+.     ||
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~   96 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK------YYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNN   96 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCe------EEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCC
Confidence            4444555677899999999999999999998765443      4999998743  344456678999999886     99


Q ss_pred             ccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-
Q 016481          137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-  215 (389)
Q Consensus       137 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-  215 (389)
                      ||+++++++...+..++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++. 
T Consensus        97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~  173 (360)
T 3llt_A           97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDP  173 (360)
T ss_dssp             GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCT
T ss_pred             CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccc
Confidence            9999999999999999999999 899999998876667999999999999999999999977  999999999999975 


Q ss_pred             ------------------------CCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHH
Q 016481          216 ------------------------DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVV  271 (389)
Q Consensus       216 ------------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~i  271 (389)
                                              ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                                    789999999999864432     234679999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCchhhhhhHHHHhH-----HHHhhh--hhhhhcCC-----CCCCCC----------------ChHH
Q 016481          272 LLEILTGRKSLDKSRPAREQNLADWALP-----LLKEKK--KLLNIIDP-----RLEGDY----------------PVKG  323 (389)
Q Consensus       272 l~elltg~~pf~~~~~~~~~~~~~~~~~-----~~~~~~--~~~~~~~~-----~~~~~~----------------~~~~  323 (389)
                      +|+|++|+.||.................     ......  .....+..     .+....                ....
T Consensus       249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (360)
T 3llt_A          249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK  328 (360)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred             HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence            9999999999987654432211111000     000000  00000000     000000                0011


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          324 VHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       324 ~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +..+.+|+.+||+.||++|||+.++++|
T Consensus       329 ~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          329 HELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            2678899999999999999999999976

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=351.87  Aligned_cols=254  Identities=23%  Similarity=0.287  Sum_probs=193.3

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|++....   ....+.+|+.+++.++||||+++++++....
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~------~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQK------PYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCc------EEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            46789999999999999999998765443      39999987643   2345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC---CCcEEEeccCC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGL  226 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~---~~~vkl~Dfg~  226 (389)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.   ++.+||+|||+
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             eEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence            9999999999999999886653  6899999999999999999999977  999999999999975   88999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||........  ..    ..+..   
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~----~~i~~---  265 (349)
T 2w4o_A          198 SKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF----RRILN---  265 (349)
T ss_dssp             ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH----HHHHT---
T ss_pred             ccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH----HHHHh---
Confidence            98654322   23346799999999999999999999999999999999999999976543211  00    00000   


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                          .............+.++.+|+.+||+.||++|||+.++++|-
T Consensus       266 ----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  307 (349)
T 2w4o_A          266 ----CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP  307 (349)
T ss_dssp             ----TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             ----CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                000111122234568899999999999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-46  Score=341.37  Aligned_cols=263  Identities=26%  Similarity=0.369  Sum_probs=213.2

Q ss_pred             hcCCcccc-eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDR-VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .++|.+.+ .||+|+||.||+|.+...    ..+..||+|++...........+.+|+.+++.++||||+++++++ ..+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMR----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccC----CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            35666666 999999999999975422    123459999998776666778889999999999999999999999 566


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.+||+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceee
Confidence            799999999999999988654 346899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCcc-ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          230 GPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       230 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.........   .            
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~------------  224 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A------------  224 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---H------------
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---H------------
Confidence            65432211 1223457899999999998899999999999999999998 99999865432111   0            


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                        .+........+..++.++.+++.+||+.||++||++.+++++|+.+...
T Consensus       225 --~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          225 --FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             --HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence              0111112233456678999999999999999999999999999887443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=349.38  Aligned_cols=274  Identities=21%  Similarity=0.269  Sum_probs=199.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||+|+||.||+|.+..+.+      .||+|++...........+.+|+.+++.++||||+++++++...+..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDN------LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCc------EEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEE
Confidence            579999999999999999998765443      39999987654333223445799999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++....
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            99999997 58988887653 36899999999999999999999977  9999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH--------HH
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL--------LK  302 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------~~  302 (389)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..................        ..
T Consensus       152 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          152 IPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             CCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence            322  12334578999999999876 56899999999999999999999999876543321111100000        00


Q ss_pred             hhhhhhhhcCCCCCCC----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccC
Q 016481          303 EKKKLLNIIDPRLEGD----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQV  357 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~  357 (389)
                      ..........+.....    .....+.++.+|+.+||+.||++|||+.++++|  |..+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            0000000000000000    012346788999999999999999999999997  444433

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.9e-46  Score=365.47  Aligned_cols=264  Identities=25%  Similarity=0.364  Sum_probs=211.1

Q ss_pred             HHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           65 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      +.+.+..++|++.+.||+|+||.||+|.+...       ..||+|++.....  ....+.+|+.+++.++||||++++++
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~  247 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV  247 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-------EEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCC-------ceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            33455667899999999999999999987643       2399999886532  34578899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      +.+ +..++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus       248 ~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCC
Confidence            876 77899999999999999997544446899999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      |+++....... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.........            
T Consensus       325 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~------------  391 (452)
T 1fmk_A          325 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------------  391 (452)
T ss_dssp             CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------------
T ss_pred             ccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH------------
Confidence            99987643221 11223457889999999999999999999999999999999 99999875432110            


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                           ..+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       392 -----~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          392 -----DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -----HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -----HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                 11111122233456678899999999999999999999999999987654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.1e-46  Score=352.04  Aligned_cols=255  Identities=21%  Similarity=0.277  Sum_probs=203.8

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||.||+|.++.+.+      .||+|++......     ..+|+.++.++ +||||+++++++.+.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~   88 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNM------EFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDG   88 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCC------EEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence            45789999999999999999998765544      3999998765322     23578888877 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC----CcEEEecc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD----YNAKLSDF  224 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~----~~vkl~Df  224 (389)
                      ..+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||+...    +.+||+||
T Consensus        89 ~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Df  164 (342)
T 2qr7_A           89 KYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDF  164 (342)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence            99999999999999999887654  6899999999999999999999977  9999999999998433    35999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      |++........  .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..........+...+    .. 
T Consensus       165 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~-  237 (342)
T 2qr7_A          165 GFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GS-  237 (342)
T ss_dssp             TTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HH-
T ss_pred             CCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----cc-
Confidence            99987543321  234468999999999999888999999999999999999999999864322111111110    00 


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                            -........+...+.++.+|+.+||+.||++|||+.++++|-
T Consensus       238 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          238 ------GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             ------CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             ------CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence                  011112223345678899999999999999999999999873

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.9e-47  Score=367.32  Aligned_cols=264  Identities=19%  Similarity=0.227  Sum_probs=209.0

Q ss_pred             HHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEE
Q 016481           65 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLI  142 (389)
Q Consensus        65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~  142 (389)
                      .++.+..++|++.+.||+|+||+||+|+++.+.+      .||+|++.....  ......+.+|+.++..++||||++++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~------~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  140 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK------VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH  140 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCc------EEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            3444556789999999999999999998765544      399999864211  11122367899999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          143 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                      +++.+.+.+|+||||++||+|.+++.... ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+
T Consensus       141 ~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             EEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEc
Confidence            99999999999999999999999987632 36899999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA  297 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  297 (389)
                      |||+++....... ......+||+.|+|||++.     ...|+.++|||||||++|||++|+.||.........   .  
T Consensus       218 DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~---~--  291 (437)
T 4aw2_A          218 DFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---G--  291 (437)
T ss_dssp             CCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H--
T ss_pred             chhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH---H--
Confidence            9999976544322 2233468999999999997     457899999999999999999999999875433211   0  


Q ss_pred             hHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 016481          298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA--RPLMRDIVDS  351 (389)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~il~~  351 (389)
                       ..+....   ...   + .......+.++.+|+.+||..+|++  ||++.++++|
T Consensus       292 -~i~~~~~---~~~---~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          292 -KIMNHKE---RFQ---F-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             -HHHTHHH---HCC---C-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             -hhhhccc---ccc---C-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence             0010000   000   0 0111235688999999999998888  9999999988

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-46  Score=342.20  Aligned_cols=262  Identities=25%  Similarity=0.380  Sum_probs=210.8

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE-
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR-  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-  151 (389)
                      .|...+.||+|+||.||+|.+..+..   ....||+|.+...........+.+|+.+++.++||||+++++++...+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQ---NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSS---CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCC---ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            46677999999999999998654332   23459999998776666778889999999999999999999999876655 


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++...
T Consensus        99 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999998764 346899999999999999999999977  9999999999999999999999999998654


Q ss_pred             CCCC--ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCC-CCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          232 EGDK--SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS-LDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       232 ~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ....  ........+|+.|+|||++.+..++.++||||||+++|+|++|..| |........                 .
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~-----------------~  238 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-----------------T  238 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH-----------------H
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH-----------------H
Confidence            3221  1122345789999999999999999999999999999999995554 544332211                 1


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      ..+........+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          239 HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1111111222344556889999999999999999999999999988743

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-45  Score=338.22  Aligned_cols=255  Identities=21%  Similarity=0.289  Sum_probs=208.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||.||+|.+..+...      ||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLE------FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   77 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCce------EEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence            457899999999999999999987655443      9999986543 344556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc---EEEeccC
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN---AKLSDFG  225 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~---vkl~Dfg  225 (389)
                      +..++||||+.+|+|.+.+....  .+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.   +||+|||
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            99999999999999998887653  6899999999999999999999977  999999999999976655   9999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      ++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........      .. .  
T Consensus       154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~------~~-~--  221 (284)
T 3kk8_A          154 LAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ------IK-A--  221 (284)
T ss_dssp             TCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-H--
T ss_pred             eeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH------HH-h--
Confidence            997664432   22346799999999999999999999999999999999999999986543221100      00 0  


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                           -............+.++.+|+.+||+.||++|||+.++++|
T Consensus       222 -----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          222 -----GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             -----TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -----ccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                 00011111123456789999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2e-46  Score=346.08  Aligned_cols=278  Identities=25%  Similarity=0.326  Sum_probs=212.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  148 (389)
                      ..+|++.+.||+|+||.||+|++...  ....+..||+|++...........+.+|+.+++.++||||+++++++...  
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPE--GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTT--SSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccc--cCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            35689999999999999999975322  22345569999998665555667888999999999999999999999876  


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++.
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccc
Confidence            67899999999999999985543 36899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ........ .......||..|+|||++.+..++.++||||||+++|+|++|..|+................  .......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~  252 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG--QMTVTRL  252 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG--GGHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc--ccCHHHH
Confidence            76543322 22334678899999999999999999999999999999999999875321110000000000  0001111


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ...+........+..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            222222233344556678999999999999999999999999999865

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=342.43  Aligned_cols=269  Identities=24%  Similarity=0.294  Sum_probs=201.8

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC----ChhhHHHHHHHHHHHhcc---CCCccceE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHL---SHPNLVKL  141 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l---~h~niv~~  141 (389)
                      .+.++|++.+.||+|+||+||+|++..+.+      .||+|++....    .......+.+|+.+++.+   +||||+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~   79 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGH------FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL   79 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCC------EEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCc------EEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence            456899999999999999999997655443      49999876322    111123455677777666   49999999


Q ss_pred             EeEEEeCC-----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          142 IGYCCEDE-----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       142 ~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      ++++....     .+++||||+. |+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.+
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~  156 (308)
T 3g33_A           80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG  156 (308)
T ss_dssp             EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT
T ss_pred             eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC
Confidence            99998765     5899999997 59999998776666999999999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      +.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|++||...........   
T Consensus       157 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---  230 (308)
T 3g33_A          157 GTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK---  230 (308)
T ss_dssp             SCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH---
T ss_pred             CCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Confidence            999999999998764332   23346799999999999999999999999999999999999999987654322111   


Q ss_pred             HhHHHHhh--hhhh-------hhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          297 ALPLLKEK--KKLL-------NIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       297 ~~~~~~~~--~~~~-------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      +.......  ....       ..+.+....   ......+..+.+|+.+||+.||++|||+.++++|-
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~  298 (308)
T 3g33_A          231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS  298 (308)
T ss_dssp             HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence            00000000  0000       000000000   00123467889999999999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.5e-46  Score=354.56  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=201.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccC--CCccceEEeEEEe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLS--HPNLVKLIGYCCE  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~  147 (389)
                      ..+|++.+.||+|+||.||+|....       +..||||++.... .......+.+|+.+++.+.  ||||+++++++..
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~  127 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT  127 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-------CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence            3569999999999999999997543       2349999987543 3455677889999999996  5999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+.+|+||| +.+++|.+++....  .+++..+..++.|++.||.|||+++  |+||||||+|||++ ++.+||+|||++
T Consensus       128 ~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          128 DQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             SSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             CCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            999999999 56789999987754  6888899999999999999999977  99999999999995 579999999999


Q ss_pred             cCCCCCCCccccccccccccccCcccccc-----------CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMT-----------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      +..............+||+.|+|||++.+           ..|+.++|||||||++|+|++|+.||.......       
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------  274 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------  274 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-------
Confidence            87654433333445689999999999875           368899999999999999999999997643221       


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                              ..+..++++.....++...+.++.+|+.+||+.||++|||+.++++|-
T Consensus       275 --------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          275 --------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             --------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence                    111222333333333444467899999999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.9e-46  Score=353.52  Aligned_cols=292  Identities=18%  Similarity=0.201  Sum_probs=213.8

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhh----------HHHHHHHHHHHhccCCCccc
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG----------HREWLAEVIFLGHLSHPNLV  139 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv  139 (389)
                      ..++|++.+.||+|+||.||+|.+..+. ....+..||+|++........          ...+..|+..++.++|+||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSE-SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSS-CCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCcc-ccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3458999999999999999999876542 122345699999876532110          01233466677788899999


Q ss_pred             eEEeEEEeC----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc-
Q 016481          140 KLIGYCCED----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-  214 (389)
Q Consensus       140 ~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~-  214 (389)
                      ++++++...    ...++||||+ |++|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~  187 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY  187 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence            999998764    5689999999 99999988764 347999999999999999999999977  99999999999999 


Q ss_pred             -CCCcEEEeccCCCcCCCCCCCc-----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCch
Q 016481          215 -TDYNAKLSDFGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA  288 (389)
Q Consensus       215 -~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  288 (389)
                       .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999765432211     1113356999999999999999999999999999999999999999853322


Q ss_pred             hhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCCCCCCc
Q 016481          289 REQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNF  368 (389)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~~p~~~  368 (389)
                      ..  .......  .....+...+++.+.   ...++.++.+++..||+.||++||++.+|++.|+.+....+........
T Consensus       268 ~~--~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d  340 (364)
T 3op5_A          268 PK--YVRDSKI--RYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLD  340 (364)
T ss_dssp             HH--HHHHHHH--HHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCC
T ss_pred             HH--HHHHHHH--HhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccc
Confidence            11  1111110  011122222222221   1234578999999999999999999999999998876554444444455


Q ss_pred             ccccC
Q 016481          369 VTVVT  373 (389)
Q Consensus       369 ~~~~~  373 (389)
                      |....
T Consensus       341 w~~~~  345 (364)
T 3op5_A          341 LSVVE  345 (364)
T ss_dssp             C----
T ss_pred             eEecc
Confidence            55443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.3e-46  Score=356.17  Aligned_cols=256  Identities=18%  Similarity=0.225  Sum_probs=195.3

Q ss_pred             hcCCccc-ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHh-ccCCCccceEEeEEEe-
Q 016481           71 TANFRQD-RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG-HLSHPNLVKLIGYCCE-  147 (389)
Q Consensus        71 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~-  147 (389)
                      .++|.+. +.||+|+||+||+|.++.+.+.      ||+|++...      ..+.+|+.++. ..+||||+++++++.. 
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~------vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEK------FALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCE------EEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            4567766 7899999999999987655443      999998642      24557888774 4579999999999875 


Q ss_pred             ---CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC---CCcEEE
Q 016481          148 ---DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKL  221 (389)
Q Consensus       148 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~---~~~vkl  221 (389)
                         ...+|+||||++||+|.+++.......+++..+..++.|++.||.|||+++  |+||||||+|||++.   ++.+||
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl  205 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKL  205 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEE
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEE
Confidence               567899999999999999998766567999999999999999999999977  999999999999987   789999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhh-hHHHHhHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN-LADWALPL  300 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~  300 (389)
                      +|||+++......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......... ....    
T Consensus       206 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----  278 (400)
T 1nxk_A          206 TDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----  278 (400)
T ss_dssp             CCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----
T ss_pred             EecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----
Confidence            9999998654322   2335689999999999999999999999999999999999999997654322100 0000    


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                      +..       -...........++.++.+|+.+||+.||++|||+.++++|-+-
T Consensus       279 i~~-------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  325 (400)
T 1nxk_A          279 IRM-------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  325 (400)
T ss_dssp             HHH-------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             HHc-------CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence            000       00011111123457889999999999999999999999998543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.5e-46  Score=346.90  Aligned_cols=256  Identities=25%  Similarity=0.295  Sum_probs=199.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC---hhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS---YQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      ..++|++.+.||+|+||.||+|+....   ...+..||+|++.....   ......+.+|+.+++.++||||+++++++.
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTG---ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSS---TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEecc---CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            356899999999999999999976422   12344599999876531   223455678999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      ..+.+|+||||++||+|.+++....  .+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCc
Confidence            9999999999999999999887643  6889999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ++......  ......+||+.|+|||++.+..++.++||||||+++|+|++|+.||.........      ....     
T Consensus       168 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~-----  234 (327)
T 3a62_A          168 CKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI------DKIL-----  234 (327)
T ss_dssp             C------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHH-----
T ss_pred             ccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-----
Confidence            87643221  1233468999999999999999999999999999999999999999875432110      0101     


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDSL  352 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~L  352 (389)
                           ..  ...++...+.++.+|+.+||+.||++||     ++.++++|-
T Consensus       235 -----~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp  278 (327)
T 3a62_A          235 -----KC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP  278 (327)
T ss_dssp             -----HT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred             -----hC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence                 00  1123345568899999999999999999     788999873

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.1e-47  Score=352.58  Aligned_cols=271  Identities=28%  Similarity=0.377  Sum_probs=212.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||.||+|.+.... ....+..||+|.+...........+.+|+.+++.++||||+++++++....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMP-NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC---------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCC-CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            4578999999999999999999854321 223345699999986666666778899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC---CCcEEE
Q 016481          150 HRVLIYEFMARGSVENNLFSKVL-----LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKL  221 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~---~~~vkl  221 (389)
                      ..++||||+++|+|.+++.....     ..+++..+..++.|++.||.|||+.+  |+|+||||+|||++.   +..+||
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999976532     35889999999999999999999977  999999999999984   456999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      +|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.........         
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---------  255 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---------  255 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---------
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH---------
Confidence            99999875433222222334568999999999999999999999999999999998 99999865432110         


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCC
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  360 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~  360 (389)
                              ..+........+..++..+.+++.+||+.||.+||++.+++++|+.+...+.
T Consensus       256 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          256 --------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             --------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             --------HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence                    0011111122334556889999999999999999999999999998866543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.2e-46  Score=343.32  Aligned_cols=263  Identities=24%  Similarity=0.393  Sum_probs=208.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEE-eCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC-EDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~  150 (389)
                      .+|++.+.||+|+||.||+|.+..+..   ....||+|.+...........+.+|+.++++++||||+++++++. .++.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC--------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCC---ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            468999999999999999998654322   234589999987766677788999999999999999999999864 4568


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++...
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             eEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccc
Confidence            899999999999999986543 46889999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCc--cccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          231 PEGDKS--HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       231 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ......  .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...........              
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~--------------  244 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--------------  244 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH--------------
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH--------------
Confidence            443211  12233567889999999999999999999999999999999 6666765433211100              


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                         +........+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       245 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          245 ---LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               00011112233456789999999999999999999999999988754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-46  Score=365.13  Aligned_cols=252  Identities=25%  Similarity=0.316  Sum_probs=199.5

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCC--CChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ..++|++.+.||+|+||.||+|....+.+      .||+|++...  ........+.+|+.+++.++||||+++++++..
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~  219 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGR------YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT  219 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCC------EEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence            34679999999999999999998665544      3999998643  122334567789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      .+.+++||||+++|+|.+++....  .+++..+..++.|++.||+|||+ .+  |+||||||+|||++.++.+||+|||+
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCC
Confidence            999999999999999999886653  68999999999999999999997 77  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ++......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........      ..     
T Consensus       296 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------i~-----  362 (446)
T 4ejn_A          296 CKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------IL-----  362 (446)
T ss_dssp             CCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-----
T ss_pred             ceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH------HH-----
Confidence            98643322  123457899999999999999999999999999999999999999987543211100      00     


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                           ..  ...++...+.++.+|+.+||+.||.+||     ++.++++|
T Consensus       363 -----~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          363 -----ME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             -----HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----hC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                 00  1123445568899999999999999999     99999987

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-46  Score=345.32  Aligned_cols=251  Identities=23%  Similarity=0.218  Sum_probs=197.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      .+.++|++.++||+|+||+||+|.+..+.+      .||+|++.... ..........|+..+..+ .|+||+++++++.
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~  127 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGR------LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE  127 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSC------EEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCe------EEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence            345789999999999999999998765544      39999876543 333444555666666555 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      +.+.+++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEcccee
Confidence            999999999999 678988876653 36899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      +.......   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......                  
T Consensus       204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~------------------  261 (311)
T 3p1a_A          204 LVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW------------------  261 (311)
T ss_dssp             CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH------------------
T ss_pred             eeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH------------------
Confidence            88764322   2334579999999999876 7999999999999999999997766542110                  


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                       ..+.........+...+.++.+|+.+||+.||++|||+.+++++-
T Consensus       262 -~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  306 (311)
T 3p1a_A          262 -QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALP  306 (311)
T ss_dssp             -HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             -HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence             000011111111223468899999999999999999999999863

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.6e-46  Score=348.54  Aligned_cols=262  Identities=26%  Similarity=0.356  Sum_probs=209.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  149 (389)
                      .++|++.+.||+|+||.||+|.+..+...    ..+|+|.+...........+.+|+.+++.+ +||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLR----MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEE----EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcc----cceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            36899999999999999999987654332    226999887655555566788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT  215 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~  215 (389)
                      ..++||||+++|+|.+++....              ...+++..+..++.|++.||+|||+++  |+||||||+||+++.
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE  177 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcC
Confidence            9999999999999999987643              246899999999999999999999977  999999999999999


Q ss_pred             CCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhH
Q 016481          216 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLA  294 (389)
Q Consensus       216 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~  294 (389)
                      ++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||........    
T Consensus       178 ~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~----  250 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----  250 (327)
T ss_dssp             GGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----
T ss_pred             CCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH----
Confidence            9999999999987533211   1223467889999999999899999999999999999998 9999987643211    


Q ss_pred             HHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                                   ...+........+..++..+.+|+.+||+.||++|||+.+++++|+.+...
T Consensus       251 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          251 -------------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             -------------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -------------HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                         011111122233445678899999999999999999999999999877543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.9e-46  Score=340.75  Aligned_cols=262  Identities=26%  Similarity=0.361  Sum_probs=210.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||.||+|.+....   .....||+|.+...........+.+|+.+++.++||||+++++++.+ +
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHK---GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTT---CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCC---CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence            3568999999999999999999865432   22345999999877666667788999999999999999999999764 5


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++..
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcc
Confidence            5689999999999999986543 35899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..........       .+..     
T Consensus       163 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-------~~~~-----  229 (281)
T 3cc6_A          163 IEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-------VLEK-----  229 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-------HHHH-----
T ss_pred             cccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-------HHhc-----
Confidence            644321 12233567889999999999999999999999999999998 999997654322110       0000     


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                           ......+..++..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       230 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          230 -----GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence                 0111223445688999999999999999999999999998764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.6e-46  Score=345.91  Aligned_cols=256  Identities=22%  Similarity=0.260  Sum_probs=207.9

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-----hhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      +.++|++.+.||+|+||.||+|.+..+..      .||+|++......     .....+.+|+.+++.++||||++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   83 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGL------EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV   83 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCe------EEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            35679999999999999999998765443      3999998654322     135678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC----cEE
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAK  220 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~----~vk  220 (389)
                      +......++||||+++++|.+++....  .+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++    .+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           84 YENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEE
Confidence            999999999999999999999987643  6899999999999999999999977  99999999999999887    799


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........      ..
T Consensus       160 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~i  230 (321)
T 2a2a_A          160 LIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------NI  230 (321)
T ss_dssp             ECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HH
T ss_pred             EccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH------HH
Confidence            99999998765432   1234579999999999999999999999999999999999999998654321110      00


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .       . .............+..+.+|+.+||+.||++|||+.++++|-
T Consensus       231 ~-------~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp  274 (321)
T 2a2a_A          231 T-------S-VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (321)
T ss_dssp             H-------T-TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred             H-------h-cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            0       0 000000001123457899999999999999999999999874

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.7e-46  Score=346.79  Aligned_cols=265  Identities=19%  Similarity=0.252  Sum_probs=212.3

Q ss_pred             CHHHHHHHhcCCccc-ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccC-CCccc
Q 016481           63 TYDELRIITANFRQD-RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLS-HPNLV  139 (389)
Q Consensus        63 ~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv  139 (389)
                      .+.....+.++|.+. +.||+|+||.||+|....+.+.      ||+|++.... .......+.+|+.+++.+. ||||+
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv   92 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQE------YAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI   92 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBC
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCE------EEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEE
Confidence            344456778889888 8999999999999987655443      9999987543 2334567889999999995 79999


Q ss_pred             eEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC---C
Q 016481          140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---D  216 (389)
Q Consensus       140 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~---~  216 (389)
                      ++++++......++||||+.+|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.   +
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~  170 (327)
T 3lm5_A           93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPL  170 (327)
T ss_dssp             CEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTB
T ss_pred             EEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCC
Confidence            99999999999999999999999999987766668999999999999999999999977  999999999999987   7


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      +.+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........   
T Consensus       171 ~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---  244 (327)
T 3lm5_A          171 GDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN---  244 (327)
T ss_dssp             CCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---
T ss_pred             CcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH---
Confidence            899999999998764322   22346799999999999999999999999999999999999999987543221100   


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                                 ................+..+.+|+.+||+.||++|||+.++++|-
T Consensus       245 -----------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~  289 (327)
T 3lm5_A          245 -----------ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS  289 (327)
T ss_dssp             -----------HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred             -----------HHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence                       000111122222335678899999999999999999999999884

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=341.46  Aligned_cols=269  Identities=22%  Similarity=0.284  Sum_probs=202.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++...... .....+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQ------IVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR   75 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCc------EEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence            4689999999999999999998765444      3999988665433 33566788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++++|.+++....  .+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++..
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            9999999999998888775543  6899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh--------HH
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--------PL  300 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~~  300 (389)
                      ......  ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||................        ..
T Consensus       152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          152 LTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             CC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence            543221  2234578999999999976 678999999999999999999999998776543322211110        00


Q ss_pred             HHhhhhhhhhcCCCCCCCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKEKKKLLNIIDPRLEGDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ............+......     ....+..+.+|+.+||+.||++|||+.++++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000000000000000000     02346778999999999999999999999987

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.6e-46  Score=348.52  Aligned_cols=262  Identities=23%  Similarity=0.321  Sum_probs=199.1

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|++....  .......+.+|+.+++.++||||+++++++..
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   83 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHR------DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   83 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCc------eEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence            45789999999999999999998655443      49999987653  33445678899999999999999999999876


Q ss_pred             CC----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          148 DE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       148 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      ..    ..|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~D  159 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMD  159 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEee
Confidence            54    3499999999999999987653  6899999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          224 FGLAKDGPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       224 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      ||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........      ....
T Consensus       160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~  233 (311)
T 3ork_A          160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVR  233 (311)
T ss_dssp             CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHH
T ss_pred             ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhc
Confidence            9999876443221 12334679999999999999999999999999999999999999998765432110      0000


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH-hccc
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS-LEPL  355 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~-L~~~  355 (389)
                      .......        ......+.++.+|+.+||+.||++||+..+++.+ |...
T Consensus       234 ~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          234 EDPIPPS--------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCCCCHH--------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCCCcc--------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0000000        0012346789999999999999999977666654 5444

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.8e-46  Score=339.26  Aligned_cols=255  Identities=25%  Similarity=0.289  Sum_probs=201.8

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +.++|.+.+.||+|+||.||+|....+..      .||+|++...........+.+|+.+++.++||||+++++++.+..
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   93 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGL------ERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH   93 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCc------eEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence            34689999999999999999998665443      399999876655555677889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE---cCCCcEEEecc
Q 016481          150 HRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDF  224 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili---~~~~~vkl~Df  224 (389)
                      ..++||||+++|+|.+.+...  ....+++..+..++.|++.||+|||+.+  |+||||||+||++   +.++.+||+||
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEee
Confidence            999999999999999988543  2347899999999999999999999977  9999999999999   45678999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      |++.......   ......||+.|+|||++. ..++.++||||||+++|+|++|+.||............          
T Consensus       172 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~----------  237 (285)
T 3is5_A          172 GLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA----------  237 (285)
T ss_dssp             CCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----------
T ss_pred             ecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh----------
Confidence            9998654322   233467999999999875 56899999999999999999999999876432211100          


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                          ......... .....+.++.+|+.+||+.||++|||+.+++++
T Consensus       238 ----~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          238 ----TYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ----HHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ----ccCCccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                000111110 011245788999999999999999999999976

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-46  Score=355.33  Aligned_cols=263  Identities=25%  Similarity=0.404  Sum_probs=202.0

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe-CCeE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-DEHR  151 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  151 (389)
                      .|.+.+.||+|+||.||+|.+....   .....||+|.+...........+.+|+.+++.++||||+++++++.. ++..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETT---TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCC---CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            4778899999999999999865332   12345899998766556667889999999999999999999998754 5688


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccc
Confidence            99999999999999986543 36789999999999999999999977  9999999999999999999999999998654


Q ss_pred             CCCCc--cccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          232 EGDKS--HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       232 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .....  .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||.........   ..    +..     
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~~----~~~-----  311 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VY----LLQ-----  311 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---HH----HHT-----
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---HH----HHc-----
Confidence            33211  11233567889999999999999999999999999999999 77788765432211   00    000     


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                           ......+..++..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus       312 -----~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          312 -----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                 111122344568899999999999999999999999999887544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.3e-46  Score=361.89  Aligned_cols=271  Identities=22%  Similarity=0.303  Sum_probs=190.0

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||.||+|++..+.+      .||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKR------VVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--C------EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCc------EEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            34789999999999999999998765544      39999986543 344557788999999999999999999998543


Q ss_pred             -----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          149 -----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       149 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                           ..+|+||||+ +|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus       125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~D  199 (458)
T 3rp9_A          125 DVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCD  199 (458)
T ss_dssp             CTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECC
T ss_pred             CcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecc
Confidence                 5799999998 57898888654  36899999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCc-------------------------cccccccccccccCcccc-ccCCCCcccchhHHHHHHHHHHh
Q 016481          224 FGLAKDGPEGDKS-------------------------HVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEILT  277 (389)
Q Consensus       224 fg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwslG~il~ellt  277 (389)
                      ||+++........                         ......+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus       200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            9999876432111                         122346789999999986 56679999999999999999999


Q ss_pred             -----------CCCCCCCCCchhhh-----------------hhHHHHhHHHH-------------hhhhhhhhcCCCCC
Q 016481          278 -----------GRKSLDKSRPAREQ-----------------NLADWALPLLK-------------EKKKLLNIIDPRLE  316 (389)
Q Consensus       278 -----------g~~pf~~~~~~~~~-----------------~~~~~~~~~~~-------------~~~~~~~~~~~~~~  316 (389)
                                 |+++|.+.......                 .....+...+.             ........+.....
T Consensus       280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  359 (458)
T 3rp9_A          280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG  359 (458)
T ss_dssp             TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCC
T ss_pred             hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCC
Confidence                       77777654321100                 00000000000             00000011111000


Q ss_pred             CC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          317 GD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       317 ~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..   .....+.++.+|+.+||++||++|||+.++|+|
T Consensus       360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00   112346889999999999999999999999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.9e-46  Score=361.77  Aligned_cols=251  Identities=25%  Similarity=0.332  Sum_probs=207.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|.+.+.||+|+||.||+|.+..+.+      .||+|++.....  ......+.+|+.+++.++||||+++++++...
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~------~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~   88 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGH------KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP   88 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCC------EEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            4689999999999999999998765444      399999864321  12345678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++.
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchh
Confidence            99999999999999999986543  6899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........   .             
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~-------------  225 (476)
T 2y94_A          165 MMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---F-------------  225 (476)
T ss_dssp             ECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---H-------------
T ss_pred             hccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---H-------------
Confidence            765432   2344689999999999998876 6899999999999999999999986543211   0             


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ..+....  ...+...+.++.+|+.+||+.||++|||+.++++|-
T Consensus       226 ~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp  268 (476)
T 2y94_A          226 KKICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE  268 (476)
T ss_dssp             HHHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred             HHHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence            0011111  112334567899999999999999999999999873

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.5e-46  Score=340.21  Aligned_cols=265  Identities=21%  Similarity=0.274  Sum_probs=199.8

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||.||+|.+. +      +..||+|.+...... .....+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-~------~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN-Y------GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-T------SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC-C------CCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            57999999999999999999763 2      234999998765422 223567789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            9999999975 8888776543 36899999999999999999999977  999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh-----h
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-----K  304 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----~  304 (389)
                      ....  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........   +......     .
T Consensus       151 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~  225 (288)
T 1ob3_A          151 GIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNW  225 (288)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTS
T ss_pred             Cccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHHCCCChhhc
Confidence            3221  122335789999999999764 589999999999999999999999987654322111   0000000     0


Q ss_pred             hhhh--hhcCCCCC-------CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          305 KKLL--NIIDPRLE-------GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       305 ~~~~--~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ....  ...++...       .......+.++.+|+.+||+.||++|||+.++++|-
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  282 (288)
T 1ob3_A          226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (288)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence            0000  00011000       011223568899999999999999999999999873

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.3e-46  Score=354.38  Aligned_cols=251  Identities=25%  Similarity=0.294  Sum_probs=196.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHH-HhccCCCccceEEeEEEe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIF-LGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~  147 (389)
                      .++|++.+.||+|+||.||+|+.+.+..      .||+|++.....  ......+..|..+ ++.++||||+++++++.+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~------~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEV------FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCC------EEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCC------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence            4689999999999999999998765543      499999865431  2233455667776 567899999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+.+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||++
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a  186 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLC  186 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccc
Confidence            999999999999999999887643  6889999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|||++|..||........   .             
T Consensus       187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~-------------  248 (373)
T 2r5t_A          187 KENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---Y-------------  248 (373)
T ss_dssp             GGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---H-------------
T ss_pred             cccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---H-------------
Confidence            8633221  123457899999999999999999999999999999999999999986543211   0             


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM----RDIVDS  351 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~~il~~  351 (389)
                      ..++...  ..++...+..+.+|+.+||+.||.+||++    .++++|
T Consensus       249 ~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          249 DNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             HHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             HHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence            0111111  12234456889999999999999999987    466655

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.2e-46  Score=342.55  Aligned_cols=263  Identities=25%  Similarity=0.354  Sum_probs=206.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccc-cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLR-EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .++|.+.+.||+|+||.||+|.+..+.. .......||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            4689999999999999999998765442 1112345999998654 2344567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc--------EEE
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN--------AKL  221 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~--------vkl  221 (389)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.        +||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999999997653 24899999999999999999999977  999999999999988887        999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCC-CCCCCCchhhhhhHHHHhH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRK-SLDKSRPAREQNLADWALP  299 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~-pf~~~~~~~~~~~~~~~~~  299 (389)
                      +|||++.....      .....||+.|+|||++.+ ..++.++||||||+++|+|++|.. ||..........       
T Consensus       163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-------  229 (289)
T 4fvq_A          163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-------  229 (289)
T ss_dssp             CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------
T ss_pred             ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-------
Confidence            99999875432      223468899999999987 678999999999999999999554 554432211100       


Q ss_pred             HHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCC
Q 016481          300 LLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEA  362 (389)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~  362 (389)
                      ....            ....+...+.++.+|+.+||+.||++|||+.+++++|+.+....+..
T Consensus       230 ~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~  280 (289)
T 4fvq_A          230 FYED------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP  280 (289)
T ss_dssp             HHHT------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred             Hhhc------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence            0000            01112223466889999999999999999999999999997754443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-46  Score=350.52  Aligned_cols=261  Identities=23%  Similarity=0.265  Sum_probs=202.8

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC----ChhhHHHHHHHHHHHhccCCCccceEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN----SYQGHREWLAEVIFLGHLSHPNLVKLI  142 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~  142 (389)
                      +..+.++|++.+.||+|+||.||+|.+..+..      .||+|++....    .......+.+|+.+++.++||||++++
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   94 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRA------IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY   94 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCc------eEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceee
Confidence            44567899999999999999999998665543      39999976431    234456788999999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCC--------------------------------------CCCCCHHHHHHHH
Q 016481          143 GYCCEDEHRVLIYEFMARGSVENNLFSKV--------------------------------------LLPLPWSIRMKIA  184 (389)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~~~~~~~~~i~  184 (389)
                      +++.+.+..++||||++||+|.+++....                                      ...+++..+..++
T Consensus        95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  174 (345)
T 3hko_A           95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM  174 (345)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred             hhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence            99999999999999999999999884210                                      1123567788899


Q ss_pred             HHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC--cEEEeccCCCcCCCCCC--CccccccccccccccCcccccc--CC
Q 016481          185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY--NAKLSDFGLAKDGPEGD--KSHVSTRIMGTYGYAAPEYIMT--GH  258 (389)
Q Consensus       185 ~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~--~vkl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~--~~  258 (389)
                      .|++.||+|||+.+  |+||||||+|||++.++  .+||+|||++.......  .........||+.|+|||++.+  ..
T Consensus       175 ~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          175 RQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            99999999999977  99999999999998776  89999999998653221  1112334679999999999975  67


Q ss_pred             CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCC--CCCCChHHHHHHHHHHHHhhc
Q 016481          259 LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRL--EGDYPVKGVHKAAMLAYHCLN  336 (389)
Q Consensus       259 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~  336 (389)
                      ++.++||||||+++|+|++|+.||.........                ...+....  ........+..+.+|+.+||+
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  316 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI----------------SQVLNKKLCFENPNYNVLSPLARDLLSNLLN  316 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHHCCCCTTSGGGGGSCHHHHHHHHHHSC
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH----------------HHHHhcccccCCcccccCCHHHHHHHHHHcC
Confidence            899999999999999999999999876533211                01111111  111122356889999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 016481          337 HNPKARPLMRDIVDS  351 (389)
Q Consensus       337 ~dP~~Rps~~~il~~  351 (389)
                      .||.+||++.++++|
T Consensus       317 ~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          317 RNVDERFDAMRALQH  331 (345)
T ss_dssp             SCTTTSCCHHHHHHS
T ss_pred             CChhHCCCHHHHhcC
Confidence            999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1e-45  Score=343.19  Aligned_cols=266  Identities=27%  Similarity=0.388  Sum_probs=203.3

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      +..++|.+.+.||+|+||.||+|.+....   ..+..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQED---GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTT---SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccC---CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            34578999999999999999999765432   223459999987553 34455678899999999999999999999876


Q ss_pred             CC-----eEEEEEEecCCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc
Q 016481          148 DE-----HRVLIYEFMARGSVENNLFSK----VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN  218 (389)
Q Consensus       148 ~~-----~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~  218 (389)
                      ..     ..++||||+++|+|.+++...    ....+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTTSC
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCc
Confidence            54     459999999999999988432    3346899999999999999999999977  999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHH
Q 016481          219 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWA  297 (389)
Q Consensus       219 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~  297 (389)
                      +||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.........   .  
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~--  260 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---D--  260 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H--
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---H--
Confidence            99999999987654332223334567889999999999999999999999999999999 89999865432211   0  


Q ss_pred             hHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                                  .+........+..++..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       261 ------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          261 ------------YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             ------------HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                        00111122334456688999999999999999999999999998764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.5e-46  Score=370.64  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=210.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|..+.+.+      .||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~------~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGK------MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK  256 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCC------EEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence            4579999999999999999998765443      49999986432  112345677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+|+||||++||+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||+++
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccce
Confidence            99999999999999999998766556999999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhh-hhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE-QNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  307 (389)
                      ......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ ..+...    +      
T Consensus       335 ~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~----i------  401 (576)
T 2acx_A          335 HVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL----V------  401 (576)
T ss_dssp             ECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH----H------
T ss_pred             ecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH----h------
Confidence            765432   23346899999999999999999999999999999999999999986543211 111100    0      


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                       ..    ....++...+.++.+|+.+||+.||++||     ++.++++|
T Consensus       402 -~~----~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          402 -KE----VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -HH----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -hc----ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence             00    11223445678999999999999999999     78999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.7e-46  Score=341.46  Aligned_cols=260  Identities=25%  Similarity=0.362  Sum_probs=207.7

Q ss_pred             HhcCCcccc-eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           70 ITANFRQDR-VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ...+|.+.+ .||+|+||.||+|.+...    ..+..||+|++..... ......+.+|+.+++.++||||+++++++ .
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECS----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             cchhhhhccCccccccCeeeEeeeecCC----CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            346788888 999999999999964321    2234599999876533 33356788999999999999999999999 6


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+..++||||+++++|.+++....  .+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            778899999999999999997653  6899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCcc-ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          228 KDGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       228 ~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      .......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.........              
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--------------  230 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT--------------  230 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH--------------
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH--------------
Confidence            8765433221 1223456789999999998889999999999999999999 99999876432211              


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                         ..+........+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus       231 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          231 ---AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             ---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               01111112233445678899999999999999999999999999876

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-45  Score=347.88  Aligned_cols=253  Identities=27%  Similarity=0.349  Sum_probs=204.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..|...+.||+|+||.||+|+...+.+      .||+|++....  .......+.+|+.+++.++||||+++++++...+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH  127 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCe------EEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            458999999999999999997655443      49999987543  2334467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+. |+|.+.+.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++..
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             eEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            9999999997 67887775432 37899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ...      .....||+.|+|||++.   +..++.++|||||||++|+|++|+.||.........      ..       
T Consensus       204 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~-------  264 (348)
T 1u5q_A          204 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YH-------  264 (348)
T ss_dssp             SSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HH-------
T ss_pred             cCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HH-------
Confidence            543      22357999999999985   567899999999999999999999999765432110      00       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      +.....   ....+...+..+.+|+.+||+.||++|||+.+++++..-..
T Consensus       265 ~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          265 IAQNES---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             HHHSCC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HHhcCC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence            011111   11112345678999999999999999999999998865443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=349.97  Aligned_cols=253  Identities=21%  Similarity=0.267  Sum_probs=199.6

Q ss_pred             cCCcc--cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQ--DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~--~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +.|.+  .+.||+|+||.||+|....+..      .||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~------~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  159 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGL------KLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKN  159 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCC------EEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCc------EEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34444  5789999999999998665443      39999987653 345567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE--cCCCcEEEeccCCC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL--DTDYNAKLSDFGLA  227 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili--~~~~~vkl~Dfg~a  227 (389)
                      .+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||+  +.++.+||+|||++
T Consensus       160 ~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a  236 (373)
T 2x4f_A          160 DIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLA  236 (373)
T ss_dssp             EEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence            9999999999999999886543 36889999999999999999999977  9999999999999  56789999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      +.......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.........      ........  
T Consensus       237 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~~~~--  305 (373)
T 2x4f_A          237 RRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL------NNILACRW--  305 (373)
T ss_dssp             EECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTCC--
T ss_pred             eecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhccC--
Confidence            87654322   23357999999999999999999999999999999999999999876532211      00000000  


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                            ..........+.++.+|+.+||+.||++|||+.++++|
T Consensus       306 ------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          306 ------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             ------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  01111112456889999999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.1e-45  Score=340.82  Aligned_cols=263  Identities=24%  Similarity=0.361  Sum_probs=199.4

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhc--cCCCccceEEeEEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH--LSHPNLVKLIGYCC  146 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~  146 (389)
                      .+.++|++.+.||+|+||.||+|.+.        +..||+|++...    ....+..|..++..  ++||||+++++++.
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~   72 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSWQ--------GENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDM   72 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEET--------TEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEEC--------CEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence            34678999999999999999999763        233999998643    33445556666655  78999999999865


Q ss_pred             e----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceecCCCCCCeEEc
Q 016481          147 E----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH--------EAEKPVIYRDFKTSNILLD  214 (389)
Q Consensus       147 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~ivH~Dlkp~Nili~  214 (389)
                      .    ...+++||||+++|+|.+++...   .+++..+..++.|++.||+|||        +.+  |+||||||+|||++
T Consensus        73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~  147 (301)
T 3q4u_A           73 TSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK  147 (301)
T ss_dssp             EEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC
T ss_pred             cccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc
Confidence            4    34689999999999999999543   6899999999999999999999        766  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCcc--ccccccccccccCccccccC------CCCcccchhHHHHHHHHHHhC--------
Q 016481          215 TDYNAKLSDFGLAKDGPEGDKSH--VSTRIMGTYGYAAPEYIMTG------HLTPRSDVYSFGVVLLEILTG--------  278 (389)
Q Consensus       215 ~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwslG~il~elltg--------  278 (389)
                      .++.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|+|++|        
T Consensus       148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~  227 (301)
T 3q4u_A          148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE  227 (301)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence            99999999999997654322211  12235799999999999876      455799999999999999999        


Q ss_pred             --CCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCC-CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          279 --RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLE-GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       279 --~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                        +.||....+..... .. .....     ......+... ...+...+..+.+|+.+||+.||++|||+.++++.|+++
T Consensus       228 ~~~~pf~~~~~~~~~~-~~-~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          228 DYKPPFYDVVPNDPSF-ED-MRKVV-----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCCTTTTTSCSSCCH-HH-HHHHH-----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccccCCCCcch-hh-hhHHH-----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence              88886543322110 00 00000     0000111111 112345788999999999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-45  Score=341.55  Aligned_cols=271  Identities=23%  Similarity=0.347  Sum_probs=205.0

Q ss_pred             CHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc--CCCccce
Q 016481           63 TYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL--SHPNLVK  140 (389)
Q Consensus        63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~  140 (389)
                      .......+.++|++.+.||+|+||.||+|.+.        +..||+|++...    ....+..|..++..+  +||||++
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~   95 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--------GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILG   95 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCC
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC--------CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeee
Confidence            34445566789999999999999999999764        234999998543    223344555555544  8999999


Q ss_pred             EEeEEEeC----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceecCCCCCC
Q 016481          141 LIGYCCED----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA------EKPVIYRDFKTSN  210 (389)
Q Consensus       141 ~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~ivH~Dlkp~N  210 (389)
                      +++++...    ...++||||+++|+|.+++...   .+++..+..++.|++.||+|||+.      ..+|+||||||+|
T Consensus        96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~N  172 (337)
T 3mdy_A           96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN  172 (337)
T ss_dssp             EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGG
T ss_pred             EEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHH
Confidence            99999887    7899999999999999999664   689999999999999999999987      1139999999999


Q ss_pred             eEEcCCCcEEEeccCCCcCCCCCCCcc--ccccccccccccCccccccCCCCcc------cchhHHHHHHHHHHhC----
Q 016481          211 ILLDTDYNAKLSDFGLAKDGPEGDKSH--VSTRIMGTYGYAAPEYIMTGHLTPR------SDVYSFGVVLLEILTG----  278 (389)
Q Consensus       211 ili~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~------~DiwslG~il~elltg----  278 (389)
                      ||++.++.+||+|||++..........  ......||+.|+|||++.+..++..      +|||||||++|+|++|    
T Consensus       173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            999999999999999997654432211  1224579999999999988776665      9999999999999999    


Q ss_pred             ------CCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCC-----hHHHHHHHHHHHHhhccCCCCCCCHHH
Q 016481          279 ------RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYP-----VKGVHKAAMLAYHCLNHNPKARPLMRD  347 (389)
Q Consensus       279 ------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~~  347 (389)
                            +.||....+.... .... .       .  ...........+     ..++.++.+|+.+||+.||++|||+.+
T Consensus       253 ~~~~~~~~p~~~~~~~~~~-~~~~-~-------~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPS-YEDM-R-------E--IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCC-HHHH-H-------H--HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             cccccccccHhhhcCCCCc-hhhh-H-------H--HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence                  5666543222111 0000 0       0  001111122222     367889999999999999999999999


Q ss_pred             HHHHhccccCCC
Q 016481          348 IVDSLEPLQVLP  359 (389)
Q Consensus       348 il~~L~~~~~~~  359 (389)
                      ++++|+.+....
T Consensus       322 ll~~L~~l~~~~  333 (337)
T 3mdy_A          322 VKKTLAKMSESQ  333 (337)
T ss_dssp             HHHHHHHHHHTT
T ss_pred             HHHHHHHHHhhc
Confidence            999999886543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.7e-46  Score=350.89  Aligned_cols=269  Identities=23%  Similarity=0.287  Sum_probs=210.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||.||+|.+..+..      .||+|++...........+.+|+.+++.++||||+++++++..++
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  104 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGL------VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG  104 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCc------EEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence            35689999999999999999998765443      399999987766666778899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..++||||+++|+|.+++....  .+++..+..++.+++.||+|||+. +  |+|+||||+|||++.++.+||+|||++.
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            9999999999999999987654  688999999999999999999984 7  9999999999999999999999999986


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH-HH------
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-LL------  301 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~------  301 (389)
                      .....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................. ..      
T Consensus       181 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          181 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             HHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred             ccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence            53211    12335799999999999999999999999999999999999999987654332111100000 00      


Q ss_pred             -------------------HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          302 -------------------KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       302 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                                         ......................+.++.+|+.+||+.||++|||+.++++|-
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                               000000011111111111233567899999999999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.5e-46  Score=341.61  Aligned_cols=262  Identities=27%  Similarity=0.387  Sum_probs=211.9

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      +.+..++|++.+.||+|+||.||+|.+...       ..||+|.+.....  ....+.+|+.+++.++||||+++++++.
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~   78 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCC-------cEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence            445567899999999999999999975432       2399999876532  3457889999999999999999999886


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                       .+..++||||+++++|.+++.......+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||+
T Consensus        79 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~  155 (279)
T 1qpc_A           79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGL  155 (279)
T ss_dssp             -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             -CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcc
Confidence             456899999999999999986543346899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +........ .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.........              
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--------------  220 (279)
T 1qpc_A          156 ARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--------------  220 (279)
T ss_dssp             CEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH--------------
T ss_pred             cccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH--------------
Confidence            987654321 11223467889999999998899999999999999999999 99999865432110              


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                         ..+........+..++.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       221 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          221 ---QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             ---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence               00111112223345668899999999999999999999999999887543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=348.94  Aligned_cols=247  Identities=21%  Similarity=0.301  Sum_probs=205.3

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-------hhHHHHHHHHHHHhccCCCccceEE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-------QGHREWLAEVIFLGHLSHPNLVKLI  142 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~  142 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|++......       .....+.+|+.+++.++||||++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~   95 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNK------EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL   95 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTE------EEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCc------EEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            45789999999999999999998665544      3999998765321       1223456799999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCC-ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          143 GYCCEDEHRVLIYEFMARG-SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                      +++.+.+..++||||+.+| +|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A           96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             EEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEE
T ss_pred             EEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEE
Confidence            9999999999999999777 8988886654  6899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      +|||++.......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......            
T Consensus       172 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------  236 (335)
T 3dls_A          172 IDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------  236 (335)
T ss_dssp             CCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------
T ss_pred             eecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------
Confidence            9999998765432   2334679999999999998887 78999999999999999999999753211            


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                                ....  ...+...+.++.+|+.+||+.||++|||+.+++++-+
T Consensus       237 ----------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          237 ----------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             ----------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             ----------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence                      0000  1122335678999999999999999999999999843

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.8e-45  Score=335.61  Aligned_cols=249  Identities=22%  Similarity=0.291  Sum_probs=204.7

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +.++|++.+.||+|+||.||+|.+..+..      .||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRI------RRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT   79 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCc------EEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            45789999999999999999998765543      389998865422 23567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE---cCCCcEEEeccCC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFGL  226 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili---~~~~~vkl~Dfg~  226 (389)
                      ..++||||+++++|.+++....  .+++..+..++.|++.||+|||+++  |+|+||||+||++   +.++.+||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~  155 (277)
T 3f3z_A           80 DIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGL  155 (277)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             eEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence            9999999999999999886653  6899999999999999999999977  9999999999999   7889999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      +.......   ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........             
T Consensus       156 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------------  218 (277)
T 3f3z_A          156 AARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK-------------  218 (277)
T ss_dssp             CEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------------
T ss_pred             ceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH-------------
Confidence            98765432   23346799999999988764 89999999999999999999999987543221100             


Q ss_pred             hhhhcCCCCCCCCCh----HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          307 LLNIIDPRLEGDYPV----KGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         +.....  ..+.    ..+..+.+|+.+||+.||++|||+.++++|
T Consensus       219 ---~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          219 ---IREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             ---HHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ---HHhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000000  1111    346789999999999999999999999976

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7e-46  Score=346.31  Aligned_cols=251  Identities=24%  Similarity=0.296  Sum_probs=180.9

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCCeEEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  155 (389)
                      .+.||+|+||.||+|.++.+.+      .||+|++...    ....+.+|+.+++.+. ||||+++++++.+....|+||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQ------AFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCC------EEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCccccCCCeEEEEEEECCCCC------EEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            4789999999999998765544      3999998643    3456678999999997 999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC---cEEEeccCCCcCCCC
Q 016481          156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---NAKLSDFGLAKDGPE  232 (389)
Q Consensus       156 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~---~vkl~Dfg~a~~~~~  232 (389)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++   .+||+|||+++....
T Consensus        86 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           86 ELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             CCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            9999999999997753  7899999999999999999999977  99999999999997765   899999999986543


Q ss_pred             CCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcC
Q 016481          233 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID  312 (389)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (389)
                      ...  .....+||+.|+|||++.+..|+.++||||||+++|+|++|+.||...............         +..+..
T Consensus       162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---------~~~i~~  230 (325)
T 3kn6_A          162 DNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI---------MKKIKK  230 (325)
T ss_dssp             ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH---------HHHHTT
T ss_pred             CCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH---------HHHHHc
Confidence            221  233467899999999999999999999999999999999999999865432111000000         011111


Q ss_pred             CCC--CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          313 PRL--EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       313 ~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ...  ........+.++.+|+.+||+.||++|||+.++++|-
T Consensus       231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~  272 (325)
T 3kn6_A          231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE  272 (325)
T ss_dssp             TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence            111  1111123578899999999999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8e-46  Score=338.30  Aligned_cols=250  Identities=28%  Similarity=0.405  Sum_probs=204.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|.+..+..      .||+|++.....  ......+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKF------ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   81 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCc------EEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence            4689999999999999999998765543      399999854321  12245678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||++.
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccc
Confidence            99999999999999999887653  6899999999999999999999977  9999999999999999999999999986


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||..........      .       +.
T Consensus       158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~-------~~  220 (279)
T 3fdn_A          158 HAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK------R-------IS  220 (279)
T ss_dssp             CC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------H-------HH
T ss_pred             cCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH------H-------HH
Confidence            543321    234579999999999999999999999999999999999999998654321110      0       00


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                       ..    ....+...+..+.+|+.+||+.||++|||+.++++|-
T Consensus       221 -~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          221 -RV----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             -HT----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             -hC----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence             01    1123344567899999999999999999999999884

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=344.50  Aligned_cols=272  Identities=18%  Similarity=0.213  Sum_probs=202.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh----------hHHHHHHHHHHHhccCCCccce
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ----------GHREWLAEVIFLGHLSHPNLVK  140 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~  140 (389)
                      .++|++.+.||+|+||.||+|.+....   .....||+|+........          ....+.+|+..++.++||||++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKP---EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSC---GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCC---CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            468999999999999999999876521   123449999987654321          1123557888899999999999


Q ss_pred             EEeEEEe----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          141 LIGYCCE----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       141 ~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      +++++..    ....++||||+ +++|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC
Confidence            9999988    78899999999 999999887654  7899999999999999999999977  9999999999999887


Q ss_pred             C--cEEEeccCCCcCCCCCCC-----ccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchh
Q 016481          217 Y--NAKLSDFGLAKDGPEGDK-----SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR  289 (389)
Q Consensus       217 ~--~vkl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  289 (389)
                      +  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  999999999976543211     111234689999999999999999999999999999999999999996432211


Q ss_pred             hhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          290 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      .. ...........   +...+.....   ....+.++.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       268 ~~-~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 VA-VQTAKTNLLDE---LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HH-HHHHHHHHHHT---TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HH-HHHHHHhhccc---ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            11 11111111111   1110000000   11345789999999999999999999999999998754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=340.41  Aligned_cols=262  Identities=27%  Similarity=0.408  Sum_probs=202.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+..        ..||+|.+...   .....+.+|+.+++.++||||+++++++.  +.
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~   73 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWRA--------KDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NP   73 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETT--------EEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TT
T ss_pred             HhHeeeeeEeecCCCceEEEEEECC--------eeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CC
Confidence            3579999999999999999997642        23999998643   34567889999999999999999999876  45


Q ss_pred             EEEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC-CCceecCCCCCCeEEcCCCc-EEEeccCCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAE-KPVIYRDFKTSNILLDTDYN-AKLSDFGLA  227 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~-~~ivH~Dlkp~Nili~~~~~-vkl~Dfg~a  227 (389)
                      .++||||+++|+|.+++..... ..++...+..++.|++.||+|||+.+ ++|+||||||+||+++.++. +||+|||++
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence            7999999999999999876542 24788899999999999999999932 33999999999999998886 799999998


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ......     .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............           ..
T Consensus       154 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-----------~~  217 (307)
T 2eva_A          154 CDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW-----------AV  217 (307)
T ss_dssp             ----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH-----------HH
T ss_pred             cccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH-----------HH
Confidence            765321     22346999999999999999999999999999999999999999764332111000           00


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCCCC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTP  365 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~~p  365 (389)
                      ..    ......+..++..+.+++.+||+.||++|||+.++++.|+.+.........|
T Consensus       218 ~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  271 (307)
T 2eva_A          218 HN----GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP  271 (307)
T ss_dssp             HT----TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred             hc----CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence            00    1112223445678999999999999999999999999998886554443333

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.3e-46  Score=346.90  Aligned_cols=281  Identities=23%  Similarity=0.259  Sum_probs=216.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEE--eC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC--ED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~  148 (389)
                      .++|++.+.||+|+||.||+|.+...  ....+..||+|++... .......+.+|+.+++.++||||+++++++.  +.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPL--GDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTT--SSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccC--CCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            36899999999999999999975321  2234456999998765 3444567889999999999999999999887  45


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..+++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+  |+|+||||+|||++.++.+||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             ceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccce
Confidence            678999999999999999865432 5899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||............. . ........+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~-~-~~~~~~~~~  253 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC-E-RDVPALSRL  253 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc-c-cccccHHHH
Confidence            76543322 12233568889999999999999999999999999999999999987543211100000 0 000001112


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                      ...+........+..++..+.+|+.+||+.||++|||+.+++++|+.+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            2223333344445667789999999999999999999999999999886543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-45  Score=334.90  Aligned_cols=256  Identities=25%  Similarity=0.407  Sum_probs=210.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|.+...       ..||+|++.....  ....+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeEecCCCceeEEEEEecCC-------CeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            46899999999999999999986532       2399999986543  23578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             eEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccccccc
Confidence            999999999999999987653 36899999999999999999999977  999999999999999999999999998865


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .... ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||.........                 .
T Consensus       155 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-----------------~  216 (267)
T 3t9t_A          155 LDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-----------------E  216 (267)
T ss_dssp             CCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-----------------H
T ss_pred             cccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH-----------------H
Confidence            3321 111223567889999999999999999999999999999999 89999865432110                 0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      .+........+...+..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       217 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          217 DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            00111112223345688999999999999999999999999998764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-45  Score=339.10  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=211.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ...|++.+.||+|+||.||+|....+.+      .||+|++...........+.+|+.+++.++||||+++++++.....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQK------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCc------EEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            3579999999999999999997655443      3999998776555566788899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.+||+|||++...
T Consensus        95 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceec
Confidence            99999999999999988643   6899999999999999999999977  999999999999999999999999999765


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ....  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........             +...
T Consensus       170 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~  234 (303)
T 3a7i_A          170 TDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-------------IPKN  234 (303)
T ss_dssp             BTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHHS
T ss_pred             Cccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------------hhcC
Confidence            4322  122346799999999999999999999999999999999999999986543221100             0011


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                          .....+...+..+.+|+.+||+.||++|||+.+++++..-
T Consensus       235 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  274 (303)
T 3a7i_A          235 ----NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI  274 (303)
T ss_dssp             ----CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred             ----CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence                1112233456789999999999999999999999987543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=370.41  Aligned_cols=258  Identities=26%  Similarity=0.375  Sum_probs=206.4

Q ss_pred             CCcccc-eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           73 NFRQDR-VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        73 ~~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++.+.+ .||+|+||.||+|.+....    ....||||++...........+.+|+.+++.++||||+++++++.. +.+
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSS----CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCC----CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            444444 7999999999999765321    2344999999876555667889999999999999999999999876 668


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus       411 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            9999999999999988654 346899999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCcc-ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          232 EGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       232 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.........                 .
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-----------------~  550 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-----------------A  550 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-----------------H
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----------------H
Confidence            432211 1222456789999999999999999999999999999998 99999876543211                 1


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .+........+..++.++.+|+.+||+.||++||++.+|++.|+.+
T Consensus       551 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          551 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1111122234556778999999999999999999999999999876

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.2e-45  Score=358.61  Aligned_cols=267  Identities=21%  Similarity=0.270  Sum_probs=198.3

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||.||+|++..+.+      .||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDR------NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTE------EEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCC------EEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            35789999999999999999998665544      39999987542 334456788999999999999999999999654


Q ss_pred             ------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          149 ------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       149 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                            ..+|+||||+++ +|.+.+..    .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus       134 ~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~  206 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  206 (464)
T ss_dssp             CSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEEC
T ss_pred             CccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEE
Confidence                  467999999976 46665532    4889999999999999999999987  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh----
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL----  298 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----  298 (389)
                      |||+++......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+............    
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~  283 (464)
T 3ttj_A          207 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  283 (464)
T ss_dssp             CCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998754322   2344689999999999999999999999999999999999999998765433211100000    


Q ss_pred             -HHHHh-hhhhhhhcCCCCC-CC-----------------CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          299 -PLLKE-KKKLLNIIDPRLE-GD-----------------YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       299 -~~~~~-~~~~~~~~~~~~~-~~-----------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                       ..... .......+..... ..                 .....+.++.+|+.+||+.||++|||+.++++|-
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence             00000 0000001110000 00                 0112267899999999999999999999999983

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=360.17  Aligned_cols=262  Identities=20%  Similarity=0.193  Sum_probs=206.2

Q ss_pred             HHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEe
Q 016481           66 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIG  143 (389)
Q Consensus        66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~  143 (389)
                      +.....++|++.+.||+|+||.||+|+.+.+.+      .||+|++....  .......+.+|..++..++||||+++++
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~------~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  128 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ------VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF  128 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            344456789999999999999999998765444      49999986421  1112234678999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          144 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       144 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      ++.+.+.+|+||||++||+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus       129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          129 AFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECC
T ss_pred             EEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEee
Confidence            9999999999999999999999987643 36899999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccc-------cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      ||+++....... ......+||+.|+|||++.       +..|+.++|||||||++|||++|+.||.........   . 
T Consensus       206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~-  280 (412)
T 2vd5_A          206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY---G-  280 (412)
T ss_dssp             CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H-
T ss_pred             chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH---H-
Confidence            999987644321 1233468999999999997       356899999999999999999999999875432211   0 


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR---PLMRDIVDS  351 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~~il~~  351 (389)
                        ........    +.   ....+...+.++.+|+.+||. +|.+|   |++.++++|
T Consensus       281 --~i~~~~~~----~~---~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          281 --KIVHYKEH----LS---LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             --HHHTHHHH----CC---CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             --HHHhcccC----cC---CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence              00000000    00   001123456889999999999 99998   599999988

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.6e-46  Score=370.65  Aligned_cols=264  Identities=25%  Similarity=0.364  Sum_probs=215.5

Q ss_pred             HHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           65 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      +.+.+..++|++.+.||+|+||.||+|.+...       ..||||++.....  ....+.+|+.+|+.++|+||++++++
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-------~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~  330 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV  330 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTT-------EEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCC-------ceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34556677899999999999999999987643       2399999986542  34578899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      +.+ +.+++||||+.+|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus       331 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             ECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCT
T ss_pred             Eee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEccc
Confidence            866 77899999999999999997544446899999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      |+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||.........            
T Consensus       408 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~------------  474 (535)
T 2h8h_A          408 GLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------------  474 (535)
T ss_dssp             TSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH------------
T ss_pred             ccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------------
Confidence            9998764321 111223457889999999999999999999999999999999 99999875432110            


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                           ..+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+-..
T Consensus       475 -----~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          475 -----DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             -----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             -----HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                 11111122233456678899999999999999999999999999987544

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3e-45  Score=339.64  Aligned_cols=265  Identities=22%  Similarity=0.301  Sum_probs=201.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|....+..      .||+|++....  .......+.+|+.+++.++||||+++++++...
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGV------PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED  104 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCC------EEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCc------eEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            4579999999999999999998655433      49999987532  344556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          149 EHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      +..++||||+++|+|.+++..  .....+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence            999999999999999998854  22346899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      +........  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||........    .....       
T Consensus       183 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~-------  249 (310)
T 2wqm_A          183 GRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCKK-------  249 (310)
T ss_dssp             ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH----HHHHH-------
T ss_pred             eeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH----HHHHH-------
Confidence            876543221  22345789999999999999999999999999999999999999975432111    00000       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                      +.   ............+.++.+|+.+||+.||++|||+.++++.|+.+....
T Consensus       250 ~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          250 IE---QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             HH---TTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hh---cccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            00   011111112345678999999999999999999999999999887653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.5e-45  Score=341.02  Aligned_cols=269  Identities=22%  Similarity=0.249  Sum_probs=199.5

Q ss_pred             hcCCccc-ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeC
Q 016481           71 TANFRQD-RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  148 (389)
                      .++|++. +.||+|+||.||+|.+..+.+      .||+|++.... ......+.+|+.++.++ +||||+++++++.+.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQ------EYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCC------EEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCc------EEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            4678885 789999999999997654443      49999987653 33456788999999885 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc---EEEeccC
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN---AKLSDFG  225 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~---vkl~Dfg  225 (389)
                      +.+++||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.   +||+|||
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            99999999999999999987653  6899999999999999999999977  999999999999988766   9999999


Q ss_pred             CCcCCCCCCC-----ccccccccccccccCcccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH
Q 016481          226 LAKDGPEGDK-----SHVSTRIMGTYGYAAPEYIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       226 ~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  295 (389)
                      ++........     .......+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            9876542211     111223569999999999875     568899999999999999999999998754322110000


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCC----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYP----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ...... .......+.....  .++    ...+..+.+|+.+||+.||++|||+.++++|-.
T Consensus       240 ~~~~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  298 (316)
T 2ac3_A          240 EACPAC-QNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW  298 (316)
T ss_dssp             -CCHHH-HHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred             ccchhH-HHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence            000000 0000000011111  111    124678999999999999999999999999843

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.4e-45  Score=360.12  Aligned_cols=255  Identities=23%  Similarity=0.292  Sum_probs=205.1

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||+||+|.+..+.+      .||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQ------EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCC------EEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCC------EEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence            46789999999999999999998765443      39999975321 122346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc---CCCcEEEeccC
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD---TDYNAKLSDFG  225 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~---~~~~vkl~Dfg  225 (389)
                      ..+++||||+.+|+|.+.+....  .+++..+..++.|++.||.|||+++  |+||||||+|||++   .++.+||+|||
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECC
Confidence            99999999999999999886653  6899999999999999999999977  99999999999995   45679999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      ++.......   .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.........      .. +... 
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~-i~~~-  237 (486)
T 3mwu_A          170 LSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL------KR-VETG-  237 (486)
T ss_dssp             CTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH-HHHT-
T ss_pred             cCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhC-
Confidence            998654332   2334679999999999876 5999999999999999999999999876432211      00 0000 


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                            ......+.....+.++.+|+.+||+.||++|||+.++++|-
T Consensus       238 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          238 ------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             ------CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             ------CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence                  00011111234578899999999999999999999999984

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-45  Score=338.00  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=207.1

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe-
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-  147 (389)
                      .+..+|++.+.||+|+||.||+|.+..+.+      .||+|.+....     ..+.+|+.+++.++||||+++++++.. 
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGK------TYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGF   76 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCC------EEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCe------EEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence            456789999999999999999998765443      39999987653     234579999999999999999998854 


Q ss_pred             ---------------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeE
Q 016481          148 ---------------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  212 (389)
Q Consensus       148 ---------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nil  212 (389)
                                     ...+++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+  |+|+||||+||+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil  154 (284)
T 2a19_B           77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIF  154 (284)
T ss_dssp             EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEE
Confidence                           456899999999999999997665557899999999999999999999977  999999999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhh
Q 016481          213 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN  292 (389)
Q Consensus       213 i~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  292 (389)
                      ++.++.+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||....      
T Consensus       155 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------  225 (284)
T 2a19_B          155 LVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------  225 (284)
T ss_dssp             EEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------
T ss_pred             EcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------
Confidence            9999999999999988765432   1233579999999999999999999999999999999999998874210      


Q ss_pred             hHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCC
Q 016481          293 LADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  360 (389)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~  360 (389)
                        ..    .      .......    .+...+..+.+++.+||+.||++|||+.+++++|+.++..+.
T Consensus       226 --~~----~------~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          226 --KF----F------TDLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             --HH----H------HHHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             --HH----H------HHhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence              00    0      0001111    122345778999999999999999999999999998876644

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.3e-45  Score=334.25  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=202.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe---
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE---  147 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---  147 (389)
                      ..|++.+.||+|+||.||+|.+..+..      .||+|.+.... .......+.+|+.+++.++||||+++++++..   
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~------~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTV------EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCce------EEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            358888999999999999997665443      39999876543 34456778899999999999999999999875   


Q ss_pred             -CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc-CCCcEEEeccC
Q 016481          148 -DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFG  225 (389)
Q Consensus       148 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~-~~~~vkl~Dfg  225 (389)
                       ...+++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+.+|+|+||||+||+++ .++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             CCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence             456899999999999999997643  68899999999999999999999665699999999999997 78999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      ++......    ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||..........             
T Consensus       178 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-------------  239 (290)
T 1t4h_A          178 LATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-------------  239 (290)
T ss_dssp             GGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-------------
T ss_pred             Cccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-------------
Confidence            99764332    2234679999999998864 58999999999999999999999998654322110             


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                        ............+...+.++.+|+.+||+.||++|||+.++++|-
T Consensus       240 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  284 (290)
T 1t4h_A          240 --RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  284 (290)
T ss_dssp             --HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             --HHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence              000011111112223357899999999999999999999999873

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.5e-45  Score=335.60  Aligned_cols=255  Identities=23%  Similarity=0.299  Sum_probs=204.0

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-----hhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|++......     .....+.+|+.+++.++||||++++++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGK------EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI   76 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCC------eeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence            45689999999999999999998765444      3999987654321     235678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC----cEE
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAK  220 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~----~vk  220 (389)
                      +......++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++    .+|
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           77 FENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEE
T ss_pred             ecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceE
Confidence            999999999999999999999986643  6899999999999999999999977  99999999999998877    899


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........       
T Consensus       153 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------  222 (283)
T 3bhy_A          153 LIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN-------  222 (283)
T ss_dssp             ECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------
T ss_pred             EEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH-------
Confidence            99999998764322   12345799999999999999999999999999999999999999987543211100       


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +..       .............+..+.+|+.+||+.||++|||+.++++|
T Consensus       223 ~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          223 ISA-------VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             HHT-------TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             hHh-------cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            000       00000000112345788999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=354.22  Aligned_cols=274  Identities=21%  Similarity=0.237  Sum_probs=213.4

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  149 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++...........+.+|+.+++.++||||+++++++.... 
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGD------LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCc------EEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence            4689999999999999999998765443      499999876544445667789999999999999999999998765 


Q ss_pred             -eEEEEEEecCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE----cCCCcEEEec
Q 016481          150 -HRVLIYEFMARGSVENNLFSKVL-LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTDYNAKLSD  223 (389)
Q Consensus       150 -~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili----~~~~~vkl~D  223 (389)
                       ..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+  |+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEec
Confidence             78999999999999999865432 24899999999999999999999977  9999999999999    7778899999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCcccccc--------CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT--------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  295 (389)
                      ||+++......   ......||+.|+|||++.+        ..++.++|||||||++|+|++|+.||.........  ..
T Consensus       160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~  234 (396)
T 4eut_A          160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KE  234 (396)
T ss_dssp             GGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HH
T ss_pred             CCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HH
Confidence            99998764422   2334679999999999875        56788999999999999999999999754322111  11


Q ss_pred             HHhHHHHhhhh-hhhhc------------CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          296 WALPLLKEKKK-LLNII------------DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       296 ~~~~~~~~~~~-~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      ........... ....+            ........+...+..+.+++.+||+.||++||++.++++.++.+..
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            11111111100 00000            0011223456788999999999999999999999999999877644

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3e-45  Score=361.88  Aligned_cols=257  Identities=23%  Similarity=0.327  Sum_probs=208.4

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|.+.+.||+|+||.||+|+++.+.+      .||+|++.....  ......+..|+.+++.++||||+++++++...
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~------~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  257 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGK------LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK  257 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCc------EEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC
Confidence            3679999999999999999998765444      399999864321  12345678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          149 EHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      ..+|+||||++||+|..++....  ...+++..+..++.|++.||.|||+++  |+||||||+|||++.+|.+||+|||+
T Consensus       258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGl  335 (543)
T 3c4z_A          258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGL  335 (543)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecce
Confidence            99999999999999999887643  346899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ++.......  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........  .......       
T Consensus       336 a~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~-------  404 (543)
T 3c4z_A          336 AVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQR-------  404 (543)
T ss_dssp             CEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHH-------
T ss_pred             eeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHH-------
Confidence            987654322  22346899999999999999999999999999999999999999986532111  0001000       


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  351 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~il~~  351 (389)
                         +...  ...++...+..+.+|+.+||+.||++||++     .+|++|
T Consensus       405 ---i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          405 ---VLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ---HHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ---Hhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence               1111  112344567899999999999999999964     788866

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-45  Score=344.67  Aligned_cols=270  Identities=20%  Similarity=0.259  Sum_probs=196.0

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ...++|++.+.||+|+||.||+|.+..+.+      .||+|++...... .....+.+|+.+++.++||||+++++++..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNE------TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTE------EEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCc------eEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            345789999999999999999997665544      4999998765432 234566789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc-----CCCcEEEe
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-----TDYNAKLS  222 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~-----~~~~vkl~  222 (389)
                      ...+++||||++ |+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++     ..+.+||+
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             CCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEEC
Confidence            999999999997 59999887654  6899999999999999999999977  99999999999994     45569999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      |||++.......  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...................
T Consensus       180 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          180 DFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            999987653221  122345789999999999874 58999999999999999999999998765432211100000000


Q ss_pred             Hh-----hhhhhhhcC--CCCCCC-----CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          302 KE-----KKKLLNIID--PRLEGD-----YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       302 ~~-----~~~~~~~~~--~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..     .........  +.....     .+...+.++.+|+.+||+.||++|||+.++++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            00     000000000  000000     011246788999999999999999999999987

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8e-45  Score=335.88  Aligned_cols=254  Identities=21%  Similarity=0.298  Sum_probs=205.5

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +.++|++.+.||+|+||.||+|....+.+      .||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGK------LFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTT   79 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCC------EEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence            45789999999999999999998665443      499999875432 23356778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE---cCCCcEEEeccCC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFGL  226 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili---~~~~~vkl~Dfg~  226 (389)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  |+|+||||+||++   +.++.+||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             EEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            9999999999999999886643  6899999999999999999999977  9999999999999   7889999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      +......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||.........   .   . +...  
T Consensus       156 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~---~-i~~~--  222 (304)
T 2jam_A          156 SKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF---E---K-IKEG--  222 (304)
T ss_dssp             TCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H---H-HHHC--
T ss_pred             ceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---H---H-HHcC--
Confidence            8764322    123357999999999999999999999999999999999999999865432110   0   0 0000  


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                           ............+..+.+|+.+||+.||++|||+.++++|-
T Consensus       223 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (304)
T 2jam_A          223 -----YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP  263 (304)
T ss_dssp             -----CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             -----CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence                 00111222345578899999999999999999999999873

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2e-45  Score=361.60  Aligned_cols=255  Identities=25%  Similarity=0.333  Sum_probs=208.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      +.++|++.+.||+|+||.||+|....+.+      .||+|++....  .......+.+|+.+++.++||||+++++++..
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQ------ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCC------EEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            45789999999999999999998765444      39999986543  23445678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE---cCCCcEEEecc
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDF  224 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili---~~~~~vkl~Df  224 (389)
                      .+..++||||+.+|+|.+.+....  .+++..+..++.|++.||+|||+++  |+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            999999999999999999887654  6899999999999999999999977  9999999999999   56789999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      |++.......   .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||..........      . +...
T Consensus       174 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~-i~~~  242 (484)
T 3nyv_A          174 GLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK------K-VEKG  242 (484)
T ss_dssp             THHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H-HHHC
T ss_pred             eeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH------H-HHcC
Confidence            9987654432   2334679999999999876 69999999999999999999999998765432110      0 0000


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                             ......+.....+..+.+|+.+||+.||++|||+.++++|-
T Consensus       243 -------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          243 -------KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             -------CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             -------CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence                   00011111235678899999999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=335.05  Aligned_cols=256  Identities=22%  Similarity=0.254  Sum_probs=203.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC---ChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      +.++|++.+.||+|+||.||+|.+..+..      .||+|++....   .......+.+|+.+++.++||||+++++++.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLC------RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY   76 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCC------EEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCc------EEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            45789999999999999999998655443      39999986532   1234567889999999999999999999984


Q ss_pred             --eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          147 --EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       147 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                        +....++||||++++ |.+.+.......+++..+..++.|++.||.|||+++  |+|+||||+||+++.++.+||+||
T Consensus        77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~df  153 (305)
T 2wtk_C           77 NEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISAL  153 (305)
T ss_dssp             CC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecc
Confidence              456889999999876 777776665667999999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      |++................||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.........      .. +.
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~-i~  226 (305)
T 2wtk_C          154 GVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF------EN-IG  226 (305)
T ss_dssp             TTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HH-HH
T ss_pred             ccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH------HH-Hh
Confidence            9998765433333344567999999999997654  378999999999999999999999865422110      00 00


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .         .  ....+..++..+.+|+.+||+.||++|||+.++++|-
T Consensus       227 ~---------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          227 K---------G--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             H---------C--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             c---------C--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            0         0  1122334567899999999999999999999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=341.31  Aligned_cols=265  Identities=23%  Similarity=0.266  Sum_probs=205.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe---
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE---  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---  147 (389)
                      .++|++.+.||+|+||.||+|....+.+      .||+|++... .......+.+|+.+++.++||||+++++++..   
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGH------FYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERG  100 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCC------EEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCc------EEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence            4689999999999999999998655433      4999987653 34556778899999999999999999999873   


Q ss_pred             -CCeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          148 -DEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       148 -~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                       ....++||||+.+|+|.+++...  ....+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+||
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCC
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEec
Confidence             34789999999999999988652  3347899999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCcc-------ccccccccccccCccccccCC---CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH
Q 016481          225 GLAKDGPEGDKSH-------VSTRIMGTYGYAAPEYIMTGH---LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  294 (389)
Q Consensus       225 g~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  294 (389)
                      |++..........       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||........ .  
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~--  255 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-S--  255 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-C--
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-h--
Confidence            9987643211110       011245799999999987654   68999999999999999999999953211000 0  


Q ss_pred             HHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                                  .............+...+..+.+++.+||+.||++|||+.+++++|+.++..+
T Consensus       256 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          256 ------------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             ------------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             ------------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence                        00000111112223345688999999999999999999999999999887543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.9e-45  Score=355.05  Aligned_cols=258  Identities=23%  Similarity=0.324  Sum_probs=194.5

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-------ChhhHHHHHHHHHHHhccCCCccce
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-------SYQGHREWLAEVIFLGHLSHPNLVK  140 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~  140 (389)
                      ..+.++|.+.+.||+|+||.||+|.+..+.+.      ||+|++....       .......+.+|+.++++++||||++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  204 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKK------VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK  204 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCE------EEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcE------EEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEee
Confidence            35678999999999999999999987665443      9999986432       1112234678999999999999999


Q ss_pred             EEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC---
Q 016481          141 LIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY---  217 (389)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~---  217 (389)
                      +++++. .+..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++   
T Consensus       205 l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~  279 (419)
T 3i6u_A          205 IKNFFD-AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDC  279 (419)
T ss_dssp             CCEEEE-SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSC
T ss_pred             EEEEEe-cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcc
Confidence            999975 566899999999999999886543  7899999999999999999999977  99999999999996544   


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccccccccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH
Q 016481          218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  294 (389)
Q Consensus       218 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  294 (389)
                      .+||+|||+++......   .....+||+.|+|||++.+   ..|+.++|||||||++|+|++|..||........  +.
T Consensus       280 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~  354 (419)
T 3i6u_A          280 LIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK  354 (419)
T ss_dssp             CEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HH
T ss_pred             eEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HH
Confidence            59999999998764322   2344689999999999864   5788899999999999999999999986533211  10


Q ss_pred             HHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ..+    ...       ............+..+.+|+.+||+.||++|||+.++++|-
T Consensus       355 ~~i----~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  401 (419)
T 3i6u_A          355 DQI----TSG-------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  401 (419)
T ss_dssp             HHH----HTT-------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHH----hcC-------CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence            000    000       00000000113467899999999999999999999999874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.6e-45  Score=360.09  Aligned_cols=255  Identities=24%  Similarity=0.293  Sum_probs=203.5

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh------------hhHHHHHHHHHHHhccCCCc
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY------------QGHREWLAEVIFLGHLSHPN  137 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~n  137 (389)
                      +.++|++.+.||+|+||+||+|.+..+..      .||+|++......            .....+.+|+.+++.++|||
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  107 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHS------EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN  107 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCC------EEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCc------EEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence            46789999999999999999998765544      3999998754321            23467889999999999999


Q ss_pred             cceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       138 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      |+++++++.+...+++||||++||+|.+.+....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKN  183 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTT
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCC
Confidence            9999999999999999999999999999887653  6899999999999999999999977  99999999999998776


Q ss_pred             ---cEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH
Q 016481          218 ---NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  294 (389)
Q Consensus       218 ---~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  294 (389)
                         .+||+|||++.......   ......||+.|+|||++. ..|+.++|||||||++|+|++|.+||..........  
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--  257 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK--  257 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--
T ss_pred             CCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence               69999999998765432   233467999999999987 469999999999999999999999998765432110  


Q ss_pred             HHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                          . +....       ...........+.++.+|+.+||+.||.+|||+.++++|-
T Consensus       258 ----~-i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          258 ----K-VEKGK-------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             ----H-HHHCC-------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ----H-HHcCC-------CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence                0 00000       0000000123467899999999999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.1e-45  Score=359.46  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=200.9

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||.||+|+++.+..      .||+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  108 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHV------ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK  108 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCC------EEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCc------EEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            45679999999999999999998765543      39999987543 223346778999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC---CcEEEeccC
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAKLSDFG  225 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~---~~vkl~Dfg  225 (389)
                      ..+|+||||+.+|+|.+.+....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++..   +.+||+|||
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            99999999999999998886653  6899999999999999999999977  9999999999999764   559999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      ++.......   .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.........      ......  
T Consensus       185 ~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~~--  252 (494)
T 3lij_A          185 LSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL------RKVEKG--  252 (494)
T ss_dssp             TCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHT--
T ss_pred             CCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhC--
Confidence            998764332   233467999999999886 56999999999999999999999999876543211      000000  


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                            ............+..+.+|+.+||+.||.+|||+.++++|
T Consensus       253 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          253 ------KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             ------CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ------CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                  0001111112456789999999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-44  Score=349.77  Aligned_cols=269  Identities=21%  Similarity=0.250  Sum_probs=207.8

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc------CCCccceEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL------SHPNLVKLIG  143 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~  143 (389)
                      +..+|++.+.||+|+||.||+|.+..+.+      .||+|++...  ......+.+|+.+++.+      +|+||+++++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~------~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQ------HVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTE------EEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCc------EEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            45689999999999999999998665444      3999999754  33445667788888776      5779999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc--EEE
Q 016481          144 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN--AKL  221 (389)
Q Consensus       144 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~--vkl  221 (389)
                      ++.....+++||||+. ++|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.  +||
T Consensus       167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL  243 (429)
T 3kvw_A          167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKV  243 (429)
T ss_dssp             EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEE
T ss_pred             ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEE
Confidence            9999999999999996 68999988776667999999999999999999999977  999999999999999887  999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH----
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA----  297 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~----  297 (389)
                      +|||++......     .....||+.|+|||++.+..|+.++|||||||++|+|++|.+||...............    
T Consensus       244 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p  318 (429)
T 3kvw_A          244 IDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP  318 (429)
T ss_dssp             CCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999999764332     23457999999999999999999999999999999999999999876544321111000    


Q ss_pred             -hHHHHhhhhhhhhcCCCCC--------------------------------C----CCChHHHHHHHHHHHHhhccCCC
Q 016481          298 -LPLLKEKKKLLNIIDPRLE--------------------------------G----DYPVKGVHKAAMLAYHCLNHNPK  340 (389)
Q Consensus       298 -~~~~~~~~~~~~~~~~~~~--------------------------------~----~~~~~~~~~l~~li~~cl~~dP~  340 (389)
                       ..+..........++....                                .    ..+...+..+.+|+.+||++||+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~  398 (429)
T 3kvw_A          319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA  398 (429)
T ss_dssp             CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence             0000000111111110000                                0    00111257789999999999999


Q ss_pred             CCCCHHHHHHHhcc
Q 016481          341 ARPLMRDIVDSLEP  354 (389)
Q Consensus       341 ~Rps~~~il~~L~~  354 (389)
                      +|||+.++|+|-+-
T Consensus       399 ~Rpta~e~L~Hpw~  412 (429)
T 3kvw_A          399 VRMTPGQALRHPWL  412 (429)
T ss_dssp             TSCCHHHHHTSTTT
T ss_pred             hCCCHHHHhCChhh
Confidence            99999999998543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-45  Score=345.15  Aligned_cols=270  Identities=23%  Similarity=0.292  Sum_probs=201.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGA------KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   97 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCC------EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCC------EEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence            5689999999999999999998765544      39999986543 3344567889999999999999999999997653


Q ss_pred             ------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          150 ------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       150 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                            .+|+||||+ +++|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEe
Confidence                  469999999 78999988763   6889999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh----
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL----  298 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----  298 (389)
                      ||+++.....     .....+|+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+..............    
T Consensus       172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          172 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  246 (367)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999875432     234578999999999887 689999999999999999999999998765433211100000    


Q ss_pred             -HHHH-----hhhhhhhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccC
Q 016481          299 -PLLK-----EKKKLLNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQV  357 (389)
Q Consensus       299 -~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~  357 (389)
                       ....     ........+.....   .......+..+.+|+.+||+.||++|||+.++++|  |..+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence             0000     00000011110000   11123456889999999999999999999999997  554443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-44  Score=332.27  Aligned_cols=278  Identities=18%  Similarity=0.181  Sum_probs=212.0

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEE-EeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC-CED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~  148 (389)
                      +.++|++.+.||+|+||.||+|++..+.+      .||+|++......   ..+.+|+.+++.+.|++++..+..+ ...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGE------EVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTE------EEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCc------EEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence            35789999999999999999998655443      4999998765432   3467899999999988766655554 667


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE---cCCCcEEEeccC
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFG  225 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili---~~~~~vkl~Dfg  225 (389)
                      ...++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||+   +.++.+||+|||
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           78 DYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             CceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence            8889999999 899999886443 36899999999999999999999977  9999999999999   488899999999


Q ss_pred             CCcCCCCCCCc-----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          226 LAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       226 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      ++.........     .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..............+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 3uzp_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence            99876543221     1123467999999999999999999999999999999999999999875433222222111110


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCCCCCCccc
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVT  370 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~~p~~~~~  370 (389)
                      ...  .....+        ....+.++.+|+.+||+.||++|||+.+|++.|+.+.........-...|.
T Consensus       234 ~~~--~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 3uzp_A          234 KMS--TPIEVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             HHH--SCHHHH--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred             ccC--CchHHH--------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence            000  000000        123457899999999999999999999999999888655444333333343

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-45  Score=336.83  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=201.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC-
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  148 (389)
                      ..++|++.+.||+|+||.||+|.+.        +..||+|++....   ....+.+|+.+++.++||||+++++++... 
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   87 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--------CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3568999999999999999999754        2349999987653   345678999999999999999999987654 


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccc
Confidence            57899999999999999987654334788999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      .....     .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||........                 
T Consensus       166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-----------------  223 (278)
T 1byg_A          166 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----------------  223 (278)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-----------------
T ss_pred             ccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------
Confidence            64332     123467889999999999999999999999999999998 9999986543211                 


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      ...+........+...+..+.+++.+||+.||++|||+.++++.|+.++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          224 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            11111112223345567889999999999999999999999999987753

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=346.33  Aligned_cols=278  Identities=20%  Similarity=0.293  Sum_probs=204.4

Q ss_pred             HHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEE
Q 016481           64 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLI  142 (389)
Q Consensus        64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~  142 (389)
                      ...+.+..++|++.+.||+|+||.||+|.+..         .+|+|++..... ......+.+|+.+++.++||||++++
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM   95 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCC
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC---------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEE
Confidence            34445556889999999999999999997643         199999875432 22234566799999999999999999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          143 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                      +++......++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++  |+|+||||+||+++ ++.+||+
T Consensus        96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B           96 GACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             EEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEEC
T ss_pred             EEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEe
Confidence            99999999999999999999999886543 36889999999999999999999977  99999999999998 6799999


Q ss_pred             ccCCCcCCCCCC---CccccccccccccccCcccccc---------CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhh
Q 016481          223 DFGLAKDGPEGD---KSHVSTRIMGTYGYAAPEYIMT---------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE  290 (389)
Q Consensus       223 Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  290 (389)
                      |||++.......   .........||+.|+|||++.+         ..++.++||||||+++|+|++|+.||........
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  251 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI  251 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999987643211   1112233569999999999874         4578899999999999999999999986543211


Q ss_pred             hhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCCCCCCccc
Q 016481          291 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKNFVT  370 (389)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~~p~~~~~  370 (389)
                      ..             .+.....+.   ......+.++.+++.+||+.||++|||+.++++.|+.+.......+.|..+|.
T Consensus       252 ~~-------------~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~  315 (319)
T 2y4i_B          252 IW-------------QMGTGMKPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK  315 (319)
T ss_dssp             HH-------------HHHTTCCCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred             HH-------------HhccCCCCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence            10             001111111   11123456789999999999999999999999999999988888787777764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=333.45  Aligned_cols=253  Identities=25%  Similarity=0.362  Sum_probs=185.9

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++.....  ......+.+|+.+++.++||||+++++++.+.
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGL------EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS   83 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCc------eEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence            3579999999999999999997654433      399999864321  12235678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++.
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeeccee
Confidence            99999999999999999887543 46899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........                ..
T Consensus       161 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~  222 (278)
T 3cok_A          161 QLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LN  222 (278)
T ss_dssp             ECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------
T ss_pred             eccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HH
Confidence            7543221  12235789999999999999999999999999999999999999986542211                00


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .....  ....+...+.++.+|+.+||+.||++|||+.++++|-
T Consensus       223 ~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  264 (278)
T 3cok_A          223 KVVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP  264 (278)
T ss_dssp             -CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred             HHhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence            11111  1122344567899999999999999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-44  Score=332.52  Aligned_cols=268  Identities=18%  Similarity=0.213  Sum_probs=204.1

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEE-EeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC-CED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~  148 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|+.......   ..+..|+.+++.++|++++..+..+ ...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGE------EVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTE------EEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCc------eEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence            46789999999999999999998655443      4999987654322   2456799999999987766666554 677


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE---cCCCcEEEeccC
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFG  225 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili---~~~~~vkl~Dfg  225 (389)
                      ...++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||+   +.++.+||+|||
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           78 DYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             CceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            8889999999 899999887543 36899999999999999999999977  9999999999999   788999999999


Q ss_pred             CCcCCCCCCCc-----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          226 LAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       226 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      ++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..................
T Consensus       154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 4hgt_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence            99876543221     1223468999999999999999999999999999999999999999875443322221111110


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCC
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  360 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~  360 (389)
                      ...  ......        ....+.++.+|+.+||+.||++|||+.++++.|+.+....+
T Consensus       234 ~~~--~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          234 KMS--TPIEVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHH--SCHHHH--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             ccc--chhhhh--------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            000  000000        11235789999999999999999999999999988755433

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.8e-45  Score=334.61  Aligned_cols=249  Identities=18%  Similarity=0.246  Sum_probs=202.2

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  147 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|++.... .......+.+|+..+..+ +||||+++++++.+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~   82 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGC------IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE   82 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCc------eEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            45789999999999999999998765443      39999987643 334456788899999998 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC---------
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKV--LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---------  216 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~---------  216 (389)
                      .+..++||||+++|+|.+++....  ...+++..+..++.|++.||+|||+++  |+||||||+||+++.+         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-----------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccc
Confidence            999999999999999999986542  246899999999999999999999977  9999999999999844         


Q ss_pred             ----------CcEEEeccCCCcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCC
Q 016481          217 ----------YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKS  285 (389)
Q Consensus       217 ----------~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~  285 (389)
                                ..+||+|||++.......      ...||+.|+|||++.+. .++.++||||||+++|+|++|.+++...
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             cccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                      479999999988764322      24599999999999876 5678999999999999999999877543


Q ss_pred             CchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          286 RPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ...                ..+..    ......+...+..+.+|+.+||+.||++|||+.++++|-
T Consensus       235 ~~~----------------~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          235 DQW----------------HEIRQ----GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             HHH----------------HHHHT----TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             hHH----------------HHHHc----CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence            210                00111    111223445568899999999999999999999999874

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4e-45  Score=354.21  Aligned_cols=276  Identities=22%  Similarity=0.315  Sum_probs=201.5

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||.||+|++..+.+      .||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEK------NVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTE------EEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCc------EEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            45789999999999999999998765544      39999987543 344557788999999999999999999999766


Q ss_pred             -----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          149 -----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       149 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                           ..+|+||||++ |+|.+++...  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~D  172 (432)
T 3n9x_A           98 DLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCD  172 (432)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEcc
Confidence                 57999999996 5999988654  36899999999999999999999987  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCc--------------------cccccccccccccCcccc-ccCCCCcccchhHHHHHHHHHHhCCCC-
Q 016481          224 FGLAKDGPEGDKS--------------------HVSTRIMGTYGYAAPEYI-MTGHLTPRSDVYSFGVVLLEILTGRKS-  281 (389)
Q Consensus       224 fg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwslG~il~elltg~~p-  281 (389)
                      ||+++........                    ......+||+.|+|||++ .+..|+.++|||||||++|||++|..| 
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            9999876443211                    123457899999999986 566799999999999999999985444 


Q ss_pred             ----------CCCCCchh--------------hhhhHHHHhHHHHh-------------hhhhhhhcCCCCCCCC---Ch
Q 016481          282 ----------LDKSRPAR--------------EQNLADWALPLLKE-------------KKKLLNIIDPRLEGDY---PV  321 (389)
Q Consensus       282 ----------f~~~~~~~--------------~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~---~~  321 (389)
                                |.+.....              .......+...+..             .......+........   ..
T Consensus       253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (432)
T 3n9x_A          253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP  332 (432)
T ss_dssp             CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred             ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence                      43322100              00000000000000             0000011111000000   12


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hcccc
Q 016481          322 KGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQ  356 (389)
Q Consensus       322 ~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~  356 (389)
                      ..+.++.+|+.+||+.||++|||+.++++|  |..+.
T Consensus       333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            356889999999999999999999999998  55443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.8e-45  Score=333.63  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=208.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKE------VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCc------eEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            4689999999999999999998765443      39999876542  334456788899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCce
Confidence            99999999999999999886543  6899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........      .          
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~----------  225 (294)
T 2rku_A          164 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------L----------  225 (294)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H----------
T ss_pred             ecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H----------
Confidence            7543221  233467999999999999999999999999999999999999999875432110      0          


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .....  ....+...+..+.+++.+||+.||++|||+.+++++-
T Consensus       226 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          226 RIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             HHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             HHhhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            00000  1122334567899999999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.5e-45  Score=343.50  Aligned_cols=269  Identities=23%  Similarity=0.345  Sum_probs=203.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++..... ......+.+|+.+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGR------IVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCC------EEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCc------eEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            4689999999999999999998765444      399998765443 334456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++++|.++.....  .+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            9999999999988887765443  6899999999999999999999977  99999999999999999999999999976


Q ss_pred             CCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH--------hHH
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA--------LPL  300 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--------~~~  300 (389)
                      ......  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...............        ...
T Consensus       174 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          174 LAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            543221  23346799999999999875 7899999999999999999999999876544321111000        000


Q ss_pred             HHhhhhhhhhcCCCCCCCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKEKKKLLNIIDPRLEGDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ............+......     ....+..+.+|+.+||+.||++|||+.++++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0011111111111111111     11346889999999999999999999999976

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-44  Score=335.82  Aligned_cols=264  Identities=23%  Similarity=0.253  Sum_probs=201.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++....  .......+.+|+.+++.++||||+++++++..+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRER------IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTE------EEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCe------EEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            4789999999999999999998665443      49999987543  233346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||++.
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~  182 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIAS  182 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred             CeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCc
Confidence            99999999999999999987653  6899999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......   +.    ..+...    
T Consensus       183 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~----~~~~~~----  250 (309)
T 2h34_A          183 ATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MG----AHINQA----  250 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HH----HHHHSC----
T ss_pred             ccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HH----HHhccC----
Confidence            6543221 12234579999999999999999999999999999999999999998653221   00    000000    


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhccccCCCC
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-LMRDIVDSLEPLQVLPD  360 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~~il~~L~~~~~~~~  360 (389)
                        .  ......+...+.++.+++.+||+.||++|| ++.++++.|+.....+.
T Consensus       251 --~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          251 --I--PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             --C--CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             --C--CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence              0  001112334567899999999999999999 99999999987765543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=342.96  Aligned_cols=255  Identities=26%  Similarity=0.325  Sum_probs=199.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  147 (389)
                      ...++|++.+.||+|+||.||+|.+..+.+      .||+|++.....  ....+.+|+.+++.+ +||||+++++++..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQ------LAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCC------eEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            346789999999999999999998765443      399999875432  335677899999998 79999999999987


Q ss_pred             ------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          148 ------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       148 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                            ...+++||||+++|+|.+++.......+++..+..++.|++.||.|||+++  |+|+||||+||+++.++.+||
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEE
Confidence                  568999999999999999998765557899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      +|||++........  ......||+.|+|||++.     +..++.++|||||||++|+|++|..||...........   
T Consensus       171 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---  245 (326)
T 2x7f_A          171 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---  245 (326)
T ss_dssp             CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---
T ss_pred             eeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH---
Confidence            99999886543211  123457999999999987     56789999999999999999999999976543221100   


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                                ......   ....+...+..+.+|+.+||+.||++||++.++++|
T Consensus       246 ----------~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          246 ----------IPRNPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ----------HHHSCC---CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ----------hhcCcc---ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                      000001   111123346789999999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.1e-45  Score=340.25  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=208.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      ..+|.+.+.||+|+||.||+|.+..+.+      .||+|++....  .......+.+|+.+++.++|+||+++++++.+.
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  113 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKE------VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN  113 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4689999999999999999998765443      39999986542  334556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||.|||+++  |+|+||||+||+++.++.+||+|||++.
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCce
Confidence            99999999999999999886543  6899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........      ......     
T Consensus       190 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~-----  256 (335)
T 2owb_A          190 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKKN-----  256 (335)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHT-----
T ss_pred             ecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHhcC-----
Confidence            7643221  233467999999999999999999999999999999999999999865432110      000000     


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                             ....+...+..+.+|+.+||+.||++|||+.+++++
T Consensus       257 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 -------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   011233456788999999999999999999999987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6e-45  Score=334.09  Aligned_cols=255  Identities=24%  Similarity=0.263  Sum_probs=190.1

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHH-HHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW-LAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      ..++|++.+.||+|+||.||+|.+..+.+      .||+|++............ .++...++.++||||+++++++...
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   78 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQ------IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE   78 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCe------EEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence            45789999999999999999998755444      3999999876544444444 3445557888999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          149 EHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      +..++||||++ |+|.+++..  .....+++..+..++.|++.||+|||+. +  |+||||||+||+++.++.+||+|||
T Consensus        79 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           79 GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecC
Confidence            99999999997 588776643  2334789999999999999999999996 7  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCcccc----ccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHH
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYI----MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      ++.......   ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||.........          
T Consensus       156 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------  222 (290)
T 3fme_A          156 ISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ----------  222 (290)
T ss_dssp             -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH----------
T ss_pred             Ccccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH----------
Confidence            998654422   22335799999999996    5667899999999999999999999999864322111          


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                           +................+.++.+|+.+||+.||++|||+.++++|
T Consensus       223 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          223 -----LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             -----HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -----HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                 011111111111223456889999999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.8e-45  Score=371.11  Aligned_cols=254  Identities=25%  Similarity=0.325  Sum_probs=208.8

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhcc-CCCccceEEeE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHL-SHPNLVKLIGY  144 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~  144 (389)
                      .+..++|.+.+.||+|+||.||+|.++.+.+      .||+|++....  .......+..|..++..+ +||+|+.++++
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~------~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~  410 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDE------LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC  410 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCC------EEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCc------EEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            3445789999999999999999998766544      39999986431  122335667899999987 69999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      +.+.+.+|+||||++||+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus       411 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DF  486 (674)
T 3pfq_A          411 FQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADF  486 (674)
T ss_dssp             CBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCC
T ss_pred             EEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeec
Confidence            999999999999999999999987654  6899999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      |+++......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........              
T Consensus       487 Gla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~--------------  550 (674)
T 3pfq_A          487 GMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--------------  550 (674)
T ss_dssp             TTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------
T ss_pred             ceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH--------------
Confidence            9998643322  124457899999999999999999999999999999999999999987543211              


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM-----RDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~il~~  351 (389)
                        ...++..  ...++...+.++.+||.+||+.||++||++     .+|++|
T Consensus       551 --~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          551 --FQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             --HHHHHSS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             --HHHHHhC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence              1111111  123445677899999999999999999998     888876

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.8e-45  Score=348.90  Aligned_cols=268  Identities=19%  Similarity=0.237  Sum_probs=206.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC--------CCccce
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS--------HPNLVK  140 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~  140 (389)
                      .+.++|++.+.||+|+||.||+|++..+.+      .||+|++...  ......+.+|+.+++.+.        |+||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKK------FVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCe------EEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            345789999999999999999997655443      4999998754  344567788999999885        788999


Q ss_pred             EEeEEE----eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCeEEcC
Q 016481          141 LIGYCC----EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDT  215 (389)
Q Consensus       141 ~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~Dlkp~Nili~~  215 (389)
                      +++++.    ....+++||||+ +++|.+.+.......+++..+..++.|++.||+|||++ +  |+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~  182 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSV  182 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECC
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEec
Confidence            999987    556899999999 66788777766656799999999999999999999997 7  999999999999987


Q ss_pred             CC-------------------------------------------------cEEEeccCCCcCCCCCCCccccccccccc
Q 016481          216 DY-------------------------------------------------NAKLSDFGLAKDGPEGDKSHVSTRIMGTY  246 (389)
Q Consensus       216 ~~-------------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~  246 (389)
                      ++                                                 .+||+|||++......     .....||+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~  257 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTR  257 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCG
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCC
Confidence            75                                                 7999999999865432     23357999


Q ss_pred             cccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh---HHHHhHHHHh--------hhhhhhhcCCC-
Q 016481          247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL---ADWALPLLKE--------KKKLLNIIDPR-  314 (389)
Q Consensus       247 ~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---~~~~~~~~~~--------~~~~~~~~~~~-  314 (389)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...........   ..........        ........... 
T Consensus       258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  337 (397)
T 1wak_A          258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG  337 (397)
T ss_dssp             GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred             cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence            99999999999999999999999999999999999986543221111   1111110000        00000000000 


Q ss_pred             ----C--------------CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          315 ----L--------------EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       315 ----~--------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                          .              ....+...+..+.+|+.+||+.||++|||+.++++|-
T Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  393 (397)
T 1wak_A          338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP  393 (397)
T ss_dssp             SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred             ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence                0              0123456788899999999999999999999999873

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.6e-45  Score=333.58  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=206.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|.+.+.||+|+||.||+|.+..+..      .||+|++.....  ......+.+|+.+++.++||||+++++++.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   86 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKF------IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR   86 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCc------EEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence            4689999999999999999998665443      399999864321  12235678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+++  |+|+||||+||+++.++.+||+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           87 KRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccc
Confidence            99999999999999999887653  6899999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......    .....|++.|+|||++.+..++.++||||||+++|+|++|..||.........                .
T Consensus       163 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------------~  222 (284)
T 2vgo_A          163 HAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH----------------R  222 (284)
T ss_dssp             ECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------H
T ss_pred             cCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH----------------H
Confidence            654321    23467999999999999999999999999999999999999999865432110                0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      .+...  ...++...+..+.+++.+||+.||++|||+.++++|-
T Consensus       223 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~  264 (284)
T 2vgo_A          223 RIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP  264 (284)
T ss_dssp             HHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred             HHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence            00111  1123344567899999999999999999999999873

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-45  Score=340.44  Aligned_cols=269  Identities=23%  Similarity=0.331  Sum_probs=189.2

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      +.+..++|++.+.||+|+||.||+|.+..+..      .||+|.+...........+.+|+.+++.++||||+++++++.
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   83 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKE------KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV   83 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----C------EEEEECCC----------------CCCCCCCTTBCCEEEEEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCc------EEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence            34556799999999999999999997654433      399999876544445567889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          147 EDEHRVLIYEFMARGSVENNLFS------KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      ..+..++||||+++|+|.+++..      .....+++..+..++.|++.||.|||+++  |+|+||||+||+++.++.+|
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEE
T ss_pred             ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEE
Confidence            99999999999999999998864      12346899999999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCC---ccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH
Q 016481          221 LSDFGLAKDGPEGDK---SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW  296 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  296 (389)
                      |+|||++........   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........   
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---  238 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML---  238 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH---
Confidence            999999876543221   112234579999999999876 5789999999999999999999999987654321100   


Q ss_pred             HhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         ....  ..................+.++.+|+.+||+.||.+|||+.++++|
T Consensus       239 ---~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          239 ---TLQN--DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             ---HHTS--SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ---Hhcc--CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               0000  0000000000111223446789999999999999999999999987

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-44  Score=339.44  Aligned_cols=269  Identities=25%  Similarity=0.277  Sum_probs=199.1

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh----hHHHHHHHHHHHhccCCCccceEEeEE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ----GHREWLAEVIFLGHLSHPNLVKLIGYC  145 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~  145 (389)
                      ..++|++.+.||+|+||.||+|.+..+.+      .||+|++.......    ....+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQ------IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF   81 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCS------EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCc------EEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            45789999999999999999998665433      49999987543211    124577899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      ...+..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           82 GHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             CCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             eeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecc
Confidence            999999999999975 8888776543 36888899999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh-
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-  303 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-  303 (389)
                      +++.......  ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.........  ... ...... 
T Consensus       158 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~--~~i-~~~~~~~  232 (346)
T 1ua2_A          158 LAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL--TRI-FETLGTP  232 (346)
T ss_dssp             GGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHH-HHHHCCC
T ss_pred             cceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHH-HHHcCCC
Confidence            9987643221  23346799999999999764 5899999999999999999999999876543211  110 000000 


Q ss_pred             ----hh---hhhhhcCCCCCCCCC-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          304 ----KK---KLLNIIDPRLEGDYP-----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       304 ----~~---~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                          ..   .....+........+     ...+.++.+|+.+||+.||++|||+.++++|-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence                00   000000000000011     234688999999999999999999999999854

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.8e-44  Score=342.15  Aligned_cols=258  Identities=22%  Similarity=0.310  Sum_probs=207.2

Q ss_pred             HHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-------hhHHHHHHHHHHHhcc-CCCc
Q 016481           66 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-------QGHREWLAEVIFLGHL-SHPN  137 (389)
Q Consensus        66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~n  137 (389)
                      ....+.++|.+.+.||+|+||.||+|.+..+.+      .||||++......       .....+.+|+.+++.+ +|||
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~  161 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH------EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH  161 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCc------EEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            345566789999999999999999998765443      3999998754321       1234567899999999 7999


Q ss_pred             cceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC
Q 016481          138 LVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY  217 (389)
Q Consensus       138 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~  217 (389)
                      |+++++++......++||||++||+|.+++....  .+++..+..++.|++.||.|||+.+  |+|+||||+|||++.++
T Consensus       162 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~  237 (365)
T 2y7j_A          162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNM  237 (365)
T ss_dssp             BCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTC
T ss_pred             EeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCC
Confidence            9999999999999999999999999999987643  6899999999999999999999977  99999999999999999


Q ss_pred             cEEEeccCCCcCCCCCCCccccccccccccccCcccccc------CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhh
Q 016481          218 NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ  291 (389)
Q Consensus       218 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  291 (389)
                      .+||+|||++.......   ......||+.|+|||++.+      ..++.++|||||||++|+|++|+.||.........
T Consensus       238 ~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  314 (365)
T 2y7j_A          238 QIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML  314 (365)
T ss_dssp             CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            99999999998765432   2334689999999999864      35889999999999999999999999865432111


Q ss_pred             hhHHHHhHHHHhhhhhhhhcCCCCCCC--CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          292 NLADWALPLLKEKKKLLNIIDPRLEGD--YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                         ..    +..         ......  .....+..+.+|+.+||+.||++|||+.++++|-
T Consensus       315 ---~~----i~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  361 (365)
T 2y7j_A          315 ---RM----IME---------GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP  361 (365)
T ss_dssp             ---HH----HHH---------TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             ---HH----HHh---------CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence               00    000         000000  0012357799999999999999999999999873

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=342.64  Aligned_cols=263  Identities=24%  Similarity=0.322  Sum_probs=191.3

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEE--
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCC--  146 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--  146 (389)
                      ...+|++.+.||+|+||.||+|.+..+.+      .||+|++... .......+.+|+.+++.+. ||||+++++++.  
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGR------EYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCC------EEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCc------EEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            34689999999999999999998765443      3999988554 3445567889999999996 999999999984  


Q ss_pred             ------eCCeEEEEEEecCCCChhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcE
Q 016481          147 ------EDEHRVLIYEFMARGSVENNLFS-KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA  219 (389)
Q Consensus       147 ------~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~v  219 (389)
                            ....+++||||+. |+|.+++.. .....+++..+..++.|++.||+|||+.+.+|+|+||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                  3445899999996 689888754 22346899999999999999999999966559999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCcc----------ccccccccccccCcccc---ccCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Q 016481          220 KLSDFGLAKDGPEGDKSH----------VSTRIMGTYGYAAPEYI---MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSR  286 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~l---~~~~~~~~~DiwslG~il~elltg~~pf~~~~  286 (389)
                      ||+|||++..........          ......||+.|+|||++   .+..++.++||||||+++|+|++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998765432111          11135699999999998   56678999999999999999999999997543


Q ss_pred             chhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCC
Q 016481          287 PAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPD  360 (389)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~  360 (389)
                      ...                    .+............+..+.+|+.+||+.||++|||+.+++++|+.+.....
T Consensus       258 ~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          258 KLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             HHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            210                    111111111222334568899999999999999999999999998865533

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.4e-45  Score=334.98  Aligned_cols=263  Identities=21%  Similarity=0.259  Sum_probs=208.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  147 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|.+.... .......+.+|+.+++.++||||+++++++..  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGK------ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCc------EEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            4689999999999999999998765443      39999987643 34455678899999999999999999998854  


Q ss_pred             CCeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---CCceecCCCCCCeEEcCCCcEEEe
Q 016481          148 DEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAE---KPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~---~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                      ....++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.+   .+|+|+||||+||+++.++.+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            57899999999999999988653  2345899999999999999999999854   239999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      |||++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........   ..   . + 
T Consensus       159 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~-i-  228 (279)
T 2w5a_A          159 DFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG---K-I-  228 (279)
T ss_dssp             CCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---H-H-
T ss_pred             cCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HH---H-H-
Confidence            999987654322  122335789999999999999999999999999999999999999987643211   00   0 0 


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                           ..    ......+...+.++.+++.+||+.||++|||+.+|+++++.....
T Consensus       229 -----~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          229 -----RE----GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             -----HH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             -----hh----cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                 00    011123345668899999999999999999999999988765543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.4e-45  Score=336.86  Aligned_cols=265  Identities=25%  Similarity=0.343  Sum_probs=202.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|.+.....   ....||+|++....  .......+.+|+.+++.++||||+++++++...
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCC---ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            4689999999999999999997643221   22348999887543  234557788999999999999999999999765


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      . .++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||+++  |+|+||||+||+++.++.+||+|||++.
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             C-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccc
Confidence            5 899999999999999887642 35889999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCcc-ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          229 DGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       229 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.........               
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---------------  234 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---------------  234 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---------------
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH---------------
Confidence            765433221 2233567889999999999889999999999999999999 99999876432110               


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                       ..+.........+..++.++.+++.+||+.||++|||+.+++++|+.+...
T Consensus       235 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          235 -HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             -HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             -HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence             011111112223345678899999999999999999999999999877643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.3e-44  Score=339.58  Aligned_cols=273  Identities=21%  Similarity=0.245  Sum_probs=203.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEe--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  147 (389)
                      .++|++.+.||+|+||.||+|++..+.+      .||+|++..... ......+.+|+.+++.++||||+++++++..  
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   89 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQ------KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCC------EEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCC------EEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence            3689999999999999999998765544      399998865432 2234567789999999999999999999877  


Q ss_pred             ------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          148 ------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       148 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                            .+.+++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||
T Consensus        90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl  165 (351)
T 3mi9_A           90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKL  165 (351)
T ss_dssp             -------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEE
T ss_pred             cccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEE
Confidence                  4578999999975 7777775543 36899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCC--ccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh
Q 016481          222 SDFGLAKDGPEGDK--SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  298 (389)
                      +|||+++.......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||................
T Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  245 (351)
T 3mi9_A          166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  245 (351)
T ss_dssp             CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99999987643221  122334678999999999876 458999999999999999999999998765433221111000


Q ss_pred             HHHH-----hh--hhhhhhcCCCCCCCCC--h-----HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          299 PLLK-----EK--KKLLNIIDPRLEGDYP--V-----KGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       299 ~~~~-----~~--~~~~~~~~~~~~~~~~--~-----~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ....     ..  ......+.........  .     ..+..+.+|+.+||+.||++|||+.++++|-.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  314 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  314 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence            0000     00  0000000000000000  0     11466899999999999999999999999843

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.5e-44  Score=336.28  Aligned_cols=261  Identities=17%  Similarity=0.252  Sum_probs=202.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEe--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCE--  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--  147 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++...    ....+.+|+.+++.+. ||||+++++++..  
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~  104 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNE------KVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPV  104 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCc------EEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence            3689999999999999999998665544      3999998753    2356778999999997 9999999999987  


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-cEEEeccCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGL  226 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-~vkl~Dfg~  226 (389)
                      ....++||||+.+++|.+++.     .++...+..++.|++.||+|||+++  |+||||||+|||++.++ .+||+|||+
T Consensus       105 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          105 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             TCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence            678899999999999998774     3788899999999999999999977  99999999999999776 899999999


Q ss_pred             CcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH------
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP------  299 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------  299 (389)
                      ++.......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... +......      
T Consensus       178 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~  253 (330)
T 3nsz_A          178 AEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDL  253 (330)
T ss_dssp             CEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHH
T ss_pred             ceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchh
Confidence            987654322   234578999999999987 67899999999999999999999999655433221 1110000      


Q ss_pred             --HHHhh-----hhhhhhcC--------CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          300 --LLKEK-----KKLLNIID--------PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       300 --~~~~~-----~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                        .+...     ......+.        .......+...+.++.+|+.+||+.||++|||+.++++|-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp  321 (330)
T 3nsz_A          254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP  321 (330)
T ss_dssp             HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred             hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence              00000     00000000        0111112233578899999999999999999999999873

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=345.86  Aligned_cols=283  Identities=18%  Similarity=0.200  Sum_probs=212.8

Q ss_pred             hcCCcccceecCCCceEEEEeeecccccc--CcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccce--------
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLRE--GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVK--------  140 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------  140 (389)
                      .++|++.+.||+|+||.||+|.+..+...  ...+..||+|++...      ..+.+|+.+++.++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            46899999999999999999987653110  002345999998754      24668999999999999987        


Q ss_pred             -------EEeEEEe-CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeE
Q 016481          141 -------LIGYCCE-DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  212 (389)
Q Consensus       141 -------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nil  212 (389)
                             +++++.. ....++||||+ +|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl  191 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIF  191 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEE
Confidence                   6777776 78899999999 999999998764457999999999999999999999977  999999999999


Q ss_pred             EcCCC--cEEEeccCCCcCCCCCCCc-----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCC
Q 016481          213 LDTDY--NAKLSDFGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKS  285 (389)
Q Consensus       213 i~~~~--~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~  285 (389)
                      ++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  8999999999866432211     1123357999999999999999999999999999999999999999865


Q ss_pred             CchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCCCCCCCC
Q 016481          286 RPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTP  365 (389)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~~~~~~p  365 (389)
                      ...... .........   ..........   ......+.++.+|+.+||+.||++|||+.+|++.|+.+..........
T Consensus       272 ~~~~~~-~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~  344 (352)
T 2jii_A          272 LPNTED-IMKQKQKFV---DKPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD  344 (352)
T ss_dssp             TTCHHH-HHHHHHHHH---HSCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             CcCHHH-HHHHHHhcc---CChhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence            422211 111111100   0011111100   001234688999999999999999999999999998886655544433


Q ss_pred             CCcc
Q 016481          366 KNFV  369 (389)
Q Consensus       366 ~~~~  369 (389)
                      ...|
T Consensus       345 ~~dw  348 (352)
T 2jii_A          345 PIGL  348 (352)
T ss_dssp             CCCC
T ss_pred             cccC
Confidence            3333

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.1e-45  Score=344.12  Aligned_cols=270  Identities=22%  Similarity=0.270  Sum_probs=206.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  148 (389)
                      ..+|++.+.||+|+||.||+|.+..+..      .||+|++...........+.+|+.+++.++||||+++++++...  
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKV------RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCe------EEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            4689999999999999999997655443      49999998765566667888999999999999999999999765  


Q ss_pred             ---CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          149 ---EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       149 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                         ...++||||+. |+|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCc
Confidence               47899999997 5899888654   6899999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCC-ccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh-H-HH
Q 016481          226 LAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL-P-LL  301 (389)
Q Consensus       226 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~-~~  301 (389)
                      ++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................ . ..
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9987643221 111234689999999998764 458999999999999999999999998765443221110000 0 00


Q ss_pred             Hhhh-----hhhhhc-CCCCCCCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          302 KEKK-----KLLNII-DPRLEGDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       302 ~~~~-----~~~~~~-~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ....     ...... ........     ....+.++.+|+.+||+.||++|||+.++++|-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            0000     000000 00000011     123467899999999999999999999999883

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.7e-44  Score=336.00  Aligned_cols=270  Identities=24%  Similarity=0.355  Sum_probs=210.2

Q ss_pred             ccCHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhc--cCCCcc
Q 016481           61 AFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH--LSHPNL  138 (389)
Q Consensus        61 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~--l~h~ni  138 (389)
                      .........+.++|++.+.||+|+||.||+|.+.        +..||+|++...    ....+..|..++..  ++||||
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni   98 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI   98 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTB
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEc--------CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcE
Confidence            3445555677889999999999999999999763        234999998643    34566778888877  789999


Q ss_pred             ceEEeEEEeCC----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceecCC
Q 016481          139 VKLIGYCCEDE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH--------EAEKPVIYRDF  206 (389)
Q Consensus       139 v~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~ivH~Dl  206 (389)
                      +++++++....    ..++||||+++|+|.+++...   .+++..+..++.|++.||+|||        +.+  |+||||
T Consensus        99 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dl  173 (342)
T 1b6c_B           99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDL  173 (342)
T ss_dssp             CCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCC
T ss_pred             EEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCC
Confidence            99999998876    899999999999999999764   6899999999999999999999        756  999999


Q ss_pred             CCCCeEEcCCCcEEEeccCCCcCCCCCCCcc--ccccccccccccCccccccCC------CCcccchhHHHHHHHHHHhC
Q 016481          207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSH--VSTRIMGTYGYAAPEYIMTGH------LTPRSDVYSFGVVLLEILTG  278 (389)
Q Consensus       207 kp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~------~~~~~DiwslG~il~elltg  278 (389)
                      ||+|||++.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++||||||+++|+|++|
T Consensus       174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            9999999999999999999997654332211  123457999999999997652      34689999999999999999


Q ss_pred             ----------CCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCC-----ChHHHHHHHHHHHHhhccCCCCCC
Q 016481          279 ----------RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDY-----PVKGVHKAAMLAYHCLNHNPKARP  343 (389)
Q Consensus       279 ----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rp  343 (389)
                                ..||......... ...+.          ............     .......+.+|+.+||+.||++||
T Consensus       254 ~~~~~~~~~~~~p~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  322 (342)
T 1b6c_B          254 CSIGGIHEDYQLPYYDLVPSDPS-VEEMR----------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL  322 (342)
T ss_dssp             BCBTTBCCCCCCTTTTTSCSSCC-HHHHH----------HHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred             cCcCCcccccccCccccCcCccc-HHHHH----------HHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC
Confidence                      6777654322110 00000          011111122222     236678899999999999999999


Q ss_pred             CHHHHHHHhccccCC
Q 016481          344 LMRDIVDSLEPLQVL  358 (389)
Q Consensus       344 s~~~il~~L~~~~~~  358 (389)
                      |+.+|+++|+.+..-
T Consensus       323 s~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          323 TALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHHHH
Confidence            999999999887543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.6e-45  Score=346.30  Aligned_cols=267  Identities=22%  Similarity=0.304  Sum_probs=197.9

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ....++|++.+.||+|+||.||+|.+..+.+      .||+|++.......     .+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~------~vAiK~~~~~~~~~-----~~E~~il~~l~hpnIv~l~~~~~~   71 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGK------RFALKKVLQDPRYK-----NRELDIMKVLDHVNIIKLVDYFYT   71 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCC------EEEEEEEECCTTSC-----CHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCC------EEEEEEEecCcchH-----HHHHHHHHHcCCCCccchhheeee
Confidence            3456789999999999999999998765544      39999887553222     269999999999999999999844


Q ss_pred             --------------------------------------CCeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHH
Q 016481          148 --------------------------------------DEHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGA  187 (389)
Q Consensus       148 --------------------------------------~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i  187 (389)
                                                            ...+++||||++ |+|.+.+..  .....+++..+..++.|+
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi  150 (383)
T 3eb0_A           72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQL  150 (383)
T ss_dssp             C-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred             cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence                                                  334899999997 577776643  233478999999999999


Q ss_pred             HHHHHHHHhCCCCceecCCCCCCeEEc-CCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccC-CCCcccch
Q 016481          188 AKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDV  265 (389)
Q Consensus       188 ~~~l~~LH~~~~~ivH~Dlkp~Nili~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Di  265 (389)
                      +.||+|||+.+  |+||||||+|||++ .++.+||+|||+++......   ......||+.|+|||++.+. .++.++||
T Consensus       151 ~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (383)
T 3eb0_A          151 FRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDL  225 (383)
T ss_dssp             HHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred             HHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence            99999999977  99999999999997 68899999999998764432   22345789999999998875 48999999


Q ss_pred             hHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh------HHHHhhhhhhhhc-----CCCCCCCCChHHHHHHHHHHHHh
Q 016481          266 YSFGVVLLEILTGRKSLDKSRPAREQNLADWAL------PLLKEKKKLLNII-----DPRLEGDYPVKGVHKAAMLAYHC  334 (389)
Q Consensus       266 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~c  334 (389)
                      |||||++|+|++|++||.+..............      .+...........     ...+...++...+.++.+|+.+|
T Consensus       226 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            999999999999999998765433211100000      0000000000000     00011112334567899999999


Q ss_pred             hccCCCCCCCHHHHHHH
Q 016481          335 LNHNPKARPLMRDIVDS  351 (389)
Q Consensus       335 l~~dP~~Rps~~~il~~  351 (389)
                      |+.||++|||+.++++|
T Consensus       306 L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          306 LRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CCSSGGGSCCHHHHHTS
T ss_pred             ccCChhhCCCHHHHhcC
Confidence            99999999999999977

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.3e-44  Score=365.64  Aligned_cols=252  Identities=26%  Similarity=0.376  Sum_probs=201.4

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  156 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (389)
                      +.||+|+||.||+|.+...    .....||||++.... .......+.+|+.+++.++||||+++++++. .+..++|||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS----SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCC----CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEE
Confidence            4799999999999965322    223449999987643 2334578899999999999999999999986 456899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCc
Q 016481          157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  236 (389)
Q Consensus       157 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~  236 (389)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++........
T Consensus       450 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          450 MAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             ccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            999999999997653  6899999999999999999999977  999999999999999999999999999876543221


Q ss_pred             -cccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          237 -HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       237 -~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                       .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........                 ...+...
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-----------------~~~i~~~  588 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----------------TAMLEKG  588 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------HHHHHTT
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHcC
Confidence             12233467889999999999999999999999999999998 9999987654321                 1111122


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .....+..++.++.+|+.+||+.||++||++.+|++.|+.+
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            22334556778999999999999999999999999999764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=332.02  Aligned_cols=255  Identities=25%  Similarity=0.327  Sum_probs=202.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      ...++|++.+.||+|+||.||+|.+..+.+      .||+|.+....   ....+.+|+.+++.++||||+++++++...
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   96 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQ------IVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKN   96 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCC------EEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCC------EEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            345789999999999999999998765443      39999987653   235677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.+||+|||++.
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~  173 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAG  173 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccch
Confidence            9999999999999999988643 236899999999999999999999977  9999999999999999999999999997


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........             ..
T Consensus       174 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~  238 (314)
T 3com_A          174 QLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-------------IP  238 (314)
T ss_dssp             ECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HH
T ss_pred             hhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------Hh
Confidence            654321  122345799999999999999999999999999999999999999986543221100             00


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ....  .....+...+..+.+|+.+||+.||++|||+.+++++-
T Consensus       239 ~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~  280 (314)
T 3com_A          239 TNPP--PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP  280 (314)
T ss_dssp             HSCC--CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             cCCC--cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence            0001  11112334568899999999999999999999999863

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=329.43  Aligned_cols=253  Identities=24%  Similarity=0.343  Sum_probs=200.2

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEE
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV  152 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  152 (389)
                      +|.....||+|+||.||+|.+..+..      .||+|.+.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQV------RIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCC------EEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCe------EEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence            34555699999999999998655443      49999987653 334567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-CCcEEEeccCCCcCC
Q 016481          153 LIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKDG  230 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-~~~vkl~Dfg~a~~~  230 (389)
                      +||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+  |+|+||||+||+++. ++.+||+|||++...
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            9999999999999987653 335678889999999999999999977  999999999999987 899999999999875


Q ss_pred             CCCCCccccccccccccccCccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .....  ......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||............        .   ..
T Consensus       174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~---~~  240 (295)
T 2clq_A          174 AGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK--------V---GM  240 (295)
T ss_dssp             CC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH--------H---HH
T ss_pred             CCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh--------h---cc
Confidence            43221  223457999999999997653  889999999999999999999999754322111000        0   00


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .    ......+...+.++.+|+.+||+.||++||++.+++++
T Consensus       241 ~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          241 F----KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             H----CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             c----cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0    11223344567889999999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.8e-44  Score=339.41  Aligned_cols=266  Identities=20%  Similarity=0.253  Sum_probs=195.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .++|++.+.||+|+||.||+|++..+.+      .||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILER------NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCc------eEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            4689999999999999999997655443      49999987543 3444567889999999999999999999997654


Q ss_pred             ------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          150 ------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       150 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                            ..++||||+++ +|.+.+..    .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEE
Confidence                  78999999974 78877742    5889999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH--------
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD--------  295 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--------  295 (389)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...........        
T Consensus       171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          171 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             eeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99998654321   2334679999999999999999999999999999999999999998765432111000        


Q ss_pred             -HH-------hHHHHhhhh-----hhhhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          296 -WA-------LPLLKEKKK-----LLNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       296 -~~-------~~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                       +.       .........     ...........   ......+.++.+|+.+||+.||++|||+.++++|-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence             00       000000000     00000000000   00123477899999999999999999999999883

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=338.18  Aligned_cols=279  Identities=24%  Similarity=0.311  Sum_probs=212.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  149 (389)
                      ..+|++.+.||+|+||.||+|.+...  ....+..||+|++.... ......+.+|+.+++.++||||+++++++...+ 
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPL--QDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTT--SSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccc--cCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            46799999999999999999975321  12234569999987653 345567889999999999999999999987644 


Q ss_pred             -eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          150 -HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       150 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                       .+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||++.
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchh
Confidence             7899999999999999987653 36899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCcc-ccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          229 DGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       229 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      ......... ......++..|+|||++.+..++.++||||||+++|+|++|..||................. ......+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  272 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHL  272 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCT-HHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccch-hhhHHHH
Confidence            765433211 12235678889999999998899999999999999999999999864311100000000000 0000011


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ...+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1222222222334566789999999999999999999999999998764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-44  Score=337.25  Aligned_cols=256  Identities=24%  Similarity=0.334  Sum_probs=198.0

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-------hhhHHHHHHHHHHHhccCCCccceE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-------YQGHREWLAEVIFLGHLSHPNLVKL  141 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~  141 (389)
                      .+.++|++.+.||+|+||.||+|.+..+.+.      ||+|++.....       ......+.+|+.+++.++||||+++
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   80 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKK------VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI   80 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcE------EEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence            3567899999999999999999987655443      99999865421       1223457789999999999999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc---
Q 016481          142 IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN---  218 (389)
Q Consensus       142 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~---  218 (389)
                      ++++.... .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+++  |+|+||||+|||++.++.   
T Consensus        81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~  155 (322)
T 2ycf_A           81 KNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCL  155 (322)
T ss_dssp             EEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCC
T ss_pred             eeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCe
Confidence            99987654 89999999999999988654  37899999999999999999999977  999999999999987654   


Q ss_pred             EEEeccCCCcCCCCCCCccccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH
Q 016481          219 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       219 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  295 (389)
                      +||+|||++.......   ......||+.|+|||++.   +..++.++|||||||++|+|++|..||........  +..
T Consensus       156 ~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~  230 (322)
T 2ycf_A          156 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD  230 (322)
T ss_dssp             EEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH
T ss_pred             EEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH
Confidence            9999999998754321   223457999999999974   56789999999999999999999999976543211  111


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .+    ....       ...........+..+.+|+.+||+.||++||++.++++|
T Consensus       231 ~~----~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          231 QI----TSGK-------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HH----HHTC-------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HH----HhCc-------cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            00    0000       000000011345789999999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-44  Score=329.12  Aligned_cols=252  Identities=25%  Similarity=0.325  Sum_probs=198.3

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ..++|++.+.||+|+||.||+|.+..+.+      .||+|++....  .......+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   82 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGH------KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST   82 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCc------eEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            45789999999999999999998765433      39999986432  11234567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+..++||||+++++|.+++....  .+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~  158 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLS  158 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccc
Confidence            999999999999999999987653  6889999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      .......   ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........   ..   . +..   
T Consensus       159 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~---~-~~~---  225 (276)
T 2h6d_A          159 NMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FK---K-IRG---  225 (276)
T ss_dssp             GCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---H-HHH---
T ss_pred             cccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HH---H-hhc---
Confidence            8764432   2234578999999999988766 6899999999999999999999986532211   00   0 000   


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                         .     ....+...+..+.+++.+||+.||++|||+.++++|-
T Consensus       226 ---~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~  263 (276)
T 2h6d_A          226 ---G-----VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHE  263 (276)
T ss_dssp             ---C-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred             ---C-----cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence               0     0112334567899999999999999999999999973

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.1e-44  Score=333.85  Aligned_cols=268  Identities=22%  Similarity=0.296  Sum_probs=207.6

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCC------ccceEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP------NLVKLI  142 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~  142 (389)
                      .+.++|++.+.||+|+||.||+|.+...     .+..||+|++...  ......+.+|+.+++.++|+      ++++++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKA-----GGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCC-----CCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            3467899999999999999999976321     2344999998753  34456677899999888765      499999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-------
Q 016481          143 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------  215 (389)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-------  215 (389)
                      +++...+..++||||+ +++|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.       
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEE
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEecccccccc
Confidence            9999999999999999 889999998776667899999999999999999999977  999999999999987       


Q ss_pred             ------------CCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCC
Q 016481          216 ------------DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD  283 (389)
Q Consensus       216 ------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~  283 (389)
                                  ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  235 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP  235 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence                        668999999999864332     234579999999999999999999999999999999999999998


Q ss_pred             CCCchhhhhhHHHHhH-----HHHhhh--------------------hhhhhcCCC-CCCCCChHHHHHHHHHHHHhhcc
Q 016481          284 KSRPAREQNLADWALP-----LLKEKK--------------------KLLNIIDPR-LEGDYPVKGVHKAAMLAYHCLNH  337 (389)
Q Consensus       284 ~~~~~~~~~~~~~~~~-----~~~~~~--------------------~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~  337 (389)
                      ................     ......                    .......+. .........+.++.+|+.+||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  315 (339)
T 1z57_A          236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY  315 (339)
T ss_dssp             CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence            7654432211111100     000000                    000000000 00112345678899999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 016481          338 NPKARPLMRDIVDS  351 (389)
Q Consensus       338 dP~~Rps~~~il~~  351 (389)
                      ||++|||+.++++|
T Consensus       316 dP~~Rpt~~ell~h  329 (339)
T 1z57_A          316 DPAKRITLREALKH  329 (339)
T ss_dssp             STTTSCCHHHHTTS
T ss_pred             CcccccCHHHHhcC
Confidence            99999999999977

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-44  Score=343.68  Aligned_cols=265  Identities=23%  Similarity=0.328  Sum_probs=187.5

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGL------RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTE------EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCC------EEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            35789999999999999999997655443      49999987543 344556788999999999999999999998654


Q ss_pred             ------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          149 ------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       149 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                            ...|+|+|++ +++|.+++..   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEe
Confidence                  5679999999 6899887754   36899999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH--
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--  299 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--  299 (389)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...............  
T Consensus       175 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  249 (367)
T 2fst_X          175 DFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  249 (367)
T ss_dssp             C--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             ecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999865332     234679999999999887 6789999999999999999999999987654332111100000  


Q ss_pred             ---HHH-----hhhhhhhhcCCCCCCCC---ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          300 ---LLK-----EKKKLLNIIDPRLEGDY---PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       300 ---~~~-----~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         ...     ........+.......+   ....+..+.+|+.+||+.||++|||+.++++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence               000     00000000100000000   11235789999999999999999999999988

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-43  Score=327.17  Aligned_cols=257  Identities=24%  Similarity=0.295  Sum_probs=206.9

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--------hhhHHHHHHHHHHHhccC-CCccc
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--------YQGHREWLAEVIFLGHLS-HPNLV  139 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv  139 (389)
                      .+.++|++.+.||+|+||.||+|.++.+.+      .||+|++.....        ......+.+|+.+++++. ||||+
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~   87 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCK------EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII   87 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCc------eEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            345789999999999999999998765544      399999875431        122356778999999996 99999


Q ss_pred             eEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcE
Q 016481          140 KLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNA  219 (389)
Q Consensus       140 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~v  219 (389)
                      ++++++......++||||+++++|.+++....  .+++..+..++.|++.||.|||+++  |+|+||||+||+++.++.+
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~  163 (298)
T 1phk_A           88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNI  163 (298)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCE
T ss_pred             eeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcE
Confidence            99999999999999999999999999987643  6899999999999999999999977  9999999999999999999


Q ss_pred             EEeccCCCcCCCCCCCccccccccccccccCccccc------cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 016481          220 KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIM------TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL  293 (389)
Q Consensus       220 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  293 (389)
                      ||+|||++.......   ......||+.|+|||++.      ...++.++||||||+++|+|++|+.||.........  
T Consensus       164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--  238 (298)
T 1phk_A          164 KLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--  238 (298)
T ss_dssp             EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--
T ss_pred             EEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH--
Confidence            999999998765432   233467999999999985      456889999999999999999999999765432110  


Q ss_pred             HHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          294 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                       .   . +..       .............+..+.+|+.+||+.||++|||+.++++|-
T Consensus       239 -~---~-~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (298)
T 1phk_A          239 -R---M-IMS-------GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP  285 (298)
T ss_dssp             -H---H-HHH-------TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             -H---H-Hhc-------CCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence             0   0 000       000111112235678899999999999999999999999763

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.9e-44  Score=348.24  Aligned_cols=263  Identities=19%  Similarity=0.232  Sum_probs=206.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCC-CccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||||++.......   .+..|+.+++.+.| ++|..+..++...
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~vAvK~~~~~~~~~---~~~~E~~il~~L~~~~~i~~i~~~~~~~   75 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE------EVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNVRWFGVEG   75 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCC------EEEEEEEETTCSSC---CHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCc------EEEEEEeccccccH---HHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence            35789999999999999999998665444      39999987654332   35679999999986 5666677777888


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE---cCCCcEEEeccC
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFG  225 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili---~~~~~vkl~Dfg  225 (389)
                      ...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+++  |+||||||+|||+   +.++.+||+|||
T Consensus        76 ~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFG  151 (483)
T 3sv0_A           76 DYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (483)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             CEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCC
Confidence            8999999999 899999886543 36899999999999999999999977  9999999999999   688999999999


Q ss_pred             CCcCCCCCCCc-----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          226 LAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       226 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      +++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+...
T Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (483)
T 3sv0_A          152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (483)
T ss_dssp             TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred             cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence            99876543221     1122568999999999999999999999999999999999999999876543322222111110


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ... .....+         ...++.++.+|+..||+.||++||++.+|++.|+.+
T Consensus       232 ~~~-~~~~~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          232 KVA-TSIEAL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHH-SCHHHH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ccc-ccHHHH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            000 000000         112357899999999999999999999999998776

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3e-44  Score=338.88  Aligned_cols=267  Identities=21%  Similarity=0.295  Sum_probs=204.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC-
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  148 (389)
                      +.++|.+.+.||+|+||.||+|.+..+.+      .||+|.+...........+.+|+.+++.++||||+++++++... 
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGE------IVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCc------EEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            35789999999999999999998765443      49999997665566667788999999999999999999988654 


Q ss_pred             ----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          149 ----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       149 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                          ...++||||+. |+|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCC
T ss_pred             cCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEec
Confidence                68899999997 6898888663   6899999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCcc--------ccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH
Q 016481          225 GLAKDGPEGDKSH--------VSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       225 g~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  295 (389)
                      |++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ 
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-  235 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI-  235 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-
Confidence            9998764322111        1123578999999998764 67899999999999999999999999876533211110 


Q ss_pred             HHhHHHHh--------------hhhhhhhcCCCCCC---CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          296 WALPLLKE--------------KKKLLNIIDPRLEG---DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       296 ~~~~~~~~--------------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        ......              .......+......   ......+.++.+|+.+||+.||++|||+.++++|
T Consensus       236 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          236 --FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             --HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              000000              00000000000000   0112456789999999999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=339.95  Aligned_cols=258  Identities=17%  Similarity=0.157  Sum_probs=202.8

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC---CCccceEEeEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYC  145 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~  145 (389)
                      +..++|.+.+.||+|+||.||+|.+... .....+..||+|++....    ..++..|+.+++.+.   |+||+.+++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDL-NDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCC-cccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            3456799999999999999999965332 223345569999997642    335567777777776   99999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-------
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSK---VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-------  215 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-------  215 (389)
                      ...+..++||||+++|+|.+++...   ....+++..+..++.|++.||+|||+.+  |+||||||+|||++.       
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC--
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccc
Confidence            9999999999999999999998642   2347999999999999999999999977  999999999999988       


Q ss_pred             ----CCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhh
Q 016481          216 ----DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ  291 (389)
Q Consensus       216 ----~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  291 (389)
                          ++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......  
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--  292 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--  292 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence                89999999999975443233334455789999999999999999999999999999999999999996432210  


Q ss_pred             hhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhccc
Q 016481          292 NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-LMRDIVDSLEPL  355 (389)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~~il~~L~~~  355 (389)
                                   ..    +...+. ..  .....+.+++..||+.+|.+|+ +++++.+.|+..
T Consensus       293 -------------~~----~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          293 -------------CK----PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             -------------EE----ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             -------------ee----echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                         00    111111 11  2356788999999999999985 778877777654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.7e-44  Score=364.48  Aligned_cols=264  Identities=24%  Similarity=0.357  Sum_probs=212.4

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      +.+..++|++.+.||+|+||.||+|.+.....   ....||+|.............+.+|+.+++.++||||+++++++.
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPEN---PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSS---CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCC---ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            34456789999999999999999998754322   245599999887666666678899999999999999999999984


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                       ++..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCC
Confidence             567899999999999999987653 36899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      ++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.........   ..    +.   
T Consensus       538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~----i~---  606 (656)
T 2j0j_A          538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GR----IE---  606 (656)
T ss_dssp             CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HH----HH---
T ss_pred             CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH----HH---
Confidence            987644322 12233567889999999999999999999999999999997 99999876433211   00    00   


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                             .......+..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       607 -------~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          607 -------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             -------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   0111223445678899999999999999999999999999876

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=339.05  Aligned_cols=271  Identities=23%  Similarity=0.363  Sum_probs=195.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHH--HhccCCCccceEEeEEEe-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF--LGHLSHPNLVKLIGYCCE-  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-  147 (389)
                      .++|++.+.||+|+||.||+|.+.        +..||+|++...    ....+..|..+  +..++|+||+++++.+.. 
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD--------ERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET--------TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEEC--------CeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence            468999999999999999999653        234999998643    22333344444  456899999999986543 


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceecCCCCCCeEEc
Q 016481          148 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA---------EKPVIYRDFKTSNILLD  214 (389)
Q Consensus       148 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---------~~~ivH~Dlkp~Nili~  214 (389)
                          ...+++||||+++|+|.+++...   ..++..+..++.|++.||+|||+.         +  |+||||||+|||++
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~  154 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK  154 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc
Confidence                23678999999999999999765   458888999999999999999997         6  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCC------ccccccccccccccCcccccc-------CCCCcccchhHHHHHHHHHHhCCCC
Q 016481          215 TDYNAKLSDFGLAKDGPEGDK------SHVSTRIMGTYGYAAPEYIMT-------GHLTPRSDVYSFGVVLLEILTGRKS  281 (389)
Q Consensus       215 ~~~~vkl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwslG~il~elltg~~p  281 (389)
                      .++.+||+|||++........      ........||+.|+|||++.+       ..++.++|||||||++|+|++|..|
T Consensus       155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  234 (336)
T 3g2f_A          155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD  234 (336)
T ss_dssp             TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred             CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence            999999999999986643211      112234579999999999987       4567789999999999999999777


Q ss_pred             CCCCCchhhh-hhHHH-H--hHHHHhhhhh--hhhcCCCCCCC--CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          282 LDKSRPAREQ-NLADW-A--LPLLKEKKKL--LNIIDPRLEGD--YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       282 f~~~~~~~~~-~~~~~-~--~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      |......... ..... .  .+........  .....+.+...  .....+.++.+|+.+||+.||++|||+.++++.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            6443222110 00000 0  0000000000  00011111111  12346778999999999999999999999999998


Q ss_pred             cccCC
Q 016481          354 PLQVL  358 (389)
Q Consensus       354 ~~~~~  358 (389)
                      .+...
T Consensus       315 ~ll~~  319 (336)
T 3g2f_A          315 ELMMI  319 (336)
T ss_dssp             HHHHC
T ss_pred             HHHHH
Confidence            87543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.1e-45  Score=346.74  Aligned_cols=256  Identities=13%  Similarity=0.047  Sum_probs=184.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhcc--CCCccceEE-----
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHL--SHPNLVKLI-----  142 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l--~h~niv~~~-----  142 (389)
                      .+|.+.+.||+|+||.||+|.+..+.+      .||+|++.....  ......+.+|+.+++.+  +||||++++     
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~  135 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLE------DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL  135 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCc------eeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEe
Confidence            458999999999999999998765544      499999887643  23345666775544444  699988755     


Q ss_pred             --eEEEeC-----------------CeEEEEEEecCCCChhhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhC
Q 016481          143 --GYCCED-----------------EHRVLIYEFMARGSVENNLFSKVLLPLPWSIR------MKIAFGAAKGLAFLHEA  197 (389)
Q Consensus       143 --~~~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~  197 (389)
                        +++...                 ..+|+||||++ |+|.+++..... .+....+      ..++.|++.||+|||++
T Consensus       136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~  213 (371)
T 3q60_A          136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK  213 (371)
T ss_dssp             CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence              555443                 33899999998 899999876422 2344444      67779999999999997


Q ss_pred             CCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCcccccc--CCCCcccchhHHHHHHHHH
Q 016481          198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEI  275 (389)
Q Consensus       198 ~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwslG~il~el  275 (389)
                      +  |+||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..|+.++|||||||++|+|
T Consensus       214 ~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el  286 (371)
T 3q60_A          214 G--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV  286 (371)
T ss_dssp             T--EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred             C--CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence            7  999999999999999999999999999865321     113457799999999987  6799999999999999999


Q ss_pred             HhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          276 LTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       276 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ++|+.||....+.....+..         ...................+..+.+|+.+||+.||++|||+.++++|
T Consensus       287 ltg~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          287 WCLFLPFGLVTPGIKGSWKR---------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             HHSSCSTTBCCTTCTTCCCB---------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             HhCCCCCCCcCcccccchhh---------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            99999998764332111000         00001111111122223567899999999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.9e-44  Score=338.07  Aligned_cols=266  Identities=18%  Similarity=0.226  Sum_probs=202.3

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-----------CCccc
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-----------HPNLV  139 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv  139 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++...  ......+.+|+.+++.+.           |+||+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~   89 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNT------HVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL   89 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCc------EEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence            4689999999999999999998655443      4999998753  334456778999998876           89999


Q ss_pred             eEEeEEEeCC----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCeEEc
Q 016481          140 KLIGYCCEDE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLD  214 (389)
Q Consensus       140 ~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~Dlkp~Nili~  214 (389)
                      ++++++...+    .+++||||+ +++|.+++.......+++..+..++.|++.||+|||++ +  |+||||||+|||++
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~  166 (373)
T 1q8y_A           90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLME  166 (373)
T ss_dssp             CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEE
T ss_pred             HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEe
Confidence            9999987654    789999999 88999999876666799999999999999999999996 7  99999999999994


Q ss_pred             ------CCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCch
Q 016481          215 ------TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPA  288 (389)
Q Consensus       215 ------~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  288 (389)
                            ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence                  4458999999999865432     23357899999999999999999999999999999999999999865432


Q ss_pred             hhhhhHHHHhHHHHhhh-----------hhhhhcCC-------------------CCCCCCChHHHHHHHHHHHHhhccC
Q 016481          289 REQNLADWALPLLKEKK-----------KLLNIIDP-------------------RLEGDYPVKGVHKAAMLAYHCLNHN  338 (389)
Q Consensus       289 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~d  338 (389)
                      .................           .....+..                   .....++...+.++.+|+.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  321 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  321 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence            11111111111000000           00000000                   0011345677899999999999999


Q ss_pred             CCCCCCHHHHHHHh
Q 016481          339 PKARPLMRDIVDSL  352 (389)
Q Consensus       339 P~~Rps~~~il~~L  352 (389)
                      |++|||+.++++|-
T Consensus       322 P~~Rpt~~ell~hp  335 (373)
T 1q8y_A          322 PRKRADAGGLVNHP  335 (373)
T ss_dssp             TTTCBCHHHHHTCG
T ss_pred             ccccCCHHHHhhCh
Confidence            99999999999974

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-43  Score=337.30  Aligned_cols=270  Identities=22%  Similarity=0.247  Sum_probs=205.7

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CC-----ccceEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HP-----NLVKLI  142 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~  142 (389)
                      .+.++|++.+.||+|+||.||+|.+..+.+      .||+|++...  ......+..|+.+++.+. |+     +|+.++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQE------WVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTE------EEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCc------EEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            346799999999999999999998665443      4999999753  334456677888888875 54     499999


Q ss_pred             eEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc--CCCcEE
Q 016481          143 GYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD--TDYNAK  220 (389)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~--~~~~vk  220 (389)
                      +++...+..++||||+. |+|.+++.......+++..+..++.|++.||.|||.+..+|+||||||+|||++  .++.+|
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence            99999999999999996 599999987766679999999999999999999996545599999999999994  578899


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh--
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--  298 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--  298 (389)
                      |+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||................  
T Consensus       202 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  276 (382)
T 2vx3_A          202 IVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI  276 (382)
T ss_dssp             ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             EEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999999876432     234679999999999999999999999999999999999999998765433211110000  


Q ss_pred             ---HHHHhhhhhhhhcCCC----------------C-------------------------CCCCChHHHHHHHHHHHHh
Q 016481          299 ---PLLKEKKKLLNIIDPR----------------L-------------------------EGDYPVKGVHKAAMLAYHC  334 (389)
Q Consensus       299 ---~~~~~~~~~~~~~~~~----------------~-------------------------~~~~~~~~~~~l~~li~~c  334 (389)
                         ............+...                .                         ..........++.+|+.+|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  356 (382)
T 2vx3_A          277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM  356 (382)
T ss_dssp             CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence               0000000000000000                0                         0001123346899999999


Q ss_pred             hccCCCCCCCHHHHHHHh
Q 016481          335 LNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       335 l~~dP~~Rps~~~il~~L  352 (389)
                      |+.||++|||+.++|+|-
T Consensus       357 L~~dP~~Rpta~e~L~hp  374 (382)
T 2vx3_A          357 LDYDPKTRIQPYYALQHS  374 (382)
T ss_dssp             TCSCTTTSCCHHHHTTSG
T ss_pred             cCCChhhCCCHHHHhcCc
Confidence            999999999999999873

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.9e-44  Score=343.13  Aligned_cols=262  Identities=24%  Similarity=0.350  Sum_probs=195.4

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED--  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  148 (389)
                      ..+|++.+.||+|+||.||+|++..+.+      .||||++......     ..+|+.+++.++||||+++++++...  
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~------~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~  121 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGE------LVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGE  121 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCc------EEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCC
Confidence            3479999999999999999998765443      3999998654322     23699999999999999999988542  


Q ss_pred             ----CeEEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC-CcEEE
Q 016481          149 ----EHRVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKL  221 (389)
Q Consensus       149 ----~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~-~~vkl  221 (389)
                          ..+++||||+++ +|.+.+..  .....+++..+..++.|++.||+|||+++  |+||||||+|||++.+ +.+||
T Consensus       122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl  198 (420)
T 1j1b_A          122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKL  198 (420)
T ss_dssp             TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEE
T ss_pred             CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEe
Confidence                246799999975 66655532  23347899999999999999999999977  9999999999999955 67899


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      +|||+++.......   .....||+.|+|||++.+. .|+.++|||||||++|||++|++||.+......  +.......
T Consensus       199 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~l  273 (420)
T 1j1b_A          199 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVL  273 (420)
T ss_dssp             CCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHH
T ss_pred             ccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHh
Confidence            99999987644322   2345789999999999765 799999999999999999999999987654321  11111100


Q ss_pred             HHhhhhhhhhcCCC--------CCC-----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKEKKKLLNIIDPR--------LEG-----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~~~~~~~~~~~~--------~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .....+......+.        ...     .++...+.++.+|+.+||+.||++|||+.++++|
T Consensus       274 g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            00000000001110        000     0123446889999999999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-45  Score=343.77  Aligned_cols=262  Identities=26%  Similarity=0.293  Sum_probs=204.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC---ChhhHHHHHHHHHHHhcc-CCCccceEEeEEE
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCC  146 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  146 (389)
                      .++|++.+.||+|+||.||+|+....   ...+..||+|++....   .......+.+|+.+++.+ .||||+++++++.
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISG---HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSS---TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             ccceEEEEEeccCCCEEEEEEEEccc---CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            36899999999999999999976431   1234559999986432   112223455799999999 6999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      ....+++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCC
Confidence            9999999999999999999987653  6899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      ++...... .......+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||........  .........   
T Consensus       206 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~---  279 (355)
T 1vzo_A          206 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRIL---  279 (355)
T ss_dssp             EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHH---
T ss_pred             CeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHh---
Confidence            98654322 122334679999999999986  3578999999999999999999999975432211  111110000   


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHhcc
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDSLEP  354 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~L~~  354 (389)
                             .  ....++...+..+.+|+.+||+.||++||     ++.++++|..-
T Consensus       280 -------~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f  325 (355)
T 1vzo_A          280 -------K--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  325 (355)
T ss_dssp             -------H--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             -------c--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence                   0  01223445668899999999999999999     99999998643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6e-44  Score=333.44  Aligned_cols=257  Identities=26%  Similarity=0.333  Sum_probs=183.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHH-HHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI-FLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++...........+..|+. +++.++||||+++++++...+
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQ------IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG   94 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTE------EEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCC------EEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence            4789999999999999999998765443      499999987655555556666666 677789999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          150 HRVLIYEFMARGSVENNLF---SKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      ..++||||+.+ +|.+++.   ......+++..+..++.|++.||.|||+. +  |+|+||||+||+++.++.+||+|||
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCC
Confidence            99999999975 7776664   23345789999999999999999999997 7  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCcccc----ccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHH
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYI----MTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      ++.......   ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||.........          
T Consensus       172 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------  238 (327)
T 3aln_A          172 ISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ----------  238 (327)
T ss_dssp             SSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------
T ss_pred             Cceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH----------
Confidence            998764322   12234799999999998    4667899999999999999999999999864321100          


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                        .........+.+........+..+.+|+.+||+.||++|||+.+++++
T Consensus       239 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          239 --LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             ---CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence              000111111112222223457889999999999999999999999876

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-43  Score=329.57  Aligned_cols=258  Identities=22%  Similarity=0.316  Sum_probs=201.3

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccC--CCccceEEeE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLS--HPNLVKLIGY  144 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~niv~~~~~  144 (389)
                      .+...+|++.+.||+|+||.||+|.+..       +..||+|++.... .......+.+|+.+++.+.  |+||++++++
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTT-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcCC-------CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            3456789999999999999999997543       2349999987543 3445677889999999997  5999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                      +...+..++||| +.+++|.+++....  .+++..+..++.|++.||.|||+.+  |+|+||||+||+++. +.+||+||
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Df  170 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDF  170 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeec
Confidence            999999999999 55789999987654  6889999999999999999999977  999999999999965 89999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCcccccc-----------CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-----------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL  293 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  293 (389)
                      |++................||+.|+|||++.+           ..++.++||||||+++|+|++|+.||........   
T Consensus       171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---  247 (313)
T 3cek_A          171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---  247 (313)
T ss_dssp             SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---
T ss_pred             cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---
Confidence            99987654333223344679999999999875           4688899999999999999999999976532211   


Q ss_pred             HHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          294 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                                  .+...++......++...+.++.+|+.+||+.||++|||+.+++++-.
T Consensus       248 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~  295 (313)
T 3cek_A          248 ------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  295 (313)
T ss_dssp             ------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence                        111222333333334445678999999999999999999999998743

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.3e-44  Score=332.27  Aligned_cols=255  Identities=24%  Similarity=0.339  Sum_probs=200.1

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||.||+|.+..+..      .||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGA------LAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCC------EEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCc------EEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence            35689999999999999999998765443      39999987543 334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.+||+|||++..
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            9999999999999998876532 36899999999999999999999977  99999999999999999999999998653


Q ss_pred             CCCCCCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      ....  ........||+.|+|||++.     +..++.++||||||+++|+|++|+.||.........      ....   
T Consensus       167 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~---  235 (302)
T 2j7t_A          167 NLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIA---  235 (302)
T ss_dssp             HHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHH---
T ss_pred             cccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHh---
Confidence            2110  01122357899999999984     667899999999999999999999999876432110      0000   


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                          ...  ......+...+..+.+|+.+||+.||++|||+.++++|
T Consensus       236 ----~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          236 ----KSD--PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ----HSC--CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ----ccC--CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                000  00111234557889999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.9e-45  Score=349.20  Aligned_cols=244  Identities=16%  Similarity=0.133  Sum_probs=189.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCC--CChhhHHHHHHHHH---HHhccCCCccceEE---
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD--NSYQGHREWLAEVI---FLGHLSHPNLVKLI---  142 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~---~l~~l~h~niv~~~---  142 (389)
                      .++|++.+.||+|+||.||+|++..+.+      .||+|++...  ........+.+|+.   +++.++||||++++   
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGE------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCC------EEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCc------EEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            4679999999999999999998655433      4999998643  23344567889994   45555799999998   


Q ss_pred             ----eEEEeCC-----------------eEEEEEEecCCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHh
Q 016481          143 ----GYCCEDE-----------------HRVLIYEFMARGSVENNLFSKVL-----LPLPWSIRMKIAFGAAKGLAFLHE  196 (389)
Q Consensus       143 ----~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~  196 (389)
                          +++...+                 ..|+||||+ +|+|.+++.....     ..+++..+..++.|++.||+|||+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence                6666553                 389999999 6899999865421     123357788899999999999999


Q ss_pred             CCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccC-----------CCCcccch
Q 016481          197 AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-----------HLTPRSDV  265 (389)
Q Consensus       197 ~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~~Di  265 (389)
                      ++  |+||||||+|||++.++.+||+|||+++....     .....+| +.|+|||++.+.           .|+.++||
T Consensus       225 ~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          225 YG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             TT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             CC--eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            77  99999999999999999999999999986322     2334577 999999999887           89999999


Q ss_pred             hHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCH
Q 016481          266 YSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLM  345 (389)
Q Consensus       266 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  345 (389)
                      |||||++|+|++|+.||........                ...+.. .     ...++.++.+|+.+||+.||++|||+
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGG----------------SEWIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CC----------------SGGGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccc----------------hhhhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            9999999999999999976432211                011111 0     12345789999999999999999999


Q ss_pred             HHHHHH
Q 016481          346 RDIVDS  351 (389)
Q Consensus       346 ~~il~~  351 (389)
                      .++++|
T Consensus       355 ~e~l~h  360 (377)
T 3byv_A          355 LQAMET  360 (377)
T ss_dssp             HHHHTS
T ss_pred             HHHhhC
Confidence            999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.8e-44  Score=343.31  Aligned_cols=270  Identities=23%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  149 (389)
                      ..+|++.+.||+|+||.||+|++..+..       ||+|.+.......     .+|+.+++.++||||+++++++...+ 
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-------~aikk~~~~~~~~-----~~E~~il~~l~h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-------VAIKKVLQDKRFK-----NRELQIMRIVKHPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-------EEEEEEECCTTSC-----CHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-------EEEEEEecCcchH-----HHHHHHHHhCCCCCcceEEEEEEecCC
Confidence            4579999999999999999998655432       7888765443222     26999999999999999999986544 


Q ss_pred             -----eEEEEEEecCCCChhhhhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc-CCCcEEE
Q 016481          150 -----HRVLIYEFMARGSVENNLF--SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKL  221 (389)
Q Consensus       150 -----~~~lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~-~~~~vkl  221 (389)
                           .+++||||++++ +...+.  ......+++..+..++.|++.||+|||+++  |+||||||+|||++ .++.+||
T Consensus       107 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL  183 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKL  183 (394)
T ss_dssp             SSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEE
T ss_pred             CCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEE
Confidence                 388999999864 443332  122347899999999999999999999977  99999999999999 7999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh--
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--  298 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--  298 (389)
                      +|||+++.......   .....||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+..............  
T Consensus       184 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  260 (394)
T 4e7w_A          184 IDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT  260 (394)
T ss_dssp             CCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             eeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999987644332   2345789999999998765 58999999999999999999999998765432211100000  


Q ss_pred             HHHHhh-hhhhhhcCCCCCC--------CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccCC
Q 016481          299 PLLKEK-KKLLNIIDPRLEG--------DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  358 (389)
Q Consensus       299 ~~~~~~-~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~~  358 (389)
                      +..... ..........+..        .++...+.++.+|+.+||+.||++|||+.++++|  +..+...
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            000000 0000111111110        1122356789999999999999999999999988  5555443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2e-43  Score=335.75  Aligned_cols=264  Identities=22%  Similarity=0.301  Sum_probs=200.0

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|.+.+.||+|+||.||+|.+..+.+      .||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  113 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGE------KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA  113 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCC------EEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence            45789999999999999999998765544      39999987653 334456788999999999999999999999877


Q ss_pred             CeE------EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          149 EHR------VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       149 ~~~------~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                      +..      ++||||+. ++|.+.+.    ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~  186 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKIL  186 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEEC
T ss_pred             CCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEE
Confidence            655      99999997 58877663    25899999999999999999999977  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH--
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--  299 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--  299 (389)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................  
T Consensus       187 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  261 (371)
T 4exu_A          187 DFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  261 (371)
T ss_dssp             STTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999865332     234578999999999987 7889999999999999999999999987654322111000000  


Q ss_pred             ---HH-----HhhhhhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          300 ---LL-----KEKKKLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       300 ---~~-----~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         ..     .........+.......   .....+..+.+|+.+||+.||++|||+.++++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence               00     00000001111111100   112346889999999999999999999999988

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.6e-44  Score=339.65  Aligned_cols=274  Identities=23%  Similarity=0.304  Sum_probs=199.6

Q ss_pred             HHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC----------hhhHHHHHHHHHHHhcc
Q 016481           64 YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS----------YQGHREWLAEVIFLGHL  133 (389)
Q Consensus        64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~E~~~l~~l  133 (389)
                      ..++..+.++|++.+.||+|+||.||+|....       +..||+|++.....          ......+.+|+.+++.+
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   86 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF   86 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCC-------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC
Confidence            45667788999999999999999999997543       34499998754322          12236788999999999


Q ss_pred             CCCccceEEeEEEe-----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCC
Q 016481          134 SHPNLVKLIGYCCE-----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKT  208 (389)
Q Consensus       134 ~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp  208 (389)
                      +||||+++++++..     ...+++||||+. |+|.+.+... ...+++..+..++.|++.||.|||+++  |+|+||||
T Consensus        87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp  162 (362)
T 3pg1_A           87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHP  162 (362)
T ss_dssp             CCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred             CCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCCh
Confidence            99999999999854     336899999997 6888887654 346899999999999999999999977  99999999


Q ss_pred             CCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCc
Q 016481          209 SNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRP  287 (389)
Q Consensus       209 ~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~  287 (389)
                      +|||++.++.+||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             GGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             HHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999997543322   2334678999999999887 6789999999999999999999999987654


Q ss_pred             hhhhhhH-HHHh-HHH-----HhhhhhhhhcCCCCC---C----CCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          288 AREQNLA-DWAL-PLL-----KEKKKLLNIIDPRLE---G----DYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       288 ~~~~~~~-~~~~-~~~-----~~~~~~~~~~~~~~~---~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ....... .... +..     .........+.....   .    ......+..+.+|+.+||+.||++|||+.++++|
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            3221110 0000 000     000000111111110   0    0112346779999999999999999999999988

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.5e-44  Score=336.98  Aligned_cols=262  Identities=19%  Similarity=0.211  Sum_probs=204.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh----------------hhHHHHHHHHHHHhccC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY----------------QGHREWLAEVIFLGHLS  134 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~E~~~l~~l~  134 (389)
                      .++|++.+.||+|+||.||+|.+  +      +..||+|.+......                .....+.+|+.+++.++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--D------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--T------TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--C------CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            46899999999999999999976  2      234999997643111                11267889999999999


Q ss_pred             CCccceEEeEEEeCCeEEEEEEecCCCChhhh------hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCC
Q 016481          135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENN------LFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFK  207 (389)
Q Consensus       135 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlk  207 (389)
                      ||||+++++++.+.+..++||||+++|+|.++      +.......+++..+..++.|++.||+|||+ .+  |+|+|||
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~  179 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVK  179 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCC
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCC
Confidence            99999999999999999999999999999998      655445689999999999999999999998 88  9999999


Q ss_pred             CCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccC-CCCc-ccchhHHHHHHHHHHhCCCCCCCC
Q 016481          208 TSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTP-RSDVYSFGVVLLEILTGRKSLDKS  285 (389)
Q Consensus       208 p~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~~DiwslG~il~elltg~~pf~~~  285 (389)
                      |+||+++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++||||||+++|+|++|+.||...
T Consensus       180 p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          180 PSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999875432    23346799999999999877 6666 999999999999999999999876


Q ss_pred             CchhhhhhHHHHhHHHHhhhhhhh----hcC---CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          286 RPAREQNLADWALPLLKEKKKLLN----IID---PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .....  ....+.   ........    ...   ...........+..+.+|+.+||+.||++|||+.++++|
T Consensus       256 ~~~~~--~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          256 ISLVE--LFNNIR---TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             SCSHH--HHHHHT---SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CcHHH--HHHHHh---ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            54211  110000   00000000    000   000000113456889999999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.9e-43  Score=330.37  Aligned_cols=267  Identities=20%  Similarity=0.241  Sum_probs=205.7

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc------cceEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN------LVKLIG  143 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~  143 (389)
                      +.++|++.+.||+|+||.||+|.+..+.     +..||+|++...  ......+.+|+.+++.+.|++      ++.+++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARG-----KSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTT-----TEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCC-----ceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            4678999999999999999999865443     134999998753  344566778999999987655      899999


Q ss_pred             EEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE----------
Q 016481          144 YCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----------  213 (389)
Q Consensus       144 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili----------  213 (389)
                      ++...+..++||||+ +++|.+.+.......+++..+..++.|++.||+|||+++  |+||||||+|||+          
T Consensus        90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccc
Confidence            999999999999999 678888887766567999999999999999999999977  9999999999999          


Q ss_pred             ---------cCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCC
Q 016481          214 ---------DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDK  284 (389)
Q Consensus       214 ---------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~  284 (389)
                               +.++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                     56789999999999864332     2345799999999999999999999999999999999999999987


Q ss_pred             CCchhhhhhHHHHhH-----HHHhhhh--------------------hhhhcCCC-CCCCCChHHHHHHHHHHHHhhccC
Q 016481          285 SRPAREQNLADWALP-----LLKEKKK--------------------LLNIIDPR-LEGDYPVKGVHKAAMLAYHCLNHN  338 (389)
Q Consensus       285 ~~~~~~~~~~~~~~~-----~~~~~~~--------------------~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~d  338 (389)
                      ...............     +......                    ......+. .........+.++.+|+.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            654332111111000     0000000                    00000000 000112345678999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 016481          339 PKARPLMRDIVDS  351 (389)
Q Consensus       339 P~~Rps~~~il~~  351 (389)
                      |++|||+.++++|
T Consensus       322 P~~Rpt~~e~l~h  334 (355)
T 2eu9_A          322 PAQRITLAEALLH  334 (355)
T ss_dssp             TTTSCCHHHHTTS
T ss_pred             hhhCcCHHHHhcC
Confidence            9999999999977

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.8e-43  Score=329.82  Aligned_cols=268  Identities=23%  Similarity=0.308  Sum_probs=202.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhcc---CCCccceEEeEE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHL---SHPNLVKLIGYC  145 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~  145 (389)
                      ..++|++.+.||+|+||.||+|.+...     .+..||+|++..... ......+.+|+.+++.+   .||||+++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCC-----CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            347899999999999999999976421     123499998764321 11122345677776666   899999999998


Q ss_pred             E-----eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEE
Q 016481          146 C-----EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAK  220 (389)
Q Consensus       146 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vk  220 (389)
                      .     .....++||||+. |+|.+++.......+++..+..++.|++.||.|||+++  |+|+||||+||+++.++.+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred             eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEE
Confidence            7     5568899999997 69999988766667999999999999999999999977  99999999999999999999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |+|||++......   .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........   .+...
T Consensus       161 l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~  234 (326)
T 1blx_A          161 LADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDV  234 (326)
T ss_dssp             ECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHH
T ss_pred             EecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHH
Confidence            9999999865432   12334678999999999999999999999999999999999999998765432111   11000


Q ss_pred             HHh--hhhhhh-------hcCC---CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKE--KKKLLN-------IIDP---RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~--~~~~~~-------~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ...  ......       ....   ..........+..+.+|+.+||+.||++|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000  000000       0000   00011223457889999999999999999999999977

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6e-43  Score=330.83  Aligned_cols=276  Identities=24%  Similarity=0.294  Sum_probs=192.9

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      .....++|++.+.||+|+||.||+|.+..+..      .||+|++......  .....+++..++.++||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGM------SVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCC------EEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            44556899999999999999999998765443      3999988654322  234556788888899999999999987


Q ss_pred             eCCe-------EEEEEEecCCCChhhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceecCCCCCCeEEcC
Q 016481          147 EDEH-------RVLIYEFMARGSVENNLFS--KVLLPLPWSIRMKIAFGAAKGLAFLH--EAEKPVIYRDFKTSNILLDT  215 (389)
Q Consensus       147 ~~~~-------~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~~ivH~Dlkp~Nili~~  215 (389)
                      ..+.       +++||||+++ +|...+..  .....+++..+..++.|++.||.|||  +.+  |+||||||+|||++.
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNE  166 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEET
T ss_pred             ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeC
Confidence            6443       8899999986 55444432  23447889999999999999999999  655  999999999999996


Q ss_pred             -CCcEEEeccCCCcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhh
Q 016481          216 -DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNL  293 (389)
Q Consensus       216 -~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  293 (389)
                       ++.+||+|||++........   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  243 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE  243 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence             89999999999987654332   2345789999999998765 489999999999999999999999987654322111


Q ss_pred             HHHHhHHHHhhhhhhhhcCCCC----------------CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccc
Q 016481          294 ADWALPLLKEKKKLLNIIDPRL----------------EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPL  355 (389)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~  355 (389)
                        ...............+.+..                ........+.++.+|+.+||+.||++|||+.++++|  |..+
T Consensus       244 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          244 --IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             --HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             --HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence              11000000000000010000                011122357889999999999999999999999988  5555


Q ss_pred             cCC
Q 016481          356 QVL  358 (389)
Q Consensus       356 ~~~  358 (389)
                      ...
T Consensus       322 ~~~  324 (360)
T 3e3p_A          322 HDP  324 (360)
T ss_dssp             GCT
T ss_pred             CCc
Confidence            443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-43  Score=325.04  Aligned_cols=256  Identities=23%  Similarity=0.298  Sum_probs=204.4

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      ..+.++|++.+.||+|+||.||+|....+.+      .||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQ------EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCc------EEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            4556799999999999999999998655433      39999986432 2334567889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC---CcEEEec
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD---YNAKLSD  223 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~---~~vkl~D  223 (389)
                      .....++||||+.+++|.+.+....  .+++..+..++.|++.||.|||+.+  |+|+||||+||+++.+   +.+||+|
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEec
Confidence            9999999999999999998886543  6899999999999999999999977  9999999999999754   4699999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      ||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.........   .   . +..
T Consensus       168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~---~-~~~  236 (287)
T 2wei_A          168 FGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---K---R-VET  236 (287)
T ss_dssp             TTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H-HHH
T ss_pred             cCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH---H---H-HHc
Confidence            999886543221   223468999999998876 4899999999999999999999999875432110   0   0 000


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .       ............+.++.+++.+||+.||++|||+.+++++
T Consensus       237 ~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          237 G-------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             C-------CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             C-------CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            0       0000001112346789999999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-43  Score=325.61  Aligned_cols=257  Identities=25%  Similarity=0.361  Sum_probs=196.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe--
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  147 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|++...  ......+.+|+.+++.++||||+++++++.+  
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSR------YYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERR   75 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCe------EEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence            35689999999999999999998655443      3999998642  3445678899999999999999999998865  


Q ss_pred             -----------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          148 -----------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       148 -----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                                 ....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+|+||||+||+++.+
T Consensus        76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~  152 (303)
T 1zy4_A           76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES  152 (303)
T ss_dssp             CCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT
T ss_pred             chhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCC
Confidence                       457899999999999999997643 35788899999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCC------------ccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCC
Q 016481          217 YNAKLSDFGLAKDGPEGDK------------SHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLD  283 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~  283 (389)
                      +.+||+|||++........            ........||+.|+|||++.+. .++.++||||||+++|+|++   ||.
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence            9999999999986543210            1122345799999999999865 68999999999999999998   554


Q ss_pred             CCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          284 KSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      ....  ....   ...        .......+....+...+..+.+|+.+||+.||++|||+.+++++-+
T Consensus       230 ~~~~--~~~~---~~~--------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  286 (303)
T 1zy4_A          230 TGME--RVNI---LKK--------LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW  286 (303)
T ss_dssp             SHHH--HHHH---HHH--------HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred             Cchh--HHHH---HHh--------ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence            2111  0000   000        0111122233344556678999999999999999999999998743

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=339.55  Aligned_cols=274  Identities=22%  Similarity=0.285  Sum_probs=184.8

Q ss_pred             hcCCcc-cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe--
Q 016481           71 TANFRQ-DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  147 (389)
Q Consensus        71 ~~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  147 (389)
                      .+.|.+ +++||+|+||.||+|+++..    ..+..||+|++......   ..+.+|+.+++.++||||+++++++..  
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~----~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDG----KDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSS----SCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccC----CCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            345766 56899999999999986532    12344999998755322   356789999999999999999999965  


Q ss_pred             CCeEEEEEEecCCCChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE----cCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSK-------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL----DTD  216 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili----~~~  216 (389)
                      ...+++||||+. |+|.+.+...       ....+++..+..++.|++.||+|||+++  |+||||||+|||+    +.+
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTT
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCC
Confidence            678999999996 5787776421       2235899999999999999999999977  9999999999999    677


Q ss_pred             CcEEEeccCCCcCCCCCCC-ccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhh---
Q 016481          217 YNAKLSDFGLAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ---  291 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---  291 (389)
                      +.+||+|||+++....... .......+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.........   
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence            8999999999987643221 1223346899999999999874 5899999999999999999999999765432100   


Q ss_pred             ---hhHHHHhHHHH--------------hhhhhhhhcCCCCCCC---------CChHHHHHHHHHHHHhhccCCCCCCCH
Q 016481          292 ---NLADWALPLLK--------------EKKKLLNIIDPRLEGD---------YPVKGVHKAAMLAYHCLNHNPKARPLM  345 (389)
Q Consensus       292 ---~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~  345 (389)
                         .....+...+.              ........+.......         .....+..+.+||.+||+.||.+|||+
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence               00000000000              0000000000000000         000114678899999999999999999


Q ss_pred             HHHHHHhcc
Q 016481          346 RDIVDSLEP  354 (389)
Q Consensus       346 ~~il~~L~~  354 (389)
                      .++|+|-+-
T Consensus       329 ~e~L~hp~f  337 (405)
T 3rgf_A          329 EQAMQDPYF  337 (405)
T ss_dssp             HHHHTSGGG
T ss_pred             HHHhcChhh
Confidence            999998543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=328.91  Aligned_cols=260  Identities=22%  Similarity=0.303  Sum_probs=199.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .++|.+.+.||+|+||.||+|.+..+.+      .||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGE------KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCC------EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            4689999999999999999998765444      39999987643 3344567889999999999999999999998765


Q ss_pred             e------EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          150 H------RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       150 ~------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      .      .++||||+. |+|.+.+.    ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECS
T ss_pred             ccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEee
Confidence            4      499999997 58877663    25899999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      ||++......     .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........   +.....
T Consensus       170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~  241 (353)
T 3coi_A          170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ---ILKVTG  241 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHH---HHHHHC
T ss_pred             cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhC
Confidence            9999864322     233578999999999887 6789999999999999999999999987654321111   000000


Q ss_pred             h-------------hhhhhhhcCCCCC---CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          303 E-------------KKKLLNIIDPRLE---GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       303 ~-------------~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .             .......+.....   .......+.++.+|+.+||+.||++|||+.++++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0             0000011111111   11223557889999999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-43  Score=332.39  Aligned_cols=257  Identities=19%  Similarity=0.222  Sum_probs=177.5

Q ss_pred             HhcCCcccc-eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe-
Q 016481           70 ITANFRQDR-VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-  147 (389)
Q Consensus        70 ~~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-  147 (389)
                      +.++|.+.+ .||+|+||.||+|.+..+.+      .||+|++...  .....   .....++.+.||||+++++++.. 
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~--~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~   94 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQ------KCALKLLYDS--PKARQ---EVDHHWQASGGPHIVCILDVYENM   94 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEESS--HHHHH---HHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCC------EEEEEEecCc--HHHHH---HHHHHHHhcCCCChHHHHHHHhhc
Confidence            467899855 69999999999998765544      3999998653  12212   22233566789999999999876 


Q ss_pred             ---CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC---CCcEEE
Q 016481          148 ---DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKL  221 (389)
Q Consensus       148 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~---~~~vkl  221 (389)
                         ...+++||||++||+|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+|||++.   ++.+||
T Consensus        95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A           95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEE
T ss_pred             cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEE
Confidence               456899999999999999998776667999999999999999999999977  999999999999976   455999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      +|||++......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||............       
T Consensus       173 ~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------  241 (336)
T 3fhr_A          173 TDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-------  241 (336)
T ss_dssp             CCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             eccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH-------
Confidence            999999865432    123457899999999998888999999999999999999999999765432110000       


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                         ...................+.++.+|+.+||+.||++|||+.++++|-.
T Consensus       242 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          242 ---KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             ------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             ---HHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence               0000000011111222345788999999999999999999999999743

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=329.49  Aligned_cols=269  Identities=22%  Similarity=0.308  Sum_probs=196.1

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEE---
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC---  146 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~---  146 (389)
                      +.++|++.+.||+|+||.||+|.+..+.+      .||+|.+... .......+.+|+.+++.++||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDK------RVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG   81 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTE------EEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCe------EEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence            35789999999999999999998765444      3999998755 3455677889999999999999999999873   


Q ss_pred             -----------eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc-
Q 016481          147 -----------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-  214 (389)
Q Consensus       147 -----------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~-  214 (389)
                                 .....++||||++ |+|.+++..   ..+++..+..++.|++.||+|||+++  |+|+||||+||+++ 
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~  155 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINT  155 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEET
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcC
Confidence                       4468899999997 699988854   36889999999999999999999977  99999999999997 


Q ss_pred             CCCcEEEeccCCCcCCCCCCC-ccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhh
Q 016481          215 TDYNAKLSDFGLAKDGPEGDK-SHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN  292 (389)
Q Consensus       215 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  292 (389)
                      .++.+||+|||++........ ........+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||..........
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  235 (320)
T 2i6l_A          156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ  235 (320)
T ss_dssp             TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            567999999999987643211 111233567999999998875 678999999999999999999999998765432211


Q ss_pred             hHHHHhHH--HHhhhhhhh--------hcC-CCC-CCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          293 LADWALPL--LKEKKKLLN--------IID-PRL-EGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       293 ~~~~~~~~--~~~~~~~~~--------~~~-~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ......+.  ......+..        ... +.. ........+.++.+|+.+||+.||++|||+.++++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            10000000  000000000        000 000 000112346889999999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=326.54  Aligned_cols=249  Identities=26%  Similarity=0.379  Sum_probs=193.9

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-----hhHHHHHHHHHHHhcc----CCCc
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHL----SHPN  137 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~n  137 (389)
                      ...+.++|++.+.||+|+||.||+|.+..+.+      .||+|++......     .....+..|+.+++.+    +|+|
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~   99 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRL------QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG   99 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCC------EEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCe------EEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence            35567899999999999999999997655433      4999998754321     1223345688888888    8999


Q ss_pred             cceEEeEEEeCCeEEEEEEe-cCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc-C
Q 016481          138 LVKLIGYCCEDEHRVLIYEF-MARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-T  215 (389)
Q Consensus       138 iv~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~-~  215 (389)
                      |+++++++...+..++|||+ +.+++|.+++....  .+++..+..++.|++.||+|||+++  |+|+||||+||+++ .
T Consensus       100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A          100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLR  175 (312)
T ss_dssp             BCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETT
T ss_pred             eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCC
Confidence            99999999999999999999 78999999987643  6899999999999999999999977  99999999999999 8


Q ss_pred             CCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCC-cccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH
Q 016481          216 DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLT-PRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA  294 (389)
Q Consensus       216 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  294 (389)
                      ++.+||+|||++.......    .....||+.|+|||++.+..+. .++||||||+++|+|++|+.||......      
T Consensus       176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------  245 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------  245 (312)
T ss_dssp             TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------
T ss_pred             CCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------
Confidence            8999999999998765432    2345799999999999877764 5899999999999999999999752110      


Q ss_pred             HHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          295 DWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                            ..          .  ...++...+..+.+|+.+||+.||++|||+.+++++-.
T Consensus       246 ------~~----------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          246 ------LE----------A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             ------HH----------T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             ------hh----------h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                  00          0  11123345678999999999999999999999999754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-43  Score=330.78  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=201.0

Q ss_pred             HHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-----hhHHHHHHHHHHHhccC--CCcc
Q 016481           66 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLS--HPNL  138 (389)
Q Consensus        66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~ni  138 (389)
                      ....+.++|++.+.||+|+||.||+|.+..+.+      .||+|++......     .....+..|+.+++.+.  |+||
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTE------EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCc------EEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence            344567889999999999999999997665443      4999998654211     11234557899999996  5999


Q ss_pred             ceEEeEEEeCCeEEEEEEecCC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc-CC
Q 016481          139 VKLIGYCCEDEHRVLIYEFMAR-GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TD  216 (389)
Q Consensus       139 v~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~-~~  216 (389)
                      +++++++...+..++|||++.+ ++|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++ .+
T Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNR  186 (320)
T ss_dssp             CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTT
T ss_pred             eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCC
Confidence            9999999999999999999986 89999887643  6899999999999999999999977  99999999999999 78


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  295 (389)
                      +.+||+|||++.......    .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......       
T Consensus       187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------  255 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------  255 (320)
T ss_dssp             TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------
T ss_pred             CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-------
Confidence            999999999998764322    234579999999999987776 68899999999999999999999753110       


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                           ...            ....+...+.++.+|+.+||+.||++|||+.+++++-
T Consensus       256 -----~~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp  295 (320)
T 3a99_A          256 -----IRG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP  295 (320)
T ss_dssp             -----HHC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             -----hcc------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence                 000            0012233467899999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=322.28  Aligned_cols=254  Identities=25%  Similarity=0.341  Sum_probs=182.0

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHH-HHHHHHHhccCCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW-LAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++..........++ ..+..+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGH------VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCC------EEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hccccccceeeecCCeeEEEEEEecCCe------EEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            4689999999999999999998765443      3999998876544444343 34455678889999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-EKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ..++||||+ ++.+.. +.......+++..+..++.|++.||.|||+. +  |+|+||||+||+++.++.+||+|||++.
T Consensus        98 ~~~lv~e~~-~~~~~~-l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEK-LKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             EEEEEECCC-SEEHHH-HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             cEEEEEecc-CCcHHH-HHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            999999999 444444 4333234789999999999999999999984 7  9999999999999999999999999987


Q ss_pred             CCCCCCCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      ......   ......||+.|+|||++.     +..++.++||||||+++|+|++|+.||.........     .....  
T Consensus       174 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~--  243 (318)
T 2dyl_A          174 RLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-----LTKVL--  243 (318)
T ss_dssp             ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHH--
T ss_pred             hccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-----HHHHh--
Confidence            654322   223357999999999984     557889999999999999999999999864322110     00000  


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                           ....+.+  ......+.++.+|+.+||+.||.+||++.++++|
T Consensus       244 -----~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          244 -----QEEPPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -----HSCCCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -----ccCCCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                 0001111  1112356789999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-42  Score=347.87  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=201.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe---
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE---  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---  147 (389)
                      .++|++.+.||+|+||.||+|.+..+.+      .||+|++...........+.+|+.+++.++||||+++++++..   
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~------~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGE------QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTC------CEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCc------EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            4789999999999999999997655443      3999998876666667788999999999999999999998755   


Q ss_pred             ---CCeEEEEEEecCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCc---EE
Q 016481          148 ---DEHRVLIYEFMARGSVENNLFSKV-LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN---AK  220 (389)
Q Consensus       148 ---~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~---vk  220 (389)
                         .+..++||||++||+|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.   +|
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vK  164 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHK  164 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEE
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEE
Confidence               678899999999999999987643 235888899999999999999999977  999999999999987765   99


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......     .|....
T Consensus       165 L~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i  236 (676)
T 3qa8_A          165 IIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKV  236 (676)
T ss_dssp             ECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTC
T ss_pred             Eccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhh
Confidence            99999998765432   2334689999999999999999999999999999999999999997643211     110000


Q ss_pred             HHhhhh---hhhhcC------C--CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 016481          301 LKEKKK---LLNIID------P--RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV  349 (389)
Q Consensus       301 ~~~~~~---~~~~~~------~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il  349 (389)
                      ......   ......      .  ..........+..+.+|+.+||+.||++|||+.+++
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            000000   000000      0  112234456789999999999999999999997744

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.9e-42  Score=330.53  Aligned_cols=254  Identities=25%  Similarity=0.290  Sum_probs=186.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  149 (389)
                      .+.|...+.||+|+||+||.+...       .+..||||.+..+    ....+.+|+.+++.+ +||||+++++++....
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~-------~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSF-------QGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEES-------SSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             hheeeccCeEeeCCCeEEEEEEEE-------CCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            345677889999999999864221       2345999998643    234567899999876 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC--------
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPL-----PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--------  216 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~--------  216 (389)
                      .+|+||||+. |+|.+++........     .+..+..++.|++.||+|||+++  |+||||||+|||++.+        
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~  159 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQ  159 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCT
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccc
Confidence            9999999996 699999876543211     22245679999999999999977  9999999999999754        


Q ss_pred             -----CcEEEeccCCCcCCCCCCCcc--ccccccccccccCcccccc-------CCCCcccchhHHHHHHHHHHh-CCCC
Q 016481          217 -----YNAKLSDFGLAKDGPEGDKSH--VSTRIMGTYGYAAPEYIMT-------GHLTPRSDVYSFGVVLLEILT-GRKS  281 (389)
Q Consensus       217 -----~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwslG~il~ellt-g~~p  281 (389)
                           +.+||+|||++..........  ......||+.|+|||++.+       ..++.++|||||||++|+|++ |..|
T Consensus       160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence                 489999999998765432211  1234679999999999976       678999999999999999999 9999


Q ss_pred             CCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          282 LDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       282 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      |.........        ......     ..+..........+.++.+|+.+||+.||++|||+.++++|
T Consensus       240 f~~~~~~~~~--------i~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          240 FGDKYSRESN--------IIRGIF-----SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             TCSTTTHHHH--------HHHTCC-----CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCchhhHHH--------HhcCCC-----CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            9754322110        000000     00111112244678899999999999999999999999976

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.2e-41  Score=308.26  Aligned_cols=236  Identities=14%  Similarity=0.108  Sum_probs=186.8

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      ++.++|++.+.||+|+||.||+|.+..+.+      .||+|++.....  ......+.+|+.+++.++||||+++++++.
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  101 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDR------QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH  101 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTE------EEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCc------eEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence            345789999999999999999998765443      399999986543  344577889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      ..+..|+||||++|++|.+++...    .....+..++.|++.||+|||+++  |+||||||+|||++.++.+||+++|.
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~~  175 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPAT  175 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCCC
T ss_pred             ECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEeccc
Confidence            999999999999999999998432    345567889999999999999977  99999999999999999999985542


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                                            ++       .++.++|||||||++|+|++|+.||...........             
T Consensus       176 ----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------------  213 (286)
T 3uqc_A          176 ----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------------  213 (286)
T ss_dssp             ----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-------------
T ss_pred             ----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-------------
Confidence                                  22       368899999999999999999999987653211000             


Q ss_pred             hhhhcCCCCC--CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          307 LLNIIDPRLE--GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       307 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                      ....+.....  .......+.++.+|+.+||+.||++| |+.++++.|+.+....
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          214 AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            0000000000  00122356789999999999999999 9999999998876553

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=326.54  Aligned_cols=250  Identities=24%  Similarity=0.277  Sum_probs=184.7

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  150 (389)
                      .+|.+.+.||+|+||+||.....       .+..||||.+......    .+.+|+.+++.+ +||||+++++++.+...
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~-------~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~   92 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMF-------DNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQF   92 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEES-------SSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred             EEEecCCeeecCcCEEEEEEEEe-------CCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence            46889999999999996542211       2334999998764322    234799999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-----CCcEEEeccC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-----DYNAKLSDFG  225 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-----~~~vkl~Dfg  225 (389)
                      .|+||||+. |+|.+++..... ......+..++.|++.||+|||+++  |+||||||+|||++.     ...+||+|||
T Consensus        93 ~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A           93 QYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             EEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            999999996 699998876543 3444456789999999999999977  999999999999943     2368899999


Q ss_pred             CCcCCCCCCCc-cccccccccccccCccccc---cCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHH
Q 016481          226 LAKDGPEGDKS-HVSTRIMGTYGYAAPEYIM---TGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       226 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      +++........ ......+||+.|+|||++.   +..++.++|||||||++|+|++ |..||.........         
T Consensus       169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~---------  239 (432)
T 3p23_A          169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---------  239 (432)
T ss_dssp             EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH---------
T ss_pred             ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH---------
Confidence            99876543211 2233467999999999997   4567889999999999999999 99999654322110         


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                           ....... ..........+..+.+|+.+||+.||++|||+.++++|
T Consensus       240 -----~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          240 -----ILLGACS-LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             -----HHTTCCC-CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----HHhccCC-ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                 0000000 00111233557778999999999999999999999976

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.5e-41  Score=343.47  Aligned_cols=244  Identities=21%  Similarity=0.357  Sum_probs=194.9

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .+.++|++.+.||+|+||.||+|.+...     .+..||||++...........+.+|+.+++.++||||+++++++...
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNV-----NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT  151 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGG-----TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCC-----CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence            3457999999999999999999986542     12349999987665556667788999999999999999999999876


Q ss_pred             Ce-----EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          149 EH-----RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       149 ~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      +.     .|+||||++|++|.+++..    .+++..+..++.|++.||.|||+++  |+||||||+|||++.+ .+||+|
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECC
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEe
Confidence            65     7999999999999886643    6899999999999999999999977  9999999999999875 899999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE  303 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  303 (389)
                      ||+++.....      ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.......              
T Consensus       225 FG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------  283 (681)
T 2pzi_A          225 LGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------  283 (681)
T ss_dssp             CTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------
T ss_pred             cccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------------
Confidence            9999875432      345799999999998765 4899999999999999999999887421100              


Q ss_pred             hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHhccc
Q 016481          304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-MRDIVDSLEPL  355 (389)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~~il~~L~~~  355 (389)
                             +   .........+..+.+|+.+||+.||++||+ +.++.+.|..+
T Consensus       284 -------~---~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          284 -------L---PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -------C---CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------c---cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                   0   000011223467899999999999999995 55555555543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2e-40  Score=305.73  Aligned_cols=231  Identities=19%  Similarity=0.277  Sum_probs=181.7

Q ss_pred             HhcCCccc-ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHH-hccCCCccceEEeEEEe
Q 016481           70 ITANFRQD-RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFL-GHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~  147 (389)
                      +.++|.+. +.||+|+||.||+|.+..+.+      .||+|++...      ..+.+|+.++ +.++||||+++++++..
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQE------KFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCc------EEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            34677776 789999999999998765443      4999998642      3455788887 55689999999999887


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC---CCcEE
Q 016481          148 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAK  220 (389)
Q Consensus       148 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~---~~~vk  220 (389)
                          ...+++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+||+++.   ++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEE
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEE
Confidence                678999999999999999998876667999999999999999999999977  999999999999998   78999


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |+|||++....                        +..++.++|||||||++|+|++|+.||.........         
T Consensus       161 l~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------  207 (299)
T 3m2w_A          161 LTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------  207 (299)
T ss_dssp             ECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------
T ss_pred             Eeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---------
Confidence            99999886432                        244678999999999999999999999765322100         


Q ss_pred             HHhhhhhhhhcCCCCCCCCC----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          301 LKEKKKLLNIIDPRLEGDYP----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                          ......+.. .....+    ...+.++.+|+.+||+.||++|||+.++++|-
T Consensus       208 ----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          208 ----PGMKTRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             ----CCSCCSSCT-TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ----HHHHHHHhh-ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence                000000000 001111    23578899999999999999999999999874

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-40  Score=319.80  Aligned_cols=243  Identities=17%  Similarity=0.120  Sum_probs=180.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh--hhHHHHHHHHHHHhccCC-Cccc---------
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--QGHREWLAEVIFLGHLSH-PNLV---------  139 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h-~niv---------  139 (389)
                      ..|...+.||+|+||.||+|.+..+.+      .||||++......  .....+.+|+.+++.+.| .|..         
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~------~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGE------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCC------ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            347788999999999999998765544      3999998744322  235678899999999976 2211         


Q ss_pred             e------------EEeEEEe-----CCeEEEEEEecCCCChhhhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 016481          140 K------------LIGYCCE-----DEHRVLIYEFMARGSVENNLF-----SKVLLPLPWSIRMKIAFGAAKGLAFLHEA  197 (389)
Q Consensus       140 ~------------~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~  197 (389)
                      .            +..++..     ....+++|+++ +++|.+++.     ......+++..+..++.|++.||+|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  230 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  230 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            1            1111111     22457777776 679988874     22334577888899999999999999997


Q ss_pred             CCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCcccc----------ccCCCCcccchhH
Q 016481          198 EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYI----------MTGHLTPRSDVYS  267 (389)
Q Consensus       198 ~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~~Diws  267 (389)
                      +  |+||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++          .+..|+.++||||
T Consensus       231 ~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS  302 (413)
T 3dzo_A          231 G--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT  302 (413)
T ss_dssp             T--EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred             C--cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence            7  999999999999999999999999998764321     334677 999999999          5556889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHH
Q 016481          268 FGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRD  347 (389)
Q Consensus       268 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  347 (389)
                      |||++|+|++|+.||........                ....+..      ....+..+.+|+.+||+.||++||++.+
T Consensus       303 lGvil~elltg~~Pf~~~~~~~~----------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          303 LGLAIYWIWCADLPNTDDAALGG----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHHHHHSSCCCCTTGGGSC----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHCCCCCCCcchhhh----------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            99999999999999986532211                0111110      0123478999999999999999999877


Q ss_pred             HHHH
Q 016481          348 IVDS  351 (389)
Q Consensus       348 il~~  351 (389)
                      ++++
T Consensus       361 ~l~~  364 (413)
T 3dzo_A          361 AMET  364 (413)
T ss_dssp             HTTS
T ss_pred             HHhC
Confidence            7654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.8e-40  Score=311.19  Aligned_cols=244  Identities=17%  Similarity=0.196  Sum_probs=185.9

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-------ChhhHHHHHHHHHHHhccC--------
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-------SYQGHREWLAEVIFLGHLS--------  134 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~--------  134 (389)
                      ..++|++.+.||+|+||.||+|++.        +..||+|++....       .......+.+|+.+++.++        
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~   89 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIAD--------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN   89 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEET--------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred             ccccchheeeecccCceEEEEEEeC--------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence            3467999999999999999999762        2349999987543       2223466778999888885        


Q ss_pred             -CCccceEEeEEE------------------------------eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHH
Q 016481          135 -HPNLVKLIGYCC------------------------------EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI  183 (389)
Q Consensus       135 -h~niv~~~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i  183 (389)
                       ||||+++.+++.                              ..+.+|+||||+++|++.+.+..   ..+++..+..+
T Consensus        90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i  166 (336)
T 2vuw_A           90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSI  166 (336)
T ss_dssp             BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHH
T ss_pred             cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHH
Confidence             777777776543                              26899999999999988777744   36899999999


Q ss_pred             HHHHHHHHHHHH-hCCCCceecCCCCCCeEEcCCC--------------------cEEEeccCCCcCCCCCCCccccccc
Q 016481          184 AFGAAKGLAFLH-EAEKPVIYRDFKTSNILLDTDY--------------------NAKLSDFGLAKDGPEGDKSHVSTRI  242 (389)
Q Consensus       184 ~~~i~~~l~~LH-~~~~~ivH~Dlkp~Nili~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~~  242 (389)
                      +.|++.||+||| +++  |+||||||+|||++.++                    .+||+|||+|+....       ...
T Consensus       167 ~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~  237 (336)
T 2vuw_A          167 LHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIV  237 (336)
T ss_dssp             HHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEE
T ss_pred             HHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcE
Confidence            999999999999 877  99999999999999887                    899999999986532       134


Q ss_pred             cccccccCccccccCCCCcccchhHHHHH-HHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh--hcCCCCCCCC
Q 016481          243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVV-LLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN--IIDPRLEGDY  319 (389)
Q Consensus       243 ~gt~~y~aPE~l~~~~~~~~~DiwslG~i-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  319 (389)
                      +||+.|+|||++.+.. +.++||||||++ .+++++|..||...         .|.....   ..+..  ..........
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~---~~~~~~~~~~~~~~~~~  304 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLT---DKMLKQMTFKTKCNTPA  304 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHH---HHHHHTCCCSSCCCSHH
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHH---HhhhhhhccCcccchhh
Confidence            7999999999998776 889999998777 77788899988531         1100000   00110  0111111122


Q ss_pred             ChHHHHHHHHHHHHhhccCCCCCCCHHHHH-HH
Q 016481          320 PVKGVHKAAMLAYHCLNHNPKARPLMRDIV-DS  351 (389)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dP~~Rps~~~il-~~  351 (389)
                      +...+.++.+|+.+||++|     |+.+++ +|
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            3467899999999999977     999999 76

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=8.9e-33  Score=275.31  Aligned_cols=168  Identities=17%  Similarity=0.104  Sum_probs=125.2

Q ss_pred             cccEEEEEecCCC---------ChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCC
Q 016481          103 PVPVAVKVHDGDN---------SYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL  172 (389)
Q Consensus       103 ~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~  172 (389)
                      +..|++|.+....         .....+++.+|+.+|+++ .|+||+++++++.+++.+||||||++||+|.+.+.... 
T Consensus       259 g~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~-  337 (569)
T 4azs_A          259 GEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE-  337 (569)
T ss_dssp             CSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-
T ss_pred             cceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-
Confidence            3449999986542         123346788999999999 69999999999999999999999999999999997654 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCcc
Q 016481          173 LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE  252 (389)
Q Consensus       173 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  252 (389)
                       +++..   .|+.||+.||+|+|++|  ||||||||+|||++.+|.+||+|||+|+.......  .....+||+.|+|||
T Consensus       338 -~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE  409 (569)
T 4azs_A          338 -EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNE  409 (569)
T ss_dssp             -CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHH
T ss_pred             -CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHH
Confidence             56554   57899999999999988  99999999999999999999999999987654321  234578999999999


Q ss_pred             ccccCCCCcccchhHHHHHHHHHHhCCC
Q 016481          253 YIMTGHLTPRSDVYSFGVVLLEILTGRK  280 (389)
Q Consensus       253 ~l~~~~~~~~~DiwslG~il~elltg~~  280 (389)
                      ++.+ .+..++|+||+|+++++|.+|..
T Consensus       410 ~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          410 LFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             HC------------------CCCCTTHH
T ss_pred             HhCC-CCCCcccccccccchhhhccccc
Confidence            9876 46778999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.5e-29  Score=249.07  Aligned_cols=187  Identities=14%  Similarity=0.176  Sum_probs=143.9

Q ss_pred             cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-------hhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           75 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-------QGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ...+.||+|+||.||+|....        ..+++|........       ...+.+.+|+.++++++||||+.+..++..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  410 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLD--------FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD  410 (540)
T ss_dssp             ---------CCEEEEEEECSS--------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECC--------CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence            446789999999999994332        23888876543211       113457899999999999999966666667


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+..|+||||++||+|.+++..          +..++.|++.||+|||+++  |+||||||+|||++.  .+||+|||++
T Consensus       411 ~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          411 LDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             TTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             CCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccC
Confidence            8888999999999999998865          4589999999999999977  999999999999998  9999999999


Q ss_pred             cCCCCCCCcc-----ccccccccccccCcccccc--CCCCcccchhHHHHHHHHHHhCCCCCC
Q 016481          228 KDGPEGDKSH-----VSTRIMGTYGYAAPEYIMT--GHLTPRSDVYSFGVVLLEILTGRKSLD  283 (389)
Q Consensus       228 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwslG~il~elltg~~pf~  283 (389)
                      +.........     .....+||+.|+|||++..  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9875432111     1235789999999999987  678888999999999888888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=6e-25  Score=200.20  Aligned_cols=159  Identities=14%  Similarity=0.107  Sum_probs=120.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-----------------hhHHHHHHHHHHHhccC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----------------QGHREWLAEVIFLGHLS  134 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~  134 (389)
                      ..|.+.+.||+|+||.||+|.+ .+.      ..||+|++......                 .....+.+|+.+++.++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g------~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKF------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTT------EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCC------CEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3466779999999999999986 333      33999998653211                 13456889999999998


Q ss_pred             CCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc
Q 016481          135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD  214 (389)
Q Consensus       135 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~  214 (389)
                        | +++.+++.. +..++||||++||+|.+ +..        .....++.|++.||.|||+++  |+||||||+|||++
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS  227 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE
Confidence              4 666665543 56699999999999988 421        123569999999999999977  99999999999999


Q ss_pred             CCCcEEEeccCCCcCCCCCCCccccccccccccccCcccccc----------CCCCcccchhHH
Q 016481          215 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT----------GHLTPRSDVYSF  268 (389)
Q Consensus       215 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----------~~~~~~~Diwsl  268 (389)
                       ++.+||+|||+|+.               +..++|||++..          ..|...+|+|.+
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence             99999999999863               334678888753          345555666643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=3.3e-20  Score=166.71  Aligned_cols=138  Identities=20%  Similarity=0.091  Sum_probs=102.5

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCccc--EEEEEecCCCCh-----------------------hhHHHHHHHHH
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVP--VAVKVHDGDNSY-----------------------QGHREWLAEVI  128 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~--vaiK~~~~~~~~-----------------------~~~~~~~~E~~  128 (389)
                      |.+.+.||+|+||.||+|.+..+      +..  ||+|+++.....                       .....+.+|+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~------g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFD------GKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEET------TEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCC------CcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            67889999999999999976322      345  899987543211                       11135678999


Q ss_pred             HHhccCCCcc--ceEEeEEEeCCeEEEEEEecCC-C----ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCC
Q 016481          129 FLGHLSHPNL--VKLIGYCCEDEHRVLIYEFMAR-G----SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH-EAEKP  200 (389)
Q Consensus       129 ~l~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~  200 (389)
                      ++..+.|+++  +.++++    ...++||||+.+ |    +|.+....     .++..+..++.|++.+|.||| ..+  
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g--  191 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE--  191 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC--
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC--
Confidence            9999988754  344432    356899999942 4    55554432     123456789999999999999 877  


Q ss_pred             ceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          201 VIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       201 ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      |+||||||+|||++.  .++|+|||+|...
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999999988  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=1.1e-18  Score=163.49  Aligned_cols=139  Identities=11%  Similarity=0.041  Sum_probs=95.9

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-------------hhhHHH--------HHHHHHHHhc
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-------------YQGHRE--------WLAEVIFLGH  132 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~--------~~~E~~~l~~  132 (389)
                      |.+++.||.|+||.||+|....       +..||||+++....             ......        ...|...|.+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~-------G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEK-------GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTT-------CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEECCC-------CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            8999999999999999997532       34499998764310             000111        1245666666


Q ss_pred             cCCCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeE
Q 016481          133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNIL  212 (389)
Q Consensus       133 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nil  212 (389)
                      +.+.++.-..-+...  ..+|||||++|++|......        .....++.|++.+|.+||.+|  ||||||||.|||
T Consensus       170 L~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NIL  237 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG--LIHGDFNEFNIL  237 (397)
T ss_dssp             HHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEE
T ss_pred             HHhcCCCCCeeeecc--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEE
Confidence            644333211111122  22799999999887654321        123567889999999999987  999999999999


Q ss_pred             EcCCC----------cEEEeccCCCcCCC
Q 016481          213 LDTDY----------NAKLSDFGLAKDGP  231 (389)
Q Consensus       213 i~~~~----------~vkl~Dfg~a~~~~  231 (389)
                      ++.++          .+.|+||+.+....
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EeCCCCcccccccccceEEEEeCCcccCC
Confidence            98776          38999999887543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.38  E-value=2.6e-12  Score=115.22  Aligned_cols=143  Identities=15%  Similarity=0.081  Sum_probs=107.9

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  148 (389)
                      ....|++...++.|+.+.||++...        +..+++|+...... .....+.+|+.+++.+. +..+.++++++...
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~--------~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~   82 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE--------NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS--------SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HhccceeEeeccCCCCCeEEEEECC--------CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC
Confidence            3457888889999999999998532        12399999864211 11124668999999885 67788999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE------------------------------  198 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------  198 (389)
                      +..|+||||++|.+|.+.+...       .....++.+++.+|+.||...                              
T Consensus        83 ~~~~lv~e~i~G~~l~~~~~~~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           83 GWSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHCCTT-------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             CceEEEEEecCCeehhhccCCc-------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            9999999999999987753211       123467789999999999810                              


Q ss_pred             ---------------------------CCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          199 ---------------------------KPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       199 ---------------------------~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                                                 ..++|+|++|.||+++.++.+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                       338999999999999876566799998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=6.3e-11  Score=111.20  Aligned_cols=142  Identities=13%  Similarity=0.177  Sum_probs=103.1

Q ss_pred             ccceecCCCceEEEEeeeccccccCcCcccEEEEEec--CCCChhhHHHHHHHHHHHhccC--CCccceEEeEEEeC---
Q 016481           76 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD--GDNSYQGHREWLAEVIFLGHLS--HPNLVKLIGYCCED---  148 (389)
Q Consensus        76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---  148 (389)
                      ..+.|+.|.++.||+....+        ..+++|+..  ..........+.+|+.+++.+.  +..+++++.++.+.   
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~--------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~  113 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG--------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI  113 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS--------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred             eEEEcCCcccceEEEEEECC--------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence            35778999999999975432        238888876  3322222345668999999887  45678888888766   


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-------------------------------  197 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------  197 (389)
                      +..|+||||++|..+.+..    ...++......++.+++..|+.||..                               
T Consensus       114 g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          114 GRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             SSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            4589999999998775422    12456777888999999999999973                               


Q ss_pred             -------------------------CCCceecCCCCCCeEEcCCCc--EEEeccCCCcC
Q 016481          198 -------------------------EKPVIYRDFKTSNILLDTDYN--AKLSDFGLAKD  229 (389)
Q Consensus       198 -------------------------~~~ivH~Dlkp~Nili~~~~~--vkl~Dfg~a~~  229 (389)
                                               ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     135999999999999987653  68999998875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=5.1e-11  Score=106.30  Aligned_cols=136  Identities=15%  Similarity=0.053  Sum_probs=94.6

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc--cceEEeEEEeCCe
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN--LVKLIGYCCEDEH  150 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~  150 (389)
                      .+.+....+.|..+.||++....       +..+++|+.....    ...+..|+.+++.+.+.+  +.+++++...++.
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~-------g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~   89 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQG-------RPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR   89 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTT-------SCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred             CCceEecccCCCCceEEEEecCC-------CCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence            34443333456679999975321       1239999976541    134557888888886434  5668888888888


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE--------------------------------  198 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------  198 (389)
                      .++||||++|.+|.  ...     ..   ...++.+++..|+.||...                                
T Consensus        90 ~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (264)
T 1nd4_A           90 DWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD  159 (264)
T ss_dssp             EEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred             CEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence            99999999998874  211     11   1256667777888888642                                


Q ss_pred             ------------------------CCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          199 ------------------------KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       199 ------------------------~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                                              ..++|+|++|.||+++.++.+.|+|||.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                    1299999999999998776677999998653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.05  E-value=1.7e-10  Score=105.75  Aligned_cols=182  Identities=19%  Similarity=0.182  Sum_probs=118.8

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCc--cceEEeEEEeCC---e
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPN--LVKLIGYCCEDE---H  150 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~  150 (389)
                      .+.++.|.+..||+..     .      .+++|+....   .....+.+|..+++.+. +..  +..++......+   .
T Consensus        25 i~~~~~G~~n~v~~v~-----~------~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~   90 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----R------DFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQM   90 (304)
T ss_dssp             CCEEEECSSEEEEEST-----T------SEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSC
T ss_pred             eEecCCCCcceEEEEC-----C------EEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCc
Confidence            4568999999999862     1      2899986532   33456778999998874 332  344444433332   3


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAE--------------------------------  198 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------  198 (389)
                      .|+||++++|.++......    .++......++.+++..|+.||...                                
T Consensus        91 ~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (304)
T 3sg8_A           91 SFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK  166 (304)
T ss_dssp             SCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred             ceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence            4889999999888654332    3566667778888888888888511                                


Q ss_pred             ------------------------CCceecCCCCCCeEEcC--CCcEEEeccCCCcCCCCCCCccccccccccccc---c
Q 016481          199 ------------------------KPVIYRDFKTSNILLDT--DYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGY---A  249 (389)
Q Consensus       199 ------------------------~~ivH~Dlkp~Nili~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~  249 (389)
                                              ..++|+|++|.||+++.  ++.+.|+||+.+.......   ..   .....+   .
T Consensus       167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl---~~~~~~~~~~  240 (304)
T 3sg8_A          167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DF---ISLMEDDEEY  240 (304)
T ss_dssp             HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HH---HTTCCTTTSC
T ss_pred             cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HH---HHHHhhcccc
Confidence                                    23799999999999988  5567899999876542210   00   000011   1


Q ss_pred             Cccccc----c-CCC---------CcccchhHHHHHHHHHHhCCCCC
Q 016481          250 APEYIM----T-GHL---------TPRSDVYSFGVVLLEILTGRKSL  282 (389)
Q Consensus       250 aPE~l~----~-~~~---------~~~~DiwslG~il~elltg~~pf  282 (389)
                      .|+...    . ...         ....+.|++|.++|.+.+|..+|
T Consensus       241 ~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          241 GMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            222111    0 001         12358999999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.61  E-value=3.8e-07  Score=81.58  Aligned_cols=135  Identities=17%  Similarity=0.110  Sum_probs=91.8

Q ss_pred             eecCCCce-EEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCCeEEEEEE
Q 016481           79 VLGGGGFG-CVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYE  156 (389)
Q Consensus        79 ~lg~G~~g-~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  156 (389)
                      .+..|..| .||+........      .+++|+....    ....+.+|..+|+.+. +--+.++++++.+.+..++|||
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~------~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme  100 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAP------ELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT  100 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCC------CEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             EccCCCcCCeEEEEEecCCCe------EEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence            34556555 689865433322      3889986532    3345678999998885 3347788899999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 016481          157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA---------------------------------------  197 (389)
Q Consensus       157 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---------------------------------------  197 (389)
                      +++|.++.+......      .....++.+++..|+-||..                                       
T Consensus       101 ~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A          101 AIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             CCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             eeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            999987766443211      11233455555666666641                                       


Q ss_pred             -----------------CCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          198 -----------------EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       198 -----------------~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                                       ...++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                             01278999999999999877777999997754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.54  E-value=1.8e-06  Score=78.91  Aligned_cols=135  Identities=18%  Similarity=0.120  Sum_probs=90.0

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCC---ccceEEeEEE-eCCeEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP---NLVKLIGYCC-EDEHRV  152 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~  152 (389)
                      .+.++.|....||+.     ..      .+++|+...   ......+..|..+|+.+.+.   .+...+.+.. ..+..+
T Consensus        24 v~~l~~G~~n~v~~v-----g~------~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~   89 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NG------DWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPF   89 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TT------TEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEE
T ss_pred             eeecCCCcceeEEEE-----CC------EEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceE
Confidence            456888998999986     12      288898532   23445678899999998742   3566666664 455678


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 016481          153 LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA-----------------------------------  197 (389)
Q Consensus       153 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----------------------------------  197 (389)
                      +|||+++|.++......    .++......++.++...|+.||..                                   
T Consensus        90 ~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~  165 (306)
T 3tdw_A           90 VGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD  165 (306)
T ss_dssp             EEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred             EEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence            99999999887653211    123333444444444444444432                                   


Q ss_pred             -----------------------CCCceecCCCCCCeEEcC---CCc-EEEeccCCCcC
Q 016481          198 -----------------------EKPVIYRDFKTSNILLDT---DYN-AKLSDFGLAKD  229 (389)
Q Consensus       198 -----------------------~~~ivH~Dlkp~Nili~~---~~~-vkl~Dfg~a~~  229 (389)
                                             ...++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                   123699999999999987   455 48999998765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.27  E-value=3.9e-06  Score=79.48  Aligned_cols=78  Identities=14%  Similarity=0.057  Sum_probs=47.7

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC------hhhHHHHHHHHHHHhccCC--C-ccceEEeEEEe
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS------YQGHREWLAEVIFLGHLSH--P-NLVKLIGYCCE  147 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~  147 (389)
                      .+.||.|.++.||++......      ..+++|.......      ......+..|..+++.+..  + .+.+++.+  +
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~------~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHD------RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEECCCCceEEEEEEEECCCC------cEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence            467999999999998644322      2389997653211      0112345678888887742  3 34455543  4


Q ss_pred             CCeEEEEEEecCCCC
Q 016481          148 DEHRVLIYEFMARGS  162 (389)
Q Consensus       148 ~~~~~lv~e~~~~gs  162 (389)
                      .+..++|||+++|..
T Consensus       107 ~~~~~lvmE~l~g~~  121 (397)
T 2olc_A          107 TEMAVTVMEDLSHLK  121 (397)
T ss_dssp             TTTTEEEECCCTTSE
T ss_pred             CCccEEEEEeCCCcc
Confidence            556689999997743

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.24  E-value=2.4e-06  Score=79.71  Aligned_cols=88  Identities=2%  Similarity=-0.130  Sum_probs=52.4

Q ss_pred             ccee-cCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccC-C--CccceEEeEEEeC--
Q 016481           77 DRVL-GGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLS-H--PNLVKLIGYCCED--  148 (389)
Q Consensus        77 ~~~l-g~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~--  148 (389)
                      .+.| +.|....+|+............+..+++|+......  ......+.+|..+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 889899999875430000000022388888654320  000123457888888774 2  3467778777654  


Q ss_pred             -CeEEEEEEecCCCChh
Q 016481          149 -EHRVLIYEFMARGSVE  164 (389)
Q Consensus       149 -~~~~lv~e~~~~gsL~  164 (389)
                       +..++|||+++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.13  E-value=4.1e-05  Score=70.51  Aligned_cols=31  Identities=19%  Similarity=0.200  Sum_probs=27.5

Q ss_pred             CCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       199 ~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++|+|+++.||+++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            5599999999999998888899999997754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.85  E-value=0.00013  Score=66.48  Aligned_cols=75  Identities=19%  Similarity=0.146  Sum_probs=56.7

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC---CCccceEEeEEEeCCeEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS---HPNLVKLIGYCCEDEHRVL  153 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l  153 (389)
                      .+.|+.|....+|+....        ...+++|+....    ....+..|...|+.|.   ...+++++.+....+..++
T Consensus        41 ~~~l~gG~~n~~y~v~~~--------~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~l  108 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE--------VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFL  108 (312)
T ss_dssp             EEEECCSSSSEEEEEESS--------SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEE
T ss_pred             eEEeCCccceeeeEEEEC--------CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEE
Confidence            467899999999997531        123888987532    2455678988888874   3568888888888888999


Q ss_pred             EEEecCCCCh
Q 016481          154 IYEFMARGSV  163 (389)
Q Consensus       154 v~e~~~~gsL  163 (389)
                      ||||++|..+
T Consensus       109 vme~l~G~~~  118 (312)
T 3jr1_A          109 LLEALNKSKN  118 (312)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeccCCCC
Confidence            9999998765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.60  E-value=0.0004  Score=62.83  Aligned_cols=71  Identities=7%  Similarity=0.154  Sum_probs=43.4

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCcc-ceEEeEEEeCCeEEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  155 (389)
                      .+.|+.|....+|+.      ..      +++|+........  .....|..+++.+...++ .+++++  +...-++|+
T Consensus        23 i~~l~gG~tN~~~~~------~~------~vlR~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~   86 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GD------LCLRIPGKGTEEY--INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVT   86 (301)
T ss_dssp             CEEEESCSSEEEEEE------TT------EEEEEECC----C--CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEE
T ss_pred             eeEcCCcccccccee------ee------EEEECCCCCccce--eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEE
Confidence            678989999999997      11      8999876542111  112357777776642222 455543  344457899


Q ss_pred             Eec-CCCCh
Q 016481          156 EFM-ARGSV  163 (389)
Q Consensus       156 e~~-~~gsL  163 (389)
                      ||+ +|.++
T Consensus        87 e~i~~g~~l   95 (301)
T 3dxq_A           87 RYIAGAQTM   95 (301)
T ss_dssp             ECCTTCEEC
T ss_pred             eecCCCccC
Confidence            999 66554

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.58  E-value=0.00032  Score=66.75  Aligned_cols=76  Identities=13%  Similarity=0.097  Sum_probs=46.4

Q ss_pred             CCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCcccccccc--ccccccCccccccCC---CCcccchhHHHHHHH
Q 016481          199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM--GTYGYAAPEYIMTGH---LTPRSDVYSFGVVLL  273 (389)
Q Consensus       199 ~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~---~~~~~DiwslG~il~  273 (389)
                      ..++|+|+++.|||++.++ ++|+||+.+.......   ......  -...|++|+......   -....++.++...+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            4599999999999998876 9999999887643210   000001  123456665543111   112344557777777


Q ss_pred             HHHhC
Q 016481          274 EILTG  278 (389)
Q Consensus       274 elltg  278 (389)
                      +.+.+
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.51  E-value=0.0011  Score=60.44  Aligned_cols=155  Identities=15%  Similarity=0.166  Sum_probs=80.4

Q ss_pred             HHHHHHHhcCCcc-----cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC----
Q 016481           64 YDELRIITANFRQ-----DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS----  134 (389)
Q Consensus        64 ~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~----  134 (389)
                      .+.+..+...|.+     .+.|+.|....+|+......        .+++|+........   .+..|..+++.+.    
T Consensus         9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g--------~~vlk~~~~~~~~~---~l~~e~~~l~~L~~~g~   77 (322)
T 2ppq_A            9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--------PLILTLYEKRVEKN---DLPFFLGLMQHLAAKGL   77 (322)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--------CEEEEEECC---CC---HHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc--------cEEEEEeCCCCCHH---HHHHHHHHHHHHHHCCC
Confidence            3444444444544     34577788889998753221        28999987532112   2335666666553    


Q ss_pred             -CCccceEE-e--EEEeCCeEEEEEEecCCCChhh--------------hhhcC--C-CCC----C---CHHHHHH----
Q 016481          135 -HPNLVKLI-G--YCCEDEHRVLIYEFMARGSVEN--------------NLFSK--V-LLP----L---PWSIRMK----  182 (389)
Q Consensus       135 -h~niv~~~-~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~--~-~~~----~---~~~~~~~----  182 (389)
                       -|.++... +  +....+..+++++|++|..+..              .++..  . ..+    .   .|.....    
T Consensus        78 ~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~  157 (322)
T 2ppq_A           78 SCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEE  157 (322)
T ss_dssp             CCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGG
T ss_pred             CCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHH
Confidence             23333211 1  1223467789999999865421              11110  0 000    0   1111000    


Q ss_pred             --------HHHHHHHHHHHHHhC-----CCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          183 --------IAFGAAKGLAFLHEA-----EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       183 --------i~~~i~~~l~~LH~~-----~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                              +...+...++.+...     ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       158 ~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          158 RADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                    001133445555531     23499999999999998876568999987653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.40  E-value=0.00076  Score=63.13  Aligned_cols=147  Identities=15%  Similarity=0.163  Sum_probs=80.4

Q ss_pred             cceecCCCceEEEEeeeccccc-cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCCeEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLR-EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  154 (389)
                      .+.|..|-...+|++....... .......+++++.....  .......+|..+++.+. +.-..++++++.  +.  +|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~g--~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFP--EG--RL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--TE--EE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--Cc--cE
Confidence            3567778888999986532110 01122448888864321  22344558988888875 322356666553  32  89


Q ss_pred             EEecCCCChhhh-----------------hhcCC---CCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 016481          155 YEFMARGSVENN-----------------LFSKV---LLPLP--WSIRMKIAFGAAK-------------------GLAF  193 (389)
Q Consensus       155 ~e~~~~gsL~~~-----------------l~~~~---~~~~~--~~~~~~i~~~i~~-------------------~l~~  193 (389)
                      |||++|.+|...                 ++...   .....  +..+..+..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            999998665321                 11110   11122  3444444443321                   1222


Q ss_pred             ----HHhC--CCCceecCCCCCCeEEcCC----CcEEEeccCCCcC
Q 016481          194 ----LHEA--EKPVIYRDFKTSNILLDTD----YNAKLSDFGLAKD  229 (389)
Q Consensus       194 ----LH~~--~~~ivH~Dlkp~Nili~~~----~~vkl~Dfg~a~~  229 (389)
                          |...  ...++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                3222  2348999999999999876    7899999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.37  E-value=0.002  Score=61.89  Aligned_cols=75  Identities=15%  Similarity=0.061  Sum_probs=45.0

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCcc-ceEEeEEEeCCeEEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-VKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  155 (389)
                      .+.|+.|-...+|++.....      +..+++|+........  .....|..+++.|...++ .++++.+  .+.  +||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~------~~~~vLRi~g~~~~~~--idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~  180 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSK------QAKYLIRLYGPKTDEI--INREREKKISCILYNKNIAKKIYVFF--TNG--RIE  180 (458)
T ss_dssp             EEEECC--CEEEEEEEETTT------TEEEEEEEECC-CCSC--SCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEE
T ss_pred             EEEcCCCeEeEEEEEEECCC------CceEEEEECCCChhhh--cCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEE
Confidence            45688888899999864331      1238899875432111  112368888888864444 5666665  232  599


Q ss_pred             EecCCCCh
Q 016481          156 EFMARGSV  163 (389)
Q Consensus       156 e~~~~gsL  163 (389)
                      ||++|.+|
T Consensus       181 e~I~G~~l  188 (458)
T 2qg7_A          181 EFMDGYAL  188 (458)
T ss_dssp             ECCCSEEC
T ss_pred             EeeCCccC
Confidence            99987554

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.36  E-value=0.0013  Score=55.79  Aligned_cols=100  Identities=14%  Similarity=0.052  Sum_probs=63.7

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccc
Q 016481          162 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLH-EAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVST  240 (389)
Q Consensus       162 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~  240 (389)
                      +|.+.|...+ .++.+.+++.++.|.+.+|.-+- ...  -..+=+.|..|++..+|.|-+.+ +.+.            
T Consensus        34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------------
Confidence            5677665543 48999999999999999886652 111  12333457899999999988774 1111            


Q ss_pred             cccccccccCccccccCCCCcccchhHHHHHHHHHHhCCC
Q 016481          241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK  280 (389)
Q Consensus       241 ~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~  280 (389)
                        .....+.|||.+. ...+.+.=|||||+++|..+--..
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence              1122356888763 344677889999999999887443

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.32  E-value=0.00051  Score=61.75  Aligned_cols=81  Identities=17%  Similarity=0.183  Sum_probs=52.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCC---CccceEEeEEEe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH---PNLVKLIGYCCE  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~  147 (389)
                      .....-.+.+|.|..+.||+....+.       ..|++|+...... .....+..|...|+.|.-   -.+.+++++.  
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~DG-------~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--   83 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELADG-------TPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--   83 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEETTS-------CEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--
T ss_pred             CCCeEEEEecCCCCCeEEEEEEECCC-------CEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc--
Confidence            34566678899999999999865432       2399998654422 222345679888888742   2244555432  


Q ss_pred             CCeEEEEEEecCCCCh
Q 016481          148 DEHRVLIYEFMARGSV  163 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL  163 (389)
                        .-++||||++++..
T Consensus        84 --~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 --DRTLAMEWVDERPP   97 (288)
T ss_dssp             --TTEEEEECCCCCCC
T ss_pred             --CceEEEEeecccCC
Confidence              23789999987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.25  E-value=0.0013  Score=62.64  Aligned_cols=80  Identities=19%  Similarity=0.179  Sum_probs=48.0

Q ss_pred             cceecCCCceEEEEeeecccccc-CcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc-cceEEeEEEeCCeEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN-LVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  154 (389)
                      .+.|+.|....||++........ ......+++|+......   ...+..|..+++.+...+ ..++++.+.  +  .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence            46788888899999865321100 01123488998854211   133446888888775333 356666543  2  289


Q ss_pred             EEecCCCCh
Q 016481          155 YEFMARGSV  163 (389)
Q Consensus       155 ~e~~~~gsL  163 (389)
                      +||++|.++
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999987544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.15  E-value=0.00092  Score=61.34  Aligned_cols=32  Identities=31%  Similarity=0.379  Sum_probs=27.5

Q ss_pred             CCceecCCCCCCeEEcCC----CcEEEeccCCCcCC
Q 016481          199 KPVIYRDFKTSNILLDTD----YNAKLSDFGLAKDG  230 (389)
Q Consensus       199 ~~ivH~Dlkp~Nili~~~----~~vkl~Dfg~a~~~  230 (389)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            459999999999999874    67999999988754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.98  E-value=0.015  Score=52.81  Aligned_cols=140  Identities=14%  Similarity=0.090  Sum_probs=75.5

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCC--ccceEEeE-----EEeCCe
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP--NLVKLIGY-----CCEDEH  150 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~  150 (389)
                      ..|+ |....||+.....       +..+++|+......  ....+..|..+++.+...  .+++++..     ....+.
T Consensus        32 ~~l~-g~~n~~y~v~~~~-------g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~  101 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDED-------RRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGF  101 (328)
T ss_dssp             EEEC-CSSSEEEEECCTT-------CCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTE
T ss_pred             Eeec-CcccceEEEEcCC-------CCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCE
Confidence            4566 7788999864321       12399999874321  223455677777766421  13333332     223566


Q ss_pred             EEEEEEecCCCChhh----h----------hhc----CC---CCCCCHHHH----HHH---------------HHHHHHH
Q 016481          151 RVLIYEFMARGSVEN----N----------LFS----KV---LLPLPWSIR----MKI---------------AFGAAKG  190 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~----~----------l~~----~~---~~~~~~~~~----~~i---------------~~~i~~~  190 (389)
                      .++||++++|..+..    .          ++.    ..   .........    ..+               ...+...
T Consensus       102 ~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  181 (328)
T 1zyl_A          102 YFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDEL  181 (328)
T ss_dssp             EEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHH
T ss_pred             EEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHH
Confidence            788999998754321    0          110    00   001121110    000               0011112


Q ss_pred             HHHHHh-----CCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          191 LAFLHE-----AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       191 l~~LH~-----~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ++.+..     ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       182 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          182 IAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            222221     224489999999999998 4 899999987764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.92  E-value=0.0026  Score=59.28  Aligned_cols=81  Identities=10%  Similarity=0.030  Sum_probs=43.0

Q ss_pred             cceecCCCceEEEEeeeccccc--cCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc-cceEEeEEEeCCeEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLR--EGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN-LVKLIGYCCEDEHRVL  153 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~l  153 (389)
                      .+.|+.|....+|+........  .......+++|+......  .......|..+++.+...+ +.++++..  .+  ++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence            4567788888999976432110  000113488888764321  1112346777887775323 44666544  22  68


Q ss_pred             EEEecCCCCh
Q 016481          154 IYEFMARGSV  163 (389)
Q Consensus       154 v~e~~~~gsL  163 (389)
                      ||||++|.++
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.64  E-value=0.0081  Score=55.22  Aligned_cols=31  Identities=13%  Similarity=0.158  Sum_probs=27.2

Q ss_pred             CCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       199 ~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3599999999999999888899999987664

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.38  E-value=0.06  Score=50.95  Aligned_cols=81  Identities=14%  Similarity=0.041  Sum_probs=46.3

Q ss_pred             cceecCCCceEEEEeeecccccc-CcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCCeEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  154 (389)
                      .+.|..|-...+|+......... ......+++++.......  .....+|..+++.+. +.-..++++.+  .+  ++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence            45677788889999865421110 011244888886543211  112236888887775 32234555533  22  689


Q ss_pred             EEecCCCCh
Q 016481          155 YEFMARGSV  163 (389)
Q Consensus       155 ~e~~~~gsL  163 (389)
                      ++|++|.+|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.69  E-value=0.98  Score=42.16  Aligned_cols=29  Identities=28%  Similarity=0.318  Sum_probs=24.4

Q ss_pred             ceecCCCCCCeEE------cCCCcEEEeccCCCcC
Q 016481          201 VIYRDFKTSNILL------DTDYNAKLSDFGLAKD  229 (389)
Q Consensus       201 ivH~Dlkp~Nili------~~~~~vkl~Dfg~a~~  229 (389)
                      ++|+|+.+.|||+      +.+..+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4457799999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.14  E-value=0.69  Score=39.02  Aligned_cols=116  Identities=7%  Similarity=0.051  Sum_probs=77.1

Q ss_pred             CCCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEE
Q 016481          134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILL  213 (389)
Q Consensus       134 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili  213 (389)
                      .||+.+.. .+-..++.+.+.++.-+.+.-...+     ...+....++++.+++....+++.    =+|--|.|+|+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE
Confidence            48888876 5666667766666654332222222     246778889999998887755542    5788899999999


Q ss_pred             cCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCC
Q 016481          214 DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD  283 (389)
Q Consensus       214 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~  283 (389)
                      +.++.+++.-.|+-..+.+                   .     .++...=.-.+=+++..+++|+..|.
T Consensus       113 ~~~~~p~i~~RGik~~l~P-------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVDP-------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CTTSCEEESCCEETTTBSC-------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cCCCCEEEEEccCccCCCC-------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999998886433221                   1     11112223356778888999988775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.71  E-value=0.078  Score=50.86  Aligned_cols=63  Identities=11%  Similarity=0.110  Sum_probs=17.1

Q ss_pred             cccceecCCCceEEEEeeeccccccCcCcccEEE------EEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           75 RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAV------KVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vai------K~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      .+.+.||   ||.||+|.+....      .+||+      |...... .......+.+|..+++.+.|+|+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~------~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKH------MPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccC------CchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4456676   9999999875421      23666      6655422 2233456778889999999999999988764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.01  E-value=1.8  Score=36.63  Aligned_cols=115  Identities=8%  Similarity=0.066  Sum_probs=74.9

Q ss_pred             CCCccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceecCCCCCCeE
Q 016481          134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA-FLHEAEKPVIYRDFKTSNIL  212 (389)
Q Consensus       134 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~ivH~Dlkp~Nil  212 (389)
                      .||++  -..+-.+++.+.+.++.-+++.-...+.     .++....++++.+++.... +++  .  -+|--|.|+|++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEE
Confidence            47777  3444567777777777654443333332     4677788888888776554 333  2  688889999999


Q ss_pred             EcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCC
Q 016481          213 LDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLD  283 (389)
Q Consensus       213 i~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~  283 (389)
                      ++.++.+++...|+-..+                   +|.-+     +..-=+-.+=+++..++.++..|.
T Consensus       117 f~~~~~p~i~hRGi~~~l-------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESL-------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETTTB-------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCcccC-------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999998864322                   22111     111113356677888888877664

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	389
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-70
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-65
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-64
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-62
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-60
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-52
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-45
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 7e-70
 Identities = 79/296 (26%), Positives = 123/296 (41%), Gaps = 29/296 (9%)

Query: 65  DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREW 123
           D+  I        + +G G FG VYKG    D         VAVK+ +    + Q  + +
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAF 51

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
             EV  L    H N++  +GY        ++ ++    S+ ++L             + I
Sbjct: 52  KNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDI 109

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           A   A+G+ +LH   K +I+RD K++NI L  D   K+ DFGLA        SH   ++ 
Sbjct: 110 ARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167

Query: 244 GTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
           G+  + APE I        + +SDVY+FG+VL E++TG+       P    N  D  + +
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFM 221

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
           +         + P L              L   CL      RPL   I+ S+E L 
Sbjct: 222 VGR-----GYLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  208 bits (531), Expect = 1e-65
 Identities = 71/312 (22%), Positives = 131/312 (41%), Gaps = 34/312 (10%)

Query: 62  FTYDELRIITANF---------RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHD 112
           FT+++       F         + ++V+G G FG V  G        G + + VA+K   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSG---HLKLPGKREIFVAIKTLK 63

Query: 113 GDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVL 172
              + +  R++L+E   +G   HPN++ L G   +    ++I EFM  GS++ +   +  
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQND 122

Query: 173 LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPE 232
                   + +  G A G+ +L   +   ++RD    NIL++++   K+SDFGL++   +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 233 GDKSHVSTR---IMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAR 289
                  T          + APE I     T  SDV+S+G+V+ E+++  +     RP  
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYW 235

Query: 290 EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIV 349
           +    D           ++N I+       P+        L   C   +   RP    IV
Sbjct: 236 DMTNQD-----------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 350 DSLEPLQVLPDE 361
           ++L+ +   P+ 
Sbjct: 285 NTLDKMIRNPNS 296

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 2e-64
 Identities = 73/301 (24%), Positives = 128/301 (42%), Gaps = 22/301 (7%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 128
           I  +   + +V+G G FG VYKG +      G + VPVA+K      + +   ++L E  
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
            +G  SH N+++L G   + +  ++I E+M  G+  +    +          + +  G A
Sbjct: 62  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG-DKSHVSTRIMGTYG 247
            G+ +L       ++RD    NIL++++   K+SDFGL++   +  + ++ ++       
Sbjct: 121 AGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 307
           + APE I     T  SDV+SFG+V+ E++T  +         E                +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------V 222

Query: 308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTPKN 367
           +  I+       P+        L   C       RP   DIV  L+ L   PD   T  +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282

Query: 368 F 368
           F
Sbjct: 283 F 283

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-62
 Identities = 74/315 (23%), Positives = 116/315 (36%), Gaps = 41/315 (13%)

Query: 62  FTYDELRIITA-NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGH 120
           + YD        N    +VLG G FG V         + G   + VAVK+          
Sbjct: 26  YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTG-VSIQVAVKMLKEKADSSER 84

Query: 121 REWLAEVIFLGHL-SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------- 170
              ++E+  +  L SH N+V L+G C       LI+E+   G + N L SK         
Sbjct: 85  EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144

Query: 171 ------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYN 218
                        L  L +   +  A+  AKG+ FL    K  ++RD    N+L+     
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKV 202

Query: 219 AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG 278
            K+ DFGLA+D        V         + APE +  G  T +SDV+S+G++L EI + 
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262

Query: 279 RKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHN 338
             +     P                      +I    + D P     +  ++   C   +
Sbjct: 263 GVNPYPGIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD 307

Query: 339 PKARPLMRDIVDSLE 353
            + RP   ++   L 
Sbjct: 308 SRKRPSFPNLTSFLG 322

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (507), Expect = 4e-62
 Identities = 71/292 (24%), Positives = 119/292 (40%), Gaps = 27/292 (9%)

Query: 64  YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW 123
           YD+  +   +      LGGG +G VY+G   +          VAVK    D       E+
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT------VAVKTLKEDT--MEVEEF 60

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
           L E   +  + HPNLV+L+G C  +    +I EFM  G++ + L       +   + + +
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
           A   +  + +L   +K  I+RD    N L+  ++  K++DFGL++    GD         
Sbjct: 121 ATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 177

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 303
               + APE +     + +SDV++FGV+L EI T   S        +             
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------- 224

Query: 304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
              +  +++     + P     K   L   C   NP  RP   +I  + E +
Sbjct: 225 ---VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 5e-62
 Identities = 70/310 (22%), Positives = 130/310 (41%), Gaps = 23/310 (7%)

Query: 67  LRIITAN-FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           LRI+    F++ +VLG G FG VYKG    +  +    +PVA+K      S + ++E L 
Sbjct: 3   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILD 60

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E   +  + +P++ +L+   C      LI + M  G + + +       +     +    
Sbjct: 61  EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCV 118

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             AKG+ +L +  + +++RD    N+L+ T  + K++DFGLAK     +K + +      
Sbjct: 119 QIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 246 YGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK 305
             + A E I+    T +SDV+S+GV + E++T         PA E               
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------- 221

Query: 306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLPDEAPTP 365
            + +I++       P        M+   C   +  +RP  R+++     +   P      
Sbjct: 222 -ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280

Query: 366 KNFVTVVTPE 375
           +    +  P 
Sbjct: 281 QGDERMHLPS 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-61
 Identities = 80/316 (25%), Positives = 129/316 (40%), Gaps = 37/316 (11%)

Query: 43  NPEEVEDLRRDSAANPLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQ 102
           NPE V+ ++        +      L +   +F  + V+G G FGCVY G     L    +
Sbjct: 10  NPELVQAVQH-------VVIGPSSLIV---HF--NEVIGRGHFGCVYHG---TLLDNDGK 54

Query: 103 PVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRV-LIYEFMARG 161
            +  AVK  +         ++L E I +   SHPN++ L+G C   E    ++  +M  G
Sbjct: 55  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114

Query: 162 SVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 221
            + N               +      AKG+ FL    K  ++RD    N +LD  +  K+
Sbjct: 115 DLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKV 171

Query: 222 SDFGLAKD--GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR 279
           +DFGLA+D    E D  H  T       + A E + T   T +SDV+SFGV+L E++T  
Sbjct: 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231

Query: 280 KSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNP 339
                  P  + N  D  + LL+ ++ L            P         +   C +   
Sbjct: 232 A-----PPYPDVNTFDITVYLLQGRRLLQ-----------PEYCPDPLYEVMLKCWHPKA 275

Query: 340 KARPLMRDIVDSLEPL 355
           + RP   ++V  +  +
Sbjct: 276 EMRPSFSELVSRISAI 291

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-61
 Identities = 72/291 (24%), Positives = 119/291 (40%), Gaps = 29/291 (9%)

Query: 65  DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +     +    LG G FG V+ G+ +           VAVK     +       +L
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLKQGS--MSPDAFL 56

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
           AE   +  L H  LV+L       E   +I E+M  GS+ + L +   + L  +  + +A
Sbjct: 57  AEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
              A+G+AF+ E  +  I+RD + +NIL+    + K++DFGLA+   + ++         
Sbjct: 116 AQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKF 172

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 304
              + APE I  G  T +SDV+SFG++L EI+T  +         E              
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------------- 218

Query: 305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
             ++  ++       P     +   L   C    P+ RP    +   LE  
Sbjct: 219 --VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 7e-61
 Identities = 64/308 (20%), Positives = 116/308 (37%), Gaps = 39/308 (12%)

Query: 67  LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAE 126
           + +   +F +   LG G  G V+K         G   + +A K+   +       + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKV---SHKPSG---LVMARKLIHLEIKPAIRNQIIRE 54

Query: 127 VIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
           +  L   + P +V   G    D    +  E M  GS++  L       +P  I  K++  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIA 112

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
             KGL +L E +  +++RD K SNIL+++    KL DFG++    +     ++   +GT 
Sbjct: 113 VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 167

Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRK----------------------SLDK 284
            Y +PE +   H + +SD++S G+ L+E+  GR                       +   
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 285 SRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHK----AAMLAYHCLNHNPK 340
            RP              +    +  ++D  +    P                 CL  NP 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 341 ARPLMRDI 348
            R  ++ +
Sbjct: 288 ERADLKQL 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 2e-60
 Identities = 61/281 (21%), Positives = 108/281 (38%), Gaps = 29/281 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           +    + LG G FG V  G              VA+K+           E++ E   + +
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIK--EGSMSEDEFIEEAKVMMN 55

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
           LSH  LV+L G C +     +I E+MA G + N L             +++     + + 
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAME 114

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
           +L    K  ++RD    N L++     K+SDFGL++   + D+   S        ++ PE
Sbjct: 115 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPE 171

Query: 253 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID 312
            +M    + +SD+++FGV++ EI +  K   +     E                    I 
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIA 215

Query: 313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
             L    P     K   + Y C +     RP  + ++ ++ 
Sbjct: 216 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 3e-60
 Identities = 68/284 (23%), Positives = 119/284 (41%), Gaps = 29/284 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
                + +G G FG V+ G+     +       VA+K            +++ E   +  
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDK-------VAIKTIR--EGAMSEEDFIEEAEVMMK 56

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
           LSHP LV+L G C E     L++EFM  G + + L ++  L       + +     +G+A
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMA 115

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
           +L E    VI+RD    N L+  +   K+SDFG+ +   + D+   ST       +A+PE
Sbjct: 116 YLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE 172

Query: 253 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID 312
                  + +SDV+SFGV++ E+ +  K   ++R   E         ++++      +  
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYK 223

Query: 313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
           PRL              +  HC    P+ RP    ++  L  + 
Sbjct: 224 PRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 4e-60
 Identities = 68/302 (22%), Positives = 112/302 (37%), Gaps = 37/302 (12%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN 137
             +G G FG V++G    +         VAVK+          RE  AE+     L H N
Sbjct: 9   ESIGKGRFGEVWRGKWRGE--------EVAVKIFSSREERSWFRE--AEIYQTVMLRHEN 58

Query: 138 LVKLIGYCCEDE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 193
           ++  I    +D        L+ ++   GS+ + L       +     +K+A   A GLA 
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAH 115

Query: 194 LHE------AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK--DGPEGDKSHVSTRIMGT 245
           LH        +  + +RD K+ NIL+  +    ++D GLA   D             +GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 246 YGYAAPEYIMT------GHLTPRSDVYSFGVVLLEILTGRK----SLDKSRPAREQNLAD 295
             Y APE +             R+D+Y+ G+V  EI           D   P  +   +D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 296 WALPLLKEKKKLLNIIDPRLEGDY-PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 354
            ++  ++ K      + P +   +   + +   A +   C   N  AR     I  +L  
Sbjct: 236 PSVEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

Query: 355 LQ 356
           L 
Sbjct: 295 LS 296

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 1e-59
 Identities = 69/308 (22%), Positives = 119/308 (38%), Gaps = 29/308 (9%)

Query: 58  PLIAFTYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY 117
                  D   I   + R +  LG G FG V+ G  +   R       VA+K        
Sbjct: 3   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-------VAIKTLK--PGT 53

Query: 118 QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW 177
                +L E   +  L H  LV+L     E+    ++ E+M++GS+ + L  +    L  
Sbjct: 54  MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRL 112

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
              + +A   A G+A++       ++RD + +NIL+  +   K++DFGLA+   + ++  
Sbjct: 113 PQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYT 169

Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 297
                     + APE  + G  T +SDV+SFG++L E+ T  +        RE       
Sbjct: 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------- 222

Query: 298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV 357
                    +L+ ++       P +       L   C    P+ RP    +   LE    
Sbjct: 223 ---------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

Query: 358 LPDEAPTP 365
             +    P
Sbjct: 274 STEPQYQP 281

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-59
 Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 35/285 (12%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
             +  + +G G FG V  G          +   VAVK    D + Q    +LAE   +  
Sbjct: 8   ELKLLQTIGKGEFGDVMLGD--------YRGNKVAVKCIKNDATAQ---AFLAEASVMTQ 56

Query: 133 LSHPNLVKLIGYCCEDEHRV-LIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
           L H NLV+L+G   E++  + ++ E+MA+GS+ + L S+    L     +K +    + +
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
            +L       ++RD    N+L+  D  AK+SDFGL K+      S           + AP
Sbjct: 117 EYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAP 169

Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 311
           E +     + +SDV+SFG++L EI +  +      P ++                ++  +
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRV 213

Query: 312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
           +   + D P         +  +C + +   RP    + + LE ++
Sbjct: 214 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-59
 Identities = 70/290 (24%), Positives = 120/290 (41%), Gaps = 26/290 (8%)

Query: 66  ELRIITANFR-QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           +L +   N    D  LG G FG V +G      R   + + VA+KV           E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMM 57

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            E   +  L +P +V+LIG  C+ E  +L+ E    G +   L  K    +P S   ++ 
Sbjct: 58  REAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELL 115

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGDKSHVSTRIM 243
              + G+ +L E  K  ++RD    N+LL   + AK+SDFGL+K  G +       +   
Sbjct: 116 HQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE 303
               + APE I     + RSDV+S+GV + E L+  +     +P ++    +        
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE-------- 220

Query: 304 KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
              ++  I+     + P +   +   L   C  +  + RP    +   + 
Sbjct: 221 ---VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 5e-59
 Identities = 72/298 (24%), Positives = 109/298 (36%), Gaps = 35/298 (11%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
                + LG G FG V +      ++     + VAVK+             ++E+  L +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAA-MTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 133 LS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK----------------VLLPL 175
           L  H N+V L+G C      ++I E+   G + N L  K                  L L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 176 PWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK 235
                +  ++  AKG+AFL    K  I+RD    NILL      K+ DFGLA+D      
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 236 SHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD 295
             V         + APE I     T  SDV+S+G+ L E+ +   S     P   +    
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---- 256

Query: 296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                         +I        P     +   +   C + +P  RP  + IV  +E
Sbjct: 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 6e-59
 Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 26/277 (9%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           ++   + LG G +G V                 VAVK+ D   +         E+     
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEA------VAVKIVDMKRAVDCPENIKKEICINKM 59

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
           L+H N+VK  G+  E   + L  E+ + G + + +   +   +P     +       G+ 
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 117

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
           +LH     + +RD K  N+LLD   N K+SDFGLA      ++  +  ++ GT  Y APE
Sbjct: 118 YLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 253 YIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 311
            +          DV+S G+VL  +L G    D+   + ++                 +  
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWK 220

Query: 312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
           + +   +   K       L +  L  NP AR  + DI
Sbjct: 221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (485), Expect = 8e-59
 Identities = 72/314 (22%), Positives = 116/314 (36%), Gaps = 41/314 (13%)

Query: 64  YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW 123
              L     N    R +G G FG V++   +  L        VAVK+   + S     ++
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQA-RAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK------------- 170
             E   +    +PN+VKL+G C   +   L++E+MA G +   L S              
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 171 ---------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL 221
                       PL  + ++ IA   A G+A+L E  +  ++RD  T N L+  +   K+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKI 181

Query: 222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS 281
           +DFGL+++    D             +  PE I     T  SDV+++GVVL EI +    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 282 LDKSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKA 341
                   E                +  + D  +    P     +   L   C +  P  
Sbjct: 242 PYYGMAHEEV---------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPAD 285

Query: 342 RPLMRDIVDSLEPL 355
           RP    I   L+ +
Sbjct: 286 RPSFCSIHRILQRM 299

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-58
 Identities = 70/298 (23%), Positives = 118/298 (39%), Gaps = 40/298 (13%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           + +   V+G G FG V K      +++    +  A+K      S   HR++  E+  L  
Sbjct: 11  DIKFQDVIGEGNFGQVLKAR----IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66

Query: 133 LS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--------------PLPW 177
           L  HPN++ L+G C    +  L  E+   G++ + L    +L               L  
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSH 237
              +  A   A+G+ +L +  K  I+RD    NIL+  +Y AK++DFGL++      K  
Sbjct: 127 QQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 297
           +         + A E +     T  SDV+S+GV+L EI++   +     P      A+  
Sbjct: 185 MGR---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAE-- 234

Query: 298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
                    L   +      + P+    +   L   C    P  RP    I+ SL  +
Sbjct: 235 ---------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 2e-57
 Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 27/281 (9%)

Query: 76  QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGHLS 134
           +D+ LG G FG V KG+     +       VAVK+  +  N      E LAE   +  L 
Sbjct: 11  EDKELGSGNFGTVKKGY----YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 66

Query: 135 HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFL 194
           +P +V++IG  CE E  +L+ E    G +   L       +     +++    + G+ +L
Sbjct: 67  NPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYL 123

Query: 195 HEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEG-DKSHVSTRIMGTYGYAAPEY 253
            E     ++RD    N+LL T + AK+SDFGL+K      +     T       + APE 
Sbjct: 124 EE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181

Query: 254 IMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP 313
           I     + +SDV+SFGV++ E  +  +     +P R    ++           +  +++ 
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE-----------VTAMLEK 225

Query: 314 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP 354
                 P     +   L   C  ++ + RP    +   L  
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-57
 Identities = 72/287 (25%), Positives = 112/287 (39%), Gaps = 25/287 (8%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 130
           + R    LG G FG V +G       +    V VAVK    D  +  +   +++ EV  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKT---VSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
             L H NL++L G       + ++ E    GS+ + L              + A   A+G
Sbjct: 66  HSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEG 123

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHV-STRIMGTYGYA 249
           + +L    K  I+RD    N+LL T    K+ DFGL +  P+ D  +V        + + 
Sbjct: 124 MGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 309
           APE + T   +  SD + FGV L E+ T  +      P    N +     + KE ++L  
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERL-- 234

Query: 310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
                     P         +   C  H P+ RP    + D L   Q
Sbjct: 235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-56
 Identities = 62/283 (21%), Positives = 106/283 (37%), Gaps = 34/283 (12%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVIFLGH 132
            + D  +G G F  VYKG  +E   E      VA     D   +    + +  E   L  
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVE------VAWCELQDRKLTKSERQRFKEEAEMLKG 64

Query: 133 LSHPNLVKLIGYCCE----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
           L HPN+V+            +  VL+ E M  G+++  L       +   +         
Sbjct: 65  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQIL 122

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILL-DTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           KGL FLH    P+I+RD K  NI +     + K+ D GLA       ++  +  ++GT  
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPE 178

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 307
           + APE           DVY+FG+ +LE+ T      + + A +                 
Sbjct: 179 FMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------Y 222

Query: 308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
             +        +    + +   +   C+  N   R  ++D+++
Sbjct: 223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 5e-55
 Identities = 68/280 (24%), Positives = 107/280 (38%), Gaps = 34/280 (12%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 130
           +F   R LG G FG VY     +          +A+KV             +   EV   
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFI------LALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
            HL HPN+++L GY  +     LI E+   G+V   L                    A  
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANA 118

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L++ H   K VI+RD K  N+LL +    K++DFG +   P   ++ +     GT  Y  
Sbjct: 119 LSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLP 172

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 310
           PE I       + D++S GV+  E L G+       P       +    + + +    + 
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEFTFPDF 226

Query: 311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
           +               A  L    L HNP  RP++R++++
Sbjct: 227 VTE------------GARDLISRLLKHNPSQRPMLREVLE 254

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 76/297 (25%), Positives = 131/297 (44%), Gaps = 27/297 (9%)

Query: 65  DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL 124
           DE  +        R LG G FG VY+G     +++  +   VA+K  +   S +   E+L
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFL 71

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLF--------SKVLLPLP 176
            E   +   +  ++V+L+G   + +  ++I E M RG +++ L         + VL P  
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
            S  +++A   A G+A+L+      ++RD    N ++  D+  K+ DFG+ +D  E D  
Sbjct: 132 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
               + +    + +PE +  G  T  SDV+SFGVVL EI T  +   +     +      
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----- 244

Query: 297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
                     L  +++  L  D P         L   C  +NPK RP   +I+ S++
Sbjct: 245 ----------LRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-54
 Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 24/283 (8%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
                R +G G FG V++G            + VA+K      S     ++L E + +  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPA---LAVAIKTCKNCTSDSVREKFLQEALTMRQ 64

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
             HP++VKLIG   E+    +I E    G + +         L  +  +  A+  +  LA
Sbjct: 65  FDHPHIVKLIGVITEN-PVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALA 122

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
           +L    K  ++RD    N+L+ ++   KL DFGL++   +    + +++      + APE
Sbjct: 123 YLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPE 179

Query: 253 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID 312
            I     T  SDV+ FGV + EIL         +P +     D          ++ N   
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVI-------GRIENGER 227

Query: 313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
             +  + P         L   C  ++P  RP   ++   L  +
Sbjct: 228 LPMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 8e-54
 Identities = 77/302 (25%), Positives = 120/302 (39%), Gaps = 39/302 (12%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
            +     LG G FG VYK    ++       V  A KV D   S +   +++ E+  L  
Sbjct: 13  FWEIIGELGDGAFGKVYKA---QNKETS---VLAAAKVID-TKSEEELEDYMVEIDILAS 65

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
             HPN+VKL+     + +  ++ EF A G+V+  +      PL  S    +       L 
Sbjct: 66  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALN 124

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
           +LH+    +I+RD K  NIL   D + KL+DFG++       +       +GT  + APE
Sbjct: 125 YLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPE 180

Query: 253 YIMT-----GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 307
            +M           ++DV+S G+ L+E+           P  E N     L + K +   
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKSEPPT 234

Query: 308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI-------VDSLEPLQVLPD 360
           L           P +           CL  N  AR     +       VDS +P++ L  
Sbjct: 235 L---------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIA 285

Query: 361 EA 362
           EA
Sbjct: 286 EA 287

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 9e-54
 Identities = 58/286 (20%), Positives = 108/286 (37%), Gaps = 33/286 (11%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-WLAEVIFLG 131
           ++     +G G +G   K     D +       +  K  D  +  +  ++  ++EV  L 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKI------LVWKELDYGSMTEAEKQMLVSEVNLLR 58

Query: 132 HLSHPNLVKLIGYCCEDEHRVL--IYEFMARGSVENNLF--SKVLLPLPWSIRMKIAFGA 187
            L HPN+V+      +  +  L  + E+   G + + +   +K    L     +++    
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 188 AKGLAFLHE---AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
              L   H        V++RD K +N+ LD   N KL DFGLA+       +  +   +G
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVG 176

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 304
           T  Y +PE +       +SD++S G +L E+           P    +  + A       
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELA------- 223

Query: 305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD 350
            K+      R+   Y      +   +    LN     RP + +I++
Sbjct: 224 GKIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-53
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 34/299 (11%)

Query: 73  NFRQDRVLGGGGFGCVYKGF-ISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLG 131
                + LG G FG V     I  D  +  +   VAVK+   D + +   + ++E+  + 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 132 HLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSK--------------VLLPLP 176
            +  H N++ L+G C +D    +I E+ ++G++   L ++                  L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
               +  A+  A+G+ +L    K  I+RD    N+L+  D   K++DFGLA+D    D  
Sbjct: 134 SKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
             +T       + APE +     T +SDV+SFGV+L EI T   S     P  E      
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------ 245

Query: 297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
                     L  ++      D P    ++  M+   C +  P  RP  + +V+ L+ +
Sbjct: 246 ----------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (445), Expect = 1e-52
 Identities = 75/306 (24%), Positives = 110/306 (35%), Gaps = 42/306 (13%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLG 131
           F   R +G G FG VY      +         VA+K   + G  S +  ++ + EV FL 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L HPN ++  G    +    L+ E+    + +     K   PL       +  GA +GL
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGL 128

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           A+LH     +I+RD K  NILL      KL DFG A           +   +GT  + AP
Sbjct: 129 AYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAP 180

Query: 252 EYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL 308
           E I+    G    + DV+S G+  +E+   +       P    N                
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSAL------YHIAQ 228

Query: 309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI-----VDSLEPLQVLPDEAP 363
           N       G +              CL   P+ RP    +     V    P  V+ D   
Sbjct: 229 NESPALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284

Query: 364 TPKNFV 369
             K+ V
Sbjct: 285 RTKDAV 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-52
 Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 34/299 (11%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
             +  + LG G FG V +   +  + +      VAVK+     ++  HR  ++E+  L H
Sbjct: 14  RLKLGKPLGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 133 LSH-PNLVKLIGYCCEDEHRVLI-YEFMARGSVENNLFSK--------------VLLPLP 176
           + H  N+V L+G C +    +++  EF   G++   L SK                  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 177 WSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS 236
               +  +F  AKG+ FL    +  I+RD    NILL      K+ DFGLA+D  +    
Sbjct: 133 LEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 237 HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW 296
                      + APE I     T +SDV+SFGV+L EI +   S     P     + + 
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEE 245

Query: 297 ALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
               LKE  ++            P     +       C +  P  RP   ++V+ L  L
Sbjct: 246 FCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-49
 Identities = 64/286 (22%), Positives = 101/286 (35%), Gaps = 30/286 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 130
           +F+  ++LG G F  V         RE       A+K+                 E   +
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSRE------YAIKILEKRHIIKENKVPYVTRERDVM 62

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
             L HP  VKL     +DE       +   G +   +          +            
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSA 120

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L +LH   K +I+RD K  NILL+ D + +++DFG AK      K   +   +GT  Y +
Sbjct: 121 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 310
           PE +        SD+++ G ++ +++ G        P R  N          E      I
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGN----------EYLIFQKI 222

Query: 311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ 356
           I  +LE D+P K   KA  L    L  +   R    ++        
Sbjct: 223 I--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 3e-49
 Identities = 55/276 (19%), Positives = 105/276 (38%), Gaps = 29/276 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
            + +   +G G  G VY        +E      VA++  +           + E++ +  
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQE------VAIRQMNLQQQ-PKKELIINEILVMRE 73

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
             +PN+V  +      +   ++ E++A GS+ + +       +       +     + L 
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALE 130

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPE 252
           FLH     VI+RD K+ NILL  D + KL+DFG         +    + ++GT  + APE
Sbjct: 131 FLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPE 186

Query: 253 YIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIID 312
            +      P+ D++S G++ +E++ G        P R                  L   +
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---------------LIATN 231

Query: 313 PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
              E   P K           CL+ + + R   +++
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  154 bits (389), Expect = 7e-45
 Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 32/295 (10%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEV 127
           ++  +    +LG GG   V+      DLR       VAVKV   D       +  +  E 
Sbjct: 5   LSDRYELGEILGFGGMSEVHLA---RDLRLH---RDVAVKVLRADLARDPSFYLRFRREA 58

Query: 128 IFLGHLSHPNLVKLIGYCCEDEHR----VLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
                L+HP +V +      +        ++ E++   ++ + + ++   P+     +++
Sbjct: 59  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEV 116

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGDKSHVSTRI 242
              A + L F H+    +I+RD K +NI++      K+ DFG+A+     G+    +  +
Sbjct: 117 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK 302
           +GT  Y +PE      +  RSDVYS G VL E+LTG        P    +    A   ++
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVR 228

Query: 303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-MRDIVDSLEPLQ 356
           E     +     L  D           +    L  NP+ R     ++   L  + 
Sbjct: 229 EDPIPPSARHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  154 bits (390), Expect = 4e-44
 Identities = 59/278 (21%), Positives = 97/278 (34%), Gaps = 29/278 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
           ++     LG G FG V++                A K     +          E+  +  
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNN------FAAKFVMTPHE-SDKETVRKEIQTMSV 79

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
           L HP LV L     +D   V+IYEFM+ G +   +  +    +     ++      KGL 
Sbjct: 80  LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLC 138

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYN--AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
            +H  E   ++ D K  NI+  T  +   KL DFGL           V+T   GT  +AA
Sbjct: 139 HMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAA 193

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 310
           PE      +   +D++S GV+   +L+G        P   +N  +    +      + + 
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNMDDS 247

Query: 311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
               +  D                L  +P  R  +   
Sbjct: 248 AFSGISED--------GKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  154 bits (389), Expect = 5e-44
 Identities = 52/281 (18%), Positives = 102/281 (36%), Gaps = 29/281 (10%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
           +   +     LG G FG V++       R          K  +             E+  
Sbjct: 27  VYDYYDILEELGSGAFGVVHRCVEKATGRV------FVAKFINTPYP-LDKYTVKNEISI 79

Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
           +  L HP L+ L     +    VLI EF++ G + + + ++    +  +  +     A +
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACE 138

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
           GL  +HE    +++ D K  NI+ +T   +  K+ DFGLA      +          T  
Sbjct: 139 GLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAE 193

Query: 248 YAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL 307
           +AAPE +    +   +D+++ GV+   +L+G        P   ++  +    + +   + 
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEF 247

Query: 308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
                  +  +        A     + L   P+ R  + D 
Sbjct: 248 DEDAFSSVSPE--------AKDFIKNLLQKEPRKRLTVHDA 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 2e-43
 Identities = 78/334 (23%), Positives = 121/334 (36%), Gaps = 50/334 (14%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 130
           +F   ++LG G FG V+     +  +        A+K    D           + E   L
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQF------FAIKALKKDVVLMDDDVECTMVEKRVL 56

Query: 131 GH-LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAK 189
                HP L  +       E+   + E++  G +  ++ S        S     A     
Sbjct: 57  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIIL 114

Query: 190 GLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           GL FLH   K ++YRD K  NILLD D + K++DFG+ K+   GD         GT  Y 
Sbjct: 115 GLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYI 170

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 309
           APE ++        D +SFGV+L E+L G+       P   Q+  +    +  +      
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFYPR 224

Query: 310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKAR----------PLMRDIV-DSLEPLQVL 358
            ++              A  L        P+ R          PL R+I  + LE  ++ 
Sbjct: 225 WLEKE------------AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID 272

Query: 359 PDEAPTPK------NFVTVVTPEEPKAEIQTKDS 386
           P   P  K      NF      E+P+     +  
Sbjct: 273 PPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRAL 306

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (381), Expect = 3e-43
 Identities = 65/288 (22%), Positives = 105/288 (36%), Gaps = 30/288 (10%)

Query: 64  YDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREW 123
           + +   I   +    VLG G F  V      ED R       VA+K              
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILA---EDKRTQ---KLVAIKCIAKKALEGKEGSM 54

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
             E+  L  + HPN+V L        H  LI + ++ G + + +  K           ++
Sbjct: 55  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRL 112

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILL---DTDYNAKLSDFGLAKDGPEGDKSHVST 240
            F     + +LH  +  +++RD K  N+L    D D    +SDFGL+K     D   V +
Sbjct: 113 IFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 167

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
              GT GY APE +     +   D +S GV+   +L G        P  ++N A     +
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQI 221

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
           LK + +  +     +           A     H +  +P+ R      
Sbjct: 222 LKAEYEFDSPYWDDISDS--------AKDFIRHLMEKDPEKRFTCEQA 261

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (378), Expect = 5e-43
 Identities = 58/296 (19%), Positives = 103/296 (34%), Gaps = 31/296 (10%)

Query: 66  ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLA 125
           ELR+    +R  R +G G FG +Y G    D+  G +   VA+K+         H +   
Sbjct: 2   ELRV-GNRYRLGRKIGSGSFGDIYLG---TDIAAGEE---VAIKLECVKTK---HPQLHI 51

Query: 126 EVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAF 185
           E      +     +  I +C  +    ++   +   S+E+ LF+           + +A 
Sbjct: 52  ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLAD 110

Query: 186 GAAKGLAFLHEAEKPVIYRDFKTSNIL---LDTDYNAKLSDFGLAKDGPEGD-----KSH 237
                + ++H   K  I+RD K  N L           + DFGLAK   +          
Sbjct: 111 QMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168

Query: 238 VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 297
            +  + GT  YA+    +    + R D+ S G VL+    G       + A ++      
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK---- 224

Query: 298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE 353
               +  +K ++     L   YP     + A     C +     +P    +     
Sbjct: 225 --YERISEKKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  148 bits (374), Expect = 1e-42
 Identities = 63/291 (21%), Positives = 103/291 (35%), Gaps = 42/291 (14%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--------HDGDNSYQGHREWL 124
           N+    +LG G    V +       +E       AVK+           +   +     L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKE------YAVKIIDVTGGGSFSAEEVQELREATL 57

Query: 125 AEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
            EV  L  +S HPN+++L      +    L+++ M +G + + L  KV   L      KI
Sbjct: 58  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKI 115

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
                + +  LH+    +++RD K  NILLD D N KL+DFG +    + D       + 
Sbjct: 116 MRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVC 170

Query: 244 GTYGYAAPEYIMTGHL------TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA 297
           GT  Y APE I               D++S GV++  +L G        P   +      
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLML 224

Query: 298 LPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
             ++    +  +                    L    L   P+ R    + 
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEA 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  149 bits (378), Expect = 2e-42
 Identities = 61/277 (22%), Positives = 100/277 (36%), Gaps = 35/277 (12%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVI-- 128
           +F   R++G GGFG VY    ++  +        A+K          QG    L E I  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKM------YAMKCLDKKRIKMKQGETLALNERIML 58

Query: 129 -FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGA 187
             +     P +V +       +    I + M  G +  +L          +     A   
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEI 116

Query: 188 AKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYG 247
             GL  +H   + V+YRD K +NILLD   + ++SD GLA D  +          +GT+G
Sbjct: 117 ILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHG 170

Query: 248 YAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK 306
           Y APE +  G      +D +S G +L ++L G     + +   +  +    L        
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------- 223

Query: 307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
               +   L   +      +   L    L  +   R 
Sbjct: 224 ----MAVELPDSFS----PELRSLLEGLLQRDVNRRL 252

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 8e-42
 Identities = 47/278 (16%), Positives = 93/278 (33%), Gaps = 30/278 (10%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH 132
            +     LG G FG V++   +   +          K      + Q       E+  L  
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKT------YMAKFVKVKGTDQ--VLVKKEISILNI 57

Query: 133 LSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
             H N++ L       E  V+I+EF++   +   + +     L     +       + L 
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQ 116

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYNA--KLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           FLH     + + D +  NI+  T  ++  K+ +FG A+    GD   +   +     Y A
Sbjct: 117 FLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYA 171

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 310
           PE      ++  +D++S G ++  +L+G        P   +        ++  +      
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTFDEE 225

Query: 311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
               +  +        A       L    K+R    + 
Sbjct: 226 AFKEISIE--------AMDFVDRLLVKERKSRMTASEA 255

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  146 bits (368), Expect = 1e-41
 Identities = 48/297 (16%), Positives = 94/297 (31%), Gaps = 32/297 (10%)

Query: 69  IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVI 128
           ++  +++  R +G G FG +++G    +L        VA+K     +     R+      
Sbjct: 2   VVGVHYKVGRRIGEGSFGVIFEG---TNLLNN---QQVAIKFEPRRSDAPQLRDEYRTYK 55

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
            L       +  +  +  E  H VL+ + +  G    +L                A    
Sbjct: 56  LLAG--CTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQML 111

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLD-----TDYNAKLSDFGLAKDGPEGDKS-----HV 238
             +  +HE  K ++YRD K  N L+            + DFG+ K   +           
Sbjct: 112 ARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169

Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 298
              + GT  Y +    +    + R D+ + G V +  L G       + A  +       
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK----- 224

Query: 299 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL 355
              +  +K  +     L   +P     +     ++  N    A P    +      +
Sbjct: 225 -YERIGEKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 4e-41
 Identities = 61/295 (20%), Positives = 110/295 (37%), Gaps = 24/295 (8%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIF 129
           +   +     +G G +G V   + + +         VA+K           +  L E+  
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVR------VAIKKISPFEHQTYCQRTLREIKI 59

Query: 130 LGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL-PLPWSIRMKIAFGAA 188
           L    H N++ +           +   ++    +  +L+  +    L         +   
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 119

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD-GPEGDKSHVSTRIMGTYG 247
           +GL ++H     V++RD K SN+LL+T  + K+ DFGLA+   P+ D +   T  + T  
Sbjct: 120 RGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 248 YAAPEYIMTGHLTPRS-DVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL--PLLKEK 304
           Y APE ++      +S D++S G +L E+L+ R          + N     L  P  ++ 
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 305 KKLLNIIDPRLEGDYPVKGV-----------HKAAMLAYHCLNHNPKARPLMRDI 348
             ++N+         P K              KA  L    L  NP  R  +   
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 9e-41
 Identities = 66/311 (21%), Positives = 106/311 (34%), Gaps = 41/311 (13%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWL 124
           +   +     LG G F  V K     +   GLQ    A K                 +  
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKC---REKSTGLQ---YAAKFIKKRRTKSSRRGVSREDIE 61

Query: 125 AEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
            EV  L  + HPN++ L          +LI E +A G + + L  K    L      +  
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFL 119

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD----YNAKLSDFGLAKDGPEGDKSHVST 240
                G+ +LH     + + D K  NI+L          K+ DFGLA     G++     
Sbjct: 120 KQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---K 174

Query: 241 RIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL 300
            I GT  + APE +    L   +D++S GV+   +L+G                      
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------------- 221

Query: 301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI-----VDSLEPL 355
            +E    ++ ++   E +Y       A       L  +PK R  ++D      +   +  
Sbjct: 222 -QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280

Query: 356 QVLPDEAPTPK 366
           Q L      P+
Sbjct: 281 QALSSAWSHPQ 291

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-40
 Identities = 65/293 (22%), Positives = 107/293 (36%), Gaps = 27/293 (9%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-WLAEVIFLG 131
            +     +G G +G V+K     DL+ G + V  A+K        +G     + EV  L 
Sbjct: 8   QYECVAEIGEGAYGKVFKA---RDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLR 62

Query: 132 HLS---HPNLVKLIGYCC----EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIA 184
           HL    HPN+V+L   C     + E ++ +        +   L       +P      + 
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122

Query: 185 FGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMG 244
           F   +GL FLH     V++RD K  NIL+ +    KL+DFGLA+           T ++ 
Sbjct: 123 FQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVV 177

Query: 245 TYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 304
           T  Y APE ++        D++S G +  E+   +     S    +       + L  E+
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 305 ---------KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
                    ++  +    +    +          L   CL  NP  R      
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  143 bits (361), Expect = 2e-40
 Identities = 62/273 (22%), Positives = 106/273 (38%), Gaps = 35/273 (12%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 130
           +F+  R LG G FG V+      + R        A+KV   +     +       E + L
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRY------YAMKVLKKEIVVRLKQVEHTNDERLML 58

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
             ++HP ++++ G   + +   +I +++  G + + L        P  +    A      
Sbjct: 59  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLA 116

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L +LH   K +IYRD K  NILLD + + K++DFG AK  P+   +       GT  Y A
Sbjct: 117 LEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIA 169

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 310
           PE + T       D +SFG+++ E+L G        P  + N       +L  + +    
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYT------PFYDSNTMKTYEKILNAELRFPPF 223

Query: 311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
            +                 L    +  +   R 
Sbjct: 224 FNE------------DVKDLLSRLITRDLSQRL 244

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 62/288 (21%), Positives = 112/288 (38%), Gaps = 22/288 (7%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQG-HREWLAEVIFLG 131
           NF++   +G G +G VYK               VA+K    D   +G     + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEV------VALKKIRLDTETEGVPSTAIREISLLK 56

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L+HPN+VKL+     +    L++EF+ +   +  + +  L  +P  +     F   +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDL-KKFMDASALTGIPLPLIKSYLFQLLQGL 115

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           AF H     V++RD K  N+L++T+   KL+DFGLA+      +   +  ++  +  A  
Sbjct: 116 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPE 172

Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 311
             +   + +   D++S G +  E++T R          +       L    E        
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232

Query: 312 DPRLEGDYPVKGVHK-----------AAMLAYHCLNHNPKARPLMRDI 348
            P  +  +P                    L    L+++P  R   +  
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-39
 Identities = 71/307 (23%), Positives = 117/307 (38%), Gaps = 31/307 (10%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV----HDGDNSYQGHREWLAEVIFLGHL 133
             LG G F  VYK       +       VA+K     H  +     +R  L E+  L  L
Sbjct: 4   DFLGEGQFATVYKARDKNTNQI------VAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57

Query: 134 SHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAF 193
           SHPN++ L+       +  L+++FM   +    +     L L  S          +GL +
Sbjct: 58  SHPNIIGLLDAFGHKSNISLVFDFM--ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 194 LHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEY 253
           LH  +  +++RD K +N+LLD +   KL+DFGLAK     ++++  T  + T  Y APE 
Sbjct: 116 LH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPEL 171

Query: 254 IMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQN--LADWALPLLKEKKKLLNI 310
           +    +     D+++ G +L E+L     L       +          P  ++   + ++
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 311 IDPRLEGDYPVKGVHK--------AAMLAYHCLNHNPKARPLMRDIVD----SLEPLQVL 358
            D      +P   +H            L       NP AR      +     S  P    
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291

Query: 359 PDEAPTP 365
             + P P
Sbjct: 292 GCQLPRP 298

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-37
 Identities = 59/284 (20%), Positives = 102/284 (35%), Gaps = 46/284 (16%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-----HDGDNSYQGHREWLAEVI 128
           ++   +LG GGFG VY G     + +    +PVA+K                     EV+
Sbjct: 6   YQVGPLLGSGGFGSVYSG---IRVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVV 59

Query: 129 FLGHLS--HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFG 186
            L  +S     +++L+ +    +  VLI E         +  ++    L   +     + 
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQ 118

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDGPEGDKSHVSTRIMGT 245
             + +   H     V++RD K  NIL+D +    KL DFG         K  V T   GT
Sbjct: 119 VLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGT 172

Query: 246 YGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK 304
             Y+ PE+I    +    + V+S G++L +++ G        P            +++ +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDE------EIIRGQ 220

Query: 305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
                 +              +   L   CL   P  RP   +I
Sbjct: 221 VFFRQRVSS------------ECQHLIRWCLALRPSDRPTFEEI 252

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-37
 Identities = 70/326 (21%), Positives = 114/326 (34%), Gaps = 40/326 (12%)

Query: 68  RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEV 127
           R    ++   +V+G G FG VY+  + +          VA+K        Q  R    E+
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKVL-----QDKRFKNREL 64

Query: 128 IFLGHLSHPNLVKLIGYCCE------DEHRVLIYEFMARGSVENNL-FSKVLLPLPWSIR 180
             +  L H N+V+L  +         + +  L+ +++          +S+    LP    
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 181 MKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDGPEGDKSHVS 239
               +   + LA++H     + +RD K  N+LLD D    KL DFG AK    G+ +   
Sbjct: 125 KLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-- 180

Query: 240 TRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP 299
           + I   Y  A          T   DV+S G VL E+L G+          +       L 
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240

Query: 300 LLKE-----------KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
                          + K   I        +  +   +A  L    L + P AR    + 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

Query: 349 V------DSLEPLQVLPDEAPTPKNF 368
                  +  +P   LP+   TP  F
Sbjct: 301 CAHSFFDELRDPNVKLPNGRDTPALF 326

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  135 bits (339), Expect = 1e-37
 Identities = 54/288 (18%), Positives = 107/288 (37%), Gaps = 24/288 (8%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-WLAEVIFLG 131
            +     +G G +G VYK   +            A+K    +   +G     + E+  L 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGET-------FALKKIRLEKEDEGIPSTTIREISILK 55

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L H N+VKL       +  VL++E + +   +     +    L              G+
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGI 113

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
           A+ H  ++ V++RD K  N+L++ +   K++DFGLA+      + +    I+  +  A  
Sbjct: 114 AYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPD 170

Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE----------QNLADWALPLL 301
             + +   +   D++S G +  E++ G         A +           N  +W     
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 302 KEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMRDI 348
             K      +   L  +  +KG+ ++ + L    L  +P  R   +  
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 7e-37
 Identities = 47/279 (16%), Positives = 95/279 (34%), Gaps = 33/279 (11%)

Query: 77  DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHP 136
            +VLG G  G V + F      +       A+K+    +  +  RE     +       P
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEK------FALKMLQ--DCPKARRE---VELHWRASQCP 65

Query: 137 NLVKLIGYC----CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLA 192
           ++V+++          +  +++ E +  G + + +  +           +I     + + 
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 193 FLHEAEKPVIYRDFKTSNILLDTDYN---AKLSDFGLAKDGPEGDKSHVSTRIMGTYGYA 249
           +LH     + +RD K  N+L  +       KL+DFG AK+    +          T  Y 
Sbjct: 126 YLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYV 180

Query: 250 APEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN 309
           APE +         D++S GV++  +L G        P    +    +  +    +    
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQY 234

Query: 310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
                   +       +  ML  + L   P  R  + + 
Sbjct: 235 EFPNPEWSEVS----EEVKMLIRNLLKTEPTQRMTITEF 269

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-36
 Identities = 62/273 (22%), Positives = 99/273 (36%), Gaps = 32/273 (11%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFL 130
           +F   ++LG G FG V         R        A+K+   +   +       + E   L
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRY------YAMKILRKEVIIAKDEVAHTVTESRVL 59

Query: 131 GHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKG 190
            +  HP L  L       +    + E+   G +  +L  +                    
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSA 117

Query: 191 LAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAA 250
           L +LH   + V+YRD K  N++LD D + K++DFGL K+G     +       GT  Y A
Sbjct: 118 LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLA 173

Query: 251 PEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNI 310
           PE +         D +  GVV+ E++ GR       P   Q+       +L E+ +    
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFPRT 227

Query: 311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
           + P            +A  L    L  +PK R 
Sbjct: 228 LSP------------EAKSLLAGLLKKDPKQRL 248

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 3e-36
 Identities = 58/289 (20%), Positives = 104/289 (35%), Gaps = 24/289 (8%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVK-VHDGDNSYQGHREWLAEVIFLG 131
            + +   +G G +G V+K    E          VA+K V   D+        L E+  L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEI------VALKRVRLDDDDEGVPSSALREICLLK 56

Query: 132 HLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGL 191
            L H N+V+L      D+   L++EF  +   +          L   I     F   KGL
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGL 114

Query: 192 AFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAP 251
            F H   + V++RD K  N+L++ +   KL++FGLA+      + + S  ++  +     
Sbjct: 115 GFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPD 171

Query: 252 EYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII 311
                   +   D++S G +  E+    + L       +Q    + L     +++  ++ 
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 312 DPRLEGDYPVKGVHK------------AAMLAYHCLNHNPKARPLMRDI 348
                  YP+                    L  + L  NP  R    + 
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 7e-36
 Identities = 65/302 (21%), Positives = 113/302 (37%), Gaps = 36/302 (11%)

Query: 73  NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHR-EWLAEVIFLG 131
            + +   +G G FG V+K    +  ++      VA+K    +N  +G     L E+  L 
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQK------VALKKVLMENEKEGFPITALREIKILQ 64

Query: 132 HLSHPNLVKLIGYCCEDEHRV--------LIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
            L H N+V LI  C               L+++F         L S VL+    S   ++
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKRV 122

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVS--TR 241
                 GL ++H     +++RD K +N+L+  D   KL+DFGLA+       S  +  T 
Sbjct: 123 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 242 IMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAR----------- 289
            + T  Y  PE ++      P  D++  G ++ E+ T    +  +               
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 290 --EQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAM-LAYHCLNHNPKARPLMR 346
              +   +     L EK +L+     +++           A+ L    L  +P  R    
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 347 DI 348
           D 
Sbjct: 301 DA 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 7e-35
 Identities = 58/315 (18%), Positives = 111/315 (35%), Gaps = 30/315 (9%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVI 128
           + A +R  + +G G +G V          +      VA+K  +    S    +    E+ 
Sbjct: 16  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAK------VAIKKLYRPFQSELFAKRAYRELR 69

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLL--PLPWSIRMKIAFG 186
            L H+ H N++ L+     DE      +F            K++    L       + + 
Sbjct: 70  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129

Query: 187 AAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTY 246
             KGL ++H     +I+RD K  N+ ++ D   K+ DFGLA+       S ++  ++  +
Sbjct: 130 MLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRW 183

Query: 247 GYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR-------------KSLDKSRPAREQNL 293
             A    +     T   D++S G ++ E++TG+             + +  +     + +
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243

Query: 294 ADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS-- 351
                   K   K L  ++ +            A  L    L  + + R    + +    
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303

Query: 352 LEPLQVLPDEAPTPK 366
            E L    DE    K
Sbjct: 304 FESLHDTEDEPQVQK 318

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (307), Expect = 3e-32
 Identities = 70/362 (19%), Positives = 121/362 (33%), Gaps = 34/362 (9%)

Query: 38  SKLPSNPEEVEDLRRDSAANPLIAFTYDELRIITAN-FRQDRVLGGGGFGCVYKGFISED 96
           +K  S  E V++    +  + L  +          + F + + LG G FG V      E 
Sbjct: 6   AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES 65

Query: 97  LREGLQPVPVAVKV--HDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLI 154
                     A+K+         +     L E   L  ++ P LVKL     ++ +  ++
Sbjct: 66  GNH------YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119

Query: 155 YEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD 214
            E++A G + ++L                A        +LH     +IYRD K  N+L+D
Sbjct: 120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLID 175

Query: 215 TDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLE 274
                +++DFG AK       +     + GT    APE I++       D ++ GV++ E
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 275 ILTGRKSLDKSRPAREQNLADWALPLLKEK--KKLLNIIDPRLEGDYPVKGVHKAAMLAY 332
           +  G       +P +                   L +++   L+ D   K          
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD-LTKRFGNLKNGVN 289

Query: 333 HCLNHNPKARPLMRDI-VDSLEPLQVLPDEAPTPK------NFVTVVTPEEPKAEIQTKD 385
              NH              ++   +V     P  K      NF      EE +  I  K 
Sbjct: 290 DIKNH-----KWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD-YEEEEIRVSINEKC 343

Query: 386 SQ 387
            +
Sbjct: 344 GK 345

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (296), Expect = 6e-31
 Identities = 55/313 (17%), Positives = 110/313 (35%), Gaps = 44/313 (14%)

Query: 62  FTYDELRIITAN---FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ 118
           + Y+   +   N   ++  R LG G +  V++     ++    +   V VK+        
Sbjct: 22  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEA---INITNNEK---VVVKILKPVK--- 72

Query: 119 GHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPW 177
             ++   E+  L +L   PN++ L     +   R     F     V N  F ++   L  
Sbjct: 73  -KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTD 128

Query: 178 SIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD-YNAKLSDFGLAKDGPEGDKS 236
                  +   K L + H     +++RD K  N+++D +    +L D+GLA+    G + 
Sbjct: 129 YDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186

Query: 237 HVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQ---- 291
                 + +  +  PE ++         D++S G +L  ++  ++         +Q    
Sbjct: 187 ---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243

Query: 292 -------NLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHK---------AAMLAYHCL 335
                  +L D+      E     N I  R       + VH          A       L
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303

Query: 336 NHNPKARPLMRDI 348
            ++ ++R   R+ 
Sbjct: 304 RYDHQSRLTAREA 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-30
 Identities = 65/282 (23%), Positives = 102/282 (36%), Gaps = 28/282 (9%)

Query: 68  RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV---HDGDNSYQGHREWL 124
           ++   NF   +VLG G +G V+          G      A+KV          +      
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTG---KLYAMKVLKKATIVQKAKTTEHTR 76

Query: 125 AEVIFLGHLSH-PNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
            E   L H+   P LV L      +    LI +++  G +  +L  +             
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIY 134

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
                  L  LH+    +IYRD K  NILLD++ +  L+DFGL+K+    D++  +    
Sbjct: 135 VGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFC 191

Query: 244 GTYGYAAPEYIMTGH--LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL 301
           GT  Y AP+ +  G        D +S GV++ E+LTG        P       +    + 
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA------SPFTVDGEKNSQAEIS 245

Query: 302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP 343
           +   K        +           A  L    L  +PK R 
Sbjct: 246 RRILKSEPPYPQEMSAL--------AKDLIQRLLMKDPKKRL 279

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 1e-28
 Identities = 60/310 (19%), Positives = 115/310 (37%), Gaps = 37/310 (11%)

Query: 65  DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHRE-W 123
           D    +   ++  + +G G  G V   + +   R       VA+K        Q H +  
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRA 63

Query: 124 LAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE-FMARGSVENNLFSKVLLPLPWSIRMK 182
             E++ +  ++H N++ L+      +      + ++    ++ NL   + + L       
Sbjct: 64  YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123

Query: 183 IAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRI 242
           + +    G+  LH     +I+RD K SNI++ +D   K+ DFGLA+       S + T  
Sbjct: 124 LLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 178

Query: 243 MGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR----------------KSLDKSR 286
           + T  Y APE I+        D++S G ++ E++  +                + L    
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 287 PAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHK--------AAMLAYHCLNHN 338
           P   + L       ++ + K   +  P+L  D       +        A  L    L  +
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 339 PKARPLMRDI 348
           P  R  + D 
Sbjct: 299 PAKRISVDDA 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 6e-28
 Identities = 56/298 (18%), Positives = 106/298 (35%), Gaps = 34/298 (11%)

Query: 70  ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKV-HDGDNSYQGHREWLAEVI 128
           +   ++    +G G +G V   F   D + GL+   VAVK       S    +    E+ 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELR 69

Query: 129 FLGHLSHPNLVKLIGYC-----CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKI 183
            L H+ H N++ L+         E+ + V +   +    + N +  +    L       +
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFL 126

Query: 184 AFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIM 243
            +   +GL ++H     +I+RD K SN+ ++ D   K+ DFGLA+         ++  + 
Sbjct: 127 IYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVA 180

Query: 244 GTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR-------------KSLDKSRPARE 290
             +  A    +   H     D++S G ++ E+LTGR               L        
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240

Query: 291 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDI 348
           + L   +    +   + L  +      +  +     A  L    L  +   R      
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.8 bits (242), Expect = 2e-23
 Identities = 51/320 (15%), Positives = 101/320 (31%), Gaps = 38/320 (11%)

Query: 74  FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL 133
           +   R LG G F  V+     +D+        VA+K+  GD  Y        E+  L  +
Sbjct: 15  YILVRKLGWGHFSTVWLA---KDMVNN---THVAMKIVRGDKVY--TEAAEDEIKLLQRV 66

Query: 134 SHPNLVKLIGYCCEDEHRVLIYE--------------FMARGSVENNLFSKVLLPLPWSI 179
           +  +  K          ++L +                +   ++   +       +P   
Sbjct: 67  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126

Query: 180 RMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKLSDFGLAKDGPEGDKSHV 238
             +I+     GL ++H     +I+ D K  N+L++  D    L    +A  G        
Sbjct: 127 VKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185

Query: 239 STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL 298
            T  + T  Y +PE ++       +D++S   ++ E++TG    +           D   
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245

Query: 299 -----------PLLKEKKKLLNIIDPR-LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR 346
                       LL+  K      + R L  +           +       +      + 
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305

Query: 347 DIVDSLEPLQVLPDEAPTPK 366
           D +  +  LQ+ P +     
Sbjct: 306 DFLSPM--LQLDPRKRADAG 323

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 73.3 bits (179), Expect = 6e-16
 Identities = 24/161 (14%), Positives = 52/161 (32%), Gaps = 24/161 (14%)

Query: 78  RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS---------YQGHREWLAEVI 128
           +++G G    V+    SE   E        VK H   ++           G   +    I
Sbjct: 6   KLMGEGKESAVFNC-YSEKFGE------CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 58

Query: 129 FLGHLSHPNLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAA 188
                    L KL G          +Y +     +   + +K L  +      ++     
Sbjct: 59  RSARNEFRALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMIL 113

Query: 189 KGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD 229
           + +A  +   + +++ D    N+L+  +    + DF  + +
Sbjct: 114 EEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	389
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.64
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.1
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.97
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.07
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.75
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.72

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-59  Score=420.37  Aligned_cols=257  Identities=25%  Similarity=0.327  Sum_probs=209.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||+||+|+++.+.+      .||+|++...........+.+|+.+++.++||||+++++++.+++.
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~------~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEE------AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   77 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCC------EEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence            3579999999999999999998766544      3999998766544455678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+..
T Consensus        78 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheee
Confidence            999999999999999986543  7899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..              .
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~--------------~  218 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS--------------D  218 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HH--------------H
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HH--------------H
Confidence            54443334455789999999999998876 57899999999999999999999765432211 00              0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSL  352 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L  352 (389)
                      ..............+.++.+|+.+||+.||++|||+.++++|=
T Consensus       219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp  261 (271)
T d1nvra_         219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  261 (271)
T ss_dssp             HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence            1111111122335578899999999999999999999999873

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-58  Score=416.71  Aligned_cols=264  Identities=27%  Similarity=0.383  Sum_probs=208.2

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      +..++|++.+.||+|+||+||+|+++..         ||||+++... .......|.+|+.++++++|||||++++++. 
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~---------vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-   74 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-   74 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESSSE---------EEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEECCE---------EEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-
Confidence            4457899999999999999999975432         9999987543 3455678899999999999999999999875 


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      .+.+++|||||++|+|.+++.... ..+++..+..++.|++.||+|||+++  ||||||||+|||++.++.+||+|||+|
T Consensus        75 ~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla  151 (276)
T d1uwha_          75 APQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLA  151 (276)
T ss_dssp             SSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred             ccEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccce
Confidence            457899999999999999987553 36899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTG---HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      +...............||+.|+|||++.+.   .|+.++|||||||++|||+||+.||.+........      ..+.. 
T Consensus       152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------~~~~~-  224 (276)
T d1uwha_         152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------FMVGR-  224 (276)
T ss_dssp             CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHH-
T ss_pred             eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH------HHHhc-
Confidence            876554444445567899999999999743   58999999999999999999999998764432111      00111 


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                           ...+......+..++.++.+|+.+||+.||++|||+++|+++|+.++.
T Consensus       225 -----~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         225 -----GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             -----TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 001111112234567889999999999999999999999999998753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-57  Score=410.23  Aligned_cols=251  Identities=21%  Similarity=0.345  Sum_probs=210.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      .+|++.+.||+|+||+||+|.+..+.+      .||+|++..... ...+.+.+|+.+++.++|||||++++++.+++.+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~------~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   92 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCC------EEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCC------EEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEE
Confidence            479999999999999999998665544      499999865432 2346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |+|||||+||+|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+...
T Consensus        93 ~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeec
Confidence            9999999999999887654   6899999999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhc
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNII  311 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (389)
                      ....  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+........      ....         
T Consensus       168 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~---------  230 (293)
T d1yhwa1         168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIAT---------  230 (293)
T ss_dssp             STTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHH---------
T ss_pred             cccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHh---------
Confidence            4322  2345689999999999999999999999999999999999999998654332110      0000         


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          312 DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ........+..++.++.+|+.+||+.||++|||+.++++|
T Consensus       231 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0111122345667899999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-57  Score=414.74  Aligned_cols=264  Identities=24%  Similarity=0.406  Sum_probs=208.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||+||+|.++.+.+   ....||||.+.........+.|.+|+.+|++++|||||++++++..++.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            3578899999999999999998765432   2345899998877677777889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++|||||++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence            999999999999999876543 36899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccc---cccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          231 PEGDKSHV---STRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       231 ~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ........   .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+......                
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~----------------  242 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV----------------  242 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH----------------
Confidence            54322211   122468999999999999999999999999999999998 8999987643211                


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                       ...+......+.+..++.++.+|+.+||+.||++|||+.+|++.|+++..
T Consensus       243 -~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         243 -INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             -HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence             11111222334455678899999999999999999999999999987643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.8e-58  Score=416.24  Aligned_cols=264  Identities=25%  Similarity=0.377  Sum_probs=220.1

Q ss_pred             HHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEE
Q 016481           66 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC  145 (389)
Q Consensus        66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  145 (389)
                      +|++..++|++.+.||+|+||+||+|+++.+.+.      ||||++..+.  ...+++.+|+.+++.++|||||++++++
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~------vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT------VAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEE------EEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeE------EEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            4455567899999999999999999987765443      9999987653  3356788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      .+++.+++|||||++|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG  160 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFG  160 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEcccc
Confidence            99999999999999999999998777778999999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +|+...... ........||+.|+|||++.+..|+.++|||||||++|||++|..||........               
T Consensus       161 ~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~---------------  224 (287)
T d1opja_         161 LSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------  224 (287)
T ss_dssp             CTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---------------
T ss_pred             ceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH---------------
Confidence            998765432 2223345689999999999999999999999999999999997766543322111               


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                       +...+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       225 -~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         225 -VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -HHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence             11112222333445567789999999999999999999999999998764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-57  Score=407.01  Aligned_cols=248  Identities=28%  Similarity=0.415  Sum_probs=209.1

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||+||+|+++.+.+      .||+|++....  .......+.+|+.+++.++||||+++++++.+++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKF------ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCc------EEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            579999999999999999998765544      39999986432  1223456789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+|||||++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|..
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             EEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeee
Confidence            9999999999999999987654  6899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .....    ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.........   .             .
T Consensus       156 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---~-------------~  215 (263)
T d2j4za1         156 APSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY---K-------------R  215 (263)
T ss_dssp             CCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H-------------H
T ss_pred             cCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH---H-------------H
Confidence            65432    23468999999999999999999999999999999999999999875432110   0             0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +...  ...++...+.++.+|+.+||+.||++|||+.++++|
T Consensus       216 i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         216 ISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             HHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            0111  122344567899999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=421.53  Aligned_cols=266  Identities=26%  Similarity=0.392  Sum_probs=217.0

Q ss_pred             HHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEe
Q 016481           69 IITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCE  147 (389)
Q Consensus        69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  147 (389)
                      +..++|++.+.||+|+||+||+|++....+ ......||+|.+...........+.+|+.++.++ +|||||++++++.+
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISK-TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSS-SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCc-ccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            445789999999999999999998765433 2234569999987665555567788999999998 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVL---------------------LPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF  206 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dl  206 (389)
                      .+.+++|||||++|+|.+++.....                     ..+++..+..++.|++.||+|||+++  ||||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDl  190 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDL  190 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccC
Confidence            9999999999999999999865432                     35889999999999999999999977  999999


Q ss_pred             CCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCC
Q 016481          207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKS  285 (389)
Q Consensus       207 kp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~  285 (389)
                      ||+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987655444334445678999999999999999999999999999999998 89999865


Q ss_pred             CchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 016481          286 RPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLE  353 (389)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~  353 (389)
                      .....                +...+......+.+..++.++.+|+.+||+.||++|||+++|+++|.
T Consensus       271 ~~~~~----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVDAN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSHH----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHH----------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            43211                11112222333445667789999999999999999999999999984

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-57  Score=408.16  Aligned_cols=256  Identities=21%  Similarity=0.280  Sum_probs=198.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  147 (389)
                      .++|++.+.||+|+||+||+|+++.+.+      .||+|.+.... .......+.+|+.++++++|||||++++++.+  
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   76 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGK------ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   76 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCC------EEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence            3689999999999999999998766544      39999987654 34455678899999999999999999999865  


Q ss_pred             CCeEEEEEEecCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---CCceecCCCCCCeEEcCCCcEEEe
Q 016481          148 DEHRVLIYEFMARGSVENNLFSK--VLLPLPWSIRMKIAFGAAKGLAFLHEAE---KPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~---~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                      .+.+|+|||||+||+|.+++...  ....+++..+..++.|++.||+|||+.+   .+|+||||||+|||++.++.+||+
T Consensus        77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~  156 (269)
T d2java1          77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  156 (269)
T ss_dssp             --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence            46789999999999999988542  2347999999999999999999999853   349999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      |||+|+......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........   ..   . + 
T Consensus       157 DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~~---~-i-  226 (269)
T d2java1         157 DFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG---K-I-  226 (269)
T ss_dssp             CHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---H-H-
T ss_pred             eccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---HH---H-H-
Confidence            999998765422  123457899999999999999999999999999999999999999987543211   10   0 0 


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                              .... ....+..++.++.+|+.+||+.||++|||+.++++|
T Consensus       227 --------~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         227 --------REGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             --------HHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------HcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                    0011 112344567889999999999999999999999976

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-56  Score=410.65  Aligned_cols=255  Identities=23%  Similarity=0.307  Sum_probs=195.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      +.+.|++.+.||+|+||+||+|+++.+.+      .||+|++...........+.+|+.+++.++|||||++++++.+++
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQK------LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG   80 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCC------EEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCC------EEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            45679999999999999999998765544      399999876654444556778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc---CCCcEEEeccCC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD---TDYNAKLSDFGL  226 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~---~~~~vkl~Dfg~  226 (389)
                      .+|+|||||+||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||+.   .++.+||+|||+
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             EEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccce
Confidence            9999999999999999997654  7999999999999999999999977  99999999999994   578999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      |+......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+......   ...+   .     
T Consensus       157 a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i---~-----  222 (307)
T d1a06a_         157 SKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---FEQI---L-----  222 (307)
T ss_dssp             -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHH---H-----
T ss_pred             eEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHH---h-----
Confidence            98654332   23446899999999999999999999999999999999999999987543221   0000   0     


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         ........+.+...+.++.+|+.+||+.||++|||+.|+++|
T Consensus       223 ---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         223 ---KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ---TTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ---ccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence               011112223344567899999999999999999999999997

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-57  Score=417.68  Aligned_cols=268  Identities=23%  Similarity=0.290  Sum_probs=210.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||+||+|++..+..      .||+|++...........+.+|+.+|+.++|||||+++++|.+++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~------~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   77 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGL------VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   77 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTE------EEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCc------EEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            45789999999999999999998765543      499999987655566678899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ++|+|||||+||+|.+++.+..  .+++..+..++.|++.||.|||+ ++  |+||||||+|||++.++.+||+|||+|+
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCcc
Confidence            9999999999999999987654  68999999999999999999997 47  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHH-HhHHHHh----
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADW-ALPLLKE----  303 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~----  303 (389)
                      .....    .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.............. .......    
T Consensus       154 ~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (322)
T d1s9ja_         154 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  229 (322)
T ss_dssp             HHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred             ccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence            65321    23346899999999999999999999999999999999999999986543322111000 0000000    


Q ss_pred             ---------------------hhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 ---------------------KKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 ---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                                           ....................+.++.+|+.+||+.||++|||+.++|+|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                                 000000000000111112346789999999999999999999999987

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=402.04  Aligned_cols=256  Identities=25%  Similarity=0.419  Sum_probs=201.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||+||+|.+...       ..||||++....  ....++.+|+.++++++|||||++++++..++.
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   74 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTT-------EEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCC-------CEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCc
Confidence            36799999999999999999986532       239999987643  334678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          75 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             eEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheec
Confidence            999999999999999886653 36889999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhC-CCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG-RKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...... ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||.......   +..              
T Consensus       152 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~--------------  213 (263)
T d1sm2a_         152 LDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVE--------------  213 (263)
T ss_dssp             --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHH--------------
T ss_pred             cCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHH--------------
Confidence            543222 22346789999999999999999999999999999999995 55565433211   110              


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      .+........+..++.++.+|+.+||+.||++|||+++|+++|+++.
T Consensus       214 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         214 DISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            01111222334556788999999999999999999999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-57  Score=409.98  Aligned_cols=251  Identities=23%  Similarity=0.290  Sum_probs=206.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||+||+|+++.+.+.      ||||++....  .......+.+|+.++++++||||+++++++.+++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~------vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSRE------YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCE------EEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            6799999999999999999987665444      9999986432  1223456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+|+.
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEeccccccee
Confidence            9999999999999999887654  7899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      .............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.....                .+
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----------------~~  221 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----------------QK  221 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HH
T ss_pred             cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH----------------HH
Confidence            76544333445578999999999999999999999999999999999999999875432110                01


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVD  350 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~  350 (389)
                      +...  ...++...+.++.+|+.+||+.||++|||+.|+++
T Consensus       222 i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         222 IIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             HHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            1111  11234456788999999999999999999998643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=404.13  Aligned_cols=268  Identities=26%  Similarity=0.407  Sum_probs=211.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|.+.++||+|+||.||+|.++.+..  .....||||.+...........|.+|+.++++++|||||++++++.+.+.
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCC--EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            4678999999999999999998765432  23355999999877666666789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++||||+.+|++.+.+.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhcc
Confidence            999999999999998776553 36899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...... .......||+.|+|||++.+..|+.++|||||||++|||++|..||.......  .              +..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~--------------~~~  224 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--E--------------VMK  224 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H--------------HHH
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--H--------------HHH
Confidence            543222 22334578999999999999999999999999999999999666554332211  1              111


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCCC
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVLP  359 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~~  359 (389)
                      .+......+.+..++.++.+|+.+||+.||++|||+.+|++.|+++...|
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            12222334455567789999999999999999999999999998876543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-56  Score=403.85  Aligned_cols=259  Identities=26%  Similarity=0.386  Sum_probs=212.4

Q ss_pred             cCCcccce-ecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRV-LGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~-lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|.+.+. ||+|+||.||+|.++...    ....||||++...........|.+|+.+|++++|||||++++++.. +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCC----CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            46777774 999999999999765432    2345999999877666777889999999999999999999999864 56


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +|+|||||++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcc
Confidence            899999999999999875443 37899999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          231 PEGDKS-HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       231 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ...... .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||........   .              
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~--------------  222 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M--------------  222 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---H--------------
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---H--------------
Confidence            543322 22334678999999999999999999999999999999998 9999987543211   1              


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ..+........+..++.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       223 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11111222344556778999999999999999999999999888654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-56  Score=399.69  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=202.0

Q ss_pred             CC-cccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe---
Q 016481           73 NF-RQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE---  147 (389)
Q Consensus        73 ~~-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---  147 (389)
                      +| ++.+.||+|+||+||+|++..+..      .||+|.+.... .......+.+|++++++++|||||++++++..   
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~------~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   82 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTV------EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   82 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCe------EEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence            44 667789999999999998765543      39999876543 34455678899999999999999999999865   


Q ss_pred             -CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc-CCCcEEEeccC
Q 016481          148 -DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD-TDYNAKLSDFG  225 (389)
Q Consensus       148 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~-~~~~vkl~Dfg  225 (389)
                       ...+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+++.+|+||||||+|||++ .++.+||+|||
T Consensus        83 ~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          83 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             cCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence             356899999999999999987654  68999999999999999999999776799999999999996 57899999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +|+.....    .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||........  +..          
T Consensus       161 la~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~----------  223 (270)
T d1t4ha_         161 LATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR----------  223 (270)
T ss_dssp             GGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH----------
T ss_pred             cceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHH----------
Confidence            99864332    2335689999999998865 599999999999999999999999976543221  100          


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         .+.........+...++++.+|+.+||+.||++|||+.|+++|
T Consensus       224 ---~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         224 ---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             ---HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---HHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence               0011111111223345789999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=405.27  Aligned_cols=260  Identities=27%  Similarity=0.397  Sum_probs=210.9

Q ss_pred             HHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEE
Q 016481           66 ELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYC  145 (389)
Q Consensus        66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  145 (389)
                      +|++..++|++.+.||+|+||.||+|.++..       ..||||++....  ...+.+.+|+.++++++|||||++++++
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~   77 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVV   77 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEECCC-------CEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeee
Confidence            3445567899999999999999999986532       239999987643  3346789999999999999999999987


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccC
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFG  225 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg  225 (389)
                      . ++.+++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        78 ~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             c-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeecccc
Confidence            5 456799999999999999876655556899999999999999999999977  9999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCC-CCCCCchhhhhhHHHHhHHHHhh
Q 016481          226 LAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKS-LDKSRPAREQNLADWALPLLKEK  304 (389)
Q Consensus       226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~  304 (389)
                      +|+....... .......||+.|+|||++.+..|+.++|||||||++|||+||..| |.......   .           
T Consensus       155 la~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~-----------  219 (272)
T d1qpca_         155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V-----------  219 (272)
T ss_dssp             TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H-----------
T ss_pred             ceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---H-----------
Confidence            9987654322 223346799999999999999999999999999999999996554 44432211   1           


Q ss_pred             hhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          305 KKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                         ...+........+..++.++.+|+.+||+.||++|||+++|++.|+.+
T Consensus       220 ---~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         220 ---IQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence               111111222334556678899999999999999999999999988754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-56  Score=403.99  Aligned_cols=253  Identities=26%  Similarity=0.373  Sum_probs=207.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      +.|++.+.||+|+||.||+|++..+..      .||+|++.... ......+.+|+.++++++|||||++++++.+++.+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~------~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~   84 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSV------LAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL   84 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCe------EEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeE
Confidence            468999999999999999998765544      39999987653 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++|||||+||+|.+++.... ..+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+|+...
T Consensus        85 ~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          85 WILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccC
Confidence            99999999999999876543 36899999999999999999999977  9999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccCccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIM-----TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ..  .......+||+.|+|||++.     +..|+.++|||||||++|+|++|+.||....+....      ......   
T Consensus       162 ~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~i~~~---  230 (288)
T d2jfla1         162 RT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIAKS---  230 (288)
T ss_dssp             HH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHHS---
T ss_pred             CC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HHHHcC---
Confidence            21  11233578999999999984     456899999999999999999999999876543211      000000   


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                            .......+...+.++.+|+.+||+.||++|||+.++++|
T Consensus       231 ------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         231 ------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             ------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  011122344667899999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=393.92  Aligned_cols=255  Identities=23%  Similarity=0.382  Sum_probs=213.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||+||+|+++..       ..||||.++....  ...++.+|+.++++++||||+++++++.+++.
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~   73 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   73 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTT-------EEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCC-------CEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Confidence            36899999999999999999986432       2399999876533  34578999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        74 ~~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~  150 (258)
T d1k2pa_          74 IFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYV  150 (258)
T ss_dssp             EEEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred             eEEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheec
Confidence            9999999999999988765433 6889999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ...... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.........                 .
T Consensus       151 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~-----------------~  212 (258)
T d1k2pa_         151 LDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-----------------E  212 (258)
T ss_dssp             SSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-----------------H
T ss_pred             cCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH-----------------H
Confidence            543322 2334679999999999999999999999999999999998 89999876532111                 1


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .+........|...+.++.+|+.+||+.||++|||+++|+++|..+
T Consensus       213 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         213 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             HHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1111222334556678999999999999999999999999998653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.9e-56  Score=406.20  Aligned_cols=248  Identities=26%  Similarity=0.353  Sum_probs=204.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC--hhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS--YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..|+..+.||+|+||+||+|++..+.+.      ||||++.....  ......+.+|+.++++++|||||++++++.+++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~------vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   88 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEE------EEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcE------EEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence            3599999999999999999987665443      99999876532  334467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+|||||.+|+|..++....  ++++..+..++.|++.||.|||+++  ||||||||+|||++.++.+||+|||+|..
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccc
Confidence            9999999999998876665543  7899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccccccccCcccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMT---GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ...      ....+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||.+.......               
T Consensus       165 ~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~---------------  223 (309)
T d1u5ra_         165 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------------  223 (309)
T ss_dssp             SSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---------------
T ss_pred             cCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH---------------
Confidence            543      234689999999999864   45899999999999999999999999865432211               


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       ..+.........+...+.++.+|+.+||+.||++|||+.++++|
T Consensus       224 -~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         224 -YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence             01111111111233456889999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.9e-55  Score=407.21  Aligned_cols=258  Identities=22%  Similarity=0.263  Sum_probs=212.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|+++.+.+      .||+|++.... ......+.+|+.+++.++|||||++++++.+++.
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~------~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGN------NFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTE------EEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCC------EEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4689999999999999999998765544      39999987653 3445678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc--CCCcEEEeccCCCc
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD--TDYNAKLSDFGLAK  228 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~--~~~~vkl~Dfg~a~  228 (389)
                      +|+|||||+||+|.+++.... ..+++..+..++.||+.||+|||+++  ||||||||+|||++  .++.+||+|||+|+
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~  174 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA  174 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhe
Confidence            999999999999999886543 36999999999999999999999977  99999999999995  46789999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......   ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.......   .   ...       
T Consensus       175 ~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---~---~i~-------  238 (350)
T d1koaa2         175 HLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---R---NVK-------  238 (350)
T ss_dssp             ECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---HHH-------
T ss_pred             eccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH---H---HHH-------
Confidence            765432   234468999999999999999999999999999999999999999865432211   0   000       


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPL  355 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~  355 (389)
                       .............++.++.+||.+||+.||++|||+.++++|  |...
T Consensus       239 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         239 -SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             -HTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             -hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence             001111112223457889999999999999999999999998  5443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-55  Score=395.40  Aligned_cols=251  Identities=26%  Similarity=0.374  Sum_probs=202.5

Q ss_pred             ceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeEEEEEE
Q 016481           78 RVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHRVLIYE  156 (389)
Q Consensus        78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (389)
                      ++||+|+||+||+|.+...    .....||||++.... .......+.+|+.++++++|||||++++++.. +..++|||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccC----CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEE
Confidence            5799999999999976432    223459999987543 33345678999999999999999999999854 56789999


Q ss_pred             ecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCCc
Q 016481          157 FMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDKS  236 (389)
Q Consensus       157 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~  236 (389)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++........
T Consensus        88 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          88 MAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             CCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             cCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            999999999987654  6899999999999999999999977  999999999999999999999999999876544322


Q ss_pred             c-ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCCC
Q 016481          237 H-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDPR  314 (389)
Q Consensus       237 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (389)
                      . ......||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+......                 ...+...
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-----------------~~~i~~~  226 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----------------TAMLEKG  226 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------HHHHHTT
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH-----------------HHHHHcC
Confidence            2 2334679999999999999999999999999999999998 8999987543211                 1111112


Q ss_pred             CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 016481          315 LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEP  354 (389)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~  354 (389)
                      .....+..++.++.+|+.+||+.||++|||+++|++.|+.
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            2334455677899999999999999999999999887754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-54  Score=405.72  Aligned_cols=254  Identities=20%  Similarity=0.274  Sum_probs=211.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||.||+|++..+.+      .||+|++.... ......+.+|+.++++++|||||++++++.+++.
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~------~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGR------VFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCC------EEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4679999999999999999998765544      39999987653 3345677899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEc--CCCcEEEeccCCCc
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLD--TDYNAKLSDFGLAK  228 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~--~~~~vkl~Dfg~a~  228 (389)
                      +|+|||||+||+|.+.+.... .++++..+..++.||+.||+|||+++  |+||||||+|||++  .++.+||+|||+|.
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~  177 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLAT  177 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccce
Confidence            999999999999998776543 36899999999999999999999977  99999999999997  57899999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......   ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.......   .   .        .
T Consensus       178 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~---~--------i  240 (352)
T d1koba_         178 KLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---Q---N--------V  240 (352)
T ss_dssp             ECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H---H--------H
T ss_pred             ecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---H---H--------H
Confidence            875432   234468999999999999999999999999999999999999999876533211   0   0        0


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ...............+.++.+|+.+||+.||++|||+.++++|
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             HHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0111112223334567899999999999999999999999987

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-55  Score=398.10  Aligned_cols=255  Identities=23%  Similarity=0.287  Sum_probs=209.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-----ChhhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-----SYQGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      +.++|++.+.||+|+||+||+|+++.+.+      .||+|++....     .......+.+|+.+|++++|||||+++++
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~------~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~   81 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGL------QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   81 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCC------EEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            35689999999999999999998765544      39999986432     22235678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC----cEE
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY----NAK  220 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~----~vk  220 (389)
                      +.+.+.+|+|||||+||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++    .+|
T Consensus        82 ~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          82 YENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceE
Confidence            999999999999999999999987654  7899999999999999999999977  99999999999998776    599


Q ss_pred             EeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          221 LSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       221 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      |+|||+|.......   ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.......   ..    
T Consensus       158 l~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~----  227 (293)
T d1jksa_         158 IIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---AN----  227 (293)
T ss_dssp             ECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH----
T ss_pred             ecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH---HH----
Confidence            99999998765432   234468999999999999999999999999999999999999999875433211   00    


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      +..       .........+...+.++.+|+.+||+.||++|||+.++++|
T Consensus       228 i~~-------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         228 VSA-------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HHT-------TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHh-------cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000       00111111122456789999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=398.16  Aligned_cols=261  Identities=24%  Similarity=0.355  Sum_probs=205.6

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ..++|++.+.||+|+||.||+|++..+..   ....||||.+...........+.+|+.++++++||||+++++++. ++
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCc---eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            35689999999999999999998764432   234589999877666666778999999999999999999999985 56


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+|+.
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             eEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhee
Confidence            7899999999999998876553 36899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ...... .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.........   .             
T Consensus       158 ~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~-------------  220 (273)
T d1mp8a_         158 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G-------------  220 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H-------------
T ss_pred             ccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---H-------------
Confidence            654322 22334678999999999999999999999999999999998 89999876543211   0             


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                       .+......+.+..++.++.+|+.+||+.||++|||+.+|+++|+.+
T Consensus       221 -~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         221 -RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             0111112234556778999999999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-55  Score=401.76  Aligned_cols=274  Identities=27%  Similarity=0.332  Sum_probs=212.6

Q ss_pred             CHHHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceE
Q 016481           63 TYDELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKL  141 (389)
Q Consensus        63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~  141 (389)
                      ....|.+..++|++.+.||+|+||.||+|.+.... .......||||.+.........+.+..|..++.++ +|+||+.+
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID-KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTT-SSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCC-cccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            44566666789999999999999999999876542 23345669999998766666677888888888877 58999999


Q ss_pred             EeEEEeC-CeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCC
Q 016481          142 IGYCCED-EHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDF  206 (389)
Q Consensus       142 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dl  206 (389)
                      ++++... ..+++|||||++|+|.+++....              ...+++..+..++.|++.||+|||+++  ||||||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl  160 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL  160 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence            9988764 46899999999999999986542              235889999999999999999999977  999999


Q ss_pred             CCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhC-CCCCCCC
Q 016481          207 KTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTG-RKSLDKS  285 (389)
Q Consensus       207 kp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg-~~pf~~~  285 (389)
                      ||+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++| .+||...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876554444444557899999999999999999999999999999999996 5578655


Q ss_pred             CchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          286 RPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .....  +    ..          .+........+..++.++.+|+.+||+.||++|||+.+|+++|+.+
T Consensus       241 ~~~~~--~----~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         241 KIDEE--F----CR----------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CCSHH--H----HH----------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHH--H----HH----------HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            43211  1    01          1111112234455678899999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-55  Score=402.35  Aligned_cols=263  Identities=25%  Similarity=0.400  Sum_probs=210.5

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ++|++.+.||+|+||+||+|.+..+.+.  ....||+|.+.........+.+.+|+.++++++|||||++++++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCE--EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            4799999999999999999987655432  23458999987766666678899999999999999999999999764 56


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      ++++||+.+|+|.+.+.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+...
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             eEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            78899999999999887653 47899999999999999999999977  9999999999999999999999999998776


Q ss_pred             CCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhh
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLLNI  310 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (389)
                      ............||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.......                 ..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-----------------~~  225 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------------SI  225 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-----------------HH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-----------------HH
Confidence            5444434444678999999999999999999999999999999998 88899865433211                 11


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          311 IDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      +........+..++.++.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus       226 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            11112233455677899999999999999999999999999987743

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-55  Score=396.02  Aligned_cols=262  Identities=25%  Similarity=0.365  Sum_probs=207.3

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      ++-.++|++.+.||+|+||.||+|+++.+.       .||||++....  .....|.+|+.++++++|||||++++++. 
T Consensus        13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~-------~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-   82 (285)
T d1fmka3          13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-   82 (285)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTE-------EEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             EcCHHHEEEeeEEeeCCCeEEEEEEECCCC-------EEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEe-
Confidence            344578999999999999999999875432       39999987553  33467899999999999999999999985 


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ++..++||||+++|+|..++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchh
Confidence            456799999999999999887665557999999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKL  307 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (389)
                      +....... .......||+.|+|||++.+..++.++|||||||++|||++|..||........  .              
T Consensus       161 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~--------------  223 (285)
T d1fmka3         161 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--V--------------  223 (285)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--H--------------
T ss_pred             hhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--H--------------
Confidence            87644322 223346799999999999999999999999999999999996665544322211  1              


Q ss_pred             hhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCC
Q 016481          308 LNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQVL  358 (389)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~~  358 (389)
                      ...+......+.+..++.++.+|+.+||+.||++|||+++|++.|+..-..
T Consensus       224 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         224 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            111111223344556778999999999999999999999999999876543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=400.75  Aligned_cols=251  Identities=24%  Similarity=0.317  Sum_probs=210.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      .++|++.+.||+|+||.||+|+.+.+.+      .||+|++....  .......+.+|+.+|+.++||||+++++++.+.
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~------~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   77 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGR------YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH   77 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCC------EEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc
Confidence            3689999999999999999998766544      49999986432  122346678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+|+|||||+||+|..++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||+|+
T Consensus        78 ~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~  153 (337)
T d1o6la_          78 DRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             cccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeeccccc
Confidence            99999999999999999887654  6899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .......  .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.....   .   .         
T Consensus       154 ~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---~---~---------  216 (337)
T d1o6la_         154 EGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---E---L---------  216 (337)
T ss_dssp             CSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H---------
T ss_pred             ccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH---H---H---------
Confidence            7543221  234578999999999999999999999999999999999999999876543210   0   0         


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~  351 (389)
                       +...  ...+|...+.++.+||.+||++||++|++     +.++++|
T Consensus       217 -i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         217 -ILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -HhcC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence             0000  12334556788999999999999999995     8999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-54  Score=398.42  Aligned_cols=270  Identities=26%  Similarity=0.338  Sum_probs=219.5

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      ++...++|++.+.||+|+||+||+|+++... .......||||++...........+.+|+.+++.++||||+++++++.
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSS-TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCc-cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            3445678999999999999999999875421 223345599999987766666778999999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKV----------------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYR  204 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~  204 (389)
                      ..+..++||||+.+|+|.+++....                      ...+++..+..++.|++.||+|||+.+  ||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHr  164 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR  164 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEee
Confidence            9999999999999999999886432                      234788999999999999999999977  9999


Q ss_pred             CCCCCCeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCC-CCCC
Q 016481          205 DFKTSNILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR-KSLD  283 (389)
Q Consensus       205 Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~-~pf~  283 (389)
                      ||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998654443333444578999999999999999999999999999999999985 5777


Q ss_pred             CCCchhhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          284 KSRPAREQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      .....+..   .             . +........+..++.++.+|+.+||+.||++||||.+|++.|+++.
T Consensus       245 ~~~~~e~~---~-------------~-v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEEVI---Y-------------Y-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHHHH---H-------------H-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHHHH---H-------------H-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            65433211   0             0 1111122334556788999999999999999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=394.55  Aligned_cols=270  Identities=25%  Similarity=0.383  Sum_probs=219.2

Q ss_pred             HHHhcCCcccceecCCCceEEEEeeecccccc-CcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEE
Q 016481           68 RIITANFRQDRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  145 (389)
Q Consensus        68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  145 (389)
                      .+..++|++++.||+|+||.||+|+.....+. ......||||++..+.......++.+|...+.++ +|||||++++++
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            34567899999999999999999987654432 2334669999998877777778888999999888 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCe
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKV--------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNI  211 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Ni  211 (389)
                      .+++.+++||||+++|+|.+++....              ...+++..+..++.|++.||+|||+++  ||||||||+||
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~Ni  166 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV  166 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccce
Confidence            99999999999999999999996553              245899999999999999999999977  99999999999


Q ss_pred             EEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhh
Q 016481          212 LLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPARE  290 (389)
Q Consensus       212 li~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~  290 (389)
                      |++.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++ |.+||........
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            999999999999999987655444434455789999999999999999999999999999999998 7888876543211


Q ss_pred             hhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          291 QNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                                       ...+........+..++.++.+|+.+||+.||++|||+.+|++.|+++.
T Consensus       247 -----------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         247 -----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             -----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------------HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence                             1111122233445556788999999999999999999999999998764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.3e-54  Score=394.79  Aligned_cols=247  Identities=26%  Similarity=0.371  Sum_probs=208.0

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||+||+|+++.+.+      .||+|++....  .......+.+|+.+++.++||||+++++++.+++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~------~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGR------YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCC------EEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            579999999999999999998765544      39999986432  1233467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+|+|||||.||+|...+....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.+|.+||+|||+|+.
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceE
Confidence            9999999999999998887665  6788888999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ....     ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.....                ..
T Consensus       154 ~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----------------~~  212 (316)
T d1fota_         154 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY----------------EK  212 (316)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HH
T ss_pred             eccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH----------------HH
Confidence            6432     33478999999999999999999999999999999999999999875432211                01


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      +...  ...++...+.++.+++.+||+.||.+|+     |+.++++|
T Consensus       213 i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         213 ILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHcC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            1111  1123445668899999999999999996     99999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=388.43  Aligned_cols=263  Identities=26%  Similarity=0.356  Sum_probs=204.1

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      ..+|++.+.||+|+||.||+|++.....   ....||||++....  .....+.|.+|+.++++++||||+++++++.+ 
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~---~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-   82 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-   82 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCC---cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence            3579999999999999999998654322   23458999887543  33445688999999999999999999999965 


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      ...++||||+++|++.+.+.... ..+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhh
Confidence            56789999999999998876543 36899999999999999999999977  9999999999999999999999999999


Q ss_pred             CCCCCCCcc-ccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhh
Q 016481          229 DGPEGDKSH-VSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKK  306 (389)
Q Consensus       229 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
                      ......... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||........                
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----------------  223 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----------------  223 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH----------------
Confidence            875543322 2334568889999999999999999999999999999998 8999986543321                


Q ss_pred             hhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          307 LLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ...+.......+.+..++.++.+|+.+||+.||++|||+.+|++.|++.+
T Consensus       224 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence            11111222233344566788999999999999999999999999987643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=393.50  Aligned_cols=270  Identities=26%  Similarity=0.371  Sum_probs=222.8

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYC  145 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  145 (389)
                      |.+..++|+++++||+|+||.||+|++....+ ......||||++...........+.+|+.+++.+ +|||||++++++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEecccc-CCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            44556799999999999999999998754322 2445679999998776677777899999999999 699999999999


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCC
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKV----------------LLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTS  209 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~  209 (389)
                      .+...+++|||||++|+|.+++....                ...+++..+..++.|++.||+|||+++  ||||||||+
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~  174 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR  174 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccc
Confidence            99999999999999999999986543                235889999999999999999999977  999999999


Q ss_pred             CeEEcCCCcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCch
Q 016481          210 NILLDTDYNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPA  288 (389)
Q Consensus       210 Nili~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~  288 (389)
                      ||+++.++.+|++|||+++..............+||+.|+|||++.+..++.++|||||||++|||+| |.+||......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999998765544444556789999999999999999999999999999999999 55566554322


Q ss_pred             hhhhhHHHHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          289 REQNLADWALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      ..                +..++........+...+..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus       255 ~~----------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         255 SK----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HH----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH----------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            11                1111111222333445678899999999999999999999999999764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-54  Score=387.32  Aligned_cols=251  Identities=26%  Similarity=0.399  Sum_probs=202.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe-CC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-DE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~  149 (389)
                      .++|++.+.||+|+||.||+|.+++        ..||||+++.+.   ..+.+.+|+.++++++||||+++++++.+ .+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT--------EEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             HHHeEEeEEEecCCCeEEEEEEECC--------eEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            4678999999999999999998643        239999997653   34568899999999999999999999865 46


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeeccccccee
Confidence            7899999999999999997655446899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILT-GRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ....     .....+|+.|+|||++.+..++.++|||||||++|||+| |++||.......   +              .
T Consensus       153 ~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~--------------~  210 (262)
T d1byga_         153 ASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V--------------V  210 (262)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H--------------H
T ss_pred             cCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---H--------------H
Confidence            5432     223568999999999999999999999999999999998 788887654321   1              1


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ..+......+.+...+.++.+|+.+||+.||++|||+.+|+++|+.++
T Consensus       211 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         211 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            111222334455667789999999999999999999999999998775

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.7e-53  Score=385.33  Aligned_cols=263  Identities=23%  Similarity=0.324  Sum_probs=205.4

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEe
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE  147 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  147 (389)
                      +.++|++.+.||+|+||.||+|++..+.+      .||+|++....  .......+.+|+.+++.++||||+++++++..
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~   78 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHR------DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   78 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCC------EEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence            35789999999999999999998765544      39999987653  33445678899999999999999999999876


Q ss_pred             CC----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          148 DE----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       148 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                      .+    .+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.++|+|
T Consensus        79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d  154 (277)
T d1o6ya_          79 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMD  154 (277)
T ss_dssp             ECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECC
T ss_pred             ccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeeh
Confidence            54    4899999999999998886654  7899999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCC-CccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHH
Q 016481          224 FGLAKDGPEGD-KSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLK  302 (389)
Q Consensus       224 fg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  302 (389)
                      ||.+....... ........+||+.|+|||++.+..|+.++|||||||++|+|++|++||....+....      ...+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~  228 (277)
T d1o6ya_         155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVR  228 (277)
T ss_dssp             CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHH
T ss_pred             hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHh
Confidence            99987654332 222334468999999999999999999999999999999999999999876543211      11111


Q ss_pred             hhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhcccc
Q 016481          303 EKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-LMRDIVDSLEPLQ  356 (389)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~~il~~L~~~~  356 (389)
                      ..        +..........+.++.+|+.+||+.||++|| |++++++.|.++.
T Consensus       229 ~~--------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         229 ED--------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CC--------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cC--------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            10        1111112234568899999999999999999 8999998887653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1e-52  Score=380.25  Aligned_cols=254  Identities=24%  Similarity=0.314  Sum_probs=208.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh--------hhHHHHHHHHHHHhccC-CCccceE
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY--------QGHREWLAEVIFLGHLS-HPNLVKL  141 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~-h~niv~~  141 (389)
                      .++|++.+.||+|+||+||+|++..+.+      .||+|++......        .....+.+|+.++++++ ||||+++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~------~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~   75 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCK------EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   75 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCC------EEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            3689999999999999999998765544      4999998754321        12345778999999997 9999999


Q ss_pred             EeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          142 IGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       142 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                      ++++.+++++|||||||+||+|.+++....  ++++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          76 KDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEE
T ss_pred             EeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEE
Confidence            999999999999999999999999997654  7899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCcccccc------CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT------GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD  295 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  295 (389)
                      +|||+++......   ......||+.|+|||++.+      ..++.++||||+||++|+|++|+.||....+....    
T Consensus       152 ~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~----  224 (277)
T d1phka_         152 TDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML----  224 (277)
T ss_dssp             CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----
T ss_pred             ccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH----
Confidence            9999998765432   2344689999999999863      35788999999999999999999999876532211    


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                         ..+...       ............++++.+|+.+||+.||++|||+.++++|
T Consensus       225 ---~~i~~~-------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         225 ---RMIMSG-------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ---HHHHHT-------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ---HHHHhC-------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               000000       1111222334677899999999999999999999999987

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=390.81  Aligned_cols=253  Identities=18%  Similarity=0.216  Sum_probs=207.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      .++|++.+.||+|+||+||+|+++.+.+.      ||+|++....  .....+.+|+.+|+.++|||||++++++.+++.
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~------~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   75 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKT------YMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcE------EEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            46899999999999999999987765544      9999997653  233567799999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC--CcEEEeccCCCc
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD--YNAKLSDFGLAK  228 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~--~~vkl~Dfg~a~  228 (389)
                      +|+|||||+||+|.+++.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.+  +.+||+|||+++
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhh
Confidence            999999999999999886543 36899999999999999999999977  9999999999999754  589999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      ......   ......+|+.|+|||++.+..|+.++|||||||++|+|++|..||.........      .......    
T Consensus       153 ~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~------~~i~~~~----  219 (321)
T d1tkia_         153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII------ENIMNAE----  219 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTC----
T ss_pred             ccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC----
Confidence            764433   234467999999999999999999999999999999999999999876533210      0000000    


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                          ..+........+.++.+|+.+||+.||++|||+.++++|
T Consensus       220 ----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         220 ----YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                000000111346789999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=391.29  Aligned_cols=260  Identities=27%  Similarity=0.364  Sum_probs=209.8

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhcc-CCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHL-SHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||.||+|+++.+...    ..||||.+...........+.+|+.+|+++ +|||||++++++.+.+.
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLR----MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEE----EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeE----EEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            6899999999999999999987654332    237888876655555566789999999998 69999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          151 RVLIYEFMARGSVENNLFSK--------------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      +++||||+++|+|.+++...              ....+++..+..++.|++.||.|||+.+  |+||||||+|||++.+
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCC
Confidence            99999999999999998654              2357899999999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCC-CCCCCCCchhhhhhHH
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR-KSLDKSRPAREQNLAD  295 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~  295 (389)
                      +.+||+|||+++......   ......||..|+|||.+.+..|+.++|||||||++|||++|. +||.......      
T Consensus       164 ~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~------  234 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------  234 (309)
T ss_dssp             GCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------
T ss_pred             CceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH------
Confidence            999999999998654322   122357899999999999999999999999999999999976 4676543221      


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                                 +...+........+..++.++.+|+.+||+.||++|||+.+|+++|+++..
T Consensus       235 -----------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         235 -----------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             -----------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                       111111122334455678899999999999999999999999999988753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-53  Score=395.86  Aligned_cols=247  Identities=23%  Similarity=0.287  Sum_probs=208.2

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE  149 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  149 (389)
                      ++|++.+.||+|+||.||+|+++.+.+.      ||+|++....  .......+.+|+.+|+.++||||+++++++....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~------~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNH------YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCE------EEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            5899999999999999999987655443      9999986432  1233456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .+++||||+.||+|..++....  .+++..+..++.||+.||.|||+++  ||||||||+|||++.+|.+||+|||+|+.
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            9999999999999999887654  6899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhh
Q 016481          230 GPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLN  309 (389)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (389)
                      ....     ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.......      .          .
T Consensus       191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~----------~  249 (350)
T d1rdqe_         191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY------E----------K  249 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------H----------H
T ss_pred             cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH------H----------H
Confidence            6432     23468999999999999999999999999999999999999999875432110      0          0


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          310 IIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                      +...  ....+...+.++.+|+.+||+.||.+|+     |++++++|
T Consensus       250 i~~~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         250 IVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HhcC--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            0111  1122445678899999999999999994     89999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-53  Score=392.33  Aligned_cols=252  Identities=19%  Similarity=0.229  Sum_probs=201.5

Q ss_pred             hcCCcccc-eecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhc-cCCCccceEEeEEEe-
Q 016481           71 TANFRQDR-VLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGH-LSHPNLVKLIGYCCE-  147 (389)
Q Consensus        71 ~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~-  147 (389)
                      .++|.+.+ .||+|+||+||+|++..+.+.      ||||++...      ..+.+|+.++.+ .+|||||+++++|.+ 
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~------vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEK------FALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCE------EEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            46898765 699999999999987655443      999998643      345578988655 479999999999875 


Q ss_pred             ---CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC---CCcEEE
Q 016481          148 ---DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKL  221 (389)
Q Consensus       148 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~---~~~vkl  221 (389)
                         ...+|+|||||+||+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.   .+.+||
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEE
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccc
Confidence               467899999999999999998776668999999999999999999999977  999999999999975   567999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      +|||+|+......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.........        
T Consensus       156 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~--------  224 (335)
T d2ozaa1         156 TDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--------  224 (335)
T ss_dssp             CCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------
T ss_pred             cccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH--------
Confidence            9999998765433   23346899999999999999999999999999999999999999976543211000        


Q ss_pred             HhhhhhhhhcCCC--CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          302 KEKKKLLNIIDPR--LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       302 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                          ....+....  +.......++.++.+|+.+||+.||++|||+.++++|
T Consensus       225 ----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         225 ----MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----HHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                000111111  1111123567889999999999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1e-52  Score=394.68  Aligned_cols=251  Identities=22%  Similarity=0.293  Sum_probs=202.8

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-----ChhhHHHHHHHHHHHhccCCCccceEEeEEE
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-----SYQGHREWLAEVIFLGHLSHPNLVKLIGYCC  146 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  146 (389)
                      ++|++.+.||+|+||.||+|++..+.+.      ||+|++....     ..........++.+++.++|||||++++++.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~------vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~   77 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKM------YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH   77 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCE------EEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence            5899999999999999999987665443      9999985421     1111122234577778888999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          147 EDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       147 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                      +.+.+|+|||||+||+|.+++....  .+++..+..++.|++.||.|||+++  ||||||||+|||++.+|.+||+|||+
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeece
Confidence            9999999999999999999987654  6789999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCCccccccccccccccCccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          227 AKDGPEGDKSHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       227 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      |+......    ....+||+.|+|||++. +..|+.++|||||||++|+|++|+.||..........+            
T Consensus       154 a~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------------  217 (364)
T d1omwa3         154 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI------------  217 (364)
T ss_dssp             CEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH------------
T ss_pred             eeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH------------
Confidence            98765432    23468999999999997 45789999999999999999999999986543221111            


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPL-----MRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~il~~  351 (389)
                        ... ........+..++.++.+||.+||+.||++|||     +.++++|
T Consensus       218 --~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         218 --DRM-TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             --HHH-SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             --HHh-cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence              000 011122334456788999999999999999999     7999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-53  Score=388.35  Aligned_cols=273  Identities=27%  Similarity=0.402  Sum_probs=222.9

Q ss_pred             HHHHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeE
Q 016481           65 DELRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGY  144 (389)
Q Consensus        65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  144 (389)
                      ++|.+..++|.+.+.||+|+||+||+|.++...+ ......||||++...........+.+|+.++++++||||++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEET-TEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCccc-CCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            3455566899999999999999999998764321 122345999999876666666788999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          145 CCEDEHRVLIYEFMARGSVENNLFSK--------VLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       145 ~~~~~~~~lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      +..++..++||||+.+|+|.+++...        ....+++..+..++.|++.||.|||+.+  |+||||||+|||++.+
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED  169 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCC
Confidence            99999999999999999999987542        2345788999999999999999999977  9999999999999999


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCC-CCCCCCCchhhhhhHH
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGR-KSLDKSRPAREQNLAD  295 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~  295 (389)
                      +++||+|||+|+...............||+.|+|||.+.+..++.++||||||+++|||+||. +||.........    
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~----  245 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL----  245 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH----
Confidence            999999999998765444333445567999999999999999999999999999999999984 677655432111    


Q ss_pred             HHhHHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          296 WALPLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                                  ..+.+ ......+..++..+.+|+.+||+.||++|||+.+|+++|++...
T Consensus       246 ------------~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 ------------RFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             ------------HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ------------HHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                        01111 11223345567889999999999999999999999999987643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-53  Score=389.67  Aligned_cols=250  Identities=27%  Similarity=0.376  Sum_probs=205.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC--ChhhHHHHHHHHHHHh-ccCCCccceEEeEEEeC
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN--SYQGHREWLAEVIFLG-HLSHPNLVKLIGYCCED  148 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~  148 (389)
                      ++|++.+.||+|+||+||+|+++.+.+      .||+|++....  .......+..|..++. .++||||+++++++.++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~------~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQ------FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTE------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCC------EEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            579999999999999999998766544      39999986431  1223345666777665 68999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCc
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAK  228 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~  228 (389)
                      +.+|+|||||++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhh
Confidence            99999999999999999987654  6889999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhh
Q 016481          229 DGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLL  308 (389)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (389)
                      .......  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.......   .   . +.      
T Consensus       152 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~---~-i~------  216 (320)
T d1xjda_         152 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF---H---S-IR------  216 (320)
T ss_dssp             CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H-HH------
T ss_pred             hcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH---H---H-HH------
Confidence            6543322  234468999999999999999999999999999999999999999876543211   0   0 00      


Q ss_pred             hhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 016481          309 NIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMR-DIVDS  351 (389)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~il~~  351 (389)
                       .-    ...++..++.++.+|+.+||+.||++||++. ++++|
T Consensus       217 -~~----~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         217 -MD----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             -HC----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -cC----CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence             00    1123445678899999999999999999995 78764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-52  Score=381.09  Aligned_cols=269  Identities=25%  Similarity=0.330  Sum_probs=203.4

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-hhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-QGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||+||+|++..+.+.      ||+|++...... .....+.+|+.++++++|||||++++++.++++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~------vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEV------VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCE------EEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCE------EEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            5899999999999999999987655443      999998654322 234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      +|+||||+.+ .+...+.......+++..+..++.|++.||+|||+.+  ||||||||+|||++.++.+||+|||+|+..
T Consensus        76 ~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          76 LYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             eeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceec
Confidence            9999999965 5555665555667999999999999999999999977  999999999999999999999999999765


Q ss_pred             CCCCCccccccccccccccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh--hhhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE--KKKL  307 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~  307 (389)
                      ....  .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+................+  ....
T Consensus       153 ~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         153 GVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             CCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence            4322  2233468999999999987665 478999999999999999999999876543221110000000000  0000


Q ss_pred             hhh--cCCCC----CCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          308 LNI--IDPRL----EGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       308 ~~~--~~~~~----~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ...  .....    ...   .....+.++.+|+.+||+.||++|||+.|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000  00000    000   011345788999999999999999999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-52  Score=381.96  Aligned_cols=259  Identities=24%  Similarity=0.407  Sum_probs=208.0

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe-CCeEEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-DEHRVLIY  155 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~  155 (389)
                      .++||+|+||+||+|++..+..   ....||||.+..........++.+|+.++++++||||+++++++.. ++..++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            5789999999999998765432   2345899999876667777889999999999999999999999876 46899999


Q ss_pred             EecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCCCCCC
Q 016481          156 EFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGPEGDK  235 (389)
Q Consensus       156 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~~~~~  235 (389)
                      |||++|+|.+++.... ...++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999999999876543 36788889999999999999999977  99999999999999999999999999987654322


Q ss_pred             c--cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhhhhhhhcCC
Q 016481          236 S--HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKKKLLNIIDP  313 (389)
Q Consensus       236 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (389)
                      .  .......||+.|+|||.+.+..++.++||||||+++|||++|..||.......  ....+              +..
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~--------------i~~  249 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY--------------LLQ  249 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH--------------HHT
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH--------------HHc
Confidence            2  22333678999999999999999999999999999999999888876532211  11111              111


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 016481          314 RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQV  357 (389)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~~  357 (389)
                      ......+..++.++.+|+.+||+.||++|||+.||+++|+++..
T Consensus       250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            11222344567889999999999999999999999999988854

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-52  Score=379.83  Aligned_cols=261  Identities=25%  Similarity=0.258  Sum_probs=196.0

Q ss_pred             ccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChh----hHHHHHHHHHHHhccCCCccceEEeEEEeCCeE
Q 016481           76 QDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQ----GHREWLAEVIFLGHLSHPNLVKLIGYCCEDEHR  151 (389)
Q Consensus        76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  151 (389)
                      ..++||+|+||+||+|+++.+.+      .||||++.......    ....+.+|+.+++.++|||||++++++..++++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~   75 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQ------IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   75 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCS------EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             cceEeccCcCeEEEEEEECCCCc------EEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce
Confidence            35789999999999998765443      49999986543221    124678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCCC
Q 016481          152 VLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDGP  231 (389)
Q Consensus       152 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~~  231 (389)
                      |+||||+.++++......  ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+|+...
T Consensus        76 ~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             eehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccC
Confidence            999999988776655433  336888899999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh-------
Q 016481          232 EGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-------  303 (389)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------  303 (389)
                      ....  .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...........   +......       
T Consensus       152 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~---i~~~~~~~~~~~~~  226 (299)
T d1ua2a_         152 SPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEEQWP  226 (299)
T ss_dssp             SCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTSS
T ss_pred             CCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH---HHHhcCCCChhhcc
Confidence            4322  2334689999999999875 4689999999999999999999999987654332111   1110000       


Q ss_pred             -hhhhhhhcCCCCCCCCC-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 -KKKLLNIIDPRLEGDYP-----VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 -~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       ................+     ...+.++.+|+.+||+.||++|||+.|+|+|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence             00000000000000011     1346789999999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=377.06  Aligned_cols=243  Identities=24%  Similarity=0.390  Sum_probs=197.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCCh-----hhHHHHHHHHHHHhccC--CCccceEEe
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSY-----QGHREWLAEVIFLGHLS--HPNLVKLIG  143 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~~~~  143 (389)
                      .++|++.+.||+|+||+||+|++..+.+      .||||++......     ....++.+|+.++++++  |||||++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~   76 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNL------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD   76 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCC------EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence            4689999999999999999998765544      3999987643211     11223557999999986  899999999


Q ss_pred             EEEeCCeEEEEEEecCC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-CCcEEE
Q 016481          144 YCCEDEHRVLIYEFMAR-GSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-DYNAKL  221 (389)
Q Consensus       144 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-~~~vkl  221 (389)
                      ++.+++..++||||+.+ +++.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++. ++.+||
T Consensus        77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          77 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEE
T ss_pred             EEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEE
Confidence            99999999999999986 56777765543  7899999999999999999999977  999999999999985 479999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHL-TPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPL  300 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  300 (389)
                      +|||+|+.....    ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....            .
T Consensus       153 ~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i  216 (273)
T d1xwsa_         153 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------I  216 (273)
T ss_dssp             CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------H
T ss_pred             Cccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------H
Confidence            999999865432    2334689999999999988776 5779999999999999999999975211            0


Q ss_pred             HHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          301 LKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ...            ...++...+.++.+|+.+||+.||++|||++|+++|
T Consensus       217 ~~~------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         217 IRG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             HHC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhc------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            000            011233456889999999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=375.52  Aligned_cols=266  Identities=24%  Similarity=0.340  Sum_probs=198.8

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHH--HHHHHHhccCCCccceEEeEEEeC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWL--AEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      ..+|.+.+.||+|+||.||+|++.+        ..||||++....    ...+.  .|+..+..++||||+++++++...
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~g--------~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~   69 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWRG--------EEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKD   69 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETT--------EEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEECC--------EEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeC
Confidence            4578899999999999999997532        339999986432    22333  455556678999999999999865


Q ss_pred             C----eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceecCCCCCCeEEcCCCc
Q 016481          149 E----HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA------EKPVIYRDFKTSNILLDTDYN  218 (389)
Q Consensus       149 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~ivH~Dlkp~Nili~~~~~  218 (389)
                      +    .+++|||||++|+|.+++.+.   .+++..+..++.+++.||+|||+.      .++||||||||+|||++.++.
T Consensus        70 ~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~  146 (303)
T d1vjya_          70 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             CCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence            4    689999999999999999765   688999999999999999999974      245999999999999999999


Q ss_pred             EEEeccCCCcCCCCCCCc--cccccccccccccCccccccCC------CCcccchhHHHHHHHHHHhCCCCCCCCCchhh
Q 016481          219 AKLSDFGLAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMTGH------LTPRSDVYSFGVVLLEILTGRKSLDKSRPARE  290 (389)
Q Consensus       219 vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~------~~~~~DiwslG~il~elltg~~pf~~~~~~~~  290 (389)
                      +||+|||+++........  .......||+.|+|||++.+..      ++.++|||||||++|||+||..||........
T Consensus       147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~  226 (303)
T d1vjya_         147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence            999999999876443221  1233478999999999987643      56789999999999999999988864432221


Q ss_pred             hhhH----HHHhHHHHhhhhhhhhcCCCCCCCC-----ChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 016481          291 QNLA----DWALPLLKEKKKLLNIIDPRLEGDY-----PVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPLQ  356 (389)
Q Consensus       291 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~~  356 (389)
                      ....    ........     ............     .......+.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus       227 ~~~~~~~~~~~~~~~~-----~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         227 PYYDLVPSDPSVEEMR-----KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             TTTTTSCSSCCHHHHH-----HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhhcccccchHHHHH-----HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1000    00000000     011112222222     2345677999999999999999999999999998764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=372.96  Aligned_cols=274  Identities=23%  Similarity=0.282  Sum_probs=201.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhcc---CCCccceEEeEEE
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHL---SHPNLVKLIGYCC  146 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~  146 (389)
                      .++|++.+.||+|+||+||+|++..+.     +..||||++..... ......+.+|+.+++.+   +||||+++++++.
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNG-----GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTT-----TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCC-----CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            468999999999999999999864432     23489998754321 11122345677776665   7999999999985


Q ss_pred             e-----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          147 E-----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       147 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                      .     ...++++|||+.++.+.... ......+++..+..++.|++.||+|||+++  ||||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEE
T ss_pred             ccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeee
Confidence            3     35789999999887665433 344457899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHH
Q 016481          222 SDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      +|||+++.....   .......||+.|+|||++.+..|+.++|||||||++|||++|++||....+..............
T Consensus       158 ~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         158 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            999998765332   23445789999999999999999999999999999999999999998765433211110000000


Q ss_pred             H-----hhhhhhh-hcC---CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccc
Q 016481          302 K-----EKKKLLN-IID---PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPL  355 (389)
Q Consensus       302 ~-----~~~~~~~-~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~  355 (389)
                      .     ....... ...   ......+....+..+.+|+.+||+.||++|||+.|+|+|  |+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            0     0000000 000   000111233456889999999999999999999999987  5544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-50  Score=374.65  Aligned_cols=273  Identities=23%  Similarity=0.286  Sum_probs=201.8

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||+||+|+++.+.+      .||||++.... .......+.+|+.+|+.++|||||+++++|...
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGA------KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   89 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCC------EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence            35789999999999999999998765544      39999987643 334456788999999999999999999999765


Q ss_pred             C------eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEe
Q 016481          149 E------HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLS  222 (389)
Q Consensus       149 ~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~  222 (389)
                      +      ++|+||||+ +++|...+...   .+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+|++
T Consensus        90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~  163 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKIL  163 (346)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred             ccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccc
Confidence            4      579999999 56677666443   6899999999999999999999987  9999999999999999999999


Q ss_pred             ccCCCcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH--
Q 016481          223 DFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP--  299 (389)
Q Consensus       223 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--  299 (389)
                      |||+|+.....     .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.................  
T Consensus       164 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  238 (346)
T d1cm8a_         164 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  238 (346)
T ss_dssp             CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC
Confidence            99999876432     2346799999999998764 568999999999999999999999987754432211110000  


Q ss_pred             ---HHH-----hhhhhhhhcCC---CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccCCC
Q 016481          300 ---LLK-----EKKKLLNIIDP---RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVLP  359 (389)
Q Consensus       300 ---~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~~~  359 (389)
                         ...     ........+..   ..........+.++.+|+.+||..||++|||+.++|+|  |+.+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~  311 (346)
T d1cm8a_         239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  311 (346)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence               000     00000000100   00111123456788999999999999999999999998  66665443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.8e-50  Score=367.16  Aligned_cols=267  Identities=20%  Similarity=0.239  Sum_probs=200.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||+||+|+++.       +..||+|++..... ......+.+|+.+|+.++||||+++++++..++.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNY-------GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETT-------SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeCC-------CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            589999999999999999997642       23499999876542 2234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .+++||++.++.+.......  ..+++..+..++.|++.||+|||+++  ||||||||+|||++.++.+||+|||++...
T Consensus        75 ~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             eeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceec
Confidence            99999999876655554333  47999999999999999999999977  999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH-----HHHhh
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP-----LLKEK  304 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----~~~~~  304 (389)
                      .....  ......|++.|+|||++.+. .++.++|||||||++|||++|+.||.................     .....
T Consensus       151 ~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         151 GIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence            43221  22335689999999998764 568999999999999999999999987654332111100000     00000


Q ss_pred             hhhhhhc------CCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNII------DPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .......      .+..........+..+.+|+.+||+.||++|||++|+++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000000      0000011223456789999999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=372.62  Aligned_cols=277  Identities=22%  Similarity=0.258  Sum_probs=205.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEeCC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDE-  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  149 (389)
                      +.+|++.+.||+|+||+||+|+++.+.+      .||||++...........+++|+.+|+.++||||+++++++.... 
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKV------RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCS------EEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCc------EEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            4689999999999999999998665544      399999987666666778899999999999999999999987543 


Q ss_pred             ---eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCC
Q 016481          150 ---HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGL  226 (389)
Q Consensus       150 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~  226 (389)
                         ..+++++++.+|+|.+++...   .+++..+..++.|++.||+|||+++  ||||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCc
Confidence               234445566799999998754   6899999999999999999999977  99999999999999999999999999


Q ss_pred             CcCCCCCCC-ccccccccccccccCccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh-
Q 016481          227 AKDGPEGDK-SHVSTRIMGTYGYAAPEYIM-TGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-  303 (389)
Q Consensus       227 a~~~~~~~~-~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-  303 (389)
                      +........ .......+||+.|+|||++. +..++.++||||+||++|+|++|+.||..................... 
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            987644321 12234467999999999985 456789999999999999999999999876544322221111000000 


Q ss_pred             ---------hhhhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccCC
Q 016481          304 ---------KKKLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQVL  358 (389)
Q Consensus       304 ---------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~~  358 (389)
                               ..............+   .....+.++.+|+.+||+.||++|||+.++|+|  |+.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                     000000000000000   011335689999999999999999999999998  5544443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-49  Score=362.93  Aligned_cols=269  Identities=22%  Similarity=0.248  Sum_probs=197.5

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEe--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  147 (389)
                      .++|++.+.||+|+||+||+|++..+.+      .||||++..... ......+.+|+.+|+.++||||+++++++..  
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~   82 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQ------KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   82 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCC------EEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence            3689999999999999999998765544      399999765432 3334667899999999999999999998754  


Q ss_pred             ------CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEE
Q 016481          148 ------DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKL  221 (389)
Q Consensus       148 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl  221 (389)
                            .+++++||||+.++.+....  .....+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl  158 (318)
T d3blha1          83 SPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKL  158 (318)
T ss_dssp             --------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEE
T ss_pred             ccccccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEe
Confidence                  45789999999876655433  33347899999999999999999999977  999999999999999999999


Q ss_pred             eccCCCcCCCCCCCc--cccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh
Q 016481          222 SDFGLAKDGPEGDKS--HVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       222 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  298 (389)
                      +|||++.........  ......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+..............
T Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~  238 (318)
T d3blha1         159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  238 (318)
T ss_dssp             CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999766543221  122336799999999998765 68999999999999999999999998765433222111110


Q ss_pred             HHHHhhhhhhhhc---------CCCCCCCCC-------hHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          299 PLLKEKKKLLNII---------DPRLEGDYP-------VKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       299 ~~~~~~~~~~~~~---------~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      ..  .........         .........       ...+..+.+|+.+||+.||++|||++|+++|
T Consensus       239 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         239 GS--ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CC--CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CC--CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00  000000000         000000000       1124577899999999999999999999998

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-49  Score=366.75  Aligned_cols=269  Identities=24%  Similarity=0.318  Sum_probs=198.4

Q ss_pred             CCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCccceEEeEEEe-----
Q 016481           73 NFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE-----  147 (389)
Q Consensus        73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----  147 (389)
                      +|+..++||+|+||+||+|++..+.+      .||||++..+....     .+|+.+|++++||||+++++++..     
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~------~vAiK~i~~~~~~~-----~~Ei~il~~l~h~niv~~~~~~~~~~~~~   89 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGE------LVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFFYSSGEKK   89 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCSSSC-----CHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCC------EEEEEEECccchHH-----HHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence            68899999999999999998765544      39999987654222     269999999999999999999854     


Q ss_pred             -CCeEEEEEEecCCCChhhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-cEEEecc
Q 016481          148 -DEHRVLIYEFMARGSVENNLF-SKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDF  224 (389)
Q Consensus       148 -~~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-~vkl~Df  224 (389)
                       ..++++|||||+++.+..... ......+++..+..++.|++.||+|||+++  |+||||||+|||++.++ .+||+||
T Consensus        90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCC
T ss_pred             CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecc
Confidence             336899999997654333221 123447999999999999999999999977  99999999999999775 8999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCcccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHH-----h
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMT-GHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWA-----L  298 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-----~  298 (389)
                      |++.......   ......||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...............     .
T Consensus       168 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~  244 (350)
T d1q5ka_         168 GSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR  244 (350)
T ss_dssp             TTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence            9998765433   2334689999999998875 57899999999999999999999999876543321111000     0


Q ss_pred             HHHHhh-hhhhhhcCCC-----CCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccccC
Q 016481          299 PLLKEK-KKLLNIIDPR-----LEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQV  357 (389)
Q Consensus       299 ~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~~  357 (389)
                      ...... .......-+.     +........+.++.+|+.+||+.||++|||+.|+|+|  |+.+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            000000 0000000000     0011123456789999999999999999999999987  555543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-48  Score=355.20  Aligned_cols=262  Identities=18%  Similarity=0.193  Sum_probs=197.6

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCc-cceEEeEEEeCC
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPN-LVKLIGYCCEDE  149 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~  149 (389)
                      .++|++.+.||+|+||.||+|++..+.+      .||||++......   .++..|+++++.++|+| |+.+.+++.+.+
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~------~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~   76 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGE------EVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   76 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTE------EEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCC------EEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence            4679999999999999999998765544      3999998765332   24568999999998665 555566677888


Q ss_pred             eEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC---CCcEEEeccCC
Q 016481          150 HRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT---DYNAKLSDFGL  226 (389)
Q Consensus       150 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~---~~~vkl~Dfg~  226 (389)
                      ..++||||+ +|+|...+.... ..+++..+..++.|++.||+|||+++  |+||||||+|||++.   +..+||+|||+
T Consensus        77 ~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~  152 (299)
T d1ckia_          77 YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  152 (299)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred             EEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCc
Confidence            999999999 456666554433 37899999999999999999999977  999999999999854   45799999999


Q ss_pred             CcCCCCCCCc-----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHH
Q 016481          227 AKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLL  301 (389)
Q Consensus       227 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  301 (389)
                      |+........     .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...................
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ckia_         153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  232 (299)
T ss_dssp             CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred             ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc
Confidence            9876543321     12334689999999999999999999999999999999999999998755433221111100000


Q ss_pred             HhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          302 KEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                       ..... ..        ....++.++.+|+..||+.||++||++.+|.+.|+.+
T Consensus       233 -~~~~~-~~--------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         233 -MSTPI-EV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             -HHSCH-HH--------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             -CCCCh-hH--------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence             00000 00        0123457899999999999999999999888777665

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6e-48  Score=358.51  Aligned_cols=260  Identities=17%  Similarity=0.231  Sum_probs=199.9

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEe--C
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCE--D  148 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~  148 (389)
                      ++|++.+.||+|+||+||+|++..+.+      .||+|++...    ....+.+|+.+|+.+. ||||+++++++..  .
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~------~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~  104 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNE------KVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVS  104 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCC------EEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence            589999999999999999998765444      4999998754    2356778999999996 9999999999974  4


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCC-cEEEeccCCC
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDY-NAKLSDFGLA  227 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~-~vkl~Dfg~a  227 (389)
                      ..+++||||+.+|+|....     ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++ .+||+|||+|
T Consensus       105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a  177 (328)
T d3bqca1         105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA  177 (328)
T ss_dssp             CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred             CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccc
Confidence            5799999999999987653     36899999999999999999999987  99999999999998655 6999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhH--HHHh-HHHHh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLA--DWAL-PLLKE  303 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~-~~~~~  303 (389)
                      +......   .....++|+.|+|||++.+. .|+.++|||||||++|+|++|+.||............  .... +....
T Consensus       178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~  254 (328)
T d3bqca1         178 EFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  254 (328)
T ss_dssp             EECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             eeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence            8765432   23446799999999998765 5799999999999999999999999876543322111  0000 00000


Q ss_pred             h---------hhhhhhcCC--------CCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          304 K---------KKLLNIIDP--------RLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       304 ~---------~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .         .........        ..........+.++.+||.+||+.||++|||++|+|+|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0         000000000        01111223457889999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.8e-48  Score=351.34  Aligned_cols=263  Identities=17%  Similarity=0.185  Sum_probs=205.8

Q ss_pred             HhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCC-CccceEEeEEEeC
Q 016481           70 ITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCED  148 (389)
Q Consensus        70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~  148 (389)
                      +.++|++.+.||+|+||+||+|++..+.+      .||+|++.......   .+.+|+++++.+.| +|++.+++++...
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~------~vAvK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~~   73 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQ------QVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQEG   73 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTE------EEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEccccCcH---HHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence            45789999999999999999998765544      49999986554332   34568888888874 8999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcC-----CCcEEEec
Q 016481          149 EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDT-----DYNAKLSD  223 (389)
Q Consensus       149 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~-----~~~vkl~D  223 (389)
                      ...++||||+ +|+|.+.+.... ..++...+..++.|++.||+|||+.+  |+||||||+|||++.     ++.+||+|
T Consensus        74 ~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~D  149 (293)
T d1csna_          74 LHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVD  149 (293)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             CccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcc
Confidence            9999999999 689988876543 36899999999999999999999977  999999999999964     57899999


Q ss_pred             cCCCcCCCCCCCc-----cccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHh
Q 016481          224 FGLAKDGPEGDKS-----HVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWAL  298 (389)
Q Consensus       224 fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  298 (389)
                      ||+|+........     ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+.
T Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~  229 (293)
T d1csna_         150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  229 (293)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence            9999876433211     12334689999999999999999999999999999999999999998654433222211111


Q ss_pred             HHHHhhhhhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 016481          299 PLLKEKKKLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDSLEPL  355 (389)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~L~~~  355 (389)
                      .. ........ +        ...++.++.+++..|++.+|++||+++.+.+.|+.+
T Consensus       230 ~~-~~~~~~~~-l--------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         230 EK-KQSTPLRE-L--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HH-HHHSCHHH-H--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hc-cCCCChHH-h--------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            10 00000111 1        112347799999999999999999999998887765

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-48  Score=353.07  Aligned_cols=266  Identities=23%  Similarity=0.264  Sum_probs=206.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-hhhHHHHHHHHHHHhccCCCccceEEeEEEeCCe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-YQGHREWLAEVIFLGHLSHPNLVKLIGYCCEDEH  150 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  150 (389)
                      ++|++.+.||+|+||+||+|++..+.+      .||||+++.... ......+.+|+.+++.++||||+++++++.....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHE------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCc------EEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            589999999999999999998765544      399999865543 3445778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCCcCC
Q 016481          151 RVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLAKDG  230 (389)
Q Consensus       151 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~~  230 (389)
                      .++|++++.+++|...+...  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||.++..
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcc
Confidence            99999999998887766544  37889999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHh-----h
Q 016481          231 PEGDKSHVSTRIMGTYGYAAPEYIMTGH-LTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKE-----K  304 (389)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----~  304 (389)
                      .....  ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||........... . +......     .
T Consensus       152 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~-~-~~~~~~~~~~~~~  227 (292)
T d1unla_         152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-R-IFRLLGTPTEEQW  227 (292)
T ss_dssp             CSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH-H-HHHHHCCCCTTTC
T ss_pred             cCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH-H-HHhhcCCCChhhh
Confidence            54332  223356788999999987665 68999999999999999999999755443222110 0 0000000     0


Q ss_pred             hhhhhhcC---------CCCCCCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          305 KKLLNIID---------PRLEGDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       305 ~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                      .......+         ...........+..+.+|+.+||+.||++|||++|+|+|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000000         001111233456789999999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-48  Score=361.58  Aligned_cols=265  Identities=20%  Similarity=0.258  Sum_probs=193.7

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEe--
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCE--  147 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  147 (389)
                      .++|++.++||+|+||+||+|++..+.+      .||||++.... .......+.+|+.+++.++||||++++++|..  
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~------~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~   89 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDR------NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTE------EEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCC------EEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence            3689999999999999999998765544      49999987654 33445678899999999999999999999964  


Q ss_pred             ----CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEec
Q 016481          148 ----DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSD  223 (389)
Q Consensus       148 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~D  223 (389)
                          ..++|+||||+.++ +...+.    ..+++..+..++.|++.||.|||++|  |+||||||+|||++.++.+|++|
T Consensus        90 ~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          90 TLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             STTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECC
T ss_pred             ccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeec
Confidence                36889999999765 444443    25889999999999999999999977  99999999999999999999999


Q ss_pred             cCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHH--------
Q 016481          224 FGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLAD--------  295 (389)
Q Consensus       224 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--------  295 (389)
                      ||+++......   .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+...........        
T Consensus       163 f~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~  239 (355)
T d2b1pa1         163 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_dssp             CCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             hhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence            99988654432   2344679999999999999999999999999999999999999998765433211110        


Q ss_pred             -HHhH-------HHHhhh-----hhhhhcC-CCCC--CCCChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 016481          296 -WALP-------LLKEKK-----KLLNIID-PRLE--GDYPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS  351 (389)
Q Consensus       296 -~~~~-------~~~~~~-----~~~~~~~-~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~  351 (389)
                       +...       ......     ....... ....  .......+.++.+|+.+||..||++|||+.|+|+|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             0000       000000     0000000 0000  11123457889999999999999999999999988

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=361.17  Aligned_cols=258  Identities=26%  Similarity=0.303  Sum_probs=204.3

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC---ChhhHHHHHHHHHHHhccCC-CccceEEeEEEe
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN---SYQGHREWLAEVIFLGHLSH-PNLVKLIGYCCE  147 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~  147 (389)
                      ++|++.+.||+|+||+||+|+....   ...+..||+|++....   .......+.+|+.++++++| |||+++++++.+
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISG---HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSS---TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECcc---CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            6799999999999999999975332   2234559999986432   11223456789999999976 899999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEeccCCC
Q 016481          148 DEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDFGLA  227 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a  227 (389)
                      ...+++||||+.+|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999999999987665  5678889999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccccccccCccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhHHHHhhh
Q 016481          228 KDGPEGDKSHVSTRIMGTYGYAAPEYIMTG--HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALPLLKEKK  305 (389)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
                      +........ ......|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||...........  .....     
T Consensus       177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~-----  248 (322)
T d1vzoa_         177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRI-----  248 (322)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHH-----
T ss_pred             hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhc-----
Confidence            876443222 23446899999999999765  468899999999999999999999976643321111  00000     


Q ss_pred             hhhhhcCCCCCCCCChHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 016481          306 KLLNIIDPRLEGDYPVKGVHKAAMLAYHCLNHNPKARP-----LMRDIVDS  351 (389)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~il~~  351 (389)
                           ..  .....+...+.++.+|+.+||+.||++||     |++|+++|
T Consensus       249 -----~~--~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         249 -----LK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             -----HH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -----cc--CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                 00  01223445678999999999999999999     48999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=358.73  Aligned_cols=270  Identities=22%  Similarity=0.307  Sum_probs=201.2

Q ss_pred             hcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCC-ChhhHHHHHHHHHHHhccCCCccceEEeEEEeC-
Q 016481           71 TANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDN-SYQGHREWLAEVIFLGHLSHPNLVKLIGYCCED-  148 (389)
Q Consensus        71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  148 (389)
                      .++|++.+.||+|+||+||+|++..+.+      .||||++.... .......+.+|+.+|+.++||||+++++++... 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGL------RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTE------EEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCC------EEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            5789999999999999999998765544      49999987653 334456788999999999999999999998643 


Q ss_pred             ----CeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCCCcEEEecc
Q 016481          149 ----EHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTDYNAKLSDF  224 (389)
Q Consensus       149 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~~~vkl~Df  224 (389)
                          ...+++++|+.||+|.+++...   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+|++||
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccccccccccc
Confidence                3446677788899999988543   6999999999999999999999977  999999999999999999999999


Q ss_pred             CCCcCCCCCCCccccccccccccccCccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCCchhhhhhHHHHhH----
Q 016481          225 GLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTG-HLTPRSDVYSFGVVLLEILTGRKSLDKSRPAREQNLADWALP----  299 (389)
Q Consensus       225 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----  299 (389)
                      |++.....     ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.............    
T Consensus       166 g~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         166 GLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             ----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             chhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            99876432     23446899999999987765 468999999999999999999999987654432211110000    


Q ss_pred             -HHH-----hhhhhhhhcCCCCCCC---CChHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hcccc
Q 016481          300 -LLK-----EKKKLLNIIDPRLEGD---YPVKGVHKAAMLAYHCLNHNPKARPLMRDIVDS--LEPLQ  356 (389)
Q Consensus       300 -~~~-----~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~il~~--L~~~~  356 (389)
                       ...     ........+.......   .....+.++.+||.+||+.||++|||+.|+|+|  |.++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence             000     0000000000000000   011346788999999999999999999999997  55443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-42  Score=324.32  Aligned_cols=265  Identities=18%  Similarity=0.219  Sum_probs=192.6

Q ss_pred             cCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-----------CCccce
Q 016481           72 ANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-----------HPNLVK  140 (389)
Q Consensus        72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~  140 (389)
                      ++|+++++||+|+||+||+|++..+.+.      ||||+++.+.  .....+.+|+.+++.++           |+||++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~------vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~   84 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTH------VAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   84 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCE------EEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence            4699999999999999999987655443      9999997642  33456678888888775           578999


Q ss_pred             EEeEEEe--CCeEEEEEEecCCCCh-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCeEEcCC
Q 016481          141 LIGYCCE--DEHRVLIYEFMARGSV-ENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHE-AEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       141 ~~~~~~~--~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivH~Dlkp~Nili~~~  216 (389)
                      +++++..  ....+++++++..+.. ...........+++..+..++.|++.||+|||+ .+  |+||||||+|||++.+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred             EEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeecc
Confidence            9988754  4567777777665543 333444555678999999999999999999997 66  9999999999999766


Q ss_pred             C------cEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCCchhh
Q 016481          217 Y------NAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVVLLEILTGRKSLDKSRPARE  290 (389)
Q Consensus       217 ~------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  290 (389)
                      +      .++++|||.+......     ....+||+.|+|||++.+..|+.++||||+||++++|++|+.||........
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~  237 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  237 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence            5      3999999998765332     2346799999999999999999999999999999999999999975433221


Q ss_pred             hhhHHHHhHHHH-----------hhhhhhhhcC-----CC--------------CCCCCChHHHHHHHHHHHHhhccCCC
Q 016481          291 QNLADWALPLLK-----------EKKKLLNIID-----PR--------------LEGDYPVKGVHKAAMLAYHCLNHNPK  340 (389)
Q Consensus       291 ~~~~~~~~~~~~-----------~~~~~~~~~~-----~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~  340 (389)
                      ....+.....+.           .........+     ..              .........+.++.+|+.+||.+||+
T Consensus       238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~  317 (362)
T d1q8ya_         238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  317 (362)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence            111111100000           0000000000     00              01123456788999999999999999


Q ss_pred             CCCCHHHHHHH
Q 016481          341 ARPLMRDIVDS  351 (389)
Q Consensus       341 ~Rps~~~il~~  351 (389)
                      +|||++|+|+|
T Consensus       318 ~Rpta~e~L~H  328 (362)
T d1q8ya_         318 KRADAGGLVNH  328 (362)
T ss_dssp             TCBCHHHHHTC
T ss_pred             HCcCHHHHhcC
Confidence            99999999987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=3.6e-25  Score=188.03  Aligned_cols=170  Identities=13%  Similarity=0.094  Sum_probs=116.3

Q ss_pred             CcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCC-----------------hhhHHHHHHHHHHHhccCCC
Q 016481           74 FRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNS-----------------YQGHREWLAEVIFLGHLSHP  136 (389)
Q Consensus        74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~-----------------~~~~~~~~~E~~~l~~l~h~  136 (389)
                      +.++++||+|+||+||+|.+..       +..||||+++....                 .........|...+.++.|.
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~-------g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~   74 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEK-------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL   74 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETT-------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTS
T ss_pred             chhCCEeeeCcceEEEEEECCC-------CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCC
Confidence            4568999999999999997543       23399998754211                 01112344688889999999


Q ss_pred             ccceEEeEEEeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCeEEcCC
Q 016481          137 NLVKLIGYCCEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEAEKPVIYRDFKTSNILLDTD  216 (389)
Q Consensus       137 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH~Dlkp~Nili~~~  216 (389)
                      +++..+++.    ..+++|||++++.+..         ++......++.|++.+|+|||.++  |+||||||+|||++++
T Consensus        75 ~v~~~~~~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~  139 (191)
T d1zara2          75 AVPKVYAWE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE  139 (191)
T ss_dssp             SSCCEEEEE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT
T ss_pred             CcceEEEec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC
Confidence            999887653    2379999998865443         222334678899999999999977  9999999999999865


Q ss_pred             CcEEEeccCCCcCCCCCCCccccccccccccccCccccccCCCCcccchhHHHHH
Q 016481          217 YNAKLSDFGLAKDGPEGDKSHVSTRIMGTYGYAAPEYIMTGHLTPRSDVYSFGVV  271 (389)
Q Consensus       217 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwslG~i  271 (389)
                       .++|+|||+|+..............+..    -.+ +....|+.++|+||+.--
T Consensus       140 -~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHH
Confidence             5899999999765432211100000000    001 124568899999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.64  E-value=1.3e-07  Score=82.06  Aligned_cols=147  Identities=16%  Similarity=0.094  Sum_probs=94.9

Q ss_pred             HHHHhcCCcccceecCCCceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEE
Q 016481           67 LRIITANFRQDRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYC  145 (389)
Q Consensus        67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~  145 (389)
                      +......|++.+..+.++.+.||+.....  .      .+++|+....... ....+.+|...++.+. +--+.+++.+.
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~~--~------~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~   79 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVGEN--E------NLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFE   79 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEECSS--C------EEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEeCC--C------eEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEE
Confidence            44445678777766656667899864221  1      2788886543211 1123456888877764 43467788888


Q ss_pred             EeCCeEEEEEEecCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------
Q 016481          146 CEDEHRVLIYEFMARGSVENNLFSKVLLPLPWSIRMKIAFGAAKGLAFLHEA----------------------------  197 (389)
Q Consensus       146 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------  197 (389)
                      ..++..++||++++|.++........    .   ...++.+++..++.||+.                            
T Consensus        80 ~~~~~~~lv~~~l~G~~~~~~~~~~~----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T d1j7la_          80 RHDGWSNLLMSEADGVLCSEEYEDEQ----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             EETTEEEEEEECCSSEEHHHHTTTCS----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             ecCCceEEEEEecccccccccccccc----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence            88899999999999887755432211    1   122344455555555531                            


Q ss_pred             -----------------------------CCCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          198 -----------------------------EKPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       198 -----------------------------~~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                                                   ...++|+|+.|.||++++++.+-|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                         11278999999999999876667999987653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.10  E-value=7.9e-06  Score=69.98  Aligned_cols=75  Identities=13%  Similarity=0.004  Sum_probs=49.1

Q ss_pred             eecCCCc-eEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC--CCccceEEeEEEeCCeEEEEE
Q 016481           79 VLGGGGF-GCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS--HPNLVKLIGYCCEDEHRVLIY  155 (389)
Q Consensus        79 ~lg~G~~-g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  155 (389)
                      .+..|.. +.||+......       ..+++|........    .+..|...++.+.  .-.+.+++.+..+++..++||
T Consensus        17 ~~~~G~s~~~v~r~~~~~~-------~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~   85 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGR-------PVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   85 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTS-------CCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             EcCCcccCCeEEEEEeCCC-------CEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEE
Confidence            3445543 67898753322       22888887654322    2446777777664  233677788888888999999


Q ss_pred             EecCCCChh
Q 016481          156 EFMARGSVE  164 (389)
Q Consensus       156 e~~~~gsL~  164 (389)
                      ++++|.++.
T Consensus        86 ~~i~G~~~~   94 (255)
T d1nd4a_          86 GEVPGQDLL   94 (255)
T ss_dssp             ECCSSEETT
T ss_pred             Eeeeccccc
Confidence            999887653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.97  E-value=1.3e-05  Score=73.50  Aligned_cols=79  Identities=15%  Similarity=0.076  Sum_probs=46.6

Q ss_pred             cceecCCCceEEEEeeeccccccCcCcccEEEEEecCC------CChhhHHHHHHHHHHHhccC-C--CccceEEeEEEe
Q 016481           77 DRVLGGGGFGCVYKGFISEDLREGLQPVPVAVKVHDGD------NSYQGHREWLAEVIFLGHLS-H--PNLVKLIGYCCE  147 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~  147 (389)
                      .+.||.|....||+.......+      .+++|.-...      .-.....+...|..+|+.+. +  ..+++++.+  +
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~------svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDR------ALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----C------EEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEEeCCCceEeEEEEEeCCCCe------EEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c
Confidence            4568999999999986443332      3888864321      11112223446777777663 2  345555543  4


Q ss_pred             CCeEEEEEEecCCCCh
Q 016481          148 DEHRVLIYEFMARGSV  163 (389)
Q Consensus       148 ~~~~~lv~e~~~~gsL  163 (389)
                      +...++|||++.+..+
T Consensus       103 ~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         103 TEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTTEEEECCCTTSEE
T ss_pred             CCCCEEEEeccCCccc
Confidence            5566889999977543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.07  E-value=0.0019  Score=58.61  Aligned_cols=80  Identities=19%  Similarity=0.162  Sum_probs=50.3

Q ss_pred             cceecCCCceEEEEeeecccccc-CcCcccEEEEEecCCCChhhHHHHHHHHHHHhccC-CCccceEEeEEEeCCeEEEE
Q 016481           77 DRVLGGGGFGCVYKGFISEDLRE-GLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLS-HPNLVKLIGYCCEDEHRVLI  154 (389)
Q Consensus        77 ~~~lg~G~~g~Vy~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  154 (389)
                      .+.|+.|-.-.+|++........ ......|++++......   .....+|..+++.+. +.-..++++++.  +  .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceE
Confidence            46788888899999865543221 12234477777653222   223457888888875 433456777663  2  679


Q ss_pred             EEecCCCCh
Q 016481          155 YEFMARGSV  163 (389)
Q Consensus       155 ~e~~~~gsL  163 (389)
                      +||++|.++
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.75  E-value=0.0052  Score=53.96  Aligned_cols=69  Identities=13%  Similarity=0.047  Sum_probs=42.1

Q ss_pred             ceEEEEeeeccccccCcCcccEEEEEecCCCChhhHHHHHHHHHHHhccCCCcc-----ceE--EeEEEeCCeEEEEEEe
Q 016481           85 FGCVYKGFISEDLREGLQPVPVAVKVHDGDNSYQGHREWLAEVIFLGHLSHPNL-----VKL--IGYCCEDEHRVLIYEF  157 (389)
Q Consensus        85 ~g~Vy~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~--~~~~~~~~~~~lv~e~  157 (389)
                      --.||++...+.       ..|++|+.+....  ...++..|...+..|...++     +..  -..+...+..+.++++
T Consensus        35 EN~vy~v~~~dg-------~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~  105 (325)
T d1zyla1          35 ENRVYQFQDEDR-------RRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  105 (325)
T ss_dssp             SSEEEEECCTTC-------CCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             cceeEEEEcCCC-------CEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEee
Confidence            457999864332       2399999876532  23456678888877642221     111  1133456778899999


Q ss_pred             cCCCC
Q 016481          158 MARGS  162 (389)
Q Consensus       158 ~~~gs  162 (389)
                      +.|..
T Consensus       106 ~~G~~  110 (325)
T d1zyla1         106 VGGRQ  110 (325)
T ss_dssp             CCCEE
T ss_pred             cCCcC
Confidence            98754

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.72  E-value=0.014  Score=50.55  Aligned_cols=31  Identities=29%  Similarity=0.270  Sum_probs=26.9

Q ss_pred             CCceecCCCCCCeEEcCCCcEEEeccCCCcC
Q 016481          199 KPVIYRDFKTSNILLDTDYNAKLSDFGLAKD  229 (389)
Q Consensus       199 ~~ivH~Dlkp~Nili~~~~~vkl~Dfg~a~~  229 (389)
                      .++||+|+.++||+++.+...-|+||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            4599999999999999887778999997653